Citrus Sinensis ID: 002826

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870------
Protein Sequence
MATASSPLSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHcccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccEEEEEEcccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccEEEccccccEEcccccccccccccEEEEccccccccccHHHHccccccEEccccccccccccccccccccccccccccccEEEEcccHHccccccccEEEcccccccccccHHHHHccccccEEEEEcccccccccHHHHccccccEEEccccccEEcccccccccccccEEEcccccccccccHHccccccccEEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEccccccccccHHHccccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHcccccccccccccccEEEEEEcccccEEEEEEEccccccccHHHHHHHHHHHcccccccccHHHEEccccccEEEEcccccccHHHHHccccccccHHHHHHHHHHHHHHHHccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHHHHHHccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccHHHHHHHHHHHHHHHHHHcHccccHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccEEEEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccEEEccccccEEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHHHcccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccccccccccEEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccEEEEEEccccccccccHHHHccccHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccEEEEcccccccHHHHHHHHccccEEEccccccEEEEEEcccccEEEEEEccccccccccHHHHHHHHHHHccHHHHHHHHEEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEcccccccHHHHHcHHHHEcccccccccEEEEcccccEcccHEEEEEEcccccHEHHHHEHHHHHcccccccccccccccHHHHHHHHcccccccHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccccccccccc
Coil and Loop (DISEMBL)
matassplsFLCLHLLVCLTFfaftsastekdTLLSFKAsiddsknslstwsntsnihycnwtgVTCVTTATASLTVASINLQslnlsgeisssvcelsslsnlnladnlfnqpiplhlsqcssletlnlsNNLIWVLDLsrnhiegkipesigSLVNLQVLnlgsnllsgsvpfvfGNFSELVVLDLsqnayliseipsdigkLEKLEQLFLqssgfhgvipdsfvglqslsildlsqnnltgevpqsLGSSLLKLVSFDvsqnklsgsfpngickangLVNLSLhknffngsipgsineclnlerfqvqdngfsgdfpdklwslprIKLIRAEsnrfsgaipdsISMAAQLEQVqidnnrftssipqglgsvkSLYRFsasqnsfygslppnfcdspvmsIINLSqnsisgqipelkkCRKLVSLSladnsltgeippslaelpvltyldlsdnnltgpipqgLQNLKLALFNVSfnklsgrvpyslisglpasylqgnpglcgpglsnscdenqpkhrtsgptALACVMISLAVAVGIMMVAAGFFVFHRyskkksqagvwrslffyplrvtehdlvigmdekssagnggpfgRVYILSLPSGELIAVKKLVnfgcqsskTLKTEVKTLAKIRHKNIVKVlgffhsdeSIFLIYEFLQMgslgdlicrqdFQLQWSIRLKIAIGVAQGLAYLhkdyvphllhrnvksknilldadfepkltDFALDRIVGEAAFqstmsseyalscynapeygyskkataQMDAYSFGVVLLELITGrqaeqaepaesldVVKWVRRKInitngaiqvldpkiANCYQQQMLGALEIALRCtsvmpekrpsMFEVVKALHSLSTRTSLLSIELsssqehsipl
Flexible Loop (DISEMBL)
matassplsFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLAdnsltgeippslaELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKkksqagvwrSLFFYPLRVTEHDLVIGMDekssagnggPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGrqaeqaepaesldvvkWVRRKINItngaiqvldpKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSllsielsssqehsipl
Low Complexity Region (SEG)
MATAssplsflclhllvcltffAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGvtcvttatasltvaSINLQSLNLSGEIsssvcelsslsnlnladnlfnQPIPLHLSQCssletlnlsnnlIWVLDLSRNHIEGKIPESIgslvnlqvlnlgsnllsgsvPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLavavgimmvaagFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAlhslstrtsllsielsssqehsiPL
Disordered region (IsUnstruct)
*******LSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASI******LSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCG*******************TALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDE***AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAE****AESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPE***SMFEVVKALH***********************
Disordered Region (DISOPRED)
*****SP**FLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP**********************CVMISLAVAVGIMMVAAGFFV********************PLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC*SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA**STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL************************
Disordered Region (DISEMBL)
MATASSPLSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCD**********PTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ********SLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIE***********
Disordered Region (DISPRO)
***ASSPLSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS********************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MATASSPLSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	876	2.2.26 [Sep-21-2011]
Q9FL51	872	Probably inactive leucine	yes	no	0.937	0.941	0.636	0.0
Q9SGP2	996	Receptor-like protein kin	no	no	0.925	0.814	0.350	1e-138
Q9M0G7	1013	Leucine-rich repeat recep	no	no	0.949	0.821	0.336	1e-132
C0LGX3	993	LRR receptor-like serine/	no	no	0.915	0.807	0.331	1e-129
O49545	1003	Leucine-rich repeat recep	no	no	0.929	0.811	0.327	1e-128
Q9M2Z1	1002	Leucine-rich repeat recep	no	no	0.950	0.831	0.326	1e-128
P47735	999	Receptor-like protein kin	no	no	0.941	0.825	0.339	1e-123
Q9FRS6	1029	Leucine-rich repeat recep	no	no	0.953	0.811	0.319	1e-120
Q9SYQ8	980	Receptor protein kinase C	no	no	0.929	0.830	0.319	1e-117
Q9FII5	1041	Leucine-rich repeat recep	no	no	0.899	0.756	0.309	1e-113

>sp|Q9FL51|Y5694_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g06940 OS=Arabidopsis thaliana GN=At5g06940 PE=3 SV=1

 Score = 1054 bits (2726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 543/853 (63%), Positives = 648/853 (75%), Gaps = 32/853 (3%)

Query: 30  EKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSG 89
           E   LL FKAS DD K SLS W NTS+ H+CNWTG+TC  T   +L V+SINLQSLNLSG
Sbjct: 32  ELGNLLRFKASFDDPKGSLSGWFNTSSSHHCNWTGITC--TRAPTLYVSSINLQSLNLSG 89

Query: 90  EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW------------- 136
           EIS S+C+L  L++L+L+ N FNQPIPL LS+C +LETLNLS+NLIW             
Sbjct: 90  EISDSICDLPYLTHLDLSLNFFNQPIPLQLSRCVTLETLNLSSNLIWGTIPDQISEFSSL 149

Query: 137 -VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            V+D S NH+EG IPE +G L NLQVLNLGSNLL+G VP   G  SELVVLDLS+N+YL+
Sbjct: 150 KVIDFSSNHVEGMIPEDLGLLFNLQVLNLGSNLLTGIVPPAIGKLSELVVLDLSENSYLV 209

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           SEIPS +GKL+KLEQL L  SGFHG IP SFVGL SL  LDLS NNL+GE+P+SLG SL 
Sbjct: 210 SEIPSFLGKLDKLEQLLLHRSGFHGEIPTSFVGLTSLRTLDLSLNNLSGEIPRSLGPSLK 269

Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF 315
            LVS DVSQNKLSGSFP+GIC    L+NLSLH NFF GS+P SI ECL+LER QVQ+NGF
Sbjct: 270 NLVSLDVSQNKLSGSFPSGICSGKRLINLSLHSNFFEGSLPNSIGECLSLERLQVQNNGF 329

Query: 316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK 375
           SG+FP  LW LPRIK+IRA++NRF+G +P+S+S+A+ LEQV+I NN F+  IP GLG VK
Sbjct: 330 SGEFPVVLWKLPRIKIIRADNNRFTGQVPESVSLASALEQVEIVNNSFSGEIPHGLGLVK 389

Query: 376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT 435
           SLY+FSASQN F G LPPNFCDSPV+SI+N+S N + G+IPELK C+KLVSLSLA N+ T
Sbjct: 390 SLYKFSASQNRFSGELPPNFCDSPVLSIVNISHNRLLGKIPELKNCKKLVSLSLAGNAFT 449

Query: 436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
           GEIPPSLA+L VLTYLDLSDN+LTG IPQGLQNLKLALFNVSFN LSG VP+SL+SGLPA
Sbjct: 450 GEIPPSLADLHVLTYLDLSDNSLTGLIPQGLQNLKLALFNVSFNGLSGEVPHSLVSGLPA 509

Query: 496 SYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYS 555
           S+LQGNP LCGPGL NSC  ++      G  AL   +I LA+A+   +      V +RYS
Sbjct: 510 SFLQGNPELCGPGLPNSCSSDRSNFHKKGGKALVLSLICLALAIATFLA-----VLYRYS 564

Query: 556 KKKSQ-AGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL 614
           +KK Q    WRS F+YP ++TEH+L+  ++E   +G+      VY+LSL SGEL+AVKKL
Sbjct: 565 RKKVQFKSTWRSEFYYPFKLTEHELMKVVNESCPSGS-----EVYVLSLSSGELLAVKKL 619

Query: 615 VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
           VN    SSK+LK +V+T+AKIRHKNI ++LGF   DE IFLIYEF Q GSL D++ R   
Sbjct: 620 VNSKNISSKSLKAQVRTIAKIRHKNITRILGFCFKDEMIFLIYEFTQNGSLHDMLSRAGD 679

Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE 734
           QL WSIRLKIA+GVAQ LAY+ KDYVPHLLHRN+KS NI LD DFEPKL+DFALD IVGE
Sbjct: 680 QLPWSIRLKIALGVAQALAYISKDYVPHLLHRNLKSANIFLDKDFEPKLSDFALDHIVGE 739

Query: 735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP---AES 791
            AFQS + +    SCY APE  YSKKAT  MD YSFGVVLLEL+TG+ AE+AE     ES
Sbjct: 740 TAFQSLVHANTN-SCYTAPENHYSKKATEDMDVYSFGVVLLELVTGQSAEKAEEGSSGES 798

Query: 792 LDVVKWVRRKINITNGAIQVLDPKI-ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           LD+VK VRRKIN+T+GA QVLD KI ++  Q  M   L+IAL CT+V  EKRPS+ +V+K
Sbjct: 799 LDIVKQVRRKINLTDGAAQVLDQKILSDSCQSDMRKTLDIALDCTAVAAEKRPSLVKVIK 858

Query: 851 ALHSLSTRTSLLS 863
            L  +S+  S +S
Sbjct: 859 LLEGISSSVSPVS 871

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1

 Score =  493 bits (1269), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 333/951 (35%), Positives = 485/951 (50%), Gaps = 140/951 (14%)

Query: 34  LLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISS 93
           L   K S+DD  + LS+W N+++   C W+GV+C    +   +V S++L S NL+G   S
Sbjct: 23  LQQVKLSLDDPDSYLSSW-NSNDASPCRWSGVSCAGDFS---SVTSVDLSSANLAGPFPS 78

Query: 94  SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV--------------LD 139
            +C LS+L++L+L +N  N  +PL+++ C SL+TL+LS NL+                LD
Sbjct: 79  VICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLADIPTLVHLD 138

Query: 140 LSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY------ 193
           L+ N+  G IP S G   NL+VL+L  NLL G++P   GN S L +L+LS N +      
Sbjct: 139 LTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSYNPFSPSRIP 198

Query: 194 ------------------LISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGL------ 229
                             L+ +IP  +G+L KL  L L  +   G IP S  GL      
Sbjct: 199 PEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSLGGLTNVVQI 258

Query: 230 ------------------QSLSILDLSQNNLTGEVPQSLGSSLLK--------------- 256
                             +SL +LD S N LTG++P  L    L+               
Sbjct: 259 ELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVPLESLNLYENNLEGELPA 318

Query: 257 -------------------------------LVSFDVSQNKLSGSFPNGICKANGLVNLS 285
                                          L   DVS+N+ SG  P  +C    L  L 
Sbjct: 319 SIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADLCAKGELEELL 378

Query: 286 LHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD 345
           +  N F+G IP S+ +C +L R ++  N FSG  P   W LP + L+   +N FSG I  
Sbjct: 379 IIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELVNNSFSGEISK 438

Query: 346 SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIIN 405
           SI  A+ L  + + NN FT S+P+ +GS+ +L + SAS N F GSLP +      +  ++
Sbjct: 439 SIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSLMSLGELGTLD 498

Query: 406 LSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           L  N  SG++   +K  +KL  L+LADN  TG+IP  +  L VL YLDLS N  +G IP 
Sbjct: 499 LHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLSGNMFSGKIPV 558

Query: 465 GLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCG--PGLSNSCDENQPKHRT 522
            LQ+LKL   N+S+N+LSG +P SL   +  +   GNPGLCG   GL  S  EN+ K R 
Sbjct: 559 SLQSLKLNQLNLSYNRLSGDLPPSLAKDMYKNSFIGNPGLCGDIKGLCGS--ENEAKKR- 615

Query: 523 SGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKS-QAGVWRSLFFYPLRVTEHDLVI 581
            G   L   +  LA  V +  VA  +F +  + K ++ +   W  + F+ L  +EH+++ 
Sbjct: 616 -GYVWLLRSIFVLAAMVLLAGVAWFYFKYRTFKKARAMERSKWTLMSFHKLGFSEHEILE 674

Query: 582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFG------CQSSKTLK--------- 626
            +DE +  G G   G+VY + L +GE +AVK+L          C   K  K         
Sbjct: 675 SLDEDNVIGAGAS-GKVYKVVLTNGETVAVKRLWTGSVKETGDCDPEKGYKPGVQDEAFE 733

Query: 627 TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIA 685
            EV+TL KIRHKNIVK+     + +   L+YE++  GSLGDL+   +   L W  R KI 
Sbjct: 734 AEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYMPNGSLGDLLHSSKGGMLGWQTRFKII 793

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           +  A+GL+YLH D VP ++HR++KS NIL+D D+  ++ DF + + V          S  
Sbjct: 794 LDAAEGLSYLHHDSVPPIVHRDIKSNNILIDGDYGARVADFGVAKAVDLTGKAPKSMSVI 853

Query: 746 ALSC-YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
           A SC Y APEY Y+ +   + D YSFGVV+LE++T ++    E  E  D+VKWV   ++ 
Sbjct: 854 AGSCGYIAPEYAYTLRVNEKSDIYSFGVVILEIVTRKRPVDPELGEK-DLVKWVCSTLD- 911

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
             G   V+DPK+ +C+++++   L + L CTS +P  RPSM  VVK L  +
Sbjct: 912 QKGIEHVIDPKLDSCFKEEISKILNVGLLCTSPLPINRPSMRRVVKMLQEI 962

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1

 Score =  472 bits (1215), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 328/974 (33%), Positives = 491/974 (50%), Gaps = 142/974 (14%)

Query: 30  EKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSG 89
           E   LLS K+++ D  N L  W  +    +CNWTGV C +       V  ++L  +NL+G
Sbjct: 30  ELSVLLSVKSTLVDPLNFLKDWKLSDTSDHCNWTGVRCNSNGN----VEKLDLAGMNLTG 85

Query: 90  EISSSVCELSSLSNLNLADNLFNQPIP--------LHLSQCS------------------ 123
           +IS S+ +LSSL + N++ N F   +P        + +SQ S                  
Sbjct: 86  KISDSISQLSSLVSFNISCNGFESLLPKSIPPLKSIDISQNSFSGSLFLFSNESLGLVHL 145

Query: 124 -------------------SLETLNLSNNL--------------IWVLDLSRNHIEGKIP 150
                              SLE L+L  N               +  L LS N++ G++P
Sbjct: 146 NASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELP 205

Query: 151 ESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQ 210
             +G L +L+   LG N   G +P  FGN + L  LDL+    L  EIPS++GKL+ LE 
Sbjct: 206 SVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAI-GKLSGEIPSELGKLKSLET 264

Query: 211 LFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG------------------- 251
           L L  + F G IP     + +L +LD S N LTGE+P  +                    
Sbjct: 265 LLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSI 324

Query: 252 ----SSLLKLVSF------------------------DVSQNKLSGSFPNGICKANGLVN 283
               SSL +L                           DVS N  SG  P+ +C    L  
Sbjct: 325 PPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNKGNLTK 384

Query: 284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI 343
           L L  N F G IP +++ C +L R ++Q+N  +G  P     L +++ +    NR SG I
Sbjct: 385 LILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGI 444

Query: 344 PDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSI 403
           P  IS +  L  +    N+  SS+P  + S+ +L  F  + N   G +P  F D P +S 
Sbjct: 445 PGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDCPSLSN 504

Query: 404 INLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
           ++LS N+++G IP  +  C KLVSL+L +N+LTGEIP  +  +  L  LDLS+N+LTG +
Sbjct: 505 LDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVL 564

Query: 463 PQGL-QNLKLALFNVSFNKLSGRVPYS-LISGLPASYLQGNPGLCGPGLSNSCDENQPKH 520
           P+ +  +  L L NVS+NKL+G VP +  +  +    L+GN GLCG G+   C + Q   
Sbjct: 565 PESIGTSPALELLNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCG-GVLPPCSKFQRAT 623

Query: 521 RT----SGPTALACVMISLA--VAVGIMMVAAGFFVFHRYSK-----KKSQAGV--WRSL 567
            +     G   +A  +I +A  +A+GI+ +         YS      + +  G   WR +
Sbjct: 624 SSHSSLHGKRIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLM 683

Query: 568 FFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ----SS 622
            F+ L  T  D++  + E +  G G   G VY   +  S  ++AVKKL          ++
Sbjct: 684 AFHRLGFTASDILACIKESNMIGMGAT-GIVYKAEMSRSSTVLAVKKLWRSAADIEDGTT 742

Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD----FQLQW 678
                EV  L K+RH+NIV++LGF ++D+++ ++YEF+  G+LGD I  ++      + W
Sbjct: 743 GDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDW 802

Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ 738
             R  IA+GVA GLAYLH D  P ++HR++KS NILLDA+ + ++ DF L R++  A  +
Sbjct: 803 VSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMM--ARKK 860

Query: 739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV 798
            T+S       Y APEYGY+ K   ++D YS+GVVLLEL+TGR+  + E  ES+D+V+WV
Sbjct: 861 ETVSMVAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVEWV 920

Query: 799 RRKINITNGAIQVLDPKIANC--YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
           RRKI       + LDP + NC   Q++ML  L+IAL CT+ +P+ RPSM +V+  L    
Sbjct: 921 RRKIRDNISLEEALDPNVGNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAK 980

Query: 857 TRTSLLSIELSSSQ 870
            R    S E ++S+
Sbjct: 981 PRRKSNSNEENTSR 994

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1

 Score =  464 bits (1194), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 320/964 (33%), Positives = 469/964 (48%), Gaps = 162/964 (16%)

Query: 38  KASIDDSKNSLSTWSNT-SNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVC 96
           K  + D   +L  W  T  N   CNWTG+TC     +SL V +I+L   N+SG      C
Sbjct: 36  KTRLFDPDGNLQDWVITGDNRSPCNWTGITCHIRKGSSLAVTTIDLSGYNISGGFPYGFC 95

Query: 97  ELSSLSNLNLADNLFNQPIP-LHLSQCSSLETLNLSNN--------------LIWVLDLS 141
            + +L N+ L+ N  N  I    LS CS L+ L L+ N               + VL+L 
Sbjct: 96  RIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSPEFRKLRVLELE 155

Query: 142 RNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY-------- 193
            N   G+IP+S G L  LQVLNL  N LSG VP   G  +EL  LDL+  ++        
Sbjct: 156 SNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYISFDPSPIPST 215

Query: 194 ----------------------------------------LISEIPSDIGKLEKLEQLFL 213
                                                   L  EIP  IG+LE + Q+ L
Sbjct: 216 LGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGRLESVYQIEL 275

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSF------------- 260
             +   G +P+S   L  L   D+SQNNLTGE+P+ + +  L+L+SF             
Sbjct: 276 YDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAA--LQLISFNLNDNFFTGGLPD 333

Query: 261 -----------------------------------DVSQNKLSGSFPNGICKANGLVNLS 285
                                              DVS N+ SG  P  +C    L  + 
Sbjct: 334 VVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCYRRKLQKII 393

Query: 286 LHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD 345
              N  +G IP S  +C +L   ++ DN  SG+ P + W LP  +L  A +N+  G+IP 
Sbjct: 394 TFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELPLTRLELANNNQLQGSIPP 453

Query: 346 SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIIN 405
           SIS A  L Q++I  N F+  IP  L  ++ L     S+NSF GS+P        +  + 
Sbjct: 454 SISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCINKLKNLERVE 513

Query: 406 LSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           + +N + G+IP  +  C +L  L+L++N L G IPP L +LPVL YLDLS+N LTG IP 
Sbjct: 514 MQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPA 573

Query: 465 GLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLS--NSCDENQPKHRT 522
            L  LKL  FNVS NKL G++P      +      GNP LC P L     C  ++ + R 
Sbjct: 574 ELLRLKLNQFNVSDNKLYGKIPSGFQQDIFRPSFLGNPNLCAPNLDPIRPC-RSKRETRY 632

Query: 523 SGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIG 582
             P ++ C++      V + +      +F R  K+ ++  +++ + F     TE D+   
Sbjct: 633 ILPISILCIVALTGALVWLFIKTKP--LFKRKPKRTNKITIFQRVGF-----TEEDIYPQ 685

Query: 583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKN 639
           + E +  G+GG  G VY + L SG+ +AVKKL        +S    ++EV+TL ++RH N
Sbjct: 686 LTEDNIIGSGGS-GLVYRVKLKSGQTLAVKKLWGETGQKTESESVFRSEVETLGRVRHGN 744

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-----LQWSIRLKIAIGVAQGLAY 694
           IVK+L   + +E  FL+YEF++ GSLGD++  +        L W+ R  IA+G AQGL+Y
Sbjct: 745 IVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSY 804

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----- 749
           LH D VP ++HR+VKS NILLD + +P++ DF L + +          S+ ++SC     
Sbjct: 805 LHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGV--SDVSMSCVAGSY 862

Query: 750 -YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI------ 802
            Y APEYGY+ K   + D YSFGVVLLELITG++   +   E+ D+VK+           
Sbjct: 863 GYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSP 922

Query: 803 NITNGAI------------QVLDP--KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           +  +GA+            +++DP  K++    +++   L++AL CTS  P  RP+M +V
Sbjct: 923 SAEDGAMNQDSLGNYRDLSKLVDPKMKLSTREYEEIEKVLDVALLCTSSFPINRPTMRKV 982

Query: 849 VKAL 852
           V+ L
Sbjct: 983 VELL 986

Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  461 bits (1185), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 316/966 (32%), Positives = 485/966 (50%), Gaps = 152/966 (15%)

Query: 22  FAFTSASTEKDTLLSFKASI----DDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTV 77
           F  +   +E   LLS K S+    DD  + LS+W  +++  +C W GVTC     +   V
Sbjct: 17  FTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTS--FCTWIGVTC---DVSRRHV 71

Query: 78  ASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL--- 134
            S++L  LNLSG +S  V  L  L NL+LA+NL + PIP  +S  S L  LNLSNN+   
Sbjct: 72  TSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNG 131

Query: 135 ------------IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF----- 177
                       + VLD+  N++ G +P S+ +L  L+ L+LG N  +G +P  +     
Sbjct: 132 SFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPV 191

Query: 178 --------------------------------------------GNFSELVVLDLSQNAY 193
                                                       GN SELV  D   N  
Sbjct: 192 IEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFD-GANCG 250

Query: 194 LISEIPSDIGKLEKLEQLFLQ------------------------SSGFHGVIPDSFVGL 229
           L  EIP +IGKL+KL+ LFLQ                        ++ F G IP SF  L
Sbjct: 251 LTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAEL 310

Query: 230 QSLSILD------------------------LSQNNLTGEVPQSLGSSLLKLVSFDVSQN 265
           ++L++L+                        L +NN TG +PQ LG +  KL   D+S N
Sbjct: 311 KNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGEN-GKLNLVDLSSN 369

Query: 266 KLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWS 325
           KL+G+ P  +C  N L  L    NF  GSIP S+ +C +L R ++ +N  +G  P  L+ 
Sbjct: 370 KLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFG 429

Query: 326 LPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN 385
           LP++  +  + N  SG +P +  ++  L Q+ + NN+ +  +P  +G+   + +     N
Sbjct: 430 LPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGN 489

Query: 386 SFYGSLPPNFCDSPVMSIINLSQNSISGQI-PELKKCRKLVSLSLADNSLTGEIPPSLAE 444
            F G +P        +S I+ S N  SG+I PE+ +C+ L  + L+ N L+GEIP  +  
Sbjct: 490 KFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITA 549

Query: 445 LPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS-LISGLPASYLQGNP 502
           + +L YL+LS N+L G IP  + +++ L   + S+N LSG VP +   S    +   GNP
Sbjct: 550 MKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLGNP 609

Query: 503 GLCGPGLSNSCDENQPK--HRTSGPTALACVM----------ISLAVAVGIMMVAAGFFV 550
            LCGP L   C +   K  H++     L+  M           S+A AV  ++ A     
Sbjct: 610 DLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKA----- 663

Query: 551 FHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIA 610
             R  KK S++  WR   F  L  T  D++  + E +  G GG  G VY   +P+G+L+A
Sbjct: 664 --RSLKKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGA-GIVYKGVMPNGDLVA 720

Query: 611 VKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDL 668
           VK+L  ++ G         E++TL +IRH++IV++LGF  + E+  L+YE++  GSLG++
Sbjct: 721 VKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEV 780

Query: 669 I-CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA 727
           +  ++   L W  R KIA+  A+GL YLH D  P ++HR+VKS NILLD++FE  + DF 
Sbjct: 781 LHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFG 840

Query: 728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAE 787
           L + + ++     MS+      Y APEY Y+ K   + D YSFGVVLLEL+TGR+    E
Sbjct: 841 LAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKP-VGE 899

Query: 788 PAESLDVVKWVRRKINITNGAI-QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMF 846
             + +D+V+WVR+  +    ++ +VLDP++++    ++     +A+ C      +RP+M 
Sbjct: 900 FGDGVDIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMR 959

Query: 847 EVVKAL 852
           EVV+ L
Sbjct: 960 EVVQIL 965

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1

 Score =  460 bits (1183), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 317/971 (32%), Positives = 490/971 (50%), Gaps = 138/971 (14%)

Query: 22  FAFTSASTEKDTLLSFKAS--IDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVAS 79
           F      TE   LLS K+S  ID+    L++W+ ++   +C+WTGVTC  +      V S
Sbjct: 19  FTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLSTT--FCSWTGVTCDVSLRH---VTS 73

Query: 80  INLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL----- 134
           ++L  LNLSG +SS V  L  L NL+LA N  + PIP  +S    L  LNLSNN+     
Sbjct: 74  LDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSF 133

Query: 135 ----------IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG------ 178
                     + VLDL  N++ G +P S+ +L  L+ L+LG N  SG +P  +G      
Sbjct: 134 PDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLE 193

Query: 179 -------------------------------------------NFSELVVLDLSQNAYLI 195
                                                      N SELV  D + N  L 
Sbjct: 194 YLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFD-AANCGLT 252

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVI------------------------PDSFVGLQS 231
            EIP +IGKL+KL+ LFLQ + F G I                        P SF  L++
Sbjct: 253 GEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKN 312

Query: 232 LSILDL------------------------SQNNLTGEVPQSLGSSLLKLVSFDVSQNKL 267
           L++L+L                         +NN TG +PQ LG +  +LV  D+S NKL
Sbjct: 313 LTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENG-RLVILDLSSNKL 371

Query: 268 SGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
           +G+ P  +C  N L+ L    NF  GSIP S+ +C +L R ++ +N  +G  P +L+ LP
Sbjct: 372 TGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLP 431

Query: 328 RIKLIRAESNRFSGAIPDSIS-MAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS 386
           ++  +  + N  +G +P S   ++  L Q+ + NN+ + S+P  +G++  + +     N 
Sbjct: 432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNK 491

Query: 387 FYGSLPPNFCDSPVMSIINLSQNSISGQI-PELKKCRKLVSLSLADNSLTGEIPPSLAEL 445
           F GS+PP       +S ++ S N  SG+I PE+ +C+ L  + L+ N L+G+IP  L  +
Sbjct: 492 FSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGM 551

Query: 446 PVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS-LISGLPASYLQGNPG 503
            +L YL+LS N+L G IP  + +++ L   + S+N LSG VP +   S    +   GN  
Sbjct: 552 KILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSH 611

Query: 504 LCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGV 563
           LCGP L   C +   +      +A   +++ L +    M+ A    +  R  +  S+A  
Sbjct: 612 LCGPYLG-PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKARSLRNASEAKA 670

Query: 564 WRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL--VNFGCQS 621
           WR   F  L  T  D++  + E +  G GG  G VY  ++P G+L+AVK+L  ++ G   
Sbjct: 671 WRLTAFQRLDFTCDDVLDSLKEDNIIGKGGA-GIVYKGTMPKGDLVAVKRLATMSHGSSH 729

Query: 622 SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI-CRQDFQLQWSI 680
                 E++TL +IRH++IV++LGF  + E+  L+YE++  GSLG+++  ++   L W+ 
Sbjct: 730 DHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNT 789

Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
           R KIA+  A+GL YLH D  P ++HR+VKS NILLD++FE  + DF L + + ++     
Sbjct: 790 RYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSEC 849

Query: 741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR 800
           MS+      Y APEY Y+ K   + D YSFGVVLLELITG++    E  + +D+V+WVR 
Sbjct: 850 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKP-VGEFGDGVDIVQWVRS 908

Query: 801 KINITNGAI-QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT 859
             +     + +V+D ++++    ++     +AL C      +RP+M EVV+ L      T
Sbjct: 909 MTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL------T 962

Query: 860 SLLSIELSSSQ 870
            +  I LS  Q
Sbjct: 963 EIPKIPLSKQQ 973

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1

 Score =  443 bits (1139), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 328/967 (33%), Positives = 479/967 (49%), Gaps = 142/967 (14%)

Query: 20  TFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVAS 79
           T+    S + +   L   K  + D   SLS+WS+ +++  C W GV+C  T+     V S
Sbjct: 14  TYLPSLSLNQDATILRQAKLGLSDPAQSLSSWSDNNDVTPCKWLGVSCDATSN----VVS 69

Query: 80  INLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNNLIW-- 136
           ++L S  L G   S +C L SL +L+L +N  N  +       C +L +L+LS NL+   
Sbjct: 70  VDLSSFMLVGPFPSILCHLPSLHSLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGS 129

Query: 137 -------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL 183
                         L++S N++   IP S G    L+ LNL  N LSG++P   GN + L
Sbjct: 130 IPKSLPFNLPNLKFLEISGNNLSDTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTL 189

Query: 184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT 243
             L L+ N +  S+IPS +G L +L+ L+L      G IP S   L SL  LDL+ N LT
Sbjct: 190 KELKLAYNLFSPSQIPSQLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLT 249

Query: 244 ------------------------GEVPQSLGSSLLKLVSFDVSQNKLSGSFPN------ 273
                                   GE+P+S+G ++  L  FD S NKL+G  P+      
Sbjct: 250 GSIPSWITQLKTVEQIELFNNSFSGELPESMG-NMTTLKRFDASMNKLTGKIPDNLNLLN 308

Query: 274 -----------------GICKANGLVNLSLHK------------------------NFFN 292
                             I ++  L  L L                          N F+
Sbjct: 309 LESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFS 368

Query: 293 GSIPGSI------------------------NECLNLERFQVQDNGFSGDFPDKLWSLPR 328
           G IP ++                         +C +L R ++ +N  SG  P   W LPR
Sbjct: 369 GEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPR 428

Query: 329 IKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFY 388
           + L+    N F+G+IP +I  A  L  ++I  NRF+ SIP  +GS+  +   S ++N F 
Sbjct: 429 LSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFS 488

Query: 389 GSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPV 447
           G +P +      +S ++LS+N +SG+IP EL+  + L  L+LA+N L+GEIP  +  LPV
Sbjct: 489 GEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPV 548

Query: 448 LTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP 507
           L YLDLS N  +G IP  LQNLKL + N+S+N LSG++P    + + A    GNPGLC  
Sbjct: 549 LNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYAHDFIGNPGLC-V 607

Query: 508 GLSNSCDENQPKHRTSGPTALACVMI--SLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWR 565
            L   C +            L  + +   L   VGI+M  A              A  WR
Sbjct: 608 DLDGLCRKITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWR 667

Query: 566 SLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL---VNFGCQ-- 620
           S  F+ L  +EH++   +DEK+  G G   G+VY + L  GE++AVKKL   V  G    
Sbjct: 668 S--FHKLHFSEHEIADCLDEKNVIGFGSS-GKVYKVELRGGEVVAVKKLNKSVKGGDDEY 724

Query: 621 SSKTLK-----TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLIC---RQ 672
           SS +L       EV+TL  IRHK+IV++     S +   L+YE++  GSL D++    + 
Sbjct: 725 SSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKG 784

Query: 673 DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
              L W  RL+IA+  A+GL+YLH D VP ++HR+VKS NILLD+D+  K+ DF + + V
Sbjct: 785 GVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAK-V 843

Query: 733 GEAAFQST--MSSEYALSC-YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA 789
           G+ +   T    S  A SC Y APEY Y+ +   + D YSFGVVLLEL+TG+Q   +E  
Sbjct: 844 GQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELG 903

Query: 790 ESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           +  D+ KWV   ++   G   V+DPK+   +++++   + I L CTS +P  RPSM +VV
Sbjct: 904 DK-DMAKWVCTALDKC-GLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVV 961

Query: 850 KALHSLS 856
             L  +S
Sbjct: 962 IMLQEVS 968

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1

 Score =  432 bits (1111), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 322/1009 (31%), Positives = 477/1009 (47%), Gaps = 174/1009 (17%)

Query: 13   LHLLVCLTFFAFTSAST----EKDTLLSFKASIDDSKNSLSTWSNTSN------IHYCNW 62
            L   +    F F S+ T    E++ LL+FK+ + D  N+L  W    N      + +C+W
Sbjct: 9    LFYYIGFALFPFVSSETFQNSEQEILLAFKSDLFDPSNNLQDWKRPENATTFSELVHCHW 68

Query: 63   TGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQC 122
            TGV C     A+  VA + L ++NLSG +S  +    SL  L+L++N F   +P  LS  
Sbjct: 69   TGVHC----DANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNL 124

Query: 123  SSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNL 168
            +SL+ +++S N  +               ++ S N+  G +PE +G+   L+VL+     
Sbjct: 125  TSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGY 184

Query: 169  LSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVG 228
              GSVP  F N   L  L LS N +   ++P  IG+L  LE + L  +GF G IP+ F  
Sbjct: 185  FEGSVPSSFKNLKNLKFLGLSGNNF-GGKVPKVIGELSSLETIILGYNGFMGEIPEEFGK 243

Query: 229  LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
            L  L  LDL+  NLTG++P SLG  L +L +  + QN+L+G  P  +     LV L L  
Sbjct: 244  LTRLQYLDLAVGNLTGQIPSSLGQ-LKQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSD 302

Query: 289  NFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE------------- 335
            N   G IP  + E  NL+   +  N  +G  P K+  LP ++++                
Sbjct: 303  NQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLG 362

Query: 336  -----------------------------------SNRFSGAIPDSISMAAQLEQVQIDN 360
                                               +N FSG IP+ I     L +V+I  
Sbjct: 363  KNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQK 422

Query: 361  NRFTSSIPQGLGSV---------------------------------------------- 374
            N  + SIP G G +                                              
Sbjct: 423  NHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDISFNHLSSLSSSIFS 482

Query: 375  -KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADN 432
              +L  F AS N+F G +P    D P +S+++LS N  SG IPE +    KLVSL+L  N
Sbjct: 483  SPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSN 542

Query: 433  SLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGL-QNLKLALFNVSFNKLSGRVPYS-LI 490
             L GEIP +LA + +L  LDLS+N+LTG IP  L  +  L + NVSFNKL G +P + L 
Sbjct: 543  QLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNVSFNKLDGPIPSNMLF 602

Query: 491  SGLPASYLQGNPGLCGPGLSNSCDEN---QPKHRTSGPTALA------CVMISLAVAVGI 541
            + +    L GN GLCG G+   C ++     K R  G   +        V  S+ VA+G 
Sbjct: 603  AAIDPKDLVGNNGLCG-GVLPPCSKSLALSAKGRNPGRIHVNHAVFGFIVGTSVIVAMG- 660

Query: 542  MMVAAGFFVFHRYS------------KKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSA 589
            MM  AG +++ R+             KK  +   WR + F  L  T  D++  + E +  
Sbjct: 661  MMFLAGRWIYTRWDLYSNFAREYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESNII 720

Query: 590  GNGGPFGRVYILSLPSGEL--IAVKKL------------VNFGCQSSKTLKTEVKTLAKI 635
            G G   G VY   +    L  +AVKKL             +        +  EV  L  +
Sbjct: 721  GMGA-IGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGL 779

Query: 636  RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQL---QWSIRLKIAIGVAQGL 692
            RH+NIVK+LG+ H++  + ++YE++  G+LG  +  +D +     W  R  +A+GV QGL
Sbjct: 780  RHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDEKFLLRDWLSRYNVAVGVVQGL 839

Query: 693  AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
             YLH D  P ++HR++KS NILLD++ E ++ DF L +++       T+S       Y A
Sbjct: 840  NYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMMLHK--NETVSMVAGSYGYIA 897

Query: 753  PEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
            PEYGY+ K   + D YS GVVLLEL+TG+        +S+DVV+W+RRK+       +V+
Sbjct: 898  PEYGYTLKIDEKSDIYSLGVVLLELVTGKMPIDPSFEDSIDVVEWIRRKVKKNESLEEVI 957

Query: 813  DPKIA-NCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
            D  IA +C    ++ML AL IAL CT+ +P+ RPS+ +V+  L     R
Sbjct: 958  DASIAGDCKHVIEEMLLALRIALLCTAKLPKDRPSIRDVITMLAEAKPR 1006

Involved in the regulation of procambium maintenance and polarity during vascular-tissue development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3

 Score =  422 bits (1084), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 305/956 (31%), Positives = 464/956 (48%), Gaps = 142/956 (14%)

Query: 27  ASTEKDTLLSFKASIDDSK-NSLSTWSNTSNIH-YCNWTGVTCVTTATASLTVASINLQS 84
           A T+ + LL+ K+S+   K + L  W ++S+   +C+++GV+C   A     V S+N+  
Sbjct: 24  AYTDMEVLLNLKSSMIGPKGHGLHDWIHSSSPDAHCSFSGVSCDDDAR----VISLNVSF 79

Query: 85  LNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL---------- 134
             L G IS  +  L+ L NL LA N F   +PL +   +SL+ LN+SNN           
Sbjct: 80  TPLFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEI 139

Query: 135 ------IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDL 188
                 + VLD   N+  GK+P  +  L  L+ L+ G N  SG +P  +G+   L  L L
Sbjct: 140 LKAMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGL 199

Query: 189 S-------------------------QNAY-----------------------LISEIPS 200
           +                          N+Y                       L  EIP+
Sbjct: 200 NGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPT 259

Query: 201 DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS---LGSSLL-- 255
            +  L+ L  LFL  +   G IP    GL SL  LDLS N LTGE+PQS   LG+  L  
Sbjct: 260 SLSNLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLIN 319

Query: 256 ------------------------------------------KLVSFDVSQNKLSGSFPN 273
                                                      L+  DVS N L+G  P 
Sbjct: 320 LFRNNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPK 379

Query: 274 GICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR 333
            +C+   L  L L  NFF G IP  + +C +L + ++  N  +G  P  L++LP + +I 
Sbjct: 380 DLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIE 439

Query: 334 AESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP 393
              N FSG +P ++S    L+Q+ + NN F+  IP  +G+  +L      +N F G++P 
Sbjct: 440 LTDNFFSGELPVTMS-GDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPR 498

Query: 394 NFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLD 452
              +   +S IN S N+I+G IP+ + +C  L+S+ L+ N + GEIP  +  +  L  L+
Sbjct: 499 EIFELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLN 558

Query: 453 LSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS---LISGLPASYLQGNPGLCGPG 508
           +S N LTG IP G+ N+  L   ++SFN LSGRVP     L+     +   GN  LC P 
Sbjct: 559 ISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQFLV--FNETSFAGNTYLCLPH 616

Query: 509 LSNSCDENQPKHRTSGPTAL----ACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVW 564
              SC     +      TAL      V+  +A   G+++++      ++   +KS A  W
Sbjct: 617 RV-SCPTRPGQTSDHNHTALFSPSRIVITVIAAITGLILISVAIRQMNKKKNQKSLA--W 673

Query: 565 RSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC-QSSK 623
           +   F  L     D++  + E++  G GG  G VY  S+P+   +A+K+LV  G  +S  
Sbjct: 674 KLTAFQKLDFKSEDVLECLKEENIIGKGGA-GIVYRGSMPNNVDVAIKRLVGRGTGRSDH 732

Query: 624 TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRL 682
               E++TL +IRH++IV++LG+  + ++  L+YE++  GSLG+L+   +   LQW  R 
Sbjct: 733 GFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLHGSKGGHLQWETRH 792

Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
           ++A+  A+GL YLH D  P +LHR+VKS NILLD+DFE  + DF L + + + A    MS
Sbjct: 793 RVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFLVDGAASECMS 852

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR-K 801
           S      Y APEY Y+ K   + D YSFGVVLLELI G++    E  E +D+V+WVR  +
Sbjct: 853 SIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKP-VGEFGEGVDIVRWVRNTE 911

Query: 802 INITNGA-----IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
             IT  +     + ++DP++       ++   +IA+ C       RP+M EVV  L
Sbjct: 912 EEITQPSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHML 967

Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1

 Score =  411 bits (1057), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 290/938 (30%), Positives = 448/938 (47%), Gaps = 150/938 (15%)

Query: 59  YCNWTGVTCVTTATASLTVASINLQSLNLSGEI------------------------SSS 94
           +C+W+GV C      +  V S++L   NLSG I                         +S
Sbjct: 68  WCSWSGVVC---DNVTAQVISLDLSHRNLSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTS 124

Query: 95  VCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLN-LSNNLIWVL--DLSR--------- 142
           + +L+ L+ L+++ N F+   P  +S+   L+  N  SNN   +L  D+SR         
Sbjct: 125 IFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNF 184

Query: 143 --NHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY------- 193
             ++ EG+IP + G L  L+ ++L  N+L G +P   G  +EL  +++  N +       
Sbjct: 185 GGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQHMEIGYNHFNGNIPSE 244

Query: 194 ----------------LISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL 237
                           L   +P ++G L  LE LFL  +GF G IP+S+  L+SL +LD 
Sbjct: 245 FALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGEIPESYSNLKSLKLLDF 304

Query: 238 S------------------------QNNLTGEVPQSLG---------------------- 251
           S                         NNL+GEVP+ +G                      
Sbjct: 305 SSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFLWNNNFTGVLPHK 364

Query: 252 -SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQV 310
             S  KL + DVS N  +G+ P+ +C  N L  L L  N F G +P S+  C +L RF+ 
Sbjct: 365 LGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTRCESLWRFRS 424

Query: 311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG 370
           Q+N  +G  P    SL  +  +   +NRF+  IP   + A  L+ + +  N F   +P+ 
Sbjct: 425 QNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTNFFHRKLPEN 484

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSL 429
           +    +L  FSAS ++  G + PN+        I L  NS++G IP ++  C KL+ L+L
Sbjct: 485 IWKAPNLQIFSASFSNLIGEI-PNYVGCKSFYRIELQGNSLNGTIPWDIGHCEKLLCLNL 543

Query: 430 ADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS 488
           + N L G IP  ++ LP +  +DLS N LTG IP    + K +  FNVS+N+L G +P  
Sbjct: 544 SQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYNQLIGPIPSG 603

Query: 489 LISGLPASYLQGNPGLCGPGLSNSCDENQ---------PKHRTSGP--TALACVMI-SLA 536
             + L  S+   N GLCG  +   C+ ++           H+   P  TA A V I + A
Sbjct: 604 SFAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKEERPKKTAGAIVWILAAA 663

Query: 537 VAVGIMMVAAGFFVFHRYSKKKSQAGV--------WRSLFFYPLRVTEHDLVIGMDEKSS 588
           + VG  ++ A    F +    +   G         W+   F  L  T  D+V  + +  +
Sbjct: 664 IGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDN 723

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLK------TEVKTLAKIRHKNIVK 642
               G  G VY   +P+GE+IAVKKL     ++ K  +       EV  L  +RH+NIV+
Sbjct: 724 ILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRKSGVLAEVDVLGNVRHRNIVR 783

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQL----QWSIRLKIAIGVAQGLAYLHKD 698
           +LG   + +   L+YE++  GSL DL+   D  +    +W+   +IAIGVAQG+ YLH D
Sbjct: 784 LLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHD 843

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
             P ++HR++K  NILLDADFE ++ DF + +++      S ++  Y    Y APEY Y+
Sbjct: 844 CDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESMSVVAGSYG---YIAPEYAYT 900

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
            +   + D YS+GV+LLE+ITG+++ + E  E   +V WVR K+       +VLD  +  
Sbjct: 901 LQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVRSKLKTKEDVEEVLDKSMGR 960

Query: 819 C---YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
                +++M   L IAL CTS  P  RP M +V+  L 
Sbjct: 961 SCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQ 998

Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	876
255571606	891	Receptor protein kinase CLAVATA1 precurs	0.981	0.965	0.780	0.0
359481824	887	PREDICTED: LOW QUALITY PROTEIN: probably	0.985	0.972	0.770	0.0
224139842	887	predicted protein [Populus trichocarpa]	0.993	0.980	0.751	0.0
224120192	883	predicted protein [Populus trichocarpa]	0.989	0.981	0.745	0.0
356572056	869	PREDICTED: probably inactive leucine-ric	0.952	0.959	0.738	0.0
351723505	861	protein kinase [Glycine max] gi|21271714	0.922	0.938	0.746	0.0
357509801	889	Probably inactive leucine-rich repeat re	0.992	0.977	0.694	0.0
449453830	889	PREDICTED: probably inactive leucine-ric	0.981	0.967	0.675	0.0
15240215	872	probably inactive leucine-rich repeat re	0.937	0.941	0.636	0.0
297810803	861	leucine-rich repeat family protein [Arab	0.918	0.934	0.624	0.0

>gi|255571606|ref|XP_002526749.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223533938|gb|EEF35663.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis]

 Score = 1388 bits (3593), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 684/876 (78%), Positives = 765/876 (87%), Gaps = 16/876 (1%)

Query: 13  LHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTAT 72
           L L +  T    +SASTE D L+SFKASI D KN+LS+WS+ SN+H+CNWTGVTC +T +
Sbjct: 13  LSLTLSFTLSILSSASTEADILVSFKASIQDPKNALSSWSSGSNVHHCNWTGVTCSSTPS 72

Query: 73  ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSN 132
             +TV S+NLQSLNLSGEISS++C+L++L+ LNLADNLFNQPIPLHLS+CSSL TLNLSN
Sbjct: 73  L-VTVTSLNLQSLNLSGEISSTICQLANLTVLNLADNLFNQPIPLHLSECSSLVTLNLSN 131

Query: 133 NLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG 178
           NLIW              VLD  RNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG
Sbjct: 132 NLIWGTIPDQISQFKSLEVLDFGRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG 191

Query: 179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
           NF+ LVVLDLSQNAYL+SEIPSDIGKLEKLEQLFLQSSGFHG IPDSFVGLQSL+ +DLS
Sbjct: 192 NFTRLVVLDLSQNAYLVSEIPSDIGKLEKLEQLFLQSSGFHGHIPDSFVGLQSLAFVDLS 251

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS 298
           QNNL+GE+P +LGSSL  LVSFDVSQNKLSGSF +G+C A GL+NL+LH NFFNG IP S
Sbjct: 252 QNNLSGEIPPTLGSSLKSLVSFDVSQNKLSGSFLDGVCSAQGLINLALHTNFFNGQIPTS 311

Query: 299 INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQI 358
           IN CL+LERFQVQ+N FSGDFPD+LWSL +IKLIRAE+NRFSG IPDSISMA QLEQVQI
Sbjct: 312 INACLSLERFQVQNNEFSGDFPDELWSLRKIKLIRAENNRFSGTIPDSISMAGQLEQVQI 371

Query: 359 DNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPEL 418
           DNN FTS IP+GLG VKSLYRFSAS N FYG LPPNFCDSPVMSIINLS NS+SG IPEL
Sbjct: 372 DNNSFTSKIPRGLGLVKSLYRFSASLNGFYGELPPNFCDSPVMSIINLSHNSLSGHIPEL 431

Query: 419 KKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSF 478
           KKCRKLVSLSLADNSLTGEIP SLAELPVLTYLDLSDNNLTG IPQGLQNLKLALFNVSF
Sbjct: 432 KKCRKLVSLSLADNSLTGEIPSSLAELPVLTYLDLSDNNLTGSIPQGLQNLKLALFNVSF 491

Query: 479 NKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTS-GPTALACVMISLAV 537
           N+LSGRVP +LISGLPAS+L+GNPGLCGPGL NSC E  P+H +S G +A AC +IS+A 
Sbjct: 492 NQLSGRVPPALISGLPASFLEGNPGLCGPGLPNSCSEELPRHHSSVGLSATACALISIAF 551

Query: 538 AVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGR 597
            +GI++VAA FFVFHR SK KSQ G WRS+FFYPLRVTEHDLV+ MDEK++ G+ G FGR
Sbjct: 552 GIGILLVAAAFFVFHRSSKWKSQMGGWRSVFFYPLRVTEHDLVMAMDEKTAVGSSGAFGR 611

Query: 598 VYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY 657
           +YI+SLPSGEL+AVK+LVN G Q+SK LK EVKTLAKIRHK+IVKVLGF HSDESIFLIY
Sbjct: 612 LYIISLPSGELVAVKRLVNIGSQTSKALKAEVKTLAKIRHKSIVKVLGFCHSDESIFLIY 671

Query: 658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
           E+LQ GSLGDLI + D QLQWS+RLKIAIGVAQGLAYLHKDY PHLLHRNVKSKNILLDA
Sbjct: 672 EYLQRGSLGDLIGKPDCQLQWSVRLKIAIGVAQGLAYLHKDYAPHLLHRNVKSKNILLDA 731

Query: 718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
           +FEPKLTDFALDRI+GEAAF+ST++SE A SCYNAPE GYSKKAT QMD YSFGVVLLEL
Sbjct: 732 EFEPKLTDFALDRILGEAAFRSTIASESADSCYNAPELGYSKKATEQMDVYSFGVVLLEL 791

Query: 778 ITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSV 837
           ITGRQAEQAEP ESLD+VKWVRRKINITNGA+Q+LDPKI+N +QQ+MLGAL+IA+RCTSV
Sbjct: 792 ITGRQAEQAEPTESLDIVKWVRRKINITNGAVQILDPKISNSFQQEMLGALDIAIRCTSV 851

Query: 838 MPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHS 873
           MPEKRP M EVV+ L SLS+RT L   + S+S+E S
Sbjct: 852 MPEKRPQMVEVVRGLLSLSSRTHLPHSDFSTSEESS 887

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481824|ref|XP_002283010.2| PREDICTED: LOW QUALITY PROTEIN: probably inactive leucine-rich repeat receptor-like protein kinase At5g06940-like [Vitis vinifera]

 Score = 1349 bits (3491), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 680/883 (77%), Positives = 759/883 (85%), Gaps = 20/883 (2%)

Query: 9   SFLCLHLLVCLTF--FAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVT 66
           SF    L   LTF  F   SAS+E + LL+FKASI+D    LSTWSNTS  H+CNWTGVT
Sbjct: 3   SFCTYPLFFSLTFAFFIVASASSEAEILLTFKASIEDPMKYLSTWSNTSETHHCNWTGVT 62

Query: 67  CVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLE 126
           C TT    L+V S+NLQSLNLSGEIS+S+C L +LS LNLADNLFNQPIPLHLSQCSSLE
Sbjct: 63  CTTTPP--LSVTSLNLQSLNLSGEISASLCGLHNLSYLNLADNLFNQPIPLHLSQCSSLE 120

Query: 127 TLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS 172
           TLNLSNNLIW               LD SRNH+EGKIPE+IGSL NLQVLNLGSNLLSGS
Sbjct: 121 TLNLSNNLIWGTVPEQISQFGSLRTLDFSRNHVEGKIPETIGSLKNLQVLNLGSNLLSGS 180

Query: 173 VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL 232
           VP VFGNF+EL+VLDLSQN +L+SEIP  IGKLEKL+QL LQSSGF+G IP SF GLQ L
Sbjct: 181 VPSVFGNFTELLVLDLSQNRFLVSEIPGGIGKLEKLKQLLLQSSGFYGEIPQSFAGLQGL 240

Query: 233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN 292
           +ILDLSQNNLTG VPQ+LG+SL  LVSFDVSQN L GSFP GIC+  GL+NLSLH N F+
Sbjct: 241 TILDLSQNNLTGGVPQTLGASLKNLVSFDVSQNNLLGSFPTGICRGKGLINLSLHTNSFS 300

Query: 293 GSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQ 352
           GSIP SI+ECLNLERFQVQ+NGFSGDFP+ LWSLP+IKLIRAE+NRFSG IPDSIS+AAQ
Sbjct: 301 GSIPNSISECLNLERFQVQNNGFSGDFPNGLWSLPKIKLIRAENNRFSGEIPDSISVAAQ 360

Query: 353 LEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSIS 412
           LEQVQIDNN FTS IPQGLGSV+SLYRFSAS N FYG LPPNFCDSPVMSIINLS NS+S
Sbjct: 361 LEQVQIDNNSFTSKIPQGLGSVRSLYRFSASLNGFYGELPPNFCDSPVMSIINLSHNSLS 420

Query: 413 GQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLA 472
           G IPELKKCRKLVSLSLADNSL G+IP SLAELPVLTYLDLSDNNLTG IPQ LQNLKLA
Sbjct: 421 GLIPELKKCRKLVSLSLADNSLVGQIPASLAELPVLTYLDLSDNNLTGSIPQELQNLKLA 480

Query: 473 LFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVM 532
           LFNVSFN LSG+VP+ LISGLPAS+LQGNP LCGPGL NSC +++P H+  G T LAC +
Sbjct: 481 LFNVSFNHLSGKVPFPLISGLPASFLQGNPELCGPGLPNSCYDDEPIHKAGGLTKLACAL 540

Query: 533 ISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNG 592
           ISLA+  GI+++AAGFFV +R S++KSQ GVWRS+FFYPLRVTEHDL++GMDEKS+ G+G
Sbjct: 541 ISLALGAGILIIAAGFFVIYRTSQRKSQMGVWRSVFFYPLRVTEHDLIMGMDEKSAVGSG 600

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FGRVYI+SLPSGEL+AVKKL+N G QSSK+LK EVKTLAKIRHKNIVK+LGF HS +S
Sbjct: 601 GAFGRVYIISLPSGELVAVKKLLNPGSQSSKSLKNEVKTLAKIRHKNIVKLLGFCHSSDS 660

Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           IFLIYEFLQ GSLGDLICR DFQ QWS RL+IAIGVAQGLAYLHKDYVPH+LHRN+KSKN
Sbjct: 661 IFLIYEFLQKGSLGDLICRPDFQFQWSTRLRIAIGVAQGLAYLHKDYVPHILHRNLKSKN 720

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           ILLDAD EPKLTDFALDRIVGE AFQSTM+SE A SCY APE GYSK+AT QMD YSFGV
Sbjct: 721 ILLDADLEPKLTDFALDRIVGETAFQSTMASESAFSCYIAPENGYSKRATEQMDVYSFGV 780

Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           VLLEL+TGRQAEQAE AES+D+VKWVRRKINIT+GA+QVLDPKI+N  QQ+MLGALE+AL
Sbjct: 781 VLLELVTGRQAEQAESAESIDIVKWVRRKINITDGALQVLDPKISNSSQQEMLGALEMAL 840

Query: 833 RCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELS--SSQEHS 873
           RCTSVMPEKRP+MFEVV+AL SLS++T +  +ELS  +S EHS
Sbjct: 841 RCTSVMPEKRPTMFEVVRALQSLSSKTHIPDLELSIGTSDEHS 883

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139842|ref|XP_002323303.1| predicted protein [Populus trichocarpa] gi|222867933|gb|EEF05064.1| predicted protein [Populus trichocarpa]

 Score = 1313 bits (3397), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 671/893 (75%), Positives = 756/893 (84%), Gaps = 23/893 (2%)

Query: 1   MATASSPLSFLCLHLLVCLTFFAFTSA--STEKDTLLSFKASIDDSKNSLSTWSNTSNIH 58
           MAT  +    LCL L     FF  ++A  STE D LLSFK SI D KNSLS+WSN+SN H
Sbjct: 1   MATTCTYTFALCLSL----AFFMCSTAASSTEADILLSFKDSIQDPKNSLSSWSNSSNAH 56

Query: 59  YCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLH 118
           +CNWTG+TC T+   SLTV S+NLQ+LNLSGEISSS+C+L++L  LNLADN FNQPIPLH
Sbjct: 57  HCNWTGITCSTSP--SLTVTSLNLQNLNLSGEISSSICDLTNLGLLNLADNFFNQPIPLH 114

Query: 119 LSQCSSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNL 164
           LSQCSSLE+LN+SNNLIW              VLD S+NHIEG+IPESIGSLV LQVLNL
Sbjct: 115 LSQCSSLESLNVSNNLIWGPIPDQISQFQSLRVLDFSKNHIEGRIPESIGSLVKLQVLNL 174

Query: 165 GSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPD 224
           GSNLLSGSVP VF NF+ELVVLDLSQN YL+S +PS+IGKL KLEQL LQSSGF+G IPD
Sbjct: 175 GSNLLSGSVPSVFVNFTELVVLDLSQNLYLMSGVPSEIGKLGKLEQLLLQSSGFYGQIPD 234

Query: 225 SFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL 284
           SFVGLQSL+ILDLSQNNL+G +PQ+LGSS   LVSFDVSQNKL GSFPN IC A GL NL
Sbjct: 235 SFVGLQSLTILDLSQNNLSGMIPQTLGSSSKNLVSFDVSQNKLLGSFPNDICSAPGLKNL 294

Query: 285 SLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP 344
            LH NFFNGSIP SI+EC NLERFQVQ+N FSGDFP  LWSL +IKLIRAE+NRFSGAIP
Sbjct: 295 GLHTNFFNGSIPNSISECSNLERFQVQNNEFSGDFPGGLWSLSKIKLIRAENNRFSGAIP 354

Query: 345 DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSII 404
           DS+SMAAQLEQVQIDNN FT  IP GLG VKSLYRFSAS N  YG LPPNFCDSPVMSII
Sbjct: 355 DSMSMAAQLEQVQIDNNSFTGKIPHGLGLVKSLYRFSASLNGLYGELPPNFCDSPVMSII 414

Query: 405 NLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           NLS NS+SGQIPE+KKCRKLVSLSLADNSLTGEIPPSLA+LPVLTYLDLSDNNLTG IP+
Sbjct: 415 NLSHNSLSGQIPEMKKCRKLVSLSLADNSLTGEIPPSLADLPVLTYLDLSDNNLTGSIPE 474

Query: 465 GLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTS- 523
           GLQNLKLALFNVSFN LSG VP +L+SGLPAS+L+GNP LCGPGL NSC ++ P+HR S 
Sbjct: 475 GLQNLKLALFNVSFNLLSGEVPPALVSGLPASFLEGNPHLCGPGLPNSCFDDLPRHRNSA 534

Query: 524 GPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGM 583
           G ++LAC +IS+A  +G+++VAAGFFVFHR +K KS+ G W S+FFYPLRVTEHDLV+GM
Sbjct: 535 GLSSLACALISIAFGLGVLLVAAGFFVFHRSTKWKSEMGSWHSVFFYPLRVTEHDLVMGM 594

Query: 584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           DEKSS GNGG FGRVYI+ LPS EL+AVKKLVN G QS K LK EVKTLAKIRHKNI KV
Sbjct: 595 DEKSSVGNGGAFGRVYIICLPSDELVAVKKLVNIGNQSPKALKAEVKTLAKIRHKNITKV 654

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           LGF HS+ESIFLIYE+LQ GSLGDLI R DFQLQWS RLKIAIGVAQGLAYLHK YV HL
Sbjct: 655 LGFCHSEESIFLIYEYLQKGSLGDLISRPDFQLQWSDRLKIAIGVAQGLAYLHKHYVQHL 714

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           LHRN+KS NILLDADFEPKLTDFALDRIVGEA+FQ+T++SE A SCYNAPE GY+KKAT 
Sbjct: 715 LHRNIKSTNILLDADFEPKLTDFALDRIVGEASFQTTVASESANSCYNAPECGYTKKATE 774

Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
           QMD YSFGVVLLELI GRQA++AEPA+S+D+VKWVRRKINITNGA+QVLD KI+N  QQ+
Sbjct: 775 QMDVYSFGVVLLELIAGRQADRAEPADSVDIVKWVRRKINITNGAVQVLDSKISNSSQQE 834

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL 876
           ML AL+IA+RCTSV+PEKRPSM EV++AL SL  +T +    LS+ +E+S+P+
Sbjct: 835 MLAALDIAIRCTSVLPEKRPSMLEVIRALQSLGPKTHVSDSYLSTPEENSVPV 887

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224120192|ref|XP_002330987.1| predicted protein [Populus trichocarpa] gi|222872917|gb|EEF10048.1| predicted protein [Populus trichocarpa]

 Score = 1308 bits (3385), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 665/892 (74%), Positives = 748/892 (83%), Gaps = 25/892 (2%)

Query: 1   MATASSPLSFLCLHLLVCLTFFAFTSAS-TEKDTLLSFKASIDDSKNSLSTWSNTSNIHY 59
           MAT  +    LCL     LTFF F+SAS TE D LLSFK SI D KN+LS+WS+ S +HY
Sbjct: 1   MATTCTCTFVLCL----SLTFFMFSSASSTEADVLLSFKGSIQDPKNTLSSWSSNSTVHY 56

Query: 60  CNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHL 119
           CNWTG+TC T+    LT+ S+NLQSLNLSGEISSS+CEL++L+ LNLADN FNQPIPLHL
Sbjct: 57  CNWTGITCTTSPP--LTLTSLNLQSLNLSGEISSSICELTNLALLNLADNFFNQPIPLHL 114

Query: 120 SQCSSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLG 165
           SQCSSLE+LNLSNNLIW              V DLS+NHIEG+IPES G L  LQVLNLG
Sbjct: 115 SQCSSLESLNLSNNLIWGPIPDQISQFHSLRVFDLSKNHIEGRIPESFGLLEKLQVLNLG 174

Query: 166 SNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDS 225
           SNLLSGSVP VF N +ELVVLDLSQN YL+S++PS+IGKL KLEQL LQSSGF+G IPDS
Sbjct: 175 SNLLSGSVPSVFVNLTELVVLDLSQNVYLMSDVPSEIGKLGKLEQLLLQSSGFYGQIPDS 234

Query: 226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLS 285
           FVGLQSL+ILDLSQNNL+G +PQ+L SSL  LVSFDVSQNKLSGSFPN IC A GL NL 
Sbjct: 235 FVGLQSLTILDLSQNNLSGMIPQTLVSSLKNLVSFDVSQNKLSGSFPNDICSAPGLKNLG 294

Query: 286 LHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD 345
           LH NFFNGSIP SI EC NLERFQVQ+N FSGDFP  L SL +IKL+RAE+NRFSGAIPD
Sbjct: 295 LHTNFFNGSIPNSIGECSNLERFQVQNNEFSGDFPAGLLSLSKIKLVRAENNRFSGAIPD 354

Query: 346 SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIIN 405
           S+SMA QLEQVQIDNN FT  IP  LG VKSLYRFSAS N  YG LPPNFCDSPVMSIIN
Sbjct: 355 SMSMATQLEQVQIDNNSFTGKIPHALGLVKSLYRFSASLNGLYGELPPNFCDSPVMSIIN 414

Query: 406 LSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG 465
           LS NS+SGQIP++KKCRKLVSLSLADNSL+GEIPPSLA+LPVLTYLDLS+NNLTG IPQG
Sbjct: 415 LSHNSLSGQIPKMKKCRKLVSLSLADNSLSGEIPPSLADLPVLTYLDLSNNNLTGSIPQG 474

Query: 466 LQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTS-G 524
           LQNLKLALFNVSFN+LSG VP  L+SGLPAS+L+GNPGLCGPGL NSC  + P+H    G
Sbjct: 475 LQNLKLALFNVSFNQLSGEVPPDLVSGLPASFLEGNPGLCGPGLPNSCSVDLPRHHNPVG 534

Query: 525 PTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMD 584
            +ALAC ++S+A  +GI++VAAGFFVFHR +K KS+ G W S+FFYPLRVTEHDLV+GMD
Sbjct: 535 LSALACALLSIAFGLGILLVAAGFFVFHRSTKWKSEMGGWHSVFFYPLRVTEHDLVVGMD 594

Query: 585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           EKS+ G+GG FGRVYI+SLPSGEL+AVKKLVN G QSSK LK EVKTLAKIRHKNI+KVL
Sbjct: 595 EKSAVGSGGAFGRVYIISLPSGELVAVKKLVNIGNQSSKALKAEVKTLAKIRHKNIIKVL 654

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           GF HS+ESIFLIYE+LQ GSLGDLI R DF LQWS RLKIAIGVAQGLAYLHK YVPHLL
Sbjct: 655 GFCHSEESIFLIYEYLQKGSLGDLISRADFLLQWSDRLKIAIGVAQGLAYLHKHYVPHLL 714

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HRNVKS NILLDADFEPKLTDFALDRIVGEAAFQ+T++SE A SCYNAPE GY+KKAT Q
Sbjct: 715 HRNVKSTNILLDADFEPKLTDFALDRIVGEAAFQTTIASESAYSCYNAPECGYTKKATEQ 774

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           MD YSFGVVLLELI GRQA+Q   AES+D+VKWVRRKINI NGA+QVLD KI+N  QQ+M
Sbjct: 775 MDVYSFGVVLLELIAGRQADQ---AESVDIVKWVRRKINIANGAVQVLDSKISNSSQQEM 831

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL 876
           L AL+IA+ CTSV+PEKRPSM EV +AL SL ++T L    LS+ +E+S+P+
Sbjct: 832 LAALDIAIYCTSVLPEKRPSMLEVTRALQSLGSKTHLSDSYLSTPEENSVPV 883

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356572056|ref|XP_003554186.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g06940-like [Glycine max]

 Score = 1265 bits (3274), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 629/852 (73%), Positives = 715/852 (83%), Gaps = 18/852 (2%)

Query: 39  ASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCEL 98
           ASI+DSK +LS+WSNTS+ H+CNWTG+TC TT   SL+V SINLQSLNLSG+ISSS+C+L
Sbjct: 22  ASIEDSKRALSSWSNTSSNHHCNWTGITCSTTP--SLSVTSINLQSLNLSGDISSSICDL 79

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNH 144
            +LS LNLADN+FNQPIPLHLSQCSSLETLNLS NLIW              VLDLSRNH
Sbjct: 80  PNLSYLNLADNIFNQPIPLHLSQCSSLETLNLSTNLIWGTIPSQISQFGSLRVLDLSRNH 139

Query: 145 IEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGK 204
           IEG IPESIGSL NLQVLNLGSNLLSGSVP VFGN ++L VLDLSQN YL+SEIP DIG+
Sbjct: 140 IEGNIPESIGSLKNLQVLNLGSNLLSGSVPAVFGNLTKLEVLDLSQNPYLVSEIPEDIGE 199

Query: 205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQ 264
           L  L+QL LQSS F G IPDS VG+ SL+ LDLS+NNLTG VP++L SSL  LVS DVSQ
Sbjct: 200 LGNLKQLLLQSSSFQGGIPDSLVGIVSLTHLDLSENNLTGGVPKALPSSLKNLVSLDVSQ 259

Query: 265 NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLW 324
           NKL G FP+GICK  GL+NL LH N F GSIP SI EC +LERFQVQ+NGFSGDFP  LW
Sbjct: 260 NKLLGEFPSGICKGQGLINLGLHTNAFTGSIPTSIGECKSLERFQVQNNGFSGDFPLGLW 319

Query: 325 SLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQ 384
           SLP+IKLIRAE+NRFSG IP+S+S A QLEQVQ+DNN F   IPQGLG VKSLYRFSAS 
Sbjct: 320 SLPKIKLIRAENNRFSGQIPESVSGAVQLEQVQLDNNSFAGKIPQGLGLVKSLYRFSASL 379

Query: 385 NSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAE 444
           N FYG LPPNFCDSPVMSI+NLS NS+SG+IPELKKCRKLVSLSLADNSLTG+IP SLAE
Sbjct: 380 NRFYGELPPNFCDSPVMSIVNLSHNSLSGEIPELKKCRKLVSLSLADNSLTGDIPSSLAE 439

Query: 445 LPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGL 504
           LPVLTYLDLS NNLTG IPQGLQNLKLALFNVSFN+LSG+VPYSLISGLPAS+L+GNPGL
Sbjct: 440 LPVLTYLDLSHNNLTGSIPQGLQNLKLALFNVSFNQLSGKVPYSLISGLPASFLEGNPGL 499

Query: 505 CGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVW 564
           CGPGL NSC ++ PKH     T LAC +ISLA   G  +V  G F+ +R S K  Q GVW
Sbjct: 500 CGPGLPNSCSDDMPKHHIGSITTLACALISLAFVAGTAIVVGG-FILNRRSCKSDQVGVW 558

Query: 565 RSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKT 624
           RS+FFYPLR+TEHDL+ GM+EKSS GNGG FG+VY+L+LPSGEL+AVKKLVNFG QSSK+
Sbjct: 559 RSVFFYPLRITEHDLLTGMNEKSSMGNGGIFGKVYVLNLPSGELVAVKKLVNFGNQSSKS 618

Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           LK EVKTLAKIRHKN+VK+LGF HSDES+FLIYE+L  GSL DLI   +FQLQW IRL+I
Sbjct: 619 LKAEVKTLAKIRHKNVVKILGFCHSDESVFLIYEYLHGGSLEDLISSPNFQLQWGIRLRI 678

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           AIGVAQGLAYLHKDYVPHLLHRNVKS NILLDA+FEPKLTDFALDR+VGEAAFQS ++SE
Sbjct: 679 AIGVAQGLAYLHKDYVPHLLHRNVKSSNILLDANFEPKLTDFALDRVVGEAAFQSVLNSE 738

Query: 745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
            A SCY APE GY+KKAT Q+D YSFGVVLLEL++GRQAEQ E  +SLD+VKWVRRK+NI
Sbjct: 739 AASSCYIAPENGYTKKATEQLDVYSFGVVLLELVSGRQAEQTESNDSLDIVKWVRRKVNI 798

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSI 864
           TNG  QVLDPKI++   Q+M+GAL+IAL CTSV+PEKRPSM EV++ LHSL +RT + ++
Sbjct: 799 TNGVQQVLDPKISHTCHQEMIGALDIALHCTSVVPEKRPSMVEVLRGLHSLESRTCIANL 858

Query: 865 ELSSSQEHSIPL 876
               ++E SIP+
Sbjct: 859 H-EPNEEPSIPV 869

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351723505|ref|NP_001238049.1| protein kinase [Glycine max] gi|212717141|gb|ACJ37412.1| protein kinase [Glycine max]

 Score = 1241 bits (3210), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 617/827 (74%), Positives = 700/827 (84%), Gaps = 19/827 (2%)

Query: 39  ASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCEL 98
           ASI+DSK +LS+W NTS+ H+CNWTG+TC TT   SL+V SINLQSLNLSG+ISSS+C+L
Sbjct: 22  ASIEDSKKALSSWFNTSSNHHCNWTGITCSTTP--SLSVTSINLQSLNLSGDISSSICDL 79

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNH 144
            +LS LNLADN+FNQPIPLHLSQCSSLETLNLS NLIW              VLDLSRNH
Sbjct: 80  PNLSYLNLADNIFNQPIPLHLSQCSSLETLNLSTNLIWGTIPSQISQFGSLKVLDLSRNH 139

Query: 145 IEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGK 204
           IEG IPESIGSL NLQVLNLGSNLLSGSVP VFGN ++L VLDLSQN YL+SEIP DIG+
Sbjct: 140 IEGNIPESIGSLKNLQVLNLGSNLLSGSVPAVFGNLTKLEVLDLSQNPYLVSEIPEDIGE 199

Query: 205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK-LVSFDVS 263
           L  L+QL LQSS F G IP+S VGL SL+ LDLS+NNLTG V ++L  S LK LVS DVS
Sbjct: 200 LGNLKQLLLQSSSFQGGIPESLVGLVSLTHLDLSENNLTGGVTKALQPSSLKNLVSLDVS 259

Query: 264 QNKLSGSFPNGICKANGLV-NLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDK 322
           QNKL G FP+GIC+  GL+ NLSLH N F GSIP SI EC +LERFQVQ+NGFSGDFP  
Sbjct: 260 QNKLLGPFPSGICRGQGLIINLSLHTNAFTGSIPNSIGECKSLERFQVQNNGFSGDFPIG 319

Query: 323 LWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSA 382
           LWSLP+IKLIRAE+NRFSG IP+S+S A QLEQVQ+DNN F   IPQGLG VKSLYRFSA
Sbjct: 320 LWSLPKIKLIRAENNRFSGKIPESVSGAGQLEQVQLDNNTFAGKIPQGLGLVKSLYRFSA 379

Query: 383 SQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSL 442
           S N FYG LPPNFCDSPVMSI+NLS NS+SGQIPELKKCRKLVSLSLADNSL GEIP SL
Sbjct: 380 SLNRFYGELPPNFCDSPVMSIVNLSHNSLSGQIPELKKCRKLVSLSLADNSLIGEIPSSL 439

Query: 443 AELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNP 502
           AELPVLTYLDLSDNNLTG IPQGLQNLKLALFNVSFN+LSG+VPYSLISGLPAS+L+GNP
Sbjct: 440 AELPVLTYLDLSDNNLTGSIPQGLQNLKLALFNVSFNQLSGKVPYSLISGLPASFLEGNP 499

Query: 503 GLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAG 562
            LCGPGL NSC ++ PKH     T LAC +ISLA   G  +V  GF ++ R S K  + G
Sbjct: 500 DLCGPGLPNSCSDDMPKHHIGSTTTLACALISLAFVAGTAIVVGGFILYRR-SCKGDRVG 558

Query: 563 VWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS 622
           VWRS+FFYPLR+TEHDL++GM+EKSS GNGG FG+VY+++LPSGEL+AVKKLVNFG QSS
Sbjct: 559 VWRSVFFYPLRITEHDLLMGMNEKSSRGNGGAFGKVYVVNLPSGELVAVKKLVNFGNQSS 618

Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           K+LK EVKTLAKIRHKN+VK+LGF HSDES+FLIYE+L  GSLGDLI R +FQLQW +RL
Sbjct: 619 KSLKAEVKTLAKIRHKNVVKILGFCHSDESVFLIYEYLHGGSLGDLISRPNFQLQWGLRL 678

Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
           +IAIGVAQGLAYLHKDYVPHLLHRNVKS NILL+A+FEPKLTDFALDR+VGEAAFQS ++
Sbjct: 679 RIAIGVAQGLAYLHKDYVPHLLHRNVKSSNILLEANFEPKLTDFALDRVVGEAAFQSVLN 738

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
           SE A SCY APE GYSKKAT Q+D YSFGVVLLEL++GR+AEQ E ++SLD+VKWVRRK+
Sbjct: 739 SEAASSCYIAPENGYSKKATEQLDIYSFGVVLLELVSGRKAEQTESSDSLDIVKWVRRKV 798

Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           NITNG  QVLDPKI++   Q+M+GAL+IALRCTSV+PEKRPSM EV+
Sbjct: 799 NITNGVQQVLDPKISHTCHQEMIGALDIALRCTSVVPEKRPSMVEVI 845

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357509801|ref|XP_003625189.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|124360122|gb|ABN08138.1| Protein kinase [Medicago truncatula] gi|355500204|gb|AES81407.1| Probably inactive leucine-rich repeat receptor-like protein kinase [Medicago truncatula]

 Score = 1227 bits (3175), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 622/896 (69%), Positives = 731/896 (81%), Gaps = 27/896 (3%)

Query: 1   MATASSPLSFLCLHLLVCLTF--FAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIH 58
           MAT +    F     L+ +TF  F  TS+S E DTLLSFK++I DSK +LSTWSNTS+ H
Sbjct: 1   MATTT----FCIFLFLLSITFQIFNLTSSSLEVDTLLSFKSTIQDSKKALSTWSNTSSNH 56

Query: 59  YCNWTGVTCV-TTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPL 117
           +CNWTG++C  TT + SL+V S+NLQSLNLSG+ISSS+C+L SLS LNLA+N+FNQPIPL
Sbjct: 57  FCNWTGISCSSTTPSDSLSVTSVNLQSLNLSGDISSSICDLPSLSYLNLANNIFNQPIPL 116

Query: 118 HLSQCSSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLN 163
           HLSQCSSL++LNLSNNLIW              VLDLSRNHIEG IP+S+GSL NL+VLN
Sbjct: 117 HLSQCSSLKSLNLSNNLIWGTIPSQISQFVSLSVLDLSRNHIEGNIPDSLGSLKNLEVLN 176

Query: 164 LGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIP 223
           +GSNLLSG VP VFGN ++L VLDLS N YL+SEIP D+G+L  L+QL LQ S F G +P
Sbjct: 177 MGSNLLSGDVPNVFGNLTKLEVLDLSMNPYLVSEIPEDVGELGNLKQLLLQGSSFQGEVP 236

Query: 224 DSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVN 283
           +S  GL SL+ LDLS+NNLTGEV ++L SSL+ LVSFDVSQNKL GSFPNG+CK  GL+N
Sbjct: 237 ESLKGLISLTHLDLSENNLTGEVSKTLVSSLMNLVSFDVSQNKLLGSFPNGLCKGKGLIN 296

Query: 284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI 343
           LSLH N F G IP S +EC +LERFQVQ+NGFSGDFP  L+SLP+IKLIR E+NRF+G I
Sbjct: 297 LSLHTNRFTGLIPNSTSECKSLERFQVQNNGFSGDFPIVLFSLPKIKLIRGENNRFTGKI 356

Query: 344 PDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSI 403
           P+SIS A QLEQVQ+DNN     IP GLG VKSLYRFSAS N FYG LPPNFCDSPVMSI
Sbjct: 357 PESISEAVQLEQVQLDNNLLDGKIPSGLGFVKSLYRFSASLNHFYGELPPNFCDSPVMSI 416

Query: 404 INLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP 463
           +NLS NS+SG IP+LKKC+KLVSLSLADNSLTGEIP SLAELPVLTYLDLSDNNLTG IP
Sbjct: 417 VNLSHNSLSGSIPQLKKCKKLVSLSLADNSLTGEIPNSLAELPVLTYLDLSDNNLTGSIP 476

Query: 464 QGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSC-DENQPKHRT 522
           Q LQNLKLALFNVSFN+LSG+VPY LISGLPAS+L+GN GLCGPGL NSC D+ +P H T
Sbjct: 477 QSLQNLKLALFNVSFNQLSGKVPYYLISGLPASFLEGNIGLCGPGLPNSCSDDGKPIHHT 536

Query: 523 -SGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVI 581
            SG   L C +ISLA   G ++VA+G  ++ R S K  +  VWRS+FFYPLR+TEHDLVI
Sbjct: 537 ASGLITLTCALISLAFVAGTVLVASGCILYRR-SCKGDEDAVWRSVFFYPLRITEHDLVI 595

Query: 582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIV 641
           GM+EKSS GNG  FG VY++SLPSG+L++VKKLV FG QSSK+LK EVKTLAKIRHKN+ 
Sbjct: 596 GMNEKSSIGNGD-FGNVYVVSLPSGDLVSVKKLVKFGNQSSKSLKVEVKTLAKIRHKNVA 654

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
           K+LGF HSDES+FLIYE+L  GSLGDLIC Q+FQL W IRLKIAIGVAQGLAYLHKDYVP
Sbjct: 655 KILGFCHSDESVFLIYEYLHGGSLGDLICSQNFQLHWGIRLKIAIGVAQGLAYLHKDYVP 714

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
           HL+HRN+KSKNILLD +FEPKLT FALD+IVGEAAFQST+ SE A SCY APEYGY+KKA
Sbjct: 715 HLVHRNLKSKNILLDVNFEPKLTHFALDKIVGEAAFQSTLDSEAASSCYIAPEYGYNKKA 774

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAE-SLDVVKWVRRKINITNGAIQVLDPKIANCY 820
           + Q+D YSFGVVLLEL+ GRQA+Q + ++ SLD+VKWVRRK+NITNG  QVLD + +N  
Sbjct: 775 SEQLDVYSFGVVLLELVCGRQADQKDSSDSSLDIVKWVRRKVNITNGVQQVLDTRTSNTC 834

Query: 821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL 876
            QQM+GAL+IALRCTSV+PEKRPSM EVV+ L  L +RT + +++  ++ E SIP+
Sbjct: 835 HQQMIGALDIALRCTSVVPEKRPSMLEVVRGLQFLESRTCVANLQ-GANDEPSIPV 889

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449453830|ref|XP_004144659.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g06940-like [Cucumis sativus] gi|449517277|ref|XP_004165672.1| PREDICTED: probably inactive leucine-rich repeat receptor-like protein kinase At5g06940-like [Cucumis sativus]

 Score = 1161 bits (3004), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 592/877 (67%), Positives = 711/877 (81%), Gaps = 17/877 (1%)

Query: 15  LLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATAS 74
           L +   FF    +S+E+ TLL+FKASI DS NSLS W ++S  H+CNWTG+ CVT+++ S
Sbjct: 11  LSLAFAFFILGYSSSEEPTLLTFKASIKDSTNSLSNWVSSSQTHFCNWTGIACVTSSSPS 70

Query: 75  LTVA-SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
           L    +I+LQ LNLSGEISSS+CEL  L++LNLADN FNQPIPLHLSQC SLETLNLSNN
Sbjct: 71  LLSVSAIDLQGLNLSGEISSSICELPRLAHLNLADNRFNQPIPLHLSQCRSLETLNLSNN 130

Query: 134 LIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP-FVFG 178
           LIW              VLD  +NH+EGKIPE IG+L +LQ+LNL SNL+SG+VP  VF 
Sbjct: 131 LIWGTIPDQISLFSSLRVLDFGKNHVEGKIPEGIGALKSLQILNLRSNLISGTVPSLVFH 190

Query: 179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
           N +EL+V+DLS+N+YL+SEIPS+IGKLEKLE+L L SSGF+G IP S +GL+SLS+LDLS
Sbjct: 191 NLTELLVVDLSENSYLLSEIPSEIGKLEKLEELLLHSSGFYGEIPSSLLGLRSLSVLDLS 250

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS 298
           QNNLTG++P+ LGSSL  LV FDVS+NKL GSFPNG C    LV+ S+H NFF GS+P S
Sbjct: 251 QNNLTGKIPEMLGSSLKNLVYFDVSENKLVGSFPNGFCSGKSLVSFSVHTNFFAGSLPNS 310

Query: 299 INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQI 358
           +N+CLNLERFQVQ+NGFSGDFP+ LWSLP+IKLIRAE+N FSG IP+SISMAA LEQVQ+
Sbjct: 311 LNQCLNLERFQVQNNGFSGDFPEALWSLPKIKLIRAENNGFSGEIPESISMAAHLEQVQL 370

Query: 359 DNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPEL 418
           DNN F+S IP GLGS++SLYRFS S N FYG LPPNFCDSP+MSIINLS NS+SG+IPE 
Sbjct: 371 DNNSFSSKIPWGLGSIRSLYRFSVSLNRFYGELPPNFCDSPLMSIINLSHNSLSGRIPEP 430

Query: 419 KKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSF 478
           K C+KLVSLSLA NSLTG IP SLA LPVLTYLDLSDNNLTG IPQGL+NLKLALFNVSF
Sbjct: 431 KNCKKLVSLSLAGNSLTGGIPTSLANLPVLTYLDLSDNNLTGSIPQGLENLKLALFNVSF 490

Query: 479 NKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVA 538
           N+LSG VP+SLISGLPAS+LQGNP LCGPGL   C    P +   G   + C +ISLA  
Sbjct: 491 NRLSGSVPFSLISGLPASFLQGNPDLCGPGLQTPCPHGHPTNHMYGLNKMTCALISLACV 550

Query: 539 VGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRV 598
           +G++ +AAGF +++R  + KS+   W S++FYPLR++EH+LV+GM+EK++ G GG FG+V
Sbjct: 551 LGVLSLAAGFILYYRSYRPKSRLDNWHSVYFYPLRISEHELVMGMNEKTAQGCGGAFGQV 610

Query: 599 YILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE 658
           +ILSLPS ELIAVKKL+NFG +S K+LK E+KTLAKIRHKNI+K+LGF HSD++IFLIYE
Sbjct: 611 FILSLPSRELIAVKKLINFGRRSWKSLKAEIKTLAKIRHKNIIKILGFCHSDDAIFLIYE 670

Query: 659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD 718
           FL  GSL DLICR D  L W++RL+IAI VAQGLAY+HKDYVPHLLHRNVKS NILLDAD
Sbjct: 671 FLHKGSLADLICRNDSCLNWNVRLRIAIEVAQGLAYIHKDYVPHLLHRNVKSSNILLDAD 730

Query: 719 FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
           F PKLTDFAL  IVGE+AF ST++SE + SCY APEY Y+KKAT QMD YSFGVVLLEL+
Sbjct: 731 FVPKLTDFALHHIVGESAFHSTVASESSHSCYIAPEYKYNKKATEQMDVYSFGVVLLELL 790

Query: 779 TGRQAEQAEPAE-SLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSV 837
           TGRQAE++E  E SLDVV+WVRRK+NITNGA QVLDP ++   QQQML AL+IAL+CTS+
Sbjct: 791 TGRQAERSESTEDSLDVVQWVRRKVNITNGASQVLDPSVSEHCQQQMLEALDIALQCTSL 850

Query: 838 MPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSI 874
           MPEKRPSM EV KAL  + + T+L       +++ S+
Sbjct: 851 MPEKRPSMLEVAKALQLIGSTTNLQDATFLGAEDSSV 887

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15240215|ref|NP_196311.1| probably inactive leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|75171405|sp|Q9FL51.1|Y5694_ARATH RecName: Full=Probably inactive leucine-rich repeat receptor-like protein kinase At5g06940; Flags: Precursor gi|9759550|dbj|BAB11152.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|332003701|gb|AED91084.1| probably inactive leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana]

 Score = 1054 bits (2726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 543/853 (63%), Positives = 648/853 (75%), Gaps = 32/853 (3%)

Query: 30  EKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSG 89
           E   LL FKAS DD K SLS W NTS+ H+CNWTG+TC  T   +L V+SINLQSLNLSG
Sbjct: 32  ELGNLLRFKASFDDPKGSLSGWFNTSSSHHCNWTGITC--TRAPTLYVSSINLQSLNLSG 89

Query: 90  EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW------------- 136
           EIS S+C+L  L++L+L+ N FNQPIPL LS+C +LETLNLS+NLIW             
Sbjct: 90  EISDSICDLPYLTHLDLSLNFFNQPIPLQLSRCVTLETLNLSSNLIWGTIPDQISEFSSL 149

Query: 137 -VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            V+D S NH+EG IPE +G L NLQVLNLGSNLL+G VP   G  SELVVLDLS+N+YL+
Sbjct: 150 KVIDFSSNHVEGMIPEDLGLLFNLQVLNLGSNLLTGIVPPAIGKLSELVVLDLSENSYLV 209

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           SEIPS +GKL+KLEQL L  SGFHG IP SFVGL SL  LDLS NNL+GE+P+SLG SL 
Sbjct: 210 SEIPSFLGKLDKLEQLLLHRSGFHGEIPTSFVGLTSLRTLDLSLNNLSGEIPRSLGPSLK 269

Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF 315
            LVS DVSQNKLSGSFP+GIC    L+NLSLH NFF GS+P SI ECL+LER QVQ+NGF
Sbjct: 270 NLVSLDVSQNKLSGSFPSGICSGKRLINLSLHSNFFEGSLPNSIGECLSLERLQVQNNGF 329

Query: 316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK 375
           SG+FP  LW LPRIK+IRA++NRF+G +P+S+S+A+ LEQV+I NN F+  IP GLG VK
Sbjct: 330 SGEFPVVLWKLPRIKIIRADNNRFTGQVPESVSLASALEQVEIVNNSFSGEIPHGLGLVK 389

Query: 376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT 435
           SLY+FSASQN F G LPPNFCDSPV+SI+N+S N + G+IPELK C+KLVSLSLA N+ T
Sbjct: 390 SLYKFSASQNRFSGELPPNFCDSPVLSIVNISHNRLLGKIPELKNCKKLVSLSLAGNAFT 449

Query: 436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
           GEIPPSLA+L VLTYLDLSDN+LTG IPQGLQNLKLALFNVSFN LSG VP+SL+SGLPA
Sbjct: 450 GEIPPSLADLHVLTYLDLSDNSLTGLIPQGLQNLKLALFNVSFNGLSGEVPHSLVSGLPA 509

Query: 496 SYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYS 555
           S+LQGNP LCGPGL NSC  ++      G  AL   +I LA+A+   +      V +RYS
Sbjct: 510 SFLQGNPELCGPGLPNSCSSDRSNFHKKGGKALVLSLICLALAIATFLA-----VLYRYS 564

Query: 556 KKKSQ-AGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL 614
           +KK Q    WRS F+YP ++TEH+L+  ++E   +G+      VY+LSL SGEL+AVKKL
Sbjct: 565 RKKVQFKSTWRSEFYYPFKLTEHELMKVVNESCPSGS-----EVYVLSLSSGELLAVKKL 619

Query: 615 VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
           VN    SSK+LK +V+T+AKIRHKNI ++LGF   DE IFLIYEF Q GSL D++ R   
Sbjct: 620 VNSKNISSKSLKAQVRTIAKIRHKNITRILGFCFKDEMIFLIYEFTQNGSLHDMLSRAGD 679

Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE 734
           QL WSIRLKIA+GVAQ LAY+ KDYVPHLLHRN+KS NI LD DFEPKL+DFALD IVGE
Sbjct: 680 QLPWSIRLKIALGVAQALAYISKDYVPHLLHRNLKSANIFLDKDFEPKLSDFALDHIVGE 739

Query: 735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP---AES 791
            AFQS + +    SCY APE  YSKKAT  MD YSFGVVLLEL+TG+ AE+AE     ES
Sbjct: 740 TAFQSLVHANTN-SCYTAPENHYSKKATEDMDVYSFGVVLLELVTGQSAEKAEEGSSGES 798

Query: 792 LDVVKWVRRKINITNGAIQVLDPKI-ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           LD+VK VRRKIN+T+GA QVLD KI ++  Q  M   L+IAL CT+V  EKRPS+ +V+K
Sbjct: 799 LDIVKQVRRKINLTDGAAQVLDQKILSDSCQSDMRKTLDIALDCTAVAAEKRPSLVKVIK 858

Query: 851 ALHSLSTRTSLLS 863
            L  +S+  S +S
Sbjct: 859 LLEGISSSVSPVS 871

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297810803|ref|XP_002873285.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297319122|gb|EFH49544.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata]

 Score = 1014 bits (2621), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 529/847 (62%), Positives = 633/847 (74%), Gaps = 42/847 (4%)

Query: 30  EKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSG 89
           E   LL FKASIDD K SLS W NTS+ H+CNWTG+TC  T   SL V+SINLQSLNLSG
Sbjct: 31  ELGNLLRFKASIDDPKGSLSGWLNTSSSHHCNWTGITC--TRAPSLYVSSINLQSLNLSG 88

Query: 90  EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW------------- 136
           EIS S+C+L  L++L+L+ N FNQPIPLHLS+C +LETLNLS+NLIW             
Sbjct: 89  EISDSICDLPYLTHLDLSLNFFNQPIPLHLSRCLTLETLNLSSNLIWGTIPDQISEFSSL 148

Query: 137 -VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            VLD S NH+EGKIPE +G L NLQVLNLGSNLL+G VP   G  SELVVLDLS N+YL+
Sbjct: 149 KVLDFSSNHVEGKIPEDLGLLFNLQVLNLGSNLLTGIVPSAIGKLSELVVLDLSANSYLV 208

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           SEIPS IGKL+KLEQL L  SGFHG IP SFVGL SL  LDL  NNL+GE+P+S+G SL 
Sbjct: 209 SEIPSFIGKLDKLEQLLLHRSGFHGEIPSSFVGLTSLKTLDLCLNNLSGEIPRSVGPSLK 268

Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF 315
            LVS DVS NKLSGSFP+GIC    L+NLSLH NFF GS+P SI ECL+LE FQVQ+NGF
Sbjct: 269 NLVSLDVSHNKLSGSFPSGICSGKRLINLSLHSNFFEGSLPNSIGECLSLEMFQVQNNGF 328

Query: 316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK 375
           SG+FP  LW LP+IK+IRA++NRF+G +PDS+S+A+ LEQV+IDNN F+  IP GLG VK
Sbjct: 329 SGEFPVVLWKLPKIKIIRADNNRFTGQVPDSVSLASALEQVEIDNNSFSGEIPHGLGLVK 388

Query: 376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT 435
           SLY+FSAS+N F G LPPNFCDSPV+SI+N+S N + G+IPELK C+KLVSLSLA N+ T
Sbjct: 389 SLYKFSASENGFGGELPPNFCDSPVLSIVNISHNRLLGKIPELKNCKKLVSLSLAGNAFT 448

Query: 436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
           GE+PPSLA+L VLTYLDLSDN+LTG IP  LQNLKLALFNVSFN+LSG VP+SL+SGLPA
Sbjct: 449 GEVPPSLADLHVLTYLDLSDNSLTGLIPPDLQNLKLALFNVSFNRLSGEVPHSLVSGLPA 508

Query: 496 SYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYS 555
           S+LQGNP LCGPGL N C  ++      G  AL      LA+    + +A    V +RYS
Sbjct: 509 SFLQGNPELCGPGLPNFCSSDRSSFHKKGGKALV-----LALICLALAIATLLAVLYRYS 563

Query: 556 KKKSQ-AGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL 614
           +KK Q    WRS F+YPL++TEH+L+  ++E  S         VY+LSL SGELIAVKKL
Sbjct: 564 RKKVQFKSTWRSEFYYPLKLTEHELMKVVNECPSG------SEVYVLSLSSGELIAVKKL 617

Query: 615 VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
           VN    SSK LK +V+T+AKIRHKNI ++LGF  +DE IFLIYEF Q GSL D++ R   
Sbjct: 618 VNSKNISSKALKAQVRTIAKIRHKNITRILGFCFTDELIFLIYEFTQNGSLHDILSRPGD 677

Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE 734
           +L WSIRLKIA+GVAQ LAY+ KDYVPHLLHRN+KS NILLD DFEPKL+DFALD IVGE
Sbjct: 678 RLPWSIRLKIALGVAQALAYISKDYVPHLLHRNLKSANILLDKDFEPKLSDFALDHIVGE 737

Query: 735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDV 794
            AFQS + +  + SCY APE  YSKKAT  MD Y            ++ E+    ESLD+
Sbjct: 738 TAFQSLVHAN-SNSCYTAPENNYSKKATEDMDVY------------KEVEEGASRESLDI 784

Query: 795 VKWVRRKINITNGAIQVLDPKI-ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
           VK VRRKIN+T+GA QVLD KI ++  Q +ML  L++AL CT+V  EKRPS+ +V+KAL 
Sbjct: 785 VKQVRRKINLTDGAGQVLDQKILSDSCQSEMLKTLDVALDCTAVAAEKRPSLVQVIKALE 844

Query: 854 SLSTRTS 860
            +S+  S
Sbjct: 845 GISSSVS 851

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	876
TAIR|locus:2169384	872	AT5G06940 [Arabidopsis thalian	0.929	0.933	0.589	4e-248
TAIR|locus:2168907	966	XIP1 "XYLEM INTERMIXED WITH PH	0.320	0.290	0.419	1.5e-116
TAIR|locus:2139885	1013	AT4G28650 [Arabidopsis thalian	0.539	0.466	0.329	2.3e-116
TAIR|locus:2169975	993	HSL2 "HAESA-like 2" [Arabidops	0.735	0.648	0.366	1.7e-113
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.799	0.700	0.371	2.1e-113
TAIR|locus:2032553	996	HSL1 "HAESA-like 1" [Arabidops	0.802	0.705	0.363	4.2e-111
TAIR|locus:2024432	977	LRR XI-23 [Arabidopsis thalian	0.799	0.716	0.352	1.3e-107
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.799	0.697	0.339	4.6e-105
TAIR|locus:2180617	1005	AT5G25930 [Arabidopsis thalian	0.801	0.698	0.345	2.9e-103
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.805	0.704	0.331	4.7e-103

TAIR|locus:2169384 AT5G06940 [Arabidopsis thaliana (taxid:3702)]

 Score = 2390 (846.4 bits), Expect = 4.0e-248, P = 4.0e-248
 Identities = 499/847 (58%), Positives = 588/847 (69%)

Query:    23 AFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGXXXXXXXXXXXXXXSINL 82
             +FT  + E   LL FKAS DD K SLS W NTS+ H+CNWTG              SINL
Sbjct:    26 SFTE-NEELGNLLRFKASFDDPKGSLSGWFNTSSSHHCNWTGITCTRAPTLYVS--SINL 82

Query:    83 QSLNLSGEIXXXXXXXXXXXXXXXXXXXXXQPIPLHLSQCXXXXXXXXXXXXIW------ 136
             QSLNLSGEI                     QPIPL LS+C            IW      
Sbjct:    83 QSLNLSGEISDSICDLPYLTHLDLSLNFFNQPIPLQLSRCVTLETLNLSSNLIWGTIPDQ 142

Query:   137 --------VLDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDL 188
                     V+D S NH+EG IPE +                    P   G  SELVVLDL
Sbjct:   143 ISEFSSLKVIDFSSNHVEGMIPEDLGLLFNLQVLNLGSNLLTGIVPPAIGKLSELVVLDL 202

Query:   189 SQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ 248
             S+N+YL+SEIPS +GKL+KLEQL L  SGFHG IP SFVGL SL  LDLS NNL+GE+P+
Sbjct:   203 SENSYLVSEIPSFLGKLDKLEQLLLHRSGFHGEIPTSFVGLTSLRTLDLSLNNLSGEIPR 262

Query:   249 SLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERF 308
             SLG SL  LVS DVSQNKLSGSFP+GIC    L+NLSLH NFF GS+P SI ECL+LER 
Sbjct:   263 SLGPSLKNLVSLDVSQNKLSGSFPSGICSGKRLINLSLHSNFFEGSLPNSIGECLSLERL 322

Query:   309 QVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP 368
             QVQ+NGFSG+FP  LW LPRIK+IRA++NRF+G +P+S+S+A+ LEQV+I NN F+  IP
Sbjct:   323 QVQNNGFSGEFPVVLWKLPRIKIIRADNNRFTGQVPESVSLASALEQVEIVNNSFSGEIP 382

Query:   369 QGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLS 428
              GLG VKSLY+FSASQN F G LPPNFCDSPV+SI+N+S N + G+IPELK C+KLVSLS
Sbjct:   383 HGLGLVKSLYKFSASQNRFSGELPPNFCDSPVLSIVNISHNRLLGKIPELKNCKKLVSLS 442

Query:   429 LADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYS 488
             LA N+ TGEIPPSLA+L VLTYLDLSDN+LTG IPQGLQNLKLALFNVSFN LSG VP+S
Sbjct:   443 LAGNAFTGEIPPSLADLHVLTYLDLSDNSLTGLIPQGLQNLKLALFNVSFNGLSGEVPHS 502

Query:   489 LISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXF 548
             L+SGLPAS+LQGNP LCGPGL NSC  ++      G  AL   +I L             
Sbjct:   503 LVSGLPASFLQGNPELCGPGLPNSCSSDRSNFHKKGGKALVLSLICLALAIATFLA---- 558

Query:   549 FVFHRYSKKKSQ-AGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGE 607
              V +RYS+KK Q    WRS F+YP ++TEH+L+  ++E   +G+      VY+LSL SGE
Sbjct:   559 -VLYRYSRKKVQFKSTWRSEFYYPFKLTEHELMKVVNESCPSGS-----EVYVLSLSSGE 612

Query:   608 LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
             L+AVKKLVN    SSK+LK +V+T+AKIRHKNI ++LGF   DE IFLIYEF Q GSL D
Sbjct:   613 LLAVKKLVNSKNISSKSLKAQVRTIAKIRHKNITRILGFCFKDEMIFLIYEFTQNGSLHD 672

Query:   668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA 727
             ++ R   QL WSIRLKIA+GVAQ LAY+ KDYVPHLLHRN+KS NI LD DFEPKL+DFA
Sbjct:   673 MLSRAGDQLPWSIRLKIALGVAQALAYISKDYVPHLLHRNLKSANIFLDKDFEPKLSDFA 732

Query:   728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAE 787
             LD IVGE AFQS + +    SCY APE  YSKKAT  MD YSFGVVLLEL+TG+ AE+AE
Sbjct:   733 LDHIVGETAFQSLVHAN-TNSCYTAPENHYSKKATEDMDVYSFGVVLLELVTGQSAEKAE 791

Query:   788 PA---ESLDVVKWVRRKINITNGAIQVLDPKI-ANCYQQQMLGALEIALRCTSVMPEKRP 843
                  ESLD+VK VRRKIN+T+GA QVLD KI ++  Q  M   L+IAL CT+V  EKRP
Sbjct:   792 EGSSGESLDIVKQVRRKINLTDGAAQVLDQKILSDSCQSDMRKTLDIALDCTAVAAEKRP 851

Query:   844 SMFEVVK 850
             S+ +V+K
Sbjct:   852 SLVKVIK 858

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2168907 XIP1 "XYLEM INTERMIXED WITH PHLOEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 578 (208.5 bits), Expect = 1.5e-116, Sum P(3) = 1.5e-116
 Identities = 122/291 (41%), Positives = 182/291 (62%)

Query:   569 FYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS------ 622
             F+ +   + +++  + +K+  G+GG  G VY + L SGE++AVKKL +   + S      
Sbjct:   642 FHRISFDQREILESLVDKNIVGHGGS-GTVYRVELKSGEVVAVKKLWSQSNKDSASEDKM 700

Query:   623 ---KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS 679
                K LKTEV+TL  IRHKNIVK+  +F S +   L+YE++  G+L D + +    L+W 
Sbjct:   701 HLNKELKTEVETLGSIRHKNIVKLFSYFSSLDCSLLVYEYMPNGNLWDALHKGFVHLEWR 760

Query:   680 IRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS 739
              R +IA+GVAQGLAYLH D  P ++HR++KS NILLD +++PK+ DF + +++      S
Sbjct:   761 TRHQIAVGVAQGLAYLHHDLSPPIIHRDIKSTNILLDVNYQPKVADFGIAKVLQARGKDS 820

Query:   740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
             T +       Y APEY YS KAT + D YSFGVVL+ELITG++   +   E+ ++V WV 
Sbjct:   821 TTTVMAGTYGYLAPEYAYSSKATIKCDVYSFGVVLMELITGKKPVDSCFGENKNIVNWVS 880

Query:   800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
              KI+   G I+ LD +++   +  M+ AL +A+RCTS  P  RP+M EVV+
Sbjct:   881 TKIDTKEGLIETLDKRLSESSKADMINALRVAIRCTSRTPTIRPTMNEVVQ 931

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010051 "xylem and phloem pattern formation" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)]

 Score = 626 (225.4 bits), Expect = 2.3e-116, Sum P(2) = 2.3e-116
 Identities = 163/494 (32%), Positives = 245/494 (49%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             LDL+   + G+IP  +                    P   G+ + L VLD S NA L  E
Sbjct:   241 LDLAIGKLSGEIPSELGKLKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNA-LTGE 299

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             IP +I KL+ L+ L L  +   G IP +   L  L +L+L  N L+GE+P  LG +   L
Sbjct:   300 IPMEITKLKNLQLLNLMRNKLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNS-PL 358

Query:   258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
                DVS N  SG  P+ +C    L  L L  N F G IP +++ C +L R ++Q+N  +G
Sbjct:   359 QWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNG 418

Query:   318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
               P     L +++ +    NR SG IP  IS +  L  +    N+  SS+P  + S+ +L
Sbjct:   419 SIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNL 478

Query:   378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTG 436
               F  + N   G +P  F D P +S ++LS N+++G IP  +  C KLVSL+L +N+LTG
Sbjct:   479 QAFLVADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTG 538

Query:   437 EIPPSLAELPVLTYLDLSDNNLTGPIPQGL-QNLKLALFNVSFNKLSGRVPYS-LISGLP 494
             EIP  +  +  L  LDLS+N+LTG +P+ +  +  L L NVS+NKL+G VP +  +  + 
Sbjct:   539 EIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFLKTIN 598

Query:   495 ASYLQGNPGLCGPGLSNSCDENQ---PKHRT-SGPTALACVMISLXXXXXXXXXXXXFFV 550
                L+GN GLCG G+   C + Q     H +  G   +A  +I +               
Sbjct:   599 PDDLRGNSGLCG-GVLPPCSKFQRATSSHSSLHGKRIVAGWLIGIASVLALGILTIVTRT 657

Query:   551 FHR--YSK-----KKSQAGVW--RSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYIL 601
              ++  YS      + +  G W  R + F+ L  T  D++  + E +  G G   G VY  
Sbjct:   658 LYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTASDILACIKESNMIGMGAT-GIVYKA 716

Query:   602 SLP-SGELIAVKKL 614
              +  S  ++AVKKL
Sbjct:   717 EMSRSSTVLAVKKL 730

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010067 "procambium histogenesis" evidence=ISS

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1020 (364.1 bits), Expect = 1.7e-113, Sum P(3) = 1.7e-113
 Identities = 249/679 (36%), Positives = 366/679 (53%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             LDL+ N + G+IPESI                    P   GN +EL   D+SQN  L  E
Sbjct:   249 LDLAMNSLTGEIPESIGRLESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNN-LTGE 307

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             +P  I  L+ L    L  + F G +PD      +L    +  N+ TG +P++LG    ++
Sbjct:   308 LPEKIAALQ-LISFNLNDNFFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGK-FSEI 365

Query:   258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
               FDVS N+ SG  P  +C    L  +    N  +G IP S  +C +L   ++ DN  SG
Sbjct:   366 SEFDVSTNRFSGELPPYLCYRRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSG 425

Query:   318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
             + P + W LP  +L  A +N+  G+IP SIS A  L Q++I  N F+  IP  L  ++ L
Sbjct:   426 EVPARFWELPLTRLELANNNQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDL 485

Query:   378 YRFSASQNSFYGSLPPNFCDSPVMSI--INLSQNSISGQIPE-LKKCRKLVSLSLADNSL 434
                  S+NSF GS+P   C + + ++  + + +N + G+IP  +  C +L  L+L++N L
Sbjct:   486 RVIDLSRNSFLGSIPS--CINKLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRL 543

Query:   435 TGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLP 494
              G IPP L +LPVL YLDLS+N LTG IP  L  LKL  FNVS NKL G++P      + 
Sbjct:   544 RGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLKLNQFNVSDNKLYGKIPSGFQQDIF 603

Query:   495 ASYLQGNPGLCGPGLS--NSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFH 552
                  GNP LC P L     C  ++ + R   P ++ C+ ++L              +F 
Sbjct:   604 RPSFLGNPNLCAPNLDPIRPC-RSKRETRYILPISILCI-VALTGALVWLFIKTKP-LFK 660

Query:   553 RYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVK 612
             R  K+ ++  +++ + F     TE D+   + E +  G+GG  G VY + L SG+ +AVK
Sbjct:   661 RKPKRTNKITIFQRVGF-----TEEDIYPQLTEDNIIGSGGS-GLVYRVKLKSGQTLAVK 714

Query:   613 KL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI 669
             KL        +S    ++EV+TL ++RH NIVK+L   + +E  FL+YEF++ GSLGD++
Sbjct:   715 KLWGETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVL 774

Query:   670 C-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
                   R    L W+ R  IA+G AQGL+YLH D VP ++HR+VKS NILLD + +P++ 
Sbjct:   775 HSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVA 834

Query:   725 DFALDRIVGEAAFQSTMSSEYALSC------YNAPEYGYSKKATAQMDAYSFGVVLLELI 778
             DF L + +          S+ ++SC      Y APEYGY+ K   + D YSFGVVLLELI
Sbjct:   835 DFGLAKPLKREDNDGV--SDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELI 892

Query:   779 TGRQAEQAEPAESLDVVKW 797
             TG++   +   E+ D+VK+
Sbjct:   893 TGKRPNDSSFGENKDIVKF 911

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 1071 (382.1 bits), Expect = 2.1e-113, Sum P(2) = 2.1e-113
 Identities = 272/733 (37%), Positives = 393/733 (53%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             LDL+ N + G IP  I                    P   GN + L   D S N  L  +
Sbjct:   241 LDLTFNQLTGSIPSWITQLKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNK-LTGK 299

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS-SLLK 256
             IP ++  L  LE L L  +   G +P+S    ++LS L L  N LTG +P  LG+ S L+
Sbjct:   300 IPDNLNLLN-LESLNLFENMLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQ 358

Query:   257 LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS 316
              V  D+S N+ SG  P  +C    L  L L  N F+G I  ++ +C +L R ++ +N  S
Sbjct:   359 YV--DLSYNRFSGEIPANVCGEGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLS 416

Query:   317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS 376
             G  P   W LPR+ L+    N F+G+IP +I  A  L  ++I  NRF+ SIP  +GS+  
Sbjct:   417 GQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNG 476

Query:   377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLT 435
             +   S ++N F G +P +      +S ++LS+N +SG+IP EL+  + L  L+LA+N L+
Sbjct:   477 IIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLS 536

Query:   436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
             GEIP  +  LPVL YLDLS N  +G IP  LQNLKL + N+S+N LSG++P    + + A
Sbjct:   537 GEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLKLNVLNLSYNHLSGKIPPLYANKIYA 596

Query:   496 SYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFHRYS 555
                 GNPGLC   L   C     + +  G   +   +  L                 +  
Sbjct:   597 HDFIGNPGLC-VDLDGLC-RKITRSKNIGYVWILLTIFLLAGLVFVVGIVMFIAKCRKLR 654

Query:   556 KKKSQ---AGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVK 612
               KS    A  WRS  F+ L  +EH++   +DEK+  G G   G+VY + L  GE++AVK
Sbjct:   655 ALKSSTLAASKWRS--FHKLHFSEHEIADCLDEKNVIGFGSS-GKVYKVELRGGEVVAVK 711

Query:   613 KL---VNFGCQ--SSKTLK-----TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
             KL   V  G    SS +L       EV+TL  IRHK+IV++     S +   L+YE++  
Sbjct:   712 KLNKSVKGGDDEYSSDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPN 771

Query:   663 GSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF 719
             GSL D++    +    L W  RL+IA+  A+GL+YLH D VP ++HR+VKS NILLD+D+
Sbjct:   772 GSLADVLHGDRKGGVVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDY 831

Query:   720 EPKLTDFALDRIVGEAAFQSTMS--SEYALSC-YNAPEYGYSKKATAQMDAYSFGVVLLE 776
               K+ DF + + VG+ +   T    S  A SC Y APEY Y+ +   + D YSFGVVLLE
Sbjct:   832 GAKVADFGIAK-VGQMSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLE 890

Query:   777 LITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTS 836
             L+TG+Q   +E  +  D+ KWV   ++   G   V+DPK+   +++++   + I L CTS
Sbjct:   891 LVTGKQPTDSELGDK-DMAKWVCTALDKC-GLEPVIDPKLDLKFKEEISKVIHIGLLCTS 948

Query:   837 VMPEKRPSMFEVV 849
              +P  RPSM +VV
Sbjct:   949 PLPLNRPSMRKVV 961

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1097 (391.2 bits), Expect = 4.2e-111, P = 4.2e-111
 Identities = 267/734 (36%), Positives = 392/734 (53%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             LDL+ N + G IP S+                    P   GN   L +LD S N  L  +
Sbjct:   234 LDLALNDLVGHIPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQ-LTGK 292

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG-SSLLK 256
             IP ++ ++  LE L L  +   G +P S     +L  + +  N LTG +P+ LG +S L+
Sbjct:   293 IPDELCRVP-LESLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLR 351

Query:   257 LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS 316
              +  DVS+N+ SG  P  +C    L  L +  N F+G IP S+ +C +L R ++  N FS
Sbjct:   352 WL--DVSENEFSGDLPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFS 409

Query:   317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS 376
             G  P   W LP + L+   +N FSG I  SI  A+ L  + + NN FT S+P+ +GS+ +
Sbjct:   410 GSVPTGFWGLPHVNLLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDN 469

Query:   377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLT 435
             L + SAS N F GSLP +      +  ++L  N  SG++   +K  +KL  L+LADN  T
Sbjct:   470 LNQLSASGNKFSGSLPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFT 529

Query:   436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
             G+IP  +  L VL YLDLS N  +G IP  LQ+LKL   N+S+N+LSG +P SL   +  
Sbjct:   530 GKIPDEIGSLSVLNYLDLSGNMFSGKIPVSLQSLKLNQLNLSYNRLSGDLPPSLAKDMYK 589

Query:   496 SYLQGNPGLCGPGLSNSC-DENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFHRY 554
             +   GNPGLCG  +   C  EN+ K R  G   L   +  L            +F +  +
Sbjct:   590 NSFIGNPGLCGD-IKGLCGSENEAKKR--GYVWLLRSIFVLAAMVLLAGVAWFYFKYRTF 646

Query:   555 SKKKS-QAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKK 613
              K ++ +   W  + F+ L  +EH+++  +DE +  G G   G+VY + L +GE +AVK+
Sbjct:   647 KKARAMERSKWTLMSFHKLGFSEHEILESLDEDNVIGAGAS-GKVYKVVLTNGETVAVKR 705

Query:   614 L-----VNFG-CQSSKTLK---------TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE 658
             L        G C   K  K          EV+TL KIRHKNIVK+     + +   L+YE
Sbjct:   706 LWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYE 765

Query:   659 FLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
             ++  GSLGDL+   +   L W  R KI +  A+GL+YLH D VP ++HR++KS NIL+D 
Sbjct:   766 YMPNGSLGDLLHSSKGGMLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILIDG 825

Query:   718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQMDAYSFGVVLLE 776
             D+  ++ DF + + V          S  A SC Y APEY Y+ +   + D YSFGVV+LE
Sbjct:   826 DYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAPEYAYTLRVNEKSDIYSFGVVILE 885

Query:   777 LITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTS 836
             ++T ++    E  E  D+VKWV   ++   G   V+DPK+ +C+++++   L + L CTS
Sbjct:   886 IVTRKRPVDPELGEK-DLVKWVCSTLD-QKGIEHVIDPKLDSCFKEEISKILNVGLLCTS 943

Query:   837 VMPEKRPSMFEVVK 850
              +P  RPSM  VVK
Sbjct:   944 PLPINRPSMRRVVK 957

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2024432 LRR XI-23 [Arabidopsis thaliana (taxid:3702)]

 Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
 Identities = 261/740 (35%), Positives = 387/740 (52%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             L++S + + G+IP  I                    P  FGN   L  LD S N  L+  
Sbjct:   224 LEISDSGLTGEIPSEISKLTNLWQLELYNNSLTGKLPTGFGNLKNLTYLDASTN--LLQG 281

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
               S++  L  L  L +  + F G IP  F   + L  L L  N LTG +PQ LGS L   
Sbjct:   282 DLSELRSLTNLVSLQMFENEFSGEIPLEFGEFKDLVNLSLYTNKLTGSLPQGLGS-LADF 340

Query:   258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
                D S+N L+G  P  +CK   +  L L +N   GSIP S   CL L+RF+V +N  +G
Sbjct:   341 DFIDASENLLTGPIPPDMCKNGKMKALLLLQNNLTGSIPESYANCLTLQRFRVSENNLNG 400

Query:   318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
               P  LW LP++++I  E N F G I   I     L  + +  N+ +  +P+ +G  +SL
Sbjct:   401 TVPAGLWGLPKLEIIDIEMNNFEGPITADIKNGKMLGALYLGFNKLSDELPEEIGDTESL 460

Query:   378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTG 436
              +   + N F G +P +      +S + +  N  SG+IP+ +  C  L  +++A NS++G
Sbjct:   461 TKVELNNNRFTGKIPSSIGKLKGLSSLKMQSNGFSGEIPDSIGSCSMLSDVNMAQNSISG 520

Query:   437 EIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPAS 496
             EIP +L  LP L  L+LSDN L+G IP+ L +L+L+L ++S N+LSGR+P SL S    S
Sbjct:   521 EIPHTLGSLPTLNALNLSDNKLSGRIPESLSSLRLSLLDLSNNRLSGRIPLSL-SSYNGS 579

Query:   497 YLQGNPGLCGPGLS--NSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFHRY 554
             +  GNPGLC   +   N C      H  +    L C++  L            FF++ + 
Sbjct:   580 F-NGNPGLCSTTIKSFNRCINPSRSHGDTRVFVL-CIVFGLLILLASLV----FFLYLKK 633

Query:   555 SKKKSQAGV----WRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIA 610
             ++KK    +    W    F  +  TE D++  + E++  G GG  G VY + L  G+ +A
Sbjct:   634 TEKKEGRSLKHESWSIKSFRKMSFTEDDIIDSIKEENLIGRGG-CGDVYRVVLGDGKEVA 692

Query:   611 VKKL------VNFGCQS---------SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
             VK +       NF             SK  +TEV+TL+ IRH N+VK+     SD+S  L
Sbjct:   693 VKHIRCSSTQKNFSSAMPILTEREGRSKEFETEVQTLSSIRHLNVVKLYCSITSDDSSLL 752

Query:   656 IYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI 713
             +YE+L  GSL D++  C++   L W  R  IA+G A+GL YLH  Y   ++HR+VKS NI
Sbjct:   753 VYEYLPNGSLWDMLHSCKKS-NLGWETRYDIALGAAKGLEYLHHGYERPVIHRDVKSSNI 811

Query:   714 LLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--AP-EYGYSKKATAQMDAYSF 770
             LLD   +P++ DF L +I+ +A+     S+      Y   AP EYGY+ K T + D YSF
Sbjct:   812 LLDEFLKPRIADFGLAKIL-QASNGGPESTHVVAGTYGYIAPAEYGYASKVTEKCDVYSF 870

Query:   771 GVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
             GVVL+EL+TG++  +AE  ES D+V WV   +      ++++D KI   Y++  +  L I
Sbjct:   871 GVVLMELVTGKKPIEAEFGESKDIVNWVSNNLKSKESVMEIVDKKIGEMYREDAVKMLRI 930

Query:   831 ALRCTSVMPEKRPSMFEVVK 850
             A+ CT+ +P  RP+M  VV+
Sbjct:   931 AIICTARLPGLRPTMRSVVQ 950

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0006979 "response to oxidative stress" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0070825 "micropyle" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
 Identities = 244/719 (33%), Positives = 387/719 (53%)

Query:   145 IEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISEIPSDIGK 204
             + G+IP  I                     +  G  S L  +DLS N +   EIP+   +
Sbjct:   251 LTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFT-GEIPASFAE 309

Query:   205 LEKLEQLFLQSSGFHGVIPDSFVG-LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS 263
             L+ L  L L  +  HG IP+ F+G L  L +L L +NN TG +PQ LG +  KL   D+S
Sbjct:   310 LKNLTLLNLFRNKLHGEIPE-FIGDLPELEVLQLWENNFTGSIPQKLGENG-KLNLVDLS 367

Query:   264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL 323
              NKL+G+ P  +C  N L  L    NF  GSIP S+ +C +L R ++ +N  +G  P  L
Sbjct:   368 SNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGL 427

Query:   324 WSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSAS 383
             + LP++  +  + N  SG +P +  ++  L Q+ + NN+ +  +P  +G+   + +    
Sbjct:   428 FGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLD 487

Query:   384 QNSFYGSLPPNFCDSPVMSIINLSQNSISGQI-PELKKCRKLVSLSLADNSLTGEIPPSL 442
              N F G +P        +S I+ S N  SG+I PE+ +C+ L  + L+ N L+GEIP  +
Sbjct:   488 GNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEI 547

Query:   443 AELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS-LISGLPASYLQG 500
               + +L YL+LS N+L G IP  + +++ L   + S+N LSG VP +   S    +   G
Sbjct:   548 TAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTSFLG 607

Query:   501 NPGLCGPGLSNSCDENQPK--HRT--SGPTALAC-VMISLXXXXXXXXXXXXFFVFHRYS 555
             NP LCGP L   C +   K  H++   GP + +  +++ L              +  R  
Sbjct:   608 NPDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKARSL 666

Query:   556 KKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKL- 614
             KK S++  WR   F  L  T  D++  + E +  G GG  G VY   +P+G+L+AVK+L 
Sbjct:   667 KKASESRAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGA-GIVYKGVMPNGDLVAVKRLA 725

Query:   615 -VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLIC-RQ 672
              ++ G         E++TL +IRH++IV++LGF  + E+  L+YE++  GSLG+++  ++
Sbjct:   726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKK 785

Query:   673 DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
                L W  R KIA+  A+GL YLH D  P ++HR+VKS NILLD++FE  + DF L + +
Sbjct:   786 GGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFL 845

Query:   733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
              ++     MS+      Y APEY Y+ K   + D YSFGVVLLEL+TGR+    E  + +
Sbjct:   846 QDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPV-GEFGDGV 904

Query:   793 DVVKWVRRKINITNGAI-QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             D+V+WVR+  +    ++ +VLDP++++    ++     +A+ C      +RP+M EVV+
Sbjct:   905 DIVQWVRKMTDSNKDSVLKVLDPRLSSIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQ 963

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2180617 AT5G25930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1023 (365.2 bits), Expect = 2.9e-103, P = 2.9e-103
 Identities = 253/732 (34%), Positives = 383/732 (52%)

Query:   138 LDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISE 197
             +DLS N++ G+IP+ +                    P    + + LV LDLS N  L   
Sbjct:   240 VDLSVNNLTGRIPDVLFGLKNLTEFYLFANGLTGEIPKSI-SATNLVFLDLSANN-LTGS 297

Query:   198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             IP  IG L KL+ L L ++   G IP     L  L    +  N LTGE+P  +G    KL
Sbjct:   298 IPVSIGNLTKLQVLNLFNNKLTGEIPPVIGKLPGLKEFKIFNNKLTGEIPAEIGVHS-KL 356

Query:   258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
               F+VS+N+L+G  P  +CK   L  + ++ N   G IP S+ +C  L   Q+Q+N FSG
Sbjct:   357 ERFEVSENQLTGKLPENLCKGGKLQGVVVYSNNLTGEIPESLGDCGTLLTVQLQNNDFSG 416

Query:   318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
              FP ++W+   +  ++  +N F+G +P+++  A  + +++IDNNRF+  IP+ +G+  SL
Sbjct:   417 KFPSRIWNASSMYSLQVSNNSFTGELPENV--AWNMSRIEIDNNRFSGEIPKKIGTWSSL 474

Query:   378 YRFSASQNSFYGSLPPNFCD-SPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLT 435
               F A  N F G  P      S ++SI  L +N ++G++P E+   + L++LSL+ N L+
Sbjct:   475 VEFKAGNNQFSGEFPKELTSLSNLISIF-LDENDLTGELPDEIISWKSLITLSLSKNKLS 533

Query:   436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLIS-GLP 494
             GEIP +L  LP L  LDLS+N  +G IP  + +LKL  FNVS N+L+G +P  L +    
Sbjct:   534 GEIPRALGLLPRLLNLDLSENQFSGGIPPEIGSLKLTTFNVSSNRLTGGIPEQLDNLAYE 593

Query:   495 ASYLQGNPGLCG--PGLSNSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFH 552
              S+L  N  LC   P LS      Q +     P  +  +++ +            FFV  
Sbjct:   594 RSFLN-NSNLCADNPVLSLPDCRKQRRGSRGFPGKILAMILVIAVLLLTITLFVTFFVVR 652

Query:   553 RYSKKKSQAGV--WRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELI 609
              Y++K+ + G+  W+   F+ +   E D+V  + E    G+GG  G+VY I    SG+ +
Sbjct:   653 DYTRKQRRRGLETWKLTSFHRVDFAESDIVSNLMEHYVIGSGGS-GKVYKIFVESSGQCV 711

Query:   610 AVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
             AVK++ +      K  K    EV+ L  IRH NIVK+L     ++S  L+YE+L+  SL 
Sbjct:   712 AVKRIWDSKKLDQKLEKEFIAEVEILGTIRHSNIVKLLCCISREDSKLLVYEYLEKRSLD 771

Query:   667 DLI-------CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF 719
               +         +   L WS RL IA+G AQGL Y+H D  P ++HR+VKS NILLD++F
Sbjct:   772 QWLHGKKKGGTVEANNLTWSQRLNIAVGAAQGLCYMHHDCTPAIIHRDVKSSNILLDSEF 831

Query:   720 EPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
               K+ DF L ++ + +     TMS+      Y APEY Y+ K   ++D YSFGVVLLEL+
Sbjct:   832 NAKIADFGLAKLLIKQNQEPHTMSAVAGSFGYIAPEYAYTSKVDEKIDVYSFGVVLLELV 891

Query:   779 TGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ-MLGALEIALRCTSV 837
             TGR+    +  E  ++  W  +         +  D  I      + M    ++ L CT+ 
Sbjct:   892 TGREGNNGD--EHTNLADWSWKHYQSGKPTAEAFDEDIKEASTTEAMTTVFKLGLMCTNT 949

Query:   838 MPEKRPSMFEVV 849
             +P  RPSM EV+
Sbjct:   950 LPSHRPSMKEVL 961

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1021 (364.5 bits), Expect = 4.7e-103, P = 4.7e-103
 Identities = 239/721 (33%), Positives = 386/721 (53%)

Query:   139 DLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLISEI 198
             D +   + G+IP  I                        G  S L  +DLS N +   EI
Sbjct:   245 DAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFT-GEI 303

Query:   199 PSDIGKLEKLEQLFLQSSGFHGVIPDSFVG-LQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             P+   +L+ L  L L  +  +G IP+ F+G +  L +L L +NN TG +PQ LG +  +L
Sbjct:   304 PTSFSQLKNLTLLNLFRNKLYGAIPE-FIGEMPELEVLQLWENNFTGSIPQKLGENG-RL 361

Query:   258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
             V  D+S NKL+G+ P  +C  N L+ L    NF  GSIP S+ +C +L R ++ +N  +G
Sbjct:   362 VILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNG 421

Query:   318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSIS-MAAQLEQVQIDNNRFTSSIPQGLGSVKS 376
               P +L+ LP++  +  + N  +G +P S   ++  L Q+ + NN+ + S+P  +G++  
Sbjct:   422 SIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSG 481

Query:   377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQI-PELKKCRKLVSLSLADNSLT 435
             + +     N F GS+PP       +S ++ S N  SG+I PE+ +C+ L  + L+ N L+
Sbjct:   482 VQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 541

Query:   436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS-LISGL 493
             G+IP  L  + +L YL+LS N+L G IP  + +++ L   + S+N LSG VP +   S  
Sbjct:   542 GDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYF 601

Query:   494 PASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLXXXXXXXXXXXXFFVFHR 553
               +   GN  LCGP L   C +   +      +A   +++ L              +  R
Sbjct:   602 NYTSFVGNSHLCGPYLG-PCGKGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIKAR 660

Query:   554 YSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKK 613
               +  S+A  WR   F  L  T  D++  + E +  G GG  G VY  ++P G+L+AVK+
Sbjct:   661 SLRNASEAKAWRLTAFQRLDFTCDDVLDSLKEDNIIGKGGA-GIVYKGTMPKGDLVAVKR 719

Query:   614 L--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLIC- 670
             L  ++ G         E++TL +IRH++IV++LGF  + E+  L+YE++  GSLG+++  
Sbjct:   720 LATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG 779

Query:   671 RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
             ++   L W+ R KIA+  A+GL YLH D  P ++HR+VKS NILLD++FE  + DF L +
Sbjct:   780 KKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAK 839

Query:   731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE 790
              + ++     MS+      Y APEY Y+ K   + D YSFGVVLLELITG++    E  +
Sbjct:   840 FLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPV-GEFGD 898

Query:   791 SLDVVKWVRRKINITNGAI-QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
              +D+V+WVR   +     + +V+D ++++    ++     +AL C      +RP+M EVV
Sbjct:   899 GVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVV 958

Query:   850 K 850
             +
Sbjct:   959 Q 959

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FL51	Y5694_ARATH	No assigned EC number	0.6365	0.9372	0.9415	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00160451 hypothetical protein (887 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	876
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-114
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-34
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-25
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	7e-24
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-21
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	7e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-18
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-18
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-18
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-18
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-15
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	5e-14
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	7e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	9e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-13
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-13
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-13
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	6e-13
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-12
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-12
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-11
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	9e-11
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-10
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-09
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-08
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-07
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-07
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-06
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-06
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-06
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	9e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-04
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-04
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-04
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
PLN03210	1153	PLN03210, PLN03210, Resistant to P	0.003
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	0.003
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.003
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  371 bits (955), Expect = e-114
 Identities = 259/804 (32%), Positives = 403/804 (50%), Gaps = 53/804 (6%)

Query: 87  LSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLS-NNL----------- 134
           L G+I +S+  L+SL  L LA N     IP  L Q  SL+ + L  NNL           
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235

Query: 135 --IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNA 192
             +  LDL  N++ G IP S+G+L NLQ L L  N LSG +P    +  +L+ LDLS N 
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN- 294

Query: 193 YLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS 252
            L  EIP  + +L+ LE L L S+ F G IP +   L  L +L L  N  +GE+P++LG 
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 253 SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD 312
               L   D+S N L+G  P G+C +  L  L L  N   G IP S+  C +L R ++QD
Sbjct: 355 HN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413

Query: 313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLG 372
           N FSG+ P +   LP +  +   +N   G I         L+ + +  N+F   +P   G
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFG 473

Query: 373 SVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLAD 431
           S K L     S+N F G++P        +  + LS+N +SG+IP EL  C+KLVSL L+ 
Sbjct: 474 S-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532

Query: 432 NSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYS-L 489
           N L+G+IP S +E+PVL+ LDLS N L+G IP+ L N++ L   N+S N L G +P +  
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592

Query: 490 ISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFF 549
              + AS + GN  LCG    ++     P  R     +    +     A  ++ + A  F
Sbjct: 593 FLAINASAVAGNIDLCG---GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGF 649

Query: 550 VFHR------YSKKKSQAGVWRSLFF---YPLRVTEHDLVIGMDEKSSAGNGGPFGRVYI 600
           VF R        + +++ G W   FF       +T +D++  + E++    G        
Sbjct: 650 VFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG 709

Query: 601 LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL 660
            S+ +G    VK++ +     S    +E+  + K++H NIVK++G   S++  +LI+E++
Sbjct: 710 KSIKNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765

Query: 661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
           +  +L +++      L W  R KIAIG+A+ L +LH    P ++  N+  + I++D   E
Sbjct: 766 EGKNLSEVL----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE 821

Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           P L        +       T +  +  S Y APE   +K  T + D Y FG++L+EL+TG
Sbjct: 822 PHL-------RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874

Query: 781 RQAEQAEPAESLDVVKWVRRKINITNGAIQV-LDPKI---ANCYQQQMLGALEIALRCTS 836
           +    AE      +V+W R     ++  + + +DP I    +  Q +++  + +AL CT+
Sbjct: 875 KSPADAEFGVHGSIVEWAR--YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTA 932

Query: 837 VMPEKRPSMFEVVKALHSLSTRTS 860
             P  RP   +V+K L S S  +S
Sbjct: 933 TDPTARPCANDVLKTLESASRSSS 956

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  166 bits (423), Expect = 2e-42
 Identities = 111/345 (32%), Positives = 165/345 (47%), Gaps = 39/345 (11%)

Query: 86  NLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------- 136
           NL+G I SS+  L +L  L L  N  + PIP  +     L +L+LS+N +          
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Query: 137 -----VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
                +L L  N+  GKIP ++ SL  LQVL L SN  SG +P   G  + L VLDLS N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 192 AY-----------------------LISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVG 228
                                    L  EIP  +G    L ++ LQ + F G +P  F  
Sbjct: 367 NLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Query: 229 LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
           L  +  LD+S NNL G +  S    +  L    +++NK  G  P+    +  L NL L +
Sbjct: 427 LPLVYFLDISNNNLQGRI-NSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSR 484

Query: 289 NFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSIS 348
           N F+G++P  +     L + ++ +N  SG+ PD+L S  ++  +    N+ SG IP S S
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544

Query: 349 MAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP 393
               L Q+ +  N+ +  IP+ LG+V+SL + + S N  +GSLP 
Sbjct: 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  140 bits (354), Expect = 1e-37
 Identities = 63/192 (32%), Positives = 104/192 (54%), Gaps = 10/192 (5%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGFF 647
           G GG FG VY+     +G+ +A+K +      S    L  E++ L K+ H NIVK+ G F
Sbjct: 2   GEGG-FGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
             +  ++L+ E+ + GSL DL+   + +L     L+I + + +GL YLH +    ++HR+
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRD 117

Query: 708 VKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSKKATAQM 765
           +K +NILLD+D  + KL DF L +++     +S + +      Y APE        + + 
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 766 DAYSFGVVLLEL 777
           D +S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  131 bits (332), Expect = 3e-34
 Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 28/269 (10%)

Query: 590 GNGGPFGRVYILSLPS-GELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G+G  FG VY       G+++AVK L   +   +  +T + E++ L ++ H NIV+++  
Sbjct: 8   GSGS-FGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F   + ++L+ E+ + G L D +  +   L      KIA+ + +GL YLH +    ++HR
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-----YGYSKKA 761
           ++K +NILLD +   K+ DF L + + +    S++++      Y APE      GY  K 
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
               D +S GV+L EL+TG+     E           R                      
Sbjct: 181 ----DVWSLGVILYELLTGKPPFSGENILDQL-QLIRRILGPPLEFDEPKWSSGSEEA-- 233

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                  ++  +C +  P KRP+  E+++
Sbjct: 234 ------KDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  130 bits (329), Expect = 7e-34
 Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 24/201 (11%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G  FG+VY      +G+L+A+K +      +  + +  E+K L K++H NIV++   F
Sbjct: 8   GEGS-FGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             ++ ++L+ E+ + G L DL+ ++         R      +   L YLH      ++HR
Sbjct: 67  EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSALEYLHSK---GIVHR 121

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----YGYSKK 760
           ++K +NILLD D   KL DF L R +      +T   + EY      APE     GY K 
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYM-----APEVLLGKGYGKA 176

Query: 761 ATAQMDAYSFGVVLLELITGR 781
                D +S GV+L EL+TG+
Sbjct: 177 V----DIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 22/200 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G GG FG VY      +G+ +A+K +     +  + +  E++ L K +H NIVK  G + 
Sbjct: 9   GKGG-FGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 649 SDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             + ++++ EF   GSL DL+    Q       I   +   + +GL YLH +    ++HR
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IA-YVCKELLKGLEYLHSN---GIIHR 122

Query: 707 NVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEY----GYSKKA 761
           ++K+ NILL +D E KL DF L  ++    A  + + + Y    + APE      Y  KA
Sbjct: 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPY----WMAPEVINGKPYDYKA 178

Query: 762 TAQMDAYSFGVVLLELITGR 781
               D +S G+  +EL  G+
Sbjct: 179 ----DIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  121 bits (306), Expect = 8e-31
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 48/278 (17%)

Query: 593 GPFGRVY--ILSLPSG---ELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLG 645
           G FG VY   L    G     +AVK L          +    E + + K+ H N+VK+LG
Sbjct: 10  GAFGEVYKGKLKGKGGKKKVEVAVKTLKE-DASEQQIEEFLREARIMRKLDHPNVVKLLG 68

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
               +E ++++ E+++ G L   + +   +L  S  L  A+ +A+G+ YL  K+++    
Sbjct: 69  VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFI---- 124

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE-----YALSCYNAPEYGYSK 759
           HR++ ++N L+  +   K++DF L R + +  +      +      A       E  ++ 
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK--EGKFTS 182

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIAN 818
           K+    D +SFGV+L E+ T    EQ  P  S  +V+++++      NG      P+  N
Sbjct: 183 KS----DVWSFGVLLWEIFTL--GEQPYPGMSNEEVLEYLK------NGYRL---PQPPN 227

Query: 819 C----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           C    Y         + L+C +  PE RP+  E+V+ L
Sbjct: 228 CPPELYD--------LMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (298), Expect = 1e-29
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 59/284 (20%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLG 645
           G FG VY              +AVK L          +    E + + K+ H NIVK+LG
Sbjct: 10  GAFGEVYKGTLKGKGDGKEVEVAVKTLKE-DASEQQIEEFLREARIMRKLDHPNIVKLLG 68

Query: 646 FFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHL 703
               +E + ++ E++  G L D L   +  +L  S  L  A+ +A+G+ YL  K+++   
Sbjct: 69  VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFI--- 125

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN------APE--- 754
            HR++ ++N L+  +   K++DF L R + +          Y +          APE   
Sbjct: 126 -HRDLAARNCLVGENLVVKISDFGLSRDLYD-------DDYYKVKGGKLPIRWMAPESLK 177

Query: 755 YG-YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQVL 812
            G ++ K+    D +SFGV+L E+ T    E+  P  S  +V++++++            
Sbjct: 178 EGKFTSKS----DVWSFGVLLWEIFTL--GEEPYPGMSNAEVLEYLKKGY---------R 222

Query: 813 DPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
            PK  NC    Y+        + L+C +  PE RP+  E+V+ L
Sbjct: 223 LPKPPNCPPELYK--------LMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  115 bits (290), Expect = 1e-28
 Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 43/276 (15%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY          +   +AVK L      +  +    E   + K+ H NIV++LG 
Sbjct: 10  GAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGV 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLH 705
               E ++++ E++  G L D + +   +L     L++A+ +A+G+ YL  K++V    H
Sbjct: 70  CTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFV----H 125

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKKA 761
           R++ ++N L+  +   K++DF L R + E  +            + APE      ++ K+
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKS 185

Query: 762 TAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC- 819
               D +SFGV+L E+ T G Q       E  +V++ +             L P+  NC 
Sbjct: 186 ----DVWSFGVLLWEIFTLGEQPYPGMSNE--EVLELLEDG--------YRL-PRPENCP 230

Query: 820 ---YQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
              Y        E+ L+C +  PE RP+  E+V+ L
Sbjct: 231 DELY--------ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  112 bits (283), Expect = 1e-27
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 55/276 (19%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLG 645
           G G  FG VY  L   +GEL+AVK  V     S +    L+ E++ L+ ++H NIV+  G
Sbjct: 9   GRGS-FGSVYLALDKDTGELMAVKS-VELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66

Query: 646 FFHSDE----SIFLIYEFLQMGSLGDLICR----QDFQLQWSIRLKIAIGVAQGLAYLH- 696
               +E    +IFL  E++  GSL  L+ +     +  ++     K    + +GLAYLH 
Sbjct: 67  SERDEEKNTLNIFL--EYVSGGSLSSLLKKFGKLPEPVIR-----KYTRQILEGLAYLHS 119

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA---FQSTMS-SEYALSCYNA 752
              V    HR++K  NIL+D+D   KL DF   + +G+        ++  + Y    + A
Sbjct: 120 NGIV----HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY----WMA 171

Query: 753 PEY----GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA 808
           PE      Y + A    D +S G  ++E+ TG+    +E    +  +     KI  +   
Sbjct: 172 PEVIRGEEYGRAA----DIWSLGCTVIEMATGKPP-WSELGNPMAALY----KIGSSGEP 222

Query: 809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
                P+I     ++   A +   +C    P+KRP+
Sbjct: 223 -----PEIPEHLSEE---AKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 8e-26
 Identities = 81/289 (28%), Positives = 126/289 (43%), Gaps = 60/289 (20%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G FG VY   L    G+    AVK L      S +  K    E + + K+ H N+V++LG
Sbjct: 6   GAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNVVRLLG 63

Query: 646 FFHSDESIFLIYEFLQMGSLGDLI--CRQDFQ------LQWSIRLKIAIGVAQGLAYLHK 697
               +E ++L+ E+++ G L D +   R  F       L     L  AI +A+G+ YL  
Sbjct: 64  VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------- 749
                 +HR++ ++N L+  D   K++DF L R V           +Y            
Sbjct: 124 ---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDV--------YDDDYYRKKTGGKLPIR 172

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINIT 805
           + APE       T++ D +SFGV+L E+ T G     A P   L   +V++++R      
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLG-----ATPYPGLSNEEVLEYLR------ 221

Query: 806 NGAIQVLDPKIANCYQQQMLGAL-EIALRCTSVMPEKRPSMFEVVKALH 853
            G      PK   C  +     L E+ L C  + PE RP+  E+V+ L 
Sbjct: 222 KGYRL---PKPEYCPDE-----LYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  105 bits (265), Expect = 2e-25
 Identities = 69/266 (25%), Positives = 114/266 (42%), Gaps = 36/266 (13%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G  G VY +   P+G++ A+KK ++        K L  E+KTL       +VK  G F+ 
Sbjct: 12  GSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK 70

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           +  I ++ E++  GSL DL+ ++  ++   +   IA  + +GL YLH     H++HR++K
Sbjct: 71  EGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQILKGLDYLHTKR--HIIHRDIK 127

Query: 710 SKNILLDADFEPKLTDF----ALDRIVGEAA-FQST---MSSEYALSCYNAPEYGYSKKA 761
             N+L+++  E K+ DF     L+  + +   F  T   MS E          Y Y+   
Sbjct: 128 PSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPER----IQGESYSYAA-- 181

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
               D +S G+ LLE   G+      P        +      I +G    L       + 
Sbjct: 182 ----DIWSLGLTLLECALGKF-----PFLPPGQPSFFELMQAICDGPPPSLPA---EEFS 229

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFE 847
            +    +     C    P+KRPS  E
Sbjct: 230 PEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  104 bits (263), Expect = 5e-25
 Identities = 69/278 (24%), Positives = 118/278 (42%), Gaps = 58/278 (20%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG+VY +     G+L  +K+ ++    S K  +    EVK L K+ H NI+K    F 
Sbjct: 11  GSFGKVYLVRRKSDGKLYVLKE-IDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE 69

Query: 649 SDESIFLIYEFLQMGSLGDLI-----CRQDFQ----LQWSIRLKIAIGVAQGLAYLHKDY 699
               + ++ E+   G L   I       + F     L W ++L +A      L YLH   
Sbjct: 70  EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYLHSR- 122

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPE 754
              +LHR++K +NI L ++   KL DF + +++         + + A +      Y +PE
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS-------TVDLAKTVVGTPYYLSPE 173

Query: 755 ----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ 810
                 Y+ K+    D +S G VL EL T +   + E    L  +K ++ +         
Sbjct: 174 LCQNKPYNYKS----DIWSLGCVLYELCTLKHPFEGENLLEL-ALKILKGQY-------- 220

Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
              P I + Y  ++     +        PE+RPS+ ++
Sbjct: 221 ---PPIPSQYSSEL---RNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  103 bits (258), Expect = 4e-24
 Identities = 75/279 (26%), Positives = 120/279 (43%), Gaps = 48/279 (17%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V       L   +GE +AVK L  +   Q     + E++ L  + H+NIVK  G 
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                  S+ LI E+L  GSL D + R   Q+     L  +  + +G+ YL        +
Sbjct: 75  CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYI 131

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS--------CYNAPEYG 756
           HR++ ++NIL++++   K++DF L +++           +Y            + APE  
Sbjct: 132 HRDLAARNILVESEDLVKISDFGLAKVL-------PEDKDYYYVKEPGESPIFWYAPECL 184

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD--- 813
            + K ++  D +SFGV L EL T     Q+ PAE L       R I I  G + V     
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL-------RMIGIAQGQMIVTRLLE 237

Query: 814 --------PKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
                   P+  +C  +      ++   C    P+ RPS
Sbjct: 238 LLKEGERLPRPPSCPDE----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (255), Expect = 5e-24
 Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 16/197 (8%)

Query: 593 GPFGRVYI-LSLPSGELIAVK--KLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L+L  G+  AVK   L + G       K L+ E+  L+K++H NIV+ LG 
Sbjct: 11  GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
              ++++++  E +  GSL  L+ +     +  IRL     +  GL YLH     + +HR
Sbjct: 71  EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLHDR---NTVHR 126

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM-SSEYALSCYNAPEYGYSKKA-TAQ 764
           ++K  NIL+D +   KL DF + + V E +F  +   S Y    + APE    +      
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY----WMAPEVIAQQGGYGLA 182

Query: 765 MDAYSFGVVLLELITGR 781
            D +S G  +LE+ TG+
Sbjct: 183 ADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  101 bits (254), Expect = 7e-24
 Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 19/197 (9%)

Query: 593 GPFGRVY-ILSLPSGELIAVKK--LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG VY  L+L +G+ +A+K+  L     ++ K++  E+  L  ++H NIVK +G   +
Sbjct: 11  GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET 70

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHR 706
            +S+++I E+ + GSL  +I +       S+   +A+ V Q   GLAYLH+  V   +HR
Sbjct: 71  SDSLYIILEYAENGSLRQIIKKFG-PFPESL---VAVYVYQVLQGLAYLHEQGV---IHR 123

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS--SEYALSCYNAPEYGYSKKATAQ 764
           ++K+ NIL   D   KL DF +   + + +        + Y +    APE      A+  
Sbjct: 124 DIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWM----APEVIEMSGASTA 179

Query: 765 MDAYSFGVVLLELITGR 781
            D +S G  ++EL+TG 
Sbjct: 180 SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  100 bits (251), Expect = 3e-23
 Identities = 66/262 (25%), Positives = 117/262 (44%), Gaps = 24/262 (9%)

Query: 592 GGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
            G  G VY      +G+ +A+KK +    Q+ + +  E+  +   +H NIV     +   
Sbjct: 29  EGASGEVYKATDRATGKEVAIKK-MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG 87

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
           + ++++ E++  GSL D+I +   ++       +   V QGL YLH     +++HR++KS
Sbjct: 88  DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKS 144

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQ-STM-SSEYALSCYNAPEYGYSKKATAQMDAY 768
            NILL  D   KL DF     + +   + +++  + Y    + APE    K    ++D +
Sbjct: 145 DNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY----WMAPEVIKRKDYGPKVDIW 200

Query: 769 SFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           S G++ +E+  G      EP         +R    IT   I  L       +  +    L
Sbjct: 201 SLGIMCIEMAEGEPPYLREPP--------LRALFLITTKGIPPLKN--PEKWSPEFKDFL 250

Query: 829 EIALRCTSVMPEKRPSMFEVVK 850
               +C    PEKRPS  E+++
Sbjct: 251 N---KCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 4e-22
 Identities = 64/204 (31%), Positives = 112/204 (54%), Gaps = 19/204 (9%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSS-----------KTLKTEVKTLAKIRHKNI 640
           G +GRVY+ L++ +GE++AVK+ V      +           K L++E++TL  + H NI
Sbjct: 12  GTYGRVYLALNVTTGEMMAVKQ-VELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI 70

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           V+ LGF  ++E + +  E++  GS+G  + R   + +  +       V +GLAYLH    
Sbjct: 71  VQYLGFETTEEYLSIFLEYVPGGSIGSCL-RTYGRFEEQLVRFFTEQVLEGLAYLHSK-- 127

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYS 758
             +LHR++K+ N+L+DAD   K++DF + +   +        S      + APE  + YS
Sbjct: 128 -GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 759 KKATAQMDAYSFGVVLLELITGRQ 782
           +  +A++D +S G V+LE+  GR+
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 31/196 (15%)

Query: 603 LPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           LP+ E +A+K++    CQ+S   L+ EV+ +++  H N+VK    F   + ++L+  +L 
Sbjct: 23  LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82

Query: 662 MGSLGDLI---CRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            GSL D++     +    +  I   LK    V +GL YLH +     +HR++K+ NILL 
Sbjct: 83  GGSLLDIMKSSYPRGGLDEAIIATVLK---EVLKGLEYLHSN---GQIHRDIKAGNILLG 136

Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALS------CYNAPE-----YGYSKKATAQM 765
            D   K+ DF     V  +       +           C+ APE     +GY  KA    
Sbjct: 137 EDGSVKIADFG----VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKA---- 188

Query: 766 DAYSFGVVLLELITGR 781
           D +SFG+  +EL TG 
Sbjct: 189 DIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 8e-22
 Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 24/290 (8%)

Query: 593 GPFGRVYILSLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFH 648
           G FG VY+      +L+A+K L   +    +  +    E++ LA + H  NIVK+  FF 
Sbjct: 11  GSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ 68

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQ--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
            + S++L+ E++  GSL DL+ +   +  L  S  L I   +   L YLH      ++HR
Sbjct: 69  DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHR 125

Query: 707 NVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEY---GYS 758
           ++K +NILLD D    KL DF L +++ +    S++ +  + S     Y APE       
Sbjct: 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSL 185

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
             A++  D +S G+ L EL+TG    + E   S         KI +      +  P   +
Sbjct: 186 AYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPTPSLASPLSPS 242

Query: 819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSS 868
             +     A ++  +  +  P+ R S    +   H L     L   +LS 
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLS--HDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 592 GGPFGRVYI-LSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GG FG+VY  ++L +GEL+AVK  ++ +   ++ K +  E+K L  ++H N+VK  G   
Sbjct: 10  GGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             E +++  E+   G+L +L       L   +     + + +GLAYLH      ++HR++
Sbjct: 70  HREKVYIFMEYCSGGTLEEL-LEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDI 125

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-----CYNAPE---YGYSKK 760
           K  NI LD +   KL DF     +      +T   E   S      Y APE    G  K 
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKN---NTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 761 ATAQMDAYSFGVVLLELITGR 781
                D +S G V+LE+ TG+
Sbjct: 183 HGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 95.4 bits (237), Expect = 2e-21
 Identities = 76/284 (26%), Positives = 136/284 (47%), Gaps = 39/284 (13%)

Query: 593 GPFGRVYILSLP-----SGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE++AVK L    G Q++   K E+  L  + H+NIVK  G 
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGC 74

Query: 647 F--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                 + + LI E++ +GSL D + +    L  +  L  A  + +G+AYLH     H +
Sbjct: 75  CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--AQLLLFAQQICEGMAYLHSQ---HYI 129

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSE-----YALSCYNAPEYGY 757
           HR++ ++N+LLD D   K+ DF L + V  G   ++     +     YA+ C    ++ Y
Sbjct: 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSY 189

Query: 758 SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD---- 813
           +       D +SFGV L EL+T   ++Q+ P +  +++   + ++ +    I++L+    
Sbjct: 190 AS------DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR-LIELLERGMR 242

Query: 814 -PKIANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVKALH 853
            P   NC Q+       +   C     + RP+   +  ++K +H
Sbjct: 243 LPCPKNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEMH 282

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 2e-20
 Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 18/197 (9%)

Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V ++    +G+L A+K L        K      TE   L++I H  IVK+   F 
Sbjct: 4   GSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ 63

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRN 707
           ++E ++L+ E+   G L   + ++    +   R   A  +   L YLH    +    +R+
Sbjct: 64  TEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHSLGII----YRD 118

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQ-STM--SSEYALSCYNAPEYGYSKKATAQ 764
           +K +NILLDAD   KLTDF L + +     + +T   + EY      APE    K     
Sbjct: 119 LKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL-----APEVLLGKGYGKA 173

Query: 765 MDAYSFGVVLLELITGR 781
           +D +S GV+L E++TG+
Sbjct: 174 VDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 55/196 (28%), Positives = 102/196 (52%), Gaps = 14/196 (7%)

Query: 592 GGPFGRVY--ILSLPSGE--LIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLG 645
           GG FG V    L LP  +   +A+K L   G    + L   TE   + +  H NI+++ G
Sbjct: 14  GGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNIIRLEG 72

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLL 704
                  + +I E+++ GSL   +   D +      + +  G+A G+ YL + +YV    
Sbjct: 73  VVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---- 128

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEA-AFQSTMSSEYALSCYNAPEYGYSKKATA 763
           HR++ ++NIL++++   K++DF L R + ++ A  +T   +  +  + APE    +K T+
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR-WTAPEAIAYRKFTS 187

Query: 764 QMDAYSFGVVLLELIT 779
             D +SFG+V+ E+++
Sbjct: 188 ASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.0 bits (227), Expect = 5e-20
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 26/201 (12%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G +G VY      +GE++A+KK+       G  S+  L+ E+  L +++H NIVK+L   
Sbjct: 10  GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPST-ALR-EISLLKELKHPNIVKLLDVI 67

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           H++  ++L++E+  M  L   + ++   L  ++   I   + +GLAY H   +   LHR+
Sbjct: 68  HTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI---LHRD 123

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-------YGYSKK 760
           +K +NIL++ D   KL DF L R  G      T + E     Y APE       Y  +  
Sbjct: 124 LKPQNILINRDGVLKLADFGLARAFGIP--LRTYTHEVVTLWYRAPEILLGSKHYSTA-- 179

Query: 761 ATAQMDAYSFGVVLLELITGR 781
               +D +S G +  E+ITG+
Sbjct: 180 ----VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 90.2 bits (224), Expect = 7e-20
 Identities = 65/195 (33%), Positives = 106/195 (54%), Gaps = 12/195 (6%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V    +P+G ++A KK+V+ G +SS  K +  E++ + + R   IV   G 
Sbjct: 15  AGNGGSVSKV--KHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++ +I +  EF+  GSL D I ++   +   I  KIA+ V +GL YL+   V  ++HR
Sbjct: 72  FLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLY--NVHRIMHR 128

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K  NIL+++  + KL DF    + GE    S   +    S Y +PE     K T + D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFG---VSGE-LINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 767 AYSFGVVLLELITGR 781
            +S G+ ++EL  G+
Sbjct: 185 VWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 62/197 (31%), Positives = 99/197 (50%), Gaps = 15/197 (7%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKK-LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           AGN G   +V     P+G+++AVK   +       K +  E+  L K     IV   G F
Sbjct: 11  AGNSGVVSKVLHR--PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           +++  I +  E++  GSL  ++     ++   I  KIA+ V +GL YLH+ +   ++HR+
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126

Query: 708 VKSKNILLDADFEPKLTDFALD-RIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           VK  NIL+++  + KL DF +  ++V   A  F  T       S Y APE       + +
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGT-------SSYMAPERIQGNDYSVK 179

Query: 765 MDAYSFGVVLLELITGR 781
            D +S G+ L+EL TGR
Sbjct: 180 SDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 89.2 bits (221), Expect = 2e-19
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 24/278 (8%)

Query: 593 GPFGRVYILSLP-----SGELIAVKKLV-NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE +AVK L    G      LK E++ L  + H+NIVK  G 
Sbjct: 15  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 74

Query: 647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHL 703
              D    I LI EFL  GSL + + R   ++    +LK A+ + +G+ YL  + YV   
Sbjct: 75  CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV--- 131

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY-NAPEYGYSKKAT 762
            HR++ ++N+L++++ + K+ DF L + +       T+  +     +  APE     K  
Sbjct: 132 -HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD-----PKIA 817
              D +SFGV L EL+T   +E +     L ++     ++ +T   ++VL+     P+  
Sbjct: 191 IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LVRVLEEGKRLPRPP 249

Query: 818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           NC ++      ++  +C    P KR +   +++   ++
Sbjct: 250 NCPEE----VYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 53/195 (27%), Positives = 95/195 (48%), Gaps = 13/195 (6%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G  G V+      +GE +A+KK+      G   ++ L+ E+K L   +H  +VK+L  F 
Sbjct: 11  GAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFP 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
                 L+ E+     L +++  ++  L  +        + +G+AY+H + +   +HR++
Sbjct: 70  HGSGFVLVMEY-MPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI---MHRDL 125

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMD 766
           K  N+L+ AD   K+ DF L R+  E   +   S + A   Y APE  YG ++K    +D
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRL-YSHQVATRWYRAPELLYG-ARKYDPGVD 183

Query: 767 AYSFGVVLLELITGR 781
            ++ G +  EL+ G 
Sbjct: 184 LWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 21/199 (10%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT------LKTEVKTLAKIRHKNIVKVLG 645
           G FGRVY+   + +G  +AVK+ V F   S +T      L+ E++ L  ++H+ IV+  G
Sbjct: 13  GAFGRVYLCYDVDTGRELAVKQ-VPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYG 71

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
               DE++ +  E++  GS+ D + +    L  ++  K    + +G+ YLH +    ++H
Sbjct: 72  CLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSN---MIVH 127

Query: 706 RNVKSKNILLDADFEPKLTDF-ALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKK 760
           R++K  NIL D+    KL DF A  R+    +  + M S      + +PE     GY +K
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRK 187

Query: 761 ATAQMDAYSFGVVLLELIT 779
           A    D +S G  ++E++T
Sbjct: 188 A----DVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 47/197 (23%), Positives = 94/197 (47%), Gaps = 22/197 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY  +   +G+++A+K +        + +  E+  L +     IVK  G +  + 
Sbjct: 14  GSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYFKNT 71

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQL---QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            ++++ E+   GS+ D++   +  L   + +  L       +GL YLH +     +HR++
Sbjct: 72  DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---QTLKGLEYLHSN---KKIHRDI 125

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY----GYSKKATAQ 764
           K+ NILL+ + + KL DF +   + +   +   ++      + APE     GY+ KA   
Sbjct: 126 KAGNILLNEEGQAKLADFGVSGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNNKA--- 180

Query: 765 MDAYSFGVVLLELITGR 781
            D +S G+  +E+  G+
Sbjct: 181 -DIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 16/209 (7%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V  L    G+ +AVK L +    +   L  E   +  +RH N+V++LG       
Sbjct: 17  GEFGDVM-LGDYRGQKVAVKCLKDDSTAAQAFL-AEASVMTTLRHPNLVQLLGVVLQGNP 74

Query: 653 IFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKS 710
           ++++ E++  GSL D +  R    +  + +L  A+ V +G+ YL  K++V    HR++ +
Sbjct: 75  LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV----HRDLAA 130

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +     A Q   S +  +  + APE    KK + + D +SF
Sbjct: 131 RNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVK-WTAPEALREKKFSTKSDVWSF 185

Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWV 798
           G++L E+ + GR      P +  DVV  V
Sbjct: 186 GILLWEIYSFGRVPYPRIPLK--DVVPHV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 62/255 (24%), Positives = 122/255 (47%), Gaps = 25/255 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++        +A+K  +  G  S +    E + + K+ H  +V++ G       
Sbjct: 15  GQFGLVWLGYWLEKRKVAIKT-IREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP 73

Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q  +      L + + V +G+AYL    V   +HR++ ++N
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV---IHRDLAARN 130

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  +++PE     K +++ D +SFGV
Sbjct: 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK-WSSPEVFSFSKYSSKSDVWSFGV 189

Query: 773 VLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           ++ E+ +    E   P E+    +VV+ +       N   ++  P++A+          E
Sbjct: 190 LMWEVFS----EGKTPYENRSNSEVVETI-------NAGFRLYKPRLASQS------VYE 232

Query: 830 IALRCTSVMPEKRPS 844
           +   C    PE RPS
Sbjct: 233 LMQHCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 72/266 (27%), Positives = 135/266 (50%), Gaps = 27/266 (10%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           GNG  FG V++ +      +AVK L   G  S ++   E + + K+RH  +V++     S
Sbjct: 15  GNG-QFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-S 71

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRN 707
           +E I+++ E++  GSL D +   + + L+    + +A  VA G+AY+ + +Y+    HR+
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI----HRD 127

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           ++S NIL+      K+ DF L R++ +  + +   +++ +  + APE     + T + D 
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 186

Query: 768 YSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
           +SFG++L EL+T GR         + +V++ V R   +              C Q   + 
Sbjct: 187 WSFGILLTELVTKGRVPYPG--MNNREVLEQVERGYRMP-------------CPQDCPIS 231

Query: 827 ALEIALRCTSVMPEKRPSMFEVVKAL 852
             E+ L+C    PE+RP+ FE +++ 
Sbjct: 232 LHELMLQCWKKDPEERPT-FEYLQSF 256

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 6e-18
 Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 18/197 (9%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G VY      +GE++A+KK+          KT   E+K L ++ H NI+K+L  F  
Sbjct: 10  GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              ++L++EF+    L  LI  +   L  S+       + QGLA+ H   +   LHR++K
Sbjct: 70  KGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI---LHRDLK 125

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-----YGYSKKATAQ 764
            +N+L++ +   KL DF L R  G        +       Y APE      GYS      
Sbjct: 126 PENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGYSTP---- 179

Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G +  EL++ R
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.3 bits (219), Expect = 6e-18
 Identities = 58/164 (35%), Positives = 81/164 (49%), Gaps = 22/164 (13%)

Query: 400 VMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL 458
            +  + L    + G IP ++ K R L S++L+ NS+ G IPPSL  +  L  LDLS N+ 
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 459 TGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLP---ASY-LQGNPGLCG-PGLSNS 512
            G IP+ L  L  L + N++ N LSGRVP +L  G     AS+    N GLCG PGL   
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAAL-GGRLLHRASFNFTDNAGLCGIPGL--- 534

Query: 513 CDENQPKHRTSGPT--ALACVMISLAVAVGIM-MVAAGFFVFHR 553
                   R  GP     A + I+  V+V  + +V      + R
Sbjct: 535 --------RACGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKR 570

Length = 623

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 84.1 bits (208), Expect = 6e-18
 Identities = 62/263 (23%), Positives = 131/263 (49%), Gaps = 25/263 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    +   +A+K  +N G  S +    E K + K+ H  +V++ G     + 
Sbjct: 15  GQFGVVHLGKWRAQIKVAIKA-INEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP 73

Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           ++++ EF++ G L + + ++  +L   + L +   V +G+ YL ++     +HR++ ++N
Sbjct: 74  LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARN 130

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+ +    K++DF + R V +  + S+  +++ +  ++ PE     K +++ D +SFGV
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK-WSPPEVFNFSKYSSKSDVWSFGV 189

Query: 773 VLLELITGRQAEQAEPAES---LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           ++ E+ T    E   P E     +VV+ + R         ++  PK+A+          E
Sbjct: 190 LMWEVFT----EGKMPFEKKSNYEVVEMISR-------GFRLYRPKLASMT------VYE 232

Query: 830 IALRCTSVMPEKRPSMFEVVKAL 852
           +   C    PE RP+  E+++A+
Sbjct: 233 VMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 32/267 (11%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+     +   +A+K L +      +  + EV+ L ++RHK+++ +       E 
Sbjct: 17  GYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP 76

Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +++I E ++ GSL   +   + Q L  +  + +A  VA+G+AYL +    + +HR++ ++
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAAR 133

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE---YG-YSKKATAQMDA 767
           NIL+  D   K+ DF L R++ E  + S  S +     + APE   +G +S K+    D 
Sbjct: 134 NILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFSTKS----DV 187

Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA 827
           +SFG++L E+ T  Q     P   ++  +   +   IT G      P  A C Q+     
Sbjct: 188 WSFGILLYEMFTYGQV----PYPGMNNHEVYDQ---ITAGYRM---PCPAKCPQE----I 233

Query: 828 LEIALRCTSVMPEKRPSMFEVVKALHS 854
            +I L C +  PE RPS     KAL  
Sbjct: 234 YKIMLECWAAEPEDRPSF----KALRE 256

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.0 bits (207), Expect = 8e-18
 Identities = 54/192 (28%), Positives = 104/192 (54%), Gaps = 10/192 (5%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G    +    E + + K+RH  +V +     S+E 
Sbjct: 17  GCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEP 74

Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ EF+  GSL D +   D + L+    + +A  +A G+AY+ + +Y+    HR++++
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI----HRDLRA 130

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 189

Query: 771 GVVLLELIT-GR 781
           G++L EL+T GR
Sbjct: 190 GILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 1e-17
 Identities = 78/293 (26%), Positives = 136/293 (46%), Gaps = 44/293 (15%)

Query: 593 GPFGRVYILSL----PSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++       P+ +  L+AVK L +    + K  + E + L  ++H++IVK  G 
Sbjct: 16  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 75

Query: 647 FHSDESIFLIYEFLQMGSLGD-----------LICRQDFQ----LQWSIRLKIAIGVAQG 691
               + + +++E+++ G L             L+  Q  Q    L  S  L IA  +A G
Sbjct: 76  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 135

Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YL      H +HR++ ++N L+ A+   K+ DF + R V    +            + 
Sbjct: 136 MVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAE-QAEPAESLDVVKWVRRKINITNGAI 809
            PE    +K T + D +SFGV+L E+ T G+Q   Q    E ++          IT G  
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---------ITQG-- 241

Query: 810 QVLD-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
           +VL+ P++  C ++      +I L C    P++R ++ E+ K LH+L   T +
Sbjct: 242 RVLERPRV--CPKE----VYDIMLGCWQREPQQRLNIKEIYKILHALGKATPI 288

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 68/272 (25%), Positives = 136/272 (50%), Gaps = 27/272 (9%)

Query: 583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVK 642
           +++K  AG    FG V++ +      +AVK +   G  S +    E   +  ++H  +VK
Sbjct: 10  LEKKLGAGQ---FGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL-KIAIGVAQGLAYLHKDYVP 701
            L    + E I++I EF+  GSL D +   +   Q   +L   +  +A+G+A++ +    
Sbjct: 66  -LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR--- 121

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
           + +HR++++ NIL+ A    K+ DF L R++ +  + +   +++ +  + APE       
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSF 180

Query: 762 TAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY 820
           T + D +SFG++L+E++T GR         + +V++ + R   +         P+  NC 
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM---------PRPENCP 229

Query: 821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           ++       I +RC    PE+RP+ FE ++++
Sbjct: 230 EE----LYNIMMRCWKNRPEERPT-FEYIQSV 256

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.7 bits (207), Expect = 2e-17
 Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 15/208 (7%)

Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 15  GNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVC 74

Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
           +S    ++ L+ E+L  GSL D + +   +L     L  A  + +G+ YL  K YV    
Sbjct: 75  YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV---- 130

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++++   K+ DF L +++   +  ++     E  +  Y APE     K +
Sbjct: 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFS 189

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAE 790
              D +SFGVVL EL T      + PAE
Sbjct: 190 VASDVWSFGVVLYELFTYSDKSCSPPAE 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 17  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 74

Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 75  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 130

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 131 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 189

Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 190 GILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 70/278 (25%), Positives = 136/278 (48%), Gaps = 44/278 (15%)

Query: 581 IGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI 640
           + ++ K  AG    FG V++ +      +AVK L   G  S +    E + + K+RH  +
Sbjct: 8   LKLERKLGAGQ---FGEVWMGTWNGTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKL 63

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF-------QLQWSIRLKIAIGVAQGLA 693
           V++      +E I+++ E++  GSL       DF       +L+    + +A  +A+G+A
Sbjct: 64  VQLYAVCSEEEPIYIVTEYMSKGSL------LDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL      + +HR++ ++NIL+  +   K+ DF L R++ +  + +   +++ +  + AP
Sbjct: 118 YLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK-WTAP 173

Query: 754 EYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAI 809
           E     + T + D +SFG++L E++T GR      P   +   +V++ V R   +     
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGRV-----PYPGMTNREVLEQVERGYRM----- 223

Query: 810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFE 847
               P+  NC ++      ++ L+C    PE+RP+ FE
Sbjct: 224 ----PRPPNCPEE----LYDLMLQCWDKDPEERPT-FE 252

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 65/262 (24%), Positives = 122/262 (46%), Gaps = 25/262 (9%)

Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V+     +   +AVK L   G    K    E + + K+RH  ++++      +E
Sbjct: 16  AGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE 74

Query: 652 SIFLIYEFLQMGSLGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            I+++ E ++ GSL + +       L+    + +A  VA G+AYL      + +HR++ +
Sbjct: 75  PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAA 131

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  +   K+ DF L R++ E  +++   +++ +  + APE     + + + D +SF
Sbjct: 132 RNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK-WTAPEAALYNRFSIKSDVWSF 190

Query: 771 GVVLLELIT-GRQAEQAEP-AESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           G++L E++T GR        AE L  V    R             P    C ++      
Sbjct: 191 GILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM------------PCPPGCPKE----LY 234

Query: 829 EIALRCTSVMPEKRPSMFEVVK 850
           +I L C    P+ RP+ FE ++
Sbjct: 235 DIMLDCWKEDPDDRPT-FETLQ 255

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.4 bits (201), Expect = 1e-16
 Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 47/289 (16%)

Query: 593 GPFGRVY---ILSLPSGE---LIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FGRV+      L   E   ++AVK L            + E   +A+  H NIVK+LG
Sbjct: 16  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLG 75

Query: 646 FFHSDESIFLIYEFLQMGSL-----------------GDLICRQD----FQLQWSIRLKI 684
                + + L++E++  G L                      R+       L  + +L I
Sbjct: 76  VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCI 135

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           A  VA G+AYL +      +HR++ ++N L+  +   K+ DF L R +  A +     ++
Sbjct: 136 AKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192

Query: 745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN 803
                +  PE  +  + T + D +++GVVL E+ + G Q       E  +V+ +VR    
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--EVIYYVR---- 246

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
                    D  + +C     L    +   C S +P  RPS   + + L
Sbjct: 247 ---------DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 61/220 (27%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G+VY   +  +GEL+A+KK+   N       T   E+K L K+RH NIV++     S
Sbjct: 10  GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS 69

Query: 650 DE--SIFLIYEFLQMGSLGDLICRQDFQLQWSIR---LKIAIG--------VAQGLAYLH 696
               SI++++E++            D  L   +    +K            + +GL YLH
Sbjct: 70  KGKGSIYMVFEYM------------DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC------- 749
            +    +LHR++K  NIL++ D   KL DF L R           +   +          
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLAR---------PYTKRNSADYTNRVITL 165

Query: 750 -YNAPE-------YGYSKKATAQMDAYSFGVVLLELITGR 781
            Y  PE       YG       ++D +S G +L EL  G+
Sbjct: 166 WYRPPELLLGATRYGP------EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 61/268 (22%), Positives = 120/268 (44%), Gaps = 36/268 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFHS 649
           G FG V+ +   + + +   K ++    + +  +    E + LAK+    I++    F  
Sbjct: 11  GSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD 70

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQ-----LQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
              + ++ E+ + G L  L+  Q  +       W   ++I +G    LA+LH   +   L
Sbjct: 71  KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHLHSKKI---L 123

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQSTM-SSEYALSCYNAPEYGYSKKAT 762
           HR++KS N+ LDA    K+ D  + +++ +   F +T+  + Y    Y +PE    K   
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY----YLSPELCEDKPYN 179

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
            + D ++ GVVL E  TG+    A    +L ++K +R              P ++  Y Q
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANNQGAL-ILKIIRGVF-----------PPVSQMYSQ 227

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVK 850
           Q+    ++  +C +    +RP  F++++
Sbjct: 228 QL---AQLIDQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 593 GPFGRVYILSLPSG------ELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V++            EL+AVK L       + K  + E + L   +H+NIVK  G
Sbjct: 16  GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQD-------------FQLQWSIRLKIAIGVAQGL 692
                +   +++E+++ G L   +                  +L  S  L+IA+ +A G+
Sbjct: 76  VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H +HR++ ++N L+  D   K+ DF + R V    +            +  
Sbjct: 136 VYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMP 192

Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQ 782
           PE    +K T + D +SFGVVL E+ T G+Q
Sbjct: 193 PESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.3 bits (200), Expect = 2e-16
 Identities = 76/281 (27%), Positives = 133/281 (47%), Gaps = 31/281 (11%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY    + + E++A+KK+   G QS++  +    EVK L +I+H N ++  G + 
Sbjct: 36  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  DL+      LQ      I  G  QGLAYLH     +++HR++
Sbjct: 96  REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDI 151

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQM 765
           K+ NILL    + KL DF      G A+  S  +S      + APE   +    +   ++
Sbjct: 152 KAGNILLTEPGQVKLADF------GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +S G+  +EL     AE+  P  +++ +  +    +I       L     + Y +  +
Sbjct: 206 DVWSLGITCIEL-----AERKPPLFNMNAMSAL---YHIAQNESPTLQSNEWSDYFRNFV 257

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIEL 866
            +      C   +P+ RP+  E++K +  L  R   + I+L
Sbjct: 258 DS------CLQKIPQDRPTSEELLKHMFVLRERPETVLIDL 292

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 57/254 (22%), Positives = 121/254 (47%), Gaps = 20/254 (7%)

Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++    +   +AVK L   G  S +    E   +  ++H  +V++      +E
Sbjct: 16  AGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 74

Query: 652 SIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            I++I E++  GSL D +   +  ++     +  +  +A+G+AY+ +    + +HR++++
Sbjct: 75  PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRA 131

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            N+L+      K+ DF L R++ +  + +   +++ +  + APE       T + D +SF
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSF 190

Query: 771 GVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           G++L E++T  +      + S DV+  ++R   +         P++ NC  +      +I
Sbjct: 191 GILLYEIVTYGKIPYPGMSNS-DVMSALQRGYRM---------PRMENCPDE----LYDI 236

Query: 831 ALRCTSVMPEKRPS 844
              C     E+RP+
Sbjct: 237 MKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 65/195 (33%), Positives = 99/195 (50%), Gaps = 12/195 (6%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V  L  PSG LI  +KL++   + +    +  E+K L +     IV   G 
Sbjct: 11  AGNGGVVTKV--LHRPSG-LIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++  +I  KI+I V +GL YL + +   ++HR
Sbjct: 68  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKH--KIMHR 124

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       T Q D
Sbjct: 125 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSD 180

Query: 767 AYSFGVVLLELITGR 781
            +S G+ L+E+  GR
Sbjct: 181 IWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 43/211 (20%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL-----------VNFGCQSSKTLKTEVKTLAKIRHKNI 640
           G +  VY      +G ++A+KK+           +NF      T   E+K L +++H NI
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF------TALREIKLLQELKHPNI 64

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLK------IAIGVAQGL 692
           + +L  F    +I L++EF++     DL  + +       SI L         +   +GL
Sbjct: 65  IGLLDVFGHKSNINLVFEFME----TDLEKVIKDK-----SIVLTPADIKSYMLMTLRGL 115

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YLH +++   LHR++K  N+L+ +D   KL DF L R  G       M+ +     Y A
Sbjct: 116 EYLHSNWI---LHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NRKMTHQVVTRWYRA 170

Query: 753 PE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           PE  +G ++     +D +S G +  EL+   
Sbjct: 171 PELLFG-ARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 11  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 70  TENKLYLVFEFLHQ----DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---L 122

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 181 A-VDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 18/194 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLG-FFHSD 650
           G FG V      +G+ +AVK   N  C  +++    E   + K+ HKN+V++LG   H  
Sbjct: 17  GEFGAVLQGEY-TGQKVAVK---NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-- 70

Query: 651 ESIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
             ++++ E +  G+L + +  R    +     L+ ++ VA+G+ YL       L+HR++ 
Sbjct: 71  NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLA 127

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           ++NIL+  D   K++DF L R+       S +  +     + APE    KK +++ D +S
Sbjct: 128 ARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWS 182

Query: 770 FGVVLLELIT-GRQ 782
           +GV+L E+ + GR 
Sbjct: 183 YGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 78.8 bits (194), Expect = 8e-16
 Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 35/266 (13%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A+K++ N   Q  K L   E+  + + +H NIV  L  +   
Sbjct: 30  GASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG 88

Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH +    ++HR+
Sbjct: 89  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QVIHRD 140

Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTM-SSEYALSCYNAPEYGYSKKATAQM 765
           +KS NILL  D   KLTDF    +I  E + +STM  + Y    + APE    K    ++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY----WMAPEVVTRKAYGPKV 196

Query: 766 DAYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           D +S G++ +E++ G      E P  +L ++         TNG  ++ +P+  +   +  
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDF 248

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVK 850
           L       RC  +  EKR S  E+++
Sbjct: 249 LN------RCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 79.3 bits (195), Expect = 8e-16
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG LI  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 15  AGNGGVVTKVQ--HKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GLAYL + +   ++HR
Sbjct: 72  FYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHR 128

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+EL  GR       A+ L+ +
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAI 213

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.9 bits (194), Expect = 8e-16
 Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 17/192 (8%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY    + + E++A+KK+   G QS++  +    EV+ L K+RH N ++  G + 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  DL+      LQ      +  G  QGLAYLH     +++HR+V
Sbjct: 86  REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 141

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQM 765
           K+ NILL      KL DF      G A+  +  +       + APE   +    +   ++
Sbjct: 142 KAGNILLSEPGLVKLGDF------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 766 DAYSFGVVLLEL 777
           D +S G+  +EL
Sbjct: 196 DVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.6 bits (199), Expect = 1e-15
 Identities = 50/149 (33%), Positives = 70/149 (46%), Gaps = 35/149 (23%)

Query: 136 WVLD---LSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNA 192
           W +D   L    + G IP  I  L +LQ +NL  N + G++P   G+ + L VLDLS N+
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477

Query: 193 YLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS 252
                                    F+G IP+S   L SL IL+L+ N+L+G VP +LG 
Sbjct: 478 -------------------------FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512

Query: 253 SLLKLVSFDVSQNKLSGSFPNGICKANGL 281
            LL   SF+ + N        G+C   GL
Sbjct: 513 RLLHRASFNFTDNA-------GLCGIPGL 534

Length = 623

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 42/167 (25%), Positives = 88/167 (52%), Gaps = 4/167 (2%)

Query: 613 KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQ 672
           K++  G  S      E K + K+ H+ +V++ G       I+++ E++  G L + +   
Sbjct: 34  KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH 93

Query: 673 DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
             + Q S  L++   V +G+AYL        +HR++ ++N L+D     K++DF L R V
Sbjct: 94  GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150

Query: 733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 151 LDDEYTSSVGSKFPVR-WSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 66/267 (24%), Positives = 122/267 (45%), Gaps = 48/267 (17%)

Query: 605 SGELIAVKKLVNFGCQSSK--------TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           +G L+AVK+ V +  +++          L+ E++ +A++ H +I+++LG    D    L 
Sbjct: 24  TGTLMAVKQ-VTY-VRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81

Query: 657 YEFLQMGSLGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
            E++  GS+  L+    +   + ++ +     + +GL+YLH++ +   +HR+VK  N+L+
Sbjct: 82  VEWMAGGSVSHLL--SKYGAFKEAVIINYTEQLLRGLSYLHENQI---IHRDVKGANLLI 136

Query: 716 DADFEP-KLTDFAL-----DRIVGEAAFQSTMSSEYALSCYNAPE------YGYSKKATA 763
           D+  +  ++ DF        +  G   FQ  +    A   + APE      YG S     
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA---FMAPEVLRGEQYGRS----- 188

Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
             D +S G V++E+ T +    AE   +   + +   KI     A     P I       
Sbjct: 189 -CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASATTA-----PSIPEHLSP- 238

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVK 850
             G  ++ LRC  + PE RP   E++K
Sbjct: 239 --GLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 45/188 (23%), Positives = 93/188 (49%), Gaps = 5/188 (2%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++        +A+K ++  G  S      E K + K+ H N+V++ G       
Sbjct: 15  GQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP 73

Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           IF++ E++  G L + +  +  +L     L +   V + + YL  +     +HR++ ++N
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF---IHRDLAARN 130

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  D   K++DF L R V +  + S+  +++ +  +  PE     + +++ D +SFGV
Sbjct: 131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK-WAPPEVFDYSRFSSKSDVWSFGV 189

Query: 773 VLLELITG 780
           ++ E+ + 
Sbjct: 190 LMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 79/281 (28%), Positives = 124/281 (44%), Gaps = 38/281 (13%)

Query: 593 GPFGRVY------ILSLPSGEL-IAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVL 644
           G FG VY      IL   SG + +AVK L      Q  K    E   ++   H NIVK+L
Sbjct: 6   GAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLL 65

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI---CRQDFQ---LQWSIRLKIAIGVAQGLAYLHKD 698
           G    +E  ++I E ++ G L   +     + F    L     L I + VA+G  YL + 
Sbjct: 66  GVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ- 124

Query: 699 YVPHLLHRNVKSKNILL-----DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
              H +HR++ ++N L+     DAD   K+ DF L R + ++ +            + AP
Sbjct: 125 --MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAP 182

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVVKWVRRKINITNGAIQVL 812
           E     K T Q D +SFGV++ E++T  Q  Q  PA +  +V++ V        G +Q  
Sbjct: 183 ESLLDGKFTTQSDVWSFGVLMWEILTLGQ--QPYPALNNQEVLQHVT-----AGGRLQ-- 233

Query: 813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
             K  NC  +      ++   C +  P +RP+   + + L 
Sbjct: 234 --KPENCPDK----IYQLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 77.4 bits (190), Expect = 3e-15
 Identities = 70/265 (26%), Positives = 128/265 (48%), Gaps = 31/265 (11%)

Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY  +   + E++AVKK+   G Q+++  +    EVK L +++H N ++  G + 
Sbjct: 32  GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  DL+      LQ      I  G  QGLAYLH     +++HR++
Sbjct: 92  KEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDI 147

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQM 765
           K+ NILL    + KL DF      G A+  S  +S      + APE   +    +   ++
Sbjct: 148 KAGNILLTEPGQVKLADF------GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +S G+  +EL     AE+  P  +++ +  +       +  +Q      +N +     
Sbjct: 202 DVWSLGITCIEL-----AERKPPLFNMNAMSALYHIAQNDSPTLQ------SNEWTDSFR 250

Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
           G ++    C   +P++RP+  E+++
Sbjct: 251 GFVDY---CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 75.3 bits (185), Expect = 7e-15
 Identities = 66/268 (24%), Positives = 134/268 (50%), Gaps = 36/268 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++        +A+K L   G  S +    E   + +++H  +V++     + E 
Sbjct: 17  GQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEP 74

Query: 653 IFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKS 710
           I++I E+++ GSL D +   +  +L  +  + +A  +A+G+A++  K+Y+    HR++++
Sbjct: 75  IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI----HRDLRA 130

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKATAQMDA 767
            NIL+      K+ DF L R++ +  + +   +++ +  + APE   YG     T + D 
Sbjct: 131 ANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYG---TFTIKSDV 186

Query: 768 YSFGVVLLELIT-GR--QAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           +SFG++L E++T GR        P    +V++ + R   +         P+  NC ++  
Sbjct: 187 WSFGILLTEIVTYGRIPYPGMTNP----EVIQNLERGYRM---------PRPDNCPEE-- 231

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKAL 852
               E+   C    PE+RP+ FE ++++
Sbjct: 232 --LYELMRLCWKEKPEERPT-FEYLRSV 256

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 35/231 (15%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQL-QWSIRLKIAI 686
           E+  L+ ++H NI+     F  D ++ +  E+   G+L D I RQ  QL +  + L    
Sbjct: 49  EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108

Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY- 745
            +   ++Y+HK  +   LHR++K+ NI L      KL DF + +I         + SEY 
Sbjct: 109 QIVSAVSYIHKAGI---LHRDIKTLNIFLTKAGLIKLGDFGISKI---------LGSEYS 156

Query: 746 -ALSC-----YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
            A +      Y +PE     K   + D ++ G VL EL+T ++   A             
Sbjct: 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------------ 204

Query: 800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             +N+    +Q     + + Y  ++   + +        PEKRP+  EV+ 
Sbjct: 205 NPLNLVVKIVQGNYTPVVSVYSSEL---ISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 1e-14
 Identities = 42/118 (35%), Positives = 57/118 (48%), Gaps = 11/118 (9%)

Query: 62  WTGVTCVTTATASLTVAS-INLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLS 120
           W+G  C   +T        + L +  L G I + + +L  L ++NL+ N     IP  L 
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463

Query: 121 QCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG 178
             +SLE L          DLS N   G IPES+G L +L++LNL  N LSG VP   G
Sbjct: 464 SITSLEVL----------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 55/208 (26%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V  +     G+++  K++ ++G  + K    L +EV  L +++H NIV+      
Sbjct: 11  GSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII 69

Query: 649 --SDESIFLIYEFLQMGSLGDLI--CRQDFQ-LQWSIRLKIAIGVAQGLAYLH--KDYVP 701
             S+++++++ E+ + G L  LI  C+++ + ++     +I   +   L   H   D   
Sbjct: 70  DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQST-------MSSEYALSCYNAP 753
            +LHR++K  NI LDA+   KL DF L +I+G  + F  T       MS E         
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS--- 186

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGR 781
              Y +K+    D +S G ++ EL    
Sbjct: 187 ---YDEKS----DIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 593 GPFGRVYILSLPSGELIAVKKL------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G +G VY      G+LIAVK++      V    +  + L+ EV  L  ++H NIV+ LG 
Sbjct: 11  GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
              D +I +  EF+  GS+  ++ R     +     K    +  G+AYLH + V   +HR
Sbjct: 71  CLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFC-KYTKQILDGVAYLHNNCV---VHR 126

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS----SEYALSCYNAPEY----GYS 758
           ++K  N++L  +   KL DF   R +       T S    S +    + APE     GY 
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYG 186

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           +K+    D +S G  + E+ TG+
Sbjct: 187 RKS----DIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 62/240 (25%), Positives = 93/240 (38%), Gaps = 38/240 (15%)

Query: 591 NGGPFGRVY------------ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHK 638
           + G FG VY            I  L   ++IA  ++ N        +K E   +      
Sbjct: 5   SKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN--------VKAERAIMMIQGES 56

Query: 639 -NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLH 696
             + K+   F S + ++L+ E+L  G    LI         W  +  IA  V  G+  LH
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW-AKQYIA-EVVLGVEDLH 114

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQSTMSSEYALSCYNAPEY 755
           +     ++HR++K +N+L+D     KLTDF L R   E   F  T         Y APE 
Sbjct: 115 QR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-------YLAPET 164

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDP 814
                     D +S G V+ E + G     AE P    D +  + R+IN      +   P
Sbjct: 165 ILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI--LSRRINWPEEVKEFCSP 222

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 49/294 (16%)

Query: 593 GPFGRV------YILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V       +        +AVK L      S  + L +E   L ++ H +++K+ G
Sbjct: 11  GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYG 70

Query: 646 FFHSDESIFLIYEFLQMGSL------------------GDLICRQDFQ-----LQWSIRL 682
               D  + LI E+ + GSL                  G+             L     +
Sbjct: 71  ACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI 130

Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
             A  +++G+ YL +     L+HR++ ++N+L+    + K++DF L R V E       S
Sbjct: 131 SFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK 801
                  + A E  +    T Q D +SFGV+L E++T G         E L         
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL--------- 238

Query: 802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
            N+     ++  P+  NC ++       + L C    P+KRP+  ++ K L  +
Sbjct: 239 FNLLKTGYRMERPE--NCSEE----MYNLMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 25/207 (12%)

Query: 593 GPFGRVYI--LSLPSGEL----IAVKKLV-NFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+VY   L+ P+  L    +A+K L  N   +  +  + E + ++ ++H NIV +LG
Sbjct: 16  GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75

Query: 646 FFHSDESIFLIYEFLQMGSL----------GDLICRQDFQ-----LQWSIRLKIAIGVAQ 690
               ++   +++E+L  G L           D+      +     L  S  L IAI +A 
Sbjct: 76  VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           G+ YL      H +HR++ ++N L+      K++DF L R +  A +    S       +
Sbjct: 136 GMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRW 192

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLEL 777
             PE     K T + D +SFGVVL E+
Sbjct: 193 MPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 47/274 (17%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG++Y+    S     V K ++      +  +  K EV  LAK++H NIV     F  
Sbjct: 11  GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE 70

Query: 650 DESIFLIYEFLQMGSLGDLICRQ-------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           +  +F++ E+   G L   I RQ       D  L W ++      ++ GL ++H      
Sbjct: 71  NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISLGLKHIHDR---K 121

Query: 703 LLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPEYG 756
           +LHR++KS+NI L  +    KL DF + R + +       S E A +C     Y +PE  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-------SMELAYTCVGTPYYLSPEIC 174

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
            ++    + D +S G VL EL T +      P E  ++ + V   + I  G    + P  
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKH-----PFEGNNLHQLV---LKICQGYFAPISPNF 226

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           +     + L +     +   V P  RPS+  ++K
Sbjct: 227 S--RDLRSLIS-----QLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 50/190 (26%), Positives = 98/190 (51%), Gaps = 7/190 (3%)

Query: 592 GGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY  +       +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 16  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 74

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              ++I EF+  G+L D +   + Q +   + L +A  ++  + YL K    + +HR++ 
Sbjct: 75  PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLA 131

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D ++
Sbjct: 132 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVWA 190

Query: 770 FGVVLLELIT 779
           FGV+L E+ T
Sbjct: 191 FGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 50/186 (26%), Positives = 85/186 (45%), Gaps = 20/186 (10%)

Query: 605 SGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
           +GE++A+KK           KT   EVK L ++RH+NIV +   F     ++L++E+++ 
Sbjct: 25  TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER 84

Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK 722
            +L +L+      L           + Q +AY H   +   +HR++K +NIL+      K
Sbjct: 85  -TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI---IHRDIKPENILVSESGVLK 140

Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-------YGYSKKATAQMDAYSFGVVLL 775
           L DF   R +      S ++   A   Y APE       YG        +D ++ G ++ 
Sbjct: 141 LCDFGFARALRARP-ASPLTDYVATRWYRAPELLVGDTNYG------KPVDVWAIGCIMA 193

Query: 776 ELITGR 781
           EL+ G 
Sbjct: 194 ELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 29/181 (16%)

Query: 623 KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQ---DFQLQW 678
           K +K E + L ++  H  I+K+   F  +E+++ + E+   G L   I +    D +   
Sbjct: 46  KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK--- 102

Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE---- 734
             R   A  +   L YLH   +   +HR++K +NILLD D   K+TDF   +++      
Sbjct: 103 CTRFYAA-EILLALEYLHSKGI---IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Query: 735 ----AAFQSTMSSEYALSC----------YNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
                   +  S                 Y +PE    K A    D ++ G ++ +++TG
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218

Query: 781 R 781
           +
Sbjct: 219 K 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 78/283 (27%), Positives = 134/283 (47%), Gaps = 38/283 (13%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89

Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R  +     Q L +LH + V   +HR+
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSNQV---IHRD 141

Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E   QS  S+      + APE    K    ++D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 250

Query: 826 GALEIALRCTSVMPEKRPSMFEV-----VKALHSLSTRTSLLS 863
                  RC  +  EKR S  E+     +K    LS+ T L++
Sbjct: 251 N------RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 65/233 (27%), Positives = 119/233 (51%), Gaps = 18/233 (7%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE- 651
           G FG V +L    G  +AVK + N    +++    E   + ++RH N+V++LG    ++ 
Sbjct: 17  GEFGDV-MLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73

Query: 652 SIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            ++++ E++  GSL D L  R    L     LK ++ V + + YL  +   + +HR++ +
Sbjct: 74  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAA 130

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +   EA+  ST  +      + APE    KK + + D +SF
Sbjct: 131 RNVLVSEDNVAKVSDFGLTK---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185

Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRR--KINITNGAIQVLDPKIANCY 820
           G++L E+ + GR      P +  DVV  V +  K++  +G   V+   +  C+
Sbjct: 186 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPVVYDVMKQCW 236

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 21/201 (10%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS----KTLKTEVKTLAKIRHKNIVKVLG 645
           G GG   +  +    +  +I   K +      +    K +  E++     +   IVK  G
Sbjct: 12  GAGGSVTKCRL---KNTGMIFALKTIT--TDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 646 FF--HSDESIFLIYEFLQMGSLGDL---ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F   S  SI +  E+ + GSL  +   + ++  ++   +  KIA  V +GL+YLH   +
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
              +HR++K  NILL    + KL DF    + GE    S   +    S Y APE    K 
Sbjct: 127 ---IHRDIKPSNILLTRKGQVKLCDFG---VSGELV-NSLAGTFTGTSFYMAPERIQGKP 179

Query: 761 ATAQMDAYSFGVVLLELITGR 781
            +   D +S G+ LLE+   R
Sbjct: 180 YSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 47/193 (24%), Positives = 88/193 (45%), Gaps = 11/193 (5%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V I+    + ++ A+K +    C    S + +  E + L ++ H  +V +   F 
Sbjct: 11  GAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ 70

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            +E+++L+ + L  G L   + ++    +  ++  I   +   L YLH      ++HR++
Sbjct: 71  DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALEYLHSK---GIIHRDI 126

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K  NILLD      +TDF +   V      ++ S       Y APE    +  +  +D +
Sbjct: 127 KPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG---YMAPEVLCRQGYSVAVDWW 183

Query: 769 SFGVVLLELITGR 781
           S GV   E + G+
Sbjct: 184 SLGVTAYECLRGK 196

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 46/240 (19%)

Query: 590 GNGGPFGRVYILSL-PSGELIAVKKL-----VNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G GG FGRV ++ +       A+K +     V  G Q  + + +E + L +  H  IVK+
Sbjct: 2   GVGG-FGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
              F   + I+++ E+   G L  ++  +    +++ R  IA  V     YLH      +
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GI 114

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----- 754
           ++R++K +N+LLD++   KL DF   + +       T        C    Y APE     
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF-------CGTPEYVAPEIILNK 167

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGRQ---AEQAEPAESLDVVKWVRRKINITNGAIQ 810
            Y +S      +D +S G++L EL+TGR     +  +P E       +   I   NG ++
Sbjct: 168 GYDFS------VDYWSLGILLYELLTGRPPFGEDDEDPME-------IYNDILKGNGKLE 214

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 20/201 (9%)

Query: 596 GRVYILSLPSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF 654
           G +Y+  +   +L+A+K L +    Q     + E   +A++ H NIV +LG    ++ + 
Sbjct: 24  GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83

Query: 655 LIYEFLQMGSLGD-LICR-----------QDFQLQWSIR----LKIAIGVAQGLAYLHKD 698
           +++E+L  G L + LI R           +D  ++ S+     L IAI +A G+ YL   
Sbjct: 84  MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
           +    +H+++ ++NIL+      K++D  L R +  A +            +  PE    
Sbjct: 144 F---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200

Query: 759 KKATAQMDAYSFGVVLLELIT 779
            K ++  D +SFGVVL E+ +
Sbjct: 201 GKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 27/265 (10%)

Query: 592 GGPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGF 646
            G FG V   +  + SG+ +  AVK L      + K     E   +A++ H  IV+++G 
Sbjct: 5   HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGV 64

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
               E + L+ E   +G L   + ++  ++  S   ++A  VA G+AYL      H +HR
Sbjct: 65  CKG-EPLMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESK---HFVHR 119

Query: 707 NVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           ++ ++N+LL    + K++DF + R +  G   +++T +  + L  Y APE     K +++
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINYGKFSSK 178

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
            D +S+GV L E  +       E   + +V+  +     +         P+   C Q+  
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLESGERL---------PRPEECPQE-- 226

Query: 825 LGALEIALRCTSVMPEKRPSMFEVV 849
                I L C    PE RP+  E+ 
Sbjct: 227 --IYSIMLSCWKYRPEDRPTFSELE 249

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 30/263 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G +G VY +  L   +  A+K+ V+ G  S K  +    E++ LA + H NI+     F 
Sbjct: 11  GSYGSVYKVKRLSDNQFYALKE-VDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQ---LQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
               + ++ E+   G L   I ++  +   +      +I I + +GL  LH+     +LH
Sbjct: 70  DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILH 126

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++KS NILL A+   K+ D      + +   ++   ++     Y APE    +  + + 
Sbjct: 127 RDLKSANILLVANDLVKIGDLG----ISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +S G +L E+ T     +A   + L   K  R K            P I   Y Q + 
Sbjct: 183 DIWSLGCLLYEMATFAPPFEARSMQDLR-YKVQRGKY-----------PPIPPIYSQDL- 229

Query: 826 GALEIALRCTSVMPEKRPSMFEV 848
                      V P+ RP+  ++
Sbjct: 230 --QNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 72.8 bits (178), Expect = 8e-14
 Identities = 71/265 (26%), Positives = 128/265 (48%), Gaps = 33/265 (12%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A+K++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 30  GASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 88

Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R  +     Q L +LH + V   +HR+
Sbjct: 89  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSNQV---IHRD 140

Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E + +STM        + APE    K    ++D
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVD 197

Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E++ G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------TNGTPELQNPERLSAVFRDFL 249

Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  ++R S  E+++
Sbjct: 250 N------RCLEMDVDRRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 73.1 bits (179), Expect = 9e-14
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG LI  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 15  AGNGGVVFKV--SHKPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 72  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 128

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 129 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+E+  GR       A+ L+++
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 73/302 (24%), Positives = 130/302 (43%), Gaps = 48/302 (15%)

Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSL----PSGE--LIAVKKLVNFGCQSSKTLKT 627
           +  H++V+    K   G G  FG+V++       P  +  L+AVK L +    + K    
Sbjct: 2   IKRHNIVL----KRELGEGA-FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR 56

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD------------FQ 675
           E + L  ++H++IVK  G     + + +++E+++ G L   +                 +
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 676 LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA 735
           L  S  L IA  +A G+ YL      H +HR++ ++N L+  +   K+ DF + R V   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173

Query: 736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQA-EQAEPAESLD 793
            +            +  PE    +K T + D +S GVVL E+ T G+Q   Q    E ++
Sbjct: 174 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233

Query: 794 VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
                     IT G + +  P+   C ++      ++ L C     ++ P M   +K +H
Sbjct: 234 C---------ITQGRV-LQRPR--TCPKE----VYDLMLGCW----QREPHMRLNIKEIH 273

Query: 854 SL 855
           SL
Sbjct: 274 SL 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 36/218 (16%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           GNG  +G+VY    + +G+L A+K +++      + +K E+  L K   H+NI    G F
Sbjct: 25  GNG-TYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 648 ------HSDESIFLIYEFLQMGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLHKD 698
                   D+ ++L+ EF   GS+ DL+        +  W     I   + +GLA+LH  
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH-- 138

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFA----LDRIVGEA-AFQST---MSSEYALSCY 750
               ++HR++K +N+LL  + E KL DF     LDR VG    F  T   M+ E  ++C 
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE-VIACD 196

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP 788
             P+  Y  ++    D +S G+  +E+     AE A P
Sbjct: 197 ENPDATYDYRS----DIWSLGITAIEM-----AEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 70/251 (27%), Positives = 122/251 (48%), Gaps = 32/251 (12%)

Query: 606 GELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           G+ +A+K+ +N   Q  K L   E+  + ++++ NIV  L  F   + +F++ E+L  GS
Sbjct: 44  GQEVAIKQ-INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGS 102

Query: 665 LGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP 721
           L D++   C  + Q+    R  +     Q L +LH + V   +HR++KS N+LL  D   
Sbjct: 103 LTDVVTETCMDEAQIAAVCRECL-----QALEFLHANQV---IHRDIKSDNVLLGMDGSV 154

Query: 722 KLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           KLTDF    +I  E + +STM        + APE    K    ++D +S G++ +E++ G
Sbjct: 155 KLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Query: 781 RQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMP 839
                 E P  +L ++         TNG  ++ +P+  +   +  L       RC  +  
Sbjct: 212 EPPYLNENPLRALYLIA--------TNGTPELQNPEKLSPIFRDFLN------RCLEMDV 257

Query: 840 EKRPSMFEVVK 850
           EKR S  E+++
Sbjct: 258 EKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 45/208 (21%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAKIRHKNIV 641
           G FGRV +     SG+  A+K L       SK           +  E + L  IRH  +V
Sbjct: 12  GSFGRVMLVRHKGSGKYYALKIL-------SKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            + G F  D +++L+ E++  G L   + +   F    + R   A  V   L YLH    
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAA-QVVLALEYLHSL-- 120

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEY- 755
             +++R++K +N+LLD+D   K+TDF   + V    +  T+       C    Y APE  
Sbjct: 121 -DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TL-------CGTPEYLAPEII 170

Query: 756 ---GYSKKATAQMDAYSFGVVLLELITG 780
              GY K      D ++ G+++ E++ G
Sbjct: 171 LSKGYGKAV----DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 55/225 (24%), Positives = 99/225 (44%), Gaps = 25/225 (11%)

Query: 593 GPFGRVYILS----LPSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++      LP  +  L+AVK L      + +  + E + L  ++H++IV+  G 
Sbjct: 16  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGV 75

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQD--------------FQLQWSIRLKIAIGVAQGL 692
                 + +++E+++ G L   +                   QL     L IA  +A G+
Sbjct: 76  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM 135

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H +HR++ ++N L+      K+ DF + R +    +            +  
Sbjct: 136 VYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192

Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQA-EQAEPAESLDVV 795
           PE    +K T + D +SFGVVL E+ T G+Q   Q    E+++ +
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 36/198 (18%)

Query: 603 LPSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVL-----GFFHSDESI 653
            P+G  +A+KK+  F     CQ  +TL+ E+K L + +H+NI+ +L       F S   +
Sbjct: 27  KPTGVKVAIKKISPFEHQTFCQ--RTLR-EIKILRRFKHENIIGILDIIRPPSFESFNDV 83

Query: 654 FLIYEFLQMGSLGDLICRQD--------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +++ E ++   L  LI  Q         F  Q          + +GL Y+H   V   LH
Sbjct: 84  YIVQELMET-DLYKLIKTQHLSNDHIQYFLYQ----------ILRGLKYIHSANV---LH 129

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATA 763
           R++K  N+LL+ + + K+ DF L RI       +   +EY A   Y APE    SK  T 
Sbjct: 130 RDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 189

Query: 764 QMDAYSFGVVLLELITGR 781
            +D +S G +L E+++ R
Sbjct: 190 AIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 22/199 (11%)

Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE +    A+K L      +++K +  E   +A + H ++V++LG 
Sbjct: 18  GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             S   + LI + + +G L D +      +     L   + +A+G++YL +     L+HR
Sbjct: 78  CLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHR 133

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC------YNAPEYGYSKK 760
           ++ ++N+L+      K+TDF L +++           EY          + A E    + 
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLL------DVDEKEYHAEGGKVPIKWMALESILHRI 187

Query: 761 ATAQMDAYSFGVVLLELIT 779
            T + D +S+GV + EL+T
Sbjct: 188 YTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 24/204 (11%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY    + + E++A+KK+   G QS++  +    EV+ L ++RH N ++  G + 
Sbjct: 26  GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  D++      LQ      I  G  QGLAYLH       +HR++
Sbjct: 86  REHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDI 141

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEA-AFQST---MSSEYALSCYNAPEYGYSKKATAQ 764
           K+ NILL      KL DF    +V  A +F  T   M+ E  L+     E  Y  K    
Sbjct: 142 KAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILA---MDEGQYDGKV--- 195

Query: 765 MDAYSFGVVLLELITGRQAEQAEP 788
            D +S G+  +EL     AE+  P
Sbjct: 196 -DVWSLGITCIEL-----AERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 44/156 (28%)

Query: 592 GGPFGRVY-ILSLPSGELIAVK--KLV---NFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
            G +G VY    + +GEL+A+K  KL    +F     + ++ E+  L + RH NIV   G
Sbjct: 13  SGTYGDVYKARDIATGELVAIKVIKLEPGDDF-----EIIQQEISMLKECRHPNIVAYFG 67

Query: 646 FFHSDESIFLIYEFLQMGSLGDL---------------ICRQDFQLQWSIRLKIAIGVAQ 690
            +   + ++++ E+   GSL D+               +CR+                 +
Sbjct: 68  SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE---------------TLK 112

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           GLAYLH+      +HR++K  NILL  D + KL DF
Sbjct: 113 GLAYLHET---GKIHRDIKGANILLTEDGDVKLADF 145

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 15/196 (7%)

Query: 593 GPFGRVYI--LSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V    L LP    I  A+K L   +  +  +   +E   + +  H NI+ + G  
Sbjct: 15  GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHR 706
              + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    HR
Sbjct: 75  TKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV----HR 130

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + APE    +K T+
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTAPEAIAYRKFTS 188

Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+V+ E+++
Sbjct: 189 ASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 55/201 (27%), Positives = 102/201 (50%), Gaps = 25/201 (12%)

Query: 593 GPFGRVY--ILSLP--SGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V+  IL +P      +A+K L   +  +  +   +E   + +  H NI+++ G  
Sbjct: 16  GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-----FQLQWSIRLKIAIGVAQGLAYLHK-DYVP 701
              +   +I E+++ G+L   +   D     +QL   +R     G+A G+ YL   +YV 
Sbjct: 76  TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYLSDMNYV- 129

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYS 758
              HR++ ++NIL++++ E K++DF L R++    E  +  T S       + APE    
Sbjct: 130 ---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY--TTSGGKIPIRWTAPEAIAY 184

Query: 759 KKATAQMDAYSFGVVLLELIT 779
           +K T+  D +SFG+V+ E+++
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 28/201 (13%)

Query: 593 GPFGRVYILSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG VY   L     +AVK  +         K L+ E + L +  H NIVK++G     
Sbjct: 6   GNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIGVCVQK 64

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
           + I+++ E +  GSL   + ++  +L     L++++  A G+ YL      + +HR++ +
Sbjct: 65  QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAA 121

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--------YNAPE---YGYSK 759
           +N L+  +   K++DF + R              Y +S         + APE   YG   
Sbjct: 122 RNCLVGENNVLKISDFGMSR--------EEEGGIYTVSDGLKQIPIKWTAPEALNYG--- 170

Query: 760 KATAQMDAYSFGVVLLELITG 780
           + T++ D +S+G++L E  + 
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 21/200 (10%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFHS 649
           G FG+VY        L A  K++    +S + L+    E+  L++ +H NIV +   +  
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           +  ++++ EF   G+L  ++   +  L       +   + + L +LH   V   +HR++K
Sbjct: 74  ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV---IHRDLK 130

Query: 710 SKNILLDADFEPKLTDFA-----LDRIVGEAAFQST---MSSEYALSCYNAPEYGYSKKA 761
           + NILL  D + KL DF         +     F  T   M+ E  ++C    +  Y  KA
Sbjct: 131 AGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE-VVACETFKDNPYDYKA 189

Query: 762 TAQMDAYSFGVVLLELITGR 781
               D +S G+ L+EL    
Sbjct: 190 ----DIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 17/198 (8%)

Query: 593 GPFGRVYI--LSLPSGE--LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V    L LP      +A+K L   +  +  +   +E   + +  H NI+ + G  
Sbjct: 15  GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHR 706
                + +I EF++ G+L   + + D Q      + +  G+A G+ YL + +YV    HR
Sbjct: 75  TKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV----HR 130

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPEYGYSKKA 761
           ++ ++NIL++++   K++DF L R + +     T +S  +L       + APE    +K 
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS--SLGGKIPIRWTAPEAIAYRKF 188

Query: 762 TAQMDAYSFGVVLLELIT 779
           T+  D +S+G+V+ E+++
Sbjct: 189 TSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 70.5 bits (172), Expect = 3e-13
 Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 23/203 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT------LKTEVKTLAKIRHKNIVKVLG 645
           G FGRVY+   + +G  +A K+ V F  +S +T      L+ E++ L  ++H+ IV+  G
Sbjct: 13  GAFGRVYLCYDVDTGRELAAKQ-VQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYG 71

Query: 646 FF--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
                +++++ +  E++  GS+ D + +    L  S+  K    + +G++YLH + +   
Sbjct: 72  CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSNMI--- 127

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST-MSSEYALSCYNAPEY----GYS 758
           +HR++K  NIL D+    KL DF   + +       T + S      + +PE     GY 
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           +KA    D +S G  ++E++T +
Sbjct: 188 RKA----DVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 3e-13
 Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 36/206 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKT--------EVKTLAKI-RHKNIVK 642
           G FG VY+  +  +GEL+A+KK+        K   +        EVK+L K+  H NIVK
Sbjct: 10  GTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK-IAIGVAQGLAYLHKDYVP 701
           +   F  ++ ++ ++E+++ G+L  L+  +  +      ++ I   + QGLA++HK    
Sbjct: 63  LKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH--- 118

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEY----- 755
              HR++K +N+L+      K+ DF L R I     +   +S+ +    Y APE      
Sbjct: 119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW----YRAPEILLRST 174

Query: 756 GYSKKATAQMDAYSFGVVLLELITGR 781
            YS    + +D ++ G ++ EL T R
Sbjct: 175 SYS----SPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 45/183 (24%), Positives = 78/183 (42%), Gaps = 13/183 (7%)

Query: 604 PSGELI--AVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE 658
             G++I  AVK L                E   +  + H+N++++ G       + ++ E
Sbjct: 19  SGGKVIPVAVKCLKSDKLSDIMDD--FLKEAAIMHSLDHENLIRLYGVV-LTHPLMMVTE 75

Query: 659 FLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
              +GSL D L          S     A+ +A G+ YL        +HR++ ++NILL +
Sbjct: 76  LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLAS 132

Query: 718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLE 776
           D + K+ DF L R + +      M     +   + APE   ++  +   D + FGV L E
Sbjct: 133 DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWE 192

Query: 777 LIT 779
           + T
Sbjct: 193 MFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVL----- 644
           G FG V+ ++ P  G+ +A+KK+ N      S K +  E+K L   +H N++  L     
Sbjct: 11  GAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQP 70

Query: 645 ---GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
                F   E I+++ E +Q   L  +I          +++     + +GL YLH     
Sbjct: 71  PHIDPF---EEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKV-FLYQILRGLKYLHS---A 122

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSK 759
            +LHR++K  N+L++++   K+ DF L R V E      M+ E     Y APE   G S+
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAPEILMG-SR 180

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAE-PAESLDVV 795
             T+ +D +S G +  EL+  R   QA+ P + LD++
Sbjct: 181 HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.4 bits (172), Expect = 5e-13
 Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 23/219 (10%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++     ++       + + V + L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 104 LTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 158

Query: 725 DFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
           DF     V +     +S + + Y    + APE         ++D +S G++++E++ G  
Sbjct: 159 DFGFCAQVSKEVPRRKSLVGTPY----WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214

Query: 783 AEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
               EP   L  +K +R            L PK+ N ++
Sbjct: 215 PYFNEP--PLKAMKMIRDN----------LPPKLKNLHK 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 33/205 (16%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +  VY   +  +GE++A+K+ ++   +  +  T   E+  + +++H+NIV++    H+
Sbjct: 11  GTYATVYKGRNRTTGEIVALKE-IHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT 69

Query: 650 DESIFLIYEFLQ------MGSLG-----DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           +  + L++E++       M + G     D    + F  Q          + +G+A+ H++
Sbjct: 70  ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQ----------LLKGIAFCHEN 119

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YG 756
            V   LHR++K +N+L++   E KL DF L R  G     +T S+E     Y AP+   G
Sbjct: 120 RV---LHRDLKPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLG 174

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
            S+  +  +D +S G ++ E+ITGR
Sbjct: 175 -SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 70.0 bits (172), Expect = 7e-13
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK-----TLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY    + +G ++A+KK++     + K     T   E+K L K++H N+V ++  
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 647 F--HSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWS-IRLKIAIGVAQGLAYLHKD 698
                D+S        +        L  L+     +L  S I+    + + +G+ YLH++
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKC-YMLQLLEGINYLHEN 134

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ----STMSSEYALSC----- 749
              H+LHR++K+ NIL+D     K+ DF L R                +    +      
Sbjct: 135 ---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRW 191

Query: 750 YNAPEY--GYSKKATAQMDAYSFGVVLLELITGR 781
           Y  PE   G  ++ T  +D +  G V  E+ T R
Sbjct: 192 YRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (170), Expect = 8e-13
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 36/211 (17%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF--- 647
           G +G+VY      +G+L+A+K +        + +K E   L K   H NI    G F   
Sbjct: 17  GTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75

Query: 648 ----HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHK 697
               + D+ ++L+ E    GS+ DL+     + +   RLK      I     +GLAYLH+
Sbjct: 76  NPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGK---RLKEEWIAYILRETLRGLAYLHE 131

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFA----LDRIVGE-AAFQST---MSSEYALSC 749
           +    ++HR++K +NILL  + E KL DF     LD  +G    F  T   M+ E  ++C
Sbjct: 132 N---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPE-VIAC 187

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
              P+  Y  ++    D +S G+  +EL  G
Sbjct: 188 DEQPDASYDARS----DVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.4 bits (169), Expect = 8e-13
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 31/210 (14%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           GNG  +G+VY    + +G+L A+K +++      + +K E+  L K   H+NI    G F
Sbjct: 15  GNG-TYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 648 HS------DESIFLIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
                   D+ ++L+ EF   GS+ DLI        + +W     I   + +GL++LH+ 
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFA----LDRIVGEA-AFQST---MSSEYALSCY 750
            V   +HR++K +N+LL  + E KL DF     LDR VG    F  T   M+ E  ++C 
Sbjct: 131 KV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE-VIACD 186

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             P+  Y  K+    D +S G+  +E+  G
Sbjct: 187 ENPDATYDFKS----DLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 48/162 (29%), Positives = 83/162 (51%), Gaps = 21/162 (12%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ------MGSLGDLICRQDFQLQWSIR 681
           EV  L  ++H NIV +    H+D+S+ L++E+L       M   G+++   + ++     
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI----- 108

Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
                 + +GLAY H+  V   LHR++K +N+L++   E KL DF L R   ++    T 
Sbjct: 109 --FLYQILRGLAYCHRRKV---LHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTY 161

Query: 742 SSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           S+E     Y  P+   G S+ +T Q+D +  G +  E+ +GR
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYST-QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 63/274 (22%), Positives = 118/274 (43%), Gaps = 41/274 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG V+  +L     +AVK       Q  K    +E + L +  H NIVK++G     +
Sbjct: 6   GNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ 65

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            I+++ E +  G     + ++  +L+    +K A+  A G+AYL      + +HR++ ++
Sbjct: 66  PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAAR 122

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N L+  +   K++DF + R   +  + S+   +  +  + APE     + +++ D +S+G
Sbjct: 123 NCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK-WTAPEALNYGRYSSESDVWSYG 181

Query: 772 VVLLEL----------ITGRQA-EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY 820
           ++L E           +T +QA EQ E    +                         +C 
Sbjct: 182 ILLWETFSLGVCPYPGMTNQQAREQVEKGYRM-------------------------SCP 216

Query: 821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS 854
           Q+      ++  RC    PE RP   E+ K L +
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 22/199 (11%)

Query: 593 GPFGRVY----ILSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+    I    +G+L A+K  K      +     K E   LA++ H  IVK+   
Sbjct: 7   GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++  ++LI +FL+ G L   + ++    +  ++  +A  +A  L +LH      +++R
Sbjct: 67  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LGIIYR 122

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-C----YNAPEYGYSKKA 761
           ++K +NILLD +   KLTDF L +       +S    + A S C    Y APE    +  
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSK-------ESIDHEKKAYSFCGTVEYMAPEVVNRRGH 175

Query: 762 TAQMDAYSFGVVLLELITG 780
           T   D +SFGV++ E++TG
Sbjct: 176 TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.3 bits (169), Expect = 2e-12
 Identities = 71/271 (26%), Positives = 124/271 (45%), Gaps = 38/271 (14%)

Query: 609 IAVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +       + L +E++ +  I +HKNI+ +LG    D  ++++ E+   G+L 
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 667 DLI--------------CR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + +              C+  + QL +   +  A  VA+G+ YL        +HR++ ++
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R V    +    ++      + APE  + +  T Q D +SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223

Query: 772 VVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           V+L E+ T G       P E L  ++K   R           +D K ANC  +  +    
Sbjct: 224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------MD-KPANCTHELYM---- 267

Query: 830 IALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
           I   C   +P +RP+  ++V+ L  + T TS
Sbjct: 268 IMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 11/178 (6%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG  +AVK +     Q  + L  EV  +   +H+N+V++   +   E ++++ EFLQ G+
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++     +L       +   V Q L YLH   V   +HR++KS +ILL  D   KL+
Sbjct: 105 LTDIV--SQTRLNEEQIATVCESVLQALCYLHSQGV---IHRDIKSDSILLTLDGRVKLS 159

Query: 725 DFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           DF     + +     +S + + Y    + APE         ++D +S G++++E++ G
Sbjct: 160 DFGFCAQISKDVPKRKSLVGTPY----WMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 23/197 (11%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNGG   + Y L   +  ++AVK + ++   +  K + +E++ L K     I+   G F 
Sbjct: 12  GNGGTVYKAYHL--LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL----KIAIGVAQGLAYLHKDYVPHLL 704
            +  I +  EF+  GSL          +   I      +IA+ V +GL YL   +   +L
Sbjct: 70  VENRISICTEFMDGGSL---------DVYRKIPEHVLGRIAVAVVKGLTYL---WSLKIL 117

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR+VK  N+L++   + KL DF     V      S   +    + Y APE    ++    
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFG----VSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 765 MDAYSFGVVLLELITGR 781
            D +S G+  +EL  GR
Sbjct: 174 SDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 23/200 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G +G VY      +GE++A+KK+     + G  S  T   E+  L ++ H NIV++L   
Sbjct: 10  GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPS--TAIREISLLKELNHPNIVRLLDVV 67

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD----FQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           HS+  ++L++EFL +    DL    D      L   +       + QG+AY H   V   
Sbjct: 68  HSENKLYLVFEFLDL----DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV--- 120

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKA 761
           LHR++K +N+L+D +   KL DF L R  G      T + E     Y APE   G  + +
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYS 178

Query: 762 TAQMDAYSFGVVLLELITGR 781
           T  +D +S G +  E++  R
Sbjct: 179 TP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 71/283 (25%), Positives = 129/283 (45%), Gaps = 48/283 (16%)

Query: 609 IAVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +   + L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 667 DLI---------------CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + +                  + QL +   +  A  VA+G+ YL        +HR++ ++
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 169

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229

Query: 772 VVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           V+L E+ T G       P E L  ++K   R           +D K +NC  +     L 
Sbjct: 230 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-----------MD-KPSNCTNE-----LY 272

Query: 830 IALR-CTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQE 871
           + +R C   +P +RP+  ++V+ L  +        + L+S+QE
Sbjct: 273 MMMRDCWHAVPSQRPTFKQLVEDLDRI--------LALTSNQE 307

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 34/210 (16%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FGR  ++   + +     K +     SS  +  + E   LAK++H NIV     F +D
Sbjct: 11  GSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD 70

Query: 651 ESIFLIYEFLQMGSLGDLICRQ-------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
             ++++ E+   G L   I  Q       D  LQW +++ +      G+ ++H+  V   
Sbjct: 71  GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEKRV--- 121

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPEYG 756
           LHR++KSKNI L  + + KL DF   R+         ++S  A +C       Y  PE  
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARL---------LTSPGAYACTYVGTPYYVPPEIW 172

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQA 786
            +     + D +S G +L EL T +   QA
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.3 bits (168), Expect = 3e-12
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 28/193 (14%)

Query: 605 SGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-----HSDESIF 654
           +G  +A+KK+ N        +  + L+ E+K L  +RH+NI+ +L             ++
Sbjct: 24  TGRKVAIKKISNVFDDLIDAK--RILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80

Query: 655 LIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHRNVKS 710
           ++ E ++   L  +I   Q           I   + Q   GL YLH     +++HR++K 
Sbjct: 81  IVTELMET-DLHKVIKSPQPLTDD-----HIQYFLYQILRGLKYLHS---ANVIHRDLKP 131

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPE-YGYSKKATAQMDAY 768
            NIL++++ + K+ DF L R V     +    +EY     Y APE    S + T  +D +
Sbjct: 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIW 191

Query: 769 SFGVVLLELITGR 781
           S G +  EL+T +
Sbjct: 192 SVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 62/273 (22%)

Query: 608 LIAVKKLVNFGCQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG 663
           L+AVK L      +S   +     EVK L+++   NI ++LG    D  + +I E+++ G
Sbjct: 48  LVAVKVL---RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 664 SL-----------GDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKSK 711
            L             L C     L +S  L +A  +A G+ YL   ++V    HR++ ++
Sbjct: 105 DLNQFLQKHVAETSGLACNSK-SLSFSTLLYMATQIASGMRYLESLNFV----HRDLATR 159

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP--------EYGYSKKATA 763
           N L+  ++  K+ DF + R        +  SS+Y      AP        E     K T 
Sbjct: 160 NCLVGKNYTIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGA-------IQVLDPK 815
           + D ++FGV L E++T  R  EQ  P E L   + V     I N          Q+  P+
Sbjct: 212 KSDVWAFGVTLWEILTLCR--EQ--PYEHLT-DQQV-----IENAGHFFRDDGRQIYLPR 261

Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
             NC +       E+ L C     E RP+  E+
Sbjct: 262 PPNCPK----DIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 50/186 (26%), Positives = 94/186 (50%), Gaps = 11/186 (5%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           +G+ +AVKK+     Q  + L  EV  +    H+N+V +   +   + ++++ EFL+ G+
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++     ++       + + V + L+YLH   V   +HR++KS +ILL +D   KL+
Sbjct: 106 LTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLS 160

Query: 725 DFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
           DF     V +     +S + + Y    + APE         ++D +S G++++E+I G  
Sbjct: 161 DFGFCAQVSKEVPKRKSLVGTPY----WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216

Query: 783 AEQAEP 788
               EP
Sbjct: 217 PYFNEP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 34/223 (15%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+  ++ S   G+   +K+ +N    S K     + EV  L+ ++H NIV+    F 
Sbjct: 11  GSFGKAILVKSKEDGKQYVIKE-INISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE 69

Query: 649 SDESIFLIYEFLQMGSLGDLICRQ-------DFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
            + +++++ ++ + G L   I  Q       D  L W +++ +A      L ++H     
Sbjct: 70  ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDR--- 120

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPEYG 756
            +LHR++KS+NI L  D   KL DF + R++      ST+  E A +C     Y +PE  
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTV--ELARTCIGTPYYLSPEIC 173

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
            ++    + D ++ G VL E+ T + A +A   ++L V+K +R
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL-VLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 47/178 (26%), Positives = 92/178 (51%), Gaps = 11/178 (6%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           +G  +AVKK+     Q  + L  EV  +   +H NIV++   +   + ++++ EFL+ G+
Sbjct: 43  TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++     ++       + + V + L++LH   V   +HR++KS +ILL +D   KL+
Sbjct: 103 LTDIVTHT--RMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLS 157

Query: 725 DFALDRIVGEAAFQ--STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           DF     V +   +  S + + Y    + APE         ++D +S G++++E++ G
Sbjct: 158 DFGFCAQVSKEVPRRKSLVGTPY----WMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 71/277 (25%), Positives = 127/277 (45%), Gaps = 35/277 (12%)

Query: 593 GPFGRVY--ILSLPSG---ELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGF 646
           G FGR++  IL        E + VK + +   +   T L  E   L  + H+NI+ +L  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 647 FHSD-ESIFLIY---------EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH 696
              D E  F++Y          FLQ   LG+    Q    Q  + +  AI +A G++YLH
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM--AIQIACGMSYLH 134

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
           K  V   +H+++ ++N ++D + + K+TD AL R +    +     +E     + A E  
Sbjct: 135 KRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
            +K+ ++  D +SFGV+L EL+T  Q    E  +  ++  +++    +          + 
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKDGYRL---------AQP 241

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
            NC  +       +   C ++ PE+RPS  ++V+ L 
Sbjct: 242 INCPDE----LFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.8 bits (163), Expect = 4e-12
 Identities = 60/268 (22%), Positives = 120/268 (44%), Gaps = 38/268 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG V++    + + + + K +     +       + E + L  + H NI++    F  
Sbjct: 11  GAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE 70

Query: 650 DESIFLIYEFLQMGSLGDLI---CRQDFQ----LQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           D+++ ++ E+   G+L + I   C         L + +++ +A         LH  +   
Sbjct: 71  DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHVHTKL 121

Query: 703 LLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
           +LHR++K++NILLD      K+ DF + +I+     +S   +     CY +PE    K  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKPY 178

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
             + D ++ G VL EL + ++A +A    +L V+K       I +G    +  + +   +
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAANLPAL-VLK-------IMSGTFAPISDRYSPDLR 230

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVV 849
           Q +L  L       ++ P KRP + +++
Sbjct: 231 QLILSML-------NLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 5e-12
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 21/162 (12%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ------MGSLGDLICRQDFQLQWSIR 681
           EV  L  ++H NIV +    H++  + L++E+L       + + G+L+   + ++     
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI----- 107

Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
                 + +GL+Y HK     +LHR++K +N+L++   E KL DF L R   ++    T 
Sbjct: 108 --FMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR--AKSVPTKTY 160

Query: 742 SSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           S+E     Y  P+   G ++ +T  +D +  G +L E+ TGR
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 50/184 (27%), Positives = 95/184 (51%), Gaps = 19/184 (10%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL 660
           +G+++A+KK +    +  K +K     E++ L ++RH+N+V ++  F   + ++L++EF+
Sbjct: 25  TGQIVAIKKFLE--SEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82

Query: 661 QMGSLGDLICRQDFQ--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD 718
               L DL   + +   L  S   K    + +G+ + H     +++HR++K +NIL+   
Sbjct: 83  DHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQS 136

Query: 719 FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY--GYSKKATAQMDAYSFGVVLLE 776
              KL DF   R +  AA     +   A   Y APE   G +K   A +D ++ G ++ E
Sbjct: 137 GVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPELLVGDTKYGRA-VDIWAVGCLVTE 193

Query: 777 LITG 780
           ++TG
Sbjct: 194 MLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT------LKTEVKTLAKIRHKNIVKVLG 645
           G FGRVY+     +G  +AVK+ V F  +S +T      L+ E++ L  + H+ IV+  G
Sbjct: 13  GAFGRVYLCYDADTGRELAVKQ-VQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG 71

Query: 646 FFHS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
                 + ++ +  E +  GS+ D + +    L  ++  K    + +G++YLH + +   
Sbjct: 72  CLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNMI--- 127

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST-MSSEYALSCYNAPEY----GYS 758
           +HR++K  NIL D+    KL DF   + +       T M S      + +PE     GY 
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYG 187

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           +KA    D +S G  ++E++T +
Sbjct: 188 RKA----DIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 69/274 (25%), Positives = 116/274 (42%), Gaps = 38/274 (13%)

Query: 592 GGPFGRVY--ILSLPSGELIAVK-KLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
            G FG VY  +   P  E IAV  K        S   K   E   + +  H +IVK++G 
Sbjct: 16  EGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGV 75

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLH 705
             ++  ++++ E   +G L   +    + L  +  +  +  ++  LAYL  K +V    H
Sbjct: 76  I-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV----H 130

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQ 764
           R++ ++N+L+ +    KL DF L R + + ++    +S+  L   + APE    ++ T+ 
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK--ASKGKLPIKWMAPESINFRRFTSA 188

Query: 765 MDAYSFGVVLLE-LITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC---- 819
            D + FGV + E L+ G +  Q       DV+        I NG      P   NC    
Sbjct: 189 SDVWMFGVCMWEILMLGVKPFQGVKNN--DVI------GRIENGERL---PMPPNCPPTL 237

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
           Y         +  +C +  P KRP   E+   L 
Sbjct: 238 YS--------LMTKCWAYDPSKRPRFTELKAQLS 263

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.1 bits (161), Expect = 8e-12
 Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 33/271 (12%)

Query: 592 GGPFGRVY--ILSLPSG-ELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
            G FG +    L LPS  EL      +  GC   +      E  TL +  H NIV++ G 
Sbjct: 15  TGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGV 74

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
                ++ ++ E++  G+L   + + + QL     + +  G+A G+ YL +  YV    H
Sbjct: 75  ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYV----H 130

Query: 706 RNVKSKNILLDADFEPKLTDFA-LDRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKA 761
           + + +  +L+++D   K++ F  L     EA + +TMS + +   + APE   Y +   A
Sbjct: 131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGK-SPVLWAAPEAIQYHHFSSA 188

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
           +   D +SFG+V+ E+++  +    + +   DV+K V     +         P   NC  
Sbjct: 189 S---DVWSFGIVMWEVMSYGERPYWDMSGQ-DVIKAVEDGFRL---------PAPRNC-- 233

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
             +L  L   L C      +RP   ++   L
Sbjct: 234 PNLLHQL--MLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 8e-12
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 19/161 (11%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ------MGSLGDLICRQDFQLQWSIR 681
           EV  L  ++H NIV +    H+++S+ L++E+L       +   G+ I   + +L     
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL----- 108

Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
                 + +GL Y H+  V   LHR++K +N+L++   E KL DF L R   ++    T 
Sbjct: 109 --FLFQLLRGLNYCHRRKV---LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTY 161

Query: 742 SSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGR 781
           S+E     Y  P+    S   + Q+D +  G +  E+ TGR
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 18/209 (8%)

Query: 583 MD--EKSSAGNGGPFGRVY-ILSLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKI 635
           MD  EK      G +G VY      + E IA+KK+     + G  S  T   E+  L ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPS--TAIREISLLKEM 58

Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
           +H NIV++    HS++ ++L++E+L +     +    DF     +       + +G+AY 
Sbjct: 59  QHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEP-KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE 754
           H   V   LHR++K +N+L+D      KL DF L R  G      T + E     Y APE
Sbjct: 119 HSHRV---LHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPE 173

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
              G S+  +  +D +S G +  E++  +
Sbjct: 174 ILLG-SRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 1e-11
 Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 36/257 (14%)

Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG---------------DLICRQDFQLQWSI 680
           +HKNI+ +LG    +  +++I E+   G+L                D+    + QL +  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +  A  VA+G+ YL        +HR++ ++N+L+  D   K+ DF L R V +  +   
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192

Query: 741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVR 799
            S+      + APE  + +  T Q D +SFG+++ E+ T G       P E L   K +R
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL--FKLLR 250

Query: 800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALR-CTSVMPEKRPSMFEVVKALHSLSTR 858
               +          K +NC  +     L + +R C   +P +RP+  ++V+AL  +   
Sbjct: 251 EGHRMD---------KPSNCTHE-----LYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296

Query: 859 TSLLSIELSSSQEHSIP 875
            S   ++LS   E   P
Sbjct: 297 VSEEYLDLSMPFEQYSP 313

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 60/276 (21%), Positives = 122/276 (44%), Gaps = 43/276 (15%)

Query: 593 GPFGRVYIL--SLPSGELIAVKKL----VNFGC------QSSKTLKTEVKTLAK-IRHKN 639
           G FG VY +        L+A+K++      FG       +S   + +EV  + + +RH N
Sbjct: 11  GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLIC-----RQDFQLQ--WSIRLKIAIGVAQGL 692
           IV+    F  ++ ++++ + ++   LG+        +Q F  +  W+I +++ +     L
Sbjct: 71  IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA----L 126

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YLHK+    ++HR++   NI+L  D +  +TDF L +       +S ++S      Y+ 
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP---ESKLTSVVGTILYSC 181

Query: 753 PEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
           PE   ++    + D ++FG +L ++ T        P  S +++    + +        V 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT-----LQPPFYSTNMLSLATKIVE------AVY 230

Query: 813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           +P     Y + +   +     C +   E RP + +V
Sbjct: 231 EPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 50/284 (17%)

Query: 593 GPFGRVYILSLPSGE------LIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLG 645
           G FG V++      E      L+ VK L     ++ ++  + E+    K+ HKN+V++LG
Sbjct: 16  GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLG 75

Query: 646 FFHSDESIFLIYEFLQMGSLGDLI--------CRQDFQLQWSIRLKIAIGVAQGLAYLHK 697
                E  ++I E+  +G L   +          +   L    ++ +   +A G+ +L  
Sbjct: 76  LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL-- 133

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN------ 751
                 +HR++ ++N L+ +  E K++  +L +           +SEY            
Sbjct: 134 -SNARFVHRDLAARNCLVSSQREVKVSLLSLSK--------DVYNSEYYK--LRNALIPL 182

Query: 752 ---APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA 808
              APE       + + D +SFGV++ E+ T  Q E   P   L   + + R   +  G 
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--QGEL--PFYGLSDEEVLNR---LQAGK 235

Query: 809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           +++  P+   C  +      ++  RC +V P+ RPS  E+V AL
Sbjct: 236 LELPVPE--GCPSR----LYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.2 bits (164), Expect = 1e-11
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 35/205 (17%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G  G VY ++  P+G L A+K  V +G       +    E++ L  + H N+VK    F 
Sbjct: 85  GAGGTVYKVIHRPTGRLYALK--VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD 142

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            +  I ++ EF+  GSL       +  L       +A  +  G+AYLH+    H++HR++
Sbjct: 143 HNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRR---HIVHRDI 194

Query: 709 KSKNILLDADFEPKLTDFALDRI-----------VGEAAFQSTMSSEYALSCYNAPEY-G 756
           K  N+L+++    K+ DF + RI           VG  A+   MS E   +  N   Y G
Sbjct: 195 KPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY---MSPERINTDLNHGAYDG 251

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
           Y+       D +S GV +LE   GR
Sbjct: 252 YAG------DIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 68/281 (24%), Positives = 117/281 (41%), Gaps = 45/281 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKT----LKTEVKTLAKIRHKNIVKVLGFF 647
           G F  VY  + L  G ++A+KK+  F    +K     LK E+  L ++ H N++K L  F
Sbjct: 13  GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYLASF 71

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYLHKD 698
             +  + ++ E    G L  +I  + F+ Q         W    K  + +   L ++H  
Sbjct: 72  IENNELNIVLELADAGDLSRMI--KHFKKQKRLIPERTIW----KYFVQLCSALEHMHSK 125

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYG 756
            +   +HR++K  N+ + A    KL D  L R       A  S + + Y +S     E G
Sbjct: 126 RI---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
           Y+ K+    D +S G +L E+   +     +      + K       I         P  
Sbjct: 183 YNFKS----DIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEKCDYP---PLP 229

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVKALHS 854
           A+ Y +++   +    RC +  PEKRP    + +V K +H+
Sbjct: 230 ADHYSEELRDLVS---RCINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 31/167 (18%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ------MGSLGDLICRQD-----FQL 676
           E   L  ++H NIV +    H+ +++ L++E+L       M   G  +   +     FQL
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQL 112

Query: 677 QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA 736
              +R         GLAY H+  V   LHR++K +N+L+    E KL DF L R   ++ 
Sbjct: 113 ---LR---------GLAYCHQRRV---LHRDLKPQNLLISERGELKLADFGLAR--AKSV 155

Query: 737 FQSTMSSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
              T S+E     Y  P+   G S + +  +D +  G +  E+ TGR
Sbjct: 156 PSKTYSNEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 40/272 (14%)

Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 667 D-LICRQDFQLQWSIRL--------------KIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   VA+G+ YL        +HR++ ++
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R V    +    ++      + APE  + +  T Q D +SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226

Query: 772 VVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           V++ E+ T G       P E L  ++K   R           +D K ANC  +     L 
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------MD-KPANCTNE-----LY 269

Query: 830 IALR-CTSVMPEKRPSMFEVVKALHSLSTRTS 860
           + +R C   +P  RP+  ++V+ L  + T T+
Sbjct: 270 MMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 71/299 (23%), Positives = 114/299 (38%), Gaps = 79/299 (26%)

Query: 593 GPFGRVY---ILSLPSGEL---IAVKKLVNFGCQSSKT----LKTEVKTLAKIRHKNIVK 642
           G FG VY      +  GE    +A+K +      S +     L  E   + +    ++V+
Sbjct: 17  GSFGMVYEGLAKGVVKGEPETRVAIKTV--NENASMRERIEFLN-EASVMKEFNCHHVVR 73

Query: 643 VLGFFHSDESIFLIYEFLQMGSL----------------GDLICRQDFQLQWSIRLKIAI 686
           +LG   + +   ++ E +  G L                      Q F +Q       A 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-IQM------AA 126

Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            +A G+AYL        +HR++ ++N ++  D   K+ DF + R + E        ++Y 
Sbjct: 127 EIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--------TDY- 174

Query: 747 LSCYN------------APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD- 793
              Y             APE       T + D +SFGVVL E+ T   AEQ     S + 
Sbjct: 175 ---YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEE 229

Query: 794 VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           V+K+V             LD    NC  +     LE+   C    P+ RP+  E+V +L
Sbjct: 230 VLKFV--------IDGGHLDLPE-NCPDK----LLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 44/285 (15%)

Query: 593 GPFGRVYI-----LSLPSGEL-IAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       L  P+    +AVK L +    +    L +E++ +  I +HKNI+ +L
Sbjct: 23  GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI---------CRQDFQLQWSIRLK------IAIGVA 689
           G    +  ++++ E+   G+L D +            D        L        A  VA
Sbjct: 83  GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVA 142

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +G+ +L        +HR++ ++N+L+  D   K+ DF L R +    +    ++      
Sbjct: 143 RGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVK 199

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNG 807
           + APE  + +  T Q D +SFGV+L E+ T G       P E L  ++K   R       
Sbjct: 200 WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR------- 252

Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
               ++ K  NC  Q++     +   C   +P +RP+  ++V+ L
Sbjct: 253 ----ME-KPQNC-TQELYH---LMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 31/239 (12%)

Query: 628 EVKTLAKIRHKNIVKVLGFFH--SDE--SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK 683
           E+K L +I   NI+K+ GF     D+   + LI E+   G L +++  ++  L +  +L 
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLD 126

Query: 684 IAIGVAQGLAYLHKDY-VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
           +AI   +GL  L+K    P+   +N+ S + L+  +++ K+    L++I+    F++   
Sbjct: 127 MAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
             Y    Y      +S+  T + D YS GVVL E+ TG+      P E+L   +     I
Sbjct: 184 MVY--FSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKI-----PFENLTTKEIYDLII 235

Query: 803 NITNGAIQVLD-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
           N  N     LD P    C          I   CTS    KRP++ E+   L++LS    
Sbjct: 236 NKNNSLKLPLDCPLEIKC----------IVEACTSHDSIKRPNIKEI---LYNLSLYKF 281

Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 591 NGGPFGRVYILSLPS-GELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           + G +GRV++    S G++ A+K   K           + TE   L++ +   +VK+   
Sbjct: 2   SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYS 61

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F   ++++L+ E+L  G L  L+       +   R+ IA  +   L YLH + +   +HR
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSNGI---IHR 117

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPE----Y 755
           ++K  NIL+D++   KLTDF L + VG    Q  ++ +            Y APE     
Sbjct: 118 DLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
           G+SK      D +S G +L E + G
Sbjct: 177 GHSKTV----DWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 21/200 (10%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL-VNFGCQSS----KTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY+     +G  +AVK++  +   Q +      L+ E++ L  +RH  IV+  G 
Sbjct: 13  GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGC 72

Query: 647 F--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                ++ + +  E++  GS+ D + +    L  ++  +    + QG++YLH + +   +
Sbjct: 73  LRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNMI---V 128

Query: 705 HRNVKSKNILLDADFEPKLTDF-ALDRI----VGEAAFQSTMSSEYALSCYNAPEYGYSK 759
           HR++K  NIL D+    KL DF A  RI    +     +S   + Y +S       GY +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGR 188

Query: 760 KATAQMDAYSFGVVLLELIT 779
           KA    D +S    ++E++T
Sbjct: 189 KA----DVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 26/204 (12%)

Query: 593 GPFGRVYILSLPS----GELIAVKKLVNFG-CQSSKTL---KTEVKTLAKIRHKNIVKVL 644
           G +G+V+++        G+L A+K L      Q +KT    +TE + L  +R    +  L
Sbjct: 11  GAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTL 70

Query: 645 GF-FHSDESIFLIYEFLQMGSLGDLIC-RQDFQLQWSIRLKIA-IGVAQGLAYLHKDYVP 701
            + F +D  + LI +++  G L   +  R+ F     +R+ IA I +A  L +LH+  + 
Sbjct: 71  HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIAEIVLA--LDHLHQLGI- 126

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIV----GEAAFQSTMSSEY-ALSCYNAPEYG 756
             ++R++K +NILLD++    LTDF L +       E A+    + EY A         G
Sbjct: 127 --IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           + K     +D +S GV+  EL+TG
Sbjct: 185 HDKA----VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 593 GPFGRVYI-LSLPSGELIAVKK--LVNFGCQSSK-------TLKTEVKTLAKIRHKNIVK 642
           G FG VY+ ++  SGEL+AVK+  L +    S          L  E+  L +++H+NIV+
Sbjct: 11  GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            LG     + + +  E++  GS+  L+       + ++       + +GL YLH      
Sbjct: 71  YLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKGLNYLHNR---G 126

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPEYGY 757
           ++HR++K  NIL+D     K++DF + + + EA   ST ++    S      + APE   
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKL-EANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 758 SKKATAQMDAYSFGVVLLELITGR 781
               T + D +S G +++E++TG+
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 33/271 (12%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNF-GCQSS--KTLKT----EVKTLAKIRHKNIVKVLG 645
           G FG V+     SG L A    V    C+ +    LK     E + L +  H NIV+++G
Sbjct: 6   GNFGEVF-----SGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
                + I+++ E +Q G     +  +  +L+    +++    A G+ YL      H +H
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIH 117

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++ ++N L+      K++DF + R   +  + ST   +     + APE     + +++ 
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSES 177

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ--VLDPKIANCYQQQ 823
           D +SFG++L E            A SL  V +       T  AI+  V  P    C    
Sbjct: 178 DVWSFGILLWE------------AFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDA- 224

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVKALHS 854
                 +  RC    P +RPS   V + L S
Sbjct: 225 ---VYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 64.3 bits (157), Expect = 7e-11
 Identities = 51/196 (26%), Positives = 85/196 (43%), Gaps = 27/196 (13%)

Query: 604 PSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL 660
           P+  L+AVKK +N    S + LK    E+ T  +++H NI+  +  F  D  ++++   +
Sbjct: 23  PTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81

Query: 661 QMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD 718
             GS  DL+     +   + +I   I   V   L Y+H       +HR+VK+ +ILL  D
Sbjct: 82  AYGSCEDLLKTHFPEGLPELAIAF-ILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137

Query: 719 FEPKLTDFALDRIVGE------AAFQSTMSSEYALSCYNAPE------YGYSKKATAQMD 766
            +  L+       + +             SS   L  + +PE       GY++K+    D
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVLQQNLQGYNEKS----D 192

Query: 767 AYSFGVVLLELITGRQ 782
            YS G+   EL  G  
Sbjct: 193 IYSVGITACELANGHV 208

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 52/194 (26%), Positives = 101/194 (52%), Gaps = 12/194 (6%)

Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE + +    K++N   G +++     E   +A + H ++V++LG 
Sbjct: 18  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             S  +I L+ + +  G L D +      +   + L   + +A+G+ YL +     L+HR
Sbjct: 78  CLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHR 133

Query: 707 NVKSKNILLDADFEPKLTDFALDRIV-GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           ++ ++N+L+ +    K+TDF L R++ G+    +    +  +  + A E  + +K T Q 
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK-WMALECIHYRKFTHQS 192

Query: 766 DAYSFGVVLLELIT 779
           D +S+GV + EL+T
Sbjct: 193 DVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 9e-11
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 31/201 (15%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY  +   + +++A+K +++   + ++     ++ E++ L++ R   I K  G F
Sbjct: 12  GSFGEVYKAIDKRTNQVVAIK-VIDL--EEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLL 704
                +++I E+   GS  DL+              IA     V  GL YLH++     +
Sbjct: 69  LKGSKLWIIMEYCGGGSCLDLLKPGKLDET-----YIAFILREVLLGLEYLHEE---GKI 120

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY-NAPEY----GYSK 759
           HR++K+ NILL  + + KL DF    + G+     +  + +  + +  APE     GY +
Sbjct: 121 HRDIKAANILLSEEGDVKLADFG---VSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDE 177

Query: 760 KATAQMDAYSFGVVLLELITG 780
           KA    D +S G+  +EL  G
Sbjct: 178 KA----DIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 9e-11
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 24/200 (12%)

Query: 590 GNGGPFGRVYIL-SLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG +G+V++     +GE++A+K++   + F     + + TE   L   + + +VK+L 
Sbjct: 10  GQGG-YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 646 FFHSDESIFLIYEFLQMGSLGDLIC-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F  DE ++L  E++  G    L+       +D    +   +  A+     L Y+H+D  
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRD-- 126

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
                  +K +N L+DA    KLTDF L + +   A     S +Y      APE    K 
Sbjct: 127 -------LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM-----APEVLRGKG 174

Query: 761 ATAQMDAYSFGVVLLELITG 780
               +D +S G +L E + G
Sbjct: 175 YDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.5 bits (154), Expect = 9e-11
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 29/208 (13%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY   +  +G L A K +     +  +    E++ LA   H  IVK+LG F+ D 
Sbjct: 23  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            ++++ EF   G++  ++   D  L       I   + + L YLH      ++HR++K+ 
Sbjct: 83  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAG 139

Query: 712 NILLDADFEPKLTDFAL-----------DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           N+LL  D + KL DF +           D  +G   +   M+ E  + C    +  Y  K
Sbjct: 140 NVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYW---MAPEVVM-CETMKDTPYDYK 195

Query: 761 ATAQMDAYSFGVVLLELITGRQAEQAEP 788
           A    D +S G+ L+E+       Q EP
Sbjct: 196 A----DIWSLGITLIEM------AQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 42/119 (35%), Positives = 57/119 (47%), Gaps = 15/119 (12%)

Query: 191 NAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSL 250
           N  L   IP+DI KL  L+ + L  +   G IP S   + SL +LDLS N+  G +P+SL
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486

Query: 251 GSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS-------IPGSINEC 302
           G  L  L   +++ N LSG  P        L    LH+  FN +       IPG +  C
Sbjct: 487 G-QLTSLRILNLNGNSLSGRVP------AALGGRLLHRASFNFTDNAGLCGIPG-LRAC 537

Length = 623

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 15/181 (8%)

Query: 605 SGELIAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-ESIFLIYEFLQ 661
           +G+ +A+KK++  F     +K    E+K L  +RH+NI+ +   F S  E I+ + E L 
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE-LL 92

Query: 662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP 721
              L  L+  +  + Q+       I   +GL Y+H   V   +HR++K  NIL++ + + 
Sbjct: 93  GTDLHRLLTSRPLEKQFIQYFLYQI--LRGLKYVHSAGV---VHRDLKPSNILINENCDL 147

Query: 722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITG 780
           K+ DF L RI  +      +S+ Y    Y APE   + +K   ++D +S G +  E++ G
Sbjct: 148 KICDFGLARI-QDPQMTGYVSTRY----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202

Query: 781 R 781
           +
Sbjct: 203 K 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 32/200 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G +G V+   +  + E++A+K++     + G  SS     E+  L +++HKNIV++    
Sbjct: 11  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHKNIVRLYDVL 68

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQW-SIRLKIAIGVAQ--------GLAYLHKD 698
           HSD+ + L++E+          C QD +  + S    I   + +        GLA+ H  
Sbjct: 69  HSDKKLTLVFEY----------CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
              ++LHR++K +N+L++ + E KL DF L R  G        S+E     Y  P+  + 
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFG 173

Query: 759 KKA-TAQMDAYSFGVVLLEL 777
            K  +  +D +S G +  EL
Sbjct: 174 AKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 35/192 (18%)

Query: 605 SGELIAVKKLVNFGCQSS------KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE 658
           +G+++A+KK V    +S       K    E++ L +++H N+V ++  F     + L++E
Sbjct: 25  TGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80

Query: 659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD 718
           +     L +L        +  I+ KI     Q + + HK      +HR+VK +NIL+   
Sbjct: 81  YCDHTVLNELEKNPRGVPEHLIK-KIIWQTLQAVNFCHKHNC---IHRDVKPENILITKQ 136

Query: 719 FEPKLTDFALDRIV--GEAAFQSTMSSEY-ALSCYNAPE-------YGYSKKATAQMDAY 768
            + KL DF   RI+      +     ++Y A   Y APE       YG        +D +
Sbjct: 137 GQIKLCDFGFARILTGPGDDY-----TDYVATRWYRAPELLVGDTQYG------PPVDVW 185

Query: 769 SFGVVLLELITG 780
           + G V  EL+TG
Sbjct: 186 AIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 43/172 (25%), Positives = 80/172 (46%), Gaps = 24/172 (13%)

Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLI-----CRQDFQLQWSIRLKIAIGVAQGLA 693
           N+V +  +  S++S+FL+ +  + G L   I       ++   +W+  + +A      L 
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
            LH++ +   + R++   NILLD     +LT F+    V ++        E   + Y AP
Sbjct: 100 ALHREGI---VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAP 151

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA-----ESLDVVKWVRR 800
           E G   + T   D +S G +L EL+TG+   +  P+      +L++ +WV  
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSE 203

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 51/199 (25%), Positives = 95/199 (47%), Gaps = 27/199 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFHS 649
           G FG+VY        ++A  K+++   +S + L+    E+  LA   H NIVK+L  F+ 
Sbjct: 16  GAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY 73

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           + +++++ EF   G++  ++   +  L       +     + L YLH++    ++HR++K
Sbjct: 74  ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLK 130

Query: 710 SKNILLDADFEPKLTDFAL-----------DRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
           + NIL   D + KL DF +           D  +G   +   M+ E  + C  + +  Y 
Sbjct: 131 AGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW---MAPEVVM-CETSKDRPYD 186

Query: 759 KKATAQMDAYSFGVVLLEL 777
            KA    D +S G+ L+E+
Sbjct: 187 YKA----DVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 24/202 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK-----TLKTEVKTLAKIRHKNIVK---- 642
           G +G VY      +GE++A+KKL        K     T   E+  L K++H NIV     
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           V+G   + + I+++ E+++   L  L+         S    + + +  G+A+LH +++  
Sbjct: 73  VVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI-- 127

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKK 760
            LHR++K+ N+LL+     K+ DF L R  G        +       Y APE   G +K+
Sbjct: 128 -LHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLG-AKE 183

Query: 761 ATAQMDAYSFGVVLLELITGRQ 782
            +  +D +S G +  EL+T + 
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-10
 Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 56/230 (24%)

Query: 593 GPFGRVY---ILSLPSGELIAVKKLVNFGCQSSKTLKT--------EVKTLAKIRHKNIV 641
           G +GRVY     +   G+  A+KK         K   T        E+  L +++H+N+V
Sbjct: 11  GTYGRVYKAKRKNGKDGKEYAIKKFK-----GDKEQYTGISQSACREIALLRELKHENVV 65

Query: 642 KVLGFF--HSDESIFLIYEFLQMGSLGDL--ICR-----QDFQLQWSIRLKIAIGVAQGL 692
            ++  F  H+D+S++L++++ +     DL  I +     +   +  S+   +   +  G+
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYAL- 747
            YLH ++V   LHR++K  NIL+  +       K+ D  L R+     F + +     L 
Sbjct: 122 HYLHSNWV---LHRDLKPANILVMGEGPERGVVKIGDLGLARL-----FNAPLKPLADLD 173

Query: 748 -----SCYNAPE--YGYSKKATAQMDAYSFGVVLLELIT------GRQAE 784
                  Y APE   G ++  T  +D ++ G +  EL+T      GR+A+
Sbjct: 174 PVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 35/205 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRH---KNIVKVLGF 646
           G +G VY    +P+G ++A+K ++N          ++ EV  L+++R     NI K  G 
Sbjct: 12  GAYGAVYRGKHVPTGRVVALK-IINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGS 70

Query: 647 FHSDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           +     +++I E+ + GS+  L+      +  +   IR      V   L Y+HK  V   
Sbjct: 71  YLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKVGV--- 122

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS--SEYALSCY-NAPEY----- 755
           +HR++K+ NIL+      KL DF +      A      S  S +  + Y  APE      
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGV-----AALLNQNSSKRSTFVGTPYWMAPEVITEGK 177

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
            Y  KA    D +S G+ + E+ TG
Sbjct: 178 YYDTKA----DIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 61.9 bits (150), Expect = 4e-10
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 31/204 (15%)

Query: 593 GPFGRV-YILSLPSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G V   L   +G  +A+KKL     QS   +K    E++ L  ++H+N++ +L  F 
Sbjct: 26  GAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84

Query: 649 SDESI------FLIYEFLQMGS-LGDLICRQDF---QLQWSIRLKIAIGVAQGLAYLHKD 698
            D S+      +L+  F  MG+ LG L+  +     ++Q+     +   + +GL Y+H  
Sbjct: 85  PDLSLDRFHDFYLVMPF--MGTDLGKLMKHEKLSEDRIQF-----LVYQMLKGLKYIHA- 136

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
               ++HR++K  N+ ++ D E K+ DF L R        S M+       Y APE   +
Sbjct: 137 --AGIIHRDLKPGNLAVNEDCELKILDFGLARQT-----DSEMTGYVVTRWYRAPEVILN 189

Query: 759 -KKATAQMDAYSFGVVLLELITGR 781
               T  +D +S G ++ E++TG+
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 28/203 (13%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G +G VY      SGE++A+KK V       G   S +L+ E+  L  +RH NIV++   
Sbjct: 18  GTYGIVYRARDTTSGEIVALKK-VRMDNERDGIPIS-SLR-EITLLLNLRHPNIVELKEV 74

Query: 647 FHSD--ESIFLIYEFLQ--MGSLGDLICRQDFQLQWSI-RLK-IAIGVAQGLAYLHKDYV 700
                 +SIFL+ E+ +  + SL D     +    +S  ++K + + + +GL YLH++++
Sbjct: 75  VVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQYLHENFI 129

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYS 758
              +HR++K  N+LL      K+ DF L R  G  A    M+ +     Y APE   G  
Sbjct: 130 ---IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLG-C 183

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
              T  +D ++ G +L EL+  +
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 25/192 (13%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKT--EVKTLAKIRHKNIVKVLGFF-----HSDESIFLIY 657
           +GE +A+KK+ +     S   +   E+K L  +RH +IV++            + I++++
Sbjct: 24  TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83

Query: 658 EFL-----QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           E +     Q+    D +  +  Q      L+        L Y+H   V    HR++K KN
Sbjct: 84  ELMESDLHQVIKANDDLTPEHHQFFLYQLLR-------ALKYIHTANV---FHRDLKPKN 133

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY--GYSKKATAQMDAYS 769
           IL +AD + K+ DF L R+       +   ++Y A   Y APE    +  K T  +D +S
Sbjct: 134 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 193

Query: 770 FGVVLLELITGR 781
            G +  E++TG+
Sbjct: 194 IGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 5e-10
 Identities = 64/273 (23%), Positives = 124/273 (45%), Gaps = 44/273 (16%)

Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 18  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 77

Query: 647 FHSDESIFLIYEFLQMGSLGDL-------ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
             +  ++ LI + +  G L D        I  Q + L W ++      +A+G+ YL +  
Sbjct: 78  CLT-STVQLITQLMPFGCLLDYVREHKDNIGSQ-YLLNWCVQ------IAKGMNYLEER- 128

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGY 757
              L+HR++ ++N+L+      K+TDF L +++G  E  + +    +  +  + A E   
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE-GGKVPIK-WMALESIL 184

Query: 758 SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
            +  T Q D +S+GV + EL+T G +     PA  +          +I     ++  P I
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---------SILEKGERLPQPPI 235

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                   +    I ++C  +  + RP   E++
Sbjct: 236 CT------IDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 50/215 (23%), Positives = 101/215 (46%), Gaps = 32/215 (14%)

Query: 593 GPFGRVYI---------LSLPSGE------LIAVKKLVNFGCQSSKT--LKTEVKTLAKI 635
           G FG V++         L   + E      L+AVK L     ++++   LK E+K ++++
Sbjct: 16  GQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK-EIKIMSRL 74

Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR-----------LKI 684
           ++ NI+++LG   SD+ + +I E+++ G L   + +++ +  ++             L +
Sbjct: 75  KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM 134

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           A+ +A G+ YL      + +HR++ ++N L+   +  K+ DF + R +    +       
Sbjct: 135 AVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRA 191

Query: 745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
                + A E     K T   D ++FGV L E+ T
Sbjct: 192 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 24/201 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G +G VY   +  +G+++A+KK+       G  S  T   E+  L +++H NIV +    
Sbjct: 11  GTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPS--TAIREISLLKELQHPNIVCLQDVL 68

Query: 648 HSDESIFLIYEFLQMGSLGDL-----ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
             +  ++LI+EFL M    DL        +   +   +       + QG+ + H   V  
Sbjct: 69  MQESRLYLIFEFLSM----DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV-- 122

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKK 760
            LHR++K +N+L+D     KL DF L R  G      T   E     Y APE   G  + 
Sbjct: 123 -LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT--HEVVTLWYRAPEVLLGSPRY 179

Query: 761 ATAQMDAYSFGVVLLELITGR 781
           +T  +D +S G +  E+ T +
Sbjct: 180 STP-VDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 8e-10
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 33/206 (16%)

Query: 592 GGPFGRVYILSLP-SGELIAVKKLVN-FGCQS---SKTLKTEVKTLAKIRHKNIVKVLGF 646
            G +G+V       +G  +A+KKL   F  QS   +K    E++ L  + H+N++ +L  
Sbjct: 25  SGAYGQVCSAFDTKTGRKVAIKKLSRPF--QSAIHAKRTYRELRLLKHMDHENVIGLLDV 82

Query: 647 FHSDESI------FLIYEFLQMGS-LGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLH 696
           F    S+      +L+     MG+ L +++  Q   D  +Q+     +   + +GL Y+H
Sbjct: 83  FTPASSLEDFQDVYLVTHL--MGADLNNIVKCQKLSDDHIQF-----LVYQILRGLKYIH 135

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  NI ++ D E K+ DF L R          M+   A   Y APE  
Sbjct: 136 S---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEIM 187

Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TG+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 34/117 (29%), Positives = 46/117 (39%), Gaps = 25/117 (21%)

Query: 211 LFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGS 270
           L L + G  G IP+    L+ L  ++LS N++ G +P SLGS                  
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS------------------ 464

Query: 271 FPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
                     L  L L  N FNGSIP S+ +  +L    +  N  SG  P  L    
Sbjct: 465 -------ITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 1e-09
 Identities = 57/195 (29%), Positives = 103/195 (52%), Gaps = 33/195 (16%)

Query: 605 SGELIAVKKLVNFGCQSSKT--LKT--EVKTLAKIR-HKNIVKVLGFFHS--DESIFLIY 657
           + E++A+KK+  F    + T   +T  E+  L ++  H NIVK+L    +  D+ I+L++
Sbjct: 31  TKEVVALKKI--FDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88

Query: 658 EFLQMGSLGDL--ICR----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           E+++     DL  + R    +D   ++     I   + + L Y+H     +++HR++K  
Sbjct: 89  EYMET----DLHAVIRANILEDVHKRY-----IMYQLLKALKYIHSG---NVIHRDLKPS 136

Query: 712 NILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEY-ALSCYNAPE--YGYSKKATAQMD 766
           NILL++D   KL DF L R +   E   ++ + ++Y A   Y APE   G S + T  +D
Sbjct: 137 NILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG-STRYTKGVD 195

Query: 767 AYSFGVVLLELITGR 781
            +S G +L E++ G+
Sbjct: 196 MWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 65/271 (23%), Positives = 121/271 (44%), Gaps = 41/271 (15%)

Query: 593 GPFGRVYILSLPS-GELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G V ++   + G+   +KKL N    S +  K    E + L++++H NIV     + 
Sbjct: 11  GSYGEVSLVRHRTDGKQYVIKKL-NLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE 69

Query: 649 -SDESIFLIYEFLQMGSLGDLICRQDFQL-------QWSIRLKIAIGVAQGLAYLHKDYV 700
             D  ++++  F + G L   +  Q  +L       +W ++      +A  L YLH+   
Sbjct: 70  GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLHEK-- 121

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSK 759
            H+LHR++K++N+ L      K+ D  + R++     Q  M+S       Y +PE   +K
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN---QCDMASTLIGTPYYMSPELFSNK 177

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC 819
               + D ++ G  + E+ T + A  A+   SL V + +  K+           P +   
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKL-----------PPMPKD 225

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           Y  ++    E+     S  PEKRPS+  +++
Sbjct: 226 YSPEL---GELIATMLSKRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 15/197 (7%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK--TLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +  VY  +S  +G+L+A+K +++   +     T   E   L  ++H NIV +    H+
Sbjct: 16  GSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQ-WSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            E++  ++E++    L   + +    L  +++RL     + +GLAY+H     H+LHR++
Sbjct: 75  KETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ---HILHRDL 129

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMD 766
           K +N+L+    E KL DF L R   ++    T SSE     Y  P+   G +  ++A +D
Sbjct: 130 KPQNLLISYLGELKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA-LD 186

Query: 767 AYSFGVVLLELITGRQA 783
            +  G + +E++ G+ A
Sbjct: 187 IWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 43/220 (19%)

Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRH-KNIV 641
           +    G G  FG V  +L  PSG ++AVK++      +  K L  ++  + +      IV
Sbjct: 8   DLGEIGRGA-FGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 642 KVLG-FFHS----------DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ 690
           K  G  F            D S+   Y+++               +   I  KIA+   +
Sbjct: 67  KFYGALFREGDCWICMELMDISLDKFYKYVY--------EVLKSVIPEEILGKIAVATVK 118

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC- 749
            L YL ++    ++HR+VK  NILLD +   KL DF    I G+     +++      C 
Sbjct: 119 ALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFG---ISGQ--LVDSIAKTRDAGCR 171

Query: 750 -YNAPEY-------GYSKKATAQMDAYSFGVVLLELITGR 781
            Y APE        GY  ++    D +S G+ L E+ TG+
Sbjct: 172 PYMAPERIDPSARDGYDVRS----DVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 26/204 (12%)

Query: 593 GPFGRVYILSLPSG----ELIAVKKLVNFG-CQSSKT---LKTEVKTLAKIRHKNIVKVL 644
           G +G+V+++   SG    +L A+K L      Q +KT    +TE + L  IR    +  L
Sbjct: 11  GAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 70

Query: 645 GF-FHSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIG-VAQGLAYLHKDYVP 701
            + F +D  + LI +++  G L   L  R+ F+ Q    ++I  G +   L +LHK    
Sbjct: 71  HYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ---EVQIYSGEIVLALEHLHK---L 124

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDR----IVGEAAFQSTMSSEY-ALSCYNAPEYG 756
            +++R++K +NILLD++    LTDF L +       E A+    + EY A       + G
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           + K     +D +S GV++ EL+TG
Sbjct: 185 HDKA----VDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 64/278 (23%), Positives = 123/278 (44%), Gaps = 40/278 (14%)

Query: 593 GPFGRVYI-LSLPSGELI----AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE +    A+K L  N   +++K +  E   +A +    + ++LG 
Sbjct: 18  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGI 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ L+ + +  G L D +     ++     L   + +A+G++YL +     L+HR
Sbjct: 78  CLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHR 133

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP------EYGYSKK 760
           ++ ++N+L+ +    K+TDF L R++          +EY       P      E    ++
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLARLL------DIDETEYHADGGKVPIKWMALESILHRR 187

Query: 761 ATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIAN 818
            T Q D +S+GV + EL+T G +     PA  + D+++   R             P+   
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------------PQPPI 235

Query: 819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
           C     +    I ++C  +  E RP   E+V     ++
Sbjct: 236 CTIDVYM----IMVKCWMIDSECRPRFRELVDEFSRMA 269

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.6 bits (144), Expect = 3e-09
 Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 29/272 (10%)

Query: 54  TSNIHYCNWTGVTCVTTATASLTVASINLQ-----SLNLSGEISSSVCELSSLSNLNLAD 108
            S         ++  T      +++ +        S   S + S ++  L  L +L+L  
Sbjct: 43  ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNL 102

Query: 109 NLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESIG 154
           N     I   L + ++L +L+L NN I                LDLS N IE  +P  + 
Sbjct: 103 NRLRSNI-SELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLR 160

Query: 155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQ 214
           +L NL+ L+L  N LS  +P +  N S L  LDLS N   IS++P +I  L  LE+L L 
Sbjct: 161 NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN--KISDLPPEIELLSALEELDL- 216

Query: 215 SSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNG 274
           S+     +  S   L++LS L+LS N L  ++P+S+G +L  L + D+S N++  S  + 
Sbjct: 217 SNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIG-NLSNLETLDLSNNQI--SSISS 272

Query: 275 ICKANGLVNLSLHKNFFNGSIPGSINECLNLE 306
           +     L  L L  N  + ++P      L LE
Sbjct: 273 LGSLTNLRELDLSGNSLSNALPLIALLLLLLE 304

Length = 394

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 36/196 (18%)

Query: 605 SGELIAVKKLVN-FGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFF-----HSDESIFLI 656
           + E +A+KK+ N F  +  + +TL+ E+K L  + H+N++ +          +   ++++
Sbjct: 29  TNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87

Query: 657 YEFLQMG---------SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           YE +            +L D  C Q F  Q          + +GL Y+H   V   LHR+
Sbjct: 88  YELMDTDLHQIIRSSQTLSDDHC-QYFLYQ----------LLRGLKYIHSANV---LHRD 133

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMD 766
           +K  N+LL+A+ + K+ DF L R   E      M+       Y APE   +  + T  +D
Sbjct: 134 LKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAID 191

Query: 767 AYSFGVVLLELITGRQ 782
            +S G +  EL+ GR+
Sbjct: 192 VWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 48/238 (20%)

Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELIAVKK--LVNFGCQSSKTLKTEVK 630
           V + D++  + E       G +G+VY      +GEL+A+KK  L N       T   E+K
Sbjct: 6   VDKFDIIGQIGE-------GTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK 58

Query: 631 TLAKIRHKNIVKV----------LGFFHSDESIFLIYEFLQ---MGSL--------GDLI 669
            L ++ H+NIV +          L F     + +L++E++    MG L         D I
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118

Query: 670 CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD 729
                QL             +GL Y HK    + LHR++K  NILL+   + KL DF L 
Sbjct: 119 KSFMKQL------------LEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLA 163

Query: 730 RIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQA 786
           R+   +      +++     Y  PE     ++    +D +S G +L EL T +   QA
Sbjct: 164 RLY-NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 66/269 (24%), Positives = 112/269 (41%), Gaps = 46/269 (17%)

Query: 593 GPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY     S ++ IA+K++     +  + L  E+   + ++H+NIV+ LG    + 
Sbjct: 19  GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG--VAQGLAYLHKDYVPHLLHRNVK 709
              +  E +  GSL  L+  +   L+ + +  I     + +GL YLH +    ++HR++K
Sbjct: 79  FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIK 135

Query: 710 SKNILLDA-DFEPKLTDFALD-RIVG----EAAFQSTMSSEYALSCYNAPEY------GY 757
             N+L++      K++DF    R+ G       F  T+        Y APE       GY
Sbjct: 136 GDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ-------YMAPEVIDKGPRGY 188

Query: 758 SKKATAQMDAYSFGVVLLELITGRQA--EQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
              A    D +S G  ++E+ TG+    E  EP  ++  V   +    I           
Sbjct: 189 GAPA----DIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIP---------- 234

Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPS 844
                +     A    LRC    P+KR S
Sbjct: 235 -----ESLSAEAKNFILRCFEPDPDKRAS 258

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 27/213 (12%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGFF 647
           G FG+V++  L  + +  A+K L   V       +    E + L+    H  +  +   F
Sbjct: 6   GSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAYLHKDYVP 701
            + E++F + E+L  G   DL+    F +Q   +  +      A  +  GL +LH   + 
Sbjct: 66  QTKENLFFVMEYLNGG---DLM----FHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI- 117

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSCYNAPEYGYSK 759
             ++R++K  NILLD D   K+ DF +  + ++G+A       +      Y APE    +
Sbjct: 118 --VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA----KTCTFCGTPDYIAPEILLGQ 171

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
           K    +D +SFGV+L E++ G+        E L
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 52.7 bits (127), Expect = 4e-09
 Identities = 19/42 (45%), Positives = 29/42 (69%), Gaps = 2/42 (4%)

Query: 27 ASTEKDTLLSFKASI-DDSKNSLSTWSNTSNIHYCNWTGVTC 67
           + ++D LL+FK+S+  D   +LS+W N S+   C+WTGVTC
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSW-NPSSSDPCSWTGVTC 41

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 5e-09
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 7/181 (3%)

Query: 602 SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           S P  +++A   ++N   Q++   ++E+  LA   H  IVK    F SD+ + LI E+  
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY-- 146

Query: 662 MGSLGDLICRQDFQLQWSIRLK---IAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD 718
            GS GDL  +   +L+  +  +   + +   Q +  L + +   ++HR++KS NI L   
Sbjct: 147 -GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205

Query: 719 FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
              KL DF   +   ++      SS      Y APE    K+ + + D +S GV+L EL+
Sbjct: 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265

Query: 779 T 779
           T
Sbjct: 266 T 266

Length = 478

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.1 bits (140), Expect = 5e-09
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD 650
           G +G+VY + +   G L AVK L        + ++ E   L  +  H N+VK  G F+  
Sbjct: 33  GTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91

Query: 651 E-----SIFLIYEFLQMGSL-----GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           +      ++L+ E    GS+     G LIC Q  +L  ++   I  G   GL +LH +  
Sbjct: 92  DKLVGGQLWLVLELCNGGSVTELVKGLLICGQ--RLDEAMISYILYGALLGLQHLHNN-- 147

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS-------SEYALSCYNAP 753
             ++HR+VK  NILL  +   KL DF +   +     +   S       +   ++C    
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITG 780
           +Y Y     A+ D +S G+  +EL  G
Sbjct: 207 DYSYD----ARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 27/192 (14%)

Query: 609 IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV---LGFFHSD-----------ESIF 654
           +AVKK+V    QS K    E+K + ++ H NIVKV   LG   SD            S++
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92

Query: 655 LIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           ++ E+++     DL  +  Q    +   RL     + +GL Y+H   V   LHR++K  N
Sbjct: 93  IVQEYMET----DLANVLEQGPLSEEHARL-FMYQLLRGLKYIHSANV---LHRDLKPAN 144

Query: 713 ILLDA-DFEPKLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYS 769
           + ++  D   K+ DF L RIV    + +  +S       Y +P    S    T  +D ++
Sbjct: 145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 204

Query: 770 FGVVLLELITGR 781
            G +  E++TG+
Sbjct: 205 AGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 58.3 bits (141), Expect = 6e-09
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 22/154 (14%)

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAYLHKDYV 700
           F + E +F + E+L  G   DL+    F +Q S R         A  +  GL +LHK  +
Sbjct: 65  FQTKEHLFFVMEYLNGG---DLM----FHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
              ++R++K  N+LLD D   K+ DF +  + + GE       S+      Y APE    
Sbjct: 118 ---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG----KASTFCGTPDYIAPEILKG 170

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
           +K    +D +SFGV+L E++ G+     E  + L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 26/234 (11%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR---- 681
           E   + +    ++V++LG     +   +I E +  G L   +   R + +          
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118

Query: 682 ---LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ 738
              +++A  +A G+AYL+ +     +HR++ ++N ++  DF  K+ DF + R + E  + 
Sbjct: 119 KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 175

Query: 739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV 798
                      + +PE       T   D +SFGVVL E+ T   AEQ  P + +   + +
Sbjct: 176 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGMSNEQVL 231

Query: 799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           R    +  G +  LD K  NC    ML   E+   C    P+ RPS  E++ ++
Sbjct: 232 RF---VMEGGL--LD-KPDNC--PDML--FELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V+  + +P G+ I    A+K + +  G Q+ + +   +  +  + H  IV++LG 
Sbjct: 18  GVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGI 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
                S+ L+ +   +GSL D + +    L     L   + +A+G+ YL +     ++HR
Sbjct: 78  C-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHR 133

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           N+ ++NILL +D   ++ DF +  ++     +   S       + A E     + T Q D
Sbjct: 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSD 193

Query: 767 AYSFGVVLLELITGRQAEQAEPAESL 792
            +S+GV + E+++      AEP   +
Sbjct: 194 VWSYGVTVWEMMS----YGAEPYAGM 215

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 7e-09
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 25/198 (12%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV I     +GE  A+K L        +  + +  E   L ++ H  IV ++  F 
Sbjct: 29  GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88

Query: 649 SDESIFLIYEFLQMGSLGDLICR-----QDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPH 702
            +  ++ + EF+  G L   + +      D    +   L +A        YLH KD +  
Sbjct: 89  DENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA------FEYLHSKDII-- 140

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
             +R++K +N+LLD     K+TDF   + V +  F    + EY      APE   SK   
Sbjct: 141 --YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYL-----APEVIQSKGHG 193

Query: 763 AQMDAYSFGVVLLELITG 780
             +D ++ GV+L E I G
Sbjct: 194 KAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 59.5 bits (144), Expect = 8e-09
 Identities = 42/174 (24%), Positives = 82/174 (47%), Gaps = 13/174 (7%)

Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFLQMGSLGDLICRQDFQLQWSIR 681
              + E    A++ H NIV +L    +    +F ++E++   +L +++   D  L     
Sbjct: 23  ARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL-AADGALPAGET 81

Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEP--KLTDFALDRI---VGEA 735
            ++ + V   LA  H   +   +HR++K +NI++      P  K+ DF +  +   V +A
Sbjct: 82  GRLMLQVLDALACAHNQGI---VHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 736 AFQS-TMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAE 787
              + T ++E   +  Y APE    +  T   D Y++G++ LE +TG++  Q  
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGA 192

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.6 bits (139), Expect = 8e-09
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 18/200 (9%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK--TLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G VY +L  P+G  +A+K+ +      SK   +  E+  L K     IV   G F  
Sbjct: 12  GNYGSVYKVLHRPTGVTMAMKE-IRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 650 DESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++  E++  GSL  L         +   +  +I   V +GL +L +++  +++HR+
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRD 128

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA---- 763
           VK  N+L++ + + KL DF     V      S   +      Y APE   S         
Sbjct: 129 VKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184

Query: 764 --QMDAYSFGVVLLELITGR 781
             Q D +S G+ +LE+  GR
Sbjct: 185 TVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.4 bits (138), Expect = 9e-09
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 9/158 (5%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   L  ++H NIV +    H+ E++ L++E++    L   + +    L           
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ 111

Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           + +GL+Y+H+ Y+   LHR++K +N+L+    E KL DF L R   ++    T S+E   
Sbjct: 112 LLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVT 166

Query: 748 SCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGRQA 783
             Y  P+   G ++ +T  +D +  G + +E+I G  A
Sbjct: 167 LWYRPPDVLLGSTEYSTC-LDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 44/175 (25%), Positives = 97/175 (55%), Gaps = 16/175 (9%)

Query: 609 IAVKKLVNFGCQSSKTLKTEVKTLAKIRHK----NIVKVLGFFHSDESIFLIYEFLQMGS 664
           +A+K L N   ++ K+++ E+   A+I H+     IV+++G   + E++ L+ E    G 
Sbjct: 25  VAIKVLKN---ENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPKL 723
           L   +  +  ++  S  +++   V+ G+ YL  K++V    HR++ ++N+LL      K+
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV----HRDLAARNVLLVNQHYAKI 136

Query: 724 TDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
           +DF L + +G  ++ +++  + ++ L  Y APE    +K +++ D +S+G+ + E
Sbjct: 137 SDFGLSKALGADDSYYKARSAGKWPLKWY-APECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 52/198 (26%), Positives = 98/198 (49%), Gaps = 15/198 (7%)

Query: 593 GPFGRVYILSLPSG----ELIAVKKLVNFG-CQSSKTL---KTEVKTLAKIRHKNIVKVL 644
           G +G+V+++   +G    +L A+K L      Q +KT+   +TE   L  +R    +  L
Sbjct: 11  GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTL 70

Query: 645 GF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
            + F ++  + LI +++  G +   + ++D   +  +R      +   L +LHK  +   
Sbjct: 71  HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLHKLGI--- 126

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++R++K +NILLD++    LTDF L +       + T S    +  Y APE    K    
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE-YMAPEIIRGKGGHG 185

Query: 764 Q-MDAYSFGVVLLELITG 780
           + +D +S G+++ EL+TG
Sbjct: 186 KAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 54/196 (27%), Positives = 90/196 (45%), Gaps = 24/196 (12%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY   +L +GEL AVK +          ++ E+  + + +H NIV   G + S E
Sbjct: 20  GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE 79

Query: 652 SIFLIYEFLQMGSLGDLI----CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            +++  E+   GSL D+        + Q+ +  R  +     QGLAYLH       +HR+
Sbjct: 80  KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK---GKMHRD 131

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL---SCYNAPEYGYSKKATAQ 764
           +K  NILL  + + KL DF +      A   +T++   +      + APE    +K    
Sbjct: 132 IKGANILLTDNGDVKLADFGV-----AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 765 ---MDAYSFGVVLLEL 777
               D ++ G+  +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 33/276 (11%)

Query: 593 GPFGRV-----YILSLPSGEL-IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V     Y LS     + +AVK L      S +  L +E+K ++ +  H+NIV +L
Sbjct: 46  GAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLL 105

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           G       I +I E+   G L + + R+ +  L     L  +  VA+G+A+L      + 
Sbjct: 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NC 162

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           +HR++ ++N+LL      K+ DF L R I+ ++ +    ++   +  + APE  ++   T
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK-WMAPESIFNCVYT 221

Query: 763 AQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA--NC 819
            + D +S+G++L E+ + G       P +S    K ++          ++  P+ A    
Sbjct: 222 FESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKE-------GYRMAQPEHAPAEI 273

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           Y        +I   C    P KRP+  ++V+ +   
Sbjct: 274 Y--------DIMKTCWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 39/278 (14%)

Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G F  VY  + L  G  +A+KK+  F    +K       E+  L ++ H N++K    F 
Sbjct: 13  GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSI-----RLKIAIGVAQGLAYLHKDYVPHL 703
            D  + ++ E    G L  +I  + F+ Q  +       K  + +   L ++H   V   
Sbjct: 73  EDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV--- 127

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKA 761
           +HR++K  N+ + A    KL D  L R       A  S + + Y +S     E GY+ K+
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD--PKIANC 819
               D +S G +L E+   +     +      + K            I+  D  P  ++ 
Sbjct: 188 ----DIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-----------KIEQCDYPPLPSDH 232

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSM---FEVVKALHS 854
           Y +++   + +   C +  PEKRP +   ++V K +H+
Sbjct: 233 YSEELRQLVNM---CINPDPEKRPDITYVYDVAKRMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.3 bits (136), Expect = 3e-08
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 51/226 (22%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK----------------TLKTEVKTLAKI 635
           G +G+V       +G+++A+KK+     + S                 T   E+K + +I
Sbjct: 20  GTYGKVEKAYDTLTGKIVAIKKVKI--IEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI 77

Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVA 689
           +H+NI+ ++  +   + I L+ + +    L  ++ R+       IRL       I + + 
Sbjct: 78  KHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQIL 129

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR------IVGEAAFQST--- 740
            GL  LHK Y    +HR++   NI +++    K+ DF L R           +   T   
Sbjct: 130 NGLNVLHKWYF---MHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 741 ---MSSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
              M+S+     Y APE   G ++K    +D +S G +  EL+TG+
Sbjct: 187 REEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 56.1 bits (135), Expect = 3e-08
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 27/202 (13%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGFF 647
           G FG+V +  L   GE  AVK L   V       +    E + LA    +  +  +   F
Sbjct: 6   GSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAYLHKDYVP 701
            + E +F + EFL  G   DL+    F +Q   R  +      A  +  GL +LH   + 
Sbjct: 66  QTKEHLFFVMEFLNGG---DLM----FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI- 117

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSCYNAPEYGYSK 759
             ++R++K  N++LD D   K+ DF +  + + G+    +  S+      Y APE     
Sbjct: 118 --IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NRASTFCGTPDYIAPEILQGL 171

Query: 760 KATAQMDAYSFGVVLLELITGR 781
           K T  +D +SFGV+L E++ G+
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 35/277 (12%)

Query: 590 GNGGPFGRVY---ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           GNG  FG+V         S   + VK+L  +           EV+   ++ H N+++ LG
Sbjct: 4   GNGW-FGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 646 FFHSDESI--FLIYEFLQMGSLGDLI--CRQDFQL--QWSIRLKIAIGVAQGLAYLHKDY 699
                ESI   L+ EF  +G L + +   R       Q  +  ++A  VA GL +LH+  
Sbjct: 63  --QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS- 758
               +H ++  +N  L AD   K+ D+ L        +  T         + APE     
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 759 ------KKATAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVVKWVRRKINITNGAIQV 811
                 K  T + + +S GV + EL T   A+Q  P  S   V+K V R+ +     I++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTA--ADQPYPDLSDEQVLKQVVREQD-----IKL 230

Query: 812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
             P++   Y  +     E+   C  + PE RP+  EV
Sbjct: 231 PKPQLDLKYSDRW---YEVMQFCW-LDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 48/194 (24%), Positives = 92/194 (47%), Gaps = 36/194 (18%)

Query: 608 LIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           L+AVK L     ++++   LK E+K +++++  NI+++L    + + + +I E+++ G L
Sbjct: 48  LVAVKMLREDANKNARNDFLK-EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 666 GDLICRQDFQ----------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
              + R + Q          + +S  + +A  +A G+ YL      + +HR++ ++N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163

Query: 716 DADFEPKLTDFALD---------RIVGEAAFQ-STMSSEYALSCYNAPEYGYSKKATAQM 765
             ++  K+ DF +          RI G A      MS E  L            K T   
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL----------LGKFTTAS 213

Query: 766 DAYSFGVVLLELIT 779
           D ++FGV L E++T
Sbjct: 214 DVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 47/192 (24%), Positives = 95/192 (49%), Gaps = 10/192 (5%)

Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           +GN G   +       S + +AVK L N     +    L  E   + ++ +  IV+++G 
Sbjct: 5   SGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI 64

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             + ES  L+ E  ++G L   + +     + +I  ++   V+ G+ YL +    + +HR
Sbjct: 65  CEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNI-TELVHQVSMGMKYLEET---NFVHR 119

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           ++ ++N+LL      K++DF L + +G  E  +++    ++ +  Y APE     K +++
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APECMNYYKFSSK 178

Query: 765 MDAYSFGVVLLE 776
            D +SFGV++ E
Sbjct: 179 SDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 33/205 (16%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V +  L  + EL AVK L   V       +   TE + LA   +H  + ++   F
Sbjct: 6   GSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + +F + E++  G   DL+    F +Q S R         A  +  GL +LH+  + 
Sbjct: 66  QTKDRLFFVMEYVNGG---DLM----FHIQRSGRFDEPRARFYAAEIVLGLQFLHERGI- 117

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPEYG 756
             ++R++K  N+LLD++   K+ DF + +  +      ST        C    Y APE  
Sbjct: 118 --IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF-------CGTPDYIAPEIL 168

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
             +     +D ++ GV+L E++ G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 4e-08
 Identities = 67/240 (27%), Positives = 105/240 (43%), Gaps = 68/240 (28%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTE----VKT----LAKIRHKNIVKV 643
           G FG V ++    +G + A+KKL     + S+ L+ E    V+     LA+  +  +VK+
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKKL-----RKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA--YLHK-DYV 700
              F  +  ++LI E+L  G +  L+ ++D   +   R  IA  +   LA   +HK  Y+
Sbjct: 67  YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI---LAIDSIHKLGYI 123

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFAL------------DRIVGEAA-------FQSTM 741
               HR++K  N+LLDA    KL+DF L             RI+  A            M
Sbjct: 124 ----HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 742 SSE------------YALSC-----YNAPE----YGYSKKATAQMDAYSFGVVLLELITG 780
           SS+             A S      Y APE     GY+K+     D +S GV++ E++ G
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC----DWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 52/212 (24%), Positives = 96/212 (45%), Gaps = 36/212 (16%)

Query: 637 HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH 696
           + N +K+     + +   LI ++++ G L DL+ ++   L  +   KI   + + L  LH
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVEALNDLH 126

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPK--LTDFALDRIVG-EAAFQSTMSSEYALSCYNAP 753
           K    +++H ++K +N+L D   + +  L D+ L +I+G  + +  T+        Y +P
Sbjct: 127 KH---NIIHNDIKLENVLYD-RAKDRIYLCDYGLCKIIGTPSCYDGTLD-------YFSP 175

Query: 754 E------YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR---KINI 804
           E      Y  S       D ++ GV+  EL+TG+   + +  E LD+   ++R   K+  
Sbjct: 176 EKIKGHNYDVS------FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTS 836
                     K AN + Q ML    I  R T+
Sbjct: 230 IKNV-----SKNANDFVQSMLK-YNINYRLTN 255

Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 55.4 bits (134), Expect = 5e-08
 Identities = 46/192 (23%), Positives = 84/192 (43%), Gaps = 24/192 (12%)

Query: 605 SGELIAVKKLVNFGCQSSKTLKT------EVKTLAKIRHKNIVKVLGFFHSDE----SIF 654
           SG+ +A+KK+      +            E+K L   +H NI+ +             ++
Sbjct: 29  SGKKVAIKKI----PHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84

Query: 655 LIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI 713
           ++ + L    L  +I   Q    +  IR      + +GL Y+H   V   +HR++K  N+
Sbjct: 85  VVMD-LMESDLHHIIHSDQPLTEE-HIRY-FLYQLLRGLKYIHSANV---IHRDLKPSNL 138

Query: 714 LLDADFEPKLTDFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSF 770
           L++ D E ++ DF + R +  +    +  M+   A   Y APE   S  + T  +D +S 
Sbjct: 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSV 198

Query: 771 GVVLLELITGRQ 782
           G +  E++  RQ
Sbjct: 199 GCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.7 bits (134), Expect = 6e-08
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 27/215 (12%)

Query: 80  INLQSLNLSG----EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
            NL++L+LS     ++   +  LS+L+NL+L+ N     +P  +   S+LE L+LSNN I
Sbjct: 163 PNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSI 221

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
                       ++  S+ +L NL  L L +N L      + GN S L  LDLS N   I
Sbjct: 222 I-----------ELLSSLSNLKNLSGLELSNNKLEDLPESI-GNLSNLETLDLSNN--QI 267

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF-VGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           S I S +G L  L +L L  +     +P    + L    +L+L       E+        
Sbjct: 268 SSISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL-----KLN 321

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
             L++ ++  N    S P  +     L NL    N
Sbjct: 322 SILLNNNILSNGE-TSSPEALSILESLNNLWTLDN 355

Length = 394

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 6e-08
 Identities = 59/278 (21%), Positives = 115/278 (41%), Gaps = 30/278 (10%)

Query: 590 GNGGPFGRVYILSL---PSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           GNG  FG+V +  +        + VK+L  N   +       +      ++H NI++ LG
Sbjct: 4   GNGW-FGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL---KIAIGVAQGLAYLHKDYVPH 702
                    L++E+ ++G L   + ++ +  + S  L   ++A  +A G+ ++HK    +
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA- 761
            LH ++  +N  L +D   K+ D+ +     +  +  T   +     + APE        
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 762 ------TAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVVKWVRRKINITNGAIQVLDP 814
                 T   + ++ GV L EL     A Q     S  +V+  V     I +  +++  P
Sbjct: 180 LITAEQTKPSNVWALGVTLWELF--ENAAQPYSHLSDREVLNHV-----IKDQQVKLFKP 232

Query: 815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           ++   Y ++    L+       + PEKR +  EV + L
Sbjct: 233 QLELPYSERWYEVLQFCW----LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 30/191 (15%)

Query: 605 SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFL 655
           +G  +AVKKL     QS   +K    E++ L  ++H+N++ +L  F    S      ++L
Sbjct: 41  TGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99

Query: 656 IYEFLQMGS-LGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +     MG+ L +++ C++  D  +Q+ I       + +GL Y+H      ++HR++K  
Sbjct: 100 VTHL--MGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIHS---ADIIHRDLKPS 149

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSF 770
           N+ ++ D E K+ DF L R   +      M+   A   Y APE   +     Q +D +S 
Sbjct: 150 NLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 204

Query: 771 GVVLLELITGR 781
           G ++ EL+TGR
Sbjct: 205 GCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 16/194 (8%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G F  VY    L   + +A+KK+  F    +K  +    E+  L ++ H N++K L  F 
Sbjct: 13  GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72

Query: 649 SDESIFLIYEFLQMGSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            D  + ++ E    G L  +I    +Q   +      K  + +   + ++H   V   +H
Sbjct: 73  EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV---MH 129

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           R++K  N+ + A    KL D  L R       A  S + + Y +S     E GY+ K+  
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS-- 187

Query: 764 QMDAYSFGVVLLEL 777
             D +S G +L E+
Sbjct: 188 --DIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 47/194 (24%), Positives = 91/194 (46%), Gaps = 17/194 (8%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKL-----VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FGRV+++    S    A+K +     +    +  + +  E + L ++ H  I+++   
Sbjct: 12  GTFGRVHLVRDRISEHYYALKVMAIPEVIRL--KQEQHVHNEKRVLKEVSHPFIIRLFWT 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
            H    ++++ E++  G L   + R   +   S  L  A  +   L YLH      +++R
Sbjct: 70  EHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYR 125

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +NILLD +   KLTDF   + + +  +    + EY      APE   SK     +D
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYL-----APEVIQSKGHNKAVD 180

Query: 767 AYSFGVVLLELITG 780
            ++ G+++ E++ G
Sbjct: 181 WWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 62/271 (22%), Positives = 116/271 (42%), Gaps = 36/271 (13%)

Query: 608 LIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           L+AVK L     ++++   LK EVK L++++  NI+++LG    ++ + +I E+++ G L
Sbjct: 48  LVAVKILRPDANKNARNDFLK-EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106

Query: 666 ---------------GDLICRQDFQL---QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                          G+        L    +S  L +A+ +A G+ YL      + +HR+
Sbjct: 107 NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRD 163

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N L+  +   K+ DF + R +    +            + A E     K T   D 
Sbjct: 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV 223

Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-TNGAIQVLDPKIANCYQQQMLG 826
           ++FGV L E++      + +P   L   + +        +   QV   +   C Q    G
Sbjct: 224 WAFGVTLWEILM---LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ----G 276

Query: 827 ALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
             E+ L+C S    +RPS  +    +H+  T
Sbjct: 277 LYELMLQCWSRDCRERPSFSD----IHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 43/187 (22%), Positives = 80/187 (42%), Gaps = 23/187 (12%)

Query: 610 AVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           A+K++  +  +   +    E++ L K+  H NI+ +LG       ++L  E+   G+L D
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97

Query: 668 LI---------------CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            +                     L     L  A  VA+G+ YL +      +HR++ ++N
Sbjct: 98  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN 154

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           IL+  ++  K+ DF L R  G+  +         +         YS   T   D +S+GV
Sbjct: 155 ILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGV 211

Query: 773 VLLELIT 779
           +L E+++
Sbjct: 212 LLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 66/275 (24%), Positives = 119/275 (43%), Gaps = 46/275 (16%)

Query: 593 GPFGRVYILS---LPSGELIAVKKLVNFG-CQSSKTLKT--EVKTLAKIRHKNIVKVLGF 646
           G FG VY++      + E + V K +  G    ++T++   E + L+K+ H  IVK    
Sbjct: 11  GSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHAS 70

Query: 647 FHSDESIFLIYEFLQMGSLGDLI--CRQDFQ-------LQWSIRLKIAIGVAQGLAYLHK 697
           F   ++  +I E+ +   L   +   +   +        +W I+L +      G+ Y+H 
Sbjct: 71  FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVHYMH- 123

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMS-SEYALSCYNAPEY 755
                +LHR++K+KNI L  +   K+ DF + R ++G     +T + + Y +S       
Sbjct: 124 --QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ 180

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
           GY  K+    D +S G +L E+     A + +    L VV      + I  G      P 
Sbjct: 181 GYDSKS----DIWSLGCILYEMCCLAHAFEGQ--NFLSVV------LRIVEGPT----PS 224

Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           +   Y +Q+   ++  L      P  RPS  E+++
Sbjct: 225 LPETYSRQLNSIMQSMLNKD---PSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 50/202 (24%), Positives = 92/202 (45%), Gaps = 32/202 (15%)

Query: 593 GPFGRVYILSLPSGEL--IAVKKLVNFGCQSSKTLK--------TEVKTLAKIRHKNIVK 642
           G FGRV + +  + +   +A+K+      + SK +K        +E K L  I H   V 
Sbjct: 41  GSFGRVILATYKNEDFPPVAIKRF-----EKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           + G F  +  ++L+ EF+  G     + R++ +    +    A  +     YL      +
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQS---LN 151

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYS 758
           +++R++K +N+LLD D   K+TDF   ++V    +    + EY      APE     G+ 
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYI-----APEILLNVGHG 206

Query: 759 KKATAQMDAYSFGVVLLELITG 780
           K A    D ++ G+ + E++ G
Sbjct: 207 KAA----DWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 55.6 bits (134), Expect = 9e-08
 Identities = 29/76 (38%), Positives = 43/76 (56%)

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
           G IP+ IS    L+ + +  N    +IP  LGS+ SL     S NSF GS+P +      
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 401 MSIINLSQNSISGQIP 416
           + I+NL+ NS+SG++P
Sbjct: 492 LRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFF 647
           G FG+V +  L  SG L AVK L   V       +   TE + L+  R H  + ++   F
Sbjct: 6   GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + +F + EF+  G   DL+    F +Q S R         A  +   L +LH   + 
Sbjct: 66  QTPDRLFFVMEFVNGG---DLM----FHIQKSRRFDEARARFYAAEITSALMFLHDKGI- 117

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGY 757
             ++R++K  N+LLD +   KL DF + +   E  F    +S +   C    Y APE   
Sbjct: 118 --IYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTF---CGTPDYIAPEILQ 169

Query: 758 SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
                  +D ++ GV+L E++ G    +AE  + L
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 34/119 (28%), Positives = 53/119 (44%), Gaps = 2/119 (1%)

Query: 312 DN-GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG 370
           DN G  G  P+ +  L  ++ I    N   G IP S+     LE + +  N F  SIP+ 
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVM-SIINLSQNSISGQIPELKKCRKLVSLS 428
           LG + SL   + + NS  G +P       +  +  N + N+    IP L+ C   +S+ 
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVG 544

Length = 623

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 59/190 (31%), Positives = 94/190 (49%), Gaps = 26/190 (13%)

Query: 605 SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSDESIFLIYEFLQ 661
           +G ++AVK++   G  + +K +  ++  + K  H    IVK  G+F +D  +F+  E   
Sbjct: 39  TGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYGYFITDSDVFICMEL-- 95

Query: 662 MGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
           M +  D L+ R    +   I  K+ + + + L YL + +   ++HR+VK  NILLDA   
Sbjct: 96  MSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGN 153

Query: 721 PKLTDFALD-RIVGEAAFQSTMSSEYALSCYNAPEY--------GYSKKATAQMDAYSFG 771
            KL DF +  R+V   A   T S+  A   Y APE          Y  +A    D +S G
Sbjct: 154 VKLCDFGISGRLVDSKA--KTRSAGCAA--YMAPERIDPPDPNPKYDIRA----DVWSLG 205

Query: 772 VVLLELITGR 781
           + L+EL TG+
Sbjct: 206 ISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 580 VIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN 639
           VI + EK+S       G+ Y + +   E+I  K  V      + TL TE + L   RH  
Sbjct: 11  VILVREKAS-------GKYYAMKILKKEVIIAKDEV------AHTL-TESRVLKNTRHPF 56

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +  +   F + + +  + E++  G L   + R+    +   R   A  +   L YLH   
Sbjct: 57  LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYLHSG- 114

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
              +++R++K +N++LD D   K+TDF L    + +AA   TM +      Y APE    
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPEYLAPEVLED 169

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
                 +D +  GVV+ E++ GR
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 21/109 (19%)

Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
           KIA+ + + L YLH      ++HR+VK  N+L++ + + KL DF    I G      +++
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFG---ISGY--LVDSVA 159

Query: 743 SEYALSC--YNAPE--------YGYSKKATAQMDAYSFGVVLLELITGR 781
                 C  Y APE         GY  K+    D +S G+ ++EL TGR
Sbjct: 160 KTIDAGCKPYMAPERINPELNQKGYDVKS----DVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.3 bits (131), Expect = 1e-07
 Identities = 59/193 (30%), Positives = 86/193 (44%), Gaps = 29/193 (15%)

Query: 606 GELIAVKKLVN-FGCQSSKTLKT-----EVKTLAKIR-HKNIVKVLGF---FHSDESIFL 655
            E +A+KK+ N F    SK +       E+K L   R HKNI  +      F  + +   
Sbjct: 27  EETVAIKKITNVF----SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82

Query: 656 IYEFLQMGSLGDLICR----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +YE L    L  +I       D   Q  I       +  GL Y+H   V   LHR++K  
Sbjct: 83  LYEELMEADLHQIIRSGQPLTDAHFQSFI-----YQILCGLKYIHSANV---LHRDLKPG 134

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPEYGYS-KKATAQMDAY 768
           N+L++AD E K+ DF L R   E   ++   M+   A   Y APE   S +  T  +D +
Sbjct: 135 NLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVW 194

Query: 769 SFGVVLLELITGR 781
           S G +L EL+  +
Sbjct: 195 SVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 76/285 (26%), Positives = 122/285 (42%), Gaps = 65/285 (22%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI----------------- 635
           G FG VY      G LI             + +   VK+L +I                 
Sbjct: 6   GHFGCVY-----HGTLID---------SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMK 51

Query: 636 --RHKNIVKVLGFFHSDE-SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG--VAQ 690
              H N++ +LG     E S  ++  +++ G L + I  +      +++  I  G  VA+
Sbjct: 52  DFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAK 109

Query: 691 GLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA-LS 748
           G+ YL  K +V    HR++ ++N +LD  F  K+ DF L R + +  + S  +   A L 
Sbjct: 110 GMEYLASKKFV----HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165

Query: 749 C-YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV---RRKINI 804
             + A E   ++K T + D +SFGV+L EL+T R A      +S D+  ++   RR    
Sbjct: 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVDSFDITVYLLQGRR---- 220

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 +L P+    Y    L   E+ L C    PE RP+  E+V
Sbjct: 221 ------LLQPE----YCPDPL--YEVMLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 14/229 (6%)

Query: 593 GPFGRVYILSLPSGE-LIAVKKLVNFGC---QSSKTLKTEVKTLAK-IRHKNIVKVLGFF 647
           G FG+V +    + E   AVK L        +  K + +E   L K ++H  +V +   F
Sbjct: 6   GSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            + + ++ + +++  G L   + R+   L+   R   A  +A  L YLH     ++++R+
Sbjct: 66  QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHS---LNIVYRD 121

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +K +NILLD+     LTDF L +   E     T S+      Y APE  + +     +D 
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 768 YSFGVVLLELITGRQAEQAE-PAESLDVV--KWVRRKINITNGAIQVLD 813
           +  G VL E++ G     +   AE  D +  K ++ K NITN A  +L+
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 228

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 65/286 (22%), Positives = 122/286 (42%), Gaps = 47/286 (16%)

Query: 595 FGRVY---ILSLPSGE---LIAVKKLVNFGCQSSKTLKTEVKTLAKIR----HKNIVKVL 644
           FG+VY   +     GE    +A+K L +   ++   L+ E K  A +R    H NIV +L
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKD---KAEGPLREEFKHEAMMRSRLQHPNIVCLL 74

Query: 645 GFFHSDESIFLIYEFLQMGSLGD-LICRQ----------DFQLQWSIR----LKIAIGVA 689
           G    ++ + +I+ +     L + L+ R           D  ++ ++     + I   +A
Sbjct: 75  GVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA 134

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
            G+ +L      H++H+++ ++N+L+      K++D  L R V  A +   M +      
Sbjct: 135 AGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIR 191

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGA 808
           + +PE     K +   D +S+GVVL E+ + G Q       +  DV++ +R +       
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIRNR------- 242

Query: 809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS 854
            QVL      C          + L C +  P +RP   ++   L +
Sbjct: 243 -QVLP-----CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 16/196 (8%)

Query: 593 GPFGRVYILSL-PSGELIAVKKL------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V +     +GEL A+K L           +S    K   +T    RH  +V +  
Sbjct: 10  GHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA 69

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI-AIGVAQGLAYLHKDYVPHLL 704
            F +++ +  + E+   G L   I    F      R    A  V  GL YLH++ +   +
Sbjct: 70  CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAACVVLGLQYLHENKI---V 123

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           +R++K  N+LLD +   K+ DF L +      F    S+      + APE       T  
Sbjct: 124 YRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA 181

Query: 765 MDAYSFGVVLLELITG 780
           +D +  GV++ E++ G
Sbjct: 182 VDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 580 VIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN 639
           VI + EK++       GR Y + +   E+I  K  V      + T+ TE + L   RH  
Sbjct: 11  VILVREKAT-------GRYYAMKILRKEVIIAKDEV------AHTV-TESRVLQNTRHPF 56

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +  +   F + + +  + E+   G L   + R+    +   R   A  +   L YLH   
Sbjct: 57  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRD 115

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
           V   ++R++K +N++LD D   K+TDF L  + I   A    TM +      Y APE   
Sbjct: 116 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYLAPEVLE 168

Query: 758 SKKATAQMDAYSFGVVLLELITGR 781
                  +D +  GVV+ E++ GR
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 45/187 (24%), Positives = 82/187 (43%), Gaps = 23/187 (12%)

Query: 610 AVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           A+K L  F  ++  +    E++ L K+  H NI+ +LG   +   +++  E+   G+L D
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92

Query: 668 LICRQDF---------------QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            + +                   L     L+ A  VA G+ YL +      +HR++ ++N
Sbjct: 93  FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARN 149

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           +L+  +   K+ DF L R  GE  +         +         YS   T + D +SFGV
Sbjct: 150 VLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGV 206

Query: 773 VLLELIT 779
           +L E+++
Sbjct: 207 LLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 53.0 bits (127), Expect = 3e-07
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 28/202 (13%)

Query: 593 GPFGRV-YILSLPSGELIAVKKLVN-FGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G +G V   +   +GE +A+KKL   F  QS   +K    E+  L  ++H+N++ +L  F
Sbjct: 26  GAYGSVCSAIDKRTGEKVAIKKLSRPF--QSEIFAKRAYRELTLLKHMQHENVIGLLDVF 83

Query: 648 HSDESIFLIYEF-LQMGSLGDLICRQDFQLQWSIRL---KIAIGVAQ---GLAYLHKDYV 700
            S  S     +F L M  +     + D Q      L   K+   V Q   GL Y+H   +
Sbjct: 84  TSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-K 759
              +HR++K  N+ ++ D E K+ DF L R        + M+       Y APE   +  
Sbjct: 139 ---IHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWM 190

Query: 760 KATAQMDAYSFGVVLLELITGR 781
                +D +S G ++ E++TG+
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.0 bits (127), Expect = 4e-07
 Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 44/202 (21%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVK---------- 642
           G  GRV++ + P      V K+     Q   TL  E   L  + H ++++          
Sbjct: 77  GSEGRVFVATKPGQPDPVVLKI----GQKGTTL-IEAMLLQNVNHPSVIRMKDTLVSGAI 131

Query: 643 ---VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
              VL  + SD     +Y +L   S   L   Q   ++  I         +GL YLH   
Sbjct: 132 TCMVLPHYSSD-----LYTYLTKRS-RPLPIDQALIIEKQI--------LEGLRYLHAQ- 176

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY---NAPEYG 756
              ++HR+VK++NI ++   +  + D       G A F     +   L+     NAPE  
Sbjct: 177 --RIIHRDVKTENIFINDVDQVCIGDL------GAAQFPVVAPAFLGLAGTVETNAPEVL 228

Query: 757 YSKKATAQMDAYSFGVVLLELI 778
              K  ++ D +S G+VL E++
Sbjct: 229 ARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 21/202 (10%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVL 644
           G FG VY               +AVK L    C  Q       E   ++K  H+NIV+++
Sbjct: 17  GAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLI 75

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI--CR----QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +   R    +   L     L  A  VA+G  YL ++
Sbjct: 76  GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135

Query: 699 YVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 136 ---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEA 192

Query: 756 GYSKKATAQMDAYSFGVVLLEL 777
                 T++ D +SFGV+L E+
Sbjct: 193 FLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 51.7 bits (124), Expect = 6e-07
 Identities = 50/203 (24%), Positives = 83/203 (40%), Gaps = 24/203 (11%)

Query: 590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLK---------TEVKTLAKIRHKN 639
           G GG FG V    +  +G++ A KKL        K LK          E K L K+  + 
Sbjct: 2   GKGG-FGEVCACQVKATGKMYACKKL------DKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKD 698
           IV +   F + + + L+   +  G L   I          +  +  A  +  GL +LH+ 
Sbjct: 55  IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR 114

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
            +   ++R++K +N+LLD     +++D  L     E      +        Y APE    
Sbjct: 115 RI---VYRDLKPENVLLDDHGNVRISDLGL---AVELKGGKKIKGRAGTPGYMAPEVLQG 168

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           +     +D ++ G  L E+I GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 12/111 (10%)

Query: 628 EVKTLAKIRHKNIV--------KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS 679
           E+K L  ++H+N+V        K   +     S +L++EF +   L  L+  ++ +   S
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119

Query: 680 IRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
              K+   +  GL Y+H++ +   LHR++K+ NIL+  D   KL DF L R
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 43/187 (22%), Positives = 81/187 (43%), Gaps = 23/187 (12%)

Query: 610 AVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           A+K++  +  +   +    E++ L K+  H NI+ +LG       ++L  E+   G+L D
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 668 LICRQDF---------------QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            + +                   L     L  A  VA+G+ YL +      +HR++ ++N
Sbjct: 86  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN 142

Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           IL+  ++  K+ DF L R  G+  +         +         YS   T   D +S+GV
Sbjct: 143 ILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGV 199

Query: 773 VLLELIT 779
           +L E+++
Sbjct: 200 LLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 59/229 (25%), Positives = 103/229 (44%), Gaps = 38/229 (16%)

Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQ---------LQWSIRLKIAIG 687
           ++V++LG     +   ++ E +  G L   +   R + +         LQ  I++  A  
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAE 127

Query: 688 VAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
           +A G+AYL+ K +V    HR++ ++N ++  DF  K+ DF + R + E  +         
Sbjct: 128 IADGMAYLNAKKFV----HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183

Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD---VVKWVRRKIN 803
              + APE       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV----- 234

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           +  G +   D    NC  +++   + +   C    P+ RP+  E+V  L
Sbjct: 235 MDGGYLDQPD----NC-PERVTDLMRM---CWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 19/162 (11%)

Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF-QLQWSIRLK 683
           ++ E+  L++     + K  G +     +++I E+L  GS  DL+    F + Q +  LK
Sbjct: 49  IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK 108

Query: 684 IAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL-----DRIVGEAAFQ 738
               + +GL YLH +     +HR++K+ N+LL    + KL DF +     D  +    F 
Sbjct: 109 ---EILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162

Query: 739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            T         + APE        ++ D +S G+  +EL  G
Sbjct: 163 GT-------PFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 22/195 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY   ++ +GEL A+K +     +    ++ E+  +   +H NIV   G +   +
Sbjct: 20  GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79

Query: 652 SIFLIYEFLQMGSLGDLI----CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            +++  EF   GSL D+        + Q+ +  R  +     QGL YLH       +HR+
Sbjct: 80  KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK---GKMHRD 131

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGY--SKKATA 763
           +K  NILL  +   KL DF +   +    A  +S + + Y    + APE      K    
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY----WMAPEVAAVERKGGYN 187

Query: 764 QM-DAYSFGVVLLEL 777
           Q+ D ++ G+  +EL
Sbjct: 188 QLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFF 647
           G FG+V +  L  + E+ A+K L   V           TE + LA    H  +  +   F
Sbjct: 6   GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + +F + E++  G   DL+    FQ+Q S +         A  V   L +LH+  V 
Sbjct: 66  QTKDRLFFVMEYVNGG---DLM----FQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGV- 117

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGY 757
             ++R++K  NILLDA+   KL DF + +   E       ++ +   C    Y APE   
Sbjct: 118 --IYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTF---CGTPDYIAPEILQ 169

Query: 758 SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
             +    +D ++ GV++ E++ G+   +A+  + L
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 42/177 (23%), Positives = 85/177 (48%), Gaps = 7/177 (3%)

Query: 607 ELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           E++A+KK  +     +  +T   E+K L  ++ +NIV++   F     ++L++E+++   
Sbjct: 27  EIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86

Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L  L    +      +R  I   + + + + HK+    ++HR++K +N+L+  +   KL 
Sbjct: 87  LELLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLC 142

Query: 725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           DF   R + E +  +  +   A   Y +PE          +D +S G +L EL  G+
Sbjct: 143 DFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 36/99 (36%), Positives = 54/99 (54%), Gaps = 18/99 (18%)

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS- 748
           Q L  +H  +  H++HR++KS NILL ++   KL DF   ++     + +T+S +   + 
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-----YAATVSDDVGRTF 205

Query: 749 C----YNAPEY----GYSKKATAQMDAYSFGVVLLELIT 779
           C    Y APE      YSKKA    D +S GV+L EL+T
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKA----DMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 47/164 (28%), Positives = 85/164 (51%), Gaps = 24/164 (14%)

Query: 626 KTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           K E   L  ++H  IV ++  F +   ++LI E+L  G L   + R+   ++ +    ++
Sbjct: 48  KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107

Query: 686 -IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
            I +A  L +LH+  +   ++R++K +NILLDA    KLTDF L +   E+  + T++  
Sbjct: 108 EISLA--LEHLHQQGI---IYRDLKPENILLDAQGHVKLTDFGLCK---ESIHEGTVTHT 159

Query: 745 YALSC----YNAPEY----GYSKKATAQMDAYSFGVVLLELITG 780
           +   C    Y APE     G+ K     +D +S G ++ +++TG
Sbjct: 160 F---CGTIEYMAPEILMRSGHGKA----VDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 50.7 bits (122), Expect = 1e-06
 Identities = 47/183 (25%), Positives = 76/183 (41%), Gaps = 37/183 (20%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT--EVKTLAKIR---HKNIVKVLGF 646
           G +G VY    L +G  +A+KK+     +    L T  E+  L ++    H NIV++L  
Sbjct: 10  GAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDV 69

Query: 647 FHSDE-----SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ----------G 691
            H         + L++E             QD     S   K  +              G
Sbjct: 70  CHGPRTDRELKLTLVFEH----------VDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + +LH   +   +HR++K +NIL+ +D + K+ DF L RI     F+  ++S      Y 
Sbjct: 120 VDFLHSHRI---VHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYR 173

Query: 752 APE 754
           APE
Sbjct: 174 APE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 9/157 (5%)

Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++ E+  L++     + K  G +  D  +++I E+L  GS  DL+  +   L  +    I
Sbjct: 49  IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATI 106

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
              + +GL YLH +     +HR++K+ N+LL    E KL DF    + G+        + 
Sbjct: 107 LREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNT 160

Query: 745 Y-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           +     + APE        ++ D +S G+  +EL  G
Sbjct: 161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 25/81 (30%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 423 KLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLAL--FNVSFNK 480
           ++VS+ L+  +++G+I  ++  LP +  ++LS+N L+GPIP  +     +L   N+S N 
Sbjct: 70  RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNN 129

Query: 481 LSGRVPYSLISGLPASYLQGN 501
            +G +P   I  L    L  N
Sbjct: 130 FTGSIPRGSIPNLETLDLSNN 150

Length = 968

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 23/160 (14%)

Query: 629 VKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGV 688
              ++++ HK++VK+ G    DE+I ++ E+++ G L   + R+   +    +L +A  +
Sbjct: 52  ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL 110

Query: 689 AQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEP----KLTDFALDRIVGEAAFQSTM 741
           A  L YL       L+H NV  KNIL+     +       KL+D  +   V         
Sbjct: 111 ASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-------- 159

Query: 742 SSEYALS--CYNAPEY--GYSKKATAQMDAYSFGVVLLEL 777
           S E  +    + APE         T   D +SFG  LLE+
Sbjct: 160 SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 9/190 (4%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG VY  +   + E++A+K + +       + ++ E+  L++     I +  G +   
Sbjct: 15  GSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG 74

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             +++I E+L  GS  DL+  +   L+ +    I   + +GL YLH +     +HR++K+
Sbjct: 75  TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKA 129

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            N+LL    + KL DF +   + +   Q   ++      + APE         + D +S 
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187

Query: 771 GVVLLELITG 780
           G+  +EL  G
Sbjct: 188 GITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 21/203 (10%)

Query: 580 VIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN 639
           VI + EK++       GR Y + +   E+I  K  V      + TL TE + L   RH  
Sbjct: 11  VILVKEKAT-------GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPF 56

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +  +   F + + +  + E+   G L   + R+    +   R   A  +   L YLH + 
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE- 114

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
             ++++R++K +N++LD D   K+TDF L    + + A   TM +      Y APE    
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLED 170

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
                 +D +  GVV+ E++ GR
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)

Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFL 660
           +AVKKL   F  Q+ +K    E+  L  + HKNI+ +L  F   +S      ++L+ E +
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
                  +    D +    +  ++  G+     +LH      ++HR++K  NI++ +D  
Sbjct: 109 DANLCQVIHMELDHERMSYLLYQMLCGIK----HLHS---AGIIHRDLKPSNIVVKSDCT 161

Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            K+ DF L R     A  + M + Y ++  Y APE          +D +S G ++ EL+ 
Sbjct: 162 LKILDFGLAR----TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217

Query: 780 G 780
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 6/175 (3%)

Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170

Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G +     M+       Y APE          +D +S G ++ E+I G 
Sbjct: 171 GLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 31/208 (14%)

Query: 593 GPFGRVY-ILSLPSGELIAVKK----LVNFGCQSSKTLKTEVKTLAKIRHKN-IVKVLGF 646
           G +G+VY      +G+L+A+KK    +   G   +  L+ E+  L  +     IV++L  
Sbjct: 12  GTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPT-ALR-EISLLQMLSESIYIVRLLDV 69

Query: 647 FHSDE-----SIFLIYEFLQ--MGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKD 698
            H +E     S++L++E+L   +    D   R   + L           + +G+A+ HK 
Sbjct: 70  EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH 129

Query: 699 YVPHLLHRNVKSKNILLDADFEP-KLTDFALDRIVGEAAFQSTMSS---EYALSCYNAPE 754
            V   +HR++K +N+L+D      K+ D  L R     AF   + S   E     Y APE
Sbjct: 130 GV---MHRDLKPQNLLVDKQKGLLKIADLGLGR-----AFSIPVKSYTHEIVTLWYRAPE 181

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITG 780
              G +  +T  +D +S G +  E+   
Sbjct: 182 VLLGSTHYSTP-VDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 51/197 (25%), Positives = 90/197 (45%), Gaps = 44/197 (22%)

Query: 606 GELIAVKKLVN-FGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIY 657
           G+ +A+KKL   F   +  K    E+  +  + HKNI+ +L  F   +S      ++L+ 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100

Query: 658 EFLQMGSLGDLICRQDFQLQWSIRL-----KIAIGVAQ---GLAYLHKDYVPHLLHRNVK 709
           E +            D  L   I++     +++  + Q   G+ +LH   +   +HR++K
Sbjct: 101 ELM------------DANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGI---IHRDLK 145

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPE----YGYSKKATAQ 764
             NI++ +D   K+ DF L R  G     S M + Y ++  Y APE     GY +     
Sbjct: 146 PSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVILGMGYKEN---- 197

Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G ++ E+I G 
Sbjct: 198 VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 33/137 (24%), Positives = 61/137 (44%), Gaps = 13/137 (9%)

Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIV--KVLGFFHS 649
           GG   RVY+L     + + +K   +   +     + EV  L  +  K +   KVL    S
Sbjct: 8   GGLTNRVYLLGTKDEDYV-LKINPSR--EKGADREREVAILQLLARKGLPVPKVLASGES 64

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           D   +L+ E+++  +L ++   +        +  IA  +A+ LA LH+  +  L H ++ 
Sbjct: 65  DGWSYLLMEWIEGETLDEVSEEE--------KEDIAEQLAELLAKLHQLPLLVLCHGDLH 116

Query: 710 SKNILLDADFEPKLTDF 726
             NIL+D      + D+
Sbjct: 117 PGNILVDDGKILGIIDW 133

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 29/92 (31%), Positives = 46/92 (50%), Gaps = 6/92 (6%)

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +GL +LH   V   +HR++K +NIL+ +  + KL DF L RI    +FQ  ++S      
Sbjct: 121 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 174

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE          +D +S G +  E+   +
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 49.6 bits (118), Expect = 4e-06
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 10/120 (8%)

Query: 604 PSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           P+GE + V+++    C +     L+ E+       H NIV     F +D  ++++  F+ 
Sbjct: 23  PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82

Query: 662 MGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDAD 718
            GS  DLIC    D   + +I   I  GV + L Y+H   YV    HR+VK+ +IL+  D
Sbjct: 83  YGSAKDLICTHFMDGMSELAIAY-ILQGVLKALDYIHHMGYV----HRSVKASHILISVD 137

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 5e-06
 Identities = 46/142 (32%), Positives = 71/142 (50%), Gaps = 12/142 (8%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVNF----GCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V+++    +G++ A+K L         Q +   + E   LA      IVK+   F
Sbjct: 12  GAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHV-RAERDILADADSPWIVKLYYSF 70

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +E ++L+ E++  G L +L+ R+D F  +   R  IA  V   L  +HK      +HR
Sbjct: 71  QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL-ALDSVHK---LGFIHR 125

Query: 707 NVKSKNILLDADFEPKLTDFAL 728
           ++K  NIL+DAD   KL DF L
Sbjct: 126 DIKPDNILIDADGHIKLADFGL 147

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.4 bits (118), Expect = 6e-06
 Identities = 25/81 (30%), Positives = 41/81 (50%)

Query: 267 LSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSL 326
           L G  PN I K   L +++L  N   G+IP S+    +LE   +  N F+G  P+ L  L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 327 PRIKLIRAESNRFSGAIPDSI 347
             ++++    N  SG +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 593 GPFGRVYILSLPSG--ELIAVKKL---VNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGF 646
           G FG+V +L+   G  EL A+K L   V       +    E + LA   +   + ++   
Sbjct: 11  GSFGKV-MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYV 700
           F + + ++ + E++  G   DL+    + +Q   + K       A  +A GL +LH   +
Sbjct: 70  FQTMDRLYFVMEYVNGG---DLM----YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYG 756
              ++R++K  N++LDA+   K+ DF + +   E  F    +  +   C    Y APE  
Sbjct: 123 ---IYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTF---CGTPDYIAPEII 173

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
             +     +D ++FGV+L E++ G+     E  + L
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 19/203 (9%)

Query: 590 GNGGPFGRVYILSLPSG---ELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           GNG  FG+V +  + SG     + VK+L V+   Q       E +    ++H N+++ LG
Sbjct: 4   GNGW-FGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 646 FFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVP 701
                    L+ EF  +G L   +  CR+   +        ++A  +A GL +LHK+   
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-----YG 756
           + +H ++  +N LL AD   K+ D+ L     +  +  T    +    + APE     +G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Query: 757 --YSKKATAQMDAYSFGVVLLEL 777
                  T + + +S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 11/193 (5%)

Query: 593 GPFGRVYILSLPS-GELIAVK---KLVNFGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFF 647
           G FG+V +    S G   AVK   K      +    +  E   L K ++H  +V +   F
Sbjct: 6   GSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            + E ++ + +++  G L   + R+   L+   R   A  VA  + YLH     ++++R+
Sbjct: 66  QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLHS---LNIIYRD 121

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +K +NILLD+     LTDF L +   E   + T S+      Y APE    +     +D 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 768 YSFGVVLLELITG 780
           +  G VL E++ G
Sbjct: 180 WCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 25/165 (15%)

Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           KT   E+  L  I H+ I+ ++  +    ++ ++    +     DL    D      +  
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLPLEQ 186

Query: 683 KIAI--GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            I I   + + LAYLH   +   +HR+VK++NI LD      L DF        AA +  
Sbjct: 187 AITIQRRLLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFG-------AACKLD 236

Query: 741 MSSEYALSCY--------NAPEYGYSKKATAQMDAYSFGVVLLEL 777
                   CY        N+PE        A+ D +S G+VL E+
Sbjct: 237 AHP-DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 8e-06
 Identities = 25/61 (40%), Positives = 32/61 (52%), Gaps = 3/61 (4%)

Query: 183 LVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN 241
           L  LDLS N   ++ IP      L  L+ L L  +    + P++F GL SL  LDLS NN
Sbjct: 2   LKSLDLSNN--RLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 242 L 242
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 9e-06
 Identities = 29/80 (36%), Positives = 42/80 (52%), Gaps = 15/80 (18%)

Query: 82  LQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW 136
           LQS+NLS     G I  S+  ++SL  L+L+ N FN  IP  L Q +SL  LNL+     
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG---- 499

Query: 137 VLDLSRNHIEGKIPESIGSL 156
                 N + G++P ++G  
Sbjct: 500 ------NSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 9e-06
 Identities = 23/68 (33%), Positives = 33/68 (48%), Gaps = 10/68 (14%)

Query: 124 SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL 183
           +L++L+LSNN + V+             +   L NL+VL+L  N L+   P  F     L
Sbjct: 1   NLKSLDLSNNRLTVIP----------DGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSL 50

Query: 184 VVLDLSQN 191
             LDLS N
Sbjct: 51  RSLDLSGN 58

Length = 60

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 9e-06
 Identities = 63/253 (24%), Positives = 106/253 (41%), Gaps = 53/253 (20%)

Query: 593 GPFGRVYILS-LPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++  + +  L A+K L          +  +K E   LA+  ++ +VK+   F 
Sbjct: 12  GAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRN 707
             ++++ + +++  G +  L+ R     +   R  IA  +   +  +HK  ++    HR+
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGFI----HRD 126

Query: 708 VKSKNILLDADFEPKLTDFAL--------DRIV---GEAAFQSTM--SSEYA--LSC--- 749
           +K  NIL+D D   KLTDF L        D      G+   Q +M  S E++    C   
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 750 -----------------------YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQA 786
                                  Y APE       T   D +S GV+L E++ G+    A
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246

Query: 787 E-PAES-LDVVKW 797
           + PAE+ L V+ W
Sbjct: 247 DTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 13/194 (6%)

Query: 593 GPFGRVYILSLP-SGELIAVK---KLVNFGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFF 647
           G FG+V +      G+  AVK   K +    +  K +  E   L K ++H  +V +   F
Sbjct: 6   GSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF 65

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            + E ++ + +F+  G L   + R+    +   R   A  +A  L YLH     ++++R+
Sbjct: 66  QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHS---INIVYRD 121

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQMD 766
           +K +NILLD+     LTDF L +   E   QS  ++ +     Y APE    +     +D
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVD 178

Query: 767 AYSFGVVLLELITG 780
            +  G VL E++ G
Sbjct: 179 WWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.9 bits (114), Expect = 9e-06
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 25/205 (12%)

Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLK---------TEVKTLAKIRHKN 639
           G GG FG V    +  +G+L A KKL      + K LK          E + LAK+  + 
Sbjct: 2   GKGG-FGEVSACQMRATGKLYACKKL------NKKRLKKRKGYEGAMVEKRILAKVHSRF 54

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ---LQWSIRLKIAIGVAQGLAYLH 696
           IV +   F +   + L+   +  G L   I   D +               +  GL +LH
Sbjct: 55  IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
           +     +++R++K +N+LLD D   +++D  L   V     QS          + APE  
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGL--AVELKDGQSKTKGYAGTPGFMAPELL 169

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
             ++    +D ++ GV L E+I  R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)

Query: 580 VIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN 639
           VI + EK++       G+ Y + +   E+I  K  V      + TL TE + L   RH  
Sbjct: 11  VILVREKAT-------GKYYAMKILKKEVIIAKDEV------AHTL-TESRVLQNTRHPF 56

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +  +   F + + +  + E+   G L   + R+    +   R   A  +   L YLH   
Sbjct: 57  LTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALGYLHSCD 115

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK 759
           V   ++R++K +N++LD D   K+TDF L +     +  +TM +      Y APE     
Sbjct: 116 V---VYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 760 KATAQMDAYSFGVVLLELITGR 781
                +D +  GVV+ E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 21/198 (10%)

Query: 593 GPFGRVYILSLPS-GELIAVKKLVNFGCQSSKTLK-TEVK--------TLAKIRHKNIVK 642
           G FG+V +    + G+  AVK L     Q    LK  E K         L  ++H  +V 
Sbjct: 6   GSFGKVLLAKHKADGKFYAVKVL-----QKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           +   F + + ++ + +++  G L   + R+    +   R   A  +A  L YLH     +
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLHS---LN 116

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           +++R++K +NILLD+     LTDF L +         T S+      Y APE    +   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174

Query: 763 AQMDAYSFGVVLLELITG 780
             +D +  G VL E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.7 bits (114), Expect = 1e-05
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 38/205 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-------HKNIVKVL 644
           G F  V    S  +G+  A+K +     +S +    +V  L +I+       H NI++++
Sbjct: 10  GTFSEVLKAQSRKTGKYYAIKCMKK-HFKSLE----QVNNLREIQALRRLSPHPNILRLI 64

Query: 645 GFFHSDE--SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
                 +   + L++E + M +L +LI  +   L           + + L ++H++    
Sbjct: 65  EVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---G 120

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPE------- 754
           + HR++K +NIL+  D   KL DF   R      +     +EY +   Y APE       
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTRWYRAPECLLTDGY 175

Query: 755 YGYSKKATAQMDAYSFGVVLLELIT 779
           YG       +MD ++ G V  E+++
Sbjct: 176 YGP------KMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.8 bits (113), Expect = 2e-05
 Identities = 44/173 (25%), Positives = 82/173 (47%), Gaps = 8/173 (4%)

Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 105 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163

Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++
Sbjct: 164 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 2e-05
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 29/183 (15%)

Query: 611 VKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI--------YEFLQM 662
           + K V  G +++  L+ E+  L ++ H+NI+K+     S+ + ++I        Y F+  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK 722
            +       +D  L    R  I   +   + Y+H      L+HR++K +NI L+ D +  
Sbjct: 256 EAFD----WKDRPLLKQTR-AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIV 307

Query: 723 LTDFAL------DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
           L DF        +R   +  +  T+++       N+PE           D +S G++LL+
Sbjct: 308 LGDFGTAMPFEKEREAFDYGWVGTVAT-------NSPEILAGDGYCEITDIWSCGLILLD 360

Query: 777 LIT 779
           +++
Sbjct: 361 MLS 363

Length = 501

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 48.2 bits (114), Expect = 2e-05
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 53/232 (22%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGC-----------QSSKTLKTEVKTLAKIRHK 638
           GNG  FG V+        L+  K+   F C           +    L  EV  + +++HK
Sbjct: 22  GNG-RFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72

Query: 639 NIVKVLGFF--HSDESIFLIYEFLQMGSLGDLI--CRQDF-QLQWSIRLKIAIGVAQGLA 693
           NIV+ +  F   +++ ++++ EF   G L   I  C + F +++    + I   +   LA
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132

Query: 694 YLH--KD--YVPHLLHRNVKSKNILLDADFE-----------------PKLTDFALDRIV 732
           Y H  KD      +LHR++K +NI L                       K+ DF L + +
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192

Query: 733 G-EAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           G E+   S + + Y    Y +PE     +K    + D ++ G ++ EL +G+
Sbjct: 193 GIESMAHSCVGTPY----YWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 23/157 (14%)

Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
           + ++ HK+IV + G    D    ++ EF++ G L   + R+   L    + K+A  +A  
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASA 117

Query: 692 LAYLH-KDYVPHLLHRNVKSKNILL-----DADFEP--KLTDFALDRIVGEAAFQSTMSS 743
           L+YL  KD    L+H NV +KNILL     D +  P  KL+D  +   V        +S 
Sbjct: 118 LSYLEDKD----LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV--------LSR 165

Query: 744 EYALS--CYNAPE-YGYSKKATAQMDAYSFGVVLLEL 777
           +  +    + APE    SK  +   D +SFG  L E+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/142 (28%), Positives = 69/142 (48%), Gaps = 20/142 (14%)

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F +   +FL+ E++  G L   + RQ    +   R   A  +   L +LH+  +   ++R
Sbjct: 65  FQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLHERGI---IYR 120

Query: 707 NVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPE------YGYSK 759
           ++K  N+LLDAD   KLTD+ +    +G      T S+      Y APE      YG+S 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFS- 176

Query: 760 KATAQMDAYSFGVVLLELITGR 781
                +D ++ GV++ E++ GR
Sbjct: 177 -----VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 46/192 (23%), Positives = 91/192 (47%), Gaps = 26/192 (13%)

Query: 597 RVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           R+Y + +   EL+   + +++  Q+ K +  +        H  +V +   F ++  +F +
Sbjct: 21  RIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFV 74

Query: 657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            E++  G L   + RQ    +   R   A  ++  L YLH+  +   ++R++K  N+LLD
Sbjct: 75  IEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI---IYRDLKLDNVLLD 130

Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPE------YGYSKKATAQMDAYS 769
           ++   KLTD+ + +   E       +S +     Y APE      YG+S      +D ++
Sbjct: 131 SEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS------VDWWA 181

Query: 770 FGVVLLELITGR 781
            GV++ E++ GR
Sbjct: 182 LGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 50/187 (26%), Positives = 92/187 (49%), Gaps = 30/187 (16%)

Query: 609 IAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI------FLIYEF 659
           +AVKKL     QS   ++    E++ L  ++H+N++ +L  F    SI      +L+   
Sbjct: 43  VAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101

Query: 660 LQMGS-LGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
             MG+ L +++ C++  D  +Q+ I       + +GL Y+H      ++HR++K  N+ +
Sbjct: 102 --MGADLNNIVKCQKLSDEHVQFLI-----YQLLRGLKYIHS---AGIIHRDLKPSNVAV 151

Query: 716 DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVL 774
           + D E ++ DF L R   +      M+   A   Y APE   +     Q +D +S G ++
Sbjct: 152 NEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206

Query: 775 LELITGR 781
            EL+ G+
Sbjct: 207 AELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 35/211 (16%)

Query: 593 GPFGRVYILSLPSGE---LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +G VY      G+     A+K++   G   S     E+  L +++H N++ +   F  
Sbjct: 12  GTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC--REIALLRELKHPNVIALQKVFLS 69

Query: 648 HSDESIFLIYEFLQMGSLGDLI--------CRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           HSD  ++L++++ +   L  +I         ++  QL  S+   +   +  G+ YLH ++
Sbjct: 70  HSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 700 VPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYALS------C 749
           V   LHR++K  NIL+  +       K+ D    R+     F S +     L        
Sbjct: 129 V---LHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSPLKPLADLDPVVVTFW 180

Query: 750 YNAPEYGY-SKKATAQMDAYSFGVVLLELIT 779
           Y APE    ++  T  +D ++ G +  EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 31/193 (16%)

Query: 664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL 723
           ++ DLIC   FQ            VA+G+ +L        +HR++ ++NILL  +   K+
Sbjct: 172 TMEDLIC-YSFQ------------VARGMEFLASR---KCIHRDLAARNILLSENNVVKI 215

Query: 724 TDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
            DF L R I  +  +    S+   L  + APE  + K  T Q D +SFGV+L E+ +   
Sbjct: 216 CDFGLARDIYKDPDYVRKGSARLPLK-WMAPESIFDKVYTTQSDVWSFGVLLWEIFS--L 272

Query: 783 AEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR 842
                P   ++     R K      A +   P+I             I L C    P++R
Sbjct: 273 GASPYPGVQINEEFCQRLKDGTRMRAPENATPEI-----------YRIMLACWQGDPKER 321

Query: 843 PSMFEVVKALHSL 855
           P+   +V+ L  L
Sbjct: 322 PTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 4e-05
 Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 67/238 (28%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN----------IV 641
           G FG V ++    +G + A+K L        K    E + +A IR +           +V
Sbjct: 12  GAFGEVRLVQKKDTGHIYAMKIL-------RKADMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
           K+   F    +++LI EFL  G +  L+ ++D   + + +  IA  V      L  D + 
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV------LAIDAIH 118

Query: 702 HL--LHRNVKSKNILLDADFEPKLTDFALDRIVGEA-----------------AFQSTMS 742
            L  +HR++K  N+LLDA    KL+DF L   + +A                 +FQ+  S
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 743 S-----------EYALSCYNAPEY---------GYSKKATAQMDAYSFGVVLLELITG 780
                       + A S    P+Y         GY+K      D +S GV++ E++ G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC----DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 8/140 (5%)

Query: 593 GPFGRVYILS-LPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++    +G++ A+K L+    F       +K E   LA+     +V +   F 
Sbjct: 12  GAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             + ++LI EFL  G L  ++ + D   +   R  +A  V   +  +HK      +HR++
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL-AIEAVHK---LGFIHRDI 127

Query: 709 KSKNILLDADFEPKLTDFAL 728
           K  NIL+D     KL+DF L
Sbjct: 128 KPDNILIDRGGHIKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 49/201 (24%), Positives = 90/201 (44%), Gaps = 12/201 (5%)

Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLG 645
           G GG FG V    +  +G++ A KKL     +  K       E + L K+  + +V +  
Sbjct: 9   GKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            + + +++ L+   +  G L   I    +   +    +  A  +  GL  LH++    ++
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIV 124

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           +R++K +NILLD     +++D  L   V E     T+        Y APE   +++ T  
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 765 MDAYSFGVVLLELITGRQAEQ 785
            D ++ G +L E+I G+   Q
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.7 bits (108), Expect = 6e-05
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 32/205 (15%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGFFHSD 650
           G FG+VY +    +  + A+K L       SK      K +A  I  +NI+        D
Sbjct: 4   GTFGQVYQVRKKDTRRIYAMKVL-------SKKEIVAKKEVAHTIGERNILVRTLL---D 53

Query: 651 ESIFLIYEFLQMGSLGDLICRQDF----QLQWSI---------RLKIAIG-VAQGLAYLH 696
           ES F++       +  DL    D+    +L W +         R K  I  +   L +LH
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH 113

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
           K     +++R++K +NILLDA     L DF L +         T ++    + Y APE  
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVL 168

Query: 757 YSKKA-TAQMDAYSFGVVLLELITG 780
             +K  T  +D +S GV++ E+  G
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 47/187 (25%), Positives = 78/187 (41%), Gaps = 33/187 (17%)

Query: 617 FGCQSSKTLK-------------TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG 663
           F C  +KT +             TE   L  I H +I+++ G F  ++   LI    +  
Sbjct: 109 FACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT- 167

Query: 664 SLGDLICRQDFQLQWSI--RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP 721
              DL C    +   +I   L I   V + + YLH++    ++HR++K++NI ++   + 
Sbjct: 168 ---DLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDV 221

Query: 722 KLTDFALDRIVGEAAF--QSTMSSEYALS---CYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            L DF      G A F      +  Y  +     NAPE          +D +S G+VL E
Sbjct: 222 CLGDF------GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFE 275

Query: 777 LITGRQA 783
           + T   +
Sbjct: 276 MATCHDS 282

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 7e-05
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 13/157 (8%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +   + +  L A+K L             +K E   LA+  ++ +VK+   F 
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             ++++ + +++  G +  L+ R +   +   R  IA  +   +  +HK      +HR++
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHK---MGFIHRDI 127

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           K  NIL+D D   KLTDF L        F+ T +S+Y
Sbjct: 128 KPDNILIDLDGHIKLTDFGLC-----TGFRWTHNSKY 159

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 46/204 (22%), Positives = 86/204 (42%), Gaps = 24/204 (11%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++    +G++ A+K +   V    ++    + E   L+      I ++   F 
Sbjct: 12  GHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             ++++L+ E+   G L  L+ R + Q    +       +A+ +  +H  +    +HR++
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM---AQFYLAELVLAIHSVHQMGYVHRDI 128

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY----------GYS 758
           K +N+L+D     KL DF      G AA  +      +      P+Y          G  
Sbjct: 129 KPENVLIDRTGHIKLADF------GSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182

Query: 759 KKATA-QMDAYSFGVVLLELITGR 781
           K     + D +S GV+  E+I GR
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 31/193 (16%)

Query: 664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL 723
           +L DLIC   FQ            VA+G+ +L        +HR++ ++NILL  +   K+
Sbjct: 177 TLEDLIC-YSFQ------------VAKGMEFLASR---KCIHRDLAARNILLSENNVVKI 220

Query: 724 TDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
            DF L R I  +  +     +   L  + APE  + +  T Q D +SFGV+L E+ +   
Sbjct: 221 CDFGLARDIYKDPDYVRKGDARLPLK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS--L 277

Query: 783 AEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR 842
                P   +D     R K      A     P++   YQ          L C    P +R
Sbjct: 278 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM---YQTM--------LDCWHGEPSQR 326

Query: 843 PSMFEVVKALHSL 855
           P+  E+V+ L +L
Sbjct: 327 PTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 51/199 (25%)

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +VK+   F    +++LI EFL  G +  L+ ++D   +   +  IA  V      L  D 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV------LAIDS 116

Query: 700 VPHL--LHRNVKSKNILLDADFEPKLTDFAL-----------------DRIVGEAAFQST 740
           +  L  +HR++K  N+LLD+    KL+DF L                   +  +  FQ+ 
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 741 MSS-----------EYALSCYNAPEY---------GYSKKATAQMDAYSFGVVLLELITG 780
            S            + A S    P+Y         GY+K      D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLC----DWWSLGVIMYEMLIG 232

Query: 781 RQAEQAE-PAESL-DVVKW 797
                +E P E+   V+ W
Sbjct: 233 YPPFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 26/205 (12%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY  + + + E +A+KK++    Q  +    E+  +  + H NI+ +  +++
Sbjct: 75  GNGS-FGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDYYY 129

Query: 649 SD------ESIFL--IYEFL--QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           ++      ++IFL  + EF+   +        R +  L   +    +  + + LAY+H  
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189

Query: 699 YVPHLLHRNVKSKNILLDADFEP-KLTDF-ALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
           ++    HR++K +N+L+D +    KL DF +   ++      S + S +    Y APE  
Sbjct: 190 FI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF----YRAPELM 242

Query: 757 Y-SKKATAQMDAYSFGVVLLELITG 780
             +   T  +D +S G ++ E+I G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 56/281 (19%), Positives = 113/281 (40%), Gaps = 36/281 (12%)

Query: 593 GPFGRVY--ILSLPSGEL--IAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V    LS   G    +AVK  KL        +   +E   +    H N++K++G 
Sbjct: 10  GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69

Query: 647 FHSDESI------FLIYEFLQMGSLGDLICR-----QDFQLQWSIRLKIAIGVAQGLAYL 695
                S+       +I  F++ G L   +          +L     LK  + +A G+ YL
Sbjct: 70  CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPE 754
                 + +HR++ ++N +L  D    + DF L + I     ++    ++  +  + A E
Sbjct: 130 SNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK-WIAIE 185

Query: 755 YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP 814
               +  T++ D ++FGV + E+ T  Q       E+ ++  ++R    +          
Sbjct: 186 SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDYLRHGNRLK--------- 235

Query: 815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           +  +C    +    ++   C    P+ RP+  ++ + L ++
Sbjct: 236 QPEDC----LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 50/205 (24%), Positives = 91/205 (44%), Gaps = 25/205 (12%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFH-- 648
           G +G+V+ +L+  +G   AVK L        + ++ E   L  +  H N+VK  G ++  
Sbjct: 29  GTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87

Query: 649 ---SDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
              + + ++L+ E    GS+ DL+    ++  +++  I   I      GL +LH +    
Sbjct: 88  DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT-- 145

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS-------SEYALSCYNAPEY 755
            +HR+VK  NILL  +   KL DF +   +     +   S       +   ++C    + 
Sbjct: 146 -IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS 204

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
            Y     A+ D +S G+  +EL  G
Sbjct: 205 TYD----ARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 56/193 (29%), Positives = 88/193 (45%), Gaps = 23/193 (11%)

Query: 604 PSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           P+G L+ V+   L N   +  K L+ EV      RH NI+     F +   +++I  F+ 
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 662 MGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF 719
            GS   L+ +  F    S  L   I  G  +GL YLH++     +HRN+K+ +IL+  D 
Sbjct: 83  YGSANSLL-KTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDG 138

Query: 720 EPKLTDFA-LDRIV--GEAA--------FQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
              L+  + L  +V  G+ A        F +++    +        YGY+ K+    D Y
Sbjct: 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS----DIY 194

Query: 769 SFGVVLLELITGR 781
           S G+   EL TGR
Sbjct: 195 SVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 31/205 (15%)

Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           ++ FL M  +G+    + F L     ++  I +A G+ YL      + +HR++ ++N +L
Sbjct: 94  LHTFLLMSRIGE----EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCML 146

Query: 716 DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLL 775
           + +    + DF L + +    +     +      + A E       T   D ++FGV + 
Sbjct: 147 NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206

Query: 776 ELITGRQA-----EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           E++T  Q      E +E    L  +K  R K        Q  D     C +       E+
Sbjct: 207 EIMTRGQTPYAGVENSEIYNYL--IKGNRLK--------QPPD-----CLED----VYEL 247

Query: 831 ALRCTSVMPEKRPSMFEVVKALHSL 855
             +C S  P+ RPS   +   L  +
Sbjct: 248 MCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 14/196 (7%)

Query: 593 GPFGRVYILSLPSGELI-AVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++   S + + A+K L  F       S     E   +A      +V++   F 
Sbjct: 54  GAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D+ ++++ E++  G L +L+   D   +W+         A+ +  L   +   L+HR+V
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-----KFYTAEVVLALDAIHSMGLIHRDV 168

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA----Q 764
           K  N+LLD     KL DF     + E        +      Y +PE   S+        +
Sbjct: 169 KPDNMLLDKHGHLKLADFGTCMKMDETGMVRC-DTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 765 MDAYSFGVVLLELITG 780
            D +S GV L E++ G
Sbjct: 228 CDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 46/210 (21%), Positives = 91/210 (43%), Gaps = 25/210 (11%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++ L + + +   K++N         +   + E   L    ++ I  +   F 
Sbjct: 12  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            + +++L+ ++   G L  L+ +      +D    +   + IAI     L         H
Sbjct: 72  DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---------H 122

Query: 703 LLHRNVKSKNILLDADFEPKLTDF-ALDRIVGEAAFQSTM---SSEY-ALSCYNAPEYGY 757
            +HR++K  NIL+D +   +L DF +  +++ +   QS++   + +Y +     A E G 
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182

Query: 758 SKKATAQMDAYSFGVVLLELITGRQAEQAE 787
            K    + D +S GV + E++ G     AE
Sbjct: 183 GKYG-PECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 23/89 (25%), Positives = 43/89 (48%)

Query: 284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI 343
           L L      G IP  I++  +L+   +  N   G+ P  L S+  ++++    N F+G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 344 PDSISMAAQLEQVQIDNNRFTSSIPQGLG 372
           P+S+     L  + ++ N  +  +P  LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 32/148 (21%)

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYV 700
           F ++  +F + EF+   S GDL+    F +Q   +L        +  ++  L +LH+  +
Sbjct: 65  FQTESRLFFVIEFV---SGGDLM----FHMQRQRKLPEEHARFYSAEISLALNFLHERGI 117

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPE----- 754
              ++R++K  N+LLDA+   KLTD+ + +   E       +S +     Y APE     
Sbjct: 118 ---IYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGE 171

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGR 781
            YG+S      +D ++ GV++ E++ GR
Sbjct: 172 DYGFS------VDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 2e-04
 Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 49/228 (21%)

Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G  GRV+++ L  +G+L A+K L          +K   TE + LA + H  +  +   F 
Sbjct: 12  GDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
           ++  + L+ ++   G L  L+ RQ       +   R   A  V   L YLH    V    
Sbjct: 72  TETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLLALEYLHLLGIV---- 125

Query: 705 HRNVKSKNILLDADFEPKLTDFAL-------------DRIVGEAAFQSTMSSEYALSC-- 749
           +R++K +NILL       L+DF L                 G              S   
Sbjct: 126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEP 185

Query: 750 ------------YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
                       Y APE     G+     + +D ++ G++L E++ G 
Sbjct: 186 SFRSNSFVGTEEYIAPEVISGDGH----GSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 49/211 (23%), Positives = 92/211 (43%), Gaps = 35/211 (16%)

Query: 593 GPFGRVYILSLPSGEL---IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +G VY      G+     A+K++   G   S     E+  L +++H N++ +   F  
Sbjct: 12  GTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC--REIALLRELKHPNVISLQKVFLS 69

Query: 648 HSDESIFLIYEFLQMGSLGDLI--------CRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           H+D  ++L++++ +   L  +I         ++  QL   +   +   +  G+ YLH ++
Sbjct: 70  HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128

Query: 700 VPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYALS------C 749
           V   LHR++K  NIL+  +       K+ D    R+     F S +     L        
Sbjct: 129 V---LHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSPLKPLADLDPVVVTFW 180

Query: 750 YNAPEYGY-SKKATAQMDAYSFGVVLLELIT 779
           Y APE    ++  T  +D ++ G +  EL+T
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 24/61 (39%), Positives = 34/61 (55%), Gaps = 1/61 (1%)

Query: 207 KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNK 266
            L+ L L ++    +   +F GL +L +LDLS NNLT   P++  S L  L S D+S N 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAF-SGLPSLRSLDLSGNN 59

Query: 267 L 267
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 20/153 (13%)

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYV 700
           F + + ++ + E++  G   DL+    +Q+Q   R K       A  +A GL +LH   +
Sbjct: 70  FQTMDRLYFVMEYVNGG---DLM----YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSK 759
              ++R++K  N++LD++   K+ DF + +   E  +    +  +     Y APE    +
Sbjct: 123 ---IYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQ 176

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
                +D ++FGV+L E++ G+   + E  + L
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.0 bits (104), Expect = 3e-04
 Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 36/221 (16%)

Query: 590 GNGGPFGRVYILSLPS-GELIAVKK----LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G GG  G VY+   P     +A+KK    L        + L+ E K  A + H  IV V 
Sbjct: 11  GKGG-MGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR-EAKIAADLIHPGIVPVY 68

Query: 645 GFFHSDESIFLIYEFLQMGSLGDL--------ICRQDFQLQWSIR--LKIAIGVAQGLAY 694
                 + ++    +++  +L  L           ++   + S+   L I   +   + Y
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYN-- 751
           +H   V   LHR++K  NILL    E  + D+        E      +  +    CY+  
Sbjct: 129 VHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 752 -------------APEYGYSKKATAQMDAYSFGVVLLELIT 779
                        APE      A+   D Y+ GV+L +++T
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 4e-04
 Identities = 72/311 (23%), Positives = 122/311 (39%), Gaps = 12/311 (3%)

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHG-VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
              P    +   + +L L  S     ++P S   L SL +L  S  +           +L
Sbjct: 35  LNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS--ENLLNL 92

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINE-CLNLERFQVQDN 313
           L L S D++ N+L  +  + + +   L +L L  N     IP  I     NL+   + DN
Sbjct: 93  LPLPSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDN 150

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS 373
                 P  L +LP +K +    N  S  +P  +S  + L  + +  N+  S +P  +  
Sbjct: 151 KIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIEL 207

Query: 374 VKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNS 433
           + +L     S NS    L  +  +   +S + LS N +      +     L +L L++N 
Sbjct: 208 LSALEELDLSNNS-IIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266

Query: 434 LTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGL 493
           ++     SL  L  L  LDLS N+L+  +P     L L    ++       +   L S L
Sbjct: 267 IS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSIL 324

Query: 494 PASYLQGNPGL 504
             + +  N   
Sbjct: 325 LNNNILSNGET 335

Length = 394

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 6/87 (6%)

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           GL +LH + +   +HR++K +NIL+ +  + KL DF L RI    + Q  ++       Y
Sbjct: 120 GLDFLHANCI---VHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWY 173

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLEL 777
            APE          +D +S G +  E+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 43.3 bits (102), Expect = 4e-04
 Identities = 54/193 (27%), Positives = 81/193 (41%), Gaps = 31/193 (16%)

Query: 664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL 723
           +L DLI    +  Q          VA+G+ +L        +HR++ ++NILL  +   K+
Sbjct: 171 TLEDLIS---YSFQ----------VARGMEFLASR---KCIHRDLAARNILLSENNVVKI 214

Query: 724 TDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
            DF L R I  +  +     +   L  + APE  + K  T Q D +SFGV+L E+ +   
Sbjct: 215 CDFGLARDIYKDPDYVRKGDARLPLK-WMAPESIFDKVYTTQSDVWSFGVLLWEIFS--L 271

Query: 783 AEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR 842
                P   +D     R K      A +   P+I   Y         I L C    PE R
Sbjct: 272 GASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEI---YS--------IMLDCWHNNPEDR 320

Query: 843 PSMFEVVKALHSL 855
           P+  E+V+ L  L
Sbjct: 321 PTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 5e-04
 Identities = 21/58 (36%), Positives = 29/58 (50%), Gaps = 1/58 (1%)

Query: 402 SIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL 458
             ++LS N ++       K    L  L L+ N+LT   P + + LP L  LDLS NNL
Sbjct: 3   KSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (101), Expect = 5e-04
 Identities = 45/157 (28%), Positives = 72/157 (45%), Gaps = 14/157 (8%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   LA++    IV +   F S E ++L+  F+  G L   + R+        R   A  
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-E 101

Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L  LHK  V   ++R++K +NILLD      L DF L ++          ++    
Sbjct: 102 LLCALENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGT 156

Query: 748 SCYNAPE----YGYSKKATAQMDAYSFGVVLLELITG 780
             Y APE    +GY+K     +D ++ GV+L E++TG
Sbjct: 157 PEYLAPELLLGHGYTK----AVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 6e-04
 Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 13/204 (6%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++ +   E I   K++N         +   + E   L     + I  +   F 
Sbjct: 12  GAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            +  ++L+ ++   G L  L+ + + +L   +       +A+ +  +H  +  H +HR++
Sbjct: 72  DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYIAEMVLAIHSIHQLHYVHRDI 128

Query: 709 KSKNILLDADFEPKLTDF-ALDRIVGEAAFQSTM---SSEY-ALSCYNAPEYGYSKKATA 763
           K  N+LLD +   +L DF +  ++  +   QS++   + +Y +     A E G  K    
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG-P 187

Query: 764 QMDAYSFGVVLLELITGRQAEQAE 787
           + D +S GV + E++ G     AE
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAE 211

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 42.5 bits (100), Expect = 8e-04
 Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 26/153 (16%)

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           IV++   F  D+ ++++ E++  G L +L+   D   +W+ R   A  V   L  +H   
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA-RFYTA-EVVLALDAIHS-- 160

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFAL------------DRIVGEAAFQSTMSSEYAL 747
               +HR+VK  N+LLD     KL DF              D  VG   +   +S E   
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDY---ISPEVLK 216

Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           S      YG       + D +S GV L E++ G
Sbjct: 217 SQGGDGYYG------RECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 42.3 bits (99), Expect = 9e-04
 Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 26/153 (16%)

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +V++   F  D  ++++ E++  G L +L+   D   +W+ R   A  V   L  +H   
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHS-- 160

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--------YN 751
               +HR+VK  N+LLD     KL DF              M+ E  + C        Y 
Sbjct: 161 -MGFIHRDVKPDNMLLDKSGHLKLADFGT---------CMKMNKEGMVRCDTAVGTPDYI 210

Query: 752 APEYGYSKKATA----QMDAYSFGVVLLELITG 780
           +PE   S+        + D +S GV L E++ G
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 49/189 (25%), Positives = 72/189 (38%), Gaps = 38/189 (20%)

Query: 77  VASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQ----CSSLETLNLSN 132
           V   N         ++ ++     L  LNLA+N         L++      +LE L+L+N
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202

Query: 133 NLIWVLDLSRNHIEGK-IPESIGSLVNLQVLNLGSNLLS--GSVPFVFGNFSE---LVVL 186
           N +              + E++ SL +L+VLNLG N L+  G+        S    L+ L
Sbjct: 203 NGL-------TDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL 255

Query: 187 DLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEV 246
            LS N     +I  D  K                V+ +     +SL  LDL  N    E 
Sbjct: 256 SLSCN-----DITDDGAKDLA------------EVLAEK----ESLLELDLRGNKFGEEG 294

Query: 247 PQSLGSSLL 255
            Q L  SLL
Sbjct: 295 AQLLAESLL 303

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 51/220 (23%)

Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           +K E   LA+  ++ +V++   F   ++++ + +++  G +  L+ R     +   R  I
Sbjct: 48  VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYI 107

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL--------DRIV---G 733
           A  +   +  +HK      +HR++K  NIL+D D   KLTDF L        D      G
Sbjct: 108 A-ELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163

Query: 734 EAAFQSTM--SSEY--ALSC------------------------------YNAPEYGYSK 759
           +   Q +M  S+E+    +C                              Y APE     
Sbjct: 164 DHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT 223

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAE-PAES-LDVVKW 797
             T   D +S GV+L E++ G+    A+ P E+ + V+ W
Sbjct: 224 GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.4 bits (85), Expect = 0.003
 Identities = 26/61 (42%), Positives = 32/61 (52%), Gaps = 3/61 (4%)

Query: 423 KLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNK 480
            L SL L++N LT  IP  +   LP L  LDLS NNLT   P+    L  L   ++S N 
Sbjct: 1   NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 481 L 481
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 41.4 bits (97), Expect = 0.003
 Identities = 53/185 (28%), Positives = 78/185 (42%), Gaps = 24/185 (12%)

Query: 9   SFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTC- 67
           S   L+L  C    +F   ST    L   + +I++  ++L    N   +  C        
Sbjct: 705 SLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRL-ENLDELILCEMKSEKLW 763

Query: 68  --VTTATASLTVASINLQSLNLSG-----EISSSVCELSSLSNLNLAD--NLFNQP---- 114
             V   T  +T+ S +L  L LS      E+ SS+  L  L +L + +  NL   P    
Sbjct: 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGIN 823

Query: 115 ----IPLHLSQCSSLETL-NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLG--SN 167
                 L LS CS L T  ++S N I  L+LSR  IE ++P  I    NL  L++   +N
Sbjct: 824 LESLESLDLSGCSRLRTFPDISTN-ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNN 881

Query: 168 LLSGS 172
           L   S
Sbjct: 882 LQRVS 886

syringae 6; Provisional. Length = 1153

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 45/197 (22%), Positives = 88/197 (44%), Gaps = 12/197 (6%)

Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLG 645
           G GG FG V    +  +G++ A K+L     +  K       E + L K+  + +V +  
Sbjct: 9   GKGG-FGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            + + +++ L+   +  G L   I    +   +    L  A  +  GL  LH++   + +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTV 124

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           +R++K +NILLD     +++D  L   + E     ++        Y APE   +++ T  
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLS 181

Query: 765 MDAYSFGVVLLELITGR 781
            D +  G ++ E+I G+
Sbjct: 182 PDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 40/146 (27%), Positives = 70/146 (47%), Gaps = 14/146 (9%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+VY+     + +L AVK      ++N        ++ E   LA  +   IV +   
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQ--VQAERDALALSKSPFIVHLYYS 72

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH-LLH 705
             S  +++L+ E+L  G +  L+    +     + +K    VA  L YLH+    H ++H
Sbjct: 73  LQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLHR----HGIIH 127

Query: 706 RNVKSKNILLDADFEPKLTDFALDRI 731
           R++K  N+L+  +   KLTDF L ++
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 16/168 (9%)

Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ +L      + +HR++ ++N+LL      K+ DF L R +   +   +  S +  
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG 807
             + APE  +    T   D +S+G++L E+ +        P   +D   +     N    
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS--LGGTPYPGMIVDSTFY-----NKIKS 355

Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
             ++  P  A           +I ++C +  PEKRPS   +   + SL
Sbjct: 356 GYRMAKPDHAT------QEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 47/213 (22%), Positives = 98/213 (46%), Gaps = 27/213 (12%)

Query: 593 GPFGRVYILSLP-SGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLGF 646
           G FG+V +     + EL A+K L   V       +    E + LA ++ K   + ++   
Sbjct: 11  GSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LQDKPPFLTQLHSC 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYV 700
           F + + ++ + E++   + GDL+    + +Q   + K       A  ++ GL +LH+  +
Sbjct: 70  FQTVDRLYFVMEYV---NGGDLM----YHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGI 122

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSK 759
              ++R++K  N++LD++   K+ DF + +   E       +  +     Y APE    +
Sbjct: 123 ---IYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
                +D +++GV+L E++ G+     E  + L
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	876
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.98
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.98
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.98
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.86
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.86
PRK09188	365	serine/threonine protein kinase; Provisional	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.74
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.74
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.73
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
PRK10345	210	hypothetical protein; Provisional	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
smart00090	237	RIO RIO-like kinase.	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.63
PLN03150	623	hypothetical protein; Provisional	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.61
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.53
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.5
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.49
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.49
PLN03150	623	hypothetical protein; Provisional	99.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.45
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
KOG1243	690	consensus Protein kinase [General function predict	99.21
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.18
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.17
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.17
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.17
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.17
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.14
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.11
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.11
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.06
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.0
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.92
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.87
KOG3087	229	consensus Serine/threonine protein kinase [General	98.85
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.85
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.8
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.69
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.68
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.49
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.49
COG4248	637	Uncharacterized protein with protein kinase and he	98.46
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.36
PRK09902	216	hypothetical protein; Provisional	98.34
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.31

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.2e-102  Score=969.48  Aligned_cols=805  Identities=34%  Similarity=0.585  Sum_probs=567.5

Q ss_pred             CChhHHHHHHHHHhhccCCCCCCCCCCCCCCCCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeee
Q 002826           26 SASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLN  105 (876)
Q Consensus        26 ~~~~~~~all~~k~~~~~~~~~~~sW~~~~~~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~  105 (876)
                      .++.|++||++||+++.+|.+.+++|+..  .+||.|.||+|+..+    +|..++|.+++++|.+++.+..+++|++|+
T Consensus        26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~--~~~c~w~gv~c~~~~----~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~   99 (968)
T PLN00113         26 LHAEELELLLSFKSSINDPLKYLSNWNSS--ADVCLWQGITCNNSS----RVVSIDLSGKNISGKISSAIFRLPYIQTIN   99 (968)
T ss_pred             CCHHHHHHHHHHHHhCCCCcccCCCCCCC--CCCCcCcceecCCCC----cEEEEEecCCCccccCChHHhCCCCCCEEE
Confidence            36789999999999999888888999643  589999999998543    799999999999999999999999999999


Q ss_pred             cCCCccccccCcccc-CCCCCCcccCCCccc------------ceeecCCccccccCCCccCCccccceecccccccCCC
Q 002826          106 LADNLFNQPIPLHLS-QCSSLETLNLSNNLI------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS  172 (876)
Q Consensus       106 L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l------------~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  172 (876)
                      |++|++.+.+|..+. .+++|++|+|++|.+            ++|||++|.+++.+|..++++++|++|+|++|.+++.
T Consensus       100 Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  179 (968)
T PLN00113        100 LSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK  179 (968)
T ss_pred             CCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccccc
Confidence            999999988887765 899999999999864            5788888888888888888888888888888888888


Q ss_pred             cCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccc
Q 002826          173 VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS  252 (876)
Q Consensus       173 ~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~  252 (876)
                      +|..|+++++|++|+|++|+ +.+.+|..++++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..+. 
T Consensus       180 ~p~~~~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-  257 (968)
T PLN00113        180 IPNSLTNLTSLEFLTLASNQ-LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-  257 (968)
T ss_pred             CChhhhhCcCCCeeeccCCC-CcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHh-
Confidence            88888888888888888887 3556677777777777777777777777777777777777777777776666665543 


Q ss_pred             ccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccc------------------------ccccee
Q 002826          253 SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINEC------------------------LNLERF  308 (876)
Q Consensus       253 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l------------------------~~L~~L  308 (876)
                      ++++|++|+|++|++++..|..+.++++|++|+|++|.+.+.+|..+.++                        ++|+.|
T Consensus       258 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L  337 (968)
T PLN00113        258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVL  337 (968)
T ss_pred             CCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEE
Confidence            35566666666666655555555555555555555555555555444444                        445555


Q ss_pred             ecccccCCCCCCcccCCCCcccEEEecCCcccccCcccccc------------------------CCCCCeeeccCcccC
Q 002826          309 QVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISM------------------------AAQLEQVQIDNNRFT  364 (876)
Q Consensus       309 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------------------l~~L~~L~L~~N~l~  364 (876)
                      ++++|.+++.+|..+..+++|+.|++++|++++.+|..+..                        +++|+.|++++|+++
T Consensus       338 ~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~  417 (968)
T PLN00113        338 QLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS  417 (968)
T ss_pred             ECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEee
Confidence            55555555555555555555555555555555444433322                        223333333333333


Q ss_pred             CCCCCccccccC-----------------------------------------------ccEEeCCCccccCCCCCCcCC
Q 002826          365 SSIPQGLGSVKS-----------------------------------------------LYRFSASQNSFYGSLPPNFCD  397 (876)
Q Consensus       365 ~~~p~~~~~l~~-----------------------------------------------L~~L~ls~N~l~~~~~~~~~~  397 (876)
                      +.+|..+.++++                                               |+.|++++|++++..|..|..
T Consensus       418 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~  497 (968)
T PLN00113        418 GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGS  497 (968)
T ss_pred             eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhh
Confidence            333333322222                                               223333333333444444555


Q ss_pred             CCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEE
Q 002826          398 SPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFN  475 (876)
Q Consensus       398 ~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~  475 (876)
                      ++.|+.|+|++|++++.+| .+..+++|++|+|++|++++.+|..|..+++|+.|||++|++++.+|..+..+ .++.+|
T Consensus       498 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~  577 (968)
T PLN00113        498 LSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVN  577 (968)
T ss_pred             hhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEe
Confidence            5566666666666666665 67778888888888888888888888888888888888888888888888877 488899


Q ss_pred             ccCCccccccCCcc-cCCCCCccccCCCCCCCCCCC---CCCCCCCCCCCCCCCchhhhHHHHHHHHHHHHHHhheeeEE
Q 002826          476 VSFNKLSGRVPYSL-ISGLPASYLQGNPGLCGPGLS---NSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVF  551 (876)
Q Consensus       476 ls~N~l~~~~p~~~-~~~~~~~~~~~N~~~C~~~~~---~~c~~~~~~~~~~~~~~~~~~~i~~~v~~~~~~~~~~~~~~  551 (876)
                      +++|+++|.+|... +.++....+.|||.+||.+..   ..|...  .+  .......+ ++++++++++++++++++++
T Consensus       578 ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~--~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  652 (968)
T PLN00113        578 ISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV--RK--TPSWWFYI-TCTLGAFLVLALVAFGFVFI  652 (968)
T ss_pred             ccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc--cc--cceeeeeh-hHHHHHHHHHHHHHHHHHHH
Confidence            99999998888543 667778889999999986532   345321  01  11111111 11222222222222223333


Q ss_pred             Eeecccccc-----cccccccccc---ccccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCH
Q 002826          552 HRYSKKKSQ-----AGVWRSLFFY---PLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSS  622 (876)
Q Consensus       552 ~r~~krk~~-----~~~~~~~~~~---~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~  622 (876)
                      +++++.+..     .+.|......   ...++.+++...+.+...+|.|+ ||.||+|.. .+|+.||||++.....   
T Consensus       653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~---  728 (968)
T PLN00113        653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGK-KGASYKGKSIKNGMQFVVKEINDVNS---  728 (968)
T ss_pred             HhhhcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCC-CeeEEEEEECCCCcEEEEEEccCCcc---
Confidence            332211111     1112111111   12345566666666666666666 999999976 5899999999864322   


Q ss_pred             HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCC
Q 002826          623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH  702 (876)
Q Consensus       623 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  702 (876)
                       ....|++.+++++|||||+++|+|.+++..|+||||+++|+|.++++    .++|..+.+++.|+++|++|||+.+.++
T Consensus       729 -~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~  803 (968)
T PLN00113        729 -IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPA  803 (968)
T ss_pred             -ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCC
Confidence             22356889999999999999999999999999999999999999995    3789999999999999999999766669


Q ss_pred             ccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCC
Q 002826          703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ  782 (876)
Q Consensus       703 i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~  782 (876)
                      |+|||+||+||+++.++.+++. ||.+......      ....+++.|+|||+..+..++.++|||||||++|||+||+.
T Consensus       804 iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~  876 (968)
T PLN00113        804 VVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS  876 (968)
T ss_pred             eecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCC
Confidence            9999999999999999888875 6654432211      12247889999999998899999999999999999999999


Q ss_pred             CCCCCCcchhhHHHHHHHHhhcccccccccChhhh---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          783 AEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA---NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       783 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ||+.........++|.+...... .....+||.+.   ....++..++.+++.+||+.||++||||+|++++|+++.+..
T Consensus       877 p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        877 PADAEFGVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             CCCcccCCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            99765555556777776543221 13344555442   223456677889999999999999999999999999987644


Q ss_pred             c
Q 002826          860 S  860 (876)
Q Consensus       860 ~  860 (876)
                      +
T Consensus       956 ~  956 (968)
T PLN00113        956 S  956 (968)
T ss_pred             c
Confidence            3

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=417.36  Aligned_cols=284  Identities=38%  Similarity=0.632  Sum_probs=243.2

Q ss_pred             ccccchhhhhh---cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEE
Q 002826          571 PLRVTEHDLVI---GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF  647 (876)
Q Consensus       571 ~~~~~~~~l~~---~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  647 (876)
                      ...|++.++..   +|.+...+|.|| ||.||+|..++|+.||||++.....+...+|..|++++.+++|||+|+++|||
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Gg-fg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGG-FGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCC-CeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            35577788777   788888888888 99999999999999999988664432155699999999999999999999999


Q ss_pred             EeCC-eEEEEEEcCCCCCHHHHhhccCC-cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          648 HSDE-SIFLIYEFLQMGSLGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       648 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      .+.+ +.++||||+++|+|.++++.... .++|..|.+||.++|+||+|||+.+.++|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999988765 899999999999999999999999888999999999999999999999999


Q ss_pred             ccchhhccc-cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-cchhhHHHHHHHHhh
Q 002826          726 FALDRIVGE-AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP-AESLDVVKWVRRKIN  803 (876)
Q Consensus       726 fGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~  803 (876)
                      ||+|+.... ........  .||.+|+|||+...+..++++|||||||+++|++||++|.+... .....+++|.+....
T Consensus       221 FGLa~~~~~~~~~~~~~~--~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSVSTTV--MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCccccceeeec--CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            999976554 22211111  69999999999999999999999999999999999999887644 344458889876664


Q ss_pred             cccccccccChhhh--hhcH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          804 ITNGAIQVLDPKIA--NCYQ-QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       804 ~~~~~~~~~d~~~~--~~~~-~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .. ...+++||.+.  .+.. .++..+.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       299 ~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             Cc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            33 58899999986  3332 5788899999999999999999999999999776544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.5e-47  Score=476.56  Aligned_cols=402  Identities=34%  Similarity=0.569  Sum_probs=318.3

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc--------------ceeecC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLS  141 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--------------~~LdL~  141 (876)
                      ++..+++.++.+.+.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|.+              ++|+|+
T Consensus       165 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~  244 (968)
T PLN00113        165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV  244 (968)
T ss_pred             CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECc
Confidence            466788888888888999999999999999999999888898999999999999988863              568888


Q ss_pred             CccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCccc
Q 002826          142 RNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV  221 (876)
Q Consensus       142 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~  221 (876)
                      +|++++.+|..|+++++|++|+|++|++++.+|..+.++++|++|+|++|. +.+.+|..+.++++|+.|++++|.+.+.
T Consensus       245 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~l~~n~~~~~  323 (968)
T PLN00113        245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS-LSGEIPELVIQLQNLEILHLFSNNFTGK  323 (968)
T ss_pred             CceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCe-eccCCChhHcCCCCCcEEECCCCccCCc
Confidence            888888888888888888888888888888888888888888888888887 3556777778888888888888888877


Q ss_pred             CCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCC----------------------
Q 002826          222 IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKAN----------------------  279 (876)
Q Consensus       222 ~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------------------  279 (876)
                      .|..+.++++|+.|+|++|++++.+|..+. .+++|+.|+|++|++++..|..++.++                      
T Consensus       324 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~  402 (968)
T PLN00113        324 IPVALTSLPRLQVLQLWSNKFSGEIPKNLG-KHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA  402 (968)
T ss_pred             CChhHhcCCCCCEEECcCCCCcCcCChHHh-CCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhC
Confidence            777777888888888888887777776554 366777777777766666655555544                      


Q ss_pred             --ccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeee
Q 002826          280 --GLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQ  357 (876)
Q Consensus       280 --~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  357 (876)
                        +|+.|+|++|++++..|..|..+++|+.|++++|++++.+|..++.+++|+.|++++|++.+.+|..+ ...+|+.|+
T Consensus       403 ~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~  481 (968)
T PLN00113        403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLD  481 (968)
T ss_pred             CCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEE
Confidence              44555555555555555555555555555555555555555555556666666666666666566544 346788888


Q ss_pred             ccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCC
Q 002826          358 IDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTG  436 (876)
Q Consensus       358 L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~  436 (876)
                      +++|++++.+|..+.++++|+.|++++|++.+.+|..+.++++|++|+|++|.+++.+| .+..+++|+.|+|++|++++
T Consensus       482 ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  561 (968)
T PLN00113        482 LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG  561 (968)
T ss_pred             CcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccc
Confidence            88999999999999999999999999999999999999999999999999999999888 79999999999999999999


Q ss_pred             CCCcCCCCCCCcceeeCCCCcccccCCCcccccccceEEccCCc
Q 002826          437 EIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNK  480 (876)
Q Consensus       437 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~  480 (876)
                      .+|..+..+++|+.|++++|+++|.+|..-.-..+....+.+|.
T Consensus       562 ~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~  605 (968)
T PLN00113        562 EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNI  605 (968)
T ss_pred             cCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCc
Confidence            99999999999999999999999999975333334344556665

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=370.00  Aligned_cols=257  Identities=25%  Similarity=0.367  Sum_probs=208.1

Q ss_pred             ccchhhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          573 RVTEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       573 ~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      .++.+|++.    ...+| .|..|+|||+.++ +++.+|+|.+... +....+++.+|++++++.+||+||.++|+|..+
T Consensus        75 ~i~~~dle~----~~~lG-~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   75 GISLSDLER----LGVLG-SGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             ccCHHHhhh----hhhcc-cCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            455566643    34444 5559999999664 8999999999433 334467899999999999999999999999999


Q ss_pred             C-eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          651 E-SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       651 ~-~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      + ..+++||||++|||.+++.+. +.+++....+++.+|++||.|||+ +   +|+||||||+|||++..|++||+|||.
T Consensus       150 ~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  150 GEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             CceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccc
Confidence            8 599999999999999999766 479999999999999999999996 5   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ++.+...    ......||..|||||.+.+..|+.++||||||++++|+++|+.||........+..+.+.......   
T Consensus       226 S~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---  298 (364)
T KOG0581|consen  226 SGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---  298 (364)
T ss_pred             cHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC---
Confidence            9887654    234456999999999999999999999999999999999999999875222223333322211111   


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                          .|.++..  ..+.++.+++..|+++||.+|||++|++++
T Consensus       299 ----pP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  299 ----PPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             ----CCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                1222221  245678999999999999999999999874

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=384.93  Aligned_cols=253  Identities=32%  Similarity=0.467  Sum_probs=208.2

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCC-eEEEEEEcCCCCCHH
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-SIFLIYEFLQMGSLG  666 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gsL~  666 (876)
                      .|.|+||+||+|.+.....||+|++.......  .++|.+|+.+|++++|||||+++|+|.+.. ..++||||+++|+|.
T Consensus        49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~  128 (362)
T KOG0192|consen   49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS  128 (362)
T ss_pred             cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence            34455999999999655559999997644333  458999999999999999999999999887 799999999999999


Q ss_pred             HHhhc-cCCcCCHHHHHHHHHHHHHHHHHhhccCCCC-ccccccccCceeeCCCC-CeEEccccchhhcccccccccccc
Q 002826          667 DLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH-LLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       667 ~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +++++ ....+++..+.+++.|||+||.|||+.   + |+||||||+|||++.++ .+||+|||+++......  ..++.
T Consensus       129 ~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~  203 (362)
T KOG0192|consen  129 VLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTS  203 (362)
T ss_pred             HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccC
Confidence            99988 367899999999999999999999999   7 99999999999999997 99999999998766432  23444


Q ss_pred             ccccccccCccccC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          744 EYALSCYNAPEYGY--SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       744 ~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ..||+.|||||++.  ...++.|+||||||+++|||+||+.||......  .....+-...         ..|.++.   
T Consensus       204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~~v~~~~---------~Rp~~p~---  269 (362)
T KOG0192|consen  204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVASAVVVGG---------LRPPIPK---  269 (362)
T ss_pred             CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHhcC---------CCCCCCc---
Confidence            67999999999999  568999999999999999999999999876652  2222221111         1122221   


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      .....+..++.+||+.||++||++.|++..|+.+......
T Consensus       270 ~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  270 ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            1344678899999999999999999999999998765443

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-45  Score=388.48  Aligned_cols=397  Identities=23%  Similarity=0.280  Sum_probs=356.4

Q ss_pred             CCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccce
Q 002826           58 HYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV  137 (876)
Q Consensus        58 ~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  137 (876)
                      +.|.-+-..|+...     +..  +....|.|.+|+      .-+.||+++|.++.+.+..|.++++|++++|.+|.|  
T Consensus        50 c~c~~~lldcs~~~-----lea--~~~~~l~g~lp~------~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~L--  114 (873)
T KOG4194|consen   50 CPCNTRLLDCSDRE-----LEA--IDKSRLKGFLPS------QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNEL--  114 (873)
T ss_pred             CCCCceeeecCccc-----ccc--ccccccCCcCcc------ceeeeeccccccccCcHHHHhcCCcceeeeeccchh--
Confidence            44655555665442     111  122345666665      347899999999999999999999999998887766  


Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc-ccccCcccEEEecCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSS  216 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~-~~~l~~L~~L~L~~n  216 (876)
                               ..+|...+...+|+.|+|.+|.|+.+....+..++.|+.||||.|.  +.++|.. |..-.++++|+|++|
T Consensus       115 ---------t~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~--is~i~~~sfp~~~ni~~L~La~N  183 (873)
T KOG4194|consen  115 ---------TRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL--ISEIPKPSFPAKVNIKKLNLASN  183 (873)
T ss_pred             ---------hhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch--hhcccCCCCCCCCCceEEeeccc
Confidence                     3778777777889999999999998888999999999999999997  7888864 778889999999999


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP  296 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  296 (876)
                      +|+.+..+.|.++.+|.+|.|++|+|+ .+|...|.++++|+.|+|..|+|.-..--.|..+++|+.|.|..|.|.....
T Consensus       184 ~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~D  262 (873)
T KOG4194|consen  184 RITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDD  262 (873)
T ss_pred             cccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccC
Confidence            999999999999999999999999999 9999999999999999999999996657789999999999999999999999


Q ss_pred             CCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccC
Q 002826          297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS  376 (876)
Q Consensus       297 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  376 (876)
                      +.|-+|.+++.|+|..|+++..-..++.+|+.|+.|+|++|.|..+.++.++..++|++|+|++|+|+...+..|..+..
T Consensus       263 G~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~  342 (873)
T KOG4194|consen  263 GAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQ  342 (873)
T ss_pred             cceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999888999999999


Q ss_pred             ccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc----CcccccccceEeccCCcCCCCCCcCCCCCCCcceee
Q 002826          377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP----ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLD  452 (876)
Q Consensus       377 L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~----~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  452 (876)
                      |++|.|++|.++..--..|..+.+|+.|||++|.|+..++    .|.+|++|+.|+|.+|+|..+...+|.+++.|+.||
T Consensus       343 Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~Ld  422 (873)
T KOG4194|consen  343 LEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLD  422 (873)
T ss_pred             hhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceec
Confidence            9999999999998888999999999999999999998776    488999999999999999977789999999999999


Q ss_pred             CCCCcccccCCCcccccccceEEccCCcc
Q 002826          453 LSDNNLTGPIPQGLQNLKLALFNVSFNKL  481 (876)
Q Consensus       453 Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l  481 (876)
                      |.+|.|...-|+.|+.+.++.|-+..-++
T Consensus       423 L~~NaiaSIq~nAFe~m~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  423 LGDNAIASIQPNAFEPMELKELVMNSSSF  451 (873)
T ss_pred             CCCCcceeecccccccchhhhhhhcccce
Confidence            99999999999999999887666555444

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-43  Score=362.36  Aligned_cols=254  Identities=25%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             hhcccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCcc-------CHHHHHHHHHHHhhccCccccceeeEEEeCC
Q 002826          580 VIGMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQ-------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE  651 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  651 (876)
                      ..++|...+..|.|+||.|-+| ..++|+.||||++.+....       .....++|+++|++++|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            4566667777777779999999 5669999999999653211       2234579999999999999999999999999


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEccccc
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFAL  728 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~DfGl  728 (876)
                      ..|+||||++||+|.+.+-.++ .+.+.....++.|++.|+.|||+.   ||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence            9999999999999999987664 577888899999999999999999   99999999999999766   7799999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK---ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+..+...   .+...+||+.|.|||++.++.   +..++|+||+||++|-+++|.+||........-..+..+..+.  
T Consensus       326 AK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--  400 (475)
T KOG0615|consen  326 AKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--  400 (475)
T ss_pred             hhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc--
Confidence            99987544   456667999999999987653   3457899999999999999999998755443211111111111  


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                               ..+..|.+...+..++|.+|+..||++|||+.|+++.
T Consensus       401 ---------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 ---------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ---------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                     1113355666788999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=359.69  Aligned_cols=201  Identities=28%  Similarity=0.446  Sum_probs=175.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |....+ +|.|+||+||+|+++ ++..||||.+...  .....+-+..|+.+|+.++|||||++++++..++..|+||||
T Consensus        12 y~~~~~-iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy   90 (429)
T KOG0595|consen   12 YELSRE-IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY   90 (429)
T ss_pred             ceehhh-ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence            333344 555669999999775 7899999999765  233456678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC------CCeEEccccchhhcc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD------FEPKLTDFALDRIVG  733 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~------~~~kl~DfGla~~~~  733 (876)
                      |.||+|.+++++.+ .+++.++..++.|+|.|+++||++   +|+||||||.|||++..      -.+||+|||+|+...
T Consensus        91 C~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   91 CNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999998876 799999999999999999999999   99999999999999764      468999999999987


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES  791 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~  791 (876)
                      ....   ....+|++.|||||+++.++|+.|+|+||+|+++|++++|+.||+.....+
T Consensus       167 ~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  167 PGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             chhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            5543   334569999999999999999999999999999999999999998766554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-42  Score=372.23  Aligned_cols=248  Identities=22%  Similarity=0.318  Sum_probs=205.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .+|+..+..|.|+|+.+|.++. .+|+.||+|++.+..   ...++.+.+||++.+.|+|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            3455555555566999999976 799999999997632   234567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+|+.++|.+++++ ...+++.++..+++||+.|+.|||+.   +|+|||||-.|+|++++.++||+|||+|+.+.....
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999999999984 45899999999999999999999999   999999999999999999999999999998874321


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                        .....+||+.|.|||++....++..+||||+||++|.|++|++||+.....+.     .++....     +.      
T Consensus       174 --rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket-----y~~Ik~~-----~Y------  235 (592)
T KOG0575|consen  174 --RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET-----YNKIKLN-----EY------  235 (592)
T ss_pred             --ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH-----HHHHHhc-----Cc------
Confidence              22345699999999999988999999999999999999999999987544332     1111100     00      


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..+......+.++|.++++++|.+|||+++|+..
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0111334567899999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=367.33  Aligned_cols=263  Identities=27%  Similarity=0.441  Sum_probs=215.2

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE  651 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  651 (876)
                      ..+..+++..    ..++| .|.||+||.|.+.....||+|.++.. ......|.+|+++|++++|++||+++|+|..++
T Consensus       201 wei~r~~l~l----~~~LG-~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  201 WEIPREELKL----IRELG-SGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             eeecHHHHHH----HHHhc-CCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            3444444432    23444 55599999999987889999999764 356678899999999999999999999999988


Q ss_pred             eEEEEEEcCCCCCHHHHhhc-cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          652 SIFLIYEFLQMGSLGDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ..|||||||+.|+|.+++.. .+..+...+...++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            99999999999999999986 567899999999999999999999999   99999999999999999999999999999


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ...++.+. ......-+..|.|||.+..++++.|+|||||||+||||+| |+.||..-..  .+.++.+.+..+.+    
T Consensus       352 ~~~d~~Y~-~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--~ev~~~le~GyRlp----  424 (468)
T KOG0197|consen  352 LIGDDEYT-ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--EEVLELLERGYRLP----  424 (468)
T ss_pred             ccCCCcee-ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--HHHHHHHhccCcCC----
Confidence            65554432 2333334667999999999999999999999999999999 8888765433  23344444433221    


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                               .+..++..+.+++..||+.+|++|||++.+...++++....
T Consensus       425 ---------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  425 ---------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             ---------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence                     12234556889999999999999999999999999886543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-42  Score=337.16  Aligned_cols=251  Identities=24%  Similarity=0.312  Sum_probs=198.8

Q ss_pred             CCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceee-EEEeCCe-EEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLG-FFHSDES-IFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv~e~~~  661 (876)
                      .+.+|.|+||+||++ ...+|..||.|.+.....  ..+.....|+.+|++++|||||++++ .+.++.. .++|||||+
T Consensus        24 l~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~  103 (375)
T KOG0591|consen   24 LKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCD  103 (375)
T ss_pred             HHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhc
Confidence            344445559999999 557999999999874322  23456788999999999999999999 4555555 899999999


Q ss_pred             CCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCC-CccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          662 MGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVP-HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       662 ~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      +|+|.+.+..   +...+++.++++++.|++.||.++|..... -|+||||||.||+++.+|.||++|||+++.......
T Consensus       104 ~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t  183 (375)
T KOG0591|consen  104 AGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT  183 (375)
T ss_pred             ccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhH
Confidence            9999998853   466799999999999999999999995431 289999999999999999999999999999875432


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                        .....+|||.||+||.+.+..|+.++||||+||++|||+.-++||.+....  .+..-+.   ...       -|.  
T Consensus       184 --fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~--~L~~KI~---qgd-------~~~--  247 (375)
T KOG0591|consen  184 --FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL--SLCKKIE---QGD-------YPP--  247 (375)
T ss_pred             --HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH--HHHHHHH---cCC-------CCC--
Confidence              334556999999999999999999999999999999999999999876322  1111111   111       111  


Q ss_pred             hhc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          818 NCY-QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       818 ~~~-~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                       .+ .-++.++..+|..|++.||+.||+...++..+..
T Consensus       248 -~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  248 -LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence             22 3456678899999999999999986555555444

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.3e-41  Score=381.09  Aligned_cols=257  Identities=25%  Similarity=0.466  Sum_probs=219.6

Q ss_pred             CCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ....|.|+||.||+|+.      ++.+.||||.++..... ...+|++|++.++.++|||||+++|+|.+++.+|+|+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            44455566999999965      34568999999876554 678999999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc---------CCc----CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          660 LQMGSLGDLICRQ---------DFQ----LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       660 ~~~gsL~~~l~~~---------~~~----l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      |..|||.+++...         +..    ++..+...||.|||.||.||-++   .+|||||..+|+||.++..|||+||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEeccc
Confidence            9999999999643         223    88899999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++.+...+++.......-..+||+||.+..++++.++|||||||+|||+++ |+.||++...++  +++.++..    
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i~~g----  721 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECIRAG----  721 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHHHcC----
Confidence            99999887777665555566789999999999999999999999999999999 999998765543  34444432    


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                               .+..+++..+..+++++..||+..|++||+++||-.+|+++....+.
T Consensus       722 ---------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~  768 (774)
T KOG1026|consen  722 ---------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPK  768 (774)
T ss_pred             ---------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCcc
Confidence                     22344556667899999999999999999999999999998766554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=331.32  Aligned_cols=255  Identities=21%  Similarity=0.374  Sum_probs=201.1

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...|.|+||+||+++.+ +|+.||||++......  -.+-..+|+.+|++++|||+|.++++|......++|+|||+. +
T Consensus         8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T   86 (396)
T KOG0593|consen    8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T   86 (396)
T ss_pred             hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence            33445559999999776 7999999999765432  235577999999999999999999999999999999999988 7


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      +.+.+.+...-.+...+.++++|++.|+.|+|++   +++||||||+|||++.++.+|++|||.|+......  ..++..
T Consensus        87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDY  161 (396)
T KOG0593|consen   87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDY  161 (396)
T ss_pred             HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhh
Confidence            7777777766789999999999999999999999   99999999999999999999999999999987422  234556


Q ss_pred             cccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hc---------cccccc---
Q 002826          745 YALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NI---------TNGAIQ---  810 (876)
Q Consensus       745 ~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~---------~~~~~~---  810 (876)
                      +.|.+|+|||.+.+ -+|+..+||||+||++.||++|.+.|.+..+-+.  .-.++... ..         .+..+.   
T Consensus       162 VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ--Ly~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  162 VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ--LYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH--HHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            68999999999876 6899999999999999999999999987655332  11111111 00         000110   


Q ss_pred             cc---Ch-hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VL---DP-KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~---d~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..   ++ .++.........++++++.|+..||++|++-+|++.
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            00   11 112233344557889999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=358.04  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=210.9

Q ss_pred             ccccchhhhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEE
Q 002826          571 PLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       571 ~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      .+.++.+++..     ...+|.|.||+||+|+|.  ..||||++.......  -+.|+.|+.++++-+|.||+-|+|||.
T Consensus       386 ~WeIp~~ev~l-----~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  386 EWEIPPEEVLL-----GERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccCHHHhhc-----cceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            34555556544     344455569999999984  369999997654332  367999999999999999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      .++. .||+.+|+|.+|+.+++.....++..+.+.|++|||+||.|||.+   +|+|||+|..|||+++++.|||+|||+
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             CCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            8877 999999999999999998888999999999999999999999999   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      +..-..-..........|...|||||+++.+   ++++++||||||+|+|||+||..||.....+..   -|+-      
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI---ifmV------  605 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI---IFMV------  605 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe---EEEe------
Confidence            8654311111112233467789999997743   689999999999999999999999985443322   1111      


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                        -...+.|+..........++.+++..||..++++||.+.+|+..|+.+...
T Consensus       606 --GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  606 --GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             --cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence              111222333344445566789999999999999999999999999998774

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=351.20  Aligned_cols=261  Identities=25%  Similarity=0.338  Sum_probs=206.0

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHH-HHHHHHHHhhcc-CccccceeeEEEeCC-eEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIR-HKNIVKVLGFFHSDE-SIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~  659 (876)
                      |...+..|.|+||.||+|+. .+|+.||||++++.-....+. -.+|+..|++++ |||||++.+++.+.+ ..|+||||
T Consensus        12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~   91 (538)
T KOG0661|consen   12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF   91 (538)
T ss_pred             HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence            34444455566999999954 589999999997654333332 358999999998 999999999999988 99999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      |+. +|++++++++..+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+||.+....   
T Consensus        92 Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp---  164 (538)
T KOG0661|consen   92 MDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP---  164 (538)
T ss_pred             hhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC---
Confidence            977 99999998888999999999999999999999999   99999999999999999999999999999887544   


Q ss_pred             ccccccccccccCcccc-CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-----------hHHHHHHHH-h--hc
Q 002826          740 TMSSEYALSCYNAPEYG-YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-----------DVVKWVRRK-I--NI  804 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-----------~~~~~~~~~-~--~~  804 (876)
                      ..+..+.|.+|+|||++ +++.|+.+.||||+||+++|+.+-++.|.+..+-+.           ...+|.... .  ..
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            34555689999999975 467899999999999999999999999988655332           111111100 0  00


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .-.+.+...-.+.........++.+++.+|+++||.+||||+|+++.
T Consensus       245 nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  245 NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            00011111222333344467788999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-40  Score=318.80  Aligned_cols=281  Identities=23%  Similarity=0.359  Sum_probs=216.4

Q ss_pred             cccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          584 DEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |...+..|.|+||.||+| +.++|+.||||+++.....  ......+|++.|+.++|+||+.++++|.+.+..-+|+||+
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            334445566679999999 4568999999999765333  2456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +. +|...++.....++...+..++.++++|++|||++   .|+|||+||.|+|++++|.+||+|||+|+.++...... 
T Consensus        84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~-  158 (318)
T KOG0659|consen   84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ-  158 (318)
T ss_pred             cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence            87 99999998888999999999999999999999999   99999999999999999999999999999998554332 


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh----hcccccccccC--
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI----NITNGAIQVLD--  813 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~d--  813 (876)
                       +..+-|.+|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+..+-+ .+....+...    +.+.++....|  
T Consensus       159 -~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  159 -THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             -ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCCCcccCccccccccHH
Confidence             23357889999998775 469999999999999999999998777654432 2222222211    11111111111  


Q ss_pred             -------hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccCCcccccccCCCCC
Q 002826          814 -------PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLSTRTSLLSIELSSSQE  871 (876)
Q Consensus       814 -------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~~~~~~~~~~~~~~~  871 (876)
                             +........+..+..+++..|+..+|.+|+|++|++++  +..........++...+...
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~~~  303 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPSTKS  303 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcccC
Confidence                   12222344456677999999999999999999999875  45444444444555444433

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-40  Score=344.52  Aligned_cols=255  Identities=29%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC--eEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~~  662 (876)
                      ..+.+|.|+||+||++... +|+..|||.+........+.+.+|+.+|++++|||||+++|......  .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            3455556779999999665 59999999987653233567899999999999999999999855544  69999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhccc-cccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGE-AAFQST  740 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~-~~~~~~  740 (876)
                      |+|.+++.+.+..+++..+.+.++||++|++|||++   ||+||||||+|||++. ++.+||+|||+++.... ......
T Consensus       101 GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~  177 (313)
T KOG0198|consen  101 GSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDS  177 (313)
T ss_pred             CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccc
Confidence            999999988765899999999999999999999999   9999999999999999 79999999999987663 122222


Q ss_pred             cccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....||+.|||||++..+ ....++||||+||++.||+||++||... .+..   ++.-.....     . .-|.+   
T Consensus       178 ~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~---~~~~~ig~~-----~-~~P~i---  244 (313)
T KOG0198|consen  178 ELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEA---EALLLIGRE-----D-SLPEI---  244 (313)
T ss_pred             cccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchH---HHHHHHhcc-----C-CCCCC---
Confidence            3456799999999999854 3445999999999999999999999864 1111   111111000     0 01122   


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      +...+.+..+++.+|+..+|++||||.|+++.---..
T Consensus       245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  245 PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            2223446789999999999999999999998765543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-40  Score=344.93  Aligned_cols=260  Identities=23%  Similarity=0.358  Sum_probs=206.4

Q ss_pred             ccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEEEc
Q 002826          585 EKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIYEF  659 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  659 (876)
                      .+.++ |.|+||.||+| +..+|+.||+|++....  ........+||.+|++++||||+++.+.+.+.  +.+|+|+||
T Consensus       121 ki~kI-GeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY  199 (560)
T KOG0600|consen  121 KIEKI-GEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY  199 (560)
T ss_pred             HHHHh-cCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence            33444 45669999999 45689999999997654  34456678999999999999999999999886  689999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      |+. +|.-++...+..+++.++..++.|++.||+|+|++   +|+|||||.+|||||.+|.+||+|||+|+++..... .
T Consensus       200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~  274 (560)
T KOG0600|consen  200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-A  274 (560)
T ss_pred             ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC-c
Confidence            998 99999988888999999999999999999999999   999999999999999999999999999998875442 2


Q ss_pred             ccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc--------ccc
Q 002826          740 TMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG--------AIQ  810 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~  810 (876)
                      .++..+-|.+|+|||++.+. .|+.++|+||.|||+.||++|+++|++..+.+. +-...+-+......        ...
T Consensus       275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-l~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-LHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-HHHHHHHhCCCChhccccccCCccc
Confidence            36667789999999998765 699999999999999999999999987554322 11111111100000        011


Q ss_pred             cc------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VL------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+      .+.+.+.........++++..+|+.||.+|.||.++++.
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            11      122333333445677899999999999999999998863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=352.02  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=207.0

Q ss_pred             cccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|....++|.| +.|.||.| +..+++.||+|++.......++-+..|+.+|+..+|+|||.+++.|...++.|+||||+
T Consensus       274 ~y~~~~kigqg-aSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  274 KYTDFKKIGQG-ATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhcchhhhccc-cccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            34444555555 59999999 55689999999998876666777889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +||+|.+.+...  .+++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            999999999764  589999999999999999999999   999999999999999999999999999988765432  4


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||++|||||+.....|+++.||||||++++||+.|.+||-.+..-..  ...+..  .+.        |.+ ...
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA--lyLIa~--ng~--------P~l-k~~  492 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIAT--NGT--------PKL-KNP  492 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH--HHHHhh--cCC--------CCc-CCc
Confidence            4556799999999999999999999999999999999999999986443322  111111  111        111 122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+..+.+++.+|+..||++||+|+|+++.
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            3345578899999999999999999999873

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7e-40  Score=334.72  Aligned_cols=241  Identities=25%  Similarity=0.355  Sum_probs=194.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.-...+|. |+||.||.++.+ +++.+|+|++.+...   .+.+....|..++.+++||.||++...|++.++.|+|+
T Consensus        26 dF~~lkviGk-G~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   26 DFEILKVIGK-GSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             heeeeeeeec-cCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            3434444555 559999999654 799999999977543   33467889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+.||.|..++.+++ .+++..+.-.+.+|+.||.|||+.   +|+|||+||+|||+|.+|.++++|||+++..-... 
T Consensus       105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~-  179 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG-  179 (357)
T ss_pred             eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC-
Confidence            9999999999998765 789999999999999999999999   99999999999999999999999999998654322 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......+||+.|||||++.+..++.++|.||+|+++|||++|.+||...+...     +.++....+   ... .|   
T Consensus       180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~-----~~~~I~~~k---~~~-~p---  246 (357)
T KOG0598|consen  180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK-----MYDKILKGK---LPL-PP---  246 (357)
T ss_pred             -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH-----HHHHHhcCc---CCC-CC---
Confidence             12233579999999999999999999999999999999999999998755332     222221111   000 01   


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPS  844 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs  844 (876)
                      .   --..+..+++.+.+..||++|..
T Consensus       247 ~---~ls~~ardll~~LL~rdp~~RLg  270 (357)
T KOG0598|consen  247 G---YLSEEARDLLKKLLKRDPRQRLG  270 (357)
T ss_pred             c---cCCHHHHHHHHHHhccCHHHhcC
Confidence            1   11235678999999999999963

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=356.82  Aligned_cols=369  Identities=21%  Similarity=0.254  Sum_probs=323.9

Q ss_pred             cEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccC
Q 002826           75 LTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIG  154 (876)
Q Consensus        75 ~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~  154 (876)
                      ..+..+++++|.|+..-+..|-++++|+.++|..|.++. +|.......+|+.|+|          .+|.|++.-.+++.
T Consensus        78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sghl~~L~L----------~~N~I~sv~se~L~  146 (873)
T KOG4194|consen   78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESGHLEKLDL----------RHNLISSVTSEELS  146 (873)
T ss_pred             cceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-cccccccccceeEEee----------eccccccccHHHHH
Confidence            367789999999999988999999999999999999976 7776666667887754          55556666677888


Q ss_pred             CccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC-CcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      .++.|+.||||.|.|+.+.-..|..-.++++|+|++|+  ++.+. ..|.++.+|..|.|++|+++...+..|.+|++|+
T Consensus       147 ~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~--It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~  224 (873)
T KOG4194|consen  147 ALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNR--ITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLE  224 (873)
T ss_pred             hHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccc--ccccccccccccchheeeecccCcccccCHHHhhhcchhh
Confidence            89999999999999997766788888899999999998  55664 4588899999999999999988888899999999


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      .|+|..|+|. .+....|.++++|+.|.|..|+|+..-...|..+.++++|+|+.|+++..-.+++-+++.|+.|+|++|
T Consensus       225 ~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~N  303 (873)
T KOG4194|consen  225 SLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYN  303 (873)
T ss_pred             hhhcccccee-eehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchh
Confidence            9999999998 777777888999999999999999888889999999999999999999888889999999999999999


Q ss_pred             cCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCC-
Q 002826          314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP-  392 (876)
Q Consensus       314 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~-  392 (876)
                      .|..+.++...-.++|+.|+|++|+|+...+.+|..+.+|++|.|++|+++..-...|..+.+|+.|||++|.+++.+- 
T Consensus       304 aI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED  383 (873)
T KOG4194|consen  304 AIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED  383 (873)
T ss_pred             hhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence            9998888888888999999999999999999999999999999999999987767788899999999999999987664 


Q ss_pred             --CCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcc
Q 002826          393 --PNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL  458 (876)
Q Consensus       393 --~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  458 (876)
                        ..|.+++.|+.|+|.+|+|..++. +|.++..|++|||.+|.|..+.|.+|..| .|++|.++.-.+
T Consensus       384 aa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf  451 (873)
T KOG4194|consen  384 AAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF  451 (873)
T ss_pred             chhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence              358889999999999999997776 89999999999999999999999999999 999999865433

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=329.74  Aligned_cols=259  Identities=27%  Similarity=0.348  Sum_probs=205.0

Q ss_pred             cccCCCCCCCCceEEEEEE-eCCCcEEEEEEEecCCccCH-HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          584 DEKSSAGNGGPFGRVYILS-LPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |+....+|.|..++||+|+ .+.++.||||++....+... +.+++|+..|+.++||||++++..|..+...|+||.||.
T Consensus        28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa  107 (516)
T KOG0582|consen   28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA  107 (516)
T ss_pred             eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence            3445555666679999995 46889999999987777665 889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc-ccc
Q 002826          662 MGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQS  739 (876)
Q Consensus       662 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~~~  739 (876)
                      +||+.++++.. ..-+++..+..|.+++++||.|||++   |.+|||||+.|||++.+|.|||+|||.+..+...+ ...
T Consensus       108 ~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~  184 (516)
T KOG0582|consen  108 GGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV  184 (516)
T ss_pred             CCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence            99999999765 34489999999999999999999999   99999999999999999999999999876654332 111


Q ss_pred             cc-ccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          740 TM-SSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       740 ~~-~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      .. ....||++|||||+.+.  ..|+.|+||||||++..|+++|+.||..-++...-+... +.  ..+......+|.  
T Consensus       185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn--~pp~~~t~~~~~--  259 (516)
T KOG0582|consen  185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QN--DPPTLLTSGLDK--  259 (516)
T ss_pred             EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cC--CCCCcccccCCh--
Confidence            12 45579999999999443  358999999999999999999999998766554311111 11  111001111111  


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       +........+.+++..|+.+||++|||++++++.
T Consensus       260 -d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  260 -DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence             1122334578899999999999999999999863

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.3e-39  Score=340.42  Aligned_cols=243  Identities=25%  Similarity=0.336  Sum_probs=203.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+...+|.|+||.||||+.+ +.+.||+|.+.+....+  -+.+++|+++++.++|||||.++++|+...++|+|+||+.
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~   84 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV   84 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence            34455666779999999665 78999999997755433  3568899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      | +|..++...+ .++++.+..++.+++.||.|||+.   +|.|||+||.|||++.++.+|++|||+|+.+....  ...
T Consensus        85 g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--~vl  157 (808)
T KOG0597|consen   85 G-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--SVL  157 (808)
T ss_pred             h-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCc--eee
Confidence            8 9999997654 799999999999999999999999   99999999999999999999999999999887644  334


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      +...||+.|||||...++.|+..+|+||+||++||+++|++||....     +.+.++.....+        +   ..+.
T Consensus       158 tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d~--------v---~~p~  221 (808)
T KOG0597|consen  158 TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKDP--------V---KPPS  221 (808)
T ss_pred             eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcCC--------C---CCcc
Confidence            56679999999999999999999999999999999999999997532     222222221111        1   1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+..+++..+.+||.+|.|-.+++.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            44567889999999999999999888875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-39  Score=352.98  Aligned_cols=276  Identities=21%  Similarity=0.330  Sum_probs=224.2

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCe
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES  652 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  652 (876)
                      |+-..+-.+.+++|.|.||+||+|+++    ....||||.++... +..+.+|..|+.+|.+..||||+++-|+....+.
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            344456667788888999999999774    24579999997543 3445789999999999999999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      ++||+|||++|+|..+++.++..+++.+...+.++||.||+||-+.   ++|||||.++|||++.+..+||+|||++|..
T Consensus       705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl  781 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL  781 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence            9999999999999999999988899999999999999999999999   9999999999999999999999999999987


Q ss_pred             ccccc-ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          733 GEAAF-QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       733 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .++.. ..+.....-..+|.|||.+...+++.++|||||||+|||.++ |.+||-.-.  ..+.+..+...++.+     
T Consensus       782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gyRLP-----  854 (996)
T KOG0196|consen  782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGYRLP-----  854 (996)
T ss_pred             ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhccCCC-----
Confidence            64431 111122223568999999999999999999999999999988 888865322  333444444433322     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccccccCCCCC
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQE  871 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~~~~~~~~~  871 (876)
                              -+.+++..+.+++..||++|-.+||.+.||+..|.++...-...+.-...+..
T Consensus       855 --------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~~~r  907 (996)
T KOG0196|consen  855 --------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPESPR  907 (996)
T ss_pred             --------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCCCCC
Confidence                    12345567899999999999999999999999999988766666544444333

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=333.51  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .++.|.|+|++||+|+. .+++.||||++.+.   .+...+-+..|-++|.+| .||.|++++-.|.++...|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            45566677999999954 58999999998653   123335567899999999 89999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc---
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ---  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~---  738 (876)
                      +|+|.+++++.+ .+++..+...+.+|+.|++|||+.   |||||||||+|||+|.|+++||+|||-|+.+.+....   
T Consensus       158 nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~  233 (604)
T KOG0592|consen  158 NGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQEN  233 (604)
T ss_pred             CCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccC
Confidence            999999998875 799999999999999999999999   9999999999999999999999999999988632211   


Q ss_pred             ------cc--cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          739 ------ST--MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       739 ------~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                            ..  ...-+||..|.+||++.....++.+|+|+|||++|+|+.|.+||....+-- -+...+...+..+     
T Consensus       234 ~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-iFqkI~~l~y~fp-----  307 (604)
T KOG0592|consen  234 PVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-IFQKIQALDYEFP-----  307 (604)
T ss_pred             ccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH-HHHHHHHhcccCC-----
Confidence                  11  134579999999999999999999999999999999999999998754321 1111111111111     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                ...+..+.+++.+.+..||.+|+|++||.+.
T Consensus       308 ----------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  308 ----------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             ----------CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence                      1122467899999999999999999888764

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=5.9e-38  Score=345.94  Aligned_cols=256  Identities=26%  Similarity=0.349  Sum_probs=196.9

Q ss_pred             cCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeC-CeEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD-ESIFLI  656 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv  656 (876)
                      +.+..|.|+||.||+|..      .+++.||+|++..... .....+.+|+.+++.+ +||||++++++|... +..++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI   90 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence            334444445999999963      2457899999865322 2245688999999999 899999999998764 468999


Q ss_pred             EEcCCCCCHHHHhhccC-------------------------------------------------------------Cc
Q 002826          657 YEFLQMGSLGDLICRQD-------------------------------------------------------------FQ  675 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~-------------------------------------------------------------~~  675 (876)
                      |||+++|+|.+++....                                                             ..
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            99999999999986431                                                             24


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccc
Q 002826          676 LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY  755 (876)
Q Consensus       676 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  755 (876)
                      +++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++...............++..|+|||.
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence            77888999999999999999999   999999999999999999999999999987643322222233346678999999


Q ss_pred             cCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHc
Q 002826          756 GYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRC  834 (876)
Q Consensus       756 ~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~c  834 (876)
                      +.+..++.++|||||||++|||++ |+.||........ ......   ...  .     +..   .......+.+++.+|
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~---~~~--~-----~~~---~~~~~~~l~~li~~c  313 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK---DGT--R-----MRA---PENATPEIYRIMLAC  313 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh---cCC--C-----CCC---CCCCCHHHHHHHHHH
Confidence            988889999999999999999997 9999976443221 111111   110  0     000   112234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHHhhcccC
Q 002826          835 TSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       835 l~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      |+.||++|||+.|+++.|+++..+
T Consensus       314 l~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         314 WQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=341.59  Aligned_cols=249  Identities=26%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC----Cc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCe
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF----GC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDES  652 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~  652 (876)
                      ..+.+...+..|.|+||.|+.|.. .+|+.||+|++.+.    .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345566666667777999999954 57899999976553    22 23456778999999998 9999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhh
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRI  731 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~  731 (876)
                      .|+||||+.||+|.+++.+ ..++.+..+.++++|++.|++|+|+.   ||+||||||+||+++.+ +++||+|||++..
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999999999988 55889999999999999999999999   99999999999999999 9999999999988


Q ss_pred             ccccccccccccccccccccCccccCCCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKK-A-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ..  .........+||+.|+|||++.+.. | +.++||||+||++|.|++|+.||+......     ..+..........
T Consensus       171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~-----l~~ki~~~~~~~p  243 (370)
T KOG0583|consen  171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN-----LYRKIRKGEFKIP  243 (370)
T ss_pred             cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH-----HHHHHhcCCccCC
Confidence            74  1122345667999999999998866 5 578999999999999999999998733222     1121111111111


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV  849 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell  849 (876)
                      ..++          ..++.+++.+|+..+|.+|+|+.|++
T Consensus       244 ~~~~----------S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  244 SYLL----------SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCcC----------CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            1110          45678999999999999999999999

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=332.91  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=202.7

Q ss_pred             ccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|+ |.||.||+| +..+++.||+|++..... .+.+++++|+.+++.++++||.++||.+..+...+++||||
T Consensus        15 ~~~~~~Igr-GsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   15 YTKLELIGR-GSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             cccchhccc-cccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            334444554 559999999 456899999999975433 34578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .||++.+.+.... .+++..+.-++++++.|+.|||.+   +.+|||||+.||++..+|.+|++|||++.........  
T Consensus        94 ~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--  167 (467)
T KOG0201|consen   94 GGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--  167 (467)
T ss_pred             cCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc--
Confidence            9999999997654 458888888999999999999999   9999999999999999999999999999877654322  


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|||||++....|+.++||||+|++.|||++|.+|+...++...        ...++.    -..|.+..  
T Consensus       168 r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv--------lflIpk----~~PP~L~~--  233 (467)
T KOG0201|consen  168 RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV--------LFLIPK----SAPPRLDG--  233 (467)
T ss_pred             cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE--------EEeccC----CCCCcccc--
Confidence            2455699999999999988999999999999999999999999987655322        111111    11222222  


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       .....+.+++..|+.++|+.||||.++++
T Consensus       234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 -DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence             44557899999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-37  Score=331.52  Aligned_cols=259  Identities=21%  Similarity=0.294  Sum_probs=203.1

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEE
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      ..++.+++..  +....++.|| +|.||+|.. +|+.||||++.......   .+.+.+|+.++++++||||++++|++.
T Consensus        13 ~~i~~~~i~~--~~~~~i~~g~-~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~   88 (283)
T PHA02988         13 KCIESDDIDK--YTSVLIKEND-QNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII   88 (283)
T ss_pred             eecCHHHcCC--CCCeEEeeCC-ceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence            4455566633  2334455555 999999988 79999999987654333   366789999999999999999999987


Q ss_pred             e----CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          649 S----DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       649 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      +    ....++||||+++|+|.+++.+.. .+++....+++.+++.|++|||+..  +++||||||+||++++++.+||+
T Consensus        89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         89 DIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             ecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEc
Confidence            7    346899999999999999997653 6899999999999999999999731  77899999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      |||+++......     ....|+..|+|||...+  ..++.++|||||||++|||++|+.||.......  ....+... 
T Consensus       166 dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~i~~~-  237 (283)
T PHA02988        166 CHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDLIINK-  237 (283)
T ss_pred             ccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhc-
Confidence            999998664322     22347888999999865  678999999999999999999999998654322  11211110 


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                        .  ..    +.+.   ...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       238 --~--~~----~~~~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        238 --N--NS----LKLP---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             --C--CC----CCCC---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              0  00    1111   112346889999999999999999999999998764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=333.05  Aligned_cols=239  Identities=27%  Similarity=0.381  Sum_probs=197.5

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHh
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI  669 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l  669 (876)
                      .|.|+.|.||+|++ .++.||||++..       .-+.+|+-|++|+||||+.|.|+|.....+|||||||..|-|..++
T Consensus       132 lGSGaQGAVF~Grl-~netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL  203 (904)
T KOG4721|consen  132 LGSGAQGAVFLGRL-HNETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL  203 (904)
T ss_pred             hccCcccceeeeec-cCceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence            45566999999998 688999998753       2356899999999999999999999999999999999999999999


Q ss_pred             hccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccccc
Q 002826          670 CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC  749 (876)
Q Consensus       670 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~  749 (876)
                      +.. ..+.......+..+||.||.|||.+   .|||||||+-||||+.+..|||+|||-++...+..   +.-...||..
T Consensus       204 ka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSFaGTVa  276 (904)
T KOG4721|consen  204 KAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSFAGTVA  276 (904)
T ss_pred             hcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhhhhhHh
Confidence            765 4788889999999999999999999   99999999999999999999999999998775432   2233459999


Q ss_pred             ccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHH
Q 002826          750 YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE  829 (876)
Q Consensus       750 y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  829 (876)
                      |||||++...++++|+||||||||||||+||..||..-+...     +++..      -...+.-   -.+..++..+.-
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----IIwGV------GsNsL~L---pvPstcP~Gfkl  342 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----IIWGV------GSNSLHL---PVPSTCPDGFKL  342 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----eEEec------cCCcccc---cCcccCchHHHH
Confidence            999999999999999999999999999999999987533221     11110      0111110   122344557888


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          830 IALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       830 li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      +++.||...|..||++++++..|+-..+
T Consensus       343 L~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  343 LLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             HHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            9999999999999999999999987543

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=316.21  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=200.3

Q ss_pred             CCCCCCCceEEEEEEe-CCCcEEEEEEEec--CCccCHHHHHHHHHHHhhccCccccceeeEEEe-----CCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSL-PSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-----DESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e~  659 (876)
                      +-.|.|+||.|+.|.. .+|+.||+|++..  ......++..+|+.+++.++|+||+.+.+++..     -+.+|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            3345556999999944 5899999999863  333455778899999999999999999999866     3569999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      |+. +|.+.++.+ ..++...+..++.|+++|++|+|+.   +|+|||+||+|++++.+...||+|||+|+.........
T Consensus       108 Met-DL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~  182 (359)
T KOG0660|consen  108 MET-DLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDG  182 (359)
T ss_pred             Hhh-HHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCccc
Confidence            954 999999765 3599999999999999999999999   99999999999999999999999999999886543344


Q ss_pred             ccccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-------------hHHHHHHHH-h-h
Q 002826          740 TMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-------------DVVKWVRRK-I-N  803 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-------------~~~~~~~~~-~-~  803 (876)
                      .++..+.|.+|+|||++. ...|+.+.||||.||++.||++|++.|.+.+.-..             +....+... . .
T Consensus       183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~  262 (359)
T KOG0660|consen  183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP  262 (359)
T ss_pred             chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence            567777899999999865 45799999999999999999999999987544221             111111100 0 0


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .-......-...+............+++.+|+..||.+|+|++|+++.
T Consensus       263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000011111122233344556678999999999999999999999863

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-37  Score=309.66  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=202.2

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  657 (876)
                      |....+++. |+||.||+|+. ++++.||+|+++-..+.+  .-...+||.+|.+.+|||||.+-.+...  -+.+|+||
T Consensus        78 fe~lnrI~E-GtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM  156 (419)
T KOG0663|consen   78 FEKLNRIEE-GTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM  156 (419)
T ss_pred             HHHHhhccc-CcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence            334455554 55999999965 489999999996543322  3456789999999999999999998875  35799999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |||+. +|..+++...+++...++..++.|+++|++|||..   .|+|||+|++|+|++..|.+||+|||+|+.++... 
T Consensus       157 e~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-  231 (419)
T KOG0663|consen  157 EYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-  231 (419)
T ss_pred             HHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCc-
Confidence            99998 99999998888999999999999999999999999   89999999999999999999999999999998653 


Q ss_pred             ccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh----hccccccccc
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI----NITNGAIQVL  812 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  812 (876)
                       ..++..+-|.+|+|||.+.+. .|+.+.||||+|||+.|++++++.|.+..+.+. +-...+...    .++.++...-
T Consensus       232 -k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  232 -KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             -ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccccc
Confidence             345666789999999988765 599999999999999999999999987654332 111111111    1111111100


Q ss_pred             -----------ChhhhhhcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 -----------DPKIANCYQQ--QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 -----------d~~~~~~~~~--~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                 .-.+......  -...-++++..++..||.+|.||+|.++.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                       0001111111  22566899999999999999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-37  Score=337.12  Aligned_cols=246  Identities=21%  Similarity=0.337  Sum_probs=202.9

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +..+-.|.|+.|.|.+|++ .+|+.+|||++.+...   .....+++|+-+|+-+.||||++++++|++..++|+|.||+
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv   94 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYV   94 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEec
Confidence            4444455566999999955 6899999999976522   22467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +||-|.+++-+++ .+++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||.|..-.++.-   
T Consensus        95 ~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl---  167 (786)
T KOG0588|consen   95 PGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL---  167 (786)
T ss_pred             CCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc---
Confidence            9999999998776 788999999999999999999999   999999999999999999999999999987655432   


Q ss_pred             cccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ....+|.+.|.|||++++.+| +.++||||+|||+|.++||+.||++.+..  .+...+++.      .+++        
T Consensus       168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--~LLlKV~~G------~f~M--------  231 (786)
T KOG0588|consen  168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VLLLKVQRG------VFEM--------  231 (786)
T ss_pred             ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--HHHHHHHcC------cccC--------
Confidence            334569999999999998765 67899999999999999999999853322  233333321      1221        


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      +...+.++.+++.+|+..||++|.|++||.+.-.
T Consensus       232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            1233446789999999999999999999998643

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9.8e-37  Score=331.03  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=193.4

Q ss_pred             CCCCCCCCceEEEEEEeC-----------------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          587 SSAGNGGPFGRVYILSLP-----------------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      ..+|.|| ||.||+|...                 ++..||+|++...... ...++.+|++++++++||||+++++++.
T Consensus        11 ~~lg~G~-fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          11 EKLGEGQ-FGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eEecccC-CeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            4455554 9999999653                 2347999998654322 2457889999999999999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccC------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCcccccccc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQD------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS  710 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp  710 (876)
                      +.+..++||||+++|+|.+++....                  ..+++..+.+++.|++.|++|||+.   +|+||||||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp  166 (304)
T cd05096          90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLAT  166 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcch
Confidence            9999999999999999999885431                  2467888999999999999999999   999999999


Q ss_pred             CceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCC
Q 002826          711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT--GRQAEQAEP  788 (876)
Q Consensus       711 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt--g~~p~~~~~  788 (876)
                      +||+++.++.+||+|||+++...............++..|+|||......++.++||||||+++|||++  +..||....
T Consensus       167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            999999999999999999986643332222233345778999999888889999999999999999987  456666533


Q ss_pred             cchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          789 AESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ..  .....................      ....+..+.+++.+||+.||++|||+.||.+.|++
T Consensus       247 ~~--~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         247 DE--QVIENAGEFFRDQGRQVYLFR------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HH--HHHHHHHHHhhhccccccccC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            22  222222111111000000000      11123467899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=360.29  Aligned_cols=256  Identities=25%  Similarity=0.348  Sum_probs=209.9

Q ss_pred             cCCCCCCCCceEEEEEEeC--CCc----EEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP--SGE----LIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      .....|.|.||.||.|...  +|.    .||+|.+.+. +.++..+|.+|..+|+.++|||||+++|+|.+....++++|
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence            3455667779999999654  343    4899998664 34556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhcc------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          659 FLQMGSLGDLICRQ------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       659 ~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      ||+||+|..++++.      ...++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....|||+|||+|+.+
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi  852 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDI  852 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence            99999999999877      66799999999999999999999999   9999999999999999999999999999977


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      ....++.......-...|||||.+..+.++.|+|||||||++||++| |..||..-...  ++...+.+..        .
T Consensus       853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~v~~~~~~gg--------R  922 (1025)
T KOG1095|consen  853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--EVLLDVLEGG--------R  922 (1025)
T ss_pred             hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--HHHHHHHhCC--------c
Confidence            66555544443334568999999999999999999999999999999 88888754332  2233222211        1


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ++     .+..++..++++|..||+.+|++||++..+++.+..+....
T Consensus       923 L~-----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  923 LD-----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             cC-----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            11     12234456889999999999999999999999999876533

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.1e-37  Score=325.42  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.-...+|+|| ||.||+|+.+ +|..+|+|++.+..-   ...+.++.|..+|....+|+||+++..|++.+..|+||
T Consensus       142 DFe~Lk~IgkGA-fGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  142 DFELLKVIGKGA-FGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             cchhheeecccc-ceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            455566666666 9999999655 799999999987543   33456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc---
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE---  734 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~---  734 (876)
                      ||++||++..++.+.+ .+++..+...+.+.+-|+..+|+.   |++||||||+|+|||..|.+|++|||+++-...   
T Consensus       221 EylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            9999999999998876 788888888999999999999999   999999999999999999999999999854321   


Q ss_pred             -------------------ccccc----c-------------------cccccccccccCccccCCCCCCCccchHHHHH
Q 002826          735 -------------------AAFQS----T-------------------MSSEYALSCYNAPEYGYSKKATAQMDAYSFGV  772 (876)
Q Consensus       735 -------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv  772 (876)
                                         .....    .                   ....+|||.|||||++.+..|+..+|.||+||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                               00000    0                   01247999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCcchh--hHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC---HHH
Q 002826          773 VLLELITGRQAEQAEPAESL--DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS---MFE  847 (876)
Q Consensus       773 ~l~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~e  847 (876)
                      |+|||+.|.+||..+.+.+.  .++.|.... ..+         .-.    ....++.++|.+|+. ||++|.-   ++|
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-~fP---------~~~----~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETL-KFP---------EEV----DLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-cCC---------CcC----cccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            99999999999998776654  334443221 111         000    112567899999999 9999964   555


Q ss_pred             HHH
Q 002826          848 VVK  850 (876)
Q Consensus       848 ll~  850 (876)
                      |.+
T Consensus       442 IK~  444 (550)
T KOG0605|consen  442 IKK  444 (550)
T ss_pred             Hhc
Confidence            543

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.8e-36  Score=318.91  Aligned_cols=248  Identities=23%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| ||.||+++++++..+|+|.+... ....+.+..|++++++++||||+++++++.+++..++||||+++|+
T Consensus         8 ~~~~lg~G~-~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (256)
T cd05114           8 FMKELGSGQ-FGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC   85 (256)
T ss_pred             EeeEecCCc-CceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence            345566655 99999999988889999987643 2445678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++......+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.++........ .....
T Consensus        86 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~  161 (256)
T cd05114          86 LLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGA  161 (256)
T ss_pred             HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCC
Confidence            9999976555789999999999999999999999   9999999999999999999999999998866432211 11222


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .++..|+|||......++.++||||||+++|||++ |+.||......  .....+.....       ...+.      ..
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~-------~~~~~------~~  226 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR-------LYRPK------LA  226 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-------CCCCC------CC
Confidence            34567999999988889999999999999999999 89998654322  22222221100       01111      11


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ...+.+++.+||+++|++||++.|+++.|.
T Consensus       227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            236789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.4e-39  Score=346.29  Aligned_cols=363  Identities=23%  Similarity=0.365  Sum_probs=290.2

Q ss_pred             EEEEeecCCCCCcc-cccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccC
Q 002826           76 TVASINLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIG  154 (876)
Q Consensus        76 ~~~~l~l~~~~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~  154 (876)
                      .|..+++++|+++| ..|..+.+++++++|.|...++.. +|++++.|.+|++|.+++|+|.           .+-..+.
T Consensus         8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~~-vPeEL~~lqkLEHLs~~HN~L~-----------~vhGELs   75 (1255)
T KOG0444|consen    8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLEQ-VPEELSRLQKLEHLSMAHNQLI-----------SVHGELS   75 (1255)
T ss_pred             eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhhh-ChHHHHHHhhhhhhhhhhhhhH-----------hhhhhhc
Confidence            67889999999985 789999999999999999998866 8999999999998877776653           3345677


Q ss_pred             CccccceecccccccC-CCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          155 SLVNLQVLNLGSNLLS-GSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      .|+.|+.+++++|++. .-+|..+..|..|++||||+|+  +.+.|..+..-+++-.|+|++|+|..+.-.-|.+|+.|-
T Consensus        76 ~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq--L~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLL  153 (1255)
T KOG0444|consen   76 DLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ--LREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLL  153 (1255)
T ss_pred             cchhhHHHhhhccccccCCCCchhcccccceeeecchhh--hhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHh
Confidence            7888999999999886 2356666778889999999998  788888888888888888888888876666677888888


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccc-ccCCCCCccccccceeeccc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN-GSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~  312 (876)
                      .||||+|++. .+|+.+- .+..|++|+|++|.+...--..+..+++|..|.+++.+=+ ..+|.++..+.+|..++++.
T Consensus       154 fLDLS~NrLe-~LPPQ~R-RL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~  231 (1255)
T KOG0444|consen  154 FLDLSNNRLE-MLPPQIR-RLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSE  231 (1255)
T ss_pred             hhccccchhh-hcCHHHH-HHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccc
Confidence            8888888888 7777764 4888888888888776544445556777888888776543 45777888888888888888


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccC-CC
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYG-SL  391 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~  391 (876)
                      |.+. ..|+++.++++|+.|+|++|+|+ .+.-......+|++|+||+|+++ ..|..++.+++|+.|++.+|+++- -+
T Consensus       232 N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGi  308 (1255)
T KOG0444|consen  232 NNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGI  308 (1255)
T ss_pred             cCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCC
Confidence            8888 78888888888888888888887 44445566678888888888888 788888888888888888888753 35


Q ss_pred             CCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcc
Q 002826          392 PPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL  458 (876)
Q Consensus       392 ~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  458 (876)
                      |..++.+.+|+++..++|.+.-.+..+..+.+|+.|.|++|+|- .+|+++.-|+.|+.|||..|.=
T Consensus       309 PSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  309 PSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             ccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            77788888888888888888766667888888888888888877 6788888888888888887753

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=317.60  Aligned_cols=256  Identities=20%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--------------cCHHHHHHHHHHHhhccCccccceeeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--------------QSSKTLKTEVKTLAKIRHKNIVKVLGF  646 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~~~~  646 (876)
                      +.|+....+|.|.||.|-+|+. .+++.||+|++.+...              ...+...+||.+|++++|||||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            4456666667777999999955 4899999999965211              122578899999999999999999999


Q ss_pred             EEeC--CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       647 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      ..+.  +.+|+|+|||..|.+...= .....+++.+++++++++..||+|||.+   +|+||||||+|+|++++|++||+
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIs  252 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKIS  252 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEee
Confidence            9874  5799999999998775432 1233389999999999999999999999   99999999999999999999999


Q ss_pred             cccchhhcccc---ccccccccccccccccCccccCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHH
Q 002826          725 DFALDRIVGEA---AFQSTMSSEYALSCYNAPEYGYSK----KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKW  797 (876)
Q Consensus       725 DfGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~  797 (876)
                      |||.+.....+   ..........||+.|+|||...++    ..+.+.||||+||++|.|+.|+.||-++..-+     .
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-----l  327 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-----L  327 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-----H
Confidence            99998766321   122223446799999999987763    35778999999999999999999997643322     1


Q ss_pred             HHHHhhcccccccccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          798 VRRKINITNGAIQVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       798 ~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ..+....          .+. ....+...++.++|.+++++||++|.+..+|.....--.
T Consensus       328 ~~KIvn~----------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  328 FDKIVND----------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHhcC----------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            1111111          111 111244567899999999999999999999987765433

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-36  Score=337.63  Aligned_cols=252  Identities=25%  Similarity=0.386  Sum_probs=196.6

Q ss_pred             cCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ...+|+|| ||.||+|.+      .++..||||++..... ...+.+.+|+.+++.+ +||||++++++|.+.+..++||
T Consensus        40 ~~~LG~G~-fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~  118 (375)
T cd05104          40 GKTLGAGA-FGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT  118 (375)
T ss_pred             hheecCCc-cceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence            34555555 999999853      2466899999864332 3345688999999999 8999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC----------------------------------------------------------------
Q 002826          658 EFLQMGSLGDLICRQD----------------------------------------------------------------  673 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~----------------------------------------------------------------  673 (876)
                      ||+++|+|.+++.+..                                                                
T Consensus       119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (375)
T cd05104         119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD  198 (375)
T ss_pred             hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence            9999999999886421                                                                


Q ss_pred             ----------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          674 ----------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       674 ----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                                ..+++..+.+++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.............
T Consensus       199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  275 (375)
T cd05104         199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN  275 (375)
T ss_pred             cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence                      2478889999999999999999999   999999999999999999999999999987654322222222


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||...+..++.++|||||||++|||++ |..||....... ....+......       ...+.      .
T Consensus       276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~-------~~~~~------~  341 (375)
T cd05104         276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYR-------MLSPE------C  341 (375)
T ss_pred             CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCcc-------CCCCC------C
Confidence            335667999999988899999999999999999998 888887643322 22222221110       00011      1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...++.+++.+||+.||++|||+.|+++.|++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            123678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=298.15  Aligned_cols=231  Identities=22%  Similarity=0.286  Sum_probs=191.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+-.|.|+||.|.+++.+ +|..+|+|++.+.....   .+....|..+|+.+.||.++++++.|.+.+..|+||||++|
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G  128 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG  128 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence            344455669999999765 79999999997643322   34566899999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      |.|..++++.+ +++++.+.-.+.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||.|+.+...     ..
T Consensus       129 GElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~  199 (355)
T KOG0616|consen  129 GELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TW  199 (355)
T ss_pred             ccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EE
Confidence            99999998765 799999999999999999999999   9999999999999999999999999999987654     23


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..+||+.|+|||++.++.+..++|.|||||++|||+.|.+||.......     ...+.....-.+           +.-
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-----iY~KI~~~~v~f-----------P~~  263 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-----IYEKILEGKVKF-----------PSY  263 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-----HHHHHHhCcccC-----------Ccc
Confidence            4569999999999999999999999999999999999999998866522     222211211111           122


Q ss_pred             HHHHHHHHHHHccCCCCCCC
Q 002826          823 QMLGALEIALRCTSVMPEKR  842 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~R  842 (876)
                      ...++.+++.+.++.|-++|
T Consensus       264 fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCHHHHHHHHHHHhhhhHhh
Confidence            23457788999999999888

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.4e-36  Score=321.31  Aligned_cols=250  Identities=20%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             CCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ....+.|+||.||+|.+.    .+..||+|.+..... ...+.+.+|+..+++++||||++++|++..++..++||||++
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS   89 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence            334445559999999653    467899999875422 223568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|+|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......... ..
T Consensus        90 ~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~  165 (266)
T cd05064          90 NGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TT  165 (266)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cc
Confidence            9999999987666789999999999999999999999   9999999999999999999999999987654322111 11


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||.+.+..++.++|||||||++||+++ |+.||.......  ..+.+...      ...   + .   .
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~------~~~---~-~---~  230 (266)
T cd05064         166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDG------FRL---P-A---P  230 (266)
T ss_pred             cCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCC------CCC---C-C---C
Confidence            12234678999999988889999999999999999775 999997543322  22221111      000   0 0   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...+..+.+++.+||+.+|++||+++|+.+.|+++
T Consensus       231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         231 RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            12234678999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=334.96  Aligned_cols=253  Identities=24%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCCCCCCceEEEEEEeCC--C---cEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSLPS--G---ELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +..|.|+||.||+|++..  +   ..||+|......   .....++.+|+++|+.++|||||+++|++......++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            455566799999996643  2   238999987532   34456889999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      |.||+|.+++.+.+..++..++.+++.+.|.||+|||+.   +++||||.++|+|++.++.+||+|||+++.-..  ...
T Consensus       243 ~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~  317 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVM  317 (474)
T ss_pred             cCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcc--eee
Confidence            999999999998877899999999999999999999999   999999999999999999999999999875431  111


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH-HHHhhcccccccccChhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV-RRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~~~  817 (876)
                      ......-+..|+|||.+..+.++.++|||||||++||+++ |..||.+....  +...++ ....+..      ..    
T Consensus       318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~------~~----  385 (474)
T KOG0194|consen  318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMP------IP----  385 (474)
T ss_pred             ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCC------CC----
Confidence            1112235678999999999999999999999999999999 78888764432  223333 2111111      11    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                         ...+..+..++..||..+|++||||.++.+.++.+.....
T Consensus       386 ---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  386 ---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence               1223456788889999999999999999999999976655

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.4e-36  Score=322.42  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=200.0

Q ss_pred             ccCCCCCCCCceEEEEEEeCC------CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLPS------GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ....+|.|| ||.||+|....      ...||+|.+..... ....++.+|++++++++||||+++++++...+..+++|
T Consensus         9 ~~~~lg~G~-~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           9 FLEELGEGA-FGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             hhhcccCcc-CCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            345566665 99999996532      25799999864432 22456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeE
Q 002826          658 EFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK  722 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~k  722 (876)
                      ||+++++|.+++.+..               ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~  164 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK  164 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence            9999999999986541               4578899999999999999999999   999999999999999999999


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK  801 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  801 (876)
                      |+|||+++...............+++.|+|||......++.++|||||||++|||++ |..||......+  ....+...
T Consensus       165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i~~~  242 (283)
T cd05048         165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMIRSR  242 (283)
T ss_pred             ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence            999999876543332222333456788999999888889999999999999999998 999987644322  22222211


Q ss_pred             hhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       802 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .      .       .......+..+.+++.+||+.+|.+||+++||+++|+++
T Consensus       243 ~------~-------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         243 Q------L-------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             C------c-------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            0      0       011123345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.5e-36  Score=338.01  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=197.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      |.....+|.|| ||.||+|..      .++..||+|++..... .....+.+|+++++.+ +||||++++++|.+.+..+
T Consensus        40 ~~~~~~LG~G~-fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~  118 (374)
T cd05106          40 LQFGKTLGAGA-FGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL  118 (374)
T ss_pred             ceehheecCCC-cccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence            33345555555 999999863      2345899999965432 2245678999999999 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC-------------------------------------------------------------
Q 002826          655 LIYEFLQMGSLGDLICRQD-------------------------------------------------------------  673 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  673 (876)
                      +||||+++|+|.+++.+..                                                             
T Consensus       119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (374)
T cd05106         119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK  198 (374)
T ss_pred             EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence            9999999999999885421                                                             


Q ss_pred             --------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          674 --------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       674 --------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                              ..+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++...............
T Consensus       199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                    2478888999999999999999999   99999999999999999999999999998664332221222233


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|||||++....++.++|||||||++|||++ |+.||........ .........       ....+.      ..+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~-------~~~~~~------~~~  341 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGY-------QMSRPD------FAP  341 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHccc-------CccCCC------CCC
Confidence            5667999999988889999999999999999997 9999976443221 111111100       000011      113


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            46789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.6e-36  Score=322.46  Aligned_cols=248  Identities=21%  Similarity=0.262  Sum_probs=195.0

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|| ||.||+|.. .+|+.||+|.+.....   .....+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus         4 ~~~~lg~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           4 HYRVLGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             EEEEEecCC-CEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            344555555 999999965 5899999999864321   22345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|+|.+++... ...+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++......   
T Consensus        83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---  156 (285)
T cd05631          83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---  156 (285)
T ss_pred             CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---
Confidence            999999887654 34689999999999999999999999   99999999999999999999999999997654322   


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||..|+|||.+.+..++.++||||+||++|||++|+.||........ ............           ...
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~-----------~~~  224 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKEDQ-----------EEY  224 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhccc-----------ccC
Confidence            12334589999999999988999999999999999999999999986443211 011111100000           011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                      .......+.+++.+||+.||++||+     +.|+++.
T Consensus       225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            1122346789999999999999997     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-36  Score=331.94  Aligned_cols=239  Identities=22%  Similarity=0.260  Sum_probs=192.1

Q ss_pred             CCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          591 NGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       591 ~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      |.|+||.||+|.. .+|+.||+|++.....   .....+.+|++++++++||||+++++++..++..|+||||+++|+|.
T Consensus         4 G~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~   83 (323)
T cd05571           4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF   83 (323)
T ss_pred             eeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHH
Confidence            3455999999965 4799999999975321   22346778999999999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccc
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA  746 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  746 (876)
                      +++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .......|
T Consensus        84 ~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~g  157 (323)
T cd05571          84 FHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCG  157 (323)
T ss_pred             HHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccceec
Confidence            9987654 689999999999999999999999   99999999999999999999999999987542211  12233458


Q ss_pred             cccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       747 t~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      |+.|+|||.+.+..++.++||||+||++|||++|+.||.....+..  .....   ...        ..+   .......
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~~~---~~~--------~~~---p~~~~~~  221 (323)
T cd05571         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELIL---MEE--------IRF---PRTLSPE  221 (323)
T ss_pred             CccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH--HHHHH---cCC--------CCC---CCCCCHH
Confidence            9999999999888899999999999999999999999976443221  11111   100        011   1122345


Q ss_pred             HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          827 ALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      +.+++.+|++.||++||     ++.|+++.
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            78999999999999999     79998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-36  Score=312.02  Aligned_cols=258  Identities=26%  Similarity=0.360  Sum_probs=201.9

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhh--ccCccccceeeEEEeCC----eEEEEEEcCC
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK--IRHKNIVKVLGFFHSDE----SIFLIYEFLQ  661 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~lv~e~~~  661 (876)
                      .+.+.|.||.||||.+ +++.||||++..   ++...+..|-++++.  ++|+||++|+++-....    .+++|+||.+
T Consensus       216 eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            3445555999999998 569999999965   455667777666665  48999999999876544    7999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc------CCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD------YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      .|+|.+++..+  .++|....+|+..+++||+|||+.      +.|+|+|||||++||||..|+++.|+|||+|..+..+
T Consensus       292 kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~  369 (534)
T KOG3653|consen  292 KGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPG  369 (534)
T ss_pred             CCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCC
Confidence            99999999765  689999999999999999999976      3579999999999999999999999999999988766


Q ss_pred             ccccccccccccccccCccccCCCC------CCCccchHHHHHHHHHHHhCCCCCCC-CCc------ch--------hhH
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKK------ATAQMDAYSFGVVLLELITGRQAEQA-EPA------ES--------LDV  794 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGv~l~elltg~~p~~~-~~~------~~--------~~~  794 (876)
                      ........++||.+|||||++.+..      .-.+.||||+|.|+|||+++..-++. +..      +.        .++
T Consensus       370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m  449 (534)
T KOG3653|consen  370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM  449 (534)
T ss_pred             CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence            5555556688999999999876432      23468999999999999997655431 111      10        012


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .+.+-         .+...|.+++.|.  ..+..+++.+..||+.||+-|.|+.=+-+++.++..-.+
T Consensus       450 q~~VV---------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  450 QELVV---------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HHHHH---------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            22211         1222344444433  456778999999999999999999999999998875554

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.8e-36  Score=322.28  Aligned_cols=256  Identities=25%  Similarity=0.410  Sum_probs=202.3

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||.||++..      .++..||+|.+..........+.+|++++++++||||+++++++...+..++|||
T Consensus         9 ~~~~lg~G~-~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (288)
T cd05093           9 LKRELGEGA-FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   87 (288)
T ss_pred             eccccCCcC-CeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            334555555 999999964      2356789998876544445678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          659 FLQMGSLGDLICRQD------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      |+++++|.+++...+            ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~df  164 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDF  164 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccC
Confidence            999999999986442            2489999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++...............++..|+|||......++.++||||||+++|||++ |.+||.......  .......   ..
T Consensus       165 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~~---~~  239 (288)
T cd05093         165 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQ---GR  239 (288)
T ss_pred             CccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHc---CC
Confidence            99986643322222233345678999999988889999999999999999998 899987544322  1121111   10


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                         .....       ...+..+.+++.+||+.+|.+|||++|+.+.|+++....
T Consensus       240 ---~~~~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         240 ---VLQRP-------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             ---cCCCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence               00000       112335789999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6e-36  Score=322.71  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=202.2

Q ss_pred             cCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          586 KSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ...+|.|| ||.||+|..      .++..||+|.+........+.+.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~-~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   88 (291)
T cd05094          10 KRELGEGA-FGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY   88 (291)
T ss_pred             eeeecccC-CCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEec
Confidence            34555555 999999964      24567899998655444456789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          660 LQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       660 ~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      +++++|.+++...+               ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence            99999999996532               3478999999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+++...............++..|+|||...+..++.++||||||+++|||+| |+.||.......  ..+....   
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~---  240 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECITQ---  240 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhC---
Confidence            9999976654332222233446788999999988889999999999999999999 999987644322  1121111   


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..   ...       .....+..+.+++.+||+++|++|||++++++.|+++.+.
T Consensus       241 ~~---~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         241 GR---VLE-------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CC---CCC-------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            10   000       0111234678999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.6e-36  Score=320.47  Aligned_cols=259  Identities=22%  Similarity=0.307  Sum_probs=195.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||+||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           7 YVKLDKLGEGT-YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             ceEeeEEecCC-CEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            33445555555 9999999654 789999999864332 33456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++ +|.+++...+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~  159 (288)
T cd07871          86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KT  159 (288)
T ss_pred             Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--cc
Confidence            86 99999877666789999999999999999999999   99999999999999999999999999987653221  12


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-c----------ccc
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-T----------NGA  808 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~----------~~~  808 (876)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||+||++||........  .......... .          ...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccchhh
Confidence            233457889999998765 5688999999999999999999999976543321  1111111100 0          000


Q ss_pred             ccccChhh-----hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 IQVLDPKI-----ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ~~~~d~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+..     .........++.+++.+|+..||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00111110     0111112346789999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=325.78  Aligned_cols=241  Identities=21%  Similarity=0.293  Sum_probs=194.1

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|+ ||.||+|... +|+.||+|++.....   .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   83 (291)
T cd05612           5 RIKTVGTGT-FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV   83 (291)
T ss_pred             eeeeeecCC-CeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence            344455555 9999999765 799999999865321   23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|+|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......    
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----  155 (291)
T cd05612          84 PGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----  155 (291)
T ss_pred             CCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc----
Confidence            9999999997654 689999999999999999999999   99999999999999999999999999988764321    


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                       ....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......  ....+   .....        .+   .
T Consensus       156 -~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i---~~~~~--------~~---~  218 (291)
T cd05612         156 -WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKI---LAGKL--------EF---P  218 (291)
T ss_pred             -ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCCc--------CC---C
Confidence             22358899999999988889999999999999999999999997644322  11111   11110        00   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                      ......+.+++.+|++.||.+||+     ++|+++.
T Consensus       219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            111335789999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.8e-40  Score=336.47  Aligned_cols=412  Identities=25%  Similarity=0.396  Sum_probs=336.5

Q ss_pred             EEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccc-------------eeecCCc
Q 002826           77 VASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW-------------VLDLSRN  143 (876)
Q Consensus        77 ~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------------~LdL~~n  143 (876)
                      ++-+++.++.++ ++|++++++..++.|+.++|+++. +|.+++.+.+|..|+.++|.+.             .||..+|
T Consensus        70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N  147 (565)
T KOG0472|consen   70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNN  147 (565)
T ss_pred             eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhcccc
Confidence            344566666665 568888999999999999998876 7888999999999999998753             4678889


Q ss_pred             cccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCC
Q 002826          144 HIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIP  223 (876)
Q Consensus       144 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~  223 (876)
                      +++ ..|+.++++.+|..|++.+|+++...|..+. ++.|+.||+..|-  .+.+|+.++.+.+|+.|||..|++.. .|
T Consensus       148 ~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~--L~tlP~~lg~l~~L~~LyL~~Nki~~-lP  222 (565)
T KOG0472|consen  148 QIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL--LETLPPELGGLESLELLYLRRNKIRF-LP  222 (565)
T ss_pred             ccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh--hhcCChhhcchhhhHHHHhhhccccc-CC
Confidence            998 6788888999999999999999966655555 9999999999996  88999999999999999999999985 45


Q ss_pred             ccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcccc
Q 002826          224 DSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECL  303 (876)
Q Consensus       224 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  303 (876)
                       .|.++..|+.|+++.|+|+ .+|.....+++++..|||..|+++ ..|+.++.+++|.+||+|+|.|+ ..|.+++++ 
T Consensus       223 -ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-  297 (565)
T KOG0472|consen  223 -EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-  297 (565)
T ss_pred             -CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-
Confidence             7999999999999999999 999999888999999999999998 78999999999999999999999 577789999 


Q ss_pred             ccceeecccccCCC-------------------------------------C-CCccc---CCCCcccEEEecCCccccc
Q 002826          304 NLERFQVQDNGFSG-------------------------------------D-FPDKL---WSLPRIKLIRAESNRFSGA  342 (876)
Q Consensus       304 ~L~~L~L~~N~l~~-------------------------------------~-~p~~~---~~l~~L~~L~L~~N~l~~~  342 (876)
                      .|+.|-+.+|.+..                                     . .+..|   ..+.+.+.|+++.-+++.+
T Consensus       298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V  377 (565)
T KOG0472|consen  298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV  377 (565)
T ss_pred             eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccC
Confidence            99999999998731                                     0 11111   1234578888888888865


Q ss_pred             CccccccCC--CCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCccc
Q 002826          343 IPDSISMAA--QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKK  420 (876)
Q Consensus       343 ~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  420 (876)
                      +.+.|....  -...++++.|++. ++|..+..++.+...-+..|+..+.+|..++.+++|+.|+|++|-+...+.+++.
T Consensus       378 PdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~  456 (565)
T KOG0472|consen  378 PDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGS  456 (565)
T ss_pred             CHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhh
Confidence            555553322  2678899999998 7888888777765544444444458889999999999999999999877778999


Q ss_pred             ccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCcc--cCCCCCcc
Q 002826          421 CRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSL--ISGLPASY  497 (876)
Q Consensus       421 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~--~~~~~~~~  497 (876)
                      +..|+.||+|+|++. .+|..+..+..|+.+-.++|++....|+++.++ .+..||+.+|.+. .+|..+  +.++..+.
T Consensus       457 lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLe  534 (565)
T KOG0472|consen  457 LVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLE  534 (565)
T ss_pred             hhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEE
Confidence            999999999999998 788888888888888888899887677778888 4888999999988 455433  78888888


Q ss_pred             ccCCCC
Q 002826          498 LQGNPG  503 (876)
Q Consensus       498 ~~~N~~  503 (876)
                      +.|||-
T Consensus       535 L~gNpf  540 (565)
T KOG0472|consen  535 LDGNPF  540 (565)
T ss_pred             ecCCcc
Confidence            888874

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.8e-36  Score=345.33  Aligned_cols=246  Identities=23%  Similarity=0.269  Sum_probs=195.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-C-CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-S-GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|. |++|.||+|... + ++.||+|.+..........+++|+.+++.++|||||++++++..++..|+||||+++|
T Consensus        72 ~~~lg~-G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg  150 (478)
T PTZ00267         72 TTLVGR-NPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG  150 (478)
T ss_pred             EEEEEe-CCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence            344455 459999999553 4 6789999875544344456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          664 SLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       664 sL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus       151 ~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        151 DLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             CHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            999887542   34688999999999999999999999   999999999999999999999999999987654322222


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .........  .    ++    ..
T Consensus       228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~~~~~~~~--~----~~----~~  292 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IMQQVLYGK--Y----DP----FP  292 (478)
T ss_pred             ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCC--C----CC----CC
Confidence            334568999999999988889999999999999999999999997543221     111111110  0    00    01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......+.+++.+||+.+|++||++.|+++
T Consensus       293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            112346789999999999999999999874

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.6e-37  Score=324.01  Aligned_cols=245  Identities=32%  Similarity=0.477  Sum_probs=189.9

Q ss_pred             CCCCCceEEEEEEeC-----CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          590 GNGGPFGRVYILSLP-----SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|.||.||+|.+.     .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||+++|
T Consensus         7 ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g   86 (259)
T PF07714_consen    7 IGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGG   86 (259)
T ss_dssp             EEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTE
T ss_pred             EccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccc
Confidence            445669999999775     367899999955322 23578999999999999999999999999888899999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++... ...+++..+.+++.||+.||+|||+.   +++|+||+++||++++++.+||+|||+++............
T Consensus        87 ~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~  163 (259)
T PF07714_consen   87 SLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS  163 (259)
T ss_dssp             BHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred             cccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccc
Confidence            999999887 66899999999999999999999999   99999999999999999999999999998774332223333


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      .......|+|||......++.++||||||+++||+++ |+.||.....  .+...........             ....
T Consensus       164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~~~~~~~~~-------------~~~~  228 (259)
T PF07714_consen  164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIEKLKQGQRL-------------PIPD  228 (259)
T ss_dssp             TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHHHHHTTEET-------------TSBT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccc-------------eecc
Confidence            4446778999999888889999999999999999999 7788765422  2222222111110             0011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      .....+.+++.+||+.+|++|||++|+++.|
T Consensus       229 ~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  229 NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            1234578999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-36  Score=306.28  Aligned_cols=246  Identities=22%  Similarity=0.357  Sum_probs=203.7

Q ss_pred             cccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |++.+-.|.|+||.|-+| ....|+.||||.+.+....+   --.+++|+++|+.++||||+.++++|+..+...+||||
T Consensus        55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY  134 (668)
T KOG0611|consen   55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY  134 (668)
T ss_pred             HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence            445555667779999999 44789999999997654333   34678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ..+|.|++++.+.+ .+++.++.++++||..|+.|+|..   +++|||+|-+|||+|+++++||+|||++..+...... 
T Consensus       135 aS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfL-  209 (668)
T KOG0611|consen  135 ASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFL-  209 (668)
T ss_pred             cCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccHH-
Confidence            99999999998875 799999999999999999999999   9999999999999999999999999999988766543 


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                        ...+|.+-|.+||++.+.+| ++.+|-||+||++|.++.|.-||++.+...     .+++...+.  ..+   |.   
T Consensus       210 --qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-----lvrQIs~Ga--YrE---P~---  274 (668)
T KOG0611|consen  210 --QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-----LVRQISRGA--YRE---PE---  274 (668)
T ss_pred             --HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-----HHHHhhccc--ccC---CC---
Confidence              34458999999999988765 678999999999999999999998754332     222221111  111   11   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                          .+.+..-+|++|+..+|++|.|+.+|...-.
T Consensus       275 ----~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  275 ----TPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                1234567899999999999999999987654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=328.42  Aligned_cols=238  Identities=23%  Similarity=0.273  Sum_probs=190.4

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|| ||.||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus         2 g~G~-~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           2 GKGS-FGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CcCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            4455 9999999665 68899999986532   23345677899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 689999999999999999999999   99999999999999999999999999987543221  1223345


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ||+.|+|||.+.+..++.++||||+||++|||++|+.||.......     ..+.......        .   .......
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~-----~~~~~~~~~~--------~---~~~~~~~  218 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE-----MYRKILQEPL--------R---FPDGFDR  218 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH-----HHHHHHcCCC--------C---CCCcCCH
Confidence            8999999999998889999999999999999999999997644322     1121111110        0   0112234


Q ss_pred             HHHHHHHHccCCCCCCCCC---HHHHHH
Q 002826          826 GALEIALRCTSVMPEKRPS---MFEVVK  850 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs---~~ell~  850 (876)
                      .+.+++.+||+.||++||+   +.|+++
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            5789999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.4e-36  Score=319.72  Aligned_cols=251  Identities=27%  Similarity=0.436  Sum_probs=199.1

Q ss_pred             ccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ....+|.|| ||.||+|...      +++.||+|++...... ....+.+|+++++.++||||+++++++......++||
T Consensus         9 ~~~~lg~g~-~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   87 (280)
T cd05049           9 LKRELGEGA-FGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF   87 (280)
T ss_pred             HHhhccccC-CceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEE
Confidence            344555555 9999999663      3578999998765433 3468899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC-------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          658 EFLQMGSLGDLICRQD-------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      ||+++++|.+++...+             ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~  164 (280)
T cd05049          88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIG  164 (280)
T ss_pred             ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEEC
Confidence            9999999999996542             3478899999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....+.  ..+.....  
T Consensus       165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~~~--  240 (280)
T cd05049         165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECITQG--  240 (280)
T ss_pred             CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC--
Confidence            9999876543222222223345678999999998899999999999999999998 999987544322  22222211  


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                          .....       ....+..+.+++.+||+.+|++||++.|+++.|++
T Consensus       241 ----~~~~~-------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         241 ----RLLQR-------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----CcCCC-------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                00000       11223467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=327.91  Aligned_cols=244  Identities=24%  Similarity=0.292  Sum_probs=200.5

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      -..|.|+||+||.|+.. +...+|||-+..........+.+|+...++++|.|||+++|.|.+++.+-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            34566779999999654 67789999998776677788999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCcC--CHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEccccchhhccc-cccccccc
Q 002826          667 DLICRQDFQL--QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDFALDRIVGE-AAFQSTMS  742 (876)
Q Consensus       667 ~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~~-~~~~~~~~  742 (876)
                      ++++....++  .+.++--...||++||.|||+.   .|||||||-+||||+ -.|.+||+|||-++.... ...+.+  
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET--  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET--  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc--
Confidence            9998876677  7888888999999999999999   999999999999997 579999999999887642 222222  


Q ss_pred             cccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          743 SEYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                       ..||..|||||++..+  .|+.++|||||||++.||.||++||..-.....   ++.+-.      +.    ...+..+
T Consensus       736 -FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVG------my----KvHP~iP  801 (1226)
T KOG4279|consen  736 -FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVG------MY----KVHPPIP  801 (1226)
T ss_pred             -cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhc------ce----ecCCCCc
Confidence             3499999999998755  488999999999999999999999965333221   111111      11    1122344


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .+...+...+|.+|+.+||.+||+|+++++
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            566678899999999999999999999986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.1e-36  Score=325.61  Aligned_cols=259  Identities=22%  Similarity=0.385  Sum_probs=202.0

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCc----EEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGE----LIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      +|.....+|.|+ ||.||+|.+. +|+    .||+|++..... ....++.+|+.+++.++||||++++|+|... ..++
T Consensus         8 ~f~~~~~lg~G~-~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           8 EFKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hceeeeeeecCC-CceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            344555666666 9999999753 343    489999864322 3346788999999999999999999999764 5779


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |+||+++|+|.+++......+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence            9999999999999987766789999999999999999999999   9999999999999999999999999999877543


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ..........++..|+|||.+....++.++||||||+++||+++ |+.||.......  ...........      .. +
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------~~-~  233 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERL------PQ-P  233 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhCCCCC------CC-C
Confidence            22222222334667999999988889999999999999999998 999987644322  11221111000      00 1


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                            ......+.+++.+||..+|++||++.+++..+.++.....
T Consensus       234 ------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         234 ------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             ------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence                  0122357899999999999999999999999998875543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-35  Score=313.63  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      +|.|+ ||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         3 lg~g~-~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           3 IGRGN-FGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             cCccc-CccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            45555 9999999764 79999999875432 223467889999999999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccc
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA  746 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  746 (876)
                      +++.+.+..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++.................
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            99977666789999999999999999999999   999999999999999999999999999876543221111111223


Q ss_pred             cccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       747 t~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      +..|+|||.+.+..++.++||||||+++|||++ |..||.......  ........  ..        ..   .....+.
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~--~~--------~~---~~~~~~~  223 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQG--VR--------LP---CPELCPD  223 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcC--CC--------CC---CcccCCH
Confidence            456999999988889999999999999999998 888886543321  11111110  00        00   0112234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          826 GALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      .+.+++.+|++.+|++|||+.|+.+.|+.
T Consensus       224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         224 AVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence            67899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-36  Score=306.29  Aligned_cols=272  Identities=23%  Similarity=0.326  Sum_probs=207.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCcc-ccceeeEEEeCC------e
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKN-IVKVLGFFHSDE------S  652 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~  652 (876)
                      |..+.+ .|.|+||+||+|+. .+|+.||+|++.....  .......+|+.++++++|+| ||++++++....      .
T Consensus        13 ~~~~ek-lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   13 YEKVEK-LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHH-hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            334445 45566999999955 4899999999976533  23456789999999999999 999999998876      7


Q ss_pred             EEEEEEcCCCCCHHHHhhccC---CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          653 IFLIYEFLQMGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      .++|+||++. +|..++....   ..++...+..+++|+++|++|||++   +|+||||||.||+++++|.+||+|||+|
T Consensus        92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchH
Confidence            9999999977 9999998765   4577789999999999999999999   9999999999999999999999999999


Q ss_pred             hhccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh----hc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI----NI  804 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----~~  804 (876)
                      +..+-..  .+.+..++|..|+|||++.+. .|+...||||+||+++||+++++.|.+..+.+ .+....+...    ..
T Consensus       168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCccC
Confidence            9766322  235667789999999998776 68999999999999999999999998765522 2222222111    11


Q ss_pred             ccccccccChh-----------hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccCCccc
Q 002826          805 TNGAIQVLDPK-----------IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLSTRTSLL  862 (876)
Q Consensus       805 ~~~~~~~~d~~-----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~~~~~~  862 (876)
                      +.+.....+-.           +............+++.+|++.+|.+|.|++.++++  +..+..+....
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~  315 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQL  315 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhh
Confidence            11111111100           011111112467899999999999999999999987  77665544433

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-35  Score=315.07  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             ccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|| ||.||+|.++    +...||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus         6 ~~~~~~lg~g~-~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           6 VTIEKVIGGGE-FGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             ceeeeEecCCc-cceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            33445556655 9999999764    245899998865432 23457888999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++......+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+|++|||+++.......
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            99999999999987666899999999999999999999999   999999999999999999999999999988752221


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      ........++..|+|||...+..++.++||||||+++|||++ |..||......  ............         +. 
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---------~~-  229 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYRL---------PP-  229 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCCC---------CC-
Confidence            111122234677999999988889999999999999999998 99998653322  122222111000         00 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                         ....+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus       230 ---~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         230 ---PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               112234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.6e-36  Score=316.11  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=203.7

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .....+|.|| ||.||+|...+++.||+|.+..........+..|+.+++.++||||+++++++.+.+..++||||++++
T Consensus         9 ~~~~~ig~g~-~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           9 TLERKLGSGY-FGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHhhhhccCC-CccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            3345555555 999999988889999999997665445678899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++.+. +..+++..+.+++.|++.|++|||+.   +++||||||+||++++++.+|++|||.+.........  ..
T Consensus        88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~  162 (261)
T cd05148          88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SS  162 (261)
T ss_pred             CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc--cc
Confidence            999999764 45689999999999999999999999   9999999999999999999999999999876543211  11


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...++..|+|||......++.++||||||+++|+|++ |+.||.......  ..........          +.   ...
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~----------~~---~~~  227 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYDQITAGYR----------MP---CPA  227 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHHhCCc----------CC---CCC
Confidence            3335678999999888889999999999999999998 899997644221  2222211100          00   011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+..+.+++.+||..+|++|||++++++.|+.+
T Consensus       228 ~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         228 KCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            2234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-35  Score=315.19  Aligned_cols=252  Identities=22%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      |....++|.|| +|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus         8 ~~~~~~lg~g~-~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   85 (261)
T cd05072           8 IKLVKKLGAGQ-FGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK   85 (261)
T ss_pred             eEEeeecCCcC-CceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence            33445666666 999999988888999999976532 3456888999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++.+. +..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++........ ..
T Consensus        86 ~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~  161 (261)
T cd05072          86 GSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AR  161 (261)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee-cc
Confidence            9999998754 45688999999999999999999999   9999999999999999999999999999876543211 11


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||......++.++||||||+++|||+| |+.||.......  ...........         +..    
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~---------~~~----  226 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYRM---------PRM----  226 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCC---------CCC----
Confidence            22335677999999888888999999999999999998 999997543222  22222111000         111    


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...+..+.+++.+|++.+|++||+++++.+.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            11234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2e-38  Score=337.68  Aligned_cols=367  Identities=23%  Similarity=0.342  Sum_probs=336.4

Q ss_pred             cCCCCCCeeecCCCccc-cccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcC
Q 002826           96 CELSSLSNLNLADNLFN-QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP  174 (876)
Q Consensus        96 ~~l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  174 (876)
                      +-|+-.+-.|+++|.|+ +..|.....+++++.|.|...+|           ..+|+.++.+.+|++|.+++|++. .+-
T Consensus         4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L-----------~~vPeEL~~lqkLEHLs~~HN~L~-~vh   71 (1255)
T KOG0444|consen    4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKL-----------EQVPEELSRLQKLEHLSMAHNQLI-SVH   71 (1255)
T ss_pred             cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhh-----------hhChHHHHHHhhhhhhhhhhhhhH-hhh
Confidence            44677889999999999 56899999999999997766554           378999999999999999999998 777


Q ss_pred             ccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccc
Q 002826          175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL  254 (876)
Q Consensus       175 ~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  254 (876)
                      +.++.|+.|+.+++.+|++..+.+|..+..+..|..|+|++|++.. .|..+..-+++-+|+||+|+|. .||..+|-++
T Consensus        72 GELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~E-vP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinL  149 (1255)
T KOG0444|consen   72 GELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLRE-VPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINL  149 (1255)
T ss_pred             hhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhh-cchhhhhhcCcEEEEcccCccc-cCCchHHHhh
Confidence            8899999999999999998889999999999999999999999995 5888999999999999999999 9999999999


Q ss_pred             ccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC-CCCCcccCCCCcccEEE
Q 002826          255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS-GDFPDKLWSLPRIKLIR  333 (876)
Q Consensus       255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~  333 (876)
                      +.|-.||||+|++. .+|..+..+..|++|+|++|.+....-..+..+++|+.|.+++.+=+ ..+|.++-++.+|..+|
T Consensus       150 tDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvD  228 (1255)
T KOG0444|consen  150 TDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVD  228 (1255)
T ss_pred             HhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhcc
Confidence            99999999999998 78888999999999999999998766677788999999999987643 46899999999999999


Q ss_pred             ecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccc-
Q 002826          334 AESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSIS-  412 (876)
Q Consensus       334 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~-  412 (876)
                      ++.|.+. ..|+.+..+.+|+.|+||+|+|+ ....+.+...+|+.|+||+|+++ .+|+.+|.++.|+.|.+.+|+++ 
T Consensus       229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~F  305 (1255)
T KOG0444|consen  229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTF  305 (1255)
T ss_pred             ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccc
Confidence            9999998 88999999999999999999999 66677788899999999999998 89999999999999999999986 


Q ss_pred             -cCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccc
Q 002826          413 -GQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLS  482 (876)
Q Consensus       413 -~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~  482 (876)
                       |++..++++..|+.+..++|+|. ..|+.++.+..|+.|.|++|+|. .+|.++--+ .++.||+..|.--
T Consensus       306 eGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL  375 (1255)
T KOG0444|consen  306 EGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL  375 (1255)
T ss_pred             cCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence             66668999999999999999999 99999999999999999999998 799998887 4889999999754

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-36  Score=330.28  Aligned_cols=243  Identities=22%  Similarity=0.279  Sum_probs=194.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|+.. +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        20 y~~~~~lg~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   98 (329)
T PTZ00263         20 FEMGETLGTGS-FGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE   98 (329)
T ss_pred             eEEEEEEEecC-CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence            33344555555 9999999765 68999999986532   1234568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        99 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--  172 (329)
T PTZ00263         99 FVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--  172 (329)
T ss_pred             CCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence            999999999997654 688999999999999999999999   99999999999999999999999999998664322  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                         ....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ..............        
T Consensus       173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~i~~~~~~~p~--------  236 (329)
T PTZ00263        173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-----IYEKILAGRLKFPN--------  236 (329)
T ss_pred             ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-----HHHHHhcCCcCCCC--------
Confidence               12358999999999998889999999999999999999999997643221     11111111100001        


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                         .....+.+++.+||+.||++||+     ++|+++.
T Consensus       237 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        237 ---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               12235679999999999999996     6777654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-36  Score=323.46  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=206.5

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCe-EEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES-IFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  659 (876)
                      |+..+..|.|+||.++.++.+ +++.|++|.+.....  ..++...+|+.++++++|||||.+.+.|.+++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            344445555669999999665 788999999865443  234567899999999999999999999999988 9999999


Q ss_pred             CCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          660 LQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       660 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+||++.+.+.++ +..+++..+.+++.|++.|+.|||+.   +|+|||||+.|||++.+..||++|||+|+..+...  
T Consensus        86 ~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--  160 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--  160 (426)
T ss_pred             cCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch--
Confidence            9999999999876 47899999999999999999999998   99999999999999999999999999999987654  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......||+.||.||+..+.+|..|+|+||+||++|||++-+++|...+.... ..+..+..          .+    -
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-i~ki~~~~----------~~----P  225 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-ILKINRGL----------YS----P  225 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-HHHHhhcc----------CC----C
Confidence            123455699999999999999999999999999999999999999987554332 11111111          11    1


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....+..++..+|..|+..+|..||++.+++.+
T Consensus       226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            233455678899999999999999999999987

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=313.95  Aligned_cols=250  Identities=24%  Similarity=0.406  Sum_probs=200.4

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| +|.||+|...+++.||+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++++
T Consensus        10 ~~~~lg~g~-~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05068          10 LLRKLGAGQ-FGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS   87 (261)
T ss_pred             eEEEecccC-CccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence            345555555 999999988788899999986543 446778999999999999999999999999999999999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++... +..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++........ ....
T Consensus        88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~  163 (261)
T cd05068          88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREG  163 (261)
T ss_pred             HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCC
Confidence            99999765 35689999999999999999999999   9999999999999999999999999999876532211 1112


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...+..|+|||...+..++.++||||||+++|||++ |+.||.......  ....+.....      .   +    ....
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~------~---~----~~~~  228 (261)
T cd05068         164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYR------M---P----CPPG  228 (261)
T ss_pred             CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC------C---C----CCCc
Confidence            223457999999988889999999999999999999 999987543221  1111111000      0   0    0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .+..+.+++.+|++.+|++||+++++++.|+++
T Consensus       229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            235688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.1e-35  Score=314.16  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| ||+||+|+..++..||+|.+.... ...+++.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus         8 ~~~~lg~G~-~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05113           8 FLKELGTGQ-FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC   85 (256)
T ss_pred             EeeEecCcc-cceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence            345566666 999999988777789999886432 345678999999999999999999999999889999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++......+++..+.+++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++........ .....
T Consensus        86 l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~  161 (256)
T cd05113          86 LLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGS  161 (256)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCC
Confidence            9999977655789999999999999999999999   9999999999999999999999999998766433221 11222


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .++..|+|||......++.++||||||+++|||++ |+.||.......  ........  ..    .. .+      ...
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~--~~----~~-~~------~~~  226 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQG--LR----LY-RP------HLA  226 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcC--CC----CC-CC------CCC
Confidence            35667999999988889999999999999999999 999987544322  11111110  00    00 00      012


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ...+.+++.+||+.+|++||++.++++.++
T Consensus       227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         227 SEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            346789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-36  Score=328.25  Aligned_cols=248  Identities=21%  Similarity=0.272  Sum_probs=196.9

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|+ ||.||+|+.. +++.||+|++....   ......+..|+++++.++||||+++++++.+.+..|+||||++
T Consensus         6 ~~~ig~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (333)
T cd05600           6 LTQVGQGG-YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP   84 (333)
T ss_pred             EEEEeecC-CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence            34455555 9999999765 68999999997532   1234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....     ..
T Consensus        85 g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~  155 (333)
T cd05600          85 GGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA  155 (333)
T ss_pred             CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence            999999997654 688999999999999999999999   999999999999999999999999999876543     22


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||........  ...+......   .   -.|.......
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~---~---~~~~~~~~~~  227 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKET---L---QRPVYDDPRF  227 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhcccc---c---cCCCCCcccc
Confidence            344589999999999888999999999999999999999999986543321  1111110000   0   0011110011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+|+..+|.+||+++|+++.
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            234567899999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-35  Score=323.30  Aligned_cols=260  Identities=25%  Similarity=0.315  Sum_probs=197.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||+++.. +|..||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 y~~~~~lg~G~-~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (331)
T cd06649           7 FERISELGAGN-GGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (331)
T ss_pred             ceEEEeecCCC-CEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence            44445555555 9999999765 788999999865422 23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.+.. .+++..+..++.|++.|+.|||+.+  +|+||||||+||+++.++.+||+|||++.......    
T Consensus        86 ~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----  158 (331)
T cd06649          86 DGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----  158 (331)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc----
Confidence            9999999997654 6899999999999999999999861  59999999999999999999999999987654321    


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccccccc--------
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGAIQV--------  811 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------  811 (876)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||.......  ......... .........        
T Consensus       159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCcccccc
Confidence            223458899999999988889999999999999999999999997543322  111111000 000000000        


Q ss_pred             --------cC--hh---------h-----hh-hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          812 --------LD--PK---------I-----AN-CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       812 --------~d--~~---------~-----~~-~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                              .+  +.         +     .. .......++.+++.+||..||++|||++|+++.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                    00  00         0     00 0012345688999999999999999999998764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-36  Score=287.17  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=201.3

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +..+..|.|-||.||.|+. +++-.||+|++.+..   .+-..++++|+++-+.++||||.+++++|.+....|+++||.
T Consensus        25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya  104 (281)
T KOG0580|consen   25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA  104 (281)
T ss_pred             cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence            3445555677999999965 478899999997642   234568999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|++...+..+ ...+++........|+|.|+.|+|..   +|+||||||+|+|++.++..|++|||.+.....+    
T Consensus       105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~----  177 (281)
T KOG0580|consen  105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN----  177 (281)
T ss_pred             CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC----
Confidence            999999999754 45689999999999999999999999   9999999999999999999999999998765432    


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....+||..|.+||...+..++..+|+|++|++.||++.|.+||.....++. ..+..+         .+..+|     
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et-YkrI~k---------~~~~~p-----  242 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET-YKRIRK---------VDLKFP-----  242 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH-HHHHHH---------ccccCC-----
Confidence            23445699999999999999999999999999999999999999987653221 111111         111122     


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ......+.++|.+|+..+|.+|.+..|+++.
T Consensus       243 -~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  243 -STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence             2234467899999999999999999999875

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-36  Score=318.91  Aligned_cols=258  Identities=25%  Similarity=0.349  Sum_probs=209.9

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCH-HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .+.+|.|.||+|-++....+..||||.++.....+. .+|.+|+++|.+++|||||+++|+|..++..++|+||+++|+|
T Consensus       543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL  622 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL  622 (807)
T ss_pred             hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence            344555669999999998889999999987665554 8899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCc-CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++.++..+ .......+|+.|||.||+||.+.   .+||||+.++|+|++.++++||+|||.++-...+.++......
T Consensus       623 nqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~  699 (807)
T KOG1094|consen  623 NQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRA  699 (807)
T ss_pred             HHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecce
Confidence            9999887433 35666788999999999999999   9999999999999999999999999999987766666666666


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT--GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      .-+.+|||||.+.-++++.++|||+||+++||+++  ...||.....+.  .++-........  .....-    ..+.-
T Consensus       700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~--~~~~~l----~~P~~  771 (807)
T KOG1094|consen  700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQ--GRQVVL----SRPPA  771 (807)
T ss_pred             eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCC--Ccceec----cCCCc
Confidence            66789999999999999999999999999999876  677776544332  222222222111  111111    11222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ++..+++++.+||..|-++||+++++...|.+.
T Consensus       772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            344678999999999999999999999998764

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.1e-36  Score=326.20  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=191.6

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|.| +||.||++.. .+|+.||+|++.....   .....+.+|+++++.++||||+++++++...+..|+||||+++|+
T Consensus         3 lG~G-~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           3 LGKG-TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeC-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            4444 4999999965 4799999999975321   233456789999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  ......
T Consensus        82 L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~  155 (323)
T cd05595          82 LFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTF  155 (323)
T ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccccc
Confidence            998887654 689999999999999999999999   99999999999999999999999999987532211  122334


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+..  ....   ....        ..+   .....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~~~~---~~~~--------~~~---p~~~~  219 (323)
T cd05595         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELI---LMEE--------IRF---PRTLS  219 (323)
T ss_pred             cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHH---hcCC--------CCC---CCCCC
Confidence            589999999999888899999999999999999999999976543321  1111   0000        000   11123


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      ..+.+++.+||+.||++||     ++.++++.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         220 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            4578999999999999998     88888763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.3e-35  Score=318.79  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=194.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||+|+.. +++.||+|++..... .....+.+|+++++.++||||+++++++.+++..++||||+
T Consensus         7 y~~~~~lg~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (303)
T cd07869           7 YEKLEKLGEGS-YATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV   85 (303)
T ss_pred             ceEeeeEEecC-CEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence            33444555555 9999999765 789999999865432 23356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      + +++.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++......  ..
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  159 (303)
T cd07869          86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HT  159 (303)
T ss_pred             C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--cc
Confidence            6 588888877666789999999999999999999999   99999999999999999999999999987543221  12


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----ccc--ccccC
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----NGA--IQVLD  813 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~d  813 (876)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.....................    ...  ....+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            234457889999998765 45788999999999999999999999864332221111111100000    000  00000


Q ss_pred             ---------hhhhhhcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 ---------PKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ---------~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                               ..+...+.  .....+.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                     00111011  11245789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-36  Score=293.06  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCcc----C----HHHHHHHHHHHhhc-cCccccceeeE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQ----S----SKTLKTEVKTLAKI-RHKNIVKVLGF  646 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~h~niv~~~~~  646 (876)
                      ++....|++...+|+|+ .++|.++ ..++|+.+|+|++......    .    .+.-.+|+.+|+++ .||+|+.+.++
T Consensus        13 ~~fy~~y~pkeilgrgv-ss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~   91 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGV-SSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV   91 (411)
T ss_pred             hhHHhhcChHHHhcccc-hhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence            44455666777777777 6666665 4568999999998543221    1    13456799999999 59999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      ++.+..+++|+|.|+.|.|.|++...- .++++...+|++|+.+|++|||..   .|+|||+||+|||++++.++||+||
T Consensus        92 yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   92 YESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             ccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            999999999999999999999998754 789999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~  800 (876)
                      |.++...++.   .....+||++|.|||.+.      ...|+...|+||+||+||.++.|.+||..  ....-....+. 
T Consensus       168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH--RkQmlMLR~Im-  241 (411)
T KOG0599|consen  168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH--RKQMLMLRMIM-  241 (411)
T ss_pred             ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH--HHHHHHHHHHH-
Confidence            9999987654   345567999999999753      33578889999999999999999999853  22222222211 


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        ++   ..+.-.|    .|.+......++|.+|++.||++|.|++|+++.
T Consensus       242 --eG---kyqF~sp----eWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  242 --EG---KYQFRSP----EWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             --hc---ccccCCc----chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence              11   2222223    345566778999999999999999999999864

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-35  Score=311.96  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=197.1

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|+ ||.||+|..+++..+|+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus         9 ~~~lg~G~-~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   86 (256)
T cd05059           9 LKELGSGQ-FGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCL   86 (256)
T ss_pred             hhhhccCC-CceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence            34455555 999999988888899999986432 3456788899999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++....... .......
T Consensus        87 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~  162 (256)
T cd05059          87 LNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSSQGTK  162 (256)
T ss_pred             HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccc-cccCCCC
Confidence            999987656789999999999999999999999   999999999999999999999999999876643221 1112222


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||...+..++.++||||||+++||+++ |+.||.......  ..........          ....   ...+
T Consensus       163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~----------~~~~---~~~~  227 (256)
T cd05059         163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSAGYR----------LYRP---KLAP  227 (256)
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHHHHHcCCc----------CCCC---CCCC
Confidence            4457999999988889999999999999999999 899987643322  1111111100          0000   1124


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      ..+.+++.+||..+|++|||+.|+++.|
T Consensus       228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            4688999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.9e-35  Score=317.45  Aligned_cols=250  Identities=25%  Similarity=0.449  Sum_probs=197.0

Q ss_pred             CCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||.||+|..     .+++.||+|.+..... .....+.+|++++++++||||+++++++..++..|+||||+
T Consensus        11 ~~lg~g~-~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   89 (283)
T cd05090          11 EELGECA-FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL   89 (283)
T ss_pred             eeccccC-CcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence            4555555 999999964     3568999999865332 22357889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc----------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          661 QMGSLGDLICRQ----------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       661 ~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      ++++|.+++...                ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEec
Confidence            999999998532                12478889999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+++...............++..|+|||...+..++.++||||||+++|||++ |..||......  ...+.+.....
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~  244 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMVRKRQL  244 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCc
Confidence            9999987653332222233345677999999888889999999999999999998 99998754322  22222221110


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .             .........+.+++.+||+++|++||++.++.+.|+++
T Consensus       245 ~-------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05090         245 L-------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW  283 (283)
T ss_pred             C-------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence            0             01111234678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.7e-35  Score=312.70  Aligned_cols=250  Identities=23%  Similarity=0.369  Sum_probs=198.7

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ....+|.|+ ||.||+|... .++.||+|++... .....++.+|++++++++||||+++++++..++..++||||++++
T Consensus        10 ~~~~ig~g~-~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (263)
T cd05052          10 MKHKLGGGQ-YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   87 (263)
T ss_pred             EeeecCCcc-cceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence            344555555 9999999654 6889999998643 234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++... ...+++..+..++.|+++|++|||+.   +++||||||+||++++++.+||+|||.+.......... ..
T Consensus        88 ~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~  163 (263)
T cd05052          88 NLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HA  163 (263)
T ss_pred             cHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cC
Confidence            999998654 34689999999999999999999999   99999999999999999999999999998765432211 11


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...++..|+|||...+..++.++||||||+++|||++ |..||.....+.  ........  ..        +..   ..
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~--~~--------~~~---~~  228 (263)
T cd05052         164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKG--YR--------MER---PE  228 (263)
T ss_pred             CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC--CC--------CCC---CC
Confidence            2224567999999888889999999999999999998 999987543322  11111110  00        000   11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            1234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.2e-35  Score=325.44  Aligned_cols=240  Identities=24%  Similarity=0.285  Sum_probs=192.4

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|. |+||.||+++. .+|+.||+|++....   ......+.+|+.+++.++||||+++++++.+++..|+||||+++|+
T Consensus         3 lG~-G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           3 LGK-GTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eee-CCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            444 45999999965 479999999997532   1234567789999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ......
T Consensus        82 L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~  155 (328)
T cd05593          82 LFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTF  155 (328)
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccc
Confidence            999886653 689999999999999999999999   99999999999999999999999999987543211  122334


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .||+.|+|||.+.+..++.++||||+||++|||++|+.||........     ........        ..+.   ....
T Consensus       156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-----~~~~~~~~--------~~~p---~~~~  219 (328)
T cd05593         156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMED--------IKFP---RTLS  219 (328)
T ss_pred             cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-----HHHhccCC--------ccCC---CCCC
Confidence            589999999999888899999999999999999999999976443221     11111110        0011   1123


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      ..+.+++.+|+++||++||     ++.|+++.
T Consensus       220 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         220 ADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            4578999999999999997     89998865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-35  Score=316.67  Aligned_cols=253  Identities=22%  Similarity=0.351  Sum_probs=195.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||.||+|...      .+..||+|++..... ....++.+|+.+++.++||||+++++++.+....++
T Consensus         8 ~~~~~~ig~G~-~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l   86 (277)
T cd05062           8 ITMSRELGQGS-FGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV   86 (277)
T ss_pred             ceeeeeecccc-CCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence            44445555555 9999998642      356899998854321 234568899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccC---------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          656 IYEFLQMGSLGDLICRQD---------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      ||||+++++|.+++.+..         ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++||
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence            999999999999986532         2357888999999999999999998   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++...............++..|+|||.+....++.++|||||||++|||++ |..||.....+.  ..+....   ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~~~~~~---~~  238 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VLRFVME---GG  238 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc---CC
Confidence            99876653332222223345778999999988889999999999999999999 788887543322  1221111   00


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                        ...        .....+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus       239 --~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         239 --LLD--------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --cCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              000        011123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.1e-35  Score=316.59  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||.||++..      .++..||+|.+..........+.+|+++++.++|+||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~-~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           9 LKWELGEGA-FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eccccCCcc-CCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            345566666 999999853      2466899998876554556789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC--------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          659 FLQMGSLGDLICRQD--------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      |+++++|.+++.+.+              ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~  164 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG  164 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence            999999999987643              3478999999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+++...............+++.|+|||...+..++.++|||||||++|||++ |++||.......  .......   
T Consensus       165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~---  239 (280)
T cd05092         165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECITQ---  239 (280)
T ss_pred             CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHHc---
Confidence            9999876543322222223335678999999888889999999999999999998 899986543322  1111111   


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ..  .  ...+      ...+..+.+++.+||+.||++||++.|+.+.|++
T Consensus       240 ~~--~--~~~~------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         240 GR--E--LERP------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             Cc--c--CCCC------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            10  0  0000      1123457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-35  Score=324.49  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             CCCCCCCceEEEEEEe----CCCcEEEEEEEecCC----ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSL----PSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .+|.|| ||.||+++.    .+++.||+|++....    ......+..|+++++.++||||+++++++.+++..|+||||
T Consensus         3 ~lg~G~-~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           3 VLGKGG-YGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             eeeecC-CeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            455555 999999964    368899999986532    12335677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++.+.+ .+.+..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987654 678889999999999999999999   999999999999999999999999999875432211  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ..........    .+.+     
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~~~~----~~~~-----  221 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILKGKL----NLPP-----  221 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCC----CCCC-----
Confidence            1223458999999999988888999999999999999999999997644321     1111111110    0111     


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                        .....+.+++.+|++++|++||     ++.++++.
T Consensus       222 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         222 --YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence              1223578999999999999999     78888763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=301.65  Aligned_cols=248  Identities=21%  Similarity=0.313  Sum_probs=207.7

Q ss_pred             ccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |+.+.++|.|. ||.||+| ...+|+.||+|.+...  .+-.++..|+.++++.+.|+||++||.+-.....|+|||||.
T Consensus        35 FDi~~KLGEGS-YGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGS-YGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCc-chHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            44556676665 9999999 4568999999998643  566788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      -|++.++++-+..++++.++..++++.++||+|||..   .-+|||||+.|||++.+|.+|++|||.|....+.  -...
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MAKR  186 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MAKR  186 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh--HHhh
Confidence            9999999998888999999999999999999999998   8899999999999999999999999999776532  2345


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....||+.|||||++..-.|..++||||+|++..||..|++||....+...        .+-++.     -.|..-..++
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------IFMIPT-----~PPPTF~KPE  253 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------IFMIPT-----KPPPTFKKPE  253 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------eEeccC-----CCCCCCCChH
Confidence            677899999999999988899999999999999999999999977554332        111110     0111113334


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .-+.++-++++.|+.+.|++|-|+.++++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            445678899999999999999999998764

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.4e-35  Score=314.65  Aligned_cols=257  Identities=19%  Similarity=0.254  Sum_probs=193.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.|+ ||+||+|+.. +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus         7 ~~lg~g~-~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (287)
T cd07848           7 GVVGEGA-YGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN   85 (287)
T ss_pred             EEecccC-CEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence            4445554 9999999775 688999999875422  23456788999999999999999999999999999999999987


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      .+..+. +....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus        86 ~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  160 (287)
T cd07848          86 MLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTE  160 (287)
T ss_pred             HHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccc
Confidence            665544 3345689999999999999999999999   999999999999999999999999999987643221 12233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----------cccccccC
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----------NGAIQVLD  813 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~d  813 (876)
                      ..|+..|+|||++.+..++.++||||+||++|||++|++||........ ............          ........
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4588999999999888899999999999999999999999986543221 111100000000          00000000


Q ss_pred             hhh-------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 PKI-------ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +..       .......+..+.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000       0111123456899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-36  Score=327.63  Aligned_cols=244  Identities=20%  Similarity=0.264  Sum_probs=194.0

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-C-CcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-S-GELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|... + +..||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        31 ~y~~~~~ig~G~-~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         31 DFNFIRTLGTGS-FGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hcEEEEEEeecC-CeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            344445555555 9999999654 3 3689999986432   23345678899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++|+|.+++.+.. .+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~  185 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT  185 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence            99999999999997654 689999999999999999999999   99999999999999999999999999997654321


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                           ....||+.|+|||++.+..++.++||||+||++|||++|+.||........     ........   . .+.+  
T Consensus       186 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~i~~~~---~-~~p~--  249 (340)
T PTZ00426        186 -----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-----YQKILEGI---I-YFPK--  249 (340)
T ss_pred             -----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-----HHHHhcCC---C-CCCC--
Confidence                 234589999999999888889999999999999999999999976433211     11111111   0 0111  


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                           .....+.+++.+|++.||++|+     +++|+++.
T Consensus       250 -----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        250 -----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 1123467899999999999995     89988765

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=318.81  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=205.9

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .++ |||.||.||.|.|+ ..-.||||.++. +....++|..|+.+|+.++|||+|+++|+|.....+|||+|||..|+|
T Consensus       273 hKL-GGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL  350 (1157)
T KOG4278|consen  273 HKL-GGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL  350 (1157)
T ss_pred             ecc-CCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence            444 55669999999986 577899999864 346778999999999999999999999999999999999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++++. ....+.-....++.||+.||+||..+   +++|||+.++|+|+.++-.|||+|||+++++....++.... .
T Consensus       351 LdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-A  426 (1157)
T KOG4278|consen  351 LDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-A  426 (1157)
T ss_pred             HHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-c
Confidence            9999876 44577777899999999999999999   99999999999999999999999999999997655433222 1


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .-...|.|||.+....++.|+|||+|||++||+.| |-.||.+.+....  -....+.++.             +.++.+
T Consensus       427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--Y~LLEkgyRM-------------~~PeGC  491 (1157)
T KOG4278|consen  427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--YGLLEKGYRM-------------DGPEGC  491 (1157)
T ss_pred             cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH--HHHHhccccc-------------cCCCCC
Confidence            23456999999998899999999999999999999 8888876443222  1111111111             223345


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      +..++++++.||.+.|.+||++.|+-+.++.+-..
T Consensus       492 PpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  492 PPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             CHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            56789999999999999999999999999886543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-35  Score=317.77  Aligned_cols=249  Identities=23%  Similarity=0.396  Sum_probs=195.8

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+|.|| ||.||+|...      +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus        11 ~~lg~G~-~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~   89 (283)
T cd05091          11 EELGEDR-FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSY   89 (283)
T ss_pred             HHhCCCC-CCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEc
Confidence            4455555 9999999653      3578999998654322 235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          660 LQMGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       660 ~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      +++++|.+++...               ...+++..+.+++.|++.|++|+|+.   +|+||||||+||++++++.+||+
T Consensus        90 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~  166 (283)
T cd05091          90 CSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEec
Confidence            9999999998532               23478889999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+++...............+++.|+|||.+....++.++||||+|+++|||++ |..||......  ...+.+...  
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~~~--  242 (283)
T cd05091         167 DLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIRNR--  242 (283)
T ss_pred             ccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC--
Confidence            9999887654332222333446778999999888889999999999999999998 88888654322  222222211  


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                       .   ..       .........+.+++.+||+.+|++||+++|+++.|+.
T Consensus       243 -~---~~-------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         243 -Q---VL-------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -C---cC-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence             1   00       0111233457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=291.01  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=200.4

Q ss_pred             CCCCCCCCceEEEEEE-eCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~  660 (876)
                      ..+|.|| |+-||+++ ..+++.||+|++.-...++.+...+|++..++++||||++++++...+     .+.|+++.|.
T Consensus        27 ~~LgeGG-fsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy  105 (302)
T KOG2345|consen   27 RLLGEGG-FSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY  105 (302)
T ss_pred             eeecCCC-ceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence            4455566 99999995 568999999999766556778889999999999999999999987543     3599999999


Q ss_pred             CCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       661 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ..|||.+.+.+.   +..+++.++.+++.+|.+||++||+.. ++++||||||.||++++++.+++.|||.++...-...
T Consensus       106 ~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~  184 (302)
T KOG2345|consen  106 KRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIE  184 (302)
T ss_pred             ccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEee
Confidence            999999998654   567999999999999999999999983 3699999999999999999999999999987652111


Q ss_pred             c-------cccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH-Hhhccc
Q 002826          738 Q-------STMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR-KINITN  806 (876)
Q Consensus       738 ~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~  806 (876)
                      .       ........|..|+|||.+.   ....++++|||||||++|+|+.|..||+.......++.-.+.. ++.+  
T Consensus       185 ~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~--  262 (302)
T KOG2345|consen  185 GSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISI--  262 (302)
T ss_pred             chHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccccc--
Confidence            1       1112234677899999865   4457899999999999999999999997643322211111111 0011  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                                ++. ...++.+.+++.+|++.||.+||++.+++..++++.
T Consensus       263 ----------P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  263 ----------PNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ----------CCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                      111 125667899999999999999999999999998764

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.4e-35  Score=315.54  Aligned_cols=266  Identities=27%  Similarity=0.404  Sum_probs=197.5

Q ss_pred             ccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  656 (876)
                      +..+..+.|+||+||++..     .+++.||+|.+..... .....+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4444444555999987642     4688999999865432 2456788999999999999999999998763  468999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++++|.+++.+.  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++......
T Consensus        87 ~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          87 MEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             ecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            9999999999999764  589999999999999999999999   99999999999999999999999999998765332


Q ss_pred             ccc-ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQS-TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ... ......++..|+|||......++.++||||||+++|||+||+.||........+........... ....+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  240 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV-VRLIELLERG  240 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch-hhhhhhhhcC
Confidence            111 11122355679999998888899999999999999999999999876443221111111000000 0000000000


Q ss_pred             hh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          816 IA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       816 ~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .. ......+..+.+++.+||+++|++|||++++++.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00 011123457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.2e-35  Score=309.30  Aligned_cols=247  Identities=20%  Similarity=0.308  Sum_probs=194.1

Q ss_pred             CCCCCCceEEEEEEeC---CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSLP---SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|.|| ||.||+|.+.   ++..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         3 ig~G~-~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           3 LGSGN-FGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             cCCCC-cccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            55555 9999999653   456799999865432 22456889999999999999999999885 457899999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTMSS  743 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~  743 (876)
                      |.+++......+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....... ......
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9999976666799999999999999999999999   999999999999999999999999999976543321 111222


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||......++.++||||||+++||+++ |..||.......  ....+.....      ...       ...
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------~~~-------~~~  222 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------LDC-------PAE  222 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------CCC-------CCC
Confidence            223567999999888888999999999999999996 999997643322  2222211100      001       112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-35  Score=318.84  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=209.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  656 (876)
                      .+|+.....|.|.||.||+++.+ +|+.+|+|++.+....   +...+.+|+++|+++. |||||.+.++|++...+++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            45566666677779999999765 5999999999765443   3468999999999998 99999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC----CCeEEccccchhhc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD----FEPKLTDFALDRIV  732 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~----~~~kl~DfGla~~~  732 (876)
                      ||++.||.|.+.+.+.  .+++..+..++.|++.+++|||+.   ||+|||+||+|+|+...    +.+|++|||++...
T Consensus       115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            9999999999998766  399999999999999999999999   99999999999999633    57999999999987


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      ..   .......+||+.|+|||+.....++.++||||+||++|.|++|.+||.......... ...+.       ....-
T Consensus       190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~-------~~~f~  258 (382)
T KOG0032|consen  190 KP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRG-------DFDFT  258 (382)
T ss_pred             cC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcC-------CCCCC
Confidence            66   234566779999999999998999999999999999999999999999866544321 11111       11111


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +    ..+......+.+++..|+..||.+|+|+.++++.
T Consensus       259 ~----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  259 S----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1    3445556778999999999999999999999995

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.4e-35  Score=313.15  Aligned_cols=255  Identities=21%  Similarity=0.333  Sum_probs=197.1

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCc----EEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGE----LIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||+||+|.+. +++    .||+|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus        11 ~~~~lg~G~-~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          11 KLKLLGSGV-FGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eccccCccC-CcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            345566655 9999999764 455    467777643221 123567778889999999999999998854 55789999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++......+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++........
T Consensus        89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T cd05111          89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK  165 (279)
T ss_pred             eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence            9999999999987766899999999999999999999999   9999999999999999999999999999876533322


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......++..|+|||......++.++||||||+++||+++ |+.||.......  ..+.......       ...+.. 
T Consensus       166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~-------~~~~~~-  235 (279)
T cd05111         166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGER-------LAQPQI-  235 (279)
T ss_pred             cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCc-------CCCCCC-
Confidence            22333446778999999988889999999999999999998 999987643322  2222221110       011111 


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                           ....+.+++.+||..+|++|||+.|+++.|..+....
T Consensus       236 -----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         236 -----CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                 1235678999999999999999999999999976544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-35  Score=324.56  Aligned_cols=244  Identities=23%  Similarity=0.333  Sum_probs=188.1

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|.|+ ||.||+|... +|+.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++||||+++
T Consensus        78 ~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         78 RVNRIGSGA-GGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhccCCC-CeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            345566666 9999999664 789999999865432 2245788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      ++|.+..     ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus       157 ~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~  226 (353)
T PLN00034        157 GSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCN  226 (353)
T ss_pred             Ccccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc--ccc
Confidence            9986532     356778889999999999999999   999999999999999999999999999887643221  123


Q ss_pred             cccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          743 SEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ...||..|+|||.+..     ...+.++|||||||++|||++|+.||......+.  ..........   ..    +   
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~---~~----~---  294 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDW--ASLMCAICMS---QP----P---  294 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHHhcc---CC----C---
Confidence            3458999999998642     3345689999999999999999999974332221  1111111000   00    0   


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .........+.+++.+||+.||++|||+.|+++.
T Consensus       295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111223468899999999999999999999985

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-35  Score=317.89  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      ....+|.|| ||.||++...      ....||+|.+..... ....++.+|+++++++ +||||+++++++..++..++|
T Consensus        16 ~~~~ig~g~-~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li   94 (293)
T cd05053          16 LGKPLGEGA-FGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV   94 (293)
T ss_pred             EeeEecccc-cccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence            344555555 9999999653      236899999865322 2235678899999999 899999999999999999999


Q ss_pred             EEcCCCCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          657 YEFLQMGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      |||+++|+|.+++.+.               ...+++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+
T Consensus        95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~  171 (293)
T cd05053          95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM  171 (293)
T ss_pred             EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeE
Confidence            9999999999998642               34688999999999999999999999   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      |++|||+++.+.............++..|+|||......++.++|||||||++||+++ |..||.....+..  ......
T Consensus       172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~  249 (293)
T cd05053         172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--FKLLKE  249 (293)
T ss_pred             EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH--HHHHHc
Confidence            9999999987654332222223335667999999888889999999999999999998 9998875443221  111111


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                         ..   .    +   .........+.+++.+||..+|++|||+.|+++.|+++.
T Consensus       250 ---~~---~----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         250 ---GY---R----M---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ---CC---c----C---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence               00   0    0   011122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.1e-35  Score=322.20  Aligned_cols=256  Identities=26%  Similarity=0.352  Sum_probs=197.0

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCcc-CHHHHHHHHHHHhhc-cCccccceeeEEEe-CCeEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKI-RHKNIVKVLGFFHS-DESIFL  655 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~l  655 (876)
                      ++.+..|.|+||.||+|..      .+++.||+|++...... ....+.+|++++.++ +|+||++++++|.. +...++
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~   89 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence            3444455555999999853      23578999998643222 234677899999999 89999999998865 457889


Q ss_pred             EEEcCCCCCHHHHhhccC------------------------------------------------------------Cc
Q 002826          656 IYEFLQMGSLGDLICRQD------------------------------------------------------------FQ  675 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~------------------------------------------------------------~~  675 (876)
                      +|||+++++|.+++....                                                            ..
T Consensus        90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (337)
T cd05054          90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP  169 (337)
T ss_pred             EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence            999999999999885421                                                            25


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccc
Q 002826          676 LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY  755 (876)
Q Consensus       676 l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~  755 (876)
                      +++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.+.............++..|+|||.
T Consensus       170 l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         170 LTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            78999999999999999999999   999999999999999999999999999987653332222333446678999999


Q ss_pred             cCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHc
Q 002826          756 GYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRC  834 (876)
Q Consensus       756 ~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~c  834 (876)
                      ..+..++.++||||+||++|||++ |+.||......+. ........      .....       .......+.+++.+|
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~------~~~~~-------~~~~~~~~~~l~~~c  312 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEG------TRMRA-------PEYATPEIYSIMLDC  312 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhcc------CCCCC-------CccCCHHHHHHHHHH
Confidence            988899999999999999999998 9999976433221 11111110      00000       112234678999999


Q ss_pred             cCCCCCCCCCHHHHHHHHhhccc
Q 002826          835 TSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       835 l~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      |+.+|++||++.|+++.|+++.+
T Consensus       313 l~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         313 WHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5e-35  Score=327.03  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      .+.+|.|+||.||+|...      .+..||||++..... .....+.+|+++++++. ||||++++++|.+.+..|+|||
T Consensus        42 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (400)
T cd05105          42 GRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITE  121 (400)
T ss_pred             hheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEE
Confidence            344444559999999642      235799999865332 23457889999999996 9999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC-----------------------------------------------------------------
Q 002826          659 FLQMGSLGDLICRQD-----------------------------------------------------------------  673 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-----------------------------------------------------------------  673 (876)
                      |+++|+|.+++.+..                                                                 
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (400)
T cd05105         122 YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYS  201 (400)
T ss_pred             ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhh
Confidence            999999999885421                                                                 


Q ss_pred             ------------------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEE
Q 002826          674 ------------------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL  723 (876)
Q Consensus       674 ------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl  723 (876)
                                                    ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL  278 (400)
T cd05105         202 DIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKI  278 (400)
T ss_pred             hcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEE
Confidence                                          2377888899999999999999999   9999999999999999999999


Q ss_pred             ccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHh
Q 002826          724 TDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       724 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      +|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+.. ....+... 
T Consensus       279 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~~~~~~-  356 (400)
T cd05105         279 CDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYNKIKSG-  356 (400)
T ss_pred             EeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHHHHhcC-
Confidence            99999987643322222233346778999999988889999999999999999997 9999875432221 11111110 


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                           ..    +.   .....+..+.+++.+||+.+|++|||+.++.+.|+++.+
T Consensus       357 -----~~----~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         357 -----YR----MA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -----CC----CC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                 00    00   011223467899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7e-35  Score=312.38  Aligned_cols=244  Identities=22%  Similarity=0.270  Sum_probs=191.4

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|| ||+||++... +|+.||+|++......   ..+.+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus         2 g~G~-~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           2 GKGG-FGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCC-ceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            4445 9999999654 7899999998653222   224567899999999999999999999999999999999999999


Q ss_pred             HHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          666 GDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       666 ~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      .+++..   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            888743   234689999999999999999999999   999999999999999999999999999876543321  122


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............           ......
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~-----------~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDS-----------VTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccC-----------CCCccc
Confidence            34588999999999988999999999999999999999999976433221 111111111100           011122


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      .+..+.+++.+|++.||++||     +++|+++.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            345678999999999999999     66777763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.5e-34  Score=307.58  Aligned_cols=253  Identities=19%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+..+.|+||.||+|... +++.||+|.+.....   .....+.+|+++++.++||||+++++++.+.+..++|+||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            334445559999999664 789999998864322   2234678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          663 GSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+........  
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--  161 (267)
T cd08228          87 GDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--  161 (267)
T ss_pred             CcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH--
Confidence            999988853   234588999999999999999999999   999999999999999999999999999877653221  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++||||+|+++|||++|+.||.............+..   ..       .+..  .
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~---~~-------~~~~--~  229 (267)
T cd08228         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ---CD-------YPPL--P  229 (267)
T ss_pred             HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc---CC-------CCCC--C
Confidence            1223457888999999888888999999999999999999999987644332222222111   00       1111  1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .......+.+++.+||+.+|++||++.|+++.++.+.
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1123456889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.3e-35  Score=314.14  Aligned_cols=256  Identities=20%  Similarity=0.310  Sum_probs=189.2

Q ss_pred             cCCCCCCCCceEEEEEEe-C-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhc---cCccccceeeEEEe-----CCeE
Q 002826          586 KSSAGNGGPFGRVYILSL-P-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKI---RHKNIVKVLGFFHS-----DESI  653 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~  653 (876)
                      ...+|.|+ ||+||+|+. . +++.||+|++.....  .....+.+|+++++.+   +||||++++++|..     ....
T Consensus         6 ~~~lg~G~-~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~   84 (290)
T cd07862           6 VAEIGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   84 (290)
T ss_pred             eeEeccCC-CeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence            34455555 999999965 3 478899999865332  2234566788877776   69999999999853     4568


Q ss_pred             EEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          654 FLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      ++||||++ ++|.+++... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T cd07862          85 TLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY  160 (290)
T ss_pred             EEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence            99999997 4999988654 34589999999999999999999999   9999999999999999999999999999766


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hccccc---
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGA---  808 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~---  808 (876)
                      ....   ......|+..|+|||.+....++.++||||+||++|||++|++||......+. ......... ......   
T Consensus       161 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         161 SFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             cCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhchhh
Confidence            4331   22344588999999999888899999999999999999999999987543221 111111100 000000   


Q ss_pred             ----ccccCh----hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 ----IQVLDP----KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ----~~~~d~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          ...+.+    .+..........+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                000000    011111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=298.49  Aligned_cols=258  Identities=25%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc--cCccccceeeEEEeCC----eEEEEEEcCC
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI--RHKNIVKVLGFFHSDE----SIFLIYEFLQ  661 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~----~~~lv~e~~~  661 (876)
                      +..|.|.||+||+|+| .|+.||||++...   +++...+|.++++.+  +|+||..|++.-..+.    +.|+|++|.+
T Consensus       217 e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  217 EIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            3445566999999999 7999999999753   445566666666655  9999999998754432    5899999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc-----CCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD-----YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      .|||.|++.+  ..++.....+++..+|.||++||-.     +.|.|+|||||+.||||..++.+-|+|+|+|.......
T Consensus       293 ~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t  370 (513)
T KOG2052|consen  293 HGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT  370 (513)
T ss_pred             CCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccC
Confidence            9999999987  4789999999999999999999955     56899999999999999999999999999998776442


Q ss_pred             --cccccccccccccccCccccCCC------CCCCccchHHHHHHHHHHHhC----------CCCCCCCCcchhhHHHHH
Q 002826          737 --FQSTMSSEYALSCYNAPEYGYSK------KATAQMDAYSFGVVLLELITG----------RQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       737 --~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGv~l~elltg----------~~p~~~~~~~~~~~~~~~  798 (876)
                        .....+..+||.+|||||++...      ..-..+||||||.|+||++.+          ++||+..-+.+..+.++.
T Consensus       371 ~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMr  450 (513)
T KOG2052|consen  371 DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMR  450 (513)
T ss_pred             CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHh
Confidence              23345667899999999986532      123458999999999999763          466665433333333321


Q ss_pred             HHHhhcccccccccChhhhhhc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          799 RRKINITNGAIQVLDPKIANCY--QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      .-.      ..+.+.|.+++.|  .+.+..+.++++.||..+|.-|-|+-.+.+.|.++.+
T Consensus       451 kVV------Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  451 KVV------CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cce------eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            110      2223334444333  2556788999999999999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-35  Score=323.21  Aligned_cols=257  Identities=23%  Similarity=0.352  Sum_probs=189.7

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e  658 (876)
                      ..+|.| +||.||+|.. .+|+.||+|++....  ......+.+|++++++++||||+++++++...     ...|+|||
T Consensus         6 ~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           6 EVIGKG-SYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEeec-CCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            344455 4999999965 479999999986432  12345688999999999999999999988643     35899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  737 (876)
                      |++ ++|.+++.+.. .+++..+..++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus        85 ~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          85 LME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             cCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            996 58999887654 689999999999999999999999   999999999999999999999999999976532211 


Q ss_pred             ccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----------
Q 002826          738 QSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----------  805 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  805 (876)
                      ........||..|+|||+..+  ..++.++|||||||++|||++|++||.......  ....+.......          
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH--QLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhhh
Confidence            112234568999999998765  578899999999999999999999997644321  111111000000          


Q ss_pred             -------cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 -------NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 -------~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                             .....................+.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                   0000000000111111223457899999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=315.45  Aligned_cols=253  Identities=22%  Similarity=0.349  Sum_probs=208.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC---CCc--EEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP---SGE--LIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ...+++|+|.||.||+|...   .|+  .||||..+.. ..++.+.|.+|..+|+.++|||||+++|+|.+ ...|+|||
T Consensus       392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE  470 (974)
T KOG4257|consen  392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME  470 (974)
T ss_pred             cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence            44567778889999999653   333  5788988663 33456789999999999999999999999976 56899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      .++-|.|.+++..+...++..+....+.||..||+|||+.   .+|||||..+|||+.....||++|||+++.+.+..++
T Consensus       471 L~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  471 LAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             cccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            9999999999998888899999999999999999999999   9999999999999999999999999999999877665


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ... ...-+..|||||.+.-.+++.++|||-|||++||++. |..||.+-...+.  +      ..+..       ..-.
T Consensus       548 kaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--I------~~iEn-------GeRl  611 (974)
T KOG4257|consen  548 KAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--I------GHIEN-------GERL  611 (974)
T ss_pred             hcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--E------EEecC-------CCCC
Confidence            443 3334567999999999999999999999999999987 9999987443332  0      00110       1111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      -++..++..++.++.+||++||.+||++.|+...|.++..
T Consensus       612 P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            2233445578899999999999999999999999999865

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.1e-34  Score=318.61  Aligned_cols=199  Identities=28%  Similarity=0.364  Sum_probs=168.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +|.....+|.|+ ||.||++... ++..||+|++..... .....+.+|+++++.++||||++++++|.+++..++||||
T Consensus         6 ~y~~~~~lg~g~-~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           6 DFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhheeccccCCC-CEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            344445555555 9999999765 788999998865422 2345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++.+.+ .+++..+..++.+++.|+.|||+.+  +|+||||||+||+++.++.+||+|||++.......   
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---  158 (333)
T cd06650          85 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  158 (333)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc---
Confidence            99999999997654 6889999999999999999999741  69999999999999999999999999987654321   


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP  788 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~  788 (876)
                       .....|+..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus       159 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             -cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence             123358889999999988889999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-35  Score=307.81  Aligned_cols=246  Identities=28%  Similarity=0.456  Sum_probs=200.5

Q ss_pred             CCCCCCceEEEEEEeCC----CcEEEEEEEecCCccC-HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLPS----GELIAVKKLVNFGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||.||+|....    +..||+|.+....... .+.+.+|++.++.++|+|++++++++..+...++||||++++
T Consensus         3 ig~g~-~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           3 LGEGA-FGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             cccCC-ceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            44555 99999997653    8899999997654333 578889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc--------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          664 SLGDLICRQ--------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       664 sL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      +|.+++...        ...+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999876        46799999999999999999999999   9999999999999999999999999999877644


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ..........++..|+|||......++.++||||+|+++|||++ |..||......  ...+....   .   . ..   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---~---~-~~---  226 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK---G---Y-RL---  226 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc---C---C-CC---
Confidence            32223334457888999999888889999999999999999999 69998765322  12222111   0   0 00   


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                         ......+..+.+++.+||..+|++|||+.|+++.|+
T Consensus       227 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ---PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               111122457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-34  Score=309.68  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=192.7

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|| ||+||+++.+ +|+.||+|++.....   .....+..|++++++++||||+++++++.++...++||||+++++|
T Consensus         2 g~G~-~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           2 GKGG-FGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCC-ceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            4555 9999999664 699999999864221   1234556799999999999999999999999999999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++........   ....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eecc
Confidence            9888654 34588999999999999999999999   999999999999999999999999999876643221   2234


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .|+..|+|||+..+..++.++||||+||++|||++|+.||........ .....+......      +...    .....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~----~~~~~  223 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLEDE------VKFE----HQNFT  223 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhccc------cccc----cccCC
Confidence            588899999999888899999999999999999999999975433211 112222211110      0000    01223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      .++.+++.+||+.||++||+++|+++....
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~~~  253 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKNDDPRK  253 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchhhhhc
Confidence            457899999999999999999877654443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-34  Score=323.00  Aligned_cols=255  Identities=18%  Similarity=0.191  Sum_probs=189.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |.....+|. |+||.||++.. .+++.||+|...      ...+.+|++++++++||||+++++++..+...++|+|++.
T Consensus        94 y~~~~~lg~-G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         94 FSILETFTP-GAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             cEEEEEEcC-CCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            333444444 55999999955 579999999743      2356789999999999999999999999999999999986


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                       ++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... ....
T Consensus       167 -~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~  240 (391)
T PHA03212        167 -TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKY  240 (391)
T ss_pred             -CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cccc
Confidence             5888888654 3688999999999999999999999   99999999999999999999999999987543221 1122


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc------hhhHHHHHHHHhhcccccc----c-
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE------SLDVVKWVRRKINITNGAI----Q-  810 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~----~-  810 (876)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......      ...+....+..........    . 
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            3446899999999998888999999999999999999999886542211      0111111111000000000    0 


Q ss_pred             ------------ccChh---hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 ------------VLDPK---IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ------------~~d~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                                  ...+.   ..........++.+++.+|++.||++|||++|+++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                        00000   00111123457889999999999999999999985

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-35  Score=325.05  Aligned_cols=239  Identities=22%  Similarity=0.266  Sum_probs=190.8

Q ss_pred             CCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          591 NGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       591 ~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      |.|+||.||++.. .+|+.||+|++.....   .....+..|+++++.++||||+++++++..++..|+||||+++|+|.
T Consensus         4 G~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~   83 (325)
T cd05594           4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF   83 (325)
T ss_pred             eeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHH
Confidence            4445999999965 5799999999975321   23356678999999999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++.+.. .+++..+..++.|++.|++|||+ .   +|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        84 ~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~  157 (325)
T cd05594          84 FHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFC  157 (325)
T ss_pred             HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccccccc
Confidence            9886654 68999999999999999999997 6   99999999999999999999999999987543221  1122345


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ||+.|+|||.+.+..++.++|||||||++|||++|+.||.....+..  .....   ...        ..+.   .....
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~~~i~---~~~--------~~~p---~~~~~  221 (325)
T cd05594         158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELIL---MEE--------IRFP---RTLSP  221 (325)
T ss_pred             CCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--HHHHh---cCC--------CCCC---CCCCH
Confidence            89999999999888899999999999999999999999976543221  11111   000        0000   11233


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          826 GALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      .+.+++.+|++.||++|+     +++|+++.
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            578999999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-34  Score=307.56  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=196.3

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      +.+..+.|+||.||+|...++..||+|++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+++++|
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L   87 (262)
T cd05071          10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL   87 (262)
T ss_pred             EeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcH
Confidence            333444455999999988777789999987533 345678999999999999999999998754 568999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++.+. +..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++........ .....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-~~~~~  163 (262)
T cd05071          88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGA  163 (262)
T ss_pred             HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc-cccCC
Confidence            9999764 44689999999999999999999999   9999999999999999999999999999776543221 11223


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .++..|+|||......++.++||||||+++||++| |+.||........  ..   .....   ...       ....+.
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~---~~~~~---~~~-------~~~~~~  228 (262)
T cd05071         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LD---QVERG---YRM-------PCPPEC  228 (262)
T ss_pred             cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HH---HHhcC---CCC-------CCcccc
Confidence            35667999999888889999999999999999999 8888865432211  11   11000   000       011223


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      +..+.+++.+|++++|++||++.++++.|++.
T Consensus       229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         229 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            45678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-35  Score=319.43  Aligned_cols=239  Identities=25%  Similarity=0.337  Sum_probs=186.7

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||.||+|... +++.||+|++....   ....+.+..|..++... +||||+++++++..++..|+||||+++|
T Consensus         3 lG~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           3 LGKGS-FGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            44444 9999999764 68899999997532   12334555677777654 8999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~  155 (316)
T cd05592          82 DLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAST  155 (316)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccccc
Confidence            9999987654 689999999999999999999999   99999999999999999999999999987543222  12234


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||........  ...+.   ...        +.+.   ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i~---~~~--------~~~~---~~~  219 (316)
T cd05592         156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSIL---NDR--------PHFP---RWI  219 (316)
T ss_pred             ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---cCC--------CCCC---CCC
Confidence            4589999999999888899999999999999999999999986543221  11111   111        1111   112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMF-EVVK  850 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~-ell~  850 (876)
                      ...+.+++.+||+.+|++||++. ++++
T Consensus       220 ~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         220 SKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            33567899999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.9e-35  Score=316.52  Aligned_cols=256  Identities=24%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe--------CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCe
Q 002826          583 MDEKSSAGNGGPFGRVYILSL--------PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDES  652 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  652 (876)
                      |.....+|.|| ||.||+|+.        .++..||+|.+.... .....++.+|+.+++.+ +||||+++++++...+.
T Consensus        17 ~~~~~~lg~G~-~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   95 (304)
T cd05101          17 LTLGKPLGEGC-FGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   95 (304)
T ss_pred             eeecceeeccC-CceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCc
Confidence            33345555555 999999863        234579999886432 23346788999999999 89999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC
Q 002826          653 IFLIYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA  717 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~  717 (876)
                      .++||||+++++|.+++.+..               ..+++..+.+++.|+++|++|||+.   +++||||||+||++++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~  172 (304)
T cd05101          96 LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTE  172 (304)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcC
Confidence            999999999999999997532               3478889999999999999999999   9999999999999999


Q ss_pred             CCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHH
Q 002826          718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVK  796 (876)
Q Consensus       718 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~  796 (876)
                      ++.+||+|||.++...............++..|+|||...+..++.++||||||+++||+++ |..||...+...     
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----  247 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----  247 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-----
Confidence            99999999999987754332222233345678999999988889999999999999999998 788886543322     


Q ss_pred             HHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          797 WVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       797 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      +........   ..       ......+..+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus       248 ~~~~~~~~~---~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         248 LFKLLKEGH---RM-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHHHcCC---cC-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            111111110   00       0011234467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1e-34  Score=307.61  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=196.1

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|| ||.||+|..+++..||+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||+++++|
T Consensus        11 ~~~ig~g~-~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L   87 (260)
T cd05070          11 IKKLGNGQ-FGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL   87 (260)
T ss_pred             hheecccc-CceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence            34455555 999999988888999999986543 34567899999999999999999999885 4568999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++.+. ...+++..+.+++.+++.|++|||+.   +++||||||+||++++++.++++|||.+.......... ....
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~  163 (260)
T cd05070          88 LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGA  163 (260)
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCC
Confidence            9998764 34589999999999999999999999   99999999999999999999999999997664322111 1122


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .++..|+|||......++.++||||||+++|||++ |+.||......  +..+.......          +.   .....
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~----------~~---~~~~~  228 (260)
T cd05070         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYR----------MP---CPQDC  228 (260)
T ss_pred             CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC----------CC---CCCcC
Confidence            34567999999888889999999999999999999 89998653322  12222111100          00   11122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      +..+.+++.+|+.++|++|||+.++.+.|++
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            3468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-35  Score=310.42  Aligned_cols=249  Identities=20%  Similarity=0.334  Sum_probs=194.3

Q ss_pred             CCCCCCCceEEEEEEeC----CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCe------EEE
Q 002826          588 SAGNGGPFGRVYILSLP----SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFL  655 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~l  655 (876)
                      .+|. |+||.||+|...    .+..||+|++......  ....+.+|++.++.++||||+++++++.+.+.      .++
T Consensus         6 ~lg~-G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05035           6 ILGE-GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV   84 (273)
T ss_pred             ccCc-CCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEE
Confidence            3444 459999999653    2478999998754322  23578899999999999999999999876544      799


Q ss_pred             EEEcCCCCCHHHHhhcc-----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          656 IYEFLQMGSLGDLICRQ-----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ||||+++++|.+++...     ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++
T Consensus        85 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  161 (273)
T cd05035          85 ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK  161 (273)
T ss_pred             EEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcccee
Confidence            99999999999988543     24689999999999999999999999   99999999999999999999999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      .+.............++..|+|||......++.++||||||+++|||++ |..||......  ...++....   .  . 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~---~--~-  233 (273)
T cd05035         162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHG---N--R-  233 (273)
T ss_pred             eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC---C--C-
Confidence            7654332222222335667999999888889999999999999999999 88888654322  222222111   0  0 


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                          +   ......+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       234 ----~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ----L---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ----C---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                0   01112345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.5e-35  Score=314.76  Aligned_cols=263  Identities=26%  Similarity=0.379  Sum_probs=195.3

Q ss_pred             cCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  658 (876)
                      ...+|.|| ||+||++..     .+++.||+|++........+.+.+|++++++++||||+++++++..  ....++|||
T Consensus         9 ~~~lg~g~-~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   87 (284)
T cd05081           9 IQQLGKGN-FGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME   87 (284)
T ss_pred             eeeccCCC-CceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence            34455555 999999864     3688999999876544445678899999999999999999998754  346899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||+++........
T Consensus        88 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  164 (284)
T cd05081          88 YLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY  164 (284)
T ss_pred             ecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcc
Confidence            9999999999977666789999999999999999999999   9999999999999999999999999999876533221


Q ss_pred             cc-cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc---cccccCh
Q 002826          739 ST-MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG---AIQVLDP  814 (876)
Q Consensus       739 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~  814 (876)
                      .. .....++..|+|||...+..++.++||||||+++|||++|..|+........   ............   ..+.+..
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         165 YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM---RMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh---hhcccccccccchHHHHHHHhc
Confidence            11 1112234569999998888899999999999999999999877654322110   000000000000   0000000


Q ss_pred             h-hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          815 K-IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       815 ~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      . ........+..+.+++.+||+.+|++|||++|+++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0 0000111234688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.3e-34  Score=312.82  Aligned_cols=257  Identities=23%  Similarity=0.311  Sum_probs=204.8

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCe
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES  652 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  652 (876)
                      ++.++....|.....+|.|+ +|.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++.+..++.
T Consensus        13 ~~~~~~~~~y~~~~~lg~g~-~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          13 VSVGDPKKKYTRFEKIGQGA-SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             cccCCcccceeeEEEecCCC-CeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            44555555666666676666 999999965 5789999999976555556778899999999999999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++||||+++++|.+++.+.  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~  166 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (296)
T ss_pred             EEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence            99999999999999998643  578999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....  ......+++.|+|||......++.++|||||||++|||++|+.||........ ...+..   ..   .    
T Consensus       167 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~---~~---~----  233 (296)
T cd06654         167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIAT---NG---T----  233 (296)
T ss_pred             ccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhc---CC---C----
Confidence            43221  12233578899999998888889999999999999999999999976543221 111100   00   0    


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       +.. .........+.+++.+||.++|++|||+.|+++.
T Consensus       234 -~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         234 -PEL-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             -CCC-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence             000 0112233467899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=292.87  Aligned_cols=250  Identities=22%  Similarity=0.258  Sum_probs=200.4

Q ss_pred             ccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEec--CCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .+++...++.|+|+.||+. ..++|+.+|+|++..  ....+-+++.+|+.+-+.++||||+++.+.+.+.+..|+|+|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~   91 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   91 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence            3455556677789999987 567899999998843  2234567899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchhhccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~~~~~~~  736 (876)
                      +.|++|..-+-.+ ..+++..+-..++||++++.|+|..   +|+|||+||+|+++.   ...-+|++|||+|..++.+ 
T Consensus        92 m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-  166 (355)
T KOG0033|consen   92 VTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-  166 (355)
T ss_pred             ccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCc-
Confidence            9999996544332 4688899999999999999999999   999999999999995   3456999999999988732 


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .......|||+|||||+....+++..+|||+.||++|-++.|++||.++.....     .++....   ..+.-.|  
T Consensus       167 --~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl-----ye~I~~g---~yd~~~~--  234 (355)
T KOG0033|consen  167 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-----YEQIKAG---AYDYPSP--  234 (355)
T ss_pred             --cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH-----HHHHhcc---ccCCCCc--
Confidence              234566799999999999999999999999999999999999999987544332     1111111   1111112  


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        .|....+...+++++|+..||.+|.|+.|.++.
T Consensus       235 --~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  235 --EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             --ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence              233444567899999999999999999998753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-34  Score=306.29  Aligned_cols=245  Identities=23%  Similarity=0.332  Sum_probs=197.4

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...++.|+ +|.||+|..+ +++.||+|.+....  ......+.+|++++++++|||++++++++.+++..++||||+++
T Consensus         5 ~~~l~~g~-~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08529           5 LNKIGKGS-FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN   83 (256)
T ss_pred             eEEecCCC-CeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCC
Confidence            34455555 9999999764 78999999986432  23456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... ...+++..+.+++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||.++.......  ..
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~  158 (256)
T cd08529          84 GDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FA  158 (256)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc--hh
Confidence            9999999765 56789999999999999999999999   999999999999999999999999999876654321  12


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||+..+..++.++||||||+++|||++|+.||.......  ....   ....   ..    +   ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~---~~~~---~~----~---~~~~  223 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LILK---IIRG---VF----P---PVSQ  223 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH---HHcC---CC----C---CCcc
Confidence            23347888999999988889999999999999999999999997654221  1111   1110   00    0   1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+||+.+|++||++.|+++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            234568899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.8e-35  Score=320.42  Aligned_cols=233  Identities=25%  Similarity=0.312  Sum_probs=186.2

Q ss_pred             CCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          591 NGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|+||+||+|..+ +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++|+|
T Consensus         4 g~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L   83 (320)
T cd05590           4 GKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL   83 (320)
T ss_pred             eeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchH
Confidence            34559999999764 68999999986532   23345667788888877 699999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        84 ~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~  157 (320)
T cd05590          84 MFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFC  157 (320)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccccccc
Confidence            99887654 689999999999999999999999   99999999999999999999999999987543221  1223345


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ||+.|+|||.+.+..++.++||||+||++|||++|+.||.......  ....+   ....     ...|      .....
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i---~~~~-----~~~~------~~~~~  221 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI---LNDE-----VVYP------TWLSQ  221 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---hcCC-----CCCC------CCCCH
Confidence            8999999999988889999999999999999999999998654322  11111   1111     0001      11234


Q ss_pred             HHHHHHHHccCCCCCCCCCH
Q 002826          826 GALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~  845 (876)
                      .+.+++.+|++.||++||++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCC
Confidence            57899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-36  Score=305.86  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=190.8

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC-----eEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-----SIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~  660 (876)
                      .++.|.|+||.||+|... +++.||||+....    .+.-.+|+++|+.++|||||++.-+|....     ...+||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            445566669999999664 6899999998543    334467999999999999999999886532     245899999


Q ss_pred             CCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhccccc
Q 002826          661 QMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       661 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  736 (876)
                      +. +|.++++.   .+..++.-.+.-...|+.+|++|||+.   +|+||||||.|+|+|.+ |.+||+|||.|+....+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            98 99998874   256788888899999999999999998   99999999999999966 999999999999886544


Q ss_pred             cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--------ccc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--------TNG  807 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~  807 (876)
                      ..   ....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..+ .+++.++-..-.        ...
T Consensus       181 pn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d-QL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  181 PN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD-QLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             Cc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH-HHHHHHHHhCCCCHHHHhhcCcc
Confidence            32   222357789999988765 69999999999999999999999998854432 233332221100        000


Q ss_pred             cccccChhhh-----h-hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          808 AIQVLDPKIA-----N-CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       808 ~~~~~d~~~~-----~-~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+.-.|.+.     . .......+..+++.+++.++|.+|.++.|++.
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            0011111111     1 22334567899999999999999999999884

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-34  Score=324.14  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=195.5

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      .+..|.|+||.||+|++.      .++.||+|++...... ....+.+|++++.++. ||||++++++|...+..++|||
T Consensus        42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E  121 (401)
T cd05107          42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE  121 (401)
T ss_pred             hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence            344444559999999753      3468999999754222 2346889999999997 9999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC-----------------------------------------------------------------
Q 002826          659 FLQMGSLGDLICRQD-----------------------------------------------------------------  673 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-----------------------------------------------------------------  673 (876)
                      |+++|+|.+++++.+                                                                 
T Consensus       122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (401)
T cd05107         122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY  201 (401)
T ss_pred             ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence            999999999986532                                                                 


Q ss_pred             --------------------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          674 --------------------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       674 --------------------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                                                      ..+++..+.+++.|++.|++|||+.   +++||||||+||++++++.+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~  278 (401)
T cd05107         202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLV  278 (401)
T ss_pred             hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEE
Confidence                                            1356778889999999999999998   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      |++|||+++...............++..|+|||.+....++.++||||||+++|||++ |..||...+.... .......
T Consensus       279 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-~~~~~~~  357 (401)
T cd05107         279 KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-FYNAIKR  357 (401)
T ss_pred             EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-HHHHHHc
Confidence            9999999986543221112223346788999999988889999999999999999998 8889865433221 1111111


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .      .. ...|      ......+.+++.+||..+|.+||+++|+++.|+++.
T Consensus       358 ~------~~-~~~p------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         358 G------YR-MAKP------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             C------CC-CCCC------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            0      00 0001      112346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=330.60  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=200.4

Q ss_pred             CCCCCceEEEEEEeCCC-cEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeE-EEe------CCeEEEEEEcC
Q 002826          590 GNGGPFGRVYILSLPSG-ELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGF-FHS------DESIFLIYEFL  660 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~~~~~lv~e~~  660 (876)
                      +..|+|+.||+|+...+ ..||+|++...++.+-..+++||++|+.|+ |+|||.++|. ...      ..++++.||||
T Consensus        45 LAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC  124 (738)
T KOG1989|consen   45 LAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYC  124 (738)
T ss_pred             EccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhc
Confidence            33444999999977655 999999998777677788999999999996 9999999993 221      23689999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc-cc
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQ  738 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~-~~  738 (876)
                      .||+|-|+|..+ ...+++.++++|+.|+++|+++||.. .|+|+|||||-+|||++.++..||||||-|+..-... ..
T Consensus       125 ~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~  203 (738)
T KOG1989|consen  125 KGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSA  203 (738)
T ss_pred             cCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccH
Confidence            999999999754 44599999999999999999999997 4589999999999999999999999999986543211 10


Q ss_pred             cc------cccccccccccCcccc---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          739 ST------MSSEYALSCYNAPEYG---YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       739 ~~------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ..      .-..+.|+.|+|||.+   .+...++|+||||+||+||-|+....||+....-..            ..+..
T Consensus       204 ~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI------------lng~Y  271 (738)
T KOG1989|consen  204 QEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI------------LNGNY  271 (738)
T ss_pred             HHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE------------Eeccc
Confidence            00      1123578999999964   466799999999999999999999999987532211            11111


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .+.+      ...+...+.+||..||+++|.+||++-||+..+.++.....
T Consensus       272 ~~P~------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  272 SFPP------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             cCCC------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence            1111      13556689999999999999999999999999999875443

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-34  Score=304.84  Aligned_cols=245  Identities=23%  Similarity=0.367  Sum_probs=195.6

Q ss_pred             CCCCCCceEEEEEEeCCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      +|.|| ||.||+|...+++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus         3 ig~g~-~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   81 (250)
T cd05085           3 LGKGN-FGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS   81 (250)
T ss_pred             cCCCC-CceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence            44455 9999999888899999999865432 223468899999999999999999999999999999999999999999


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL  747 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt  747 (876)
                      ++.+....+++..+..++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++......... ......++
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~  157 (250)
T cd05085          82 FLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIP  157 (250)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCc
Confidence            9977666789999999999999999999999   9999999999999999999999999998754432211 11122345


Q ss_pred             ccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       748 ~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      ..|+|||......++.++||||||+++||+++ |..||.......  .......   .   ....       .....+..
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~~~~~~---~---~~~~-------~~~~~~~~  222 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AREQVEK---G---YRMS-------CPQKCPDD  222 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHHc---C---CCCC-------CCCCCCHH
Confidence            67999999988889999999999999999998 999987543221  1111111   0   0000       01122346


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          827 ALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      +.+++.+|++.+|++||++.|+++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-34  Score=306.15  Aligned_cols=252  Identities=21%  Similarity=0.309  Sum_probs=200.6

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+|.| ++|.||+|.. .+++.||||.+.....   ....++.+|+.+++.++||||+++++++.+++..+++|||+++
T Consensus         8 ~~ig~g-~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08229           8 KKIGRG-QFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA   86 (267)
T ss_pred             hhhccc-CCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence            444554 4999999975 5899999998865332   2235778899999999999999999999999999999999999


Q ss_pred             CCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          663 GSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+........  
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  161 (267)
T cd08229          87 GDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--  161 (267)
T ss_pred             CCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc--
Confidence            999998864   244689999999999999999999999   999999999999999999999999999876643221  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++||||||+++|||++|..||.....+..........   .       ..+...  
T Consensus       162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-------~~~~~~--  229 (267)
T cd08229         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---C-------DYPPLP--  229 (267)
T ss_pred             ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhc---C-------CCCCCC--
Confidence            1223457888999999988888999999999999999999999997544332222211111   0       011110  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .......+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            1123456889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.5e-35  Score=336.39  Aligned_cols=251  Identities=24%  Similarity=0.270  Sum_probs=195.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC-------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-------  651 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  651 (876)
                      .|.....+|. |+||+||+|+. .+|+.||||++.....  .....+.+|+..+..++|+|++++++.+...+       
T Consensus        33 rY~i~~~LG~-G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         33 KYWISRVLGS-GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CEEEEEEEec-CCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            3333344555 55999999965 5799999999865432  23456788999999999999999988775432       


Q ss_pred             -eEEEEEEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          652 -SIFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       652 -~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                       ..++||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence             368999999999999998643   34689999999999999999999999   99999999999999999999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      +++.+.............||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     .........  
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~-----~~~~~~~~~--  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTLAGR--  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhcCC--
Confidence            9987653322222334568999999999998889999999999999999999999997643321     222211111  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ...+.       ......+.+++.+||+.+|++||++.++++.
T Consensus       262 -~~~~~-------~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 -YDPLP-------PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -CCCCC-------CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence             11111       1223467899999999999999999999864

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-35  Score=317.48  Aligned_cols=239  Identities=24%  Similarity=0.344  Sum_probs=188.1

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||+||+|... +++.||+|++....   ......+..|..++... +||||+++++++.+.+..++||||+++|
T Consensus         3 lG~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           3 LGKGS-FGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeCC-CEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            45555 9999999765 68899999997532   23344566788888765 8999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05619          82 DLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCT  155 (316)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cceee
Confidence            999998754 3688999999999999999999999   99999999999999999999999999987532211  11223


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||..|+|||.+.+..++.++||||+||++|||++|+.||.......  ....+..   ..        +...   ...
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~---~~--------~~~~---~~~  219 (316)
T cd05619         156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRM---DN--------PCYP---RWL  219 (316)
T ss_pred             ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC--------CCCC---ccC
Confidence            458999999999988889999999999999999999999997644322  1111111   00        1111   112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMF-EVVK  850 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~-ell~  850 (876)
                      ...+.+++.+|++.+|++||++. ++.+
T Consensus       220 ~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         220 TREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            23578999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=312.85  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=192.5

Q ss_pred             CCCCCCCCceEEEEEEeCC---------------CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          587 SSAGNGGPFGRVYILSLPS---------------GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      ..+|.|| ||.||++....               ...||+|.+..... .....+.+|++++++++|||++++++++...
T Consensus        11 ~~lg~G~-~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~   89 (295)
T cd05097          11 EKLGEGQ-FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD   89 (295)
T ss_pred             hccCCCC-CceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC
Confidence            4455554 99999986532               23589999865322 2235688999999999999999999999999


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccC-----------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQD-----------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +..++||||+++++|.+++....           ..+++..+.+++.|++.|++|||+.   +++||||||+||++++++
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~  166 (295)
T cd05097          90 DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHY  166 (295)
T ss_pred             CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCC
Confidence            99999999999999999986432           2368899999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCcchhhHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT--GRQAEQAEPAESLDVVKW  797 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt--g~~p~~~~~~~~~~~~~~  797 (876)
                      .+|++|||+++...............++..|+|||....+.++.++||||||+++|||++  |..||.....+.  ....
T Consensus       167 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--~~~~  244 (295)
T cd05097         167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--VIEN  244 (295)
T ss_pred             cEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--HHHH
Confidence            999999999876543322222233345678999999888889999999999999999998  566766543322  1111


Q ss_pred             HHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          798 VRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       798 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ..............      ......+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       245 ~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         245 TGEFFRNQGRQIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHhhhhccccccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            11111000000000      0011123468999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-34  Score=314.28  Aligned_cols=256  Identities=24%  Similarity=0.339  Sum_probs=199.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  653 (876)
                      +|.....+|.|+ ||.||++..      .++..||+|++..... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus        36 ~~~~~~~ig~G~-~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          36 NLSFGKTLGAGA-FGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HeEEcceeeccC-CeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            344445556555 999999864      2356899998865432 2245688999999999 799999999999999999


Q ss_pred             EEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          654 FLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      ++||||+++|+|.+++.+.. ..+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+|++|||+++..
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~  191 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI  191 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence            99999999999999997643 3489999999999999999999999   9999999999999999999999999998866


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      .............++..|+|||......++.++||||+||++|||++ |+.||........ ..+....   .   ....
T Consensus       192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~---~---~~~~  264 (302)
T cd05055         192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKE---G---YRMA  264 (302)
T ss_pred             cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHc---C---CcCC
Confidence            43322111222345678999999988889999999999999999998 9999876543321 1111111   0   0000


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                             ........+.+++.+|++++|++|||+.|+++.|+++
T Consensus       265 -------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         265 -------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                   0011234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.2e-35  Score=313.31  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=197.8

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+|.|| ||.||+|...      ....||+|.+..... .....+.+|+.+++.++||||+++++.+..++..++|+||
T Consensus         6 ~~lg~g~-~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           6 KTLGEGE-FGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             ccccCcC-CcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            4455555 9999999642      235788888864332 2235688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc-----------------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC
Q 002826          660 LQMGSLGDLICRQ-----------------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD  716 (876)
Q Consensus       660 ~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~  716 (876)
                      +++++|.+++...                       ...+++..+..++.|++.|++|||+.   +++||||||+||+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEc
Confidence            9999999988642                       13478999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHH
Q 002826          717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVV  795 (876)
Q Consensus       717 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~  795 (876)
                      +++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |+.||.....+.  ..
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~  239 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--LF  239 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--HH
Confidence            999999999999986543322222233345678999999888889999999999999999999 999996543322  22


Q ss_pred             HHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          796 KWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       796 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      +.......          +..   .......+.+++.+|++.+|++||++.|+++.|+++..+
T Consensus       240 ~~~~~~~~----------~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         240 NLLKTGYR----------MER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHhCCCC----------CCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            22211100          000   112234678999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.9e-35  Score=319.99  Aligned_cols=240  Identities=25%  Similarity=0.311  Sum_probs=190.4

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.| +||.||+|+.. +++.||+|++....   ......+..|.+++..+ +||||+++++++.+.+..|+||||++++
T Consensus         3 lG~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           3 LGKG-SFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             cccC-CCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            4444 49999999765 68899999987532   23335567788888876 7999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05591          82 DLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTT  155 (321)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccc
Confidence            9999886653 689999999999999999999999   99999999999999999999999999987543221  11233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||........  ....   ....     ...|.      ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--~~~i---~~~~-----~~~p~------~~  219 (321)
T cd05591         156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--FESI---LHDD-----VLYPV------WL  219 (321)
T ss_pred             cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--HHHH---HcCC-----CCCCC------CC
Confidence            4589999999999888899999999999999999999999986543221  1111   1111     00010      11


Q ss_pred             HHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRP-------SMFEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RP-------s~~ell~~  851 (876)
                      ...+.+++.+|++.||++||       +++++++.
T Consensus       220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            24578999999999999999       78888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.7e-34  Score=306.03  Aligned_cols=246  Identities=25%  Similarity=0.415  Sum_probs=194.8

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|.| ++|.||+|...++..||+|++.... ...+.+.+|++++++++|||++++++++. .+..++||||+++++|.
T Consensus        12 ~~ig~g-~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~   88 (260)
T cd05069          12 VKLGQG-CFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL   88 (260)
T ss_pred             eeecCc-CCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence            344554 4999999988777789999876433 34567889999999999999999999875 45688999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++.+. ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||.++........ ......
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~  164 (260)
T cd05069          89 DFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAK  164 (260)
T ss_pred             HHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCc
Confidence            999764 34588999999999999999999999   9999999999999999999999999999766433211 112223


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||...+..++.++||||||+++|||++ |+.||.......  ...+....  ..    ..       .....+
T Consensus       165 ~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~--~~----~~-------~~~~~~  229 (260)
T cd05069         165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERG--YR----MP-------CPQGCP  229 (260)
T ss_pred             cchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC--CC----CC-------CCcccC
Confidence            5677999999888889999999999999999999 899987643322  11221111  00    00       111234


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ..+.+++.+||+++|++||+++++++.|++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            568899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-34  Score=310.12  Aligned_cols=256  Identities=23%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCc----EEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGE----LIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||+||+|.+ .+|+    .||+|++..... ....++.+|+.+++.++||||+++++++.. ...++++|
T Consensus        11 ~~~~lg~G~-~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~   88 (279)
T cd05109          11 KVKVLGSGA-FGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQ   88 (279)
T ss_pred             eeeecCCCC-CceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEE
Confidence            345555555 999999975 3454    489999865332 234578889999999999999999999975 45789999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++........
T Consensus        89 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~  165 (279)
T cd05109          89 LMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE  165 (279)
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence            9999999999987666799999999999999999999999   9999999999999999999999999999876533221


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......++..|+|||...+..++.++|||||||++|||++ |..||.......  ...+........      .     
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~------~-----  232 (279)
T cd05109         166 YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEKGERLP------Q-----  232 (279)
T ss_pred             eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCCcCC------C-----
Confidence            11222234667999999988889999999999999999998 899986543222  222222111000      0     


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                        .......+.+++.+||+.||++||++.|+++.|+++.....
T Consensus       233 --~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~  273 (279)
T cd05109         233 --PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS  273 (279)
T ss_pred             --CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence              11223467899999999999999999999999998866553

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.1e-35  Score=313.73  Aligned_cols=258  Identities=26%  Similarity=0.381  Sum_probs=196.9

Q ss_pred             ccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  656 (876)
                      ++.+..+.|+||.||++..     .++..||+|.+.... ......+.+|+++++.++|||++++.+++.+.  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            3444444455999999863     368899999986543 23346788999999999999999999998875  568999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++......
T Consensus        87 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            999999999999977655789999999999999999999999   99999999999999999999999999998765322


Q ss_pred             cc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc----------hhhHHHHHHHHhhcc
Q 002826          737 FQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE----------SLDVVKWVRRKINIT  805 (876)
Q Consensus       737 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~----------~~~~~~~~~~~~~~~  805 (876)
                      .. .......++..|+|||...+..++.++||||||+++||+++++.|+......          .............. 
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  242 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG-  242 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC-
Confidence            11 1122334667799999988888999999999999999999988765332110          00011111110000 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                        ..       .......+..+.+++.+|++.+|++|||++++++.++++
T Consensus       243 --~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         243 --KR-------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             --cc-------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence              00       001112345788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.4e-34  Score=305.35  Aligned_cols=250  Identities=25%  Similarity=0.352  Sum_probs=188.8

Q ss_pred             CCCCCCceEEEEEEeCC---CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSLPS---GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|.|| ||.||+|...+   +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         3 lg~G~-~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           3 IGNGW-FGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             ccccC-CceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            45555 99999997643   46799998865432 233578889999999999999999999999999999999999999


Q ss_pred             HHHHhhcc----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          665 LGDLICRQ----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       665 L~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      |.+++...    ....++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            99998653    22467788889999999999999999   999999999999999999999999999876543332222


Q ss_pred             cccccccccccCccccCCC-------CCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          741 MSSEYALSCYNAPEYGYSK-------KATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....++..|+|||+....       .++.++||||||+++|||++ |+.||........  .......     ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~-----~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYTVRE-----QQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHHhhc-----ccCCCC
Confidence            3334567889999987532       35789999999999999996 9999976443321  1111110     011111


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ++.+..   .....+.+++.+|| .+|++|||++||++.|.
T Consensus       232 ~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222211   11234678999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.5e-34  Score=305.76  Aligned_cols=246  Identities=22%  Similarity=0.340  Sum_probs=193.2

Q ss_pred             CCCCCCceEEEEEEe---CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSL---PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||.||+|.+   .+++.||+|++.....  ...+++..|+.+++.++||||+++++++. .+..++||||++++
T Consensus         3 lg~G~-~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           3 LGSGN-FGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             CCCcC-CcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            45555 999999954   3678999999864332  22457889999999999999999999885 45678999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc-cccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ-STMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~  742 (876)
                      +|.+++.+.. .+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++........ ....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997543 689999999999999999999999   9999999999999999999999999999876533221 1112


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...++..|+|||......++.++||||||+++|||++ |+.||......  ...+..+....          +...   .
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~----------~~~~---~  221 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGER----------MECP---Q  221 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC----------CCCC---C
Confidence            2234568999999887888999999999999999998 99999764332  22222221100          0011   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+..+.+++.+||++||++||++.+|++.|+..
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.2e-34  Score=308.77  Aligned_cols=254  Identities=24%  Similarity=0.402  Sum_probs=198.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CC---cEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SG---ELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|| ||.||+|..+ ++   ..||+|.+.... ......+..|++++++++|||++++.+++.+.+..++||
T Consensus         7 ~~~~~~lg~g~-~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           7 ITKQKVIGAGE-FGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             ceEeeEecCCC-CccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            33445555555 9999999764 33   379999886532 223457889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||++........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            99999999999977666789999999999999999999999   999999999999999999999999999876643221


Q ss_pred             c-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          738 Q-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       738 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      . ........+..|+|||......++.++||||||+++||+++ |+.||.......  ....+......         +.
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~~~i~~~~~~---------~~  231 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VMKAINDGFRL---------PA  231 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHhcCCCC---------CC
Confidence            1 11112223457999999888888999999999999999998 999986543221  11111110000         11


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .    ......+.+++.+||..+|++||++.++++.|+++
T Consensus       232 ~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         232 P----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             C----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0    11234678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7e-35  Score=318.18  Aligned_cols=240  Identities=23%  Similarity=0.302  Sum_probs=190.8

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||+||+|... +++.||+|++....   ......+..|.++++.+ +||||+++++++.+.+..|+||||+++|
T Consensus         3 lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           3 LGKGS-FGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            44555 9999999665 68899999997532   23345667888999888 6999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  ....
T Consensus        82 ~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~  155 (318)
T cd05570          82 DLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST  155 (318)
T ss_pred             CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccc
Confidence            9999887654 689999999999999999999999   999999999999999999999999999865322111  1223


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..|+..|+|||.+.+..++.++||||+||++|||++|+.||.......  ......   ...        +..   ....
T Consensus       156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~~~i~---~~~--------~~~---~~~~  219 (318)
T cd05570         156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LFQSIL---EDE--------VRY---PRWL  219 (318)
T ss_pred             eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HHHHHH---cCC--------CCC---CCcC
Confidence            358899999999998899999999999999999999999997644322  111111   110        000   1112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSM-----FEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~-----~ell~~  851 (876)
                      ...+.+++.+||+.||++|||+     .++++.
T Consensus       220 ~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            3467899999999999999999     877654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-34  Score=303.82  Aligned_cols=247  Identities=23%  Similarity=0.356  Sum_probs=197.4

Q ss_pred             CCCCCCceEEEEEEeCCCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      +|.|| ||.||++...+++.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||+++++|.+
T Consensus         3 lg~g~-~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~   81 (251)
T cd05041           3 IGKGN-FGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT   81 (251)
T ss_pred             cccCC-CceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence            45555 99999998777999999998654433 34678899999999999999999999999999999999999999999


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL  747 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt  747 (876)
                      ++.+....+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.++...............++
T Consensus        82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            9977666789999999999999999999999   9999999999999999999999999998765432211111122235


Q ss_pred             ccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       748 ~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      ..|+|||...++.++.++||||||+++|||+| |..||........  .........       ..      .....+..
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--~~~~~~~~~-------~~------~~~~~~~~  223 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--RERIESGYR-------MP------APQLCPEE  223 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--HHHHhcCCC-------CC------CCccCCHH
Confidence            67999999888889999999999999999999 8888866443221  111111000       00      01122346


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          827 ALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      +.+++.+|+..+|++|||+.|+++.|++
T Consensus       224 ~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         224 IYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            8899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.9e-35  Score=320.11  Aligned_cols=240  Identities=20%  Similarity=0.293  Sum_probs=186.5

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||.||+|... +++.||+|++.....   .....+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus         3 lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           3 IGRGS-YAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            44555 9999999764 789999999975422   2334577888888877 7999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.. .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (329)
T cd05618          82 DLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTST  155 (329)
T ss_pred             CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccccc
Confidence            9998886653 689999999999999999999999   99999999999999999999999999987532211  11233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc---hhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE---SLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ..||..|+|||.+.+..++.++|||||||++|||++|+.||......   ......+........  ..     .   .+
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~-----~---~p  225 (329)
T cd05618         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QI-----R---IP  225 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CC-----C---CC
Confidence            45899999999999888999999999999999999999999632211   111122222211110  00     0   11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      ......+.+++.+|++.||++||++
T Consensus       226 ~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         226 RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1223457899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-34  Score=312.44  Aligned_cols=254  Identities=27%  Similarity=0.477  Sum_probs=197.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      +|.....+|.|| ||.||+|..+      ++..||+|++..... ....++.+|+.++++++||||+++++++.+++..+
T Consensus         6 ~~~~~~~lg~g~-~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~   84 (288)
T cd05050           6 NIEYVRDIGQGA-FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC   84 (288)
T ss_pred             hceecccccccc-cccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence            344556666666 9999999753      578899999865322 23467889999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC---------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCce
Q 002826          655 LIYEFLQMGSLGDLICRQD---------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI  713 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NI  713 (876)
                      +||||+++++|.+++....                     ..+++..+..++.|++.|++|||+.   +++||||||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ni  161 (288)
T cd05050          85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNC  161 (288)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhhe
Confidence            9999999999999986431                     2477889999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchh
Q 002826          714 LLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL  792 (876)
Q Consensus       714 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~  792 (876)
                      ++++++.+|++|||.++.+..............+..|+|||...+..++.++|||||||++|||++ |..||.....+. 
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~-  240 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE-  240 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999876543322222222234567999999888889999999999999999998 888886543322 


Q ss_pred             hHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          793 DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                       ......   ...  ..        ......+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus       241 -~~~~~~---~~~--~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 -VIYYVR---DGN--VL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHHHh---cCC--CC--------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             112111   110  00        0111223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.8e-35  Score=316.10  Aligned_cols=255  Identities=25%  Similarity=0.379  Sum_probs=197.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC--------CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP--------SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      ....+|.|| ||.||+|...        ++..||+|.+.... .....++..|+++++.+ +||||+++++++...+..|
T Consensus        22 i~~~lg~G~-~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~  100 (307)
T cd05098          22 LGKPLGEGC-FGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  100 (307)
T ss_pred             EeeeeccCC-CeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            334555555 9999998642        23579999987532 12335678899999999 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          655 LIYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +||||+++|+|.+++....               ..+++.++.+++.|++.|++|||+.   +++||||||+||+++.++
T Consensus       101 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~  177 (307)
T cd05098         101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDN  177 (307)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCC
Confidence            9999999999999997542               2488999999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~  798 (876)
                      .+|++|||.++...............++..|+|||...+..++.++||||+||++|||++ |+.||...+.+.  .....
T Consensus       178 ~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~~~~~  255 (307)
T cd05098         178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLL  255 (307)
T ss_pred             cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHH
Confidence            999999999876643221111122224567999999888889999999999999999998 888886544322  11111


Q ss_pred             HHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..   ..   .    .   .........+.+++.+||..+|++|||+.|+++.|+++.+.
T Consensus       256 ~~---~~---~----~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         256 KE---GH---R----M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             Hc---CC---C----C---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            11   00   0    0   01112234678999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.4e-35  Score=319.96  Aligned_cols=246  Identities=21%  Similarity=0.287  Sum_probs=190.9

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||.||+|... +++.||+|++.....   ...+.+.+|..+++.+ +||||+++++++.+.+..|+||||+++|
T Consensus         3 lG~G~-~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           3 IGRGS-YAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             EeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            44454 9999999664 789999999975322   2335678899999998 7999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~  155 (329)
T cd05588          82 DLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTST  155 (329)
T ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccccc
Confidence            999988655 3789999999999999999999999   99999999999999999999999999987532111  12233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch---hhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES---LDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.......   ....++........  ..     .+   +
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~-----~~---p  225 (329)
T cd05588         156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--QI-----RI---P  225 (329)
T ss_pred             ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--CC-----CC---C
Confidence            458999999999998889999999999999999999999996432211   11112222211110  00     01   1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPS------MFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs------~~ell~~  851 (876)
                      ......+.+++.+|++.||.+||+      +.|+++.
T Consensus       226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            112345789999999999999997      5677643

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.9e-35  Score=317.37  Aligned_cols=238  Identities=25%  Similarity=0.321  Sum_probs=187.7

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||.||+|+.. +|+.||+|++....   .........|..++... +||||+++++++.+++..|+||||+++|
T Consensus         3 lg~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           3 LGKGS-FGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            44544 9999999765 78999999997532   23345566788888765 8999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (316)
T cd05620          82 DLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAST  155 (316)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cceec
Confidence            999988765 3688999999999999999999999   99999999999999999999999999987432111  12234


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||..|+|||.+.+..++.++||||+||++|||++|+.||.......  ..+....   ..        +.+..   ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~~~---~~--------~~~~~---~~  219 (316)
T cd05620         156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRV---DT--------PHYPR---WI  219 (316)
T ss_pred             cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC--------CCCCC---CC
Confidence            458999999999998889999999999999999999999997654322  1111111   10        11111   12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMF-EVV  849 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~-ell  849 (876)
                      ..++.+++.+|++.||++||++. ++.
T Consensus       220 ~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         220 TKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            33577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-34  Score=312.03  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=194.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ....+|.| +||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 i~~~lg~G-~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (288)
T cd05061          10 LLRELGQG-SFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM   88 (288)
T ss_pred             eeeeecCC-CCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            34445555 49999998543      245899998754321 22346778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC---------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          658 EFLQMGSLGDLICRQD---------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      ||+++|+|.+++.+..         ...++..+.+++.|++.|++|||+.   +|+||||||+||++++++.+|++|||+
T Consensus        89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~  165 (288)
T cd05061          89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGM  165 (288)
T ss_pred             eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCc
Confidence            9999999999996531         3356778899999999999999999   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      ++...............++..|+|||...++.++.++|||||||++|||++ |..||.....++  ..+...   ...  
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~---~~~--  238 (288)
T cd05061         166 TRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFVM---DGG--  238 (288)
T ss_pred             cccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---cCC--
Confidence            886543322222222335677999999988889999999999999999998 788887543322  111111   110  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ..        .........+.+++.+|++.+|++|||+.|+++.+++..
T Consensus       239 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         239 YL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            00        001122346889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.1e-34  Score=305.27  Aligned_cols=248  Identities=23%  Similarity=0.406  Sum_probs=196.8

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|| ||.||+|..++++.||+|.+.... .....+.+|++++++++|||++++++++. .+..++||||+++++|
T Consensus        11 ~~~ig~G~-~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L   87 (260)
T cd05067          11 VKKLGAGQ-FGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSL   87 (260)
T ss_pred             eeeeccCc-cceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCH
Confidence            34455555 999999998899999999987543 44578899999999999999999999874 4678999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++... +..+++..+..++.|++.|++|||+.   +++||||||+||++++++.++++|||++........ ......
T Consensus        88 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  163 (260)
T cd05067          88 VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGA  163 (260)
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCC
Confidence            9998654 45789999999999999999999998   999999999999999999999999999876542221 111222


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .++..|+|||.+....++.++||||||+++||+++ |+.||......  ............          .   .....
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~----------~---~~~~~  228 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM----------P---RPDNC  228 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC----------C---CCCCC
Confidence            35678999999888888999999999999999999 99999754322  122221111000          0   01112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...+.+++.+|++.+|++|||++++.+.|+.+
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            34688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.1e-34  Score=302.92  Aligned_cols=253  Identities=21%  Similarity=0.316  Sum_probs=200.5

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+..+.|+||.||+|... +|+.||+|.+.....   ...+.+.+|++++++++|+|++++++++.+++..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            333444559999999765 899999998864322   2356788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          663 GSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|.+++...   ...+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.++++|||+++.......  
T Consensus        87 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--  161 (267)
T cd08224          87 GDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--  161 (267)
T ss_pred             CCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc--
Confidence            9999988642   45689999999999999999999999   999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++||||||+++|+|++|+.||...........+....   .   ..   .+ ..  
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~---~~---~~-~~--  229 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK---C---DY---PP-LP--  229 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhc---C---CC---CC-CC--
Confidence            1223347888999999888889999999999999999999999986544322221111111   0   00   00 00  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .......+.+++.+||.++|++|||+.++++.++++.
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            1123446889999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.8e-34  Score=317.21  Aligned_cols=248  Identities=23%  Similarity=0.293  Sum_probs=191.7

Q ss_pred             cCCCCCCCCceEEEEEEe----CCCcEEEEEEEecCC----ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL----PSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      ...+|.|| ||+||+++.    .+++.||+|++....    ....+.+..|+++++.+ +||||+++++++.+++..++|
T Consensus         5 ~~~lg~G~-~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (332)
T cd05614           5 LKVLGTGA-YGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI   83 (332)
T ss_pred             EEEEeecC-CEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence            34555555 999999864    368999999986432    12335678899999999 599999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++|+|.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          84 LDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999987653 689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .. ......||..|+|||.+.+. .++.++|||||||++|||+||+.||........ ............        +.
T Consensus       160 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~~~--------~~  229 (332)
T cd05614         160 KE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILKCD--------PP  229 (332)
T ss_pred             CC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhcCC--------CC
Confidence            11 12234589999999998765 478899999999999999999999975433211 111111111111        11


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      +.   ......+.+++.+|++.||++||     +++|+++.
T Consensus       230 ~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         230 FP---SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11   11233567899999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-35  Score=323.31  Aligned_cols=237  Identities=26%  Similarity=0.305  Sum_probs=189.0

Q ss_pred             CCCCCCCceEEEEEEe----CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          588 SAGNGGPFGRVYILSL----PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+|.|+ ||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++.+++..|+||||++
T Consensus         3 ~lg~G~-~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           3 VLGQGS-FGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             eeeeCC-CEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            355555 999999854    3689999999975322  233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|+|.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999987653 689999999999999999999999   99999999999999999999999999987654321  112


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|++.|+|||.+....++.++|||||||++|||++|+.||.......  ...   .........           ..
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~---~i~~~~~~~-----------p~  219 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TMT---MILKAKLGM-----------PQ  219 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HHH---HHHcCCCCC-----------CC
Confidence            23458999999999988888999999999999999999999997643321  111   111111000           11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFE  847 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~e  847 (876)
                      .....+.+++.+||+.||++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12345779999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-34  Score=308.04  Aligned_cols=248  Identities=20%  Similarity=0.293  Sum_probs=190.4

Q ss_pred             CCCCCceEEEEEEeCC-Cc--EEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC------CeEEEEEE
Q 002826          590 GNGGPFGRVYILSLPS-GE--LIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ESIFLIYE  658 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~e  658 (876)
                      .+.|+||.||+|...+ ++  .||+|.+....  ....+.+.+|+++++.++||||+++++++...      ...++|||
T Consensus         7 ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e   86 (272)
T cd05075           7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILP   86 (272)
T ss_pred             cCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEE
Confidence            3445599999997654 33  68999886532  22345688899999999999999999987532      24789999


Q ss_pred             cCCCCCHHHHhhc-----cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          659 FLQMGSLGDLICR-----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       659 ~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      |+++|+|.+++..     ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.+.
T Consensus        87 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  163 (272)
T cd05075          87 FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIY  163 (272)
T ss_pred             eCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccC
Confidence            9999999988742     234588999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      ............++..|+|||......++.++||||||+++|||++ |+.||......  ...+....   ..   ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~~---~~~~  235 (272)
T cd05075         164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ---GN---RLKQ  235 (272)
T ss_pred             cccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc---CC---CCCC
Confidence            4332222222335678999999988889999999999999999999 88888653321  22221111   10   0000


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .       ...+..+.+++.+||+++|++|||+.|+++.|+++
T Consensus       236 ~-------~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         236 P-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1       11234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.9e-34  Score=306.96  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=196.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|.....+|.|+ ||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus        10 ~y~~~~~lg~g~-~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646          10 DYELIQRVGSGT-YGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hcchhheeecCC-CeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            344445555555 999999975 578999999987554445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+|||+||+||+++.++.+||+|||+++.......  .
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  162 (267)
T cd06646          89 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--K  162 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc--c
Confidence            9999999987553 689999999999999999999999   999999999999999999999999999986643211  1


Q ss_pred             cccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          741 MSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .....++..|+|||.+.   ...++.++||||+||++|||++|+.||........ ...+..         .....+...
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~~~  232 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSK---------SNFQPPKLK  232 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeec---------CCCCCCCCc
Confidence            22334788899999874   34577899999999999999999999864332211 000000         000001111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                       .....+..+.+++.+||+.+|++|||++++++.+
T Consensus       233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             1112345688999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-34  Score=309.85  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=196.1

Q ss_pred             cCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ...+|.|| ||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus        11 ~~~lg~g~-~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   89 (277)
T cd05032          11 IRELGQGS-FGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVME   89 (277)
T ss_pred             EeEecCCC-CceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEe
Confidence            34455555 9999998653      347899999864321 224568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC---------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          659 FLQMGSLGDLICRQD---------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      |+++++|.+++....         ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~  166 (277)
T cd05032          90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT  166 (277)
T ss_pred             cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccc
Confidence            999999999986431         2468889999999999999999999   9999999999999999999999999999


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      +...............++..|+|||......++.++|||||||++||+++ |..||.......  .......   ..  .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~---~~--~  239 (277)
T cd05032         167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVID---GG--H  239 (277)
T ss_pred             hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHhc---CC--C
Confidence            87654332222233446778999999888889999999999999999998 999886543322  2222211   00  0


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                           +..   ....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 -----~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         240 -----LDL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             -----CCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence                 000   11124568899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=9.2e-35  Score=325.40  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=190.4

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .+..+|.|+ ||+||+|+. .+++.||+|++.....   .....+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus         5 ~~~~LG~G~-~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~   83 (381)
T cd05626           5 KIKTLGIGA-FGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (381)
T ss_pred             EEEEEeecC-CEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence            344555555 999999955 5789999999975432   22356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc---
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF---  737 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~---  737 (876)
                      ++|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......   
T Consensus        84 ~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          84 PGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence            9999999987654 688999999999999999999999   999999999999999999999999999754321000   


Q ss_pred             ------------------------------------------ccccccccccccccCccccCCCCCCCccchHHHHHHHH
Q 002826          738 ------------------------------------------QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLL  775 (876)
Q Consensus       738 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~  775 (876)
                                                                ........||+.|+|||.+.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~  239 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF  239 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHH
Confidence                                                      00011245899999999998888999999999999999


Q ss_pred             HHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHHH
Q 002826          776 ELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALR--CTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       776 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPs~~ell~~  851 (876)
                      ||++|+.||......... ......  ..   ... + |..    .....++.+++.+  |+..+|..||++.|+++.
T Consensus       240 elltG~~Pf~~~~~~~~~-~~i~~~--~~---~~~-~-~~~----~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQ-LKVINW--EN---TLH-I-PPQ----VKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHhCCCCCcCCCHHHHH-HHHHcc--cc---ccC-C-CCC----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999865433211 111100  00   000 0 000    0122356678877  556666779999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-34  Score=309.99  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=193.4

Q ss_pred             cCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ...+|.|| +|.||+|...      .+..||+|.+..... .....+..|+.++++++|+||+++++++.+.+..++|||
T Consensus        11 ~~~lg~g~-~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   89 (277)
T cd05036          11 LRALGHGA-FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE   89 (277)
T ss_pred             eeECCCCC-CCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence            34455555 9999999764      357889998754322 234568889999999999999999999999899999999


Q ss_pred             cCCCCCHHHHhhccC------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---CeEEccccch
Q 002826          659 FLQMGSLGDLICRQD------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---EPKLTDFALD  729 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~~kl~DfGla  729 (876)
                      |+++++|.+++.+.+      ..+++..+.+++.||+.|++|||+.   +++||||||+||+++.++   .+|++|||++
T Consensus        90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~  166 (277)
T cd05036          90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA  166 (277)
T ss_pred             cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence            999999999997653      2589999999999999999999999   999999999999998654   5999999999


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      +................+..|+|||.+.+..++.++|||||||++|||++ |+.||.....+.  ....+......    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----  240 (277)
T cd05036         167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGGRL----  240 (277)
T ss_pred             cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCcC----
Confidence            87643322222222234567999999988889999999999999999997 999987644332  12221110000    


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                        .       .....+..+.+++.+|++.+|++|||+.|+++.|.
T Consensus       241 --~-------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 --D-------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --C-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              0       01112346789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=309.49  Aligned_cols=247  Identities=21%  Similarity=0.280  Sum_probs=194.3

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|+ ||+||++.. .+++.||+|++.....   .....+.+|++++++++||||+++++++.+++..++||||++
T Consensus         5 ~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05605           5 YRVLGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             EEEEecCC-CeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence            34455555 999999965 4789999999865321   223456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          662 MGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       662 ~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +|+|.+++.+. ...+++..+..++.|++.|++|||+.   +++||||||+||++++++.++|+|||+++......   .
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~  157 (285)
T cd05605          84 GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T  157 (285)
T ss_pred             CCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC---c
Confidence            99999888654 34689999999999999999999999   99999999999999999999999999987654322   1


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....|+..|+|||.+.+..++.++||||+||++|||++|+.||........  .+.+......          ......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~~~~----------~~~~~~  225 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERRVKE----------DQEEYS  225 (285)
T ss_pred             cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHHhhh----------cccccC
Confidence            2234588999999999888899999999999999999999999986433211  1111111100          000111


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      ......+.+++.+||+.||++||     ++.++++.
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            22344678999999999999999     88888664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.4e-34  Score=310.21  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=199.8

Q ss_pred             cCCCCCCCCceEEEEEEeCC-----CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLPS-----GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  658 (876)
                      .....+.|+||.||+|....     +..||+|++..... .....+.+|+.++++++||||+++++++.. +...++++|
T Consensus        10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   89 (280)
T cd05043          10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP   89 (280)
T ss_pred             EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence            33444455599999997755     78899998864322 224567889999999999999999998876 567899999


Q ss_pred             cCCCCCHHHHhhccC-------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          659 FLQMGSLGDLICRQD-------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      |+++++|.+++....       ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+++.
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~  166 (280)
T cd05043          90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD  166 (280)
T ss_pred             cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence            999999999986532       4689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      +.............++..|+|||......++.++||||||+++||+++ |+.||.....  .....+.......      
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~------  238 (280)
T cd05043         167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYRL------  238 (280)
T ss_pred             ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCCC------
Confidence            643332222223345677999999888889999999999999999999 9999976432  2222222211100      


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                          ..   ....+..+.+++.+||+.+|++|||+.|+++.|+++.++
T Consensus       239 ----~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         239 ----AQ---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----CC---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                00   011234678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-35  Score=322.17  Aligned_cols=249  Identities=25%  Similarity=0.313  Sum_probs=197.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|| ||+||+|... +|+.||+|++....   ......+.+|+++++.++||||+++++++.+++..|+||||+
T Consensus         5 ~~~~lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (350)
T cd05573           5 VIKVIGRGA-FGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM   83 (350)
T ss_pred             EEEEEEeCC-cEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence            344555555 9999999765 79999999997532   133457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc----
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA----  736 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~----  736 (876)
                      ++++|.+++.+. ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......    
T Consensus        84 ~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          84 PGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999776 4789999999999999999999998   99999999999999999999999999998765332    


Q ss_pred             -----------------------cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh
Q 002826          737 -----------------------FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD  793 (876)
Q Consensus       737 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~  793 (876)
                                             .........||+.|+|||.+.+..++.++|||||||++|||++|+.||........ 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~-  238 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET-  238 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH-
Confidence                                   00122344689999999999988999999999999999999999999986543221 


Q ss_pred             HHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002826          794 VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS-MFEVVKA  851 (876)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~ell~~  851 (876)
                          ............   -|....    ....+.+++.+|+. +|.+||+ +.|+++.
T Consensus       239 ----~~~i~~~~~~~~---~p~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 ----YNKIINWKESLR---FPPDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             ----HHHHhccCCccc---CCCCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                111111000000   000000    23467899999997 9999999 9999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-34  Score=303.38  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=195.2

Q ss_pred             CCCCCCCceEEEEEEeC--C--CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          588 SAGNGGPFGRVYILSLP--S--GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+|.|| ||.||+|...  +  +..||+|.+..... ...+++.+|++++++++|||++++++++. .+..++||||+++
T Consensus         2 ~ig~G~-~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           2 ELGHGN-FGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             ccCccC-ceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            355555 9999999653  2  36899999875432 23467889999999999999999999876 4568999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc-ccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ-STM  741 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~  741 (876)
                      ++|.+++.+.. .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++........ ...
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999997665 789999999999999999999999   9999999999999999999999999999876533221 111


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||......++.++||||||+++|||++ |++||......  ....+.......       .      ..
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~-------~------~~  220 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIAMLESGERL-------P------RP  220 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHHcCCcC-------C------CC
Confidence            12223467999999988889999999999999999998 99998754332  222222211100       0      11


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ...+..+.+++.+||..+|++||++.++++.|+++.
T Consensus       221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-34  Score=304.03  Aligned_cols=249  Identities=24%  Similarity=0.410  Sum_probs=198.5

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ....+.|+||.||+|..++++.||+|.+.... ...+++.+|++++++++|||++++++++......++||||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   89 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL   89 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence            33444455999999988888999999987543 45678899999999999999999999999889999999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++.+. +..+++..+..++.+++.|++|||+.   +++|+||||+||++++++.+|++|||.++....... .......
T Consensus        90 ~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~  165 (261)
T cd05034          90 DFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-TAREGAK  165 (261)
T ss_pred             HHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh-hhhhccC
Confidence            999765 35789999999999999999999999   999999999999999999999999999877653221 1111222


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||...+..++.++||||+|+++||+++ |+.||......  ...+.....      ......       ...+
T Consensus       166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~~~~~------~~~~~~-------~~~~  230 (261)
T cd05034         166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQVERG------YRMPRP-------PNCP  230 (261)
T ss_pred             CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------CCCCCC-------CCCC
Confidence            4567999999988889999999999999999999 99998653322  112221111      000000       1113


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+.+++.+|+..+|++||+++++.+.|+.+
T Consensus       231 ~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~  261 (261)
T cd05034         231 EELYDLMLQCWDKDPEERPTFEYLQSFLEDY  261 (261)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence            4678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-34  Score=317.98  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=189.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCc-cccceeeEEEeCCeEEEEEEc
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHK-NIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ....+|.|| ||.||+|... +++.||+|++....   ....+.+..|+++++.++|+ +|+++++++.+.+..|+||||
T Consensus         4 ~~~~lg~G~-~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           4 FLMVLGKGS-FGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             EEEEEeecc-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            344556555 9999999665 67899999987532   23345677899999999764 688899999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......  .
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  156 (324)
T cd05587          83 VNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--K  156 (324)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--C
Confidence            99999999987654 688999999999999999999999   99999999999999999999999999986532211  1


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|+|||++.+..++.++||||+||++|||+||+.||........  ...+.   ...        +.+   
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~---~~~--------~~~---  220 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--FQSIM---EHN--------VSY---  220 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH---cCC--------CCC---
Confidence            12334589999999999988899999999999999999999999976543221  11111   111        000   


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSM-----FEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~-----~ell~  850 (876)
                      +......+.+++.+|++.+|.+|++.     +++.+
T Consensus       221 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         221 PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            01123357899999999999999976     55554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.6e-34  Score=311.61  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=194.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|| ||.||+|+.+ +++.||+|++..... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus         8 y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   86 (309)
T cd07872           8 YIKLEKLGEGT-YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL   86 (309)
T ss_pred             eEEEEEecccC-CEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence            33344555555 9999999664 788999999865432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++ ++.+++...+..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~  160 (309)
T cd07872          87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KT  160 (309)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc--cc
Confidence            86 89888877666789999999999999999999999   99999999999999999999999999987654322  11


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-ccccccc------
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-NGAIQVL------  812 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------  812 (876)
                      .....++..|+|||.+.+ ..++.++||||+|+++|||+||++||......+.  .....+..... ......+      
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE--LHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHhhhcchhhh
Confidence            223457889999998764 4678999999999999999999999976543321  11111110000 0000000      


Q ss_pred             ----Chh-----hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 ----DPK-----IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 ----d~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          .+.     ..........++.+++.+|++.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                000     00111123446789999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.7e-34  Score=303.89  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=196.5

Q ss_pred             CCCCCCceEEEEEEeCC--C--cEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLPS--G--ELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| +|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ ...++||||++++
T Consensus         3 ig~g~-~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           3 LGDGS-FGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             CCccC-cccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            44555 99999997643  3  3699999976554 445678899999999999999999999988 8899999999999


Q ss_pred             CHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cccc
Q 002826          664 SLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTM  741 (876)
Q Consensus       664 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~  741 (876)
                      +|.+++.+.. ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             cHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999997764 5789999999999999999999999   999999999999999999999999999987754221 1122


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||......++.++||||||+++|||++ |+.||......+  ...........      .      ...
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~------~------~~~  223 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEGER------L------ERP  223 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcCCc------C------CCC
Confidence            23346778999999888889999999999999999999 999986543322  11211110000      0      001


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ...+..+.+++.+|++.+|++|||+.|+++.|.+
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  257 (257)
T cd05040         224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLPE  257 (257)
T ss_pred             ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence            1223468899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-34  Score=337.31  Aligned_cols=261  Identities=22%  Similarity=0.256  Sum_probs=200.0

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|| ||.||+|... +|+.||+|++......   ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 Ii~~LGkGg-fG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          6 IIRLIGKGG-MGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEecCC-CEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            344555555 9999999664 6999999998653222   2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc----------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          661 QMGSLGDLICRQ----------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       661 ~~gsL~~~l~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +|++|.+++...          ....++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk  161 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI  161 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcce
Confidence            999999988642          13456778899999999999999999   99999999999999999999999999998


Q ss_pred             hcccccc----------------ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhH
Q 002826          731 IVGEAAF----------------QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDV  794 (876)
Q Consensus       731 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~  794 (876)
                      .......                ........||+.|+|||.+.+..++.++||||+||++|||+||+.||..........
T Consensus       162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~  241 (932)
T PRK13184        162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY  241 (932)
T ss_pred             ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence            7621100                001122458999999999998889999999999999999999999997643222110


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccCCccc
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRP-SMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ell~~L~~i~~~~~~~  862 (876)
                      .    ...         .+|.......+.+..+.+++.+|++.||++|| +++++.+.|+.+.+..+.+
T Consensus       242 ~----~~i---------~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w  297 (932)
T PRK13184        242 R----DVI---------LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW  297 (932)
T ss_pred             h----hhc---------cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence            0    000         01100000112334578899999999999995 7888889898876554433

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.5e-34  Score=303.77  Aligned_cols=238  Identities=23%  Similarity=0.288  Sum_probs=187.2

Q ss_pred             CCCCCCceEEEEEEeCC-------------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          589 AGNGGPFGRVYILSLPS-------------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      +|.|+ ||.||+|.+.+             ...||+|.+..........+.+|+.+++.++||||+++++++.++...++
T Consensus         3 lg~G~-~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l   81 (262)
T cd05077           3 LGRGT-RTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM   81 (262)
T ss_pred             cccCC-cceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence            45555 99999996532             23588998766544455678889999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC-------eEEccccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE-------PKLTDFAL  728 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~-------~kl~DfGl  728 (876)
                      ||||+++++|..++.+....+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.       +|++|||+
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          82 VEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            9999999999999877666799999999999999999999999   9999999999999986654       89999998


Q ss_pred             hhhccccccccccccccccccccCccccC-CCCCCCccchHHHHHHHHHHH-hCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELI-TGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      +......      ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||........  ... .   ..  
T Consensus       159 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~-~---~~--  224 (262)
T cd05077         159 PITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERF-Y---EG--  224 (262)
T ss_pred             CccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHH-H---hc--
Confidence            8655321      2234677899999876 456889999999999999998 58888765332211  111 0   00  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                       ......        .....+.+++.+||+.||++||+++|+++.+.
T Consensus       225 -~~~~~~--------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 -QCMLVT--------PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -CccCCC--------CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             011111        11245789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-34  Score=317.22  Aligned_cols=241  Identities=24%  Similarity=0.311  Sum_probs=187.2

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHH---hhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTL---AKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+|.| +||.||+|... +|+.||+|++....   ....+.+.+|+.++   +.++||||+++++++.+.+..|+||||
T Consensus         5 ~~lg~G-~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           5 AVLGRG-HFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEeec-CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            345555 49999999654 79999999997532   12234566666655   566799999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|..++.+  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        84 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~  156 (324)
T cd05589          84 AAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--D  156 (324)
T ss_pred             CCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--C
Confidence            999999988864  3689999999999999999999999   99999999999999999999999999987533211  1


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||........  .....   ...        +..   
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--~~~i~---~~~--------~~~---  220 (324)
T cd05589         157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--FDSIV---NDE--------VRY---  220 (324)
T ss_pred             cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--HHHHH---hCC--------CCC---
Confidence            22334589999999999888899999999999999999999999976543221  11111   111        000   


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      .......+.+++.+|++.||.+||     ++.++++.
T Consensus       221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            011234567899999999999999     56666653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-34  Score=321.86  Aligned_cols=259  Identities=17%  Similarity=0.192  Sum_probs=193.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|.....+|.|+ ||.||++... +++.||||...      ...+.+|++++++++|+|||++++++..++..++|||++
T Consensus       170 gy~i~~~Lg~G~-~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        170 GFAIHRALTPGS-EGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CeEEEEEEccCC-CeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            444444555555 9999999765 68899999642      234678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      . ++|.+++......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..........
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            5 599998876656799999999999999999999999   999999999999999999999999999987643322222


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcc------hhhHHHHHHHHhhcccccccccCh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE------SLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+......      ...+...++...............
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            22345899999999999888999999999999999999988765432211      112222222211000000000000


Q ss_pred             hhh-----------------hhcH---HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          815 KIA-----------------NCYQ---QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       815 ~~~-----------------~~~~---~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+.                 ..+.   .....+.+++.+|++.||.+|||+.|+++.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000                 0011   122367889999999999999999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.8e-34  Score=319.49  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=190.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||+||+|... +++.||+|++.....   .....+.+|+.++.+++||||+++++++.+.+..|+|||
T Consensus         3 y~~~~~LG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           3 FESLKVIGRGA-FGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             ceEeEEEEeCC-CEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            33445555555 9999999654 689999999965321   223567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            999999999997654 689999999999999999999999   9999999999999999999999999998765321100


Q ss_pred             ---------------------------------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002826          739 ---------------------------------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQ  785 (876)
Q Consensus       739 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~  785 (876)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                             00123468999999999988889999999999999999999999997


Q ss_pred             CCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 002826          786 AEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTS--VMPEKRPSMFEVVKA  851 (876)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~--~dP~~RPs~~ell~~  851 (876)
                      .......  ...+.   ...  ....+.+..     .....+.+++.+++.  .++..||++.|+++.
T Consensus       238 ~~~~~~~--~~~i~---~~~--~~~~~p~~~-----~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SETPQET--YKKVM---NWK--ETLIFPPEV-----PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCHHHH--HHHHH---cCc--CcccCCCcC-----CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            6543221  11111   100  000011110     112345667776543  233456899999886

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-34  Score=296.98  Aligned_cols=248  Identities=23%  Similarity=0.255  Sum_probs=198.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+| .|..|+||+++.. ++..+|+|++.+.....   ..+.+.|.++|+.+.||.++.+|..++.++..|+|||||
T Consensus        81 llk~LG-~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   81 LLKRLG-CGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHcC-CCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            334455 4559999999876 46899999997654332   346677999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc-----
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE-----  734 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~-----  734 (876)
                      +||+|..+.+++ +..+++..+.-.+.+|+-||+|||-.   |||.|||||+||||.++|.+.++||.++.....     
T Consensus       160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~  236 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV  236 (459)
T ss_pred             CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence            999999999877 66799999999999999999999999   999999999999999999999999998755420     


Q ss_pred             -c----------------------c-----cc---------------------cccccccccccccCccccCCCCCCCcc
Q 002826          735 -A----------------------A-----FQ---------------------STMSSEYALSCYNAPEYGYSKKATAQM  765 (876)
Q Consensus       735 -~----------------------~-----~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~  765 (876)
                       .                      .     ..                     .....-+||-.|.|||++.+...+.++
T Consensus       237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV  316 (459)
T KOG0610|consen  237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV  316 (459)
T ss_pred             ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence             0                      0     00                     001123578899999999999999999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC-
Q 002826          766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS-  844 (876)
Q Consensus       766 Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-  844 (876)
                      |.|+|||++|||+.|+.||.+...+.. +...+.+            ++.+++.. +.+..+.++|++.+.+||++|.. 
T Consensus       317 DWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~------------~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  317 DWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQ------------PLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             hHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcC------------CCcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence            999999999999999999998766543 1111111            11222222 44567899999999999999987 


Q ss_pred             ---HHHHHH
Q 002826          845 ---MFEVVK  850 (876)
Q Consensus       845 ---~~ell~  850 (876)
                         |.||.+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               666654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=316.94  Aligned_cols=236  Identities=25%  Similarity=0.308  Sum_probs=192.0

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+..|.|.||.|+++..+ +++.+|||++++...   .+.+..+.|-.++... +||.++.++.+|+..++.|+||||+.
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            344455669999999765 789999999987543   4556777888888877 59999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ||++..+.+  ...+++..+.-++..|+-||+|||++   +|++||||-+|||+|.+|.+||+|||+++..-.  .....
T Consensus       453 Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~T  525 (694)
T KOG0694|consen  453 GGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRT  525 (694)
T ss_pred             CCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCC--CCCcc
Confidence            999544443  34799999999999999999999999   999999999999999999999999999986431  12234


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      +..+||+.|||||++.+..|+.++|.|||||++|||+.|..||.++++++.- -..+         ..+...|      .
T Consensus       526 sTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F-dsI~---------~d~~~yP------~  589 (694)
T KOG0694|consen  526 STFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF-DSIV---------NDEVRYP------R  589 (694)
T ss_pred             ccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHh---------cCCCCCC------C
Confidence            5567999999999999999999999999999999999999999987665531 1110         1111112      2


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      ..+.+...++++++.++|++|.-+
T Consensus       590 ~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  590 FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             cccHHHHHHHHHHhccCcccccCC
Confidence            234567899999999999999755

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.5e-34  Score=310.98  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=193.2

Q ss_pred             CCCCCCCCceEEEEEEeC-CCc--EEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGE--LIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.|| ||.||+|..+ ++.  .+|+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|+||++
T Consensus         8 ~~lg~g~-~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           8 DVIGEGN-FGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeecCCC-cceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            3445555 9999999765 333  47888876422 22345788999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          662 MGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       662 ~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      +++|.+++.+..               ..+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df  163 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF  163 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCc
Confidence            999999986532               3488999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |++.......   .......+..|+|||......++.++|||||||++|||++ |+.||.......  .   ....... 
T Consensus       164 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~---~~~~~~~-  234 (297)
T cd05089         164 GLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--L---YEKLPQG-  234 (297)
T ss_pred             CCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H---HHHHhcC-
Confidence            9986432111   1111123456999999888889999999999999999997 999997644322  1   1111110 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                        ..    +..   .......+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus       235 --~~----~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         235 --YR----MEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             --CC----CCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence              00    000   1112346789999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-34  Score=302.20  Aligned_cols=243  Identities=25%  Similarity=0.447  Sum_probs=197.1

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|. |+||.||+|.. .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++.+.+..++||||+++++|.
T Consensus        12 ~~ig~-g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   88 (256)
T cd05039          12 ATIGK-GEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeec-CCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence            44444 55999999987 489999999976543 4567889999999999999999999999889999999999999999


Q ss_pred             HHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.++.......     ...
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~  160 (256)
T cd05039          89 DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGK  160 (256)
T ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-----cCC
Confidence            9997653 3689999999999999999999999   999999999999999999999999999887643221     222


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .+..|+|||.+....++.++||||||+++||+++ |+.||...+...  .........  .    ...       ....+
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~--~----~~~-------~~~~~  225 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGY--R----MEA-------PEGCP  225 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCC--C----CCC-------ccCCC
Confidence            4567999999888889999999999999999997 999987654332  111111110  0    000       11223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+.+++.+||..+|++|||+.|++++|+.+
T Consensus       226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            5678999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.6e-34  Score=302.74  Aligned_cols=247  Identities=23%  Similarity=0.429  Sum_probs=197.9

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|| ||.||+|.+.+++.+|+|.+.... .....+.+|++++++++|||++++++++......++||||+++++|
T Consensus         9 ~~~ig~g~-~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           9 VQEIGSGQ-FGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EeeecCcc-cceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            34556666 999999988778899999886432 3456789999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++......+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||.++....... .......
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~  162 (256)
T cd05112          87 SDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTK  162 (256)
T ss_pred             HHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCc
Confidence            999987666789999999999999999999999   999999999999999999999999999876543221 1112223


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||...+..++.++||||+|+++|||++ |+.||.......  ..+....   .    .....+..      .+
T Consensus       163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---~----~~~~~~~~------~~  227 (256)
T cd05112         163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVETINA---G----FRLYKPRL------AS  227 (256)
T ss_pred             cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHHHHhC---C----CCCCCCCC------CC
Confidence            4567999999988889999999999999999998 999987533221  1211111   0    01111111      13


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ..+.+++.+||+.+|++|||+.|+++.|.
T Consensus       228 ~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         228 QSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            46889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9e-35  Score=319.40  Aligned_cols=250  Identities=20%  Similarity=0.247  Sum_probs=195.5

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .....+|.|+ ||+||+|... +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~~~lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           4 DVKSLVGRGH-FGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             eEEEEEEecc-CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            3344555555 9999999654 799999999975322   2345688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++.+....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......... 
T Consensus        83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-  158 (330)
T cd05601          83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-  158 (330)
T ss_pred             CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-
Confidence            999999999987756799999999999999999999999   9999999999999999999999999999876533221 


Q ss_pred             ccccccccccccCccccC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          740 TMSSEYALSCYNAPEYGY------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ......||+.|+|||++.      ...++.++|||||||++|||++|+.||........     ......... ....  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-----~~~i~~~~~-~~~~--  230 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-----YNNIMNFQR-FLKF--  230 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-----HHHHHcCCC-ccCC--
Confidence            222345899999999876      45678899999999999999999999976443221     111111100 0000  


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      |..    ......+.+++.+|+. +|++|||+.++++.
T Consensus       231 ~~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         231 PED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             CCC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            000    0123457889999997 99999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.2e-34  Score=306.76  Aligned_cols=250  Identities=23%  Similarity=0.402  Sum_probs=196.1

Q ss_pred             CCCCCCCCceEEEEEEeC-CC---cEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SG---ELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.|| ||.||+|... ++   ..||+|++.... .....++..|+.+++.++||||+++++++.+++..++||||++
T Consensus        10 ~~lg~g~-~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065          10 EVIGAGE-FGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             eEecCCC-CCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            4455555 9999999764 33   369999986532 2234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++............
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  165 (269)
T cd05065          89 NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY  165 (269)
T ss_pred             CCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCcccccc
Confidence            9999999987666789999999999999999999999   9999999999999999999999999998766432221111


Q ss_pred             cccc---ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          742 SSEY---ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       742 ~~~~---gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ....   .+..|+|||......++.++||||+|+++||+++ |..||......  +...++.......         .  
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~~~---------~--  232 (269)
T cd05065         166 TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYRLP---------P--  232 (269)
T ss_pred             ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCcCC---------C--
Confidence            1111   2357999999988889999999999999999886 99998654322  2222222110000         0  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                        ..+.+..+.+++.+||..+|.+||++.++++.|+++
T Consensus       233 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         233 --PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              012234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3e-34  Score=305.41  Aligned_cols=250  Identities=23%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             CCCCCCCCceEEEEEEeC-C---CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-S---GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.|+ ||.||+|... +   +..||+|.+..... ...+.+..|+.++++++||||+++++++.+++..++||||++
T Consensus        10 ~~lg~g~-~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066          10 KVIGAGE-FGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeecccC-CCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            4455555 9999999653 2   34799998864322 234578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc-cc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ-ST  740 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~  740 (876)
                      +++|.+++.+....+++.++.+++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......... ..
T Consensus        89 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd05066          89 NGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT  165 (267)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeee
Confidence            9999999987766789999999999999999999999   9999999999999999999999999999876543211 11


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....++..|+|||......++.++||||||+++||+++ |+.||.......  ...........         +.    
T Consensus       166 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~~~---------~~----  230 (267)
T cd05066         166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEEGYRL---------PA----  230 (267)
T ss_pred             cCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhCCCcC---------CC----
Confidence            122223567999999988889999999999999999887 999986543221  22222111000         00    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ....+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         231 PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            011234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=311.91  Aligned_cols=244  Identities=27%  Similarity=0.391  Sum_probs=197.2

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCH---HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....||.|. ||.||-|+. .+.+.||||++...+.+..   .++..|+..|.+++|||+|.+-|+|..+.+.|+|||
T Consensus        28 f~dLrEIGHGS-FGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCc-cceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            44445565555 999999954 5789999999977665554   367889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ||-| |-.|++.-...++.+..+..|+.+.++||+|||+.   +.+|||||+.|||+++.|.||++|||.|..+.+..  
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn--  180 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN--  180 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh--
Confidence            9976 88898887777899999999999999999999999   99999999999999999999999999998776543  


Q ss_pred             cccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 STMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                          ..+|||+|||||++.   .+.|+-++||||+|+++.|+..+++|+..-+  .+...--+..   ..       .|.
T Consensus       181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQ---Ne-------sPt  244 (948)
T KOG0577|consen  181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQ---NE-------SPT  244 (948)
T ss_pred             ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHh---cC-------CCC
Confidence                445999999999754   6789999999999999999999999865321  1111111111   11       122


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +.  ..+-+..|..++..|+.+-|.+|||..++++.
T Consensus       245 Lq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  245 LQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            21  11223457889999999999999999998865

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=6.7e-34  Score=307.60  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=197.0

Q ss_pred             ccCCCCCCCCceEEEEEEeCC-----------------CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeE
Q 002826          585 EKSSAGNGGPFGRVYILSLPS-----------------GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF  646 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~  646 (876)
                      ....+|.|| ||.||+|...+                 +..||+|++..... ...+++.+|++++++++||||++++++
T Consensus         9 ~~~~lg~G~-~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   87 (296)
T cd05051           9 FVEKLGEGQ-FGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV   87 (296)
T ss_pred             ccccccCCC-CccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            345555555 99999986542                 35689999865432 234678899999999999999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhccC----------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQD----------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD  716 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~  716 (876)
                      +..++..++||||+++++|.+++.+..          ..+++..+..++.|++.|++|||+.   +++||||||+||+++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~  164 (296)
T cd05051          88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG  164 (296)
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhceeec
Confidence            999999999999999999999987643          2689999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCcchhhH
Q 002826          717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT--GRQAEQAEPAESLDV  794 (876)
Q Consensus       717 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt--g~~p~~~~~~~~~~~  794 (876)
                      .++.++++|||+++...............++..|+|||...+..++.++||||||+++|||++  |..||.......  .
T Consensus       165 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~--~  242 (296)
T cd05051         165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ--V  242 (296)
T ss_pred             CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH--H
Confidence            999999999999876544332222334446778999999888889999999999999999998  677775433221  1


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ........... ...... +    .....+.++.+++.+|++.||++|||++|+++.|+.
T Consensus       243 ~~~~~~~~~~~-~~~~~~-~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         243 IENAGHFFRDD-GRQIYL-P----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHhccccc-cccccC-C----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            12111110000 000000 0    111223468999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.5e-34  Score=311.47  Aligned_cols=195  Identities=23%  Similarity=0.398  Sum_probs=158.7

Q ss_pred             CCCCCCCCceEEEEEEeC---CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP---SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  661 (876)
                      .++|.|+ ||+||+|+..   +++.||+|.+...  .....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         7 ~~lG~G~-~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           7 CKVGRGT-YGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             cccccCC-CeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            4555555 9999999754   5688999998643  234567889999999999999999999864  456899999986


Q ss_pred             CCCHHHHhhcc--------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee----CCCCCeEEccccch
Q 002826          662 MGSLGDLICRQ--------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL----DADFEPKLTDFALD  729 (876)
Q Consensus       662 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll----~~~~~~kl~DfGla  729 (876)
                      + +|.+++...        ...+++..+..++.|++.|++|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 888877532        23588999999999999999999999   99999999999999    45688999999999


Q ss_pred             hhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002826          730 RIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEP  788 (876)
Q Consensus       730 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~  788 (876)
                      +....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            87653321 122334568999999998876 458899999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.3e-34  Score=308.32  Aligned_cols=256  Identities=22%  Similarity=0.357  Sum_probs=193.2

Q ss_pred             CCCCCCCCceEEEEEEeC-----------------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          587 SSAGNGGPFGRVYILSLP-----------------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      ..+|.|| ||.||++...                 ++..||+|++..... ....++.+|+++++.++|+||+++++++.
T Consensus        11 ~~lg~G~-~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          11 EKLGEGQ-FGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeccCCC-CCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            4455555 9999998532                 245789999865422 23467889999999999999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccC----------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQD----------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD  718 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~  718 (876)
                      .++..++||||+++++|.+++....          ..+++..+.+++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCC
Confidence            9999999999999999999986542          2467889999999999999999999   99999999999999999


Q ss_pred             CCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh--CCCCCCCCCcchhhHHH
Q 002826          719 FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT--GRQAEQAEPAESLDVVK  796 (876)
Q Consensus       719 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt--g~~p~~~~~~~~~~~~~  796 (876)
                      +.++++|||+++.+.............++..|+|||....+.++.++|||||||++|||++  |..||........  ..
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~--~~  244 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV--IE  244 (296)
T ss_pred             CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH--HH
Confidence            9999999999886643322222222334677999998888889999999999999999998  6778765433221  11


Q ss_pred             HHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          797 WVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       797 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      .........  ......+..    ...+..+.+++.+||+.||++||++.|+++.|++
T Consensus       245 ~~~~~~~~~--~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         245 NTGEFFRDQ--GRQVYLPKP----ALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHhhc--cccccCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111111000  000000111    1123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4e-34  Score=303.47  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=190.5

Q ss_pred             CCCCCCceEEEEEEeC----CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEEcCCC
Q 002826          589 AGNGGPFGRVYILSLP----SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFLQM  662 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  662 (876)
                      +|.|| ||.||+|...    ++..||+|++.... ......+.+|+.+++.++||||+++++++.. ++..++||||+.+
T Consensus         3 lg~g~-~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           3 IGKGH-FGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             ccccC-CceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            44455 9999999653    34579999875432 2234677889999999999999999998764 5568999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc--cc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ--ST  740 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~  740 (876)
                      ++|.+++.+.....++..+..++.|+++|++|||+.   +++||||||+||++++++.+|++|||+++........  ..
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          82 GDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            999999987655678888999999999999999999   9999999999999999999999999998765432111  11


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG-RQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....++..|+|||......++.++||||||+++|||++| .+||.....  .........   ..       .+...  
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~---~~-------~~~~~--  224 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQ---GR-------RLLQP--  224 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhc---CC-------CCCCC--
Confidence            1233456789999998888899999999999999999995 555543221  122222111   10       00000  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                       ...+..+.+++.+||..+|++||++.|+++.|+++.
T Consensus       225 -~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         225 -EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             111236789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-34  Score=303.04  Aligned_cols=244  Identities=24%  Similarity=0.316  Sum_probs=194.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..+|.| +||.||++... +++.||+|.+.... ....+.+..|+.+++.++|||++++++.+.+++..|+||||+++++
T Consensus         6 ~~lg~g-~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           6 RVVGEG-SFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEeecc-CCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            344444 59999999664 78999999986432 2344678889999999999999999999999999999999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++... +..+++..+.+++.|++.|++|||+.   +++|+||||+||++++++.++++|||.++.......  ....
T Consensus        85 l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~  159 (255)
T cd08219          85 LMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACT  159 (255)
T ss_pred             HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc--cccc
Confidence            99988653 45688999999999999999999999   999999999999999999999999999876643221  1123


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..|+..|+|||...+..++.++||||||+++|+|++|+.||........     .......   ....+.       ...
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~---~~~~~~-------~~~  224 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-----ILKVCQG---SYKPLP-------SHY  224 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-----HHHHhcC---CCCCCC-------ccc
Confidence            4478889999999888899999999999999999999999976443221     1111111   111111       112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+.+++.+||+.||++|||+.|++..
T Consensus       225 ~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         225 SYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            3357899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-34  Score=307.94  Aligned_cols=256  Identities=22%  Similarity=0.307  Sum_probs=204.4

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCe
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES  652 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  652 (876)
                      ++.++....|.....+|.|+ ||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++.
T Consensus        12 ~~~~~~~~~y~~~~~lg~g~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          12 VSVGDPKKKYTRFEKIGQGA-SGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             cccCChhhhceeeeeeccCC-CeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            34455666666666776666 999999965 5899999999976555556778899999999999999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++||||+++++|.+++.+.  .+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+...
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999999998653  578999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....  ......+++.|+|||...+..++.++||||||+++|++++|+.||............  ..  ..   .    
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--~~--~~---~----  232 (297)
T cd06656         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--AT--NG---T----  232 (297)
T ss_pred             cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--cc--CC---C----
Confidence            43321  122335788899999998888899999999999999999999999764432210000  00  00   0    


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       +.. .........+.+++.+||..+|++||++.++++
T Consensus       233 -~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         233 -PEL-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -CCC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             000 011122345778999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.4e-34  Score=307.97  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=199.6

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..|.....+|.|+ +|.||+|.. .+++.||+|.+........+.+.+|+++++.++|||++++++++...+..++|+||
T Consensus        19 ~~y~~~~~lg~g~-~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGA-SGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCC-CeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3455556666666 999999964 58999999999765555567888999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++.+.  .+++..+..++.+++.|++|||+.   +++||||||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--  170 (296)
T cd06655          98 LAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--  170 (296)
T ss_pred             cCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence            9999999988653  589999999999999999999999   999999999999999999999999999876543321  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++|||||||++|++++|+.||........  .......  ..   ..     + ..
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~~~~~~~--~~---~~-----~-~~  237 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLIATN--GT---PE-----L-QN  237 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc--CC---cc-----c-CC
Confidence            12234578889999999888889999999999999999999999976543221  1111110  00   00     0 01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .......+.+++.+||..||++|||+.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1122345778999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.3e-34  Score=312.10  Aligned_cols=251  Identities=22%  Similarity=0.333  Sum_probs=192.5

Q ss_pred             CCCCCCCceEEEEEEeC-CCc--EEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          588 SAGNGGPFGRVYILSLP-SGE--LIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+.|+||.||+|... ++.  .+|+|.+..... .....+.+|++++.++ +||||+++++++.+++..|+||||+++
T Consensus        13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   92 (303)
T cd05088          13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   92 (303)
T ss_pred             eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence            33444559999999764 454  457777654321 2345788899999999 899999999999999999999999999


Q ss_pred             CCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          663 GSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       663 gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      ++|.+++.+.+               ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||
T Consensus        93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg  169 (303)
T cd05088          93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  169 (303)
T ss_pred             CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccc
Confidence            99999996542               3578999999999999999999999   99999999999999999999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      +++......   ......++..|+|||.+....++.++|||||||++|||+| |..||.......  ..+...   ..  
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~---~~--  239 (303)
T cd05088         170 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP---QG--  239 (303)
T ss_pred             cCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHh---cC--
Confidence            986432111   1111224567999999888888999999999999999998 999986543322  111111   00  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                       .    .+.   ........+.+++.+||+.+|++||++.++++.++++....
T Consensus       240 -~----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         240 -Y----RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             -C----cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             0    000   01112345789999999999999999999999999875433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=316.81  Aligned_cols=270  Identities=21%  Similarity=0.309  Sum_probs=207.7

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-C-----cccccee
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-H-----KNIVKVL  644 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~  644 (876)
                      ..+-.+|.....|++...+|.|+||.|-+| +.++++.||||+++... ....+...|+.+|+.++ |     -|+|+++
T Consensus       176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            444556666667888888889999999999 66789999999997642 33456677999999997 4     3999999


Q ss_pred             eEEEeCCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC--CCe
Q 002826          645 GFFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD--FEP  721 (876)
Q Consensus       645 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~--~~~  721 (876)
                      ++|...++.|+|+|.++. +|+++++.+ -..++...+..++.||++||.+||+.   +|||+||||+|||+.+-  .++
T Consensus       255 d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCce
Confidence            999999999999999866 999999876 34588999999999999999999999   99999999999999643  579


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh---------
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---------  792 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~---------  792 (876)
                      ||+|||.++.......     ..+-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.++.+.+.         
T Consensus       331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             eEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            9999999998765432     33356679999999999999999999999999999999988887665432         


Q ss_pred             ----hHHHHHHHHhhc-------------ccc----------------cccccCh----hhhh-hcHHHHHHHHHHHHHc
Q 002826          793 ----DVVKWVRRKINI-------------TNG----------------AIQVLDP----KIAN-CYQQQMLGALEIALRC  834 (876)
Q Consensus       793 ----~~~~~~~~~~~~-------------~~~----------------~~~~~d~----~~~~-~~~~~~~~~~~li~~c  834 (876)
                          .+.+...+....             ...                ......|    .+.. ....+...+.+++++|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence                111111100000             000                0000001    1111 1114456789999999


Q ss_pred             cCCCCCCCCCHHHHHHH
Q 002826          835 TSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       835 l~~dP~~RPs~~ell~~  851 (876)
                      +..||.+|+|+.|+++.
T Consensus       486 L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCchhcCCHHHHhcC
Confidence            99999999999999874

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=321.26  Aligned_cols=250  Identities=24%  Similarity=0.312  Sum_probs=192.9

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .....+|.|+ ||+||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         4 ~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (364)
T cd05599           4 ESIKVIGRGA-FGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY   82 (364)
T ss_pred             eEEEEEEecC-CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence            3344555555 9999999664 78999999997532   12335677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.......
T Consensus        83 ~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          83 LPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            99999999987654 689999999999999999999999   99999999999999999999999999987543211000


Q ss_pred             ------------------------------------ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 002826          740 ------------------------------------TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       740 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                                                          ......||+.|+|||++....++.++|||||||++|||++|+.|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                01123589999999999888899999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002826          784 EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVKA  851 (876)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ell~~  851 (876)
                      |........     ........... . + |..    ......+.+++.+|+. +|.+|++   +.|+++.
T Consensus       239 f~~~~~~~~-----~~~i~~~~~~~-~-~-~~~----~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDNPQET-----YRKIINWKETL-Q-F-PDE----VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCHHHH-----HHHHHcCCCcc-C-C-CCC----CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            976543221     11111110000 0 0 000    0113356788999996 9999997   8888773

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.4e-34  Score=316.79  Aligned_cols=235  Identities=24%  Similarity=0.292  Sum_probs=184.6

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHH-HHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVK-TLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.| +||+||+|... +|+.||+|++.....   ....++..|.. +++.++||||+++++++.+.+..|+||||+++|
T Consensus         3 lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           3 IGKG-SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeC-CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            4444 59999999764 799999999865321   22234445544 567889999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.. .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (323)
T cd05575          82 ELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTST  155 (323)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccccc
Confidence            9999987653 688999999999999999999999   99999999999999999999999999987542211  12234


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ..........    .+.+       ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~~~----~~~~-------~~  219 (323)
T cd05575         156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE-----MYDNILNKPL----RLKP-------NI  219 (323)
T ss_pred             ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH-----HHHHHHcCCC----CCCC-------CC
Confidence            458999999999988889999999999999999999999997643322     1111111110    0111       12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMF  846 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~  846 (876)
                      ...+.+++.+|++.||++||+++
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         220 SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CHHHHHHHHHHhhcCHHhCCCCC
Confidence            34578999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-34  Score=315.95  Aligned_cols=238  Identities=21%  Similarity=0.275  Sum_probs=187.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEc
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ....+|.|| ||.||+|... +++.||+|++.....   .....+..|..++..+ +|++|+++++++.+.+..|+||||
T Consensus         4 ~~~~lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           4 FLMVLGKGS-FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             EEEEEeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            344556665 9999999665 688999999875321   2234566788888777 589999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .
T Consensus        83 ~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~  156 (323)
T cd05616          83 VNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--V  156 (323)
T ss_pred             CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--C
Confidence            99999999887654 689999999999999999999999   99999999999999999999999999987543221  1


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|+|||++.+..++.++|||||||++|||+||+.||.......  ....+.   ...        ..   .
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~~~i~---~~~--------~~---~  220 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSIM---EHN--------VA---Y  220 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HHHHHH---hCC--------CC---C
Confidence            1233458999999999998899999999999999999999999997654322  111111   111        00   0


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      +......+.+++.+|++.+|++|++.
T Consensus       221 p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            11223457899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=298.60  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=198.5

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...++.|+ ||.||+|... +++.+|+|.+..........+.+|++++++++||||+++++++.+.+..+++|||+++++
T Consensus         8 ~~~l~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~   86 (262)
T cd06613           8 IQRIGSGT-YGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGS   86 (262)
T ss_pred             EEEecCCC-ceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCc
Confidence            34455554 9999999764 688999999976555566788999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++......+++..+..++.|++.|++|||+.   +++||||||+||++++++.+||+|||.+.......  ......
T Consensus        87 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~  161 (262)
T cd06613          87 LQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSF  161 (262)
T ss_pred             HHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh--hccccc
Confidence            9999977656799999999999999999999999   99999999999999999999999999987764321  112234


Q ss_pred             cccccccCccccCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          745 YALSCYNAPEYGYSK---KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~---~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      .++..|+|||.....   .++.++||||||+++|||++|+.||......... .. .... .        +.+.......
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-~~-~~~~-~--------~~~~~~~~~~  230 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-FL-ISKS-N--------FPPPKLKDKE  230 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHhc-c--------CCCccccchh
Confidence            578889999998766   7889999999999999999999999764432211 11 1100 0        0111111122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+..+.+++.+||..+|.+|||++++++
T Consensus       231 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             hhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            34456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.9e-34  Score=311.27  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=196.7

Q ss_pred             ccCCCCCCCCceEEEEEEeC--------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP--------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      ....+|.|| ||.||+|...        .+..||+|.+..... .....+..|+++++++ +||||+++++++.+.+..+
T Consensus        16 ~~~~lg~G~-~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (314)
T cd05099          16 LGKPLGEGC-FGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY   94 (314)
T ss_pred             eeeeecCCC-cccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence            335555555 9999998642        345799998864322 2245678899999999 6999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          655 LIYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +||||+++|+|.+++....               ..+++..+.+++.|++.|++|||+.   +++||||||+||++++++
T Consensus        95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~  171 (314)
T cd05099          95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDN  171 (314)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCC
Confidence            9999999999999986532               3588999999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~  798 (876)
                      .+|++|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...+...  .....
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~~~~~  249 (314)
T cd05099         172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--LFKLL  249 (314)
T ss_pred             cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence            999999999987653222111222224467999999888889999999999999999999 888886544322  12211


Q ss_pred             HHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ..   ..  ..        .........+.+++.+||..+|++|||+.|+++.|+++..
T Consensus       250 ~~---~~--~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         250 RE---GH--RM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             Hc---CC--CC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11   00  00        0011223467799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.6e-34  Score=304.29  Aligned_cols=247  Identities=27%  Similarity=0.375  Sum_probs=193.4

Q ss_pred             CCCCCCceEEEEEEeCC-------CcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          589 AGNGGPFGRVYILSLPS-------GELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|.|+ ||.||+|...+       ++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus         3 lg~g~-~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           3 LGSGA-FGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccc-ceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            44444 99999997542       3679999875432 234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-----CeEEccccch
Q 002826          661 QMGSLGDLICRQ------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-----EPKLTDFALD  729 (876)
Q Consensus       661 ~~gsL~~~l~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-----~~kl~DfGla  729 (876)
                      ++++|.+++.+.      ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999998643      23478899999999999999999998   999999999999999877     8999999998


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      +...............++..|+|||...+..++.++||||||+++|||++ |+.||......  ............    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~~~----  232 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAGGRL----  232 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcCCcc----
Confidence            76643322222223345678999999988889999999999999999998 99998653322  122221110000    


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                               ......+..+.+++.+||..+|++||++.++.+.|++
T Consensus       233 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         233 ---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                     0111224467899999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.2e-34  Score=320.49  Aligned_cols=251  Identities=21%  Similarity=0.252  Sum_probs=194.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        44 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          44 DFDVIKVIGRGA-FGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HcEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            344445555555 9999999664 78999999996432   223455778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       123 Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         123 EYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999998654  478888999999999999999999   999999999999999999999999999876643221


Q ss_pred             ccccccccccccccCccccCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK----KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                       .......||+.|+|||.+...    .++.++|||||||++|||++|+.||........     ........   .....
T Consensus       198 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~---~~~~~  268 (370)
T cd05596         198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMDHK---NSLTF  268 (370)
T ss_pred             -ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-----HHHHHcCC---CcCCC
Confidence             112334689999999987643    478899999999999999999999987543221     11111100   00000


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                      |.    ....+..+.+++.+|+..+|++  |||+.|+++.
T Consensus       269 ~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 PD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11    0112346789999999999988  9999999765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.3e-34  Score=300.91  Aligned_cols=243  Identities=24%  Similarity=0.431  Sum_probs=192.8

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEE-eCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH-SDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|| ||.||++.. .|..||+|.+...  ...+.+.+|+.++++++|+|++++++++. +++..++||||+++++
T Consensus        11 ~~~lg~g~-~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~   86 (256)
T cd05082          11 LQTIGKGE-FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   86 (256)
T ss_pred             eeeecccC-CCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence            34555555 999999976 5888999998543  34567889999999999999999999765 4567899999999999


Q ss_pred             HHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++.+.. ..+++..+.+++.|++.|++|||+.   +++||||||+||++++++.+|++|||++.......     ..
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~  158 (256)
T cd05082          87 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  158 (256)
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-----CC
Confidence            999987653 3588999999999999999999999   99999999999999999999999999987543321     12


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||......++.++||||||+++|||++ |+.||.......  ....+....  .    .    .   ....
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~~~~~~~~--~----~----~---~~~~  223 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY--K----M----D---APDG  223 (256)
T ss_pred             CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCC--C----C----C---CCCC
Confidence            224567999999988889999999999999999998 999987543221  222221110  0    0    0   0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            234678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-34  Score=301.38  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=193.6

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc-----CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ-----SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+.|++|.||+|.. .+++.||+|.+......     ....+.+|++++++++||||+++++++.+++..++|+||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            33444445999999965 47899999998653221     2246788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc-c
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ-S  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~  739 (876)
                      ++++|.+++...+ .+++..+.+++.|++.|++|||+.   +++||||+|+||+++++++++|+|||+++........ .
T Consensus        87 ~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~  162 (263)
T cd06625          87 PGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGT  162 (263)
T ss_pred             CCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccc
Confidence            9999999987654 688999999999999999999999   9999999999999999999999999998765432111 1


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++||||+|+++||+++|+.||........  .   .......  .    .+   ..
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~--~----~~---~~  228 (263)
T cd06625         163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--I---FKIATQP--T----NP---QL  228 (263)
T ss_pred             cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--H---HHHhccC--C----CC---CC
Confidence            11234477889999999888899999999999999999999999875432211  1   1111000  0    01   11


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||..+|.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11233467899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=318.08  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=206.7

Q ss_pred             CCCCCCCCceEEEEEEe-CCCc----EEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGE----LIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .+..|.|+||+||+|.+ +.|+    +||+|++... ..+...++.+|+.+|.+++|||+++++|+|.... ..+|++|+
T Consensus       701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m  779 (1177)
T KOG1025|consen  701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM  779 (1177)
T ss_pred             hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence            44556667999999965 4454    6799988543 3345688999999999999999999999998765 88999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +.|+|.++++.++..+.......+..|||+||.|||++   .++||||.++||||..-..+||.|||+++..........
T Consensus       780 P~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~  856 (1177)
T KOG1025|consen  780 PLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS  856 (1177)
T ss_pred             ccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence            99999999998888899999999999999999999999   999999999999999999999999999998875543333


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....-.+.|||-|.+....++.++|||||||++||++| |..|+++.+.++.  .+..+..           ++  ...
T Consensus       857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--~dlle~g-----------eR--Lsq  921 (1177)
T KOG1025|consen  857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--PDLLEKG-----------ER--LSQ  921 (1177)
T ss_pred             ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--hHHHhcc-----------cc--CCC
Confidence            333334567999999999999999999999999999999 9999987665443  1221111           00  122


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ++....++..++.+||..|++.||+++++...+.++..
T Consensus       922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  922 PPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             CCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            33445678899999999999999999999999998754

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-34  Score=305.61  Aligned_cols=251  Identities=23%  Similarity=0.399  Sum_probs=197.8

Q ss_pred             CCCCCCCCceEEEEEEeC-CCc----EEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGE----LIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||.||+|..+ +|+    .||+|....... ....++.+|++++++++|||++++++++.. ...++||||+
T Consensus        13 ~~ig~g~-~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   90 (279)
T cd05057          13 KVLGSGA-FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM   90 (279)
T ss_pred             ceecCCC-CccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence            4455555 9999999754 333    589998765432 234578899999999999999999999987 7889999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|+|.+++.+....+++..+.+++.|++.|++|||+.   +++||||||+||++++++.+||+|||.++..........
T Consensus        91 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  167 (279)
T cd05057          91 PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYH  167 (279)
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCccccee
Confidence            99999999987766799999999999999999999998   999999999999999999999999999987653322111


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....++..|+|||......++.++|+||||+++||+++ |+.||.....+.  ....+......       -.+.    
T Consensus       168 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~-------~~~~----  234 (279)
T cd05057         168 AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEKGERL-------PQPP----  234 (279)
T ss_pred             cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhCCCCC-------CCCC----
Confidence            222224567999999888888999999999999999998 999997654332  22222211000       0011    


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                        .....+.+++.+||..+|.+||++.++++.|+++..
T Consensus       235 --~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         235 --ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence              112357899999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=7.4e-34  Score=302.74  Aligned_cols=250  Identities=25%  Similarity=0.343  Sum_probs=185.5

Q ss_pred             CCCCCCceEEEEEEeCC---CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSLPS---GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|.|+ ||.||+|...+   ...+|+|.+..... .....+.+|++.++.++||||+++++++.+.+..++||||+++|+
T Consensus         3 lg~G~-fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           3 IGNGW-FGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             CCccC-CceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            45555 99999996543   45788887754322 224567889999999999999999999999999999999999999


Q ss_pred             HHHHhhccC----CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          665 LGDLICRQD----FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       665 L~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      |.+++.+..    ...++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997642    2346788899999999999999999   999999999999999999999999999876443322222


Q ss_pred             cccccccccccCccccC-------CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          741 MSSEYALSCYNAPEYGY-------SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....++..|+|||+..       ...++.++||||+||++|||++ |..||........ .......   .   .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~---~---~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-LKQVVRE---Q---DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHhhc---c---CccCC
Confidence            23334567799999853       2356789999999999999999 7888865432221 1111111   0   11111


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ++...   ......+.+++..|| .||++|||++||++.|.
T Consensus       232 ~~~~~---~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQLD---LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCccc---ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22211   122345667888898 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-34  Score=318.00  Aligned_cols=240  Identities=24%  Similarity=0.277  Sum_probs=186.5

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHH-HHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVK-TLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||+||+|.. .+|+.||+|++.....   .....+..|.. +++.++||||+++++++..++..|+||||+++|
T Consensus         3 lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           3 IGKGS-FGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            44544 999999965 4799999999865321   22344555554 467789999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+. ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  155 (325)
T cd05604          82 ELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTT  155 (325)
T ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCccc
Confidence            999888654 3689999999999999999999999   99999999999999999999999999987532211  12233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.......     ..+......    ..+.+       ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~-----~~~~~~~~~----~~~~~-------~~  219 (325)
T cd05604         156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE-----MYDNILHKP----LVLRP-------GA  219 (325)
T ss_pred             ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH-----HHHHHHcCC----ccCCC-------CC
Confidence            458999999999998889999999999999999999999997644322     111111111    01111       12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+.+++.+|++.+|.+||++++.++.
T Consensus       220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         220 SLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             CHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence            3456789999999999999988644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.2e-34  Score=314.08  Aligned_cols=258  Identities=24%  Similarity=0.334  Sum_probs=195.2

Q ss_pred             cccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCcc-CHHHHHHHHHHHhhc-cCccccceeeEEEeC-CeEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD-ESIF  654 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~  654 (876)
                      +++.+..|.|+||+||+|..      .+++.||||++...... ....+.+|+.++.++ +||||+++++++... ...+
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence            34444455555999999953      35789999998653322 235678899999999 689999999988654 5689


Q ss_pred             EEEEcCCCCCHHHHhhccC-------------------------------------------------------------
Q 002826          655 LIYEFLQMGSLGDLICRQD-------------------------------------------------------------  673 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~-------------------------------------------------------------  673 (876)
                      +||||+++|+|.+++....                                                             
T Consensus        89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (343)
T cd05103          89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ  168 (343)
T ss_pred             EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence            9999999999999986421                                                             


Q ss_pred             -----CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccc
Q 002826          674 -----FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS  748 (876)
Q Consensus       674 -----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~  748 (876)
                           ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++...............++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                 2367888899999999999999999   99999999999999999999999999988754322212222233567


Q ss_pred             cccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHH
Q 002826          749 CYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA  827 (876)
Q Consensus       749 ~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  827 (876)
                      .|+|||...+..++.++||||||+++|||++ |..||........ .......   ..   .    +....   .....+
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~---~~---~----~~~~~---~~~~~~  311 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKE---GT---R----MRAPD---YTTPEM  311 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhc---cC---C----CCCCC---CCCHHH
Confidence            7999999888889999999999999999997 9999875432211 1111111   00   0    00000   112357


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          828 LEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       828 ~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .+++.+||+.+|++|||+.|+++.|+.+.+.
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            8999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-34  Score=316.82  Aligned_cols=241  Identities=23%  Similarity=0.269  Sum_probs=186.1

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHH-HHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEV-KTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||+||+|... +++.||+|++.....   .....+..|. .+++.++||||+++++++.+.+..|+||||++++
T Consensus         3 lg~G~-fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           3 IGKGS-FGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            45555 9999999665 678999999865321   2223344444 4567789999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~  155 (325)
T cd05602          82 ELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTST  155 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCccc
Confidence            9999987654 578888899999999999999999   99999999999999999999999999987543221  12234


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||++.+..++.++||||+||++|||++|++||........  ....   .....    .+.+       ..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i---~~~~~----~~~~-------~~  219 (325)
T cd05602         156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNI---LNKPL----QLKP-------NI  219 (325)
T ss_pred             ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHHH---HhCCc----CCCC-------CC
Confidence            4589999999999988899999999999999999999999976443221  1111   11110    0111       12


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      ...+.+++.+|++.+|.+||++.+.++.+
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         220 TNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            33578999999999999999987544433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=9.5e-34  Score=314.92  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=190.7

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCC------
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------  651 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  651 (876)
                      ..|.....+|.|+ ||.||++.. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++...+      
T Consensus        21 ~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          21 KRYQQLKPIGSGA-QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hceEEEEEeecCC-CEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            3454455555555 999999965 479999999986432  233456788999999999999999999986543      


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~  172 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  172 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence            57999999976 66666532   478889999999999999999999   999999999999999999999999999876


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHH-------------
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV-------------  798 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~-------------  798 (876)
                      .....   ......||..|+|||.+.+..++.++||||+||++|||++|+.||........ .....             
T Consensus       173 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         173 ACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHHHH
Confidence            53321   12334588999999999988899999999999999999999999986543211 00000             


Q ss_pred             -----HHHhhcccccc---------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          799 -----RRKINITNGAI---------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       799 -----~~~~~~~~~~~---------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           ...........         ....+............+.+++.+|++.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 00000000000         000000000111123467899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-34  Score=303.37  Aligned_cols=246  Identities=22%  Similarity=0.347  Sum_probs=190.2

Q ss_pred             CCCCCCceEEEEEEeC-CCc--EEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGE--LIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||.||+|..+ ++.  .+|+|.+.... ......+.+|+++++++ +||||+++++++...+..++||||++++
T Consensus         3 lg~g~-~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           3 IGEGN-FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             CCCCC-CceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            44455 9999999765 343  46888876432 23345788999999999 7999999999999999999999999999


Q ss_pred             CHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          664 SLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       664 sL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      +|.+++....               ..+++..+..++.|++.|++|||+.   +++||||||+||++++++.+|++|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence            9999986532               2478999999999999999999998   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      +.......   .......+..|+|||......++.++||||||+++|||++ |..||.......     ..+......  
T Consensus       159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~--  228 (270)
T cd05047         159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQGY--  228 (270)
T ss_pred             ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH-----HHHHHhCCC--
Confidence            86332111   1111223567999999888889999999999999999997 999986533221     111111100  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                       .    ..   ........+.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus       229 -~----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 -R----LE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -C----CC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             0    00   01112345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.2e-34  Score=313.83  Aligned_cols=257  Identities=26%  Similarity=0.389  Sum_probs=198.0

Q ss_pred             ccCCCCCCCCceEEEEEEeC--------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP--------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      .+.+..+.|+||.||+|...        .+..||+|.+..... ....++.+|+++++++ +||||+++++++.+++..+
T Consensus        15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   94 (334)
T cd05100          15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY   94 (334)
T ss_pred             eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence            34444445559999999642        224789998764322 2245788999999999 7999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          655 LIYEFLQMGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +||||+++|+|.+++.+.               ...+++.++.+++.|++.|++|||+.   +++||||||+||+++.++
T Consensus        95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~  171 (334)
T cd05100          95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence            999999999999998653               23478899999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~  798 (876)
                      .+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||...+.+.  .....
T Consensus       172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~  249 (334)
T cd05100         172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFKLL  249 (334)
T ss_pred             cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence            999999999987654322222222234567999999988889999999999999999998 888887544322  11111


Q ss_pred             HHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      .   ...  ...        ........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus       250 ~---~~~--~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         250 K---EGH--RMD--------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             H---cCC--CCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence            1   100  000        01122346789999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.4e-34  Score=303.84  Aligned_cols=238  Identities=20%  Similarity=0.267  Sum_probs=185.0

Q ss_pred             CCCCCCceEEEEEEeCC-------------------------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccce
Q 002826          589 AGNGGPFGRVYILSLPS-------------------------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV  643 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  643 (876)
                      +|.|+ ||.||+|.+..                         ...||+|++.........++.+|+.+++.++||||+++
T Consensus         3 lG~G~-~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           3 LGQGT-RTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             cCccc-ccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            45554 99999986421                         23588998865433344578889999999999999999


Q ss_pred             eeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----
Q 002826          644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----  719 (876)
Q Consensus       644 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----  719 (876)
                      ++++.++...++||||+++|+|.+++.+....+++..+.+++.|+++||+|||+.   +|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999977666789999999999999999999999   999999999999997543    


Q ss_pred             ---CeEEccccchhhccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHH-hCCCCCCCCCcchhhH
Q 002826          720 ---EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELI-TGRQAEQAEPAESLDV  794 (876)
Q Consensus       720 ---~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~ell-tg~~p~~~~~~~~~~~  794 (876)
                         .+|++|||.+......      ....++..|+|||.+.. ..++.++||||||+++||++ +|+.||........  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               3799999987544221      12236778999998765 56889999999999999995 69998875433221  


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ..+........               ......+.+++.+||+.+|++|||+.++++.|.
T Consensus       231 ~~~~~~~~~~~---------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEKKHRLP---------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHhccCCC---------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11111110000               011235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.7e-34  Score=304.82  Aligned_cols=248  Identities=20%  Similarity=0.282  Sum_probs=193.6

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +.+..+.|+||.||+|... ++..+|+|.+..........+.+|+++++.++|||++++++++..++..++||||+++++
T Consensus         9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~   88 (282)
T cd06643           9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   88 (282)
T ss_pred             HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCc
Confidence            3333444559999999765 578889999865444445678889999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+....+++..+..++.|++.||+|||+.   +++||||||+||+++.++++|++|||++.......  ......
T Consensus        89 l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~  163 (282)
T cd06643          89 VDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSF  163 (282)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc--cccccc
Confidence            9998876556799999999999999999999999   99999999999999999999999999987653221  112234


Q ss_pred             cccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          745 YALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       745 ~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .++..|+|||.+.     ...++.++||||+||++|||++|++||........ .......   ..   .....      
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~---~~---~~~~~------  230 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKS---EP---PTLAQ------  230 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhc---CC---CCCCC------
Confidence            5788999999863     34567899999999999999999999876432221 1111110   00   00001      


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||+.+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11123467899999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.8e-34  Score=300.91  Aligned_cols=249  Identities=24%  Similarity=0.426  Sum_probs=196.9

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| ||.||+|...++..||+|.+.... ...+.+.+|++++++++|+|++++++++.+ ...+++|||+++++
T Consensus        10 ~~~~lg~g~-~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~   86 (260)
T cd05073          10 LEKKLGAGQ-FGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS   86 (260)
T ss_pred             EEeEecCcc-ceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence            334455555 999999988788889999886432 345678899999999999999999999887 77899999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++.+. +..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++....... .....
T Consensus        87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~  162 (260)
T cd05073          87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREG  162 (260)
T ss_pred             HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc-ccccC
Confidence            99999764 45688999999999999999999998   999999999999999999999999999876543221 11122


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||.+....++.++||||||+++|++++ |+.||.......  ...+.......         +    ....
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~---------~----~~~~  227 (260)
T cd05073         163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRM---------P----RPEN  227 (260)
T ss_pred             CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhCCCCC---------C----Cccc
Confidence            235567999999988889999999999999999999 999987543221  22221111000         0    0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .+..+.+++.+|++++|++||++.++.+.|+.+
T Consensus       228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            334688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.6e-34  Score=303.85  Aligned_cols=251  Identities=22%  Similarity=0.354  Sum_probs=196.4

Q ss_pred             CCCCCCCCceEEEEEEeCC----CcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLPS----GELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.| +||.||+|...+    ...||+|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        12 ~~lg~g-~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          12 RCIGEG-QFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeCCc-cceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            344544 499999996543    3478999886543 2345678899999999999999999999875 55789999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++......... .
T Consensus        90 ~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~  165 (270)
T cd05056          90 LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-A  165 (270)
T ss_pred             CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccccee-c
Confidence            9999999987665789999999999999999999999   99999999999999999999999999987664432211 1


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||.+....++.++||||||+++||+++ |+.||.......  ...........      ..       .
T Consensus       166 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~------~~-------~  230 (270)
T cd05056         166 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIENGERL------PM-------P  230 (270)
T ss_pred             CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCcC------CC-------C
Confidence            22234567999999888888999999999999999986 999997654322  11221111000      00       1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...+..+.+++.+|+..+|++|||+.++++.|+++..+
T Consensus       231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            12234688999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.9e-34  Score=299.63  Aligned_cols=245  Identities=21%  Similarity=0.340  Sum_probs=197.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ....++.|+ ||.||+|... +++.||+|.+.....  ..++.+|++++++++||||+++++++.+++..|+++||++++
T Consensus         7 ~~~~i~~g~-~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   83 (256)
T cd06612           7 ILEKLGEGS-YGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAG   83 (256)
T ss_pred             hhhhhcCCC-CeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCC
Confidence            334455555 9999999776 489999999865432  678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||++........  ....
T Consensus        84 ~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~  158 (256)
T cd06612          84 SVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNT  158 (256)
T ss_pred             cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc--cccc
Confidence            99999987667899999999999999999999999   999999999999999999999999999887654321  1223


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..++..|+|||...+..++.++||||||+++|||++|+.||........  .....   ..   ..    +.. ......
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~~~~---~~---~~----~~~-~~~~~~  225 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IFMIP---NK---PP----PTL-SDPEKW  225 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hhhhc---cC---CC----CCC-Cchhhc
Confidence            3477889999998888899999999999999999999999975433221  00000   00   00    000 111123


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ...+.+++.+||+.+|++|||++|+++
T Consensus       226 ~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         226 SPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            346889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=322.42  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=190.9

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||+||+++. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         3 y~~~~~lG~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           3 FHTVKVIGKGA-FGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             ceEeEEEeecC-CEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            33345556555 999999965 479999999986532   1223567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.+......
T Consensus        82 ~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          82 FLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            99999999998765 3688999999999999999999999   9999999999999999999999999998643210000


Q ss_pred             ------------c---------------------------------ccccccccccccCccccCCCCCCCccchHHHHHH
Q 002826          739 ------------S---------------------------------TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVV  773 (876)
Q Consensus       739 ------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~  773 (876)
                                  .                                 ......||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                        0                                 0012358999999999988889999999999999


Q ss_pred             HHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 002826          774 LLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR---PSMFEVVK  850 (876)
Q Consensus       774 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~ell~  850 (876)
                      +|||++|+.||........ .....    .... ....  |..    ......+.+++.+|+. +|.+|   +++.|+++
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~~i~----~~~~-~~~~--p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         238 MFECLIGWPPFCSENSHET-YRKII----NWRE-TLYF--PDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHH-HHHHH----ccCC-ccCC--CCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999999976543221 11111    0000 0000  100    0123457789999997 67765   59999887


Q ss_pred             H
Q 002826          851 A  851 (876)
Q Consensus       851 ~  851 (876)
                      .
T Consensus       305 h  305 (377)
T cd05629         305 H  305 (377)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-33  Score=302.33  Aligned_cols=256  Identities=27%  Similarity=0.393  Sum_probs=199.9

Q ss_pred             cCCCCCCCCceEEEEEEeC-----CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP-----SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  657 (876)
                      ...+|.|| ||.||+|...     +++.||+|++...... ....+.+|+++++.++||||+++++++..  ....++||
T Consensus         9 ~~~ig~g~-~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   87 (284)
T cd05038           9 IKQLGEGH-FGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIM   87 (284)
T ss_pred             heeeccCC-CeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEE
Confidence            34455555 9999999753     4789999999765432 35678999999999999999999999887  55799999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+........
T Consensus        88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  164 (284)
T cd05038          88 EYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD  164 (284)
T ss_pred             ecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCc
Confidence            99999999999987766799999999999999999999999   999999999999999999999999999987753221


Q ss_pred             c-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh----------HHHHHHHHhhccc
Q 002826          738 Q-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD----------VVKWVRRKINITN  806 (876)
Q Consensus       738 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~~  806 (876)
                      . .......++..|+|||......++.++||||||+++|||++|+.|+.........          ...+.......  
T Consensus       165 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  242 (284)
T cd05038         165 YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG--  242 (284)
T ss_pred             ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC--
Confidence            1 1111223456699999988888999999999999999999999998764332211          11111111000  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                       ...       .........+.+++.+||+.+|++|||+.|++++|+++
T Consensus       243 -~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         243 -ERL-------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             -CcC-------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             000       00112235688999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=9.5e-34  Score=305.13  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=189.6

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhc---cCccccceeeEEEe-----CCeEE
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKI---RHKNIVKVLGFFHS-----DESIF  654 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~~~  654 (876)
                      ...+|.|+ ||+||+|... +|+.||+|.+......  ....+.+|+++++.+   +||||+++++++..     ....+
T Consensus         5 ~~~lg~g~-~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~   83 (288)
T cd07863           5 VAEIGVGA-YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT   83 (288)
T ss_pred             eeEEeecC-CeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence            34455555 9999999664 7899999998653222  234566788877766   69999999998864     24589


Q ss_pred             EEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          655 LIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      +||||+++ +|.+++.+. ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        84 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          84 LVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             EEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            99999985 898888664 34589999999999999999999999   99999999999999999999999999998764


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-c--------
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-I--------  804 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~--------  804 (876)
                      ...   ......++..|+|||.+.+..++.++||||+||++|||++|++||........ .......... .        
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         160 CQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             Ccc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-HHHHHHHhCCCChhhCcccc
Confidence            322   12234578899999999888899999999999999999999999976543221 1111111000 0        


Q ss_pred             --c-cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 --T-NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 --~-~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        . .....................+.+++.+|+++||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence              0 000000001111222233456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-34  Score=320.47  Aligned_cols=249  Identities=22%  Similarity=0.278  Sum_probs=188.7

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+..+|.|+ ||+||+|+. .+++.||+|++.....   .....+.+|++++++++||||+++++++.+++..|+||||
T Consensus         4 ~~~~~LG~G~-~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~   82 (382)
T cd05625           4 VKIKTLGIGA-FGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY   82 (382)
T ss_pred             EEEEEEEeCC-CEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence            3445556555 999999965 4789999999865321   2235678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc---
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA---  736 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~---  736 (876)
                      +++|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+++......   
T Consensus        83 ~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          83 IPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            99999999987654 688999999999999999999999   99999999999999999999999999975321000   


Q ss_pred             ------------------------------------------cccccccccccccccCccccCCCCCCCccchHHHHHHH
Q 002826          737 ------------------------------------------FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL  774 (876)
Q Consensus       737 ------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l  774 (876)
                                                                .........||+.|+|||++.+..++.++||||+||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                      00001123589999999999888899999999999999


Q ss_pred             HHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 002826          775 LELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVK  850 (876)
Q Consensus       775 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ell~  850 (876)
                      |||++|++||........ ...........       ..|..    ......+.+++.+|+ .+|++|++   +.|+++
T Consensus       239 ~elltG~~Pf~~~~~~~~-~~~i~~~~~~~-------~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         239 YEMLVGQPPFLAQTPLET-QMKVINWQTSL-------HIPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHhCCCCCCCCCHHHH-HHHHHccCCCc-------CCCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999986543221 11111000000       00100    111234667777765 59999987   887765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-34  Score=323.57  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=191.0

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .....+|.|+ ||.||+|+. .+++.||+|++....   ......+.+|++++++++||||+++++.+.+++..|+||||
T Consensus         4 ~~~~~lG~G~-~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           4 VKIKTIGIGA-FGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             eEEEEEEeCC-CeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            3345556555 999999965 478999999986432   12345678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc---
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA---  736 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~---  736 (876)
                      +++|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+....   
T Consensus        83 ~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          83 IPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            99999999997654 688999999999999999999999   99999999999999999999999999975331000   


Q ss_pred             --------------------------------------cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHH
Q 002826          737 --------------------------------------FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI  778 (876)
Q Consensus       737 --------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ell  778 (876)
                                                            .........||+.|+|||++.+..++.++||||+||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                  000011246899999999999888999999999999999999


Q ss_pred             hCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 002826          779 TGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRP---SMFEVVKA  851 (876)
Q Consensus       779 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~ell~~  851 (876)
                      +|+.||.........  .   ....... ...  .+..    ......+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       239 ~G~~Pf~~~~~~~~~--~---~i~~~~~-~~~--~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQ--L---KVINWET-TLH--IPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHH--H---HHhccCc-ccc--CCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999865433211  1   1000000 000  0100    112334667788876 5999999   88998876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=312.16  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=202.9

Q ss_pred             CCCCCCCCceEEEEEEeC--CCc--EEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP--SGE--LIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .++.|.|+||+|++|.|.  +|+  .||||++...... ....|.+|+.+|.+|+|||++++||++.+ ....+|||.++
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap  193 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP  193 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence            345566779999999774  455  5799999765443 56889999999999999999999999987 67889999999


Q ss_pred             CCCHHHHhhc-cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          662 MGSLGDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       662 ~gsL~~~l~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .|+|.+.+++ ....+-......++.|||.||.||.++   ++||||+..+|+++-....|||+|||+++-.+.......
T Consensus       194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv  270 (1039)
T KOG0199|consen  194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV  270 (1039)
T ss_pred             cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence            9999999987 455788899999999999999999999   999999999999999999999999999999885543333


Q ss_pred             cc-cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          741 MS-SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       741 ~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      +. ...-...|+|||.+...+++.++|||+|||++|||+| |..||.+...-.  +.+.+..             .....
T Consensus       271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--IL~~iD~-------------~erLp  335 (1039)
T KOG0199|consen  271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--ILKNIDA-------------GERLP  335 (1039)
T ss_pred             ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--HHHhccc-------------cccCC
Confidence            33 3334567999999999999999999999999999999 788888754322  1111110             11112


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ....+.+++++++..||..+|++|||+..|.+.+-....
T Consensus       336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea  374 (1039)
T KOG0199|consen  336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA  374 (1039)
T ss_pred             CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence            233456689999999999999999999999865544433

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.2e-34  Score=314.89  Aligned_cols=235  Identities=22%  Similarity=0.273  Sum_probs=183.5

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHH-HHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVK-TLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|| ||.||+|+.. +|+.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..|+||||++++
T Consensus         3 lg~G~-~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           3 IGKGS-FGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeCC-CEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            44554 9999999764 789999999865321   22334445544 678889999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+.+.+. ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (321)
T cd05603          82 ELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTST  155 (321)
T ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccccc
Confidence            999888654 3688899999999999999999999   99999999999999999999999999987532211  12233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     .........   .        ......
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~---~--------~~~~~~  219 (321)
T cd05603         156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ-----MYDNILHKP---L--------QLPGGK  219 (321)
T ss_pred             ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH-----HHHHHhcCC---C--------CCCCCC
Confidence            458999999999988889999999999999999999999997654322     111111111   0        011122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMF  846 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~  846 (876)
                      ...+.+++.+|++.||.+||++.
T Consensus       220 ~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         220 TVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CHHHHHHHHHHccCCHhhcCCCC
Confidence            34578999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-34  Score=318.18  Aligned_cols=258  Identities=21%  Similarity=0.218  Sum_probs=193.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC---CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP---SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.| +||.||++...   .++.||+|.+...     ....+|++++++++||||+++++++...+..++|||+
T Consensus        94 y~i~~~Lg~G-~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         94 YNILSSLTPG-SEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             eEEEEeecCC-CCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            4444455554 59999998643   4678999987542     3456899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +. ++|.+++.. ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus       168 ~~-~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~  242 (392)
T PHA03207        168 YK-CDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP  242 (392)
T ss_pred             cC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence            86 588888844 45799999999999999999999999   99999999999999999999999999998765433322


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--hhHHHHHHHHhhccccccc-------
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES--LDVVKWVRRKINITNGAIQ-------  810 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~-------  810 (876)
                      ......||..|+|||++....++.++||||+||++|||++|+.||.......  ..+....+...........       
T Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            3334568999999999988889999999999999999999999997654322  1111111111000000000       


Q ss_pred             --------ccChhh--hhh--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 --------VLDPKI--ANC--YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 --------~~d~~~--~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                              ...+..  ...  ......++.+++.+|+..||++|||+.|++..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    000000  000  00123467789999999999999999999986

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6.6e-34  Score=308.56  Aligned_cols=254  Identities=23%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCc----EEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGE----LIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||.||+|... +|+    .||+|.+..... ....++.+|+.+++.++||||++++|++... ..++++|
T Consensus        11 ~~~~lg~G~-~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          11 RVKVLGSGA-FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eccccccCC-CccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            445566655 9999999653 454    578888764322 2234678899999999999999999998754 4679999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        89 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  165 (303)
T cd05110          89 LMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE  165 (303)
T ss_pred             hcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccc
Confidence            9999999999987666789999999999999999999999   9999999999999999999999999999876533221


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......++..|+|||...+..++.++||||||+++||+++ |+.||.......  ..++........       .+   
T Consensus       166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~-------~~---  233 (303)
T cd05110         166 YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEKGERLP-------QP---  233 (303)
T ss_pred             cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHCCCCCC-------CC---
Confidence            12223335678999999888889999999999999999997 889987644222  222222111000       00   


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                         ......+.+++.+||..+|++||++.|+++.++++...
T Consensus       234 ---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         234 ---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence               11234678999999999999999999999999997544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.5e-34  Score=303.23  Aligned_cols=239  Identities=21%  Similarity=0.301  Sum_probs=186.7

Q ss_pred             CCCCCCCceEEEEEEeC-C-------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSLP-S-------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .+|.|| ||.||+|... .       ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~lg~G~-~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           2 SLGQGT-FTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCccc-chhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            355555 9999999653 2       335888887654434456788899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC--------eEEccccchhh
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE--------PKLTDFALDRI  731 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~--------~kl~DfGla~~  731 (876)
                      +++|+|.+++.+.+..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999987766789999999999999999999999   9999999999999987765        59999998865


Q ss_pred             ccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGR-QAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ....      ....++..|+|||.+.+. .++.++||||||+++|||++|. .||.......  .......    .   .
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~----~---~  222 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYED----R---H  222 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHc----c---c
Confidence            5432      123367789999998763 5788999999999999999995 5554322211  1111111    0   0


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      . +       ......++.+++.+||+.+|++|||++|+++.|+
T Consensus       223 ~-~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         223 Q-L-------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c-C-------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0 0       0111235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-33  Score=300.33  Aligned_cols=243  Identities=25%  Similarity=0.374  Sum_probs=192.4

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCH---------HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSS---------KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ..+.|++|.||+|.. .+++.||+|.+........         +.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         7 ~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (267)
T cd06628           7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE   86 (267)
T ss_pred             eeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence            344455999999965 4689999998865433221         467889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++++|.+++.+. ..+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+||+|||.++........
T Consensus        87 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06628          87 YVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLS  162 (267)
T ss_pred             ecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccccccc
Confidence            99999999999765 3688999999999999999999999   9999999999999999999999999998876522111


Q ss_pred             ----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          739 ----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       739 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                          .......|+..|+|||...+..++.++||||+|+++|+|++|+.||........     +.....       ...+
T Consensus       163 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~-------~~~~  230 (267)
T cd06628         163 TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFKIGE-------NASP  230 (267)
T ss_pred             CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHHHhc-------cCCC
Confidence                111223477889999999888889999999999999999999999976432111     111100       0111


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ...   ......+.+++.+||++||++||++.|+++
T Consensus       231 ~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         231 EIP---SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCC---cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111   123346789999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=8e-34  Score=317.00  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCC-----eEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-----SIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  656 (876)
                      ....+|.|| ||.||+|.. .+|+.||+|++....  .....++.+|+++++.++||||+++++++...+     ..|+|
T Consensus         4 ~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   82 (372)
T cd07853           4 PDRPIGYGA-FGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV   82 (372)
T ss_pred             ccceeeeCC-CEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence            344555555 999999965 479999999986432  123457889999999999999999999998766     78999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+.+ +|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        83 ~e~~~~-~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          83 TELMQS-DLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE  157 (372)
T ss_pred             eecccc-CHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCc
Confidence            999974 888877554 4689999999999999999999999   99999999999999999999999999997654322


Q ss_pred             cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-----------
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-----------  804 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----------  804 (876)
                      . .......++..|+|||.+.+. .++.++||||+||++|||++|+.||........  ...+......           
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         158 S-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             c-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHHhhH
Confidence            1 122334578899999988764 478999999999999999999999986543221  1111100000           


Q ss_pred             -------ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          805 -------TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       805 -------~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                             .........+............+.+++.+|++.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                   00000000000001111224567899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.1e-34  Score=322.71  Aligned_cols=254  Identities=20%  Similarity=0.297  Sum_probs=184.8

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC--------CeEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--------ESIFL  655 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~l  655 (876)
                      ....+|.|| ||.||+|.. .+++.||||++...    .....+|+.+++.++||||+++++++...        ...++
T Consensus        70 ~~~~LG~G~-fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         70 LGNIIGNGS-FGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EeEEEEeCC-CEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            334455555 999999966 47899999988542    23456799999999999999999887432        24679


Q ss_pred             EEEcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhh
Q 002826          656 IYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRI  731 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~  731 (876)
                      ||||+++ ++.+++..   ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.+ +.+||+|||+++.
T Consensus       145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~  220 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKN  220 (440)
T ss_pred             EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence            9999986 77776643   345789999999999999999999999   99999999999999865 4799999999987


Q ss_pred             ccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-----
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-----  805 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  805 (876)
                      ......   .....||+.|+|||++.+ ..++.++||||+||++|||++|++||....... ......+......     
T Consensus       221 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        221 LLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             ccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHH
Confidence            653321   123357889999998765 468999999999999999999999998654322 1111111100000     


Q ss_pred             ---cccc-----cccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 ---NGAI-----QVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ---~~~~-----~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         ....     ......+. ..+...+.++.+++.+||.+||.+|||+.|+++.
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence               0000     00000111 1111234578899999999999999999999854

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=299.46  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=205.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      +.|...+-.|.|-|++|-+|++ -+|..||||++.+..-  .....+.+|+..|+-++|||||++|++...+...|+|+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4445555555566999999855 4899999999976532  345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~  737 (876)
                      .-++|+|++++.++..-+.+..+.+.++||+.|+.|+|+.   ++||||+||+||.+- .-|-||+.|||++..+.++..
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k  174 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK  174 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence            9999999999998888899999999999999999999999   999999999998775 568999999999988776543


Q ss_pred             ccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                         ....+|...|-|||++.+..| .+++||||+||++|-+++|++||+...+.+.               +..++|-..
T Consensus       175 ---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCKY  236 (864)
T KOG4717|consen  175 ---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCKY  236 (864)
T ss_pred             ---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcccc
Confidence               344568999999999988765 4679999999999999999999987654432               111222211


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ..+.....++.++|..|+..||++|.+.+||+..
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence             1233455678999999999999999999999864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-33  Score=306.28  Aligned_cols=267  Identities=24%  Similarity=0.343  Sum_probs=198.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         8 y~~~~~lg~g~-~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           8 YIKLDKLGEGT-YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             eEEeeEeccCc-CEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            33444555555 9999999664 78999999986443 233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++ +|.+++.+....+++..+..++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||++.......  ..
T Consensus        87 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~  160 (301)
T cd07873          87 DK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KT  160 (301)
T ss_pred             cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--Cc
Confidence            75 99998877666789999999999999999999999   99999999999999999999999999987654322  11


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--cccccccc-----
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--TNGAIQVL-----  812 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-----  812 (876)
                      .....++..|+|||...+ ..++.++||||+|+++|||++|++||........  ..........  ........     
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCChhhchhhhccccc
Confidence            223346888999998765 3578899999999999999999999986543221  1111111100  00000000     


Q ss_pred             ----Chh-----hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcccC
Q 002826          813 ----DPK-----IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK--ALHSLSTR  858 (876)
Q Consensus       813 ----d~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~--~L~~i~~~  858 (876)
                          .+.     ...........+.+++.+|++.||.+|||++|+++  -++.+.++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence                000     00111122346789999999999999999999987  44444433

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-33  Score=300.33  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=193.3

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ....+|.|+ ||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus        13 ~~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~   91 (267)
T cd06645          13 LIQRIGSGT-YGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG   91 (267)
T ss_pred             HHHHhCCCC-CeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence            334555555 999999965 478999999987654344456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+ .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++.......  .....
T Consensus        92 ~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~  165 (267)
T cd06645          92 SLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI--AKRKS  165 (267)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--ccccc
Confidence            9999987654 689999999999999999999999   99999999999999999999999999987654321  12233


Q ss_pred             ccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          744 EYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       744 ~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ..|+..|+|||.+.   ...++.++||||+||++|||++|+.||........ .......  ...       .+... ..
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~--~~~-------~~~~~-~~  234 (267)
T cd06645         166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKS--NFQ-------PPKLK-DK  234 (267)
T ss_pred             ccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhcc--CCC-------CCccc-cc
Confidence            45888999999864   44578899999999999999999999865432211 0010000  000       01000 00


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......+.+++.+|++.+|++|||++++++
T Consensus       235 ~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            112335789999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-33  Score=299.96  Aligned_cols=247  Identities=23%  Similarity=0.316  Sum_probs=192.3

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|+ ||.||+|.. .+++.||+|.+..........+.+|++++++++|+||+++++++..++..++|+||+++++
T Consensus        13 ~~~lg~g~-~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          13 RVVLGKGT-YGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             eEEEecCC-ceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            34555555 999999965 4688999999876554556688999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcC--CHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhcccccccccc
Q 002826          665 LGDLICRQDFQL--QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       665 L~~~l~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      |.+++......+  ++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+|||.+........  ..
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~  166 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CT  166 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--cc
Confidence            999997654445  8888999999999999999999   9999999999999976 67999999999876543221  12


Q ss_pred             ccccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          742 SSEYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ....++..|+|||.....  .++.++||||+|+++|+|++|+.||........  ..+.......        .+.+   
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~--~~~~~~~~~~--------~~~~---  233 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA--AMFKVGMFKI--------HPEI---  233 (268)
T ss_pred             ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh--hHhhhhhhcc--------CCCC---
Confidence            223478889999987654  378899999999999999999999865322111  1111100000        0111   


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||+.+|++|||+.|+++.
T Consensus       234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            11223457899999999999999999999863

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-33  Score=303.02  Aligned_cols=257  Identities=22%  Similarity=0.306  Sum_probs=192.3

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|.|+ +|.||+|... +++.||+|++.....  .....+.+|+.++++++|||++++++++.+++..++||||++ 
T Consensus         5 ~~~l~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           5 IEKIGEGT-YGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             eeEecccC-ceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            34555555 9999999764 799999999864322  234678899999999999999999999999999999999997 


Q ss_pred             CCHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          663 GSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       663 gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|.+++...  +..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...+...  ..
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~  157 (285)
T cd07861          83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RV  157 (285)
T ss_pred             CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc--cc
Confidence            5898888654  25689999999999999999999999   99999999999999999999999999987654321  12


Q ss_pred             cccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--------------
Q 002826          741 MSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--------------  805 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------  805 (876)
                      .....++..|+|||...+. .++.++||||+|+++|||+||++||........ .....+......              
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhHHHH
Confidence            2333568889999987653 468899999999999999999999986443221 111111000000              


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ........+...........++.+++.+|++.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000001111111123456789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.4e-34  Score=311.81  Aligned_cols=237  Identities=20%  Similarity=0.282  Sum_probs=186.0

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ...+|.|+ ||+||+|... +|+.||+|++....   ......+..|..+++.+. |++|+++++++.+.+..|+||||+
T Consensus         5 ~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~   83 (323)
T cd05615           5 LMVLGKGS-FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYV   83 (323)
T ss_pred             EEEEEecC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCC
Confidence            34455555 9999999654 78999999987532   123355778888888885 578888999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  .
T Consensus        84 ~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~  157 (323)
T cd05615          84 NGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--T  157 (323)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--c
Confidence            9999999987654 689999999999999999999999   999999999999999999999999999875432211  1


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.......  ....+   .....        .   .+
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i---~~~~~--------~---~p  221 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQSI---MEHNV--------S---YP  221 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH---HhCCC--------C---CC
Confidence            223458999999999988889999999999999999999999997654322  11111   11110        0   01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      ......+.+++.+|++.+|.+|++.
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ccCCHHHHHHHHHHcccCHhhCCCC
Confidence            1123457889999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3e-33  Score=297.76  Aligned_cols=250  Identities=21%  Similarity=0.337  Sum_probs=184.4

Q ss_pred             CCCCCCceEEEEEEeCCCc---EEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSLPSGE---LIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|.|+ ||.||+++..++.   .+++|.+.... ....+.+.+|+..++.++||||+++++++.+....|+||||+++|+
T Consensus         3 lg~G~-~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           3 IGNGW-FGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             CCCCc-CceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            45555 9999999654443   45666654332 2335678899999999999999999999999999999999999999


Q ss_pred             HHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          665 LGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       665 L~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      |.+++.+.   ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999764   23466778889999999999999999   9999999999999999999999999997643222211222


Q ss_pred             ccccccccccCccccCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          742 SSEYALSCYNAPEYGYS-------KKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ....++..|+|||+...       ..++.++||||||+++|||++ |..||........ .......      ......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~------~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV-LNHVIKD------QQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhh------cccccCC
Confidence            33457888999998642       245788999999999999997 5667754332111 1111111      1122233


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      |.+...   ....+.+++..|| .+|++||+++|+++.|.
T Consensus       232 ~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333221   2345678899999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-34  Score=317.83  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=191.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|| ||.||+|+.. +++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        44 ~y~~~~~lG~G~-fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05621          44 DYDVVKVIGRGA-FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM  122 (370)
T ss_pred             HCeEEEEEEecC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            344444555555 9999999765 68899999986421   223456788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++...  .+++..+..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       123 Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         123 EYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            999999999999654  578899999999999999999999   999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCccccCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK----KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                       .......||+.|+|||.+...    .++.++||||+||++|||++|+.||........ ...........     ..  
T Consensus       198 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~-----~~--  268 (370)
T cd05621         198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-YSKIMDHKNSL-----NF--  268 (370)
T ss_pred             -eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCccc-----CC--
Confidence             122345689999999987643    378899999999999999999999976543221 11111100000     00  


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                      |.    .......+.+++.+|+..+|.+  ||++.|+++.
T Consensus       269 p~----~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         269 PE----DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CC----cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            00    0112345678889999755544  8999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-33  Score=313.46  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=191.5

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC------C
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------E  651 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  651 (876)
                      ..|.....+|.|| ||.||++.. ..++.||+|++.....  .....+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          17 KRYQNLKPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hceeEEEEeeecC-CEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            3454555566655 999999965 4789999999865322  2335677899999999999999999998643      3


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~  168 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccccc
Confidence            57999999976 67666643   478899999999999999999999   999999999999999999999999999986


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH-----------
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR-----------  800 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-----------  800 (876)
                      .....   ......||..|+|||.+.+..++.++|||||||++|||++|+.||........ .......           
T Consensus       169 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             CCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence            54322   12334588999999999888899999999999999999999999976543221 1100000           


Q ss_pred             -------HhhcccccccccChhh---------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 -------KINITNGAIQVLDPKI---------ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 -------~~~~~~~~~~~~d~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                             .............+..         ..........+.+++.+|+..||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   0000000000000000         00111123467899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-33  Score=308.44  Aligned_cols=195  Identities=23%  Similarity=0.405  Sum_probs=158.3

Q ss_pred             CCCCCCCCceEEEEEEeC---CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP---SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  661 (876)
                      .++|.|| ||+||+|+..   ++..||+|.+...  .....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         7 ~~lG~G~-~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGT-YGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCC-CeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4566665 9999999764   4578999988653  234567889999999999999999999854  567899999987


Q ss_pred             CCCHHHHhhcc--------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee----CCCCCeEEccccch
Q 002826          662 MGSLGDLICRQ--------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL----DADFEPKLTDFALD  729 (876)
Q Consensus       662 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll----~~~~~~kl~DfGla  729 (876)
                      + +|.+++...        ...+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            6 787776421        23588999999999999999999999   99999999999999    45679999999999


Q ss_pred             hhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002826          730 RIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEP  788 (876)
Q Consensus       730 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~  788 (876)
                      +....... ........+|..|+|||.+.+ ..++.++||||+||++|||+||++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            87653321 122334467899999998866 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.7e-33  Score=297.54  Aligned_cols=246  Identities=23%  Similarity=0.305  Sum_probs=196.8

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .+..+.|+||.||.++. .+++.|++|.+....  .....++.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG   84 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence            33444455999999854 478999999986543  233467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++.+. +..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.++.......  ...
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~  159 (256)
T cd08221          85 TLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAE  159 (256)
T ss_pred             cHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc--ccc
Confidence            999999765 55689999999999999999999999   999999999999999999999999999876643321  223


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...++..|+|||...+..++.++||||+|+++|||++|+.||.......     .........  . ...       ...
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~~~--~-~~~-------~~~  224 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKIVQGN--Y-TPV-------VSV  224 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHcCC--C-CCC-------ccc
Confidence            3457889999999888888899999999999999999999987543221     111111110  0 000       122


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      ....+.+++.+||..+|++||+++|+++..
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            344678999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-33  Score=297.95  Aligned_cols=246  Identities=25%  Similarity=0.370  Sum_probs=193.2

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc------CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+.|+||+||+|...+|+.||+|.+......      ....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus         6 ~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (265)
T cd06631           6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVP   85 (265)
T ss_pred             ceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCC
Confidence            334445599999998888999999988643211      12457889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc----c
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA----F  737 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~----~  737 (876)
                      +++|.+++.+.+ .+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.+|++|||.+.......    .
T Consensus        86 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (265)
T cd06631          86 GGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH  161 (265)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccc
Confidence            999999997654 678999999999999999999999   99999999999999999999999999987653211    1


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ........++..|+|||...+..++.++||||+|+++|||++|+.||........ .... ..   .. ..    .+...
T Consensus       162 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~-~~---~~-~~----~~~~~  231 (265)
T cd06631         162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYI-GA---HR-GL----MPRLP  231 (265)
T ss_pred             cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHh-hh---cc-CC----CCCCC
Confidence            1112234578899999999888889999999999999999999999975322111 1000 00   00 00    01111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ......+.+++.+||+.+|++||++.|+++
T Consensus       232 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         232 ---DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               123346789999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2e-33  Score=303.19  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=193.3

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|. |+||.||+|... +++.||+|.+..........+.+|+++++.++||||+++++++..++..++||||+++++
T Consensus        17 ~~~lg~-g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          17 IGELGD-GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hheecC-CCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            344544 559999999765 689999999876544455678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      +..++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.......  ......
T Consensus        96 l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~  170 (292)
T cd06644          96 VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSF  170 (292)
T ss_pred             HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc--ccccee
Confidence            9988876666789999999999999999999999   99999999999999999999999999886543221  112233


Q ss_pred             cccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          745 YALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       745 ~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .++..|+|||.+.     ...++.++|||||||++|||++|++||........     ........       .+.. ..
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~-------~~~~-~~  237 (292)
T cd06644         171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSE-------PPTL-SQ  237 (292)
T ss_pred             cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHhcCC-------CccC-CC
Confidence            4778899999874     34467889999999999999999999875432211     11111110       0000 00


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......++.+++.+||+.+|++||++.|+++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         238 PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1122346789999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-33  Score=308.33  Aligned_cols=240  Identities=22%  Similarity=0.296  Sum_probs=186.7

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||.||+|... +++.||+|++.....   ...+.+..|+.++.++ +||||+++++++.+.+..|+||||+++|
T Consensus         3 lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           3 IGRGS-YAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeCC-CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            44555 9999999664 688999999975322   2235577899999888 6999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        82 ~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  155 (327)
T cd05617          82 DLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTST  155 (327)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cceec
Confidence            9998886553 689999999999999999999999   99999999999999999999999999987532211  11233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....++........  ..     .+   +..
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~-----~~---p~~  225 (327)
T cd05617         156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PI-----RI---PRF  225 (327)
T ss_pred             ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CC-----CC---CCC
Confidence            458999999999988889999999999999999999999997533211 11112222111110  00     00   111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      ....+.+++.+|++.||++||++
T Consensus       226 ~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCC
Confidence            22356799999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-33  Score=297.85  Aligned_cols=246  Identities=27%  Similarity=0.447  Sum_probs=196.0

Q ss_pred             CCCCCCCCceEEEEEEeCC-----CcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLPS-----GELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||.||++...+     +..||+|++...... ....+..|++.++.++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~lg~g~-~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~   83 (258)
T smart00219        5 KKLGEGA-FGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM   83 (258)
T ss_pred             ceeccCC-CcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence            3455555 99999997653     488999999654333 4568899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCc-CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++++|.+++...... +++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++.........
T Consensus        84 ~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (258)
T smart00219       84 EGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK  160 (258)
T ss_pred             CCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence            999999999765434 89999999999999999999999   99999999999999999999999999998776442222


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .. ...++..|+|||......++.++||||+|+++|||++ |++||......  ...+.......      ..       
T Consensus       161 ~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------~~-------  224 (258)
T smart00219      161 KK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGYR------LP-------  224 (258)
T ss_pred             cc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC------CC-------
Confidence            11 2336788999999888889999999999999999998 78888653221  12222211100      00       


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      .....+..+.+++.+|+..+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0111344688999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-33  Score=296.16  Aligned_cols=236  Identities=23%  Similarity=0.333  Sum_probs=186.8

Q ss_pred             CCCCCCceEEEEEEeCCCc-----------EEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          589 AGNGGPFGRVYILSLPSGE-----------LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.|| ||.||+|...+..           .|++|.+...... ...+.+|+.+++.++||||+++++++.. +..++||
T Consensus         3 lg~G~-~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           3 LGQGT-FTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             ccccc-cceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            45555 9999999775432           5788877554322 6788899999999999999999999988 7789999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-------CeEEccccchh
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-------EPKLTDFALDR  730 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-------~~kl~DfGla~  730 (876)
                      ||+++|+|.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++       .+|++|||+++
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            99999999999987665789999999999999999999999   999999999999999887       79999999988


Q ss_pred             hccccccccccccccccccccCccccCCC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      .....      ....++..|+|||.+...  .++.++||||||+++||+++ |..||.......  ...+.....     
T Consensus       157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~~~~-----  223 (259)
T cd05037         157 TVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQDQH-----  223 (259)
T ss_pred             ccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHhcCC-----
Confidence            65431      122356679999998766  78899999999999999999 577776543211  111111000     


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ...  .+.        ...+.+++.+||..+|++|||+.|+++.|+
T Consensus       224 ~~~--~~~--------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 RLP--MPD--------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CCC--CCC--------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000  000        146789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.8e-33  Score=298.92  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..+|.|+ ||.||+|.. .+++.||+|++..... ....++.+|++++++++||||+++++++..++..++||||+++++
T Consensus         7 ~~lg~g~-~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   85 (279)
T cd06619           7 EILGHGN-GGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS   85 (279)
T ss_pred             eeeccCC-CeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence            3455554 999999965 5889999999865422 234568899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |..+.     .+++..+..++.|++.|+.|||+.   +|+|+||||+||+++.++.+||+|||++.......    ....
T Consensus        86 l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~  153 (279)
T cd06619          86 LDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTY  153 (279)
T ss_pred             hHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCC
Confidence            96542     468889999999999999999999   99999999999999999999999999987654322    2234


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh--HHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD--VVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      .|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........  .....+......       .+...  ...
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~--~~~  224 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-------PPVLP--VGQ  224 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-------CCCCC--CCc
Confidence            5888999999998888999999999999999999999999753322111  111111110000       01110  011


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...++.+++.+|++.+|++||+++|+++.
T Consensus       225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         225 FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            23457899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=300.03  Aligned_cols=244  Identities=24%  Similarity=0.322  Sum_probs=195.9

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|| +|.||+|... +++.||+|++.... ......+.+|+++++.++|||++++++++.++...++|+||++++
T Consensus         6 ~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (274)
T cd06609           6 LECIGKGS-FGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGG   84 (274)
T ss_pred             hhhhcCCC-CeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence            34455555 9999999764 78999999986543 233467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...  .+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||+++.......  ....
T Consensus        85 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~  157 (274)
T cd06609          85 SCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNT  157 (274)
T ss_pred             cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc--cccc
Confidence            999998764  789999999999999999999999   999999999999999999999999999987764321  2233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..++..|+|||...+..++.++||||||+++|||+||+.||.......  .......   .       ..+.....  ..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~---~-------~~~~~~~~--~~  223 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIPK---N-------NPPSLEGN--KF  223 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhhh---c-------CCCCCccc--cc
Confidence            457888999999988889999999999999999999999997543211  1111111   0       01111110  03


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+.+++.+||..+|++|||++++++.
T Consensus       224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         224 SKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            3467899999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.4e-33  Score=301.32  Aligned_cols=246  Identities=21%  Similarity=0.272  Sum_probs=192.5

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+|.|| ||+||+|.. .+++.||+|.+.....   .....+.+|++++++++|+|++.+.+++.+++..++||||+++
T Consensus         6 ~~lg~G~-~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           6 RVLGKGG-FGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEecCC-CeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            3455555 999999966 4789999999865322   2234567899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.+||+|||++........   .
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~  158 (285)
T cd05632          85 GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---I  158 (285)
T ss_pred             ccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---c
Confidence            9999888654 34699999999999999999999999   999999999999999999999999999876543221   2


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||.+.+..++.++|+||+|+++|||++|+.||........ ...+........    .       ....
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~----~-------~~~~  226 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE----E-------VYSA  226 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc----c-------ccCc
Confidence            234588999999999888899999999999999999999999976433221 111111111111    0       0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                      .....+.+++.+|++.||++||+     +.|+++.
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            22345689999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-33  Score=302.64  Aligned_cols=244  Identities=23%  Similarity=0.321  Sum_probs=193.8

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....++.|+ ||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||+++
T Consensus         8 ~~~~l~~g~-~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06642           8 KLERIGKGS-FGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG   86 (277)
T ss_pred             HHHHhcCCC-CeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence            334455555 999999965 468899999986433 22345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      ++|.+++..  ..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++........  ...
T Consensus        87 ~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06642          87 GSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch--hhh
Confidence            999998864  3688999999999999999999999   999999999999999999999999999876643221  122


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||........  .....   ..   .    .+.+   ...
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~---~~---~----~~~~---~~~  224 (277)
T cd06642         160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIP---KN---S----PPTL---EGQ  224 (277)
T ss_pred             cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhhh---cC---C----CCCC---Ccc
Confidence            23477889999999888889999999999999999999999864332211  11100   00   0    1111   112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+..+.+++.+||+.+|++||++.|+++.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            34567899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2e-33  Score=298.65  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=199.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|+ +|.||++... +++.||+|++..... ....++.+|++++++++||||+++++++..++..++|+||++++
T Consensus         6 ~~~ig~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (265)
T cd06605           6 LGELGAGN-SGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG   84 (265)
T ss_pred             HHHhcCCC-CeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCC
Confidence            34555555 9999999765 789999999876432 33467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++......+++..+.+++.|++.|++|||+ .   +++||||||+||+++.++.++|+|||.+.........    
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----  157 (265)
T cd06605          85 SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----  157 (265)
T ss_pred             cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----
Confidence            9999998765678999999999999999999999 7   9999999999999999999999999998766432211    


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...++..|+|||...+..++.++||||+|+++|+|++|+.||...........+..+......       .+....  ..
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~~  228 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------PPRLPS--GK  228 (265)
T ss_pred             cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-------CCCCCh--hh
Confidence            145788899999998888999999999999999999999999765322222223332221111       011110  01


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....+.++|.+||..+|++|||+.|+++.
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         229 FSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            34568899999999999999999999853

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.5e-33  Score=304.68  Aligned_cols=257  Identities=25%  Similarity=0.302  Sum_probs=195.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||++... ++..||+|.+..... ....++.+|++++++++||||+++++++.+++..++||||+
T Consensus         3 ~~~~~~lg~G~-~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           3 FEKLGELGAGN-GGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             ceEEeeccCCC-CeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            33445555555 9999999654 688899998864322 22356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++++|.+++.+. ..+++..+..++.|+++|+.|||+ .   +++||||||+||+++.++.+|++|||++.......   
T Consensus        82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  154 (308)
T cd06615          82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  154 (308)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence            999999999765 468999999999999999999997 5   89999999999999999999999999987653321   


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc--------ccc
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA--------IQV  811 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~  811 (876)
                       .....++..|+|||...+..++.++||||||+++|||++|+.||.......  ...+...........        ...
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 -ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             -cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccCCCC
Confidence             123357889999999888888999999999999999999999986543211  111111100000000        000


Q ss_pred             ------------------cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          812 ------------------LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       812 ------------------~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                                        ..|...  ......++.+++.+||..+|++|||++|+++.-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                              000000  001234688999999999999999999998874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=302.04  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=195.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|+ ||.||+|... +++.||+|++..........+.+|++++++++||||+++++++..++..++||||+++++
T Consensus        10 ~~~l~~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (280)
T cd06611          10 IGELGDGA-FGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGA   88 (280)
T ss_pred             HHHhcCCC-CceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCc
Confidence            34455555 9999999764 789999999876544445678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+.+..+++..+.+++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||.+........  .....
T Consensus        89 L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~  163 (280)
T cd06611          89 LDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTF  163 (280)
T ss_pred             HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc--cccee
Confidence            9999987666799999999999999999999999   999999999999999999999999999876543221  12234


Q ss_pred             cccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          745 YALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       745 ~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .++..|+|||...     ...++.++||||+|+++|||++|+.||........ ...+    ...   ....++     .
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~---~~~~~~-----~  230 (280)
T cd06611         164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-LLKI----LKS---EPPTLD-----Q  230 (280)
T ss_pred             ecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-HHHH----hcC---CCCCcC-----C
Confidence            5788899999864     34467789999999999999999999975432211 1111    111   000000     1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||+.+|.+||++.++++.
T Consensus       231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            11223467899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=3.1e-37  Score=314.37  Aligned_cols=391  Identities=26%  Similarity=0.368  Sum_probs=333.1

Q ss_pred             EeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccc-------------eeecCCccc
Q 002826           79 SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW-------------VLDLSRNHI  145 (876)
Q Consensus        79 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------------~LdL~~n~l  145 (876)
                      +++.+++.++ ++|+.++.+.+|+.|+.+.|.+.. +|+.++.+..|+.|+..+|+|+             .|++.+|++
T Consensus        95 ~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l  172 (565)
T KOG0472|consen   95 SLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKL  172 (565)
T ss_pred             HhhcccchHh-hccHHHhhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccch
Confidence            3455555554 689999999999999999999976 7889999999999999999874             589999999


Q ss_pred             cccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCcc
Q 002826          146 EGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDS  225 (876)
Q Consensus       146 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~  225 (876)
                      ....|..+. ++.|++||..+|-++ .+|..++.|.+|..|+|..|+  +..+| .|.++..|++|+++.|+|.-.....
T Consensus       173 ~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk--i~~lP-ef~gcs~L~Elh~g~N~i~~lpae~  247 (565)
T KOG0472|consen  173 KALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK--IRFLP-EFPGCSLLKELHVGENQIEMLPAEH  247 (565)
T ss_pred             hhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc--cccCC-CCCccHHHHHHHhcccHHHhhHHHH
Confidence            966666555 999999999999997 889999999999999999998  78888 8999999999999999999555555


Q ss_pred             ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc-----------
Q 002826          226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS-----------  294 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-----------  294 (876)
                      ..++++|.+|||..|+++ ++|+.+.- +.+|++||+|+|.|+ ..|..++++ .|+.|-+.+|.+..+           
T Consensus       248 ~~~L~~l~vLDLRdNklk-e~Pde~cl-LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~  323 (565)
T KOG0472|consen  248 LKHLNSLLVLDLRDNKLK-EVPDEICL-LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQE  323 (565)
T ss_pred             hcccccceeeeccccccc-cCchHHHH-hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHH
Confidence            669999999999999999 99999864 899999999999999 678889999 999999999987521           


Q ss_pred             ---------------------------CCCCC---ccccccceeecccccCCCCCCcccCCCCc---ccEEEecCCcccc
Q 002826          295 ---------------------------IPGSI---NECLNLERFQVQDNGFSGDFPDKLWSLPR---IKLIRAESNRFSG  341 (876)
Q Consensus       295 ---------------------------~~~~~---~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~  341 (876)
                                                 .+..|   ..+.+.+.|++++-+++ .+|+..+.-.+   ....+++.|++. 
T Consensus       324 vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-  401 (565)
T KOG0472|consen  324 VLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-  401 (565)
T ss_pred             HHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-
Confidence                                       11111   23446788999999999 66776665555   889999999998 


Q ss_pred             cCccccccCCCCCee-eccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCccc
Q 002826          342 AIPDSISMAAQLEQV-QIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKK  420 (876)
Q Consensus       342 ~~~~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  420 (876)
                      .+|..+..+..+.+. .+++|.+. .+|..++.+++|..|+|++|.+. .+|..++.+..|+.||+|+|++...+..+..
T Consensus       402 elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~  479 (565)
T KOG0472|consen  402 ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYE  479 (565)
T ss_pred             hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhh
Confidence            677777777666554 55555554 89999999999999999999997 7788889999999999999999866666677


Q ss_pred             ccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCC
Q 002826          421 CRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       421 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~  487 (876)
                      +..|+.+-.++|++....|..+.+|.+|.+|||.+|.+. .+|..++++ +++.|++++|++.  .|.
T Consensus       480 lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr--~Pr  544 (565)
T KOG0472|consen  480 LQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR--QPR  544 (565)
T ss_pred             HHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC--CCH
Confidence            778888888889999777888999999999999999998 789999998 6999999999997  553

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.8e-33  Score=303.29  Aligned_cols=247  Identities=24%  Similarity=0.366  Sum_probs=196.3

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .....+|.|| ||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+..++..++||||+++
T Consensus        25 ~~~~~lg~g~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          25 DSFIKIGEGS-TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             hhhhcccCCC-CeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            3345565555 999999965 47899999998654444556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      ++|.+++...  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........  ...
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence            9999988543  588999999999999999999999   999999999999999999999999999876543221  122


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...|+..|+|||......++.++||||||+++|||++|+.||........  .......          +.+.... ...
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~~----------~~~~~~~-~~~  243 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA--MRRIRDN----------LPPRVKD-SHK  243 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhc----------CCCcccc-ccc
Confidence            34578899999998888889999999999999999999999975433211  1111111          0111110 112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....+.+++.+|+..||++|||++|+++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            23457789999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.3e-34  Score=334.20  Aligned_cols=263  Identities=21%  Similarity=0.334  Sum_probs=194.9

Q ss_pred             chhhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe--
Q 002826          575 TEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--  649 (876)
Q Consensus       575 ~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--  649 (876)
                      ..++...+.|++...++.|+||+||+|... +++.||+|.+.....  .....+..|+.+++.++|||||+++++|.+  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            334444433444444444559999999664 678899999865322  234578899999999999999999998865  


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCC----CCccccccccCceeeCCC----
Q 002826          650 DESIFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYV----PHLLHRNVKSKNILLDAD----  718 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~i~H~Dlkp~NIll~~~----  718 (876)
                      .+.+|+||||+++++|.+++...   ...+++..++.|+.||+.||+|||+.+.    .+|+||||||+|||++.+    
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            45789999999999999998653   3469999999999999999999998521    259999999999999642    


Q ss_pred             -------------CCeEEccccchhhccccccccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCC
Q 002826          719 -------------FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       719 -------------~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                                   +.+||+|||++........   .....||+.|+|||++..  ..++.++|||||||++|||+||+.|
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P  242 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP  242 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence                         3489999999987653321   233458999999998753  4578999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002826          784 EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK--ALHSL  855 (876)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~--~L~~i  855 (876)
                      |....... .+...+..   ..       +...    ......+.++|..||+.+|.+||++.|+++  .++.+
T Consensus       243 F~~~~~~~-qli~~lk~---~p-------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        243 FHKANNFS-QLISELKR---GP-------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             CCcCCcHH-HHHHHHhc---CC-------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            97543221 11111111   11       0000    112346789999999999999999999984  45444

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.6e-33  Score=300.94  Aligned_cols=245  Identities=22%  Similarity=0.304  Sum_probs=192.5

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+|.|| ||.||++... +++.||+|.+......   ....+..|+.++++++|++++.+++.+.+++..++||||+++
T Consensus         6 ~~ig~G~-~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           6 RVLGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             EEeecCC-CeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            4455555 9999999654 7899999998653222   234567899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... ...+++..+..++.|++.|+.|||+.   +|+||||||+||++++++.++++|||++.......   ..
T Consensus        85 ~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~  158 (285)
T cd05630          85 GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TI  158 (285)
T ss_pred             CcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc---cc
Confidence            9999988654 34589999999999999999999998   99999999999999999999999999987654322   12


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....|+..|+|||.+.+..++.++||||+|+++|||++|+.||........ ........  ...        .   ...
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~--~~~--------~---~~~  225 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK--EVQ--------E---EYS  225 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh--hhh--------h---hcC
Confidence            234588999999999888899999999999999999999999976432211 11110000  000        0   011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                      ......+.+++.+||+.||++|||     ++|+++.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            122345789999999999999999     8888873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-33  Score=298.75  Aligned_cols=248  Identities=30%  Similarity=0.458  Sum_probs=193.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHH--HHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSK--TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.|| ||+||+++.. +++.||+|++.........  ...+|+.++++++||||+++++++.+.+..++||||++++
T Consensus         5 ~~lg~G~-~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~   83 (260)
T PF00069_consen    5 KKLGSGG-FGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG   83 (260)
T ss_dssp             EEEEEES-SEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred             EEEEeCC-CEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence            3455555 9999999765 5679999999875433322  2345999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++... ..+++..+..++.|+++|+++||+.   +++||||||+||+++.++.++|+|||.+......  ......
T Consensus        84 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~  157 (260)
T PF00069_consen   84 SLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNP  157 (260)
T ss_dssp             BHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSS
T ss_pred             ccccccccc-ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--cccccc
Confidence            999999833 4689999999999999999999999   9999999999999999999999999998754211  123344


Q ss_pred             ccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||... ....+.++||||+|+++|+|++|+.||.......  ............      ..... .....
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~------~~~~~-~~~~~  228 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKILKRP------LPSSS-QQSRE  228 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHHHTH------HHHHT-TSHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhccccc------ccccc-cccch
Confidence            55888999999988 7889999999999999999999999998752211  111111111000      00000 00001


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ....+.+++.+|++.||++|||+.|+++
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1257899999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5e-33  Score=297.71  Aligned_cols=246  Identities=20%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus         6 y~~~~~lg~g~-~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           6 FTKLERIGKGS-FGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhcccCC-CeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            33445556655 9999999764 68999999986532 233457888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++...  .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06640          85 GGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--c
Confidence            999999998653  588999999999999999999999   999999999999999999999999999876643221  1


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....++..|+|||...+..++.++||||||+++|||++|+.||........  ....   ...   .    .+   ...
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~---~~~---~----~~---~~~  222 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFLI---PKN---N----PP---TLT  222 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhhh---hcC---C----CC---CCc
Confidence            2233477889999998888899999999999999999999999875432211  1100   000   0    01   122


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2345678899999999999999999999776

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-33  Score=312.16  Aligned_cols=259  Identities=21%  Similarity=0.268  Sum_probs=191.1

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC------C
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------E  651 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~  651 (876)
                      ..|.....+|.|+ ||.||+|.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          24 KRYQNLKPIGSGA-QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             cceeEEEEeecCC-CeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            3454455555555 999999965 478999999986532  22345677899999999999999999987543      3


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  175 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  175 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence            57999999976 77777643   478899999999999999999999   999999999999999999999999999986


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH-----------
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR-----------  800 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-----------  800 (876)
                      .....   ......+|..|+|||++.+..++.++|||||||++|||++|+.||........ .......           
T Consensus       176 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         176 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             cCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence            64322   12234588999999999988899999999999999999999999976543221 1111100           


Q ss_pred             -------Hhhcccccc----cccChhh-----hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 -------KINITNGAI----QVLDPKI-----ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 -------~~~~~~~~~----~~~d~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                             .........    ....+..     ..........+.+++.+|+..||.+|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                   000000000    0000000     00011123467899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-33  Score=309.97  Aligned_cols=256  Identities=18%  Similarity=0.219  Sum_probs=187.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|.....+|.|+ ||.||+|... +++.||+|+....      ....|+.++++++||||+++++++.+.+..++||||+
T Consensus        67 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         67 GYTVIKTLTPGS-EGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             CcEEEEEecCCC-CeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            344445555555 9999999765 6789999975322      2356999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      . ++|.+++......+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......   .
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~  212 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---A  212 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc---c
Confidence            6 589998877767899999999999999999999999   99999999999999999999999999987543221   1


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCC-CCCCcchh--------hHHHHHHHHhhcccccccc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAE-QAEPAESL--------DVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~-~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  811 (876)
                      .....||..|+|||.+.+..++.++|||||||++|||+++..|+ ...+....        .+.................
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            22345889999999999888999999999999999999865544 43322211        1111111100000000000


Q ss_pred             cChhhh-------------------hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          812 LDPKIA-------------------NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       812 ~d~~~~-------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......                   -........+.++|.+||+.||++|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            000000                   0000113345679999999999999999999863

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-33  Score=309.22  Aligned_cols=250  Identities=18%  Similarity=0.255  Sum_probs=190.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|+ ||+||+++.. +++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+++..|+||||++
T Consensus         6 ~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597           6 LKVIGRGA-FGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEecC-CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence            34455555 9999999764 68999999986421   2234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|+|.+++.+.+..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......... ..
T Consensus        85 g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~  160 (331)
T cd05597          85 GGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QS  160 (331)
T ss_pred             CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cc
Confidence            9999999987666799999999999999999999999   9999999999999999999999999998765432211 12


Q ss_pred             ccccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          742 SSEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      ....||+.|+|||++..     ..++.++||||+||++|||++|+.||........     ........ .... +.+. 
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-----~~~i~~~~-~~~~-~~~~-  232 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHK-EHFQ-FPPD-  232 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-----HHHHHcCC-Cccc-CCCc-
Confidence            22358999999998762     4578899999999999999999999976443221     11111100 0000 1111 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPE--KRPSMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~--~RPs~~ell~~  851 (876)
                         ....+..+.+++.+|+..+++  .||+++++++.
T Consensus       233 ---~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         233 ---VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ---cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence               111234567888887755443  37899999887

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-33  Score=303.25  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=197.9

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ++....+|.|+ ||.||+|.. .+++.||+|++........+.+.+|+.+++.++|||++++++++..++..++||||++
T Consensus        23 ~~~~~~ig~g~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGS-TGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCC-ceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            33445566666 999999965 4799999999876554556778899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++..  ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++........  ..
T Consensus       102 ~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         102 GGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             CCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            9999998754  3588999999999999999999999   999999999999999999999999999876543221  12


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||...+..++.++||||||+++|||++|+.||.......  .......   ..       .+. .....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~---~~-------~~~-~~~~~  241 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRD---SP-------PPK-LKNAH  241 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc---cC-------CCC-ccccC
Confidence            23457889999999988889999999999999999999999997543221  1111111   00       000 00011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+|++.+|++||+++|+++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            123457899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.3e-33  Score=306.49  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=189.2

Q ss_pred             CCCCC-CceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGG-PFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g-~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +|+|+ +|++||++.. ++|+.||+|++.....  ...+.+.+|+++++.++||||+++++++..++..++||||+++|+
T Consensus         6 ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~   85 (327)
T cd08227           6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS   85 (327)
T ss_pred             ccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCc
Confidence            44442 4899999955 5899999999865432  223567789999999999999999999999999999999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-c----
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-Q----  738 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~----  738 (876)
                      |.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+........ .    
T Consensus        86 l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  162 (327)
T cd08227          86 AKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVH  162 (327)
T ss_pred             HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccc
Confidence            99999654 34589999999999999999999999   999999999999999999999999986544321110 0    


Q ss_pred             cccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc----------
Q 002826          739 STMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN----------  806 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------  806 (876)
                      .......++..|+|||.+..  ..++.++|||||||++|||++|+.||........ .............          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  241 (327)
T cd08227         163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM-LLEKLNGTVPCLLDTTTIPAEEL  241 (327)
T ss_pred             cccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH-HHHHhcCCccccccccchhhhhc
Confidence            01112245677999999865  4588999999999999999999999975433221 1111000000000          


Q ss_pred             -------cccc------c---cCh-----hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          807 -------GAIQ------V---LDP-----KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       807 -------~~~~------~---~d~-----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                             ....      .   ..+     ............+.+++.+||+.||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                   0000      0   000     000111223457889999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.1e-33  Score=295.67  Aligned_cols=244  Identities=24%  Similarity=0.348  Sum_probs=192.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  662 (876)
                      ..+|. |++|.||++..+ +++.||+|++.....  ...+.+.+|++++++++|+|++++++.+.. +...++||||+++
T Consensus         6 ~~lg~-g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           6 RVVGK-GSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEecC-CCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            34444 559999999654 688999999865322  334568889999999999999999998764 4468999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... ...+++.++..++.+++.|++|||+.   +++||||||+||+++.++.++|+|||++.......  ...
T Consensus        85 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~  159 (257)
T cd08223          85 GDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMA  159 (257)
T ss_pred             CcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC--Ccc
Confidence            9999998764 44689999999999999999999999   99999999999999999999999999987664322  122


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....+++.|+|||...+..++.++||||+|+++||+++|+.||.......     ........   ...       ....
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~~~---~~~-------~~~~  224 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYRIIEG---KLP-------PMPK  224 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHhc---CCC-------CCcc
Confidence            23457888999999988889999999999999999999999987543221     11111111   000       1112


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+|++.+|++|||+.|+++.
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=309.16  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=202.0

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +++++....|.|+||.||+|..+ .+-..|.|++.......-+.+.-||++|+...||+||++++.|...+..+++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            44556666777889999999665 45555778887666566678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .||-+..++-+-+..+++.++.-+++|++.||.|||+.   .|+|||+|+.|||++-+|.++++|||.+......  ...
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH--Hhh
Confidence            99999999988888999999999999999999999999   9999999999999999999999999987543221  123


Q ss_pred             cccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          741 MSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .....||++|||||++.     ..+|..++||||||+++.||..+.+|...-..... ++.. ..     ......+.|.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV-llKi-aK-----SePPTLlqPS  259 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKI-AK-----SEPPTLLQPS  259 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH-HHHH-hh-----cCCCcccCcc
Confidence            44567999999999754     56899999999999999999999998654332221 1111 10     1111222222


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                            .-...+.+++.+|+.++|..||++.++++.
T Consensus       260 ------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  260 ------HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ------hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                  234568899999999999999999999863

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.9e-33  Score=297.65  Aligned_cols=245  Identities=24%  Similarity=0.326  Sum_probs=190.0

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeC------CeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD------ESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~lv  656 (876)
                      ....+|.| +||.||+|... +++.||+|++.... .....+.+|+.+++++ +|||++++++++...      ...|+|
T Consensus        10 ~~~~lg~g-~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   87 (272)
T cd06637          10 LVELVGNG-TYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV   87 (272)
T ss_pred             HHHheeec-CCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence            33445555 49999999664 68899999986543 4556788999999999 699999999998753      468999


Q ss_pred             EEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          657 YEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |||+++++|.+++... ...+++..+..++.|++.|++|||+.   +|+|||+||+||++++++.+||+|||+++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          88 MEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             EEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            9999999999998764 45689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          736 AFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .  .......|+..|+|||.+.     ...++.++||||+||++|||++|+.||.........    ... ...  ....
T Consensus       165 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~----~~~-~~~--~~~~  235 (272)
T cd06637         165 V--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL----FLI-PRN--PAPR  235 (272)
T ss_pred             c--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH----HHH-hcC--CCCC
Confidence            1  1223445888999999875     335778999999999999999999998653322111    100 000  0111


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+.       ..+..+.+++.+||..+|.+|||+.|+++
T Consensus       236 ~~~~-------~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 LKSK-------KWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCC-------CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            1111       12235789999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=313.26  Aligned_cols=239  Identities=22%  Similarity=0.245  Sum_probs=182.8

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc---cCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI---RHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      |.|| ||+||+|+.. +++.||+|++.....   ........|..++...   +||||+++++++.+.+..|+||||+++
T Consensus         2 G~G~-~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           2 GKGT-FGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCC-ceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            4555 9999999664 699999999864321   1223344566666655   699999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      |+|.+++.+.+ .+++..+..++.||++|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999887653 689999999999999999999999   99999999999999999999999999987543221  1123


Q ss_pred             cccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...||..|+|||.+.+. .++.++||||+||++|||++|+.||.......     ..+......   ......       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~---~~~~~~-------  219 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-----MYRNIAFGK---VRFPKN-------  219 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-----HHHHHHcCC---CCCCCc-------
Confidence            34589999999988654 47899999999999999999999997643322     111111110   000000       


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRP----SMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RP----s~~ell~  850 (876)
                      .....+.+++.+||+.||++||    ++.|+++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            1233567899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-33  Score=295.69  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=195.3

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|.|+ ||.+|++.. .+|+.||+|.+....  ....+++.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus         5 ~~~lg~g~-~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08218           5 VKKIGEGS-FGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG   83 (256)
T ss_pred             EEEeccCC-ceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCC
Confidence            34555555 999999965 478999999986432  23345788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... ...+++..+.+++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+........  ..
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~  158 (256)
T cd08218          84 GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LA  158 (256)
T ss_pred             CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hh
Confidence            9999998764 34688999999999999999999999   999999999999999999999999999876643221  11


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||...+...+.++||||||+++|++++|+.||.......     .+.......   .    +.   ...
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~~~~~---~----~~---~~~  223 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----LVLKIIRGS---Y----PP---VSS  223 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----HHHHHhcCC---C----CC---Ccc
Confidence            23347888999999888888999999999999999999999987543221     111111110   0    00   111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+||+.+|++||++.|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            224468899999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.2e-33  Score=297.08  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=192.6

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..++. |++|.||+|..+ +|+.||+|++.....  ...+.+.+|++++++++|||++++++++..++..++||||++++
T Consensus         7 ~~l~~-g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~   85 (286)
T cd07847           7 SKIGE-GSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT   85 (286)
T ss_pred             eeecc-cCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence            44444 459999999765 689999999865322  23456789999999999999999999999999999999999998


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      ++..+.... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++........  ....
T Consensus        86 ~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~  159 (286)
T cd07847          86 VLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTD  159 (286)
T ss_pred             HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccC
Confidence            888776543 3689999999999999999999998   999999999999999999999999999987654321  1223


Q ss_pred             ccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc---------cc---cc
Q 002826          744 EYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN---------GA---IQ  810 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~---~~  810 (876)
                      ..++..|+|||...+ ..++.++||||+|+++|||++|+.||......+. .............         ..   ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhccccccccccc
Confidence            346788999998765 4578899999999999999999999986543221 1111110000000         00   00


Q ss_pred             ccCh----hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDP----KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..++    ............+.+++.+||+.+|++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000    011111223467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.2e-33  Score=296.20  Aligned_cols=249  Identities=21%  Similarity=0.358  Sum_probs=193.3

Q ss_pred             ccCCCCCCCCceEEEEEEeCC--CcEEEEEEEecCCc----------cCHHHHHHHHHHHhh-ccCccccceeeEEEeCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPS--GELIAVKKLVNFGC----------QSSKTLKTEVKTLAK-IRHKNIVKVLGFFHSDE  651 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~  651 (876)
                      ....+|.|+ ||.||+|....  ++.+|+|.+.....          ....++.+|+.++.+ ++||||+++++++.+++
T Consensus         4 ~~~~ig~G~-~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           4 VLEHLGSGA-FGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhcCCC-CceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            344455555 99999997754  78899998853221          122446678887765 69999999999999999


Q ss_pred             eEEEEEEcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          652 SIFLIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      ..++||||+++++|.+++..   ....+++..+++++.|++.|+.|||+ .   +++||||+|+||+++.++.+|++|||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEeccc
Confidence            99999999999999988743   34568999999999999999999996 5   89999999999999999999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      .+.......   ......++..|+|||...+..++.++||||||+++|||++|+.||.......  ......   ..   
T Consensus       160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~---~~---  228 (269)
T cd08528         160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LATKIV---EA---  228 (269)
T ss_pred             ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHHHHh---hc---
Confidence            987755432   2234457888999999988889999999999999999999999987543221  111111   10   


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      ...   +...   ......+.+++.+||+.||++||++.|+..++++
T Consensus       229 ~~~---~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         229 VYE---PLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             cCC---cCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            000   0000   0123467899999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-33  Score=298.97  Aligned_cols=251  Identities=19%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEec--CCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |....++|.|| .+.||++...+.+.||+|++..  .+.+...-+..|++.|.+++ |.+||++++|-..++..|+||||
T Consensus       363 Yeilk~iG~GG-SSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  363 YEILKQIGSGG-SSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhHHHhhcCCC-cceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            34456677777 9999999988889999998754  33344567999999999995 99999999999999999999997


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      - ..+|..++.+.....+...++.+..|++.|+.++|++   ||||.||||.|+|+- .|.+||+|||.|..+.......
T Consensus       442 G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI  516 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSI  516 (677)
T ss_pred             c-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCccccce
Confidence            5 4599999988765666447888899999999999999   999999999999985 5699999999999988766555


Q ss_pred             ccccccccccccCccccCCC-----------CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          740 TMSSEYALSCYNAPEYGYSK-----------KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ....++||+.||+||.+...           +.++++||||+||++|+|+.|++||.....       ...+...+...-
T Consensus       517 ~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~aKl~aI~~P~  589 (677)
T KOG0596|consen  517 VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIAKLHAITDPN  589 (677)
T ss_pred             eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHHHHHhhcCCC
Confidence            66678899999999975422           357889999999999999999999964221       111111111111


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .++--|.+...+     ++.++++.|++.||++|||..|+++.
T Consensus       590 ~~Iefp~~~~~~-----~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  590 HEIEFPDIPEND-----ELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ccccccCCCCch-----HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            111122222221     28899999999999999999999863

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.4e-33  Score=299.29  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=191.0

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.| +||.||+|... +|+.||+|++.....  .....+.+|++++++++||||+++++++.+.+..++|+||+++ 
T Consensus         6 ~~l~~g-~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   83 (284)
T cd07839           6 EKIGEG-TYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-   83 (284)
T ss_pred             EEeccc-CCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-
Confidence            445554 49999999664 799999999864322  2235677899999999999999999999999999999999975 


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++......+++..+..++.||++|++|||+.   +++||||||+||+++.++++||+|||+++......  .....
T Consensus        84 ~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  158 (284)
T cd07839          84 DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCYSA  158 (284)
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCcCC
Confidence            88888876556799999999999999999999999   99999999999999999999999999988654322  12233


Q ss_pred             ccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc------------cc-ccc
Q 002826          744 EYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI------------TN-GAI  809 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~-~~~  809 (876)
                      ..++..|+|||.+.+. .++.++||||+||++|||+||+.|+.......... +...+....            .. ...
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHhHHhhhccccccc
Confidence            4578889999987654 46889999999999999999998865433222111 111110000            00 000


Q ss_pred             cccChh--hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          810 QVLDPK--IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       810 ~~~d~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......  ...........+.+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000000  00111123456789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-33  Score=307.98  Aligned_cols=257  Identities=19%  Similarity=0.307  Sum_probs=189.1

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||+||+|.. .+++.||+|++.....  .....+.+|++++++++||||+++++++...      ..
T Consensus        16 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          16 RYQNLTPVGSGA-YGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhheecccCC-CeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            444445555555 999999965 5789999999865321  2335677899999999999999999987543      35


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+++|++ +++|.+++..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        95 ~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             EEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence            78999987 6799888754  3589999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc--
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI--  809 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--  809 (876)
                      ...     .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...+............  
T Consensus       169 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ-LKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             CCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHh
Confidence            432     223458889999999876 4688999999999999999999999976433211 1111110000000000  


Q ss_pred             --------------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          810 --------------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       810 --------------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                    ....+.+..........+.+++.+|+..||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                          000001111111123356799999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-33  Score=299.03  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=198.7

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|+ ||+||++... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+.+++||||++++
T Consensus        10 ~~~ig~g~-~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (284)
T cd06620          10 ISDLGAGN-GGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCG   88 (284)
T ss_pred             HHHcCCCC-CeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCC
Confidence            34555555 9999999654 68999999886543 233567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.+++.|+.|||+.  .+++||||||+||+++.++.++|+|||++.......    ...
T Consensus        89 ~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~  161 (284)
T cd06620          89 SLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADT  161 (284)
T ss_pred             CHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCc
Confidence            9999987654 689999999999999999999973  189999999999999999999999999986543221    123


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch------hhHHHHHHHHhhcccccccccChhhh
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES------LDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ..|+..|+|||.+.+..++.++|||||||++||+++|+.||.......      ....++........       .+.+.
T Consensus       162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~  234 (284)
T cd06620         162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------PPRLP  234 (284)
T ss_pred             cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-------CCCCC
Confidence            357889999999888888999999999999999999999998654321      11122222211110       01110


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                        .......+.+++.+|+++||++|||+.|+++...-+.
T Consensus       235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence              0113346789999999999999999999998754443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.6e-33  Score=297.35  Aligned_cols=247  Identities=22%  Similarity=0.356  Sum_probs=192.3

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|+ ||.||+|... +|+.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||++++
T Consensus         6 ~~~ig~g~-~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (286)
T cd06622           6 LDELGKGN-YGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG   84 (286)
T ss_pred             hhhhcccC-CeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence            34455555 9999999765 79999999886532 222457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          664 SLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       664 sL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|.+++...  ...+++..+..++.|++.|+.|||+.  .+|+||||||+||+++.++.+|++|||.+.......    .
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~  158 (286)
T cd06622          85 SLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----A  158 (286)
T ss_pred             CHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----c
Confidence            999988764  33689999999999999999999963  189999999999999999999999999987654321    1


Q ss_pred             ccccccccccCccccCCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          742 SSEYALSCYNAPEYGYSK------KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ....++..|+|||...+.      .++.++||||+||++|||++|+.||........  ..........   .       
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~---~-------  226 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQLSAIVDG---D-------  226 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHHHHHhhc---C-------
Confidence            223477889999987543      347899999999999999999999975432211  1111111000   0       


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..........++.+++.+||+.+|++||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            011122344567899999999999999999999984

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-33  Score=307.06  Aligned_cols=251  Identities=19%  Similarity=0.241  Sum_probs=191.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|+ ||+||++..+ +++.||+|++.+..   ......+.+|+.++..++|++|+++++++.+.+..|+||||+
T Consensus         5 ~~~~lG~G~-fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           5 ILKVIGRGA-FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             EEEEEEeCC-CeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            344555555 9999999765 67889999986421   122345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|+|.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........ ..
T Consensus        84 ~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~-~~  159 (332)
T cd05623          84 VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQ  159 (332)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc-ce
Confidence            99999999987666789999999999999999999999   999999999999999999999999999876533221 11


Q ss_pred             cccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          741 MSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .....||+.|+|||++.     ...++.++|||||||++|||++|+.||........     ........   ..   ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~---~~---~~  228 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHK---ER---FQ  228 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH-----HHHHhCCC---cc---cc
Confidence            22345899999999875     34578899999999999999999999976433221     11111100   00   00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                      +..........+.+++.+|+..++.+  |+++.|+++.
T Consensus       229 ~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11111123446778889988665544  6899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.3e-33  Score=297.85  Aligned_cols=253  Identities=23%  Similarity=0.392  Sum_probs=196.6

Q ss_pred             ccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||.||+|+.+      +.+.||+|.+...... ....+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~~~lg~g~-~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           7 LQEITTLGRGE-FGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             ceeeeeecccc-eeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            34445566666 9999999753      3567999988654322 34678999999999999999999999999899999


Q ss_pred             EEEcCCCCCHHHHhhccC--------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          656 IYEFLQMGSLGDLICRQD--------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      ||||+++++|.+++....        ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~  162 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLS  162 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccc
Confidence            999999999999997543        1589999999999999999999999   99999999999999999999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      ++........ .......++..|+|||...+...+.++||||||+++|++++ |..||.......  .......   .. 
T Consensus       163 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~---~~-  235 (275)
T cd05046         163 LSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQA---GK-  235 (275)
T ss_pred             cccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHc---CC-
Confidence            9865432221 12233346677999999888888999999999999999999 788886533221  2222111   00 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                        .....      ....+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       236 --~~~~~------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         236 --LELPV------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             --cCCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence              00000      01123467899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.8e-33  Score=297.34  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=194.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|+ +|.||+|... +|+.||+|++.....  .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         2 y~~~~~l~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           2 FQKVEKIGEGT-YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             ceeeeeecCCC-ceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            34445566655 9999999664 799999998864322  2235788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          660 LQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       660 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      +. ++|.+++... ...+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||+++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--  154 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  154 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--
Confidence            96 5898888654 45689999999999999999999999   99999999999999999999999999987664322  


Q ss_pred             cccccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc------------
Q 002826          739 STMSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT------------  805 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------  805 (876)
                      .......++..|+|||...+.. ++.++||||||+++|||+||+.||....... ...+..+......            
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence            1122334678899999876543 6888999999999999999999997654322 1222111110000            


Q ss_pred             --cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          806 --NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       806 --~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .....................+.+++.+|++.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              000000011111111122345789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-33  Score=308.84  Aligned_cols=251  Identities=18%  Similarity=0.239  Sum_probs=191.6

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|| ||+||+++.. +++.||+|++....   ......+.+|+.++..++|++|+++++++.+++..|+||||+
T Consensus         5 i~~~lG~G~-fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~   83 (331)
T cd05624           5 IIKVIGRGA-FGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY   83 (331)
T ss_pred             EEEEEeeCC-CeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence            334555555 9999999765 78899999986421   123345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|+|.+++.+....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        84 ~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~  159 (331)
T cd05624          84 VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQ  159 (331)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-ee
Confidence            99999999987656789999999999999999999999   999999999999999999999999999876643321 11


Q ss_pred             cccccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          741 MSSEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .....||+.|+|||++.+     +.++.++||||+||++|||++|+.||........     ........  ..    ..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~-----~~~i~~~~--~~----~~  228 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET-----YGKIMNHE--ER----FQ  228 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH-----HHHHHcCC--Cc----cc
Confidence            223458999999998764     4578899999999999999999999976443221     11111000  00    00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                      +.......+..+.+++.+|+..++.+  |++++++++.
T Consensus       229 ~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11111123446788999999876554  4688888764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2e-33  Score=312.26  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=191.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||+||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.+++..|+|||
T Consensus         3 f~~~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           3 FESLKVIGRGA-FGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             ceEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            33445556665 9999999664 78999999996532   2234567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            999999999987654 689999999999999999999999   9999999999999999999999999998754321100


Q ss_pred             ---------------------------------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002826          739 ---------------------------------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQ  785 (876)
Q Consensus       739 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~  785 (876)
                                                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             00113468999999999988889999999999999999999999997


Q ss_pred             CCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002826          786 AEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVKA  851 (876)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ell~~  851 (876)
                      .......     ........  ....+.+..     .....+.+++.+|+ .+|.+|++   +.|+++.
T Consensus       238 ~~~~~~~-----~~~i~~~~--~~~~~p~~~-----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         238 SETPQET-----YRKVMNWK--ETLVFPPEV-----PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCHHHH-----HHHHHcCC--CceecCCCC-----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            6543221     11111000  000011110     12235677888876 49999985   5666654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-33  Score=312.31  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=191.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|| ||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        44 ~y~i~~~lG~G~-fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          44 DYEVVKVIGRGA-FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hcEEEEEEeecC-CeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            444445555555 9999999765 78999999986422   123345778999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++...  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence            999999999998654  478888999999999999999999   999999999999999999999999999987643221


Q ss_pred             ccccccccccccccCccccCCC----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK----KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                       .......||+.|+|||++...    .++.++||||+||++|||++|+.||........     ......... .....+
T Consensus       198 -~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-----~~~i~~~~~-~~~~~~  270 (371)
T cd05622         198 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-----YSKIMNHKN-SLTFPD  270 (371)
T ss_pred             -ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-----HHHHHcCCC-cccCCC
Confidence             122345689999999987643    378899999999999999999999986543221     111111000 000000


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKAL  852 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~L  852 (876)
                            .......+.+++.+|+...+.+  ||++.|+++..
T Consensus       271 ------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         271 ------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                  0122345788999999844433  78999988864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.1e-33  Score=293.61  Aligned_cols=242  Identities=25%  Similarity=0.432  Sum_probs=191.2

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| ||.||++.. .++.||+|.+...  .....+.+|+.++++++|||++++++++..+ ..++||||+++++
T Consensus        10 ~~~~lg~g~-~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~   84 (254)
T cd05083          10 LGEIIGEGE-FGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN   84 (254)
T ss_pred             eeeeeccCC-CCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence            334555555 999999875 7888999998543  2346788999999999999999999998764 4799999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++... ...+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||.+.......     ..
T Consensus        85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~  156 (254)
T cd05083          85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DN  156 (254)
T ss_pred             HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC-----CC
Confidence            99999765 34588999999999999999999998   99999999999999999999999999987543221     11


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...+..|+|||.+....++.++||||||+++|||++ |+.||.......  ........      ..  .++     ...
T Consensus       157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~------~~--~~~-----~~~  221 (254)
T cd05083         157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKG------YR--MEP-----PEG  221 (254)
T ss_pred             CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCC------CC--CCC-----CCc
Confidence            224567999999888889999999999999999998 999987544322  11111110      00  000     112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      .+..+.+++.+||+.+|++||+++++++.|++
T Consensus       222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            23567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-33  Score=297.69  Aligned_cols=260  Identities=24%  Similarity=0.336  Sum_probs=192.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|. |++|.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 y~~~~~lg~-g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07844           7 YKKLDKLGE-GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL   85 (291)
T ss_pred             eeEEEEEee-cCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence            333344555 459999999765 789999999865332 22345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++ +|.+++.+....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||+++.......  .
T Consensus        86 ~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~  159 (291)
T cd07844          86 DT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--T  159 (291)
T ss_pred             CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc--c
Confidence            85 99999877666789999999999999999999999   999999999999999999999999999875432211  1


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-ccccc----------
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-ITNGA----------  808 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~----------  808 (876)
                      .....++..|+|||...+ ..++.++||||+|+++|||++|+.||......... ......... .....          
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhhhhhhcccc
Confidence            222346778999998765 45788999999999999999999999754421111 111111000 00000          


Q ss_pred             ----cccc-ChhhhhhcHHH--HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 ----IQVL-DPKIANCYQQQ--MLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ----~~~~-d~~~~~~~~~~--~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          .... ...+.......  ...+.+++.+|++.+|++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                0000 01111111111  156789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.4e-33  Score=294.48  Aligned_cols=245  Identities=23%  Similarity=0.327  Sum_probs=194.2

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEEcC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFL  660 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~  660 (876)
                      ...+|.|| ||.||+|.. .+++.||+|++.....  ...+++..|++++++++||||+++++++..  +...+++|||+
T Consensus         5 ~~~lg~g~-~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217           5 LETIGKGS-FGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             eeeeccCC-CeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence            34455555 999999954 5789999999865332  234567889999999999999999998764  45689999999


Q ss_pred             CCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhh-----ccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLH-----KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       661 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      ++++|.+++.+.   ...+++..+..++.|++.|++|||     +.   +++|+||||+||+++.++.+|++|||++...
T Consensus        84 ~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          84 EGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             cCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999998653   457899999999999999999999     66   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....  ......++..|+|||......++.++||||||+++|+|++|+.||......  ...+....   .   ...  
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~---~---~~~--  228 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLASKIKE---G---KFR--  228 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHHHHHhc---C---CCC--
Confidence            54321  122335788999999998888899999999999999999999999865422  12222111   1   111  


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           .........+.+++.+|++.+|++||++.||++.
T Consensus       229 -----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 -----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                 1112334578899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8e-33  Score=292.35  Aligned_cols=244  Identities=22%  Similarity=0.361  Sum_probs=193.7

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|.|+ ||.||++.. .+++.||+|.+.....  .....+.+|++++++++|||++++++.+..++..++||||+++
T Consensus         5 ~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd08220           5 IRVVGRGA-FGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG   83 (256)
T ss_pred             EEEecccC-ceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence            34455555 999999865 4789999999865422  2346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|.+++... +..+++..+.+++.+++.|++|||+.   +++||||||+||+++++ +.+|++|||.+........   
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---  157 (256)
T cd08220          84 GTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---  157 (256)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---
Confidence            9999999765 44589999999999999999999999   99999999999999855 5689999999987654321   


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....++..|+|||...+..++.++||||||+++|+|++|+.||.......  .......  ..   ... +       .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~--~~---~~~-~-------~  222 (256)
T cd08220         158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMS--GT---FAP-I-------S  222 (256)
T ss_pred             ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHh--cC---CCC-C-------C
Confidence            122347888999999988888999999999999999999999987643322  1111111  00   000 0       1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......+.+++.+||+++|++|||+.|+++.
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1123467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.7e-32  Score=295.03  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=195.5

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ..+.|++|.||+|... +|+.||+|++.....  .....+.+|+.++++++|||++++++++..++..++||||+ +++|
T Consensus         7 ~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L   85 (286)
T cd07832           7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL   85 (286)
T ss_pred             ecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCH
Confidence            3444559999999764 799999999876442  23467889999999999999999999999999999999999 9999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++......+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+........ .......
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~  161 (286)
T cd07832          86 SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQV  161 (286)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccccccc
Confidence            999977666799999999999999999999999   999999999999999999999999999887654321 1223345


Q ss_pred             ccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc-----c------ccccc-
Q 002826          746 ALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN-----G------AIQVL-  812 (876)
Q Consensus       746 gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~------~~~~~-  812 (876)
                      ++..|+|||...+. .++.++||||+|+++|||++|.+||.......  .............     .      ..... 
T Consensus       162 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07832         162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE--QLAIVFRTLGTPNEETWPGLTSLPDYNKITF  239 (286)
T ss_pred             CcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH--HHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence            88899999987654 46889999999999999999988876543221  1111111100000     0      00000 


Q ss_pred             ---C-hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 ---D-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 ---d-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         + ..+.....+....+.+++.+|+.++|++|||++++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0 00111122334678999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=279.03  Aligned_cols=256  Identities=22%  Similarity=0.313  Sum_probs=202.2

Q ss_pred             CCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..+.|.|+|+.|--+ ...+|..||||++.+.....+.++.+|++++... .|+||+.+++||+++..+|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            445667779999876 6679999999999887667788899999999999 49999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEccccchhhcccc-----c
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFALDRIVGEA-----A  736 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~-----~  736 (876)
                      |.+++.++. .+++.++.++..+|+.||.+||.+   ||.|||+||+|||-.+.   --+||+||.+..-....     .
T Consensus       163 lLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  163 LLSHIQKRK-HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             HHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            999997764 789999999999999999999999   99999999999999654   34899999887544311     1


Q ss_pred             cccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-----chhhHHHHHHHHh--hc
Q 002826          737 FQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPA-----ESLDVVKWVRRKI--NI  804 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~--~~  804 (876)
                      .+......+|+..|||||+..     .-.|..++|.||+|||+|-|+.|.+||.+--.     +........++..  .+
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            112233456788899999742     23588999999999999999999999975322     2222233333322  33


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+..+..|..    |...+.+..+++...+..|+.+|.++.++++
T Consensus       319 QEGkYeFPdkd----WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  319 QEGKYEFPDKD----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             hccCCcCChhh----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            33444444443    4555667889999999999999999998887

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.1e-32  Score=298.43  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=194.1

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc-----CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ-----SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|+ +|.||+|... +|+.||+|++......     ....+..|++++++++|+||+++++++.+.+..++||||+
T Consensus         6 ~~lg~g~-~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (298)
T cd07841           6 KKLGEGT-YAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM   84 (298)
T ss_pred             eeeeecc-ccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence            3455555 9999999764 7899999999754322     2345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                       +++|.+++.+....+++..+.+++.|+++||+|||+.   +++||||||+||+++.++.+||+|||+++.......  .
T Consensus        85 -~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~  158 (298)
T cd07841          85 -ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--K  158 (298)
T ss_pred             -CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--c
Confidence             8899999977655799999999999999999999999   999999999999999999999999999987654321  1


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc-------c-----
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN-------G-----  807 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~-----  807 (876)
                      .....++..|+|||.+.+ ..++.++|||||||++|||++|.+||........ .....+.......       .     
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ-LGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH-HHHHHHHcCCCchhhhhhcccccccc
Confidence            223346778999998754 4578899999999999999999888875443221 1111110000000       0     


Q ss_pred             -cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 -AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 -~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ...................+.+++.+||+++|++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000011111222335678899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6e-33  Score=296.38  Aligned_cols=249  Identities=21%  Similarity=0.334  Sum_probs=191.4

Q ss_pred             CCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC------eEEE
Q 002826          588 SAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------SIFL  655 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~l  655 (876)
                      .+|.|| ||.||+|...    +++.||+|++.....  ...+++.+|++++++++||||+++++++...+      ..++
T Consensus         6 ~ig~g~-~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   84 (273)
T cd05074           6 MLGKGE-FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV   84 (273)
T ss_pred             cccCCC-CCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEE
Confidence            445555 9999999643    478999999865322  23456888999999999999999999886532      2478


Q ss_pred             EEEcCCCCCHHHHhhcc-----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          656 IYEFLQMGSLGDLICRQ-----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ++||+++|+|.+++...     ...+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        85 ~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~  161 (273)
T cd05074          85 ILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK  161 (273)
T ss_pred             EEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccc
Confidence            99999999998887432     23578999999999999999999999   99999999999999999999999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ...............++..|++||......++.++||||||+++|||++ |++||......  ....+...   .. .. 
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~---~~-~~-  234 (273)
T cd05074         162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK---GN-RL-  234 (273)
T ss_pred             cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHc---CC-cC-
Confidence            7654332222223345677999999888888999999999999999999 88888654322  11222111   00 00 


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                       ...       ......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       235 -~~~-------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         235 -KQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             -CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             000       11234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.2e-32  Score=291.27  Aligned_cols=242  Identities=27%  Similarity=0.383  Sum_probs=192.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-----cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-----QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| +|.||+|... +++.||+|.+.....     ...+.+.+|+++++.++|+||+++++++.+++..++|+||+
T Consensus         6 ~~ig~g~-~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   84 (258)
T cd06632           6 ELLGSGS-FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV   84 (258)
T ss_pred             ceeeecC-CceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence            3445555 9999999765 899999999865432     23457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.+.. .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.......   .
T Consensus        85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~  157 (258)
T cd06632          85 PGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F  157 (258)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence            9999999997654 688999999999999999999999   99999999999999999999999999987654322   1


Q ss_pred             cccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....++..|+|||...... ++.++|+||||+++|++++|+.||....... ....+.. . .    ....+       
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~-~-~----~~~~~-------  223 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVFKIGR-S-K----ELPPI-------  223 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHHHHHh-c-c----cCCCc-------
Confidence            23345788899999887665 8899999999999999999999997644111 1111110 0 0    00011       


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .......+.+++.+||+.+|++||++.|+++
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1122345788999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-33  Score=305.68  Aligned_cols=245  Identities=22%  Similarity=0.301  Sum_probs=192.9

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEE---EEEec-CCccCHHHHHHHHHHHhhccCccccceeeEEEeCC--eEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAV---KKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vav---K~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  655 (876)
                      |-....+.|.|+|-+||+|-. .+|-.||=   |.-.. .......+|..|+.+|+.|+||||++++++|.+..  ..-+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            344456677788999999943 46777753   22111 12233478899999999999999999999998754  4889


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGE  734 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~  734 (876)
                      |+|.+..|+|..|..+.+ ..+...+++|++||++||.|||++ .|+|+|||||-+||||+.+ |.|||+|+|+|+....
T Consensus       121 iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999998775 688999999999999999999997 5699999999999999864 9999999999998865


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--cccccccc
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--TNGAIQVL  812 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  812 (876)
                      ..    .....|||.|||||... ..|.+.+||||||++++||+|+..||.-..    .-.+..++...+  +..+..+-
T Consensus       199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~----n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT----NPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC----CHHHHHHHHHcCCCHHHhhccC
Confidence            43    22367999999999876 678999999999999999999999985432    233333333311  11122222


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      |           .++.++|.+|+.. .++|||+.|+++
T Consensus       270 d-----------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 D-----------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             C-----------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            3           3478999999999 999999999986

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.4e-32  Score=292.43  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=188.4

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-----cCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-----QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~  654 (876)
                      |.....+|.|+ ||.||+|.. .+++.||+|++.....     .....+.+|++++++++||||+++++++.+  .+..+
T Consensus         4 ~~~~~~lg~g~-~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           4 WRRGKLLGQGA-FGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             ccccceecCCC-CEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            33444555555 999999965 4689999998864321     122467889999999999999999999875  36789


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +++||+++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            9999999999999997654 588999999999999999999998   999999999999999999999999999876542


Q ss_pred             ccc-ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          735 AAF-QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       735 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ... ........++..|+|||.+.+..++.++||||+||++||+++|+.||.......     .........      ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-----~~~~~~~~~------~~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-----AIFKIATQP------TN  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-----HHHHHhcCC------CC
Confidence            211 111223347888999999988888999999999999999999999997542211     111111000      01


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +.+   .......+.+++ +||..+|++||+++|+++
T Consensus       228 ~~~---~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQL---PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCC---chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            111   112233456666 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-32  Score=290.84  Aligned_cols=247  Identities=23%  Similarity=0.410  Sum_probs=192.6

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc------CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+.|+||.||+|.. .+++.||+|.+......      ..+.+.+|++++++++|||++++++++.+.+..++||||++
T Consensus         7 ~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~   86 (268)
T cd06630           7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA   86 (268)
T ss_pred             eecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence            334455999999964 57999999998653311      23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhccccccc--
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQ--  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~--  738 (876)
                      +++|.+++.+.+ .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++ .+||+|||.+.........  
T Consensus        87 ~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  162 (268)
T cd06630          87 GGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG  162 (268)
T ss_pred             CCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC
Confidence            999999997654 688999999999999999999999   999999999999998775 5999999998776532111  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......++..|+|||...+..++.++||||+|+++|++++|+.||........  ...........  .    .+   .
T Consensus       163 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~--~----~~---~  231 (268)
T cd06630         163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIASAT--T----AP---S  231 (268)
T ss_pred             ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhccC--C----CC---C
Confidence            112233578889999998888889999999999999999999999975433221  11111110000  0    01   1


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ........+.+++.+|+..+|++||++.|+++
T Consensus       232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11223456788999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.2e-32  Score=316.33  Aligned_cols=254  Identities=19%  Similarity=0.225  Sum_probs=184.5

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCc------cccceeeEEEeC-CeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHK------NIVKVLGFFHSD-ESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~-~~~~  654 (876)
                      |.....+|.|+ ||+||+|.. .+++.||||++.... ........|+++++.++|.      +++++++++... ++.|
T Consensus       131 y~i~~~lG~G~-fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~  208 (467)
T PTZ00284        131 FKILSLLGEGT-FGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC  208 (467)
T ss_pred             EEEEEEEEecc-CEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence            33334455554 999999965 468899999986432 2344566788888887654      588888888764 5789


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCC--------------
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADF--------------  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~--------------  719 (876)
                      +|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||+ .   +|+||||||+|||++.++              
T Consensus       209 iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~  283 (467)
T PTZ00284        209 IVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPD  283 (467)
T ss_pred             EEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCC
Confidence            999987 668998887653 68999999999999999999997 5   899999999999998665              


Q ss_pred             --CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHH
Q 002826          720 --EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKW  797 (876)
Q Consensus       720 --~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~  797 (876)
                        .+||+|||.+......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+  ....
T Consensus       284 ~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~  356 (467)
T PTZ00284        284 PCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE--HLHL  356 (467)
T ss_pred             CceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH
Confidence              4999999987643221     234468999999999999899999999999999999999999998654321  1111


Q ss_pred             HHHHh-h-------------------cccccccccChhhh-h-------hcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002826          798 VRRKI-N-------------------ITNGAIQVLDPKIA-N-------CYQQQMLGALEIALRCTSVMPEKRPSMFEVV  849 (876)
Q Consensus       798 ~~~~~-~-------------------~~~~~~~~~d~~~~-~-------~~~~~~~~~~~li~~cl~~dP~~RPs~~ell  849 (876)
                      +.... .                   .........++... .       ........+.+++.+||..||++|||++|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            11110 0                   00000011111100 0       0001134578999999999999999999999


Q ss_pred             H
Q 002826          850 K  850 (876)
Q Consensus       850 ~  850 (876)
                      +
T Consensus       437 ~  437 (467)
T PTZ00284        437 T  437 (467)
T ss_pred             c
Confidence            7

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.3e-33  Score=297.06  Aligned_cols=258  Identities=22%  Similarity=0.395  Sum_probs=193.2

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ....+|.|+ ||.||+|..+ +++.||+|++......  ..+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus         5 ~~~~lg~g~-~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (286)
T cd07846           5 NLGLVGEGS-YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD   83 (286)
T ss_pred             EeeeeccCC-CeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence            334555555 9999999775 6899999988653322  34568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++++.++.... ..+++..+..++.|++.|++|||+.   +++|||++|+||++++++.++++|||++.......  ...
T Consensus        84 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~  157 (286)
T cd07846          84 HTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY  157 (286)
T ss_pred             ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence            99888876544 3589999999999999999999999   99999999999999999999999999987664332  122


Q ss_pred             ccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccc---------
Q 002826          742 SSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV---------  811 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  811 (876)
                      ....++..|+|||...+ ..++.++||||||+++|||++|++||........ ..................         
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccchHhhc
Confidence            33457888999998764 4577899999999999999999999975442211 111100000000000000         


Q ss_pred             -cChh------hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          812 -LDPK------IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       812 -~d~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       ..+.      ...........+.+++.+||+.+|++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0000      00111223457889999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-32  Score=293.08  Aligned_cols=250  Identities=29%  Similarity=0.433  Sum_probs=191.5

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---c-------CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---Q-------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ..+|.|| +|.||+|.. .+|+.||+|.+.....   .       ..+.+.+|+++++.++|||++++++++...+..++
T Consensus         7 ~~lg~g~-~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           7 ELIGKGT-YGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             ceecccC-ceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            3445554 999999965 4799999998853211   0       12357789999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++++|.+++.+.+ .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||+++.....
T Consensus        86 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          86 FLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             EEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            999999999999997764 689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccccCccccCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKK--ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ..........++..|+|||......  ++.++||||+|+++||+++|..||.......    ... ......  ....++
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~-~~~~~~--~~~~~~  234 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMF-KLGNKR--SAPPIP  234 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHH-Hhhccc--cCCcCC
Confidence            2111223344788899999876544  7889999999999999999999986432211    111 110000  111111


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +.   ...+....+.+++.+||.++|++|||+.|+++.
T Consensus       235 ~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         235 PD---VSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11   112234578899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-32  Score=288.74  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=199.9

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ....++.|+ +|.||++... +++.|++|++..........+.+|++.++.++|||++++++++..++..++++||++++
T Consensus         4 ~~~~l~~g~-~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~   82 (253)
T cd05122           4 ILEKIGKGG-FGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG   82 (253)
T ss_pred             eeeeeccCC-ceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence            345556665 9999999775 78999999997655446678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++......+++..+..++.+++.|++|||+.   +++||||+|+||++++++.++|+|||.+........   ...
T Consensus        83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~  156 (253)
T cd05122          83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNT  156 (253)
T ss_pred             cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccc
Confidence            99999987656799999999999999999999998   999999999999999999999999999887654331   223


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..++..|+|||......++.++||||||+++|+|++|+.||........  ......  ..   .....++      ...
T Consensus       157 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~--~~---~~~~~~~------~~~  223 (253)
T cd05122         157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT--NG---PPGLRNP------EKW  223 (253)
T ss_pred             eecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh--cC---CCCcCcc------ccc
Confidence            4578889999998888889999999999999999999999876432211  111110  00   0000000      111


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+.+++.+||+.||++|||+.|+++.
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            3468899999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=293.27  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=192.8

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhcc---CccccceeeEEEeCCeEEEEEEcC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIR---HKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ...+|.|+ ||.||+|.. .+++.||+|.+.... .....++.+|++++++++   |||++++++++.++...++||||+
T Consensus         6 ~~~l~~g~-~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06917           6 LELIGRGA-YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA   84 (277)
T ss_pred             hhheeccC-CceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence            34455555 999999975 579999999986542 234567889999999997   999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++...  .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++........  .
T Consensus        85 ~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06917          85 EGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--K  157 (277)
T ss_pred             CCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--c
Confidence            999999998653  689999999999999999999999   999999999999999999999999999887654321  1


Q ss_pred             cccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....|+..|+|||....+ .++.++||||||+++|+|++|+.||.......     ........       ..+.+.. 
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~~~-------~~~~~~~-  224 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIPKS-------KPPRLED-  224 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccccC-------CCCCCCc-
Confidence            2333588889999987654 46889999999999999999999997543221     11100000       0111111 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ...+.++.+++.+||..||++||++.|+++.
T Consensus       225 -~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         225 -NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence             0134568899999999999999999999873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-32  Score=293.44  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=196.7

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +.....+|.|+ +|.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        21 ~~~~~~lg~g~-~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGS-TGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCC-CeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            33445566655 999999965 5789999999865444445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++..  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+........  ..
T Consensus       100 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            9999999876  3689999999999999999999999   999999999999999999999999998876543221  12


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||...+..++.++||||||+++|||++|+.||.......     ..+......       .+... ...
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-----~~~~~~~~~-------~~~~~-~~~  239 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-----AMKRIRDNL-------PPKLK-NLH  239 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-----HHHHHHhcC-------CCCCc-ccc
Confidence            23457889999999888889999999999999999999999987533211     111111110       00110 011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            13346889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-32  Score=294.55  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=199.0

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..|.....++.|+ +|.||+|... +++.||+|++..... ....+.+|++.++.++|+|++++++++...+..++|+||
T Consensus        19 ~~~~~~~~l~~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          19 ELYKNLEKIGEGA-SGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccchHhHhccCCC-CeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            3444444555555 9999999775 789999999976543 466788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++......+++..+..++.|++.|++|||+.   +++|+|++|+||+++.++.++|+|||.+........  
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  171 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--  171 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence            999999999987655799999999999999999999998   999999999999999999999999999876543221  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......++..|+|||...+..++.++||||||+++|+|++|+.||........ ...+ ..  ..   .....+      
T Consensus       172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~-~~--~~---~~~~~~------  238 (286)
T cd06614         172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLI-TT--KG---IPPLKN------  238 (286)
T ss_pred             hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-Hh--cC---CCCCcc------
Confidence            12233477889999998888889999999999999999999999875433221 1111 10  00   000000      


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .......+.+++.+|++.+|.+|||+.|+++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1112346789999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.9e-33  Score=322.59  Aligned_cols=254  Identities=26%  Similarity=0.407  Sum_probs=193.2

Q ss_pred             hhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEe-------
Q 002826          579 LVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-------  649 (876)
Q Consensus       579 l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  649 (876)
                      ...+|.+..-+|+|| ||.||+++.+ ||+.||||++.... ......+.+|+.++++|+|||||+++..|.+       
T Consensus       477 Y~~DFEEL~lLGkGG-FG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGG-FGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             HhhhhHHHHHhcCCC-CceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            445777788888888 9999999877 99999999997543 1223567889999999999999999854300       


Q ss_pred             ----------------------------------------------------------------------C---------
Q 002826          650 ----------------------------------------------------------------------D---------  650 (876)
Q Consensus       650 ----------------------------------------------------------------------~---------  650 (876)
                                                                                            +         
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                  0         


Q ss_pred             ---------------------------------CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc
Q 002826          651 ---------------------------------ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK  697 (876)
Q Consensus       651 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~  697 (876)
                                                       ...||-||||+..++.++++++...-.....++++++|+.|++|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             01589999999988888887764322577889999999999999999


Q ss_pred             cCCCCccccccccCceeeCCCCCeEEccccchhhcc----------------ccccccccccccccccccCccccCCC--
Q 002826          698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG----------------EAAFQSTMSSEYALSCYNAPEYGYSK--  759 (876)
Q Consensus       698 ~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~--  759 (876)
                      .   ||+||||||.|||++++..|||+|||+|+...                .+......+...||.-|+|||+..+.  
T Consensus       716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            9   99999999999999999999999999998821                11112245567899999999987654  


Q ss_pred             -CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCC
Q 002826          760 -KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVM  838 (876)
Q Consensus       760 -~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~d  838 (876)
                       .|+.|+|+||+|||++||+.   ||.. ..+......-.+. ..++         ..+....++...-.++|++|++.|
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T-sMERa~iL~~LR~-g~iP---------~~~~f~~~~~~~e~slI~~Ll~hd  858 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGT-SMERASILTNLRK-GSIP---------EPADFFDPEHPEEASLIRWLLSHD  858 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCc-hHHHHHHHHhccc-CCCC---------CCcccccccchHHHHHHHHHhcCC
Confidence             59999999999999999987   5554 2222222222221 1111         112334445556689999999999


Q ss_pred             CCCCCCHHHHHH
Q 002826          839 PEKRPSMFEVVK  850 (876)
Q Consensus       839 P~~RPs~~ell~  850 (876)
                      |.+||||.|+++
T Consensus       859 P~kRPtA~eLL~  870 (1351)
T KOG1035|consen  859 PSKRPTATELLN  870 (1351)
T ss_pred             CccCCCHHHHhh
Confidence            999999999986

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-32  Score=295.86  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=190.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEE-----eCCeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFH-----SDESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~  654 (876)
                      +|.....+|.|+ ||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +||||+++++++.     .++..+
T Consensus        19 ~~~~~~~lg~g~-~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~   96 (286)
T cd06638          19 TWEIIETIGKGT-YGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW   96 (286)
T ss_pred             ceeeeeeeccCC-CcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence            444455565555 999999965 478999999875432 2345688899999999 6999999999884     345789


Q ss_pred             EEEEcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          655 LIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      +||||+++++|.+++..   ....+++..+..++.|+++|+.|||+.   +++||||||+||++++++.+|++|||+++.
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceee
Confidence            99999999999998753   245688999999999999999999999   999999999999999999999999999876


Q ss_pred             ccccccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      ......  ......|+..|+|||.+.     ...++.++||||+||++|||++|+.||........ ....    .... 
T Consensus       174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~----~~~~-  245 (286)
T cd06638         174 LTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKI----PRNP-  245 (286)
T ss_pred             cccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhc----cccC-
Confidence            643221  122345888999999864     24478899999999999999999999875432111 1110    0000 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                       .....++.      .....+.+++.+||+.+|++|||++|+++..
T Consensus       246 -~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         246 -PPTLHQPE------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -CCcccCCC------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             00111111      1123578999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-32  Score=295.99  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=198.1

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..|.....+|.|+ ||.||++.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..|+|+||
T Consensus        19 ~~~~~~~~lg~g~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGA-SGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCC-CeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            3454555566555 999999964 47899999998655445556788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++.+.  .+++..+..++.|++.|+.|||+.   +++|||+||+||+++.++.+||+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--  170 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence            9999999998654  478999999999999999999999   999999999999999999999999998876543321  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......+++.|+|||......++.++||||||+++||+++|+.||.........  ....   ...   .    +.. ..
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~--~~~~---~~~---~----~~~-~~  237 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YLIA---TNG---T----PEL-QN  237 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe--eehh---cCC---C----CCC-CC
Confidence            122335788899999988888899999999999999999999999765432210  0000   000   0    000 01


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||+.+|++||++.|++..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11223467899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=299.72  Aligned_cols=248  Identities=23%  Similarity=0.277  Sum_probs=194.2

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|+ +|+||+|... +++.||+|.+......   ..+.+..|+++++.++||||+++++.+.+.+..|+||||+
T Consensus         5 ~~~~ig~g~-~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           5 KIKLLGKGD-VGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EeeeecCCc-cEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            344555555 9999999765 5999999999764322   3356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      .+++|.+++.+. +..+++..+..++.|+++|++|||+.   +++||||||+||+++.++.++++|||++..........
T Consensus        84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999998764 45789999999999999999999999   99999999999999999999999999987653221100


Q ss_pred             ---------------------------ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh
Q 002826          740 ---------------------------TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL  792 (876)
Q Consensus       740 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~  792 (876)
                                                 ......|+..|+|||...+..++.++||||||+++|+|++|+.||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                       01123578889999999888899999999999999999999999975443221


Q ss_pred             hHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 002826          793 DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS----MFEVVK  850 (876)
Q Consensus       793 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~ell~  850 (876)
                       ......    ..        ..... .......+.+++.+|++.+|++|||    +.|+++
T Consensus       241 -~~~~~~----~~--------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         241 -FSNILK----KE--------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             -HHHHhc----CC--------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence             111110    00        00000 0113457889999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.2e-32  Score=296.01  Aligned_cols=249  Identities=27%  Similarity=0.366  Sum_probs=193.4

Q ss_pred             hhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ...|.....+|.|+ ||+||+|... +++.||+|++.......   ..++.+|+++++.++|||++++++++.+++..++
T Consensus        14 ~~~y~~~~~lg~g~-~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          14 EKLFTDLREIGHGS-FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             chhhhhheeecCCC-CeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            33444445555555 9999999764 78999999986543222   2467899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++ ++.+++......+++..+..++.|++.|+.|||+.   +++||||+|+||++++++.+||+|||++......
T Consensus        93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9999974 88887766555799999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          736 AFQSTMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                            ....++..|+|||.+.   ...++.++||||||+++|||+||++||........  ......  ..   .    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~~--~~---~----  231 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ--ND---S----  231 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHhc--CC---C----
Confidence                  1234778899999864   45678899999999999999999999865432211  111000  00   0    


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                       +...  .......+.+++.+||+.+|++||++.++++.-.
T Consensus       232 -~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         232 -PTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             -CCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence             1110  1123446889999999999999999999988543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.8e-32  Score=289.02  Aligned_cols=250  Identities=26%  Similarity=0.372  Sum_probs=197.4

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|.|| ||+||+|... ++..||+|++..... ...+.+.+|++.++.++|+|++++++.+..++..++|||++++
T Consensus         5 ~~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           5 LIEVIGVGA-TAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeecCCC-CeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            344555555 9999999754 788999999865332 2456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc-
Q 002826          663 GSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS-  739 (876)
Q Consensus       663 gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  739 (876)
                      ++|.+++...  ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++.......... 
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            9999999764  24689999999999999999999999   99999999999999999999999999988776432221 


Q ss_pred             -ccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          740 -TMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       740 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......|+..|+|||.+... .++.++||||||+++|||++|+.||....... ...+..+.   .        .+.+.
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~---~--------~~~~~  228 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQN---D--------PPSLE  228 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcC---C--------CCCcC
Confidence             12333578899999988766 78899999999999999999999997644322 11111111   0        01111


Q ss_pred             h--hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 N--CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~--~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .  ........+.+++.+||..+|++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         229 TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0  01233456789999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-32  Score=292.58  Aligned_cols=257  Identities=25%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  658 (876)
                      |.....+|.|+ +|.||++... +++.||+|.+..... ....++.+|++++++++||||+++++++.+  .+..++|||
T Consensus         3 ~~~~~~lg~g~-~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           3 IVELSRLGEGA-GGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             eEEEEEeccCC-ceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            34455566665 9999999764 689999999875432 234678899999999999999999999865  347899999


Q ss_pred             cCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          659 FLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999988753   245688999999999999999999999   9999999999999999999999999998765432


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ..    ....++..|+|||...+..++.++||||+|+++|||++|+.||...........+.........   ...+...
T Consensus       159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  231 (287)
T cd06621         159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP---NPELKDE  231 (287)
T ss_pred             cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC---chhhccC
Confidence            21    1234677899999998888999999999999999999999999865331111112211111110   0000000


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      . .........+.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         232 P-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             C-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            0 0001124568899999999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.7e-32  Score=289.99  Aligned_cols=246  Identities=22%  Similarity=0.303  Sum_probs=188.5

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--c---CHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--Q---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  657 (876)
                      ...+|.|+ ||.||+|... +|+.||+|.+.....  .   ....+.+|+.++++++||||+++++++.+.  ..+++||
T Consensus         7 ~~~l~~g~-~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           7 GKLLGQGA-FGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             eeEEecCC-ceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            34455554 9999999664 689999998853221  1   124678899999999999999999998763  4688999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.+.. .+++..+.+++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          86 EHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            9999999999987654 578899999999999999999999   999999999999999999999999999876542111


Q ss_pred             -ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          738 -QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       738 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                       ........++..|+|||...+..++.++||||||+++|||++|+.||........    . .......      ..+. 
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----~-~~~~~~~------~~~~-  229 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA----I-FKIATQP------TNPV-  229 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH----H-HHHhcCC------CCCC-
Confidence             1112234578889999998888889999999999999999999999975422211    1 1111000      0111 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        .+......+.+++.+|+. +|++||+++|+++.
T Consensus       230 --~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         230 --LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              122334467788999994 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.9e-32  Score=291.87  Aligned_cols=260  Identities=22%  Similarity=0.373  Sum_probs=195.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....++.|+ +|.||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         2 y~~~~~l~~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           2 FKQLEKLGEGT-YATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             ceEeeeeccCC-ceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            33445566665 9999999775 789999999875432 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          661 QMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ++ +|.+++....  ..+++..+.+++.|++.|++|||+.   +++||||||+||++++++.++++|||+++......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            86 8988886543  4689999999999999999999999   99999999999999999999999999997654321  


Q ss_pred             cccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh--------------h
Q 002826          739 STMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI--------------N  803 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------------~  803 (876)
                      .......++..|++||...+ ..++.++||||+|+++||+++|+.||........ .....+...              .
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCch
Confidence            12233456888999998755 3568899999999999999999999986543321 111110000              0


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .........+.............+.+++.+|++.+|.+||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00000000011111122233456889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-32  Score=290.52  Aligned_cols=244  Identities=25%  Similarity=0.375  Sum_probs=193.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..++.|+ ||.||+|... +|+.||+|.+....  ....+.+.+|+++++.++|+||+++++++.+++..++|+||++++
T Consensus         6 ~~l~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           6 KKIGEGS-FGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEecCCC-cceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            4455555 9999999765 68999999986532  234467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhcccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|.+++.+. +..+++..+..++.|+++|++|||+.   +++|+||||+||++++++ .+|++|||.+........  ..
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~  159 (257)
T cd08225          85 DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LA  159 (257)
T ss_pred             cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cc
Confidence            999998764 34589999999999999999999999   999999999999999875 469999999877653321  11


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||......++.++||||||+++||+++|+.||.......     +.......   ....+.+       
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~---~~~~~~~-------  224 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQG---YFAPISP-------  224 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcc---cCCCCCC-------
Confidence            22347888999999888888999999999999999999999987543221     22211111   1111111       


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+||..+|++|||+.|+++.
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            123468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2e-32  Score=297.27  Aligned_cols=252  Identities=19%  Similarity=0.232  Sum_probs=192.7

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....++.|+ ||.||++... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+..++..++||||+
T Consensus         5 ~~~~l~~g~-~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           5 TIKLISNGA-YGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             EeeEeecCC-CeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            334455555 9999999664 688999999865432   22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc--
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ--  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--  738 (876)
                      ++++|.+++...+ .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++........  
T Consensus        84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          84 EGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999997654 689999999999999999999999   9999999999999999999999999988642110000  


Q ss_pred             -----------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          739 -----------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       739 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                                 .......++..|+|||.+....++.++|+||||+++||+++|+.||.......     +........  
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-----~~~~~~~~~--  232 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-----LFGQVISDD--  232 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcc--
Confidence                       00112346778999999888889999999999999999999999997543221     111111100  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                         ...+...   ...+..+.+++.+||+.+|++||++.++.+.++.
T Consensus       233 ---~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 ---IEWPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ---cCCCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence               0001100   0123457899999999999999997666666655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.2e-32  Score=294.01  Aligned_cols=261  Identities=22%  Similarity=0.295  Sum_probs=195.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|..+ +++.||+|.+......  ....+.+|++++++++||||+++++++...  +..|+|
T Consensus         6 ~y~~~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGT-YGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCC-CeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            444555666665 9999999775 6899999998653322  234567899999999999999999999877  889999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++ +|.+++......+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999985 99999877666799999999999999999999999   99999999999999999999999999988765432


Q ss_pred             cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----------hc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-----------NI  804 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~  804 (876)
                        .......++..|+|||.+.+. ..+.++|+||+|+++|||++|++||........ .........           ..
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhcc
Confidence              122334477889999987654 468899999999999999999999976543221 111000000           00


Q ss_pred             c----cccccccChhhhhhcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 T----NGAIQVLDPKIANCYQQ--QMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 ~----~~~~~~~d~~~~~~~~~--~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .    ..........+......  ....+.+++.+|++.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0    00000000111111111  2456789999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-32  Score=291.23  Aligned_cols=254  Identities=17%  Similarity=0.239  Sum_probs=190.3

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeC--CeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD--ESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~~  661 (876)
                      ..+|.|+ ||.||+|.. .+++.||+|++..... .......+|+..++++. |+|++++++++.++  +..++||||++
T Consensus         5 ~~lg~g~-~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (282)
T cd07831           5 GKIGEGT-FSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD   83 (282)
T ss_pred             eeccccc-cceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence            4455555 999999965 4789999999865422 22334457888999885 99999999999987  88999999997


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      + ++.+.+......+++..+..++.|++.|++|||+.   +++||||||+||+++. +.+||+|||+++.......   .
T Consensus        84 ~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~  155 (282)
T cd07831          84 M-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---Y  155 (282)
T ss_pred             c-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC---c
Confidence            5 88888876556789999999999999999999999   9999999999999999 9999999999987643321   1


Q ss_pred             ccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----------hcccc--
Q 002826          742 SSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-----------NITNG--  807 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~--  807 (876)
                      ....++..|+|||... ...++.++||||+||++|||++|++||...+..+  .........           .....  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhccccccc
Confidence            2234788899999754 4567889999999999999999999997654322  111111100           00000  


Q ss_pred             --cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 --AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 --~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        ........+.......+..+.+++.+||+++|++||+++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence              00000111112223446788999999999999999999999863

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.4e-32  Score=292.40  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=193.9

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|.|+ ||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++.+++..++||||+++
T Consensus         8 ~~~~ig~G~-~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   86 (277)
T cd06641           8 KLEKIGKGS-FGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG   86 (277)
T ss_pred             hheeEeecC-CeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence            445556655 999999965 4789999998864322 2335788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      ++|.+++...  .+++..+..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++........  ...
T Consensus        87 ~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~  159 (277)
T cd06641          87 GSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRN  159 (277)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh--hhc
Confidence            9999998643  588999999999999999999999   999999999999999999999999999876543221  122


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...++..|+|||.......+.++|||||||++|+|++|..||.......  ......   ..   ....+       ...
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~---~~---~~~~~-------~~~  224 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIP---KN---NPPTL-------EGN  224 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHh---cC---CCCCC-------Ccc
Confidence            3357888999999888888999999999999999999999986533211  111111   00   00111       112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....+.+++.+||..+|.+||++.++++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            23457899999999999999999999994

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.8e-32  Score=289.59  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|| +|.||+|... +++.||+|++..... .....+.+|++.+++++|+|++++++++..++..++||||++++
T Consensus         6 ~~~i~~g~-~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           6 VKVLGQGS-SGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeecC-CeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            34455555 9999999776 599999999876543 33567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++... ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+.........  ..
T Consensus        85 ~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~--~~  158 (264)
T cd06623          85 SLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ--CN  158 (264)
T ss_pred             cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--cc
Confidence            999999765 468999999999999999999999 8   9999999999999999999999999998876533221  12


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCc-chhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA-ESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...++..|+|||......++.++||||||+++|||++|+.||..... ...........   .   ....+       ..
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~---~~~~~-------~~  225 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---G---PPPSL-------PA  225 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---C---CCCCC-------Cc
Confidence            33478889999999888899999999999999999999999976542 11122222111   0   00111       11


Q ss_pred             H-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 Q-QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~-~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      . .+..+.+++.+|++++|++|||+.|+++.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1 34578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.8e-33  Score=276.73  Aligned_cols=265  Identities=21%  Similarity=0.296  Sum_probs=194.1

Q ss_pred             cccCCCCCCCCceEEEEEEeC---C--CcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSLP---S--GELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFL  655 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  655 (876)
                      |+....++.|+||.||+|...   +  ...+|+|.++....  .-.....+|+..++.++|||++.+..++.. +..+++
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            344444455669999999432   2  23789999975432  234567899999999999999999999887 789999


Q ss_pred             EEEcCCCCCHHHHhhcc----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC----CCeEEcccc
Q 002826          656 IYEFLQMGSLGDLICRQ----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD----FEPKLTDFA  727 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~----~~~kl~DfG  727 (876)
                      ++||.+. +|.++++-.    ...++...+..|+.||+.|+.|||+.   =|+|||+||.|||+..+    |+|||+|||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeeccc
Confidence            9999988 898888532    45689999999999999999999999   68999999999999877    999999999


Q ss_pred             chhhccccccc-cccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-------hHHHHH
Q 002826          728 LDRIVGEAAFQ-STMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESL-------DVVKWV  798 (876)
Q Consensus       728 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-------~~~~~~  798 (876)
                      +++.+...-.. ......+-|..|+|||.+.+. .|+++.||||+||++.||+|-++.|.....+-.       +.++.+
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI  261 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI  261 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence            99998754322 234556679999999998765 589999999999999999999998876433211       111111


Q ss_pred             HHHhhc-----cccccccc--------------Ch-hhhhh---cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          799 RRKINI-----TNGAIQVL--------------DP-KIANC---YQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       799 ~~~~~~-----~~~~~~~~--------------d~-~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      -.....     +..+....              |. ++...   ........++++.+++..||.+|.|++|+++..
T Consensus       262 f~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  262 FEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111100     00000000              00 00000   011122378999999999999999999998754

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.2e-32  Score=288.02  Aligned_cols=241  Identities=22%  Similarity=0.305  Sum_probs=192.9

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|+ +|.||+|... +++.||+|++.....   ...+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         2 g~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           2 GVGG-FGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCC-ceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            4444 9999999765 589999999865432   2346788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++.+.. .+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997653 589999999999999999999998   99999999999999999999999999998765432   122335


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ++..|+|||......++.++|+||+|+++|||++|+.||.....+...   ..+......  .    .+.   .......
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--~----~~~---~~~~~~~  221 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME---IYNDILKGN--G----KLE---FPNYIDK  221 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH---HHHHHhccC--C----CCC---CCcccCH
Confidence            788899999988888899999999999999999999999865532221   111111000  0    001   1111144


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002826          826 GALEIALRCTSVMPEKRPS-----MFEVVK  850 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs-----~~ell~  850 (876)
                      .+.+++.+||+.+|++||+     ++|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            6889999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.9e-32  Score=291.42  Aligned_cols=239  Identities=23%  Similarity=0.327  Sum_probs=192.2

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|| +|.||++... +++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus         6 ~~~ig~g~-~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (290)
T cd05580           6 IKTLGTGS-FGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP   84 (290)
T ss_pred             EEEeecCC-CeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence            34455555 9999999664 789999999865321   234568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++.+. ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++......     .
T Consensus        85 ~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~  155 (290)
T cd05580          85 GGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T  155 (290)
T ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence            99999999765 4789999999999999999999999   9999999999999999999999999998876543     2


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....+++.|+|||.......+.++||||||+++|+|++|+.||........     ........        ..+.   .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~--------~~~~---~  219 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-----YEKILEGK--------VRFP---S  219 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhcCC--------ccCC---c
Confidence            233478889999998888889999999999999999999999976442211     11111111        0011   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                      .....+.+++.+||..+|++||     +++|+++
T Consensus       220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            1134678999999999999998     6777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.5e-32  Score=293.40  Aligned_cols=250  Identities=25%  Similarity=0.363  Sum_probs=191.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeC-----CeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~  654 (876)
                      +|.....++.|+ ||.||+|.. .+++.||+|++.... .....+.+|+.+++++ +|||++++++++...     +..+
T Consensus        23 ~y~~~~~l~~g~-~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          23 TWEIIETIGKGT-YGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CeEEEEEeecCC-CeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            454455555555 999999966 478999999986532 3346778899999999 899999999998753     3589


Q ss_pred             EEEEcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          655 LIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      +||||+++++|.++++.   .+..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++..
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            99999999999998863   245789999999999999999999999   999999999999999999999999999887


Q ss_pred             ccccccccccccccccccccCccccCCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSK-----KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      ......  ......|+..|+|||.....     .++.++|||||||++|||++|+.||....... ....+.+    .. 
T Consensus       178 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~----~~-  249 (291)
T cd06639         178 LTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFKIPR----NP-  249 (291)
T ss_pred             cccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHHHhc----CC-
Confidence            653221  11233478889999986543     36789999999999999999999987543221 1111110    00 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       .....++      ......+.+++.+||+.+|++||++.|+++.
T Consensus       250 -~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         250 -PPTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -CCCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             0011111      1223468899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=330.70  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=197.7

Q ss_pred             cccCCCCCCCCceEEEEEE-eCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          584 DEKSSAGNGGPFGRVYILS-LPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .+....+|+|.||.||-|. ..+|+-.|+|.+...+.  ..-+.+.+|+.++..++|||+|+++|+-.+.+..+|-||||
T Consensus      1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred             eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence            4556677778899999984 45799999998865432  23357789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc--cc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA--FQ  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~--~~  738 (876)
                      ++|+|.+.+... ...++........|++.|++|||++   |||||||||.||+++.+|.+|++|||.|..+....  ..
T Consensus      1317 ~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1317 EGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             ccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            999999998654 4577777788889999999999999   99999999999999999999999999998876432  12


Q ss_pred             cccccccccccccCccccCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 STMSSEYALSCYNAPEYGYSK---KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .....-.||+.|||||++.+.   ....++||||+|||+.||+||+.||...+.+-.    .+.....+.       .|.
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a----IMy~V~~gh-------~Pq 1461 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA----IMYHVAAGH-------KPQ 1461 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH----HHhHHhccC-------CCC
Confidence            233455699999999998753   467789999999999999999999975443321    111110110       122


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ++   +....+-.+++.+|+..||++|.++.|+++.
T Consensus      1462 ~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 IP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             Cc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            22   2244456789999999999999999988765

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.5e-32  Score=293.09  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=188.7

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe------CCeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS------DESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~lv  656 (876)
                      ++....+.|+||.||+|.. .+++.||+|++.... ....++..|+.+++++ +||||+++++++..      .+..|++
T Consensus        19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv   97 (282)
T cd06636          19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLV   97 (282)
T ss_pred             hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEE
Confidence            3334444455999999966 478999999986543 3445788899999999 69999999999853      4578999


Q ss_pred             EEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          657 YEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |||+++|+|.+++... ...+++..+..++.|++.|++|||+.   +|+|||+||+||++++++.++|+|||+++.....
T Consensus        98 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636          98 MEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             EEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            9999999999998764 34588889999999999999999999   9999999999999999999999999998765422


Q ss_pred             ccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          736 AFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .  .......|+..|+|||.+.     ...++.++|||||||++|||++|+.||........  .....+   .   .  
T Consensus       175 ~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~---~---~--  242 (282)
T cd06636         175 V--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPR---N---P--  242 (282)
T ss_pred             c--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hhhHhh---C---C--
Confidence            1  1122345788899999865     34578899999999999999999999965332111  000000   0   0  


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .+...  ....+..+.+++.+||+.||.+|||+.|+++
T Consensus       243 --~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         243 --PPKLK--SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --CCCCc--ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence              01100  1123346889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.3e-32  Score=291.42  Aligned_cols=260  Identities=22%  Similarity=0.299  Sum_probs=190.9

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||.||+|.. .+|+.||+|++..... .....+.+|+++++.++|+||+++++++.+++..|+||||+
T Consensus         7 y~~~~~ig~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~   85 (291)
T cd07870           7 YLNLEKLGEGS-YATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM   85 (291)
T ss_pred             eEEEEEEEecC-CEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecc
Confidence            33344555555 999999965 4799999999865432 23346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      . +++.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++++||+|||+++.......  .
T Consensus        86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~  159 (291)
T cd07870          86 H-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--T  159 (291)
T ss_pred             c-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--C
Confidence            6 588777765555678889999999999999999999   999999999999999999999999999876543211  1


Q ss_pred             cccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--------------
Q 002826          741 MSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--------------  805 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------  805 (876)
                      .....++..|+|||.+.+. .++.++||||+|+++|||++|+.||...........+. .......              
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKI-WTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHH-HHHcCCCChhhhhhhhhcccc
Confidence            2333468889999987653 47889999999999999999999997644322211111 1100000              


Q ss_pred             -ccccccc-ChhhhhhcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          806 -NGAIQVL-DPKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       806 -~~~~~~~-d~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       ....... .+.....+.  .....+.+++.+|+..||++|||++|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             0000000 000001000  12356789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-32  Score=290.68  Aligned_cols=246  Identities=25%  Similarity=0.347  Sum_probs=190.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCC------eEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE------SIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~lv~  657 (876)
                      ..+..+.|++|.||+|... +++.||+|++.... ...+.+.+|+++++++ +|+||+++++++.+..      ..++||
T Consensus        10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~   88 (275)
T cd06608          10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVM   88 (275)
T ss_pred             heeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEE
Confidence            3344444559999999764 68899999987543 3456789999999999 7999999999997644      489999


Q ss_pred             EcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          658 EFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       658 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      ||+++++|.+++...   +..+++..+..++.|++.|+.|||+.   +++|+||+|+||++++++.+|++|||.+.....
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~  165 (275)
T cd06608          89 ELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS  165 (275)
T ss_pred             EcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence            999999999988653   35789999999999999999999999   999999999999999999999999999876543


Q ss_pred             cccccccccccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ..  .......++..|+|||.+..     ..++.++||||+|+++|+|++|+.||........ ....    ....  . 
T Consensus       166 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~--~-  235 (275)
T cd06608         166 TL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-LFKI----PRNP--P-  235 (275)
T ss_pred             ch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-HHHh----hccC--C-
Confidence            22  12233457889999998643     3467889999999999999999999975322111 1111    1100  0 


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          +.. .........+.+++.+||+.||++|||+.|+++
T Consensus       236 ----~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         236 ----PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ----CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                111 111123456789999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-32  Score=296.01  Aligned_cols=255  Identities=27%  Similarity=0.378  Sum_probs=197.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .|.....+|.|+ ||.||+|.. .+++.||+|++......   ....+.+|++++++++|||++++++++.+++..++||
T Consensus        26 ~f~~~~~lg~G~-~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGS-FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCC-CeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            344555666665 999999975 47899999998653222   2346788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++ ++.+.+......+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||++......  
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            99975 88888766666799999999999999999999999   9999999999999999999999999988654332  


Q ss_pred             ccccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          738 QSTMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                          ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||........ ...+...    .  .     +
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~----~--~-----~  242 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN----E--S-----P  242 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhc----c--C-----C
Confidence                2234788899999863   45688899999999999999999999865422111 1111110    0  0     0


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      ..  ........+.+++.+||+.+|.+||++.|+++....+..+...
T Consensus       243 ~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         243 TL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             CC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            00  0112234578999999999999999999999987665554433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-33  Score=275.48  Aligned_cols=255  Identities=20%  Similarity=0.273  Sum_probs=202.2

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe----CC
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS----DE  651 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~  651 (876)
                      .+..+|.-..++.|-|-.|.|-.+.. .+|+.+|+|++.     +....++|++..-.. .|||||.++++|..    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            34445555556667777889988744 589999999984     345678898877666 59999999999864    35


Q ss_pred             eEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEcccc
Q 002826          652 SIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFA  727 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfG  727 (876)
                      ...+|||.++||.|.+.+.++ ...+++.++..|+.||+.|+.|||+.   .|+|||+||+|+|..   .+..+|++|||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            688999999999999988766 45699999999999999999999999   999999999999996   45679999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      +|+.-...   ......+-|+.|.|||+....+|+..+|+||+||++|-|++|.+||+.......  ..-+++++  ..+
T Consensus       210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~rI--~~g  282 (400)
T KOG0604|consen  210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRRI--RTG  282 (400)
T ss_pred             cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhHh--hcc
Confidence            99865432   234445578999999999999999999999999999999999999987655322  11222222  222


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+    ..|.+.+++.+++|+.++..+|++|.|+.|+++.
T Consensus       283 qy~FP~----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  283 QYEFPE----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             CccCCC----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            333333    3466778889999999999999999999999864

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-33  Score=272.16  Aligned_cols=245  Identities=23%  Similarity=0.346  Sum_probs=194.7

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ..|.|+-|+||+++.. +|...|||.+.+.+. ++.+++.+.+.++..-. +|+||+.+|||..+..+++-||.|.. .+
T Consensus        99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~  177 (391)
T KOG0983|consen   99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CA  177 (391)
T ss_pred             hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HH
Confidence            3455669999999765 689999999976542 33456677777776664 89999999999999999999998854 56


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      ..++.+-..++++..+-++...+.+||.||-++|  +|+|||+||+|||+|+.|++|++|||.+-++-++..   .+...
T Consensus       178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---htrsA  252 (391)
T KOG0983|consen  178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---HTRSA  252 (391)
T ss_pred             HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc---ccccc
Confidence            6677776778999999999999999999999986  899999999999999999999999999977765432   33445


Q ss_pred             ccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          746 ALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       746 gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      |.+.|||||.+..   .+|..++||||||++++|+.||+.||.....+...+......   .        .|.+.. ...
T Consensus       253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~---e--------PP~L~~-~~g  320 (391)
T KOG0983|consen  253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE---E--------PPLLPG-HMG  320 (391)
T ss_pred             CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc---C--------CCCCCc-ccC
Confidence            8889999998753   468899999999999999999999999876665433333221   1        122221 112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+..+.+++..|+.+|+.+||...++++.
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            45678999999999999999999998863

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.2e-32  Score=289.34  Aligned_cols=240  Identities=19%  Similarity=0.197  Sum_probs=183.8

Q ss_pred             CCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhh---ccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          591 NGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAK---IRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +.|+||.||++... +++.||+|.+.....   .....+.+|..+++.   .+|||++.+++++..++..++||||++++
T Consensus         3 g~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (279)
T cd05633           3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG   82 (279)
T ss_pred             ccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCC
Confidence            44559999999664 689999998865322   112334445444443   37999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++.......    ...
T Consensus        83 ~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~  154 (279)
T cd05633          83 DLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA  154 (279)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccC
Confidence            9999987654 689999999999999999999999   99999999999999999999999999987554322    122


Q ss_pred             ccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..|+..|+|||.... ..++.++||||+||++|||++|+.||.............  ......        ..   ....
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~--------~~---~~~~  221 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLTVN--------VE---LPDS  221 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH--HhhcCC--------cC---Cccc
Confidence            358899999998764 557899999999999999999999997644322211111  110110        11   1112


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      ...++.+++.+|+..||++||     |++|+++.
T Consensus       222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            334678999999999999999     69999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=296.52  Aligned_cols=261  Identities=20%  Similarity=0.317  Sum_probs=191.8

Q ss_pred             cCCCCCCCCceEEEEEEeC---CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP---SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  657 (876)
                      ...+|.|+ +|.||+|...   +++.||+|.+....   ......+.+|++++++++||||+++++++.+.  +..++||
T Consensus         5 ~~~ig~g~-~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           5 EGCIGRGT-YGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEeccCC-cEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence            34455555 9999999764   48999999997632   33346778899999999999999999999987  7899999


Q ss_pred             EcCCCCCHHHHhhcc----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC----CCCeEEccccch
Q 002826          658 EFLQMGSLGDLICRQ----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA----DFEPKLTDFALD  729 (876)
Q Consensus       658 e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~----~~~~kl~DfGla  729 (876)
                      ||+++ ++.+++...    ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++|||++
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99976 777766432    23688999999999999999999999   9999999999999999    899999999999


Q ss_pred             hhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh--------hHHHHHH
Q 002826          730 RIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESL--------DVVKWVR  799 (876)
Q Consensus       730 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~--------~~~~~~~  799 (876)
                      +....... ........++..|+|||.+.+ ..++.++||||||+++|||++|++||.....+..        .....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            87653322 122233457888999998765 4578899999999999999999999986544320        1111110


Q ss_pred             HHhh-----------c---c----cccccccC-hhhhhhc---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          800 RKIN-----------I---T----NGAIQVLD-PKIANCY---QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       800 ~~~~-----------~---~----~~~~~~~d-~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....           .   .    .......+ ..+....   ......+.+++.+|+++||++|||+.|+++.
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000           0   0    00000000 0111000   1234568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-32  Score=289.81  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=194.6

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|| ||.||+|... +++.||+|.+.....   ...+.+.+|++++++++||||+++++++.++...++|+||++
T Consensus         5 ~~~i~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (258)
T cd05578           5 LRVIGKGA-FGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL   83 (258)
T ss_pred             EEEeccCC-CceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence            34455555 9999999765 699999999975432   234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++... ..+++..+..++.|+++|++|||+.   +++|+||+|+||++++++.++++|||.+.......   ..
T Consensus        84 ~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~  156 (258)
T cd05578          84 GGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LT  156 (258)
T ss_pred             CCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cc
Confidence            99999999765 4789999999999999999999999   99999999999999999999999999987765432   12


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....|+..|+|||......++.++|+||+|+++|+|++|+.||.........  ..... ....   .    +   ..+.
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~-~~~~---~----~---~~~~  223 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD--QIRAK-QETA---D----V---LYPA  223 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH--HHHHH-hccc---c----c---cCcc
Confidence            3345788899999988888899999999999999999999999865543111  11111 1100   0    0   0111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSM--FEVV  849 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~--~ell  849 (876)
                      ..+..+.+++.+||..||.+||++  +|++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            223567899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.5e-32  Score=286.29  Aligned_cols=247  Identities=28%  Similarity=0.383  Sum_probs=193.4

Q ss_pred             CCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          588 SAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+.|+||.||+|.. .+++.||+|.+......  ..+.+..|++++++++|+||+++++++...+..++|+||+++++
T Consensus         6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06626           6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT   85 (264)
T ss_pred             eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence            3334455999999965 47899999998765433  45678899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc-c-cc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS-T-MS  742 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~-~~  742 (876)
                      |.+++.+.. .+++..+..++.++++|++|||+.   +++|+||+|+||++++++.+||+|||.+.......... . ..
T Consensus        86 L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~  161 (264)
T cd06626          86 LEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQ  161 (264)
T ss_pred             HHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccccc
Confidence            999997653 578999999999999999999999   99999999999999999999999999988765332211 1 12


Q ss_pred             cccccccccCccccCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          743 SEYALSCYNAPEYGYSKK---ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ...++..|+|||......   .+.++||||||+++||+++|+.||........    ........   .    .+.+.. 
T Consensus       162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~----~~~~~~~~---~----~~~~~~-  229 (264)
T cd06626         162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ----IMFHVGAG---H----KPPIPD-  229 (264)
T ss_pred             CCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH----HHHHHhcC---C----CCCCCc-
Confidence            344778899999987665   88999999999999999999999975432111    11110000   0    111111 


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .......+.+++.+||+.+|++|||+.|+++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         230 SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1112345679999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=291.41  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=192.6

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.| .+|.||+|... +|+.||+|++.....  .....+.+|+++++.++|||++++++++.+++..|+||||++ +
T Consensus         5 ~~l~~g-~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           5 EKIGEG-TYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             eEecCC-CCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            344444 59999999664 799999999865332  233568889999999999999999999999999999999995 5


Q ss_pred             CHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++.... ..+++..+..++.|+++|++|||+.   +++||||+|+||+++.++.++++|||+++.......  ...
T Consensus        83 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~  157 (283)
T cd07835          83 DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYT  157 (283)
T ss_pred             CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccC
Confidence            9999987653 4689999999999999999999999   999999999999999999999999999876543211  122


Q ss_pred             cccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--------------cc
Q 002826          743 SEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--------------NG  807 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~  807 (876)
                      ...++..|+|||...+. .++.++||||||+++|||++|++||....... ......+......              ..
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            33467889999987654 56889999999999999999999997654322 1122211100000              00


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......+............+.+++.+|++++|++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000011111122233567899999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.3e-32  Score=290.27  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=193.0

Q ss_pred             CCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          592 GGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       592 ~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      .|+||.||++... +|+.||+|++.....   .....+.+|++++++++|||++++++.+..++..|+||||+++++|.+
T Consensus         3 ~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   82 (265)
T cd05579           3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLAS   82 (265)
T ss_pred             CCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHH
Confidence            3459999999776 599999999865432   234578889999999999999999999999999999999999999999


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc------cccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF------QSTM  741 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~------~~~~  741 (876)
                      ++.+.+ .+++..+..++.|++.||+|||+.   +++||||+|+||++++++.++++|||++........      ....
T Consensus        83 ~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          83 LLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccc
Confidence            997765 789999999999999999999999   999999999999999999999999999876543211      1122


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....++..|+|||.......+.++||||||+++||+++|+.||.....+..     ........      ..  .... .
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~~~~~~------~~--~~~~-~  224 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-----FQNILNGK------IE--WPED-V  224 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhcCC------cC--CCcc-c
Confidence            334567789999998888889999999999999999999999976543221     11111100      00  0000 0


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      .....+.+++.+||+.+|++|||++++.+.|+
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            02456789999999999999999966665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-32  Score=290.76  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=196.4

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..++.|+ +|.||+|... +++.+|+|++......  ....+.+|++++++++|+||+++++++.+++..++|+||+++ 
T Consensus         5 ~~i~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-   82 (283)
T cd05118           5 GKIGEGT-YGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-   82 (283)
T ss_pred             eeeecCC-CceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence            4455555 9999999764 7899999998654322  346788899999999999999999999999999999999976 


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      ++.+++......+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||.+.......  .....
T Consensus        83 ~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~  157 (283)
T cd05118          83 DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTH  157 (283)
T ss_pred             CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccC
Confidence            89888877656899999999999999999999999   99999999999999999999999999987765432  12223


Q ss_pred             ccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccc--------------
Q 002826          744 EYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNG--------------  807 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~--------------  807 (876)
                      ..++..|+|||...+. .++.++||||+|+++|+|+||+.||......+.  ........ .....              
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            4577889999988766 788999999999999999999999976543221  11110000 00000              


Q ss_pred             -cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          808 -AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       808 -~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       .....+.............+.+++.+||++||.+||+++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence             0000011111222344567899999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-32  Score=289.92  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=195.5

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  661 (876)
                      ..+|.|| +|.||+|... +++.||+|++....  ......+.+|+++++.++|||++++++++.+.  +..++||||++
T Consensus         5 ~~l~~g~-~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           5 AQIGEGT-YGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             EEeccCC-CeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            4455555 9999999765 58999999997653  23345688899999999999999999999988  89999999998


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      + +|.+++.+....+++..+..++.|++.|++|||+.   +++|+||||+||++++++.+|++|||.++....... ...
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  158 (287)
T cd07840          84 H-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADY  158 (287)
T ss_pred             c-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccc
Confidence            5 89998877656799999999999999999999999   999999999999999999999999999987654321 112


Q ss_pred             ccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-cccc------------
Q 002826          742 SSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-ITNG------------  807 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~------------  807 (876)
                      ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ......... ....            
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhccccccchhhh
Confidence            33346778999997654 4578899999999999999999999976553221  111111100 0000            


Q ss_pred             ---cccccChhhhhhcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 ---AIQVLDPKIANCYQQ-QMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ---~~~~~d~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         ........+...... +...+.+++.+||+.+|++||+++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               000011111111112 25678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-31  Score=286.53  Aligned_cols=242  Identities=23%  Similarity=0.300  Sum_probs=189.0

Q ss_pred             CCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|| ||+||+|.. .+|+.||+|.+....   ......+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus         2 g~g~-~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           2 GKGG-FGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCC-ceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            4444 999999965 479999999986432   12344567899999999999999999999999999999999999999


Q ss_pred             HHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++.+.. ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||.+.......   .....
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence            99987653 4689999999999999999999999   99999999999999999999999999987664321   12233


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .++..|+|||...+..++.++||||+|+++|+|++|+.||........ ............        .   .......
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~--------~---~~~~~~~  222 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLEMA--------V---EYPDKFS  222 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcccccc--------c---cCCccCC
Confidence            467789999998888889999999999999999999999976443211 111111100000        0   1111224


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                      ..+.+++.+||+.+|++||     ++.++++
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            4678999999999999999     5665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.98  E-value=8.7e-32  Score=284.54  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=197.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~~  661 (876)
                      ..++.|| +|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  +..++|+||++
T Consensus         6 ~~i~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           6 ELLGRGS-FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eEeeecC-ceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            4455555 9999999765 799999999865432  3356788999999999999999999999988  89999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +++|.+++.+.. .+++..+..++.+++.|++|||+.   +++|+|++|+||+++.++.++|+|||.+............
T Consensus        85 ~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          85 GGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            999999997765 789999999999999999999998   9999999999999999999999999998877654321112


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....++..|+|||.......+.++||||||+++|+|++|+.||........    ....... .        ........
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~-~--------~~~~~~~~  227 (260)
T cd06606         161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYKIGS-S--------GEPPEIPE  227 (260)
T ss_pred             cCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHhccc-c--------CCCcCCCc
Confidence            334578889999998888899999999999999999999999976551111    1111000 0        00001111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+.+++.+|++.+|++||++.|+++
T Consensus       228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         228 HLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            22457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=1e-31  Score=292.52  Aligned_cols=269  Identities=22%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      +++.+...+|.....+|.|+ ||.||+|... +++.||+|.+.....  .....+.+|++++++++||||+++++++...
T Consensus         5 ~~~~~~~~~y~~~~~lg~g~-~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           5 FPFCDEVSKYEKLAKIGQGT-FGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             CcccchhhheEEEEEeecCC-CEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            44555555666667777766 9999999664 799999999864322  2234567899999999999999999998764


Q ss_pred             C--------eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeE
Q 002826          651 E--------SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK  722 (876)
Q Consensus       651 ~--------~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~k  722 (876)
                      +        ..++||||+.+ ++.+.+......+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILK  159 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEE
Confidence            3        45999999975 88888876666789999999999999999999999   999999999999999999999


Q ss_pred             Eccccchhhccccccc--cccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHH
Q 002826          723 LTDFALDRIVGEAAFQ--STMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR  799 (876)
Q Consensus       723 l~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~  799 (876)
                      |+|||++.........  .......++..|+|||...+. .++.++||||||+++|||++|++||.......  ......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~  237 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLIS  237 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH
Confidence            9999999876432211  112234467889999987654 46889999999999999999999997654321  111111


Q ss_pred             HHh-hccccccc-------------------ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          800 RKI-NITNGAIQ-------------------VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       800 ~~~-~~~~~~~~-------------------~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ... ........                   .....+..  ......+.+++.+||..||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP--YVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHhCCCChhhcccccchhhhhhccCCCccchhhHHhccc--ccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            111 00000000                   00000000  0012456789999999999999999999853

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=5.2e-32  Score=291.52  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=193.9

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|.|+ +|.||+|..+ +++.||+|++....  ......+.+|++++++++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~i~~g~-~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833           6 LGVVGEGA-YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             EEEecccC-CeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence            34455555 9999999765 68999999886432  23346789999999999999999999999999999999999998


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +.+..+..+ ...+++..+..++.|++.|++|||+.   +++|||++|+||++++++.+||+|||++........ ....
T Consensus        85 ~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~  159 (288)
T cd07833          85 TLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLT  159 (288)
T ss_pred             CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-cccc
Confidence            666655543 44689999999999999999999999   999999999999999999999999999887654332 1223


Q ss_pred             cccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcc----------c----
Q 002826          743 SEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NIT----------N----  806 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~----------~----  806 (876)
                      ...++..|+|||...+. .++.++||||||+++|+|++|++||......+.  ........ ...          .    
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ--LYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHhhhcccCccccc
Confidence            34577889999998877 789999999999999999999999976433211  11111100 000          0    


Q ss_pred             -ccccccChhh-h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          807 -GAIQVLDPKI-A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       807 -~~~~~~d~~~-~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       ...+..++.. . .........+.+++++||..+|++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             0000101100 0 111122567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=1.5e-31  Score=288.25  Aligned_cols=243  Identities=26%  Similarity=0.387  Sum_probs=194.1

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ..+|.|+ ||.||++.. .+|+.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        26 ~~lg~g~-~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          26 IKIGEGS-TGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHcCCCC-CeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            4555555 999999966 47999999998654444556788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++...  .+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+........  ......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence            9987543  578999999999999999999999   999999999999999999999999998876543221  122345


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ++..|+|||...+..++.++||||+|+++|||++|+.||.......  ..........          +.+. .......
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~----------~~~~-~~~~~~~  244 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLP----------PKLK-NLHKVSP  244 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhCC----------cccC-CcccCCH
Confidence            7888999999888888999999999999999999999997543321  1222221111          1110 0111233


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          826 GALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .+.+++.+||+.+|.+||++.|+++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            5678999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=1e-31  Score=293.09  Aligned_cols=252  Identities=22%  Similarity=0.240  Sum_probs=188.0

Q ss_pred             ceEEEEEEeCCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhcc
Q 002826          595 FGRVYILSLPSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQ  672 (876)
Q Consensus       595 ~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~  672 (876)
                      ++.||++.. +++.||+|++...  .....+.+.+|+++++.++||||+++++++.+++..+++|||++++++.+++.+.
T Consensus        15 ~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~   93 (314)
T cd08216          15 IVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH   93 (314)
T ss_pred             eEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh
Confidence            555555443 7999999998754  2234467899999999999999999999999999999999999999999999764


Q ss_pred             -CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-----ccccccccc
Q 002826          673 -DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-----QSTMSSEYA  746 (876)
Q Consensus       673 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-----~~~~~~~~g  746 (876)
                       ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.+........     ........+
T Consensus        94 ~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          94 FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence             44688999999999999999999999   999999999999999999999999998875532211     111223346


Q ss_pred             cccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc----------cccccc----
Q 002826          747 LSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI----------TNGAIQ----  810 (876)
Q Consensus       747 t~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~----  810 (876)
                      +..|+|||.+..  ..++.++|||||||++|||++|+.||...+.... ..+........          ......    
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS  249 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhcCCcCccccc
Confidence            778999998765  3478899999999999999999999986443221 11111100000          000000    


Q ss_pred             ccChh-----hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VLDPK-----IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..++.     ..........++.+++.+||..+|++|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00000     011122334578899999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=7e-32  Score=285.17  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...++.|+ +|.||++... +++.||+|++.....  .....+.+|+++++.++|||++++.+.+..++..++|+||+++
T Consensus         5 ~~~l~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           5 IKQIGKGS-FGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EeeeccCC-CeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            34455555 9999999664 689999999976433  3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          663 GSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|.+++.+.   +..+++..+..++.+++.|+.|||+.   +++|+||+|+||++++++.++++|||.+.......  .
T Consensus        84 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  158 (258)
T cd08215          84 GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--D  158 (258)
T ss_pred             CcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc--c
Confidence            9999999765   36799999999999999999999999   99999999999999999999999999987765432  1


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......|++.|+|||......++.++||||+|+++++|++|+.||.......     .........   ...+       
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~---~~~~-------  223 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQ---YPPI-------  223 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHHhcCC---CCCC-------
Confidence            1223357888999999888888999999999999999999999986543221     111111110   0011       


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......+.+++.+||..+|++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11223467899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.98  E-value=8.7e-32  Score=298.47  Aligned_cols=258  Identities=21%  Similarity=0.310  Sum_probs=191.5

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|| ||.||+|.. .+|+.||+|++...  .......+.+|+.++++++||||+++++++...      ..
T Consensus        17 ~y~~~~~lg~g~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   95 (353)
T cd07850          17 RYQNLKPIGSGA-QGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD   95 (353)
T ss_pred             ceEEEEEeccCC-CEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence            455555566655 999999965 47999999998643  223345677899999999999999999998643      35


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+.+ +|.+.+...   +++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          96 VYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             EEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            7999999975 888887543   88899999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH------------
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR------------  800 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~------------  800 (876)
                      .....   .....++..|+|||...+..++.++||||+||++|+|++|+.||...+.... .......            
T Consensus       169 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         169 GTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             CCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHh
Confidence            54321   2233578889999999888899999999999999999999999975432111 0000000            


Q ss_pred             ------Hhhccc-----ccccccChhh----h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 ------KINITN-----GAIQVLDPKI----A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ------~~~~~~-----~~~~~~d~~~----~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                            ......     ..........    . .........+.+++.+|++.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  000000     0000000000    0 0011234567899999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=1.2e-31  Score=291.96  Aligned_cols=261  Identities=23%  Similarity=0.342  Sum_probs=192.8

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|.. .+|+.||+|++......  ....+.+|+.++++++|+|++++++++.+.  +..++|
T Consensus         8 ~y~~~~~ig~g~-~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           8 EFEKLNRIGEGT-YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             ceeEeeeeeecC-CEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            344445555555 999999966 47999999998643322  233566899999999999999999998764  568999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++ +|.+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+.......
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999975 89988876656799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-ccc------
Q 002826          737 FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-NGA------  808 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~------  808 (876)
                        .......++..|+|||...+ ..++.++||||+|+++|||++|++||........  ...+....... ...      
T Consensus       163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhchhhhc
Confidence              12223345778999998765 4578999999999999999999999976443221  11111111000 000      


Q ss_pred             ------ccccC---hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 ------IQVLD---PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 ------~~~~d---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                            ...-.   ..+..........+.+++.+|++.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  00000   00001111124567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.6e-31  Score=284.18  Aligned_cols=233  Identities=22%  Similarity=0.312  Sum_probs=183.4

Q ss_pred             CCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       590 g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      |.|+ ||.||++.. .+++.+|+|.+.......     .|+.....+ +|||++++++++..++..++||||+++++|.+
T Consensus        25 g~g~-~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         25 IDGK-FGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             cCCC-ceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            5555 999999965 478899999986532111     122222223 79999999999999999999999999999999


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhccccccccccccccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEYA  746 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~g  746 (876)
                      ++.+.. .+++..+..++.|+++|+.|||+.   +++||||||+||+++.++ .++++|||.++......      ...+
T Consensus        99 ~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~------~~~~  168 (267)
T PHA03390         99 LLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS------CYDG  168 (267)
T ss_pred             HHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc------cCCC
Confidence            997764 789999999999999999999999   999999999999999888 99999999987654321      2247


Q ss_pred             cccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       747 t~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      +..|+|||...+..++.++||||+|+++|||++|+.||.....+......+.... ...   .        .........
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~---~--------~~~~~~~~~  236 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKK---L--------PFIKNVSKN  236 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-ccc---C--------CcccccCHH
Confidence            8889999999888899999999999999999999999986544443333333222 110   0        111133456


Q ss_pred             HHHHHHHccCCCCCCCCC-HHHHHH
Q 002826          827 ALEIALRCTSVMPEKRPS-MFEVVK  850 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RPs-~~ell~  850 (876)
                      +.+++.+|++.+|.+||+ ++|+++
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        237 ANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHHHHHHHhccChhhCCchHHHHhc
Confidence            889999999999999996 688874

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.98  E-value=7.5e-32  Score=284.85  Aligned_cols=243  Identities=22%  Similarity=0.308  Sum_probs=195.8

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...++.|+ ||.||++.. .+++.+|+|.+.....  ....++.+|+++++.++|+||+++.+++.+....++||||+++
T Consensus         5 ~~~i~~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           5 LKKLGKGS-YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             eeeecCCC-ceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence            34455555 999999955 4789999999875432  2345677899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          663 GSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++|.+++.+.   ...+++..+..++.|++.|++|||+.   +++||||+|+||++++++.+|++|||+++......   
T Consensus        84 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~---  157 (256)
T cd08530          84 GDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---  157 (256)
T ss_pred             CCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence            9999998663   35689999999999999999999999   99999999999999999999999999998775431   


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                       .....++..|+|||...+..++.++|+||+|+++||+++|+.||........  .....   ..   ...       ..
T Consensus       158 -~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~~~~~---~~---~~~-------~~  221 (256)
T cd08530         158 -AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQ---RG---KYP-------PI  221 (256)
T ss_pred             -cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHh---cC---CCC-------CC
Confidence             2224478889999999888889999999999999999999999976543221  11111   00   111       11


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......++.+++.+|++.+|++||++.|+++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            12344568999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.98  E-value=1.4e-31  Score=294.85  Aligned_cols=263  Identities=22%  Similarity=0.296  Sum_probs=195.4

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--------------HHHHHHHHHHHhhccCccccceee
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--------------SKTLKTEVKTLAKIRHKNIVKVLG  645 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~  645 (876)
                      ..|..+....+.|+||+||+|... +++.||+|++.......              ...+.+|+++++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            345555565555669999999654 79999999986432211              124678999999999999999999


Q ss_pred             EEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       646 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      ++...+..++||||++ ++|.+++... ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECC
Confidence            9999999999999997 5999988654 3689999999999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccc------------cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchh
Q 002826          726 FALDRIVGEAA------------FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESL  792 (876)
Q Consensus       726 fGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~  792 (876)
                      ||.++......            .........++..|+|||.+.+. .++.++||||+|+++|||++|++||........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99987665111            01112233467789999987654 468899999999999999999999986543321


Q ss_pred             hHHHHHHHHhh-ccc-------------ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          793 DVVKWVRRKIN-ITN-------------GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       793 ~~~~~~~~~~~-~~~-------------~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        ...+..... ...             .......+............+.+++.+|++.+|++|||+.|++.
T Consensus       243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence              111111100 000             00001111111222223456889999999999999999999997

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.98  E-value=1e-31  Score=288.45  Aligned_cols=247  Identities=21%  Similarity=0.348  Sum_probs=186.0

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHH-HhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKT-LAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .....+|.|+ ||.||+|... +|+.||+|++..... ....++..|+.. ++..+||||+++++++..++..|+||||+
T Consensus         4 ~~~~~ig~g~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~   82 (283)
T cd06617           4 EVIEELGRGA-YGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM   82 (283)
T ss_pred             eEEEEecccC-CeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence            3445556555 9999999664 799999999865432 233455556665 56668999999999999999999999999


Q ss_pred             CCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       661 ~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      + ++|.+++...   ...+++..+..++.|++.|++|||++  .+++||||||+||+++.++.+||+|||.++...... 
T Consensus        83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-  158 (283)
T cd06617          83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-  158 (283)
T ss_pred             c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence            7 5888877542   35689999999999999999999985  279999999999999999999999999987654321 


Q ss_pred             ccccccccccccccCccccCC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYS----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                        ......++..|+|||...+    ..++.++|+||||+++|||++|+.||...............    .   .    .
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----~---~----~  225 (283)
T cd06617         159 --AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE----E---P----S  225 (283)
T ss_pred             --ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh----c---C----C
Confidence              1222347888999998754    44688999999999999999999999653322111111111    0   0    0


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +.+..  ...+..+.+++.+||..+|++||++.|+++
T Consensus       226 ~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110  112346789999999999999999999987

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.98  E-value=7.7e-32  Score=290.27  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=188.4

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|.|+ ||.||++.. .+++.||+|.+..... .....+.+|+.++.++. ||||+++++++..++..+++|||+..
T Consensus         9 ~~~lg~G~-~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~   87 (288)
T cd06616           9 LGEIGRGA-FGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI   87 (288)
T ss_pred             HHHhCCCC-ceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence            34555555 999999965 4789999999865332 23457888999999996 99999999999999999999999875


Q ss_pred             CCHHHHh---hc-cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          663 GSLGDLI---CR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       663 gsL~~~l---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                       ++.++.   .. ....+++..+.+++.+++.|++|||+.  .+++||||||+||+++.++.+||+|||+++....... 
T Consensus        88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  163 (288)
T cd06616          88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-  163 (288)
T ss_pred             -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence             655443   22 235689999999999999999999974  2899999999999999999999999999976643221 


Q ss_pred             cccccccccccccCccccCCC---CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 STMSSEYALSCYNAPEYGYSK---KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                        .....|+..|+|||.+...   .++.++||||+|+++|||++|+.||.....    ............   ...+.+ 
T Consensus       164 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~---~~~~~~-  233 (288)
T cd06616         164 --KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVVKGD---PPILSN-  233 (288)
T ss_pred             --cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhcCCC---CCcCCC-
Confidence              1223478889999988765   688999999999999999999999975431    111111111100   001111 


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        .........+.+++.+||+.+|++|||+.|+++.
T Consensus       234 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         234 --SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              1112244568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=2e-31  Score=286.84  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=191.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhc---cCccccceeeEEEeCCe-----EEE
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKI---RHKNIVKVLGFFHSDES-----IFL  655 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~~l  655 (876)
                      ..+|.|+ +|.||+|..+ +++.||+|++......  ....+.+|+++++++   +|||++++++++.+.+.     .++
T Consensus         5 ~~l~~g~-~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           5 AEIGEGA-YGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEecccC-ceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            4455555 9999999876 5899999999643322  234566788877766   59999999999988776     999


Q ss_pred             EEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          656 IYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +|||+.+ +|.+++.+.. ..+++..+..++.|+++|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        84 ~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          84 VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             Eehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999975 8999887643 3689999999999999999999999   999999999999999999999999999877643


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-c---------
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-I---------  804 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~---------  804 (876)
                      ...   .....++..|+|||...+..++.++||||||+++|||++|++||......+ ....+...... .         
T Consensus       160 ~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         160 EMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             Ccc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCCcc
Confidence            321   122346788999999988889999999999999999999999987644322 11122111100 0         


Q ss_pred             --ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 --TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 --~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .........+............+.+++.+||+.||++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence              0000011111112222334567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=7.7e-32  Score=296.82  Aligned_cols=265  Identities=23%  Similarity=0.375  Sum_probs=192.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  654 (876)
                      +|.....+|.|| ||.||+|.. .+|+.||+|++..... .....+.+|+.++++++||||+++++++...     ...|
T Consensus         6 ~y~i~~~lg~G~-~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           6 RYQNLSYIGEGA-YGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             ceEEEEEEEecC-CeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            344444555555 999999965 5799999999864322 2345678899999999999999999987653     3589


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +|+||+++ ++.+++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        85 lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  158 (336)
T cd07849          85 IVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP  158 (336)
T ss_pred             EEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence            99999975 88887754  3689999999999999999999999   999999999999999999999999999876643


Q ss_pred             ccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--cccccc
Q 002826          735 AAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--TNGAIQ  810 (876)
Q Consensus       735 ~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~  810 (876)
                      ... ........|+..|+|||.+.+ ..++.++||||+||++|||++|+.||........  ..........  ......
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ--LNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHHH
Confidence            221 112233457889999998654 4688999999999999999999999975432111  1111000000  000000


Q ss_pred             cc-------------Ch--hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002826          811 VL-------------DP--KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSL  855 (876)
Q Consensus       811 ~~-------------d~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i  855 (876)
                      +.             .+  ............+.+++.+||+.+|++|||+.|+++.  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            00             00  0011112234568899999999999999999999987  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=1.7e-31  Score=288.48  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=190.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|+ +|+||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+++..|+||||
T Consensus         4 y~~~~~l~~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          4 YEKVEKIGEGT-YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             eEEEEEecCCC-CEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            33344555555 9999999765 789999999865322  2335688899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhcccccc
Q 002826          660 LQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       660 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~  737 (876)
                      +++ ++.+++... ....++..+..++.|++.|++|||+.   +++||||+|+||+++. ++.+|++|||++....... 
T Consensus        83 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-  157 (294)
T PLN00009         83 LDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-  157 (294)
T ss_pred             ccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence            965 888877554 33468888999999999999999999   9999999999999985 5679999999997654321 


Q ss_pred             ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc--------
Q 002826          738 QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA--------  808 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  808 (876)
                       .......++..|+|||.+.+ ..++.++||||+|+++|+|+||++||......+. ...............        
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhccccccch
Confidence             11233446788999998765 4578899999999999999999999976443221 111111000000000        


Q ss_pred             ------ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 ------IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ------~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                            ..................+.+++.+|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000001111111223456789999999999999999999986

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=2.9e-31  Score=291.26  Aligned_cols=255  Identities=22%  Similarity=0.291  Sum_probs=188.1

Q ss_pred             CCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHh
Q 002826          593 GPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI  669 (876)
Q Consensus       593 g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l  669 (876)
                      |+||+||++.. .+|+.||+|++......  ..+.+++|+.+++.++||||+++++++..++..++|+||+.++++.+++
T Consensus        11 ~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l   90 (328)
T cd08226          11 CNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLL   90 (328)
T ss_pred             cCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHH
Confidence            35999999965 48999999998654322  2367889999999999999999999999999999999999999999998


Q ss_pred             hcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc-----cccc
Q 002826          670 CRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS-----TMSS  743 (876)
Q Consensus       670 ~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-----~~~~  743 (876)
                      .+. ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+..........     ....
T Consensus        91 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (328)
T cd08226          91 KTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQF  167 (328)
T ss_pred             HhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccccccc
Confidence            765 34588999999999999999999999   99999999999999999999999998654332111100     0011


Q ss_pred             ccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----------------
Q 002826          744 EYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----------------  805 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------  805 (876)
                      ..++..|+|||.+.+.  .++.++||||+||++|||++|+.||........ ............                
T Consensus       168 ~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (328)
T cd08226         168 STSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPCEESRMKNS  246 (328)
T ss_pred             ccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccchhhhhhccc
Confidence            1245669999998653  478899999999999999999999976433221 111100000000                


Q ss_pred             -ccc--------------ccccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 -NGA--------------IQVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 -~~~--------------~~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ...              ....+..+. .....+...+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         247 QSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             000              000000000 1123345678999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=1.4e-31  Score=294.76  Aligned_cols=266  Identities=22%  Similarity=0.342  Sum_probs=196.1

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  654 (876)
                      |.....+|.|| ||+||+|.. .+++.||+|.+...  .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         7 y~~~~~lg~G~-~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~   85 (337)
T cd07858           7 YVPIKPIGRGA-YGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVY   85 (337)
T ss_pred             eeEEEEeccCC-CeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEE
Confidence            34444555555 999999965 57999999998653  223345677899999999999999999988654     3589


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+. ++|.+++... ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          86 IVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             EEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            9999996 5899888765 3689999999999999999999999   999999999999999999999999999987643


Q ss_pred             cccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-c-cc----
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-T-NG----  807 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~-~~----  807 (876)
                      ..  .......++..|+|||.+.. ..++.++|||||||++|+|++|++||........  .......... . ..    
T Consensus       161 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         161 KG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ--LKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             Cc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH--HHHHHHHhCCCChHHhhhc
Confidence            32  12233447888999998764 4688999999999999999999999976432111  1110000000 0 00    


Q ss_pred             -----------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccC
Q 002826          808 -----------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLSTR  858 (876)
Q Consensus       808 -----------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~~  858 (876)
                                 .....++............+.+++.+|++.+|++|||++|+++.  ++.+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                       00000111111222345668899999999999999999999987  6665433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=298.48  Aligned_cols=264  Identities=24%  Similarity=0.280  Sum_probs=200.0

Q ss_pred             CCCCCCCCceEEEEEE-eCCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCC------eEEEEEE
Q 002826          587 SSAGNGGPFGRVYILS-LPSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------SIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e  658 (876)
                      ..+|.|| ||.||+++ ..+|+.||||.+.... ....+...+|++++++++|||||+++++-++..      ...+|||
T Consensus        19 e~LG~Ga-~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   19 ERLGKGA-FGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhcCCc-cceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            4455555 99999998 5689999999997643 244567789999999999999999999866543      5789999


Q ss_pred             cCCCCCHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CCC--CeEEccccchhhc
Q 002826          659 FLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--ADF--EPKLTDFALDRIV  732 (876)
Q Consensus       659 ~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~--~~kl~DfGla~~~  732 (876)
                      ||.||||...+.+-  ..-+++.+.+.+..+++.||.|||+.   +|+||||||.||++-  .+|  -.||+|||+|+..
T Consensus        98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999764  34599999999999999999999999   999999999999984  333  4799999999988


Q ss_pred             cccccccccccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  810 (876)
                      .++.   .....+||..|.+||... .+.++..+|.|||||++||++||..||........ ..+.|.... +.+.+...
T Consensus       175 ~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t-kkp~~v~i  250 (732)
T KOG4250|consen  175 DDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT-KKPSGVAI  250 (732)
T ss_pred             CCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc-cCCCceeE
Confidence            7654   566778999999999988 48899999999999999999999999976443321 111111110 11111111


Q ss_pred             ccCh-------------hhhhhcHHHHHHHHHHHHHccCCCCCCCC--CHHHHHHHHhhcccC
Q 002826          811 VLDP-------------KIANCYQQQMLGALEIALRCTSVMPEKRP--SMFEVVKALHSLSTR  858 (876)
Q Consensus       811 ~~d~-------------~~~~~~~~~~~~~~~li~~cl~~dP~~RP--s~~ell~~L~~i~~~  858 (876)
                      ..++             ............+-..+..++..+|.+|.  .+.+.-..+.+|...
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            1111             11122334445566788888999999998  777776666666543

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=2.7e-31  Score=288.15  Aligned_cols=258  Identities=24%  Similarity=0.339  Sum_probs=190.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC----------
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----------  651 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------  651 (876)
                      ....+| .|++|.||+|..+ +|+.||+|++.....  .....+.+|++++++++|||++++++++.+..          
T Consensus        11 ~~~~lg-~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   89 (302)
T cd07864          11 IIGQIG-EGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG   89 (302)
T ss_pred             eeeeec-ccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence            334444 4559999999775 689999999865432  23356778999999999999999999987654          


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..++|+||+++ ++.+.+......+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||.+..
T Consensus        90 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~  165 (302)
T cd07864          90 AFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARL  165 (302)
T ss_pred             cEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccccccc
Confidence            79999999987 77777766555789999999999999999999999   999999999999999999999999999887


Q ss_pred             ccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGAI  809 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  809 (876)
                      ...... .......++..|+|||...+ ..++.++||||+||++|||++|++||...... . ....+.... .......
T Consensus       166 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         166 YNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-A-QLELISRLCGSPCPAVW  242 (302)
T ss_pred             ccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-H-HHHHHHHHhCCCChhhc
Confidence            653321 11222335778999997754 35688999999999999999999999764322 1 111111111 0000000


Q ss_pred             -c--------ccC------hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          810 -Q--------VLD------PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       810 -~--------~~d------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       .        ..+      +.........+..+.+++.+||..+|.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0        000      0001111122456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.5e-31  Score=286.91  Aligned_cols=259  Identities=16%  Similarity=0.089  Sum_probs=182.0

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeCC----CcEEEEEEEecCCccCH-----------HHHHHHHHHHhhccCccccc
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLPS----GELIAVKKLVNFGCQSS-----------KTLKTEVKTLAKIRHKNIVK  642 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  642 (876)
                      ++....+.+.+..|.|+||+||+|...+    +..+|+|+.........           .....+...+..+.|+++++
T Consensus         8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~   87 (294)
T PHA02882          8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK   87 (294)
T ss_pred             ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence            3333445555555555599999997654    45566665432221110           01122334556668999999


Q ss_pred             eeeEEEeCC----eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC
Q 002826          643 VLGFFHSDE----SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD  718 (876)
Q Consensus       643 ~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~  718 (876)
                      +++++....    ..++++|++.. ++.+.+... ...++..+..++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            999876543    45788887754 677766543 2467888999999999999999999   99999999999999999


Q ss_pred             CCeEEccccchhhccccccc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh
Q 002826          719 FEPKLTDFALDRIVGEAAFQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD  793 (876)
Q Consensus       719 ~~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~  793 (876)
                      +.++|+|||+++.+......     .......||+.|+|||...+..++.++||||+||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432111     1122335899999999999889999999999999999999999999875332211


Q ss_pred             ----HHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          794 ----VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       794 ----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                          ..++..+....          ..  .....+..+.+++..|+..+|++||++.++++.++
T Consensus       243 ~~~~~~~~~~~~~~~----------~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEG----------KI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhh----------hh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence                11111111000          00  00112346889999999999999999999998763

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.7e-31  Score=281.75  Aligned_cols=242  Identities=26%  Similarity=0.384  Sum_probs=194.5

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|. |.+|.||++... +++.||+|.+.....  .....+.+|++++++++|||++++++++.+++..++||||++++
T Consensus         6 ~~l~~-g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           6 DLIGR-GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eEEcc-cCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            34444 459999999654 688999999976543  34467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+. ..+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||.+.........  ...
T Consensus        85 ~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~  158 (254)
T cd06627          85 SLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DAS  158 (254)
T ss_pred             cHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccc
Confidence            999998765 4789999999999999999999999   9999999999999999999999999999876543321  223


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..++..|+|||...+..++.++||||+|+++|+|++|+.||........ ....   ...    ....+.       ...
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-~~~~---~~~----~~~~~~-------~~~  223 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-LFRI---VQD----DHPPLP-------EGI  223 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHH---hcc----CCCCCC-------CCC
Confidence            4578889999998877788999999999999999999999875432111 1111   000    111111       112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ...+.+++.+|+..+|++|||+.|++.
T Consensus       224 ~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         224 SPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            346789999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.3e-31  Score=280.82  Aligned_cols=242  Identities=23%  Similarity=0.293  Sum_probs=184.3

Q ss_pred             CCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHH-hhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTL-AKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +|.|+ ||.||+|.. .+|+.||+|++.......   ...+..|..++ ...+|+|++++++++..++..|+|+||++++
T Consensus         4 l~~g~-~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (260)
T cd05611           4 ISKGA-FGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG   82 (260)
T ss_pred             CCcCC-CeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence            45555 999999966 468999999986543211   12334454444 4448999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+ .+++..+.+++.|++.||.|||+.   +++||||+|+||+++.++.+|++|||+++.....      ..
T Consensus        83 ~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~  152 (260)
T cd05611          83 DCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KK  152 (260)
T ss_pred             CHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceecccc------cc
Confidence            9999997654 688999999999999999999999   9999999999999999999999999988754321      22


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..++..|+|||...+..++.++||||+|+++|||++|..||........     ...........    .+..   ....
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~----~~~~---~~~~  220 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINW----PEEV---KEFC  220 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhcccCC----CCcc---cccC
Confidence            3477889999998887889999999999999999999999975433221     11111100000    0000   1122


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ...+.+++.+||+.+|++||++.++.+.++
T Consensus       221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         221 SPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            346789999999999999998876655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=3.7e-31  Score=291.61  Aligned_cols=263  Identities=23%  Similarity=0.360  Sum_probs=192.5

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC--CccCHHHHHHHHHHHhhc-cCccccceeeEEEeC--CeEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF--GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD--ESIF  654 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~  654 (876)
                      .+|.....+|.|| ||.||+|... +|+.||+|++...  .......+.+|+.+++++ +||||+++++++...  ...|
T Consensus         7 ~~y~~~~~lg~g~-~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           7 RKYEILQKLGKGA-YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hHHHHhHhhcCCC-CeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            3444555566655 9999999764 6899999988542  122335677899999999 999999999998653  4689


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+++ +|.+++.+.  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            99999975 999988654  688999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccc---cccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-------
Q 002826          735 AAFQ---STMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-------  803 (876)
Q Consensus       735 ~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  803 (876)
                      ....   .......|+..|+|||.+.+ ...+.++||||||+++|||++|+.||........ ..........       
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHH
Confidence            3211   12223457889999998654 4578899999999999999999999976443221 0000000000       


Q ss_pred             -----ccccccccc----ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          804 -----ITNGAIQVL----DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       804 -----~~~~~~~~~----d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           ........+    .+............+.+++.+||+.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 000000000    001111111234568899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1e-31  Score=309.71  Aligned_cols=265  Identities=17%  Similarity=0.218  Sum_probs=181.6

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC--CCcEEEEEEE--------------ec---CCccCHHHHHHHHHHHhhccCcccc
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP--SGELIAVKKL--------------VN---FGCQSSKTLKTEVKTLAKIRHKNIV  641 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~--~~~~vavK~~--------------~~---~~~~~~~~~~~E~~~l~~l~h~niv  641 (876)
                      ..|.....+|.|| ||+||++..+  ++..++.|.+              .+   ........+.+|++++++++||||+
T Consensus       148 ~~Y~ii~~LG~G~-fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        148 AHFRVIDDLPAGA-FGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hccEEEeEecCCC-CcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3455555666655 9999998543  2222222211              00   1112234678999999999999999


Q ss_pred             ceeeEEEeCCeEEEEEEcCCCCCHHHHhhccC----CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC
Q 002826          642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQD----FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA  717 (876)
Q Consensus       642 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~  717 (876)
                      ++++++.+.+..|+|+|++.+ ++.+++....    .......+.+++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            999999999999999999865 7777765431    2234566788999999999999999   9999999999999999


Q ss_pred             CCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCC-CCCCCcc-hhhHH
Q 002826          718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA-EQAEPAE-SLDVV  795 (876)
Q Consensus       718 ~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p-~~~~~~~-~~~~~  795 (876)
                      ++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|..+ |...... ...+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999876543211 12234589999999999988899999999999999999998754 4332221 11222


Q ss_pred             HHHHHHhhccccc-------ccccC--------hhhhhhc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          796 KWVRRKINITNGA-------IQVLD--------PKIANCY--QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       796 ~~~~~~~~~~~~~-------~~~~d--------~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +............       .+.++        ..+....  .....++.+++.+|++.||++|||+.|+++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2211100000000       00000        0000000  0112356778999999999999999999874

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-31  Score=284.76  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=191.6

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.|| +|+||+|... +++.||+|++..... .......+|+..+++++ |||++++++++.+++..++||||+ +|
T Consensus         5 ~~ig~g~-~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830           5 KQLGDGT-FGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             eeeccCC-ceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            3455555 9999999775 588999999865432 22334567999999998 999999999999999999999999 77


Q ss_pred             CHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      ++.+++.... ..+++..+..++.|++.+++|||+.   +++|+||+|+||++++++.++|+|||.++.......   ..
T Consensus        83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~  156 (283)
T cd07830          83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP---YT  156 (283)
T ss_pred             CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---cC
Confidence            9999887653 5789999999999999999999999   999999999999999999999999999876653321   22


Q ss_pred             cccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh--HHH---------HHHHHh---hcccc
Q 002826          743 SEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD--VVK---------WVRRKI---NITNG  807 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~--~~~---------~~~~~~---~~~~~  807 (876)
                      ...++..|+|||... ...++.++|+||||++++||++|++||......+..  ...         |.....   .....
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            334778899999874 445789999999999999999999999765432210  000         000000   00000


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...................+.+++.+||+.+|++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000011111112224678899999999999999999999763

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=4.4e-31  Score=282.68  Aligned_cols=239  Identities=18%  Similarity=0.199  Sum_probs=183.4

Q ss_pred             CCCCceEEEEEEe-CCCcEEEEEEEecCCcc---CHHHHHHHHH---HHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          591 NGGPFGRVYILSL-PSGELIAVKKLVNFGCQ---SSKTLKTEVK---TLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       591 ~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +.|+||.||+|.. .+|+.||+|.+......   ....+..|..   .++...||+|+++.+++.+.+..++||||++|+
T Consensus         3 g~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~   82 (278)
T cd05606           3 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG   82 (278)
T ss_pred             ccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCC
Confidence            4455999999965 46899999998653221   1222334443   344457999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+.+ .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++......    ...
T Consensus        83 ~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~  154 (278)
T cd05606          83 DLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA  154 (278)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcC
Confidence            9999886543 699999999999999999999999   99999999999999999999999999987654322    123


Q ss_pred             ccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..|+..|+|||...++ .++.++||||+|+++|||++|+.||.............  ....        .++.+.   ..
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~--------~~~~~~---~~  221 (278)
T cd05606         155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR--MTLT--------MAVELP---DS  221 (278)
T ss_pred             cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH--Hhhc--------cCCCCC---Cc
Confidence            3588899999998754 57899999999999999999999997653322211111  1000        011111   11


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                      ....+.+++.+|+..+|.+||     ++.|+++
T Consensus       222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            234688999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=1.7e-31  Score=293.75  Aligned_cols=261  Identities=20%  Similarity=0.318  Sum_probs=192.4

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l  655 (876)
                      |.....+|.|| +|.||+|.. .+|+.||+|++.....  .....+.+|+.++++++||||+++++++..    ....++
T Consensus         7 y~~~~~lg~g~-~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l   85 (334)
T cd07855           7 YKPIENIGSGA-YGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV   85 (334)
T ss_pred             eeeeeeeecCC-CeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence            33334455555 999999965 4799999999865422  234567789999999999999999998863    356899


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+. ++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||++......
T Consensus        86 v~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          86 VMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             EEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            999996 58999886654 589999999999999999999999   9999999999999999999999999998765432


Q ss_pred             cc--ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-c-----
Q 002826          736 AF--QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-N-----  806 (876)
Q Consensus       736 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-----  806 (876)
                      ..  ........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  ........... .     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCCChhHhhhh
Confidence            21  111223457888999998755 4588999999999999999999999976433211  11111100000 0     


Q ss_pred             -----------ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 -----------GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 -----------~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                 ......+.............+.+++.+|++.+|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                       000000011111222345678999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=2.8e-31  Score=286.97  Aligned_cols=258  Identities=20%  Similarity=0.274  Sum_probs=188.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCe-----EEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDES-----IFL  655 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~l  655 (876)
                      ....+|.|+ ||.||+|... +++.||+|.+.....  .....+.+|+++++.++ ||||+++++++...+.     .|+
T Consensus         5 ~~~~lg~g~-~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           5 KLEKIGEGT-YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             EeeEecccC-CeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            334455555 9999999764 799999998865322  23357888999999995 6999999999987665     899


Q ss_pred             EEEcCCCCCHHHHhhcc----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchh
Q 002826          656 IYEFLQMGSLGDLICRQ----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDR  730 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~  730 (876)
                      ||||+++ ++.+++...    ...+++..+..++.||+.||+|||+.   +|+||||||+||+++. ++.+|++|||.++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999986 898887643    24589999999999999999999999   9999999999999998 8999999999987


Q ss_pred             hccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc-
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA-  808 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  808 (876)
                      ......  .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||........ .....+......... 
T Consensus       160 ~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  236 (295)
T cd07837         160 AFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTEQVW  236 (295)
T ss_pred             ecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCChhhC
Confidence            654321  11223346778999998764 4578999999999999999999999976433221 111111100000000 


Q ss_pred             -----------ccc-cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 -----------IQV-LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 -----------~~~-~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                                 ... ....+..........+.++|.+|+.++|++||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                       000 000111111223456889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=2.5e-31  Score=287.46  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=187.2

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ...+|. |++|.||+|... +++.||||++..... ....++..|+.++.+.. ||||+++++++.++...|+||||+++
T Consensus        20 ~~~lg~-g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   98 (296)
T cd06618          20 LGEIGS-GTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST   98 (296)
T ss_pred             eeEeec-cCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence            344444 459999999876 499999999975432 23345667777777774 99999999999999999999999865


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                       ++.+++......+++..+.+++.|++.|++|||+ .   +|+||||+|+||++++++.+||+|||++........   .
T Consensus        99 -~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~  171 (296)
T cd06618          99 -CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---K  171 (296)
T ss_pred             -CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc---c
Confidence             7888776655689999999999999999999997 5   899999999999999999999999999876643221   1


Q ss_pred             ccccccccccCccccCCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          742 SSEYALSCYNAPEYGYSKK----ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....+.....    ......  .     +...
T Consensus       172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~--~-----~~~~  240 (296)
T cd06618         172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT----KILQEE--P-----PSLP  240 (296)
T ss_pred             cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH----HHhcCC--C-----CCCC
Confidence            2234778899999876543    78899999999999999999999965322211111    111110  0     0000


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      . .......+.+++.+||+.||++||++.++++.
T Consensus       241 ~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         241 P-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             C-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0 00123467899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=3.1e-31  Score=288.92  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=192.0

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeC--------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--------  650 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------  650 (876)
                      +|.....+|.|+ ||.||+|... +++.||+|++......  ....+.+|+++++.++||||+++++++.+.        
T Consensus         9 ~y~~~~~lg~g~-~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   87 (311)
T cd07866           9 DYEILGKLGEGT-FGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR   87 (311)
T ss_pred             cEEEEEEeccCC-CEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence            344445566655 9999999764 7899999998654322  234677899999999999999999987543        


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ...++|+||+++ ++.+.+......+++..+..++.|+++|++|||+.   +++||||||+||++++++.+|++|||+++
T Consensus        88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence            347999999976 78777766666799999999999999999999999   99999999999999999999999999998


Q ss_pred             hccccccc---------cccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 002826          731 IVGEAAFQ---------STMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       731 ~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~  800 (876)
                      ........         .......++..|+|||...+ ..++.++||||||+++|||++|++||........ .......
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~-~~~~~~~  242 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ-LHLIFKL  242 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH
Confidence            66432211         11223356788999998754 4578899999999999999999999976443221 1111110


Q ss_pred             Hhhc-----------cc----ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          801 KINI-----------TN----GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       801 ~~~~-----------~~----~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ....           ..    .......+............+.+++.+|+..+|++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0000           00    00011111111212223356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=8.6e-32  Score=291.25  Aligned_cols=253  Identities=22%  Similarity=0.332  Sum_probs=205.4

Q ss_pred             hhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          579 LVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       579 l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ...++|.+...++.|.|+.|.+|+.. +|..||+|.+.+..-..  ...+.+|+++|+.++|||||+++.+.......|+
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            34466777777788889999999654 79999999997653322  3457899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+.+|.+.+++.+.+. +.+..+..++.|+.+|++|||++   .|+|||||++|||++.+.++||+|||++..+...
T Consensus       133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeeccc
Confidence            9999999999999988874 55589999999999999999999   9999999999999999999999999999988744


Q ss_pred             ccccccccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      .   .....+|++.|.|||++.+.+ .++++|+||+|+++|-++.|..||++.......- ..++.++++          
T Consensus       209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~-rvl~gk~rI----------  274 (596)
T KOG0586|consen  209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP-RVLRGKYRI----------  274 (596)
T ss_pred             c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc-hheeeeecc----------
Confidence            3   344556999999999998765 4788999999999999999999998755432200 000001111          


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                           +.-...+..+++++++..+|.+|++++++.+.-..
T Consensus       275 -----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  275 -----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             -----cceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence                 11112356789999999999999999999876443

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7e-31  Score=281.77  Aligned_cols=256  Identities=26%  Similarity=0.380  Sum_probs=194.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ..+|.|+ +|.||+|... +++.||+|++....  ......+..|++++++++|+|++++++++.+.+..++||||+++ 
T Consensus         5 ~~ig~g~-~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~-   82 (282)
T cd07829           5 EKLGEGT-YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-   82 (282)
T ss_pred             hcccccC-cceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-
Confidence            4455555 9999999765 59999999997643  23346778899999999999999999999999999999999985 


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++.+....+++..+.+++.+++.|++|||+.   +|+||||+|+||++++++.+||+|||.++.......  ....
T Consensus        83 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~  157 (282)
T cd07829          83 DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTH  157 (282)
T ss_pred             CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCc
Confidence            99999987655799999999999999999999999   999999999999999999999999999887653321  1223


Q ss_pred             ccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----------hc---cccc
Q 002826          744 EYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-----------NI---TNGA  808 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~---~~~~  808 (876)
                      ..++..|+|||...+. .++.++||||||+++||+++|++||........ .....+...           ..   ....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            3456779999988766 788999999999999999999999976543221 111100000           00   0000


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..................+.+++.+||..+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000000111122457899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.5e-31  Score=291.08  Aligned_cols=263  Identities=22%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCC-----eEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-----SIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e  658 (876)
                      ..+|.| ++|.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|+|||
T Consensus         6 ~~ig~g-~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           6 KPIGSG-AYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeecCC-CCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            344444 59999999765 59999999987543  234467889999999999999999999998765     7899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  737 (876)
                      |+++ +|.+++.+.. .+++..+..++.+++.|++|||+.   +|+||||||+||+++.++.++++|||++........ 
T Consensus        85 ~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          85 LMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             chhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            9985 8999887654 799999999999999999999999   999999999999999999999999999987654321 


Q ss_pred             ccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-cccc------
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-NGAI------  809 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~------  809 (876)
                      ........++..|+|||.+.+. .++.++||||+|+++|+|++|++||........  ...+....... ....      
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhHhhhcccc
Confidence            1112334578889999998877 789999999999999999999999976553221  11111100000 0000      


Q ss_pred             ----------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhccc
Q 002826          810 ----------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLST  857 (876)
Q Consensus       810 ----------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~  857 (876)
                                ..-..............+.+++.+||+++|.+|||+.++++.  ++++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                      000000111112235578899999999999999999999985  666544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=5.3e-31  Score=286.41  Aligned_cols=250  Identities=27%  Similarity=0.373  Sum_probs=192.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|... +++.||+|.+......   ...++.+|+++++.++|+|++++.+++......++|||
T Consensus        17 ~~~~~~lg~g~-~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          17 FSDLREIGHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHheeeCC-CEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            33445555555 9999999764 6889999998643222   23467789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+. |++.+++......+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||++......   
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---  168 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---  168 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence            997 588887765556789999999999999999999999   9999999999999999999999999998765432   


Q ss_pred             cccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 STMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                         ....++..|+|||.+.   ...++.++|||||||++|||++|+.||........ ...+.+    ..  .     +.
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~----~~--~-----~~  233 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ----NE--S-----PA  233 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhh----cC--C-----CC
Confidence               1234778899999864   34678899999999999999999999865322111 011110    00  0     00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      .  ........+.+++.+||+.+|++||++.++++.-.....
T Consensus       234 ~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         234 L--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             c--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            0  011233457899999999999999999999987655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.4e-31  Score=278.35  Aligned_cols=244  Identities=20%  Similarity=0.312  Sum_probs=187.7

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-----ccCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  658 (876)
                      ..+|. |+||.||+|.. .+++.||+|.+....     ......+.+|++++++++||||+++++++.+.  +..++|+|
T Consensus         8 ~~lg~-g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           8 KLLGR-GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeEcc-CCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            44444 44999999965 469999999875321     12235788899999999999999999998764  46889999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-  737 (876)
                      |+++++|.+++.+.+ .+++..+.+++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||+++....... 
T Consensus        87 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  162 (264)
T cd06653          87 YMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS  162 (264)
T ss_pred             eCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccccc
Confidence            999999999987654 588999999999999999999999   999999999999999999999999999876532111 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ........++..|+|||...+..++.++|||||||++||+++|+.||........    . .......  .    .+.+ 
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~--~----~~~~-  230 (264)
T cd06653         163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA----I-FKIATQP--T----KPML-  230 (264)
T ss_pred             CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH----H-HHHHcCC--C----CCCC-
Confidence            1111233578889999998888889999999999999999999999975422211    1 1111000  0    1111 


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        +......+.+++.+|+. +|..||++.++++
T Consensus       231 --p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         231 --PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             --CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence              12233467899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=309.86  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             CCCCCCceEEEEEEeC----C----CcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEE
Q 002826          589 AGNGGPFGRVYILSLP----S----GELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ..|.|.||.|++|...    .    ...||||.++.... .+.+.+..|+++|+.+ +||||+.++|+|...+..++|+|
T Consensus       303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E  382 (609)
T KOG0200|consen  303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE  382 (609)
T ss_pred             eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence            4555669999998542    1    46799999875433 3457889999999999 69999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEE
Q 002826          659 FLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL  723 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl  723 (876)
                      |+..|+|.++++..+               ..++..+...++.|||.||+||++.   +++|||+.++|||++.+..+||
T Consensus       383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kI  459 (609)
T KOG0200|consen  383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKI  459 (609)
T ss_pred             eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEE
Confidence            999999999998765               3488899999999999999999999   9999999999999999999999


Q ss_pred             ccccchhhcccccccccc-ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 002826          724 TDFALDRIVGEAAFQSTM-SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK  801 (876)
Q Consensus       724 ~DfGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  801 (876)
                      +|||+|+.......+... +...-...|||||.+....++.++|||||||++||++| |..||.+.... .++.++.+..
T Consensus       460 aDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~-~~l~~~l~~G  538 (609)
T KOG0200|consen  460 ADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT-EELLEFLKEG  538 (609)
T ss_pred             ccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH-HHHHHHHhcC
Confidence            999999977655544322 22112445999999999999999999999999999999 88888763322 2234444432


Q ss_pred             hhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       802 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      .+..             .+.....+++++++.||+.+|++||++.|+++.++....
T Consensus       539 ~r~~-------------~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  539 NRME-------------QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCC-------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            2111             111224467899999999999999999999999999543

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-34  Score=318.28  Aligned_cols=407  Identities=27%  Similarity=0.343  Sum_probs=294.0

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc-------------ceeecCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-------------WVLDLSR  142 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l-------------~~LdL~~  142 (876)
                      ++.+++++++.+ +..|..+..+.+|+.|+++.|.|.. .|.+.+++++|++|+|.+|.+             +.||+|+
T Consensus        46 ~L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~lnL~~n~l~~lP~~~~~lknl~~LdlS~  123 (1081)
T KOG0618|consen   46 KLKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYLNLKNNRLQSLPASISELKNLQYLDLSF  123 (1081)
T ss_pred             eeEEeecccccc-ccCCchhhhHHHHhhcccchhhHhh-CchhhhhhhcchhheeccchhhcCchhHHhhhcccccccch
Confidence            567778776655 4567788888889999999888866 678888888888888888865             3466666


Q ss_pred             ccccccCCCccCCccccceeccccc-------------------ccCCCcCccccCCCcceEEEccCCCCcCCCCCCccc
Q 002826          143 NHIEGKIPESIGSLVNLQVLNLGSN-------------------LLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIG  203 (876)
Q Consensus       143 n~l~~~~p~~~~~l~~L~~L~L~~N-------------------~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~  203 (876)
                      |++. .+|..+..++.++.+..++|                   .+.+.++....+++.  .|||++|+.  .  -..+.
T Consensus       124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~--~--~~dls  196 (1081)
T KOG0618|consen  124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEM--E--VLDLS  196 (1081)
T ss_pred             hccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchh--h--hhhhh
Confidence            6665 55555544444444444444                   333444444444444  466666652  2  23455


Q ss_pred             ccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccce
Q 002826          204 KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVN  283 (876)
Q Consensus       204 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  283 (876)
                      .+.+|+.|+...|++....    -..++|+.|+.++|.++...+..   .-.+|+++++++|+++ .+|++++.+.+|+.
T Consensus       197 ~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p---~p~nl~~~dis~n~l~-~lp~wi~~~~nle~  268 (1081)
T KOG0618|consen  197 NLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP---VPLNLQYLDISHNNLS-NLPEWIGACANLEA  268 (1081)
T ss_pred             hccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc---ccccceeeecchhhhh-cchHHHHhcccceE
Confidence            5666666666666665431    12456777777777777222222   1357888888888888 45588888888888


Q ss_pred             eeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCC-CCeeeccCcc
Q 002826          284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQ-LEQVQIDNNR  362 (876)
Q Consensus       284 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~  362 (876)
                      ++..+|+++ .+|..+..+++|+.|.+..|.++ .+|....+++.|++|+|..|+|...++..+..+.. |..|..+.|+
T Consensus       269 l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~  346 (1081)
T KOG0618|consen  269 LNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNK  346 (1081)
T ss_pred             ecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcc
Confidence            888888885 67777777888888888888888 66767777888888888888887555444444433 6777777777


Q ss_pred             cCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcC
Q 002826          363 FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPS  441 (876)
Q Consensus       363 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~  441 (876)
                      +....-..=...+.|+.|++.+|.++...-+.+.++..|++|+|++|+|...+. .+.++..|++|+||+|+|+ .+|..
T Consensus       347 l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~t  425 (1081)
T KOG0618|consen  347 LSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDT  425 (1081)
T ss_pred             ccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHH
Confidence            773332222345678899999999998888888899999999999999987666 6889999999999999999 77899


Q ss_pred             CCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCcccc-ccCCccc-CCCCCccccCCCCC
Q 002826          442 LAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSG-RVPYSLI-SGLPASYLQGNPGL  504 (876)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~-~~p~~~~-~~~~~~~~~~N~~~  504 (876)
                      +..++.|++|...+|+|. .+| .+..+ .++.+|+|.|+|+- .+|.... .+++++.+.||+|+
T Consensus       426 va~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  426 VANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             HHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            999999999999999998 677 55555 48889999999963 4666665 77888899999974

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=8e-31  Score=285.64  Aligned_cols=240  Identities=26%  Similarity=0.374  Sum_probs=188.2

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+|.|+ ||+||+|.. .+|+.||+|++.......   ...+.+|+++++.++|||++++++++.++...|+||||+.+
T Consensus        27 ~~lg~g~-~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  105 (313)
T cd06633          27 HEIGHGS-FGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG  105 (313)
T ss_pred             eeeccCC-CeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCC
Confidence            4456655 999999965 478999999986543222   24677899999999999999999999999999999999964


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                       ++.+++......+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.+.....      ..
T Consensus       106 -~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~  175 (313)
T cd06633         106 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------AN  175 (313)
T ss_pred             -CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC------CC
Confidence             88888876666799999999999999999999999   999999999999999999999999998764322      12


Q ss_pred             cccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          743 SEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ...|+..|+|||.+.   ...++.++||||||+++|||++|.+||.......  .....   ....  ......      
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--~~~~~---~~~~--~~~~~~------  242 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHI---AQND--SPTLQS------  242 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH---HhcC--CCCCCc------
Confidence            345788899999874   4567889999999999999999999986543211  11111   1100  000001      


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ......+.+++.+||+++|++||++.++++.
T Consensus       243 -~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         243 -NEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1112357889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=5e-31  Score=290.93  Aligned_cols=261  Identities=22%  Similarity=0.295  Sum_probs=189.5

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC----------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD----------  650 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------  650 (876)
                      .|.....+|.|| ||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...          
T Consensus         6 ~y~~~~~Lg~g~-~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           6 RYMDLRPLGCGS-NGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             ceEEEEEecCCC-CEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            444455566655 999999965 47899999998766555567788999999999999999999876543          


Q ss_pred             ----CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEcc
Q 002826          651 ----ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTD  725 (876)
Q Consensus       651 ----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~D  725 (876)
                          ...|+||||+++ +|.+++...  .+++..+..++.|++.|++|||+.   +++||||||+||+++ +++.+|++|
T Consensus        85 ~~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          85 LTELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence                357999999975 898888543  588999999999999999999999   999999999999997 456789999


Q ss_pred             ccchhhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-
Q 002826          726 FALDRIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-  802 (876)
Q Consensus       726 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-  802 (876)
                      ||.++....... ........++..|+|||.... ..++.++|||||||++|||++|+.||........ ......... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~  237 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVPV  237 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence            999876542211 111223357888999997654 4578899999999999999999999976443211 111100000 


Q ss_pred             -----------hccccc---ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          803 -----------NITNGA---IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       803 -----------~~~~~~---~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                                 ......   .................++.+++.+|+.+||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                       000000   000000011111123356789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=1e-30  Score=281.50  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=192.6

Q ss_pred             CCCCCCCCceEEEEEEe----CCCcEEEEEEEecCCc----cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          587 SSAGNGGPFGRVYILSL----PSGELIAVKKLVNFGC----QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ..+|.|+ +|.||++..    .+++.||+|++.....    ...+.+..|++++.++ +||||+++++++..++..++||
T Consensus         6 ~~ig~G~-~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           6 RVLGTGA-YGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEeccCC-CceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            3445554 999999864    3678999999864321    2335678899999999 5999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.... .+++..+..++.|+++|+.|||+.   +++||||||+||+++.++.++++|||+++.......
T Consensus        85 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          85 DYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             ecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999987643 688999999999999999999998   999999999999999999999999999876543221


Q ss_pred             ccccccccccccccCccccCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKK--ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      . ......|+..|+|||...+..  .+.++||||||+++|||++|..||........ ..+..+......        +.
T Consensus       161 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~--------~~  230 (288)
T cd05583         161 E-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILKSK--------PP  230 (288)
T ss_pred             c-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHccC--------CC
Confidence            1 112234788899999876654  68899999999999999999999964332211 111111111111        00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      .   .......+.+++.+||+.+|++|||++++.+.|+..
T Consensus       231 ~---~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         231 F---PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             C---CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            1   111234577899999999999999999888877764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=1.8e-30  Score=279.96  Aligned_cols=247  Identities=25%  Similarity=0.325  Sum_probs=188.7

Q ss_pred             CCCCCCCCceEEEEEEe----CCCcEEEEEEEecCCc----cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          587 SSAGNGGPFGRVYILSL----PSGELIAVKKLVNFGC----QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ..+|.| +||.||+|..    .+|+.||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..++..++||
T Consensus         6 ~~lg~G-~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           6 KVLGTG-AYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeccC-CcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            344544 5999999965    4789999999865321    2346678899999999 5999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.... .+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.+||+|||+++.......
T Consensus        85 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          85 DYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999987653 688999999999999999999999   999999999999999999999999999876543221


Q ss_pred             ccccccccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                       .......|+..|+|||.....  .++.++||||||+++|+|++|+.||....... ....+........        +.
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~--------~~  230 (290)
T cd05613         161 -ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE--------PP  230 (290)
T ss_pred             -cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHHHhhccC--------CC
Confidence             112234478889999987653  46788999999999999999999997533211 1122222211111        00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                      .   .......+.+++.+||+.+|++||     ++.++++.
T Consensus       231 ~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 Y---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             C---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            0   111234567999999999999997     66766553

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.1e-33  Score=265.34  Aligned_cols=271  Identities=21%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEec--CCccCHHHHHHHHHHHhhccCccccceeeEEEe--------C
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--------D  650 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~  650 (876)
                      +.|+.....+.|.||+||+|+.+ .|+.||+|++.-  ..+.......+|+.++..++|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            33455556666779999999664 688899987632  333445677899999999999999999998854        2


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ..+|+||++|+. +|.-++......++..++.+++.++..||.|+|..   .|+|||+||.|+||+.++.+|++|||+++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence            358999999988 99999988777899999999999999999999999   99999999999999999999999999997


Q ss_pred             hcccc--ccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hccc
Q 002826          731 IVGEA--AFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITN  806 (876)
Q Consensus       731 ~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~  806 (876)
                      .+...  .....++..+-|..|++||.+.+ ..++++.|||+-||++.||+||.+.+++......  ...++... .+..
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqq--l~~Is~LcGs~tk  250 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQ--LHLISQLCGSITK  250 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHH--HHHHHHHhccCCc
Confidence            76522  22233455667999999998775 4699999999999999999999999887554321  11111111 1111


Q ss_pred             ccccccC----------hhhh----hhcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          807 GAIQVLD----------PKIA----NCYQQQ------MLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       807 ~~~~~~d----------~~~~----~~~~~~------~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...+-.|          +.+.    ....+.      ..+.++++..++..||.+|+++.++++.---+.+.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            1111110          0000    001111      12678999999999999999999998876555443

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=8.6e-33  Score=267.88  Aligned_cols=259  Identities=26%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             ccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEe
Q 002826          573 RVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS  649 (876)
Q Consensus       573 ~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  649 (876)
                      .|+.++++.    ...+|. |+||+|+|..+ +.|+..|||++..... .+..++..|.++..+- +.||||+++|.+-.
T Consensus        60 ~F~~~~Lqd----lg~iG~-G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~  134 (361)
T KOG1006|consen   60 TFTSDNLQD----LGEIGN-GAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS  134 (361)
T ss_pred             ccccchHHH----HHHhcC-CcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence            444455542    344554 55999999854 5899999999976543 3456778888866555 79999999999999


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhc----cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          650 DESIFLIYEFLQMGSLGDLICR----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      ++..|+-||.|+- |+..+...    +...+++...-+|+.....||.||-+.  ..|+|||+||+|||++..|.+|++|
T Consensus       135 EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  135 EGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             CCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeec
Confidence            9999999999965 76554322    245789999999999999999999987  3899999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      ||.+....++-   ..+...|...|||||.+..  ..+..++||||+|+++||+.||+.|+..+..-...+...+..   
T Consensus       212 FGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~g---  285 (361)
T KOG1006|consen  212 FGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIG---  285 (361)
T ss_pred             ccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcC---
Confidence            99987765432   2334458888999998753  348899999999999999999999998766533322222221   


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                          -.+++...  ....+....+.++|.-|+.+|-..||...++.++
T Consensus       286 ----dpp~l~~~--~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 ----DPPILLFD--KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ----CCCeecCc--ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                11111111  1122355678999999999999999999988753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=8e-31  Score=239.43  Aligned_cols=258  Identities=22%  Similarity=0.354  Sum_probs=199.3

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...++|. |+||+||+|+. .+++.||+|++...+..+  .....+|+-+++.++|.|||++++....++..-+|+|||.
T Consensus         6 kmekige-gtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd   84 (292)
T KOG0662|consen    6 KMEKIGE-GTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD   84 (292)
T ss_pred             HHHhhcC-CcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh
Confidence            3344554 55999999965 478999999997654332  3578899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      . +|..+...-...++.+.+..++.|+++|+.++|++   ++.|||+||.|.+++.+|+.|++|||+++.++-..  ...
T Consensus        85 q-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv--rcy  158 (292)
T KOG0662|consen   85 Q-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCY  158 (292)
T ss_pred             H-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eee
Confidence            7 89999887777899999999999999999999999   99999999999999999999999999999887432  345


Q ss_pred             ccccccccccCccccCCCC-CCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHh----hcccccccccC--
Q 002826          742 SSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI----NITNGAIQVLD--  813 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~d--  813 (876)
                      +...-|..|++|+++.+.+ |+...|+||-||++.|+.. |++.|.+.+.++ .+....+...    +.+.+.....|  
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCCccccCCCCc
Confidence            6667899999999988765 8889999999999999987 666676644333 2333333221    11222222222  


Q ss_pred             --hhh------hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 --PKI------ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 --~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        |..      ..........=.+++++.+.-+|.+|.++++.++
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence              111      1112222233467888889999999999998875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.1e-30  Score=288.28  Aligned_cols=261  Identities=20%  Similarity=0.325  Sum_probs=190.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||+|++....  ......+.+|+++++.++||||+++++++...      ..
T Consensus        16 ~y~~~~~ig~g~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          16 RYTSLKQVGSGA-YGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             ceEEEEEeeecC-CeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            444445555555 999999975 479999999986532  22345678999999999999999999998754      34


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++|+||+.. ++.++..   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++..
T Consensus        95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            6999999975 7776652   3588999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-c----
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-N----  806 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~----  806 (876)
                      ...     .....++..|+|||...+ ..++.++|||||||++|||++|+.||........  ........... .    
T Consensus       168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         168 DAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence            322     123346788999998765 4588899999999999999999999986543221  11100000000 0    


Q ss_pred             ------------ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhccc
Q 002826          807 ------------GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLST  857 (876)
Q Consensus       807 ------------~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~  857 (876)
                                  .........+..........+.+++.+||++||++||++.|+++.  +++..+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                        000000011111111234467899999999999999999999955  666543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=1.5e-30  Score=278.88  Aligned_cols=243  Identities=22%  Similarity=0.334  Sum_probs=193.3

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.|| ||.||+|... +|+.||+|++....   ....+.+.+|++++++++ ||||+++++++.+++..++||||++
T Consensus         7 ~~lg~g~-~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           7 KIIGEGS-FSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeecCCC-ceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            4455555 9999999664 79999999986522   123456788999999998 9999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc---
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ---  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~---  738 (876)
                      +++|.+++.+.+ .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.........   
T Consensus        86 ~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~  161 (280)
T cd05581          86 NGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESN  161 (280)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccC
Confidence            999999997654 699999999999999999999999   9999999999999999999999999998876532211   


Q ss_pred             ---------------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 002826          739 ---------------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       739 ---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                                     .......++..|+|||......++.++||||+|++++++++|+.||....... .    .+....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~----~~~~~~  236 (280)
T cd05581         162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-T----FQKILK  236 (280)
T ss_pred             CCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-H----HHHHHh
Confidence                           12223346788999999888888999999999999999999999998654211 1    111111


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSM----FEVVK  850 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~ell~  850 (876)
                      ...           .........+.+++.+||+.+|++||++    +|+++
T Consensus       237 ~~~-----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 LEY-----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             cCC-----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            110           0011123467899999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-30  Score=271.22  Aligned_cols=235  Identities=27%  Similarity=0.342  Sum_probs=189.0

Q ss_pred             CCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      |.|| ||.||++... +++.||+|++......   ..+.+..|++++++++|||++++++.+..++..++||||+++++|
T Consensus         2 g~G~-~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           2 GKGS-FGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCC-ceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            4455 9999999765 6899999998764322   345788999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++.... .+++..+..++.|+++|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99997654 689999999999999999999998   99999999999999999999999999987764332  1123344


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ++..|+|||...+...+.++|+||||+++||+++|+.||.......     ..+......        ..+.   .....
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~--------~~~~---~~~~~  218 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE-----IYEKILKDP--------LRFP---EFLSP  218 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHhcCC--------CCCC---CCCCH
Confidence            7788999999888888999999999999999999999997544311     111111111        0011   11134


Q ss_pred             HHHHHHHHccCCCCCCCCCHHH
Q 002826          826 GALEIALRCTSVMPEKRPSMFE  847 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~~e  847 (876)
                      .+.+++.+||..||++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            5789999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.6e-31  Score=273.77  Aligned_cols=220  Identities=23%  Similarity=0.262  Sum_probs=175.4

Q ss_pred             CCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhc
Q 002826          593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICR  671 (876)
Q Consensus       593 g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  671 (876)
                      |.+|.||++.. .+++.||+|++....     .+.+|...+....|||++++++++.+.+..++||||+++|+|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            66999999955 578999999986542     233455555556799999999999999999999999999999999876


Q ss_pred             cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccccccc
Q 002826          672 QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN  751 (876)
Q Consensus       672 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  751 (876)
                      .. .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+.......     ....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcccc
Confidence            54 589999999999999999999999   99999999999999999999999999876654321     2223566799


Q ss_pred             CccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHH
Q 002826          752 APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIA  831 (876)
Q Consensus       752 aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li  831 (876)
                      |||......++.++||||+|+++|||++|+.|+...+.....           .  . . +     .........+.+++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~-----------~--~-~-~-----~~~~~~~~~~~~li  209 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-----------H--T-T-L-----NIPEWVSEEARSLL  209 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc-----------c--c-c-c-----CCcccCCHHHHHHH
Confidence            999988888899999999999999999999887543221100           0  0 0 0     01111234678999


Q ss_pred             HHccCCCCCCCCCHH
Q 002826          832 LRCTSVMPEKRPSMF  846 (876)
Q Consensus       832 ~~cl~~dP~~RPs~~  846 (876)
                      .+|++.||++||++.
T Consensus       210 ~~~l~~dp~~R~~~~  224 (237)
T cd05576         210 QQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHccCCHHHhcCCC
Confidence            999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.97  E-value=1.2e-30  Score=276.54  Aligned_cols=243  Identities=22%  Similarity=0.254  Sum_probs=186.1

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-----ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +..+.|+||.||++... .+..+++|.++...     .....++..|+.+++.++||||+++++++.+.+..++||||++
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (260)
T cd08222           6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE   85 (260)
T ss_pred             eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence            33444559999999654 45556666654321     1233457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          662 MGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       662 ~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      +++|.+++.+   ....+++..+..++.|++.|+.|||+.   +++|+|+||+||++++ +.+|++|||.++....... 
T Consensus        86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~-  160 (260)
T cd08222          86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD-  160 (260)
T ss_pred             CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCCcc-
Confidence            9999998864   345789999999999999999999999   9999999999999975 5699999999876643221 


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       ......|+..|+|||......++.++|+||||+++|+|++|..||......     .........   .    .+.   
T Consensus       161 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~~~~---~----~~~---  224 (260)
T cd08222         161 -LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEG---P----TPS---  224 (260)
T ss_pred             -cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcC---C----CCC---
Confidence             122334778899999988778888999999999999999999998643221     111111111   0    111   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ........+.+++.+||..+|++||++.|+++.
T Consensus       225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            112334568899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.6e-30  Score=286.81  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=189.0

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCC------e
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------S  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||+|++......  ....+.+|++++++++||||+++++++..+.      .
T Consensus        16 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07880          16 RYRDLKQVGSGA-YGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD   94 (343)
T ss_pred             ceEEEEEeeecC-CeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence            444555565555 999999954 58999999998543222  2356788999999999999999999987643      4


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++||||+ +++|.+++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++...
T Consensus        95 ~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          95 FYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence            68999998 6699888864  3689999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc----
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG----  807 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  807 (876)
                      ....     ....++..|+|||...+ ..++.++|+||+|+++|++++|+.||........ ..............    
T Consensus       169 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (343)
T cd07880         169 DSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSKEFVQK  242 (343)
T ss_pred             ccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHh
Confidence            4321     22346788999998765 4578899999999999999999999976433211 11110000000000    


Q ss_pred             ------------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          808 ------------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       808 ------------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                                  ......+.+..........+.+++.+|++.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                        0000001111112233446789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=277.38  Aligned_cols=245  Identities=22%  Similarity=0.251  Sum_probs=195.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |..-..+|.|| ||.||-++.. +|+.+|+|++.+..   ...+.-...|-.++.+++.+.||.+--.|+..+..++|+.
T Consensus       187 F~~~RvlGkGG-FGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLt  265 (591)
T KOG0986|consen  187 FRVYRVLGKGG-FGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLT  265 (591)
T ss_pred             eeeeEEEeccc-ccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEE
Confidence            44445566666 9999988554 79999999885432   2334456679999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      .|.||+|.-++...+ ..+++..+.-.+.+|+-||++||..   +||.||+||+|||+|+.|.++|+|.|+|..+..+..
T Consensus       266 lMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  266 LMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             eecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999998887764 4589999999999999999999999   999999999999999999999999999998876542


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                         .....||.+|||||++....|+...|.||+||++|||+.|+.||..-..... ..+.-++.....           .
T Consensus       343 ---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eEvdrr~~~~~-----------~  407 (591)
T KOG0986|consen  343 ---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REEVDRRTLEDP-----------E  407 (591)
T ss_pred             ---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHHHHHHHhcch-----------h
Confidence               3344799999999999999999999999999999999999999976333221 111111111111           1


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMF  846 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~  846 (876)
                      ++....+.+..++....+++||++|...+
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            23334455677888899999999986443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.9e-30  Score=285.04  Aligned_cols=257  Identities=22%  Similarity=0.325  Sum_probs=187.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||+|++.....  ...+.+.+|++++++++||||+++++++...      ..
T Consensus        18 ~y~~~~~lg~G~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          18 RYQNLSPVGSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             ceEEEEEeeecC-CeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            444444455555 999999954 5799999999865321  2245677899999999999999999988643      34


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|++++++ +++|.+++...  .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++..
T Consensus        97 ~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          97 VYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             EEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            78888876 67998887643  589999999999999999999999   9999999999999999999999999998765


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc-
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ-  810 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  810 (876)
                      ...     .....++..|+|||...+ ..++.++||||+||++|||++|+.||........ .....+........... 
T Consensus       171 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         171 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKK  244 (345)
T ss_pred             ccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHhh
Confidence            332     123347888999998765 4678899999999999999999999975433211 11111111000000000 


Q ss_pred             ---------------ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 ---------------VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ---------------~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                     ...+............+.+++.+|++.||.+||++.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                           00000111111124467899999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.3e-30  Score=287.62  Aligned_cols=258  Identities=22%  Similarity=0.343  Sum_probs=191.8

Q ss_pred             hhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCe----
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES----  652 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  652 (876)
                      ..+|.....+|.|+ +|.||+|... +++.||+|++....  ......+.+|+.++++++|||++++++++...+.    
T Consensus        14 ~~~y~~~~~ig~g~-~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGA-YGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCC-ceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            33555556666665 9999999765 68999999886432  1233567789999999999999999998876554    


Q ss_pred             --EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          653 --IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       653 --~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                        .++|+||+ +++|.+++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999998 5699998865  3689999999999999999999999   99999999999999999999999999988


Q ss_pred             hccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc---
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN---  806 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  806 (876)
                      .....     .....++..|+|||.... ..++.++||||+|+++||+++|+.||........  ............   
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~--~~~i~~~~~~~~~~~  239 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ--LKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHhcCCCCHHH
Confidence            66432     223347788999998754 3678899999999999999999999975433211  111110000000   


Q ss_pred             --------------ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 --------------GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 --------------~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                    .....-.+.+..........+.+++.+|++++|++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                          000000011111111235678899999999999999999999763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=272.13  Aligned_cols=271  Identities=22%  Similarity=0.262  Sum_probs=208.8

Q ss_pred             cccccccchhhhhhcccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-C-c----cc
Q 002826          568 FFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-H-K----NI  640 (876)
Q Consensus       568 ~~~~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----ni  640 (876)
                      .+.+..+..+|.....+++....|.|+||.|-.+ +...+..||||+++... ...+..+-|++++.++. + |    -+
T Consensus        75 ~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rc  153 (415)
T KOG0671|consen   75 KDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRC  153 (415)
T ss_pred             CCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence            3444667778888888888888888889999988 55568999999986542 34456677999999994 2 2    57


Q ss_pred             cceeeEEEeCCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC--
Q 002826          641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA--  717 (876)
Q Consensus       641 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~--  717 (876)
                      |.+.+||+..++.|+|+|.+ |.|+.+++..+ ..+++...+..|++|+++++++||+.   +++|-|+||+||++.+  
T Consensus       154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~  229 (415)
T KOG0671|consen  154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSE  229 (415)
T ss_pred             EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccc
Confidence            88889999999999999977 55999999875 56789999999999999999999999   9999999999999821  


Q ss_pred             ------------------CCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh
Q 002826          718 ------------------DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT  779 (876)
Q Consensus       718 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt  779 (876)
                                        +..+|++|||-|+...+..     +..+.|..|+|||++.+-.++.++||||+|||++|+.|
T Consensus       230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence                              2358999999998765432     44557889999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHHh-hccccccc-----------ccC---------------h--hh---hhhcHHHHHHH
Q 002826          780 GRQAEQAEPAESLDVVKWVRRKI-NITNGAIQ-----------VLD---------------P--KI---ANCYQQQMLGA  827 (876)
Q Consensus       780 g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----------~~d---------------~--~~---~~~~~~~~~~~  827 (876)
                      |...|+.-+.  .+..+++++.. +.+..+..           .+|               +  .+   ......+...+
T Consensus       305 G~~LFqtHen--~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  305 GETLFQTHEN--LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             cceecccCCc--HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            9999987442  22223333322 11100000           001               0  00   12234566789


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 002826          828 LEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       828 ~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ++++++|+..||.+|+|++|++.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhc
Confidence            99999999999999999999985

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=4e-30  Score=282.66  Aligned_cols=257  Identities=24%  Similarity=0.311  Sum_probs=185.9

Q ss_pred             CCCCCCCCceEEEEEEeC-C--CcEEEEEEEecCCc--cCHHHHHHHHHHHhhc-cCccccceeeEEEeC----CeEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP-S--GELIAVKKLVNFGC--QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD----ESIFLI  656 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~lv  656 (876)
                      ..+|.|+ ||.||+++.. +  ++.||+|++.....  .....+.+|+++++++ +||||+++++.+...    ..+|++
T Consensus         6 ~~lg~G~-~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           6 KELGQGA-YGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEccccC-CeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            3455555 9999999764 4  78999999864321  2245678899999999 599999999976432    457899


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      +||+. ++|.+++... ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++......
T Consensus        85 ~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          85 EELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             Eeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            99886 5899988654 4689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cc--cccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--------
Q 002826          737 FQ--STMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--------  805 (876)
Q Consensus       737 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  805 (876)
                      ..  .......|+..|+|||...+ ..++.++||||+|+++|++++|++||........  ...........        
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ--LNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH--HHHHHHHhCCCCHHHHHhh
Confidence            11  11223458889999998765 4678999999999999999999999976442211  11000000000        


Q ss_pred             ---------cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 ---------NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ---------~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                               ..........+..........+.+++.+|++.+|++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                     0000000011111111224568899999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=281.04  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=208.2

Q ss_pred             CCCCCCCceEEEEEE-eCCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          588 SAGNGGPFGRVYILS-LPSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      +..|+|.||+||-|. .++|+.||||++.+-  ....+.+++.|+.+|+.+.||.||.+...|+..+..++|||-+.|.=
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            455667799999994 468999999999653  33445789999999999999999999999999999999999997755


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEccccchhhcccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      |.-++.....++++....-+..||+-||.|||.+   +|+|+|+||+|||+.+.   .++|++|||.|+.+++...   .
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF---R  723 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF---R  723 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh---h
Confidence            5556666667899999999999999999999999   99999999999999654   5799999999999987653   4


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ....||+.|.|||+++.+.|...-||||.||++|--++|.-||....+    +-+.+++.       .-+..|   +-|.
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----IndQIQNA-------aFMyPp---~PW~  789 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----INDQIQNA-------AFMYPP---NPWS  789 (888)
T ss_pred             hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----hhHHhhcc-------ccccCC---Cchh
Confidence            456799999999999999999999999999999999999999964322    22222221       011111   3355


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH-----------HHhhcccCCcccccccCCC
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK-----------ALHSLSTRTSLLSIELSSS  869 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~-----------~L~~i~~~~~~~~~~~~~~  869 (876)
                      +......++|...++..-.+|-|..+-+.           .|++++.+-+.+.+.-.|+
T Consensus       790 eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyiThesD  848 (888)
T KOG4236|consen  790 EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYITHESD  848 (888)
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCcceecCcch
Confidence            66677889999999999999998876543           4556665555555544443

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=5.2e-30  Score=280.85  Aligned_cols=257  Identities=23%  Similarity=0.327  Sum_probs=188.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  657 (876)
                      +|.....+|.|+ ||.||+|.. .+++.||+|++....  ......+.+|++++++++||||+++++++.. .+..++|+
T Consensus        11 ~y~~~~~ig~g~-~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~   89 (328)
T cd07856          11 RYVDLQPVGMGA-FGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT   89 (328)
T ss_pred             ceEEEEeecccC-CeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence            333444555555 999999965 489999999885432  2234677889999999999999999999876 56789999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+ +++|.+++...  .+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.+|++|||.++.....  
T Consensus        90 e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--  161 (328)
T cd07856          90 ELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--  161 (328)
T ss_pred             ehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence            998 45898888643  578888999999999999999999   9999999999999999999999999998754322  


Q ss_pred             ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc-cccc---
Q 002826          738 QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA-IQVL---  812 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---  812 (876)
                         .....++..|+|||.+.+ ..++.++||||+|+++|||++|++||........ ...+........... ....   
T Consensus       162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ-FSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhccchh
Confidence               122346778999998765 5688999999999999999999999976443211 110100000000000 0000   


Q ss_pred             ------------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 ------------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 ------------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                  ..............+.+++.+|++.+|++|||+.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        000001111224578899999999999999999999776

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=303.29  Aligned_cols=248  Identities=19%  Similarity=0.224  Sum_probs=197.7

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +.+++|.|+||.|..++.+ +++.||+|++.+.   ...+...|..|..+|..-+.+-|+.++-.|.++.+.|+||||++
T Consensus        79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p  158 (1317)
T KOG0612|consen   79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP  158 (1317)
T ss_pred             HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence            3444444559999999765 7899999999763   23567889999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ||+|-.++.+.+ .+++..+.-.+..|.-||..+|+.   |+|||||||+|||+|..|.+|++|||-+-.+...+. ...
T Consensus       159 GGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~-V~s  233 (1317)
T KOG0612|consen  159 GGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT-VRS  233 (1317)
T ss_pred             CchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCc-EEe
Confidence            999999999887 899999999999999999999999   999999999999999999999999998887775443 334


Q ss_pred             ccccccccccCccccC----C-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          742 SSEYALSCYNAPEYGY----S-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      ...+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||+.+..     ++...+...-...+ ...| . 
T Consensus       234 ~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl-----veTY~KIm~hk~~l-~FP~-~-  305 (1317)
T KOG0612|consen  234 SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL-----VETYGKIMNHKESL-SFPD-E-  305 (1317)
T ss_pred             ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH-----HHHHHHHhchhhhc-CCCc-c-
Confidence            5567999999999864    3 5789999999999999999999999986443     22222222111000 0000 0 


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPS---MFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ell~~  851 (876)
                          ...+....++|++.+. +|+.|..   +.++...
T Consensus       306 ----~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  306 ----TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ----cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                1234567888888776 6888877   8877654

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=263.30  Aligned_cols=242  Identities=23%  Similarity=0.255  Sum_probs=193.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCH---HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .++.|.|+||.|.+++-+ +|+.+|+|++++....++   +.-..|-.+|+..+||.+..+--.|+..++.|+||||+.|
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            445566779999999654 899999999987654443   3445799999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      |.|.-++.+.. .+++....-...+|..||.|||++   +|+.||+|-+|.++|.+|.+||+|||+++.--  ....++.
T Consensus       253 GeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~k  326 (516)
T KOG0690|consen  253 GELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTK  326 (516)
T ss_pred             ceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc--cccceec
Confidence            99998887754 678888888889999999999999   99999999999999999999999999987532  2233455


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..+||+.|.|||++....|+.++|.|.+||++|||++|+.||...+.+..--.-.+.             |-   ..+..
T Consensus       327 TFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-------------d~---kFPr~  390 (516)
T KOG0690|consen  327 TFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-------------DL---KFPRT  390 (516)
T ss_pred             cccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------------hc---cCCcc
Confidence            667999999999999999999999999999999999999999876554321111100             00   11112


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          823 QMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                      ...+...++...+.+||.+|.     .++||.+
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence            233567888899999999994     4555554

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=7e-30  Score=303.43  Aligned_cols=143  Identities=27%  Similarity=0.407  Sum_probs=124.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||+||+|... +++.||+|++.......   ...+.+|+.+++.++||||+++++++...+..|+|||
T Consensus         6 y~i~~~LG~G~-fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmE   84 (669)
T cd05610           6 FVIVKPISRGA-FGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVME   84 (669)
T ss_pred             EEEEEEEecCC-CeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEe
Confidence            33445555555 9999999765 79999999997543222   3578889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      |+.+++|.+++...+ .+++..+.+++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        85 y~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          85 YLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999997654 688999999999999999999999   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1.6e-29  Score=264.11  Aligned_cols=238  Identities=27%  Similarity=0.417  Sum_probs=193.4

Q ss_pred             CceEEEEEEeC-CCcEEEEEEEecCCccC-HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhc
Q 002826          594 PFGRVYILSLP-SGELIAVKKLVNFGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICR  671 (876)
Q Consensus       594 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  671 (876)
                      +||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            38999999776 58999999997654444 67899999999999999999999999999999999999999999999876


Q ss_pred             cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccccccc
Q 002826          672 QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN  751 (876)
Q Consensus       672 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~  751 (876)
                      .. .+++..+..++.+++++++|||+.   +++|+||+|+||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RG-RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             cc-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            54 388999999999999999999999   99999999999999999999999999998775432   223445788899


Q ss_pred             CccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHH
Q 002826          752 APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIA  831 (876)
Q Consensus       752 aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li  831 (876)
                      +||.......+.++||||+|++++++++|..||...... ....+....   ..   ...     ..........+.+++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~---~~---~~~-----~~~~~~~~~~~~~~i  221 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGK---PK---PPF-----PPPEWKISPEAKDLI  221 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhc---cC---CCC-----ccccccCCHHHHHHH
Confidence            999988888899999999999999999999998763221 112222111   10   000     000000334688999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 002826          832 LRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       832 ~~cl~~dP~~RPs~~ell~  850 (876)
                      .+|+..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-30  Score=284.77  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=197.0

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe-----CCeEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS-----DESIFLI  656 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~~~~lv  656 (876)
                      .++....+.|.||.||+++. ++|+.+|+|+..... ...++++.|.++++.. .|||++.++|++..     ++..|+|
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            34455566777999999954 589999999986543 5567788899999988 69999999999864     5689999


Q ss_pred             EEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          657 YEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||.+||..|+++.- +..+.|..+..|++.++.|+.+||..   .++|||||-.|||++.++.||++|||++......
T Consensus       100 MEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT  176 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST  176 (953)
T ss_pred             eeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecc
Confidence            9999999999999754 67899999999999999999999999   9999999999999999999999999999877543


Q ss_pred             ccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          736 AFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .  .......||+.|||||++.     ...|+.++|+||+|++..||.-|.+|+-+-.+..        ..+.+....  
T Consensus       177 ~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------aLF~IpRNP--  244 (953)
T KOG0587|consen  177 V--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRNP--  244 (953)
T ss_pred             c--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------hhccCCCCC--
Confidence            2  3345567999999999865     2346778999999999999999999876543322        112111000  


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .|.+ .-+..-...+.++|..|+.+|.++||++.++++
T Consensus       245 --PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  245 --PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              1111 122333456889999999999999999988764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=280.02  Aligned_cols=232  Identities=26%  Similarity=0.283  Sum_probs=184.9

Q ss_pred             CCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          590 GNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       590 g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      .+.|+|+.|-.+ ...+++..|+|++.+.    ..+-.+|+.++... +|||++++.+.+.++.+.|+|||.+.|+-+.+
T Consensus       330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~  405 (612)
T KOG0603|consen  330 LGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLR  405 (612)
T ss_pred             cCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHH
Confidence            445559999887 4458999999999764    23344567666666 79999999999999999999999999998887


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee-CCCCCeEEccccchhhccccccccccccccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL-DADFEPKLTDFALDRIVGEAAFQSTMSSEYA  746 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll-~~~~~~kl~DfGla~~~~~~~~~~~~~~~~g  746 (876)
                      .+.... .. ...+..|+++++.|+.|||++   |++|||+||+|||+ ++.+.++|+|||.++.....     ....+-
T Consensus       406 ri~~~~-~~-~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~  475 (612)
T KOG0603|consen  406 RIRSKP-EF-CSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPAL  475 (612)
T ss_pred             HHHhcc-hh-HHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccch
Confidence            775543 22 267778999999999999999   99999999999999 58899999999999877654     222335


Q ss_pred             cccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       747 t~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      |..|.|||+.....+++++|+||||++||+|++|+.||...+.+ .   +...+....          .+.   ...+..
T Consensus       476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~---ei~~~i~~~----------~~s---~~vS~~  538 (612)
T KOG0603|consen  476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I---EIHTRIQMP----------KFS---ECVSDE  538 (612)
T ss_pred             hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H---HHHHhhcCC----------ccc---cccCHH
Confidence            77899999999899999999999999999999999999886655 1   121111111          111   334557


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          827 ALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      +++++..|++.||.+||+|.|+...=
T Consensus       539 AKdLl~~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  539 AKDLLQQLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             HHHHHHHhccCChhhCcChhhhccCc
Confidence            89999999999999999999997653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=5.7e-31  Score=267.67  Aligned_cols=259  Identities=21%  Similarity=0.272  Sum_probs=203.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEe-CCeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~  653 (876)
                      .+.....+...|+||.||.|-|      .+.+.|-+|.++.... .....+..|.-.+..+.|||+..+.+++.+ ....
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            3344566777899999999944      3445667776654321 223456788888888999999999999876 4578


Q ss_pred             EEEEEcCCCCCHHHHhhc-----c--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          654 FLIYEFLQMGSLGDLICR-----Q--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~-----~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      +++|.++.-|+|..++..     .  .+..+..+...++.|++.|++|||.+   +++|.||.++|.+||+..++|++|=
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccc
Confidence            999999999999999862     1  34566778889999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      .++|..-+.++.........+..||+||.+....++.++|||||||++|||+| |+.|+...++.++  ..+.....+. 
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm--~~ylkdGyRl-  517 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM--EHYLKDGYRL-  517 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH--HHHHhcccee-
Confidence            99998877666555555556778999999999999999999999999999999 8888865444332  2222221111 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                                  ..+.+++.+++.++..||+.+|++||+++|++.-|.++..+
T Consensus       518 ------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  518 ------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             ------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence                        11123445789999999999999999999999999987643

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=271.88  Aligned_cols=246  Identities=20%  Similarity=0.291  Sum_probs=199.0

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCc-EEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGE-LIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+..+|-|| ||.|-++..+... .+|+|++++....   ..+.+..|-.+|...+.|.||++|-.|.+++.+|++||.
T Consensus       423 ~~iaTLGvGg-FGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  423 KRIATLGVGG-FGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhcccCc-cceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            3456677777 9999999775444 4899988765433   345677899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      |-||.+...+++++ .++..+..-++..+.+|++|||.+   +|+.||+||+|.+++.+|-+|+.|||.|+.++.+..+ 
T Consensus       502 ClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KT-  576 (732)
T KOG0614|consen  502 CLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKT-  576 (732)
T ss_pred             hcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCce-
Confidence            99999999998765 788899999999999999999999   9999999999999999999999999999999876543 


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                        ...+||+.|.|||++..+.+..++|.||+|+++||+++|++||.+.+.....-.  +-+.++      .      ...
T Consensus       577 --wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~--ILkGid------~------i~~  640 (732)
T KOG0614|consen  577 --WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL--ILKGID------K------IEF  640 (732)
T ss_pred             --eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH--HHhhhh------h------hhc
Confidence              445699999999999999999999999999999999999999987655432110  001000      0      011


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                      +........++|++.+..+|.+|..     +.+|-+.
T Consensus       641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            2222345678999999999999975     5555554

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.96  E-value=6.6e-32  Score=302.12  Aligned_cols=372  Identities=27%  Similarity=0.326  Sum_probs=288.7

Q ss_pred             ccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcc---------cceeecCCccccccCCCccCCccccce
Q 002826           91 ISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL---------IWVLDLSRNHIEGKIPESIGSLVNLQV  161 (876)
Q Consensus        91 ~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---------l~~LdL~~n~l~~~~p~~~~~l~~L~~  161 (876)
                      +|.++..+.+|++||+|.|.|.. +|..+..++.++++..++|.         ++.++|..|.+.+.++..+..+++  .
T Consensus       106 lP~~~~~lknl~~LdlS~N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~  182 (1081)
T KOG0618|consen  106 LPASISELKNLQYLDLSFNHFGP-IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--Q  182 (1081)
T ss_pred             CchhHHhhhcccccccchhccCC-CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--e
Confidence            45555555555555555555532 45555555555555555551         245788899999999998888877  8


Q ss_pred             ecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCc
Q 002826          162 LNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN  241 (876)
Q Consensus       162 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~  241 (876)
                      |+|++|.+. .  -.+.++.+|+.|....|++  ..+   .-..++|+.|+.++|.++...+.  .--.+|+++++++|+
T Consensus       183 ldLr~N~~~-~--~dls~~~~l~~l~c~rn~l--s~l---~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~  252 (1081)
T KOG0618|consen  183 LDLRYNEME-V--LDLSNLANLEVLHCERNQL--SEL---EISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNN  252 (1081)
T ss_pred             eecccchhh-h--hhhhhccchhhhhhhhccc--ceE---EecCcchheeeeccCcceeeccc--cccccceeeecchhh
Confidence            999999997 2  3456788999999999983  221   23456889999999998844332  223578999999999


Q ss_pred             cCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCc
Q 002826          242 LTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPD  321 (876)
Q Consensus       242 l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  321 (876)
                      ++ .+|.++. .+.+|+.++..+|+|. .+|..+....+|+.|++.+|.+. -+|....++++|++|+|..|+|....+.
T Consensus       253 l~-~lp~wi~-~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~  328 (1081)
T KOG0618|consen  253 LS-NLPEWIG-ACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDN  328 (1081)
T ss_pred             hh-cchHHHH-hcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchH
Confidence            99 8886664 5899999999999996 78888899999999999999998 5666778889999999999999844443


Q ss_pred             ccCCCCc-ccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCC
Q 002826          322 KLWSLPR-IKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV  400 (876)
Q Consensus       322 ~~~~l~~-L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~  400 (876)
                      .|.-+.. |..|+.+.|++.....-.=.....|+.|++.+|.+++..-..+.+.++|+.|+|++|++...+...+.+++.
T Consensus       329 ~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~  408 (1081)
T KOG0618|consen  329 FLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEE  408 (1081)
T ss_pred             HHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHH
Confidence            4444443 788888888888554333345667899999999999888788888999999999999998777788889999


Q ss_pred             ccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc-cCCCcccccccceEEccCC
Q 002826          401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG-PIPQGLQNLKLALFNVSFN  479 (876)
Q Consensus       401 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~l~~l~ls~N  479 (876)
                      |+.|+||+|+++..+..+.+++.|++|...+|+|. ..| .+..+++|+.+|+|.|+|+. .+|.....-+|++||+++|
T Consensus       409 LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN  486 (1081)
T KOG0618|consen  409 LEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGN  486 (1081)
T ss_pred             hHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCC
Confidence            99999999999987778889999999999999998 677 88999999999999999974 4565555567889999999


Q ss_pred             cc
Q 002826          480 KL  481 (876)
Q Consensus       480 ~l  481 (876)
                      .-
T Consensus       487 ~~  488 (1081)
T KOG0618|consen  487 TR  488 (1081)
T ss_pred             cc
Confidence            83

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=234.86  Aligned_cols=211  Identities=23%  Similarity=0.351  Sum_probs=168.8

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEE
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFH  648 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  648 (876)
                      +.+..+++.    ...++|+|+ ||.|-+.++ ++|+..|+|++.... .+..++..+|+.+..+- .+|.+|.++|.+.
T Consensus        41 ~eV~ad~L~----~i~elGrGa-yG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~  115 (282)
T KOG0984|consen   41 FEVPADDLV----GIEELGRGA-YGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF  115 (282)
T ss_pred             cccchhhhh----hhhhhcCCc-cchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence            344445554    346677776 999988855 589999999996542 23445667788866555 6999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhh---ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          649 SDESIFLIYEFLQMGSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      +.+..++-||.|+- ||..+..   +.+..+++...-+|+..+..||.|||++  ..++|||+||+|||++.+|++|++|
T Consensus       116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCD  192 (282)
T KOG0984|consen  116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICD  192 (282)
T ss_pred             ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcc
Confidence            99999999999976 7765543   3477899999999999999999999998  4899999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccC----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGY----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD  793 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~  793 (876)
                      ||.+-...++-.   .+...|...|||||.+.    ...|+.++||||+|++++||.+++.||+.+......
T Consensus       193 FGIsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q  261 (282)
T KOG0984|consen  193 FGISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ  261 (282)
T ss_pred             cccceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence            999877654321   12233777899999864    336889999999999999999999999887665543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=261.19  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=189.6

Q ss_pred             cCCCCCCCCceEEEEE-EeCCCcEEEEEEEecC--CccC-----HHHHHHHHHHHhhccCccccceeeEEE-eCCeEEEE
Q 002826          586 KSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNF--GCQS-----SKTLKTEVKTLAKIRHKNIVKVLGFFH-SDESIFLI  656 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~--~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv  656 (876)
                      ...+|+|| |+.||+| ++...+.||||+-...  ..++     .+...+|..+.+.+.||.||++|+++. +.+.+|-|
T Consensus       468 LhLLGrGG-FSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  468 LHLLGRGG-FSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHhcccc-HHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            34456666 9999999 6678899999986321  1111     135668999999999999999999996 45779999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchhhcc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIVG  733 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~~~~  733 (876)
                      +|||+|-+|.-++.... .+++.++..|+.||+.||.||.+. .++|+|-|+||.|||+-   ..|.+||+|||+++.+.
T Consensus       547 LEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMd  624 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMD  624 (775)
T ss_pred             eeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhcc
Confidence            99999999988886654 789999999999999999999997 45999999999999994   45899999999999987


Q ss_pred             cccccc-----ccccccccccccCccccCC----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 002826          734 EAAFQS-----TMSSEYALSCYNAPEYGYS----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI  804 (876)
Q Consensus       734 ~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  804 (876)
                      ......     ......||.+|.+||.+.-    .+.+.++||||+||++|.++.|+.||+..-... ++.+...-....
T Consensus       625 ddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILqeNTIlkAt  703 (775)
T KOG1151|consen  625 DDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQENTILKAT  703 (775)
T ss_pred             CCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHhhhchhcce
Confidence            544321     1234468999999997653    357889999999999999999999998643322 222221111000


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .    -.+.+.     .....+...+|++|+++.-++|....|+..
T Consensus       704 E----VqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  704 E----VQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             e----ccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            0    001111     122345778999999999999998887754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-30  Score=284.65  Aligned_cols=239  Identities=24%  Similarity=0.347  Sum_probs=184.4

Q ss_pred             CCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      +|.|..-+.||+|.. .|+.||||++..   +..+...+|+..++.- +|||||++++.-.+++..||..|.|.- +|.+
T Consensus       517 lG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~d  591 (903)
T KOG1027|consen  517 LGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQD  591 (903)
T ss_pred             cccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHH
Confidence            344444567899988 788999999854   3445678999999988 699999999999999999999999976 9999


Q ss_pred             Hhhcc--CCc-CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---C--CCeEEccccchhhccccc-cc
Q 002826          668 LICRQ--DFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---D--FEPKLTDFALDRIVGEAA-FQ  738 (876)
Q Consensus       668 ~l~~~--~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~--~~~kl~DfGla~~~~~~~-~~  738 (876)
                      ++...  ... ......+.+..|+++|+++||+.   +|+|||+||.||||+.   +  .+++|+|||+++..+.+. ..
T Consensus       592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~  668 (903)
T KOG1027|consen  592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSF  668 (903)
T ss_pred             HHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchh
Confidence            99773  111 11134577889999999999998   9999999999999975   2  579999999999887443 22


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG-RQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......||.+|+|||.+.....+.++||||+||++|+.++| +.||+.....+..++.-...       ... +.+.  
T Consensus       669 ~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~-------L~~-L~~~--  738 (903)
T KOG1027|consen  669 SRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYT-------LVH-LEPL--  738 (903)
T ss_pred             hcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccc-------eee-eccC--
Confidence            334566799999999999988888899999999999999996 99998754433322211110       000 0000  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         .++  ...++|.+|++++|..||+|.+|+.
T Consensus       739 ---~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  739 ---PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ---chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence               011  6789999999999999999999974

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=259.06  Aligned_cols=239  Identities=22%  Similarity=0.298  Sum_probs=187.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.-+..+|. |+||.|.+|..+ +.+.+|||++++...   .+.+--..|-.+|+-- +-|.++.+..+|+.-+..|+|
T Consensus       350 DFnFl~VlGK-GSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  350 DFNFLMVLGK-GSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             ccceEEEecc-CccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            3444444555 559999999654 678899999976432   2333445566677655 678999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+.||+|...+..-+ .+.++.+.-.+.+||-||-+||++   ||+.||+|-+||++|.+|.+||+|||+++.---..
T Consensus       429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~  504 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG  504 (683)
T ss_pred             EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCC
Confidence            99999999998886655 678888888999999999999999   99999999999999999999999999987532221


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .+...-+||+.|+|||++..++|+..+|.|||||++|||+.|++||+++++++. .........              
T Consensus       505 --~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el-F~aI~ehnv--------------  567 (683)
T KOG0696|consen  505 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-FQAIMEHNV--------------  567 (683)
T ss_pred             --cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHccC--------------
Confidence              223445699999999999999999999999999999999999999998766543 222211111              


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCC
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRP  843 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RP  843 (876)
                       .++...+.+...+....+.+.|.+|.
T Consensus       568 -syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 -SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -cCcccccHHHHHHHHHHhhcCCcccc
Confidence             22233344667788888999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7e-28  Score=271.56  Aligned_cols=255  Identities=19%  Similarity=0.228  Sum_probs=174.5

Q ss_pred             cccccCCCCCCCCceEEEEEEe-----------------CCCcEEEEEEEecCCccCH--------------HHHHHHHH
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-----------------PSGELIAVKKLVNFGCQSS--------------KTLKTEVK  630 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E~~  630 (876)
                      +|....++|+|| ||+||+|..                 .+++.||||++........              +....|+.
T Consensus       146 ~F~i~~~LG~Gg-FG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~  224 (507)
T PLN03224        146 DFQLRDKLGGGN-FGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY  224 (507)
T ss_pred             CceEeeEeecCC-CeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence            455556666666 999999853                 3467899999864322222              22344777


Q ss_pred             HHhhccCcc-----ccceeeEEEe--------CCeEEEEEEcCCCCCHHHHhhccC-----------------------C
Q 002826          631 TLAKIRHKN-----IVKVLGFFHS--------DESIFLIYEFLQMGSLGDLICRQD-----------------------F  674 (876)
Q Consensus       631 ~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~-----------------------~  674 (876)
                      ++.+++|.+     +++++++|..        .+..++||||+++++|.++++...                       .
T Consensus       225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~  304 (507)
T PLN03224        225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD  304 (507)
T ss_pred             HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence            777776654     4678888753        356899999999999999986421                       1


Q ss_pred             cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCcc
Q 002826          675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE  754 (876)
Q Consensus       675 ~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE  754 (876)
                      .+++..+..++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||+++........ ......+++.|+|||
T Consensus       305 ~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        305 KRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPE  380 (507)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChh
Confidence            246778899999999999999999   9999999999999999999999999999765432211 111223478899999


Q ss_pred             ccCCCCC----------------------CCccchHHHHHHHHHHHhCCC-CCCCCCcchh-------hHHHHHHHHhhc
Q 002826          755 YGYSKKA----------------------TAQMDAYSFGVVLLELITGRQ-AEQAEPAESL-------DVVKWVRRKINI  804 (876)
Q Consensus       755 ~~~~~~~----------------------~~~~Dv~SlGv~l~elltg~~-p~~~~~~~~~-------~~~~~~~~~~~~  804 (876)
                      .+.....                      ..+.||||+||++|||++|.. |+........       +...|.... ..
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-~~  459 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-GQ  459 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-cc
Confidence            8653221                      124699999999999999875 6543211111       111121110 00


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMP---EKRPSMFEVVKA  851 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~ell~~  851 (876)
                      .      .+-   ...........+++.+|+..+|   .+|+|++|++++
T Consensus       460 ~------~~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 K------YDF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             C------CCc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0      000   0112234567899999999766   689999999864

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=7.1e-28  Score=278.98  Aligned_cols=254  Identities=18%  Similarity=0.226  Sum_probs=161.5

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-C----CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeE------EEeC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-S----GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF------FHSD  650 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~  650 (876)
                      +|.....+|.|| ||.||+|... +    +..||+|++....  ..+....|  .+....+.+++.++..      ...+
T Consensus       133 ~y~l~~~LG~G~-FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~  207 (566)
T PLN03225        133 DFVLGKKLGEGA-FGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE  207 (566)
T ss_pred             CeEEeEEEeeCC-CeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence            344445556555 9999999765 4    7899999875432  11111111  1222223333333222      2346


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCc-------------------CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccC
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQ-------------------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK  711 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~  711 (876)
                      ...++||||+++++|.+++......                   .....+..++.|++.||+|||+.   +|+||||||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~  284 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQ  284 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHH
Confidence            6799999999999999998654321                   12334567999999999999999   9999999999


Q ss_pred             ceeeCC-CCCeEEccccchhhccccccccccccccccccccCccccCCC----------------------CCCCccchH
Q 002826          712 NILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK----------------------KATAQMDAY  768 (876)
Q Consensus       712 NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv~  768 (876)
                      |||++. ++.+||+|||+++.......+ ......+++.|+|||.+...                      .++.++|||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            999985 589999999999866432211 12334578899999954321                      234467999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcch--------hhHHHHHHHHhhcccccccccChhhh---hhcHHHHHHHHHHHHHccCC
Q 002826          769 SFGVVLLELITGRQAEQAEPAES--------LDVVKWVRRKINITNGAIQVLDPKIA---NCYQQQMLGALEIALRCTSV  837 (876)
Q Consensus       769 SlGv~l~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~d~~~~---~~~~~~~~~~~~li~~cl~~  837 (876)
                      |+||++|||+++..|+.......        .+...|.....       ....+...   +..........+++.+|++.
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-------PRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-------cccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999766543211000        01111111100       00000000   01111122456899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 002826          838 MPEKRPSMFEVVKA  851 (876)
Q Consensus       838 dP~~RPs~~ell~~  851 (876)
                      ||++|||++|+++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999985

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=2.4e-28  Score=231.84  Aligned_cols=255  Identities=20%  Similarity=0.252  Sum_probs=196.0

Q ss_pred             cccccCCCCCCCCceEEEEEE-eCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeC--CeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD--ESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~  657 (876)
                      +|.-+.++|+|- |++||.|. ..+.++++||++++   ...+.+.+|+.++..++ ||||++++++..+.  ....+|+
T Consensus        39 dYeivrk~GRGK-YSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF  114 (338)
T KOG0668|consen   39 DYEIVRKVGRGK-YSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF  114 (338)
T ss_pred             hHHHHHHHcCcc-HhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence            444455666655 99999994 56889999999975   34678999999999997 99999999999874  5688999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~  736 (876)
                      ||+.+.+...+.    ..++...+...+.+++.||.|+|+.   ||.|||+||.|+++|.. -..+++|+|+|.++.++.
T Consensus       115 E~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  115 EYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            999997776654    3577888999999999999999999   99999999999999964 679999999999987765


Q ss_pred             cccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-----hccccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-----NITNGAIQ  810 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~  810 (876)
                      .+.   ....+..|-.||.+.. +.+...-|+|||||++..|+..+.||.......+.++...+-..     ..-....-
T Consensus       188 eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  188 EYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             eee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            433   3346667899998664 45788899999999999999999999876665554444432211     00001112


Q ss_pred             ccChhhhhh--------c---------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANC--------Y---------QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~--------~---------~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .+||.+.+.        |         .-...++.+++.+.+..|-.+|||++|.+.
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            234443221        1         111357789999999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.1e-28  Score=261.99  Aligned_cols=205  Identities=23%  Similarity=0.335  Sum_probs=169.8

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |-.+..+|-| +||+|.+++.. +...||+|.+.+.+.-   .....+.|..+|+....+-||++|-.|.+++..|+|||
T Consensus       631 Fvkik~iGvG-AFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  631 FVKIKTIGVG-AFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             eEEEeeeccc-ccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4444555555 59999999554 5677899999775432   23567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc---cc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~---~~  735 (876)
                      |++||++..++-+.+ .+++..+.-.+.++.-|+++.|..   |+|||||||+|||||.+|.+|++|||+++-+.   +.
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999998776 678888888888999999999999   99999999999999999999999999986542   00


Q ss_pred             ccc-------------------------------------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHH
Q 002826          736 AFQ-------------------------------------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI  778 (876)
Q Consensus       736 ~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ell  778 (876)
                      .++                                     ......+||+.|+|||++....++.-+|.||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence            000                                     0011346899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCcchh
Q 002826          779 TGRQAEQAEPAESL  792 (876)
Q Consensus       779 tg~~p~~~~~~~~~  792 (876)
                      .|++||-.....+.
T Consensus       866 ~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  866 VGQPPFLADTPGET  879 (1034)
T ss_pred             hCCCCccCCCCCcc
Confidence            99999987665443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=6.7e-29  Score=241.12  Aligned_cols=258  Identities=25%  Similarity=0.392  Sum_probs=189.9

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e  658 (876)
                      +-+|- |+||+||-++.+ +|+.||+|++...  .-...+.+-+|++++...+|.|+...+++....     .+.|+|+|
T Consensus        59 RPIGY-GAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   59 RPIGY-GAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             Ccccc-cceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            33444 559999998664 8999999998543  223456788999999999999999999887653     25788889


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      .+.. +|..++-. .+.++...++-+..||++|++|||+.   +|.||||||.|.|++.+...||+|||+++...... .
T Consensus       138 LmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~  211 (449)
T KOG0664|consen  138 LMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-R  211 (449)
T ss_pred             HHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhh-h
Confidence            8855 78777643 45788888999999999999999999   99999999999999999999999999998765432 2


Q ss_pred             cccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hH---------HHHHHHHhhcccc
Q 002826          739 STMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DV---------VKWVRRKINITNG  807 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~---------~~~~~~~~~~~~~  807 (876)
                      ..++...-|.+|+|||++++. .|+.+.||||.||++.|++.++..|+...+-.. ++         .+.++...++  .
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG--A  289 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG--A  289 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh--h
Confidence            345666778899999998865 589999999999999999999999886554321 11         1111111100  0


Q ss_pred             ccccc-----Chhhh---hh--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          808 AIQVL-----DPKIA---NC--YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       808 ~~~~~-----d~~~~---~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ...++     .|.+.   ..  ......+...+...++..||.+|.+..+.+..+-
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            01111     11111   11  1122345667888999999999999988876543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.7e-26  Score=242.13  Aligned_cols=137  Identities=25%  Similarity=0.370  Sum_probs=114.0

Q ss_pred             chhhhhh-cccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-----C---cccccee
Q 002826          575 TEHDLVI-GMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-----H---KNIVKVL  644 (876)
Q Consensus       575 ~~~~l~~-~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~  644 (876)
                      ..+|... ++|.+.+..|=|-|++||++ +.+..+.||+|+.+.+. .-.+....||++|++++     |   .+||+++
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            3456666 67777777777779999999 66789999999987642 34556778999999994     2   3899999


Q ss_pred             eEEEe----CCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee
Q 002826          645 GFFHS----DESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL  715 (876)
Q Consensus       645 ~~~~~----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll  715 (876)
                      +.|..    +.++|+|+|++ |.+|..++.+. .+-++...+.+|++||+.||.|||.+|  ||+|-||||+|||+
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            99976    45899999998 55998888765 455899999999999999999999997  99999999999998

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-28  Score=262.87  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=198.1

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|+-..++| +|+||.|||++. .+++..|+|+++.....+..-+.+|+-+++..+|||||.++|.+...+..++.||||
T Consensus        16 dyellqrvg-sgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   16 DYELLQRVG-SGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             chhheeeec-CCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            444455555 555999999965 489999999998877677788889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .+|+|++.-+..+ ++++.++..+++..++|++|||+.   +=+|||||-.||++++.|.+|++|||.+..++..-  ..
T Consensus        95 gggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AK  168 (829)
T ss_pred             CCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh--hh
Confidence            9999999876654 789999999999999999999999   88999999999999999999999999987775432  23


Q ss_pred             cccccccccccCcccc---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          741 MSSEYALSCYNAPEYG---YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .....||++|||||+.   ..+.|...+|||+.|+...|+-.-++|.........  . +.-.        ...++|...
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--l-~LmT--------kS~~qpp~l  237 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--L-FLMT--------KSGFQPPTL  237 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--H-HHhh--------ccCCCCCcc
Confidence            3455699999999974   355689999999999999999888877543332221  1 1111        111122211


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +....-...+-++++.|+.++|++|||++.++.
T Consensus       238 kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            111222335668899999999999999998876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=6.2e-26  Score=231.22  Aligned_cols=209  Identities=32%  Similarity=0.518  Sum_probs=180.0

Q ss_pred             CCCCceEEEEEEeC-CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHH
Q 002826          591 NGGPFGRVYILSLP-SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDL  668 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~  668 (876)
                      ++|.+|.||++... +++.+++|++...... ....+.+|++.++.++|++++++++++......++++||+++++|.++
T Consensus         2 ~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~   81 (215)
T cd00180           2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL   81 (215)
T ss_pred             CcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHH
Confidence            34559999999775 4999999998764322 346789999999999999999999999999999999999999999999


Q ss_pred             hhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhcccccccccccccccc
Q 002826          669 ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYAL  747 (876)
Q Consensus       669 l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~~gt  747 (876)
                      +......+++..+..++.++++++++||+.   +++|+||+|.||+++. ++.++++|||.+........  ......+.
T Consensus        82 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          82 LKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            976545689999999999999999999999   9999999999999999 89999999999876654321  12233467


Q ss_pred             ccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHH
Q 002826          748 SCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG  826 (876)
Q Consensus       748 ~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  826 (876)
                      ..|++||..... ..+.+.|+|++|++++++                                               ..
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------------------~~  189 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------------------PE  189 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------HH
Confidence            789999998776 788999999999999999                                               14


Q ss_pred             HHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          827 ALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       827 ~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +.+++.+|++.+|++||++.++++.
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhC
Confidence            6789999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=2e-27  Score=249.77  Aligned_cols=271  Identities=21%  Similarity=0.246  Sum_probs=206.6

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc------Ccccccee
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR------HKNIVKVL  644 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~  644 (876)
                      .++..+|+....|.+..-.|.|.|++|..|.. ..|+.||||++...... .+.=..|+++|++|+      --|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            57778999999999999999999999999954 46889999999764322 233457999999995      34899999


Q ss_pred             eEEEeCCeEEEEEEcCCCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCe
Q 002826          645 GFFHSDESIFLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEP  721 (876)
Q Consensus       645 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~  721 (876)
                      -.|...++.|+|+|-+.. +|.+++.+-+  .-+....+...+.|+.-||..|-..   +|+|.||||+||||++. ..+
T Consensus       501 r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCccee
Confidence            999999999999998865 9999997664  3367788999999999999999998   99999999999999865 678


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHH----
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKW----  797 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~----  797 (876)
                      ||||||.|..+++...    +...-+..|.|||++.+..|....|+||.||++||+.||+..|.+.....+-..-+    
T Consensus       577 KLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  577 KLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             eeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            9999999988775542    22223446999999999999999999999999999999999998766544310000    


Q ss_pred             --HHHHhhcccccccccC--------------------------h------------hhhhhcHHHHHHHHHHHHHccCC
Q 002826          798 --VRRKINITNGAIQVLD--------------------------P------------KIANCYQQQMLGALEIALRCTSV  837 (876)
Q Consensus       798 --~~~~~~~~~~~~~~~d--------------------------~------------~~~~~~~~~~~~~~~li~~cl~~  837 (876)
                        ..+.........+.+|                          |            .+++........+.+++..|+..
T Consensus       653 k~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~L  732 (752)
T KOG0670|consen  653 KFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLIL  732 (752)
T ss_pred             CCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhcc
Confidence              0000000000001111                          1            11122233456788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 002826          838 MPEKRPSMFEVVKA  851 (876)
Q Consensus       838 dP~~RPs~~ell~~  851 (876)
                      ||++|.|..|+++.
T Consensus       733 dP~KRit~nqAL~H  746 (752)
T KOG0670|consen  733 DPEKRITVNQALKH  746 (752)
T ss_pred             ChhhcCCHHHHhcC
Confidence            99999999998753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-27  Score=235.46  Aligned_cols=240  Identities=20%  Similarity=0.290  Sum_probs=187.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|+-...+|+|. |+.|-.++++ +.+.+|+|++++..   .++.+-.+.|-.+..+. +||.+|.+..+|+.....++|
T Consensus       251 df~ll~vigrgs-yakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  251 DFDLLRVIGRGS-YAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             cceeeeeecCcc-hhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            555556666655 9999999764 78999999997642   23445566777777766 799999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      .||++||+|.-++.+++ .++++.+.-...+|.-||.|||++   ||+.||+|-+|+|+|..|.+|++|||.++.--.. 
T Consensus       330 ieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-  404 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-  404 (593)
T ss_pred             EEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-
Confidence            99999999988887664 788888888899999999999999   9999999999999999999999999998753221 


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--h----h-HHHHHHHHhhcccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES--L----D-VVKWVRRKINITNGAI  809 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~--~----~-~~~~~~~~~~~~~~~~  809 (876)
                       ..+.+..+||+.|.|||++.+..|+...|.|++||+++||+.|+.||+.-..+.  .    . +.-...++++++    
T Consensus       405 -gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----  479 (593)
T KOG0695|consen  405 -GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----  479 (593)
T ss_pred             -CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----
Confidence             223455679999999999999999999999999999999999999997422211  1    1 111112222222    


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRP  843 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  843 (876)
                                 ...+.....+++.-+.+||++|.
T Consensus       480 -----------rslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  480 -----------RSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----------ceeehhhHHHHHHhhcCCcHHhc
Confidence                       12223456778888999999984

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-28  Score=251.44  Aligned_cols=398  Identities=20%  Similarity=0.202  Sum_probs=272.1

Q ss_pred             ceEecCCCC------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccce
Q 002826           64 GVTCVTTAT------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV  137 (876)
Q Consensus        64 gv~c~~~~~------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  137 (876)
                      -|+|+..+.      .+...++++|..|.++...+.+|..+++||.||||+|+|+.+-|++|.++++|.+|-        
T Consensus        50 ~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lv--------  121 (498)
T KOG4237|consen   50 IVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLV--------  121 (498)
T ss_pred             eEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHH--------
Confidence            366765442      234678899999999988888999999999999999999999999999999988874        


Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSS  216 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n  216 (876)
                       ++++|+|+......|++|..|+.|.+.-|++.-+..++|..|++|..|.|.+|.  +..++. .|..+..++.+.+..|
T Consensus       122 -lyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~--~q~i~~~tf~~l~~i~tlhlA~n  198 (498)
T KOG4237|consen  122 -LYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNK--IQSICKGTFQGLAAIKTLHLAQN  198 (498)
T ss_pred             -hhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchh--hhhhccccccchhccchHhhhcC
Confidence             445567776666789999999999999999998888899999999999999997  677776 6888999999999888


Q ss_pred             C------------CcccCCccccCCCCCcEEecccCccCCCCCCc-cccccccccEEEeccccccCcCC-cccccCCccc
Q 002826          217 G------------FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS-LGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLV  282 (876)
Q Consensus       217 ~------------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~-~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~  282 (876)
                      .            +....|..+++..-..-..+.++++. .++.. +...+..+.+=-.+.....+..| ..|..+++|+
T Consensus       199 p~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~-q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~  277 (498)
T KOG4237|consen  199 PFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRIN-QEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLR  277 (498)
T ss_pred             ccccccccchhhhHHhhchhhcccceecchHHHHHHHhc-ccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccce
Confidence            8            33345556666666667777777777 44433 22222222221222232333434 3578888899


Q ss_pred             eeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcc
Q 002826          283 NLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNR  362 (876)
Q Consensus       283 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  362 (876)
                      +|+|++|+|+++.+++|.++..+++|.|..|+|...-...|.++..|+.|+|.+|+|+...|.+|..+..|.+|.|-.|.
T Consensus       278 ~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np  357 (498)
T KOG4237|consen  278 KLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP  357 (498)
T ss_pred             EeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence            99999999988888888888888889998888887777788888888888888888888888888888888888888877


Q ss_pred             cCCCC-----CCcc-----------ccccCccEEeCCCccccC---CCCCCcCC---------CCCc-cEEEccCCcccc
Q 002826          363 FTSSI-----PQGL-----------GSVKSLYRFSASQNSFYG---SLPPNFCD---------SPVM-SIINLSQNSISG  413 (876)
Q Consensus       363 l~~~~-----p~~~-----------~~l~~L~~L~ls~N~l~~---~~~~~~~~---------~~~L-~~L~Ls~N~l~~  413 (876)
                      +.-.-     -+|+           ..-..++.+.++.+.+..   ..|+..+.         .+-+ ++..-|++.+..
T Consensus       358 ~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~  437 (498)
T KOG4237|consen  358 FNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKL  437 (498)
T ss_pred             ccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhh
Confidence            64110     0000           001123344444443321   11111111         1111 122334444433


Q ss_pred             CCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCC
Q 002826          414 QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFN  479 (876)
Q Consensus       414 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N  479 (876)
                      .++.+  -...++|+|.+|.++ .+|..  .+.+| .+|+++|+++..--..|.++ .+.+|-+|+|
T Consensus       438 lp~~i--P~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  438 LPRGI--PVDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             cCCCC--CchhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            33221  134566777777777 55554  55666 77777777774444455565 3556666665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-27  Score=232.36  Aligned_cols=245  Identities=23%  Similarity=0.304  Sum_probs=183.7

Q ss_pred             EEEEE-EeCCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeCC------eEEEEEEcCCCCCHHH
Q 002826          597 RVYIL-SLPSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------SIFLIYEFLQMGSLGD  667 (876)
Q Consensus       597 ~Vy~~-~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~lv~e~~~~gsL~~  667 (876)
                      .|-.| +.-.++.||+|+....  .....++..+|..++..++|+|+++++.++....      ..|+|||+|.. +|.+
T Consensus        31 ~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~  109 (369)
T KOG0665|consen   31 IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQ  109 (369)
T ss_pred             eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHH
Confidence            44444 3347899999987542  2344577889999999999999999999997543      58999999976 8988


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccccc
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL  747 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt  747 (876)
                      .+.   ..++..++..+..|++-|++|||+.   +|+|||+||+||++..+..+||.|||+|+..+..   -.++....|
T Consensus       110 vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvt  180 (369)
T KOG0665|consen  110 VIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVT  180 (369)
T ss_pred             HHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc---cccCchhhe
Confidence            876   3578889999999999999999999   9999999999999999999999999999876543   245666788


Q ss_pred             ccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-----------------hHHHHHHHHhhc---c--
Q 002826          748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-----------------DVVKWVRRKINI---T--  805 (876)
Q Consensus       748 ~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-----------------~~~~~~~~~~~~---~--  805 (876)
                      ..|+|||++.+..+.+.+||||.||++.||++|+..|.+...-+.                 .+...++...+.   .  
T Consensus       181 Ryyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~  260 (369)
T KOG0665|consen  181 RYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQA  260 (369)
T ss_pred             eeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhc
Confidence            899999999888899999999999999999999999875443221                 111111111100   0  


Q ss_pred             ccccccc-Chhhh---hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVL-DPKIA---NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~-d~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..+.+.+ |..+.   +...-....+.+++.+|+..+|++|.|++++++.
T Consensus       261 ~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  261 ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            0000111 11111   1111224456789999999999999999999874

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=224.48  Aligned_cols=250  Identities=19%  Similarity=0.279  Sum_probs=190.5

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeE-EEeCCeEEEEEEcCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGF-FHSDESIFLIYEFLQ  661 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e~~~  661 (876)
                      .+.+..|.|.||.+-+++++ +.+.+++|.+... ....++|.+|...--.+ .|.||+.-++. |+..+.+++++||++
T Consensus        27 ~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   27 TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            44555555669999999664 7888999988653 24567888888766566 58999987764 667788999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CCCCeEEccccchhhcccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--ADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      .|+|.+-+...+  +.+....+++.|+++|+.|+|++   .+||||||.+||||-  +..++|++|||+.+..+....+ 
T Consensus       106 ~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-  179 (378)
T KOG1345|consen  106 RGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-  179 (378)
T ss_pred             cchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCceehh-
Confidence            999999886644  77888999999999999999999   999999999999993  3468999999998876543221 


Q ss_pred             ccccccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          740 TMSSEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                          ..-+..|.+||....     -...+.+|+|.||+++|.++||+.||+.....+....+|.+...+..        +
T Consensus       180 ----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--------~  247 (378)
T KOG1345|consen  180 ----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--------P  247 (378)
T ss_pred             ----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC--------c
Confidence                123456899996432     24577899999999999999999999987777777777777654332        2


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ..+.........+.++.++-+.++|++|=-..++.++-+
T Consensus       248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            333333344556778888999999999954445444433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=242.93  Aligned_cols=196  Identities=22%  Similarity=0.322  Sum_probs=162.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc------cC--HHHHHHHHHHHhhcc---CccccceeeEEEe
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC------QS--SKTLKTEVKTLAKIR---HKNIVKVLGFFHS  649 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~--~~~~~~E~~~l~~l~---h~niv~~~~~~~~  649 (876)
                      +|.....+|. |+||.|+.|.++ +...|++|.+.+...      .+  -..+-.|+++|+.++   |+||++++++|++
T Consensus       562 ~yttlq~lG~-GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  562 DYTTLQPLGE-GAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             cceeeeeccc-cccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            3444555555 559999999665 567889998865321      11  123457999999997   9999999999999


Q ss_pred             CCeEEEEEEcC-CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          650 DESIFLIYEFL-QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       650 ~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      ++.+|++||-. +|.+|.+++..+. .+++.++..|++||+.|+++||+.   +|+|||||-+|+.++.+|-+|++|||.
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence            99999999975 4669999997654 799999999999999999999999   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCC
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQA  786 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~  786 (876)
                      |.....+.    ....+||..|.|||++.+.+| +..-|||++|+++|.++....||+.
T Consensus       717 aa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            87765443    344569999999999988765 5668999999999999999998863

>PLN03210 Resistant to P

Probab=99.93  E-value=2.3e-24  Score=270.62  Aligned_cols=339  Identities=21%  Similarity=0.240  Sum_probs=235.9

Q ss_pred             cccccCCCCCCeeecCCCc------cccccCccccCCC-CCCcccCCCcccceeecCCccccccCCCccCCccccceecc
Q 002826           92 SSSVCELSSLSNLNLADNL------FNQPIPLHLSQCS-SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNL  164 (876)
Q Consensus        92 ~~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L  164 (876)
                      +.+|..+++|+.|.+..+.      +...+|..|..++ +|+.|++++|          .++ .+|..| ...+|++|+|
T Consensus       551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~----------~l~-~lP~~f-~~~~L~~L~L  618 (1153)
T PLN03210        551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKY----------PLR-CMPSNF-RPENLVKLQM  618 (1153)
T ss_pred             HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCC----------CCC-CCCCcC-CccCCcEEEC
Confidence            3567889999999887654      3334666676664 4666655444          443 566666 4688999999


Q ss_pred             cccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCC
Q 002826          165 GSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG  244 (876)
Q Consensus       165 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  244 (876)
                      ++|++. .++..+..+++|+.|+|++|. .+..+| .+..+++|+.|+|++|.....+|..+.++++|+.|++++|..-.
T Consensus       619 ~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~-~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~  695 (1153)
T PLN03210        619 QGSKLE-KLWDGVHSLTGLRNIDLRGSK-NLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLE  695 (1153)
T ss_pred             cCcccc-ccccccccCCCCCEEECCCCC-CcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcC
Confidence            999887 567778888999999998876 356676 47788899999998887666788888899999999998864334


Q ss_pred             CCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC-------CC
Q 002826          245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF-------SG  317 (876)
Q Consensus       245 ~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l-------~~  317 (876)
                      .+|..+  ++++|+.|++++|...+.+|..   ..+|++|+|++|.+. .+|..+ .+++|++|++.++..       ..
T Consensus       696 ~Lp~~i--~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~  768 (1153)
T PLN03210        696 ILPTGI--NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQP  768 (1153)
T ss_pred             ccCCcC--CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccc
Confidence            788765  5888999999888665555543   457888888888887 455544 567788887776432       11


Q ss_pred             CCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCC
Q 002826          318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCD  397 (876)
Q Consensus       318 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~  397 (876)
                      ..+..+...++|+.|++++|...+.+|..+..+++|+.|++++|...+.+|..+ ++++|+.|++++|......|..   
T Consensus       769 l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---  844 (1153)
T PLN03210        769 LTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---  844 (1153)
T ss_pred             cchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---
Confidence            222223334677777777777666777777777777777777765444566555 5677777777776554444432   


Q ss_pred             CCCccEEEccCCccccCCcCcccccccceEeccC-CcCCCCCCcCCCCCCCcceeeCCCCc
Q 002826          398 SPVMSIINLSQNSISGQIPELKKCRKLVSLSLAD-NSLTGEIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       398 ~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      ..+|+.|+|++|.++..+..+..+++|+.|+|++ |+++ .+|..+..+++|+.|+++++.
T Consensus       845 ~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        845 STNISDLNLSRTGIEEVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             ccccCEeECCCCCCccChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            2467777777777775555677777777777776 3444 466666777777777777663

syringae 6; Provisional

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1e-24  Score=225.14  Aligned_cols=195  Identities=31%  Similarity=0.468  Sum_probs=166.6

Q ss_pred             CCCCCCCCceEEEEEEeCC-CcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSLPS-GELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..++.|+ +|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus         5 ~~i~~g~-~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   83 (225)
T smart00221        5 KKLGEGA-FGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD   83 (225)
T ss_pred             eEeecCC-CeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence            3444555 99999997764 899999999765444 56788899999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+....+++..+..++.+++.++.+||+.   +++|+|++|+||+++.++.++++|||.+........ ......
T Consensus        84 L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~  159 (225)
T smart00221       84 LFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTV  159 (225)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccce
Confidence            9999977643388999999999999999999999   999999999999999999999999999887654320 112233


Q ss_pred             cccccccCcccc-CCCCCCCccchHHHHHHHHHHHhCCCCCCC
Q 002826          745 YALSCYNAPEYG-YSKKATAQMDAYSFGVVLLELITGRQAEQA  786 (876)
Q Consensus       745 ~gt~~y~aPE~~-~~~~~~~~~Dv~SlGv~l~elltg~~p~~~  786 (876)
                      .++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            467789999988 566777899999999999999999999955

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.92  E-value=3.7e-24  Score=268.77  Aligned_cols=345  Identities=20%  Similarity=0.278  Sum_probs=268.0

Q ss_pred             cCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCcc-ccceecccccccCCCcCccccCCCcceEEEccCCCC
Q 002826          115 IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLV-NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY  193 (876)
Q Consensus       115 ~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~  193 (876)
                      .+.+|.+|++|+.|.+.++...    ..+.+...+|+.|..++ +|+.|.+.+|.++ .+|..| ...+|++|+|++|+ 
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~----~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~-  622 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWD----QKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSK-  622 (1153)
T ss_pred             cHHHHhcCccccEEEEeccccc----ccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcc-
Confidence            4567888999999988765431    12345556788887775 6999999999987 777777 57899999999997 


Q ss_pred             cCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCc
Q 002826          194 LISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN  273 (876)
Q Consensus       194 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~  273 (876)
                       +..+|..+..+++|+.|+|++|.....+|+ +..+++|++|+|++|.....+|..+. .+++|+.|++++|.--..+|.
T Consensus       623 -l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~-~L~~L~~L~L~~c~~L~~Lp~  699 (1153)
T PLN03210        623 -LEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQ-YLNKLEDLDMSRCENLEILPT  699 (1153)
T ss_pred             -ccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhh-ccCCCCEEeCCCCCCcCccCC
Confidence             678888889999999999998865555664 88899999999999875558888764 589999999998754446776


Q ss_pred             ccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcc-------cccCccc
Q 002826          274 GICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRF-------SGAIPDS  346 (876)
Q Consensus       274 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l-------~~~~~~~  346 (876)
                      .+ ++++|+.|++++|......|..   ..+|++|++++|.+. .+|..+ .+++|+.|++.++..       ....+..
T Consensus       700 ~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~  773 (1153)
T PLN03210        700 GI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLM  773 (1153)
T ss_pred             cC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhh
Confidence            65 7899999999998765555543   457899999999987 556554 578888888877432       2222233


Q ss_pred             cccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccce
Q 002826          347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVS  426 (876)
Q Consensus       347 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~  426 (876)
                      +...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|..-..+|.+  .++|+.
T Consensus       774 ~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--~~nL~~  850 (1153)
T PLN03210        774 TMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--STNISD  850 (1153)
T ss_pred             hhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--ccccCE
Confidence            3445789999999998888899999999999999999987666777766 7889999999998655444433  368999


Q ss_pred             EeccCCcCCCCCCcCCCCCCCcceeeCCC-CcccccCCCccccc-ccceEEccCCc
Q 002826          427 LSLADNSLTGEIPPSLAELPVLTYLDLSD-NNLTGPIPQGLQNL-KLALFNVSFNK  480 (876)
Q Consensus       427 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l-~l~~l~ls~N~  480 (876)
                      |+|++|.++ .+|.++..+++|+.|+|++ |+|+ .+|..+..+ .++.++++++.
T Consensus       851 L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        851 LNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             eECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence            999999998 6788899999999999988 5666 466666666 47788888764

syringae 6; Provisional

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.1e-24  Score=214.11  Aligned_cols=169  Identities=21%  Similarity=0.163  Sum_probs=130.5

Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      |||.+++...+..+++..+.+++.|++.||+|||+.   +      ||+||+++.++.+|+  ||.++......      
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence            689999987666799999999999999999999998   5      999999999999999  99987654322      


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                       ..||+.|||||++.+..++.++|||||||++|||+||+.||............+.......        ++........
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~  134 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD--------DPRDRSNLES  134 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC--------CccccccHHH
Confidence             2478999999999999999999999999999999999999975433222222222211111        0000001111


Q ss_pred             HH--HHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          823 QM--LGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       823 ~~--~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ..  ..+.+++.+||+.+|++||++.|+++.+..+.+
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22  258999999999999999999999999887653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=2.6e-24  Score=250.40  Aligned_cols=262  Identities=25%  Similarity=0.324  Sum_probs=135.5

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      .|||+.|+++ .+|+.+.  ++|+.|++++|+|+. +|.   .+++|++|+|++|+  +..+|..   .++|+.|++++|
T Consensus       205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~--LtsLP~l---p~sL~~L~Ls~N  272 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQ--LTSLPVL---PPGLLELSIFSN  272 (788)
T ss_pred             EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCc--cCcccCc---ccccceeeccCC
Confidence            4566666665 4555554  356666666666663 343   23556666666665  3344432   234555555555


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP  296 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  296 (876)
                      +++.+ |..   ..+|+.|+|++|+|+ .+|..    +++|+.|+|++|+|++ +|..   ..+|+.|++++|       
T Consensus       273 ~L~~L-p~l---p~~L~~L~Ls~N~Lt-~LP~~----p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N-------  332 (788)
T PRK15387        273 PLTHL-PAL---PSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNN-------  332 (788)
T ss_pred             chhhh-hhc---hhhcCEEECcCCccc-ccccc----ccccceeECCCCcccc-CCCC---cccccccccccC-------
Confidence            55432 221   134455555555555 44431    2445555555555543 2221   122334444444       


Q ss_pred             CCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccC
Q 002826          297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS  376 (876)
Q Consensus       297 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  376 (876)
                                       +|++ +|..   .++|+.|+|++|+|++ +|..   ..+|+.|++++|+|+ .+|...   .+
T Consensus       333 -----------------~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~  383 (788)
T PRK15387        333 -----------------QLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT-SLPALP---SG  383 (788)
T ss_pred             -----------------cccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhccccc-cCcccc---cc
Confidence                             4432 2210   1244455555555543 2221   134455555555555 234322   34


Q ss_pred             ccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCC
Q 002826          377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN  456 (876)
Q Consensus       377 L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  456 (876)
                      |+.|++++|+|++ +|..   .+.|+.|++++|+|++.+..   ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N  455 (788)
T PRK15387        384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN  455 (788)
T ss_pred             cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence            5566666666653 3322   24566677777777654322   245667777777777 56777777777777777777


Q ss_pred             cccccCCCccc
Q 002826          457 NLTGPIPQGLQ  467 (876)
Q Consensus       457 ~l~~~~p~~~~  467 (876)
                      +|++..|..+.
T Consensus       456 ~Ls~~~~~~L~  466 (788)
T PRK15387        456 PLSERTLQALR  466 (788)
T ss_pred             CCCchHHHHHH
Confidence            77776666553

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.4e-24  Score=225.55  Aligned_cols=264  Identities=20%  Similarity=0.294  Sum_probs=195.6

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCe
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDES  652 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  652 (876)
                      .+...|..+.++|.| +|++||++...    .++.||+|.+...  ....++..|+++|..+ -+.||+++.+++..++.
T Consensus        33 ~~~~~~~~v~kigeG-sFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEG-SFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhcccccc-chhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            344455566666655 59999999442    5789999998764  4566789999999999 58999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhh
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRI  731 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~  731 (876)
                      +.+|+||++.....++..    .++...+...++.+..||+++|..   ||+||||||+|++.+. .++-.|+|||+|..
T Consensus       110 v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHH
Confidence            999999999988888874    466788999999999999999999   9999999999999984 57889999999983


Q ss_pred             ccccc----------------------------------cc--------cccccccccccccCccccCC-CCCCCccchH
Q 002826          732 VGEAA----------------------------------FQ--------STMSSEYALSCYNAPEYGYS-KKATAQMDAY  768 (876)
Q Consensus       732 ~~~~~----------------------------------~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~  768 (876)
                      .....                                  ..        ...-...||++|+|||+... +..++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21000                                  00        00112368999999998765 4578899999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcchhhHHHHHH--------HHhhcccc--cc---------------cccC-hhhh-----
Q 002826          769 SFGVVLLELITGRQAEQAEPAESLDVVKWVR--------RKINITNG--AI---------------QVLD-PKIA-----  817 (876)
Q Consensus       769 SlGv~l~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~--~~---------------~~~d-~~~~-----  817 (876)
                      |.||++..+++++.||.....+...+.+.+.        +.....+.  ..               +.++ ..+.     
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999999887776553333221        11100000  00               0010 0000     


Q ss_pred             -----hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 -----NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 -----~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           ......+..+++++.+|++.+|.+|.|++|+++.
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                 0111123478899999999999999999998863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=7.6e-25  Score=267.19  Aligned_cols=197  Identities=20%  Similarity=0.241  Sum_probs=142.6

Q ss_pred             hccC-ccccceeeEE-------EeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccc
Q 002826          634 KIRH-KNIVKVLGFF-------HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH  705 (876)
Q Consensus       634 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  705 (876)
                      .++| +||++++++|       .+.+.++.++||+ +++|.+++......+++..+..++.||++||+|||++   +|+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            4556 6888889887       2334678889987 5599999986666799999999999999999999999   9999


Q ss_pred             cccccCceeeCC-------------------CCCeEEccccchhhcccccc--------------ccccccccccccccC
Q 002826          706 RNVKSKNILLDA-------------------DFEPKLTDFALDRIVGEAAF--------------QSTMSSEYALSCYNA  752 (876)
Q Consensus       706 ~Dlkp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~--------------~~~~~~~~gt~~y~a  752 (876)
                      |||||+|||++.                   ++.+|++|||+++.......              ........||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999954                   45567777777654321000              000112357888999


Q ss_pred             ccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHH
Q 002826          753 PEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL  832 (876)
Q Consensus       753 PE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~  832 (876)
                      ||++.+..++.++|||||||++|||++|.+|+.....   ........          .+++...    .......+++.
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~----------~~~~~~~----~~~~~~~~~~~  246 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHR----------VLPPQIL----LNWPKEASFCL  246 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHh----------hcChhhh----hcCHHHHHHHH
Confidence            9999988899999999999999999999887542110   11111000          1111111    11223467888


Q ss_pred             HccCCCCCCCCCHHHHHHH
Q 002826          833 RCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       833 ~cl~~dP~~RPs~~ell~~  851 (876)
                      +||+++|.+||+|.|+++.
T Consensus       247 ~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        247 WLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HhCCCChhhCcChHHHhhc
Confidence            9999999999999999863

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.91  E-value=4.2e-24  Score=248.69  Aligned_cols=267  Identities=21%  Similarity=0.312  Sum_probs=181.6

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      ..-..|+|++|.++. +|..+.  ++|+.|++++|+          |+ .+|..   +++|++|+|++|+|+. +|..  
T Consensus       201 ~~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~----------Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l--  260 (788)
T PRK15387        201 NGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNN----------LT-SLPAL---PPELRTLEVSGNQLTS-LPVL--  260 (788)
T ss_pred             CCCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCc----------CC-CCCCC---CCCCcEEEecCCccCc-ccCc--
Confidence            457789999999985 777775  367777665554          44 34542   4789999999999994 5643  


Q ss_pred             CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccccc
Q 002826          179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       179 ~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                       .++|+.|+|++|.  +..+|..+   .+|+.|++++|+++.+ |.   .+++|+.|+|++|+|+ .+|..    ..+|+
T Consensus       261 -p~sL~~L~Ls~N~--L~~Lp~lp---~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~-~Lp~l----p~~L~  325 (788)
T PRK15387        261 -PPGLLELSIFSNP--LTHLPALP---SGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLA-SLPAL----PSELC  325 (788)
T ss_pred             -ccccceeeccCCc--hhhhhhch---hhcCEEECcCCccccc-cc---cccccceeECCCCccc-cCCCC----ccccc
Confidence             4689999999998  56677533   5788999999999965 44   3578999999999999 67753    34688


Q ss_pred             EEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCc
Q 002826          259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR  338 (876)
Q Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  338 (876)
                      .|++++|+|++ +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|++ +|..   ..+|+.       
T Consensus       326 ~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~-------  386 (788)
T PRK15387        326 KLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKE-------  386 (788)
T ss_pred             ccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccce-------
Confidence            99999999984 5532   2467888888888874 3332   2356666666666663 3322   123444       


Q ss_pred             ccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCc
Q 002826          339 FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPEL  418 (876)
Q Consensus       339 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~  418 (876)
                                       |++++|+|++ +|...   ++|+.|++++|+|++ +|..   ...|+.|++++|+|+..+..+
T Consensus       387 -----------------LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~LP~sl  441 (788)
T PRK15387        387 -----------------LIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTRLPESL  441 (788)
T ss_pred             -----------------EEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccccChHH
Confidence                             4455554442 33221   345555666666553 3332   234666777778777555577


Q ss_pred             ccccccceEeccCCcCCCCCCcCCCC
Q 002826          419 KKCRKLVSLSLADNSLTGEIPPSLAE  444 (876)
Q Consensus       419 ~~l~~L~~L~Ls~N~l~~~~p~~~~~  444 (876)
                      .++++|+.|+|++|+|++..|..+..
T Consensus       442 ~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        442 IHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             hhccCCCeEECCCCCCCchHHHHHHH
Confidence            77888888888888888777665533

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.89  E-value=2.2e-25  Score=228.06  Aligned_cols=276  Identities=21%  Similarity=0.224  Sum_probs=170.9

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEec
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      .-..++|..|+|+.+.|++|+.+++|++||||+|+                         |+.+.|++|.++.+|..|-+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~-------------------------Is~I~p~AF~GL~~l~~Lvl  122 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNN-------------------------ISFIAPDAFKGLASLLSLVL  122 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccc-------------------------hhhcChHhhhhhHhhhHHHh
Confidence            44566677777776666666666666666666665                         45556677777777666655


Q ss_pred             cc-CccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          238 SQ-NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       238 s~-N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      .+ |+|+ .+|...|.++.+|+.|.+.-|++.-+..+.|..+++|..|.+..|.+..+-..+|..+.+++.+.+..|.+-
T Consensus       123 yg~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i  201 (498)
T KOG4237|consen  123 YGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI  201 (498)
T ss_pred             hcCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc
Confidence            55 7777 777777777777777777777777666777777777777777777777555557777777777777777632


Q ss_pred             ------------CCCCcccCCCCcccEEEecCCcccccCccccccC-CCCCeeeccCcccCCCCC-CccccccCccEEeC
Q 002826          317 ------------GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA-AQLEQVQIDNNRFTSSIP-QGLGSVKSLYRFSA  382 (876)
Q Consensus       317 ------------~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l  382 (876)
                                  ...|..+++..-..-..+.++++..+.+..|... ..+..-..+.....+.-| ..|..+++|+.|+|
T Consensus       202 cdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnl  281 (498)
T KOG4237|consen  202 CDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNL  281 (498)
T ss_pred             cccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEecc
Confidence                        1222333333333333444444444433333211 111111111121222333 34666777777777


Q ss_pred             CCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc
Q 002826          383 SQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       383 s~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      ++|+++++-+.+|.+...++.|.|..|+|..+-. .|.++..|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|.+.
T Consensus       282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            7777777777777777777777777777764444 5667777777777777777677777777777777777777664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.88  E-value=8.5e-23  Score=239.67  Aligned_cols=261  Identities=21%  Similarity=0.386  Sum_probs=127.4

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      .|+++++.++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+  +..+|..+.  .+|+.|+|++|
T Consensus       182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~--LtsLP~~l~--~~L~~L~Ls~N  251 (754)
T PRK15370        182 ELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQ--LTSIPATLP--DTIQEMELSIN  251 (754)
T ss_pred             EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCc--cccCChhhh--ccccEEECcCC
Confidence            4444445544 2344332  35566666666665 3333222  355555555554  334444332  24555555555


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP  296 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  296 (876)
                      ++.. +|..+.  ++|+.|+|++|+|+ .+|..++   ++|+.|+|++|+|++ +|..+                     
T Consensus       252 ~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~---~sL~~L~Ls~N~Lt~-LP~~l---------------------  302 (754)
T PRK15370        252 RITE-LPERLP--SALQSLDLFHNKIS-CLPENLP---EELRYLSVYDNSIRT-LPAHL---------------------  302 (754)
T ss_pred             ccCc-CChhHh--CCCCEEECcCCccC-ccccccC---CCCcEEECCCCcccc-Ccccc---------------------
Confidence            5542 233332  24555555555555 4444332   244555555555442 22222                     


Q ss_pred             CCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccC
Q 002826          297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS  376 (876)
Q Consensus       297 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  376 (876)
                         .  .+|+.|++++|+++. +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+.  ++
T Consensus       303 ---p--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~  368 (754)
T PRK15370        303 ---P--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PT  368 (754)
T ss_pred             ---h--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CC
Confidence               1  234444444444442 22222  1345555555555553 333332  45666666666665 3444332  45


Q ss_pred             ccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcC----cccccccceEeccCCcCCCCCCcCCCCCCCcceee
Q 002826          377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE----LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLD  452 (876)
Q Consensus       377 L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  452 (876)
                      |+.|++++|+|+. +|..+.  ..|+.|++++|+|+..+..    +..++++..|+|.+|.++.      ..+.+|+.| 
T Consensus       369 L~~LdLs~N~Lt~-LP~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-  438 (754)
T PRK15370        369 ITTLDVSRNALTN-LPENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-  438 (754)
T ss_pred             cCEEECCCCcCCC-CCHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-
Confidence            6666666666653 333332  2466677777777654332    2334677788888887762      345555555 


Q ss_pred             CCCCcccc
Q 002826          453 LSDNNLTG  460 (876)
Q Consensus       453 Ls~N~l~~  460 (876)
                      ++.|.+.|
T Consensus       439 l~s~~~~g  446 (754)
T PRK15370        439 MSSVGYQG  446 (754)
T ss_pred             hhcccccC
Confidence            44555554

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.6e-23  Score=199.54  Aligned_cols=238  Identities=21%  Similarity=0.282  Sum_probs=182.1

Q ss_pred             CceEEEEEEeCCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhc
Q 002826          594 PFGRVYILSLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICR  671 (876)
Q Consensus       594 ~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~  671 (876)
                      ..|+.|+|+++ |..+++|++......  ..+.|..|.-.++-..||||..++|.|....+..++..||+.|+|+..+++
T Consensus       202 hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe  280 (448)
T KOG0195|consen  202 HSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE  280 (448)
T ss_pred             CCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc
Confidence            37899999995 555667777544333  346799999999999999999999999999999999999999999999988


Q ss_pred             c-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc--ccchhhccccccccccccccccc
Q 002826          672 Q-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD--FALDRIVGEAAFQSTMSSEYALS  748 (876)
Q Consensus       672 ~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D--fGla~~~~~~~~~~~~~~~~gt~  748 (876)
                      . +...+..++.+++.++|+|++|||+.. +-|..--+.+..+++|++.+++|+-  --++.  +       .....-.+
T Consensus       281 ~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--q-------e~gr~y~p  350 (448)
T KOG0195|consen  281 QTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q-------EVGRAYSP  350 (448)
T ss_pred             CccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--e-------ccccccCc
Confidence            7 555788899999999999999999973 2455556889999999998888752  11111  1       11122356


Q ss_pred             cccCccccCCCCC---CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          749 CYNAPEYGYSKKA---TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       749 ~y~aPE~~~~~~~---~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      .||+||.++.++.   ..++|+|||++++||+.|+..||...+..+...--..       .++...+.|.       ...
T Consensus       351 awmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-------eglrv~ippg-------is~  416 (448)
T KOG0195|consen  351 AWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-------EGLRVHIPPG-------ISR  416 (448)
T ss_pred             ccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-------ccccccCCCC-------ccH
Confidence            7999999876643   4579999999999999999999987766543211111       1123333333       334


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          826 GALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .+.+++.-|...||.+||.+..++-.|+++.
T Consensus       417 hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            6789999999999999999999999998763

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.86  E-value=5.7e-22  Score=232.73  Aligned_cols=223  Identities=23%  Similarity=0.397  Sum_probs=153.6

Q ss_pred             CCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeec
Q 002826          231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQV  310 (876)
Q Consensus       231 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  310 (876)
                      +|++|++++|+|+ .+|..++   .+|+.|+|++|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|++
T Consensus       221 nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L  290 (754)
T PRK15370        221 NIKTLYANSNQLT-SIPATLP---DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV  290 (754)
T ss_pred             CCCEEECCCCccc-cCChhhh---ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence            4555555555555 4554432   24555555555555 3444332  35666666666666 3444443  47888888


Q ss_pred             ccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCC
Q 002826          311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGS  390 (876)
Q Consensus       311 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  390 (876)
                      ++|+|++ +|..+.  ++|+.|++++|+++. +|..+  .++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .
T Consensus       291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~  360 (754)
T PRK15370        291 YDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-V  360 (754)
T ss_pred             CCCcccc-Ccccch--hhHHHHHhcCCcccc-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-c
Confidence            8888874 454443  579999999999995 44433  3689999999999995 676664  68999999999998 4


Q ss_pred             CCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcC----CCCCCCcceeeCCCCcccccCCCcc
Q 002826          391 LPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPS----LAELPVLTYLDLSDNNLTGPIPQGL  466 (876)
Q Consensus       391 ~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~~~~p~~~  466 (876)
                      +|..+.  +.|+.|+|++|+|+..++.+.  ..|+.|++++|+|+ .+|..    +..++++..|+|.+|+|+.   ..+
T Consensus       361 LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~---~tl  432 (754)
T PRK15370        361 LPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE---RTI  432 (754)
T ss_pred             CChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH---HHH
Confidence            566553  689999999999997766554  47999999999999 55554    4456889999999999973   233


Q ss_pred             cccccceEEccCCccccc
Q 002826          467 QNLKLALFNVSFNKLSGR  484 (876)
Q Consensus       467 ~~l~l~~l~ls~N~l~~~  484 (876)
                      ..  ++.+ ++.|.+.|.
T Consensus       433 ~~--L~~L-l~s~~~~gp  447 (754)
T PRK15370        433 QN--MQRL-MSSVGYQGP  447 (754)
T ss_pred             HH--HHHh-hhcccccCC
Confidence            32  3334 455666553

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-20  Score=203.47  Aligned_cols=259  Identities=22%  Similarity=0.220  Sum_probs=189.8

Q ss_pred             ccCCCCCCCCceEEEEEEeCCC--cEEEEEEEecCCccCHHHHHHHHHHHhhccC----ccccceeeEE-EeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLPSG--ELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH----KNIVKVLGFF-HSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~lv~  657 (876)
                      ....+|.| +||.||+|.....  ..+|+|............+..|+.++..+..    +++..+++.+ ..+...|+||
T Consensus        22 i~~~iG~G-~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM  100 (322)
T KOG1164|consen   22 LGKKIGEG-GFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM  100 (322)
T ss_pred             Eeeecccc-CCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence            34445555 5999999976543  5788998766533333378889999999973    6899999998 4777899999


Q ss_pred             EcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-----CCeEEccccchhh
Q 002826          658 EFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-----FEPKLTDFALDRI  731 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-----~~~kl~DfGla~~  731 (876)
                      +.+ |.+|.++..... ..++..++.+++.|++.+|+++|+.   |++||||||.|+.+...     ..+.+.|||+++.
T Consensus       101 ~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  101 SLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             ecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            976 669999886554 7899999999999999999999999   99999999999999854     4599999999983


Q ss_pred             cc--ccc-----cccc-cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 002826          732 VG--EAA-----FQST-MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       732 ~~--~~~-----~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      +.  ...     .... .....||..|+++....+...+++.|+||++.++.|+..|..||........ .....+....
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~~~  255 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDPRK  255 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHhhh
Confidence            32  111     1111 1234599999999999999999999999999999999999999976443221 1111111111


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ..      ..+ .......   .+.++...+-+.+..++|....+.+.+++...+.
T Consensus       256 ~~------~~~-~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  256 LL------TDR-FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hc------ccc-ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11      000 1111222   3445555555589999999999999988876554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=4.3e-21  Score=207.64  Aligned_cols=162  Identities=17%  Similarity=0.112  Sum_probs=121.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC--CCcEEEEEEEecCC-----ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP--SGELIAVKKLVNFG-----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      +|.....+|.|| ||+||+|...  +++.||||++....     ......+.+|++++++++|+|+++.+..   .+..|
T Consensus        19 ~Y~~~~~IG~G~-fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~   94 (365)
T PRK09188         19 RFVETAVLKRDV-FSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG   94 (365)
T ss_pred             CceEccEEeecC-cEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence            444555566555 9999999664  57888999875321     1124568999999999999999863322   24689


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCcccccc-ccCceeeCCCCCeEEccccchhhcc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV-KSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-kp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      +||||++|++|... ...+       ...++.++++|++|||+.   ||+|||| ||+||+++.++++||+|||+|+...
T Consensus        95 LVmE~~~G~~L~~~-~~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~  163 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RPHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR  163 (365)
T ss_pred             EEEEccCCCCHHHh-Cccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence            99999999999632 1111       146788999999999999   9999999 9999999999999999999998775


Q ss_pred             ccccc------cccccccccccccCccccCC
Q 002826          734 EAAFQ------STMSSEYALSCYNAPEYGYS  758 (876)
Q Consensus       734 ~~~~~------~~~~~~~gt~~y~aPE~~~~  758 (876)
                      .....      .......++..|+|||.+..
T Consensus       164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            43211      11234567788999998754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.2e-21  Score=226.06  Aligned_cols=254  Identities=19%  Similarity=0.177  Sum_probs=186.1

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC--CccCH----HHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF--GCQSS----KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ...+.+.|++|.|+.+.. ...+..+.|.+...  .....    ..+..|+.+-..++|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            344555666887776633 34444444443210  11111    125567778888899999998888877766666699


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ||++ +|..++.+. ..+...++..++.|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||.+....-....
T Consensus       402 ~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~  476 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK  476 (601)
T ss_pred             cccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcch
Confidence            9999 999999775 3688888999999999999999999   9999999999999999999999999998766533222


Q ss_pred             --cccccccccccccCccccCCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 --STMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 --~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                        .......|...|+|||...+.+|.+. .||||.|++++.|.+|+.||......+......     ...  ....+...
T Consensus       477 ~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-----~~~--~~~~~~~~  549 (601)
T KOG0590|consen  477 NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-----NYS--DQRNIFEG  549 (601)
T ss_pred             hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----ccc--cccccccC
Confidence              34556678889999999988887664 899999999999999999998765554322000     000  01111112


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ........+.....++.+|++.+|.+|.|+++|++.
T Consensus       550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            223334455667889999999999999999999864

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.8e-20  Score=180.11  Aligned_cols=260  Identities=18%  Similarity=0.170  Sum_probs=190.1

Q ss_pred             hcccccCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC-ccccceeeEEEeCCeEEEEEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  658 (876)
                      .+-+.+.+.+|.|+||.+|.| ...+|+.||+|+-...  ....++..|..+...+++ ..|..+..+..+...-.+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            344455555556669999999 5679999999986432  334567789999999974 678888888888888999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeEEccccchhhcccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~DfGla~~~~~~  735 (876)
                      .. |.||.+++.-....++..++.-++-|++.-++|+|.+   +++||||||+|+|+.-   ..++.++|||+|+.+.+.
T Consensus        92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~  167 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI  167 (341)
T ss_pred             cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence            87 6699999876666899999999999999999999999   9999999999999963   467899999999887643


Q ss_pred             cc-----ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          736 AF-----QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       736 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      ..     +.......||.+|.+-....+.+.+.+-|+-|+|.++.++-.|..||++......  .+...+.      ...
T Consensus       168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk--~QKyEkI------~Ek  239 (341)
T KOG1163|consen  168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK--KQKYEKI------SEK  239 (341)
T ss_pred             cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH--HHHHHHH------HHh
Confidence            21     1223445689999888877777888899999999999999999999997544322  0111110      001


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS  854 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~  854 (876)
                      .....+...+...+.++.-.+.-|-...-++-|...=+-+.++-
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            11112223333444556666677777777777776555444443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2e-20  Score=205.43  Aligned_cols=218  Identities=27%  Similarity=0.427  Sum_probs=172.2

Q ss_pred             HhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCc-ccccccc
Q 002826          632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL-LHRNVKS  710 (876)
Q Consensus       632 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-~H~Dlkp  710 (876)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+......+++.....+.++++.||+|+|..   +| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence            4568899999999999999999999999999999999998888999999999999999999999998   44 9999999


Q ss_pred             CceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCC-------CCCCccchHHHHHHHHHHHhCCCC
Q 002826          711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-------KATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       711 ~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                      .|.++|..+.+|++|||+.................-..-|.|||.+...       ..+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998766431111112222233459999987653       146779999999999999999999


Q ss_pred             CCCCCcchh--hHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          784 EQAEPAESL--DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       784 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      |+.......  .++..++.      +....+.|.+.... +....+..++..||..+|.+||+++++-..++.+....
T Consensus       158 ~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             cccccccCChHHHHHHHHh------cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            987554433  33333332      13333445554222 33346889999999999999999999999999887654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.4e-19  Score=181.73  Aligned_cols=264  Identities=17%  Similarity=0.160  Sum_probs=194.9

Q ss_pred             cCCCCCCCCceEEEEE-EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +.+.+|.|.||+.+.| .+-++++||||.-...  .+..+++.|...++.|. .++|..++-+..++.+-.+|+|.+ |.
T Consensus        32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP  108 (449)
T KOG1165|consen   32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP  108 (449)
T ss_pred             eccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence            3444455569999999 4568999999975432  45678889999999994 799999999988888999999987 66


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-----CCeEEccccchhhccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-----FEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-----~~~kl~DfGla~~~~~~~~~  738 (876)
                      ||.|++.-.+..++.+++..+|.|++.-++|+|++   .+|.|||||+|+||..-     ..+.++|||+|+.+.+....
T Consensus       109 SLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk  185 (449)
T KOG1165|consen  109 SLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK  185 (449)
T ss_pred             CHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence            99999887788999999999999999999999999   99999999999999643     45899999999998643321


Q ss_pred             -----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          739 -----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       739 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                           .......||.+||+=....+.+.+.+-|+=|+|-++++.+-|..||++...+.- ...+  .++...  ...   
T Consensus       186 qHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K~kY--eKIGe~--Kr~---  257 (449)
T KOG1165|consen  186 QHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-KEKY--EKIGET--KRS---  257 (449)
T ss_pred             ccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-HHHH--HHhccc--ccc---
Confidence                 222344599999999999999999999999999999999999999997544321 0011  111000  111   


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccc
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS  863 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~  863 (876)
                      ..+.+.+...+.++..-+.-.-..+-.+-|...-+...+.++..+.+...
T Consensus       258 T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~  307 (449)
T KOG1165|consen  258 TPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD  307 (449)
T ss_pred             CCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence            11112222233334444444444677778888777777776665544443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.82  E-value=8.4e-19  Score=192.20  Aligned_cols=254  Identities=29%  Similarity=0.390  Sum_probs=192.9

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCc-cccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHK-NIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+| .|+||.||++...  ..+|+|.+......   ....+.+|+.+++.+.|+ +++++.+.+......+++++++.+
T Consensus         6 ~~l~-~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~   82 (384)
T COG0515           6 RKLG-EGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG   82 (384)
T ss_pred             Eeec-CCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence            3455 4558999999776  88999998765433   356789999999999988 799999999777778999999999


Q ss_pred             CCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhcccccccc
Q 002826          663 GSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       663 gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++.+++....  ..++......+..|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.........
T Consensus        83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            99997776554  2688999999999999999999999   999999999999999888 79999999998655332211


Q ss_pred             ----ccccccccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcc--hhhHHHHHHHHhhccccccc
Q 002826          740 ----TMSSEYALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAE--SLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       740 ----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  810 (876)
                          ......|+..|+|||....   .......|+||+|++++++++|..||......  .....+.+......  ....
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~  237 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--SLAS  237 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--cccc
Confidence                2456678999999999887   57888999999999999999999997765431  12222222221100  0000


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+..   .......+.+++.+|+..+|..|.++.+....
T Consensus       238 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         238 PLSPSN---PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ccCccc---cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000   01223457789999999999999998887765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.3e-19  Score=182.05  Aligned_cols=173  Identities=9%  Similarity=0.118  Sum_probs=128.6

Q ss_pred             hhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHH---------HHHHHHHHhhccCccccceeeEEEe
Q 002826          579 LVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKT---------LKTEVKTLAKIRHKNIVKVLGFFHS  649 (876)
Q Consensus       579 l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~  649 (876)
                      +..+.+...++.++|.||.||+++. +++.+|+|.+..........         +++|+..+.+++||+|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            3334455555555666999999876 57789999996543333222         6889999999999999999988654


Q ss_pred             C--------CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          650 D--------ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       650 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      .        +..++||||++|.+|.++..     +++    ....+++.++..+|+.   |++|||+||+||+++.++ +
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence            3        35899999999999988731     222    2456899999999999   999999999999999888 9


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT  779 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt  779 (876)
                      +++|||..+.........              .+.....+..++|+||||+++.....
T Consensus       174 ~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHHH
Confidence            999999876553221110              12333345678999999998765543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=6.7e-19  Score=175.39  Aligned_cols=138  Identities=19%  Similarity=0.153  Sum_probs=105.9

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc--C-------H-----------------HHHHHHHHHHhhccCcccc
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ--S-------S-----------------KTLKTEVKTLAKIRHKNIV  641 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~niv  641 (876)
                      .+|.|| +|.||+|..++|+.||+|++......  .       .                 .....|++.+.++.++++.
T Consensus         4 ~ig~G~-~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           4 CISTGK-EANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             cccccc-ceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            344454 99999998889999999999654211  1       0                 1223599999999888775


Q ss_pred             ceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHh-hccCCCCccccccccCceeeCCCCC
Q 002826          642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFE  720 (876)
Q Consensus       642 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dlkp~NIll~~~~~  720 (876)
                      ....+..  ...++||||++|+++...... ...+++..+.+++.|++.++.|+ |+.   +|+||||||+||+++ ++.
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~  155 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK  155 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence            4433322  233899999999877654322 24688999999999999999999 688   999999999999998 478


Q ss_pred             eEEccccchhhcc
Q 002826          721 PKLTDFALDRIVG  733 (876)
Q Consensus       721 ~kl~DfGla~~~~  733 (876)
                      ++++|||+|....
T Consensus       156 v~LiDFG~a~~~~  168 (190)
T cd05147         156 LYIIDVSQSVEHD  168 (190)
T ss_pred             EEEEEccccccCC
Confidence            9999999987554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=1.8e-18  Score=169.52  Aligned_cols=187  Identities=15%  Similarity=0.114  Sum_probs=137.4

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc----CHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEc
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ----SSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ....++++| ||+||.+.. .+.+++.+.+.....-    ....+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         6 ~~~~l~~~~-f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          6 VNEPLKSDT-FGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cceeecCCC-cceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            345566666 999998876 7888887777543221    1225789999999995 5889999886    346999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCcccccc-ccCceeeCCCCCeEEccccchhhccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV-KSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dl-kp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      +.|.+|.+....        ....++.|++++++++|+.   ||+|||| ||+||+++.++.++|+|||+|.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        1135678999999999999   9999999 799999999999999999999865432210


Q ss_pred             ----c--c-----cccccccccccCccccC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002826          739 ----S--T-----MSSEYALSCYNAPEYGY--SKKATAQMDAYSFGVVLLELITGRQAEQAEP  788 (876)
Q Consensus       739 ----~--~-----~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~  788 (876)
                          .  .     ......++.|++|+-..  ......+.+.++-|.-+|.++||+.+.....
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0  0     11223566777887432  2333467899999999999999998865443

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=2.3e-19  Score=205.05  Aligned_cols=251  Identities=24%  Similarity=0.255  Sum_probs=177.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc-cCHHHHHHHHHH--HhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC-QSSKTLKTEVKT--LAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ++.-+..+|.+. |=.|.+|+...|. |+||++.+.+. -.-+.+.++++-  ...++|||++++.-+-..++..|+|=+
T Consensus        24 e~~~~~~LGstR-FlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTR-FLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchh-hhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            344456666666 9999999887777 89999977553 233444443333  444589999999888777788889989


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc--c--
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG--E--  734 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~--~--  734 (876)
                      |... +|+|.+.-+. .+...+.+-|+.|++.|+..+|..   ||+|||||.+|||++.=..+.++||.--+...  +  
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9877 9999886543 577778888999999999999999   99999999999999999999999997654321  1  


Q ss_pred             -cccccccccccccccccCccccCCC----------C-CCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHH
Q 002826          735 -AAFQSTMSSEYALSCYNAPEYGYSK----------K-ATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK  801 (876)
Q Consensus       735 -~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  801 (876)
                       ..+.-.......-.+|.|||.+...          . .+++-||||+||+++|+++ |++||.-.     .+.++.+..
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~  251 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSGN  251 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhccC
Confidence             1111111222233469999965431          1 4678899999999999988 68877531     122221110


Q ss_pred             hhcccccccccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          802 INITNGAIQVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       802 ~~~~~~~~~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                               ..|+... +.  -+...+..++..|++.||++|.+|.+.++.-+++
T Consensus       252 ---------~~~~e~~Le~--Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  252 ---------ADDPEQLLEK--IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             ---------ccCHHHHHHh--CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence                     1111111 10  0112577899999999999999999999986664

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=2.4e-20  Score=169.96  Aligned_cols=166  Identities=33%  Similarity=0.592  Sum_probs=130.5

Q ss_pred             cccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCc
Q 002826           94 SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSV  173 (876)
Q Consensus        94 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  173 (876)
                      .+.++++++.|.||+|.++. +|..+..+.+|+.|++++|+|           ..+|.+++++++|+.|+++-|++. +.
T Consensus        28 gLf~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqi-----------e~lp~~issl~klr~lnvgmnrl~-~l   94 (264)
T KOG0617|consen   28 GLFNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQI-----------EELPTSISSLPKLRILNVGMNRLN-IL   94 (264)
T ss_pred             cccchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchh-----------hhcChhhhhchhhhheecchhhhh-cC
Confidence            35677788888899998876 677888888888887776665           367888888889999999888887 88


Q ss_pred             CccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccc
Q 002826          174 PFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSS  253 (876)
Q Consensus       174 p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~  253 (876)
                      |..|+.++.|+.|||++|++.-..+|..|..++.|+.|+|++|.+. ++|..++.+++|+.|.+..|.+- ++|..++. 
T Consensus        95 prgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~-  171 (264)
T KOG0617|consen   95 PRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGD-  171 (264)
T ss_pred             ccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHH-
Confidence            8888888888888888888766677888888888888888888887 56667788888888888888877 77777754 


Q ss_pred             cccccEEEeccccccCcCCcccc
Q 002826          254 LLKLVSFDVSQNKLSGSFPNGIC  276 (876)
Q Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~  276 (876)
                      ++.|+.|++.+|+++ .+|..++
T Consensus       172 lt~lrelhiqgnrl~-vlppel~  193 (264)
T KOG0617|consen  172 LTRLRELHIQGNRLT-VLPPELA  193 (264)
T ss_pred             HHHHHHHhcccceee-ecChhhh
Confidence            777777777777777 4444443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=8.1e-18  Score=168.41  Aligned_cols=137  Identities=18%  Similarity=0.139  Sum_probs=107.1

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccC--------------------------HHHHHHHHHHHhhccCccccce
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQS--------------------------SKTLKTEVKTLAKIRHKNIVKV  643 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~niv~~  643 (876)
                      .+.|++|.||+|...+|+.||||++.......                          ...+..|.+.+.++.|+++...
T Consensus         5 ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p   84 (190)
T cd05145           5 ISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVP   84 (190)
T ss_pred             eecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCc
Confidence            34445999999987789999999987542110                          1123578999999999987554


Q ss_pred             eeEEEeCCeEEEEEEcCCCCCHHHH-hhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCe
Q 002826          644 LGFFHSDESIFLIYEFLQMGSLGDL-ICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       644 ~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      ..+...  ..++||||++|+++... +..  ..++.....+++.+++.++.++|+ .   ||+||||||+||+++ ++++
T Consensus        85 ~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          85 EPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             eEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCE
Confidence            444333  24899999998865433 332  357788899999999999999999 8   999999999999998 8899


Q ss_pred             EEccccchhhccc
Q 002826          722 KLTDFALDRIVGE  734 (876)
Q Consensus       722 kl~DfGla~~~~~  734 (876)
                      +++|||+++....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999886643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=2.4e-20  Score=203.98  Aligned_cols=83  Identities=24%  Similarity=0.211  Sum_probs=42.5

Q ss_pred             eecccccccC-CCcCccccCCCcceEEEccCCCCcC---CCCCCcccccCcccEEEecCCCCcc------cCCccccCCC
Q 002826          161 VLNLGSNLLS-GSVPFVFGNFSELVVLDLSQNAYLI---SEIPSDIGKLEKLEQLFLQSSGFHG------VIPDSFVGLQ  230 (876)
Q Consensus       161 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~~~~---~~~p~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~  230 (876)
                      .|+|..+.++ ...+..|..+.+|++|+++++.+..   ..++..+...++|++|+++++.+.+      .++..+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            4667777776 3344555566667777777665211   1233334444555555555555541      1223344445


Q ss_pred             CCcEEecccCccC
Q 002826          231 SLSILDLSQNNLT  243 (876)
Q Consensus       231 ~L~~L~Ls~N~l~  243 (876)
                      +|+.|++++|.+.
T Consensus        82 ~L~~L~l~~~~~~   94 (319)
T cd00116          82 GLQELDLSDNALG   94 (319)
T ss_pred             ceeEEEccCCCCC
Confidence            5555555555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=3.2e-20  Score=202.99  Aligned_cols=283  Identities=18%  Similarity=0.213  Sum_probs=145.2

Q ss_pred             eecCCCCCc-ccccccccCCCCCCeeecCCCccccc----cCccccCCCCCCcccCCCcccceeecCCccccccCCCccC
Q 002826           80 INLQSLNLS-GEISSSVCELSSLSNLNLADNLFNQP----IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIG  154 (876)
Q Consensus        80 l~l~~~~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~  154 (876)
                      ++|..++++ +.....+..++.|+.|+++++.++..    ++..+...++|++|+++++.+...    ...-..++..+.
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~----~~~~~~~~~~l~   78 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRI----PRGLQSLLQGLT   78 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCc----chHHHHHHHHHH
Confidence            566666666 34445556677788888888877543    455566666677766655433110    011123344566


Q ss_pred             CccccceecccccccCCCcCccccCCCc---ceEEEccCCCCcCC---CCCCccccc-CcccEEEecCCCCccc----CC
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSE---LVVLDLSQNAYLIS---EIPSDIGKL-EKLEQLFLQSSGFHGV----IP  223 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~~~~~---~~p~~~~~l-~~L~~L~L~~n~l~~~----~~  223 (876)
                      .+++|+.|+|++|.+.+..+..+..+.+   |++|++++|++...   .+...+..+ ++|+.|++++|.+++.    ++
T Consensus        79 ~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~  158 (319)
T cd00116          79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA  158 (319)
T ss_pred             hcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence            6777777777777776555555555554   77777777762211   111233444 5666666666666522    23


Q ss_pred             ccccCCCCCcEEecccCccCCCCCCccc---cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCc
Q 002826          224 DSFVGLQSLSILDLSQNNLTGEVPQSLG---SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSIN  300 (876)
Q Consensus       224 ~~~~~l~~L~~L~Ls~N~l~~~ip~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  300 (876)
                      ..+..+++|++|+|++|.+++.....+.   ..+++|++|+|++|.+++.....                    ....+.
T Consensus       159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------l~~~~~  218 (319)
T cd00116         159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA--------------------LAETLA  218 (319)
T ss_pred             HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH--------------------HHHHhc
Confidence            3344555666666666666532111111   11235555555555554221111                    112233


Q ss_pred             cccccceeecccccCCCCCCcccC-----CCCcccEEEecCCcccc----cCccccccCCCCCeeeccCcccCCC----C
Q 002826          301 ECLNLERFQVQDNGFSGDFPDKLW-----SLPRIKLIRAESNRFSG----AIPDSISMAAQLEQVQIDNNRFTSS----I  367 (876)
Q Consensus       301 ~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~  367 (876)
                      .+++|++|++++|.+++.....+.     ..++|+.|++++|.+++    .+...+..+++|+++++++|.++..    .
T Consensus       219 ~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~  298 (319)
T cd00116         219 SLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLL  298 (319)
T ss_pred             ccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHH
Confidence            344455555555544432221111     12456666666666541    1223344445666666666666633    2


Q ss_pred             CCccccc-cCccEEeCCCcc
Q 002826          368 PQGLGSV-KSLYRFSASQNS  386 (876)
Q Consensus       368 p~~~~~l-~~L~~L~ls~N~  386 (876)
                      ...+... +.|+++++.+|.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         299 AESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHhhcCCchhhcccCCCC
Confidence            2222222 456666666664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.74  E-value=5.5e-18  Score=175.37  Aligned_cols=225  Identities=24%  Similarity=0.256  Sum_probs=144.0

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc---CHHHHHHHHHHHhhcc----------CccccceeeEEEe-----
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIR----------HKNIVKVLGFFHS-----  649 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~~~~~~~~-----  649 (876)
                      .+++|.++.||.++.. +|+.+|+|++......   ..+++++|.-....+.          |-.++-.++...-     
T Consensus        19 ~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~   98 (288)
T PF14531_consen   19 IIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPP   98 (288)
T ss_dssp             EEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-S
T ss_pred             ccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCc
Confidence            3344459999999665 6999999998654322   2355666665554432          2233333333321     


Q ss_pred             ----C---C-----eEEEEEEcCCCCCHHHHhhc---cC---CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccC
Q 002826          650 ----D---E-----SIFLIYEFLQMGSLGDLICR---QD---FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK  711 (876)
Q Consensus       650 ----~---~-----~~~lv~e~~~~gsL~~~l~~---~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~  711 (876)
                          .   .     ..+++|+-+. ++|.+++.-   ..   ..+....+..+..|+++.+++||+.   |++|+||||+
T Consensus        99 ~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~  174 (288)
T PF14531_consen   99 FFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPE  174 (288)
T ss_dssp             EEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGG
T ss_pred             ceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccccee
Confidence                1   1     2367888774 488877542   21   1244556677789999999999999   9999999999


Q ss_pred             ceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCC--------CCCCCccchHHHHHHHHHHHhCCCC
Q 002826          712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS--------KKATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       712 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                      |++++.+|.++++||+.....+.....     ...+..|.+||....        -.++.+.|.|++|+++|.|++|+.|
T Consensus       175 nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  175 NFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             GEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             eEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999887766543211     224466899996532        2468889999999999999999999


Q ss_pred             CCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCC
Q 002826          784 EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR  842 (876)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~R  842 (876)
                      |+....+...                   +..+..|. +.++.+.++|..+++++|.+|
T Consensus       250 f~~~~~~~~~-------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADP-------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTS-------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCccccc-------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9875443321                   11344555 777889999999999999988

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.74  E-value=4.4e-20  Score=168.27  Aligned_cols=164  Identities=30%  Similarity=0.497  Sum_probs=98.7

Q ss_pred             cCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCee
Q 002826          277 KANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQV  356 (876)
Q Consensus       277 ~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  356 (876)
                      .+.+++.|-||+|+++ .+|..++.+.+|+.|++.+|+|. ..|..++++++                        |+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~k------------------------lr~l   84 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPK------------------------LRIL   84 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchh------------------------hhhe
Confidence            3444445555555555 33334444444444444444444 33444444444                        4444


Q ss_pred             eccCcccCCCCCCccccccCccEEeCCCccccC-CCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCC
Q 002826          357 QIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYG-SLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT  435 (876)
Q Consensus       357 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  435 (876)
                      +++-|++. ..|.+|+.++.|+.|||+.|++.. .+|..|..+..|+-|+|+.|.+.-.+++++++++|+.|.+..|.+-
T Consensus        85 nvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll  163 (264)
T KOG0617|consen   85 NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL  163 (264)
T ss_pred             ecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh
Confidence            44444444 455555555555555555555543 4566666666777777777777766667777788888888888777


Q ss_pred             CCCCcCCCCCCCcceeeCCCCcccccCCCccccc
Q 002826          436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL  469 (876)
Q Consensus       436 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  469 (876)
                       ..|..++.+++|++|.+.+|+++ .+|..+.++
T Consensus       164 -~lpkeig~lt~lrelhiqgnrl~-vlppel~~l  195 (264)
T KOG0617|consen  164 -SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL  195 (264)
T ss_pred             -hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence             67777888888888888888887 566665554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=1.2e-17  Score=171.50  Aligned_cols=198  Identities=19%  Similarity=0.227  Sum_probs=140.8

Q ss_pred             cCccccceeeEEEe---------------------------CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHH
Q 002826          636 RHKNIVKVLGFFHS---------------------------DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGV  688 (876)
Q Consensus       636 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i  688 (876)
                      +|||||+++++|.+                           ..+.|+||.-.+. +|.+++..+  ..+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence            59999999987732                           2357999997766 999999765  35566677788999


Q ss_pred             HHHHHHhhccCCCCccccccccCceeeC--CC--CCeEEccccchhhccc----cccccccccccccccccCccccCCCC
Q 002826          689 AQGLAYLHKDYVPHLLHRNVKSKNILLD--AD--FEPKLTDFALDRIVGE----AAFQSTMSSEYALSCYNAPEYGYSKK  760 (876)
Q Consensus       689 ~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~--~~~kl~DfGla~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~  760 (876)
                      ++|+.|||.+   ||.|||+|++|||+.  +|  -...|+|||++---..    -.+........|....||||+....+
T Consensus       351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999   999999999999994  33  4578999998632211    11122233344677799999865332


Q ss_pred             ------CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHc
Q 002826          761 ------ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRC  834 (876)
Q Consensus       761 ------~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~c  834 (876)
                            --.++|.|+.|.+.||+++...||+.......+...+-+.              .++..+...+..+.+++...
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~--------------qLPalp~~vpp~~rqlV~~l  493 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQES--------------QLPALPSRVPPVARQLVFDL  493 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhh--------------hCCCCcccCChHHHHHHHHH
Confidence                  2357999999999999999999998744333222221111              11122223344577899999


Q ss_pred             cCCCCCCCCCHHHHHHHHh
Q 002826          835 TSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       835 l~~dP~~RPs~~ell~~L~  853 (876)
                      +.+||++|++..-..+.|.
T Consensus       494 L~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  494 LKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             hcCCccccCCccHHHhHHH
Confidence            9999999999887766654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=2.2e-18  Score=188.63  Aligned_cols=223  Identities=25%  Similarity=0.286  Sum_probs=174.4

Q ss_pred             CCCCceEEEEEE----eCCCcEEEEEEEecCCccC--HHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          591 NGGPFGRVYILS----LPSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       591 ~~g~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +.|+||.|++++    ...|.-+|+|+.++.....  +.....|..++..++ ||.+|++.-.++.+...+++++|..||
T Consensus         3 g~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg   82 (612)
T KOG0603|consen    3 GQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGG   82 (612)
T ss_pred             CcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccc
Confidence            456699999763    2357788999886543221  225567888999996 999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      .+...+.... .+++.........++-+++++|+.   +|+|||+|++||+++.+|.+++.|||+++..-+....     
T Consensus        83 ~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-----  153 (612)
T KOG0603|consen   83 DLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-----  153 (612)
T ss_pred             hhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-----
Confidence            9988886654 566667777778899999999999   9999999999999999999999999999876544322     


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                       +||..|||||++.  ....++|.||||++++||+||..||..   +      .+++.....           ...+.+.
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~------~~~~Il~~~-----------~~~p~~l  210 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D------TMKRILKAE-----------LEMPREL  210 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H------HHHHHhhhc-----------cCCchhh
Confidence             6899999999987  567889999999999999999999986   1      111111100           0122334


Q ss_pred             HHHHHHHHHHccCCCCCCCCCH
Q 002826          824 MLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~  845 (876)
                      ...+.+++..+...+|..|.-.
T Consensus       211 ~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  211 SAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hHHHHHHHHHHHhhCHHHHhcc
Confidence            4556788888999999999654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=4.2e-17  Score=191.38  Aligned_cols=246  Identities=15%  Similarity=0.193  Sum_probs=178.7

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc---CccccceeeEEEeCCeEEEEEEcCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR---HKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+..+.|.|+||.||+|...+|+.||+|+=+....   .+|---.+++.+|+   -+-|..+...+.-.+.-++|+||.+
T Consensus       701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~  777 (974)
T KOG1166|consen  701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSP  777 (974)
T ss_pred             EEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccc
Confidence            44455555559999999887899999998765432   22222233344444   3455666666667788899999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-------CCCCeEEccccchhhccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-------ADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-------~~~~~kl~DfGla~~~~~  734 (876)
                      .|||.+++. ....++|..++.+..|+++.+++||..   +|||+||||+|.++.       +..-++|+|||.+-.+.-
T Consensus       778 ~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~l  853 (974)
T KOG1166|consen  778 YGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKL  853 (974)
T ss_pred             cccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeE
Confidence            999999998 445799999999999999999999999   999999999999993       234589999999877653


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      -....+....++|-.+--+|...++.++.++|.|.++.+++-|+.|+..-                   ..++....+++
T Consensus       854 fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------------~~~g~~~~~~~  914 (974)
T KOG1166|consen  854 FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------------VKNGSSWMVKT  914 (974)
T ss_pred             cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------hcCCcceeccc
Confidence            22223455666888899999999999999999999999999999998521                   11112222233


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .+..++..+  ..-+++..+|.+|-..=|...++...++++..+
T Consensus       915 ~~~Ry~~~~--~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  915 NFPRYWKRD--MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             cchhhhhHH--HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            333333322  234566677775555558888888888886543

>PRK10345 hypothetical protein; Provisional

Probab=99.70  E-value=1.2e-16  Score=160.58  Aligned_cols=131  Identities=19%  Similarity=0.296  Sum_probs=102.0

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-----cCccccceeeEEEeCC---eEE-EEE
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-----RHKNIVKVLGFFHSDE---SIF-LIY  657 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~  657 (876)
                      ..+|.|+ ||.||. ...++.. +||++........+.+.+|+.+++.+     .||||++++|++.++.   ..+ +|+
T Consensus         8 ~~LG~G~-~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          8 SPLGTGR-HRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             ceecCCC-ceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            4455555 999996 3334444 79998765445567899999999999     5799999999998863   434 789


Q ss_pred             Ec--CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHH-HHhhccCCCCccccccccCceeeCC----CCCeEEcccc
Q 002826          658 EF--LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL-AYLHKDYVPHLLHRNVKSKNILLDA----DFEPKLTDFA  727 (876)
Q Consensus       658 e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~i~H~Dlkp~NIll~~----~~~~kl~DfG  727 (876)
                      ||  +.+++|.+++.+.  .+++.  ..++.+++.++ +|||+.   +|+||||||+||+++.    +++++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  5579999999653  35555  35577888777 999999   9999999999999973    3489999954

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=3.4e-17  Score=176.08  Aligned_cols=173  Identities=23%  Similarity=0.371  Sum_probs=132.1

Q ss_pred             eEEEEEEcCCCCCHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          652 SIFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      ..|+.|++|...+|.+|+.+.  +...++.....++.|++.|++|   +   +.+|||+||.||+...+.++||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            588999999999999999644  5568889999999999999999   6   8999999999999999999999999998


Q ss_pred             hhccccc----cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          730 RIVGEAA----FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       730 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      +......    .....+...||..||+||.+.+..|+.++||||+|++++|++.-   |.... +......      .+ 
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~-er~~t~~------d~-  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQF-ERIATLT------DI-  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHH-HHHHhhh------hh-
Confidence            8776433    23446677899999999999999999999999999999999982   11111 1110001      11 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFE  847 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  847 (876)
                        -...++|......+    .-+.++..++.+.|.+||++.+
T Consensus       473 --r~g~ip~~~~~d~p----~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  473 --RDGIIPPEFLQDYP----EEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             --hcCCCChHHhhcCc----HHHHHHHHhcCCCcccCchHHH
Confidence              12233333332222    2357889999999999994443

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=1.2e-15  Score=157.46  Aligned_cols=140  Identities=17%  Similarity=0.154  Sum_probs=106.1

Q ss_pred             ccCCCCCCCCceEEEEEE--eCCCcEEEEEEEecCCcc------------------------CHHHHHHHHHHHhhccCc
Q 002826          585 EKSSAGNGGPFGRVYILS--LPSGELIAVKKLVNFGCQ------------------------SSKTLKTEVKTLAKIRHK  638 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~h~  638 (876)
                      .+....+.|++|.||+|.  ..+|+.||+|++......                        ....+..|++.+.++.+.
T Consensus        31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~  110 (237)
T smart00090       31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA  110 (237)
T ss_pred             HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence            344445555599999997  568999999998653211                        012356899999999753


Q ss_pred             --cccceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCC-ccccccccCceee
Q 002826          639 --NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH-LLHRNVKSKNILL  715 (876)
Q Consensus       639 --niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-i~H~Dlkp~NIll  715 (876)
                        .+.+++++    ...++||||++|+++....... .......+..++.|++.++++||+.   + ++||||||+||++
T Consensus       111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli  182 (237)
T smart00090      111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILV  182 (237)
T ss_pred             CCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEE
Confidence              33444433    2358999999998887654332 2456667789999999999999999   8 9999999999999


Q ss_pred             CCCCCeEEccccchhhcc
Q 002826          716 DADFEPKLTDFALDRIVG  733 (876)
Q Consensus       716 ~~~~~~kl~DfGla~~~~  733 (876)
                      + +++++++|||.+...+
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999887554

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.63  E-value=2.3e-15  Score=153.88  Aligned_cols=131  Identities=18%  Similarity=0.320  Sum_probs=110.1

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccC--------HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQS--------SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      +.|++|.||+|.. .|..|++|+........        ...+.+|++++..++|++++....++.+.+..++||||++|
T Consensus         5 ~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G   83 (211)
T PRK14879          5 KRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEG   83 (211)
T ss_pred             ccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCC
Confidence            4455999999987 78889999875432211        13577899999999999998888887777888999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ++|.+++....    + .+..++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.++.
T Consensus        84 ~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         84 EPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             cCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999986532    2 7889999999999999999   999999999999999 78999999998754

>PLN03150 hypothetical protein; Provisional

Probab=99.61  E-value=1.7e-15  Score=178.08  Aligned_cols=152  Identities=32%  Similarity=0.529  Sum_probs=124.8

Q ss_pred             CChhHHHHHHHHHhhccCCCCCCCCCCCCCCCCC----ccccceEecCCCC-CccEEEEeecCCCCCcccccccccCCCC
Q 002826           26 SASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHY----CNWTGVTCVTTAT-ASLTVASINLQSLNLSGEISSSVCELSS  100 (876)
Q Consensus        26 ~~~~~~~all~~k~~~~~~~~~~~sW~~~~~~~~----C~w~gv~c~~~~~-~~~~~~~l~l~~~~l~~~~~~~~~~l~~  100 (876)
                      ..+.|.+||++||+++.++..  .+|.+.   .|    |.|.||+|..... ....+..++|.+++++|.+|..++.+++
T Consensus       369 t~~~~~~aL~~~k~~~~~~~~--~~W~g~---~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~  443 (623)
T PLN03150        369 TLLEEVSALQTLKSSLGLPLR--FGWNGD---PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH  443 (623)
T ss_pred             cCchHHHHHHHHHHhcCCccc--CCCCCC---CCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence            356789999999999976542  489643   23    2799999964322 2236889999999999999999999999


Q ss_pred             CCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCC
Q 002826          101 LSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF  180 (876)
Q Consensus       101 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  180 (876)
                      |+.|+|++|.+.+.+|..++.+++|+.|          ||++|+++|.+|+.++++++|++|+|++|+++|.+|..++.+
T Consensus       444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~L----------dLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~  513 (623)
T PLN03150        444 LQSINLSGNSIRGNIPPSLGSITSLEVL----------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR  513 (623)
T ss_pred             CCEEECCCCcccCcCChHHhCCCCCCEE----------ECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhc
Confidence            9999999999999999999999999877          555667788999999999999999999999999999888764


Q ss_pred             -CcceEEEccCCC
Q 002826          181 -SELVVLDLSQNA  192 (876)
Q Consensus       181 -~~L~~L~Ls~N~  192 (876)
                       .++..+++++|.
T Consensus       514 ~~~~~~l~~~~N~  526 (623)
T PLN03150        514 LLHRASFNFTDNA  526 (623)
T ss_pred             cccCceEEecCCc
Confidence             466778888886

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=3.5e-16  Score=179.53  Aligned_cols=203  Identities=20%  Similarity=0.237  Sum_probs=136.3

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .++...|+||.||.++++ ..+.+|+|+ .+..    .-.+.   ++.....|.+|                     |+.
T Consensus        88 IklisngAygavylvrh~~trqrfa~ki-Nkq~----lilRn---ilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN----LILRN---ILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcc-cccc----hhhhc---cccccCCccee---------------------chh
Confidence            345566779999999775 578888854 2211    01111   22222233332                     455


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc--------
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF--------  737 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--------  737 (876)
                      ...+...+ .++...        +.+++|+|+.   +|+|||+||+|.+|+.-|.+|+.|||+++.......        
T Consensus       139 ~tllk~~g-~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  139 ATLLKNIG-PLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             hhhcccCC-CCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence            55554433 343333        6789999999   999999999999999999999999999876421110        


Q ss_pred             ----cc-ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          738 ----QS-TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       738 ----~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                          .. .....+||+.|.|||++..+.|+..+|.|++|+++||.+.|+.||.++..++. +...+...+..        
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel-fg~visd~i~w--------  277 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL-FGQVISDDIEW--------  277 (1205)
T ss_pred             HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH-Hhhhhhhhccc--------
Confidence                01 11234799999999999999999999999999999999999999998766653 11111110000        


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCC
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRP  843 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  843 (876)
                          .+.......++.+++...++.+|.+|-
T Consensus       278 ----pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 ----PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                011112234577888999999999994

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.61  E-value=3.6e-15  Score=150.97  Aligned_cols=128  Identities=18%  Similarity=0.293  Sum_probs=104.2

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccC--------HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQS--------SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      +.|++|.||+|.+ +|..|++|+........        ..++.+|++++..++|+++.....++...+..++||||++|
T Consensus         3 g~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         3 AKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            4455999999985 77899999865422111        24567899999999988766666666667778999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ++|.+++.....        .++.+++.++.++|+.   +++|||++|.||+++ +++++++|||+++.
T Consensus        82 ~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998754321        7889999999999999   999999999999999 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=5.1e-15  Score=149.48  Aligned_cols=136  Identities=15%  Similarity=0.115  Sum_probs=104.5

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc----------------------CHHHHHHHHHHHhhccCcc--c
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ----------------------SSKTLKTEVKTLAKIRHKN--I  640 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n--i  640 (876)
                      ......+.|+||.||++..++|+.||||++......                      .......|+..+..+.|++  +
T Consensus        18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v   97 (198)
T cd05144          18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV   97 (198)
T ss_pred             hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence            334445556699999998889999999987543210                      1123567899999998774  4


Q ss_pred             cceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC
Q 002826          641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE  720 (876)
Q Consensus       641 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~  720 (876)
                      +..++    ....++||||++|++|.+....       ....+++.+++.++.++|+.   +++||||||+||+++++++
T Consensus        98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~  163 (198)
T cd05144          98 PKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEK  163 (198)
T ss_pred             Cceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCc
Confidence            44443    2445899999999998765421       23567889999999999998   9999999999999999999


Q ss_pred             eEEccccchhhccc
Q 002826          721 PKLTDFALDRIVGE  734 (876)
Q Consensus       721 ~kl~DfGla~~~~~  734 (876)
                      ++|+|||.+.....
T Consensus       164 ~~liDfg~~~~~~~  177 (198)
T cd05144         164 IYIIDWPQMVSTDH  177 (198)
T ss_pred             EEEEECCccccCCC
Confidence            99999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.56  E-value=1.5e-14  Score=168.40  Aligned_cols=130  Identities=18%  Similarity=0.202  Sum_probs=104.1

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCC-c-------cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFG-C-------QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ...+.|+||+||++.+... .+++|+..... .       ....++.+|+++++.++|++++....++.+....++||||
T Consensus       339 ~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~  417 (535)
T PRK09605        339 HLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY  417 (535)
T ss_pred             ceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence            3444455999999987544 44444432211 1       1124578899999999999999888888777788999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      +++++|.+++.         ....++.++++++.|||+.   +++|||+||+||++ +++.++++|||+++.
T Consensus       418 ~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        418 IGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999874         3567899999999999999   99999999999999 678999999999865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.6e-16  Score=177.26  Aligned_cols=247  Identities=23%  Similarity=0.255  Sum_probs=188.7

Q ss_pred             CCCCCCceEEEEEEeC--CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          589 AGNGGPFGRVYILSLP--SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      +| .|+|+.|-.....  ....+|+|.+....  .........|..+-+.+. |+|++.+++...+.+..+++++|..|+
T Consensus        28 ig-~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~  106 (601)
T KOG0590|consen   28 IG-KGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG  106 (601)
T ss_pred             cc-ccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence            45 6779999877543  34556777665433  222344556887777776 999999999999999999999999999


Q ss_pred             CHHHHh-hccCCcCCHHHHHHHHHHHHHHHHHhh-ccCCCCccccccccCceeeCCCC-CeEEccccchhhccc-ccccc
Q 002826          664 SLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGE-AAFQS  739 (876)
Q Consensus       664 sL~~~l-~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~-~~~~~  739 (876)
                      ++.+-+ .......+.......+.|+..++.|+| ..   ++.|||+||+|.+++..+ ..+++|||+|+.+.. .+...
T Consensus       107 ~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~  183 (601)
T KOG0590|consen  107 SLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER  183 (601)
T ss_pred             ccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcce
Confidence            999888 443335677778889999999999999 77   999999999999999999 999999999998876 44444


Q ss_pred             ccccccc-cccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          740 TMSSEYA-LSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       740 ~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      ......| ++.|+|||...+. ...+..|+||.|+++.-+++|..||............|........           .
T Consensus       184 ~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~  252 (601)
T KOG0590|consen  184 SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT-----------Q  252 (601)
T ss_pred             eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc-----------c
Confidence            5556667 9999999998874 5677899999999999999999999886665554444443321100           1


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+........+++.+++..+|..|.+.+++..
T Consensus       253 ~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  253 LPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             CccccCChhhhhcccccccCCchhccccccccc
Confidence            112222334567888999899999999887754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.50  E-value=1.8e-13  Score=141.56  Aligned_cols=136  Identities=18%  Similarity=0.184  Sum_probs=103.9

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCC-------------ccCHHHHHHHHHHHhhccCccc--cceeeEEEeCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFG-------------CQSSKTLKTEVKTLAKIRHKNI--VKVLGFFHSDE  651 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~  651 (876)
                      ..+|..|+.|+||.+.. .+..++||++....             ......+.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            34553455999999987 47889999885311             1223567889999999998875  67777654422


Q ss_pred             ----eEEEEEEcCCC-CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          652 ----SIFLIYEFLQM-GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       652 ----~~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                          ..++|||+++| .+|.+++.+.  .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.++++||
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDf  186 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDF  186 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEEC
Confidence                23599999997 6999888543  34443    356899999999999   9999999999999999889999999


Q ss_pred             cchhhc
Q 002826          727 ALDRIV  732 (876)
Q Consensus       727 Gla~~~  732 (876)
                      |.++..
T Consensus       187 g~~~~~  192 (239)
T PRK01723        187 DRGELR  192 (239)
T ss_pred             CCcccC
Confidence            987653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.49  E-value=1.6e-13  Score=137.30  Aligned_cols=134  Identities=19%  Similarity=0.186  Sum_probs=94.3

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccCH--HH----------------------HHHHHHHHhhccCcc--ccce
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KT----------------------LKTEVKTLAKIRHKN--IVKV  643 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~E~~~l~~l~h~n--iv~~  643 (876)
                      .+.|+||+||+|...+|+.||||++........  ..                      ...|.+.+.++.+..  +.+.
T Consensus         5 lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~   84 (187)
T cd05119           5 IGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKP   84 (187)
T ss_pred             cccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCce
Confidence            344559999999888899999999865322111  11                      134566666664432  4444


Q ss_pred             eeEEEeCCeEEEEEEcCCCCCHHH-HhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCe
Q 002826          644 LGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       644 ~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      +++    ...++||||++++++.. .+....  . .....+++.+++.++.++|. .   +|+|||+||+||+++ ++.+
T Consensus        85 ~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          85 IDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             Eec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcE
Confidence            433    24689999999954321 111111  1 15678899999999999999 7   999999999999999 8999


Q ss_pred             EEccccchhhccc
Q 002826          722 KLTDFALDRIVGE  734 (876)
Q Consensus       722 kl~DfGla~~~~~  734 (876)
                      +++|||.+.....
T Consensus       154 ~liDfg~a~~~~~  166 (187)
T cd05119         154 YIIDVPQAVEIDH  166 (187)
T ss_pred             EEEECcccccccC
Confidence            9999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.49  E-value=1.5e-13  Score=132.06  Aligned_cols=131  Identities=25%  Similarity=0.237  Sum_probs=109.5

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC--ccccceeeEEEeCCeEEEEEEcCCCCCHHH
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSDESIFLIYEFLQMGSLGD  667 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~  667 (876)
                      .+.|.++.||++...+ ..+++|.......  ...+.+|+..++.++|  .++++++++...++..+++|||++++.+..
T Consensus         6 i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~   82 (155)
T cd05120           6 LKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE   82 (155)
T ss_pred             cccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence            3445599999998744 7899999865432  5678999999999976  599999998888888999999999877654


Q ss_pred             HhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       668 ~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      +        +......++.+++++++++|.....+++|+|++|+||++++++.++++|||.++.
T Consensus        83 ~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          83 V--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             C--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            3        5567778899999999999997444799999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PLN03150 hypothetical protein; Provisional

Probab=99.48  E-value=4.1e-14  Score=166.41  Aligned_cols=114  Identities=39%  Similarity=0.632  Sum_probs=72.9

Q ss_pred             ccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccC
Q 002826          401 MSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSF  478 (876)
Q Consensus       401 L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~  478 (876)
                      ++.|+|++|.++|.+| .+..+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+|+|.+|..+..+ +|+.||+++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            4556666666665555 56666666666666666666666666666666666666666666666666655 366666666


Q ss_pred             CccccccCCccc---CCCCCccccCCCCCCCCCCCCCCC
Q 002826          479 NKLSGRVPYSLI---SGLPASYLQGNPGLCGPGLSNSCD  514 (876)
Q Consensus       479 N~l~~~~p~~~~---~~~~~~~~~~N~~~C~~~~~~~c~  514 (876)
                      |+++|.+|..+.   .....+.+.+|+.+|+.+....|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence            666666664431   223456788999999987666785

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.45  E-value=3.7e-15  Score=160.18  Aligned_cols=192  Identities=28%  Similarity=0.460  Sum_probs=98.4

Q ss_pred             EecccCccCCCCCCcccc-ccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccc
Q 002826          235 LDLSQNNLTGEVPQSLGS-SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       235 L~Ls~N~l~~~ip~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      |.|++-++. ..|...+. .+.--...||+.|++. .+|..++.+..|+.+.|.+|.|. .+|.++.++..|.+|+|+.|
T Consensus        55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N  131 (722)
T KOG0532|consen   55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN  131 (722)
T ss_pred             cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence            444444554 44433222 2333344556666655 45555555555555555555555 45555555555555555555


Q ss_pred             cCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCC
Q 002826          314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP  393 (876)
Q Consensus       314 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~  393 (876)
                      +++ ..|..++.++ |+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++                     
T Consensus       132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~---------------------  186 (722)
T KOG0532|consen  132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG---------------------  186 (722)
T ss_pred             hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh---------------------
Confidence            555 4455555443 445555555554 33444444444444555555444 3444444                     


Q ss_pred             CcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc
Q 002826          394 NFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       394 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                         ++..|+.|++..|++...++++. .-.|..||+|.|+++ .+|-.|..|..|++|-|.+|.|+
T Consensus       187 ---~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  187 ---YLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             ---hHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence               44444444555555544444444 223555555555555 55555555666666666666555

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.43  E-value=6.2e-15  Score=158.50  Aligned_cols=167  Identities=29%  Similarity=0.522  Sum_probs=76.3

Q ss_pred             ecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCC
Q 002826          139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGF  218 (876)
Q Consensus       139 dL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l  218 (876)
                      ||+.|++. .+|..+..+..|+.|.|++|.+. .+|..+.++..|++|||+.|+  +..+|..+..++ |+.|-+++|++
T Consensus        81 DlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq--lS~lp~~lC~lp-Lkvli~sNNkl  155 (722)
T KOG0532|consen   81 DLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ--LSHLPDGLCDLP-LKVLIVSNNKL  155 (722)
T ss_pred             hccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch--hhcCChhhhcCc-ceeEEEecCcc
Confidence            44444443 44444444445555555555554 444445555555555555554  334444333332 44444444444


Q ss_pred             cccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCC
Q 002826          219 HGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS  298 (876)
Q Consensus       219 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  298 (876)
                      +. +|..++.+..|..||.+.|+|. .+|..+. ++.+|+.|.+..|++. .+|..++.++ |..||+|.|++. .+|-.
T Consensus       156 ~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~-~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~  229 (722)
T KOG0532|consen  156 TS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG-YLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVD  229 (722)
T ss_pred             cc-CCcccccchhHHHhhhhhhhhh-hchHHhh-hHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchh
Confidence            42 2333444444444444444444 4444433 2444444444444444 3333343322 444444444444 44444


Q ss_pred             CccccccceeecccccCC
Q 002826          299 INECLNLERFQVQDNGFS  316 (876)
Q Consensus       299 ~~~l~~L~~L~L~~N~l~  316 (876)
                      |..|..|++|.|.+|.+.
T Consensus       230 fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  230 FRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             hhhhhhheeeeeccCCCC
Confidence            555555555555555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.5e-13  Score=152.92  Aligned_cols=147  Identities=32%  Similarity=0.455  Sum_probs=83.0

Q ss_pred             eecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccC-cccEEEecCCCCcccCCccccCCCCCcEEeccc
Q 002826          161 VLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLE-KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ  239 (876)
Q Consensus       161 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  239 (876)
                      .|+++.|.+. ........++.++.|++.+|.  +..+|.....+. +|+.|++++|++.. +|..+..+++|+.|++++
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~--i~~i~~~~~~~~~nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNN--ITDIPPLIGLLKSNLKELDLSDNKIES-LPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcc--cccCccccccchhhcccccccccchhh-hhhhhhccccccccccCC
Confidence            5677777664 223334455677777777776  666766666664 67777777777663 334566667777777777


Q ss_pred             CccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       240 N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      |+++ .+|.... ..++|+.|++++|+++ .+|.....+..|++|.+++|.+. ..+..+..+.++..+.+.+|++
T Consensus       173 N~l~-~l~~~~~-~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~  244 (394)
T COG4886         173 NDLS-DLPKLLS-NLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL  244 (394)
T ss_pred             chhh-hhhhhhh-hhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCcee
Confidence            7776 5555432 3566666666666666 44444334444555555555322 2333333444444444444433

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.5e-13  Score=152.93  Aligned_cols=197  Identities=29%  Similarity=0.443  Sum_probs=125.5

Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCC-cceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFS-ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      ++++.|++.. .+..+..++.++.|++.+|.++ .+|.....+. +|++|++++|+  +..+|..+..+++|+.|++++|
T Consensus        98 l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~--i~~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          98 LDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK--IESLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccc--hhhhhhhhhccccccccccCCc
Confidence            3444555432 2333445577788888888887 5555556664 78888888887  6667667777888888888888


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP  296 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~  296 (876)
                      +++.+ |.....+++|+.|++++|+++ .+|.... ....|++|++++|++. ..+..+.++.++..|.+.+|++.. .+
T Consensus       174 ~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~  248 (394)
T COG4886         174 DLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LP  248 (394)
T ss_pred             hhhhh-hhhhhhhhhhhheeccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-cc
Confidence            87744 333446777888888888887 7776541 2445778888888543 456667777777777777777763 24


Q ss_pred             CCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCcc
Q 002826          297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD  345 (876)
Q Consensus       297 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~  345 (876)
                      ..+..++++++|++++|+++...+  +..+.+++.|++++|.+...+|.
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             chhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence            555555566666666666653322  55555555555555555544433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=5.2e-13  Score=134.83  Aligned_cols=207  Identities=21%  Similarity=0.295  Sum_probs=143.9

Q ss_pred             HHHHHhhccCccccceeeEEEeCC-----eEEEEEEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccC
Q 002826          628 EVKTLAKIRHKNIVKVLGFFHSDE-----SIFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDY  699 (876)
Q Consensus       628 E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~  699 (876)
                      -+.-+-++.|.|+|+++.|+.+.+     ...++.||+..|++.+++++.   ...+....-.+++.||..||.|||+. 
T Consensus       117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            344555668999999999987643     478999999999999999764   45677888899999999999999994 


Q ss_pred             CCCccccccccCceeeCCCCCeEEccccchhhcc--ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHH
Q 002826          700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL  777 (876)
Q Consensus       700 ~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~el  777 (876)
                      .|+|+|+++.-+-|++..+|-+|+.----.....  ............+.++|.|||.-..-..+.++|||+||....||
T Consensus       196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            6799999999999999999988886321111100  11111112233467889999987777778899999999999999


Q ss_pred             HhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          778 ITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       778 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ..+..--.. .........-..+...   +...-              .-..++.+|++.+|..||+|++++...-
T Consensus       276 ailEiq~tn-seS~~~~ee~ia~~i~---~len~--------------lqr~~i~kcl~~eP~~rp~ar~llfHpl  333 (458)
T KOG1266|consen  276 AILEIQSTN-SESKVEVEENIANVII---GLENG--------------LQRGSITKCLEGEPNGRPDARLLLFHPL  333 (458)
T ss_pred             HHheeccCC-Ccceeehhhhhhhhee---eccCc--------------cccCcCcccccCCCCCCcchhhhhcCce
Confidence            887642111 1111110111111100   01111              1235788999999999999999876543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.35  E-value=3.4e-12  Score=143.55  Aligned_cols=141  Identities=20%  Similarity=0.191  Sum_probs=96.5

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccC----------------------------------------HHHHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQS----------------------------------------SKTLK  626 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~  626 (876)
                      ..++++ ++|.||+|+.++|+.||||+.+......                                        +-.+.
T Consensus       123 ~plasa-SigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAA-SIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeee-ehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            445555 4999999999999999999985431100                                        00233


Q ss_pred             HHHHHHhhcc----CccccceeeEEE-eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHH-HHHHhhccCC
Q 002826          627 TEVKTLAKIR----HKNIVKVLGFFH-SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ-GLAYLHKDYV  700 (876)
Q Consensus       627 ~E~~~l~~l~----h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~~~  700 (876)
                      +|+..+.+++    |.+-+.+-.++. .....++||||++|+++.++........   .+.+++..++. .+.++|..  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~--  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD--  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC--
Confidence            4555555552    222222222222 2445789999999999988764321122   23456666665 47888988  


Q ss_pred             CCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       701 ~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                       |++|+|+||.||+++.+++++++|||++..+..
T Consensus       277 -g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 -GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=6.4e-12  Score=138.63  Aligned_cols=243  Identities=23%  Similarity=0.214  Sum_probs=177.5

Q ss_pred             CCceEEEEEEe---CCCcEEEEEEEe--cCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          593 GPFGRVYILSL---PSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       593 g~~g~Vy~~~~---~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      |.+|.||.++.   .++..+|+|+-+  .........-.+|+...+.+ .|++.++.+..+.+.+..++-+|++. .++.
T Consensus       127 g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~  205 (524)
T KOG0601|consen  127 GSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQ  205 (524)
T ss_pred             CCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhH
Confidence            55999999865   578999999843  33334445556788888878 49999999999999999999999886 5899


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHH----HHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhcccccccccc
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQ----GLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++.+.....++....+....+..+    |+.++|..   +++|-|+||.||+...+ ...+++|||+...++........
T Consensus       206 ~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~  282 (524)
T KOG0601|consen  206 SYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVF  282 (524)
T ss_pred             HhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccce
Confidence            888777666888888888888888    99999999   99999999999999999 88999999999888755422211


Q ss_pred             ---ccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          742 ---SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       742 ---~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                         -...|...|++||...+ -++...|+|++|.+..+..++..+......     ..|.+.        .....|  .+
T Consensus       283 ~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----~~W~~~--------r~~~ip--~e  346 (524)
T KOG0601|consen  283 KVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN-----SSWSQL--------RQGYIP--LE  346 (524)
T ss_pred             eeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC-----CCcccc--------ccccCc--hh
Confidence               11246667999998654 568889999999999999998765432211     112111        111100  01


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      +...-..++...+..|++.+|-.|++++++. .+.-|.
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~-~l~~i~  383 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILT-ALNVIH  383 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHh-cccccc
Confidence            2222233445588899999999999887554 344443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.21  E-value=2.2e-10  Score=127.47  Aligned_cols=167  Identities=20%  Similarity=0.283  Sum_probs=129.2

Q ss_pred             EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHH
Q 002826          602 SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR  681 (876)
Q Consensus       602 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~  681 (876)
                      +..++.+|.|...............+-++.++.+|||||+++++.++.++..|+|+|-+.  .|..++.+.+    ...+
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            455899999999876654445667888999999999999999999999999999999875  4666775543    5566


Q ss_pred             HHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCC
Q 002826          682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA  761 (876)
Q Consensus       682 ~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  761 (876)
                      .--+.||+.||.+||+.+  +++|+++.-+-|+|+..|+.||++|.++........  .....+--..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence            777899999999999764  899999999999999999999999988765432221  011111122366777654332 


Q ss_pred             CCccchHHHHHHHHHHHhC
Q 002826          762 TAQMDAYSFGVVLLELITG  780 (876)
Q Consensus       762 ~~~~Dv~SlGv~l~elltg  780 (876)
                       -..|.|-||++++|++.|
T Consensus       182 -~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             -cchhhhhHHHHHHHHhCc
Confidence             345999999999999999

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.18  E-value=7.1e-11  Score=116.08  Aligned_cols=126  Identities=21%  Similarity=0.127  Sum_probs=91.9

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCcccc-ceeeEEEeCCeEEEEEEcCCCCCHHHHh
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIV-KVLGFFHSDESIFLIYEFLQMGSLGDLI  669 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL~~~l  669 (876)
                      .+|.++.||+++. .++.|++|+..... .....+..|+.+++.+.+.+++ +++++.  ....++||||++|.++.+. 
T Consensus         7 ~~G~~~~vy~~~~-~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~-   81 (170)
T cd05151           7 KGGMTNKNYRVEV-ANKKYVVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE-   81 (170)
T ss_pred             CCcccCceEEEEE-CCeEEEEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc-
Confidence            4556999999987 47889999875432 1234567899999999765554 444443  3345799999999887543 


Q ss_pred             hccCCcCCHHHHHHHHHHHHHHHHHhhccC--CCCccccccccCceeeCCCCCeEEccccchh
Q 002826          670 CRQDFQLQWSIRLKIAIGVAQGLAYLHKDY--VPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       670 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                           .   ......+.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        82 -----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          82 -----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             -----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence                 0   112345678999999999982  12369999999999999 6689999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.17  E-value=1.7e-12  Score=136.05  Aligned_cols=210  Identities=24%  Similarity=0.263  Sum_probs=128.1

Q ss_pred             cCCCCCCcccCCCcccceeecCCccccccCC--CccCCccccceecccccccCCCcC--ccccCCCcceEEEccCCCCcC
Q 002826          120 SQCSSLETLNLSNNLIWVLDLSRNHIEGKIP--ESIGSLVNLQVLNLGSNLLSGSVP--FVFGNFSELVVLDLSQNAYLI  195 (876)
Q Consensus       120 ~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~~~~  195 (876)
                      +++++|++..|.+..+          . ..+  .....+++++.||||+|-++...|  .....|++|+.|+||.|++..
T Consensus       118 sn~kkL~~IsLdn~~V----------~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~  186 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRV----------E-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSN  186 (505)
T ss_pred             hhHHhhhheeecCccc----------c-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccC
Confidence            4566666665555433          1 122  245566777777777776663322  344567777777777776432


Q ss_pred             CCCCCcccccCcccEEEecCCCCccc-CCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCC--
Q 002826          196 SEIPSDIGKLEKLEQLFLQSSGFHGV-IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP--  272 (876)
Q Consensus       196 ~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~--  272 (876)
                      ..-...-..++.|+.|.|+.|.++-. +-.....+++|+.|+|..|... .+...-...+..|+.|||++|++- ..+  
T Consensus       187 ~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~-~~~~~~~~i~~~L~~LdLs~N~li-~~~~~  264 (505)
T KOG3207|consen  187 FISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEII-LIKATSTKILQTLQELDLSNNNLI-DFDQG  264 (505)
T ss_pred             CccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhccccc-ceecchhhhhhHHhhccccCCccc-ccccc
Confidence            22112223566777788888877632 2223445677888888888422 122222234567888888888776 333  


Q ss_pred             cccccCCccceeeeecccccccC-CCC-----CccccccceeecccccCCCCC-CcccCCCCcccEEEecCCccccc
Q 002826          273 NGICKANGLVNLSLHKNFFNGSI-PGS-----INECLNLERFQVQDNGFSGDF-PDKLWSLPRIKLIRAESNRFSGA  342 (876)
Q Consensus       273 ~~~~~l~~L~~L~L~~N~i~~~~-~~~-----~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~  342 (876)
                      .....++.|+.|+++.+.|..+- |+.     ...+++|++|+++.|+|..-. -..+..+++|+.|....|.++..
T Consensus       265 ~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e  341 (505)
T KOG3207|consen  265 YKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE  341 (505)
T ss_pred             cccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccccc
Confidence            34567778888888888777542 222     356678889999999886221 23566677888888888888743

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.17  E-value=3.9e-12  Score=143.49  Aligned_cols=228  Identities=24%  Similarity=0.302  Sum_probs=110.9

Q ss_pred             ccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCC
Q 002826          152 SIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQS  231 (876)
Q Consensus       152 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  231 (876)
                      .+..+++|+.|+|.+|+|.. +...+..+++|++|+|++|.  ++.+ ..+..++.|+.|++.+|.|+.+  ..+..+.+
T Consensus        90 ~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~--I~~i-~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~  163 (414)
T KOG0531|consen   90 HLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNK--ITKL-EGLSTLTLLKELNLSGNLISDI--SGLESLKS  163 (414)
T ss_pred             ccccccceeeeeccccchhh-cccchhhhhcchheeccccc--cccc-cchhhccchhhheeccCcchhc--cCCccchh
Confidence            35556666666666666653 22225556666666666665  3333 2344455566666666666533  33444666


Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      |+.+++++|+++ .+.......+.+++.+++.+|.+.  ....+..+..+..+++..|.++.+.+-....+..|+.+++.
T Consensus       164 L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~  240 (414)
T KOG0531|consen  164 LKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLS  240 (414)
T ss_pred             hhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcc
Confidence            666666666666 343310123555666666666654  22233334444444555555542222111111124444444


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCC-
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGS-  390 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-  390 (876)
                      +|++. ..+                        ..+..+.++..|++.+|++...  ..+...+.+..+.+..|.+... 
T Consensus       241 ~n~i~-~~~------------------------~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  293 (414)
T KOG0531|consen  241 GNRIS-RSP------------------------EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSE  293 (414)
T ss_pred             cCccc-ccc------------------------ccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchh
Confidence            44444 111                        3344445555555555555421  1233334444555555554321 


Q ss_pred             --CCCC-cCCCCCccEEEccCCccccCC
Q 002826          391 --LPPN-FCDSPVMSIINLSQNSISGQI  415 (876)
Q Consensus       391 --~~~~-~~~~~~L~~L~Ls~N~l~~~~  415 (876)
                        .... ....+.++.+.+..|.+....
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (414)
T KOG0531|consen  294 AISQEYITSAAPTLVTLTLELNPIRKIS  321 (414)
T ss_pred             hhhccccccccccccccccccCcccccc
Confidence              1111 344566677777777766543

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.17  E-value=5.6e-11  Score=134.99  Aligned_cols=148  Identities=15%  Similarity=0.135  Sum_probs=92.3

Q ss_pred             chhhhhhcccccCCCCCCCCceEEEEEEeCC-CcEEEEEEEecCCcc---------------------------------
Q 002826          575 TEHDLVIGMDEKSSAGNGGPFGRVYILSLPS-GELIAVKKLVNFGCQ---------------------------------  620 (876)
Q Consensus       575 ~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------------  620 (876)
                      +.+++...|+. ..+++ |++|.||+|+.++ |+.||||+..+....                                 
T Consensus       114 ~~~~~F~~fd~-~Plas-aSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~  191 (537)
T PRK04750        114 PVEEWFDDFDI-KPLAS-ASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA  191 (537)
T ss_pred             CHHHHHHhcCh-hhhcC-CCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence            34455555655 55555 5599999999987 999999999643110                                 


Q ss_pred             -CHH------HHHHHHHHHhhcc----CccccceeeEEEe-CCeEEEEEEcCCCCCHHHHh--hccCC---cCCHHHHHH
Q 002826          621 -SSK------TLKTEVKTLAKIR----HKNIVKVLGFFHS-DESIFLIYEFLQMGSLGDLI--CRQDF---QLQWSIRLK  683 (876)
Q Consensus       621 -~~~------~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~---~l~~~~~~~  683 (876)
                       ..+      ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.++-  ...+.   .+....+..
T Consensus       192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~  271 (537)
T PRK04750        192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEV  271 (537)
T ss_pred             HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHH
Confidence             011      1233444333332    2223333333322 44567999999999998753  22221   122222222


Q ss_pred             HHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccccchhhccc
Q 002826          684 IAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDFALDRIVGE  734 (876)
Q Consensus       684 i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~DfGla~~~~~  734 (876)
                      ++       ..+...   |++|+|+||.||+++.++    +++++|||++..+..
T Consensus       272 ~~-------~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        272 FF-------TQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HH-------HHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            33       333455   999999999999999887    999999999877653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.17  E-value=6.2e-12  Score=125.25  Aligned_cols=130  Identities=21%  Similarity=0.304  Sum_probs=73.5

Q ss_pred             ccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEe
Q 002826          302 CLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFS  381 (876)
Q Consensus       302 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  381 (876)
                      ...|+++||++|.|+ .+.++..-+|+++.|++++|.|..+.  .+..+.+|+.||||+|.++ .+..+-..+       
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KL-------  351 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKL-------  351 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhh-------
Confidence            344555555555555 44444555555555555555554322  1444555555555555554 222232333       


Q ss_pred             CCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCC-CcCCCCCCCcceeeCCCCcccc
Q 002826          382 ASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEI-PPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       382 ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                                       -+.+.|.|+.|.|. ....+.++-+|..||+++|+|.... -..++++|.|+.|.|.+|.|.+
T Consensus       352 -----------------GNIKtL~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  352 -----------------GNIKTLKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             -----------------cCEeeeehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence                             34444455555443 2224566677888888888877433 2567888888888888888874

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.14  E-value=5.7e-12  Score=132.24  Aligned_cols=209  Identities=17%  Similarity=0.156  Sum_probs=150.4

Q ss_pred             CCccccceecccccccCCCcC--ccccCCCcceEEEccCCCCcCCCCC---CcccccCcccEEEecCCCCcccCCcc-cc
Q 002826          154 GSLVNLQVLNLGSNLLSGSVP--FVFGNFSELVVLDLSQNAYLISEIP---SDIGKLEKLEQLFLQSSGFHGVIPDS-FV  227 (876)
Q Consensus       154 ~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~~~~~~~p---~~~~~l~~L~~L~L~~n~l~~~~~~~-~~  227 (876)
                      .++.+|+...|.+.... ..+  .....+++++.||||+|-  +...-   .-...|++|+.|+|+.|++....... -.
T Consensus       118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL--~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~  194 (505)
T KOG3207|consen  118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNL--FHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTL  194 (505)
T ss_pred             hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhh--HHhHHHHHHHHHhcccchhcccccccccCCccccchh
Confidence            46788999999988876 333  467789999999999994  32221   22467899999999999986433322 22


Q ss_pred             CCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC-CCCccccccc
Q 002826          228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP-GSINECLNLE  306 (876)
Q Consensus       228 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~  306 (876)
                      .++.|+.|.|+.+.++..--..+...+|+|+.|+|..|...+.......-+..|+.|||++|++-.... ...+.++.|+
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence            478899999999998832222333458899999999996444555556678889999999998874332 3467888899


Q ss_pred             eeecccccCCCCC-Ccc-----cCCCCcccEEEecCCcccccC-ccccccCCCCCeeeccCcccCC
Q 002826          307 RFQVQDNGFSGDF-PDK-----LWSLPRIKLIRAESNRFSGAI-PDSISMAAQLEQVQIDNNRFTS  365 (876)
Q Consensus       307 ~L~L~~N~l~~~~-p~~-----~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  365 (876)
                      .|+++.+.+..+- |+.     ...+++|++|++..|+|.... -..+..+.+|+.|....|.++.
T Consensus       275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            9999999887543 333     356789999999999985321 2345567778888888888873

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.11  E-value=4.3e-11  Score=115.61  Aligned_cols=108  Identities=30%  Similarity=0.362  Sum_probs=23.8

Q ss_pred             CccccceecccccccCCCcCcccc-CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFG-NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      +..++++|+|++|+|+.+ . .++ .+.+|+.|||++|.  +..++ .+..+++|++|++++|+|+.+.+.....+++|+
T Consensus        17 n~~~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~--I~~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQ--ITKLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS----S--T-T----TT--EEE--SS---S-CHHHHHH-TT--
T ss_pred             cccccccccccccccccc-c-chhhhhcCCCEEECCCCC--Ccccc-CccChhhhhhcccCCCCCCccccchHHhCCcCC
Confidence            334566666666666632 2 233 45566666666665  33332 344455555555555555543221112355555


Q ss_pred             EEecccCccCCCCCC-ccccccccccEEEecccccc
Q 002826          234 ILDLSQNNLTGEVPQ-SLGSSLLKLVSFDVSQNKLS  268 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~  268 (876)
                      +|+|++|+|. .+.. .....+++|+.|+|.+|.++
T Consensus        92 ~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   92 ELYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EEE-TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             EEECcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence            5555555554 2211 11123444555555555444

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.11  E-value=1.5e-11  Score=138.70  Aligned_cols=249  Identities=24%  Similarity=0.274  Sum_probs=149.4

Q ss_pred             CCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          154 GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       154 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      ..+..++.++++.|.+.. +-..+..+++|+.|++.+|+  +..+...+..+.+|++|+|++|+|+.+  ..+..++.|+
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~--i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~  143 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNK--IEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLK  143 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccc--hhhcccchhhhhcchheeccccccccc--cchhhccchh
Confidence            345566666677777763 33445566666666666665  444433344444555555555554433  2233344444


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC-CCCccccccceeeccc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP-GSINECLNLERFQVQD  312 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~  312 (876)
                      .|++++|.|+ .++                          .+..++.|+.+++++|++..+.+ . ...+.+++.+++.+
T Consensus       144 ~L~l~~N~i~-~~~--------------------------~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~  195 (414)
T KOG0531|consen  144 ELNLSGNLIS-DIS--------------------------GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGG  195 (414)
T ss_pred             hheeccCcch-hcc--------------------------CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccC
Confidence            4444444444 222                          23335555555555555553333 2 35556666666666


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCC--CCCeeeccCcccCCCCCCccccccCccEEeCCCccccCC
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAA--QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGS  390 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  390 (876)
                      |.+..  ...+..+..+..+++..|+++..-+-  ..+.  +|+.+++++|++. .++..+..+..+..+++.+|++...
T Consensus       196 n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~~l--~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~  270 (414)
T KOG0531|consen  196 NSIRE--IEGLDLLKKLVLLSLLDNKISKLEGL--NELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL  270 (414)
T ss_pred             Cchhc--ccchHHHHHHHHhhcccccceeccCc--ccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc
Confidence            66652  22333444555557777777643321  1222  4899999999998 4557788889999999999998643


Q ss_pred             CCCCcCCCCCccEEEccCCccccC---Cc--CcccccccceEeccCCcCCCCCCcCC
Q 002826          391 LPPNFCDSPVMSIINLSQNSISGQ---IP--ELKKCRKLVSLSLADNSLTGEIPPSL  442 (876)
Q Consensus       391 ~~~~~~~~~~L~~L~Ls~N~l~~~---~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~  442 (876)
                      -  .+.....+..+.++.|.+...   ..  .....++++.+.+..|.+....+...
T Consensus       271 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (414)
T KOG0531|consen  271 E--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSLDL  325 (414)
T ss_pred             c--cccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccccH
Confidence            2  344566777888899988742   22  26778999999999999987665443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.1e-11  Score=115.74  Aligned_cols=109  Identities=32%  Similarity=0.401  Sum_probs=29.4

Q ss_pred             cCCCcceEEEccCCCCcCCCCCCccc-ccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccc
Q 002826          178 GNFSELVVLDLSQNAYLISEIPSDIG-KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK  256 (876)
Q Consensus       178 ~~l~~L~~L~Ls~N~~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  256 (876)
                      .+..++++|+|++|+  +..+. .++ .+.+|+.|+|++|+|+.+  +.+..++.|++|++++|+|+ .+++.+...+++
T Consensus        16 ~n~~~~~~L~L~~n~--I~~Ie-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~   89 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQ--ISTIE-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN   89 (175)
T ss_dssp             -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred             ccccccccccccccc--ccccc-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence            344566777777776  44442 344 456667777777776644  24566666677777777666 554433334666


Q ss_pred             ccEEEeccccccCcCC-cccccCCccceeeeeccccc
Q 002826          257 LVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       257 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~  292 (876)
                      |++|+|++|+|..... ..+..+++|+.|+|.+|.+.
T Consensus        90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            6666666666653221 23344455555555555544

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.10  E-value=2.8e-12  Score=131.17  Aligned_cols=250  Identities=20%  Similarity=0.303  Sum_probs=120.1

Q ss_pred             ccccCCCCCCeeecCCCccccc----cCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccc
Q 002826           93 SSVCELSSLSNLNLADNLFNQP----IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNL  168 (876)
Q Consensus        93 ~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~  168 (876)
                      +.+-.+.+++.|+||+|.|...    +...+.+.++|+..++|+       +---+....+|+.+..             
T Consensus        24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-------~ftGR~~~Ei~e~L~~-------------   83 (382)
T KOG1909|consen   24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-------MFTGRLKDEIPEALKM-------------   83 (382)
T ss_pred             HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-------hhcCCcHHHHHHHHHH-------------
Confidence            3445566777777777777542    344455566666665552       1111222233332211             


Q ss_pred             cCCCcCccccCCCcceEEEccCCCCcCCCCCC---cccccCcccEEEecCCCCcccCCcc-------------ccCCCCC
Q 002826          169 LSGSVPFVFGNFSELVVLDLSQNAYLISEIPS---DIGKLEKLEQLFLQSSGFHGVIPDS-------------FVGLQSL  232 (876)
Q Consensus       169 l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~---~~~~l~~L~~L~L~~n~l~~~~~~~-------------~~~l~~L  232 (876)
                          ...++...++|++||||+|.+-...++.   -+.....|++|+|.+|.+.-.--..             ...-+.|
T Consensus        84 ----l~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~L  159 (382)
T KOG1909|consen   84 ----LSKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKL  159 (382)
T ss_pred             ----HHHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcce
Confidence                1123344456777777777643222221   2455667777777777765221111             1223345


Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc----CCCCCcccccccee
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS----IPGSINECLNLERF  308 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L  308 (876)
                      +++..++|++. .-+..                    .+...|...+.|+.+.++.|.|...    ....|..+++|+.|
T Consensus       160 rv~i~~rNrle-n~ga~--------------------~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevL  218 (382)
T KOG1909|consen  160 RVFICGRNRLE-NGGAT--------------------ALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVL  218 (382)
T ss_pred             EEEEeeccccc-cccHH--------------------HHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceee
Confidence            55555555554 22110                    0111233334444444444444311    11234455555555


Q ss_pred             ecccccCCCC----CCcccCCCCcccEEEecCCcccccCcccc-----ccCCCCCeeeccCcccCCC----CCCcccccc
Q 002826          309 QVQDNGFSGD----FPDKLWSLPRIKLIRAESNRFSGAIPDSI-----SMAAQLEQVQIDNNRFTSS----IPQGLGSVK  375 (876)
Q Consensus       309 ~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~p~~~~~l~  375 (876)
                      ||.+|-|+..    +...++.+++|+.|+++++.+......+|     ...++|+.|.+.+|.|+..    +...+...+
T Consensus       219 dl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~  298 (382)
T KOG1909|consen  219 DLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKP  298 (382)
T ss_pred             ecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcch
Confidence            5555555421    22344555556666666555554433332     2245666666666666521    222334456


Q ss_pred             CccEEeCCCccc
Q 002826          376 SLYRFSASQNSF  387 (876)
Q Consensus       376 ~L~~L~ls~N~l  387 (876)
                      .|..|+|++|.+
T Consensus       299 dL~kLnLngN~l  310 (382)
T KOG1909|consen  299 DLEKLNLNGNRL  310 (382)
T ss_pred             hhHHhcCCcccc
Confidence            677777777776

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=9.8e-11  Score=129.37  Aligned_cols=248  Identities=21%  Similarity=0.176  Sum_probs=174.0

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe--CCCcEEEEEEEecCCccCHHHH--HHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL--PSGELIAVKKLVNFGCQSSKTL--KTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      ..+|.++..++.++ |+.|++...  .++..|++|...+.-.....++  ..|+.+...+ .|.++++++..|...+..|
T Consensus       264 ~~df~~v~~i~~~~-~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  264 LTDFGLVSKISDGN-FSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             cCCcceeEEccCCc-cccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            33667778887777 999998743  4788999998765443333322  3577777777 5999999988888888888


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhcc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVG  733 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~  733 (876)
                      +--|||++++..... .-...+++..++++..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||+++.+.
T Consensus       343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~  418 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA  418 (524)
T ss_pred             CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccc
Confidence            999999999887655 2234678888999999999999999998   99999999999999875 889999999987532


Q ss_pred             ccccccccccccccccc-cCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          734 EAAFQSTMSSEYALSCY-NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      -..    .....+...| .+|+......+..+.|+||||..+.|.+++...-.    ..   +.|......        .
T Consensus       419 ~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~----~~---~~~~~i~~~--------~  479 (524)
T KOG0601|consen  419 FSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE----SG---VQSLTIRSG--------D  479 (524)
T ss_pred             eec----ccccccccccccchhhccccccccccccccccccccccccCcccCc----cc---ccceeeecc--------c
Confidence            111    0111122223 25555666678899999999999999999875211    11   111111100        0


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      -+...    .....+..+.+.+..+++..||.+.++....+..
T Consensus       480 ~p~~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  480 TPNLP----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ccCCC----chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence            01111    1113456677888999999999998887665543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.06  E-value=3.7e-11  Score=119.84  Aligned_cols=103  Identities=17%  Similarity=0.236  Sum_probs=46.7

Q ss_pred             cccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEec
Q 002826          256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE  335 (876)
Q Consensus       256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  335 (876)
                      .|+++|||+|.|+ .+.++..-++.++.|++|+|.|..+  +.+..+++|+.|||++|.++ .+..+-..+-+++.|.|+
T Consensus       285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La  360 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA  360 (490)
T ss_pred             hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence            3444444444444 3334444444444444444444422  11444444455555555444 233333344455555555


Q ss_pred             CCcccccCccccccCCCCCeeeccCcccC
Q 002826          336 SNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       336 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      .|.|...  ..+..+-+|..||+++|+|.
T Consensus       361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  361 QNKIETL--SGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             hhhHhhh--hhhHhhhhheeccccccchh
Confidence            5555321  22334445555555555554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.00  E-value=4.3e-09  Score=103.87  Aligned_cols=134  Identities=15%  Similarity=0.072  Sum_probs=95.7

Q ss_pred             CCCCCceEEEEEEeCC-------CcEEEEEEEecCCc---------------------cC-HHHH----HHHHHHHhhcc
Q 002826          590 GNGGPFGRVYILSLPS-------GELIAVKKLVNFGC---------------------QS-SKTL----KTEVKTLAKIR  636 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~-------~~~vavK~~~~~~~---------------------~~-~~~~----~~E~~~l~~l~  636 (876)
                      .+.|--+.||.|...+       +..+|||+.+....                     .. ...+    ++|+..|+++.
T Consensus         5 i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~   84 (197)
T cd05146           5 ISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQ   84 (197)
T ss_pred             cccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4456688999996543       57999998743100                     01 1223    37999999995


Q ss_pred             C--ccccceeeEEEeCCeEEEEEEcCCCCCHHH-HhhccCCcCCHHHHHHHHHHHHHHHHHh-hccCCCCccccccccCc
Q 002826          637 H--KNIVKVLGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKSKN  712 (876)
Q Consensus       637 h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~i~H~Dlkp~N  712 (876)
                      .  -++...+++    ...++||||+.+..+.. .+..  ..++......+..+++.++..+ |..   +++|+|+++.|
T Consensus        85 ~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          85 KAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             HcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            3  466666654    45689999998754422 2222  2345556677889999999999 787   99999999999


Q ss_pred             eeeCCCCCeEEccccchhhcc
Q 002826          713 ILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       713 Ill~~~~~~kl~DfGla~~~~  733 (876)
                      |+++ ++.+.++|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9997 4689999999886654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.97  E-value=2.7e-09  Score=109.84  Aligned_cols=139  Identities=22%  Similarity=0.284  Sum_probs=106.8

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccC--ccccceeeEEEeC---CeEEEEEEcCCCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSD---ESIFLIYEFLQMGS  664 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~~gs  664 (876)
                      ++|.++.||+++..+|+.+++|+...... .....+..|+++++.+++  ..+.+++.+....   +..++||||++|.+
T Consensus         7 ~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~   86 (223)
T cd05154           7 SGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRV   86 (223)
T ss_pred             CCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEe
Confidence            45669999999887778999998754322 135678899999999975  3467777777654   36789999999988


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC---------------------------------------------
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY---------------------------------------------  699 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  699 (876)
                      +.+.+..  ..+++.....++.++++++.+||+..                                             
T Consensus        87 l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (223)
T cd05154          87 LRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWL  164 (223)
T ss_pred             cCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHH
Confidence            8775532  24677788888889999999998531                                             


Q ss_pred             --------CCCccccccccCceeeCC--CCCeEEccccchhh
Q 002826          700 --------VPHLLHRNVKSKNILLDA--DFEPKLTDFALDRI  731 (876)
Q Consensus       700 --------~~~i~H~Dlkp~NIll~~--~~~~kl~DfGla~~  731 (876)
                              ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       165 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         165 EAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                    246799999999999998  56689999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=8e-09  Score=97.92  Aligned_cols=129  Identities=19%  Similarity=0.280  Sum_probs=97.0

Q ss_pred             CCCCCceEEEEEEeCCCcEEEEEEEecCCccC--------HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQS--------SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+.|+-+.+|.+.+ -|.++.+|.-.+.....        ..+..+|+.++++++--.|....=+..+.+...++|||++
T Consensus         4 i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~   82 (204)
T COG3642           4 IKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE   82 (204)
T ss_pred             hhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence            44566889999877 44456677543322211        2355679999999976666655556667788889999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      |..|.+.+...        ...++..+-.-+.-||..   +|+|+|+.++||.+..+. +.++|||++..
T Consensus        83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          83 GELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             ChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999888654        245566677777889999   999999999999998664 99999999763

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.92  E-value=1.2e-09  Score=79.33  Aligned_cols=41  Identities=39%  Similarity=0.902  Sum_probs=30.9

Q ss_pred             hhHHHHHHHHHhhcc-CCCCCCCCCCCCCCCCCccccceEec
Q 002826           28 STEKDTLLSFKASID-DSKNSLSTWSNTSNIHYCNWTGVTCV   68 (876)
Q Consensus        28 ~~~~~all~~k~~~~-~~~~~~~sW~~~~~~~~C~w~gv~c~   68 (876)
                      ++|++||++||+++. +|.+.+++|+..++.+||.|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            679999999999998 57789999987644699999999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.91  E-value=4.3e-11  Score=122.56  Aligned_cols=247  Identities=19%  Similarity=0.225  Sum_probs=161.1

Q ss_pred             CCccccceecccccccCC----CcCccccCCCcceEEEccCCC--CcCCCCCCc-------ccccCcccEEEecCCCCcc
Q 002826          154 GSLVNLQVLNLGSNLLSG----SVPFVFGNFSELVVLDLSQNA--YLISEIPSD-------IGKLEKLEQLFLQSSGFHG  220 (876)
Q Consensus       154 ~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~--~~~~~~p~~-------~~~l~~L~~L~L~~n~l~~  220 (876)
                      ..+..++.|+||+|.+..    .+...+.+.++|+.-++|+=-  ....++|..       +...++|++|+||+|.|..
T Consensus        27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~  106 (382)
T KOG1909|consen   27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP  106 (382)
T ss_pred             cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence            344556666666666542    223345555666666666531  012233432       3345578888888888764


Q ss_pred             cCCcc----ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc--
Q 002826          221 VIPDS----FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS--  294 (876)
Q Consensus       221 ~~~~~----~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~--  294 (876)
                      ..+..    +.++.+|++|.|.+|.+. ..-....  -..|..|.  .|+.       ...-+.|+.+..++|++..-  
T Consensus       107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l--~~al~~l~--~~kk-------~~~~~~Lrv~i~~rNrlen~ga  174 (382)
T KOG1909|consen  107 KGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRL--GRALFELA--VNKK-------AASKPKLRVFICGRNRLENGGA  174 (382)
T ss_pred             cchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHH--HHHHHHHH--HHhc-------cCCCcceEEEEeeccccccccH
Confidence            43333    345677888888888775 2211110  01232222  2222       23456788888888888632  


Q ss_pred             --CCCCCccccccceeecccccCCCC----CCcccCCCCcccEEEecCCccccc----CccccccCCCCCeeeccCcccC
Q 002826          295 --IPGSINECLNLERFQVQDNGFSGD----FPDKLWSLPRIKLIRAESNRFSGA----IPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       295 --~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                        +...|...+.|+.+.+..|.|...    ....|..+++|++|||..|-++..    +...++.+++|+.|+++++.+.
T Consensus       175 ~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~  254 (382)
T KOG1909|consen  175 TALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE  254 (382)
T ss_pred             HHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc
Confidence              223567778999999999998632    234678999999999999999854    3456678889999999999998


Q ss_pred             CCCCCcc-----ccccCccEEeCCCccccCC----CCCCcCCCCCccEEEccCCccc
Q 002826          365 SSIPQGL-----GSVKSLYRFSASQNSFYGS----LPPNFCDSPVMSIINLSQNSIS  412 (876)
Q Consensus       365 ~~~p~~~-----~~l~~L~~L~ls~N~l~~~----~~~~~~~~~~L~~L~Ls~N~l~  412 (876)
                      ..-...|     ...++|+.|.+.+|.++..    +...+...+.|..|+|++|.+.
T Consensus       255 ~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  255 NEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             cccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            6544333     3368999999999999642    2334555889999999999994

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=6.3e-10  Score=128.96  Aligned_cols=241  Identities=20%  Similarity=0.203  Sum_probs=161.8

Q ss_pred             CCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          589 AGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      -+..|+++.++.+.-. .|...+.|+.....   ....+....+-.+.-..++|-+++..--+......++|++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            4556668887766332 34344444432221   1222333334334433456777666555555667899999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc---------
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA---------  735 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~---------  735 (876)
                      +...++..+ ..+..........+.++.+|||..   .+.|||++|.|++...++..+++|||.....+..         
T Consensus       891 ~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~  966 (1205)
T KOG0606|consen  891 LPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP  966 (1205)
T ss_pred             chhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence            999988765 344444444555678899999998   7999999999999999999999999844333210         


Q ss_pred             -c-------------------cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHH
Q 002826          736 -A-------------------FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVV  795 (876)
Q Consensus       736 -~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~  795 (876)
                       .                   .........||+.|.+||...+......+|.|+.|++++|.++|.+||........   
T Consensus       967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~--- 1043 (1205)
T KOG0606|consen  967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQI--- 1043 (1205)
T ss_pred             cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhh---
Confidence             0                   00112345688999999999999999999999999999999999999987655432   


Q ss_pred             HHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002826          796 KWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMF  846 (876)
Q Consensus       796 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  846 (876)
                        .+....        .+..+.....+......+++.+.+..+|.+|..|.
T Consensus      1044 --f~ni~~--------~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1044 --FENILN--------RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             --hhcccc--------CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence              111111        11222233344455667888888899999997665

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.87  E-value=1.8e-09  Score=129.93  Aligned_cols=89  Identities=38%  Similarity=0.512  Sum_probs=51.8

Q ss_pred             CccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCC
Q 002826          151 ESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQ  230 (876)
Q Consensus       151 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  230 (876)
                      +.|..++.|++|||++|.=-+..|..+++|-+|++|+|++..  +..+|..+.+|++|.+|++..+.-...+|.....|+
T Consensus       565 ~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~--I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~  642 (889)
T KOG4658|consen  565 EFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTG--ISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQ  642 (889)
T ss_pred             HHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCC--ccccchHHHHHHhhheeccccccccccccchhhhcc
Confidence            345556666666666654444566666666666666666665  556666666666666666665554444455555566


Q ss_pred             CCcEEecccCc
Q 002826          231 SLSILDLSQNN  241 (876)
Q Consensus       231 ~L~~L~Ls~N~  241 (876)
                      +|++|.+..-.
T Consensus       643 ~Lr~L~l~~s~  653 (889)
T KOG4658|consen  643 SLRVLRLPRSA  653 (889)
T ss_pred             cccEEEeeccc
Confidence            66666555443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.85  E-value=2.4e-08  Score=94.04  Aligned_cols=140  Identities=25%  Similarity=0.266  Sum_probs=102.0

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc--------CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ--------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .+...|+-+.|+++.+ .|+.+.||.-......        ...+..+|+..+.+++--.|.-..=++.+...-.++|||
T Consensus        13 ~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            3455677889999887 6888778754322111        134677899999999765665555566676777899999


Q ss_pred             CCC-CCHHHHhhccCCcCCHHHH-HHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---CeEEccccchhh
Q 002826          660 LQM-GSLGDLICRQDFQLQWSIR-LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---EPKLTDFALDRI  731 (876)
Q Consensus       660 ~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~~kl~DfGla~~  731 (876)
                      ++| .++.+++......-..... ..++..|-+.+.-||..   +|+|+|+..+||++..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            987 4777777655333333333 77889999999999999   999999999999996543   458999998753

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.85  E-value=1.7e-09  Score=130.16  Aligned_cols=68  Identities=35%  Similarity=0.546  Sum_probs=35.0

Q ss_pred             ccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          147 GKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       147 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      +.+|.++++|-+|++|+|++..++ .+|..+++|.+|.+||+..+. ....+|.....|.+|++|.+...
T Consensus       585 ~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~-~l~~~~~i~~~L~~Lr~L~l~~s  652 (889)
T KOG4658|consen  585 SKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTG-RLESIPGILLELQSLRVLRLPRS  652 (889)
T ss_pred             CcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheecccccc-ccccccchhhhcccccEEEeecc
Confidence            345555555555555555555555 555555555555555555554 12223333444555555555444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.84  E-value=1.1e-07  Score=102.82  Aligned_cols=166  Identities=21%  Similarity=0.278  Sum_probs=130.0

Q ss_pred             ceEEEEEE-eCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEEEEEcCCC-CCHHHH
Q 002826          595 FGRVYILS-LPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFLIYEFLQM-GSLGDL  668 (876)
Q Consensus       595 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~~  668 (876)
                      -.+.|++. ..||..|++|++.....+.......-++.++++.|+|+|++.+++..    +...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            46788884 45999999999965544454455567899999999999999999873    4578999999876 477776


Q ss_pred             hhcc--------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          669 ICRQ--------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       669 l~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      ....              +...++...+.++.|+..||.++|+.   |+..+-+.+.+|+++.+.+++|+..|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            4321              34467889999999999999999999   999999999999999999999998887665543


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCC
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ  782 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~  782 (876)
                      +.         +       |.+.   --.+-|.-.||.+++.+.||..
T Consensus       446 d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  446 DP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CC---------C-------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence            32         0       1111   1235699999999999999965

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=3.4e-09  Score=84.16  Aligned_cols=57  Identities=44%  Similarity=0.575  Sum_probs=22.5

Q ss_pred             ccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccc
Q 002826          208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN  265 (876)
Q Consensus       208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N  265 (876)
                      |++|++++|+++.+.+++|.++++|++|++++|+|+ .+++..|.++++|++|++++|
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~-~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLT-SIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSES-EEETTTTTTSTTESEEEETSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccC-ccCHHHHcCCCCCCEEeCcCC
Confidence            334444444444333334444444444444444443 333333333334444443333

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.80  E-value=4.2e-09  Score=83.64  Aligned_cols=60  Identities=37%  Similarity=0.477  Sum_probs=36.1

Q ss_pred             CCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccc
Q 002826          231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFF  291 (876)
Q Consensus       231 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  291 (876)
                      +|++|++++|+|+ .+|...|.++++|++|++++|+|+...+..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4556666666665 55555555566666666666666655555666666666666666653

...

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.77  E-value=2.2e-08  Score=98.48  Aligned_cols=126  Identities=21%  Similarity=0.215  Sum_probs=83.0

Q ss_pred             EEEEEEeCCCcEEEEEEEecCCc----------------------cC----HHHHHHHHHHHhhccCc--cccceeeEEE
Q 002826          597 RVYILSLPSGELIAVKKLVNFGC----------------------QS----SKTLKTEVKTLAKIRHK--NIVKVLGFFH  648 (876)
Q Consensus       597 ~Vy~~~~~~~~~vavK~~~~~~~----------------------~~----~~~~~~E~~~l~~l~h~--niv~~~~~~~  648 (876)
                      .||.|..++|..||+|+......                      ..    ....++|++.|.++...  ++.+.+++- 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999989999999998853111                      01    13466899999999755  566666542 


Q ss_pred             eCCeEEEEEEcCC--CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHH-hhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          649 SDESIFLIYEFLQ--MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAY-LHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       649 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                         ..++||||++  |..+..+....   ++......++.+++..+.. +|..   ||+|+|+.+.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence               3469999999  65555443322   1134456677778775555 5687   99999999999999987 999999


Q ss_pred             ccchhhcc
Q 002826          726 FALDRIVG  733 (876)
Q Consensus       726 fGla~~~~  733 (876)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.2e-07  Score=99.11  Aligned_cols=131  Identities=18%  Similarity=0.182  Sum_probs=96.7

Q ss_pred             EEEEEEeCCCcEEEEEEEecCCcc-----------CHHHHHHHHHHHhhccCc--cccceeeEEEe-----CCeEEEEEE
Q 002826          597 RVYILSLPSGELIAVKKLVNFGCQ-----------SSKTLKTEVKTLAKIRHK--NIVKVLGFFHS-----DESIFLIYE  658 (876)
Q Consensus       597 ~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~--niv~~~~~~~~-----~~~~~lv~e  658 (876)
                      .|+++.+ +|+.|.||+.......           ....+.+|+..+.++...  .+++.+++++.     ...-++|||
T Consensus        37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            3556665 6788999977432210           112477899999998543  33344555543     235789999


Q ss_pred             cCCCC-CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-------CCCeEEccccch
Q 002826          659 FLQMG-SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-------DFEPKLTDFALD  729 (876)
Q Consensus       659 ~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-------~~~~kl~DfGla  729 (876)
                      ++++. +|.+++... ....+...+..++.+++..+.-||+.   ||+|+|++++|||++.       ++.+.++||+.+
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~  192 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA  192 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence            99986 899888542 23456677789999999999999999   9999999999999975       468999999977


Q ss_pred             hh
Q 002826          730 RI  731 (876)
Q Consensus       730 ~~  731 (876)
                      +.
T Consensus       193 ~~  194 (268)
T PRK15123        193 QI  194 (268)
T ss_pred             cc
Confidence            53

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.69  E-value=5.6e-10  Score=123.76  Aligned_cols=167  Identities=28%  Similarity=0.260  Sum_probs=115.8

Q ss_pred             cccccCCCCCCeeecCCCccccccCccccCC-CCCCcccCCC----------------------cccceeecCCcccccc
Q 002826           92 SSSVCELSSLSNLNLADNLFNQPIPLHLSQC-SSLETLNLSN----------------------NLIWVLDLSRNHIEGK  148 (876)
Q Consensus        92 ~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~----------------------N~l~~LdL~~n~l~~~  148 (876)
                      |-++..+.+||+|.|.++.+...  ..+..+ ..|++|.-++                      |.|.+.+.+.|++. .
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~~--~GL~~lr~qLe~LIC~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~-~  178 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLSTA--KGLQELRHQLEKLICHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV-L  178 (1096)
T ss_pred             CceeccccceeeEEecCcchhhh--hhhHHHHHhhhhhhhhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-h
Confidence            66788999999999999988641  111111 1233333222                      44556788888887 5


Q ss_pred             CCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc-ccccCcccEEEecCCCCcccCCcccc
Q 002826          149 IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSSGFHGVIPDSFV  227 (876)
Q Consensus       149 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~  227 (876)
                      ...++.-++.|+.|+|++|+++...  .+..+++|+.|||++|.  +..+|.- ..+. +|+.|.+++|.++..  ..+.
T Consensus       179 mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~--L~~vp~l~~~gc-~L~~L~lrnN~l~tL--~gie  251 (1096)
T KOG1859|consen  179 MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNC--LRHVPQLSMVGC-KLQLLNLRNNALTTL--RGIE  251 (1096)
T ss_pred             HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccch--hccccccchhhh-hheeeeecccHHHhh--hhHH
Confidence            5667777888899999999987443  77888889999999997  5566653 2233 388888888888754  3467


Q ss_pred             CCCCCcEEecccCccCCCCCCccccccccccEEEecccccc
Q 002826          228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS  268 (876)
Q Consensus       228 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  268 (876)
                      +|.+|+.||+++|-|.+.-.-.....+..|..|+|.+|.+-
T Consensus       252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            78888888888888875433333344677888888888764

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.68  E-value=5.8e-10  Score=123.64  Aligned_cols=130  Identities=28%  Similarity=0.370  Sum_probs=78.8

Q ss_pred             CCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEecc
Q 002826          352 QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLA  430 (876)
Q Consensus       352 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls  430 (876)
                      .|...+.+.|+++ .+...+.-++.|+.|+|++|+++...  .+..++.|+.|||++|.+...+. .-.++. |+.|+|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            5666777777777 55666666777777777777776443  55666667777777777764443 333344 6667777


Q ss_pred             CCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccccceEEccCCccccccCCcccCCCCCccccCCCCCCCC
Q 002826          431 DNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP  507 (876)
Q Consensus       431 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~  507 (876)
                      +|.++..  ..+.+|.+|+.||+++|-|.+.-.                    ..|.+.+..+..++++|||..|.+
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hse--------------------L~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSE--------------------LEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchh--------------------hhHHHHHHHHHHHhhcCCccccCH
Confidence            7766532  345566666666666666653110                    123333455556677777766643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=4.9e-07  Score=91.54  Aligned_cols=123  Identities=25%  Similarity=0.238  Sum_probs=92.5

Q ss_pred             CCcEEEEEEEecCC-------ccCHHHHHHHHHHHhhccC--ccccceeeEEEeC----CeEEEEEEcCCCC-CHHHHhh
Q 002826          605 SGELIAVKKLVNFG-------CQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSD----ESIFLIYEFLQMG-SLGDLIC  670 (876)
Q Consensus       605 ~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~  670 (876)
                      .++.+-+|.....-       .-......+|...+.++..  =.+++.+++....    ...++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            45666666543211       1223467789998888853  3455666766552    2458999999984 8999887


Q ss_pred             ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---CeEEccccchhh
Q 002826          671 RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---EPKLTDFALDRI  731 (876)
Q Consensus       671 ~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~~kl~DfGla~~  731 (876)
                      .... .+......++.+++..++-||+.   ||+|+|+++.|||++.+.   ++.++||+-++.
T Consensus       111 ~~~~-~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQ-LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcc-cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            6432 66777889999999999999999   999999999999999876   899999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=4.6e-08  Score=109.78  Aligned_cols=151  Identities=20%  Similarity=0.226  Sum_probs=103.1

Q ss_pred             HHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc-------cccccccccCccccC
Q 002826          685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS-------SEYALSCYNAPEYGY  757 (876)
Q Consensus       685 ~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~-------~~~gt~~y~aPE~~~  757 (876)
                      +.+++.|+.|+|..  .++||+.|.|++|.++.++..|++.|+.+........+....       .......|.|||++.
T Consensus       105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            34556999999987  589999999999999999999999999876654422211111       011234699999998


Q ss_pred             CCCCCCccchHHHHHHHHHHH-hCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccC
Q 002826          758 SKKATAQMDAYSFGVVLLELI-TGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTS  836 (876)
Q Consensus       758 ~~~~~~~~Dv~SlGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~  836 (876)
                      ....+.++|+||+|+.+|.+. .|+..+..........  ..+.          ..+-....+....+.++.+-+.+++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~--~~~~----------~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS--FSRN----------LLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhh--hhhc----------ccccccccccccCcHHHHHHHHHHhc
Confidence            888899999999999999999 5665554433222110  1000          01111112223344567788889999


Q ss_pred             CCCCCCCCHHHHH
Q 002826          837 VMPEKRPSMFEVV  849 (876)
Q Consensus       837 ~dP~~RPs~~ell  849 (876)
                      .++..||++.++.
T Consensus       251 ~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  251 GDSAVRPTLDLLL  263 (700)
T ss_pred             CCcccCcchhhhh
Confidence            9999999777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.49  E-value=7.9e-07  Score=89.66  Aligned_cols=134  Identities=17%  Similarity=0.157  Sum_probs=95.4

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc----------------------cCHHHHHHHHHHHhhccCc--ccc
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC----------------------QSSKTLKTEVKTLAKIRHK--NIV  641 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--niv  641 (876)
                      +...+|-|--+.||.|..+.|.++|||.-....+                      ..+...++|.++|.++...  .|.
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            3444555668999999999999999996432110                      1124567899999999654  677


Q ss_pred             ceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       642 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      +.+++    +...+||||++|--|...-      ++......++..|+.-+.-.-..   ||+|+|+.+-||+++++|.+
T Consensus       175 ~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~  241 (304)
T COG0478         175 KPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI  241 (304)
T ss_pred             Ccccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence            76655    4568999999996664431      12334444555555555555566   99999999999999999999


Q ss_pred             EEccccchhhc
Q 002826          722 KLTDFALDRIV  732 (876)
Q Consensus       722 kl~DfGla~~~  732 (876)
                      .++||-.+...
T Consensus       242 ~vIDwPQ~v~~  252 (304)
T COG0478         242 VVIDWPQAVPI  252 (304)
T ss_pred             EEEeCcccccC
Confidence            99999765443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.46  E-value=1.3e-06  Score=92.34  Aligned_cols=260  Identities=17%  Similarity=0.156  Sum_probs=151.0

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEE-------EeCCeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF-------HSDESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~-------~~~~~~~lv~e  658 (876)
                      ..+|.|| -+.+|-..  .-...+.|++.........+.   ++.|... .||-+-.=+.|-       ..+...-++|.
T Consensus        17 r~LgqGg-ea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          17 RPLGQGG-EADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             ccccCCc-cceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            4566677 88888532  112234577755433333222   3333333 455433312221       11223567777


Q ss_pred             cCCCC-CHHHHhh-----ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          659 FLQMG-SLGDLIC-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       659 ~~~~g-sL~~~l~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .+++. ...++..     +.-....|....++++.+|.+.+.||+.   |.+-+|+.++|+|+++++.+.+.|-.--...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            77653 2333332     1134578999999999999999999999   9999999999999999999999985432222


Q ss_pred             cccccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchh----hHHHHHHHHh
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITG-RQAEQAEPAESL----DVVKWVRRKI  802 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg-~~p~~~~~~~~~----~~~~~~~~~~  802 (876)
                      ..+.   ......|...|.+||.-.     +-..+...|-|.+|+++++++.| ++||.+......    .-.++....+
T Consensus       168 ~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 ANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            2221   233445888899999643     34556779999999999999886 999975332111    0001110000


Q ss_pred             hcccccccccCh-hhhhhcHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHhhcccC
Q 002826          803 NITNGAIQVLDP-KIANCYQQQMLGALEIALRCTSVM--PEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       803 ~~~~~~~~~~d~-~~~~~~~~~~~~~~~li~~cl~~d--P~~RPs~~ell~~L~~i~~~  858 (876)
                      ...........| ...--+.--..++-.+...|+...  +.-|||++..+..|.++..+
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            000000000000 000001111223445566666543  56899999999999887654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.36  E-value=1e-06  Score=99.73  Aligned_cols=138  Identities=18%  Similarity=0.184  Sum_probs=89.4

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCc----------------------c----C--------------HHHHHHHHH
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGC----------------------Q----S--------------SKTLKTEVK  630 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~----~--------------~~~~~~E~~  630 (876)
                      +.++-|.||+|++++|+.||||+.++.-.                      .    .              +-.+.+|..
T Consensus       134 AsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~  213 (517)
T COG0661         134 ASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAA  213 (517)
T ss_pred             hhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHH
Confidence            34559999999999999999999865211                      0    0              012334555


Q ss_pred             HHhhcc-----CccccceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHH-HHHhhccCCCCcc
Q 002826          631 TLAKIR-----HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG-LAYLHKDYVPHLL  704 (876)
Q Consensus       631 ~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~-l~~LH~~~~~~i~  704 (876)
                      -+.+++     .|++.-.-=|++-.....++|||++|-.+.+...-.....+.+.   ++..++++ +..+-..   |+.
T Consensus       214 n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~d---gff  287 (517)
T COG0661         214 NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRD---GFF  287 (517)
T ss_pred             HHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhc---Ccc
Confidence            555552     23322112222335678899999999988887432222344333   33333332 3333334   899


Q ss_pred             ccccccCceeeCCCCCeEEccccchhhccc
Q 002826          705 HRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       705 H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      |.|.+|.||+++.+|++.+.|||+.....+
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999877754

>PRK09902 hypothetical protein; Provisional

Probab=98.34  E-value=1.1e-05  Score=79.74  Aligned_cols=137  Identities=16%  Similarity=0.174  Sum_probs=100.4

Q ss_pred             CCCCCCceEEEEEEeCCCcEEEEEEEecCC------ccCHHHHHHHHHHHhhccC--ccccceeeEEEe-----CCeEEE
Q 002826          589 AGNGGPFGRVYILSLPSGELIAVKKLVNFG------CQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHS-----DESIFL  655 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~-----~~~~~l  655 (876)
                      .++|| .+.|+.... +|+.+-+|+-...-      ...+..|.+|+..+.++..  -.+.+.. ++..     ...-++
T Consensus        26 ~~rgG-~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNG-MSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCC-cceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            34556 888888776 44578888764211      2345789999999999953  2344444 3321     124689


Q ss_pred             EEEcCCC-CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC--eEEccccchhh
Q 002826          656 IYEFLQM-GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE--PKLTDFALDRI  731 (876)
Q Consensus       656 v~e~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~--~kl~DfGla~~  731 (876)
                      |+|-++| .+|.+++.+. -.+.+......+..++++.++-||+.   |+.|+|+.+.||+++.++.  ++++||--++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997764 5898888654 23567778889999999999999999   9999999999999986666  99999975543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.31  E-value=2.6e-08  Score=88.77  Aligned_cols=109  Identities=28%  Similarity=0.246  Sum_probs=60.4

Q ss_pred             ccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCC
Q 002826          377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN  456 (876)
Q Consensus       377 L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  456 (876)
                      |+..++++|.+....++.-...+.++.|+|++|.|+..+.++..++.|+.|+++.|.|. ..|..+..|.+|..||..+|
T Consensus        55 l~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~n  133 (177)
T KOG4579|consen   55 LTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPEN  133 (177)
T ss_pred             EEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCC
Confidence            33344444444433333223334566666666666655556666777777777777776 55666666777777777777


Q ss_pred             cccccCCCccc-ccccceEEccCCccccccCC
Q 002826          457 NLTGPIPQGLQ-NLKLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       457 ~l~~~~p~~~~-~l~l~~l~ls~N~l~~~~p~  487 (876)
                      .+. .+|..+- .-.....++.++.+.+..|.
T Consensus       134 a~~-eid~dl~~s~~~al~~lgnepl~~~~~~  164 (177)
T KOG4579|consen  134 ARA-EIDVDLFYSSLPALIKLGNEPLGDETKK  164 (177)
T ss_pred             ccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence            665 3443321 11122345566666655553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	876
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-32
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-32
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-31
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-30
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-30
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-27
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-27
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-27
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-26
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-18
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-17
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-16
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		5e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		7e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		9e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		9e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-14
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-14
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		8e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		8e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-14
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-13
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-13
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-13
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-13
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		7e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		9e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-12
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-12
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-11
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-11
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-11
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-11
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-11
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-11
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-11
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-11
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-11
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-11
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-11
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		8e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		9e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-10
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-10
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-10
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-10
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-10
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-10
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-10
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-10
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-10
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-10
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-10
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-10
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		6e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		9e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-08
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-08
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-08
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-08
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-08
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-08
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-08
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-08
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-08
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		6e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		8e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		8e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		8e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		9e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-07
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-07
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-07
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-07
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-07
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-07
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-07
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		9e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-06
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-06
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-06
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-06
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-06
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-05
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-05
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		9e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-04
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-04
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-04
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-04
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-04
1p9a_G	290	Crystal Structure Of N-terminal Domain Of Human Pla		5e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		6e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		7e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		7e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-04
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		8e-04
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-04
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		9e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 94/273 (34%), Positives = 152/273 (55%), Gaps = 11/273 (4%)
Query: 586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVL 644
           K+  G GG FG+VY   L  G L+AVK+L     Q  +   +TEV+ ++   H+N++++ 
Sbjct: 35  KNILGRGG-FGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 645 GFFHSDESIFLIYEFLQMGSLGD-LICRQDFQ--LQWSIRLKIAIGVAQGLAYLHKDYVP 701
           GF  +     L+Y ++  GS+   L  R + Q  L W  R +IA+G A+GLAYLH    P
Sbjct: 94  GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
            ++HR+VK+ NILLD +FE  + DF L +++         +    +  + APEY  + K+
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIG-HIAPEYLSTGKS 212
Query: 762 TAQMDAYSFGVVLLELITGRQA-EQAEPAESLDVV--KWVRRKINITNGAIQVLDPKIAN 818
           + + D + +GV+LLELITG++A + A  A   DV+   WV+  +        ++D  +  
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQG 271
Query: 819 CYQQQMLGAL-EIALRCTSVMPEKRPSMFEVVK 850
            Y+ + +  L ++AL CT   P +RP M EVV+
Sbjct: 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  136 bits (343), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 96/274 (35%), Positives = 153/274 (55%), Gaps = 13/274 (4%)
Query: 586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVL 644
           K+  G GG FG+VY   L  G L+AVK+L     Q  +   +TEV+ ++   H+N++++ 
Sbjct: 43  KNILGRGG-FGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLR 101
Query: 645 GFFHSDESIFLIYEFLQMGSLGD-LICRQDFQ--LQWSIRLKIAIGVAQGLAYLHKDYVP 701
           GF  +     L+Y ++  GS+   L  R + Q  L W  R +IA+G A+GLAYLH    P
Sbjct: 102 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 161
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
            ++HR+VK+ NILLD +FE  + DF L +++         +    +  + APEY  + K+
Sbjct: 162 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG-HIAPEYLSTGKS 220
Query: 762 TAQMDAYSFGVVLLELITGRQA-EQAEPAESLDVV--KWVRRKINITNGAIQVL-DPKIA 817
           + + D + +GV+LLELITG++A + A  A   DV+   WV  K  +    ++ L D  + 
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEALVDVDLQ 278
Query: 818 NCYQQQMLGAL-EIALRCTSVMPEKRPSMFEVVK 850
             Y+ + +  L ++AL CT   P +RP M EVV+
Sbjct: 279 GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 312

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  135 bits (340), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 143/263 (54%), Gaps = 11/263 (4%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG+VY   L  G  +A+K+      Q  +  +TE++TL+  RH ++V ++GF      
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 653 IFLIYEFLQMGSLGDLICRQDF---QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           + LIY++++ G+L   +   D     + W  RL+I IG A+GL YLH   +   +HR+VK
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVK 166
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           S NILLD +F PK+TDF + +   E               Y  PEY    + T + D YS
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 770 FGVVLLELITGRQA-EQAEPAESLDVVKWVRRKINITNGAI-QVLDPKIANCYQQQMLGA 827
           FGVVL E++  R A  Q+ P E +++ +W     N  NG + Q++DP +A+  + + L  
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN--NGQLEQIVDPNLADKIRPESLRK 284
Query: 828 L-EIALRCTSVMPEKRPSMFEVV 849
             + A++C ++  E RPSM +V+
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  134 bits (338), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 143/263 (54%), Gaps = 11/263 (4%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG+VY   L  G  +A+K+      Q  +  +TE++TL+  RH ++V ++GF      
Sbjct: 50  GVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109
Query: 653 IFLIYEFLQMGSLGDLICRQDF---QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           + LIY++++ G+L   +   D     + W  RL+I IG A+GL YLH   +   +HR+VK
Sbjct: 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVK 166
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           S NILLD +F PK+TDF + +   E               Y  PEY    + T + D YS
Sbjct: 167 SINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 770 FGVVLLELITGRQA-EQAEPAESLDVVKWVRRKINITNGAI-QVLDPKIANCYQQQMLGA 827
           FGVVL E++  R A  Q+ P E +++ +W     N  NG + Q++DP +A+  + + L  
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN--NGQLEQIVDPNLADKIRPESLRK 284
Query: 828 L-EIALRCTSVMPEKRPSMFEVV 849
             + A++C ++  E RPSM +V+
Sbjct: 285 FGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  131 bits (330), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 120/420 (28%), Positives = 178/420 (42%), Gaps = 74/420 (17%)
Query: 137 VLDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLIS 196
           VLDLS N   G++PES+                           + L+ LDLS N +   
Sbjct: 344 VLDLSFNEFSGELPESLTNLS-----------------------ASLLTLDLSSNNFSGP 380
Query: 197 EIPSDIGKLEK-LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            +P+     +  L++L+LQ++GF G IP +      L  L LS N L+G +P SLG SL 
Sbjct: 381 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG-SLS 439
Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF 315
           KL    +  N L G  P  +     L  L L  N   G IP  ++ C NL    + +N  
Sbjct: 440 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 499
Query: 316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP------- 368
           +G+ P  +  L  + +++  +N FSG IP  +     L  + ++ N F  +IP       
Sbjct: 500 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 559
Query: 369 -------------------------QGLGSV--------KSLYRFSA------SQNSFYG 389
                                     G G++        + L R S       +   + G
Sbjct: 560 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 619
Query: 390 SLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
              P F ++  M  +++S N +SG IP E+     L  L+L  N ++G IP  + +L  L
Sbjct: 620 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 679
Query: 449 TYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVP-YSLISGLPASYLQGNPGLCG 506
             LDLS N L G IPQ +  L  L   ++S N LSG +P        P +    NPGLCG
Sbjct: 680 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  131 bits (329), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 120/420 (28%), Positives = 178/420 (42%), Gaps = 74/420 (17%)
Query: 137 VLDLSRNHIEGKIPESIXXXXXXXXXXXXXXXXXXXXPFVFGNFSELVVLDLSQNAYLIS 196
           VLDLS N   G++PES+                           + L+ LDLS N +   
Sbjct: 347 VLDLSFNEFSGELPESLTNLS-----------------------ASLLTLDLSSNNFSGP 383
Query: 197 EIPSDIGKLEK-LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            +P+     +  L++L+LQ++GF G IP +      L  L LS N L+G +P SLG SL 
Sbjct: 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG-SLS 442
Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF 315
           KL    +  N L G  P  +     L  L L  N   G IP  ++ C NL    + +N  
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP------- 368
           +G+ P  +  L  + +++  +N FSG IP  +     L  + ++ N F  +IP       
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 369 -------------------------QGLGSV--------KSLYRFSA------SQNSFYG 389
                                     G G++        + L R S       +   + G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 390 SLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
              P F ++  M  +++S N +SG IP E+     L  L+L  N ++G IP  + +L  L
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 449 TYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVP-YSLISGLPASYLQGNPGLCG 506
             LDLS N L G IPQ +  L  L   ++S N LSG +P        P +    NPGLCG
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 102/299 (34%), Positives = 151/299 (50%), Gaps = 27/299 (9%)
Query: 564 WRSLFFYPLRVTEHDLVIGMDEK--SSAGNG---GPFGRVYILSLPSGELIAVKKLVNFG 618
           + S  FY L+    ++    DE+  S  GN    G FG VY     +   +AVKKL    
Sbjct: 12  FHSFSFYELK----NVTNNFDERPISVGGNKMGEGGFGVVY-KGYVNNTTVAVKKLAAMV 66
Query: 619 CQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
             +++ LK     E+K +AK +H+N+V++LGF    + + L+Y ++  GSL D +   D 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 675 Q--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
              L W +R KIA G A G+ +LH++   H +HR++KS NILLD  F  K++DF L R  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR-A 182
Query: 733 GEAAFQSTMSSE-YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPA 789
            E   Q+ M S     + Y APE     + T + D YSFGVVLLE+ITG  A  E  EP 
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 790 ESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
             LD+ + +  +       I   D K+ +     +     +A +C      KRP + +V
Sbjct: 242 LLLDIKEEIEDEEKTIEDYI---DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  120 bits (300), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 101/299 (33%), Positives = 150/299 (50%), Gaps = 27/299 (9%)
Query: 564 WRSLFFYPLRVTEHDLVIGMDEK--SSAGNG---GPFGRVYILSLPSGELIAVKKLVNFG 618
           + S  FY L+    ++    DE+  S  GN    G FG VY     +   +AVKKL    
Sbjct: 12  FHSFSFYELK----NVTNNFDERPISVGGNKMGEGGFGVVY-KGYVNNTTVAVKKLAAMV 66
Query: 619 CQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
             +++ LK     E+K +AK +H+N+V++LGF    + + L+Y ++  GSL D +   D 
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 126
Query: 675 Q--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
              L W +R KIA G A G+ +LH++   H +HR++KS NILLD  F  K++DF L R  
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR-A 182
Query: 733 GEAAFQSTMSSE-YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPA 789
            E   Q+ M       + Y APE     + T + D YSFGVVLLE+ITG  A  E  EP 
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 790 ESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
             LD+ + +  +       I   D K+ +     +     +A +C      KRP + +V
Sbjct: 242 LLLDIKEEIEDEEKTIEDYI---DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  119 bits (297), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 101/299 (33%), Positives = 149/299 (49%), Gaps = 27/299 (9%)
Query: 564 WRSLFFYPLRVTEHDLVIGMDEK--SSAGNG---GPFGRVYILSLPSGELIAVKKLVNFG 618
           + S  FY L+    ++    DE+  S  GN    G FG VY     +   +AVKKL    
Sbjct: 6   FHSFSFYELK----NVTNNFDERPISVGGNKMGEGGFGVVY-KGYVNNTTVAVKKLAAMV 60
Query: 619 CQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
             +++ LK     E+K +AK +H+N+V++LGF    + + L+Y ++  GSL D +   D 
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG 120
Query: 675 Q--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
              L W +R KIA G A G+ +LH++   H +HR++KS NILLD  F  K++DF L R  
Sbjct: 121 TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLAR-A 176
Query: 733 GEAAFQSTMSSE-YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPA 789
            E   Q  M       + Y APE     + T + D YSFGVVLLE+ITG  A  E  EP 
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235
Query: 790 ESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
             LD+ + +  +       I   D K+ +     +     +A +C      KRP + +V
Sbjct: 236 LLLDIKEEIEDEEKTIEDYI---DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 100/298 (33%), Positives = 145/298 (48%), Gaps = 25/298 (8%)
Query: 564 WRSLFFYPLRVTEHDLVIGMDEK--SSAGNG---GPFGRVYILSLPSGELIAVKKLVNFG 618
           + S  FY L+    ++    DE+  S  GN    G FG VY     +   +AVKKL    
Sbjct: 3   FHSFSFYELK----NVTNNFDERPISVGGNKXGEGGFGVVY-KGYVNNTTVAVKKLAAMV 57
Query: 619 CQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF 674
             +++ LK     E+K  AK +H+N+V++LGF    + + L+Y +   GSL D +   D 
Sbjct: 58  DITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG 117
Query: 675 Q--LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV 732
              L W  R KIA G A G+ +LH++   H +HR++KS NILLD  F  K++DF L R  
Sbjct: 118 TPPLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARAS 174
Query: 733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPAE 790
            + A     S     + Y APE     + T + D YSFGVVLLE+ITG  A  E  EP  
Sbjct: 175 EKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 233
Query: 791 SLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
            LD+ + +  +       I   D K  +     +     +A +C      KRP + +V
Sbjct: 234 LLDIKEEIEDEEKTIEDYI---DKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKV 288

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 127/269 (47%), Gaps = 29/269 (10%)
Query: 593 GPFGR-VYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+ + +    +GE++ +K+L+ F  ++ +T   EVK +  + H N++K +G  + D+
Sbjct: 21  GCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            +  I E+++ G+L  +I   D Q  WS R+  A  +A G+AYLH     +++HR++ S 
Sbjct: 81  RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSH 137
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQST---------MSSEYAL---SCYNAPEYGYSK 759
           N L+  +    + DF L R++ +   Q               Y +     + APE    +
Sbjct: 138 NCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR 197
Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC 819
               ++D +SFG+VL E+I    A+      ++D        +N+     +   P     
Sbjct: 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------GLNVRGFLDRYCPPNCPPS 251
Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           +         I +RC  + PEKRPS  ++
Sbjct: 252 F-------FPITVRCCDLDPEKRPSFVKL 273

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/274 (29%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 581 IGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHK 638
           + + EK  AG+   FG V+      G  +AVK L+  +F  +       EV  + ++RH 
Sbjct: 39  LNIKEKIGAGS---FGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF--QLQWSIRLKIAIGVAQGLAYLH 696
           NIV  +G      ++ ++ E+L  GSL  L+ +     QL    RL +A  VA+G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
            +  P ++HRN+KS N+L+D  +  K+ DF L R+       S   S      + APE  
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVL 211
Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAE-QAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
             + +  + D YSFGV+L EL T +Q      PA+ +  V +  +++ I       L+P+
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN----LNPQ 267
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           +A   +            C +  P KRPS   ++
Sbjct: 268 VAAIIEG-----------CWTNEPWKRPSFATIM 290

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/274 (28%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 581 IGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHK 638
           + + EK  AG+   FG V+      G  +AVK L+  +F  +       EV  + ++RH 
Sbjct: 39  LNIKEKIGAGS---FGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF--QLQWSIRLKIAIGVAQGLAYLH 696
           NIV  +G      ++ ++ E+L  GSL  L+ +     QL    RL +A  VA+G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
            +  P ++HR++KS N+L+D  +  K+ DF L R+       S  ++      + APE  
Sbjct: 155 -NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEWMAPEVL 211
Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAE-QAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
             + +  + D YSFGV+L EL T +Q      PA+ +  V +  +++ I       L+P+
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN----LNPQ 267
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           +A   +            C +  P KRPS   ++
Sbjct: 268 VAAIIEG-----------CWTNEPWKRPSFATIM 290

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 114/230 (49%), Gaps = 23/230 (10%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE++AVK L  + G Q     K E+  L  + H++I+K  G 
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGC 84
Query: 647 F--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                ++S+ L+ E++ +GSL D + R    L  +  L  A  + +G+AYLH     H +
Sbjct: 85  CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLHSQ---HYI 139
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           HRN+ ++N+LLD D   K+ DF L + V  G   ++     +  +  Y APE     K  
Sbjct: 140 HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFY 198
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
              D +SFGV L EL+T   + Q+ P + L++       I I  G + VL
Sbjct: 199 YASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-------IGIAQGQMTVL 241

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 114/230 (49%), Gaps = 23/230 (10%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE++AVK L  + G Q     K E+  L  + H++I+K  G 
Sbjct: 25  GHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGC 84
Query: 647 F--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                ++S+ L+ E++ +GSL D + R    L  +  L  A  + +G+AYLH     H +
Sbjct: 85  CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLHAQ---HYI 139
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           HRN+ ++N+LLD D   K+ DF L + V  G   ++     +  +  Y APE     K  
Sbjct: 140 HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-APECLKEYKFY 198
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
              D +SFGV L EL+T   + Q+ P + L++       I I  G + VL
Sbjct: 199 YASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-------IGIAQGQMTVL 241

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/230 (30%), Positives = 112/230 (48%), Gaps = 23/230 (10%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE++AVK L  + G Q     K E+  L  + H++I+K  G 
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101
Query: 647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
                  S+ L+ E++ +GSL D + R    L  +  L  A  + +G+AYLH     H +
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYLHAQ---HYI 156
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           HR++ ++N+LLD D   K+ DF L + V  G   ++     +  +  Y APE     K  
Sbjct: 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFY 215
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
              D +SFGV L EL+T   + Q+ P + L++       I I  G + VL
Sbjct: 216 YASDVWSFGVTLYELLTHCDSSQSPPTKFLEL-------IGIAQGQMTVL 258

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 114/251 (45%), Gaps = 8/251 (3%)
Query: 220 GVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV----SQNKLSGSFPNGI 275
           GV+ D+      ++ LDLS  NL    P  + SSL  L   +       N L G  P  I
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYP--IPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 276 CKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE 335
            K   L  L +     +G+IP  +++   L       N  SG  P  + SLP +  I  +
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 336 SNRFSGAIPDSI-SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN 394
            NR SGAIPDS  S +     + I  NR T  IP    ++ +L     S+N   G     
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216
Query: 395 FCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLS 454
           F        I+L++NS++  + ++   + L  L L +N + G +P  L +L  L  L++S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 455 DNNLTGPIPQG 465
            NNL G IPQG
Sbjct: 277 FNNLCGEIPQG 287

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/64 (45%), Positives = 41/64 (64%), Gaps = 2/64 (3%)
Query: 432 NSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYSLI 490
           N+L G IPP++A+L  L YL ++  N++G IP  L  +K L   + S+N LSG +P S I
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS-I 145
Query: 491 SGLP 494
           S LP
Sbjct: 146 SSLP 149

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 66/263 (25%), Positives = 131/263 (49%), Gaps = 26/263 (9%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++ +      +AVK +   G  S +    E   +  ++H  +VK+     + E
Sbjct: 25  AGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKE 82
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRL-KIAIGVAQGLAYL-HKDYVPHLLHRNVK 709
            I++I EF+  GSL D +   +   Q   +L   +  +A+G+A++  ++Y+    HR+++
Sbjct: 83  PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI----HRDLR 138
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+ A    K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 139 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWS 197
Query: 770 FGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           FG++L+E++T GR         + +V++ + R   +         P+  NC ++      
Sbjct: 198 FGILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM---------PRPENCPEE----LY 242
Query: 829 EIALRCTSVMPEKRPSMFEVVKA 851
            I +RC    PE+RP+ FE +++
Sbjct: 243 NIMMRCWKNRPEERPT-FEYIQS 264

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 22  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 81
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 82  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 138
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           RN+ ++NIL++ +   K+ DF L +++   +  ++     E  +  Y APE     K + 
Sbjct: 139 RNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-APESLTESKFSV 197
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 198 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 229

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 104/189 (55%), Gaps = 9/189 (4%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 335
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 391
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 450
Query: 771 GVVLLELIT 779
           G++L EL T
Sbjct: 451 GILLTELTT 459

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 137
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +    F+     E  +  Y APE     K + 
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTESKFSV 196
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 197 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 130/262 (49%), Gaps = 24/262 (9%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++ +      +AVK +   G  S +    E   +  ++H  +VK+     + E
Sbjct: 198 AGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKE 255
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRL-KIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            I++I EF+  GSL D +   +   Q   +L   +  +A+G+A++ +    + +HR++++
Sbjct: 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 312
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+ A    K+ DF L R++ +  + +   +++ +  + APE       T + D +SF
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSF 371
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           G++L+E++T GR         + +V++ + R   +         P+  NC ++       
Sbjct: 372 GILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM---------PRPENCPEE----LYN 416
Query: 830 IALRCTSVMPEKRPSMFEVVKA 851
           I +RC    PE+RP+ FE +++
Sbjct: 417 IMMRCWKNRPEERPT-FEYIQS 437

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 130/261 (49%), Gaps = 24/261 (9%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S ++   E + + K++H  +V++     S+E 
Sbjct: 20  GQFGEVWMGTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVV-SEEP 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           I+++ E++  GSL D +   + + L+    + +A  VA G+AY+ +    + +HR+++S 
Sbjct: 78  IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 134
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           NIL+      K+ DF L R++ +    +   +++ +  + APE     + T + D +SFG
Sbjct: 135 NILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSFG 193
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           ++L EL+T GR         + +V++ V R   +              C Q   +   E+
Sbjct: 194 ILLTELVTKGRVPYPG--MNNREVLEQVERGYRMP-------------CPQDCPISLHEL 238
Query: 831 ALRCTSVMPEKRPSMFEVVKA 851
            + C    PE+RP+ FE +++
Sbjct: 239 MIHCWKKDPEERPT-FEYLQS 258

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 252
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 308
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 367
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 368 GILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 252
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 308
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 367
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 368 GILLTELTTKGR 379

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 252
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 253 IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 308
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 367
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 368 GILLTELTTKGR 379

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 55/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + KIRH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 22  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 79
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 80  IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 135
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 136 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 194
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 195 GILLTELTTKGR 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG LI  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 26  AGNGGVVTKVQ--HRPSG-LIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GLAYL + +   ++HR
Sbjct: 83  FYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHR 139
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y APE       + Q D
Sbjct: 140 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQSD 195
Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+EL  GR       A+ L+ +
Sbjct: 196 IWSMGLSLVELAVGRYPIPPPDAKELEAI 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 106/195 (54%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 196 GCFGEVWMGTWNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 253
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRL----KIAIGVAQGLAYLHK-DYVPHLLHRN 707
           I+++ E++  GSL D +     ++   +RL     +A  +A G+AY+ + +YV    HR+
Sbjct: 254 IYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRD 306
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +++ NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D 
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDV 365
Query: 768 YSFGVVLLELIT-GR 781
           +SFG++L EL T GR
Sbjct: 366 WSFGILLTELTTKGR 380

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G       
Sbjct: 21  GQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARN 136
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 137 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 195
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 196 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 241
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 242 HCWRERPEDRPAFSRLLR 259

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 99  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 154
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 155 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 213
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 246

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 140
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 199
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 200 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 137
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 196
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 197 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 39  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 98
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 99  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 154
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 155 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 213
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 214 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 246

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 26  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 85
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 86  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 142
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 143 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 201
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 202 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 233

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 20  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 79
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 80  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 135
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 136 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 194
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 195 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 227

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G       
Sbjct: 18  GQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 76
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARN 133
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 134 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 192
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 193 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 238
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 239 HCWKERPEDRPAFSRLLR 256

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 28  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 87
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 88  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 144
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 145 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 203
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 204 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 235

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G       
Sbjct: 18  GQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 76
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASV---IHRDLAARN 133
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 134 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 192
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 193 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 238
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 239 HCWKERPEDRPAFSRLLR 256

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 18  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 75
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 76  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 131
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 132 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 190
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 191 GILLTELTTKGR 202

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 20  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 78  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 133
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 134 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 192
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 193 GILLTELTTKGR 204

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 129/258 (50%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G       
Sbjct: 16  GQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 74
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARN 131
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 190
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 191 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 236
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 237 HCWKERPEDRPAFSRLLR 254

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 25  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 84
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 85  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 140
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 141 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 199
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 200 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 232

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 136
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 195
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 168
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 227
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 228 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 108/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 27  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 86
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL        +H
Sbjct: 87  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIH 143
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 144 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 202
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 203 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 234

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 19  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 78
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 79  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 134
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 135 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 193
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 194 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 226

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 26  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 83
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + ++  +A G+AY+ + +YV    HR++++
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV----HRDLRA 139
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 140 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 198
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 199 GILLTELTTKGR 210

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 128/258 (49%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S      E + + K+ H  +V++ G       
Sbjct: 38  GQFGLVHLGYWLNKDKVAIKTIKE-GSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 96
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L++EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARN 153
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 154 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 212
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 213 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 258
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 259 HCWKERPEDRPAFSRLLR 276

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 15/213 (7%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
           +S    ++ LI EFL  GSL + + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 84  YSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 139
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKAT 762
           HR++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K +
Sbjct: 140 HRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFS 198
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
              D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 199 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 106/192 (55%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 26  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 83
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + ++  +A G+AY+ + +YV    HR++++
Sbjct: 84  IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV----HRDLRA 139
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 140 ANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 198
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 199 GILLTELTTKGR 210

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 14/269 (5%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKLV-NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE +AVK L    G      LK E++ L  + H+NIVK  G 
Sbjct: 20  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 79
Query: 647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHL 703
              D    I LI EFL  GSL + + +   ++    +LK A+ + +G+ YL  + YV   
Sbjct: 80  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV--- 136
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY-NAPEYGYSKKAT 762
            HR++ ++N+L++++ + K+ DF L + +       T+  +     +  APE     K  
Sbjct: 137 -HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFY 195
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
              D +SFGV L EL+T   ++ +  A  L ++     ++ +T     + + K   C   
Sbjct: 196 IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPN 255
Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKA 851
                 ++  +C    P  R S   +++ 
Sbjct: 256 CPDEVYQLMRKCWEFQPSNRTSFQNLIEG 284

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++ +
Sbjct: 87  IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLAA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 123/269 (45%), Gaps = 14/269 (5%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKLV-NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +         +GE +AVK L    G      LK E++ L  + H+NIVK  G 
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91
Query: 647 FHSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHL 703
              D    I LI EFL  GSL + + +   ++    +LK A+ + +G+ YL  + YV   
Sbjct: 92  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV--- 148
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY-NAPEYGYSKKAT 762
            HR++ ++N+L++++ + K+ DF L + +       T+  +     +  APE     K  
Sbjct: 149 -HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFY 207
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
              D +SFGV L EL+T   ++ +  A  L ++     ++ +T     + + K   C   
Sbjct: 208 IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPN 267
Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKA 851
                 ++  +C    P  R S   +++ 
Sbjct: 268 CPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +    +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  G L D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 59/258 (22%), Positives = 128/258 (49%), Gaps = 19/258 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G       
Sbjct: 19  GQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I L+ EF++ G L D +  Q         L + + V +G+AYL +  V   +HR++ ++N
Sbjct: 78  ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARN 134
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SFGV
Sbjct: 135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSFGV 193
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIAL 832
           ++ E+ +  +      + S +VV+      +I+ G  ++  P++A+ +  Q++       
Sbjct: 194 LMWEVFSEGKIPYENRSNS-EVVE------DISTG-FRLYKPRLASTHVYQIMN------ 239
Query: 833 RCTSVMPEKRPSMFEVVK 850
            C    PE RP+   +++
Sbjct: 240 HCWRERPEDRPAFSRLLR 257

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 53/192 (27%), Positives = 105/192 (54%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 29  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 86
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I+++ E++  G L D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 87  IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 142
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 201
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 202 GILLTELTTKGR 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 13/212 (6%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 24  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 83
Query: 648 HS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +S    ++ LI E+L  GSL D +     ++     L+    + +G+ YL        +H
Sbjct: 84  YSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKRYIH 140
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++ +   K+ DF L +++ +      +    E  +  Y APE     K + 
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWY-APESLTESKFSV 199
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVV 795
             D +SFGVVL EL T  +  ++ PAE + ++
Sbjct: 200 ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 27/204 (13%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+VY  +   G+ +AVK   +       Q+ + ++ E K  A ++H NI+ + G   
Sbjct: 18  GGFGKVY-RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76
Query: 649 SDESIFLIYEFLQMGSLGDLICRQ----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            + ++ L+ EF + G L  ++  +    D  + W+++      +A+G+ YLH + +  ++
Sbjct: 77  KEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIVPII 130
Query: 705 HRNVKSKNILLDADFEP--------KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
           HR++KS NIL+    E         K+TDF L R   E    + MS+  A + + APE  
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGAYA-WMAPEVI 186
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
            +   +   D +S+GV+L EL+TG
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTG 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 54/192 (28%), Positives = 104/192 (54%), Gaps = 10/192 (5%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 19  GCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 76
Query: 653 IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKS 710
           I ++ E++  GSL D +  +  + L+    + +A  +A G+AY+ + +YV    HR++++
Sbjct: 77  IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 132
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +    +   +++ +  + APE     + T + D +SF
Sbjct: 133 ANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 191
Query: 771 GVVLLELIT-GR 781
           G++L EL T GR
Sbjct: 192 GILLTELTTKGR 203

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 62/261 (23%), Positives = 127/261 (48%), Gaps = 23/261 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V  L    G+     K++  G  S      E +T+ K+ H  +VK  G    +  
Sbjct: 19  GQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           I+++ E++  G L + +      L+ S  L++   V +G+A+L        +HR++ ++N
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARN 134
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
            L+D D   K++DF + R V +  + S++ +++ +  ++APE  +  K +++ D ++FG+
Sbjct: 135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK-WSAPEVFHYFKYSSKSDVWAFGI 193
Query: 773 VLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN--CYQQQMLGALEI 830
           ++ E+ +  +        S  V+K       ++ G  ++  P +A+   YQ        I
Sbjct: 194 LMWEVFSLGKMPYDLYTNSEVVLK-------VSQGH-RLYRPHLASDTIYQ--------I 237
Query: 831 ALRCTSVMPEKRPSMFEVVKA 851
              C   +PEKRP+  +++ +
Sbjct: 238 MYSCWHELPEKRPTFQQLLSS 258

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 52/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 19  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 76
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HRN++
Sbjct: 77  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRNLR 132
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 133 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 191
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 192 FGILLTEIVTHGR 204

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 90
Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH + V   +HRN
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQV---IHRN 142
Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E + +STM        + APE    K    ++D
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVD 199
Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 251
Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  EKR S  E+++
Sbjct: 252 N------RCLEMDVEKRGSAKELIQ 270

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 91/191 (47%), Gaps = 7/191 (3%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + + K+V+   +  +  + EV  L K RH NI+  +G+   D +
Sbjct: 47  GSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-N 105
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +  Q+ + Q    + IA   AQG+ YLH     +++HR++KS N
Sbjct: 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNN 162
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQMDAYS 769
           I L      K+ DF L  +    +    +        + APE    +     + Q D YS
Sbjct: 163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYS 222
Query: 770 FGVVLLELITG 780
           +G+VL EL+TG
Sbjct: 223 YGIVLYELMTG 233

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V +         +GE++AVK L   GC  Q     + E++ L  + H++IVK  G
Sbjct: 19  GHFGKVSLYCYDPTNDGTGEMVAVKALKE-GCGPQLRSGWQREIEILRTLYHEHIVKYKG 77
Query: 646 FF--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
                 ++S+ L+ E++ +GSL D + R    L  +  L  A  + +G+AYLH     H 
Sbjct: 78  CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLHAQ---HY 132
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE-------YALSCYNAPEYG 756
           +HR + ++N+LLD D   K+ DF L + V E      +  +       YA  C    ++ 
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQA 786
           Y+       D +SFGV L EL+T   + Q+
Sbjct: 193 YAS------DVWSFGVTLYELLTYCDSNQS 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 593 GPFGRVYILSLP-----SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V +         +GE++AVK L   GC  Q     + E++ L  + H++IVK  G
Sbjct: 20  GHFGKVSLYCYDPTNDGTGEMVAVKALKE-GCGPQLRSGWQREIEILRTLYHEHIVKYKG 78
Query: 646 FF--HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
                 ++S+ L+ E++ +GSL D + R    L  +  L  A  + +G+AYLH     H 
Sbjct: 79  CCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL--AQLLLFAQQICEGMAYLHAQ---HY 133
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE-------YALSCYNAPEYG 756
           +HR + ++N+LLD D   K+ DF L + V E      +  +       YA  C    ++ 
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQA 786
           Y+       D +SFGV L EL+T   + Q+
Sbjct: 194 YAS------DVWSFGVTLYELLTYCDSNQS 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G VY      G ++A+K+ +    +      T   E+  L ++ H NIV ++   HS
Sbjct: 32  GTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI-GVAQGLAYLHKDYVPHLLHRNV 708
           +  + L++EF++   L  ++      LQ S ++KI +  + +G+A+ H+     +LHR++
Sbjct: 91  ERCLTLVFEFME-KDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQH---RILHRDL 145
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDA 767
           K +N+L+++D   KL DF L R  G      + + E     Y AP+    SKK +  +D 
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 768 YSFGVVLLELITGR 781
           +S G +  E+ITG+
Sbjct: 204 WSIGCIFAEMITGK 217

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 29  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 86
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 87  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 142
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 143 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 201
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 202 FGILLTEIVTHGR 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 33  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 90
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 91  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 146
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 147 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 205
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 206 FGILLTEIVTHGR 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 80
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 81  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 136
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 195
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 18  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 75
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 76  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 131
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 132 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 190
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 191 FGILLTEIVTHGR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 102/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 28  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 85
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 86  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 141
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 142 AANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 200
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 201 FGILLTEIVTHGR 213

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 13/194 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G VY      G ++A+K+ +    +      T   E+  L ++ H NIV ++   HS
Sbjct: 32  GTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI-GVAQGLAYLHKDYVPHLLHRNV 708
           +  + L++EF++   L  ++      LQ S ++KI +  + +G+A+ H+     +LHR++
Sbjct: 91  ERCLTLVFEFME-KDLKKVLDENKTGLQDS-QIKIYLYQLLRGVAHCHQH---RILHRDL 145
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDA 767
           K +N+L+++D   KL DF L R  G      + + E     Y AP+    SKK +  +D 
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203
Query: 768 YSFGVVLLELITGR 781
           +S G +  E+ITG+
Sbjct: 204 WSIGCIFAEMITGK 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 78  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 135 FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 191
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 192 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 247
Query: 767 AYSFGVVLLELITGR 781
            +S G+ L+E+  GR
Sbjct: 248 IWSMGLSLVEMAVGR 262

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 581 IGMDEKSSAGNGGPF--GRVYILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKI 635
           I +D+   AG  G    GR   L LPS + I  A+K L V +  +  +    E   + + 
Sbjct: 35  ISIDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 91
Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
            H NI+++ G     + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL
Sbjct: 92  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 151
Query: 696 HK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYN 751
               YV    HR++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + 
Sbjct: 152 SDMGYV----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WT 205
Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT 779
           +PE    +K T+  D +S+G+VL E+++
Sbjct: 206 SPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 581 IGMDEKSSAGNGGPF--GRVYILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKI 635
           I +D+   AG  G    GR   L LPS + I  A+K L V +  +  +    E   + + 
Sbjct: 18  ISIDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 74
Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
            H NI+++ G     + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL
Sbjct: 75  DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 134
Query: 696 HK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYN 751
               YV    HR++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + 
Sbjct: 135 SDMGYV----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WT 188
Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT 779
           +PE    +K T+  D +S+G+VL E+++
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 103/196 (52%), Gaps = 13/196 (6%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL        +HR
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHR 171
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T+
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFTS 229
Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+VL E+++
Sbjct: 230 ASDVWSYGIVLWEVMS 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 581 IGMDEKSSAGNGGPF--GRVYILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKI 635
           I +D+   AG  G    GR   L LPS + I  A+K L V +  +  +    E   + + 
Sbjct: 47  ISIDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 103
Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
            H NI+++ G     + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL
Sbjct: 104 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 696 HK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYN 751
               YV    HR++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + 
Sbjct: 164 SDMGYV----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WT 217
Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT 779
           +PE    +K T+  D +S+G+VL E+++
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 16  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 73  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 767 AYSFGVVLLELITGR 781
            +S G+ L+E+  GR
Sbjct: 186 IWSMGLSLVEMAVGR 200

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 16  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 73  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+E+  GR       A+ L+++
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL M    DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEFLSM----DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 109/208 (52%), Gaps = 18/208 (8%)
Query: 581 IGMDEKSSAGNGGPF--GRVYILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKI 635
           I +D+   AG  G    GR   L LPS + I  A+K L V +  +  +    E   + + 
Sbjct: 45  ISIDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF 101
Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
            H NI+++ G     + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL
Sbjct: 102 DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 161
Query: 696 HK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYN 751
               YV    HR++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + 
Sbjct: 162 SDMGYV----HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WT 215
Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT 779
           +PE    +K T+  D +S+G+VL E+++
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 16  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 73  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+E+  GR       A+ L+++
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 124/262 (47%), Gaps = 34/262 (12%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++ +      +AVK +   G  S +    E   +  ++H  +VK+     + E
Sbjct: 192 AGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKE 249
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRL-KIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            I++I EF+  GSL D +   +   Q   +L   +  +A+G+A++ +    + +HR++++
Sbjct: 250 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRA 306
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+ A    K+ DF L R+  +   +           + APE       T + D +SF
Sbjct: 307 ANILVSASLVCKIADFGLARVGAKFPIK-----------WTAPEAINFGSFTIKSDVWSF 355
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           G++L+E++T GR         + +V++ + R   +         P+  NC ++       
Sbjct: 356 GILLMEIVTYGRIPYPG--MSNPEVIRALERGYRM---------PRPENCPEE----LYN 400
Query: 830 IALRCTSVMPEKRPSMFEVVKA 851
           I +RC    PE+RP+ FE +++
Sbjct: 401 IMMRCWKNRPEERPT-FEYIQS 421

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL M    DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEFLSM----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPENLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 15  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 73
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL M    DL    D      I L +       + QGLA+ H   V   L
Sbjct: 74  TENKLYLVFEFLSM----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 126
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 185 A-VDIWSLGCIFAEMVTRR 202

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 16  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 73  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+E+  GR       A+ L+++
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 16  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 73  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 130 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVV 795
            +S G+ L+E+  GR       A+ L+++
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELM 214

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 127/265 (47%), Gaps = 33/265 (12%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89
Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH + V   +HR+
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQV---IHRD 141
Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E + +STM        + APE    K    ++D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVD 198
Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 250
Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  EKR S  E+++
Sbjct: 251 N------RCLDMDVEKRGSAKELLQ 269

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 16  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 74
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL M    DL    D      I L +       + QGLA+ H   V   L
Sbjct: 75  TENKLYLVFEFLSM----DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 127
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 186 A-VDIWSLGCIFAEMVTRR 203

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 230 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 288
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HRN+
Sbjct: 289 PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRNL 344
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 345 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 403
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 404 AFGVLLWEIAT 414

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 104/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 269 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 327
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HRN+
Sbjct: 328 PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRNL 383
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 384 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 442
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 443 AFGVLLWEIAT 453

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 21  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 79
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 80  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 132
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGXKYYST 190
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 191 A-VDIWSLGCIFAEMVTRR 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 43  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 100 FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 156
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 157 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 212
Query: 767 AYSFGVVLLELITGR 781
            +S G+ L+E+  GR
Sbjct: 213 IWSMGLSLVEMAVGR 227

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 14/196 (7%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 19  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 76  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQM 765
           +VK  NIL+++  E KL DF +            M++E+     Y +PE       + Q 
Sbjct: 133 DVKPSNILVNSRGEIKLCDFGVS-----GQLIDEMANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 766 DAYSFGVVLLELITGR 781
           D +S G+ L+E+  GR
Sbjct: 188 DIWSMGLSLVEMAVGR 203

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGXKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEFLHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 582 GMD--EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKI 635
           GM+  +K      G +G VY   +  +GE++A+KK +    ++     T   E+  L ++
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKEL 59
Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQG 691
            H NIVK+L   H++  ++L++EFL      DL    D      I L +       + QG
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           LA+ H   V   LHR++K +N+L++ +   KL DF L R  G      T + E     Y 
Sbjct: 116 LAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYR 170
Query: 752 APE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           APE   G    +TA +D +S G +  E++T R
Sbjct: 171 APEILLGCKYYSTA-VDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 21  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 79
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 80  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 132
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 133 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 190
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 191 A-VDIWSLGCIFAEMVTRR 208

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           AGNGG   +V     PSG L+  +KL++   + +    +  E++ L +     IV   G 
Sbjct: 35  AGNGGVVFKVS--HKPSG-LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F+SD  I +  E +  GSL D + ++  ++   I  K++I V +GL YL + +   ++HR
Sbjct: 92  FYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHR 148
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +VK  NIL+++  E KL DF     V      S  +S      Y +PE       + Q D
Sbjct: 149 DVKPSNILVNSRGEIKLCDFG----VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 204
Query: 767 AYSFGVVLLELITGR 781
            +S G+ L+E+  GR
Sbjct: 205 IWSMGLSLVEMAVGR 219

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 29/263 (11%)
Query: 604 PSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
           P  E +A+K++    CQ+S   L  E++ +++  H NIV     F   + ++L+ + L  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 663 GSLGDLIC-------RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           GS+ D+I         +   L  S    I   V +GL YLHK+     +HR+VK+ NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILL 149
Query: 716 DADFEPKLTDFALDRIV---GEAAFQSTMSSEYALSCYNAPEY-----GYSKKATAQMDA 767
             D   ++ DF +   +   G+        +     C+ APE      GY  KA    D 
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DI 205
Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA 827
           +SFG+  +EL TG       P   + ++       ++  G   V D ++   Y +     
Sbjct: 206 WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG---VQDKEMLKKYGKSFRKM 262
Query: 828 LEIALRCTSVMPEKRPSMFEVVK 850
           + +   C    PEKRP+  E+++
Sbjct: 263 ISL---CLQKDPEKRPTAAELLR 282

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 15  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 73
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 74  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 126
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 184
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 185 A-VDIWSLGCIFAEMVTRR 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY    + + E++A+KK+   G QS++  +    EV+ L K+RH N ++  G + 
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 124
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  DL+      LQ      +  G  QGLAYLH     +++HR+V
Sbjct: 125 REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 180
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQM 765
           K+ NILL      KL DF      G A+  +  +       + APE   +    +   ++
Sbjct: 181 KAGNILLSEPGLVKLGDF------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 234
Query: 766 DAYSFGVVLLEL 777
           D +S G+  +EL
Sbjct: 235 DVWSLGITCIEL 246

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 80
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 81  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 136
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 195
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 23  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 80
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 81  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 136
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 195
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 32  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 89
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 90  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 145
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 146 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 204
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 205 FGILLTEIVTHGR 217

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 29  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 86
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 87  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 142
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 143 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 201
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 202 FGILLTEIVTHGR 214

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 24  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 81
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 82  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 137
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 138 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 196
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 197 FGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 25  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 82
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 83  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 138
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 139 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 197
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 198 FGILLTEIVTHGR 210

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 18  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 76
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 77  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 129
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 187
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 188 A-VDIWSLGCIFAEMVTRR 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 593 GPFGRVYILSL----PSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++       P+ +  L+AVK L +    + K  + E + L  ++H++IVK  G 
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85
Query: 647 FHSDESIFLIYEFLQMGSLG--------DLICRQDFQ-------LQWSIRLKIAIGVAQG 691
               + + +++E+++ G L         D +   D Q       L  S  L IA  +A G
Sbjct: 86  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YL      H +HR++ ++N L+ A+   K+ DF + R V    +            + 
Sbjct: 146 MVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 202
Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT-GRQ 782
            PE    +K T + D +SFGV+L E+ T G+Q
Sbjct: 203 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 32  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 90
Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH + V   +HR+
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQV---IHRD 142
Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E   QS  S       + APE    K    ++D
Sbjct: 143 IKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 251
Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  EKR S  E+++
Sbjct: 252 N------RCLEMDVEKRGSAKELIQ 270

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 26  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E ++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 86  VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 141
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 142 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 199
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 200 SASDVWSYGIVLWEVMS 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 11/207 (5%)
Query: 578 DLVIGMDEKSSAGNGGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAK 634
           DL IG          G F +V +   + +G+ +AVK +        S + L  EV+ +  
Sbjct: 3   DLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKV 62
Query: 635 IRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAY 694
           + H NIVK+     ++++++L+ E+   G + D +    +  +   R K    +   + Y
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQY 121
Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE 754
            H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y APE
Sbjct: 122 CHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAPE 175
Query: 755 YGYSKKATA-QMDAYSFGVVLLELITG 780
               KK    ++D +S GV+L  L++G
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 117/263 (44%), Gaps = 29/263 (11%)
Query: 604 PSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
           P  E +A+K++    CQ+S   L  E++ +++  H NIV     F   + ++L+ + L  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 663 GSLGDLIC-------RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           GS+ D+I         +   L  S    I   V +GL YLHK+     +HR+VK+ NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILL 154
Query: 716 DADFEPKLTDFALDRIV---GEAAFQSTMSSEYALSCYNAPEY-----GYSKKATAQMDA 767
             D   ++ DF +   +   G+        +     C+ APE      GY  KA    D 
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA----DI 210
Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA 827
           +SFG+  +EL TG       P   + ++       ++  G   V D ++   Y +     
Sbjct: 211 WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG---VQDKEMLKKYGKSFRKM 267
Query: 828 LEIALRCTSVMPEKRPSMFEVVK 850
           + +   C    PEKRP+  E+++
Sbjct: 268 ISL---CLQKDPEKRPTAAELLR 287

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 31  AGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 88
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 89  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 144
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +    +   +++ +  + APE       T + D +S
Sbjct: 145 AANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 203
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 204 FGILLTEIVTHGR 216

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 47/190 (24%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++    +   +AVK L   G  S +    E   +  ++H  +V++      +E
Sbjct: 23  AGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREE 81
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E++  GSL D +   +  ++     +  +  +A+G+AY+  K+Y+    HR+++
Sbjct: 82  PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI----HRDLR 137
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + N+L+      K+ DF L R++ +  + +   +++ +  + APE       T + D +S
Sbjct: 138 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKSDVWS 196
Query: 770 FGVVLLELIT 779
           FG++L E++T
Sbjct: 197 FGILLYEIVT 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E ++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFT 228
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+VL E+++
Sbjct: 229 SASDVWSYGIVLWEVMS 245

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 16  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 74
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 75  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 127
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 186 A-VDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 16  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 74
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 75  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 127
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 128 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 186 A-VDIWSLGCIFAEMVTRR 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 18  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 76
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 77  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 129
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 130 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 187
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 188 A-VDIWSLGCIFAEMVTRR 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 16  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 74
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 75  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 127
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 128 HRDLKPENLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 185
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 186 A-VDIWSLGCIFAEMVTRR 203

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 17/192 (8%)
Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FG VY    + + E++A+KK+   G QS++  +    EV+ L K+RH N ++  G + 
Sbjct: 26  GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + + +L+ E+  +GS  DL+      LQ      +  G  QGLAYLH     +++HR+V
Sbjct: 86  REHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDV 141
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQM 765
           K+ NILL      KL DF      G A+  +  +       + APE   +    +   ++
Sbjct: 142 KAGNILLSEPGLVKLGDF------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKV 195
Query: 766 DAYSFGVVLLEL 777
           D +S G+  +EL
Sbjct: 196 DVWSLGITCIEL 207

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 15  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 73
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 74  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 126
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 185 A-VDIWSLGCIFAEMVTRR 202

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 592 GGPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LPS + I  A+K L V +  +  +    E   + +  H NI+++ G 
Sbjct: 55  AGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
               + + ++ E ++ GSL   + + D Q      + +  G+A G+ YL        +HR
Sbjct: 115 VTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHR 171
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + +PE    +K T+
Sbjct: 172 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTSPEAIAYRKFTS 229
Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+VL E+++
Sbjct: 230 ASDVWSYGIVLWEVMS 245

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89
Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH + V   +HR+
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQV---IHRD 141
Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E   QS  S       + APE    K    ++D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSEMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 250
Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  EKR S  E+++
Sbjct: 251 N------RCLDMDVEKRGSAKELLQ 269

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 15  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 73
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 74  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 126
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 127 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 185 A-VDIWSLGCIFAEMVTRR 202

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 47/190 (24%), Positives = 98/190 (51%), Gaps = 8/190 (4%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++    +   +AVK L   G  S +    E   +  ++H  +V++      +E
Sbjct: 22  AGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE 80
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I EF+  GSL D +   +  ++     +  +  +A+G+AY+  K+Y+    HR+++
Sbjct: 81  PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI----HRDLR 136
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + N+L+      K+ DF L R++ +  + +   +++ +  + APE       T + + +S
Sbjct: 137 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGCFTIKSNVWS 195
Query: 770 FGVVLLELIT 779
           FG++L E++T
Sbjct: 196 FGILLYEIVT 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 21  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 79
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 80  PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 135
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    F +   +++ +  + APE     K + + D +
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 194
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 15  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 73
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 74  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 126
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 127 HRDLKPENLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 184
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 185 A-VDIWSLGCIFAEMVTRR 202

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 102/196 (52%), Gaps = 12/196 (6%)
Query: 592 GGPFGRVY--ILSLPSGEL---IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
            G FG VY  +L   SG+    +A+K L   +  +       E   + +  H NI+++ G
Sbjct: 54  AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                + + +I E+++ G+L   +  +D +      + +  G+A G+ YL + +YV    
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV---- 169
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATA 763
           HR++ ++NIL++++   K++DF L R++ +    +  +S   +   + APE    +K T+
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 764 QMDAYSFGVVLLELIT 779
             D +SFG+V+ E++T
Sbjct: 230 ASDVWSFGIVMWEVMT 245

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AVK +        S + L  EV+ +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDAFCGAPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 125/265 (47%), Gaps = 33/265 (12%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G VY  + + +G+ +A++++ N   Q  K L   E+  + + ++ NIV  L  +   
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG 89
Query: 651 ESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           + ++++ E+L  GSL D++   C  + Q+    R        Q L +LH + V   +HR+
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQV---IHRD 141
Query: 708 VKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           +KS NILL  D   KLTDF    +I  E   QS  S       + APE    K    ++D
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPE---QSKRSXMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 767 AYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
            +S G++ +E+I G      E P  +L ++         TNG  ++ +P+  +   +  L
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNGTPELQNPEKLSAIFRDFL 250
Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
                  RC  +  EKR S  E+++
Sbjct: 251 N------RCLEMDVEKRGSAKELLQ 269

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 126 HRDLKPENLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V +     +G  +AVK L     +S      ++ E++ L   RH +I+K+     
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +   IF++ E++  G L D IC+   +L      ++   +  G+ Y H+  V   +HR++
Sbjct: 87  TPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMV---VHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAF--QSTMSSEYALSCYNAPEYGYSK-KATAQM 765
           K +N+LLDA    K+ DF L  ++ +  F   S  S  YA     APE    +  A  ++
Sbjct: 143 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYA-----APEVISGRLYAGPEV 197
Query: 766 DAYSFGVVLLELITG 780
           D +S GV+L  L+ G
Sbjct: 198 DIWSSGVILYALLCG 212

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 51/193 (26%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G  G V++        +AVK L   G  S      E   + +++H+ +V++     + E
Sbjct: 23  AGQAGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQE 80
Query: 652 SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
            I++I E+++ GSL D +      +L  +  L +A  +A+G+A++  ++Y+    HR+++
Sbjct: 81  PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLR 136
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + NIL+      K+ DF L R++ +A   +   +++ +  + APE       T + D +S
Sbjct: 137 AANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WTAPEAINYGTFTIKSDVWS 195
Query: 770 FGVVLLELIT-GR 781
           FG++L E++T GR
Sbjct: 196 FGILLTEIVTHGR 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGL++ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AVK +        S + L  EV+ +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 31/198 (15%)
Query: 604 PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGF-----FHSDESIFLI 656
           P+GE++A+KK+  F     + +TL+ E+K L   +H+NI+ +        F +   +++I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 657 YEFLQMGSLGDLICRQ---DFQLQWSIRLKI-AIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            E +Q   L  +I  Q   D  +Q+ I   + A+ V  G          +++HR++K  N
Sbjct: 93  QELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---------SNVIHRDLKPSN 142
Query: 713 ILLDADFEPKLTDFALDRIVGEAAF--------QSTMSSEYALSCYNAPEYGY-SKKATA 763
           +L++++ + K+ DF L RI+ E+A         QS M+   A   Y APE    S K + 
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSR 202
Query: 764 QMDAYSFGVVLLELITGR 781
            MD +S G +L EL   R
Sbjct: 203 AMDVWSCGCILAELFLRR 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AVK +        S + L  EV+ +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 86
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 201
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTE--VKTLAKIRHKNIVKVLGFFHS- 649
           G FG V+   L + E +AVK    F  Q  ++ + E  V +L  ++H+NI++ +G     
Sbjct: 35  GRFGCVWKAQLLN-EYVAVKI---FPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90
Query: 650 ---DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD-------Y 699
              D  ++LI  F + GSL D +  +   + W+    IA  +A+GLAYLH+D       +
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY---- 755
            P + HR++KSKN+LL  +    + DF L               +     Y APE     
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 756 -GYSKKATAQMDAYSFGVVLLELIT 779
             + + A  ++D Y+ G+VL EL +
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 86
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 201
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 24  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 82
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 83  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 138
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIKSDVW 197
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 83
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 139
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIK-WTAPESLAYNKFSIKSDVW 198
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 36  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 94
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 95  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 150
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 151 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 209
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 210 AFGVLLWEIAT 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 86
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 87  PPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 201
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 57/197 (28%), Positives = 94/197 (47%), Gaps = 20/197 (10%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V I     +G  +AVK L     +S      +K E++ L   RH +I+K+     
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +    F++ E++  G L D IC+     +   R ++   +   + Y H+  V   +HR++
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMV---VHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSK-KATA 763
           K +N+LLDA    K+ DF L  ++ +  F  T       SC    Y APE    +  A  
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-------SCGSPNYAAPEVISGRLYAGP 190
Query: 764 QMDAYSFGVVLLELITG 780
           ++D +S GV+L  L+ G
Sbjct: 191 EVDIWSCGVILYALLCG 207

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 31/198 (15%)
Query: 604 PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGF-----FHSDESIFLI 656
           P+GE++A+KK+  F     + +TL+ E+K L   +H+NI+ +        F +   +++I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 657 YEFLQMGSLGDLICRQ---DFQLQWSIRLKI-AIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            E +Q   L  +I  Q   D  +Q+ I   + A+ V  G          +++HR++K  N
Sbjct: 93  QELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---------SNVIHRDLKPSN 142
Query: 713 ILLDADFEPKLTDFALDRIVGEAAF--------QSTMSSEYALSCYNAPEYGY-SKKATA 763
           +L++++ + K+ DF L RI+ E+A         QS M+   A   Y APE    S K + 
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSR 202
Query: 764 QMDAYSFGVVLLELITGR 781
            MD +S G +L EL   R
Sbjct: 203 AMDVWSCGCILAELFLRR 220

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V +L    G  +AVK + N    +++    E   + ++RH N+V++LG    ++ 
Sbjct: 17  GEFGDV-MLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 653 -IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            ++++ E++  GSL D L  R    L     LK ++ V + + YL  +   + +HR++ +
Sbjct: 74  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 130
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +   EA+  ST  +      + APE    KK + + D +SF
Sbjct: 131 RNVLVSEDNVAKVSDFGLTK---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRR--KINITNGAIQVLDPKIANCYQ 821
           G++L E+ + GR      P +  DVV  V +  K++  +G    +   + NC+ 
Sbjct: 186 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 237

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 86
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 201
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 27  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 85
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 86  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 141
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 142 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 200
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 201 AFGVLLWEIAT 211

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 83
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 139
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 198
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 25  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 83
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 84  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 139
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 140 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 198
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 199 AFGVLLWEIAT 209

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 92/176 (52%), Gaps = 9/176 (5%)
Query: 609 IAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +A+K L   +  +  +   +E   + +  H NI+++ G   +   + ++ EF++ G+L  
Sbjct: 45  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 104
Query: 668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDF 726
            +   D Q      + +  G+A G+ YL +  YV    HR++ ++NIL++++   K++DF
Sbjct: 105 FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV----HRDLAARNILVNSNLVCKVSDF 160
Query: 727 ALDRIVGEAAFQSTMSSEYALSC---YNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            L R + E +   T +S         + APE    +K T+  DA+S+G+V+ E+++
Sbjct: 161 GLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 583 MDEKSSAGNGGPFGRVYILSLPSGE-LIAVKKLVNFGCQSSKT--------LKTEVKTLA 633
           ++ +   G GG FG V+   L   + ++A+K L+  G    +T         + EV  ++
Sbjct: 21  IEYEKQIGKGG-FGLVHKGRLVKDKSVVAIKSLI-LGDSEGETEMIEKFQEFQREVFIMS 78
Query: 634 KIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            + H NIVK+ G  H+     ++ EF+  G L   +  +   ++WS++L++ + +A G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 694 YLHKDYVPHLLHRNVKSKNILL-----DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           Y+ ++  P ++HR+++S NI L     +A    K+ DF+L +       QS  S    L 
Sbjct: 137 YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-------QSVHSVSGLLG 188
Query: 749 CYN--APEY--GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
            +   APE      +  T + D YSF ++L  ++TG           +  +  +R     
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---- 244
Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                + L P I      ++   +E+   C S  P+KRP    +VK
Sbjct: 245 -----EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVK 282

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 81
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D +
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 196
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 197 AFGVLLWEIAT 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V +L    G  +AVK + N    +++    E   + ++RH N+V++LG    ++ 
Sbjct: 204 GEFGDV-MLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260
Query: 653 -IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            ++++ E++  GSL D L  R    L     LK ++ V + + YL  +   + +HR++ +
Sbjct: 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 317
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +   EA+  ST  +      + APE    KK + + D +SF
Sbjct: 318 RNVLVSEDNVAKVSDFGLTK---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSF 372
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRR--KINITNGAIQVLDPKIANCYQ 821
           G++L E+ + GR      P +  DVV  V +  K++  +G    +   + NC+ 
Sbjct: 373 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWH 424

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           GNG  +G+VY    + +G+L A+K +++      + +K E+  L K   H+NI    G F
Sbjct: 33  GNG-TYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 648 HS------DESIFLIYEFLQMGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLHKD 698
                   D+ ++L+ EF   GS+ DLI        + +W     I   + +GL++LH+ 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 148
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFA----LDRIVGEA-AFQST---MSSEYALSCY 750
            V   +HR++K +N+LL  + E KL DF     LDR VG    F  T   M+ E  ++C 
Sbjct: 149 KV---IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE-VIACD 204
Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             P+  Y  K+    D +S G+  +E+  G
Sbjct: 205 ENPDATYDFKS----DLWSLGITAIEMAEG 230

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/176 (25%), Positives = 92/176 (52%), Gaps = 9/176 (5%)
Query: 609 IAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +A+K L   +  +  +   +E   + +  H NI+++ G   +   + ++ EF++ G+L  
Sbjct: 47  VAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDS 106
Query: 668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDF 726
            +   D Q      + +  G+A G+ YL +  YV    HR++ ++NIL++++   K++DF
Sbjct: 107 FLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYV----HRDLAARNILVNSNLVCKVSDF 162
Query: 727 ALDRIVGEAAFQSTMSSEYALSC---YNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            L R + E +   T +S         + APE    +K T+  DA+S+G+V+ E+++
Sbjct: 163 GLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 592 GGPFGRVYI--LSLPSGE--LIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LP      +A+K L + +  +  +   +E   + +  H N++ + G 
Sbjct: 43  AGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV 102
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
                 + +I EF++ GSL   + + D Q      + +  G+A G+ YL   +YV    H
Sbjct: 103 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV----H 158
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---YNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R + +     T +S         + APE    +K T
Sbjct: 159 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 218
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+V+ E+++
Sbjct: 219 SASDVWSYGIVMWEVMS 235

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 42/286 (14%)
Query: 583 MDEKSSAGNGGPFGRVYILSLPSGE-LIAVKKLVNFGCQSSKT--------LKTEVKTLA 633
           ++ +   G GG FG V+   L   + ++A+K L+  G    +T         + EV  ++
Sbjct: 21  IEYEKQIGKGG-FGLVHKGRLVKDKSVVAIKSLI-LGDSEGETEMIEKFQEFQREVFIMS 78
Query: 634 KIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            + H NIVK+ G  H+     ++ EF+  G L   +  +   ++WS++L++ + +A G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 694 YLHKDYVPHLLHRNVKSKNILL-----DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           Y+ ++  P ++HR+++S NI L     +A    K+ DF L +       QS  S    L 
Sbjct: 137 YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-------QSVHSVSGLLG 188
Query: 749 CYN--APEY--GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
            +   APE      +  T + D YSF ++L  ++TG           +  +  +R     
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---- 244
Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                + L P I      ++   +E+   C S  P+KRP    +VK
Sbjct: 245 -----EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVK 282

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+ K +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 14  GTYGVVYKARNKLTGEVVALXK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 72
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 73  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 125
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 126 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 184 A-VDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+ K +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALXK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++EFL      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEFLHQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 119/234 (50%), Gaps = 18/234 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V +L    G  +AVK + N    +++    E   + ++RH N+V++LG    ++ 
Sbjct: 32  GEFGDV-MLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88
Query: 653 -IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            ++++ E++  GSL D L  R    L     LK ++ V + + YL  +   + +HR++ +
Sbjct: 89  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 145
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +   EA+  ST  +      + APE    KK + + D +SF
Sbjct: 146 RNVLVSEDNVAKVSDFGLTK---EAS--STQDTGKLPVKWTAPEALREKKFSTKSDVWSF 200
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRR--KINITNGAIQVLDPKIANCYQ 821
           G++L E+ + GR      P +  DVV  V +  K++  +G    +   + NC+ 
Sbjct: 201 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 252

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AV+ +        S + L  EV+ +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIM 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 175 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 235 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 289
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 290 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 347 YFNEPP--LKAMKMIR 360

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 158 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 212
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 213 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 270 YFNEP--PLKAMKMIR 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG FG VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 21  GGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 79
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 80  PPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 135
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++      +   +++ +  + APE     K + + D +
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 194
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 20/200 (10%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G +  VY  L+  +G  +A+K++ ++    +  T   E+  + +++H+NIV++    H++
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75
Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQ--------LQWSIRLKIAIGVAQGLAYLHKDYVPH 702
             + L++EF+      DL    D +        L+ ++       + QGLA+ H++ +  
Sbjct: 76  NKLTLVFEFMD----NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI-- 129
Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKA 761
            LHR++K +N+L++   + KL DF L R  G     +T SSE     Y AP+    S+  
Sbjct: 130 -LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 762 TAQMDAYSFGVVLLELITGR 781
           +  +D +S G +L E+ITG+
Sbjct: 187 STSIDIWSCGCILAEMITGK 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 15/193 (7%)
Query: 593 GPFGRVYIL-SLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV+++ S  +G   A+K   K +    +  +    E   L+ + H  I+++ G F 
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 76
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRN 707
             + IF+I ++++ G L  L+ R+  +    +    A  V   L YLH KD    +++R+
Sbjct: 77  DAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAEVCLALEYLHSKD----IIYRD 131
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +K +NILLD +   K+TDF   + V +  +    + +Y      APE   +K     +D 
Sbjct: 132 LKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYI-----APEVVSTKPYNKSIDW 186
Query: 768 YSFGVVLLELITG 780
           +SFG+++ E++ G
Sbjct: 187 WSFGILIYEMLAG 199

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 57/195 (29%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V I     +G  +AVK L     +S      +K E++ L   RH +I+K+     
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +    F++ E++  G L D IC+     +   R ++   +   + Y H+  V   +HR++
Sbjct: 82  TPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHMV---VHRDL 137
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAF--QSTMSSEYALSCYNAPEYGYSK-KATAQM 765
           K +N+LLDA    K+ DF L  ++ +  F   S  S  YA     APE    +  A  ++
Sbjct: 138 KPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYA-----APEVISGRLYAGPEV 192
Query: 766 DAYSFGVVLLELITG 780
           D +S GV+L  L+ G
Sbjct: 193 DIWSCGVILYALLCG 207

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AV+ +        S + L  EV+ +
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIM 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + +        Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDEFCGSPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 573 RVTEHDLVIGMDEKSSAGNGGPFGRVYILSL----PSGE--LIAVKKLVNFGCQSSKTLK 626
            +  H++V+    K   G G  FG+V++       P  +  L+AVK L +    + K   
Sbjct: 9   HIKRHNIVL----KRELGEGA-FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFH 63
Query: 627 TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD------------F 674
            E + L  ++H++IVK  G     + + +++E+++ G L   +                 
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPT 123
Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE 734
           +L  S  L IA  +A G+ YL      H +HR++ ++N L+  +   K+ DF + R V  
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS 180
Query: 735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQ 782
             +            +  PE    +K T + D +S GVVL E+ T G+Q
Sbjct: 181 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 229

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 101/195 (51%), Gaps = 14/195 (7%)
Query: 593 GPFGRVYIL---SLP-SGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+++   + P SG L A+K  K      +     K E   LA + H  +VK+   
Sbjct: 39  GSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKLHYA 98
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++  ++LI +FL+ G L   + ++    +  ++  +A  +A GL +LH      +++R
Sbjct: 99  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALGLDHLHS---LGIIYR 154
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQM 765
           ++K +NILLD +   KLTDF L +   EA      +  +  +  Y APE    +  +   
Sbjct: 155 DLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSA 211
Query: 766 DAYSFGVVLLELITG 780
           D +S+GV++ E++TG
Sbjct: 212 DWWSYGVLMFEMLTG 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 13  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++E +      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 72  TENKLYLVFEHVHQ----DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 124
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T + E     Y APE   G    +T
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 183 A-VDIWSLGCIFAEMVTRR 200

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 592 GGPFGRVY--ILSLPSGE--LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LP      +A+K L V +  +  +    E   + +  H N+V + G 
Sbjct: 53  AGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGV 112
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ EF++ G+L   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 113 VTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYV----H 168
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           R++ ++NIL++++   K++DF L R++ +   A  +T   +  +  + APE    +K T+
Sbjct: 169 RDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVR-WTAPEAIQYRKFTS 227
Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+V+ E+++
Sbjct: 228 ASDVWSYGIVMWEVMS 243

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 55  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 114
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 115 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 169
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 170 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 226
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 227 YFNEP--PLKAMKMIR 240

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 592 GGPFGRVYI--LSLPSGE--LIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LP      +A+K L + +  +  +   +E   + +  H N++ + G 
Sbjct: 17  AGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV 76
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
                 + +I EF++ GSL   + + D Q      + +  G+A G+ YL   +YV    H
Sbjct: 77  VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV----H 132
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---YNAPEYGYSKKAT 762
           R + ++NIL++++   K++DF L R + +     T +S         + APE    +K T
Sbjct: 133 RALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 192
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+V+ E+++
Sbjct: 193 SASDVWSYGIVMWEVMS 209

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKLVNFGCQSS--KTLKTEVKTL 632
           DE+   GN         G F +V +   + +G+ +AVK +      SS  + L  EV+  
Sbjct: 8   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIX 67
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 68  KVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAV 126
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ ++   +HR++K++N+LLDAD   K+ DF       E  F + + +      Y A
Sbjct: 127 QYCHQKFI---VHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPYAA 180
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 53  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 112
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 113 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 167
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 168 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 224
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 225 YFNEP--PLKAMKMIR 238

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 104 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 158
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 159 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 216 YFNEP--PLKAMKMIR 229

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY+       L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 42  GGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTLE 100
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              +++ E++  G+L D +  C ++ ++   + L +A  ++  + YL K    + +HR++
Sbjct: 101 PPFYIVTEYMPYGNLLDYLRECNRE-EVTAVVLLYMATQISSAMEYLEKK---NFIHRDL 156
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++    + +   +++ +  + APE       + + D +
Sbjct: 157 AARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNTFSIKSDVW 215
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 216 AFGVLLWEIAT 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 592 GGPFGRVY--ILSLPSG-EL-IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
            G FG V    L LP   EL +A+K L V +  +  +    E   + +  H NI+ + G 
Sbjct: 32  AGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGV 91
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G++ G+ YL    YV    H
Sbjct: 92  VTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV----H 147
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           R++ ++NIL++++   K++DF L R++    EAA+ +T   +  +  + APE    +K T
Sbjct: 148 RDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY-TTRGGKIPIR-WTAPEAIAFRKFT 205
Query: 763 AQMDAYSFGVVLLELIT 779
           +  D +S+G+V+ E+++
Sbjct: 206 SASDVWSYGIVMWEVVS 222

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG+L+AVKK+     Q  + L  EV  +   +H+N+V++   +   + ++++ EFL+ G+
Sbjct: 48  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 107
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++       +      + + V Q L+ LH   V   +HR++KS +ILL  D   KL+
Sbjct: 108 LTDIVTHTRMNEEQIA--AVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLS 162
Query: 725 DFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA 783
           DF    ++  E   +  +        + APE         ++D +S G++++E++ G   
Sbjct: 163 DFGFCAQVSKEVPRRKXL---VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 219
Query: 784 EQAEPAESLDVVKWVR 799
              EP   L  +K +R
Sbjct: 220 YFNEP--PLKAMKMIR 233

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 593 GPFGRVYILSLPSG----ELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+++   SG    +L A+K  K      +     K E   L ++ H  IVK+   
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA 94
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++  ++LI +FL+ G L   + ++    +  ++  +A  +A  L +LH      +++R
Sbjct: 95  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LGIIYR 150
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQM 765
           ++K +NILLD +   KLTDF L +   E+      +  +  +  Y APE    +  T   
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 766 DAYSFGVVLLELITG 780
           D +SFGV++ E++TG
Sbjct: 208 DWWSFGVLMFEMLTG 222

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 31/198 (15%)
Query: 604 PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGF-----FHSDESIFLI 656
           P+GE++A+KK+  F     + +TL+ E+K L   +H+NI+ +        F +   +++I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92
Query: 657 YEFLQMGSLGDLICRQ---DFQLQWSIRLKI-AIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
            E +Q   L  +I  Q   D  +Q+ I   + A+ V  G          +++HR++K  N
Sbjct: 93  QELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---------SNVIHRDLKPSN 142
Query: 713 ILLDADFEPKLTDFALDRIVGEAAF--------QSTMSSEYALSCYNAPEYGY-SKKATA 763
           +L++++ + K+ DF L RI+ E+A         QS M    A   Y APE    S K + 
Sbjct: 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSR 202
Query: 764 QMDAYSFGVVLLELITGR 781
            MD +S G +L EL   R
Sbjct: 203 AMDVWSCGCILAELFLRR 220

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 24  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 82
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 83  PPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 138
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++      +   +++ +  + APE     K + + D +
Sbjct: 139 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 197
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 198 AFGVLLWEIAT 208

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 593 GPFGRVYILSLPSG----ELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+++   SG    +L A+K  K      +     K E   L ++ H  IVK+   
Sbjct: 36  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA 95
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++  ++LI +FL+ G L   + ++    +  ++  +A  +A  L +LH      +++R
Sbjct: 96  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LGIIYR 151
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQM 765
           ++K +NILLD +   KLTDF L +   E+      +  +  +  Y APE    +  T   
Sbjct: 152 DLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 208
Query: 766 DAYSFGVVLLELITG 780
           D +SFGV++ E++TG
Sbjct: 209 DWWSFGVLMFEMLTG 223

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 21  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 79
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 80  PPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKK---NFIHRDL 135
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++      +   +++ +  + APE     K + + D +
Sbjct: 136 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 194
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 195 AFGVLLWEIAT 205

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 593 GPFGRVYILSLPSG----ELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+++   SG    +L A+K  K      +     K E   L ++ H  IVK+   
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYA 94
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F ++  ++LI +FL+ G L   + ++    +  ++  +A  +A  L +LH      +++R
Sbjct: 95  FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LGIIYR 150
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQM 765
           ++K +NILLD +   KLTDF L +   E+      +  +  +  Y APE    +  T   
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 207
Query: 766 DAYSFGVVLLELITG 780
           D +SFGV++ E++TG
Sbjct: 208 DWWSFGVLMFEMLTG 222

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 51/191 (26%), Positives = 98/191 (51%), Gaps = 9/191 (4%)
Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L     +  + LK E   + +I+H N+V++LG    +
Sbjct: 28  GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTRE 86
Query: 651 ESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              ++I EF+  G+L D +  C +  ++   + L +A  ++  + YL K    + +HR++
Sbjct: 87  PPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKK---NFIHRDL 142
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            ++N L+  +   K+ DF L R++      +   +++ +  + APE     K + + D +
Sbjct: 143 AARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK-WTAPESLAYNKFSIKSDVW 201
Query: 769 SFGVVLLELIT 779
           +FGV+L E+ T
Sbjct: 202 AFGVLLWEIAT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 6/178 (3%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQM 662
           +G L+AVK+L + G    +  + E++ L  +    IVK  G  +    +S+ L+ E+L  
Sbjct: 39  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 98
Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK 722
           G L D + R   +L  S  L  +  + +G+ YL        +HR++ ++NIL++++   K
Sbjct: 99  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 155
Query: 723 LTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           + DF L +++  +  +        +   + APE       + Q D +SFGVVL EL T
Sbjct: 156 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 108/223 (48%), Gaps = 14/223 (6%)
Query: 563 VWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQS 621
           +W+  +  P+ + +HD V+   +       G FG V+ +    +G   A K ++      
Sbjct: 139 IWKQYYPQPVEI-KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 197
Query: 622 SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR 681
            +T++ E++T++ +RH  +V +   F  D  + +IYEF+  G L + +  +  ++     
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 257
Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF--EPKLTDFALDRIVG--EAAF 737
           ++    V +GL ++H++   + +H ++K +NI+       E KL DF L   +   ++  
Sbjct: 258 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            +T ++E+A     APE    K      D +S GV+   L++G
Sbjct: 315 VTTGTAEFA-----APEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 6/178 (3%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQM 662
           +G L+AVK+L + G    +  + E++ L  +    IVK  G  +    +S+ L+ E+L  
Sbjct: 38  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 97
Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK 722
           G L D + R   +L  S  L  +  + +G+ YL        +HR++ ++NIL++++   K
Sbjct: 98  GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 154
Query: 723 LTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           + DF L +++  +  +        +   + APE       + Q D +SFGVVL EL T
Sbjct: 155 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 128/286 (44%), Gaps = 42/286 (14%)
Query: 583 MDEKSSAGNGGPFGRVYILSLPSGE-LIAVKKLVNFGCQSSKT--------LKTEVKTLA 633
           ++ +   G GG FG V+   L   + ++A+K L+  G    +T         + EV  ++
Sbjct: 21  IEYEKQIGKGG-FGLVHKGRLVKDKSVVAIKSLI-LGDSEGETEMIEKFQEFQREVFIMS 78
Query: 634 KIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            + H NIVK+ G  H+     ++ EF+  G L   +  +   ++WS++L++ + +A G+ 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 694 YLHKDYVPHLLHRNVKSKNILL-----DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           Y+ ++  P ++HR+++S NI L     +A    K+ DF   +       QS  S    L 
Sbjct: 137 YM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-------QSVHSVSGLLG 188
Query: 749 CYN--APEY--GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
            +   APE      +  T + D YSF ++L  ++TG           +  +  +R     
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---- 244
Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                + L P I      ++   +E+   C S  P+KRP    +VK
Sbjct: 245 -----EGLRPTIPEDCPPRLRNVIEL---CWSGDPKKRPHFSYIVK 282

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 6/178 (3%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQM 662
           +G L+AVK+L + G    +  + E++ L  +    IVK  G  +    +S+ L+ E+L  
Sbjct: 51  TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPS 110
Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK 722
           G L D + R   +L  S  L  +  + +G+ YL        +HR++ ++NIL++++   K
Sbjct: 111 GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVK 167
Query: 723 LTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           + DF L +++  +  +        +   + APE       + Q D +SFGVVL EL T
Sbjct: 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 108/223 (48%), Gaps = 14/223 (6%)
Query: 563 VWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQS 621
           +W+  +  P+ + +HD V+   +       G FG V+ +    +G   A K ++      
Sbjct: 33  IWKQYYPQPVEI-KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 91
Query: 622 SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR 681
            +T++ E++T++ +RH  +V +   F  D  + +IYEF+  G L + +  +  ++     
Sbjct: 92  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 151
Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF--EPKLTDFALDRIVG--EAAF 737
           ++    V +GL ++H++   + +H ++K +NI+       E KL DF L   +   ++  
Sbjct: 152 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 208
Query: 738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            +T ++E+A     APE    K      D +S GV+   L++G
Sbjct: 209 VTTGTAEFA-----APEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G VY      GE  A+KK+     + G  S  T   E+  L +++H NIVK+    H
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS--TTIREISILKELKHSNIVKLYDVIH 70
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + + + L++E L    L  L+   +  L+        + +  G+AY H   V   LHR++
Sbjct: 71  TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDL 126
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDA 767
           K +N+L++ + E K+ DF L R  G    + T   E     Y AP+    SKK +  +D 
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYT--HEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 768 YSFGVVLLELITG 780
           +S G +  E++ G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G VY      GE  A+KK+     + G  S  T   E+  L +++H NIVK+    H
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS--TTIREISILKELKHSNIVKLYDVIH 70
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + + + L++E L    L  L+   +  L+        + +  G+AY H   V   LHR++
Sbjct: 71  TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDL 126
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDA 767
           K +N+L++ + E K+ DF L R  G    + T   E     Y AP+    SKK +  +D 
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYT--HEVVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 768 YSFGVVLLELITG 780
           +S G +  E++ G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G VY      GE  A+KK+     + G  S  T   E+  L +++H NIVK+    H
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS--TTIREISILKELKHSNIVKLYDVIH 70
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + + + L++E L    L  L+   +  L+        + +  G+AY H   V   LHR++
Sbjct: 71  TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDL 126
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDA 767
           K +N+L++ + E K+ DF L R  G    + T   E     Y AP+    SKK +  +D 
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTTIDI 184
Query: 768 YSFGVVLLELITG 780
           +S G +  E++ G
Sbjct: 185 WSVGCIFAEMVNG 197

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G VY   +  +GE++A+KK +    ++     T   E+  L ++ H NIVK+L   H
Sbjct: 17  GTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 75
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA----IGVAQGLAYLHKDYVPHLL 704
           ++  ++L++E +      DL    D      I L +       + QGLA+ H   V   L
Sbjct: 76  TENKLYLVFEHVDQ----DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---L 128
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKAT 762
           HR++K +N+L++ +   KL DF L R  G      T   E     Y APE   G    +T
Sbjct: 129 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 AQMDAYSFGVVLLELITGR 781
           A +D +S G +  E++T R
Sbjct: 187 A-VDIWSLGCIFAEMVTRR 204

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 593 GPFGR-VYILSLPSGELIAVKKLVNFGCQSSKTL---KTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+ + + S   G    +K+ +N    SSK     + EV  LA ++H NIV+    F 
Sbjct: 35  GSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 649 SDESIFLIYEFLQMGSLGDLICRQD---FQ----LQWSIRLKIAIGVAQGLAYLHKDYVP 701
            + S++++ ++ + G L   I  Q    FQ    L W +++ +A      L ++H     
Sbjct: 94  ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHDR--- 144
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPEYG 756
            +LHR++KS+NI L  D   +L DF + R++           E A +C     Y +PE  
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-------ELARACIGTPYYLSPEIC 197
Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
            +K    + D ++ G VL EL T + A +A   ++L
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD--------F 674
           K    E++ L+++ H NIVK+ G   +   + L+ E+ + GSL +++   +         
Sbjct: 47  KAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 104
Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP-KLTDFALDRIVG 733
            + W ++       +QG+AYLH      L+HR++K  N+LL A     K+ DF       
Sbjct: 105 AMSWCLQ------CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT----- 153
Query: 734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPAES 791
               Q+ M++    + + APE       + + D +S+G++L E+IT R+   E   PA  
Sbjct: 154 ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-- 211
Query: 792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                  R    + NG    L   +    +  M        RC S  P +RPSM E+VK
Sbjct: 212 ------FRIMWAVHNGTRPPLIKNLPKPIESLM-------TRCWSKDPSQRPSMEEIVK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD--------F 674
           K    E++ L+++ H NIVK+ G   +   + L+ E+ + GSL +++   +         
Sbjct: 46  KAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH 103
Query: 675 QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP-KLTDFALDRIVG 733
            + W ++       +QG+AYLH      L+HR++K  N+LL A     K+ DF       
Sbjct: 104 AMSWCLQ------CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT----- 152
Query: 734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA--EQAEPAES 791
               Q+ M++    + + APE       + + D +S+G++L E+IT R+   E   PA  
Sbjct: 153 ACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-- 210
Query: 792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                  R    + NG    L   +    +  M        RC S  P +RPSM E+VK
Sbjct: 211 ------FRIMWAVHNGTRPPLIKNLPKPIESLM-------TRCWSKDPSQRPSMEEIVK 256

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G  +AVK +        S + L  EV+ +
Sbjct: 9   DEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIM 68
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++L+ E+   G + D +       +   R K    +   +
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAV 127
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+ Y+   +HR++K++N+LLD D   K+ DF       E    + + +      Y A
Sbjct: 128 QYCHQKYI---VHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPYAA 181
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 117/234 (50%), Gaps = 18/234 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V +L    G  +AVK + N    +++    E   + ++RH N+V++LG    ++ 
Sbjct: 23  GEFGDV-MLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 79
Query: 653 -IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            ++++ E++  GSL D L  R    L     LK ++ V + + YL  +   + +HR++ +
Sbjct: 80  GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAA 136
Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N+L+  D   K++DF L +   EA+  ST  +      + APE       + + D +SF
Sbjct: 137 RNVLVSEDNVAKVSDFGLTK---EAS--STQDTGKLPVKWTAPEALREAAFSTKSDVWSF 191
Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRR--KINITNGAIQVLDPKIANCYQ 821
           G++L E+ + GR      P +  DVV  V +  K++  +G    +   + NC+ 
Sbjct: 192 GILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH 243

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 581 IGMDEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEV 629
           +G DE+   GN         G F +V +   + +G  +A+K +        S + L  EV
Sbjct: 3   MGSDEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV 62
Query: 630 KTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA 689
           + +  + H NIVK+     ++++++LI E+   G + D +       +   R K    + 
Sbjct: 63  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIV 121
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
             + Y H+     ++HR++K++N+LLDAD   K+ DF       E      + +      
Sbjct: 122 SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPP 175
Query: 750 YNAPEYGYSKKATA-QMDAYSFGVVLLELITG 780
           Y APE    KK    ++D +S GV+L  L++G
Sbjct: 176 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 45  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 104 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 158
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 159 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 214
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 215 LWSLGVLCYEFLVGK 229

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 23  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 81
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   A+G+ YLH      ++HR++KS N
Sbjct: 82  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNN 138
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKATAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE      S   + Q 
Sbjct: 139 IFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDSNPYSFQS 194
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 195 DVYAFGIVLYELMTGQ 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 107 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 163
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 164 FGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 116/268 (43%), Gaps = 40/268 (14%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+    + + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKNSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKKV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS  A  C    Y  PE    +   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
            ++D +S GV+  E + G+   +A   +  D  K + R        ++   P        
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFEANTYQ--DTYKRISR--------VEFTFPDFVTE--- 231
Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVK 850
              GA ++  R     P +RP + EV++
Sbjct: 232 ---GARDLISRLLKHNPSQRPMLREVLE 256

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 35  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 93
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   A+G+ YLH      ++HR++KS N
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNN 150
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKATAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE      S   + Q 
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDSNPYSFQS 206
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 207 DVYAFGIVLYELMTGQ 222

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 36  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 94
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 95  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 149
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 150 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 205
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 206 LWSLGVLCYEFLVGK 220

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 24  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 83  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 137
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEXIEGRXHDEKVD 193
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 194 LWSLGVLCYEFLVGK 208

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 188
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 189 LWSLGVLCYEFLVGK 203

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 11/178 (6%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           SG  +AVK +     Q  + L  EV  +   +H N+V++   +   E ++++ EFLQ G+
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++ +   +L       +   V Q LAYLH   V   +HR++KS +ILL  D   KL+
Sbjct: 129 LTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLS 183
Query: 725 DFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           DF     + +     +  + + Y    + APE         ++D +S G++++E++ G
Sbjct: 184 DFGFCAQISKDVPKRKXLVGTPY----WMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 92/186 (49%), Gaps = 11/186 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           +G+ +AVKK+     Q  + L  EV  +    H N+V +   +   + ++++ EFL+ G+
Sbjct: 69  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGA 128
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L D++     ++       + + V + L+YLH   V   +HR++KS +ILL +D   KL+
Sbjct: 129 LTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLS 183
Query: 725 DFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
           DF     V +     +  + + Y    + APE         ++D +S G++++E+I G  
Sbjct: 184 DFGFCAQVSKEVPKRKXLVGTPY----WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239
Query: 783 AEQAEP 788
               EP
Sbjct: 240 PYFNEP 245

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 20  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 79  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 133
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF        ++ ++T+S       Y  PE    +    ++D
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLD---YLPPEMIEGRMHDEKVD 189
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 190 LWSLGVLCYEFLVGK 204

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 191
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 192 LWSLGVLCYEFLVGK 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 24  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 82
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 139
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 140 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 195
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 196 DVYAFGIVLYELMTGQ 211

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  + + 
Sbjct: 35  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 93
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   A+G+ YLH      ++HR++KS N
Sbjct: 94  LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNN 150
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKATAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE      S   + Q 
Sbjct: 151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDSNPYSFQS 206
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 207 DVYAFGIVLYELMTGQ 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 24  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 82
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 83  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 139
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 140 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 195
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 196 DVYAFGIVLYELMTGQ 211

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS  A  C    Y  PE    +   
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 24  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 83  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 137
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 193
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 194 LWSLGVLCYEFLVGK 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 19  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH   +   +HR++KS N
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNN 134
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 190
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 191 DVYAFGIVLYELMTGQ 206

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 19  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 134
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 135 IFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 190
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 191 DVYAFGIVLYELMTGQ 206

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 21  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 79
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH   +   +HR++KS N
Sbjct: 80  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNN 136
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 137 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 192
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 193 DVYAFGIVLYELMTGQ 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 47  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 105
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 162
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 163 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 218
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 219 DVYAFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 39  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 97
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 98  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 154
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 155 IFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 210
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 211 DVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 47  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 105
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 106 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 162
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 163 IFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 218
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 219 DVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 89/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +   
Sbjct: 46  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STKPQ 104
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++KS N
Sbjct: 105 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNN 161
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 162 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 217
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 218 DVYAFGIVLYELMTGQ 233

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 584 DEKSSAGN--------GGPFGRVYILS-LPSGELIAVKKL--VNFGCQSSKTLKTEVKTL 632
           DE+   GN         G F +V +   + +G  +A+K +        S + L  EV+ +
Sbjct: 9   DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 633 AKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGL 692
             + H NIVK+     ++++++LI E+   G + D +       +   R K    +   +
Sbjct: 69  KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAV 127
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            Y H+     ++HR++K++N+LLDAD   K+ DF       E      + +      Y A
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAA 181
Query: 753 PEYGYSKKATA-QMDAYSFGVVLLELITG 780
           PE    KK    ++D +S GV+L  L++G
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 38  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 97
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 98  LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 154
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 155 FGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 32  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 92  LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 149 FGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 31  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 90
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 91  LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 147
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 148 FGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 86/174 (49%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 27  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 87  LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 143
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 144 FGLSRYVLDDEYTSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 23  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 82  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 136
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 137 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 192
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 193 LWSLGVLCYEFLVGK 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 100/196 (51%), Gaps = 15/196 (7%)
Query: 593 GPFGRVY--ILSLPSGE--LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V    L +P      +A+K L   +  +  +   +E   + +  H NI+ + G  
Sbjct: 25  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV 84
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHR 706
              + + +I E+++ GSL   + + D +      + +  G+  G+ YL    YV    HR
Sbjct: 85  TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV----HR 140
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++ ++NIL++++   K++DF + R++    EAA+ +T   +  +  + APE    +K T+
Sbjct: 141 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY-TTRGGKIPIR-WTAPEAIAYRKFTS 198
Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+V+ E+++
Sbjct: 199 ASDVWSYGIVMWEVMS 214

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 23  GKFGNVYLARERQSKFILALKVL-FKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGV---AQGLAYLHKDYVPHLL 704
           H    ++LI E+  +G+    + R+  +L      + A  +   A  L+Y H   V   +
Sbjct: 82  HDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSYCHSKRV---I 134
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++K +N+LL ++ E K+ DF    +   ++ ++T+        Y  PE    +    +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEK 190
Query: 765 MDAYSFGVVLLELITG 780
           +D +S GV+  E + G
Sbjct: 191 VDLWSLGVLCYEFLVG 206

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 15/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  + + 
Sbjct: 19  GSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ- 77
Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH   +   +HR++KS N
Sbjct: 78  LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNN 134
Query: 713 ILLDADFEPKLTDFAL----DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA---TAQM 765
           I L  D   K+ DF L     R  G   F+    S      + APE    +     + Q 
Sbjct: 135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS----ILWMAPEVIRMQDKNPYSFQS 190
Query: 766 DAYSFGVVLLELITGR 781
           D Y+FG+VL EL+TG+
Sbjct: 191 DVYAFGIVLYELMTGQ 206

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 593 GPFGRVYILS----LPSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++      LP  +  L+AVK L      + +  + E + L  ++H++IV+  G 
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 111
Query: 647 FHSDESIFLIYEFLQMGSLGD-----------LICRQDFQ---LQWSIRLKIAIGVAQGL 692
                 + +++E+++ G L             L   +D     L     L +A  VA G+
Sbjct: 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H +HR++ ++N L+      K+ DF + R +    +            +  
Sbjct: 172 VYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 228
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQA-EQAEPAESLDVV 795
           PE    +K T + D +SFGVVL E+ T G+Q   Q    E++D +
Sbjct: 229 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 18  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 76
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 77  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 131
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 132 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 187
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 188 LWSLGVLCYEFLVGK 202

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 20  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 79  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 133
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ + T+        Y  PE    +    ++D
Sbjct: 134 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLD---YLPPEMIEGRMHDEKVD 189
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 190 LWSLGVLCYEFLVGK 204

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS  A  C    Y  PE    +   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 100/196 (51%), Gaps = 15/196 (7%)
Query: 593 GPFGRVY--ILSLPSGE--LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V    L +P      +A+K L   +  +  +   +E   + +  H NI+ + G  
Sbjct: 19  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV 78
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHR 706
              + + +I E+++ GSL   + + D +      + +  G+  G+ YL    YV    HR
Sbjct: 79  TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYV----HR 134
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           ++ ++NIL++++   K++DF + R++    EAA+ +T   +  +  + APE    +K T+
Sbjct: 135 DLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY-TTRGGKIPIR-WTAPEAIAYRKFTS 192
Query: 764 QMDAYSFGVVLLELIT 779
             D +S+G+V+ E+++
Sbjct: 193 ASDVWSYGIVMWEVMS 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 121/262 (46%), Gaps = 40/262 (15%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 772 VVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           V+L E+ T G       P E L  ++K   R           +D K +NC  +     L 
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-----------MD-KPSNCTNE-----LY 323
Query: 830 IALR-CTSVMPEKRPSMFEVVK 850
           + +R C   +P +RP+  ++V+
Sbjct: 324 MMMRDCWHAVPSQRPTFKQLVE 345

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 191
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 192 LWSLGVLCYEFLVGK 206

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 49/283 (17%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLG 645
           G FGRV+      +L      ++AVK L        +   + E   +A+  + NIVK+LG
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117
Query: 646 FFHSDESIFLIYEFLQMGSLGDL--------IC---RQDFQLQWSI------------RL 682
                + + L++E++  G L +         +C     D   +  +            +L
Sbjct: 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177
Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
            IA  VA G+AYL +      +HR++ ++N L+  +   K+ DF L R +  A +     
Sbjct: 178 CIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADG 234
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK 801
           ++     +  PE  +  + T + D +++GVVL E+ + G Q       E  +V+ +VR  
Sbjct: 235 NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--EVIYYVR-- 290
Query: 802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
                      D  I  C +   L    +   C S +P  RPS
Sbjct: 291 -----------DGNILACPENCPLELYNLMRLCWSKLPADRPS 322

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 593 GPFGRVY--ILSLPSGE--LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V    L +P      +A+K L   +  +  +   +E   + +  H NI+ + G  
Sbjct: 40  GEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVV 99
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
              + + +I E+++ GSL   + + D +      + +  G+  G+ YL        +HR+
Sbjct: 100 TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRD 156
Query: 708 VKSKNILLDADFEPKLTDFALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           + ++NIL++++   K++DF + R++    EAA+ +T   +  +  + APE    +K T+ 
Sbjct: 157 LAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY-TTRGGKIPIR-WTAPEAIAYRKFTSA 214
Query: 765 MDAYSFGVVLLELIT 779
            D +S+G+V+ E+++
Sbjct: 215 SDVWSYGIVMWEVMS 229

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 16  GKFGNVYLAREKQRKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 74
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +      +  A  L+Y H   V   +HR
Sbjct: 75  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHSKRV---IHR 129
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 130 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 185
Query: 767 AYSFGVVLLELITGRQAEQA 786
            +S GV+  E + G+   +A
Sbjct: 186 LWSLGVLCYEFLVGKPPFEA 205

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE + +    K++N   G +++     E   +A + H ++V++LG 
Sbjct: 49  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 108
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             S  +I L+ + +  G L + +      +   + L   + +A+G+ YL +     L+HR
Sbjct: 109 CLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHR 164
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+ +    K+TDF L R++     +           + A E  + +K T Q D
Sbjct: 165 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 224
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 225 VWSYGVTIWELMT 237

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 32  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 92  LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 148
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +  + S+  S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 149 FGLSRYVLDDEYTSSRGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 43/213 (20%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G +G V+   L  GE +AVK + +   + S   +TE+     +RH NI   LGF  SD +
Sbjct: 19  GRYGEVW-RGLWHGESVAVK-IFSSRDEQSWFRETEIYNTVLLRHDNI---LGFIASDMT 73
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++LI  + + GSL D + RQ  +   ++RL  A+  A GLA+LH +       
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRL--AVSAACGLAHLHVEIFGTQGK 131
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           P + HR+ KS+N+L+ ++ +  + D  L       A   +  S+Y L   N P  G  + 
Sbjct: 132 PAIAHRDFKSRNVLVKSNLQCCIADLGL-------AVMHSQGSDY-LDIGNNPRVGTKRY 183
Query: 761 ATAQM----------------DAYSFGVVLLEL 777
              ++                D ++FG+VL E+
Sbjct: 184 MAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 94/196 (47%), Gaps = 20/196 (10%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 23  GKFGNVYLARERQSKFILALKVL-FKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 81
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGV---AQGLAYLHKDYVPHLL 704
           H    ++LI E+  +G+    + R+  +L      + A  +   A  L+Y H   V   +
Sbjct: 82  HDATRVYLILEYAPLGT----VYRELQKLSRFDEQRTATYITELANALSYCHSKRV---I 134
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++K +N+LL ++ E K+ DF    +   ++ + T+        Y  PE    +    +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLD---YLPPEMIEGRMHDEK 190
Query: 765 MDAYSFGVVLLELITG 780
           +D +S GV+  E + G
Sbjct: 191 VDLWSLGVLCYEFLVG 206

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 593 GPFGRVYILS----LPSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++      LP  +  L+AVK L      + +  + E + L  ++H++IV+  G 
Sbjct: 29  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 88
Query: 647 FHSDESIFLIYEFLQMGSLGD-----------LICRQDFQ---LQWSIRLKIAIGVAQGL 692
                 + +++E+++ G L             L   +D     L     L +A  VA G+
Sbjct: 89  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 148
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H +HR++ ++N L+      K+ DF + R +    +            +  
Sbjct: 149 VYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 205
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQA-EQAEPAESLDVV 795
           PE    +K T + D +SFGVVL E+ T G+Q   Q    E++D +
Sbjct: 206 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 250

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 593 GPFGRVYILS----LPSGE--LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V++      LP  +  L+AVK L      + +  + E + L  ++H++IV+  G 
Sbjct: 23  GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGV 82
Query: 647 FHSDESIFLIYEFLQMGSLGD-----------LICRQDFQ---LQWSIRLKIAIGVAQGL 692
                 + +++E+++ G L             L   +D     L     L +A  VA G+
Sbjct: 83  CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 142
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H +HR++ ++N L+      K+ DF + R +    +            +  
Sbjct: 143 VYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 199
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQA-EQAEPAESLDVV 795
           PE    +K T + D +SFGVVL E+ T G+Q   Q    E++D +
Sbjct: 200 PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 244

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V+  + +P GE I +   +       G QS + +   +  +  + H +IV++LG 
Sbjct: 42  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 101
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
                S+ L+ ++L +GSL D + +    L   + L   + +A+G+ YL +     ++HR
Sbjct: 102 C-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHR 157
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           N+ ++N+LL +  + ++ DF +  ++     Q   S       + A E  +  K T Q D
Sbjct: 158 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 217
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 218 VWSYGVTVWELMT 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 24  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+   G +  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 83  HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 137
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 138 DIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 193
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 194 LWSLGVLCYEFLVGK 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQM 765
           ++K +N+LL +  E K+ DF            S+  +E   +  Y  PE    +    ++
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS-----VHAPSSRRTELCGTLDYLPPEMIEGRMHDEKV 187
Query: 766 DAYSFGVVLLELITGR 781
           D +S GV+  E + G+
Sbjct: 188 DLWSLGVLCYEFLVGK 203

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE + +    K++N   G +++     E   +A + H ++V++LG 
Sbjct: 26  GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             S  +I L+ + +  G L + +      +   + L   + +A+G+ YL +     L+HR
Sbjct: 86  CLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+ +    K+TDF L R++     +           + A E  + +K T Q D
Sbjct: 142 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTIWELMT 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 45  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 103
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 104 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 158
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S          Y  PE    +    ++D
Sbjct: 159 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVD 214
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 215 LWSLGVLCYEFLVGK 229

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 87/175 (49%), Gaps = 9/175 (5%)
Query: 609 IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +A+K L   +  +  +   +E   + +  H NI+++ G         ++ E+++ GSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDF 726
            +   D Q      + +  GV  G+ YL    YV    HR++ ++N+L+D++   K++DF
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV----HRDLAARNVLVDSNLVCKVSDF 195
Query: 727 ALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            L R++ +   A  +T   +  +  + APE    +  ++  D +SFGVV+ E++ 
Sbjct: 196 GLSRVLEDDPDAAXTTTGGKIPIR-WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 21  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 80  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 134
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ +F    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 135 DIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 190
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 191 LWSLGVLCYEFLVGK 205

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 171
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 172 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 231
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 232 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 275
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 276 MMRDCWHAVPSQRPTFKQLVE 296

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V+  + +P GE I +   +       G QS + +   +  +  + H +IV++LG 
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
                S+ L+ ++L +GSL D + +    L   + L   + +A+G+ YL +     ++HR
Sbjct: 84  C-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHR 139
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           N+ ++N+LL +  + ++ DF +  ++     Q   S       + A E  +  K T Q D
Sbjct: 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSD 199
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 200 VWSYGVTVWELMT 212

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 85/174 (48%), Gaps = 4/174 (2%)
Query: 606 GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           G+     K++  G  S      E K +  + H+ +V++ G       IF+I E++  G L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            + +     + Q    L++   V + + YL        LHR++ ++N L++     K++D
Sbjct: 107 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSD 163
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
           F L R V +    S++ S++ +  ++ PE     K +++ D ++FGV++ E+ +
Sbjct: 164 FGLSRYVLDDEETSSVGSKFPVR-WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 283
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLVE 304

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 21  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 79
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 80  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 134
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS     C    Y  PE    +   
Sbjct: 135 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 187 EKVDLWSLGVLCYEFLVGK 205

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 89/176 (50%), Gaps = 11/176 (6%)
Query: 609 IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +A+K L   +  +  +   +E   + +  H NI+++ G         ++ E+++ GSL  
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 668 LICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDF 726
            +   D Q      + +  GV  G+ YL    YV    HR++ ++N+L+D++   K++DF
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV----HRDLAARNVLVDSNLVCKVSDF 195
Query: 727 ALDRIVG---EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            L R++    +AA+ +T   +  +  + APE    +  ++  D +SFGVV+ E++ 
Sbjct: 196 GLSRVLEDDPDAAY-TTTGGKIPIR-WTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 283
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLVE 304

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS     C    Y  PE    +   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 168
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 169 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 228
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 229 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 272
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 273 MMRDCWHAVPSQRPTFKQLVE 293

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S  +       Y  PE    +    ++D
Sbjct: 133 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 189 LWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 24  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 83  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 137
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S  +       Y  PE    +    ++D
Sbjct: 138 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 193
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 194 LWSLGVLCYEFLVGK 208

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ +F    +   ++ ++T+        Y  PE    +    ++D
Sbjct: 136 DIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLD---YLPPEMIEGRMHDEKVD 191
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 192 LWSLGVLCYEFLVGK 206

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++L+     
Sbjct: 71  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMG 129
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H   V   LHR++K  N
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHSANV---LHRDLKPSN 174
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 175 LLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 235 GCILAEMLSNR 245

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 20  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 79  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 133
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S  +       Y  PE    +    ++D
Sbjct: 134 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 190 LWSLGVLCYEFLVGK 204

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 119/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 172
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 173 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 232
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 233 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 276
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 277 MMRDCWHAVPSQRPTFKQLVE 297

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ------MGSLGDLICRQDFQLQWSIR 681
           EV  L  ++H NIV +    H+++S+ L++E+L       +   G++I   + +L     
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL----- 104
Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
                 + +GLAY H+  V   LHR++K +N+L++   E KL DF L R   ++    T 
Sbjct: 105 --FLFQLLRGLAYCHRQKV---LHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTY 157
Query: 742 SSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGR 781
            +E     Y  P+    S   + Q+D +  G +  E+ TGR
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS     C    Y  PE    +   
Sbjct: 133 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 185 EKVDLWSLGVLCYEFLVGK 203

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E   ++Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 19  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 77
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 78  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 132
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S  +       Y  PE    +    ++D
Sbjct: 133 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 188
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 189 LWSLGVLCYEFLVGK 203

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 15/194 (7%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQS------SKTLKTEVKTLAKIRHKNIVKVLG 645
           G F  VY      + +++A+KK +  G +S      ++T   E+K L ++ H NI+ +L 
Sbjct: 21  GQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 79
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F    +I L+++F++   L  +I      L  S      +   QGL YLH+ ++   LH
Sbjct: 80  AFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI---LH 135
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA-Q 764
           R++K  N+LLD +   KL DF L +  G          +     Y APE  +  +     
Sbjct: 136 RDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYXHQVVTRWYRAPELLFGARMYGVG 193
Query: 765 MDAYSFGVVLLELI 778
           +D ++ G +L EL+
Sbjct: 194 VDMWAVGCILAELL 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKKAT 762
           ++K +N+LL +  E K+ DF               SS     C    Y  PE    +   
Sbjct: 136 DIKPENLLLGSAGELKIADFGWS--------VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 763 AQMDAYSFGVVLLELITGR 781
            ++D +S GV+  E + G+
Sbjct: 188 EKVDLWSLGVLCYEFLVGK 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY        ++A  K+++   +   +    E+  LA   H NIVK+L  F+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +++++ EF   G++  ++   +  L  S    +       L YLH +    ++HR++K+ 
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 712 NILLDADFEPKLTDFAL-----------DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           NIL   D + KL DF +           D  +G   +   M+ E  + C  + +  Y  K
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW---MAPEVVM-CETSKDRPYDYK 220
Query: 761 ATAQMDAYSFGVVLLEL 777
           A    D +S G+ L+E+
Sbjct: 221 A----DVWSLGITLIEM 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK--IRHKNIVKVLGFFHS- 649
           G FG V+   L + + +AVK    F  Q  ++ ++E +  +   ++H+N+++ +      
Sbjct: 26  GRFGCVWKAQLMN-DFVAVKI---FPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 650 ---DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD-------- 698
              +  ++LI  F   GSL D +  +   + W+    +A  +++GL+YLH+D        
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYL--KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY--- 755
           + P + HR+ KSKN+LL +D    L DF L               +     Y APE    
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEG 199
Query: 756 --GYSKKATAQMDAYSFGVVLLELIT 779
              + + A  ++D Y+ G+VL EL++
Sbjct: 200 AINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 22  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 80
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+  +G++  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 81  HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+LL +  E K+ DF         A  S          Y  PE    +    ++D
Sbjct: 136 DIKPENLLLGSAGELKIADFGW----SVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVD 191
Query: 767 AYSFGVVLLELITGR 781
            +S GV+  E + G+
Sbjct: 192 LWSLGVLCYEFLVGK 206

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY        ++A  K+++   +   +    E+  LA   H NIVK+L  F+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +++++ EF   G++  ++   +  L  S    +       L YLH +    ++HR++K+ 
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 712 NILLDADFEPKLTDFAL-----------DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           NIL   D + KL DF +           D  +G   +   M+ E  + C  + +  Y  K
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYW---MAPEVVM-CETSKDRPYDYK 220
Query: 761 ATAQMDAYSFGVVLLEL 777
           A    D +S G+ L+E+
Sbjct: 221 A----DVWSLGITLIEM 233

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 51  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 154
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 155 LLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 215 GCILAEMLSNR 225

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY        ++A  K+++   +   +    E+  LA   H NIVK+L  F+ + 
Sbjct: 48  GAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 107
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           +++++ EF   G++  ++   +  L  S    +       L YLH +    ++HR++K+ 
Sbjct: 108 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAG 164
Query: 712 NILLDADFEPKLTDFAL-----------DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           NIL   D + KL DF +           D  +G   +   M+ E  + C  + +  Y  K
Sbjct: 165 NILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYW---MAPEVVM-CETSKDRPYDYK 220
Query: 761 ATAQMDAYSFGVVLLEL 777
           A    D +S G+ L+E+
Sbjct: 221 A----DVWSLGITLIEM 233

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 51  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 154
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 155 LLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 215 GCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLIYEFLQ 661
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++ + ++
Sbjct: 55  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP 721
                 L C+    L           + +GL Y+H     ++LHR++K  N+LL+   + 
Sbjct: 114 TDLYKLLKCQH---LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDL 167
Query: 722 KLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELIT 779
           K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S G +L E+++
Sbjct: 168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 227
Query: 780 GR 781
            R
Sbjct: 228 NR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 55  VAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 158
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 159 LLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 219 GCILAEMLSNR 229

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNF-GCQSS--KTLKT--- 627
           +   DLV+G  E+   GN   FG V+     SG L A   LV    C+ +    LK    
Sbjct: 111 LNHEDLVLG--EQIGRGN---FGEVF-----SGRLRADNTLVAVKSCRETLPPDLKAKFL 160
Query: 628 -EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI 686
            E + L +  H NIV+++G     + I+++ E +Q G     +  +  +L+    L++  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
             A G+ YL        +HR++ ++N L+      K++DF + R   +  + ++      
Sbjct: 221 DAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV 277
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
              + APE     + +++ D +SFG++L E
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 51  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 154
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 155 LLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 215 GCILAEMLSNR 225

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 15/177 (8%)
Query: 609 IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD- 667
           I + +  +    S+  L  EV  L  + H NI+K+  FF    + +L+ E  + G L D 
Sbjct: 67  IKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDE 126
Query: 668 LICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKL 723
           +I R  F ++  ++ +K    V  G+ YLHK    +++HR++K +N+LL++   D   K+
Sbjct: 127 IIHRMKFNEVDAAVIIK---QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKI 180
Query: 724 TDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            DF L  +      Q  M      + Y APE    KK   + D +S GV+L  L+ G
Sbjct: 181 VDFGLSAVFEN---QKKMKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 55  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 158
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 159 LLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 219 GCILAEMLSNR 229

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 667 D-LICRQDFQLQWSIR--------------LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   L++S                +  A  VA+G+ YL        +HR++ ++
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +         ++      + APE  + +  T Q D +SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 283
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLVE 304

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 19/167 (11%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD-LICRQDF-QLQW 678
           +S  L  EV  L ++ H NI+K+  FF    + +L+ E  + G L D +I RQ F ++  
Sbjct: 64  NSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA 123
Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEA 735
           ++ +K    V  G  YLHK    +++HR++K +N+LL++   D   K+ DF L      A
Sbjct: 124 AVIMK---QVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLS-----A 172
Query: 736 AFQ--STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            F+    M      + Y APE    KK   + D +S GV+L  L+ G
Sbjct: 173 HFEVGGKMKERLGTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 15/182 (8%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKT----EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL 660
           +G ++A+KK +       K +K     E+K L ++RH+N+V +L      +  +L++EF+
Sbjct: 49  TGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
               L DL    +  L + +  K    +  G+ + H     +++HR++K +NIL+     
Sbjct: 107 DHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGV 162
Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELI 778
            KL DF   R +  AA       E A   Y APE   G  K   A +D ++ G ++ E+ 
Sbjct: 163 VKLCDFGFARTL--AAPGEVYDDEVATRWYRAPELLVGDVKYGKA-VDVWAIGCLVTEMF 219
Query: 779 TG 780
            G
Sbjct: 220 MG 221

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 80
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + F L  +  +  A  ++  LAYL        +HR+
Sbjct: 81  -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRD 136
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ A    KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 137 IAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 195
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 196 WMFGVCMWEIL 206

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 53  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 156
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 157 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 217 GCILAEMLSNR 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 63  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 175
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 229
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 51  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 154
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 155 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 215 GCILAEMLSNR 225

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 667 DLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + +  +               + QL     +  A  VA+G+ YL        +HR++ ++
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 180 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 239
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 240 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 283
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 284 MMRDCWHAVPSQRPTFKQLVE 304

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 49  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 152
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 153 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 212
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 213 GCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 59  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 117
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 118 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 162
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 163 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 222
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 223 GCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 51  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 109
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 110 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 154
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 155 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 214
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 215 GCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 71  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 129
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 130 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 174
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 175 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 234
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 235 GCILAEMLSNR 245

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 49  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 107
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 108 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 152
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 153 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 212
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 213 GCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 56  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 159
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 160 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 219
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 220 GCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 57  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 115
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 116 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 160
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 161 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 220
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 221 GCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 48  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 106
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 107 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 151
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 152 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 211
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 212 GCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 55  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 158
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 219 GCILAEMLSNR 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 48  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 102
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 103 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 160
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 161 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 214
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 215 GATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 41  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 153
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 207
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 109/237 (45%), Gaps = 25/237 (10%)
Query: 620 QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS 679
           ++ K  + EV   +++ H+NIV ++     D+  +L+ E+++  +L + I      L   
Sbjct: 53  ETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVD 111
Query: 680 IRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS 739
             +     +  G+ + H      ++HR++K +NIL+D++   K+ DF + + + E +   
Sbjct: 112 TAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168
Query: 740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL------- 792
           T +       Y +PE    +      D YS G+VL E++ G      E A S+       
Sbjct: 169 T-NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD 227
Query: 793 ---DVVKWVRRKI--NITNGAIQVLDPKIANCYQ--QQMLGALEIALRCTSVMPEKR 842
              +V   VR+ I  +++N  ++  +   AN Y+  Q+M   L      +SV+ E R
Sbjct: 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL------SSVLHENR 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 37  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 91
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 92  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 149
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 150 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 203
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 204 GATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ +L        +HR++ ++N +LD  F  K+ DF L R + +  F S  +   
Sbjct: 199 LQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 311
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 312 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 347

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 667 DLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + +  +               + QL     +  A  VA+G+ YL        +HR++ ++
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  D   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V+L E+ T G       P E L   K ++    +          K +NC  +     L +
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEEL--FKLLKEGHRMD---------KPSNCTNE-----LYM 268
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 269 MMRDCWHAVPSQRPTFKQLVE 289

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 22/198 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ EV+  + +RH NI+++ G+F
Sbjct: 24  GKFGNVYLAREKQSKFILALKVL-FKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 82
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H    ++LI E+   G +  +L     F  Q +        +A  L+Y H   V   +HR
Sbjct: 83  HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTA--TYITELANALSYCHSKRV---IHR 137
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---YNAPEYGYSKKATA 763
           ++K +N+LL +  E K+ DF         +  +  S    L     Y  PE    +    
Sbjct: 138 DIKPENLLLGSAGELKIADFGW-------SVHAPSSRRXXLXGTLDYLPPEMIEGRMHDE 190
Query: 764 QMDAYSFGVVLLELITGR 781
           ++D +S GV+  E + G+
Sbjct: 191 KVDLWSLGVLCYEFLVGK 208

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 30  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 84
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 85  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 142
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 143 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 196
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 197 GATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVL 644
           K + G G     V      +G+L AVK +     +  ++ ++ E+  L KI+H+NIV + 
Sbjct: 27  KETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALE 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
             + S   ++L+ + +  G L D I  + F  +      I   V   + YLH+     ++
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR-QVLDAVYYLHR---MGIV 142
Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
           HR++K +N+L    D + +  ++DF L ++ G+      MS+      Y APE    K  
Sbjct: 143 HRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG---DVMSTACGTPGYVAPEVLAQKPY 199
Query: 762 TAQMDAYSFGVVLLELITG 780
           +  +D +S GV+   L+ G
Sbjct: 200 SKAVDCWSIGVIAYILLCG 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 41  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 153
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 154 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 207
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 208 GATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 63  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 175
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 176 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 229
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 593 GPFGRVYI----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G V +    L+     +  +KK       +S  L  EV  L ++ H NI+K+  FF 
Sbjct: 15  GAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFE 74
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
              + +L+ E  + G L D +I RQ F ++  ++ +K    V  G  YLHK    +++HR
Sbjct: 75  DKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK---QVLSGTTYLHK---HNIVHR 128
Query: 707 NVKSKNILLDA---DFEPKLTDFALDRIVGEAAFQ--STMSSEYALSCYNAPEYGYSKKA 761
           ++K +N+LL++   D   K+ DF L      A F+    M      + Y APE    KK 
Sbjct: 129 DLKPENLLLESKSRDALIKIVDFGL-----SAHFEVGGKMKERLGTAYYIAPEV-LRKKY 182
Query: 762 TAQMDAYSFGVVLLELITG 780
             + D +S GV+L  L+ G
Sbjct: 183 DEKCDVWSCGVILYILLCG 201

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 593 GPFGRVYI-----LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V +     L   +G L+AVK+L + G    +  + E++ L  +    IVK  G  
Sbjct: 18  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 77
Query: 648 HSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +      + L+ E+L  G L D + R   +L  S  L  +  + +G+ YL        +H
Sbjct: 78  YGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVH 134
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++ ++NIL++++   K+ DF L +++  +           +   + APE       + Q
Sbjct: 135 RDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQ 194
Query: 765 MDAYSFGVVLLELIT 779
            D +SFGVVL EL T
Sbjct: 195 SDVWSFGVVLYELFT 209

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 65  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 177
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 178 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 231
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 232 GATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL--KTEVKTLAKIRHKNIVKVLGFF--- 647
           G +G V+  S   GE +AVK    F  +  K+   +TE+     +RH+NI   LGF    
Sbjct: 48  GRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 100
Query: 648 ----HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV--- 700
               HS   ++LI  + +MGSL D +  Q   L     L+I + +A GLA+LH +     
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 701 --PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYG 756
             P + HR++KSKNIL+  + +  + D  L  +  ++  Q  + +        Y APE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 218
Query: 757 YSK------KATAQMDAYSFGVVLLEL 777
                     +  ++D ++FG+VL E+
Sbjct: 219 DETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 33  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 87
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 88  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 145
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 146 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 199
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 200 GATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 57  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 169
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 170 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 223
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 224 GATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVY-ILSLPSGELIA---VKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + Y I  + + E+ A   V K +       + + TE+     + + ++V   G
Sbjct: 51  GKGG-FAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  D+ ++++ E  +  SL +L  R+    +   R  +   + QG+ YLH + V   +H
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRV---IH 165
Query: 706 RNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D + K+ DF L  +I  +   + T+        Y APE    K  + +
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLC---GTPNYIAPEVLCKKGHSFE 222
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G +L  L+ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 42  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 96
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 97  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 154
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 155 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 208
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 209 GATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 98  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 157
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 158 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 214
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 215 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 270
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 271 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 306

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 34  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 146
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 147 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 200
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 201 GATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 108 GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 220
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 221 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 274
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 275 GATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 67  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 649 SD-ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-------QGLAYLHKDYV 700
           S  E    +Y  L +  + + + R       + +    I V        + LAY+H    
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 179
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 180 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 233
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 234 GATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 99  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 158
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ YL  K +V    HR++ ++N +LD  F  K+ DF L R + +  + S  +  
Sbjct: 159 LQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 214
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 215 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 271
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 272 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 307

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 85  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 144
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 145 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 201 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 257
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 258 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 293

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 93/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A++K+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 55  VAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 158
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 219 GCILAEMLSNR 229

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 140
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 141 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 197 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 253
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 254 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 289

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 140 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 252
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 253 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 288

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 72  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 131
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 132 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 188
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 189 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 244
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 245 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 280

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + F L  +  +  A  ++  LAYL        +HR+
Sbjct: 461 -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRD 516
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ A    KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 517 IAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 575
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 576 WMFGVCMWEIL 586

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 140 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 252
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 253 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL--KTEVKTLAKIRHKNIVKVLGFF--- 647
           G +G V+  S   GE +AVK    F  +  K+   +TE+     +RH+NI   LGF    
Sbjct: 19  GRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 648 ----HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV--- 700
               HS   ++LI  + +MGSL D +  Q   L     L+I + +A GLA+LH +     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 701 --PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYG 756
             P + HR++KSKNIL+  + +  + D  L  +  ++  Q  + +        Y APE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 757 YSK------KATAQMDAYSFGVVLLEL 777
                     +  ++D ++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKN 639
           EK      G +G V+   +  + E++A+K++     + G  SS     E+  L +++HKN
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHKN 62
Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ---------LQWSIRLKIAIGVAQ 690
           IV++    HSD+ + L++EF          C QD +         L   I       + +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEF----------CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           GL + H   V   LHR++K +N+L++ + E KL DF L R  G        S+E     Y
Sbjct: 113 GLGFCHSRNV---LHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWY 167
Query: 751 NAPEYGYSKK-ATAQMDAYSFGVVLLEL 777
             P+  +  K  +  +D +S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL--KTEVKTLAKIRHKNIVKVLGFF--- 647
           G +G V+  S   GE +AVK    F  +  K+   +TE+     +RH+NI   LGF    
Sbjct: 19  GRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENI---LGFIASD 71
Query: 648 ----HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV--- 700
               HS   ++LI  + +MGSL D +  Q   L     L+I + +A GLA+LH +     
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 701 --PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS--EYALSCYNAPEYG 756
             P + HR++KSKNIL+  + +  + D  L  +  ++  Q  + +        Y APE  
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 757 YSK------KATAQMDAYSFGVVLLEL 777
                     +  ++D ++FG+VL E+
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 140 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 252
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 253 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 288

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 140
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 141 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 197 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 253
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 254 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 289

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 78  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 137
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 138 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 194
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 250
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 251 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 286

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 78  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 137
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ +L  K +V    HR++ ++N +LD  F  K+ DF L R + +  F S  +  
Sbjct: 138 LQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 194 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 250
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 251 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 286

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 49  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 108
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 109 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 164
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 165 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 223
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 224 WMFGVCMWEIL 234

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L   RH+NI+ +     +      + ++++     
Sbjct: 53  VAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 156
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 157 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 217 GCILAEMLSNR 227

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 21  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 80
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 81  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 136
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 137 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 195
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 196 WMFGVCMWEIL 206

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 137 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 193
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 249
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 250 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 285

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +GR   +   S   I V K +++G  +    + L +EV  L +++H NIV+       
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 648 HSDESIFLIYEFLQMGSLGDLIC-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            ++ +++++ E+ + G L  +I      RQ    ++ +R+   + +A    +   D    
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVG-EAAFQST-MSSEYALSCYNAPEYGYSKK 760
           +LHR++K  N+ LD     KL DF L RI+  + +F  T + + Y +S        Y++K
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 761 ATAQMDAYSFGVVLLEL 777
           +    D +S G +L EL
Sbjct: 197 S----DIWSLGCLLYEL 209

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + F L  +  +  A  ++  LAYL        +HR+
Sbjct: 461 -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRD 516
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 517 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 575
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 576 WMFGVCMWEIL 586

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ YL  K +V    HR++ ++N +LD  F  K+ DF L R + +  + S  +  
Sbjct: 135 LQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 247
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 248 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 283

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 24  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 83
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 84  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 139
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 140 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 198
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 199 WMFGVCMWEIL 209

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 92/191 (48%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L   RH+NI+ +     +      + ++++     
Sbjct: 53  VAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 111
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 156
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+       +   +EY A   Y APE    SK  T  +D +S 
Sbjct: 157 LLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSV 216
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 217 GCILAEMLSNR 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 79  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 138
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 139 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 195
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 196 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 251
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 252 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 287

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 17/180 (9%)
Query: 611 VKKLVNFGCQSSKTLK-------TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG 663
            +KLV   C + K L+        E+  L KI+H NIV +   + S   ++LI + +  G
Sbjct: 42  TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 101
Query: 664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL---LDADFE 720
            L D I  + F  +     ++   V   + YLH      ++HR++K +N+L   LD D +
Sbjct: 102 ELFDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSK 157
Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             ++DF L ++       S +S+      Y APE    K  +  +D +S GV+   L+ G
Sbjct: 158 IMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 80
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 81  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 136
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 137 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 195
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 196 WMFGVCMWEIL 206

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 86  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 141
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 142 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 200
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 201 WMFGVCMWEIL 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNF-GCQSS--KTLKT--- 627
           +   DLV+G  E+   GN   FG V+     SG L A   LV    C+ +    LK    
Sbjct: 111 LNHEDLVLG--EQIGRGN---FGEVF-----SGRLRADNTLVAVKSCRETLPPDLKAKFL 160
Query: 628 -EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI 686
            E + L +  H NIV+++G     + I+++ E +Q G     +  +  +L+    L++  
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
             A G+ YL        +HR++ ++N L+      K++DF + R   +    ++      
Sbjct: 221 DAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV 277
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
              + APE     + +++ D +SFG++L E
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 20/226 (8%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 139
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ YL        +HR++ ++N +LD  F  K+ DF L R + +  + S  +   
Sbjct: 140 LQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 196
Query: 746 AL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +   
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ--- 252
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                 ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 253 ----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 288

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 23  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 82
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 83  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 138
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 139 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 197
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 198 WMFGVCMWEIL 208

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 89/191 (46%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 21  GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 80
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + F L  +  +  A  ++  LAYL        +HR+
Sbjct: 81  -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRD 136
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++        +  +  + APE    ++ T+  D 
Sbjct: 137 IAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK-WMAPESINFRRFTSASDV 195
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 196 WMFGVCMWEIL 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 43/267 (16%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +AVK L      S  + L +E   L ++ H +++K+ G    D  + LI E+ + GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 668 LICR-----------------------QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            +                          +  L     +  A  ++QG+ YL +     L+
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++NIL+    + K++DF L R V E       S       + A E  +    T Q
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 765 MDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
            D +SFGV+L E++T G       P E L          N+     ++  P   NC ++ 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERL---------FNLLKTGHRMERPD--NCSEEM 281
Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVK 850
                 + L+C    P+KRP   ++ K
Sbjct: 282 ----YRLMLQCWKQEPDKRPVFADISK 304

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 90/191 (47%), Gaps = 10/191 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G FG V+  I   P    +AV       C S    +    E  T+ +  H +IVK++G  
Sbjct: 18  GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 77
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +HR+
Sbjct: 78  -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRD 133
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  D 
Sbjct: 134 IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSASDV 192
Query: 768 YSFGVVLLELI 778
           + FGV + E++
Sbjct: 193 WMFGVCMWEIL 203

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 28/190 (14%)
Query: 605 SGELIAVKKLVN-FGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI------FLI 656
           +G  +A+KKL   F  +  +K    E++ L  +RH+N++ +L  F  DE++      +L+
Sbjct: 49  TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 657 YEFLQMGS-LGDLICRQDF---QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
             F  MG+ LG L+  +     ++Q+     +   + +GL Y+H      ++HR++K  N
Sbjct: 109 MPF--MGTDLGKLMKHEKLGEDRIQF-----LVYQMLKGLRYIH---AAGIIHRDLKPGN 158
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFG 771
           + ++ D E K+ DF L R        S M        Y APE   +  + T  +D +S G
Sbjct: 159 LAVNEDCELKILDFGLARQA-----DSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVG 213
Query: 772 VVLLELITGR 781
            ++ E+ITG+
Sbjct: 214 CIMAEMITGK 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 89
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 90  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 145
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 146 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 205
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 206 VWSYGVTVWELMT 218

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 88  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 144 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 203
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 204 VWSYGVTVWELMT 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 591 NGGPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVL 644
           + G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++L
Sbjct: 31  SSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G   +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+
Sbjct: 91  GICLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 146
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 765 MDAYSFGVVLLELIT 779
            D +S+GV + EL+T
Sbjct: 207 SDVWSYGVTVWELMT 221

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 43/267 (16%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +AVK L      S  + L +E   L ++ H +++K+ G    D  + LI E+ + GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 668 LICR-----------------------QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            +                          +  L     +  A  ++QG+ YL +     L+
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLV 172
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++NIL+    + K++DF L R V E       S       + A E  +    T Q
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 765 MDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
            D +SFGV+L E++T G       P E L          N+     ++  P   NC ++ 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERL---------FNLLKTGHRMERPD--NCSEEM 281
Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVK 850
                 + L+C    P+KRP   ++ K
Sbjct: 282 ----YRLMLQCWKQEPDKRPVFADISK 304

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 89  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 144
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 204
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 205 VWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 86
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 87  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 142
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 143 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 202
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 203 VWSYGVTVWELMT 215

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 27  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 86
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 87  CLTS-TVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 142
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 143 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 202
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 203 VWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 86  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTVWELMT 214

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 109/267 (40%), Gaps = 43/267 (16%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD 667
           +AVK L      S  + L +E   L ++ H +++K+ G    D  + LI E+ + GSL  
Sbjct: 56  VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 668 LICR-----------------------QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            +                          +  L     +  A  ++QG+ YL +     L+
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLV 172
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++NIL+    + K++DF L R V E       S       + A E  +    T Q
Sbjct: 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ 232
Query: 765 MDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
            D +SFGV+L E++T G       P E L          N+     ++  P   NC ++ 
Sbjct: 233 SDVWSFGVLLWEIVTLGGNPYPGIPPERL---------FNLLKTGHRMERPD--NCSEEM 281
Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVK 850
                 + L+C    P+KRP   ++ K
Sbjct: 282 ----YRLMLQCWKQEPDKRPVFADISK 304

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 30  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 144
Query: 706 RNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D E K+ DF L  ++  +   + T+        Y APE    K  + +
Sbjct: 145 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSKKGHSFE 201
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G ++  L+ G+
Sbjct: 202 VDVWSIGCIMYTLLVGK 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 26  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 140
Query: 706 RNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D E K+ DF L  ++  +   + T+        Y APE    K  + +
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSKKGHSFE 197
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G ++  L+ G+
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 93  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 148
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 149 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 208
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 209 VWSYGVTVWELMT 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 89  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 144
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 204
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 205 VWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 88  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 144 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 203
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 204 VWSYGVTVWELMT 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 89  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 144
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 204
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 205 VWSYGVTVWELMT 217

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 26  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 140
Query: 706 RNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D E K+ DF L  ++  +   + T+        Y APE    K  + +
Sbjct: 141 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLC---GTPNYIAPEVLSKKGHSFE 197
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G ++  L+ G+
Sbjct: 198 VDVWSIGCIMYTLLVGK 214

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q       E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 32  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 91
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 92  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 147
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 148 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 207
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 208 VWSYGVTVWELMT 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 591 NGGPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVL 644
           + G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++L
Sbjct: 31  SSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 90
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G   +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+
Sbjct: 91  GICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 146
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q
Sbjct: 147 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 206
Query: 765 MDAYSFGVVLLELIT 779
            D +S+GV + EL+T
Sbjct: 207 SDVWSYGVTVWELMT 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q       E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  + + + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SYICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 86  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 591 NGGPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVL 644
           + G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++L
Sbjct: 24  SSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G   +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+
Sbjct: 84  GICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLV 139
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 199
Query: 765 MDAYSFGVVLLELIT 779
            D +S+GV + EL+T
Sbjct: 200 SDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 29  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 88
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 89  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 144
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 145 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 204
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 205 VWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 51  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 110
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 111 CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 166
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 167 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 226
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 227 VWSYGVTVWELMT 239

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 86  CLTS-TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTVWELMT 214

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVY-ILSLPSGELIA---VKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + Y I  + + E+ A   V K +       + + TE+     + + ++V   G
Sbjct: 51  GKGG-FAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  D+ ++++ E  +  SL +L  R+    +   R  +   + QG+ YLH + V   +H
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRV---IH 165
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D + K+ DF L     +  F      +      Y APE    K  + +
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGL---ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFE 222
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G +L  L+ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 23  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 82
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 83  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR---RLVHR 138
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 139 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 198
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 199 VWSYGVTVWELMT 211

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 11/178 (6%)
Query: 607 ELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           +L+A+K +     +  + +++ E+  L KI+H NIV +   + S   ++LI + +  G L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL---LDADFEPK 722
            D I  + F  +     ++   V   + YLH      ++HR++K +N+L   LD D +  
Sbjct: 104 FDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           ++DF L ++       S +S+      Y APE    K  +  +D +S GV+   L+ G
Sbjct: 160 ISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVY-ILSLPSGELIA---VKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + Y I  + + E+ A   V K +       + + TE+     + + ++V   G
Sbjct: 35  GKGG-FAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  D+ ++++ E  +  SL +L  R+    +   R  +   + QG+ YLH + V   +H
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRV---IH 149
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D + K+ DF L     +  F      +      Y APE    K  + +
Sbjct: 150 RDLKLGNLFLNDDMDVKIGDFGL---ATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFE 206
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G +L  L+ G+
Sbjct: 207 VDIWSLGCILYTLLVGK 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 86  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTVWELMT 214

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 36  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 95
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 96  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 151
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 152 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 211
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 212 VWSYGVTVWELMT 224

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 26/200 (13%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG V        +     K++N     +K   T+  EV+ L K+ H NI+K+      
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92
Query: 650 DESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             S +++ E    G L D +I R+ F    + R  I   V  G+ Y+HK    +++HR++
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--IIKQVFSGITYMHK---HNIVHRDL 147
Query: 709 KSKNILLDA---DFEPKLTDFALDRIVGEAAFQ--STMSSEYALSCYNAPEY---GYSKK 760
           K +NILL++   D + K+ DF L        FQ  + M      + Y APE     Y +K
Sbjct: 148 KPENILLESKEKDCDIKIIDFGL-----STCFQQNTKMKDRIGTAYYIAPEVLRGTYDEK 202
Query: 761 ATAQMDAYSFGVVLLELITG 780
                D +S GV+L  L++G
Sbjct: 203 C----DVWSAGVILYILLSG 218

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 91/192 (47%), Gaps = 12/192 (6%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G F  V+++    +G+L A+K +         +L+ E+  L KI+H+NIV +   + S  
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
             +L+ + +  G L D I  +    +    L I   V   + YLH++    ++HR++K +
Sbjct: 80  HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QVLSAVKYLHEN---GIVHRDLKPE 135
Query: 712 NILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           N+L    + + +  +TDF L ++         MS+      Y APE    K  +  +D +
Sbjct: 136 NLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 769 SFGVVLLELITG 780
           S GV+   L+ G
Sbjct: 192 SIGVITYILLCG 203

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 22/227 (9%)
Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 79  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 138
Query: 686 IGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           + VA+G+ YL  K +V    HR++ ++N +LD  F  K+ DF L R + +    S  +  
Sbjct: 139 LQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKT 194
Query: 745 YAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
            A     + A E   ++K T + D +SFGV+L EL+T R A       + D+  ++ +  
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT-RGAPPYPDVNTFDITVYLLQ-- 251
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
                  ++L P+    Y    L   E+ L+C     E RPS  E+V
Sbjct: 252 -----GRRLLQPE----YCPDPL--YEVMLKCWHPKAEMRPSFSELV 287

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 68  VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 126
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++ +   +HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 127 -YQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 182
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 183 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 221

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 20  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 80  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 135
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 196 VWSYGVTVWELMT 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +GR   +   S   I V K +++G  +    + L +EV  L +++H NIV+       
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 648 HSDESIFLIYEFLQMGSLGDLIC-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            ++ +++++ E+ + G L  +I      RQ    ++ +R+   + +A    +   D    
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVG-EAAF-QSTMSSEYALSCYNAPEYGYSKK 760
           +LHR++K  N+ LD     KL DF L RI+  + +F ++ + + Y +S        Y++K
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 196
Query: 761 ATAQMDAYSFGVVLLEL 777
           +    D +S G +L EL
Sbjct: 197 S----DIWSLGCLLYEL 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 61  VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 119
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 120 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 175
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 176 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 13/197 (6%)
Query: 590 GNGGPFGRVY-ILSLPSGELIA---VKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + Y I  + + E+ A   V K +       + + TE+     + + ++V   G
Sbjct: 51  GKGG-FAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  D+ ++++ E  +  SL +L  R+    +   R  +   + QG+ YLH + V   +H
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-QGVQYLHNNRV---IH 165
Query: 706 RNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  N+ L+ D + K+ DF L  +I  +   +  +        Y APE    K  + +
Sbjct: 166 RDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLC---GTPNYIAPEVLCKKGHSFE 222
Query: 765 MDAYSFGVVLLELITGR 781
           +D +S G +L  L+ G+
Sbjct: 223 VDIWSLGCILYTLLVGK 239

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 121 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 177 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 215

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/262 (24%), Positives = 120/262 (45%), Gaps = 40/262 (15%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 175
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 176 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 772 VVLLELIT-GRQAEQAEPAESL-DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           V++ E+ T G       P E L  ++K   R           +D K ANC  +     L 
Sbjct: 293 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHR-----------MD-KPANCTNE-----LY 335
Query: 830 IALR-CTSVMPEKRPSMFEVVK 850
           + +R C   +P +RP+  ++V+
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVE 357

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV----NFGCQSSKTLKTEVKTLAKIRHKN 639
           EK      G +G V+   +  + E++A+K++     + G  SS     E+  L +++HKN
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL--REICLLKELKHKN 62
Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ---------LQWSIRLKIAIGVAQ 690
           IV++    HSD+ + L++EF          C QD +         L   I       + +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEF----------CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           GL + H   V   LHR++K +N+L++ + E KL +F L R  G        S+E     Y
Sbjct: 113 GLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWY 167
Query: 751 NAPEYGYSKK-ATAQMDAYSFGVVLLEL 777
             P+  +  K  +  +D +S G +  EL
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 118
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 119 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 175
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 176 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 235
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 236 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 279
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 280 MMRDCWHAVPSQRPTFKQLVE 300

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 121 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 177 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 62  VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 120
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 121 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 177 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 11/178 (6%)
Query: 607 ELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           +L+A+K +     +  + +++ E+  L KI+H NIV +   + S   ++LI + +  G L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL---LDADFEPK 722
            D I  + F  +     ++   V   + YLH      ++HR++K +N+L   LD D +  
Sbjct: 104 FDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           ++DF L ++       S +S+      Y APE    K  +  +D +S GV+   L+ G
Sbjct: 160 ISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 87/178 (48%), Gaps = 11/178 (6%)
Query: 607 ELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           +L+A+K +     +  + +++ E+  L KI+H NIV +   + S   ++LI + +  G L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL---LDADFEPK 722
            D I  + F  +     ++   V   + YLH      ++HR++K +N+L   LD D +  
Sbjct: 104 FDRIVEKGFYTERDAS-RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIM 159
Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           ++DF L ++       S +S+      Y APE    K  +  +D +S GV+   L+ G
Sbjct: 160 ISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 121
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 122 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 178
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 179 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 238
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 239 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 282
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 283 MMRDCWHAVPSQRPTFKQLVE 303

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 90/182 (49%), Gaps = 16/182 (8%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLIYEFLQ 661
           +A+KK+  F  Q+   +TL+ E++ L + RH+N++ +     +        ++++ + ++
Sbjct: 71  VAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLME 129
Query: 662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP 721
              L  L+  Q  QL           + +GL Y+H     ++LHR++K  N+L++   + 
Sbjct: 130 T-DLYKLLKSQ--QLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDL 183
Query: 722 KLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELIT 779
           K+ DF L RI   E      ++   A   Y APE    SK  T  +D +S G +L E+++
Sbjct: 184 KICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 780 GR 781
            R
Sbjct: 244 NR 245

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 57  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 116
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 117 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTAR 173
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 174 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 233
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 234 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 277
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 278 MMRDCWHAVPSQRPTFKQLVE 298

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 26/205 (12%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY   L  SGEL+A+KK++    Q       E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 649 SD-ESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAI-GVAQGLAYLHKDYV 700
           S  E    +Y  L +  +   + R      +  Q    I +K+ +  + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-- 141
Query: 701 PHLLHRNVKSKNILLDADFEP-KLTDF--ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
             + HR++K +N+LLD D    KL DF  A   + GE    S + S Y    Y APE  +
Sbjct: 142 -GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV-SXICSRY----YRAPELIF 195
Query: 758 -SKKATAQMDAYSFGVVLLELITGR 781
            +   T+ +D +S G VL EL+ G+
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 201 VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 259
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 260 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 315
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 316 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++TE++ L K+ H  I+K+  FF + E  +++ E ++ G L D +       + + +L  
Sbjct: 187 VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF 245
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM 741
              +   + YLH++    ++HR++K +N+LL +  E    K+TDF   +I+GE +   T+
Sbjct: 246 -YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 301
Query: 742 SSEYALSCYNAPEY-------GYSKKATAQMDAYSFGVVLLELITG 780
                   Y APE        GY++     +D +S GV+L   ++G
Sbjct: 302 C---GTPTYLAPEVLVSVGTAGYNR----AVDCWSLGVILFICLSG 340

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +GR   +   S   I V K +++G  +    + L +EV  L +++H NIV+       
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID 76
Query: 648 HSDESIFLIYEFLQMGSLGDLIC-----RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            ++ +++++ E+ + G L  +I      RQ    ++ +R+   + +A    +   D    
Sbjct: 77  RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHT 136
Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKK 760
           +LHR++K  N+ LD     KL DF L RI+   E   +  + + Y +S        Y++K
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEK 196
Query: 761 ATAQMDAYSFGVVLLEL 777
           +    D +S G +L EL
Sbjct: 197 S----DIWSLGCLLYEL 209

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 23/170 (13%)
Query: 620 QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQW 678
           + + T+  EV+ L K+ H NI+K+        S +++ E    G L D +I R+ F    
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEA 735
           + R  I   V  G+ Y+HK    +++HR++K +NILL++   D + K+ DF L       
Sbjct: 123 AAR--IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL-----ST 172
Query: 736 AFQ--STMSSEYALSCYNAPEY---GYSKKATAQMDAYSFGVVLLELITG 780
            FQ  + M      + Y APE     Y +K     D +S GV+L  L++G
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKC----DVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 84/170 (49%), Gaps = 23/170 (13%)
Query: 620 QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQW 678
           + + T+  EV+ L K+ H NI+K+        S +++ E    G L D +I R+ F    
Sbjct: 63  KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEA 735
           + R  I   V  G+ Y+HK    +++HR++K +NILL++   D + K+ DF L       
Sbjct: 123 AAR--IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL-----ST 172
Query: 736 AFQ--STMSSEYALSCYNAPEY---GYSKKATAQMDAYSFGVVLLELITG 780
            FQ  + M      + Y APE     Y +K     D +S GV+L  L++G
Sbjct: 173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKC----DVWSAGVILYILLSG 218

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 50  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 164
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K  N+ L+ D E K+ DF L   V     +  +        Y APE    K  + ++
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGHSFEV 222
Query: 766 DAYSFGVVLLELITGR 781
           D +S G ++  L+ G+
Sbjct: 223 DVWSIGCIMYTLLVGK 238

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 48  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 162
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K  N+ L+ D E K+ DF L   V     +  +        Y APE    K  + ++
Sbjct: 163 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGHSFEV 220
Query: 766 DAYSFGVVLLELITGR 781
           D +S G ++  L+ G+
Sbjct: 221 DVWSIGCIMYTLLVGK 236

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V +     +G+ +A+K   K V         ++ E+  L  +RH +I+K+     
Sbjct: 25  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 84
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           S + I ++ E+     L D I ++D   +   R +    +   + Y H+  +   +HR++
Sbjct: 85  SKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKI---VHRDL 139
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSK-KATA 763
           K +N+LLD     K+ DF L  I+ +  F  T       SC    Y APE    K  A  
Sbjct: 140 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-------SCGSPNYAAPEVISGKLYAGP 192
Query: 764 QMDAYSFGVVLLELITGR 781
           ++D +S GV+L  ++  R
Sbjct: 193 EVDVWSCGVILYVMLCRR 210

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 14/229 (6%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFF 647
           G FG+V +    + E+    K++        +  K + +E   L K ++H  +V +   F
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            + + ++ + +++  G L   + R+   L+   R   A  +A  L YLH     ++++R+
Sbjct: 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLHSL---NIVYRD 164
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +K +NILLD+     LTDF L +   E    ST S+      Y APE  + +     +D 
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDW 222
Query: 768 YSFGVVLLELITGRQAEQAE-PAESLDVV--KWVRRKINITNGAIQVLD 813
           +  G VL E++ G     +   AE  D +  K ++ K NITN A  +L+
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE 271

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V +     +G+ +A+K   K V         ++ E+  L  +RH +I+K+     
Sbjct: 24  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 83
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           S + I ++ E+     L D I ++D   +   R +    +   + Y H+  +   +HR++
Sbjct: 84  SKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKI---VHRDL 138
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSK-KATA 763
           K +N+LLD     K+ DF L  I+ +  F  T       SC    Y APE    K  A  
Sbjct: 139 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-------SCGSPNYAAPEVISGKLYAGP 191
Query: 764 QMDAYSFGVVLLELITGR 781
           ++D +S GV+L  ++  R
Sbjct: 192 EVDVWSCGVILYVMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V +     +G+ +A+K   K V         ++ E+  L  +RH +I+K+     
Sbjct: 19  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 78
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           S + I ++ E+     L D I ++D   +   R +    +   + Y H+  +   +HR++
Sbjct: 79  SKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKI---VHRDL 133
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSK-KATA 763
           K +N+LLD     K+ DF L  I+ +  F  T       SC    Y APE    K  A  
Sbjct: 134 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-------SCGSPNYAAPEVISGKLYAGP 186
Query: 764 QMDAYSFGVVLLELITGR 781
           ++D +S GV+L  ++  R
Sbjct: 187 EVDVWSCGVILYVMLCRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 21/198 (10%)
Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V +     +G+ +A+K   K V         ++ E+  L  +RH +I+K+     
Sbjct: 15  GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK 74
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           S + I ++ E+     L D I ++D   +   R +    +   + Y H+  +   +HR++
Sbjct: 75  SKDEIIMVIEYAG-NELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHRHKI---VHRDL 129
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSK-KATA 763
           K +N+LLD     K+ DF L  I+ +  F  T       SC    Y APE    K  A  
Sbjct: 130 KPENLLLDEHLNVKIADFGLSNIMTDGNFLKT-------SCGSPNYAAPEVISGKLYAGP 182
Query: 764 QMDAYSFGVVLLELITGR 781
           ++D +S GV+L  ++  R
Sbjct: 183 EVDVWSCGVILYVMLCRR 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 55  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 113
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 114 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 158
Query: 713 ILLDADFEPKLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+   +      +    A   Y APE    SK  T  +D +S 
Sbjct: 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 219 GCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 34/191 (17%)
Query: 609 IAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIFLI----- 656
           +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +     +      + ++++     
Sbjct: 56  VAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME 114
Query: 657 ---YEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
              Y+ L+   L  D IC   +Q            + +GL Y+H     ++LHR++K  N
Sbjct: 115 TDLYKLLKTQHLSNDHICYFLYQ------------ILRGLKYIHS---ANVLHRDLKPSN 159
Query: 713 ILLDADFEPKLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSF 770
           +LL+   + K+ DF L R+   +      +    A   Y APE    SK  T  +D +S 
Sbjct: 160 LLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSV 219
Query: 771 GVVLLELITGR 781
           G +L E+++ R
Sbjct: 220 GCILAEMLSNR 230

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 88  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 203
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 204 VWSYGVTVWELMT 216

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 88  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 203
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 204 VWSYGVTVWELMT 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 118/261 (45%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   ++ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 28  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 88  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 144 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 203
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 204 VWSYGVTVWELMT 216

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 590 GNGGPFGRVY----ILSLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKIRHKNIV 641
           G GG +G+V+    +    +G++ A+K L    +    + +   K E   L +++H  IV
Sbjct: 26  GKGG-YGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
            ++  F +   ++LI E+L  G L   + R+   ++ +    +A  ++  L +LH+  + 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKGI- 142
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKK 760
             ++R++K +NI+L+     KLTDF L +   E+    T++  +  +  Y APE      
Sbjct: 143 --IYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHXFCGTIEYMAPEILMRSG 197
Query: 761 ATAQMDAYSFGVVLLELITG 780
               +D +S G ++ +++TG
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 33  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 92
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 93  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 148
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 149 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 208
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 209 VWSYGVTVWELMT 221

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 30  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 89
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 90  CLTS-TVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 145
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 146 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 205
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 206 VWSYGVTVWELMT 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 590 GNGGPFGRVY----ILSLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKIRHKNIV 641
           G GG +G+V+    +    +G++ A+K L    +    + +   K E   L +++H  IV
Sbjct: 26  GKGG-YGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
            ++  F +   ++LI E+L  G L   + R+   ++ +    +A  ++  L +LH+  + 
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA-EISMALGHLHQKGI- 142
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKK 760
             ++R++K +NI+L+     KLTDF L +   E+    T++  +  +  Y APE      
Sbjct: 143 --IYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFCGTIEYMAPEILMRSG 197
Query: 761 ATAQMDAYSFGVVLLELITG 780
               +D +S G ++ +++TG
Sbjct: 198 HNRAVDWWSLGALMYDMLTG 217

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG F + + +S    + +   K+V           + +  E+     + H+++V   G
Sbjct: 24  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           FF  ++ +F++ E  +  SL +L  R+    +   R  +   +  G  YLH++ V   +H
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR-QIVLGCQYLHRNRV---IH 138
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K  N+ L+ D E K+ DF L   V     +  +        Y APE    K  + ++
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPEVLSKKGHSFEV 196
Query: 766 DAYSFGVVLLELITGR 781
           D +S G ++  L+ G+
Sbjct: 197 DVWSIGCIMYTLLVGK 212

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 92/193 (47%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELI----AVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE +    A+K+L      +++K +  E   +A + + ++ ++LG 
Sbjct: 26  GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 86  CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 141
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF   +++G    +           + A E    +  T Q D
Sbjct: 142 DLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 201
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 202 VWSYGVTVWELMT 214

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQ--------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+              + Q+ +   +     +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +         ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/261 (23%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I E+   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +         ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 90/193 (46%), Gaps = 10/193 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLV-----NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  L +P GE + +   +         +++K +  E   +A + + ++ ++LG 
Sbjct: 60  GAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 119
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ LI + +  G L D +      +     L   + +A+G+ YL       L+HR
Sbjct: 120 CLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHR 175
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+      K+TDF L +++G    +           + A E    +  T Q D
Sbjct: 176 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 235
Query: 767 AYSFGVVLLELIT 779
            +S+GV + EL+T
Sbjct: 236 VWSYGVTVWELMT 248

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG V+++   S  L  V K +N        + ++ E++ L  + H NI+K+   F   
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92
Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQ---LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            +++++ E  + G L + I     +   L      ++   +   LAY H     H++H++
Sbjct: 93  HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKD 149
Query: 708 VKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           +K +NIL   D  P    K+ DF L  +  ++   ST ++  AL  Y APE  + +  T 
Sbjct: 150 LKPENILFQ-DTSPHSPIKIIDFGLAELF-KSDEHSTNAAGTAL--YMAPEV-FKRDVTF 204
Query: 764 QMDAYSFGVVLLELITG 780
           + D +S GVV+  L+TG
Sbjct: 205 KCDIWSAGVVMYFLLTG 221

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 235
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 236 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 10/161 (6%)
Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           K ++TE+  L ++ H NI+K+   F +   I L+ E +  G L D I  + +  +     
Sbjct: 93  KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEAAFQS 739
            +   + + +AYLH++    ++HR++K +N+L      D   K+ DF L +IV     Q 
Sbjct: 153 AVK-QILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQV 205
Query: 740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            M +      Y APE         ++D +S G++   L+ G
Sbjct: 206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K+ H+NIV+ +
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKLNHQNIVRCI 114
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 115 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 174
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 175 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK +     +     ++L  EV+ L ++ H NI+K+  FF 
Sbjct: 60  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 119
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                +L+ E    G L D +I R+ F    + R  I   V  G+ Y+HK+ +   +HR+
Sbjct: 120 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKNKI---VHRD 174
Query: 708 VKSKNILLDA---DFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPE--YG-YSK 759
           +K +N+LL++   D   ++ DF L        F+++  M  +   + Y APE  +G Y +
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIAPEVLHGTYDE 229
Query: 760 KATAQMDAYSFGVVLLELITG 780
           K     D +S GV+L  L++G
Sbjct: 230 KC----DVWSTGVILYILLSG 246

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKT--EVKTLAKIR-HKNIVKVLGFFH 648
           G +G V+  +   +GE++AVKK+ +    S+   +T  E+  L ++  H+NIV +L    
Sbjct: 20  GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLR 79
Query: 649 SD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           +D    ++L++++++       + R +  L+   +  +   + + + YLH      LLHR
Sbjct: 80  ADNDRDVYLVFDYMETDLHA--VIRANI-LEPVHKQYVVYQLIKVIKYLHSG---GLLHR 133
Query: 707 NVKSKNILLDADFEPKLTDFALDR--------------IVGEAAF-----QSTMSSEYAL 747
           ++K  NILL+A+   K+ DF L R               + E        Q  ++   A 
Sbjct: 134 DMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVAT 193
Query: 748 SCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGR 781
             Y APE    S K T  +D +S G +L E++ G+
Sbjct: 194 RWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K+ H+NIV+ +
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKLNHQNIVRCI 100
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 101 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 160
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 161 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK +     +     ++L  EV+ L ++ H NI+K+  FF 
Sbjct: 61  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 120
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                +L+ E    G L D +I R+ F    + R  I   V  G+ Y+HK+ +   +HR+
Sbjct: 121 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKNKI---VHRD 175
Query: 708 VKSKNILLDA---DFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPE--YG-YSK 759
           +K +N+LL++   D   ++ DF L        F+++  M  +   + Y APE  +G Y +
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIAPEVLHGTYDE 230
Query: 760 KATAQMDAYSFGVVLLELITG 780
           K     D +S GV+L  L++G
Sbjct: 231 KC----DVWSTGVILYILLSG 247

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I  +   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK +     +     ++L  EV+ L ++ H NI+K+  FF 
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                +L+ E    G L D +I R+ F    + R  I   V  G+ Y+HK+    ++HR+
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRD 151
Query: 708 VKSKNILLDA---DFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPE--YG-YSK 759
           +K +N+LL++   D   ++ DF L        F+++  M  +   + Y APE  +G Y +
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIAPEVLHGTYDE 206
Query: 760 KATAQMDAYSFGVVLLELITG 780
           K     D +S GV+L  L++G
Sbjct: 207 KC----DVWSTGVILYILLSG 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSK-----TLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ E++  + +RH NI+++  +F
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H  + I+L+ EF   G L  +L     F  Q S      +  A  L Y H+  V   +HR
Sbjct: 84  HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCHERKV---IHR 138
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--YNAPEYGYSKKATAQ 764
           ++K +N+L+    E K+ DF      G +    ++          Y  PE    K    +
Sbjct: 139 DIKPENLLMGYKGELKIADF------GWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 192
Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
           +D +  GV+  E + G       P +S    +  RR +N+
Sbjct: 193 VDLWCAGVLCYEFLVG-----MPPFDSPSHTETHRRIVNV 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 25/220 (11%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSK-----TLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+      + I   K++ F  Q  K      L+ E++  + +RH NI+++  +F
Sbjct: 26  GKFGNVYLAREKQNKFIMALKVL-FKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 84
Query: 648 HSDESIFLIYEFLQMGSL-GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           H  + I+L+ EF   G L  +L     F  Q S      +  A  L Y H+  V   +HR
Sbjct: 85  HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCHERKV---IHR 139
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--YNAPEYGYSKKATAQ 764
           ++K +N+L+    E K+ DF      G +    ++          Y  PE    K    +
Sbjct: 140 DIKPENLLMGYKGELKIADF------GWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEK 193
Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
           +D +  GV+  E + G       P +S    +  RR +N+
Sbjct: 194 VDLWCAGVLCYEFLVG-----MPPFDSPSHTETHRRIVNV 228

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY   +  +G L A K +     +  +    E++ LA   H  IVK+LG ++ D 
Sbjct: 22  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 81
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            ++++ EF   G++  ++   D  L       +   + + L +LH      ++HR++K+ 
Sbjct: 82  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAG 138
Query: 712 NILLDADFEPKLTDFA-----LDRIVGEAAFQST---MSSEYALSCYNAPEYGYSKKATA 763
           N+L+  + + +L DF      L  +    +F  T   M+ E  + C    +  Y  KA  
Sbjct: 139 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM-CETMKDTPYDYKA-- 195
Query: 764 QMDAYSFGVVLLEL 777
             D +S G+ L+E+
Sbjct: 196 --DIWSLGITLIEM 207

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 19/203 (9%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG VY      + + PS   +AVK L   +  Q       E   ++K  H+NIV+ +G
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIG 115
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
                   F++ E +  G L   +        Q   L     L +A  +A G  YL ++ 
Sbjct: 116 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN- 174
Query: 700 VPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
             H +HR++ ++N LL         K+ DF + R +  A++            +  PE  
Sbjct: 175 --HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF 232
Query: 757 YSKKATAQMDAYSFGVVLLELIT 779
                T++ D +SFGV+L E+ +
Sbjct: 233 MEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 56  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 114
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 115 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 174
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 175 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 231
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 232 FMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 99
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 160 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 33  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 91
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 92  GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 151
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 152 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 208
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 209 FMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +S    
Sbjct: 141 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A+   D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/261 (23%), Positives = 117/261 (44%), Gaps = 38/261 (14%)
Query: 609 IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +   +     L +E++ +  I +HKNI+ +LG    D  +++I  +   G+L 
Sbjct: 70  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLR 129
Query: 667 D-LICRQDFQLQWSIRLK--------------IAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + L  R+   +++S  +                   +A+G+ YL        +HR++ ++
Sbjct: 130 EYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186
Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N+L+  +   K+ DF L R +    +    ++      + APE  + +  T Q D +SFG
Sbjct: 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 772 VVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI 830
           V++ E+ T G       P E L   K ++    +          K ANC  +     L +
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEEL--FKLLKEGHRMD---------KPANCTNE-----LYM 290
Query: 831 ALR-CTSVMPEKRPSMFEVVK 850
            +R C   +P +RP+  ++V+
Sbjct: 291 MMRDCWHAVPSQRPTFKQLVE 311

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 17/194 (8%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY   +  +G L A K +     +  +    E++ LA   H  IVK+LG ++ D 
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            ++++ EF   G++  ++   D  L       +   + + L +LH      ++HR++K+ 
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAG 146
Query: 712 NILLDADFEPKLTDFA-----LDRIVGEAAFQST---MSSEYALSCYNAPEYGYSKKATA 763
           N+L+  + + +L DF      L  +    +F  T   M+ E  + C    +  Y  KA  
Sbjct: 147 NVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM-CETMKDTPYDYKA-- 203
Query: 764 QMDAYSFGVVLLEL 777
             D +S G+ L+E+
Sbjct: 204 --DIWSLGITLIEM 215

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 99
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 100 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 160 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 216
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 217 FMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 624 TLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           TLK EV  L K+  H NI+++   + ++   FL+++ ++ G L D +  +    +   R 
Sbjct: 70  TLK-EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR- 127
Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL-------DRIVGEA 735
           KI   + + +  LHK    +++HR++K +NILLD D   KLTDF         +++    
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVC 184
Query: 736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
              S ++ E      N    GY K    ++D +S GV++  L+ G
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGK----EVDMWSTGVIMYTLLAG 225

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 11/207 (5%)
Query: 593 GPFGRVYI-LSLPSGE----LIAVKKLV-NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY  + +P GE     +A+K L  N   +++K +  E   +A +    + ++LG 
Sbjct: 28  GAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGI 87
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +  ++ L+ + +  G L D +     +L     L   + +A+G++YL       L+HR
Sbjct: 88  CLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRLVHR 143
Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++ ++N+L+ +    K+TDF L R++     +           + A E    ++ T Q D
Sbjct: 144 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSD 203
Query: 767 AYSFGVVLLELIT-GRQAEQAEPAESL 792
            +S+GV + EL+T G +     PA  +
Sbjct: 204 VWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 100
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 101 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 160
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 161 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 35/274 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 21  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 79
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 80  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 139
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E               + +PE 
Sbjct: 140 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 196
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 197 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 246
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             NC    ML  LE+   C    P+ RPS  E++
Sbjct: 247 PDNC--PDML--LELMRMCWQYNPKMRPSFLEII 276

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 593 GPFGRVYILSLPSGE----LIAVKKLVNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGFF 647
           G FG+V++           + A+KK V       +    E + L+    H  +  +   F
Sbjct: 29  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 88
Query: 648 HSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            + E++F + E+L  G L   I  C + F L  S     A  +  GL +LH   +   ++
Sbjct: 89  QTKENLFFVMEYLNGGDLMYHIQSCHK-FDL--SRATFYAAEIILGLQFLHSKGI---VY 142
Query: 706 RNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKAT 762
           R++K  NILLD D   K+ DF +  + ++G+A      ++E+     Y APE    +K  
Sbjct: 143 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-----TNEFCGTPDYIAPEILLGQKYN 197
Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESL 792
             +D +SFGV+L E++ G+     +  E L
Sbjct: 198 HSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 227

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 27/201 (13%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK +     +     ++L  EV+ L ++ H NI+K+  FF 
Sbjct: 43  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 102
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                +L+ E    G L D +I R+ F    + R  I   V  G+ Y+HK+    ++HR+
Sbjct: 103 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMHKN---KIVHRD 157
Query: 708 VKSKNILLDA---DFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPE--YG-YSK 759
           +K +N+LL++   D   ++ DF L        F+++  M  +   + Y APE  +G Y +
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLS-----THFEASKKMKDKIGTAYYIAPEVLHGTYDE 212
Query: 760 KATAQMDAYSFGVVLLELITG 780
           K     D +S GV+L  L++G
Sbjct: 213 KC----DVWSTGVILYILLSG 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 593 GPFGRV-YILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G V       +G  +AVKKL         +K    E++ L  ++H+N++ +L  F  
Sbjct: 43  GAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 102
Query: 650 DES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
             S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+H    
Sbjct: 103 ARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIHS--- 153
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
             ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE   +  
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 208
Query: 761 ATAQ-MDAYSFGVVLLELITGR 781
              Q +D +S G ++ EL+TGR
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGR 230

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 58  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 116
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 117 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 176
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 177 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 233
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 234 FMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 59  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 117
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 118 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 177
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A +            +  PE 
Sbjct: 178 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 234
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 23/168 (13%)
Query: 624 TLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           TLK EV  L K+  H NI+++   + ++   FL+++ ++ G L D +  +    +   R 
Sbjct: 57  TLK-EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR- 114
Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA----------LDRIV 732
           KI   + + +  LHK    +++HR++K +NILLD D   KLTDF           L  + 
Sbjct: 115 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 171
Query: 733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           G  ++ +    E +++  N P YG       ++D +S GV++  L+ G
Sbjct: 172 GTPSYLAPEIIECSMND-NHPGYG------KEVDMWSTGVIMYTLLAG 212

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 140
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A +            +  PE 
Sbjct: 201 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA 257
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 84  DVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 137
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 138 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 189
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 161
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 162 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 213
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 141
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +S    
Sbjct: 142 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 162
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 163 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 214
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 48  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 106
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 107 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 166
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 167 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 223
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 224 FMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 88
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 149 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 205
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 206 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 255
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 256 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 287

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 103/233 (44%), Gaps = 26/233 (11%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------W 678
           E   + +    ++V++LG     +   +I E +  G L   +     +++          
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ 738
           S  +++A  +A G+AYL+ +     +HR++ ++N ++  DF  K+ DF + R + E  + 
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV 798
                      + +PE       T   D +SFGVVL E+ T   AEQ  P + L   + +
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVL 237
Query: 799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
           R    +  G +  LD K  NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 238 R---FVMEGGL--LD-KPDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 280

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/193 (23%), Positives = 93/193 (48%), Gaps = 14/193 (7%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G +G VY  +   +G+++A+K++ V    Q    +  E+  + +    ++VK  G +  +
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVESDLQE---IIKEISIMQQCDSPHVVKYYGSYFKN 96
Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             ++++ E+   GS+ D+I  ++  L       I     +GL YLH       +HR++K+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKA 153
Query: 711 KNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
            NILL+ +   KL DF +   + +  A     + + + ++     E GY+  A    D +
Sbjct: 154 GNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVA----DIW 209
Query: 769 SFGVVLLELITGR 781
           S G+  +E+  G+
Sbjct: 210 SLGITAIEMAEGK 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 23/168 (13%)
Query: 624 TLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
           TLK EV  L K+  H NI+++   + ++   FL+++ ++ G L D +  +    +   R 
Sbjct: 70  TLK-EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR- 127
Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA----------LDRIV 732
           KI   + + +  LHK    +++HR++K +NILLD D   KLTDF           L  + 
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           G  ++ +    E +++  N P YG       ++D +S GV++  L+ G
Sbjct: 185 GTPSYLAPEIIECSMND-NHPGYG------KEVDMWSTGVIMYTLLAG 225

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 605 SGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ESIFL 655
           +G+ +A+KK+ N       + +TL+ E+K L   +H NI+ +             +S+++
Sbjct: 79  TGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 137
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + + ++      +   Q   L+  +R  +   + +GL Y+H   V   +HR++K  N+L+
Sbjct: 138 VLDLMESDLHQIIHSSQPLTLE-HVRYFL-YQLLRGLKYMHSAQV---IHRDLKPSNLLV 192
Query: 716 DADFEPKLTDFALDR--IVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGV 772
           + + E K+ DF + R      A  Q  M+   A   Y APE   S  + T  +D +S G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 773 VLLELITGRQ 782
           +  E++  RQ
Sbjct: 253 IFGEMLARRQ 262

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 144
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E A+            + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 252
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P+ RP+  E+V
Sbjct: 253 QPD----NCPER----VTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 58  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 116
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 117 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 176
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 177 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 233
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 234 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 283
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 284 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 315

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 19/209 (9%)
Query: 593 GPFGRVYILSLPSGE----LIAVKKLVNFGCQSSKTLKTEVKTLA-KIRHKNIVKVLGFF 647
           G FG+V++           + A+KK V       +    E + L+    H  +  +   F
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87
Query: 648 HSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            + E++F + E+L  G L   I  C + F L  S     A  +  GL +LH   +   ++
Sbjct: 88  QTKENLFFVMEYLNGGDLMYHIQSCHK-FDL--SRATFYAAEIILGLQFLHSKGI---VY 141
Query: 706 RNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           R++K  NILLD D   K+ DF +  + ++G+A       +      Y APE    +K   
Sbjct: 142 RDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGT----PDYIAPEILLGQKYNH 197
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESL 792
            +D +SFGV+L E++ G+     +  E L
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 87
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 148 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 204
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 205 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 254
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 255 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 286

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 94  DVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 148 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 199
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 23  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 81
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 82  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N  +  DF  K+ DF + R + E  +            + +PE 
Sbjct: 142 NAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 198
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 199 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 248
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML  LE+   C    P+ RPS  E++ +
Sbjct: 249 PDNC--PDML--LELMRMCWQYNPKMRPSFLEIISS 280

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 155 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 212 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 261
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 262 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 293

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 162
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M    A   Y APE  
Sbjct: 163 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGXVATRWYRAPEIM 214
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G FG+V I+    + ++ A+K +    C     ++    E++ +  + H  +V +   F 
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVPH 702
            +E +F++ + L  G L        + LQ ++  K          +   L YL    +  
Sbjct: 86  DEEDMFMVVDLLLGGDLR-------YHLQQNVHFKEETVKLFICELVMALDYLQNQRI-- 136
Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
            +HR++K  NILLD      +TDF +  ++      +TM+       Y APE   S+K  
Sbjct: 137 -IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA---GTKPYMAPEMFSSRKGA 192
Query: 763 A---QMDAYSFGVVLLELITGRQ 782
                +D +S GV   EL+ GR+
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT----EVKTLAKIRHKN 639
           EK      G +G V+   +  +G+++A+KK +    +    +K     E++ L +++H N
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--SEDDPVIKKIALREIRMLKQLKHPN 63
Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +V +L  F     + L++E+     L +L   Q    +  ++  I     Q + + HK  
Sbjct: 64  LVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK-SITWQTLQAVNFCHKH- 121
Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-S 758
             + +HR+VK +NIL+      KL DF   R++   +       E A   Y +PE     
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177
Query: 759 KKATAQMDAYSFGVVLLELITG 780
            +    +D ++ G V  EL++G
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSG 199

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 27  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 85
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 86  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 145
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 146 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 202
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 203 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 252
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 253 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 284

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 119/276 (43%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 29  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 87
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 148 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 204
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 205 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 254
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 255 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 286

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 40/252 (15%)
Query: 609 IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV--------------LGFFHSDESIF 654
           +A+KK+V    QS K    E+K + ++ H NIVKV              +G      S++
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 655 LIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           ++ E+++     DL  +  Q   L+   RL     + +GL Y+H   V   LHR++K  N
Sbjct: 99  IVQEYMET----DLANVLEQGPLLEEHARL-FMYQLLRGLKYIHSANV---LHRDLKPAN 150
Query: 713 ILLDA-DFEPKLTDFALDRIVG-EAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYS 769
           + ++  D   K+ DF L RI+    + +  +S       Y +P    S    T  +D ++
Sbjct: 151 LFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210
Query: 770 FGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
            G +  E++TG+       A  L+ ++ +   I           P +    +Q++L  + 
Sbjct: 211 AGCIFAEMLTGKTLFAG--AHELEQMQLILESI-----------PVVHEEDRQELLSVIP 257
Query: 830 IALRCTSVMPEK 841
           + +R     P K
Sbjct: 258 VYIRNDMTEPHK 269

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 68  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 126
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 127 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 186
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + R +  A++            +  PE 
Sbjct: 187 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA 243
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 244 FMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 27/202 (13%)
Query: 593 GPFGRV-YILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G V       +G  +AVKKL         +K    E++ L  ++H+N++ +L  F  
Sbjct: 33  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 92
Query: 650 DES------IFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
             S      ++L+   +    L +++  Q   D  +Q+ I       + +GL Y+H    
Sbjct: 93  ARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLI-----YQILRGLKYIHS--- 143
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
             ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE   +  
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 198
Query: 761 ATAQ-MDAYSFGVVLLELITGR 781
              Q +D +S G ++ EL+TGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEI 200
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 138
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVATRWYRAPEIM 190
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEI 200
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEI 200
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 593 GPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY     S ++ IA+K++     + S+ L  E+     ++HKNIV+ LG F  + 
Sbjct: 33  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG-----VAQGLAYLHKDYVPHLLHR 706
            I +  E +  GSL  L+  +   L+ + +    IG     + +GL YLH +    ++HR
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQ---TIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 707 NVKSKNILLDA-DFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPE------YGYS 758
           ++K  N+L++      K++DF    R+ G      T +       Y APE       GY 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEIIDKGPRGYG 203
Query: 759 KKATAQMDAYSFGVVLLELITGRQA--EQAEPAESL 792
           K A    D +S G  ++E+ TG+    E  EP  ++
Sbjct: 204 KAA----DIWSLGCTIIEMATGKPPFYELGEPQAAM 235

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHS 649
           G  G+V+ +    +G +IAVK++   G  + +K +  ++  + K      IV+  G F +
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95
Query: 650 DESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +  +F+  E   MG+  + L  R    +   I  K+ + + + L YL + +   ++HR+V
Sbjct: 96  NTDVFIAMEL--MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDV 151
Query: 709 KSKNILLDADFEPKLTDFALD-RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA---- 763
           K  NILLD   + KL DF +  R+V + A   +       + Y APE       T     
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA----GCAAYMAPERIDPPDPTKPDYD 207
Query: 764 -QMDAYSFGVVLLELITGR 781
            + D +S G+ L+EL TG+
Sbjct: 208 IRADVWSLGISLVELATGQ 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 53  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 107
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 165
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 222
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 223 LDDSINMKHFESFKRA----DIYAMGLVFWEI 250

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 93  DVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 146
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 147 HS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 198
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 27/202 (13%)
Query: 593 GPFGRV-YILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G V       +G  +AVKKL         +K    E++ L  ++H+N++ +L  F  
Sbjct: 38  GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 97
Query: 650 DES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
             S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+H    
Sbjct: 98  ARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIHS--- 148
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
             ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE   +  
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWM 203
Query: 761 ATAQ-MDAYSFGVVLLELITGR 781
              Q +D +S G ++ EL+TGR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 152
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 153 HS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 204
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVK-KLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY  + +   GE I V  K     C   + +   +E   +  + H +IVK++G  
Sbjct: 35  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 94
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
             +E  ++I E    G LG  + R    L+    +  ++ + + +AYL      + +HR+
Sbjct: 95  E-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRD 150
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +  +NIL+ +    KL DF L R + +  +     +   +  + +PE    ++ T   D 
Sbjct: 151 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDV 209
Query: 768 YSFGVVLLELIT-GRQ 782
           + F V + E+++ G+Q
Sbjct: 210 WMFAVCMWEILSFGKQ 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C +  D  +Q+ I       + +GL Y+H
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI-----YQILRGLKYIH 138
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 190
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++  Q   D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKXQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 29  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 87
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 88  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 145
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HRN+ ++N ++  DF  K+ DF + R + E  +            + AP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 253
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P  RP+  E+V
Sbjct: 254 QPD----NCPER----VTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 29/216 (13%)
Query: 593 GPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY     S ++ IA+K++     + S+ L  E+     ++HKNIV+ LG F  + 
Sbjct: 19  GTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 78
Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG-----VAQGLAYLHKDYVPHLLHR 706
            I +  E +  GSL  L+  +   L+ + +    IG     + +GL YLH +    ++HR
Sbjct: 79  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQ---TIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 707 NVKSKNILLDA-DFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPE------YGYS 758
           ++K  N+L++      K++DF    R+ G      T +       Y APE       GY 
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ---YMAPEIIDKGPRGYG 189
Query: 759 KKATAQMDAYSFGVVLLELITGRQA--EQAEPAESL 792
           K A    D +S G  ++E+ TG+    E  EP  ++
Sbjct: 190 KAA----DIWSLGCTIIEMATGKPPFYELGEPQAAM 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 35/276 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 30  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 88
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQ---------WSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +     +++          S  +++A  +A G+AYL
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E               + +PE 
Sbjct: 149 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 205
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 206 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 255
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA 851
             NC    ML   E+   C    P+ RPS  E++ +
Sbjct: 256 PDNC--PDML--FELMRMCWQYNPKMRPSFLEIISS 287

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 40  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 94
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 152
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 209
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 210 LDDSINMKHFESFKRA----DIYAMGLVFWEI 237

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 144
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HRN+ ++N ++  DF  K+ DF + R + E  +            + AP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 252
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P  RP+  E+V
Sbjct: 253 QPD----NCPER----VTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 154
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 206
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 154
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 206
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 40  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 99
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 154
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 155 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 206
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 241
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 242 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 148 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 199
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 139
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 140 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 191
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 148
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 149 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 200
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 47  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 161
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 162 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 213
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 231
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 232 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 605 SGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ESIFL 655
           +G+ +A+KK+ N       + +TL+ E+K L   +H NI+ +             +S+++
Sbjct: 78  TGQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYV 136
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + + ++      +   Q   L+  +R  +   + +GL Y+H   V   +HR++K  N+L+
Sbjct: 137 VLDLMESDLHQIIHSSQPLTLE-HVRYFL-YQLLRGLKYMHSAQV---IHRDLKPSNLLV 191
Query: 716 DADFEPKLTDFALDR--IVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGV 772
           + + E K+ DF + R      A  Q  M+   A   Y APE   S  + T  +D +S G 
Sbjct: 192 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 251
Query: 773 VLLELITGRQ 782
           +  E++  RQ
Sbjct: 252 IFGEMLARRQ 261

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 138
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 190
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 143
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 144 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 195
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 146
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 147 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 198
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 26  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 85
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 140
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 141 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 192
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 39  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 98
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 152
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 153 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 204
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 33  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 92
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 147
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 148 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 199
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 27  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 86
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 141
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 142 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 193
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 144
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 196
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 48  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 161
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 162 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 213
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 164
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 165 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 216
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 137
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +S    
Sbjct: 138 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 144
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 145 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 196
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 25  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 84
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 139
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 140 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 191
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 72/153 (47%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  ++    
Sbjct: 139 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 17  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 71
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 129
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 186
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 187 LDDSINMKHFESFKRA----DIYAMGLVFWEI 214

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 15  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 69
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 127
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 184
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 185 LDDSINMKHFESFKRA----DIYAMGLVFWEI 212

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 30  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 89
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 143
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 144 HS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 195
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 14  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 68
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 126
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 183
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 184 LDDSINMKHFESFKRA----DIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 41/212 (19%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V+      GE +AVK + +   + S   + E+     +RH+NI   LGF  +D  
Sbjct: 20  GRFGEVW-RGKWRGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGFIAADNK 74
Query: 653 -------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
                  ++L+ ++ + GSL D + R    ++  I  K+A+  A GLA+LH + V     
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI--KLALSTASGLAHLHMEIVGTQGK 132
Query: 701 PHLLHRNVKSKNILLDA---------------DFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           P + HR++KSKNIL+                 D      D A +  VG   +   M+ E 
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY---MAPEV 189
Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLEL 777
                N   +   K+A    D Y+ G+V  E+
Sbjct: 190 LDDSINMKHFESFKRA----DIYAMGLVFWEI 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 100/227 (44%), Gaps = 22/227 (9%)
Query: 563 VWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS 622
           +W+     P+ V +  +    D     G+G  FG V+     +   + V K +N      
Sbjct: 33  IWKKYVPQPVEVKQGSVYDYYDILEELGSGA-FGVVHRCVEKATGRVFVAKFINTPYPLD 91
Query: 623 K-TLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR 681
           K T+K E+  + ++ H  ++ +   F     + LI EFL  G L D I  +D+++  +  
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV 151
Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--KLTDFAL------DRIVG 733
           +       +GL ++H+  + HL   ++K +NI+ +       K+ DF L      D IV 
Sbjct: 152 INYMRQACEGLKHMHEHSIVHL---DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208
Query: 734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
                +T ++E+A     APE    +      D ++ GV+   L++G
Sbjct: 209 ----VTTATAEFA-----APEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 92/183 (50%), Gaps = 16/183 (8%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 71  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 667 DLICRQ---DFQ------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
           + + R+   D        L+    L  +  VAQG+A+L      + +HR+V ++N+LL  
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 187
Query: 718 DFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
               K+ DF L R I+ ++ +    ++   +  + APE  +    T Q D +S+G++L E
Sbjct: 188 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWE 246
Query: 777 LIT 779
           + +
Sbjct: 247 IFS 249

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NI++ A    K+ DF + R + ++    T
Sbjct: 118 AIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   L    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 94  DVFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 148 HS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 199
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 667 DLICRQDFQLQWSIRLKIAIG-------------VAQGLAYLHKDYVPHLLHRNVKSKNI 713
           + + R+   L+      IA               VAQG+A+L      + +HR+V ++N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195
Query: 714 LLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           LL      K+ DF L R I+ ++ +    ++   +  + APE  +    T Q D +S+G+
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGI 254
Query: 773 VLLELIT 779
           +L E+ +
Sbjct: 255 LLWEIFS 261

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 34  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 147
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 148 HS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEI 199
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 123
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 124 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 181 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 235
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 236 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 231
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 232 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 130 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 241
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 242 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/218 (23%), Positives = 97/218 (44%), Gaps = 18/218 (8%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           EV  +  + H+N++++ G   +   + ++ E   +GSL D + +           + A+ 
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ YL        +HR++ ++N+LL      K+ DF L R + +      M     +
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 748 S-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
              + APE   ++  +   D + FGV L E+ T  Q    EP   L+  + +  KI+   
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQ-ILHKIDKEG 231
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS 844
             +    P+  +C Q        + ++C +  PE RP+
Sbjct: 232 ERL----PRPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 667 DLICRQDFQLQWSIRLKIAIG-------------VAQGLAYLHKDYVPHLLHRNVKSKNI 713
           + + R+   L+      IA               VAQG+A+L      + +HR+V ++N+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNV 195
Query: 714 LLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           LL      K+ DF L R I+ ++ +    ++   +  + APE  +    T Q D +S+G+
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGI 254
Query: 773 VLLELIT 779
           +L E+ +
Sbjct: 255 LLWEIFS 261

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 85  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 143
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 144 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 17/162 (10%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           ++ E+  L  +RH +I+K+     +   I ++ E+   G L D I  +    +   R + 
Sbjct: 56  VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGR-RF 113
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
              +   + Y H+     ++HR++K +N+LLD +   K+ DF L  I+ +  F  T    
Sbjct: 114 FQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---- 166
Query: 745 YALSC----YNAPEYGYSK-KATAQMDAYSFGVVLLELITGR 781
              SC    Y APE    K  A  ++D +S G+VL  ++ GR
Sbjct: 167 ---SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 92/190 (48%), Gaps = 28/190 (14%)
Query: 605 SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFL 655
           SG  IAVKKL     QS   +K    E++ L  ++H+N++ +L  F    S      ++L
Sbjct: 75  SGLKIAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYL 133
Query: 656 IYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN 712
           +   L    L +++ C++  D  +Q+ I       + +GL Y+H      ++HR++K  N
Sbjct: 134 V-THLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIHS---ADIIHRDLKPSN 184
Query: 713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFG 771
           + ++ D E K+ DF L R   +      M+   A   Y APE   +       +D +S G
Sbjct: 185 LAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVG 239
Query: 772 VVLLELITGR 781
            ++ EL+TGR
Sbjct: 240 CIMAELLTGR 249

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 83  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 141
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 142 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 141 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 60  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 118
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 119 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      + + PS   +AVK L    C     L    E   ++K  H+NIV+ +
Sbjct: 42  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCI 100
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICR------QDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           G        F++ E +  G L   +        Q   L     L +A  +A G  YL ++
Sbjct: 101 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 160
Query: 699 YVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
              H +HR++ ++N LL         K+ DF + + +  A++            +  PE 
Sbjct: 161 ---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEA 217
Query: 756 GYSKKATAQMDAYSFGVVLLELIT 779
                 T++ D +SFGV+L E+ +
Sbjct: 218 FMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 92/189 (48%), Gaps = 22/189 (11%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 667 DLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           + + R+               + QL     L  +  VAQG+A+L      + +HR+V ++
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAAR 195
Query: 712 NILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           N+LL      K+ DF L R I+ ++ +    ++   +  + APE  +    T Q D +S+
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSY 254
Query: 771 GVVLLELIT 779
           G++L E+ +
Sbjct: 255 GILLWEIFS 263

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++  Q   D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKSQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ DF L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 139 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 141 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 141 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 59  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 117
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 118 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 141 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 87  ERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 145
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 146 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 51  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 110
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 165
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+ DF L R   +      M    A   Y APE  
Sbjct: 166 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXGYVATRWYRAPEIM 217
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 139 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 82  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 140
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 141 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH   +   +HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 139 IVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 57  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 115
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 116 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NI++ A    K+ DF + R + ++    T
Sbjct: 118 AIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 92/183 (50%), Gaps = 16/183 (8%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 79  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 667 DLICRQ---DFQ------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
           + + R+   D        L+    L  +  VAQG+A+L      + +HR+V ++N+LL  
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 195
Query: 718 DFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
               K+ DF L R I+ ++ +    ++   +  + APE  +    T Q D +S+G++L E
Sbjct: 196 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTVQSDVWSYGILLWE 254
Query: 777 LIT 779
           + +
Sbjct: 255 IFS 257

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NI++ A    K+ DF + R + ++    T
Sbjct: 118 AIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 58  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 116
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 117 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NI++ A    K+ DF + R + ++    T
Sbjct: 118 AIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           S EL+AVK  +  G + +  +K E+     +RH NIV+      +   + ++ E+   G 
Sbjct: 43  SNELVAVK-YIERGEKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L + IC      +   R      +  G++Y H   V    HR++K +N LLD    P+L 
Sbjct: 102 LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLK 157
Query: 725 --DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGR 781
             DF   +    +   S   S      Y APE    K+   ++ D +S GV L  ++ G 
Sbjct: 158 ICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 782 QAEQAEPAESLDVVKWVRRKINI 804
              + +P E  +  K + R +N+
Sbjct: 215 YPFE-DPEEPKNFRKTIHRILNV 236

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 627 TEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIA 685
            E+  L  + H NI+K+   F   +  +L+ EF + G L + +I R  F         I 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIM 152
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFALDRIVGEAAFQSTMS 742
             +  G+ YLHK    +++HR++K +NILL+        K+ DF L          S  S
Sbjct: 153 KQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGL---------SSFFS 200
Query: 743 SEYAL------SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            +Y L      + Y APE    KK   + D +S GV++  L+ G
Sbjct: 201 KDYKLRDRLGTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 27  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 85
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 86  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 143
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E  +            + AP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 251
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P+ RP+  E+V
Sbjct: 252 QPD----NCPER----VTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ D+ L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 35/274 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQL---------QWSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +      +           S  +++A  +A G+AYL
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 155 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 211
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 212 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 261
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             NC    ML   E+   C    P+ RPS  E++
Sbjct: 262 PDNC--PDML--FELMRMCWQYNPKMRPSFLEII 291

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 34/221 (15%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELI---------AVKKLVNFG-CQSSK 623
           VT  D VIG          G FG VY      GE I         A+K L      Q  +
Sbjct: 22  VTHSDRVIG---------KGHFGVVY-----HGEYIDQAQNRIQCAIKSLSRITEMQQVE 67
Query: 624 TLKTEVKTLAKIRHKNIVKVLGFFHSDESI-FLIYEFLQMGSLGDLICRQDFQLQWSIRL 682
               E   +  + H N++ ++G     E +  ++  ++  G L   I  +  Q   +++ 
Sbjct: 68  AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKD 125
Query: 683 KIAIG--VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            I+ G  VA+G+ YL +      +HR++ ++N +LD  F  K+ DF L R + +  + S 
Sbjct: 126 LISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV 182
Query: 741 MSSEYAL--SCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
               +A     + A E   + + T + D +SFGV+L EL+T
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 144
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E  +            + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 252
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P+ RP+  E+V
Sbjct: 253 QPD----NCPER----VTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G +G VY  SL   E     K+ +F  + +   +  +  +  + H NI +   F   DE 
Sbjct: 24  GRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIAR---FIVGDER 78
Query: 653 I--------FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD------ 698
           +         L+ E+   GSL   +        W    ++A  V +GLAYLH +      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFAL------DRIVGEAAFQSTMSSEYALSCYNA 752
           Y P + HR++ S+N+L+  D    ++DF L      +R+V      +   SE     Y A
Sbjct: 137 YKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196
Query: 753 PEY-------GYSKKATAQMDAYSFGVVLLEL 777
           PE           + A  Q+D Y+ G++  E+
Sbjct: 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           S EL+AVK  +  G +  + +K E+     +RH NIV+      +   + ++ E+   G 
Sbjct: 42  SNELVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 100
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L + IC      +   R      +  G++Y H   V    HR++K +N LLD    P+L 
Sbjct: 101 LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLK 156
Query: 725 --DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGR 781
             DF   +    +   S   S      Y APE    K+   ++ D +S GV L  ++ G 
Sbjct: 157 ICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 213
Query: 782 QAEQAEPAESLDVVKWVRRKINI 804
              + +P E  +  K + R +N+
Sbjct: 214 YPFE-DPEEPKNFRKTIHRILNV 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/193 (22%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V   +  +   ++    K++  G + + T  +  E + + ++ +  IV+++G   
Sbjct: 347 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 406
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + E++ L+ E    G L   +  +  ++  S   ++   V+ G+ YL +    + +HRN+
Sbjct: 407 A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNL 462
Query: 709 KSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
            ++N+LL      K++DF L + +G  ++ + +  + ++ L  Y APE    +K +++ D
Sbjct: 463 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKFSSRSD 521
Query: 767 AYSFGVVLLELIT 779
            +S+GV + E ++
Sbjct: 522 VWSYGVTMWEALS 534

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 64  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 122
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 123 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/274 (24%), Positives = 116/274 (42%), Gaps = 35/274 (12%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      ++       +A+K  VN      + ++   E   + +    ++V++L
Sbjct: 26  GSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNCHHVVRLL 84
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQL---------QWSIRLKIAIGVAQGLAYL 695
           G     +   +I E +  G L   +      +           S  +++A  +A G+AYL
Sbjct: 85  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 144
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           + +     +HR++ ++N ++  DF  K+ DF + R + E  +            + +PE 
Sbjct: 145 NAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 201
Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
                 T   D +SFGVVL E+ T   AEQ  P + L   + +R    +  G +  LD K
Sbjct: 202 LKDGVFTTYSDVWSFGVVLWEIAT--LAEQ--PYQGLSNEQVLR---FVMEGGL--LD-K 251
Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             NC    ML   E+   C    P+ RPS  E++
Sbjct: 252 PDNC--PDML--FELMRMCWQYNPKMRPSFLEII 281

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 605 SGELIAVKKLVN-FGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
           SGE +A+KKL   F  +  +K    E+  L  ++H+N++ +L  F    S+   Y+F  +
Sbjct: 48  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHRNVKSKNILLDADF 719
                   ++   L++S   KI   V Q   GL Y+H   V   +HR++K  N+ ++ D 
Sbjct: 108 MPFMQTDLQKIMGLKFS-EEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDC 163
Query: 720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLELI 778
           E K+ DF L R        + M+       Y APE   S     Q +D +S G ++ E++
Sbjct: 164 ELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218
Query: 779 TGRQAEQAEPAESLDVVKWVRRKINITNGA-IQVLDPKIANCYQQQM 824
           TG+   + +  + LD +  + +   +     +Q L+ K A  Y Q +
Sbjct: 219 TGKTLFKGK--DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 263

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 605 SGELIAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
           SGE +A+KKL   F  +  +K    E+  L  ++H+N++ +L  F    S+   Y+F  +
Sbjct: 66  SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 663 GSLGDLICRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHRNVKSKNILLDADF 719
                   ++   +++S   KI   V Q   GL Y+H   V   +HR++K  N+ ++ D 
Sbjct: 126 MPFMQTDLQKIMGMEFS-EEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDC 181
Query: 720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLELI 778
           E K+ DF L R        + M+       Y APE   S     Q +D +S G ++ E++
Sbjct: 182 ELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236
Query: 779 TGRQAEQAEPAESLDVVKWVRRKINITNGA-IQVLDPKIANCYQQQM 824
           TG+   + +  + LD +  + +   +     +Q L+ K A  Y Q +
Sbjct: 237 TGKTLFKGK--DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSL 281

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 134
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NI++ A    K+ DF + R + ++    T
Sbjct: 135 AIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 593 GPFGRVYILSLPSG----ELIAVKKLVNFG-CQSSKTL---KTEVKTLAKIRHKNIVKVL 644
           G +G+V+++   SG    +L A+K L      Q +KT    +TE + L  IR    +  L
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 645 GF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
            + F ++  + LI +++  G L   + +++   +  +++ +   +   L +LHK     +
Sbjct: 125 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHK---LGI 180
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIV----GEAAFQSTMSSEY-ALSCYNAPEYGYS 758
           ++R++K +NILLD++    LTDF L +       E A+    + EY A       + G+ 
Sbjct: 181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHD 240
Query: 759 KKATAQMDAYSFGVVLLELITG 780
           K     +D +S GV++ EL+TG
Sbjct: 241 K----AVDWWSLGVLMYELLTG 258

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 144
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E               + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 252
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P+ RP+  E+V
Sbjct: 253 QPD----NCPER----VTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 71/153 (46%), Gaps = 4/153 (2%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E   ++++ H   VK+   F  DE ++    + + G L   I +     +   R   A  
Sbjct: 79  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 137
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +   L YLH      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +     
Sbjct: 138 IVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + Y +PE    K A    D ++ G ++ +L+ G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 25  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 83
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 84  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 141
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E               + AP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 249
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P+ RP+  E+V
Sbjct: 250 QPD----NCPER----VTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 604 PSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           P+GE + V+++    C +     L+ E+       H NIV     F +D  ++++  F+ 
Sbjct: 34  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 93
Query: 662 MGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDAD 718
            GS  DLIC    D   + +I   I  GV + L Y+H   YV    HR+VK+ +IL+  D
Sbjct: 94  YGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIHHMGYV----HRSVKASHILISVD 148
Query: 719 FEPKLTDFALD-RIVGEAAFQSTMSS--EYALSC--YNAPEY------GYSKKATAQMDA 767
            +  L+    +  ++     Q  +    +Y++    + +PE       GY  K+    D 
Sbjct: 149 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DI 204
Query: 768 YSFGVVLLELITGRQAEQAEPAESL 792
           YS G+   EL  G    +  PA  +
Sbjct: 205 YSVGITACELANGHVPFKDMPATQM 229

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 25/205 (12%)
Query: 604 PSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ 661
           P+GE + V+++    C +     L+ E+       H NIV     F +D  ++++  F+ 
Sbjct: 50  PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 662 MGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDAD 718
            GS  DLIC    D   + +I   I  GV + L Y+H   YV    HR+VK+ +IL+  D
Sbjct: 110 YGSAKDLICTHFMDGMNELAIAY-ILQGVLKALDYIHHMGYV----HRSVKASHILISVD 164
Query: 719 FEPKLTDFALD-RIVGEAAFQSTMSS--EYALSC--YNAPEY------GYSKKATAQMDA 767
            +  L+    +  ++     Q  +    +Y++    + +PE       GY  K+    D 
Sbjct: 165 GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DI 220
Query: 768 YSFGVVLLELITGRQAEQAEPAESL 792
           YS G+   EL  G    +  PA  +
Sbjct: 221 YSVGITACELANGHVPFKDMPATQM 245

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/161 (22%), Positives = 74/161 (45%), Gaps = 9/161 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESI----FLIYEFLQMGSLGDLICRQDFQLQWSI 680
            + E +  A + H  IV V     ++       +++ E++   +L D++   +  +    
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKR 117
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
            +++     Q L + H++ +   +HR+VK  NIL+ A    K+ DF + R + ++     
Sbjct: 118 AIEVIADACQALNFSHQNGI---IHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 741 MSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            ++     + Y +PE        A+ D YS G VL E++TG
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 20/196 (10%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY+        I   K++ F  Q  K      L+ E++  A + H NI+++  +F
Sbjct: 34  GKFGNVYLAREKKSHFIVALKVL-FKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYF 92
Query: 648 HSDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           +    I+LI E+   G L   +   C  D Q   +I  ++    A  L Y H   V   +
Sbjct: 93  YDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL----ADALMYCHGKKV---I 145
Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++K +N+LL    E K+ DF    +   +  + TM        Y  PE    +    +
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLD---YLPPEMIEGRMHNEK 201
Query: 765 MDAYSFGVVLLELITG 780
           +D +  GV+  EL+ G
Sbjct: 202 VDLWCIGVLCYELLVG 217

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 86/180 (47%), Gaps = 11/180 (6%)
Query: 607 ELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +++ V K  +    S++ LK E      ++H +IV++L  + SD  +++++EF+    L 
Sbjct: 55  KIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114
Query: 667 -DLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP-- 721
            +++ R D  F    ++       + + L Y H +   +++HR+VK +N+LL +      
Sbjct: 115 FEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAP 171
Query: 722 -KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            KL DF +   +GE+              + APE    +     +D +  GV+L  L++G
Sbjct: 172 VKLGDFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S GV++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD 650
           G + +V   +SL +G+  AVK +      S   +  EV+TL + + +KNI++++ FF  D
Sbjct: 24  GAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDD 83
Query: 651 ESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              +L++E LQ GS+   I +Q  F  + + R  +   VA  L +LH      + HR++K
Sbjct: 84  TRFYLVFEKLQGGSILAHIQKQKHFNEREASR--VVRDVAAALDFLH---TKGIAHRDLK 138
Query: 710 SKNILLDA--DFEP-KLTDFALDRIVG-EAAFQSTMSSEYALSC----YNAPEY--GYSK 759
            +NIL ++     P K+ DF L   +    +     + E    C    Y APE    ++ 
Sbjct: 139 PENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTD 198
Query: 760 KAT---AQMDAYSFGVVLLELITG 780
           +AT    + D +S GVVL  +++G
Sbjct: 199 QATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 114/279 (40%), Gaps = 45/279 (16%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVL 644
           G FG VY      I+   +   +AVK  VN      + ++   E   +      ++V++L
Sbjct: 28  GSFGMVYEGNARDIIKGEAETRVAVKT-VNESASLRERIEFLNEASVMKGFTCHHVVRLL 86
Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI-----------CRQDFQLQWSIRLKIAIGVAQGLA 693
           G     +   ++ E +  G L   +            R    LQ  I++  A  +A G+A
Sbjct: 87  GVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM--AAEIADGMA 144
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E               + AP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
           E       T   D +SFGVVL E+ +   AEQ  P + L    V+K+V     +  G + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS--LAEQ--PYQGLSNEQVLKFV-----MDGGYLD 252
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
             D    NC ++      ++   C    P  RP+  E+V
Sbjct: 253 QPD----NCPER----VTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 82
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 83  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 138
Query: 716 DADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L +  + + A   TM +      Y APE          +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 775 LELITGR 781
            E++ GR
Sbjct: 196 YEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 33  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 85
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 86  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 141
Query: 716 DADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L +  + + A   TM +      Y APE          +D +  GVV+
Sbjct: 142 DKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 198
Query: 775 LELITGR 781
            E++ GR
Sbjct: 199 YEMMCGR 205

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 16/194 (8%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G F  VY  + L  G  +A+KK+  F    +K       E+  L ++ H N++K    F 
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 649 SDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            D  + ++ E    G L  +I    +Q   +      K  + +   L ++H   V   +H
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MH 159
Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           R++K  N+ + A    KL D  L R       A  S + + Y +S     E GY+ K+  
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS-- 217
Query: 764 QMDAYSFGVVLLEL 777
             D +S G +L E+
Sbjct: 218 --DIWSLGCLLYEM 229

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 82
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 83  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 138
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM +      Y APE          +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 775 LELITGR 781
            E++ GR
Sbjct: 196 YEMMCGR 202

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVK-KLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY  + +   GE I V  K     C   + +   +E   +  + H +IVK++G  
Sbjct: 19  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 78
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
             +E  ++I E    G LG  + R    L+    +  ++ + + +AYL      + +HR+
Sbjct: 79  E-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRD 134
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +  +NIL+ +    KL DF L R + +  +     +   +  + +PE    ++ T   D 
Sbjct: 135 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDV 193
Query: 768 YSFGVVLLELIT-GRQ 782
           + F V + E+++ G+Q
Sbjct: 194 WMFAVCMWEILSFGKQ 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 48/196 (24%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVK-KLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY  + +   GE I V  K     C   + +   +E   +  + H +IVK++G  
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
             +E  ++I E    G LG  + R    L+    +  ++ + + +AYL      + +HR+
Sbjct: 83  E-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRD 138
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +  +NIL+ +    KL DF L R + +  +     +   +  + +PE    ++ T   D 
Sbjct: 139 IAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK-WMSPESINFRRFTTASDV 197
Query: 768 YSFGVVLLELIT-GRQ 782
           + F V + E+++ G+Q
Sbjct: 198 WMFAVCMWEILSFGKQ 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S GV++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           GNG  FG V+   L   + +A+KK++    Q  +    E++ +  ++H N+V +  FF+S
Sbjct: 49  GNGS-FGVVFQAKLVESDEVAIKKVL----QDKRFKNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 650 D----ESIFLIYEFLQMGSLGDLICRQDFQLQWSI-RLKIAIGVAQ---GLAYLHKDYVP 701
           +    + +FL      +        R   +L+ ++  L I + + Q    LAY+H   + 
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI- 162
Query: 702 HLLHRNVKSKNILLDADFEP----KLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPEY 755
              HR++K +N+LLD    P    KL DF   +I+  GE    S + S Y    Y APE 
Sbjct: 163 --CHRDIKPQNLLLDP---PSGVLKLIDFGSAKILIAGEPNV-SXICSRY----YRAPEL 212
Query: 756 GY-SKKATAQMDAYSFGVVLLELITGR 781
            + +   T  +D +S G V+ EL+ G+
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/277 (21%), Positives = 118/277 (42%), Gaps = 41/277 (14%)
Query: 595 FGRVY---ILSLPSGE---LIAVKKLVNFGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFF 647
           FG+VY   +     GE    +A+K L +       +  + E    A+++H N+V +LG  
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQ-----------DFQLQWSIR----LKIAIGVAQGL 692
             D+ + +I+ +   G L + +  +           D  ++ ++     + +   +A G+
Sbjct: 82  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H++H+++ ++N+L+      K++D  L R V  A +   + +      + A
Sbjct: 142 EYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 198
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQV 811
           PE     K +   D +S+GVVL E+ + G Q       +  DVV+ +R +        QV
Sbjct: 199 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIRNR--------QV 248
Query: 812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           L      C          + + C +  P +RP   ++
Sbjct: 249 L-----PCPDDCPAWVYALMIECWNEFPSRRPRFKDI 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/277 (20%), Positives = 117/277 (42%), Gaps = 41/277 (14%)
Query: 595 FGRVY---ILSLPSGE---LIAVKKLVNFGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFF 647
           FG+VY   +     GE    +A+K L +       +  + E    A+++H N+V +LG  
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQ-----------DFQLQWSIR----LKIAIGVAQGL 692
             D+ + +I+ +   G L + +  +           D  ++ ++     + +   +A G+
Sbjct: 99  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL      H++H+++ ++N+L+      K++D  L R V  A +   + +      + A
Sbjct: 159 EYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 215
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQV 811
           PE     K +   D +S+GVVL E+ + G Q       +  DVV+ +R +          
Sbjct: 216 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIRNR---------- 263
Query: 812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
              ++  C          + + C +  P +RP   ++
Sbjct: 264 ---QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 27/201 (13%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK +     +     ++L  EV+ L ++ H NI K+  FF 
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFE 96
Query: 649 SDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                +L+ E    G L D +I R+ F    + R  I   V  G+ Y HK+    ++HR+
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYXHKN---KIVHRD 151
Query: 708 VKSKNILLDA---DFEPKLTDFALDRIVGEAAFQST--MSSEYALSCYNAPE--YG-YSK 759
           +K +N+LL++   D   ++ DF L        F+++     +   + Y APE  +G Y +
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGL-----STHFEASKKXKDKIGTAYYIAPEVLHGTYDE 206
Query: 760 KATAQMDAYSFGVVLLELITG 780
           K     D +S GV+L  L++G
Sbjct: 207 KC----DVWSTGVILYILLSG 223

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V      + TL TE + L   RH  +  +   F + + +  
Sbjct: 173 GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCF 225
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH +   ++++R++K +N++L
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLML 282
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM +      Y APE          +D +  GVV+
Sbjct: 283 DKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 775 LELITGR 781
            E++ GR
Sbjct: 340 YEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V      + TL TE + L   RH  +  +   F + + +  
Sbjct: 176 GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCF 228
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH +   ++++R++K +N++L
Sbjct: 229 VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLML 285
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM +      Y APE          +D +  GVV+
Sbjct: 286 DKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 342
Query: 775 LELITGR 781
            E++ GR
Sbjct: 343 YEMMCGR 349

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH   +    HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITG 780
           APE    ++  A+ +D +S G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH   +    HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITG 780
           APE    ++  A+ +D +S G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + EL+AVK  +  G +  + +K E+     +RH NIV+      +   + ++ E+   G 
Sbjct: 43  ANELVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--K 722
           L + IC      +   R      +  G++Y H   V    HR++K +N LLD    P  K
Sbjct: 102 LFERICNAGRFSEDEARFFFQ-QLISGVSYAHAMQV---AHRDLKLENTLLDGSPAPRLK 157
Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGR 781
           + DF   +    +   S   S      Y APE    K+   ++ D +S GV L  ++ G 
Sbjct: 158 IADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGA 214
Query: 782 QAEQAEPAESLDVVKWVRRKINI 804
              + +P E  +  K + R +N+
Sbjct: 215 YPFE-DPEEPKNFRKTIHRILNV 236

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 8/201 (3%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           S EL+AVK  +  G +  + +K E+     +RH NIV+      +   + ++ E+   G 
Sbjct: 43  SNELVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L + IC      +   R      +  G++Y H   V    HR++K +N LLD    P+L 
Sbjct: 102 LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLK 157
Query: 725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGRQA 783
             A       +   S   S      Y APE    K+   ++ D +S GV L  ++ G   
Sbjct: 158 ICAFG-YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216
Query: 784 EQAEPAESLDVVKWVRRKINI 804
            + +P E  +  K + R +N+
Sbjct: 217 FE-DPEEPKNFRKTIHRILNV 236

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLH 696
             F    S      ++L+   +       + C++  D  +Q+ I       + +GL Y+H
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYIH 142
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
                 ++HR++K  N+ ++ D E K+  F L R   +      M+   A   Y APE  
Sbjct: 143 S---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIM 194
Query: 757 YSKKATAQ-MDAYSFGVVLLELITGR 781
            +     Q +D +S G ++ EL+TGR
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/207 (24%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 593 GPFGRVYILSLPSGEL---IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V    +    L    A+K++  +  +   +    E++ L K+  H NI+ +LG  
Sbjct: 33  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 92
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-------FQLQWSIR--------LKIAIGVAQGL 692
                ++L  E+   G+L D + +         F +  S          L  A  VA+G+
Sbjct: 93  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 152
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL +      +HRN+ ++NIL+  ++  K+ DF L R  G+  +         +     
Sbjct: 153 DYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAI 207
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT 779
               YS   T   D +S+GV+L E+++
Sbjct: 208 ESLNYS-VYTTNSDVWSYGVLLWEIVS 233

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)
Query: 593 GPFGRVYILSL-PSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFF 647
           G FG+V +  +  +G+L AVK L   V       +   TE + L+  R H  + ++   F
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + +F + EF+  G L        F +Q S R         A  +   L +LH   + 
Sbjct: 94  QTPDRLFFVMEFVNGGDLM-------FHIQKSRRFDEARARFYAAEIISALMFLHDKGI- 145
Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKK 760
             ++R++K  N+LLD +   KL DF + +   E       ++ +     Y APE      
Sbjct: 146 --IYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 761 ATAQMDAYSFGVVLLELITGRQAEQAEPAESL 792
               +D ++ GV+L E++ G    +AE  + L
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 81/174 (46%), Gaps = 6/174 (3%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G +     M+ E     Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAGTSFM---MTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 82
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 83  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 138
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM        Y APE          +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 775 LELITGR 781
            E++ GR
Sbjct: 196 YEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 35  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 87
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 88  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 143
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM        Y APE          +D +  GVV+
Sbjct: 144 DKDGHIKITDFGLCKEGISDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 200
Query: 775 LELITGR 781
            E++ GR
Sbjct: 201 YEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 82
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 83  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 138
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM        Y APE          +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 775 LELITGR 781
            E++ GR
Sbjct: 196 YEMMCGR 202

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 12/203 (5%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + EL+AVK  +  G    + ++ E+     +RH NIV+      +   + +I E+   G 
Sbjct: 44  TKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--K 722
           L + IC      +   R      +  G++Y H      + HR++K +N LLD    P  K
Sbjct: 103 LYERICNAGRFSEDEARFFFQ-QLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLK 158
Query: 723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGR 781
           + DF   +    +   S   S      Y APE    ++   ++ D +S GV L  ++ G 
Sbjct: 159 ICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215
Query: 782 QAEQAEPAESLDVVKWVRRKINI 804
              + +P E  D  K ++R +++
Sbjct: 216 YPFE-DPEEPRDYRKTIQRILSV 237

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ D  L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ D  L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 15/187 (8%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V           TE + L   RH  +  +   F + + +  
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTV-------TESRVLQNTRHPFLTALKYAFQTHDRLCF 82
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH   V   ++R++K +N++L
Sbjct: 83  VMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLHSRDV---VYRDIKLENLML 138
Query: 716 DADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L +  + + A   TM        Y APE          +D +  GVV+
Sbjct: 139 DKDGHIKITDFGLCKEGISDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 195
Query: 775 LELITGR 781
            E++ GR
Sbjct: 196 YEMMCGR 202

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITG 780
           APE    ++  A+ +D +S G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITG 780
           APE    ++  A+ +D +S G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITG 780
           APE    ++  A+ +D +S G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 116
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 117 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 174 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 93/196 (47%), Gaps = 29/196 (14%)
Query: 609 IAVKKLVNFGCQSSK-TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +AVK L +      K  L +E+K ++ + +H+NIV +LG       + +I E+   G L 
Sbjct: 64  VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 667 DLICR-------------QDFQ---------LQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           + + R             QD +         L+    L  +  VAQG+A+L      + +
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCI 180
Query: 705 HRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           HR+V ++N+LL      K+ DF L R I+ ++ +    ++   +  + APE  +    T 
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK-WMAPESIFDCVYTV 239
Query: 764 QMDAYSFGVVLLELIT 779
           Q D +S+G++L E+ +
Sbjct: 240 QSDVWSYGILLWEIFS 255

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 587 SSAGNGGPFGRVYILSLPSGELIAVKKLVN--FGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           S  G+G            +G  +AVKKL         +K    E++ L  ++H+N++ +L
Sbjct: 28  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 645 GFFHSDES------IFLIYEFLQMGSLGDLI-CRQ--DFQLQWSIRLKIAIGVAQGLAYL 695
             F    S      ++L+   +    L +++ C++  D  +Q+ I       + +GL Y+
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-----YQILRGLKYI 141
Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY 755
           H      ++HR++K  N+ ++ D E K+ D  L R   +      M+   A   Y APE 
Sbjct: 142 HS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEI 193
Query: 756 GYSKKATAQ-MDAYSFGVVLLELITGR 781
             +     Q +D +S G ++ EL+TGR
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V      + TL TE + L   RH  +  +   F + + +  
Sbjct: 33  GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCF 85
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH +   ++++R++K +N++L
Sbjct: 86  VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLML 142
Query: 716 DADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L +  + + A   TM        Y APE          +D +  GVV+
Sbjct: 143 DKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 199
Query: 775 LELITGR 781
            E++ GR
Sbjct: 200 YEMMCGR 206

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 14/187 (7%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V      + TL TE + L   RH  +  +   F + + +  
Sbjct: 35  GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCF 87
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH +   ++++R++K +N++L
Sbjct: 88  VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLML 144
Query: 716 DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L    + + A   TM        Y APE          +D +  GVV+
Sbjct: 145 DKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 201
Query: 775 LELITGR 781
            E++ GR
Sbjct: 202 YEMMCGR 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 417 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 474
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 475 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            ++ +  Y APE     K +++ D +SFGV++ E  +
Sbjct: 532 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 14/187 (7%)
Query: 596 GRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL 655
           GR Y + +   E+I  K  V      + TL TE + L   RH  +  +   F + + +  
Sbjct: 34  GRYYAMKILKKEVIVAKDEV------AHTL-TENRVLQNSRHPFLTALKYSFQTHDRLCF 86
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           + E+   G L   + R+    +   R   A  +   L YLH +   ++++R++K +N++L
Sbjct: 87  VMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE--KNVVYRDLKLENLML 143
Query: 716 DADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL 774
           D D   K+TDF L +  + + A   TM        Y APE          +D +  GVV+
Sbjct: 144 DKDGHIKITDFGLCKEGIKDGA---TMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 200
Query: 775 LELITGR 781
            E++ GR
Sbjct: 201 YEMMCGR 207

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 83/157 (52%), Gaps = 8/157 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 418 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 475
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 476 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            ++ +  Y APE     K +++ D +SFGV++ E  +
Sbjct: 533 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 53  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 110
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 111 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 168 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 200

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 65  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 122
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 123 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 180 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 112
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 113 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 170 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 59  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 116
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 117 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 174 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 206

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 8/154 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 73  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 130
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 131 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            ++ +  Y APE     K +++ D +SFGV++ E
Sbjct: 188 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWE 220

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 42/193 (21%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 593 GPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKT--LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V   +  +   ++    K++  G + + T  +  E + + ++ +  IV+++G   
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 80
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + E++ L+ E    G L   +  +  ++  S   ++   V+ G+ YL +    + +HR++
Sbjct: 81  A-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDL 136
Query: 709 KSKNILLDADFEPKLTDFALDRIVG--EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
            ++N+LL      K++DF L + +G  ++ + +  + ++ L  Y APE    +K +++ D
Sbjct: 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY-APECINFRKFSSRSD 195
Query: 767 AYSFGVVLLELIT 779
            +S+GV + E ++
Sbjct: 196 VWSYGVTMWEALS 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 40/280 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 645 GF-FHSDESIFLIYEFLQMGSLGDLI------------CRQDFQLQWSIRLKIAIGVAQG 691
           G        + +I EF + G+L   +              +DF L     +  +  VA+G
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLIXYSFQVAKG 156
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCY 750
           + +L        +HR++ ++NILL      K+ DF L R I  +  +     +   L  +
Sbjct: 157 MEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK-W 212
Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ 810
            APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++      ++
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFXRRLK-EGTRMR 267
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             D      YQ          L C    P +RP+  E+V+
Sbjct: 268 APDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 299

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 8/201 (3%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           S EL+AVK  +  G +  + +K E+     +RH NIV+      +   + ++ E+   G 
Sbjct: 43  SNELVAVK-YIERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 101
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           L + IC      +   R      +  G++Y H   V    HR++K +N LLD    P+L 
Sbjct: 102 LFERICNAGRFSEDEARFFFQ-QLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLK 157
Query: 725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM-DAYSFGVVLLELITGRQA 783
             A       +   S          Y APE    K+   ++ D +S GV L  ++ G   
Sbjct: 158 ICAFG-YSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216
Query: 784 EQAEPAESLDVVKWVRRKINI 804
            + +P E  +  K + R +N+
Sbjct: 217 FE-DPEEPKNFRKTIHRILNV 236

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 593 GPFGRVY-ILSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G F  VY   S+ +G  +A+K   K   +     + ++ EVK   +++H +I+++  +F 
Sbjct: 22  GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
               ++L+ E    G +   +  +      +        +  G+ YLH   +   LHR++
Sbjct: 82  DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI---LHRDL 138
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA----- 763
              N+LL  +   K+ DF L       A Q  M  E   +    P Y   + AT      
Sbjct: 139 TLSNLLLTRNMNIKIADFGL-------ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191
Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
           + D +S G +   L+ GR      P    D VK    K+
Sbjct: 192 ESDVWSLGCMFYTLLIGR------PPFDTDTVKNTLNKV 224

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 14/178 (7%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL 723
           D    Q  Q++     +++  + Q   G+ +LH      ++HR++K  NI++ +D   K+
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKI 167
Query: 724 TDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            DF L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 168 LDFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 593 GPFGRVYILSLPSGEL---IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V    +    L    A+K++  +  +   +    E++ L K+  H NI+ +LG  
Sbjct: 26  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 85
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-------FQLQWSIR--------LKIAIGVAQGL 692
                ++L  E+   G+L D + +         F +  S          L  A  VA+G+
Sbjct: 86  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 145
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL +      +HR++ ++NIL+  ++  K+ DF L R  G+  +         +     
Sbjct: 146 DYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAI 200
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT 779
               YS   T   D +S+GV+L E+++
Sbjct: 201 ESLNYS-VYTTNSDVWSYGVLLWEIVS 226

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLSQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 84/160 (52%), Gaps = 8/160 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 132
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 133 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
            ++ +  Y APE     K +++ D +SFGV++ E  +  Q
Sbjct: 190 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQ 228

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 84/160 (52%), Gaps = 8/160 (5%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI 684
           L  E   + ++ +  IV+++G   + ES  L+ E  ++G L   + +Q+  ++    +++
Sbjct: 75  LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIEL 132
Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV--GEAAFQSTMS 742
              V+ G+ YL +    + +HR++ ++N+LL      K++DF L + +   E  +++   
Sbjct: 133 VHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
            ++ +  Y APE     K +++ D +SFGV++ E  +  Q
Sbjct: 190 GKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEAFSYGQ 228

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 21/149 (14%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLK-TEVKTLAKIRHKNIVKVLGFFHSD- 650
           G +G V++     GE +AVK  V F  + +   + TE+     +RH+NI   LGF  +D 
Sbjct: 48  GRYGEVWMGKW-RGEKVAVK--VFFTTEEASWFRETEIYQTVLMRHENI---LGFIAADI 101
Query: 651 ------ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV---- 700
                   ++LI ++ + GSL D +  +   L     LK+A     GL +LH +      
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 701 -PHLLHRNVKSKNILLDADFEPKLTDFAL 728
            P + HR++KSKNIL+  +    + D  L
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGL 188

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 593 GPFGRVYILSLPSGEL---IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V    +    L    A+K++  +  +   +    E++ L K+  H NI+ +LG  
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQD-------FQLQWSIR--------LKIAIGVAQGL 692
                ++L  E+   G+L D + +         F +  S          L  A  VA+G+
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155
Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
            YL +      +HR++ ++NIL+  ++  K+ DF L R  G+  +         +     
Sbjct: 156 DYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAI 210
Query: 753 PEYGYSKKATAQMDAYSFGVVLLELIT 779
               YS   T   D +S+GV+L E+++
Sbjct: 211 ESLNYS-VYTTNSDVWSYGVLLWEIVS 236

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
            A + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 225

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 90/192 (46%), Gaps = 11/192 (5%)
Query: 593 GPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG V+  +   + +++A+K + +       + ++ E+  L++     + K  G +   
Sbjct: 34  GSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKG 93
Query: 651 ESIFLIYEFLQMGSLGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
             +++I E+L  GS  DL+    F + Q +  LK    + +GL YLH +     +HR++K
Sbjct: 94  SKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE---KKIHRDIK 147
Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           + N+LL    + KL DF +   + +   Q   ++      + APE        ++ D +S
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWS 205
Query: 770 FGVVLLELITGR 781
            G+  +EL  G 
Sbjct: 206 LGITAIELAKGE 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 86/195 (44%), Gaps = 38/195 (19%)
Query: 613 KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVL-GFFHSDESIFL------IYEFLQMGSL 665
           +L N      K ++ EVK LAK+ H  IV+    +   + +  L      +Y ++QM   
Sbjct: 39  RLPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-- 95
Query: 666 GDLICRQDFQLQW------------SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI 713
              +CR++    W            S+ L I + +A+ + +LH      L+HR++K  NI
Sbjct: 96  ---LCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNI 149
Query: 714 LLDADFEPKLTDF----ALDRIVGEAAFQSTM------SSEYALSCYNAPEYGYSKKATA 763
               D   K+ DF    A+D+   E    + M      + +     Y +PE  +    + 
Sbjct: 150 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSH 209
Query: 764 QMDAYSFGVVLLELI 778
           ++D +S G++L EL+
Sbjct: 210 KVDIFSLGLILFELL 224

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/255 (22%), Positives = 103/255 (40%), Gaps = 33/255 (12%)
Query: 554 YSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKK 613
           + +K SQ  ++   +  P    E   +IG          G FG+VY         I +  
Sbjct: 14  FPRKASQTSIFLQEWDIPFEQLEIGELIGK---------GRFGQVYHGRWHGEVAIRLID 64
Query: 614 LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD 673
           +        K  K EV    + RH+N+V  +G   S   + +I    +  +L  ++    
Sbjct: 65  IERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 674 FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG 733
             L  +   +IA  + +G+ YLH      +LH+++KSKN+  D + +  +TDF L  I G
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180
Query: 734 ---EAAFQSTMSSEYALSCYNAPE-------------YGYSKKATAQMDAYSFGVVLLEL 777
                  +  +  +    C+ APE               +SK +    D ++ G +  EL
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS----DVFALGTIWYEL 236
Query: 778 ITGRQAEQAEPAESL 792
                  + +PAE++
Sbjct: 237 HAREWPFKTQPAEAI 251

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 113 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 172 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 83/175 (47%), Gaps = 8/175 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G     S M + Y ++  Y APE          +D +S G ++ E+I G
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 225

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 20/181 (11%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFL 660
           +AVKKL   F  Q+ +K    E+  L  + HKNI+ +L  F   ++      ++L+ E +
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
              +L  +I     +L       +   +  G+ +LH      ++HR++K  NI++ +D  
Sbjct: 112 D-ANLCQVI---HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            K+ DF L R     A  + M + Y ++  Y APE        A +D +S G ++ EL+ 
Sbjct: 165 LKILDFGLAR----TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVK 220
Query: 780 G 780
           G
Sbjct: 221 G 221

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 28/200 (14%)
Query: 593 GPFGRVYILSLPSGELI--AVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G +G V I ++  G  I  A KK+  +  +     K E++ +  + H NI+++   F  +
Sbjct: 37  GSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 95
Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             I+L+ E    G L + +  +    + S   +I   V   +AY HK    ++ HR++K 
Sbjct: 96  TDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKP 151
Query: 711 KNILL--DADFEP-KLTDFALDRIVGEAAFQ--STMSSEYALSCYNAPE-----YGYSKK 760
           +N L   D+   P KL DF L      A F+    M ++     Y +P+     YG    
Sbjct: 152 ENFLFLTDSPDSPLKLIDFGL-----AARFKPGKMMRTKVGTPYYVSPQVLEGLYG---- 202
Query: 761 ATAQMDAYSFGVVLLELITG 780
              + D +S GV++  L+ G
Sbjct: 203 --PECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 28/200 (14%)
Query: 593 GPFGRVYILSLPSGELI--AVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G +G V I ++  G  I  A KK+  +  +     K E++ +  + H NI+++   F  +
Sbjct: 20  GSWGEVKI-AVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78
Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             I+L+ E    G L + +  +    + S   +I   V   +AY HK    ++ HR++K 
Sbjct: 79  TDIYLVMELCTGGELFERVVHKRV-FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKP 134
Query: 711 KNILL--DADFEP-KLTDFALDRIVGEAAFQ--STMSSEYALSCYNAPE-----YGYSKK 760
           +N L   D+   P KL DF L      A F+    M ++     Y +P+     YG    
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGL-----AARFKPGKMMRTKVGTPYYVSPQVLEGLYG---- 185
Query: 761 ATAQMDAYSFGVVLLELITG 780
              + D +S GV++  L+ G
Sbjct: 186 --PECDEWSAGVMMYVLLCG 203

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 116/280 (41%), Gaps = 40/280 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI------------CRQDFQLQWSIRLKIAIGVAQG 691
           G        + +I EF + G+L   +              +DF L     +  +  VA+G
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF-LTLEHLICYSFQVAKG 156
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCY 750
           + +L        +HR++ ++NILL      K+ DF L R I  +  +     +   L  +
Sbjct: 157 MEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK-W 212
Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ 810
            APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++      ++
Sbjct: 213 MAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGTRMR 267
Query: 811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             D      YQ          L C    P +RP+  E+V+
Sbjct: 268 APDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 299

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+  L++     + K  G +  D  +++I E+L  GS  DL+  +   L  +    I   
Sbjct: 75  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILRE 132
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           + +GL YLH +     +HR++K+ N+LL    E KL DF +   + +   Q   ++    
Sbjct: 133 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGT 187
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
             + APE        ++ D +S G+  +EL  G 
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 98/233 (42%), Gaps = 42/233 (18%)
Query: 578 DLVIGMDEKSSA--GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI 635
           D   GMD K     G+GG FG+V+           V + V +  + ++    EVK LAK+
Sbjct: 7   DKRFGMDFKEIELIGSGG-FGQVFKAKHRIDGKTYVIRRVKYNNEKAER---EVKALAKL 62
Query: 636 RHKNIVKVLGFFH--------SDESI---------------------FLIYEFLQMGSLG 666
            H NIV   G +         SD+S+                     F+  EF   G+L 
Sbjct: 63  DHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLE 122
Query: 667 DLI-CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
             I  R+  +L   + L++   + +G+ Y+H      L+HR++K  NI L    + K+ D
Sbjct: 123 QWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGD 179
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
           F L   V         +       Y +PE   S+    ++D Y+ G++L EL+
Sbjct: 180 FGL---VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 609 IAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-----FLIYEFL 660
           +AVKKL         + +T + E++ L  ++H+N++ +L  F    SI       +   L
Sbjct: 56  VAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
               L +++  Q   D  +Q+     +   + +GL Y+H      ++HR++K  N+ ++ 
Sbjct: 115 MGADLNNIVKSQALSDEHVQF-----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNE 166
Query: 718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLE 776
           D E ++ DF L R   E      M+   A   Y APE   +     Q +D +S G ++ E
Sbjct: 167 DSELRILDFGLARQADE-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 777 LITGR 781
           L+ G+
Sbjct: 222 LLQGK 226

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+  L++     + K  G +  D  +++I E+L  GS  DL+  +   L  +    I   
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILRE 127
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-A 746
           + +GL YLH +     +HR++K+ N+LL    E KL DF    + G+        + +  
Sbjct: 128 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNXFVG 181
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
              + APE        ++ D +S G+  +EL  G 
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+  L++     + K  G +  D  +++I E+L  GS  DL+  +   L  +    I   
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILRE 112
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           + +GL YLH +     +HR++K+ N+LL    E KL DF +   + +   Q   ++    
Sbjct: 113 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGT 167
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
             + APE        ++ D +S G+  +EL  G 
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSI-RLKIAI-GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           D    Q  Q++    R+   +  +  G+ +LH      ++HR++K  NI++ +D   K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 725 DFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           DF L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 169 DFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSXQEYSDWKEKK 224

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 113/281 (40%), Gaps = 40/281 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 40  GAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI--------------CRQDFQLQWSIRLKIAIGVA 689
           G        + +I EF + G+L   +                +DF L     +  +  VA
Sbjct: 100 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDF-LTLEHLIXYSFQVA 158
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +G+ +L        +HR++ ++NILL      K+ DF L R + +               
Sbjct: 159 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLK 215
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI 809
           + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++      +
Sbjct: 216 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGTRM 270
Query: 810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           +  D      YQ          L C    P +RP+  E+V+
Sbjct: 271 RAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 303

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+  L++     + K  G +  D  +++I E+L  GS  DL+  +   L  +    I   
Sbjct: 55  EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILRE 112
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-A 746
           + +GL YLH +     +HR++K+ N+LL    E KL DF    + G+        + +  
Sbjct: 113 ILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG---VAGQLTDTQIKRNXFVG 166
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
              + APE        ++ D +S G+  +EL  G 
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 586 KSSAGNGGPFGRVYILSL---PSGELIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIV 641
           K   G GG FG  Y+L      +GE +A+K+       ++ +    E++ + K+ H N+V
Sbjct: 19  KERLGTGG-FG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 642 KV------LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-----LQWSIRLKIAIGVAQ 690
                   L     ++   L  E+ + G L   +    F+      +  IR  ++  ++ 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLS-DISS 132
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC- 749
            L YLH++ +   +HR++K +NI+L    + +L    +D    +   Q  + +E+  +  
Sbjct: 133 ALRYLHENRI---IHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           Y APE    KK T  +D +SFG +  E ITG
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLXQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 586 KSSAGNGGPFGRVYILSL---PSGELIAVKKLVN-FGCQSSKTLKTEVKTLAKIRHKNIV 641
           K   G GG FG  Y+L      +GE +A+K+       ++ +    E++ + K+ H N+V
Sbjct: 20  KERLGTGG-FG--YVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 642 KV------LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-----LQWSIRLKIAIGVAQ 690
                   L     ++   L  E+ + G L   +    F+      +  IR  ++  ++ 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLS-DISS 133
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC- 749
            L YLH++ +   +HR++K +NI+L    + +L    +D    +   Q  + +E+  +  
Sbjct: 134 ALRYLHENRI---IHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQ 189
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           Y APE    KK T  +D +SFG +  E ITG
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 637 HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH 696
           H +I+ ++  + S   +FL+++ ++ G L D +  +    +   R  I   + + +++LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR-SIMRSLLEAVSFLH 217
Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFA----------LDRIVGEAAFQSTMSSEYA 746
            +   +++HR++K +NILLD + + +L+DF           L  + G   +   ++ E  
Sbjct: 218 AN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY---LAPEIL 271
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
               +    GY K    ++D ++ GV+L  L+ G
Sbjct: 272 KCSMDETHPGYGK----EVDLWACGVILFTLLAG 301

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIV 641
           EK +    G FG V+      +G+ +A+KK++  N       T   E+K L  ++H+N+V
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 642 KVLGFFHSDES--------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            ++    +  S        I+L+++F +   L  L+     +   S   ++   +  GL 
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
           Y+H++ +   LHR++K+ N+L+  D   KL DF L R
Sbjct: 140 YIHRNKI---LHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 6/175 (3%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G +     M  E     Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAGTSFM---MEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 29/220 (13%)
Query: 578 DLVIGMD--EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI 635
           D   GMD  E    G+GG FG+V+           V K V +   +++  + EVK LAK+
Sbjct: 6   DKRFGMDFKEIELIGSGG-FGQVFKAKHRIDGKTYVIKRVKY---NNEKAEREVKALAKL 61
Query: 636 RHKNIVKVLG----FFHSDES------------IFLIYEFLQMGSLGDLI-CRQDFQLQW 678
            H NIV   G    F +  E+            +F+  EF   G+L   I  R+  +L  
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 679 SIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ 738
            + L++   + +G+ Y+H      L++R++K  NI L    + K+ DF L   V      
Sbjct: 122 VLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGL---VTSLKND 175
Query: 739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELI 778
                      Y +PE   S+    ++D Y+ G++L EL+
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 609 IAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-----FLIYEFL 660
           +AVKKL         + +T + E++ L  ++H+N++ +L  F    SI       +   L
Sbjct: 48  VAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 106
Query: 661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
               L +++  Q   D  +Q+     +   + +GL Y+H      ++HR++K  N+ ++ 
Sbjct: 107 MGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNE 158
Query: 718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLE 776
           D E ++ DF L R   E      M+   A   Y APE   +     Q +D +S G ++ E
Sbjct: 159 DCELRILDFGLARQADE-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 213
Query: 777 LITGR 781
           L+ G+
Sbjct: 214 LLQGK 218

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 15/211 (7%)
Query: 573 RVTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVK 630
           RV   +L   +D        G FG VY  +   + E++A+K + +       + ++ E+ 
Sbjct: 14  RVDPEELFTKLDRIGK----GSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEIT 69
Query: 631 TLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ 690
            L++     I +  G +     +++I E+L  GS  DL+  +   L+ +    I   + +
Sbjct: 70  VLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILK 127
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSC 749
           GL YLH +     +HR++K+ N+LL    + KL DF    + G+        + +     
Sbjct: 128 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFG---VAGQLTDTQIKRNXFVGTPF 181
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           + APE         + D +S G+  +EL  G
Sbjct: 182 WMAPEVIKQSAYDFKADIWSLGITAIELAKG 212

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 4   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 56
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 115
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 116 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 225

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 5   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 57
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 116
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 117 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 224

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 56/232 (24%), Positives = 103/232 (44%), Gaps = 16/232 (6%)
Query: 574 VTEHDLVIGMDEKSSAGNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKT 631
           V + DLV  + E       G +G V + ++  + E +AVK + +       + +K E+  
Sbjct: 6   VEDWDLVQTLGE-------GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
              + H+N+VK  G        +L  E+   G L D I   D  +      +    +  G
Sbjct: 59  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAG 117
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           + YLH      + HR++K +N+LLD     K++DF L  +      +  ++       Y 
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 752 APEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRK 801
           APE    ++  A+ +D +S G+VL  ++ G +    +P++S  +   W  +K
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEKK 225

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/185 (23%), Positives = 87/185 (47%), Gaps = 12/185 (6%)
Query: 597 RVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           R+Y + +   EL+   + +++  Q+ K +  +        H  +V +   F ++  +F +
Sbjct: 78  RIYAMRVVKKELVNDDEDIDW-VQTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFV 131
Query: 657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            E++  G L   + RQ    +   R   A  ++  L YLH+  +   ++R++K  N+LLD
Sbjct: 132 IEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI---IYRDLKLDNVLLD 187
Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
           ++   KLTD+ + +         T S+      Y APE    +     +D ++ GV++ E
Sbjct: 188 SEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245
Query: 777 LITGR 781
           ++ GR
Sbjct: 246 MMAGR 250

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 26/185 (14%)
Query: 609 IAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-----FLIYEFL 660
           +AVKKL         + +T + E++ L  ++H+N++ +L  F    SI       +   L
Sbjct: 56  VAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 661 QMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA 717
               L +++  Q   D  +Q+     +   + +GL Y+H      ++HR++K  N+ ++ 
Sbjct: 115 MGADLNNIVKCQALSDEHVQF-----LVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNE 166
Query: 718 DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLE 776
           D E ++ DF L R   E      M+   A   Y APE   +     Q +D +S G ++ E
Sbjct: 167 DSELRILDFGLARQADE-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 777 LITGR 781
           L+ G+
Sbjct: 222 LLQGK 226

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIV 641
           EK +    G FG V+      +G+ +A+KK++  N       T   E+K L  ++H+N+V
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 642 KVLG--------FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            ++         +     SI+L+++F +   L  L+     +   S   ++   +  GL 
Sbjct: 81  NLIEICRTKASPYNRCKASIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
           Y+H++    +LHR++K+ N+L+  D   KL DF L R
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 597 RVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           R+Y + +   EL+   + +++  Q+ K +  +        H  +V +   F ++  +F +
Sbjct: 35  RIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFV 88
Query: 657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            E++  G L   + RQ    +   R   A  ++  L YLH+  +   ++R++K  N+LLD
Sbjct: 89  IEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHERGI---IYRDLKLDNVLLD 144
Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLL 775
           ++   KLTD+ +     E       +S +     Y APE    +     +D ++ GV++ 
Sbjct: 145 SEGHIKLTDYGM---CKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201
Query: 776 ELITGR 781
           E++ GR
Sbjct: 202 EMMAGR 207

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-------------K 638
           G FG+V    +       A+KK+ +   + S T+ +EV  LA + H             +
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYAAWLERR 75
Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           N VK +       ++F+  E+ + G+L DLI  ++   Q     ++   + + L+Y+H  
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA------------AFQSTMSSEYA 746
            +   +HR++K  NI +D     K+ DF L + V  +                 ++S   
Sbjct: 136 GI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 747 LSCYNAPEY-GYSKKATAQMDAYSFGVVLLELI 778
            + Y A E    +     ++D YS G++  E+I
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +IRH NI+ +   F +   + LI E +  G L D +  ++  L    
Sbjct: 51  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDE 109
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFAL-DRIVGEA 735
             +    +  G+ YLH   + H    ++K +NI+L     P    KL DF +  +I    
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 166
Query: 736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            F++   +      + APE    +    + D +S GV+   L++G
Sbjct: 167 EFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIV 641
           EK +    G FG V+      +G+ +A+KK++  N       T   E+K L  ++H+N+V
Sbjct: 21  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 80
Query: 642 KVLGFFHSDES--------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            ++    +  S        I+L+++F +   L  L+     +   S   ++   +  GL 
Sbjct: 81  NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 139
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
           Y+H++ +   LHR++K+ N+L+  D   KL DF L R
Sbjct: 140 YIHRNKI---LHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 80/175 (45%), Gaps = 6/175 (3%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G +     M  E     Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAGTSFM---MEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +IRH NI+ +   F +   + LI E +  G L D +  ++  L    
Sbjct: 58  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDE 116
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFAL-DRIVGEA 735
             +    +  G+ YLH   + H    ++K +NI+L     P    KL DF +  +I    
Sbjct: 117 ATQFLKQILDGVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 173
Query: 736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            F++   +      + APE    +    + D +S GV+   L++G
Sbjct: 174 EFKNIFGTPE----FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 585 EKSSAGNGGPFGRVY-ILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIV 641
           EK +    G FG V+      +G+ +A+KK++  N       T   E+K L  ++H+N+V
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 642 KVLGFFHSDES--------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
            ++    +  S        I+L+++F +   L  L+     +   S   ++   +  GL 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR 730
           Y+H++ +   LHR++K+ N+L+  D   KL DF L R
Sbjct: 139 YIHRNKI---LHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 593 GPFGRVY-ILSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           GPF  V   ++  +G+  AVK     K  +    S++ LK E      ++H +IV++L  
Sbjct: 37  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 96
Query: 647 FHSDESIFLIYEFLQMGSLG-DLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           + SD  +++++EF+    L  +++ R D  F    ++       + + L Y H +   ++
Sbjct: 97  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NI 153
Query: 704 LHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           +HR+VK   +LL +       KL  F +   +GE+              + APE    + 
Sbjct: 154 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREP 211
Query: 761 ATAQMDAYSFGVVLLELITG 780
               +D +  GV+L  L++G
Sbjct: 212 YGKPVDVWGCGVILFILLSG 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 597 RVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           R+Y + +   EL+   + +++  Q+ K +  +        H  +V +   F ++  +F +
Sbjct: 31  RIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFV 84
Query: 657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            E++  G L   + RQ    +   R   A  ++  L YLH+     +++R++K  N+LLD
Sbjct: 85  IEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKLDNVLLD 140
Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLL 775
           ++   KLTD+ +     E       +S +     Y APE    +     +D ++ GV++ 
Sbjct: 141 SEGHIKLTDYGM---CKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 197
Query: 776 ELITGR 781
           E++ GR
Sbjct: 198 EMMAGR 203

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 84/178 (47%), Gaps = 12/178 (6%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 667 DLICRQDFQLQWSI-RLKIAI-GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           D    Q  Q++    R+   +  +  G+ +LH      ++HR++K  NI++ +D   K+ 
Sbjct: 105 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 161
Query: 725 DFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           DF L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 162 DFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSIRLK--IAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
           D    Q  Q++        +   +  G+ +LH      ++HR++K  NI++ +D   K+ 
Sbjct: 112 DANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKIL 168
Query: 725 DFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           DF L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 169 DFGLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 620 QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQW 678
           +S +    E++ L +  +H NI+ +   +   + ++++ E ++ G L D I RQ F   +
Sbjct: 57  KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---F 113
Query: 679 SIRLKIAI--GVAQGLAYLHKDYVPHLLHRNVKSKNIL-LDADFEP---KLTDFALDRIV 732
           S R   A+   + + + YLH   V   +HR++K  NIL +D    P   ++ DF      
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFG----- 165
Query: 733 GEAAFQSTMSSEYAL---SCYNA----PEYGYSKKATAQMDAYSFGVVLLELITG 780
               F   + +E  L    CY A    PE    +   A  D +S GV+L  ++TG
Sbjct: 166 ----FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 87/186 (46%), Gaps = 14/186 (7%)
Query: 597 RVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI 656
           R+Y + +   EL+   + +++  Q+ K +  +        H  +V +   F ++  +F +
Sbjct: 46  RIYAMKVVKKELVNDDEDIDW-VQTEKHVFEQASN-----HPFLVGLHSCFQTESRLFFV 99
Query: 657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            E++  G L   + RQ    +   R   A  ++  L YLH+     +++R++K  N+LLD
Sbjct: 100 IEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE---RGIIYRDLKLDNVLLD 155
Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQMDAYSFGVVLL 775
           ++   KLTD+ +     E       +S +     Y APE    +     +D ++ GV++ 
Sbjct: 156 SEGHIKLTDYGM---CKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 212
Query: 776 ELITGR 781
           E++ GR
Sbjct: 213 EMMAGR 218

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 593 GPFGRVY-ILSLPSGELIAVKK--LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G VY  +   + E +A+K+  L +       T   EV  L +++H+NI+++    H 
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104
Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVPHLLHRN 707
           +  + LI+E+ +     DL    D     S+R+       +  G+ + H       LHR+
Sbjct: 105 NHRLHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRD 157
Query: 708 VKSKNILL---DADFEP--KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY-SKKA 761
           +K +N+LL   DA   P  K+ DF L R  G    Q T   E     Y  PE    S+  
Sbjct: 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT--HEIITLWYRPPEILLGSRHY 215
Query: 762 TAQMDAYSFGVVLLELI 778
           +  +D +S   +  E++
Sbjct: 216 STSVDIWSIACIWAEML 232

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 75  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 193
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 194 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 250
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 251 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 304
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 305 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 340

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 40  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 99
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 100 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDF-LTLEHLICYSFQ 158
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 159 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 216 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 269
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 270 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 305

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 156
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 157 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 214 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 267
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 268 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 303

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 79/174 (45%), Gaps = 6/174 (3%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 114 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 172
Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            L R  G +     M        Y APE          +D +S G ++ E+I G
Sbjct: 173 GLARTAGTSFM---MVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 593 GPFGRVY-ILSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           GPF  V   ++  +G+  AVK     K  +    S++ LK E      ++H +IV++L  
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94
Query: 647 FHSDESIFLIYEFLQMGSLG-DLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           + SD  +++++EF+    L  +++ R D  F    ++       + + L Y H +   ++
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NI 151
Query: 704 LHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
           +HR+VK   +LL +       KL  F +   +GE+              + APE    + 
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREP 209
Query: 761 ATAQMDAYSFGVVLLELITG 780
               +D +  GV+L  L++G
Sbjct: 210 YGKPVDVWGCGVILFILLSG 229

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 41/282 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 39  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 98
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI---------------CRQDFQLQWSIRLKIAIGV 688
           G        + +I EF + G+L   +                 +DF L     +  +  V
Sbjct: 99  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDF-LTLEHLICYSFQV 157
Query: 689 AQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           A+G+ +L        +HR++ ++NILL      K+ DF L R + +              
Sbjct: 158 AKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 749 CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA 808
            + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++      
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGTR 269
Query: 809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 270 MRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 303

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 117 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 175
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 176 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 8/198 (4%)
Query: 607 ELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL 665
           E +AVK + +       + +K E+     + H+N+VK  G        +L  E+   G L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD 725
            D I   D  +      +    +  G+ YLH      + HR++K +N+LLD     K++D
Sbjct: 92  FDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISD 147
Query: 726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLELITGRQAE 784
           F L  +      +  ++       Y APE    ++  A+ +D +S G+VL  ++ G +  
Sbjct: 148 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG-ELP 206
Query: 785 QAEPAESL-DVVKWVRRK 801
             +P++S  +   W  +K
Sbjct: 207 WDQPSDSCQEYSDWKEKK 224

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 90/205 (43%), Gaps = 15/205 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++ L + + +   K++N         +   + E   L     K I  +   F 
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D +++L+ ++   G L  L+ + + +L   +       +   +  +H+    H +HR++
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDI 201
Query: 709 KSKNILLDADFEPKLTDF-ALDRIVGEAAFQSTMSSEYALSCYNAPEY-----GYSKKAT 762
           K  NIL+D +   +L DF +  +++ +   QS+++       Y +PE      G   +  
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPEILQAMEGGKGRYG 259
Query: 763 AQMDAYSFGVVLLELITGRQAEQAE 787
            + D +S GV + E++ G     AE
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 29  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 88
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 89  GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 147
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 148 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 205 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 258
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 259 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 294

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFL 660
           +AVKKL   F  Q+ +K    E+  L  + HKNI+ +L  F   ++      ++L+ E +
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE 720
              +L  +I     +L       +   +  G+ +LH      ++HR++K  NI++ +D  
Sbjct: 110 D-ANLCQVI---HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 162
Query: 721 PKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELIT 779
            K+ DF L R     A  + M + Y ++  Y APE          +D +S G ++ EL+ 
Sbjct: 163 LKILDFGLAR----TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 218
Query: 780 G 780
           G
Sbjct: 219 G 219

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 150 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 209 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 14/196 (7%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++   + + +   KL++         S     E   +A      +V++   F 
Sbjct: 86  GAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 145
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D+ ++++ E++  G L +L+   D   +W+         A+ +  L   +   L+HR+V
Sbjct: 146 DDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA-----KFYTAEVVLALDAIHSMGLIHRDV 200
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA----Q 764
           K  N+LLD     KL DF     + E        +      Y +PE   S+        +
Sbjct: 201 KPDNMLLDKHGHLKLADFGTCMKMDETGMVHC-DTAVGTPDYISPEVLKSQGGDGYYGRE 259
Query: 765 MDAYSFGVVLLELITG 780
            D +S GV L E++ G
Sbjct: 260 CDWWSVGVFLFEMLVG 275

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 44/284 (15%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 29  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 88
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 89  GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 147
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 148 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 204
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 205 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 258
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 259 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 294

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 13/165 (7%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +IRH NI+ +   F +   + LI E +  G L D +  ++  L    
Sbjct: 72  SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDE 130
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFAL-DRIVGEA 735
             +    +  G+ YLH   + H    ++K +NI+L     P    KL DF +  +I    
Sbjct: 131 ATQFLKQILDGVHYLHSKRIAHF---DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN 187
Query: 736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            F++     +    + APE    +    + D +S GV+   L++G
Sbjct: 188 EFKNI----FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +S+    +   +  L 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 106 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 164
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 165 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 105 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 164 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 106 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 164
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 165 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 593 GPFGRVYILS-LPSGELIAVKKL-VNFGCQSSKTLKTEVK-TLAKIRHKNIVKVLGFFHS 649
           G +G V  +  +PSG+++AVK++      Q  K L  ++  ++  +     V   G    
Sbjct: 62  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 121
Query: 650 DESIFLIYEFLQ--MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           +  +++  E +   +      +  +   +   I  KIA+ + + L +LH      ++HR+
Sbjct: 122 EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRD 179
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY--------GYSK 759
           VK  N+L++A  + K+ DF +   + ++  ++    +     Y APE         GYS 
Sbjct: 180 VKPSNVLINALGQVKMCDFGISGYLVDSVAKTI---DAGCKPYMAPERINPELNQKGYSV 236
Query: 760 KATAQMDAYSFGVVLLELITGR 781
           K+    D +S G+ ++EL   R
Sbjct: 237 KS----DIWSLGITMIELAILR 254

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 150 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 208
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 209 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 106 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 164
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 165 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 113 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 172 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 14/178 (7%)
Query: 608 LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF--LIYEFLQMGSL 665
           ++ V K+ ++  + S+    E   L    H N++ VLG   S  +    LI  +   GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSL 96
Query: 666 GDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
            +++    +F +  S  +K A+  A+G A+LH    P +    + S+++ +D D   +++
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSRSVXIDEDXTARIS 155
Query: 725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ---MDAYSFGVVLLELIT 779
              +     + +FQS     YA   + APE    K         D +SF V+L EL+T
Sbjct: 156 XADV-----KFSFQSP-GRXYA-PAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 156
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ +L        +HR++ ++NILL      K+ DF L R + +             
Sbjct: 157 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG 807
             + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++     
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGT 268
Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 269 RMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 303

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 112 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 170
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 171 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 111 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 169
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 170 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 8/176 (4%)
Query: 609 IAVKKLVN-FGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG 666
           +A+KKL   F  Q+ +K    E+  +  + HKNI+ +L  F   +++    +   +  L 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF 726
           D    Q  Q++     +++  + Q L  +   +   ++HR++K  NI++ +D   K+ DF
Sbjct: 113 DANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171
Query: 727 ALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            L R  G     S M + Y ++  Y APE          +D +S G ++ E++  +
Sbjct: 172 GLARTAG----TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G GG FG V+   +  +G+L A KKL     +  K  +    E K LAK+  + IV +  
Sbjct: 194 GRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQD-----FQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F +   + L+   +  G +   I   D     FQ   +I     I    GL +LH+   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQR-- 308
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
            ++++R++K +N+LLD D   +++D  L   V   A Q+          + APE    ++
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 761 ATAQMDAYSFGVVLLELITGR 781
               +D ++ GV L E+I  R
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +GL +LH   V   +HR++K +NIL+ +  + KL DF L RI    +FQ  ++S      
Sbjct: 131 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 184
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLEL 777
           Y APE          +D +S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +GL +LH   V   +HR++K +NIL+ +  + KL DF L RI    +FQ  ++S      
Sbjct: 131 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 184
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLEL 777
           Y APE          +D +S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 81/198 (40%), Gaps = 24/198 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL-----KTEVKTLAKIRHKNIVKVLGFF 647
           G FG V+ +           K   F C   K         E+   A +    IV + G  
Sbjct: 104 GSFGEVHRME---------DKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAV 154
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-QGLAYLHKDYVPHLLHR 706
                + +  E L+ GSLG L+  Q    +   R    +G A +GL YLH   +   LH 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPE--DRALYYLGQALEGLEYLHSRRI---LHG 209
Query: 707 NVKSKNILLDAD-FEPKLTDFALDRIVGEAAF-QSTMSSEY--ALSCYNAPEYGYSKKAT 762
           +VK+ N+LL +D     L DF     +      +S ++ +Y      + APE    +   
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCD 269
Query: 763 AQMDAYSFGVVLLELITG 780
           A++D +S   ++L ++ G
Sbjct: 270 AKVDVWSSCCMMLHMLNG 287

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 34/228 (14%)
Query: 632 LAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ 690
           ++K+ HK++V   G  F  DE+I L+ EF++ GSL   + +    +    +L++A  +A 
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENI-LVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAW 124
Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDADFEP--------KLTDFALDRIVGEAAFQSTMS 742
            + +L ++    L+H NV +KNILL  + +         KL+D  +   V          
Sbjct: 125 AMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
                 C   P     K      D +SFG  L E+ +G      +P  +LD     +RK+
Sbjct: 182 PWVPPECIENP-----KNLNLATDKWSFGTTLWEICSGGD----KPLSALD----SQRKL 228
Query: 803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                  Q+  PK A            +   C    P+ RPS   +++
Sbjct: 229 QFYEDRHQLPAPKAAELAN--------LINNCMDYEPDHRPSFRAIIR 268

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G GG FG V+   +  +G+L A KKL     +  K  +    E K LAK+  + IV +  
Sbjct: 194 GRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQD-----FQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F +   + L+   +  G +   I   D     FQ   +I     I    GL +LH+   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQR-- 308
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
            ++++R++K +N+LLD D   +++D  L   V   A Q+          + APE    ++
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 761 ATAQMDAYSFGVVLLELITGR 781
               +D ++ GV L E+I  R
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +GL +LH   V   +HR++K +NIL+ +  + KL DF L RI    +FQ  ++S      
Sbjct: 131 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLW 184
Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLEL 777
           Y APE          +D +S G +  E+
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G GG FG V+   +  +G+L A KKL     +  K  +    E K LAK+  + IV +  
Sbjct: 194 GRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQD-----FQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F +   + L+   +  G +   I   D     FQ   +I     I    GL +LH+   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQR-- 308
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
            ++++R++K +N+LLD D   +++D  L   V   A Q+          + APE    ++
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 761 ATAQMDAYSFGVVLLELITGR 781
               +D ++ GV L E+I  R
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 590 GNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G GG FG V+   +  +G+L A KKL     +  K  +    E K LAK+  + IV +  
Sbjct: 194 GRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQD-----FQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            F +   + L+   +  G +   I   D     FQ   +I     I    GL +LH+   
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI--VSGLEHLHQR-- 308
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
            ++++R++K +N+LLD D   +++D  L   V   A Q+          + APE    ++
Sbjct: 309 -NIIYRDLKPENVLLDDDGNVRISDLGL--AVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 761 ATAQMDAYSFGVVLLELITGR 781
               +D ++ GV L E+I  R
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 29  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 88
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 89  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 147
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ +L        +HR++ ++NILL      K+ DF L R + +             
Sbjct: 148 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG 807
             + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++     
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGT 259
Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 260 RMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 294

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 29  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 88
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 89  GACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 147
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ +L        +HR++ ++NILL      K+ DF L R + +             
Sbjct: 148 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 204
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG 807
             + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++     
Sbjct: 205 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGT 259
Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 260 RMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 294

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 113/283 (39%), Gaps = 42/283 (14%)
Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L      S  + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97
Query: 645 GFFHSDES-IFLIYEFLQMGSLGDLI----------------CRQDFQLQWSIRLKIAIG 687
           G        + +I EF + G+L   +                  +DF L     +  +  
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF-LTLEHLICYSFQ 156
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           VA+G+ +L        +HR++ ++NILL      K+ DF L R + +             
Sbjct: 157 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLP 213
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG 807
             + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++     
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EGT 268
Query: 808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 269 RMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 303

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Composition-based stats.
 Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 608 LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF--LIYEFLQMGSL 665
           ++ V K+ ++  + S+    E   L    H N++ VLG   S  +    LI  ++  GSL
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96
Query: 666 GDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT 724
            +++    +F +  S  +K A+ +A+G+A+LH    P +    + S+++++D D   +++
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARIS 155
Query: 725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ---MDAYSFGVVLLELIT 779
                  + +  F            + APE    K         D +SF V+L EL+T
Sbjct: 156 -------MADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDF--QLQWSIRLKIA 685
           E+  L+++ H NI+KVL  F +     L+ E  + GS  DL    D   +L   +   I 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
             +   + YL    +  ++HR++K +NI++  DF  KL DF      G AA+       Y
Sbjct: 137 RQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF------GSAAYLERGKLFY 187
Query: 746 ALSC---YNAPEYGYSKKATA-QMDAYSFGVVLLELI 778
                  Y APE          +++ +S GV L  L+
Sbjct: 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 33/284 (11%)
Query: 593 GPFGRVYILSLP-SGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIR------HKNIVKV 643
           G +G VY    P SG  +A+K  ++ N G        + V+ +A +R      H N+V++
Sbjct: 20  GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79
Query: 644 LGFFHSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           +    +  +     + L++E +       L       L       +     +GL +LH +
Sbjct: 80  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
            +   +HR++K +NIL+ +    KL DF L RI    ++Q  ++       Y APE    
Sbjct: 140 CI---VHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALTPVVVTLWYRAPEVLLQ 193
Query: 759 KKATAQMDAYSFGVVLLELITGR-----QAEQAEPAESLDVV------KWVRRKINITNG 807
                 +D +S G +  E+   +      +E  +  +  D++       W  R +++  G
Sbjct: 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRG 252
Query: 808 AIQVLDPKIANCYQQQM-LGALEIALRCTSVMPEKRPSMFEVVK 850
           A     P+       +M     ++ L   +  P KR S F  ++
Sbjct: 253 AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 29/175 (16%)
Query: 620 QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQW 678
           +S +    E++ L +  +H NI+ +   +   + ++++ E  + G L D I RQ F   +
Sbjct: 57  KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF---F 113
Query: 679 SIRLKIAI--GVAQGLAYLHKDYVPHLLHRNVKSKNIL-LDADFEP---KLTDFALDRIV 732
           S R   A+   + + + YLH   V   +HR++K  NIL +D    P   ++ DF      
Sbjct: 114 SEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFG----- 165
Query: 733 GEAAFQSTMSSEYAL---SCYNA----PEYGYSKKATAQMDAYSFGVVLLELITG 780
               F   + +E  L    CY A    PE    +   A  D +S GV+L   +TG
Sbjct: 166 ----FAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 593 GPFGRVYILS-LPSGELIAVKKL-VNFGCQSSKTLKTEVK-TLAKIRHKNIVKVLGFFHS 649
           G +G V  +  +PSG+++AVK++      Q  K L  ++  ++  +     V   G    
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77
Query: 650 DESIFLIYEFLQ--MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           +  +++  E +   +      +  +   +   I  KIA+ + + L +LH      ++HR+
Sbjct: 78  EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRD 135
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY--------GYSK 759
           VK  N+L++A  + K+ DF    I G          +     Y APE         GYS 
Sbjct: 136 VKPSNVLINALGQVKMCDFG---ISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192
Query: 760 KATAQMDAYSFGVVLLELITGR 781
           K+    D +S G+ ++EL   R
Sbjct: 193 KS----DIWSLGITMIELAILR 210

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 23/203 (11%)
Query: 593 GPFGRVYILSLPS-GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-- 649
           G FG V +    S G  +A+KK++      ++ L+  ++ LA + H NIV++  +F++  
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSYFYTLG 92
Query: 650 DESIFLIYEFLQMGSLGDLI---CRQDFQLQWS---IRLKIAI-GVAQGLAYLHKDYVPH 702
           +     IY  + M  + D +   CR  ++ Q +   I +K+ +  + + +  LH   V +
Sbjct: 93  ERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-N 151
Query: 703 LLHRNVKSKNILL-DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---YNAPEYGY- 757
           + HR++K  N+L+ +AD   KL DF      G A   S      A  C   Y APE  + 
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDF------GSAKKLSPSEPNVAYICSRYYRAPELIFG 205
Query: 758 SKKATAQMDAYSFGVVLLELITG 780
           ++  T  +D +S G +  E++ G
Sbjct: 206 NQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 592 GGPFGRVY------ILSLPSGELIAVKKLV-NFGCQSSKTLKTEVKTLAKI-RHKNIVKV 643
            G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +
Sbjct: 33  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92
Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS-----------------IRLKIAI 686
           LG         +I E+   G L + + R+      S                   L  + 
Sbjct: 93  LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      +   
Sbjct: 153 QVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT 805
              + APE  ++   T + D +S+G+ L EL + G       P +S        +   + 
Sbjct: 210 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------KFYKMI 261
Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++L P+ A     +M    +I   C    P KRP+  ++V+
Sbjct: 262 KEGFRMLSPEHA---PAEM---YDIMKTCWDADPLKRPTFKQIVQ 300

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 79/198 (39%), Gaps = 33/198 (16%)
Query: 605 SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFH--SDESIFLIYEFLQ 661
           +G+L A+K   N    +       E + L K+ HKNIVK+       +     LI EF  
Sbjct: 33  TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92
Query: 662 MGSLGDLICR--QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---- 715
            GSL  ++      + L  S  L +   V  G+ +L ++ +   +HRN+K  NI+     
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGE 149
Query: 716 DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY-------------GYSKKAT 762
           D     KLTDF         A +     E  +S Y   EY              + KK  
Sbjct: 150 DGQSVYKLTDF--------GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 763 AQMDAYSFGVVLLELITG 780
           A +D +S GV      TG
Sbjct: 202 ATVDLWSIGVTFYHAATG 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-------------K 638
           G FG+V    +       A+KK+ +   + S T+ +EV  LA + H             +
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYAAWLERR 75
Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           N VK +       ++F+  E+ +  +L DLI  ++   Q     ++   + + L+Y+H  
Sbjct: 76  NFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA------------AFQSTMSSEYA 746
            +   +HR++K  NI +D     K+ DF L + V  +                 ++S   
Sbjct: 136 GI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 747 LSCYNAPEY-GYSKKATAQMDAYSFGVVLLELI 778
            + Y A E    +     ++D YS G++  E+I
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 114/282 (40%), Gaps = 32/282 (11%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR------HKNIVKVLG 645
           G +G VY    P SG  +A+K +     +    + T V+ +A +R      H N+V+++ 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST-VREVALLRRLEAFEHPNVVRLMD 73
Query: 646 FFHSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
              +  +     + L++E +       L       L       +     +GL +LH + +
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
              +HR++K +NIL+ +    KL DF L RI    ++Q  ++       Y APE      
Sbjct: 134 ---VHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVVVTLWYRAPEVLLQST 187
Query: 761 ATAQMDAYSFGVVLLELITGR-----QAEQAEPAESLDVV------KWVRRKINITNGAI 809
               +D +S G +  E+   +      +E  +  +  D++       W  R +++  GA 
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGAF 246
Query: 810 QVLDPKIANCYQQQM-LGALEIALRCTSVMPEKRPSMFEVVK 850
               P+       +M     ++ L   +  P KR S F  ++
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 88/213 (41%), Gaps = 31/213 (14%)
Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-------------K 638
           G FG+V    +       A+KK+ +   + S T+ +EV  LA + H             +
Sbjct: 17  GAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVXLLASLNHQYVVRYYAAWLERR 75
Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           N VK         ++F+  E+ +  +L DLI  ++   Q     ++   + + L+Y+H  
Sbjct: 76  NFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ 135
Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA------------AFQSTMSSEYA 746
            +   +HRN+K  NI +D     K+ DF L + V  +                 ++S   
Sbjct: 136 GI---IHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 747 LSCYNAPEY-GYSKKATAQMDAYSFGVVLLELI 778
            + Y A E    +     ++D YS G++  E I
Sbjct: 193 TAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 592 GGPFGRVY------ILSLPSGELIAVKKLV-NFGCQSSKTLKTEVKTLAKI-RHKNIVKV 643
            G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +
Sbjct: 49  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 108
Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS-----------------IRLKIAI 686
           LG         +I E+   G L + + R+      S                   L  + 
Sbjct: 109 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 168
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      +   
Sbjct: 169 QVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT 805
              + APE  ++   T + D +S+G+ L EL + G       P +S        +   + 
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------KFYKMI 277
Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++L P+ A     +M    +I   C    P KRP+  ++V+
Sbjct: 278 KEGFRMLSPEHA---PAEM---YDIMKTCWDADPLKRPTFKQIVQ 316

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + ++I  KKL     +  + L+ E +   K++H NIV++      +   +L+++ +  G 
Sbjct: 58  AAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 114
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--- 721
           L + I  ++F  +      I   + + +AY H + +   +HRN+K +N+LL +  +    
Sbjct: 115 LFEDIVAREFYSEADASHCIQ-QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAV 170
Query: 722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           KL DF L   V ++      +       Y +PE       +  +D ++ GV+L  L+ G
Sbjct: 171 KLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/162 (21%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 625 LKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFLIYEFLQMG--SLGDLICRQDFQLQWSI 680
           +K E++ L ++RHKN+++++   +++E   ++++ E+   G   + D +  + F +  + 
Sbjct: 53  VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH 112
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST 740
                +    GL YLH   +   +H+++K  N+LL      K++   +   +   A   T
Sbjct: 113 GYFCQL--IDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 741 MSSEYALSCYNAPEY--GYSKKATAQMDAYSFGVVLLELITG 780
             +      +  PE   G    +  ++D +S GV L  + TG
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 18/213 (8%)
Query: 577 HDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR 636
           HD V    E       G FG+V              K+V    +  +    E++ L  +R
Sbjct: 92  HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR 151
Query: 637 HK------NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVA 689
            +      N++ +L  F     I + +E L M +L +LI +  FQ     +  K A  + 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYAL 747
           Q L  LHK+ +   +H ++K +NILL        K+ DF       +  +    S     
Sbjct: 211 QCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSR---- 263
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             Y APE     +    +D +S G +L EL+TG
Sbjct: 264 -FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 107/247 (43%), Gaps = 39/247 (15%)
Query: 568 FFYPLRVTEHDLVIGMD----EKSSAGNGGPFGRV-----YILSLPSGELIAVKKLVNFG 618
           F+   R  E+DL         E       G FG+V     Y +S     +    K++   
Sbjct: 27  FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK 86
Query: 619 CQSSK--TLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI--CRQD 673
             SS+   L +E+K + ++  H+NIV +LG       I+LI+E+   G L + +   R+ 
Sbjct: 87  ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREK 146
Query: 674 FQ--------------------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI 713
           F                     L +   L  A  VA+G+ +L        +HR++ ++N+
Sbjct: 147 FSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNV 203
Query: 714 LLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGV 772
           L+      K+ DF L R I+ ++ +    ++   +  + APE  +    T + D +S+G+
Sbjct: 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK-WMAPESLFEGIYTIKSDVWSYGI 262
Query: 773 VLLELIT 779
           +L E+ +
Sbjct: 263 LLWEIFS 269

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 18/213 (8%)
Query: 577 HDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR 636
           HD V    E       G FG+V              K+V    +  +    E++ L  +R
Sbjct: 92  HDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR 151
Query: 637 HK------NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVA 689
            +      N++ +L  F     I + +E L M +L +LI +  FQ     +  K A  + 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYAL 747
           Q L  LHK+ +   +H ++K +NILL        K+ DF       +  +    S     
Sbjct: 211 QCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSR---- 263
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             Y APE     +    +D +S G +L EL+TG
Sbjct: 264 -FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 18/213 (8%)
Query: 577 HDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR 636
           HD V    E       G FG+V              K+V    +  +    E++ L  +R
Sbjct: 92  HDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLR 151
Query: 637 HK------NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVA 689
            +      N++ +L  F     I + +E L M +L +LI +  FQ     +  K A  + 
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYAL 747
           Q L  LHK+ +   +H ++K +NILL        K+ DF       +  +    S     
Sbjct: 211 QCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSR---- 263
Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             Y APE     +    +D +S G +L EL+TG
Sbjct: 264 -FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 592 GGPFGRVY------ILSLPSGELIAVKKLV-NFGCQSSKTLKTEVKTLAKI-RHKNIVKV 643
            G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +
Sbjct: 51  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 110
Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS-----------------IRLKIAI 686
           LG         +I E+   G L + + R+      S                   L  + 
Sbjct: 111 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 170
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      +   
Sbjct: 171 QVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT 805
              + APE  ++   T + D +S+G+ L EL + G       P +S        +   + 
Sbjct: 228 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------KFYKMI 279
Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++L P+ A     +M    +I   C    P KRP+  ++V+
Sbjct: 280 KEGFRMLSPEHA---PAEM---YDIMKTCWDADPLKRPTFKQIVQ 318

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 80/198 (40%), Gaps = 24/198 (12%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL-----KTEVKTLAKIRHKNIVKVLGFF 647
           G FG V+ +           K   F C   K         E+   A +    IV + G  
Sbjct: 85  GSFGEVHRME---------DKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAV 135
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA-QGLAYLHKDYVPHLLHR 706
                + +  E L+ GSLG L+  Q    +   R    +G A +GL YLH   +   LH 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPE--DRALYYLGQALEGLEYLHSRRI---LHG 190
Query: 707 NVKSKNILLDAD-FEPKLTDFALDRIVGEAAF-QSTMSSEY--ALSCYNAPEYGYSKKAT 762
           +VK+ N+LL +D     L DF     +      +  ++ +Y      + APE    +   
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCD 250
Query: 763 AQMDAYSFGVVLLELITG 780
           A++D +S   ++L ++ G
Sbjct: 251 AKVDVWSSCCMMLHMLNG 268

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 592 GGPFGRVY------ILSLPSGELIAVKKLV-NFGCQSSKTLKTEVKTLAKI-RHKNIVKV 643
            G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS-----------------IRLKIAI 686
           LG         +I E+   G L + + R+      S                   L  + 
Sbjct: 116 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 175
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      +   
Sbjct: 176 QVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT 805
              + APE  ++   T + D +S+G+ L EL + G       P +S        +   + 
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------KFYKMI 284
Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++L P+ A     +M    +I   C    P KRP+  ++V+
Sbjct: 285 KEGFRMLSPEHA---PAEM---YDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 32/282 (11%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR------HKNIVKVLG 645
           G +G VY    P SG  +A+K +     +    + T V+ +A +R      H N+V+++ 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST-VREVALLRRLEAFEHPNVVRLMD 73
Query: 646 FFHSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
              +  +     + L++E +       L       L       +     +GL +LH + +
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
              +HR++K +NIL+ +    KL DF L RI    ++Q  +        Y APE      
Sbjct: 134 ---VHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVVVTLWYRAPEVLLQST 187
Query: 761 ATAQMDAYSFGVVLLELITGR-----QAEQAEPAESLDVV------KWVRRKINITNGAI 809
               +D +S G +  E+   +      +E  +  +  D++       W  R +++  GA 
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGAF 246
Query: 810 QVLDPKIANCYQQQM-LGALEIALRCTSVMPEKRPSMFEVVK 850
               P+       +M     ++ L   +  P KR S F  ++
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + ++I  KKL     +  + L+ E +   K++H NIV++      +   +L+++ +  G 
Sbjct: 35  AAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--- 721
           L + I  ++F  +      I   + + +AY H +    ++HRN+K +N+LL +  +    
Sbjct: 92  LFEDIVAREFYSEADASHCIQ-QILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAV 147
Query: 722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           KL DF L   V ++      +       Y +PE       +  +D ++ GV+L  L+ G
Sbjct: 148 KLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 43/285 (15%)
Query: 592 GGPFGRVY------ILSLPSGELIAVKKLV-NFGCQSSKTLKTEVKTLAKI-RHKNIVKV 643
            G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +
Sbjct: 56  AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 115
Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWS-----------------IRLKIAI 686
           LG         +I E+   G L + + R+      S                   L  + 
Sbjct: 116 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 175
Query: 687 GVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
            VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      +   
Sbjct: 176 QVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT 805
              + APE  ++   T + D +S+G+ L EL + G       P +S        +   + 
Sbjct: 233 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--------KFYKMI 284
Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++L P+ A     +M    +I   C    P KRP+  ++V+
Sbjct: 285 KEGFRMLSPEHA---PAEM---YDIMKTCWDADPLKRPTFKQIVQ 323

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 91/227 (40%), Gaps = 32/227 (14%)
Query: 632 LAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQG 691
           ++K+ HK++V   G     +   L+ EF++ GSL   + +    +    +L++A  +A  
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125
Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEP--------KLTDFALDRIVGEAAFQSTMSS 743
           + +L ++    L+H NV +KNILL  + +         KL+D  +   V           
Sbjct: 126 MHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
                C   P     K      D +SFG  L E+ +G      +P  +LD     +RK+ 
Sbjct: 183 WVPPECIENP-----KNLNLATDKWSFGTTLWEICSGGD----KPLSALD----SQRKLQ 229
Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                 Q+  PK A            +   C    P+ RPS   +++
Sbjct: 230 FYEDRHQLPAPKAAELAN--------LINNCMDYEPDHRPSFRAIIR 268

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++   S   +   KL++         S     E   +A      +V++   F 
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 139
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D  ++++ E++  G L +L+   D   +W+ R   A  V   L  +H       +HR+V
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHS---MGFIHRDV 194
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA---PEY---------- 755
           K  N+LLD     KL DF              M+ E  + C  A   P+Y          
Sbjct: 195 KPDNMLLDKSGHLKLADFGT---------CMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 756 --GYSKKATAQMDAYSFGVVLLELITG 780
             GY  +   + D +S GV L E++ G
Sbjct: 246 GDGYYGR---ECDWWSVGVFLYEMLVG 269

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 89/210 (42%), Gaps = 37/210 (17%)
Query: 593 GPFGRV-YILSLPSGELIAVKKLVN-FGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHS 649
           G +G V  ++  PSG+++AVK++ +    +  K L  ++  + +      IV+  G    
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92
Query: 650 DESIFLIYEFLQMG----------SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +   ++  E +              L D+I  +       I  KI +   + L +L ++ 
Sbjct: 93  EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEE-------ILGKITLATVKALNHLKENL 145
Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY---- 755
              ++HR++K  NILLD     KL DF    I G+       + +     Y APE     
Sbjct: 146 --KIIHRDIKPSNILLDRSGNIKLCDFG---ISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 756 ----GYSKKATAQMDAYSFGVVLLELITGR 781
               GY  ++    D +S G+ L EL TGR
Sbjct: 201 ASRQGYDVRS----DVWSLGITLYELATGR 226

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++   S   +   KL++         S     E   +A      +V++   F 
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 144
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D  ++++ E++  G L +L+   D   +W+ R   A  V   L  +H       +HR+V
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHS---MGFIHRDV 199
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA---PEY---------- 755
           K  N+LLD     KL DF              M+ E  + C  A   P+Y          
Sbjct: 200 KPDNMLLDKSGHLKLADFGT---------CMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 756 --GYSKKATAQMDAYSFGVVLLELITG 780
             GY  +   + D +S GV L E++ G
Sbjct: 251 GDGYYGR---ECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 82/207 (39%), Gaps = 36/207 (17%)
Query: 593 GPFGRVYILSLPSGELIAVKKLVN----FGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++   S   +   KL++         S     E   +A      +V++   F 
Sbjct: 85  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 144
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D  ++++ E++  G L +L+   D   +W+ R   A  V   L  +H       +HR+V
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHS---MGFIHRDV 199
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA---PEY---------- 755
           K  N+LLD     KL DF              M+ E  + C  A   P+Y          
Sbjct: 200 KPDNMLLDKSGHLKLADFGT---------CMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 250
Query: 756 --GYSKKATAQMDAYSFGVVLLELITG 780
             GY  +   + D +S GV L E++ G
Sbjct: 251 GDGYYGR---ECDWWSVGVFLYEMLVG 274

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 78/198 (39%), Gaps = 33/198 (16%)
Query: 605 SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFH--SDESIFLIYEFLQ 661
           +G+L A+K   N    +       E + L K+ HKNIVK+       +     LI EF  
Sbjct: 33  TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92
Query: 662 MGSLGDLICR--QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---- 715
            GSL  ++      + L  S  L +   V  G+ +L ++ +   +HRN+K  NI+     
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGE 149
Query: 716 DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY-------------GYSKKAT 762
           D     KLTDF         A +     E  +  Y   EY              + KK  
Sbjct: 150 DGQSVYKLTDF--------GAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYG 201
Query: 763 AQMDAYSFGVVLLELITG 780
           A +D +S GV      TG
Sbjct: 202 ATVDLWSIGVTFYHAATG 219

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + ++I  KKL     +  + L+ E +   K++H NIV++      +   +L+++ +  G 
Sbjct: 34  AAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 90
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--- 721
           L + I  ++F  +      I   + + +AY H + +   +HRN+K +N+LL +  +    
Sbjct: 91  LFEDIVAREFYSEADASHCIQ-QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAV 146
Query: 722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           KL DF L   V ++      +       Y +PE       +  +D ++ GV+L  L+ G
Sbjct: 147 KLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+   A +    IV + G       + +  E L+ GSLG LI +Q   L     L     
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQ 158
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVG-EAAFQSTMSSEY 745
             +GL YLH   +   LH +VK+ N+LL +D     L DF     +  +   +S ++ +Y
Sbjct: 159 ALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 746 --ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
                 + APE    K   A++D +S   ++L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 84/179 (46%), Gaps = 13/179 (7%)
Query: 605 SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS 664
           + ++I  KKL     +  + L+ E +   K++H NIV++      +   +L+++ +  G 
Sbjct: 35  AAKIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE 91
Query: 665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--- 721
           L + I  ++F  +      I   + + +AY H + +   +HRN+K +N+LL +  +    
Sbjct: 92  LFEDIVAREFYSEADASHCIQ-QILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAV 147
Query: 722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           KL DF L   V ++      +       Y +PE       +  +D ++ GV+L  L+ G
Sbjct: 148 KLADFGLAIEVNDSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+   A +    IV + G       + +  E L+ GSLG LI +Q   L     L     
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQ 172
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVG-EAAFQSTMSSEY 745
             +GL YLH   +   LH +VK+ N+LL +D     L DF     +  +   +S ++ +Y
Sbjct: 173 ALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 746 --ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
                 + APE    K   A++D +S   ++L ++ G
Sbjct: 230 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E+   A +    IV + G       + +  E L+ GSLG LI +Q   L     L     
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQ 174
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVG-EAAFQSTMSSEY 745
             +GL YLH   +   LH +VK+ N+LL +D     L DF     +  +   +S ++ +Y
Sbjct: 175 ALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 746 --ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
                 + APE    K   A++D +S   ++L ++ G
Sbjct: 232 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 30/145 (20%)
Query: 656 IYEFLQMGSLGDLICRQDFQLQWSIR------------LKIAIGVAQGLAYLHKDYVPHL 703
           +Y ++QM      +CR++    W  R            L I I +A+ + +LH      L
Sbjct: 134 VYLYIQMQ-----LCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GL 185
Query: 704 LHRNVKSKNILLDADFEPKLTDF----ALDRIVGEAAFQSTMSS------EYALSCYNAP 753
           +HR++K  NI    D   K+ DF    A+D+   E    + M +      +     Y +P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSP 245
Query: 754 EYGYSKKATAQMDAYSFGVVLLELI 778
           E  +    + ++D +S G++L EL+
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 188
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V  A +    + EY      APE   SK     +D +
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYL-----APEIILSKGYNKAVDWW 243
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 244 ALGVLIYEMAAG 255

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 17  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E ++ +  L D I  +   LQ  +       V + + + H   
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 134
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 135 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 186
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 639 NIVKVLGFF----HSDESIFLIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQG 691
           +IV +L  +    H    + +I E ++ G L   I     Q F  + +  +   IG A  
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA-- 140
Query: 692 LAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           + +LH     ++ HR+VK +N+L    + D   KLTDF   +   + A Q+   + Y   
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY--- 194
Query: 749 CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            Y APE    +K     D +S GV++  L+ G
Sbjct: 195 -YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 36/216 (16%)
Query: 590 GNGGPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF- 647
           G GG F  V ++  L  G   A+K+++    Q  +  + E        H NI++++ +  
Sbjct: 38  GEGG-FSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 648 ---HSDESIFLIYEFLQMGSLGDLICR--------QDFQLQWSIRLKIAIGVAQGLAYLH 696
               +    +L+  F + G+L + I R         + Q+ W     + +G+ +GL  +H
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGLEAIH 151
Query: 697 -KDYVPHLLHRNVKSKNILLDADFEPKLTDF-ALDR--IVGEAAFQS-TMSSEYALSC-- 749
            K Y     HR++K  NILL  + +P L D  ++++  I  E + Q+ T+    A  C  
Sbjct: 152 AKGYA----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 750 -YNAPEYGYSKKATA----QMDAYSFGVVLLELITG 780
            Y APE  +S ++      + D +S G VL  ++ G
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 60/282 (21%), Positives = 113/282 (40%), Gaps = 32/282 (11%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR------HKNIVKVLG 645
           G +G VY    P SG  +A+K +     +    + T V+ +A +R      H N+V+++ 
Sbjct: 15  GAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIST-VREVALLRRLEAFEHPNVVRLMD 73
Query: 646 FFHSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
              +  +     + L++E +       L       L       +     +GL +LH + +
Sbjct: 74  VCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 133
Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK 760
              +HR++K +NIL+ +    KL DF L RI    ++Q  +        Y APE      
Sbjct: 134 ---VHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLLQST 187
Query: 761 ATAQMDAYSFGVVLLELITGR-----QAEQAEPAESLDVV------KWVRRKINITNGAI 809
               +D +S G +  E+   +      +E  +  +  D++       W  R +++  GA 
Sbjct: 188 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVSLPRGAF 246
Query: 810 QVLDPKIANCYQQQM-LGALEIALRCTSVMPEKRPSMFEVVK 850
               P+       +M     ++ L   +  P KR S F  ++
Sbjct: 247 PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 288

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E+   G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+++D     K+TDF L + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 639 NIVKVLGFF----HSDESIFLIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQG 691
           +IV +L  +    H    + +I E ++ G L   I     Q F  + +  +   IG A  
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA-- 121
Query: 692 LAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           + +LH     ++ HR+VK +N+L    + D   KLTDF   +   + A Q+   + Y   
Sbjct: 122 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY--- 175
Query: 749 CYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
            Y APE    +K     D +S GV++  L+ G
Sbjct: 176 -YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/206 (22%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 593 GPFGRVYILSLP-SGELIAVK---KLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V +     + EL A+K   K V       +    E + LA + +   + ++   F
Sbjct: 30  GSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCF 89
Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            + + ++ + E++  G L   I +Q  + +    +  A  ++ GL +LHK     +++R+
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISIGLFFLHKR---GIIYRD 145
Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGYSKKATAQMD 766
           +K  N++LD++   K+ DF + +   E       + E+     Y APE    +     +D
Sbjct: 146 LKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVD 202
Query: 767 AYSFGVVLLELITGRQAEQAEPAESL 792
            +++GV+L E++ G+     E  + L
Sbjct: 203 WWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLI----------YEFLQMGSLGDLICRQDFQLQ 677
           E + L K+  + +V +   + + +++ L+          +    MG  G    R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF--- 290
Query: 678 WSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF 737
                  A  +  GL  LH++    +++R++K +NILLD     +++D  L   V E   
Sbjct: 291 ------YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 339
Query: 738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
             T+        Y APE   +++ T   D ++ G +L E+I G+
Sbjct: 340 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 168
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 223
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 224 ALGVLIYEMAAG 235

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 71/164 (43%), Gaps = 25/164 (15%)
Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLI----------YEFLQMGSLGDLICRQDFQLQ 677
           E + L K+  + +V +   + + +++ L+          +    MG  G    R  F   
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF--- 290
Query: 678 WSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF 737
                  A  +  GL  LH++    +++R++K +NILLD     +++D  L   V E   
Sbjct: 291 ------YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-- 339
Query: 738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
             T+        Y APE   +++ T   D ++ G +L E+I G+
Sbjct: 340 -QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E+   G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+++D     K+TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 352 QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI 411
           +L Q+ +D    T    Q  G++  L     S N    SLP      P ++++++S N +
Sbjct: 56  RLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL 112
Query: 412 SG-QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK 470
           +   +  L+   +L  L L  N L    P  L   P L  L L++NNLT  +P GL N  
Sbjct: 113 TSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLN-- 169
Query: 471 LALFNVSFNKLSGRVPYSLISG------LPASYLQGNPGLC 505
             L N+    L     Y++  G      LP ++L GNP LC
Sbjct: 170 -GLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/148 (26%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 637 HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH 696
           H NIVK+   FH     FL+ E L  G L + I ++      +    I   +   ++++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 697 KDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
              V   +HR++K +N+L    + + E K+ DF   R+      Q   +  + L  Y AP
Sbjct: 124 DVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLH-YAAP 178
Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGR 781
           E           D +S GV+L  +++G+
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 73  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 132
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 133 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 188
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 189 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 243
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 244 ALGVLIYEMAAG 255

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Composition-based stats.
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 32/172 (18%)
Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDES-------IFLIYEFLQMGSLGDLICRQDFQ 675
           +  K E + L  ++H NIV+   F+ S ES       I L+ E    G+L   + R  F+
Sbjct: 70  QRFKEEAEXLKGLQHPNIVR---FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKR--FK 124
Query: 676 LQWSIRLKIAIG----VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI 731
           +    ++K+       + +GL +LH    P ++HR++K  NI +        T       
Sbjct: 125 VX---KIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFI--------TGPTGSVK 172
Query: 732 VGEAAFQSTMSSEYALSCYNAPEYG----YSKKATAQMDAYSFGVVLLELIT 779
           +G+    +   + +A +    PE+     Y +K    +D Y+FG   LE  T
Sbjct: 173 IGDLGLATLKRASFAKAVIGTPEFXAPEXYEEKYDESVDVYAFGXCXLEXAT 224

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 114
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 168
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 42/229 (18%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI-----VKVLGF 646
           G FGRV +   + + +  AVK + N   + +++ K E   L KI++ +I     VK  G 
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104
Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           F   + + LI+E L   SL ++I R +   F ++  I+L   I + + L YL K     L
Sbjct: 105 FMYYDHMCLIFEPLG-PSLYEIITRNNYNGFHIE-DIKL-YCIEILKALNYLRK---MSL 158
Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ----------------STMSSEYAL 747
            H ++K +NILLD  +  K +   + R+      Q                +T  S+Y  
Sbjct: 159 THTDLKPENILLDDPYFEK-SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217
Query: 748 SC-----YNAPEYGYSKKATAQMDAYSFGVVLLELITG----RQAEQAE 787
           S      Y APE   +       D +SFG VL EL TG    R  E  E
Sbjct: 218 SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 38  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 97
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 98  DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 153
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 154 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYL-----APEIILSKGYNKAVDWW 208
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 209 ALGVLIYEMAAG 220

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 168
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 223
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 224 ALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     K+ DF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 53  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 112
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 113 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 168
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 169 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYL-----APEIILSKGYNKAVDWW 223
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 224 ALGVLIYEMAAG 235

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 56  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 114
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 168
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     K+ DF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 257 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 310
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 311 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 346

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR-IVGEAAFQSTMSSEYA 746
           VA+G+ +L        +HR++ ++NILL      K+ DF L R I  +  +     +   
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 747 LSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           L  + APE  + +  T Q D +SFGV+L E+ +      A P   + + +   R++    
Sbjct: 259 LK-WMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRLK-EG 312
Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             ++  D      YQ          L C    P +RP+  E+V+
Sbjct: 313 TRMRAPDYTTPEMYQTM--------LDCWHGEPSQRPTFSELVE 348

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 73/164 (44%), Gaps = 11/164 (6%)
Query: 621 SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSI 680
           S + ++ EV  L +I+H N++ +   + +   + LI E +  G L D +  ++  L    
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEE 115
Query: 681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAA 736
             +    +  G+ YLH   + H    ++K +NI+L     P    K+ DF L   +    
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHF---DLKPENIMLLDRNVPKPRIKIIDFGLAHKID--- 169
Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG 780
           F +   + +    + APE    +    + D +S GV+   L++G
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 46  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 163
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 164 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 47  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 106
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 107 DNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 162
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 163 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 217
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 218 ALGVLIYEMAAG 229

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 609 IAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF--HSDESI---FLIYEFLQ 661
           +AVK  KL N   +  +   +E   +    H N++++LG     S + I    +I  F++
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 662 MGSLGDLICRQDFQ-----LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD 716
            G L   +     +     +     LK  + +A G+ YL      + LHR++ ++N +L 
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLR 181
Query: 717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLE 776
            D    + DF L + +    +            + A E    +  T++ D ++FGV + E
Sbjct: 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 241
Query: 777 LIT 779
           + T
Sbjct: 242 IAT 244

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E+   G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+++D     K+TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 46  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 163
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 164 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 45  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 162
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 163 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 33  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 150
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 151 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 202
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/192 (23%), Positives = 86/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++  + +G   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E+   G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+++D     ++TDF L + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 46  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 163
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 164 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 215
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 46/192 (23%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 593 GPFGRVYILS-LPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLGFFH 648
           G FGRV ++    SG   A+K L        K ++    E + L  +    +VK+   F 
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ E++  G +   + R     +   R   A  +     YLH      L++R++
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLHS---LDLIYRDL 167
Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           K +N+L+D     ++TDF   + V    +    + EY      APE   SK     +D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYL-----APEIILSKGYNKAVDWW 222
Query: 769 SFGVVLLELITG 780
           + GV++ E+  G
Sbjct: 223 ALGVLIYEMAAG 234

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 45  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 162
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 163 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 590 GNGGPFGRVYILSLPSGEL-IAVK-----KLVNFGCQSSKT-LKTEVKTLAKIR--HKNI 640
           G+GG FG VY     S  L +A+K     ++ ++G   + T +  EV  L K+      +
Sbjct: 45  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
           +++L +F   +S  LI E  + +  L D I  +   LQ  +       V + + + H   
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCG 162
Query: 700 VPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-G 756
           V   LHR++K +NIL+D +  E KL DF        A  + T+ +++     Y+ PE+  
Sbjct: 163 V---LHRDIKDENILIDLNRGELKLIDFG-----SGALLKDTVYTDFDGTRVYSPPEWIR 214
Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y +        +S G++L +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	876
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-115
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-99
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-29
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-71
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	7e-70
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-69
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-66
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-62
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-59
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-34
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-29
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-60
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-56
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-43
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-53
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-44
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-46
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-42
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-40
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-44
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-41
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-34
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-39
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-22
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-16
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-40
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-39
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	5e-39
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-38
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-37
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-31
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	9e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-36
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-35
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-33
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-35
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-33
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-32
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-25
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-23
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-21
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-33
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-09
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-29
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-31
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-28
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-27
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-26
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-07
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-29
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-21
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-12
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-28
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-28
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-26
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-24
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-20
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-25
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-15
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	7e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-20
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-20
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-16
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-23
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-23
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-23
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-22
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-21
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-21
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-21
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-19
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-12
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-20
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-20
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-19
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-08
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-18
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-10
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-20
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-20
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	8e-20
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	8e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-18
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-06
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-19
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-19
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-19
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-17
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-11
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-07
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-19
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-18
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-18
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-18
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-18
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-18
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-18
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-04
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-18
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-09
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-17
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-17
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-17
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-17
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-05
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-16
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-16
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	7e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-16
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-16
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-15
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-07
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	7e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	8e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	9e-15
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-14
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-14
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-14
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-13
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-05
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-14
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-13
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-13
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-05
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-13
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-13
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	5e-05
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-06
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-12
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-12
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-05
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-10
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-10
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	6e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-08
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-04
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-08
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-08
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	9e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-07
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	7e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  368 bits (946), Expect = e-115
 Identities = 153/521 (29%), Positives = 228/521 (43%), Gaps = 62/521 (11%)

Query: 20  TFFAFTSAS--TEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTV 77
           +F A  S S   E   L+SFK  + D  N L  WS+  N   C + GVTC      S+ +
Sbjct: 1   SFQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNKN--PCTFDGVTCRDDKVTSIDL 57

Query: 78  ASIN-----------------LQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQPI 115
           +S                   L+SL LS     G +S      +SL++L+L+ N  + P+
Sbjct: 58  SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPV 116

Query: 116 P--LHLSQCSSLETLNLSNNLI---------------WVLDLSRNHIEGKIPESI---GS 155
                L  CS L+ LN+S+N +                VLDLS N I G           
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDG 176

Query: 156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS 215
              L+ L +  N +SG V         L  LD+S N    + IP  +G    L+ L +  
Sbjct: 177 CGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSN-NFSTGIPF-LGDCSALQHLDISG 232

Query: 216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI 275
           +   G    +      L +L++S N   G +P      L  L    +++NK +G  P+ +
Sbjct: 233 NKLSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPLKSLQYLSLAENKFTGEIPDFL 289

Query: 276 C-KANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFP-DKLWSLPRIKLIR 333
               + L  L L  N F G++P     C  LE   +  N FSG+ P D L  +  +K++ 
Sbjct: 290 SGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLD 349

Query: 334 AESNRFSGAIPDSIS-MAAQLEQVQIDNNRFTSSIPQGLGSV--KSLYRFSASQNSFYGS 390
              N FSG +P+S++ ++A L  + + +N F+  I   L      +L       N F G 
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 391 LPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLT 449
           +PP   +   +  ++LS N +SG IP  L    KL  L L  N L GEIP  L  +  L 
Sbjct: 410 IPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLE 469

Query: 450 YLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYSL 489
            L L  N+LTG IP GL N   L   ++S N+L+G +P  +
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI 510

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  325 bits (835), Expect = 5e-99
 Identities = 114/431 (26%), Positives = 194/431 (45%), Gaps = 26/431 (6%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--- 135
            +++ S N S  I   + + S+L +L+++ N  +      +S C+ L+ LN+S+N     
Sbjct: 204 FLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 136 ---------WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                      L L+ N   G+IP+ + G+   L  L+L  N   G+VP  FG+ S L  
Sbjct: 263 IPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322

Query: 186 LDLSQNAYLISEIPSD-IGKLEKLEQLFLQSSGFHGVIPDSFVGL-QSLSILDLSQNNLT 243
           L LS N     E+P D + K+  L+ L L  + F G +P+S   L  SL  LDLS NN +
Sbjct: 323 LALSSNN-FSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFS 381

Query: 244 GEVPQSLGSSLLK-LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINEC 302
           G +  +L  +    L    +  N  +G  P  +   + LV+L L  N+ +G+IP S+   
Sbjct: 382 GPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441

Query: 303 LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNR 362
             L   ++  N   G+ P +L  +  ++ +  + N  +G IP  +S    L  + + NNR
Sbjct: 442 SKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNR 501

Query: 363 FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKC 421
            T  IP+ +G +++L     S NSF G++P    D   +  ++L+ N  +G IP  + K 
Sbjct: 502 LTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQ 561

Query: 422 RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN--NLTGPIPQGLQNL-KLALFNVSF 478
               S  +A N + G+    +    +      + N     G   + L  L      N++ 
Sbjct: 562 ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617

Query: 479 NKLSGRVPYSL 489
               G    + 
Sbjct: 618 RVYGGHTSPTF 628

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  286 bits (733), Expect = 2e-84
 Identities = 122/454 (26%), Positives = 184/454 (40%), Gaps = 70/454 (15%)

Query: 79  SINLQSL-----NLSGEISSSVCE--LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLS 131
           S +L +L     N SG I  ++C+   ++L  L L +N F   IP  LS CS L      
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELV----- 421

Query: 132 NNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
                 L LS N++ G IP S+GSL  L+ L L  N+L G +P        L  L L  N
Sbjct: 422 -----SLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476

Query: 192 AYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG 251
             L  EIPS +     L  + L ++   G IP     L++L+IL LS N+ +G +P  LG
Sbjct: 477 -DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELG 535

Query: 252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ 311
                L+  D++ N  +G+ P  + K +G     +  NF  G     I      +     
Sbjct: 536 D-CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGA 590

Query: 312 DNG--FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQ 369
            N   F G   ++L  L         S  + G    +      +  + +  N  +  IP+
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650

Query: 370 GLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSL 429
            +GS+  L+  +   N   GS+P    D   ++I++LS N +                  
Sbjct: 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD----------------- 693

Query: 430 ADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSL 489
                 G IP +++ L +LT +DLS+NNL+GPIP+  Q                      
Sbjct: 694 ------GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ---------------------- 725

Query: 490 ISGLPASYLQGNPGLCGPGLSNSCDENQPKHRTS 523
               P +    NPGLCG  L      N   +   
Sbjct: 726 FETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHH 759

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  159 bits (405), Expect = 1e-40
 Identities = 58/295 (19%), Positives = 104/295 (35%), Gaps = 53/295 (17%)

Query: 203 GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV 262
            K+  ++      +     +  S + L  L  L LS +++ G V          L S D+
Sbjct: 50  DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF--KCSASLTSLDL 107

Query: 263 SQNKLSGSFPNG--ICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFP 320
           S+N LSG       +   +GL  L++  N  +     S                      
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSG--------------------- 146

Query: 321 DKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRF 380
                L  ++++   +N  SGA      +                           L   
Sbjct: 147 --GLKLNSLEVLDLSANSISGANVVGWVL---------------------SDGCGELKHL 183

Query: 381 SASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPP 440
           + S N   G +         +  +++S N+ S  IP L  C  L  L ++ N L+G+   
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241

Query: 441 SLAELPVLTYLDLSDNNLTGPIPQG-LQNLKLALFNVSFNKLSGRVPYSLISGLP 494
           +++    L  L++S N   GPIP   L++L+    +++ NK +G +P  L     
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPLPLKSLQ--YLSLAENKFTGEIPDFLSGACD 294

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  125 bits (315), Expect = 1e-29
 Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 35/176 (19%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
                      L   G  S  +  LS+ +  N+   ++            S+  L     
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFL----- 637

Query: 134 LIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY 193
                D+S N + G IP+ IGS+  L +LNLG N +SGS+P   G+   L +LDLS N  
Sbjct: 638 -----DMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK- 691

Query: 194 LISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS 249
                                     G IP +   L  L+ +DLS NNL+G +P+ 
Sbjct: 692 ------------------------LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  236 bits (604), Expect = 5e-71
 Identities = 88/277 (31%), Positives = 149/277 (53%), Gaps = 23/277 (8%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGFFH 648
           G GG FG+VY   L  G L+AVK+L     Q  +   +TEV+ ++   H+N++++ GF  
Sbjct: 39  GRGG-FGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97

Query: 649 SDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +     L+Y ++  GS+   +         L W  R +IA+G A+GLAYLH    P ++H
Sbjct: 98  TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIH 157

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEA------AFQSTMSSEYALSCYNAPEYGYSK 759
           R+VK+ NILLD +FE  + DF L +++         A + T+        + APEY  + 
Sbjct: 158 RDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI-------GHIAPEYLSTG 210

Query: 760 KATAQMDAYSFGVVLLELITGRQA---EQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
           K++ + D + +GV+LLELITG++A    +    + + ++ WV + +        ++D  +
Sbjct: 211 KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV-KGLLKEKKLEALVDVDL 269

Query: 817 ANCY-QQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
              Y  +++   +++AL CT   P +RP M EVV+ L
Sbjct: 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  233 bits (596), Expect = 7e-70
 Identities = 95/276 (34%), Positives = 153/276 (55%), Gaps = 14/276 (5%)

Query: 584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           D K   G+G  FG+VY   L  G  +A+K+      Q  +  +TE++TL+  RH ++V +
Sbjct: 42  DHKFLIGHGV-FGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSL 100

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ---LQWSIRLKIAIGVAQGLAYLHKDYV 700
           +GF      + LIY++++ G+L   +   D     + W  RL+I IG A+GL YLH   +
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSK 759
              +HR+VKS NILLD +F PK+TDF + +  G    Q+ +S+    +  Y  PEY    
Sbjct: 161 ---IHRDVKSINILLDENFVPKITDFGISKK-GTELDQTHLSTVVKGTLGYIDPEYFIKG 216

Query: 760 KATAQMDAYSFGVVLLELITGRQA-EQAEPAESLDVVKWVRRKINITNGAI-QVLDPKIA 817
           + T + D YSFGVVL E++  R A  Q+ P E +++ +W     N  NG + Q++DP +A
Sbjct: 217 RLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN--NGQLEQIVDPNLA 274

Query: 818 NCY-QQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           +    + +    + A++C ++  E RPSM +V+  L
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  231 bits (591), Expect = 2e-69
 Identities = 91/281 (32%), Positives = 141/281 (50%), Gaps = 27/281 (9%)

Query: 590 GNGGPFGRVY--ILSLPSGELIAVKKLVNFGCQSS----KTLKTEVKTLAKIRHKNIVKV 643
           G GG FG VY   ++      +AVKKL      ++    +    E+K +AK +H+N+V++
Sbjct: 40  GEGG-FGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 644 LGFFHSDESIFLIYEFLQMGSLGD-LICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVP 701
           LGF    + + L+Y ++  GSL D L C      L W +R KIA G A G+ +LH++   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN--- 152

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE----YALSCYNAPEYGY 757
           H +HR++KS NILLD  F  K++DF L R   + A Q+ M+S      A   Y APE   
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA-QTVMTSRIVGTTA---YMAPEA-L 207

Query: 758 SKKATAQMDAYSFGVVLLELITGRQA-EQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
             + T + D YSFGVVLLE+ITG  A ++    + L  +       +        +D K+
Sbjct: 208 RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--LDIKEEIEDEEKTIEDYIDKKM 265

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
            +     +     +A +C      KRP + +V + L  ++ 
Sbjct: 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  223 bits (570), Expect = 3e-66
 Identities = 83/369 (22%), Positives = 133/369 (36%), Gaps = 61/369 (16%)

Query: 28  STEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNL 87
             +K  LL  K  + +   +LS+W  T++     W GV C  T T +  V +++L  LNL
Sbjct: 5   PQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLC-DTDTQTYRVNNLDLSGLNL 62

Query: 88  SGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEG 147
                                     PIP  L+    L  L +            N++ G
Sbjct: 63  PKPY----------------------PIPSSLANLPYLNFLYIGGI---------NNLVG 91

Query: 148 KIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEK 207
            IP +I  L  L  L +    +SG++P        LV LD S NA               
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA--------------- 136

Query: 208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKL 267
                       G +P S   L +L  +    N ++G +P S GS      S  +S+N+L
Sbjct: 137 ----------LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186

Query: 268 SGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
           +G  P      N L  + L +N   G          N ++  +  N  + D   K+    
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK 244

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
            +  +   +NR  G +P  ++    L  + +  N     IPQG G+++     + + N  
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKC 303

Query: 388 YGSLPPNFC 396
               P   C
Sbjct: 304 LCGSPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  220 bits (562), Expect = 4e-65
 Identities = 83/398 (20%), Positives = 130/398 (32%), Gaps = 101/398 (25%)

Query: 115 IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP 174
           I   L   ++L +   +       D       G + ++      +  L+L    L    P
Sbjct: 14  IKKDLGNPTTLSSWLPTT------DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS-GFHGVIPDSFVGLQSLS 233
                                  IPS +  L  L  L++       G IP +   L  L 
Sbjct: 68  -----------------------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104

Query: 234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG 293
            L ++  N++G +P  L   +  LV+ D S N LSG+ P  I     LV ++   N  +G
Sbjct: 105 YLYITHTNVSGAIPDFLSQ-IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL 353
           +IP S      L                          +    NR +G IP + +    L
Sbjct: 164 AIPDSYGSFSKLFTS-----------------------MTISRNRLTGKIPPTFANL-NL 199

Query: 354 EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG 413
             V +  N          GS K+                           I+L++NS++ 
Sbjct: 200 AFVDLSRNMLEGDASVLFGSDKNT------------------------QKIHLAKNSLAF 235

Query: 414 QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLAL 473
            + ++   + L  L L +N + G +P  L +L  L  L++S NNL G IPQG        
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN------ 289

Query: 474 FNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSN 511
                           +     S    N  LCG  L  
Sbjct: 290 ----------------LQRFDVSAYANNKCLCGSPLPA 311

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  229 bits (586), Expect = 3e-65
 Identities = 54/421 (12%), Positives = 127/421 (30%), Gaps = 46/421 (10%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDL 140
           N +              L  L+++ + +      +P  L     ++ +N++ N    +  
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG--ISG 288

Query: 141 SRNHIEGKIPESIGSLVNLQVLNLGSN-LLSGSVPFVFGNFSELVVLDLSQNAYLISEIP 199
            +   + +          +Q++ +G N L +  V        +L +L+   N   +    
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQ--LEGKL 346

Query: 200 SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVS 259
              G   KL  L L  +    +  +     + +  L  + N L          S+  + +
Sbjct: 347 PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSA 406

Query: 260 FDVSQNKLSG-------SFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD 312
            D S N++                K   + +++L  N  +       +    L    +  
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466

Query: 313 NGFSG-------DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA--AQLEQVQIDNNRF 363
           N  +        D  +   +   +  I    N+ +  + D         L  + +  N F
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF 525

Query: 364 TSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCR 422
           +   P    +  +L  F                        +   N    + P  +  C 
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQ------------------RDAQGNRTLREWPEGITLCP 566

Query: 423 KLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGL-QNLKLALFNVSFNKL 481
            L  L +  N +   +   +   P ++ LD+ DN         +   ++  ++ + ++K 
Sbjct: 567 SLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

Query: 482 S 482
            
Sbjct: 624 Q 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  222 bits (568), Expect = 1e-62
 Identities = 75/485 (15%), Positives = 148/485 (30%), Gaps = 59/485 (12%)

Query: 46  NSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLN 105
              + W    N     W     V+  +    V  ++L+    SG +  ++ +L+ L  L 
Sbjct: 55  QPGANW--NFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLA 111

Query: 106 LADNLFNQP----IPLHLSQCSSLETLNLSNNLI----------------WVLDLSRNHI 145
           L  +          P  +S   S E                             ++ +  
Sbjct: 112 LGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQ 171

Query: 146 EGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKL 205
           +  I +S    +    +   SN ++  V       ++L    +  +   ++E   +  + 
Sbjct: 172 QKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSP-FVAENICEAWEN 229

Query: 206 EKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN 265
           E  E         +      +  L+ L+ +++       ++P  L  +L ++   +V+ N
Sbjct: 230 ENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACN 283

Query: 266 KL--------SGSFPNGICKANGLVNLSLHKN-FFNGSIPGSINECLNLERFQVQDNGFS 316
           +                      +  + +  N      +  S+ +   L   +   N   
Sbjct: 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLE 343

Query: 317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS-SIPQGLGSVK 375
           G       S  ++  +    N+ +    +      Q+E +   +N+           SV 
Sbjct: 344 G-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVS 402

Query: 376 SLYRFSASQNSFYG-------SLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSL 427
            +     S N            L P       +S INLS N IS    E       L S+
Sbjct: 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSI 462

Query: 428 SLADNSLTG-------EIPPSLAELPVLTYLDLSDNNLTG-PIPQGLQNL-KLALFNVSF 478
           +L  N LT        +   +     +LT +DL  N LT          L  L   ++S+
Sbjct: 463 NLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSY 522

Query: 479 NKLSG 483
           N  S 
Sbjct: 523 NSFSK 527

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  217 bits (555), Expect = 6e-61
 Identities = 62/469 (13%), Positives = 131/469 (27%), Gaps = 58/469 (12%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
              +    + S      I  S       + +    N     +   + + + L    + N+
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216

Query: 134 ---------LIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELV 184
                         +               +L +L  + + +      +P       E+ 
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ 276

Query: 185 VLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL-T 243
           +++++ N            +    EQL                  + + I+ +  NNL T
Sbjct: 277 LINVACN------------RGISGEQLKDD-----WQALADAPVGEKIQIIYIGYNNLKT 319

Query: 244 GEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECL 303
             V  SL   + KL   +   N+L G           L +L+L  N              
Sbjct: 320 FPVETSLQK-MKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377

Query: 304 NLERFQVQDNGFSGDFPDKL--WSLPRIKLIRAESNRFSG-------AIPDSISMAAQLE 354
            +E      N      P+     S+  +  I    N            +  +      + 
Sbjct: 378 QVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVS 436

Query: 355 QVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF-------YGSLPPNFCDSPVMSIINLS 407
            + + NN+ +    +   +   L   +   N               NF ++ +++ I+L 
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496

Query: 408 QNSISGQIPELK--KCRKLVSLSLADNSLTGEIPPSLAELPVLTYL------DLSDNNLT 459
            N ++    + +      LV + L+ NS +   P        L         D   N   
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 460 GPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP 507
              P+G+     L    +  N +   V   +   +    ++ NP +   
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDIKDNPNISID 603

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  219 bits (559), Expect = 4e-61
 Identities = 79/441 (17%), Positives = 149/441 (33%), Gaps = 38/441 (8%)

Query: 79  SINLQSLNLSG----EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL 134
           +++ +  + S     ++   +   ++++ LNL  N   +    + ++ S L         
Sbjct: 3   TVSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLT-------- 52

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
              LD+  N I    PE    L  L+VLNL  N LS      F   + L  L L  N  +
Sbjct: 53  --SLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSN-SI 109

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS-S 253
                +   K + L  L L  +G       + V L++L  L LS N +     + L   +
Sbjct: 110 QKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169

Query: 254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLN---LERFQV 310
              L   ++S N++    P        L  L L+      S+   +   L    +    +
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229

Query: 311 QDNGFSGDFPDKLWSLPRIKL--IRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP 368
            ++  S         L    L  +    N  +    DS +   QLE   ++ N       
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS 289

Query: 369 QGLGSVKSLYRFSASQNSFYGSLPPN---------FCDSPVMSIINLSQNSISGQIPE-L 418
             L  + ++   +  ++    S+            F     +  +N+  N I G      
Sbjct: 290 HSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMF 349

Query: 419 KKCRKLVSLSLADNSLTGEIPPSLA----ELPVLTYLDLSDNNLTGPIPQGLQNLK-LAL 473
                L  LSL+++  +     +          L  L+L+ N ++         L  L +
Sbjct: 350 TGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409

Query: 474 FNVSFNKLSGRVPYSLISGLP 494
            ++  N++   +      GL 
Sbjct: 410 LDLGLNEIGQELTGQEWRGLE 430

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  213 bits (544), Expect = 5e-59
 Identities = 77/416 (18%), Positives = 121/416 (29%), Gaps = 54/416 (12%)

Query: 81  NLQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           NL  L+LS        + S   L  L    L  N         L    ++  LNL  +  
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
               +S   +      S   L  L+ LN+  N + G    +F     L  L LS +   +
Sbjct: 309 K-QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSL 367

Query: 196 SEIPSDIGK---LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS 252
             + ++         L  L L  +    +  D+F  L  L +LDL  N +  E+      
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427

Query: 253 SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG--SIPGSINECLNLERFQV 310
            L  +    +S NK      N       L  L L +       S P       NL    +
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

Query: 311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG 370
            +N  +    D L  L                         +LE + + +N         
Sbjct: 488 SNNNIANINDDMLEGLE------------------------KLEILDLQHNNLARLWK-- 521

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSL 429
                         ++  G           + I+NL  N       E  K   +L  + L
Sbjct: 522 --------------HANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567

Query: 430 ADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLSG 483
             N+L             L  L+L  N +T    +        L   ++ FN    
Sbjct: 568 GLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  138 bits (349), Expect = 6e-34
 Identities = 60/261 (22%), Positives = 83/261 (31%), Gaps = 29/261 (11%)

Query: 81  NLQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNNL 134
            L  LNL+        S +   L  L  L+L  N   Q +         ++         
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF-------- 433

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG--SVPFVFGNFSELVVLDLSQNA 192
              + LS N        S   + +LQ L L    L    S P  F     L +LDLS N 
Sbjct: 434 --EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN- 490

Query: 193 YLISEIPSDIGKLEKLEQLFLQS--------SGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
            + +     +  LEKLE L LQ             G       GL  L IL+L  N    
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550

Query: 245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECL- 303
              +     L +L   D+  N L+    +       L +L+L KN               
Sbjct: 551 IPVEVFK-DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

Query: 304 NLERFQVQDNGFSGDFPDKLW 324
           NL    ++ N F        W
Sbjct: 610 NLTELDMRFNPFDCTCESIAW 630

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  123 bits (312), Expect = 2e-29
 Identities = 47/276 (17%), Positives = 91/276 (32%), Gaps = 36/276 (13%)

Query: 231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNF 290
           S  + D S   LT +VP  L +++  L   +++ N+L         + + L +L +  N 
Sbjct: 5   SHEVADCSHLKLT-QVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 291 FNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA 350
            +   P    +   L+   +Q N  S            +  +   SN       +     
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120

Query: 351 AQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
             L  + + +N  +S+       +++L                          + LS N 
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENL------------------------QELLLSNNK 156

Query: 411 ISGQIPE---LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ--- 464
           I     E   +     L  L L+ N +    P     +  L  L L++  L   + +   
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLC 216

Query: 465 -GLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQ 499
             L N  +   ++S ++LS     +   GL  + L 
Sbjct: 217 LELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNLT 251

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.7 bits (218), Expect = 6e-18
 Identities = 37/188 (19%), Positives = 58/188 (30%), Gaps = 37/188 (19%)

Query: 63  TGVTCVTTATASLTVASINLQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQPIPL 117
             V    +    L     NL  L+LS           +  L  L  L+L  N   +    
Sbjct: 467 KNVDSSPSPFQPLR----NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH 522

Query: 118 HLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF 177
                       LS+  + +L+L  N  +    E    L  L++++LG N L+     VF
Sbjct: 523 ANPGGPIYFLKGLSH--LHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580

Query: 178 GNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF-VGLQSLSILD 236
            N   L  L+L +N                             V    F    ++L+ LD
Sbjct: 581 NNQVSLKSLNLQKNL-------------------------ITSVEKKVFGPAFRNLTELD 615

Query: 237 LSQNNLTG 244
           +  N    
Sbjct: 616 MRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 9e-08
 Identities = 20/95 (21%), Positives = 33/95 (34%), Gaps = 11/95 (11%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
            +NL+S            +L  L  ++L  N  N       +   SL++LNL        
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK------ 593

Query: 139 DLSRNHIEGKIPESIG-SLVNLQVLNLGSNLLSGS 172
               N I     +  G +  NL  L++  N    +
Sbjct: 594 ----NLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  215 bits (550), Expect = 2e-60
 Identities = 81/472 (17%), Positives = 142/472 (30%), Gaps = 58/472 (12%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
            +   +     LN   +I  ++    S  NL+L+ N               L+ L+LS  
Sbjct: 6   VVPNITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC 62

Query: 134 LIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGN 179
            I                L L+ N I+     +   L +LQ L      L+    F  G+
Sbjct: 63  EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI----L 235
              L  L+++ N     ++P     L  LE L L S+    +       L  + +    L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA-NGLVNLSLHKNFFNGS 294
           DLS N +    P +     ++L    +  N  S +      +   GL    L    F   
Sbjct: 183 DLSLNPMNFIQPGAF--KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240

Query: 295 I---PGSINECLNLERFQVQDN------GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD 345
                   +    L    +++        +  D  D    L  +      S         
Sbjct: 241 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF 300

Query: 346 SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYR---------------------FSASQ 384
           S +     + +++ N +F       L S+K L                        S + 
Sbjct: 301 SYNF--GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 385 NSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPS-LA 443
            SF G    +   +  +  ++LS N +           +L  L    ++L      S   
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418

Query: 444 ELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLP 494
            L  L YLD+S  +           L  L +  ++ N         + + L 
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (538), Expect = 7e-59
 Identities = 89/459 (19%), Positives = 153/459 (33%), Gaps = 58/459 (12%)

Query: 81  NLQSLNLS-----GEISSSVCELSSLSNLNLADNLFNQ-PIPLHLSQCSSLETLNLSNNL 134
           +LQ L           +  +  L +L  LN+A NL     +P + S  ++LE L+LS+N 
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160

Query: 135 I------------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP-F 175
           I                    LDLS N +    P +   +  L  L L +N  S +V   
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219

Query: 176 VFGNFSELVVLDLSQNAY--LISEIPSDIGKLEKLEQLFLQS------SGFHGVIPDSFV 227
                + L V  L    +    +    D   LE L  L ++         +   I D F 
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLV------------------SFDVSQNKLSG 269
            L ++S   L    +      S       L                       + NK   
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 339

Query: 270 SFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRI 329
           +F      +   ++LS +   F G    S     +L+   +  NG           L ++
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQL 398

Query: 330 KLIRAESNRFSGAIPDSI-SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFY 388
           + +  + +        S+      L  + I +     +       + SL     + NSF 
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 389 GSLPPN-FCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELP 446
            +  P+ F +   ++ ++LSQ  +    P        L  L+++ N+           L 
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518

Query: 447 VLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLSG 483
            L  LD S N++     Q LQ+    LA  N++ N  + 
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  166 bits (422), Expect = 2e-43
 Identities = 74/411 (18%), Positives = 132/411 (32%), Gaps = 26/411 (6%)

Query: 79  SINLQSLNLSGEISSSVCE-LSSLSNLNLADNLF---NQPIPLHLSQCSSLETLNLSNNL 134
            + L++   S  +  +  + L+ L    L    F           S    L  L +    
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
           +  LD   +     I +    L N+   +L S  +     F +        L+L      
Sbjct: 264 LAYLDYYLD----DIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNC--K 315

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT--GEVPQSLGS 252
             + P+    L+ L++L    +   G    S V L SL  LDLS+N L+  G   QS   
Sbjct: 316 FGQFPTLK--LKSLKRLTF--TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 253 SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECL-NLERFQVQ 311
               L   D+S N +     +       L +L    +        S+   L NL    + 
Sbjct: 372 -TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI-PDSISMAAQLEQVQIDNNRFTSSIPQG 370
                  F      L  +++++   N F     PD  +    L  + +   +     P  
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPEL--KKCRKLVSLS 428
             S+ SL   + S N+F+      +     + +++ S N I     +        L  L+
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549

Query: 429 LADNSLTGEIPPS--LAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVS 477
           L  N           L  +     L +    +    P   Q + +   N++
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  197 bits (503), Expect = 6e-57
 Identities = 73/292 (25%), Positives = 124/292 (42%), Gaps = 27/292 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF----FH 648
           G FG V+  +    E +AVK       + S   + EV +L  ++H+NI++ +G       
Sbjct: 35  GRFGCVW-KAQLLNEYVAVKIF-PIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV-------P 701
            D  ++LI  F + GSL D +      + W+    IA  +A+GLAYLH+D         P
Sbjct: 93  VDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKP 150

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY-----G 756
            + HR++KSKN+LL  +    + DF L               +     Y APE       
Sbjct: 151 AISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN 210

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAE-SLDVVKWVRRKINITNGAIQV---- 811
           + + A  ++D Y+ G+VL EL +   A      E  L   + + +  ++ +    V    
Sbjct: 211 FQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK 270

Query: 812 LDPKIANCYQQ-QMLGAL-EIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
             P + + +Q+   +  L E    C     E R S   V + +  +   T++
Sbjct: 271 KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  208 bits (532), Expect = 1e-56
 Identities = 70/439 (15%), Positives = 133/439 (30%), Gaps = 52/439 (11%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
             N            S   L  L+++ L +      +P  L     L++LN++ N     
Sbjct: 471 DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISA 530

Query: 139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLSQNAYLISE 197
              +     ++ +   +   +Q+  +G N L             +L +LD   N   +  
Sbjct: 531 AQLKADW-TRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN--KVRH 587

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG-SSLLK 256
           + +  G   KL  L L  +    +  D       +  L  S N L   +P      S+  
Sbjct: 588 LEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV 645

Query: 257 LVSFDVSQNKLSG-----SFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ 311
           + S D S NK+       S      K      ++L  N               +    + 
Sbjct: 646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILS 705

Query: 312 DNGFS-------GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAA--QLEQVQIDNNR 362
           +N  +               +   +  I    N+ +  + D         L  + +  N 
Sbjct: 706 NNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNC 764

Query: 363 FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LKKC 421
           F+ S P    +   L  F                        +   N I  Q P  +  C
Sbjct: 765 FS-SFPTQPLNSSQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTC 805

Query: 422 RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT-GPIPQGLQNLKLALFNVSFNK 480
             L+ L +  N +  ++   L   P L  LD++DN      +      ++  ++ + ++K
Sbjct: 806 PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862

Query: 481 LSGRVPYSLISGLPASYLQ 499
                    I G  A  ++
Sbjct: 863 T------QDIRGCDALGIE 875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  168 bits (428), Expect = 2e-43
 Identities = 59/482 (12%), Positives = 130/482 (26%), Gaps = 69/482 (14%)

Query: 29  TEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLS 88
            +   L +   ++D       + +  + IH  NW                + N +     
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW----------------NFNKELDMWG 312

Query: 89  GEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGK 148
            +    +     ++ L+LA       +P  + Q + L+ L+             +     
Sbjct: 313 DQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGT----------HSETVS 362

Query: 149 IPESIGSLVNLQVLNLGSNLLSGSV-PFVFGNFSELVVLDLSQNAYL----ISEIPSDIG 203
                   +   +     + +              L + DL Q+A      +  I  D  
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 204 KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS 263
              K  Q+   ++     I  +   L  L I+  + +  T +                  
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS------D 475

Query: 264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL 323
             K   +          L ++ L+       +P  + +   L+   +  N          
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ--- 532

Query: 324 WSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS-SIPQGLGSVKSLYRFSA 382
                              + D      +++   +  N          L  +  L     
Sbjct: 533 ------------LKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 383 SQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP 440
             N         F  +  ++ + L  N I  +IPE       ++  L  + N L   IP 
Sbjct: 581 VHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636

Query: 441 --SLAELPVLTYLDLSDNNLTGPIP------QGLQNLKLALFNVSFNKLSGRVPYSLISG 492
             +   + V+  +D S N +              + +  +   +S+N++    P  L + 
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFAT 695

Query: 493 LP 494
             
Sbjct: 696 GS 697

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  161 bits (409), Expect = 5e-41
 Identities = 55/381 (14%), Positives = 113/381 (29%), Gaps = 28/381 (7%)

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
           W  +   +    +    + +   +  L+L      G VP   G  +EL VL    ++  +
Sbjct: 302 WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG----EVPQSLG 251
           S       +L        +               Q L++ DL Q+ +      +  +   
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421

Query: 252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ 311
              LK        N+++      I +   L  +    + F         E  N       
Sbjct: 422 RISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS-----D 475

Query: 312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS------ 365
                 +      +L  +  +   +      +PD +    +L+ + I  NR  S      
Sbjct: 476 YAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKA 535

Query: 366 ---SIPQGLGSVKSLYRFSASQNSFYGSLPPN--FCDSPVMSIINLSQNSISGQIPELKK 420
               +     +   +  F    N+     P +        + +++   N +   +     
Sbjct: 536 DWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGT 593

Query: 421 CRKLVSLSLADNSLTGEIPPSL-AELPVLTYLDLSDNNLTG-PIPQGLQNL-KLALFNVS 477
             KL  L L  N +  EIP    A    +  L  S N L   P     +++  +   + S
Sbjct: 594 NVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFS 652

Query: 478 FNKLSGRVPYSLISGLPASYL 498
           +NK+      ++   +     
Sbjct: 653 YNKIGS-EGRNISCSMDDYKG 672

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  195 bits (498), Expect = 2e-53
 Identities = 86/454 (18%), Positives = 162/454 (35%), Gaps = 30/454 (6%)

Query: 65  VTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSS 124
            +            + N ++L L+ EI  ++   +S   L  + N+         S+  +
Sbjct: 2   TSSDQKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLIN 58

Query: 125 LETLNLSNNLIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS 170
           L  L+L+   I+               L L+ N +      ++     L+ L      +S
Sbjct: 59  LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118

Query: 171 GSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQ 230
                   N   L  L L  N ++ S         EKL+ L  Q++  H +  +    LQ
Sbjct: 119 SIDFIPLHNQKTLESLYLGSN-HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177

Query: 231 SLSI--LDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
             +   L+L+ N++ G  P +  S++ + ++F  +QN L             L   +   
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237

Query: 289 NFFNGSIPGSINEC--LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDS 346
                  P        +++E   +Q + F     +       ++ +   +   S  +P  
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

Query: 347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIIN 405
           +   + L+++ +  N+F +       +  SL   S   N+    L      +   +  ++
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 406 LSQNSISGQIP---ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
           LS + I        +L+    L SL+L+ N        +  E P L  LDL+   L    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 463 PQG-LQNLK-LALFNVSFNKLSGRVPYSLISGLP 494
            Q   QNL  L + N+S + L       L  GLP
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDI-SSEQLFDGLP 449

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  187 bits (478), Expect = 8e-51
 Identities = 76/445 (17%), Positives = 143/445 (32%), Gaps = 33/445 (7%)

Query: 81  NLQSLNLSG-----EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           NL  L+L+          +      L  L L  N         LS   +L+ L      I
Sbjct: 58  NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117

Query: 136 --------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFS 181
                           L L  NHI             L+VL+  +N +         +  
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ 177

Query: 182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPD--SFVGLQSLSILDLSQ 239
           +   L L+ N   I+ I          + L    +    VI        +QSL +     
Sbjct: 178 QATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFED 237

Query: 240 NNLTGEVPQSL-GSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS 298
            +     P    G   + + S ++ ++       N     +GL  L L     +  +P  
Sbjct: 238 MDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

Query: 299 INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI-PDSISMAAQLEQVQ 357
           +     L++  +  N F         + P +  +  + N     +    +     L ++ 
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 358 IDNNRFTSS--IPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQI 415
           + ++   +S      L ++  L   + S N         F + P + +++L+   +  + 
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 416 PE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ---GLQNL- 469
            +   +    L  L+L+ + L          LP L +L+L  N+      Q    LQ L 
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 470 KLALFNVSFNKLSGRVPYSLISGLP 494
           +L +  +SF  LS  +     + L 
Sbjct: 477 RLEILVLSFCDLSS-IDQHAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  169 bits (431), Expect = 1e-44
 Identities = 80/446 (17%), Positives = 148/446 (33%), Gaps = 68/446 (15%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCS--SLETLNLS 131
             T  S+NL   +++  I     + +   +LN         I   L   +  SL      
Sbjct: 178 QATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFE 236

Query: 132 NNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
           +            I   + E +  + +++ +NL  +         F  FS L  LDL+  
Sbjct: 237 DMDD-------EDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288

Query: 192 AYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG 251
              +SE+PS +  L  L++L L ++ F  +   S     SL+ L +  N    E+     
Sbjct: 289 --HLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346

Query: 252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ 311
            +L  L   D+S + +  S                            +    +L+   + 
Sbjct: 347 ENLENLRELDLSHDDIETS----------------------DCCNLQLRNLSHLQSLNLS 384

Query: 312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI-SMAAQLEQVQIDNNRFTSSIPQG 370
            N       +     P+++L+     R       S       L+ + + ++    S  Q 
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE----LKKCRKLVS 426
              + +L                          +NL  N       +    L+   +L  
Sbjct: 445 FDGLPALQ------------------------HLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 427 LSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVP 486
           L L+   L+     +   L ++ ++DLS N LT    + L +LK    N++ N +S  + 
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISI-IL 539

Query: 487 YSLISGLPAS---YLQGNPGLCGPGL 509
            SL+  L       L+ NP  C    
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCTCSN 565

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  157 bits (400), Expect = 1e-40
 Identities = 79/411 (19%), Positives = 130/411 (31%), Gaps = 35/411 (8%)

Query: 78  ASINLQSLNLSG-------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCS--SLETL 128
            S   QSLN  G               + SL      D       P         S+E++
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 129 NLSNNLI--------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP 174
           NL  +                  LDL+  H+  ++P  +  L  L+ L L +N       
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ 318

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFH--GVIPDSFVGLQSL 232
               NF  L  L +  N   +      +  LE L +L L                 L  L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378

Query: 233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFF 291
             L+LS N       ++      +L   D++  +L            + L  L+L  +  
Sbjct: 379 QSLNLSYNEPLSLKTEAF-KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437

Query: 292 NGSIPGSINECLNLERFQVQDNGFSG---DFPDKLWSLPRIKLIRAESNRFSGAIPDSIS 348
           + S     +    L+   +Q N F        + L +L R++++       S     + +
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497

Query: 349 MAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQ 408
               +  V + +NR TSS  + L  +K +Y  + + N     LP           INL Q
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQ 556

Query: 409 NSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT 459
           N +           +          L           P+L  + LSD  L+
Sbjct: 557 NPLDC-TCSNIYFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  167 bits (424), Expect = 3e-46
 Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 34/290 (11%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V        + +A+K++        K    E++ L+++ H NIVK+ G       
Sbjct: 19  GAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGA--CLNP 73

Query: 653 IFLIYEFLQMGSLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
           + L+ E+ + GSL +++           +  +   +  +QG+AYLH      L+HR++K 
Sbjct: 74  VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133

Query: 711 KNILLDADFE-PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKKATAQM 765
            N+LL A     K+ DF     +     Q+ M++    + + APE      YS+K     
Sbjct: 134 PNLLLVAGGTVLKICDFGTACDI-----QTHMTNNKGSAAWMAPEVFEGSNYSEKC---- 184

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +S+G++L E+IT R     +P + +    +      I         P +     + + 
Sbjct: 185 DVFSWGIILWEVITRR-----KPFDEIGGPAFR-----IMWAVHNGTRPPLIKNLPKPI- 233

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIP 875
               +  RC S  P +RPSM E+VK +  L          L    +HS+P
Sbjct: 234 --ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  174 bits (443), Expect = 4e-46
 Identities = 81/471 (17%), Positives = 145/471 (30%), Gaps = 57/471 (12%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
            +   +       LS ++   +   SS  N++L+ N          S  S L+ L+LS  
Sbjct: 10  VVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRC 66

Query: 134 LIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGN 179
            I                L L+ N I+   P S   L +L+ L      L+    F  G 
Sbjct: 67  EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI----L 235
              L  L+++ N     ++P+    L  L  + L  +    +  +    L+        L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186

Query: 236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA-NGLVNLSLHKNFFNGS 294
           D+S N +     Q+     +KL    +  N  S +      +   GL    L    F   
Sbjct: 187 DMSLNPIDFIQDQAF--QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE 244

Query: 295 IPGSINEC--------LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDS 346
               I E         + ++ F++       D   K   L  +  +            + 
Sbjct: 245 RNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LED 302

Query: 347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY----------RFSA---------SQNSF 387
           +    + + + I   +        L  +KSL           +  A         S+N+ 
Sbjct: 303 VPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNAL 362

Query: 388 YGSLPPNFCDSPVMSI--INLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPS-LAE 444
             S   ++ D    S+  ++LS N             +L  L    ++L      S    
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 445 LPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLP 494
           L  L YLD+S  N           L  L    ++ N        ++ +   
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (411), Expect = 5e-42
 Identities = 81/436 (18%), Positives = 148/436 (33%), Gaps = 43/436 (9%)

Query: 89  GEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW------------ 136
           G ++  +  + +++     D   ++ +P  +   SS + ++LS N +             
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 137 --VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
              LDLSR  IE    ++   L +L  L L  N +    P  F   + L  L   +   L
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET-KL 116

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGV-IPDSFVGLQSLSILDLSQNNLTGEVP---QSL 250
            S     IG+L  L++L +  +  H   +P  F  L +L  +DLS N +        Q L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 251 GSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP-GSINECLNLERFQ 309
             +    +S D+S N +     +   +   L  L+L  NF + +I    +     L   +
Sbjct: 177 RENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235

Query: 310 VQDNGFSGDF------PDKLWSLPRIKL--IRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
           +    F  +       P  +  L  + +   R                 A +  + +   
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295

Query: 362 RFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKC 421
                  + +         S  +       P        +  + L+ N  S    +    
Sbjct: 296 SIKY--LEDVPKHFKWQSLSIIRCQL-KQFPTLDLPF--LKSLTLTMNKGS-ISFKKVAL 349

Query: 422 RKLVSLSLADNSLTGEIPPSLAEL--PVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSF 478
             L  L L+ N+L+     S ++L    L +LDLS N     +      L +L   +   
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQH 408

Query: 479 NKLSGRVPYSLISGLP 494
           + L     +S    L 
Sbjct: 409 STLKRVTEFSAFLSLE 424

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  157 bits (398), Expect = 3e-40
 Identities = 69/439 (15%), Positives = 140/439 (31%), Gaps = 46/439 (10%)

Query: 81  NLQSLNLSG------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQ----CSSLETLNL 130
            L+ LN++       ++ +    L++L +++L+ N         L           +L++
Sbjct: 129 TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188

Query: 131 S-NNLIWV------------LDLSRNHIEGKIPE-SIGSLVNLQVLNLGSNLLSGSVPF- 175
           S N + ++            L L  N     I +  + +L  L V  L            
Sbjct: 189 SLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248

Query: 176 -----VFGNFSELVVLDLSQNAYLISEI-PSDIGKLEKLEQLFLQSSGFHGVIPDSFVGL 229
                +     ++ + +                  L  +  + L       +  +     
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKH 306

Query: 230 QSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
                L + +  L       L      L S  ++ NK S SF      +  L  L L +N
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKGSISFKKVALPS--LSYLDLSRN 360

Query: 290 FFNGSIPGSINE--CLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDS- 346
             + S   S ++    +L    +  NG           L  ++ +  + +        S 
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

Query: 347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIIN 405
                +L  + I               + SL     + NSF  +   N F ++  ++ ++
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479

Query: 406 LSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           LS+  +            +L  L+++ N+L         +L  L+ LD S N +      
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 465 GLQNLK-LALFNVSFNKLS 482
                K LA FN++ N ++
Sbjct: 540 LQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  139 bits (353), Expect = 1e-34
 Identities = 53/314 (16%), Positives = 102/314 (32%), Gaps = 26/314 (8%)

Query: 81  NLQSLNLSG---EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW- 136
           N+ +++L+G   +    V +     +L++      Q   L L     L++L L+ N    
Sbjct: 286 NVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLTMNKGSI 342

Query: 137 -----------VLDLSRNHIEGKIPES--IGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL 183
                       LDLSRN +      S       +L+ L+L  N     +   F    EL
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401

Query: 184 VVLDLSQNAYLISEIP--SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN 241
             LD   +   +  +   S    LEKL  L +  +         F+GL SL+ L ++ N+
Sbjct: 402 QHLDFQHS--TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNS 459

Query: 242 LTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINE 301
                  ++ ++   L   D+S+ +L           + L  L++  N          N+
Sbjct: 460 FKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQ 519

Query: 302 CLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
             +L       N               +      +N  +  I +       +++ +    
Sbjct: 520 LYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKFLQWVKEQKQFLV 578

Query: 362 RFTSSIPQGLGSVK 375
                       + 
Sbjct: 579 NVEQMTCATPVEMN 592

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.0 bits (203), Expect = 4e-16
 Identities = 35/250 (14%), Positives = 66/250 (26%), Gaps = 12/250 (4%)

Query: 269 GSFPNGICKANGL-VNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
           GS    I     +       +      +P  I    + +   +  N           +  
Sbjct: 2   GSLNPCIEVVPNITYQCM-DQKLS--KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFS 56

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
            ++ +             +      L  + +  N   S  P     + SL    A +   
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 388 YGSLPPNFCDSPVMSIINLSQNSISG--QIPELKKCRKLVSLSLADNSLTGEIPPSLAEL 445
                        +  +N++ N I              LV + L+ N +       L  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 446 ----PVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGN 501
                V   LD+S N +     Q  Q +KL    +  N  S  +  + +  L   ++   
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 502 PGLCGPGLSN 511
                    N
Sbjct: 237 ILGEFKDERN 246

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  162 bits (412), Expect = 1e-44
 Identities = 82/317 (25%), Positives = 135/317 (42%), Gaps = 47/317 (14%)

Query: 578 DLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR 636
           DL+ G  E    G    FG+   ++   +GE++ +K+L+ F  ++ +T   EVK +  + 
Sbjct: 11  DLIHG--EVLGKGC---FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE 65

Query: 637 HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH 696
           H N++K +G  + D+ +  I E+++ G+L  +I   D Q  WS R+  A  +A G+AYLH
Sbjct: 66  HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125

Query: 697 -KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN---- 751
             + +    HR++ S N L+  +    + DF L R++ +   Q                 
Sbjct: 126 SMNII----HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 752 --------APE---YG-YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
                   APE      Y +K     D +SFG+VL E+I    A+      ++D    VR
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKV----DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237

Query: 800 RKINITNGAIQVLDPKI-ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
                       LD     NC          I +RC  + PEKRPS  ++   L +L   
Sbjct: 238 GF----------LDRYCPPNCPPS----FFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

Query: 859 TSLLSIELSSSQEHSIP 875
            +   + L    E    
Sbjct: 284 LA-GHLPLGPQLEQLDR 299

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  160 bits (405), Expect = 2e-43
 Identities = 64/319 (20%), Positives = 111/319 (34%), Gaps = 43/319 (13%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF--- 646
           G G  +G VY  SL     +AVK   +F  + +   +  +  +  + H NI + +     
Sbjct: 22  GRGR-YGAVYKGSL-DERPVAVKVF-SFANRQNFINEKNIYRVPLMEHDNIARFIVGDER 78

Query: 647 --FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD------ 698
                     L+ E+   GSL   +        W    ++A  V +GLAYLH +      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDH 136

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS------CYNA 752
           Y P + HR++ S+N+L+  D    ++DF L   +           + A         Y A
Sbjct: 137 YKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196

Query: 753 PEY-------GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVK-----WVRR 800
           PE           + A  Q+D Y+ G++  E+          P ES+   +      V  
Sbjct: 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF--PGESVPEYQMAFQTEVGN 254

Query: 801 KINITNGAIQV----LDPKIANCYQ--QQMLGAL-EIALRCTSVMPEKRPSMFEVVKALH 853
                +  + V      PK    ++     + +L E    C     E R +     + + 
Sbjct: 255 HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314

Query: 854 SLSTRTSLLSIELSSSQEH 872
            L            ++  H
Sbjct: 315 ELMMIWERNKSVSPTAHHH 333

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  152 bits (385), Expect = 3e-41
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 59/290 (20%)

Query: 593 GPFGRVYILSLPS-GELIAVKKLVNFGCQSSKTL-------KTEVKTLAKIRHKNIVKVL 644
           G FG V+   L     ++A+K L+    +    +       + EV  ++ + H NIVK+ 
Sbjct: 30  GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G         ++ EF+  G L   +  +   ++WS++L++ + +A G+ Y+  +  P ++
Sbjct: 90  GL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIV 146

Query: 705 HRNVKSKNILLD-----ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----- 754
           HR+++S NI L      A    K+ DF L +         ++S       + APE     
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAE 201

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD 813
              Y++KA    D YSF ++L  ++TG       P +              + G I+ ++
Sbjct: 202 EESYTEKA----DTYSFAMILYTILTGE-----GPFD------------EYSYGKIKFIN 240

Query: 814 --------PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                   P I      ++     +   C S  P+KRP    +VK L  L
Sbjct: 241 MIREEGLRPTIPEDCPPRLR---NVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  152 bits (385), Expect = 3e-41
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 31/274 (11%)

Query: 593 GPFGRVYILSLPSGEL---IAVKKLVNFGCQSSKTL---KTEVKTLAKIRHKNIVKVLGF 646
           G FG VY      G+    +AVK L N    + + L   K EV  L K RH NI+  +G+
Sbjct: 35  GSFGTVY-----KGKWHGDVAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
             +   + ++ ++ +  SL   +   + + +    + IA   A+G+ YLH      ++HR
Sbjct: 89  S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE---YGYSKKATA 763
           ++KS NI L  D   K+ DF L       +             + APE      S   + 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI-ANCYQQ 822
           Q D Y+FG+VL EL+TG+      P  +++    +   +    G++     K+ +NC ++
Sbjct: 205 QSDVYAFGIVLYELMTGQL-----PYSNINNRDQIIEMVG--RGSLSPDLSKVRSNCPKR 257

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
                  +   C     ++RPS   ++  +  L+
Sbjct: 258 ----MKRLMAECLKKKRDERPSFPRILAEIEELA 287

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  153 bits (390), Expect = 4e-41
 Identities = 82/405 (20%), Positives = 142/405 (35%), Gaps = 64/405 (15%)

Query: 82  LQSLNLSGEISSSVCELSSLSN---LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
             +L       + +   + L+      L        +     +  S+  L ++   +   
Sbjct: 2   AATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKV--- 56

Query: 139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEI 198
                       + I  L NL+ LNL  N ++   P    N  +L  L +  N   I++I
Sbjct: 57  ---------ASIQGIEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTN--KITDI 103

Query: 199 PSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV 258
            + +  L  L +L+L       + P     L  +  L+L  N+        L + +  L 
Sbjct: 104 SA-LQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSN-MTGLN 158

Query: 259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGD 318
              V+++K+    P        L +LSL+ N      P                      
Sbjct: 159 YLTVTESKVKDVTPIANLTD--LYSLSLNYNQIEDISP---------------------- 194

Query: 319 FPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY 378
               L SL  +    A  N+ +   P  ++   +L  ++I NN+ T   P  L ++  L 
Sbjct: 195 ----LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT 246

Query: 379 RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEI 438
                 N    S      D   + ++N+  N IS  I  L    +L SL L +N L  E 
Sbjct: 247 WLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNED 303

Query: 439 PPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLS 482
              +  L  LT L LS N++T   P  L +L K+   + +   + 
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  133 bits (338), Expect = 2e-34
 Identities = 72/358 (20%), Positives = 133/358 (37%), Gaps = 59/358 (16%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
           ++  L ++G +++S   +  L++L  LNL  N      P  LS    L  L +  N I  
Sbjct: 45  SITKLVVAGEKVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI-- 100

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
                         ++ +L NL+ L L  + +S   P    N +++  L+L  N      
Sbjct: 101 ----------TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGAN--HNLS 146

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             S +  +  L  L +  S    V P     L  L  L L+ N +    P    +SL  L
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP---LASLTSL 201

Query: 258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
             F    N+++      +     L +L +  N      P  +     L   ++  N  S 
Sbjct: 202 HYFTAYVNQITDI--TPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

Query: 318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
              + +  L ++K++   SN+ S      ++  +QL  + ++NN+  +   + +G + +L
Sbjct: 258 --INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT 435
                                   + + LSQN I+  I  L    K+ S   A+  + 
Sbjct: 314 ------------------------TTLFLSQNHITD-IRPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.1 bits (214), Expect = 3e-18
 Identities = 41/257 (15%), Positives = 93/257 (36%), Gaps = 23/257 (8%)

Query: 228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLH 287
           G  +L+ L    N +  +      + L + +   + +  ++        +   +  L + 
Sbjct: 1   GAATLATLPAPINQIFPD------ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVA 52

Query: 288 KNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI 347
                 SI G I    NLE   +  N  +      L +L ++  +   +N+ +     ++
Sbjct: 53  GEKVA-SIQG-IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISAL 106

Query: 348 SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLS 407
                L ++ ++ +  +   P  L ++  +Y  +   N    S      +   ++ + ++
Sbjct: 107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVT 163

Query: 408 QNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP-QGL 466
           ++ +   +  +     L SLSL  N +    P  LA L  L Y     N +T   P   +
Sbjct: 164 ESKVKD-VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVANM 220

Query: 467 QNLKLALFNVSFNKLSG 483
             L      +  NK++ 
Sbjct: 221 TRLN--SLKIGNNKITD 235

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  151 bits (383), Expect = 1e-40
 Identities = 80/273 (29%), Positives = 124/273 (45%), Gaps = 30/273 (10%)

Query: 593 GPFGRVYILSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG V+      G  +AVK L   +F  +       EV  + ++RH NIV  +G     
Sbjct: 48  GSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106

Query: 651 ESIFLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            ++ ++ E+L  GSL  L+ +     QL    RL +A  VA+G+ YLH    P ++HRN+
Sbjct: 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNL 165

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKKATAQ 764
           KS N+L+D  +  K+ DF L R+  +A+   +  S      + APE       ++K+   
Sbjct: 166 KSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKS--- 220

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
            D YSFGV+L EL T +Q     P  +L+  + V           +    +I      Q+
Sbjct: 221 -DVYSFGVILWELATLQQ-----PWGNLNPAQVVAAVGF------KCKRLEIPRNLNPQV 268

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
                I   C +  P KRPS   ++  L  L  
Sbjct: 269 ---AAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  154 bits (391), Expect = 2e-40
 Identities = 77/417 (18%), Positives = 141/417 (33%), Gaps = 44/417 (10%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW- 136
            + +L      I S   V  L++L+ +N ++N      PL     + L  + ++NN I  
Sbjct: 47  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIAD 104

Query: 137 -----------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L L  N I     + + +L NL  L L SN +S          + L  
Sbjct: 105 ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISAL--SGLTSLQQ 160

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
           L        ++++   +  L  LE+L + S+            L +L  L  + N ++  
Sbjct: 161 LSFGNQ---VTDLKP-LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDI 214

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL 305
            P      L  L    ++ N+L       +     L +L L  N  +   P  ++    L
Sbjct: 215 TPLG---ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 267

Query: 306 ERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS 365
              ++  N  S      L  L  +  +    N+     P  IS    L  + +  N  + 
Sbjct: 268 TELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323

Query: 366 SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLV 425
             P  + S+  L R     N    S   +  +   ++ ++   N IS  +  L    ++ 
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD-LTPLANLTRIT 378

Query: 426 SLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLS 482
            L L D + T       A + +   +      L  P             ++++N  S
Sbjct: 379 QLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS-DGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  152 bits (386), Expect = 1e-39
 Identities = 75/406 (18%), Positives = 145/406 (35%), Gaps = 43/406 (10%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLV 157
           L+      L        +    +    + TL      I            K  + +  L 
Sbjct: 23  LAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI------------KSIDGVEYLN 68

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG 217
           NL  +N  +N L+   P    N ++LV + ++ N   I++I   +  L  L  L L ++ 
Sbjct: 69  NLTQINFSNNQLTDITP--LKNLTKLVDILMNNN--QIADITP-LANLTNLTGLTLFNNQ 123

Query: 218 FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICK 277
              + P     L +L+ L+LS N ++        S L  L       N+++   P  +  
Sbjct: 124 ITDIDP--LKNLTNLNRLELSSNTISDISAL---SGLTSLQQLSFG-NQVTDLKP--LAN 175

Query: 278 ANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN 337
              L  L +  N    S    + +  NLE     +N  S   P  L  L  +  +    N
Sbjct: 176 LTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGN 231

Query: 338 RFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCD 397
           +       +++    L  + + NN+ ++  P  L  +  L       N    S       
Sbjct: 232 QLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI--SNISPLAG 285

Query: 398 SPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNN 457
              ++ + L++N +   I  +   + L  L+L  N+++   P  ++ L  L  L   +N 
Sbjct: 286 LTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNK 342

Query: 458 LTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLPASYLQGNP 502
           ++      L NL  +   +   N++S   P + ++ +    L    
Sbjct: 343 VSDVSS--LANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQA 386

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 98.9 bits (247), Expect = 7e-22
 Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 28/231 (12%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
           NL  L+L+  +IS+   +  L+ L+ L L  N  +   PL  +  ++L  L L+ N +  
Sbjct: 244 NLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPL--AGLTALTNLELNENQLED 301

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L L  N+I    P  + SL  LQ L   +N +S        N + +  
Sbjct: 302 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSL--ANLTNINW 357

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
           L    N   IS++   +  L ++ QL L    +     +      ++SI +  +N     
Sbjct: 358 LSAGHN--QISDLTP-LANLTRITQLGLNDQAWTNAPVNYK---ANVSIPNTVKNVTGAL 411

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP 296
           +  +  S        D++ N  S          +  V +      F+G++ 
Sbjct: 412 IAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.2 bits (201), Expect = 4e-16
 Identities = 42/208 (20%), Positives = 69/208 (33%), Gaps = 47/208 (22%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
            L  L L   +IS  S +  L++L+NL L +N      P+  S   +L  L L  N I  
Sbjct: 266 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISD 323

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L    N +      S+ +L N+  L+ G N +S   P    N + +  
Sbjct: 324 ISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQ 379

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT-- 243
           L L+      +  P +      +       +G   + P +     S +  D++ N  +  
Sbjct: 380 LGLNDQ--AWTNAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYT 436

Query: 244 ---------------------GEVPQSL 250
                                G V Q L
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTVTQPL 464

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  146 bits (371), Expect = 1e-39
 Identities = 69/279 (24%), Positives = 123/279 (44%), Gaps = 41/279 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTL----KTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+VY  +   G+ +AVK   +   +         + E K  A ++H NI+ + G   
Sbjct: 18  GGFGKVY-RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + ++ L+ EF + G L  ++  +  ++   I +  A+ +A+G+ YLH + +  ++HR++
Sbjct: 77  KEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134

Query: 709 KSKNILLDADFEP--------KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YG 756
           KS NIL+    E         K+TDF L R       ++T  S      + APE      
Sbjct: 135 KSSNILILQKVENGDLSNKILKITDFGLAREWH----RTTKMSAAGAYAWMAPEVIRASM 190

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
           +SK +    D +S+GV+L EL+TG       P   +D +          N     L   I
Sbjct: 191 FSKGS----DVWSYGVLLWELLTGEV-----PFRGIDGLAVAYGVAM--NK----LALPI 235

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
            +   +      ++   C +  P  RPS   ++  L ++
Sbjct: 236 PSTCPEPF---AKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  146 bits (370), Expect = 2e-39
 Identities = 62/277 (22%), Positives = 108/277 (38%), Gaps = 37/277 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS- 649
              G ++      G  I VK L   ++  + S+    E   L    H N++ VLG   S 
Sbjct: 21  NHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79

Query: 650 -DESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                 LI  ++  GSL + L    +F +  S  +K A+ +A+G+A+LH    P +    
Sbjct: 80  PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHA 138

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQST---MSSEYALSCYNAPEYGYSKKATAQ 764
           + S+++++D D   +++   +               ++ E AL     PE    + A   
Sbjct: 139 LNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPE-ALQ--KKPEDTNRRSA--- 192

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLD---VVKWVRRKINITNGAIQVLDPKIANCYQ 821
            D +SF V+L EL+T        P   L    +   V         A++ L P I     
Sbjct: 193 -DMWSFAVLLWELVTREV-----PFADLSNMEIGMKV---------ALEGLRPTIPPGIS 237

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
             +    ++   C +  P KRP    +V  L  +  +
Sbjct: 238 PHV---SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  146 bits (371), Expect = 5e-39
 Identities = 64/309 (20%), Positives = 117/309 (37%), Gaps = 64/309 (20%)

Query: 593 GPFGRVYILSLPSGEL---IAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG+VY      G     +A++ +          K  K EV    + RH+N+V  +G  
Sbjct: 44  GRFGQVY-----HGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            S   + +I    +  +L  ++      L  +   +IA  + +G+ YLH      +LH++
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKD 155

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE---------- 754
           +KSKN+  D + +  +TDF L  I G          +  +    C+ APE          
Sbjct: 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214

Query: 755 ---YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD-------VVKWVRRKINI 804
                +SK +    D ++ G +  EL          P ++         +   ++  ++ 
Sbjct: 215 EDKLPFSKHS----DVFALGTIWYELHAREW-----PFKTQPAEAIIWQMGTGMKPNLSQ 265

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS- 863
                  +  +I+           +I L C +   E+RP+  +++  L  L  R   LS 
Sbjct: 266 IG-----MGKEIS-----------DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

Query: 864 -IELSSSQE 871
                 S E
Sbjct: 310 PGHFWKSAE 318

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  143 bits (363), Expect = 8e-38
 Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 27/288 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG----FFH 648
           G +G V++     GE +AVK       ++S   +TE+     +RH+NI+  +        
Sbjct: 48  GRYGEVWMGKW-RGEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV-----PHL 703
           S   ++LI ++ + GSL D +      L     LK+A     GL +LH +       P +
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SCYNAPE------Y 755
            HR++KSKNIL+  +    + D  L         +  +     +    Y  PE       
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD-- 813
               ++    D YSFG++L E+     +        L     V    +  +    V    
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283

Query: 814 --PKIANCYQQ-QMLGAL-EIALRCTSVMPEKRPSMFEVVKALHSLST 857
             P   N +   + L  + ++   C +  P  R +   V K L  +S 
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (362), Expect = 1e-37
 Identities = 62/290 (21%), Positives = 113/290 (38%), Gaps = 31/290 (10%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG----FFH 648
           G FG V+      GE +AVK   +   + S   + E+     +RH+NI+  +        
Sbjct: 53  GRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV-----PHL 703
           +   ++L+ ++ + GSL D + R    +     +K+A+  A GLA+LH + V     P +
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SCYNAPE------Y 755
            HR++KSKNIL+  +    + D  L      A     ++  + +    Y APE       
Sbjct: 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN 228

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV---- 811
               ++  + D Y+ G+V  E+              L     V    ++      V    
Sbjct: 229 MKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK 288

Query: 812 ----LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
               +  +  +C   +++   +I   C       R +   + K L  LS 
Sbjct: 289 LRPNIPNRWQSCEALRVMA--KIMRECWYANGAARLTALRIKKTLSQLSQ 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  140 bits (356), Expect = 3e-37
 Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 27/286 (9%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG----FFH 648
           G +G V+  S   GE +AVK   +   + S   +TE+     +RH+NI+  +       H
Sbjct: 19  GRYGEVWRGSW-QGENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV-----PHL 703
           S   ++LI  + +MGSL D +      L     L+I + +A GLA+LH +       P +
Sbjct: 77  SSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SCYNAPE------Y 755
            HR++KSKNIL+  + +  + D  L  +  ++  Q  + +   +    Y APE       
Sbjct: 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ 194

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD-- 813
                +  ++D ++FG+VL E+     +              V    +  +    V    
Sbjct: 195 VDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ 254

Query: 814 --PKI-ANCYQQQMLGAL-EIALRCTSVMPEKRPSMFEVVKALHSL 855
             P I    +    L +L ++   C    P  R +   + K L  +
Sbjct: 255 QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  142 bits (360), Expect = 3e-36
 Identities = 48/392 (12%), Positives = 105/392 (26%), Gaps = 37/392 (9%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRN 143
            +      + D+   Q +        +++ L+LS N +               +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 144 HIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIG 203
            +       + SL  L+ L+L +N +             +  L  + N   IS +     
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN--ISRVSCSR- 118

Query: 204 KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS 263
             +  + ++L ++    +          +  LDL  N +       L +S   L   ++ 
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL 323
            N +       +  A  L  L L  N     +         +    +++N         L
Sbjct: 178 YNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 324 WSLPRIKLIRAESNRFS-GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSA 382
                ++      N F  G + D  S   +++   +          Q             
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 383 SQNSFYGSLPPNFC-----DSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGE 437
                     P             ++++   +       E +   +   +          
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351

Query: 438 IPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL 469
           I            L+     L   +  G +  
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  126 bits (318), Expect = 8e-31
 Identities = 52/385 (13%), Positives = 117/385 (30%), Gaps = 38/385 (9%)

Query: 124 SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL 183
           ++  +  + N   +  ++ + ++  +     S  N++ L+L  N LS         F++L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 184 VVLDLSQNAYLISEIP------------------SDIGKLEKLEQLFLQSSGFHGVIPDS 225
            +L+LS N   + E                     ++     +E L   ++    V    
Sbjct: 61  ELLNLSSNV--LYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR 118

Query: 226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG-SFPNGICKANGLVNL 284
             G ++   + L+ N +T  +         ++   D+  N++   +F      ++ L +L
Sbjct: 119 GQGKKN---IYLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL 174

Query: 285 SLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP 344
           +L  NF    + G +     L+   +  N  +     +  S   +  I   +N+    I 
Sbjct: 175 NLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIE 230

Query: 345 DSISMAAQLEQVQIDNNRF-TSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSI 403
            ++  +  LE   +  N F   ++       + +   +              C  P  ++
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP--TL 288

Query: 404 INLSQNSISG-QIPELKKCRKLVSLSLADNSLTG----EIPPSLAELPVLTYLDLSDNNL 458
            +           P   +   L     A  S  G     +            +D      
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348

Query: 459 TGPIPQGLQNLK-LALFNVSFNKLS 482
              I Q     +           L 
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALD 373

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  121 bits (306), Expect = 3e-29
 Identities = 67/426 (15%), Positives = 141/426 (33%), Gaps = 39/426 (9%)

Query: 81  NLQSLNLSG-EISS----SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           N++ L+LSG  +S      +   + L  LNL+ N+  + + L     S+L TL+L+NN +
Sbjct: 35  NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV 92

Query: 136 ---------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                      L  + N+I  ++  S G     + + L +N ++       G  S +  L
Sbjct: 93  QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 187 DLSQNAYLISEIPSD--IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
           DL  N   I  +         + LE L LQ +  + V          L  LDLS N L  
Sbjct: 150 DLKLNE--IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA- 204

Query: 245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN-GSIPGSINECL 303
            +     S    +    +  NKL       +  +  L +  L  N F+ G++    ++  
Sbjct: 205 FMGPEFQS-AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 304 NLERFQVQDNGFSGDFPDKLWSLPRI-KLIRAESNRFSGAIPDSISM--AAQLEQVQIDN 360
            ++    Q         ++  ++P +                D +      +   +    
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 361 NRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI----SGQIP 416
           +     +     +        A +  +   +            +   + ++    S    
Sbjct: 323 SETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRR 381

Query: 417 ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNV 476
              +    +  ++    L        + L +L  +      +     Q +QN  +  +++
Sbjct: 382 AHAELDGTLQQAVGQIELQH-ATEEQSPLQLLRAIVKRYEEMYVE-QQSVQNNAIRDWDM 439

Query: 477 SFNKLS 482
             +K +
Sbjct: 440 YQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 98.8 bits (246), Expect = 9e-22
 Identities = 45/373 (12%), Positives = 110/373 (29%), Gaps = 29/373 (7%)

Query: 81  NLQSLNLSG-EISS----SVCELSSLSNLNLADNLFNQ-PIPLHLSQCSSLETLNLSNNL 134
             +++ L+  +I+          S +  L+L  N  +        +   +LE LNL  N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 135 IW------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE 182
           I+             LDLS N +   +     S   +  ++L +N L   +         
Sbjct: 181 IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
           L   DL  N +    +     K ++++ +  Q+     +   +       ++        
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT--VKKLTGQNEEECTVPTLGHYGAYCC 296

Query: 243 TGEVPQSLGSSLLKLVSFDVSQNKLSGS----FPNGICKANGLVNLSLHKNFFNGSIPGS 298
             ++P      L+ L   + +     GS                 +   K  +   I   
Sbjct: 297 E-DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQV 355

Query: 299 INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQI 358
                     + +         +   +   +     ++      +  +    + L+ ++ 
Sbjct: 356 TLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRA 414

Query: 359 DNNRFT-SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE 417
              R+    + Q      ++  +   Q+        N     +    +L+  S +  + E
Sbjct: 415 IVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQE 474

Query: 418 LKKCRKLVSLSLA 430
           L    + ++  L 
Sbjct: 475 LVVREQNLASQLG 487

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  144 bits (366), Expect = 9e-36
 Identities = 100/539 (18%), Positives = 177/539 (32%), Gaps = 58/539 (10%)

Query: 81  NLQSLNLSGEISSSVCE-------LSSLSNLNLADNLFNQPIPLHLSQCS------SLET 127
           +L+S++ S      VCE         +LS  +LA N     + +   +C        LE 
Sbjct: 149 SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208

Query: 128 LNLSNNLIWVL--DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF--SEL 183
           L++S N   V       N I      S+    ++     G + +       F     S +
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSV 268

Query: 184 VVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
             LDLS     +  + S +   L+ L+ L L  +  + +  ++F GL +L +L+LS N L
Sbjct: 269 RHLDLSHG--FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 243 TGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINEC 302
             E+  S    L K+   D+ +N ++            L  L L  N        +I+  
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFI 380

Query: 303 LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA--AQLEQVQIDN 360
            ++    +  N      P    +   I L     NR    +     +     L+ + ++ 
Sbjct: 381 PSIPDIFLSGNKLV-TLPKINLTANLIHL---SENRLEN-LDILYFLLRVPHLQILILNQ 435

Query: 361 NRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPNFCDS-----PVMSIINLSQNSISGQ 414
           NRF+S           SL +    +N    +     C         + ++ L+ N ++  
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-S 494

Query: 415 IPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLA 472
           +P         L  LSL  N LT  +  +      L  LD+S N L  P P    +L   
Sbjct: 495 LPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLEILDISRNQLLAPNPDVFVSLS-- 550

Query: 473 LFNVSFNKLSG-----------RVPYSLISGLPASYLQGNPG-LCGPGLSNSCDENQPKH 520
           + +++ NK                    I+G PA      P    G  L +   E   + 
Sbjct: 551 VLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEE 610

Query: 521 RTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDL 579
                   +  ++        +M       F  +     +         +P        
Sbjct: 611 EVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPDMY 669

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  115 bits (290), Expect = 1e-26
 Identities = 73/375 (19%), Positives = 129/375 (34%), Gaps = 36/375 (9%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
           +      ++  ++P+    L   + L L  N +       F    +L +L+L    Y   
Sbjct: 8   IAFYRFCNLT-QVPQV---LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ-YTPL 62

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE-VPQSLGSSL 254
            I  +    L  L  L L SS  + + PD+F GL  L  L L    L+   +      +L
Sbjct: 63  TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122

Query: 255 LKLVSFDVSQNKLSG-SFPNGICKANGLVNLSLHKNFFNGSIPGSIN--ECLNLERFQVQ 311
             L   D+S+N++          K N L ++    N         +   +   L  F + 
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182

Query: 312 DNGF----SGDFPDKLWSLPRIKL--------------IRAESNRFSGAIPDSISMAAQL 353
            N      S D+   +     + L                  SN  S +   S+ +A  +
Sbjct: 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242

Query: 354 EQVQIDNNRFTS---SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
                  +       +   GL    S+     S    +      F     + ++NL+ N 
Sbjct: 243 MGAGFGFHNIKDPDQNTFAGLARS-SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

Query: 411 ISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQN 468
           I+ +I +        L  L+L+ N L      +   LP + Y+DL  N++     Q  + 
Sbjct: 302 IN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 469 L-KLALFNVSFNKLS 482
           L KL   ++  N L+
Sbjct: 361 LEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 4e-11
 Identities = 32/179 (17%), Positives = 65/179 (36%), Gaps = 10/179 (5%)

Query: 326 LPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG-LGSVKSLYRFSASQ 384
           L   + +    N        S     QL+ +++ +     +I +    ++ +L       
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 385 NSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE---LKKCRKLVSLSLADNSLTG-EIP 439
           +  Y  L P+ F     +  + L    +S  + +    +  + L  L L+ N +    + 
Sbjct: 83  SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141

Query: 440 PSLAELPVLTYLDLSDNNLTGPIP---QGLQNLKLALFNVSFNKLSGRVPYSLISGLPA 495
           PS  +L  L  +D S N +        + LQ   L+ F+++ N L  RV       +  
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 42/209 (20%), Positives = 73/209 (34%), Gaps = 17/209 (8%)

Query: 56  NIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPI 115
               C+         +   L +    LQ    +         LS L  L L  N  N   
Sbjct: 437 RFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLP 496

Query: 116 PLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF 175
           P   S  ++L  L+L++N + VL  +                NL++L++  N L    P 
Sbjct: 497 PGVFSHLTALRGLSLNSNRLTVLSHNDL------------PANLEILDISRNQLLAPNPD 544

Query: 176 VFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL 235
           VF +   L VLD++ N ++     S          + + +     +          +S+ 
Sbjct: 545 VFVS---LSVLDITHNKFICECELSTFINWLNHTNVTI-AGPPADIYCVYPDSFSGVSLF 600

Query: 236 DLSQNNLT-GEVPQSLGSSLLKLVSFDVS 263
            LS       EV +SL  SL  + +  ++
Sbjct: 601 SLSTEGCDEEEVLKSLKFSLFIVCTVTLT 629

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  141 bits (357), Expect = 2e-35
 Identities = 86/439 (19%), Positives = 147/439 (33%), Gaps = 47/439 (10%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNH 144
            S  NL+L+ N               L+ L+LS   I                L L+ N 
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87

Query: 145 IEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGK 204
           I+     +   L +LQ L      L+    F  G+   L  L+++ N     ++P     
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSI----LDLSQNNLTGEVPQSLGSSLLKLVSF 260
           L  LE L L S+    +       L  + +    LDLS N +    P +     ++L   
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF--KEIRLHKL 205

Query: 261 DVSQNKLSGSFPNGICKA-NGLVNLSLHKNFFNG-----SIPGSINE---CLNLERFQV- 310
            +  N  S +      +   GL    L    F           S  E    L +E F++ 
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG 370
             + +  D  D    L  +      S      + D  S     + +++ N +F       
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKD-FSYNFGWQHLELVNCKFGQFPTLK 323

Query: 371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ---IPELKKCRKLVSL 427
           L S+K L     + N    +   +  D P +  ++LS+N +S +            L  L
Sbjct: 324 LKSLKRLTF---TSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 428 SLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG-LQNL-KLALFNVSFNKLSGRV 485
            L+ N +   +  +   L  L +LD   +NL          +L  L   ++S        
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-A 436

Query: 486 PYSLISGLPAS---YLQGN 501
              + +GL +     + GN
Sbjct: 437 FNGIFNGLSSLEVLKMAGN 455

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  136 bits (344), Expect = 1e-33
 Identities = 82/459 (17%), Positives = 144/459 (31%), Gaps = 61/459 (13%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           +L +L L+G     ++      LSSL  L   +          +    +L+ LN+++NLI
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 136 ---------------WVLDLSRNHIEGKIPESIGSLVNLQV----LNLGSNLLSGSVPFV 176
                            LDLS N I+      +  L  + +    L+L  N ++   P  
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA 196

Query: 177 FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHG------VIPDSFVGLQ 230
           F     L  L L  N   ++ + + I  L  LE   L    F            +  GL 
Sbjct: 197 FKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLC 255

Query: 231 SLSI--LDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
           +L+I    L+  +   +    L + L  + SF +    +     +      G  +L L  
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVN 313

Query: 289 NFFNG-------------------SIPGSINECLNLERFQVQDNG--FSGDFPDKLWSLP 327
             F                         S  +  +LE   +  NG  F G      +   
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG-LGSVKSLYRFSASQNS 386
            +K +    N     +  +     QLE +   ++            S+++L     S   
Sbjct: 374 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 387 FYGSLPPNFCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAE 444
              +    F     + ++ ++ NS           + R L  L L+   L    P +   
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 445 LPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLS 482
           L  L  L+++ N L          L  L    +  N   
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (285), Expect = 2e-26
 Identities = 50/260 (19%), Positives = 93/260 (35%), Gaps = 19/260 (7%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW---- 136
           N+ S +L       V + S        + +  +       +  SL+ L  ++N       
Sbjct: 283 NVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS 342

Query: 137 --------VLDLSRNHIE--GKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                    LDLSRN +   G   +S     +L+ L+L  N +  ++   F    +L  L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 401

Query: 187 DLSQNAYLISEIP--SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
           D   +   + ++   S    L  L  L +  +         F GL SL +L ++ N+   
Sbjct: 402 DFQHSN--LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459

Query: 245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLN 304
                + + L  L   D+SQ +L    P      + L  L++  N       G  +   +
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519

Query: 305 LERFQVQDNGFSGDFPDKLW 324
           L++  +  N +    P   +
Sbjct: 520 LQKIWLHTNPWDCSCPRIDY 539

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 97.9 bits (244), Expect = 3e-21
 Identities = 63/335 (18%), Positives = 109/335 (32%), Gaps = 71/335 (21%)

Query: 74  SLTVASINLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSN 132
           +LT+    L  L+    +I      L+++S+ +L      + +    S     + L L N
Sbjct: 256 NLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VK-DFSYNFGWQHLELVN 313

Query: 133 NLI-----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS--GSVPFVFGN 179
                           L  + N       E    L +L+ L+L  N LS  G        
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDS-FVGLQSLSILDLS 238
            + L  LDLS N   +  + S+   LE+LE L  Q S    +   S F+ L++L  LD+S
Sbjct: 372 TTSLKYLDLSFNG--VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIPG 297
             +        + + L  L    ++ N    +F   I  +   L  L L +         
Sbjct: 430 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC-------- 480

Query: 298 SINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQ 357
                                   +L  L                 P + +  + L+ + 
Sbjct: 481 ------------------------QLEQLS----------------PTAFNSLSSLQVLN 500

Query: 358 IDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP 392
           + +N+  S        + SL +     N +  S P
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  138 bits (351), Expect = 3e-35
 Identities = 79/414 (19%), Positives = 140/414 (33%), Gaps = 76/414 (18%)

Query: 81  NLQSLNLSG----EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW 136
           +L+SL  S     E+      L SL   N      +   P        LE L +SNN + 
Sbjct: 92  HLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE 144

Query: 137 ------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELV 184
                       ++D+  N ++ K+P+      +L+ +  G+N L   +P    N   L 
Sbjct: 145 KLPELQNSSFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELPE-LQNLPFLT 198

Query: 185 VLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
            +    N   + ++P     LE +      ++            L  L+ +    N L  
Sbjct: 199 AIYADNN--SLKKLPDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLK- 250

Query: 245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLN 304
            +P    S    L + +V  N L+   P        L  L + +N F+  +        N
Sbjct: 251 TLPDLPPS----LEALNVRDNYLT-DLPELPQS---LTFLDVSENIFS-GLSELPP---N 298

Query: 305 LERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT 364
           L       N       D   SL  + +    +N+    +P       +LE++    N   
Sbjct: 299 LYYLNASSNEIR-SLCDLPPSLEELNV---SNNKLI-ELPALPP---RLERLIASFNHLA 350

Query: 365 SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKL 424
             +P+   ++K L+      N      P         S+ +L  NS   ++PEL   + L
Sbjct: 351 E-VPELPQNLKQLH---VEYNPLR-EFPDIPE-----SVEDLRMNSHLAEVPEL--PQNL 398

Query: 425 VSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP---QGLQNLKLALFN 475
             L +  N L  E P     +     L ++   +  P     +    L+  +F 
Sbjct: 399 KQLHVETNPLR-EFPDIPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFE 448

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  137 bits (348), Expect = 7e-35
 Identities = 82/467 (17%), Positives = 148/467 (31%), Gaps = 94/467 (20%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW---- 136
           N++S     E  ++  E    +     +        L          L L+N  +     
Sbjct: 32  NVKSKT---EYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88

Query: 137 ------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG----------------SVP 174
                  L  S N +  ++PE   SL +L V N     LS                  +P
Sbjct: 89  LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLP 147

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI 234
               N S L ++D+  N+  + ++P     LE +      ++     +P+    L  L+ 
Sbjct: 148 -ELQNSSFLKIIDVDNNS--LKKLPDLPPSLEFIA---AGNNQLE-ELPE-LQNLPFLTA 199

Query: 235 LDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS 294
           +    N+L       L    L L S     N L       +     L  +    N    +
Sbjct: 200 IYADNNSLK-----KLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-T 251

Query: 295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLE 354
           +P       +LE   V+DN  + D P+   SL  + +     +  S   P        L 
Sbjct: 252 LPDLPP---SLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP-------NLY 300

Query: 355 QVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ 414
            +   +N    S+     S++ L     S N     LP        +  +  S N ++ +
Sbjct: 301 YLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPPR---LERLIASFNHLA-E 351

Query: 415 IPELKKCRKLVSLSLADNSLTGEIPPSLAELPV----------------LTYLDLSDNNL 458
           +PEL   + L  L +  N L  E P     +                  L  L +  N L
Sbjct: 352 VPEL--PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408

Query: 459 TG--PIPQGLQNLKLALFNVSFNKLSG--RVPYSLISGLPASYLQGN 501
                IP+ +++L++     +  ++       +     L     + +
Sbjct: 409 REFPDIPESVEDLRM-----NSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  119 bits (301), Expect = 1e-28
 Identities = 70/389 (17%), Positives = 128/389 (32%), Gaps = 67/389 (17%)

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE------ 182
           N+SN  +       +++  ++P    ++ +        +    + P   G   E      
Sbjct: 7   NVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL 65

Query: 183 -------LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL 235
                     L+L+     +S +P     LE L       +     +P+    L+SL + 
Sbjct: 66  RDCLDRQAHELELNNLG--LSSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVD 119

Query: 236 DLSQNNLTGEVPQSLGS---------------SLLKLVSFDVSQNKLSGSFPNGICKANG 280
           + +   L+ ++P  L                 +   L   DV  N L    P+       
Sbjct: 120 NNNLKALS-DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS--- 174

Query: 281 LVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS 340
           L  ++   N     +P  +     L      +N      PD   SL  I      +N   
Sbjct: 175 LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIVA---GNNILE 228

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
                 +     L  +  DNN    ++P    S+++L       N     LP        
Sbjct: 229 --ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYL-TDLPELPQS--- 278

Query: 401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG 460
           ++ +++S+N  S  + EL     L  L+ + N +   +       P L  L++S+N L  
Sbjct: 279 LTFLDVSENIFS-GLSELPP--NLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE 331

Query: 461 PIPQGLQNLKLALFNVSFNKLSGRVPYSL 489
            +P     L+      SFN L+  VP   
Sbjct: 332 -LPALPPRLE--RLIASFNHLA-EVPELP 356

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  107 bits (270), Expect = 8e-25
 Identities = 70/339 (20%), Positives = 120/339 (35%), Gaps = 45/339 (13%)

Query: 149 IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL 208
           I     S   LQ     S+ L+  +P    N         + +       P   G+  ++
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSE-WERNAPPGNGEQREM 60

Query: 209 EQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS 268
               L+               +    L+L+   L+  +P+        L S   S N L+
Sbjct: 61  AVSRLRDC-----------LDRQAHELELNNLGLS-SLPELPPH----LESLVASCNSLT 104

Query: 269 GSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPR 328
              P        L+  + +    +   P        LE   V +N      P+ L +   
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSF 154

Query: 329 IKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFY 388
           +K+I  ++N     +PD       LE +   NN+    +P+ L ++  L    A  NS  
Sbjct: 155 LKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSL- 207

Query: 389 GSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
             LP        +  I    N +  ++PEL+    L ++   +N L   +P      P L
Sbjct: 208 KKLPDLPLS---LESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPD---LPPSL 259

Query: 449 TYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVP 486
             L++ DN LT  +P+  Q+L  L +    F+ LS   P
Sbjct: 260 EALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.3 bits (100), Expect = 6e-04
 Identities = 8/56 (14%), Positives = 17/56 (30%), Gaps = 1/56 (1%)

Query: 81  NLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           NL+ L++    +        S+ +L +       P          LE     ++  
Sbjct: 397 NLKQLHVETNPLREFPDIPESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  137 bits (346), Expect = 4e-35
 Identities = 58/386 (15%), Positives = 142/386 (36%), Gaps = 48/386 (12%)

Query: 121 QCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF 180
           +   +++    + + + + +     +        +L N +++   ++ +      +  +F
Sbjct: 9   EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSF 68

Query: 181 SELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
            ++ +L+L+     I EI +        +++L++  +    + P  F  +  L++L L +
Sbjct: 69  RQVELLNLNDLQ--IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI 299
           N+L+  +P+ +  +  KL +  +S N L                  +  + F        
Sbjct: 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE----------------RIEDDTFQA------ 163

Query: 300 NECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQID 359
               +L+  Q+  N  +      + SL    +     N  S     ++++   +E++   
Sbjct: 164 --TTSLQNLQLSSNRLTHVDLSLIPSLFHANV---SYNLLS-----TLAIPIAVEELDAS 213

Query: 360 NNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-- 417
           +N     +   +     L       N+   +      + P +  ++LS N +  +I    
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHP 267

Query: 418 LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNV 476
             K ++L  L +++N L   +      +P L  LDLS N+L   + +      +L    +
Sbjct: 268 FVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 325

Query: 477 SFNKLSGRVPYSLISGLPASYLQGNP 502
             N +   +  S    L    L  N 
Sbjct: 326 DHNSIV-TLKLSTHHTLKNLTLSHND 350

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  135 bits (342), Expect = 2e-34
 Identities = 60/399 (15%), Positives = 130/399 (32%), Gaps = 40/399 (10%)

Query: 100 SLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNL 159
              ++++     +          ++ + +   N+ +  L              + S   +
Sbjct: 22  VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP----------AALLDSFRQV 71

Query: 160 QVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGF 218
           ++LNL    +     + F     +  L +  N   I  +P  +   +  L  L L+ +  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN--AIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 219 HGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA 278
             +    F     L+ L +S NNL   +      +   L +  +S N+L+      +   
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP- 186

Query: 279 NGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR 338
             L + ++  N  +     ++   + +E      N  +         L  +KL   + N 
Sbjct: 187 -SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKL---QHNN 237

Query: 339 FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDS 398
            +      +     L +V +  N     +      ++ L R   S N    +L       
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPI 294

Query: 399 PVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL 458
           P + +++LS N +        +  +L +L L  NS+   +  S      L  L LS N+ 
Sbjct: 295 PTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDW 351

Query: 459 TG----PIPQGLQNLKLALFNVSFNKLSGRVPYSLISGL 493
                  + + +    +            ++ Y L  GL
Sbjct: 352 DCNSLRALFRNVARPAV-----DDADQHCKIDYQLEHGL 385

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 28/127 (22%), Positives = 46/127 (36%), Gaps = 20/127 (15%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
            L  L L    ++    +     L  ++L+ N   + +     +   LE L +SNN +  
Sbjct: 227 ELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA 286

Query: 136 -----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELV 184
                       VLDLS NH+   +  +      L+ L L  N +  ++         L 
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 342

Query: 185 VLDLSQN 191
            L LS N
Sbjct: 343 NLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 51.2 bits (123), Expect = 9e-07
 Identities = 24/140 (17%), Positives = 44/140 (31%), Gaps = 7/140 (5%)

Query: 359 DNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE- 417
                   I   L      Y       +                I+    +++  ++P  
Sbjct: 5   PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAA 63

Query: 418 -LKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALF 474
            L   R++  L+L D  +  EI   + A    +  L +  N +    P   QN+  L + 
Sbjct: 64  LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122

Query: 475 NVSFNKLSGRVPYSLISGLP 494
            +  N LS  +P  +    P
Sbjct: 123 VLERNDLS-SLPRGIFHNTP 141

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  140 bits (354), Expect = 4e-35
 Identities = 79/431 (18%), Positives = 151/431 (35%), Gaps = 57/431 (13%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRN 143
            +++ +L+L+ N         L  C++L+ L L ++ I                LDLS N
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84

Query: 144 HIEGKIPESIGSLVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLSQNAYLISEIP-SD 201
           H+        G L +L+ LNL  N      V  +F N + L  L +       SEI   D
Sbjct: 85  HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNV-ETFSEIRRID 143

Query: 202 IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFD 261
              L  L +L +++         S   ++ +  L L  +     + +     L  +   +
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLE 202

Query: 262 VSQNKLSGSFPNGICKANGLVNLSLHKNFFN-------GSIPGSINECLNLERFQVQDNG 314
           +    L+    + +        +       +         +   +   L L   +  D  
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCT 262

Query: 315 FSG------DFPDKLWSLPRIKLI-----RAESNRFSGAIPDSISMAAQLEQVQIDNNRF 363
            +G         D +  L +++ +               +    S+  +++++ ++N++ 
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

Query: 364 TS---SIPQGLGSVKSLYRFSASQNSFYGSLPPN---FCDSPVMSIINLSQN---SISGQ 414
                S  Q L S++ L     S+N        N       P +  + LSQN   S+   
Sbjct: 323 FLVPCSFSQHLKSLEFLD---LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT 379

Query: 415 IPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT---GPIPQGLQNLKL 471
              L   + L SL ++ N+    +P S      + +L+LS   +      IPQ L+ L +
Sbjct: 380 GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDV 438

Query: 472 ALFNVSFNKLS 482
                S N L 
Sbjct: 439 -----SNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  133 bits (337), Expect = 6e-33
 Identities = 74/415 (17%), Positives = 146/415 (35%), Gaps = 44/415 (10%)

Query: 96  CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS 155
               +    +     F   IP  L+  +++++L+LS N I  +              + +
Sbjct: 2   LSCDASGVCDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIG----------HGDLRA 48

Query: 156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQ 214
             NLQVL L S+ ++      F +   L  LDLS N   +S + S   G L  L+ L L 
Sbjct: 49  CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNH--LSSLSSSWFGPLSSLKYLNLM 106

Query: 215 SSGFHGVIPDS-FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN 273
            + +  +   S F  L +L  L +       E+ +   + L  L   ++    L      
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166

Query: 274 GICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR 333
            +     + +L+LH +     +    +   ++   +++D   +      L        ++
Sbjct: 167 SLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMK 226

Query: 334 AESNRFS-------GAIPDSISMAAQLEQVQIDNNRFTS---------SIPQGLGSVK-- 375
             + R S         +   +    +L +V+ D+               +   LG V+  
Sbjct: 227 KLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETV 286

Query: 376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNS 433
           ++ R    Q   +  L   +     +  I +  + +   +P    +  + L  L L++N 
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENL 345

Query: 434 LTGEIPPS---LAELPVLTYLDLSDNNLT--GPIPQGLQNL-KLALFNVSFNKLS 482
           +  E   +       P L  L LS N+L       + L  L  L   ++S N   
Sbjct: 346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  132 bits (333), Expect = 2e-32
 Identities = 84/486 (17%), Positives = 152/486 (31%), Gaps = 68/486 (13%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
            ++SL+LS      I        ++L  L L  +  N           SLE L+LS+N +
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 136 W--------------VLDLSRNHI-EGKIPESIGSLVNLQVLNLGSNLLSGSVP-FVFGN 179
                           L+L  N      +     +L NLQ L +G+      +    F  
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 180 FSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
            + L  L++   +  +    S  +  +  +  L L  S    ++      L S+  L+L 
Sbjct: 147 LTSLNELEIKALS--LRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204

Query: 239 QNNLTG--EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVN------------- 283
             NL      P  +      +       + L+    N + K    +              
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264

Query: 284 --LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG 341
                + +  +        E + + R  +       D       L ++K I  E+++   
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL 324

Query: 342 AIPDSISMAAQLEQVQIDNNRFTSSI---PQGLGSVKSLYRFSASQNSFY--GSLPPNFC 396
                      LE + +  N             G+  SL     SQN             
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384

Query: 397 DSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT---GEIPPSL----------- 442
               ++ +++S+N+        +   K+  L+L+   +      IP +L           
Sbjct: 385 TLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD 444

Query: 443 ---AELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPAS--- 496
                LP L  L +S N L   +P       L +  +S N+L   VP  +   L +    
Sbjct: 445 SFSLFLPRLQELYISRNKLKT-LPDASLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKI 502

Query: 497 YLQGNP 502
           +L  NP
Sbjct: 503 WLHTNP 508

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  109 bits (274), Expect = 4e-25
 Identities = 67/325 (20%), Positives = 115/325 (35%), Gaps = 29/325 (8%)

Query: 3   TASSPLSFLCLHLLVCLTF-FAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCN 61
             SSP+  L     V     F            LS     D + N L  ++ + +     
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279

Query: 62  WTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQ 121
              V         +T+  +++    L  ++S+    L  +  + + ++            
Sbjct: 280 LGKVET-------VTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332

Query: 122 CSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS--GSVPFVFGN 179
             SLE L+LS NL+            K     G+  +LQ L L  N L        +   
Sbjct: 333 LKSLEFLDLSENLM-------VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
              L  LD+S+N      +P      EK+  L L S+G   V        Q+L +LD+S 
Sbjct: 386 LKNLTSLDISRN--TFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIP---QTLEVLDVSN 440

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI 299
           NNL      S    L +L    +S+NKL  + P+       L+ + + +N       G  
Sbjct: 441 NNLD-----SFSLFLPRLQELYISRNKLK-TLPDASLFPV-LLVMKISRNQLKSVPDGIF 493

Query: 300 NECLNLERFQVQDNGFSGDFPDKLW 324
           +   +L++  +  N +    P   +
Sbjct: 494 DRLTSLQKIWLHTNPWDCSCPRIDY 518

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  104 bits (260), Expect = 3e-23
 Identities = 66/396 (16%), Positives = 124/396 (31%), Gaps = 53/396 (13%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           +L  L +         S     +  + +L L  +     + +     SS+  L L +  +
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL- 194
                S   ++              VL   S      +       SE+   D + N    
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD 268

Query: 195 ----ISEIPSDIGKLE--KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ 248
                S++ S++GK+E   + +L +        +   +  L+ +  + +  + +   VP 
Sbjct: 269 FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPC 327

Query: 249 SLGSSLLKLVSFDVSQNKLS-GSFPNGICKAN--GLVNLSLHKNFFN--GSIPGSINECL 303
           S    L  L   D+S+N +      N  CK     L  L L +N           +    
Sbjct: 328 SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK 387

Query: 304 NLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRF 363
           NL    +  N F    PD      +++ +   S      +   I     LE + + NN  
Sbjct: 388 NLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNL 443

Query: 364 TSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRK 423
             S    L  ++ LY                           +S+N +   +P+      
Sbjct: 444 D-SFSLFLPRLQELY---------------------------ISRNKLK-TLPDASLFPV 474

Query: 424 LVSLSLADNSLTGEIPPS-LAELPVLTYLDLSDNNL 458
           L+ + ++ N L   +P      L  L  + L  N  
Sbjct: 475 LLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 97.9 bits (244), Expect = 2e-21
 Identities = 61/358 (17%), Positives = 117/358 (32%), Gaps = 36/358 (10%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
            + L+  NL+    S +      S +       +       ++   L    L  + +   
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFD 259

Query: 139 DLSRNHIEGKIPESIGS--------LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQ 190
           D + N +    P              V ++ L++    L   +  V+    ++  + +  
Sbjct: 260 DCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVEN 319

Query: 191 NAYLISEIPSDIGK-LEKLEQLFLQSSGFHGVIPDS---FVGLQSLSILDLSQNNLTG-E 245
           +   +  +P    + L+ LE L L  +        +        SL  L LSQN+L   +
Sbjct: 320 S--KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECL-- 303
               +  +L  L S D+S+N      P+       +  L+L            +  C+  
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-----VVKTCIPQ 431

Query: 304 NLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRF 363
            LE   V +N     F   L  L  + +     N+    +PD+      L  ++I  N+ 
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQELYI---SRNKLK-TLPDASLFP-VLLVMKISRNQL 485

Query: 364 TSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKC 421
            S        + SL +     N +        C  P +  ++   N  S +     KC
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLSRWLNKNSQKEQGSAKC 536

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (345), Expect = 9e-34
 Identities = 63/380 (16%), Positives = 127/380 (33%), Gaps = 25/380 (6%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDL 140
             Q  N+        C  S+L    +  ++        +      E + L+N  I  +  
Sbjct: 3   GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVY--FGFEDITLNNQKI--VTF 58

Query: 141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS 200
             + +       + S   +++LNL    +     + F     +  L +  N   I  +P 
Sbjct: 59  KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN--AIRYLPP 116

Query: 201 DI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVS 259
            +   +  L  L L+ +    +    F     L+ L +S NNL   +      +   L +
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQN 175

Query: 260 FDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDF 319
             +S N+L+      +     L + ++  N  +     ++   + +E      N  +   
Sbjct: 176 LQLSSNRLT-HVDLSLIP--SLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVR 227

Query: 320 PDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYR 379
                 L  +KL   + N  +      +     L +V +  N     +      ++ L R
Sbjct: 228 GPVNVELTILKL---QHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282

Query: 380 FSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIP 439
              S N    +L       P + +++LS N +        +  +L +L L  NS+   + 
Sbjct: 283 LYISNNRL-VALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK 340

Query: 440 PSLAELPVLTYLDLSDNNLT 459
            S      L  L LS N+  
Sbjct: 341 LST--HHTLKNLTLSHNDWD 358

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  135 bits (340), Expect = 4e-33
 Identities = 76/356 (21%), Positives = 130/356 (36%), Gaps = 79/356 (22%)

Query: 117 LHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV 176
           +     +    LN+  + +             +P+ + +  ++  L +  N L+ S+P  
Sbjct: 34  MRACLNNGNAVLNVGESGL-----------TTLPDCLPA--HITTLVIPDNNLT-SLP-- 77

Query: 177 FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD 236
                EL  L++S N   ++ +P     L +L             +P        L  L 
Sbjct: 78  -ALPPELRTLEVSGN--QLTSLPVLPPGLLELSIFSNP----LTHLPAL---PSGLCKLW 127

Query: 237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP 296
           +  N LT     SL      L    VS N+L+ S P    +   L  L  + N    S+P
Sbjct: 128 IFGNQLT-----SLPVLPPGLQELSVSDNQLA-SLPALPSE---LCKLWAYNNQLT-SLP 177

Query: 297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQV 356
              +    L+   V DN  +   P     L ++      +NR + ++P   S    L+++
Sbjct: 178 MLPS---GLQELSVSDNQLA-SLPTLPSELYKLWA---YNNRLT-SLPALPS---GLKEL 226

Query: 357 QIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP 416
            +  NR TS +P     +K L                            +S N ++  +P
Sbjct: 227 IVSGNRLTS-LPVLPSELKEL---------------------------MVSGNRLT-SLP 257

Query: 417 ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLA 472
            L     L+SLS+  N LT  +P SL  L   T ++L  N L+    Q L+ +  A
Sbjct: 258 ML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA 310

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  114 bits (286), Expect = 2e-26
 Identities = 60/365 (16%), Positives = 114/365 (31%), Gaps = 63/365 (17%)

Query: 96  CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW----------VLDLSRNHI 145
           C  +  + LN+ ++     +P  L   + + TL + +N +            L++S N +
Sbjct: 37  CLNNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLTSLPALPPELRTLEVSGNQL 93

Query: 146 EGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKL 205
              +P     L+ L + +     L           S L  L +  N   ++ +P     L
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQ--LTSLPVLPPGL 143

Query: 206 EKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN 265
           ++L     Q +     +P     L  L       N LT  +P         L    VS N
Sbjct: 144 QELSVSDNQLA----SLPALPSELCKL---WAYNNQLT-SLPMLPSG----LQELSVSDN 191

Query: 266 KLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI-----------------NECLNLERF 308
           +L+ S P    +   L  L  + N    S+P                         L+  
Sbjct: 192 QLA-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGLKELIVSGNRLTSLPVLPSELKEL 246

Query: 309 QVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP 368
            V  N  +   P     L  + +     N+ +  +P+S+   +    V ++ N  +    
Sbjct: 247 MVSGNRLT-SLPMLPSGLLSLSV---YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTL 301

Query: 369 QGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLS 428
           Q L  + S   +S     F      +         +  +   +  +  E     +     
Sbjct: 302 QALREITSAPGYSGPIIRFD-MAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFG 360

Query: 429 LADNS 433
             DN+
Sbjct: 361 QEDNA 365

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 61.8 bits (150), Expect = 5e-10
 Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 16/124 (12%)

Query: 81  NLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI---- 135
            L  L      ++S     S L  L ++ N     +P+  S+   L+ L +S N +    
Sbjct: 202 ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLTSLP 257

Query: 136 ------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLS 189
                   L + RN +  ++PES+  L +   +NL  N LS          +        
Sbjct: 258 MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316

Query: 190 QNAY 193
              +
Sbjct: 317 IIRF 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  129 bits (327), Expect = 4e-33
 Identities = 57/373 (15%), Positives = 120/373 (32%), Gaps = 72/373 (19%)

Query: 118 HLSQCSSLETLNLSNN--------------LIWVLDLSRNHIEGKIPESIGSLVNLQVLN 163
           H    S  E L    +                +  D +R H          +  N Q+  
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIET 62

Query: 164 LGSNLLSGSVPFVFGNFSE--LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV 221
                L  +   +  + ++   V L+L      + + P    +L  L+ + + ++G    
Sbjct: 63  RTGRALK-ATADLLEDATQPGRVALELRSVP--LPQFPDQAFRLSHLQHMTIDAAGLM-E 118

Query: 222 IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGL 281
           +PD+      L  L L++N L   +P S+  SL +L    +         P  +      
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIA-SLNRLRELSIRACPELTELPEPLA----- 171

Query: 282 VNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG 341
                     +    G     +NL+  +++  G                           
Sbjct: 172 ----------STDASGEHQGLVNLQSLRLEWTGIR------------------------- 196

Query: 342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVM 401
           ++P SI+    L+ ++I N+  + ++   +  +  L        +   + PP F     +
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 402 SIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG 460
             + L   S    +P ++ +  +L  L L        +P  +A+LP    + +  +    
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA- 314

Query: 461 PIPQGLQNLKLAL 473
              Q  Q+  +A 
Sbjct: 315 ---QLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  128 bits (324), Expect = 1e-32
 Identities = 47/284 (16%), Positives = 95/284 (33%), Gaps = 33/284 (11%)

Query: 81  NLQSL-NLSGEISSSVCELSSLSNLNLADNLFN--QPIPLHLSQCSS--LETLNLSNNLI 135
             Q   N       S    ++ +N  +        +     L   +      L L +  +
Sbjct: 34  QWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL 93

Query: 136 W-------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE 182
                          + +    +  ++P+++     L+ L L  N L  ++P    + + 
Sbjct: 94  PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNR 151

Query: 183 LVVLDLSQNAYLISEIPSDIGK---------LEKLEQLFLQSSGFHGVIPDSFVGLQSLS 233
           L  L +     L +E+P  +           L  L+ L L+ +G    +P S   LQ+L 
Sbjct: 152 LRELSIRACPEL-TELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK 209

Query: 234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG 293
            L +  + L+  +  ++   L KL   D+       ++P        L  L L       
Sbjct: 210 SLKIRNSPLS-ALGPAIHH-LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN 337
           ++P  I+    LE+  ++        P  +  LP   +I    +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  128 bits (324), Expect = 1e-32
 Identities = 60/401 (14%), Positives = 119/401 (29%), Gaps = 88/401 (21%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLV 157
            S   NL    +   +P    LSQ       + +                       +  
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW--------------HSAWRQANSN 56

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSE--LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS 215
           N Q+       L  +   +  + ++   V L+L      + + P    +L  L+ + + +
Sbjct: 57  NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVP--LPQFPDQAFRLSHLQHMTIDA 113

Query: 216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI 275
           +G    +PD+      L  L L++N L   +P S+ S L +L    +         P  +
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIAS-LNRLRELSIRACPELTELPEPL 170

Query: 276 CKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE 335
                           +    G     +NL+  +++  G                     
Sbjct: 171 A---------------STDASGEHQGLVNLQSLRLEWTGIR------------------- 196

Query: 336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNF 395
                 ++P SI+    L+ ++I N+  ++ +   +  +  L        +   + PP F
Sbjct: 197 ------SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIF 249

Query: 396 CDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSD 455
                                       L  L L D S    +P  +  L  L  LDL  
Sbjct: 250 G-----------------------GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286

Query: 456 NNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYSLISGLPA 495
                 +P  +  L    +  V  +  +    +  ++  PA
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVA-RPA 326

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.4 bits (142), Expect = 4e-09
 Identities = 28/203 (13%), Positives = 57/203 (28%), Gaps = 21/203 (10%)

Query: 293 GSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQ 352
           GS     +     E    Q +     + D L    R           +    +S      
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56

Query: 353 LEQVQIDNNRFTSSIPQGLG--SVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
             Q++    R   +    L   +                  P        +  + +    
Sbjct: 57  NPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 411 ISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL 469
           +  ++P  +++   L +L+LA N L   +P S+A L  L  L +        +P+ L + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 470 K----------LALFNVSFNKLS 482
                      L    + +  + 
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR 196

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  123 bits (310), Expect = 5e-31
 Identities = 46/329 (13%), Positives = 97/329 (29%), Gaps = 35/329 (10%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRN 143
            +      + D+   Q +        +++ L+LS N +               +L+LS N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 144 HIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIG 203
            +       + SL  L+ L+L +N +             +  L  + N   IS +     
Sbjct: 69  VLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNN--ISRVSCSR- 118

Query: 204 KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS 263
             +  + ++L ++    +          +  LDL  N +       L +S   L   ++ 
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL 323
            N +       +  A  L  L L  N     +         +    +++N         L
Sbjct: 178 YNFIY-DVKGQVVFAK-LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 324 WSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSAS 383
                ++      N F           ++ ++VQ    +    +        ++      
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFF--SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 384 QNSFYGSLPPNFCDSPVMSIINLSQNSIS 412
                  LP  F D     +I L  +   
Sbjct: 292 GAYCCEDLPAPFAD----RLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  115 bits (291), Expect = 2e-28
 Identities = 58/266 (21%), Positives = 105/266 (39%), Gaps = 29/266 (10%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           N++ L+LSG    +IS++     + L  LNL+ N+  + +   L   S+L TL+L+NN +
Sbjct: 35  NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92

Query: 136 ---------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                      L  + N+I  ++  S G     + + L +N ++       G  S +  L
Sbjct: 93  QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 187 DLSQNAYLISEIPSD--IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
           DL  N   I  +         + LE L LQ +  + V          L  LDLS N L  
Sbjct: 150 DLKLNE--IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA- 204

Query: 245 EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN-GSIPGSINECL 303
            +      S   +    +  NKL       +  +  L +  L  N F+ G++    ++  
Sbjct: 205 FMGPEFQ-SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 304 NLERFQVQDNGFSGDFPDKLWSLPRI 329
            ++    Q         ++  ++P +
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTL 288

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  112 bits (282), Expect = 3e-27
 Identities = 56/333 (16%), Positives = 117/333 (35%), Gaps = 19/333 (5%)

Query: 124 SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL 183
           ++  +  + N   +  ++ + ++  +     S  N++ L+L  N LS         F++L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT 243
            +L+LS N   + E   D+  L  L  L L ++          +   S+  L  + NN++
Sbjct: 61  ELLNLSSNV--LYETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 244 GEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG-SIPGSINEC 302
             V  S G     +    ++ NK++          + +  L L  N  +  +        
Sbjct: 113 -RVSCSRGQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168

Query: 303 LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNR 362
             LE   +Q N    D         ++K +   SN+ +  +      AA +  + + NN+
Sbjct: 169 DTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225

Query: 363 FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG-QIPELKKC 421
               I + L   ++L  F    N F+     +F  S    +  +++ ++        ++C
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEEC 283

Query: 422 RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLS 454
                             P    L  L +    
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  108 bits (273), Expect = 5e-26
 Identities = 53/358 (14%), Positives = 109/358 (30%), Gaps = 65/358 (18%)

Query: 149 IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEK 207
           I E   +    ++  +  + L  ++  +  +   +  LDLS N   +S+I +  +    K
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN--PLSQISAADLAPFTK 59

Query: 208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKL 267
           LE L L S+  +  +      L +L  LDL+ N +  E+          + +   + N +
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNI 111

Query: 268 SGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
           S        +  G  N+ L  N               ++   ++ N              
Sbjct: 112 S-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN-------------- 154

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
            I  +            +  + +  LE + +  N     +   +     L          
Sbjct: 155 EIDTVN---------FAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKL---------- 193

Query: 388 YGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPV 447
                           ++LS N ++   PE +    +  +SL +N L   I  +L     
Sbjct: 194 --------------KTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 448 LTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLC 505
           L + DL  N       +   +    +  V+   +  ++            L      C
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYC 295

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 32/195 (16%), Positives = 65/195 (33%), Gaps = 23/195 (11%)

Query: 81  NLQSLNLSG-EISS----SVCELSSLSNLNLADNLFNQ-PIPLHLSQCSSLETLNLSNNL 134
             +++ L+  +I+          S +  L+L  N  +        +   +LE LNL  N 
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180

Query: 135 IW------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE 182
           I+             LDLS N +   +     S   +  ++L +N L   +         
Sbjct: 181 IYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

Query: 183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
           L   DL  N +    +     K ++++ +  Q+      +        ++  L       
Sbjct: 239 LEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTLGHYGAYC 295

Query: 243 TGEVPQSLGSSLLKL 257
             ++P      L+ L
Sbjct: 296 CEDLPAPFADRLIAL 310

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 17/95 (17%), Positives = 37/95 (38%), Gaps = 4/95 (4%)

Query: 390 SLPPNFCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
           ++     +     I  ++ +S+   +    +    +  L L+ N L+      LA    L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 449 TYLDLSDNNLTGPIP-QGLQNLKLALFNVSFNKLS 482
             L+LS N L   +  + L  L+    +++ N + 
Sbjct: 61  ELLNLSSNVLYETLDLESLSTLR--TLDLNNNYVQ 93

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  119 bits (299), Expect = 3e-29
 Identities = 68/273 (24%), Positives = 118/273 (43%), Gaps = 45/273 (16%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLG 645
           G G  FG+   + S   G    +K+ +N    SSK  +    EV  LA ++H NIV+   
Sbjct: 33  GEGS-FGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
            F  + S++++ ++ + G L   I  Q     Q    L   + +   L ++H      +L
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPE----Y 755
           HR++KS+NI L  D   +L DF + R++         + E A +C     Y +PE     
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNS-------TVELARACIGTPYYLSPEICENK 200

Query: 756 GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK 815
            Y+ K+    D ++ G VL EL T + A +A   ++L         + I +G+     P 
Sbjct: 201 PYNNKS----DIWALGCVLYELCTLKHAFEAGSMKNL--------VLKIISGSF----PP 244

Query: 816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           ++  Y   +     +  +     P  RPS+  +
Sbjct: 245 VSLHYSYDL---RSLVSQLFKRNPRDRPSVNSI 274

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  120 bits (302), Expect = 6e-29
 Identities = 86/396 (21%), Positives = 142/396 (35%), Gaps = 47/396 (11%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLI 195
            +DLS N I      S   L +LQ L +        +    F   S L++L L  N    
Sbjct: 34  YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ--F 91

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVI--PDSFVGLQSLSILDLSQNNLTGEVPQSLGS 252
            ++ +     L  LE L L      G +   + F  L SL +L L  NN+    P S   
Sbjct: 92  LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151

Query: 253 SLLKLVSFDVSQNKLSGSFPNGICKANGLVNL-----------SLHKNFFNGSIPGSINE 301
           ++ +    D++ NK+  S            +             +++ +      G+  +
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210

Query: 302 CLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
             ++    +  NGF      + +       I++     S  +  S            DN 
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG---HTNFKDPDNF 267

Query: 362 RFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE--L 418
            F      G+ +   L     S++    +L  + F     +  + L+QN I+ +I +   
Sbjct: 268 TFKGLEASGVKTC-DL-----SKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAF 319

Query: 419 KKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIP----QGLQNLK-LA 472
                L+ L+L+ N L   I       L  L  LDLS N++   +      GL NLK LA
Sbjct: 320 WGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELA 377

Query: 473 LFNVSFNKLSGRVPYSLISGLPAS---YLQGNPGLC 505
           L     N+L   VP  +   L +    +L  NP  C
Sbjct: 378 LDT---NQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 96.0 bits (239), Expect = 6e-21
 Identities = 67/359 (18%), Positives = 114/359 (31%), Gaps = 38/359 (10%)

Query: 157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS 216
            ++  ++L  N ++      F    +L  L + Q    +    +    L  L  L L  +
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 217 GFHGVIPDSFVGLQSLSILDLSQNNLTG-EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI 275
            F  +   +F GL +L +L L+Q NL G  +  +    L  L    +  N +    P   
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

Query: 276 -CKANGLVNLSLHKNFFNGSIPGSI--------NECLNLERFQVQD---NGFSGDFPDKL 323
                    L L  N    SI               L L    +QD        +     
Sbjct: 150 FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 324 WSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSAS 383
           +    I  +    N F  ++      A    ++Q      + ++    G           
Sbjct: 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK---DPD 265

Query: 384 QNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP- 440
             +F G           +   +LS++ I   + +        L  L+LA N +  +I   
Sbjct: 266 NFTFKGLEASG------VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317

Query: 441 SLAELPVLTYLDLSDNNLTGPIP----QGLQNLK-LALFNVSFNKLSGRVPYSLISGLP 494
           +   L  L  L+LS N L   I     + L  L+ L L     N +   +      GLP
Sbjct: 318 AFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY---NHIR-ALGDQSFLGLP 371

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 79.8 bits (197), Expect = 1e-15
 Identities = 46/199 (23%), Positives = 83/199 (41%), Gaps = 18/199 (9%)

Query: 80  INLQSLNLSG--------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETL--- 128
            ++ +L+LSG        +        + + +L L+++ +N       +     +     
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS-YNMGSSFGHTNFKDPDNFTFK 270

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLD 187
            L  + +   DLS++ I   + +S+     +L+ L L  N ++      F   + L+ L+
Sbjct: 271 GLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLN 329

Query: 188 LSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEV 246
           LSQN   +  I S +   L+KLE L L  +    +   SF+GL +L  L L  N L   V
Sbjct: 330 LSQN--FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SV 386

Query: 247 PQSLGSSLLKLVSFDVSQN 265
           P  +   L  L    +  N
Sbjct: 387 PDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 71.7 bits (176), Expect = 4e-13
 Identities = 44/171 (25%), Positives = 65/171 (38%), Gaps = 21/171 (12%)

Query: 90  EISSSVCELSSLSNLNLADNLFNQPIPLHLS--QCSSLETLNLSNNLI------------ 135
           +I S +   S     +     F  P        + S ++T +LS + I            
Sbjct: 240 KIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299

Query: 136 --WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNA 192
               L L++N I  KI ++    L +L  LNL  N L      +F N  +L VLDLS N 
Sbjct: 300 DLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358

Query: 193 YLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
             I  +       L  L++L L ++    V    F  L SL  + L  N  
Sbjct: 359 --IRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 58/337 (17%), Positives = 112/337 (33%), Gaps = 55/337 (16%)

Query: 197 EIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK 256
           E+P+ +        + L  +    +   SF  LQ L  L + Q      +  +    L  
Sbjct: 27  ELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 257 LVSFDVSQNKLSGSFPNGICKANGLVN---LSLHKNFFNGS-IPGSINECL-NLERFQVQ 311
           L+   +  N+       G    NGL N   L+L +   +G+ + G+  + L +LE   ++
Sbjct: 81  LIILKLDYNQFL-QLETGAF--NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137

Query: 312 DNGFSGDFPDKLW-SLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQ-----------ID 359
           DN      P   + ++ R  ++    N+   +I +   +  Q +              ++
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMN 196

Query: 360 NNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSII---------NLSQNS 410
                           S+     S N F  S+   F D+   + I         N+  + 
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256

Query: 411 ISGQIPELKKC-------RKLVSLSLADNSLTGEIPPSL-AELPVLTYLDLSDNNLTGPI 462
                 +             + +  L+ + +   +  S+ +    L  L L+ N +   I
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KI 314

Query: 463 P----QGLQNL-KLALFNVSFNKLSGRVPYSLISGLP 494
                 GL +L KL L   S N L   +   +   L 
Sbjct: 315 DDNAFWGLTHLLKLNL---SQNFLG-SIDSRMFENLD 347

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  115 bits (291), Expect = 2e-28
 Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 42/272 (15%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK---TLKTEVKTLAKIRHKNIVKVLGFFH 648
           G F  VY    L  G  +A+KK+  F    +K       E+  L ++ H N++K    F 
Sbjct: 43  GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102

Query: 649 SDESIFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            D  + ++ E    G L  +I         +      K  + +   L ++H      ++H
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMH 159

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPE----YG 756
           R++K  N+ + A    KL D  L R      F S  +   A S      Y +PE     G
Sbjct: 160 RDIKPANVFITATGVVKLGDLGLGRF-----FSSKTT--AAHSLVGTPYYMSPERIHENG 212

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
           Y+ K+    D +S G +L E+   +     +      + K       I         P  
Sbjct: 213 YNFKS----DIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEQCDY---PPLP 259

Query: 817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           ++ Y +++    ++   C +  PEKRP +  V
Sbjct: 260 SDHYSEEL---RQLVNMCINPDPEKRPDVTYV 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  114 bits (287), Expect = 4e-28
 Identities = 53/260 (20%), Positives = 103/260 (39%), Gaps = 28/260 (10%)

Query: 593 GPFGRVYI-LSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH- 648
           G F  VY  L   +   +A    +         +  K E + L  ++H NIV+    +  
Sbjct: 37  GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96

Query: 649 ---SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
                + I L+ E +  G+L   + R    ++  +       + +GL +LH    P ++H
Sbjct: 97  TVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TRTPPIIH 154

Query: 706 RNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R++K  NI +       K+ D  L  +   +  ++ + +      + APE  Y +K    
Sbjct: 155 RDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FMAPEM-YEEKYDES 209

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           +D Y+FG+ +LE+ T        P         + R+  +T+G       K+A    +++
Sbjct: 210 VDVYAFGMCMLEMATSEY-----PYSECQNAAQIYRR--VTSGVKPASFDKVAIPEVKEI 262

Query: 825 LGALEIALRCTSVMPEKRPS 844
           +        C     ++R S
Sbjct: 263 I------EGCIRQNKDERYS 276

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  117 bits (294), Expect = 8e-28
 Identities = 63/329 (19%), Positives = 123/329 (37%), Gaps = 18/329 (5%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
            +   R      +PE I      ++L+LG N +       F +F  L  L+L++N   +S
Sbjct: 15  AVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI--VS 69

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            +       L  L  L L+S+    +    F GL +L+ LD+S+N +   +   +   L 
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128

Query: 256 KLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG 314
            L S +V  N L     +      N L  L+L K         +++    L   +++   
Sbjct: 129 NLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLN 187

Query: 315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG-LGS 373
            +         L R+K++      +   +  +      L  + I +   T+ +P   +  
Sbjct: 188 INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRH 246

Query: 374 VKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLA 430
           +  L   + S N    ++  +   +   +  I L    ++  +     +    L  L+++
Sbjct: 247 LVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVS 304

Query: 431 DNSLTGEIPPSL-AELPVLTYLDLSDNNL 458
            N LT  +  S+   +  L  L L  N L
Sbjct: 305 GNQLT-TLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  111 bits (280), Expect = 5e-26
 Identities = 59/290 (20%), Positives = 108/290 (37%), Gaps = 21/290 (7%)

Query: 81  NLQSLNLSG-EISS----SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           +L+ L L+   +S+    +   L +L  L L  N          +  S+L  L++S N I
Sbjct: 57  HLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKI 116

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            +L                 L NL+ L +G N L       F   + L  L L +    +
Sbjct: 117 VILL----------DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN--L 164

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           + IP++    L  L  L L+    + +   SF  L  L +L++S       +  +     
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC-LYG 223

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANG-LVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
           L L S  ++   L+ + P    +    L  L+L  N  +      ++E L L+  Q+   
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRF 363
             +   P     L  ++++    N+ +            LE + +D+N  
Sbjct: 283 QLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  111 bits (280), Expect = 2e-27
 Identities = 61/278 (21%), Positives = 115/278 (41%), Gaps = 47/278 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G +GR   I     G+++  K+ +++G  +      L +EV  L +++H NIV+      
Sbjct: 17  GSYGRCQKIRRKSDGKILVWKE-LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75

Query: 649 --SDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLH--KDYVP 701
             ++ +++++ E+ + G L  +I    ++   L     L++   +   L   H   D   
Sbjct: 76  DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPE-- 754
            +LHR++K  N+ LD     KL DF L RI+          + +A +      Y +PE  
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-------DTSFAKTFVGTPYYMSPEQM 188

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
               Y++K+    D +S G +L EL        A   + L           I  G     
Sbjct: 189 NRMSYNEKS----DIWSLGCLLYELCALMPPFTAFSQKEL--------AGKIREGKF--- 233

Query: 813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             +I   Y  ++   +    R  ++    RPS+ E+++
Sbjct: 234 -RRIPYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 267

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  111 bits (280), Expect = 5e-27
 Identities = 61/294 (20%), Positives = 112/294 (38%), Gaps = 55/294 (18%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G GG F  V  +  L  G   A+K+++    Q  +  + E        H NI++++ +  
Sbjct: 38  GEGG-FSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96

Query: 649 SDES----IFLIYEFLQMGSLGDLICRQDFQLQWSIR------LKIAIGVAQGLAYLHKD 698
            +       +L+  F + G+L + I R                L + +G+ +GL  +H  
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERL---KDKGNFLTEDQILWLLLGICRGLEAIHA- 152

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDF---ALDRIVGEAAFQSTMSSEYALSC----YN 751
                 HR++K  NILL  + +P L D        I  E + Q+    ++A       Y 
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 752 APE----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--- 804
           APE      +      + D +S G VL  ++ G         +   V   V+ +++I   
Sbjct: 211 APELFSVQSH-CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 805 ---TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
              ++   Q+L           M+          +V P +RP +  ++  L +L
Sbjct: 270 PRHSSALWQLL---------NSMM----------TVDPHQRPHIPLLLSQLEAL 304

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (278), Expect = 1e-26
 Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 22/199 (11%)

Query: 592 GGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
            G FG V+      +G   AVKK V       +    E+   A +    IV + G     
Sbjct: 68  RGSFGEVHRMKDKQTGFQCAVKK-VRLEVFRVE----ELVACAGLSSPRIVPLYGAVREG 122

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             + +  E L+ GSLG LI +Q   L     L       +GL YLH   +   LH +VK+
Sbjct: 123 PWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKA 178

Query: 711 KNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALS---CYNAPE----YGYSKKAT 762
            N+LL +D     L DF     +       ++ +   +     + APE         K  
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV- 237

Query: 763 AQMDAYSFGVVLLELITGR 781
              D +S   ++L ++ G 
Sbjct: 238 ---DIWSSCCMMLHMLNGC 253

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  110 bits (276), Expect = 2e-26
 Identities = 55/268 (20%), Positives = 89/268 (33%), Gaps = 41/268 (15%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKI-RHKNIVKVLGFF 647
           G +G V+ + S   G L AVK+      +  K       EV +  K+ +H   V++   +
Sbjct: 68  GSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                ++L  E     SL          L  +            LA+LH      L+H +
Sbjct: 127 EEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLD 182

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPEY---GYSKKAT 762
           VK  NI L      KL DF L   +G A           Y      APE     Y   A 
Sbjct: 183 VKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYM-----APELLQGSYGTAA- 236

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
              D +S G+ +LE+         E     +  + +R+           L P+       
Sbjct: 237 ---DVFSLGLTILEVACNM-----ELPHGGEGWQQLRQGY---------LPPEFTAGLSS 279

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVK 850
           +      + +      P+ R +   ++ 
Sbjct: 280 E---LRSVLVMMLEPDPKLRATAEALLA 304

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/292 (19%), Positives = 107/292 (36%), Gaps = 57/292 (19%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           G GG FG V+   +       A+K+ +    +    + +  EVK LAK+ H  IV+    
Sbjct: 14  GRGG-FGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 647 F------------HSDESIFLIYEFLQMGSLGDLICRQDFQLQ--WSIRLKIAIGVAQGL 692
           +                 +++  +  +  +L D +  +    +   S+ L I + +A+ +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS---- 748
            +LH      L+HR++K  NI    D   K+ DF L   + +   + T+ +         
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188

Query: 749 ------CYNAPE----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV 798
                  Y +PE      YS K     D +S G++L EL+     +     E +  +   
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKV----DIFSLGLILFELLYPFSTQM----ERVRTLT-- 238

Query: 799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
               ++ N       P +             +     S  P +RP    +++
Sbjct: 239 ----DVRNLKF----PPLFTQKYPC---EYVMVQDMLSPSPMERPEAINIIE 279

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  108 bits (273), Expect = 3e-26
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 25/203 (12%)

Query: 592 GGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
            G +G VY    L +   IA+K++     + S+ L  E+     ++HKNIV+ LG F  +
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ---GLAYLHKDYVPHLLHRN 707
             I +  E +  GSL  L+  +   L+ + +  I     Q   GL YLH + +   +HR+
Sbjct: 92  GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQI---VHRD 147

Query: 708 VKSKNILLDA-DFEPKLTDFAL-DRIVGEAAFQSTMS-SEYALSCYNAPE------YGYS 758
           +K  N+L++      K++DF    R+ G      T + +      Y APE       GY 
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ----YMAPEIIDKGPRGYG 203

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           K A    D +S G  ++E+ TG+
Sbjct: 204 KAA----DIWSLGCTIIEMATGK 222

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  108 bits (272), Expect = 4e-26
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G    V      P  E +A+K++    CQ+S   L  E++ +++  H NIV     F   
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL----KIAI---GVAQGLAYLHKDYVPHL 703
           + ++L+ + L  GS+ D+I     + +    +     IA     V +GL YLHK+     
Sbjct: 86  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQ 142

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS---------CYNAPE 754
           +HR+VK+ NILL  D   ++ DF      G +AF +T                 C+ APE
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADF------GVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196

Query: 755 -----YGYSKKATAQMDAYSFGVVLLELITGR 781
                 GY  KA    D +SFG+  +EL TG 
Sbjct: 197 VMEQVRGYDFKA----DIWSFGITAIELATGA 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (274), Expect = 8e-26
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 33/213 (15%)

Query: 590 GNG-GPFGRVYI-LSLPSGELIAVKK--LVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G G      V +    P+GE + V++  L     +    L+ E+       H NIV    
Sbjct: 34  GKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK---IAI---GVAQGLAYLHKDY 699
            F +D  ++++  F+  GS  DLIC           +    IA    GV + L Y+H   
Sbjct: 94  TFIADNELWVVTSFMAYGSAKDLICTHFMD-----GMNELAIAYILQGVLKALDYIHHM- 147

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDF-ALDRIVGEAAFQSTMSSEYALS----CYNAPE 754
               +HR+VK+ +IL+  D +  L+   +   ++     Q  +      S     + +PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 755 ------YGYSKKATAQMDAYSFGVVLLELITGR 781
                  GY  K+    D YS G+   EL  G 
Sbjct: 206 VLQQNLQGYDAKS----DIYSVGITACELANGH 234

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  110 bits (278), Expect = 8e-26
 Identities = 73/453 (16%), Positives = 145/453 (32%), Gaps = 60/453 (13%)

Query: 78  ASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
           AS    +  +    + S  +L++L++L+  ++       +   + + L  L  ++N I  
Sbjct: 21  ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGI--EKLTGLTKLICTSNNITT 78

Query: 136 ---------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                      L    N +   +   +  L  L  LN  +N L+            L  L
Sbjct: 79  LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYL 132

Query: 187 DLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEV 246
           + ++N   ++EI  D+    +L +L         +          L+ LD S N +T   
Sbjct: 133 NCARNT--LTEI--DVSHNTQLTELDC--HLNKKITKLDVTPQTQLTTLDCSFNKIT--- 183

Query: 247 PQSLG-SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL 305
              L  S    L   +   N ++            L  L    N     I   +     L
Sbjct: 184 --ELDVSQNKLLNRLNCDTNNIT-KLDLNQNIQ--LTFLDCSSNKLT-EID--VTPLTQL 235

Query: 306 ERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS 365
             F    N  + +    + +L ++  +          I   ++   QL   Q +  R   
Sbjct: 236 TYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIK 289

Query: 366 SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLV 425
            +   +     LY            L  +    P +  + L+   ++ ++  +    KL 
Sbjct: 290 ELD--VTHNTQLYLLDCQAAGI-TELDLSQN--PKLVYLYLNNTELT-ELD-VSHNTKLK 342

Query: 426 SLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRV 485
           SLS  +  +  +    + ++P L     ++        + L N  L +  VS + L    
Sbjct: 343 SLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTI-AVSPDLLD--- 396

Query: 486 PYSLISGLPASYLQGNPGLCGPGLSNSCDENQP 518
                 G P +   G+ G+     +    EN  
Sbjct: 397 ----QFGNPMNIEPGDGGVYDQATNTITWENLS 425

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  107 bits (269), Expect = 1e-24
 Identities = 59/394 (14%), Positives = 127/394 (32%), Gaps = 51/394 (12%)

Query: 101 LSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI------------WVLDLSRNHIEGK 148
            ++   A         +   Q ++L +L+  N+ I              L  + N+I   
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNIT-T 78

Query: 149 IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL 208
           +   +    NL  L   SN L+          ++L  L+   N   ++++   + +   L
Sbjct: 79  LD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTN--KLTKLD--VSQNPLL 129

Query: 209 EQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS 268
             L    +    +          L+ LD   N    ++     +   +L + D S NK++
Sbjct: 130 TYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKIT 183

Query: 269 GSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPR 328
                   K   L  L+   N     +   +N+ + L       N  + +    +  L +
Sbjct: 184 -ELDVSQNKL--LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234

Query: 329 IKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFY 388
           +       N  +  +   +S  ++L  +          I   L     L  F A      
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288

Query: 389 GSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
             L  +   +  + +++     I+ ++  L +  KLV L L +  LT E+   ++    L
Sbjct: 289 KEL--DVTHNTQLYLLDCQAAGIT-ELD-LSQNPKLVYLYLNNTELT-ELD--VSHNTKL 341

Query: 449 TYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLS 482
             L   + ++        +   L     +  +  
Sbjct: 342 KSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 93.2 bits (232), Expect = 5e-20
 Identities = 73/411 (17%), Positives = 129/411 (31%), Gaps = 78/411 (18%)

Query: 81  NLQSLNLSG-EISS-SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
           NL  L     ++++  V  L+ L+ LN   N       L +SQ   L  LN + N +  +
Sbjct: 86  NLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTEI 142

Query: 139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEI 198
           D+S                 L  L+   N     +       ++L  LD S N   I+E+
Sbjct: 143 DVS-------------HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN--KITEL 185

Query: 199 PSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV 258
             D+ + + L +L   ++    +          L+ LD S N LT E+     + L +L 
Sbjct: 186 --DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID---VTPLTQLT 236

Query: 259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGD 318
            FD S N L+            L  L   +      I   +     L  FQ +      +
Sbjct: 237 YFDCSVNPLT-ELDVSTLSK--LTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKE 290

Query: 319 FPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY 378
               +    ++ L+  ++   +      +S   +L  + ++N   T              
Sbjct: 291 LD--VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELTE------------- 332

Query: 379 RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEI 438
               S N               +  ++     I      + K   L +   A+      +
Sbjct: 333 -LDVSHN-------------TKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQTI-TM 376

Query: 439 PPSLAELPVLTY------LDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSG 483
           P        LT       LD   N +    P        A   +++  LS 
Sbjct: 377 PKETLTNNSLTIAVSPDLLDQFGNPMN-IEPGDGGVYDQATNTITWENLST 426

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 47/345 (13%), Positives = 99/345 (28%), Gaps = 52/345 (15%)

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS----------------- 200
           N       +  +  +        + L  LD   ++  I+++                   
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSS--ITDMTGIEKLTGLTKLICTSNNI 76

Query: 201 ---DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
              D+ +   L  L   S+    +       L  L+ L+   N LT        S    L
Sbjct: 77  TTLDLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDV----SQNPLL 129

Query: 258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
              + ++N L+            L  L  H N         +     L       N  + 
Sbjct: 130 TYLNCARNTLT-EIDVSHNTQ--LTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKIT- 183

Query: 318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
           +    +     +  +  ++N  +  +   ++   QL  +   +N+ T  I   +  +  L
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQL 235

Query: 378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGE 437
             F  S N     L  +      ++ ++  Q  +  +I  L    +L+           E
Sbjct: 236 TYFDCSVNPL-TELDVSTLSK--LTTLHCIQTDLL-EID-LTHNTQLIYFQAEGCRKIKE 290

Query: 438 IPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLS 482
           +   +     L  LD     +T         L      ++  +L+
Sbjct: 291 LD--VTHNTQLYLLDCQAAGITELDLSQNPKLV--YLYLNNTELT 331

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 50/319 (15%), Positives = 101/319 (31%), Gaps = 35/319 (10%)

Query: 206 EKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN 265
           +        +         S   L +L+ LD   +++T ++       L  L     + N
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI--EKLTGLTKLICTSN 74

Query: 266 KLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWS 325
            ++ +    + +   L  L+   N    ++   +     L       N  +      +  
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQ 125

Query: 326 LPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN 385
            P +  +    N  +      +S   QL ++    N+  + +   +     L     S N
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 386 SFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAEL 445
                L  +      ++ +N   N+I+    +L +  +L  L  + N LT EI   +  L
Sbjct: 181 KIT-ELDVSQNKL--LNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKLT-EID--VTPL 232

Query: 446 PVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLC 505
             LTY D S N LT      L  L     +     L   +  +  + L     +G   + 
Sbjct: 233 TQLTYFDCSVNPLTELDVSTLSKLT--TLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIK 289

Query: 506 GPGLSN-------SCDENQ 517
              +++        C    
Sbjct: 290 ELDVTHNTQLYLLDCQAAG 308

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.7 bits (145), Expect = 2e-09
 Identities = 29/171 (16%), Positives = 50/171 (29%), Gaps = 21/171 (12%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDL 140
            L      G       +++  + L L D        L LSQ   L  L L+N  +  LD+
Sbjct: 276 QLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTELDV 335

Query: 141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS 200
           S                 L+ L+  +  +        G    L     ++       +P 
Sbjct: 336 S-------------HNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEG--QTITMPK 378

Query: 201 DIGKLEKLEQLF----LQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVP 247
           +      L        L   G    I     G+   +   ++  NL+ + P
Sbjct: 379 ETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (267), Expect = 1e-25
 Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 44/209 (21%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY+     S  ++A+K     +L   G +    L+ EV+  + +RH NI+++ G+
Sbjct: 20  GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVE--HQLRREVEIQSHLRHPNILRLYGY 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL------KIAIGVAQGLAYLHKDYV 700
           FH    ++LI E+  +G++   + +         +            +A  L+Y H    
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLS-------KFDEQRTATYITELANALSYCHSK-- 128

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE-- 754
             ++HR++K +N+LL +  E K+ DF    +   ++ ++ +       C    Y  PE  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL-------CGTLDYLPPEMI 179

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
               + +K     D +S GV+  E + G+
Sbjct: 180 EGRMHDEKV----DLWSLGVLCYEFLVGK 204

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  105 bits (265), Expect = 3e-25
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 32/203 (15%)

Query: 593 GPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG VY+     +  ++A+K     +L   G +    L+ E++  + +RH NI+++  +
Sbjct: 25  GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVE--HQLRREIEIQSHLRHPNILRMYNY 82

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           FH  + I+L+ EF   G L   + +     +      +   +A  L Y H+     ++HR
Sbjct: 83  FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME-ELADALHYCHER---KVIHR 138

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----YGYS 758
           ++K +N+L+    E K+ DF    +   +  + TM       C    Y  PE      + 
Sbjct: 139 DIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM-------CGTLDYLPPEMIEGKTHD 190

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
           +K     D +  GV+  E + G 
Sbjct: 191 EKV----DLWCAGVLCYEFLVGM 209

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (275), Expect = 4e-25
 Identities = 69/400 (17%), Positives = 128/400 (32%), Gaps = 52/400 (13%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQ-PIPLHLSQCSSLETLNLSNNLIW- 136
           S N     +SG  +             L     N+    L     +    L L+   +  
Sbjct: 14  SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS 73

Query: 137 ----------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                     VL++++N +   +PE      +L+ L+   N LS ++P +  +   L  L
Sbjct: 74  LPDNLPPQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPAS---LKHL 125

Query: 187 DLSQNAYLISEIPSDIGKLEKLE----QLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
           D+  N   ++ +P     LE +     QL         ++P+      SL +L +  N L
Sbjct: 126 DVDNNQ--LTMLPELPALLEYINADNNQL--------TMLPEL---PTSLEVLSVRNNQL 172

Query: 243 TGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN---GSIPGSI 299
           T  +P+   S    L + DVS N L  S P    + +      +           IP +I
Sbjct: 173 T-FLPELPES----LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITHIPENI 226

Query: 300 NECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQID 359
                     ++DN  S    + L               FS +     ++   L      
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286

Query: 360 NNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELK 419
              F  +    +  +   +      N+F   L     D+      +  +  ++     L+
Sbjct: 287 W--FPENKQSDVSQIWHAFEHEEHANTFSAFL-DRLSDTVSARNTSGFREQVAA---WLE 340

Query: 420 KCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT 459
           K      L     ++  +   S  +   LT+ +L    L 
Sbjct: 341 KLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV 380

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  101 bits (253), Expect = 2e-22
 Identities = 59/297 (19%), Positives = 103/297 (34%), Gaps = 42/297 (14%)

Query: 98  LSSLSNLNLADNLFNQ---PIPLHLSQC-SSLETLNLSNNLIWVLDLSRNHIEGKIPESI 153
           L   +N +L+ N F                  E   L          +RN     + E +
Sbjct: 5   LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGE-------NRNEAVSLLKECL 57

Query: 154 GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
             +     L L    LS S+P       ++ VL+++QNA  +  +P     LE L+    
Sbjct: 58  --INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNA--LISLPELPASLEYLDACDN 110

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN 273
           + S     +P+    L+ L   D+  N LT  +P+        L   +   N+L+   P 
Sbjct: 111 RLS----TLPELPASLKHL---DVDNNQLT-MLPELPAL----LEYINADNNQLT-MLPE 157

Query: 274 GICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG--DFPDKLWSLPRIKL 331
                  L  LS+  N     +P       +LE   V  N        P +       ++
Sbjct: 158 LPTS---LEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLESLPAVPVRNHHSEETEI 210

Query: 332 I-RAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
             R   NR +  IP++I        + +++N  +S I + L    +   +   +  F
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 97.0 bits (241), Expect = 5e-21
 Identities = 57/306 (18%), Positives = 110/306 (35%), Gaps = 61/306 (19%)

Query: 186 LDLSQNAYL--ISEIPSDI----GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
             LSQN++   IS   +D      K EK        +    ++ +    +   S L L++
Sbjct: 11  FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNR 68

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI 299
            NL+  +P +L   +  L   +++QN L  S P        L  L    N  + ++P   
Sbjct: 69  LNLS-SLPDNLPPQITVL---EITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELP 119

Query: 300 NECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQID 359
               +L+   V +N  +   P+    L   + I A++N+ +  +P+  +    LE + + 
Sbjct: 120 ---ASLKHLDVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPT---SLEVLSVR 168

Query: 360 NNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG---QIP 416
           NN+ T  +P+   S+++L                           ++S N +        
Sbjct: 169 NNQLTF-LPELPESLEAL---------------------------DVSTNLLESLPAVPV 200

Query: 417 ELKKCRKL-VSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFN 475
                 +  +     +N +T  IP ++  L     + L DN L+  I + L         
Sbjct: 201 RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDY 259

Query: 476 VSFNKL 481
                 
Sbjct: 260 HGPRIY 265

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  105 bits (263), Expect = 9e-25
 Identities = 68/306 (22%), Positives = 119/306 (38%), Gaps = 53/306 (17%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG-- 645
           G FG V       L   +G L+AVK+L + G    +  + E++ L  +    IVK  G  
Sbjct: 34  GNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVS 93

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
           +    +S+ L+ E+L  G L D + R   +L  S  L  +  + +G+ YL  +  V    
Sbjct: 94  YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCV---- 149

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEYG 756
           HR++ ++NIL++++   K+ DF L +++           +Y +            APE  
Sbjct: 150 HRDLAARNILVESEAHVKIADFGLAKLLPL-------DKDYYVVREPGQSPIFWYAPESL 202

Query: 757 YSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD-- 813
                + Q D +SFGVVL EL T   +               +           ++L+  
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDK-----SCSPSAEFLRMMGCERDVPALSRLLELL 257

Query: 814 ------PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS 863
                 P    C    +        E+   C +  P+ RPS   +   L  L + +    
Sbjct: 258 EEGQRLPAPPACPAEVH--------ELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309

Query: 864 IELSSS 869
               ++
Sbjct: 310 THAFTA 315

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (261), Expect = 1e-24
 Identities = 57/284 (20%), Positives = 98/284 (34%), Gaps = 52/284 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKI-RHKNIVKVLGFF 647
           G FG V+  +    G + A+K+        S   +    EV   A + +H ++V+    +
Sbjct: 22  GEFGSVFKCVKRLDGCIYAIKR-SKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80

Query: 648 HSDESIFLIYEFLQMGSLGDLI---CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
             D+ + +  E+   GSL D I    R     + +    + + V +GL Y+H      L+
Sbjct: 81  AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLV 137

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIV-------------GEAAFQSTMSSEYALSCYN 751
           H ++K  NI +     P       D                G     S+   E   S + 
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFL 197

Query: 752 APE-----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN 806
           A E     Y +  KA    D ++  + ++               + D          I  
Sbjct: 198 ANEVLQENYTHLPKA----DIFALALTVVCAAGAE-----PLPRNGDQWH------EIRQ 242

Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           G +    P+I     Q+    L+         PE+RPS   +VK
Sbjct: 243 GRL----PRIPQVLSQEFTELLK---VMIHPDPERRPSAMALVK 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  103 bits (259), Expect = 1e-24
 Identities = 61/287 (21%), Positives = 116/287 (40%), Gaps = 65/287 (22%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G+GG FG+V+       G+   +K++      +++  + EVK LAK+ H NIV   G + 
Sbjct: 20  GSGG-FGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCWD 74

Query: 649 SDES----------------IFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQG 691
             +                 +F+  EF   G+L   I ++  + L   + L++   + +G
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKG 134

Query: 692 LAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-- 749
           + Y+H      L++R++K  NI L    + K+ DF L   +     ++            
Sbjct: 135 VDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-------KGT 184

Query: 750 --YNAPE----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
             Y +PE      Y K+     D Y+ G++L EL+        + A            + 
Sbjct: 185 LRYMSPEQISSQDYGKEV----DLYALGLILAELLHV-----CDTAFETSKFF---TDLR 232

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                    D  I++ + ++    L+   +  S  PE RP+  E+++
Sbjct: 233 ---------DGIISDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILR 267

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (257), Expect = 3e-24
 Identities = 69/296 (23%), Positives = 128/296 (43%), Gaps = 50/296 (16%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG-- 645
           G FG V       L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 21  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 80

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
           +     ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 81  YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 136

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEYG 756
           HR++ ++NIL++ +   K+ DF L +++ +         E+              APE  
Sbjct: 137 HRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEFFKVKEPGESPIFWYAPESL 189

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD--- 813
              K +   D +SFGVVL EL T  +  ++ PAE + ++   ++   +      +++   
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIV--FHLIELLK 246

Query: 814 -----PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
                P+   C    Y         I   C +    +RPS  ++   +  +    +
Sbjct: 247 NNGRLPRPDGCPDEIY--------MIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (266), Expect = 3e-24
 Identities = 71/379 (18%), Positives = 122/379 (32%), Gaps = 25/379 (6%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
           +L++S+N+I       I SL  L++L +  N +      VF    EL  LDLS N   + 
Sbjct: 25  ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN--KLV 82

Query: 197 EIPSDIGKLEKLEQLFLQSSGFHGV-IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           +I         L+ L L  + F  + I   F  +  L  L LS  +L       +    +
Sbjct: 83  KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNI 140

Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVN--LSLHKNFFNGSIPGSINECLNLERFQVQDN 313
             V   + +       P G+   N      +      F+  +  S+    NLE   ++  
Sbjct: 141 SKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

Query: 314 GFSGDFPDKLWSLPRIKLIRAESN------RFSGAIPDSISMAA---QLEQVQIDNNRFT 364
                    L  L +++     SN        +      I        +    I N +  
Sbjct: 201 LEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260

Query: 365 -----SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI-SGQIPEL 418
                        S+K+L       + F       +     M+I N + +      +   
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320

Query: 419 KKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT--GPIPQGLQNL-KLALFN 475
            K    + L  ++N LT  +  +   L  L  L L  N L     I +    +  L   +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380

Query: 476 VSFNKLSGRVPYSLISGLP 494
           +S N +S        S   
Sbjct: 381 ISQNSVSYDEKKGDCSWTK 399

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 99.2 bits (247), Expect = 9e-22
 Identities = 95/478 (19%), Positives = 160/478 (33%), Gaps = 76/478 (15%)

Query: 81  NLQSLNLSG----EISSSVC-ELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
               LN+S     E+ +S    LS L  L ++ N               LE L+LS+N +
Sbjct: 22  KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF--VFGNFSELVVLDLSQNAY 193
             +             S    VNL+ L+L  N    ++P    FGN S+L  L LS   +
Sbjct: 82  VKI-------------SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTT-H 126

Query: 194 LISEIPSDIGKLEKLEQLFLQSSGFHGVI-PDSFVGL--QSLSILDLSQNNLTGEVPQSL 250
           L       I  L   + L +    +     P+       +SL I+  +       +  S+
Sbjct: 127 LEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSV 186

Query: 251 GS----------SLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG---SIPG 297
            +           +L+        + L+    N       L N+    N F      +  
Sbjct: 187 KTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 298 SINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI-------------- 343
           +     ++   ++Q      DF     SL  + + +  S+ F                  
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 344 ----------PDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP 393
                         S  +    +   NN  T ++ +  G +  L       N     L  
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL-KELSK 365

Query: 394 N---FCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVL 448
                     +  +++SQNS+S    +      + L+SL+++ N LT  I   L   P +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423

Query: 449 TYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLP---ASYLQGNP 502
             LDL  N +   IP+ +  L  L   NV+ N+L   VP  +   L      +L  NP
Sbjct: 424 KVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 62/333 (18%), Positives = 125/333 (37%), Gaps = 24/333 (7%)

Query: 19  LTFFAFTSASTEKDTLLSFKASIDDSKNSLS--TWSNTSNIHYCNWTGVTC--VTTATAS 74
           L  F   S      T   F   +D S  +++    SN   +   N        +     +
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219

Query: 75  LTVASINLQSLNLSGEISSSV---CELSSLSNLNLADNLFNQPIPLHLSQCS--SLETLN 129
             ++++ L ++  +      +      +++   ++++      +       S  SL+ L+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279

Query: 130 LSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLS 189
           +   +  V    +++I            N+ + N   +             S  + LD S
Sbjct: 280 IHQVVSDVFGFPQSYIYEI-------FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332

Query: 190 QNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV--IPDSFVGLQSLSILDLSQNNLTGEVP 247
            N  L   +  + G L +LE L LQ +    +  I +    ++SL  LD+SQN+++ +  
Sbjct: 333 NNL-LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391

Query: 248 QSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLER 307
           +   S    L+S ++S N L+ +     C    +  L LH N    SIP  + +   L+ 
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFR--CLPPRIKVLDLHSNKIK-SIPKQVVKLEALQE 448

Query: 308 FQVQDNGFSGDFPDKLW-SLPRIKLIRAESNRF 339
             V  N      PD ++  L  ++ I   +N +
Sbjct: 449 LNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 79.1 bits (195), Expect = 2e-15
 Identities = 55/306 (17%), Positives = 113/306 (36%), Gaps = 41/306 (13%)

Query: 86  NLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHI 145
            L+   ++      +L+N+    N F +   L L   +++   ++SN       L     
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSISNV-----KLQGQLD 264

Query: 146 EGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN-AYLISEIPSDIGK 204
                 S  SL  L +  + S++      +++  FS + + + + +   ++  +     K
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPS--K 322

Query: 205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG--SSLLKLVSFDV 262
           +     L   ++     + ++   L  L  L L  N L  E+ +     + +  L   D+
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDI 381

Query: 263 SQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDK 322
           SQN +S     G C  +   +L                  LN+       N  +      
Sbjct: 382 SQNSVSYDEKKGDC--SWTKSLLS----------------LNM-----SSNILTDTIFRC 418

Query: 323 LWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG-LGSVKSLYRFS 381
           L   PRIK++   SN+   +IP  +     L+++ + +N+   S+P G    + SL +  
Sbjct: 419 L--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIW 474

Query: 382 ASQNSF 387
              N +
Sbjct: 475 LHTNPW 480

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  106 bits (265), Expect = 4e-24
 Identities = 61/277 (22%), Positives = 119/277 (42%), Gaps = 33/277 (11%)

Query: 593 GPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G VY        L +AVK L        +    E   + +I+H N+V++LG    + 
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289

Query: 652 SIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK 709
             ++I EF+  G+L D L      ++   + L +A  ++  + YL  K+++    HRN+ 
Sbjct: 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI----HRNLA 345

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D ++
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSDVWA 404

Query: 770 FGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC----YQQQM 824
           FGV+L E+ T G             V + + +   +          +   C    Y+   
Sbjct: 405 FGVLLWEIATYGMSPYPGIDLS--QVYELLEKDYRM---------ERPEGCPEKVYE--- 450

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
                +   C    P  RPS  E+ +A  ++   +S+
Sbjct: 451 -----LMRACWQWNPSDRPSFAEIHQAFETMFQESSI 482

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 4e-24
 Identities = 70/296 (23%), Positives = 129/296 (43%), Gaps = 50/296 (16%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG-- 645
           G FG V       L   +GE++AVKKL +   +  +  + E++ L  ++H NIVK  G  
Sbjct: 52  GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC 111

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLL 704
           +     ++ LI E+L  GSL D + +   ++     L+    + +G+ YL  K Y+    
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI---- 167

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEYG 756
           HR++ ++NIL++ +   K+ DF L +++ +         EY              APE  
Sbjct: 168 HRDLATRNILVENENRVKIGDFGLTKVLPQ-------DKEYYKVKEPGESPIFWYAPESL 220

Query: 757 YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD--- 813
              K +   D +SFGVVL EL T  +  ++ PAE + ++   ++   +      +++   
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG-QMIV--FHLIELLK 277

Query: 814 -----PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
                P+   C    Y         I   C +    +RPS  ++   +  +  + +
Sbjct: 278 NNGRLPRPDGCPDEIY--------MIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  101 bits (255), Expect = 7e-24
 Identities = 50/235 (21%), Positives = 101/235 (42%), Gaps = 25/235 (10%)

Query: 626 KTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           + EV   +++ H+NIV ++     D+  +L+ E+++  +L + I      L     +   
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI-ESHGPLSVDTAINFT 117

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST---MS 742
             +  G+ + H      ++HR++K +NIL+D++   K+ DF + + + E +   T   + 
Sbjct: 118 NQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI 802
           +      Y +PE    +      D YS G+VL E++ G      E A S+  +K ++  +
Sbjct: 175 TVQ----YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-AIKHIQDSV 229

Query: 803 NITNGAIQVLDPKIANCYQQQMLGALE-IALRCTSVMPEKRP-SMFEVVKALHSL 855
                    +   I          +L  + LR T      R  ++ E+   L S+
Sbjct: 230 PN---VTTDVRKDIPQ--------SLSNVILRATEKDKANRYKTIQEMKDDLSSV 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  102 bits (255), Expect = 8e-24
 Identities = 72/290 (24%), Positives = 115/290 (39%), Gaps = 48/290 (16%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG- 645
           G FG+V           +GE +AVK L    G      LK E++ L  + H+NIVK  G 
Sbjct: 32  GHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGI 91

Query: 646 -FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHL 703
                   I LI EFL  GSL + + +   ++    +LK A+ + +G+ YL  + YV   
Sbjct: 92  CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV--- 148

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEY 755
            HR++ ++N+L++++ + K+ DF L + +           EY     +        APE 
Sbjct: 149 -HRDLAARNVLVESEHQVKIGDFGLTKAIET-------DKEYYTVKDDRDSPVFWYAPEC 200

Query: 756 GYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD- 813
               K     D +SFGV L EL+T               +     +        +  L  
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV--TRLVNTLKE 258

Query: 814 ----PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
               P   NC    YQ        +  +C    P  R S   +++   +L
Sbjct: 259 GKRLPCPPNCPDEVYQ--------LMRKCWEFQPSNRTSFQNLIEGFEAL 300

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (261), Expect = 1e-23
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 33/275 (12%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 252

Query: 653 IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKS 710
           I+++ E++  GSL D L       L+    + +A  +A G+AY+   +YV    HR++++
Sbjct: 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 308

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 309 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 367

Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC----YQQQML 825
           G++L EL T GR           +V+  V R   +         P    C    +     
Sbjct: 368 GILLTELTTKGRVPYPGMVNR--EVLDQVERGYRM---------PCPPECPESLHD---- 412

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
               +  +C    PE+RP+   +   L    T T 
Sbjct: 413 ----LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  101 bits (253), Expect = 1e-23
 Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 30/206 (14%)

Query: 590 GNGGPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G G  F  VY   S+ +G  +A+K      +   G    + ++ EVK   +++H +I+++
Sbjct: 20  GKGS-FAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILEL 76

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
             +F     ++L+ E    G +   +  +      +        +  G+ YLH   +   
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI--- 133

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----Y 755
           LHR++   N+LL  +   K+ DF L      A        ++   C    Y +PE     
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMPHEKHYTLCGTPNYISPEIATRS 187

Query: 756 GYSKKATAQMDAYSFGVVLLELITGR 781
            +  ++    D +S G +   L+ GR
Sbjct: 188 AHGLES----DVWSLGCMFYTLLIGR 209

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  101 bits (253), Expect = 2e-23
 Identities = 76/298 (25%), Positives = 128/298 (42%), Gaps = 56/298 (18%)

Query: 593 GPFGRVY-----ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG- 645
           G FG+V        +  +GE++AVK L  + G Q     K E+  L  + H++I+K  G 
Sbjct: 42  GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGC 101

Query: 646 -FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHL 703
                  S+ L+ E++ +GSL D + R    L     L  A  + +G+AYLH + Y+   
Sbjct: 102 CEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQ--LLLFAQQICEGMAYLHAQHYI--- 156

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN------------ 751
            HR++ ++N+LLD D   K+ DF L + V E         EY    Y             
Sbjct: 157 -HRDLAARNVLLDNDRLVKIGDFGLAKAVPE-------GHEY----YRVREDGDSPVFWY 204

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV 811
           APE     K     D +SFGV L EL+T   + Q+ P + L+++   + ++ +     ++
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTEL 263

Query: 812 LD-----PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
           L+     P+   C    Y         +   C       RP+   ++  L ++  +  
Sbjct: 264 LERGERLPRPDKCPAEVY--------HLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 2e-23
 Identities = 45/213 (21%), Positives = 78/213 (36%), Gaps = 29/213 (13%)

Query: 81  NLQSLNLSG-EISSSVCE------LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN 133
            L  L+LS   +S   C        +SL  L+L+ N     +  +      LE L+  ++
Sbjct: 53  QLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHS 111

Query: 134 LI---------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSN-LLSGSVPFVF 177
            +                 LD+S  H           L +L+VL +  N      +P +F
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 171

Query: 178 GNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD 236
                L  LDLSQ    + ++       L  L+ L +  + F  +    +  L SL +LD
Sbjct: 172 TELRNLTFLDLSQCQ--LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229

Query: 237 LSQNNLTGEVPQSLGSSLLK-LVSFDVSQNKLS 268
            S N++     +         L   +++QN  +
Sbjct: 230 YSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 57/256 (22%), Positives = 92/256 (35%), Gaps = 29/256 (11%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW-- 136
            I   S  L+  + + +   SS + L L  N           + + L  L+LS+N +   
Sbjct: 11  EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 137 --------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFS 181
                          LDLS N +   +  +   L  L+ L+   + L     F VF +  
Sbjct: 68  GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126

Query: 182 ELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQS-SGFHGVIPDSFVGLQSLSILDLSQ 239
            L+ LD+S          + I   L  LE L +   S     +PD F  L++L+ LDLSQ
Sbjct: 127 NLIYLDISHTH--TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI 299
             L  ++  +  +SL  L   ++S N             N L  L    N    +     
Sbjct: 185 CQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242

Query: 300 NECL--NLERFQVQDN 313
            +    +L    +  N
Sbjct: 243 LQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 52/295 (17%), Positives = 95/295 (32%), Gaps = 59/295 (20%)

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT-GEVPQSLGSS 253
           ++ +P+ I       +L L+S+    +    F  L  L+ L LS N L+           
Sbjct: 19  LTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFG 76

Query: 254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
              L   D+S N +                          ++  +      LE    Q +
Sbjct: 77  TTSLKYLDLSFNGVI-------------------------TMSSNFLGLEQLEHLDFQHS 111

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS 373
                    L  +        E + F             L  + I +     +       
Sbjct: 112 --------NLKQMS-------EFSVFLSL--------RNLIYLDISHTHTRVAFNGIFNG 148

Query: 374 VKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLA 430
           + SL     + NSF  +  P+ F +   ++ ++LSQ  +  Q+          L  L+++
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMS 207

Query: 431 DNSLTGEIPPS-LAELPVLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLS 482
            N+    +       L  L  LD S N++     Q LQ+    LA  N++ N  +
Sbjct: 208 HNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  103 bits (258), Expect = 2e-23
 Identities = 69/284 (24%), Positives = 131/284 (46%), Gaps = 39/284 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +AVK +   G  S +    E   +  ++H  +VK+     + E 
Sbjct: 199 GQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TKEP 256

Query: 653 IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKS 710
           I++I EF+  GSL D L   +  +      +  +  +A+G+A++  ++Y+    HR++++
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI----HRDLRA 312

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+ A    K+ DF L R++ +  + +   +++ +  + APE       T + D +SF
Sbjct: 313 ANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK-WTAPEAINFGSFTIKSDVWSF 371

Query: 771 GVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANC----YQQ 822
           G++L+E++T GR      P   +   +V++ + R   +         P+  NC    Y  
Sbjct: 372 GILLMEIVTYGRI-----PYPGMSNPEVIRALERGYRM---------PRPENCPEELYN- 416

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIEL 866
                  I +RC    PE+RP+   +   L    T T     E+
Sbjct: 417 -------IMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYEEI 453

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  104 bits (260), Expect = 3e-23
 Identities = 77/379 (20%), Positives = 125/379 (32%), Gaps = 27/379 (7%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLI 195
            L LS+N I       I  L  L+VL L  N +  S+ F VF    +L  LD+S N   +
Sbjct: 56  ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN--RL 112

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDS--FVGLQSLSILDLSQNNLTGEVPQSLGSS 253
             I      +  L  L L  + F  V+P    F  L  L+ L LS           +   
Sbjct: 113 QNISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169

Query: 254 LLKLVSFDVSQNKLSGSFPNGICKAN-GLVNLSLHKN-FFNGSIPGSINECLNLERFQVQ 311
            L  +  D+    + G     +   N  +++L  H N  F+  +  S+N   +L+   ++
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229

Query: 312 DNGFSGDFPDKL--WSLPRIKLIRAESNRFSGAIPDSISM-----AAQLEQVQIDNNRFT 364
            N  +                L+             S+ +        +E + I N   T
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 365 SSIPQGLG-----SVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI-SGQIPEL 418
             I +        ++KSL         F  S    +     M+I  LS +      +   
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 419 KKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT--GPIPQGLQNLK-LALFN 475
                   L+   N  T  +    + L  L  L L  N L     +    +N+  L   +
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409

Query: 476 VSFNKLSGRVPYSLISGLP 494
           VS N L+        +   
Sbjct: 410 VSLNSLNSHAYDRTCAWAE 428

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 93.4 bits (232), Expect = 8e-20
 Identities = 54/327 (16%), Positives = 103/327 (31%), Gaps = 28/327 (8%)

Query: 3   TASSPLSFLCLHLLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNW 62
            + + L  L L  +           +   +            ++  +TW  +  +    W
Sbjct: 215 MSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFW 274

Query: 63  TGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQC 122
                       L + ++ +       E + S   L SL   ++ + +F        S  
Sbjct: 275 P------RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVF 328

Query: 123 SSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE 182
           + +    LS +     D    H          S  +   LN   N+ + SV         
Sbjct: 329 AEMNIKMLSIS-----DTPFIH-----MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378

Query: 183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGF----HGVIPDSFVGLQSLSILDLS 238
           L  L L +N   +          + +  L                 +    +S+ +L+LS
Sbjct: 379 LQTLILQRNG--LKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP-G 297
            N LTG V + L   +  L   D+  N++  S P  +     L  L++  N    S+P G
Sbjct: 437 SNMLTGSVFRCLPPKVKVL---DLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDG 491

Query: 298 SINECLNLERFQVQDNGFSGDFPDKLW 324
             +   +L+   + DN +    P   +
Sbjct: 492 VFDRLTSLQYIWLHDNPWDCTCPGIRY 518

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 87.6 bits (217), Expect = 4e-18
 Identities = 83/453 (18%), Positives = 150/453 (33%), Gaps = 71/453 (15%)

Query: 81  NLQSLNLSG----EISSSVCE-LSSLSNLNLADNLFNQPIPLHL-SQCSSLETLNLSNNL 134
             ++L+LS     E+       LS L  L L+ N   + +  H+      LE L++S+N 
Sbjct: 53  RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHNR 111

Query: 135 I-----------WVLDLSRNHIEG-KIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSE 182
           +             LDLS N  +   + +  G+L  L  L L +      +  +      
Sbjct: 112 LQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLH 170

Query: 183 LVVLDLSQNAYLISEIPSDI---GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
           L  + L   +Y I    ++         L  +F  +S F   +  S   L  L + ++  
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKL 230

Query: 240 NNLTGEVPQSLGSSLLK--------LVSFDVSQNKLSGSFPNGICKA---NGLVNLSLHK 288
           N+   +   +  S L +        L   + +       F     +      + NL++ +
Sbjct: 231 NDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITE 290

Query: 289 NFFNGSIPGSINECLNLERFQVQDNGFSGDFP---DKLWSLPRIKLIRAESNRFSGAIPD 345
                    S     +L    V++  F             +    L  +++       P 
Sbjct: 291 RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP 350

Query: 346 SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF------------------ 387
           S S       +    N FT S+ QG  ++K L      +N                    
Sbjct: 351 SPS---SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407

Query: 388 ----YGSLPPNFCDSPV-----MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEI 438
                 SL  +  D        + ++NLS N ++G +       K+  L L +N +   I
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRIM-SI 465

Query: 439 PPSLAELPVLTYLDLSDNNLTGPIPQG-LQNLK 470
           P  +  L  L  L+++ N L   +P G    L 
Sbjct: 466 PKDVTHLQALQELNVASNQLKS-VPDGVFDRLT 497

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  101 bits (254), Expect = 3e-23
 Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 61/286 (21%)

Query: 593 GPFGRVY--ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG V+   L   +   +AVK                E + L +  H NIV+++G    
Sbjct: 125 GNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
            + I+++ E +Q G     +  +  +L+    L++    A G+ YL        +HR++ 
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLA 240

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APE---YG-Y 757
           ++N L+      K++DF + R   +          YA S           APE   YG Y
Sbjct: 241 ARNCLVTEKNVLKISDFGMSREEAD--------GVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 758 SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLD 813
           S ++    D +SFG++L E  + G       P  +L      ++V +   +         
Sbjct: 293 SSES----DVWSFGILLWETFSLGAS-----PYPNLSNQQTREFVEKGGRL--------- 334

Query: 814 PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           P    C    +         +  +C +  P +RPS   + + L S+
Sbjct: 335 PCPELCPDAVF--------RLMEQCWAYEPGQRPSFSTIYQELQSI 372

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (259), Expect = 3e-23
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 33/275 (12%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++     S+E 
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEP 335

Query: 653 IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVKS 710
           I+++ E++  GSL D L       L+    + +A  +A G+AY+   +YV    HR++++
Sbjct: 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV----HRDLRA 391

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
            NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +SF
Sbjct: 392 ANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK-WTAPEAALYGRFTIKSDVWSF 450

Query: 771 GVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC----YQQQML 825
           G++L EL T GR           +V+  V R   +         P    C    +     
Sbjct: 451 GILLTELTTKGRVPYPGMVNR--EVLDQVERGYRM---------PCPPECPESLHD---- 495

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
               +  +C    PE+RP+   +   L    T T 
Sbjct: 496 ----LMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 58/292 (19%), Positives = 112/292 (38%), Gaps = 54/292 (18%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  FG+V    +       A+KK +    +   T+ +EV  LA + H+ +V+    + 
Sbjct: 15  GQGA-FGQVVKARNALDSRYYAIKK-IRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72

Query: 649 SDES-------------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
              +             +F+  E+ + G+L DLI  ++   Q     ++   + + L+Y+
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS------- 748
           H      ++HR++K  NI +D     K+ DF L + V  +     + S+           
Sbjct: 133 HSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTS 189

Query: 749 -----CYNAPE-----YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWV 798
                 Y A E       Y++K     D YS G++  E+I           E ++++K  
Sbjct: 190 AIGTAMYVATEVLDGTGHYNEKI----DMYSLGIIFFEMIYPFSTGM----ERVNILK-- 239

Query: 799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                + + +I+   P   +   +      +I        P KRP    ++ 
Sbjct: 240 ----KLRSVSIE-FPPDFDDNKMKV---EKKIIRLLIDHDPNKRPGARTLLN 283

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  100 bits (250), Expect = 5e-23
 Identities = 66/300 (22%), Positives = 120/300 (40%), Gaps = 57/300 (19%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
           G  G V    L +P    +  A+K L   G    +     +E   + +  H NI+++ G 
Sbjct: 60  GDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
                   ++ E+++ GSL   +   D Q      + +  GV  G+ YL    YV    H
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV----H 174

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEYGY 757
           R++ ++N+L+D++   K++DF L R++ +         + A +           APE   
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLED-------DPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 758 SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLD 813
            +  ++  D +SFGVV+ E++  G +     P  ++   DV+       ++  G    L 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER-----PYWNMTNRDVIS------SVEEG--YRL- 273

Query: 814 PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSS 869
           P    C    +Q        + L C      +RP   ++V  L +L      L    + S
Sbjct: 274 PAPMGCPHALHQ--------LMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  100 bits (250), Expect = 6e-23
 Identities = 67/363 (18%), Positives = 115/363 (31%), Gaps = 86/363 (23%)

Query: 120 SQCS-SLETLNLSNN-----------LIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSN 167
            +C   L  +  S+               +LDL  N I         +L NL  L L +N
Sbjct: 27  FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 86

Query: 168 LLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV 227
            +S   P  F    +L  L LS+N   + E+P  +   + L++L +  +    V    F 
Sbjct: 87  KISKISPGAFAPLVKLERLYLSKN--QLKELPEKM--PKTLQELRVHENEITKVRKSVFN 142

Query: 228 GLQSLSILDLSQNNLT-GEVPQSLGSSLLKLVSFDVSQNKLS----GSFPNGICKANGLV 282
           GL  + +++L  N L    +       + KL    ++   ++    G  P+       L 
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS-------LT 195

Query: 283 NLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGA 342
            L L  N         I +        V      G        L  +  +    N  S  
Sbjct: 196 ELHLDGN--------KITK--------VDAASLKG--------LNNLAKLGLSFNSISAV 231

Query: 343 IPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMS 402
              S++    L ++ ++NN+                            +P    D   + 
Sbjct: 232 DNGSLANTPHLRELHLNNNKLV-------------------------KVPGGLADHKYIQ 266

Query: 403 IINLSQNSIS-------GQIPELKKCRKLVSLSLADNSLT-GEIPPSL-AELPVLTYLDL 453
           ++ L  N+IS              K      +SL  N +   EI PS    + V   + L
Sbjct: 267 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 326

Query: 454 SDN 456
            + 
Sbjct: 327 GNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 40/212 (18%), Positives = 74/212 (34%), Gaps = 29/212 (13%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADN-LFNQPIPLH-LSQCSSLETLNLSNN 133
            LQ L +      ++  SV   L+ +  + L  N L +  I          L  + +++ 
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181

Query: 134 LIW-----------VLDLSRNHIEGKIPE-SIGSLVNLQVLNLGSNLLSGSVPFVFGNFS 181
            I             L L  N I  K+   S+  L NL  L L  N +S        N  
Sbjct: 182 NITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240

Query: 182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF------VGLQSLSIL 235
            L  L L+ N   + ++P  +   + ++ ++L ++    +  + F          S S +
Sbjct: 241 HLRELHLNNNK--LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298

Query: 236 DLSQNNLT-GEVPQSLGSSLLKLVSFDVSQNK 266
            L  N +   E+  S    +    +  +   K
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 67/306 (21%), Positives = 116/306 (37%), Gaps = 66/306 (21%)

Query: 182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN 241
            L V+  S     + ++P D+        L LQ++    +    F  L++L  L L  N 
Sbjct: 32  HLRVVQCSDLG--LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 242 LTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINE 301
           ++ ++     + L+KL    +S+N+L    P  + K   L  L +H+N          N 
Sbjct: 88  IS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEITKVRKSVFNG 143

Query: 302 CLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
              +   ++  N               +K    E+  F G          +L  ++I + 
Sbjct: 144 LNQMIVVELGTN--------------PLKSSGIENGAFQGMK--------KLSYIRIADT 181

Query: 362 RFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE--L 418
             T+ IPQGL  S+  L+                           L  N I+ ++    L
Sbjct: 182 NITT-IPQGLPPSLTELH---------------------------LDGNKIT-KVDAASL 212

Query: 419 KKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNV 476
           K    L  L L+ NS++  +   SLA  P L  L L++N L   +P GL + K + +  +
Sbjct: 213 KGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYL 270

Query: 477 SFNKLS 482
             N +S
Sbjct: 271 HNNNIS 276

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  100 bits (250), Expect = 6e-23
 Identities = 51/207 (24%), Positives = 93/207 (44%), Gaps = 33/207 (15%)

Query: 590 GNGGPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G GG F + + +    + E+ A K      L+    Q  K +  E+     + H+++V  
Sbjct: 50  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREK-MSMEISIHRSLAHQHVVGF 106

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
            GFF  ++ +F++ E  +  SL +L  R+    +   R      +  G  YLH++ V   
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV--- 162

Query: 704 LHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSC----YNAPEY--- 755
           +HR++K  N+ L+ D E K+ DF L  ++  +   +  +       C    Y APE    
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-------CGTPNYIAPEVLSK 215

Query: 756 -GYSKKATAQMDAYSFGVVLLELITGR 781
            G+S +     D +S G ++  L+ G+
Sbjct: 216 KGHSFEV----DVWSIGCIMYTLLVGK 238

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.8 bits (247), Expect = 7e-23
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 45/213 (21%)

Query: 590 GNGGPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G GG F + + +    + E+ A K      L+    Q  K +  E+     + H+++V  
Sbjct: 24  GKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPH-QREK-MSMEISIHRSLAHQHVVGF 80

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL------KIAIGVAQGLAYLHK 697
            GFF  ++ +F++ E  +  SL +L  R+         L           +  G  YLH+
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRK-------ALTEPEARYYLRQIVLGCQYLHR 133

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSC----YNA 752
           + V   +HR++K  N+ L+ D E K+ DF L  ++  +   +  +       C    Y A
Sbjct: 134 NRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL-------CGTPNYIA 183

Query: 753 PE----YGYSKKATAQMDAYSFGVVLLELITGR 781
           PE     G+S +     D +S G ++  L+ G+
Sbjct: 184 PEVLSKKGHSFEV----DVWSIGCIMYTLLVGK 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.9 bits (247), Expect = 9e-23
 Identities = 49/200 (24%), Positives = 93/200 (46%), Gaps = 23/200 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG+VY   +  +G L A K +     +  +    E++ LA   H  IVK+LG ++ D 
Sbjct: 30  GAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG 89

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLLHRNV 708
            ++++ EF   G++  ++   D  L      +I +    + + L +LH      ++HR++
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RIIHRDL 143

Query: 709 KSKNILLDADFEPKLTDFA----LDRIVGEAA-FQST---MSSEYALSCYNAPEYGYSKK 760
           K+ N+L+  + + +L DF       + + +   F  T   M+ E  + C    +  Y  K
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE-VVMCETMKDTPYDYK 202

Query: 761 ATAQMDAYSFGVVLLELITG 780
           A    D +S G+ L+E+   
Sbjct: 203 A----DIWSLGITLIEMAQI 218

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (249), Expect = 1e-22
 Identities = 30/230 (13%), Positives = 61/230 (26%), Gaps = 48/230 (20%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLV---NFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
             G     V++   +   E  A+K             + L       A++  ++  +   
Sbjct: 71  RVGD-RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 646 FFH--------------------------SDESIFLIYEFLQMGSLGDLICRQDF----- 674
                                        +  +  L+        L  L    DF     
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 675 -QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG 733
                     +   + +  A L       L+H +    N+ +  D    L D +    VG
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 734 EAAFQSTMSSEYALSCYNAPEYGYSKKA--TAQMDAYSFGVVLLELITGR 781
                S++   YA       E+  +  A  T  ++A+  G+ +  +    
Sbjct: 246 TRGPASSVPVTYA-----PREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 33/202 (16%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG V+  +   + +++A+K +     +     ++ E+  L++     + K  G +  D
Sbjct: 33  GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD 92

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLLHRN 707
             +++I E+L  GS  DL+              IA     + +GL YLH +     +HR+
Sbjct: 93  TKLWIIMEYLGGGSALDLLEPGPLDETQ-----IATILREILKGLDYLHSE---KKIHRD 144

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-----CYNAPE----YGYS 758
           +K+ N+LL    E KL DF      G A  Q T +     +      + APE      Y 
Sbjct: 145 IKAANVLLSEHGEVKLADF------GVAG-QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197

Query: 759 KKATAQMDAYSFGVVLLELITG 780
            KA    D +S G+  +EL  G
Sbjct: 198 SKA----DIWSLGITAIELARG 215

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 76/309 (24%), Positives = 134/309 (43%), Gaps = 60/309 (19%)

Query: 593 GPFGRVY--ILSLPSGE---LIAVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLG 645
           G FG VY  +L   SG+    +A+K L   G    + +    E   + +  H NI+++ G
Sbjct: 55  GEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 113

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                + + +I E+++ G+L   +  +D +      + +  G+A G+ YL + +YV    
Sbjct: 114 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV---- 169

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN------APE---Y 755
           HR++ ++NIL++++   K++DF L R++ +        + Y  S         APE   Y
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGGKIPIRWTAPEAISY 224

Query: 756 GYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQV 811
               K T+  D +SFG+V+ E++T G +     P   L   +V+K       I +G    
Sbjct: 225 R---KFTSASDVWSFGIVMWEVMTYGER-----PYWELSNHEVMK------AINDG--FR 268

Query: 812 LDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELS 867
           L P   +C    YQ        + ++C      +RP   ++V  L  L      L     
Sbjct: 269 L-PTPMDCPSAIYQ--------LMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 319

Query: 868 SSQEHSIPL 876
                SI L
Sbjct: 320 FDPRVSIRL 328

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 60/287 (20%), Positives = 108/287 (37%), Gaps = 47/287 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G  G V+ +   PSG ++A K + +         +  E++ L +     IV   G F+SD
Sbjct: 44  GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             I +  E +  GSL  ++ ++  ++   I  K++I V +GL YL + +   ++HR+VK 
Sbjct: 104 GEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKP 160

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA-LSCYNAPE----YGYSKKATAQM 765
            NIL+++  E KL DF    + G+     +M++ +     Y +PE      YS ++    
Sbjct: 161 SNILVNSRGEIKLCDFG---VSGQ--LIDSMANSFVGTRSYMSPERLQGTHYSVQS---- 211

Query: 766 DAYSFGVVLLELITGR----QAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
           D +S G+ L+E+  GR      +  E                                  
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271

Query: 822 QQMLGALEIALR------------------------CTSVMPEKRPS 844
           +  +   E+                           C    P +R  
Sbjct: 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 59/309 (19%), Positives = 108/309 (34%), Gaps = 67/309 (21%)

Query: 593 GPFGRVY--ILSLPSGE------LIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G F +++  +              + +K L       S++       ++K+ HK++V   
Sbjct: 19  GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHL 703
           G     +   L+ EF++ GSL   + +    +    +L++A  +A  + +L     +   
Sbjct: 79  GVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLI--- 135

Query: 704 LHRNVKSKNILLDADFEP--------KLTDFALDRIVGEAAFQSTMSSEYALSCYN---- 751
            H NV +KNILL  + +         KL+D  +   V        +  +           
Sbjct: 136 -HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--------LPKDI----LQERIP 182

Query: 752 --APE-YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINI 804
              PE     K      D +SFG  L E+ + G +     P  +L     ++        
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK-----PLSALDSQRKLQ------FY 231

Query: 805 TNGAIQVLD-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS 863
            +     L  PK A            +   C    P+ RPS   +++ L+SL T   L+ 
Sbjct: 232 EDR--HQLPAPKAAELAN--------LINNCMDYEPDHRPSFRAIIRDLNSLFT-PDLVP 280

Query: 864 IELSSSQEH 872
                   H
Sbjct: 281 RGSHHHHHH 289

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 98.2 bits (245), Expect = 5e-22
 Identities = 74/300 (24%), Positives = 131/300 (43%), Gaps = 43/300 (14%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
           G FG V    L LPS + I  A+K L   G    +      E   + +  H NI+++ G 
Sbjct: 56  GEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV 114

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
               + + ++ E+++ GSL   + + D Q      + +  G+A G+ YL    YV    H
Sbjct: 115 VTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----H 170

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATAQ 764
           R++ ++NIL++++   K++DF L R++ +    +  +    +   + +PE    +K T+ 
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSA 230

Query: 765 MDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANC- 819
            D +S+G+VL E+++ G +     P   +   DV+K       +  G    L P   +C 
Sbjct: 231 SDVWSYGIVLWEVMSYGER-----PYWEMSNQDVIK------AVDEG--YRL-PPPMDCP 276

Query: 820 ---YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQEHSIPL 876
              YQ        + L C       RP   ++V  L  L      L I  S++   S  L
Sbjct: 277 AALYQ--------LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLL 328

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 98.7 bits (246), Expect = 7e-22
 Identities = 53/268 (19%), Positives = 102/268 (38%), Gaps = 29/268 (10%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE 651
           G  G +    +     +AVK+++    +       EV+ L +   H N+++        +
Sbjct: 35  GAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQ 91

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
             ++  E     +L + + ++DF       + +      GLA+LH   +   +HR++K  
Sbjct: 92  FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI---VHRDLKPH 147

Query: 712 NILL-----DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPEY---GYSKKAT 762
           NIL+         +  ++DF L  ++       S  S       + APE       +  T
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
             +D +S G V   +I+       +  +         R+ NI  GA  +           
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANILLGACSLDCLHPEKHEDV 258

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVK 850
               A E+  +  ++ P+KRPS   V+K
Sbjct: 259 I---ARELIEKMIAMDPQKRPSAKHVLK 283

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 95.3 bits (238), Expect = 7e-22
 Identities = 63/275 (22%), Positives = 125/275 (45%), Gaps = 37/275 (13%)

Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G      
Sbjct: 18  SGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 76

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKS 710
            I L+ EF++ G L D +  Q         L + + V +G+AYL     +    HR++ +
Sbjct: 77  PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI----HRDLAA 132

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSF 770
           +N L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +SF
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK-WASPEVFSFSRYSSKSDVWSF 191

Query: 771 GVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANC----YQQ 822
           GV++ E+ + G+      P E+    +VV+      +I+ G    L  K        YQ 
Sbjct: 192 GVLMWEVFSEGKI-----PYENRSNSEVVE------DISTG--FRL-YKPRLASTHVYQ- 236

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
                  I   C    PE RP+   +++ L  ++ 
Sbjct: 237 -------IMNHCWRERPEDRPAFSRLLRQLAEIAE 264

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 68/282 (24%), Positives = 122/282 (43%), Gaps = 47/282 (16%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V++        +AVK L   G  S      E   + +++H+ +V++     + E 
Sbjct: 24  GQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEP 81

Query: 653 IFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKS 710
           I++I E+++ GSL D L      +L  +  L +A  +A+G+A++  ++Y+    HR++++
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYI----HRDLRA 137

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPEYGYSKKATA 763
            NIL+      K+ DF L R++ +        +EY           + APE       T 
Sbjct: 138 ANILVSDTLSCKIADFGLARLIED--------NEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC--- 819
           + D +SFG++L E++T GR           +V++ + R   +          +  NC   
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQNLERGYRM---------VRPDNCPEE 238

Query: 820 -YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
            YQ        +   C    PE RP+   +   L    T T 
Sbjct: 239 LYQ--------LMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 55/288 (19%), Positives = 119/288 (41%), Gaps = 53/288 (18%)

Query: 593 GPFGRVY--ILSLPSGEL-IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V   +  +   ++ +A+K L        ++ +  E + + ++ +  IV+++G   
Sbjct: 21  GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV-C 79

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRN 707
             E++ L+ E    G L   +  +  ++  S   ++   V+ G+ YL  K++V    HR+
Sbjct: 80  QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV----HRD 135

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------APEYGYSKK 760
           + ++N+LL      K++DF L + +G         S Y             APE    +K
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGAD------DSYYTARSAGKWPLKWYAPECINFRK 189

Query: 761 ATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKI 816
            +++ D +S+GV + E ++ G++     P + +   +V+ ++ +      G  + +    
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQ------G--KRM-ECP 235

Query: 817 ANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
             C    Y         +   C     E RP    V + + +     +
Sbjct: 236 PECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 96.2 bits (240), Expect = 8e-22
 Identities = 36/158 (22%), Positives = 61/158 (38%), Gaps = 13/158 (8%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
           E +T  +++  ++V +  F   D  +++    +    L  ++ R+   L     + I   
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQ 142

Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM----SS 743
           +   L   H        HR+VK +NIL+ AD    L DF +     +           + 
Sbjct: 143 IGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTL 199

Query: 744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            Y      APE      AT + D Y+   VL E +TG 
Sbjct: 200 YYM-----APERFSESHATYRADIYALTCVLYECLTGS 232

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 66/294 (22%), Positives = 118/294 (40%), Gaps = 66/294 (22%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
           G FG V+  I   P    +  A+K         S   K   E  T+ +  H +IVK++G 
Sbjct: 26  GQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 84

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
             ++  +++I E   +G L   +  + + L  +  +  A  ++  LAYL  K +V    H
Sbjct: 85  I-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV----H 139

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-----------APE 754
           R++ ++N+L+ ++   KL DF L R + +        S Y    Y            APE
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMED--------STY----YKASKGKLPIKWMAPE 187

Query: 755 YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQ 810
               ++ T+  D + FGV + E++  G +     P + +   DV+  +           +
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENG--------E 234

Query: 811 VLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
            L P   NC    Y         +  +C +  P +RP   E+   L ++     
Sbjct: 235 RL-PMPPNCPPTLYS--------LMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 95.8 bits (239), Expect = 1e-21
 Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 59/298 (19%)

Query: 592 GGPFGRVY--ILSLPSGEL---IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
            G FG VY  +      ++   +A+K+L      +++K +  E   +A + + ++ ++LG
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                 ++ LI + +  G L D +      +     L   + +A+G+ YL  +  V    
Sbjct: 85  I-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV---- 139

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS--------CYNAPEYG 756
           HR++ ++N+L+      K+TDF L +++G          EY              A E  
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVPIKWM--ALESI 191

Query: 757 YSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVL 812
             +  T Q D +S+GV + EL+T G +     P + +   ++   + +      G  + L
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEK------G--ERL 238

Query: 813 DPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR-TSLLSIE 865
            P+   C    Y         I  +C  +  + RP   E++     ++      L I+
Sbjct: 239 -PQPPICTIDVYM--------IMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 287

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 47/285 (16%)

Query: 592 GGPFGRVYILSLPSGEL-IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG +G VY        L +AVK L        +    E   + +I+H N+V++LG    +
Sbjct: 23  GGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81

Query: 651 ESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNV 708
              ++I EF+  G+L D L      ++   + L +A  ++  + YL  K+++    HR++
Sbjct: 82  PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFI----HRDL 137

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPEYGYSKKA 761
            ++N L+  +   K+ DF L R++            Y           + APE     K 
Sbjct: 138 AARNCLVGENHLVKVADFGLSRLMTG--------DTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 762 TAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC- 819
           + + D ++FGV+L E+ T G             V + + +           +  +   C 
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK------D--YRM-ERPEGCP 238

Query: 820 ---YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
              Y        E+   C    P  RPS  E+ +A  ++   +S+
Sbjct: 239 EKVY--------ELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 63/287 (21%), Positives = 116/287 (40%), Gaps = 55/287 (19%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G FG V       PSG+ +  AVK L        + +     EV  +  + H+N++++ G
Sbjct: 29  GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                  + ++ E   +GSL D + +           + A+ VA+G+ YL  K ++    
Sbjct: 89  V-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI---- 143

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------APEYGY 757
           HR++ ++N+LL      K+ DF L R + +          Y +  +        APE   
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQN------DDHYVMQEHRKVPFAWCAPESLK 197

Query: 758 SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLD 813
           ++  +   D + FGV L E+ T G++     P   L    ++  + +      G  + L 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDK-----EG--ERL- 244

Query: 814 PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
           P+  +C    Y         + ++C +  PE RP+   +   L    
Sbjct: 245 PRPEDCPQDIYN--------VMVQCWAHKPEDRPTFVALRDFLLEAQ 283

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 99.2 bits (247), Expect = 2e-21
 Identities = 65/281 (23%), Positives = 119/281 (42%), Gaps = 38/281 (13%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK--TEVKTLAKIRHKNIVKVLGF 646
           G FG V+  I   P    +  A+K         S   K   E  T+ +  H +IVK++G 
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLH 705
             ++  +++I E   +G L   +  + F L  +  +  A  ++  LAYL  K +V    H
Sbjct: 460 I-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFV----H 514

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++ ++N+L+ ++   KL DF L R + ++ +      +  +  + APE    ++ T+  
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK-WMAPESINFRRFTSAS 573

Query: 766 DAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC----Y 820
           D + FGV + E++  G +  Q       DV+  +           + L P   NC    Y
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG--------ERL-PMPPNCPPTLY 622

Query: 821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
                    +  +C +  P +RP   E+   L ++     L
Sbjct: 623 S--------LMTKCWAYDPSRRPRFTELKAQLSTILEEEKL 655

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 19/167 (11%)

Query: 626 KTEVKTLAKIRHKNIVKVL--GFFHSDESI--FLIYEFLQMGSLGDLICRQDFQLQWSIR 681
           + E +  A + H  IV V   G   +      +++ E++   +L D++   +  +     
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-HTEGPMTPKRA 118

Query: 682 LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
           +++     Q L + H++    ++HR+VK  NI++ A    K+ DF + R + ++    T 
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 742 SS------EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ 782
           ++      +Y LS    PE        A+ D YS G VL E++TG  
Sbjct: 176 TAAVIGTAQY-LS----PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 63/272 (23%), Positives = 127/272 (46%), Gaps = 37/272 (13%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES 652
           G FG V +        +AVK +   G  S      E +T+ K+ H  +VK  G    +  
Sbjct: 19  GQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77

Query: 653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKSK 711
           I+++ E++  G L + +      L+ S  L++   V +G+A+L    ++    HR++ ++
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI----HRDLAAR 133

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFG 771
           N L+D D   K++DF + R V +  + S++ +++ +  ++APE  +  K +++ D ++FG
Sbjct: 134 NCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK-WSAPEVFHYFKYSSKSDVWAFG 192

Query: 772 VVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANC----YQQQ 823
           +++ E+ + G+      P +     +VV  V +           L  +        YQ  
Sbjct: 193 ILMWEVFSLGKM-----PYDLYTNSEVVLKVSQG--------HRL-YRPHLASDTIYQ-- 236

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                 I   C   +PEKRP+  +++ ++  L
Sbjct: 237 ------IMYSCWHELPEKRPTFQQLLSSIEPL 262

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 70/298 (23%), Positives = 120/298 (40%), Gaps = 64/298 (21%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY  + +   GE I  AVK    +    + +   +E   +  + H +IVK++G  
Sbjct: 23  GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHR 706
             +E  ++I E    G LG  + R    L+    +  ++ + + +AYL   + V    HR
Sbjct: 83  -EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV----HR 137

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-----------APEY 755
           ++  +NIL+ +    KL DF L R + +         +Y    Y            +PE 
Sbjct: 138 DIAVRNILVASPECVKLGDFGLSRYIED--------EDY----YKASVTRLPIKWMSPES 185

Query: 756 GYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQV 811
              ++ T   D + F V + E+++ G+Q     P   L   DV+  + +      G    
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ-----PFFWLENKDVIGVLEK------G--DR 232

Query: 812 LDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIE 865
           L PK   C    Y         +  RC    P  RP   E+V +L  +      +++E
Sbjct: 233 L-PKPDLCPPVLYT--------LMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME 281

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 38/215 (17%), Positives = 81/215 (37%), Gaps = 33/215 (15%)

Query: 593 GPFGRVYILSLPSGELIAVKKL-----------------VNFGCQSSKTLKTEVKTLAKI 635
           G F ++  L     +  A+KK                             K E++ +  I
Sbjct: 42  GKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 636 RHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRL------KIAIGV 688
           +++  +   G   + + +++IYE+++  S+             ++  +       I   V
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 689 AQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
               +Y+H +   ++ HR+VK  NIL+D +   KL+DF     + +   + +  +     
Sbjct: 161 LNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGT----Y 214

Query: 749 CYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
            +  PE     S    A++D +S G+ L  +    
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.8 bits (236), Expect = 4e-21
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 36/210 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF--- 647
           G +G+VY    + +G+L A+K  ++      + +K E+  L K   H+NI    G F   
Sbjct: 35  GTYGQVYKGRHVKTGQLAAIKV-MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93

Query: 648 ---HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK---IAI---GVAQGLAYLHKD 698
                D+ ++L+ EF   GS+ DLI     +      LK   IA     + +GL++LH+ 
Sbjct: 94  NPPGMDDQLWLVMEFCGAGSVTDLI-----KNTKGNTLKEEWIAYICREILRGLSHLHQH 148

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDF----ALDRIVGEAA-FQST---MSSEYALSCY 750
               ++HR++K +N+LL  + E KL DF     LDR VG    F  T   M+ E  ++C 
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPE-VIACD 204

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITG 780
             P+  Y  K+    D +S G+  +E+  G
Sbjct: 205 ENPDATYDFKS----DLWSLGITAIEMAEG 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 40/205 (19%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G +G VY  +   +G+++A+K++ V       + +  E+  + +    ++VK  G +  +
Sbjct: 40  GSYGSVYKAIHKETGQIVAIKQVPVE---SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN 96

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLLHRN 707
             ++++ E+   GS+ D+I  ++  L      +IA       +GL YLH       +HR+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLT---EDEIATILQSTLKGLEYLHFM---RKIHRD 150

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAA-FQSTMS-------SEYALSCYNAPE----Y 755
           +K+ NILL+ +   KL DF      G A     TM+       + +    + APE     
Sbjct: 151 IKAGNILLNTEGHAKLADF------GVAGQLTDTMAKRNTVIGTPF----WMAPEVIQEI 200

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
           GY+  A    D +S G+  +E+  G
Sbjct: 201 GYNCVA----DIWSLGITAIEMAEG 221

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 66/317 (20%), Positives = 114/317 (35%), Gaps = 69/317 (21%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG VY      + + PS   +AVK L      Q       E   ++K  H+NIV+ +G
Sbjct: 41  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 100

Query: 646 FFHSDESIFLIYEFLQMGSLGD------LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKD 698
                   F++ E +  G L            Q   L     L +A  +A G  YL    
Sbjct: 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160

Query: 699 YVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSCYN---- 751
           ++    HR++ ++N LL         K+ DF + R +          + Y    Y     
Sbjct: 161 FI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRASY----YRKGGC 204

Query: 752 --------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI 802
                    PE       T++ D +SFGV+L E+ + G     ++  +  +V+++V    
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTS-- 260

Query: 803 NITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
               G    +     NC    Y         I  +C    PE RP+   +++ +   +  
Sbjct: 261 ----G--GRM-DPPKNCPGPVY--------RIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

Query: 859 TSLLSIELSSSQEHSIP 875
             +++  L       + 
Sbjct: 306 PDVINTALPIEYGPLVE 322

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 73/309 (23%), Positives = 129/309 (41%), Gaps = 80/309 (25%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V+      +       L+AVK L +    + K  + E + L  ++H++IVK  G 
Sbjct: 26  GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGV 85

Query: 647 FHSDESIFLIYEFLQMGSL---------------GDLICRQDFQLQWSIRLKIAIGVAQG 691
               + + +++E+++ G L                    +   +L  S  L IA  +A G
Sbjct: 86  CGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG 145

Query: 692 LAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           + YL  + +V    HR++ ++N L+ A+   K+ DF + R V         S++Y    Y
Sbjct: 146 MVYLASQHFV----HRDLATRNCLVGANLLVKIGDFGMSRDV--------YSTDY----Y 189

Query: 751 N------------APE---YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDV 794
                         PE   Y    K T + D +SFGV+L E+ T G+Q          +V
Sbjct: 190 RVGGHTMLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EV 244

Query: 795 VKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           ++ + +         +VL  +   C    Y        ++ L C    P++R ++ E+ K
Sbjct: 245 IECITQG--------RVL-ERPRVCPKEVY--------DVMLGCWQREPQQRLNIKEIYK 287

Query: 851 ALHSLSTRT 859
            LH+L   T
Sbjct: 288 ILHALGKAT 296

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 38/204 (18%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G  G VY  + + +G+ +A++++        + +  E+  + + ++ NIV  L  +   +
Sbjct: 31  GASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD 90

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLLHRNV 708
            ++++ E+L  GSL D++              IA       Q L +LH +    ++HR++
Sbjct: 91  ELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLHSN---QVIHRDI 142

Query: 709 KSKNILLDADFEPKLTDFA----LDRIVGEAA-FQST---MSSEYALSCYNAPE----YG 756
           KS NILL  D   KLTDF     +     + +    T   M          APE      
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM----------APEVVTRKA 192

Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y  K     D +S G++ +E+I G
Sbjct: 193 YGPKV----DIWSLGIMAIEMIEG 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 93.5 bits (233), Expect = 6e-21
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 37/282 (13%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF- 646
           G FG VY   L    G+ I  AVK L             TE   +    H N++ +LG  
Sbjct: 36  GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLH 705
             S+ S  ++  +++ G L + I  +         +   + VA+G+ YL  K +V    H
Sbjct: 96  LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV----H 151

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SCYNAPEYGYSKKATA 763
           R++ ++N +LD  F  K+ DF L R + +  + S  +   A     + A E   ++K T 
Sbjct: 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTT 211

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC--- 819
           + D +SFGV+L EL+T G            D+  ++        G  + L  +   C   
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL------QG--RRL-LQPEYCPDP 260

Query: 820 -YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
            Y+        + L+C     E RPS  E+V  + ++ +   
Sbjct: 261 LYE--------VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 94.0 bits (234), Expect = 6e-21
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 38/204 (18%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G  G V +     SG  +AVK +     Q  + L  EV  +   +H N+V++   +   E
Sbjct: 56  GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE 115

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLLHRNV 708
            ++++ EFLQ G+L D++ +     +      IA     V Q LAYLH      ++HR++
Sbjct: 116 ELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLHAQ---GVIHRDI 167

Query: 709 KSKNILLDADFEPKLTDFA----LDRIVGEAA-FQST---MSSEYALSCYNAPE----YG 756
           KS +ILL  D   KL+DF     + + V +      T   M          APE      
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM----------APEVISRSL 217

Query: 757 YSKKATAQMDAYSFGVVLLELITG 780
           Y+ +     D +S G++++E++ G
Sbjct: 218 YATEV----DIWSLGIMVIEMVDG 237

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 57/285 (20%), Positives = 111/285 (38%), Gaps = 51/285 (17%)

Query: 592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
            G FG V          +A+K +   G  S      E K +  + H+ +V++ G      
Sbjct: 34  TGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHRNVKS 710
            IF+I E++  G L + +     + Q    L++   V + + YL  K ++    HR++ +
Sbjct: 93  PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL----HRDLAA 148

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPEYGYSKKATA 763
           +N L++     K++DF L R V +         EY  S        ++ PE     K ++
Sbjct: 149 RNCLVNDQGVVKVSDFGLSRYVLD--------DEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPKIANC 819
           + D ++FGV++ E+ + G+      P E     +  + + +      G    L  +    
Sbjct: 201 KSDIWAFGVLMWEIYSLGKM-----PYERFTNSETAEHIAQ------G--LRL-YRPHLA 246

Query: 820 ----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
               Y         I   C     ++RP+   ++  +  +    S
Sbjct: 247 SEKVYT--------IMYSCWHEKADERPTFKILLSNILDVMDEES 283

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.6 bits (240), Expect = 8e-21
 Identities = 56/289 (19%), Positives = 119/289 (41%), Gaps = 53/289 (18%)

Query: 592 GGPFGRVY--ILSLPSGEL-IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
            G FG V   +  +   ++ +A+K L        ++ +  E + + ++ +  IV+++G  
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV- 404

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLHR 706
              E++ L+ E    G L   +  +  ++  S   ++   V+ G+ YL  K++V    HR
Sbjct: 405 CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV----HR 460

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------APEYGYSK 759
           N+ ++N+LL      K++DF L + +G         S Y             APE    +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGAD------DSYYTARSAGKWPLKWYAPECINFR 514

Query: 760 KATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDPK 815
           K +++ D +S+GV + E ++ G++     P + +   +V+ ++ +      G  + +   
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQ------G--KRM-EC 560

Query: 816 IANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
              C    Y         +   C     E RP    V + + +     +
Sbjct: 561 PPECPPELYA--------LMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.3 bits (232), Expect = 8e-21
 Identities = 52/212 (24%), Positives = 82/212 (38%), Gaps = 29/212 (13%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G     V+      +G+L A+K   N    +       E + L K+ HKNIVK+    
Sbjct: 18  GQGA-TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 648 HSDES--IFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHL 703
               +    LI EF   GSL  ++              L +   V  G+ +L ++    +
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133

Query: 704 LHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE--- 754
           +HRN+K  NI+     +     KLTDF   R + +     ++  + EY       P+   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL-----HPDMYE 188

Query: 755 -----YGYSKKATAQMDAYSFGVVLLELITGR 781
                  + KK  A +D +S GV      TG 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.5 bits (235), Expect = 1e-20
 Identities = 68/320 (21%), Positives = 108/320 (33%), Gaps = 42/320 (13%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G     V+      +G+L A+K   N    +       E + L K+ HKNIVK+    
Sbjct: 18  GQGA-TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 648 HSDES--IFLIYEFLQMGSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
               +    LI EF   GSL  ++      + L  S  L +   V  G+ +L ++    +
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GI 133

Query: 704 LHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE--- 754
           +HRN+K  NI+     +     KLTDF   R + +     ++  + EY       P+   
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL-----HPDMYE 188

Query: 755 -----YGYSKKATAQMDAYSFGVVLLELITG-----------RQAEQAEPAESLDVVKWV 798
                  + KK  A +D +S GV      TG           R  E      +      +
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIAL--RCTSVMPEKRPSMFEVVKALHSLS 856
                  NG I        +C   + L  L   +         EK     +       + 
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308

Query: 857 TRTSLLSIELSSSQEHSIPL 876
            R  +    L     H I +
Sbjct: 309 HRMVIHVFSLQQMTAHKIYI 328

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 59/231 (25%), Positives = 94/231 (40%), Gaps = 28/231 (12%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           N + LNL       I  +    L  L  L L+ N          +  ++L TL L +N +
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 136 --------------WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGS-NLLSGSVPFVFGN 179
                           L L  N IE  IP      + +L+ L+LG    LS      F  
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
            S L  L+L+     + EIP ++  L KL++L L  +    + P SF GL  L  L + Q
Sbjct: 184 LSNLRYLNLAMC--NLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQ 240

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG-LVNLSLHKN 289
           + +   + ++   +L  LV  +++ N L+   P+ +      L  + LH N
Sbjct: 241 SQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 46/228 (20%), Positives = 90/228 (39%), Gaps = 9/228 (3%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
           +L+L  N I+     S   L +L++L L  N +       F   + L  L+L  N   ++
Sbjct: 68  LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN--RLT 125

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            IP+     L KL++L+L+++    +   +F  + SL  LDL +      + +     L 
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLS 185

Query: 256 KLVSFDVSQNKLS--GSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
            L   +++   L    +          L  L L  N  +   PGS    ++L++  +  +
Sbjct: 186 NLRYLNLAMCNLREIPNLTP----LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
                  +   +L  +  I    N  +    D  +    LE++ + +N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 61/245 (24%), Positives = 90/245 (36%), Gaps = 25/245 (10%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVN 158
           ++   LNL +N               LE L LS N I  ++            +   L N
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE----------IGAFNGLAN 113

Query: 159 LQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSG 217
           L  L L  N L+      F   S+L  L L  N   I  IPS    ++  L +L L    
Sbjct: 114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP--IESIPSYAFNRIPSLRRLDLGELK 171

Query: 218 FHGVIP-DSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS----GSFP 272
               I   +F GL +L  L+L+  NL  E+P    + L+KL   D+S N LS    GSF 
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN--LTPLIKLDELDLSGNHLSAIRPGSFQ 228

Query: 273 NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLI 332
                   L  L + ++        + +   +L    +  N  +    D    L  ++ I
Sbjct: 229 G----LMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284

Query: 333 RAESN 337
               N
Sbjct: 285 HLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 70/342 (20%), Positives = 118/342 (34%), Gaps = 94/342 (27%)

Query: 174 PFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS 233
           P V    ++   +   +    + E+P  I        L L  +    +  +SF  L+ L 
Sbjct: 36  PSVCSCSNQFSKVICVRKN--LREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLE 91

Query: 234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS----GSFPNGICKANGLVNLSLHKN 289
           IL LS+N++   +     + L  L + ++  N+L+    G+F       + L  L L  N
Sbjct: 92  ILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVY----LSKLKELWLRNN 146

Query: 290 FFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISM 349
                          +E   +    F+      + SL R+ L   E  R S         
Sbjct: 147 --------------PIES--IPSYAFNR-----IPSLRRLDL--GELKRLS--------- 174

Query: 350 AAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQN 409
                   I    F     +GL +++ L                            L+  
Sbjct: 175 -------YISEGAF-----EGLSNLRYLN---------------------------LAMC 195

Query: 410 SISGQIPELKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIPQG-LQ 467
           ++  +IP L    KL  L L+ N L+  I P S   L  L  L +  + +   I +    
Sbjct: 196 NLR-EIPNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFD 252

Query: 468 NL-KLALFNVSFNKLSGRVPYSLISGLPAS---YLQGNPGLC 505
           NL  L   N++ N L+  +P+ L + L      +L  NP  C
Sbjct: 253 NLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNC 293

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 68/297 (22%), Positives = 113/297 (38%), Gaps = 56/297 (18%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFF 647
             GG F  VY    + SG   A+K+L++   + ++ +  EV  + K+  H NIV+     
Sbjct: 37  AEGG-FAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95

Query: 648 HSDES-------IFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKD 698
              +         FL+   L  G L + + + + +   S    LKI     + + ++H+ 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS---------- 748
             P ++HR++K +N+LL      KL DF     +      S  +   AL           
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214

Query: 749 CYNAPE--YGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT 805
            Y  PE    YS      + D ++ G +L  L   +      P E    ++       I 
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH-----PFEDGAKLR-------IV 262

Query: 806 NGAIQVLDPKIANCYQ------QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
           NG   +  P     Y       + ML           V PE+R S+ EVV  L  ++
Sbjct: 263 NGKYSI--PPHDTQYTVFHSLIRAML----------QVNPEERLSIAEVVHQLQEIA 307

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 93.3 bits (232), Expect = 2e-20
 Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 39/206 (18%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK----TLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG VY    + + E++A+KK +++  + S      +  EV+ L K+RH N ++  G +
Sbjct: 65  GSFGAVYFARDVRNSEVVAIKK-MSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAI---GVAQGLAYLHKDYVPHLL 704
             + + +L+ E+   GS  DL+      LQ    ++IA    G  QGLAYLH     +++
Sbjct: 124 LREHTAWLVMEYCL-GSASDLLEVHKKPLQ---EVEIAAVTHGALQGLAYLHSH---NMI 176

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAA-------FQST---MSSEYALSCYNAPE 754
           HR+VK+ NILL      KL DF      G A+       F  T   M+ E  L      E
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDF------GSASIMAPANSFVGTPYWMAPEVIL---AMDE 227

Query: 755 YGYSKKATAQMDAYSFGVVLLELITG 780
             Y  K     D +S G+  +EL   
Sbjct: 228 GQYDGKV----DVWSLGITCIELAER 249

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 93.2 bits (232), Expect = 2e-20
 Identities = 66/317 (20%), Positives = 116/317 (36%), Gaps = 69/317 (21%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG VY      + + PS   +AVK L      Q       E   ++K  H+NIV+ +G
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141

Query: 646 FFHSDESIFLIYEFLQMGSLGD------LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKD 698
                   F++ E +  G L            Q   L     L +A  +A G  YL    
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201

Query: 699 YVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSCYN---- 751
           ++    HR++ ++N LL         K+ DF + R +          + Y    Y     
Sbjct: 202 FI----HRDIAARNCLLTCPGPGRVAKIGDFGMARDI--------YRAGY----YRKGGC 245

Query: 752 --------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI 802
                    PE       T++ D +SFGV+L E+ + G     ++  +  +V+++V    
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVT--- 300

Query: 803 NITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
              +G    +     NC    Y+        I  +C    PE RP+   +++ +   +  
Sbjct: 301 ---SG--GRM-DPPKNCPGPVYR--------IMTQCWQHQPEDRPNFAIILERIEYCTQD 346

Query: 859 TSLLSIELSSSQEHSIP 875
             +++  L       + 
Sbjct: 347 PDVINTALPIEYGPLVE 363

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.0 bits (234), Expect = 3e-20
 Identities = 49/228 (21%), Positives = 91/228 (39%), Gaps = 9/228 (3%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
            L+L  N+I+    ++   L +L+VL LG N +       F   + L  L+L  N   ++
Sbjct: 79  YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN--WLT 136

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            IPS     L KL +L+L+++    +   +F  + SL  LDL +      + +     L 
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196

Query: 256 KLVSFDVSQNKLS--GSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
            L   ++    +    +         GL  L +  N F    PGS +   +L++  V ++
Sbjct: 197 NLKYLNLGMCNIKDMPNLTP----LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
             S    +    L  +  +    N  S    D  +    L ++ + +N
Sbjct: 253 QVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 54/245 (22%), Positives = 85/245 (34%), Gaps = 25/245 (10%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVN 158
           S+   LNL +N               LE L L  N I  ++            +   L +
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE----------VGAFNGLAS 124

Query: 159 LQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSG 217
           L  L L  N L+      F   S+L  L L  N   I  IPS    ++  L +L L    
Sbjct: 125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP--IESIPSYAFNRVPSLMRLDLGELK 182

Query: 218 FHGVIP-DSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS----GSFP 272
               I   +F GL +L  L+L   N+  ++P    + L+ L   ++S N       GSF 
Sbjct: 183 KLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN--LTPLVGLEELEMSGNHFPEIRPGSFH 239

Query: 273 NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLI 332
                 + L  L +  +  +     + +   +L    +  N  S    D    L  +  +
Sbjct: 240 G----LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVEL 295

Query: 333 RAESN 337
               N
Sbjct: 296 HLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 56/206 (27%), Positives = 82/206 (39%), Gaps = 26/206 (12%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           +L+ L L      +I       L+SL+ L L DN             S L  L L NN I
Sbjct: 100 HLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159

Query: 136 --------------WVLDLSR-NHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF 180
                           LDL     +E     +   L NL+ LNLG   +   +P      
Sbjct: 160 ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPL 217

Query: 181 SELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
             L  L++S N     EI       L  L++L++ +S    +  ++F GL SL  L+L+ 
Sbjct: 218 VGLEELEMSGN--HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH 275

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQN 265
           NNL+  +P  L + L  LV   +  N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 55.1 bits (133), Expect = 5e-08
 Identities = 40/211 (18%), Positives = 78/211 (36%), Gaps = 20/211 (9%)

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL 353
            +P  I    N     + +N       D    L  +++++   N        + +  A L
Sbjct: 68  EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 354 EQVQIDNNRFTSSIP----QGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQ 408
             +++ +N  T  IP    + L  ++ L+      N    S+P   F   P +  ++L +
Sbjct: 126 NTLELFDNWLTV-IPSGAFEYLSKLRELW---LRNNPI-ESIPSYAFNRVPSLMRLDLGE 180

Query: 409 -NSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG 465
              +   I E   +    L  L+L   ++     P+L  L  L  L++S N+     P  
Sbjct: 181 LKKLE-YISEGAFEGLFNLKYLNLGMCNIKD--MPNLTPLVGLEELEMSGNHFPEIRPGS 237

Query: 466 LQNL-KLALFNVSFNKLSGRVPYSLISGLPA 495
              L  L    V  +++S  +  +   GL +
Sbjct: 238 FHGLSSLKKLWVMNSQVS-LIERNAFDGLAS 267

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 51/209 (24%), Positives = 76/209 (36%), Gaps = 23/209 (11%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLSRNH 144
           ++   + L  N  +         C +L  L L +N++                LDLS N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 145 IEGKIPESI-GSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLISEIPSDI 202
               +  +    L  L  L+L    L   +   +F   + L  L L  NA  +  +P D 
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA--LQALPDDT 148

Query: 203 -GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFD 261
              L  L  LFL  +    V   +F GL SL  L L QN +   V       L +L++  
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207

Query: 262 VSQNKLSGSFPNGICKANG-LVNLSLHKN 289
           +  N LS + P         L  L L+ N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 53/212 (25%), Positives = 77/212 (36%), Gaps = 8/212 (3%)

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDL 188
            +       + L  N I      S  +  NL +L L SN+L+      F   + L  LDL
Sbjct: 29  GIPAASQ-RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87

Query: 189 SQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVP 247
           S NA  +  +       L +L  L L   G   + P  F GL +L  L L  N L   +P
Sbjct: 88  SDNA-QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALP 145

Query: 248 QSLGSSLLKLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIPGSINECL-NL 305
                 L  L    +  N++S S P       + L  L LH+N     +       L  L
Sbjct: 146 DDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRL 203

Query: 306 ERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN 337
               +  N  S    + L  L  ++ +R   N
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 25/184 (13%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNNL 134
           NL  L L       I ++    L+ L  L+L+DN   + +          L TL+L    
Sbjct: 57  NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCG 116

Query: 135 I--------------WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGN 179
           +                L L  N ++  +P+     L NL  L L  N +S      F  
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175

Query: 180 FSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
              L  L L QN   ++ +       L +L  L+L ++    +  ++   L++L  L L+
Sbjct: 176 LHSLDRLLLHQNR--VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233

Query: 239 QNNL 242
            N  
Sbjct: 234 DNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 45/225 (20%), Positives = 81/225 (36%), Gaps = 23/225 (10%)

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL 353
           ++P  I      +R  +  N  S        +   + ++   SN  +     + +  A L
Sbjct: 25  AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 354 EQVQIDNNRFTSSIPQG-LGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSI 411
           EQ+ + +N    S+       +  L+     +      L P  F     +  + L  N++
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL 141

Query: 412 SGQIPE--LKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIP----Q 464
              +P+   +    L  L L  N ++  +P  +   L  L  L L  N +   +     +
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFR 198

Query: 465 GLQNLK-LALFNVSFNKLSGRVPYSLISGLPAS---YLQGNPGLC 505
            L  L  L LF    N LS  +P   ++ L A     L  NP +C
Sbjct: 199 DLGRLMTLYLFA---NNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 61/294 (20%), Positives = 111/294 (37%), Gaps = 61/294 (20%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF- 646
           G FG VY       +   I  A+K L      Q  +    E   +  + H N++ ++G  
Sbjct: 32  GHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
              +    ++  ++  G L   I            +   + VA+G+ YL  + +V    H
Sbjct: 92  LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV----H 147

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------------- 751
           R++ ++N +LD  F  K+ DF L R +        +  EY    Y+              
Sbjct: 148 RDLAARNCMLDESFTVKVADFGLARDI--------LDREY----YSVQQHRHARLPVKWT 195

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQ 810
           A E   + + T + D +SFGV+L EL+T G    +       D+  ++ +      G  +
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLAQ------G--R 245

Query: 811 VLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
            L P+   C    Y        ++  +C    P  RP+   +V  +  + +   
Sbjct: 246 RL-PQPEYCPDSLY--------QVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 94.9 bits (236), Expect = 3e-20
 Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 54/279 (19%)

Query: 590 GNGGPFGRVYI---LSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLG 645
            +GG  G +Y+    ++ +G  + +K LV+ G   ++     E + LA++ H +IV++  
Sbjct: 89  AHGG-LGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 646 F-----FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           F      H D   +++ E++   SL     ++   L  +  +   + +   L+YLH    
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI-- 201

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDF----ALDR---IVGEAAFQSTMSSEYALSCYNAP 753
             L++ ++K +NI+L  + + KL D      ++    + G   FQ+             P
Sbjct: 202 -GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQA-------------P 246

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQ-------AEQAEPAESLDVVKWVRRKINITN 806
           E       T   D Y+ G  L  L                E    L       R +    
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL---- 301

Query: 807 GAIQVLDPKIANCYQ--QQMLGALEIALRCTSVMPEKRP 843
              + +DP     +   ++M   L   LR         P
Sbjct: 302 --RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 92.5 bits (230), Expect = 3e-20
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 37/282 (13%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF- 646
           G FG VY   L    G+ I  AVK L             TE   +    H N++ +LG  
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
             S+ S  ++  +++ G L + I  +         +   + VA+G+ +L  K +V    H
Sbjct: 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV----H 215

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS--CYNAPEYGYSKKATA 763
           R++ ++N +LD  F  K+ DF L R + +  F S  +   A     + A E   ++K T 
Sbjct: 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC--- 819
           + D +SFGV+L EL+T G            D+  ++        G  + L  +   C   
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL------QG--RRL-LQPEYCPDP 324

Query: 820 -YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
            Y+        + L+C     E RPS  E+V  + ++ +   
Sbjct: 325 LYE--------VMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 90.9 bits (226), Expect = 6e-20
 Identities = 59/308 (19%), Positives = 123/308 (39%), Gaps = 59/308 (19%)

Query: 592 GGPFGRVY--ILSLPSGEL---IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
            G FG VY  +      ++   +A+K+L      +++K +  E   +A + + ++ ++LG
Sbjct: 25  SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                 ++ LI + +  G L D +      +     L   + +A+G+ YL  +  V    
Sbjct: 85  I-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV---- 139

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--------APEYG 756
           HR++ ++N+L+      K+TDF L +++G          E               A E  
Sbjct: 140 HRDLAARNVLVKTPQHVKITDFGLAKLLGA--------EEKEYHAEGGKVPIKWMALESI 191

Query: 757 YSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVL 812
             +  T Q D +S+GV + EL+T G +     P + +   ++   + +      G  + L
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSK-----PYDGIPASEISSILEK------G--ERL 238

Query: 813 DPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSS 868
            P+   C    Y         I ++C  +  + RP   E++     ++       + +  
Sbjct: 239 -PQPPICTIDVYM--------IMVKCWMIDADSRPKFRELIIEFSKMARDPQRY-LVIQG 288

Query: 869 SQEHSIPL 876
            +   +P 
Sbjct: 289 DERMHLPS 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 70/317 (22%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLG 645
           G FG VY      ++       +A+K +        +     E   + +    ++V++LG
Sbjct: 36  GSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95

Query: 646 FFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR-------LKIAIGVAQGLAYLH 696
                +   +I E +  G L   +   R        +        +++A  +A G+AYL+
Sbjct: 96  VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN 155

Query: 697 -KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN---- 751
              +V    HR++ ++N ++  DF  K+ DF + R +          ++Y    Y     
Sbjct: 156 ANKFV----HRDLAARNCMVAEDFTVKIGDFGMTRDI--------YETDY----YRKGGK 199

Query: 752 --------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI 802
                   +PE       T   D +SFGVVL E+ T   Q  Q    E   V+++V    
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRFVM--- 254

Query: 803 NITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
               G   +L  K  NC    +        E+   C    P+ RPS  E++ ++      
Sbjct: 255 ---EG--GLL-DKPDNCPDMLF--------ELMRMCWQYNPKMRPSFLEIISSIKEE-ME 299

Query: 859 TSLLSIELSSSQEHSIP 875
                +    S+E+ +P
Sbjct: 300 PGFREVSFYYSEENKLP 316

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 90.5 bits (225), Expect = 8e-20
 Identities = 60/285 (21%), Positives = 117/285 (41%), Gaps = 56/285 (19%)

Query: 593 GPFGRVY--ILSLPSGEL---IAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V+  +       +   + +K +    G QS + +   +  +  + H +IV++LG 
Sbjct: 24  GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLH 705
                S+ L+ ++L +GSL D + +    L   + L   + +A+G+ YL     V    H
Sbjct: 84  -CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV----H 138

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------YNAPEYGYS 758
           RN+ ++N+LL +  + ++ DF +  ++           +  L         + A E  + 
Sbjct: 139 RNLAARNVLLKSPSQVQVADFGVADLLPP-------DDKQLLYSEAKTPIKWMALESIHF 191

Query: 759 KKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLDP 814
            K T Q D +S+GV + EL+T G +     P   L   +V   + +      G  + L  
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAE-----PYAGLRLAEVPDLLEK------G--ERL-A 237

Query: 815 KIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           +   C    Y         + ++C  +    RP+  E+      +
Sbjct: 238 QPQICTIDVYM--------VMVKCWMIDENIRPTFKELANEFTRM 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 93.6 bits (232), Expect = 8e-20
 Identities = 47/207 (22%), Positives = 88/207 (42%), Gaps = 24/207 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLGFF 647
           G GG FG V   +   +GE +A+K+        ++     E++ + K+ H N+V      
Sbjct: 23  GTGG-FGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 648 ------HSDESIFLIYEFLQMGSLGDLICR--QDFQLQWSIRLKIAIGVAQGLAYLHKDY 699
                   ++   L  E+ + G L   + +      L+      +   ++  L YLH++ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN- 140

Query: 700 VPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE 754
              ++HR++K +NI+L    +    K+ D    + + +    +    + +Y      APE
Sbjct: 141 --RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYL-----APE 193

Query: 755 YGYSKKATAQMDAYSFGVVLLELITGR 781
               KK T  +D +SFG +  E ITG 
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGF 220

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 56/347 (16%), Positives = 107/347 (30%), Gaps = 49/347 (14%)

Query: 115 IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP 174
           I L   + S+  +L+   N   +   S   +   IP  +     ++ L+L +N ++    
Sbjct: 15  ISLSKEESSNQASLSCDRNG--ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISN 69

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS 233
                   L  L L+ N   I+ I  D    L  LE L L  +    +    F  L SL+
Sbjct: 70  SDLQRCVNLQALVLTSN--GINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLT 127

Query: 234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG 293
            L+L  N        SL S L KL    V                     L+        
Sbjct: 128 FLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD-----FAGLT-------- 174

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL 353
                      LE  ++  +      P  L S+  +  +     +    +   + + + +
Sbjct: 175 ----------FLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224

Query: 354 EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG 413
           E +++ +    +     L + ++                 +         + ++  S+  
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETN----------------SLIKKFTFRNVKITDESLFQ 268

Query: 414 QIPELKKCRKLVSLSLADNSLTGEIPPS-LAELPVLTYLDLSDNNLT 459
            +  L +   L+ L  + N L   +P      L  L  + L  N   
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 85.2 bits (211), Expect = 8e-18
 Identities = 49/261 (18%), Positives = 93/261 (35%), Gaps = 32/261 (12%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNH 144
            ++ +L+L++N         L +C +L+ L L++N I                LDLS N+
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111

Query: 145 IEGKIPESI-GSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLISEIPSDI 202
           +   +  S    L +L  LNL  N         +F + ++L +L +       ++I    
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM-DTFTKIQRKD 169

Query: 203 -GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFD 261
              L  LE+L + +S      P S   +Q++S L L        + +        +   +
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228

Query: 262 VSQNKLSGSFPNGIC--------KANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
           +    L     + +         K     N+ +        +   +N+   L   +   N
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRN 287

Query: 314 ---GFSGDFPDKLWSLPRIKL 331
                     D+L SL +I L
Sbjct: 288 QLKSVPDGIFDRLTSLQKIWL 308

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 45/225 (20%), Positives = 76/225 (33%), Gaps = 30/225 (13%)

Query: 81  NLQSLNLSG----EISSSVCE-LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           +L+ L+LS      +SSS  + LSSL+ LNL  N                   +    L 
Sbjct: 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN--------PYKTLGETSLFSHLTKLQ 152

Query: 136 WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
             L +       KI       L  L+ L + ++ L    P    +   +  L L      
Sbjct: 153 I-LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ-- 209

Query: 195 ISEIPSDI-GKLEKLEQLFL--------QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
              +          +E L L          S       +S +   +   + ++  +L   
Sbjct: 210 HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-- 267

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG-LVNLSLHKN 289
               L + +  L+  + S+N+L  S P+GI      L  + LH N
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 26/192 (13%), Positives = 54/192 (28%), Gaps = 31/192 (16%)

Query: 81  NLQSLNLSG-EISS-----SVCELSSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNN 133
           +L  LNL G    +         L+ L  L + +      I     +  + LE L +  +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184

Query: 134 LIW--------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS------- 172
            +                L L        +   +    +++ L L    L          
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST 244

Query: 173 -VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQS 231
                         + ++  +  + ++   + ++  L +L    +    V    F  L S
Sbjct: 245 GETNSLIKKFTFRNVKITDES--LFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTS 302

Query: 232 LSILDLSQNNLT 243
           L  + L  N   
Sbjct: 303 LQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 43/251 (17%), Positives = 82/251 (32%), Gaps = 25/251 (9%)

Query: 276 CKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE 335
           C  NG+   S   +    SIP  + E   ++   + +N  +      L     ++ +   
Sbjct: 30  CDRNGICKGS-SGSL--NSIPSGLTE--AVKSLDLSNNRITYISNSDLQRCVNLQALVLT 84

Query: 336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPN 394
           SN  +    DS S    LE + +  N  ++ +       + SL   +   N +  +L   
Sbjct: 85  SNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPY-KTLGET 142

Query: 395 --FCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTY 450
             F     + I+ +       +I          L  L +  + L    P SL  +  +++
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202

Query: 451 LDLSDNNLTGPIPQG-------LQNLKL---ALFNVSFNKLSGRVPYSLI--SGLPASYL 498
           L L        + +        ++ L+L    L    F++LS     SLI         +
Sbjct: 203 LILHMKQHIL-LLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261

Query: 499 QGNPGLCGPGL 509
                     L
Sbjct: 262 TDESLFQVMKL 272

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 63/324 (19%), Positives = 116/324 (35%), Gaps = 79/324 (24%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G FG V    L    G  +  AVK L      +S  ++    E   + +  H ++ K++G
Sbjct: 34  GEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92

Query: 646 F------FHSDESIFLIYEFLQMGSLGDLI-----CRQDFQLQWSIRLKIAIGVAQGLAY 694
                          +I  F++ G L   +         F L     ++  + +A G+ Y
Sbjct: 93  VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152

Query: 695 L-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-- 751
           L  ++++    HR++ ++N +L  D    + DF L R +         S +Y    Y   
Sbjct: 153 LSSRNFI----HRDLAARNCMLAEDMTVCVADFGLSRKI--------YSGDY----YRQG 196

Query: 752 ----------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR 800
                     A E       T   D ++FGV + E++T G+           ++  ++  
Sbjct: 197 CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--EIYNYLI- 253

Query: 801 KINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
                 G    L  +   C    Y        ++  +C S  P++RPS   +   L ++ 
Sbjct: 254 -----GG--NRL-KQPPECMEEVY--------DLMYQCWSADPKQRPSFTCLRMELENIL 297

Query: 857 TRTSLLS-------IELSSSQEHS 873
              S+LS       I +  +  H 
Sbjct: 298 GHLSVLSTSQDPLYINIERAHHHH 321

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 91.7 bits (227), Expect = 1e-19
 Identities = 37/238 (15%), Positives = 65/238 (27%), Gaps = 56/238 (23%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIR--------- 636
           G               +GE   V          S   K +K EV  L  +R         
Sbjct: 87  GQED-PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 637 -------------HKNIVKVLGFFHSDESIFLIYEFLQM----GSLGDLI------CRQD 673
                             K++     +  ++++  F        +L              
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 674 FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG 733
             L    RL++ + V + LA LH      L+H  ++  +I+LD      LT F      G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 734 EAAFQSTMSSEYALSCYNAPEY----------GYSKKATAQMDAYSFGVVLLELITGR 781
            +A             +  PE            +    T   D ++ G+ +  +    
Sbjct: 263 ASAVSPIGRG------FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 90.8 bits (225), Expect = 1e-19
 Identities = 29/229 (12%), Positives = 65/229 (28%), Gaps = 24/229 (10%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G F +VY      +    + +   +K                ++ L        +K    
Sbjct: 76  GAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSA 135

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQ----LQWSIRLKIAIGVAQGLAYLHKDYVPH 702
                   L+ E    G+L + I          +   + +  A+ +   +  +H      
Sbjct: 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---E 192

Query: 703 LLHRNVKSKNILLDADFEP-----------KLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
           ++H ++K  N +L   F              L D      +      +  +++   S + 
Sbjct: 193 IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ 252

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR 800
             E   +K    Q+D +     +  ++ G   +              RR
Sbjct: 253 CVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 20/200 (10%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFFHS 649
           G  G+V+ +    +G +IAVK++  +   + +K +  ++  + K      IV+  G F +
Sbjct: 36  GTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95

Query: 650 DESIFLIYEFLQMG-SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +  +F+  E   MG     L  R    +   I  K+ + + + L YL + +   ++HR+V
Sbjct: 96  NTDVFIAMEL--MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDV 151

Query: 709 KSKNILLDADFEPKLTDF----ALDRIVGEAAFQST---MSSEYALSCYNAPEYGYSKKA 761
           K  NILLD   + KL DF     L     +         M+ E  +   +  +  Y  +A
Sbjct: 152 KPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPE-RIDPPDPTKPDYDIRA 210

Query: 762 TAQMDAYSFGVVLLELITGR 781
               D +S G+ L+EL TG+
Sbjct: 211 ----DVWSLGISLVELATGQ 226

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.5 bits (224), Expect = 2e-19
 Identities = 39/236 (16%), Positives = 68/236 (28%), Gaps = 56/236 (23%)

Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIR------------ 636
                        +GE   V            + K +K EV  L  +R            
Sbjct: 84  EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143

Query: 637 -------------HKNIVKVLGFFHSDE--SIFLIYEFLQ--MGSLGDLI---CRQDFQL 676
                         K +++V          S F +Y  +Q  + + G+++         L
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203

Query: 677 QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA 736
               RL++ + V + LA LH      L+H  ++  +I+LD      LT F          
Sbjct: 204 VHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF------EHLV 254

Query: 737 FQSTMSSEYALSCYNAPEY-----------GYSKKATAQMDAYSFGVVLLELITGR 781
                        +  PE                  T   DA++ G+V+  +    
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 68/310 (21%), Positives = 117/310 (37%), Gaps = 81/310 (26%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKIRHKNIVKVLG 645
           G FG+V+      +L      L+AVK L     +S++   + E + L  ++H++IV+  G
Sbjct: 52  GAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQHIVRFFG 110

Query: 646 FFHSDESIFLIYEFLQMGSL--------------GDLICRQDFQLQWSIRLKIAIGVAQG 691
                  + +++E+++ G L                        L     L +A  VA G
Sbjct: 111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170

Query: 692 LAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           + YL    +V    HR++ ++N L+      K+ DF + R +         S++Y    Y
Sbjct: 171 MVYLAGLHFV----HRDLATRNCLVGQGLVVKIGDFGMSRDI--------YSTDY----Y 214

Query: 751 N------------APE---YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDV 794
                         PE   Y    K T + D +SFGVVL E+ T G+Q          + 
Sbjct: 215 RVGGRTMLPIRWMPPESILYR---KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EA 269

Query: 795 VKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           +  +        G  + L  +   C    Y         I   C    P++R S+ +V  
Sbjct: 270 IDCIT------QG--REL-ERPRACPPEVYA--------IMRGCWQREPQQRHSIKDVHA 312

Query: 851 ALHSLSTRTS 860
            L +L+    
Sbjct: 313 RLQALAQAPP 322

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 59/291 (20%)

Query: 593 GPFGRVY--ILSLPSGEL-IAVKKLVNFGCQSSKTLK----TEVKTLAKIRHKNIVKVLG 645
           G FG V      +      +AVK L N    +   LK     E   + ++ +  IV+++G
Sbjct: 28  GNFGTVKKGYYQMKKVVKTVAVKILKN--EANDPALKDELLAEANVMQQLDNPYIVRMIG 85

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLL 704
                ES  L+ E  ++G L   + +Q+  ++    +++   V+ G+ YL   ++V    
Sbjct: 86  I-CEAESWMLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFV---- 139

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------APEYGY 757
           HR++ ++N+LL      K++DF L + +          + Y    +        APE   
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRAD------ENYYKAQTHGKWPVKWYAPECIN 193

Query: 758 SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL---DVVKWVRRKINITNGAIQVLD 813
             K +++ D +SFGV++ E  + G++     P   +   +V   + +      G  + + 
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTAMLEK------G--ERM- 239

Query: 814 PKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
              A C    Y         +   C +   E RP    V   L +      
Sbjct: 240 GCPAGCPREMYD--------LMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 91.0 bits (226), Expect = 2e-19
 Identities = 55/285 (19%), Positives = 113/285 (39%), Gaps = 46/285 (16%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE 651
           G  G V       G  +AVK+++            E+K L +   H N+++      +D 
Sbjct: 26  GSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRL------KIAIGVAQGLAYLHKDYVPHLLH 705
            +++  E     +L DL+  ++   +            +   +A G+A+LH   +   +H
Sbjct: 83  FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IH 138

Query: 706 RNVKSKNILLD-------------ADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCY 750
           R++K +NIL+               +    ++DF L + +  G+++F++ +++    S +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 751 NAPE-------YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
            APE           ++ T  +D +S G V   +++  +     P           R+ N
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK----HPFGD-----KYSRESN 249

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEV 848
           I  G    LD       +  +  A ++  +     P KRP+  +V
Sbjct: 250 IIRGIFS-LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 90.9 bits (226), Expect = 2e-19
 Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 61/285 (21%)

Query: 593 GPFGRVYILSLPSGEL----IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF-F 647
           G FG V       G+     +AVK + N    +++    E   + ++RH N+V++LG   
Sbjct: 204 GEFGDVM-----LGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 648 HSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
                ++++ E++  GSL D L  R    L     LK ++ V + + YL   ++V    H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV----H 312

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-------APEYGYS 758
           R++ ++N+L+  D   K++DF L +               +            APE    
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK------------EASSTQDTGKLPVKWTAPEALRE 360

Query: 759 KKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA 817
           KK + + D +SFG++L E+ + GR      P +  DVV  V +      G    +     
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK------G--YKM-DAPD 409

Query: 818 NC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
            C    Y         +   C  +    RP+  ++ + L  + T 
Sbjct: 410 GCPPAVYD--------VMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 53/255 (20%), Positives = 82/255 (32%), Gaps = 22/255 (8%)

Query: 74  SLTVASINLQSLNLSGEISSSVCEL---SSLSNLNLADNLFNQPIPLHLSQCS--SLETL 128
           SL++  + +++  +   I      +   S L  L L +       P  L + +   L  L
Sbjct: 67  SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDL 188
           NL N      D     ++  +         L+VL++               F  L  LDL
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKP------GLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180

Query: 189 SQNAYL------ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
           S N  L       +  P     L+ L           GV          L  LDLS N+L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240

Query: 243 TGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINEC 302
                        +L S ++S   L    P G+     L  L L  N  +   P S +E 
Sbjct: 241 RDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNP-SPDEL 295

Query: 303 LNLERFQVQDNGFSG 317
             +    ++ N F  
Sbjct: 296 PQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 43/201 (21%), Positives = 70/201 (34%), Gaps = 13/201 (6%)

Query: 74  SLTVASINLQSLNLSGEISS----SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLN 129
              +  +NL++++ +   +            L  L++A           +    +L TL+
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179

Query: 130 LSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLS 189
           LS+N        R  I    P    +L  L + N G    SG    +     +L  LDLS
Sbjct: 180 LSDNPELG---ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLS 236

Query: 190 QNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS 249
            N+   +          +L  L L  +G   V          LS+LDLS N L    P  
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP---AKLSVLDLSYNRLD-RNPSP 292

Query: 250 LGSSLLKLVSFDVSQNKLSGS 270
               L ++ +  +  N    S
Sbjct: 293 DE--LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 55/298 (18%), Positives = 92/298 (30%), Gaps = 36/298 (12%)

Query: 176 VFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDS---FVGLQSL 232
           ++G    L  L    +        +DI K   L++L ++++     I       +G+  L
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGL 97

Query: 233 SILDLSQNNLTGEVPQSLGS-SLLKLVSFDVSQNKLSGSFPN----GICKANGLVNLSLH 287
             L L    +TG  P  L   +   L   ++     +               GL  LS+ 
Sbjct: 98  QELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIA 157

Query: 288 KNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI 347
           +          +     L    + DN   G+    + +L  +K                 
Sbjct: 158 QAHSLNFSCEQVRVFPALSTLDLSDNPELGERG-LISALCPLKF---------------- 200

Query: 348 SMAAQLEQVQIDNNRFTS---SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV-MSI 403
                L+ + + N    +          +   L     S NS   +     CD P  ++ 
Sbjct: 201 ---PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 404 INLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGP 461
           +NLS   +      L    KL  L L+ N L     PS  ELP +  L L  N     
Sbjct: 258 LNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 44/275 (16%), Positives = 76/275 (27%), Gaps = 24/275 (8%)

Query: 104 LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLN 163
           L   D   +      + +  SL+ L +    I    L            +  +  LQ L 
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFG-------ALRVLGISGLQELT 101

Query: 164 LGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKL-----EKLEQLFLQSSGF 218
           L +  ++G+ P      +   +  L+      +   + + +L       L+ L +  +  
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161

Query: 219 HGVIPDSFVGLQSLSILDLSQNNLTGEVP---QSLGSSLLKLVSFDVSQNK---LSGSFP 272
                +      +LS LDLS N   GE              L    +        SG   
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221

Query: 273 NGICKANGLVNLSLHKNFFNGSIPGSINECL-NLERFQVQDNGFSGDFPDKLWSLPRIKL 331
                   L  L L  N    +      +    L    +   G           L  + L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVLDL 281

Query: 332 IRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSS 366
                NR     P    +  Q+  + +  N F  S
Sbjct: 282 ---SYNRLDR-NPSPDEL-PQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 44/230 (19%), Positives = 78/230 (33%), Gaps = 22/230 (9%)

Query: 284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPD---KLWSLPRIKLIRAESNRFS 340
           L       +      I + L+L+R  V+             ++  +  ++ +  E+   +
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 341 GAIPDSISMAA--QLEQVQIDNNRFTSSIPQGLGSV-----KSLYRFSASQNSFYGSLPP 393
           G  P  +  A    L  + + N  + +     L  +       L   S +Q         
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCE 167

Query: 394 NFCDSPVMSIINLSQNSISGQIPE-----LKKCRKLVSLSLADN---SLTGEIPPSLAEL 445
                P +S ++LS N   G+          K   L  L+L +    + +G      A  
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227

Query: 446 PVLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLSGRVPYSLISGL 493
             L  LDLS N+L         +   +L   N+SF  L  +VP  L + L
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKL 276

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 59.9 bits (145), Expect = 9e-10
 Identities = 32/144 (22%), Positives = 56/144 (38%), Gaps = 32/144 (22%)

Query: 81  NLQSLNLSG-------EISSSVCE--LSSLSNLNLADNLFNQP---IPLHLSQCSSLETL 128
            L +L+LS         + S++C     +L  L L +     P        +    L+ L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233

Query: 129 NLSNNLIW---------------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSV 173
           +LS+N +                 L+LS   ++ ++P+ + +   L VL+L  N L    
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RN 289

Query: 174 PFVFGNFSELVVLDLSQNAYLISE 197
           P       ++  L L  N +L SE
Sbjct: 290 PS-PDELPQVGNLSLKGNPFLDSE 312

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 44/219 (20%), Positives = 70/219 (31%), Gaps = 31/219 (14%)

Query: 291 FNGSIP--GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSIS 348
           F+   P   S   CL     ++   G S ++  K            +  +          
Sbjct: 17  FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIK---------- 66

Query: 349 MAAQLEQVQIDNNRFTSSIPQG---LGSVKSLYRFSASQNSFYGSLPPN--FCDSPVMSI 403
            +  L+++ +   R  S I  G   +  +  L   +       G+ PP       P ++I
Sbjct: 67  -SLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125

Query: 404 INLSQNSISGQIPELKKC-----RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL 458
           +NL   S + +   L +        L  LS+A           +   P L+ LDLSDN  
Sbjct: 126 LNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPE 185

Query: 459 TGPI-------PQGLQNLK-LALFNVSFNKLSGRVPYSL 489
            G         P     L+ LAL N      SG      
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALA 224

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 88.1 bits (219), Expect = 4e-19
 Identities = 36/211 (17%), Positives = 80/211 (37%), Gaps = 30/211 (14%)

Query: 590 GNGGPFGRVYILSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLG 645
           G+GG   +V+ +     ++ A+K   L     Q+  + + E+  L K++  +  I+++  
Sbjct: 37  GSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +  +D+ I+++ E      L   + ++   +    R      + + +  +H+  +   +H
Sbjct: 96  YEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGI---VH 150

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----YGY 757
            ++K  N L+  D   KL DF +   +          S          Y  PE       
Sbjct: 151 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS----QVGTVNYMPPEAIKDMSS 205

Query: 758 SKKATAQMDAY-------SFGVVLLELITGR 781
           S++               S G +L  +  G+
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 87.8 bits (218), Expect = 7e-19
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 31/207 (14%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFFHS 649
           G +G V  ++  PSG+++AVK++      +  K L  ++  + +      IV+  G    
Sbjct: 33  GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIR----LKIAIGVAQGLAYLHKDYVPHLLH 705
           +   ++  E +   S           L   I      KI +   + L +L ++    ++H
Sbjct: 93  EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIH 149

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAA-FQSTMSSEYALSC--YNAPE-------- 754
           R++K  NILLD     KL DF      G +     +++      C  Y APE        
Sbjct: 150 RDIKPSNILLDRSGNIKLCDF------GISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 755 YGYSKKATAQMDAYSFGVVLLELITGR 781
            GY  ++    D +S G+ L EL TGR
Sbjct: 204 QGYDVRS----DVWSLGITLYELATGR 226

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 87.8 bits (218), Expect = 8e-19
 Identities = 36/211 (17%), Positives = 80/211 (37%), Gaps = 30/211 (14%)

Query: 590 GNGGPFGRVYILSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLG 645
           G+GG   +V+ +     ++ A+K   L     Q+  + + E+  L K++  +  I+++  
Sbjct: 18  GSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +  +D+ I+++ E      L   + ++   +    R      + + +  +H+  +   +H
Sbjct: 77  YEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGI---VH 131

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----YGY 757
            ++K  N L+  D   KL DF +   +          S          Y  PE       
Sbjct: 132 SDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS----QVGTVNYMPPEAIKDMSS 186

Query: 758 SKKATAQMDAY-------SFGVVLLELITGR 781
           S++               S G +L  +  G+
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.2 bits (223), Expect = 9e-19
 Identities = 45/248 (18%), Positives = 94/248 (37%), Gaps = 31/248 (12%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
                NL    ++   +  EL+S+  +   ++     +   +    ++  L L+ N +  
Sbjct: 22  ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD 79

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L L  N I+  +  S+  L  L+ L+L  N +S  +     +  +L  
Sbjct: 80  IKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLES 135

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
           L L  N   I++I + + +L KL+ L L+ +    +      GL  L  L LS+N+++  
Sbjct: 136 LYLGNN--KITDI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-- 188

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL 305
             ++L + L  L   ++   +      N          +           P  I++  + 
Sbjct: 189 DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDY 245

Query: 306 ERFQVQDN 313
           E+  V+ +
Sbjct: 246 EKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.0 bits (181), Expect = 1e-13
 Identities = 50/247 (20%), Positives = 85/247 (34%), Gaps = 33/247 (13%)

Query: 101 LSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW------------VLDLSRNHIEGK 148
           +           Q  P      +     NL    +              +  + + I+  
Sbjct: 1   MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-S 57

Query: 149 IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL 208
           + + I  L N+  L L  N L+   P    N   L  L L +N   I ++ S +  L+KL
Sbjct: 58  V-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENK--IKDL-SSLKDLKKL 111

Query: 209 EQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS 268
           + L L+ +G   +  +  V L  L  L L  N +T      L S L KL +  +  N++S
Sbjct: 112 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT--DITVL-SRLTKLDTLSLEDNQIS 166

Query: 269 GSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPD---KLWS 325
                 +     L NL L KN  +  +   +    NL+  ++          +    L  
Sbjct: 167 -DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 326 LPRIKLI 332
              +K  
Sbjct: 223 PNTVKNT 229

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 71.7 bits (175), Expect = 6e-13
 Identities = 56/294 (19%), Positives = 99/294 (33%), Gaps = 19/294 (6%)

Query: 208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKL 267
           + +    S+    + PD           +L + ++T  V Q+    L  +     + + +
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDI 55

Query: 268 SGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
             S   GI     +  L L+ N     I   +    NL    + +N    D    L  L 
Sbjct: 56  K-SVQ-GIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLK 109

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
           ++K +  E N  S  I + +    QLE + + NN+ T      L  +  L   S   N  
Sbjct: 110 KLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQI 165

Query: 388 YGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPV 447
              + P       +  + LS+N IS  +  L   + L  L L       +     + L V
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 448 LTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGN 501
              +  +D +L  P      +      NV ++        S I   P +  +  
Sbjct: 223 PNTVKNTDGSLVTPEIIS-DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.4 bits (217), Expect = 2e-18
 Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 44/199 (22%)

Query: 604 PSGELIAVKKLVN-FGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IF 654
                +A+KKL   F  Q+   +  + E+  +  + HKNI+ +L  F   +S      ++
Sbjct: 48  ILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106

Query: 655 LIYEFLQMGSLGDL--ICRQD----------FQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           ++ E   M +  +L  + + +          +Q+     L        G+ +LH      
Sbjct: 107 IVMEL--MDA--NLCQVIQMELDHERMSYLLYQM-----LC-------GIKHLHS---AG 147

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKAT 762
           ++HR++K  NI++ +D   K+ DF L R  G +     M+       Y APE        
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYK 204

Query: 763 AQMDAYSFGVVLLELITGR 781
             +D +S G ++ E+I G 
Sbjct: 205 ENVDIWSVGCIMGEMIKGG 223

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 86.5 bits (214), Expect = 2e-18
 Identities = 62/337 (18%), Positives = 107/337 (31%), Gaps = 102/337 (30%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           G GG FG V+   +       A+K+ +    +    + +  EVK LAK+ H  IV+    
Sbjct: 15  GRGG-FGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 647 F-----------------------------------------HSDESIFLIYEFL----- 660
           +                                             S       L     
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 661 ------QM-----GSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRN 707
                 QM      +L D + R+           L I I +A+ + +LH      L+HR+
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRD 189

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS----------CYNAPEY-- 755
           +K  NI    D   K+ DF L   + +   + T+ +                Y +PE   
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249

Query: 756 --GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD 813
              YS K     D +S G++L EL+     +     E + ++       ++ N       
Sbjct: 250 GNNYSHKV----DIFSLGLILFELLYSFSTQM----ERVRIIT------DVRNLKF---- 291

Query: 814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
           P +      Q      +     S  P +RP   ++++
Sbjct: 292 PLLFTQKYPQ---EHMMVQDMLSPSPTERPEATDIIE 325

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 29/202 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL-------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G +  VY   S  +  L+A+K++                T   EV  L  ++H NIV + 
Sbjct: 13  GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC------TAIREVSLLKDLKHANIVTLH 66

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
              H+++S+ L++E+L    L   +      +           + +GLAY H+  V   L
Sbjct: 67  DIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV---L 122

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE--YGYSK 759
           HR++K +N+L++   E KL DF L R     A      T  +E     Y  P+   G S 
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYDNEVVTLWYRPPDILLG-ST 176

Query: 760 KATAQMDAYSFGVVLLELITGR 781
             + Q+D +  G +  E+ TGR
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGR 198

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 38/212 (17%), Positives = 82/212 (38%), Gaps = 32/212 (15%)

Query: 590 GNGGPFGRVYILSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLG 645
           G+GG   +V+ +     ++ A+K   L     Q+  + + E+  L K++  +  I+++  
Sbjct: 65  GSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +  +D+ I+++ E      L   + ++   +    R      + + +  +H+  +   +H
Sbjct: 124 YEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGI---VH 178

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-----YNAPE----YG 756
            ++K  N L+  D   KL DF +         Q   +S    S      Y  PE      
Sbjct: 179 SDLKPANFLIV-DGMLKLIDFGIAN-----QMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 757 YSKKATAQMDAY-------SFGVVLLELITGR 781
            S++               S G +L  +  G+
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.5 bits (215), Expect = 2e-18
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 31/221 (14%)

Query: 581 IGMDEKSSAGN-------G-GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSK------TL 625
           + +D KS A         G G F  VY      + +++A+KK +  G +S        T 
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGINRTA 59

Query: 626 KTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
             E+K L ++ H NI+ +L  F    +I L+++F++   L  +I      L  S      
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMS 742
           +   QGL YLH+ ++   LHR++K  N+LLD +   KL DF L +     +F S     +
Sbjct: 119 LMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAK-----SFGSPNRAYT 170

Query: 743 SEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
            +     Y APE  +G ++     +D ++ G +L EL+   
Sbjct: 171 HQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRV 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 68/283 (24%), Positives = 115/283 (40%), Gaps = 59/283 (20%)

Query: 593 GPFGRVYILSLPSGEL----IAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF-F 647
           G FG V       G+     +AVK +      +   L  E   + ++RH N+V++LG   
Sbjct: 32  GEFGDVM-----LGDYRGNKVAVKCI-KNDATAQAFLA-EASVMTQLRHSNLVQLLGVIV 84

Query: 648 HSDESIFLIYEFLQMGSLGD-LICRQDFQLQWSIRLKIAIGVAQGLAYL-HKDYVPHLLH 705
                ++++ E++  GSL D L  R    L     LK ++ V + + YL   ++V    H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV----H 140

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS------TMSSEYALSCYNAPEYGYSK 759
           R++ ++N+L+  D   K++DF L +               T           APE    K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT-----------APEALREK 189

Query: 760 KATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
           K + + D +SFG++L E+ + GR      P +  DVV  V +      G    +      
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEK------G--YKM-DAPDG 238

Query: 819 C----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
           C    Y        E+   C  +    RPS  ++ + L  + T
Sbjct: 239 CPPAVY--------EVMKNCWHLDAAMRPSFLQLREQLEHIKT 273

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 46/214 (21%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVK-TLAKIRHKNIVKVLGFFHS 649
           G +G V  +  +PSG+++AVK++      Q  K L  ++  ++  +     V   G    
Sbjct: 18  GAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR 77

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIR----LKIAIGVAQGLAYLHKDYVPHLLH 705
           +  +++  E +   SL D   +Q      +I      KIA+ + + L +LH      ++H
Sbjct: 78  EGDVWICMELMD-TSL-DKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIH 133

Query: 706 RNVKSKNILLDADFEPKLTDF----------ALDRIVGEAAFQSTMSSEYALSCYNAPE- 754
           R+VK  N+L++A  + K+ DF          A D   G                Y APE 
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG------C-------KPYMAPER 180

Query: 755 -------YGYSKKATAQMDAYSFGVVLLELITGR 781
                   GYS K+    D +S G+ ++EL   R
Sbjct: 181 INPELNQKGYSVKS----DIWSLGITMIELAILR 210

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 65/307 (21%), Positives = 114/307 (37%), Gaps = 85/307 (27%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKV 643
             FG+VY             + +A+K L           +    E    A+++H N+V +
Sbjct: 20  DRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKA-EGPLREEFRHEAMLRARLQHPNVVCL 77

Query: 644 LGFFHSDESIFLIYEFLQMGSL---------------GDLICRQDFQLQWSIRLKIAIGV 688
           LG    D+ + +I+ +   G L                D        L+    + +   +
Sbjct: 78  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137

Query: 689 AQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           A G+ YL     V    H+++ ++N+L+      K++D  L R V         +++Y  
Sbjct: 138 AAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREV--------YAADY-- 183

Query: 748 SCYN------------APE---YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAES 791
             Y             APE   YG   K +   D +S+GVVL E+ + G Q       + 
Sbjct: 184 --YKLLGNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ- 237

Query: 792 LDVVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFE 847
            DVV+ +R +        QVL P   +C    Y         + + C +  P +RP   +
Sbjct: 238 -DVVEMIRNR--------QVL-PCPDDCPAWVYA--------LMIECWNEFPSRRPRFKD 279

Query: 848 VVKALHS 854
           +   L +
Sbjct: 280 IHSRLRA 286

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 59/303 (19%), Positives = 108/303 (35%), Gaps = 71/303 (23%)

Query: 593 GPFGRVY--ILSLPSGELI--AVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G FG V    L    G  +  AVK +      S + ++   +E   +    H N++++LG
Sbjct: 45  GEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103

Query: 646 -----FFHSDESIFLIYEFLQMGSLGDLI--CR---QDFQLQWSIRLKIAIGVAQGLAYL 695
                         +I  F++ G L   +   R       +     LK  + +A G+ YL
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163

Query: 696 -HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--- 751
            +++++    HR++ ++N +L  D    + DF L + +         S +Y    Y    
Sbjct: 164 SNRNFL----HRDLAARNCMLRDDMTVCVADFGLSKKI--------YSGDY----YRQGR 207

Query: 752 ---------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRK 801
                    A E    +  T++ D ++FGV + E+ T G            ++  ++   
Sbjct: 208 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--EMYDYLL-- 263

Query: 802 INITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST 857
               +G    L  +  +C    Y        EI   C    P  RP+   +   L  L  
Sbjct: 264 ----HG--HRL-KQPEDCLDELY--------EIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308

Query: 858 RTS 860
              
Sbjct: 309 SLP 311

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 84.5 bits (210), Expect = 6e-18
 Identities = 46/195 (23%), Positives = 86/195 (44%), Gaps = 14/195 (7%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G V+   +  +G+++A+KK            K    E++ L +++H N+V +L  F 
Sbjct: 14  GSYGVVFKCRNRDTGQIVAIKK-FLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR 72

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
               + L++E+    ++   + R    +   +   I     Q + + HK      +HR+V
Sbjct: 73  RKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---IHRDV 128

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMD 766
           K +NIL+      KL DF   R++   +       E A   Y +PE   G   +    +D
Sbjct: 129 KPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVG-DTQYGPPVD 185

Query: 767 AYSFGVVLLELITGR 781
            ++ G V  EL++G 
Sbjct: 186 VWAIGCVFAELLSGV 200

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.2 bits (211), Expect = 7e-18
 Identities = 47/212 (22%), Positives = 78/212 (36%), Gaps = 42/212 (19%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKV 643
           G FG V+  +     + + VK     K++            +  E+  L+++ H NI+KV
Sbjct: 35  GAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV 94

Query: 644 LGFFHSDESIFLIYEFLQMGS-LGDLI----------CRQDFQLQWSIRLKIAIGVAQGL 692
           L  F +     L+ E    G  L   I              F+ Q          +   +
Sbjct: 95  LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFR-Q----------LVSAV 143

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM--SSEYALSCY 750
            YL    +   +HR++K +NI++  DF  KL DF     +       T   + EY     
Sbjct: 144 GYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC---- 196

Query: 751 NAPEYGYSKK-ATAQMDAYSFGVVLLELITGR 781
            APE          +++ +S GV L  L+   
Sbjct: 197 -APEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 31/224 (13%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
           N   +      ++   +  +L  ++ L+         I   +   ++L  L L +N I  
Sbjct: 20  NAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD 77

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L+LS N +  K   +I  L +++ L+L S  ++   P      S L V
Sbjct: 78  LAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQV 133

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
           L L  N   I+ I S +  L  L+ L + ++    + P     L  L+ L    N ++  
Sbjct: 134 LYLDLNQ--ITNI-SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI 188

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
            P    +SL  L+   +  N++S    + +   + L  ++L   
Sbjct: 189 SPL---ASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 45/191 (23%), Positives = 78/191 (40%), Gaps = 24/191 (12%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
            +  L LSG  +   S++  L S+  L+L         PL  +  S+L+ L L  N I  
Sbjct: 86  KITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPL--AGLSNLQVLYLDLNQITN 143

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
           +              +  L NLQ L++G+  +S   P    N S+L  L    N   IS+
Sbjct: 144 I------------SPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK--ISD 187

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
           I S +  L  L ++ L+++    V P       +L I+ L+   +T +      + ++  
Sbjct: 188 I-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPN 244

Query: 258 VSFDVSQNKLS 268
           V    S   ++
Sbjct: 245 VVKGPSGAPIA 255

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 47/259 (18%), Positives = 97/259 (37%), Gaps = 20/259 (7%)

Query: 213 LQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP 272
            Q +  + + PD    L +   +   ++N+T  V Q+    L  + +       ++    
Sbjct: 4   TQPTAINVIFPDP--ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI-- 56

Query: 273 NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLI 332
            G+   N L+ L L  N     +   +     +   ++  N         +  L  IK +
Sbjct: 57  EGVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSA--IAGLQSIKTL 112

Query: 333 RAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP 392
              S + +   P  ++  + L+ + +D N+ T+  P  L  + +L   S         L 
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLT 167

Query: 393 PNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLD 452
           P   +   ++ +    N IS  I  L     L+ + L +N ++ ++ P LA    L  + 
Sbjct: 168 P-LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVT 223

Query: 453 LSDNNLTGPIPQGLQNLKL 471
           L++  +T        NL +
Sbjct: 224 LTNQTITNQPVFYNNNLVV 242

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 43/240 (17%), Positives = 93/240 (38%), Gaps = 20/240 (8%)

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
           +   ++++      +   L  +  L+     ++ ++       + L+ L+L  N   I++
Sbjct: 24  IAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN--QITD 77

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
           + + +  L K+ +L L  +    V      GLQS+  LDL+   +T   P    + L  L
Sbjct: 78  L-APLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPL---AGLSNL 131

Query: 258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
               +  N+++    + +     L  LS+     +  +   +     L   +  DN  S 
Sbjct: 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKIS- 186

Query: 318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
           D    L SLP +  +  ++N+ S   P  ++  + L  V + N   T+       ++   
Sbjct: 187 DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 32/151 (21%), Positives = 55/151 (36%), Gaps = 19/151 (12%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
           NLQ L L   +I+  S +  L++L  L++ +   +   PL  +  S L TL   +N I  
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPL--ANLSKLTTLKADDNKISD 187

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       + L  N I       + +  NL ++ L +  ++    F   N     V
Sbjct: 188 ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSS 216
           +     A +     SD G        +  +S
Sbjct: 246 VKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 18/99 (18%), Positives = 41/99 (41%), Gaps = 5/99 (5%)

Query: 405 NLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           +++Q +    I         + ++   +++T  +    A+L  +T L      +T    +
Sbjct: 2   SITQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IE 57

Query: 465 GLQNLK-LALFNVSFNKLSGRVPYSLISGLPASYLQGNP 502
           G+Q L  L    +  N+++   P   ++ +    L GNP
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNP 96

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 84.2 bits (209), Expect = 8e-18
 Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 76/310 (24%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I    +   +AVK L         + L +E+K L  I  H N+V +L
Sbjct: 38  GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97

Query: 645 GF-FHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR-------------LKIAIGV 688
           G        + +I EF + G+L   +   R +F                    +  +  V
Sbjct: 98  GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 157

Query: 689 AQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           A+G+ +L  +  +    HR++ ++NILL      K+ DF L R +               
Sbjct: 158 AKGMEFLASRKCI----HRDLAARNILLSEKNVVKICDFGLARDI--------YKDPD-- 203

Query: 748 SCYN------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDV 794
             Y             APE  + +  T Q D +SFGV+L E+ + G       P   + +
Sbjct: 204 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKI 256

Query: 795 VKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            +   R+  +  G    +           Y        +  L C    P +RP+  E+V+
Sbjct: 257 DEEFCRR--LKEG--TRM-RAPDYTTPEMY--------QTMLDCWHGEPSQRPTFSELVE 303

Query: 851 ALHSLSTRTS 860
            L +L    +
Sbjct: 304 HLGNLLQANA 313

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 83.3 bits (207), Expect = 1e-17
 Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 30/205 (14%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL--------VNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G +G V+   +  + E++A+K++        V        +   E+  L +++HKNIV++
Sbjct: 13  GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS------SALREICLLKELKHKNIVRL 66

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
               HSD+ + L++EF     L       +  L   I       + +GL + H   V   
Sbjct: 67  HDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV--- 122

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE--YGYS 758
           LHR++K +N+L++ + E KL +F L R     AF       S+E     Y  P+  +G +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWYRPPDVLFG-A 176

Query: 759 KKATAQMDAYSFGVVLLELITGRQA 783
           K  +  +D +S G +  EL    + 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRP 201

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.2 bits (201), Expect = 1e-17
 Identities = 27/174 (15%), Positives = 65/174 (37%), Gaps = 20/174 (11%)

Query: 84  SLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-------- 135
             + +  I+ +  +++SL+ + LA+        +      +++ L ++N           
Sbjct: 31  GQSSTANITEA--QMNSLTYITLANINVTDLTGI--EYAHNIKDLTINNIHATNYNPISG 86

Query: 136 ----WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
                 L +    +      ++  L +L +L++  +    S+        ++  +DLS N
Sbjct: 87  LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

Query: 192 AYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
              I++I   +  L +L+ L +Q  G H            L+ L      + G+
Sbjct: 147 G-AITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 34/193 (17%), Positives = 65/193 (33%), Gaps = 22/193 (11%)

Query: 97  ELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSL 156
              +  N  L  +       +  +Q +SL  + L+N  +         + G     I   
Sbjct: 21  TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINV-------TDLTG-----IEYA 65

Query: 157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS 216
            N++ L + +   +   P      S L  L +     + S+   ++  L  L  L +  S
Sbjct: 66  HNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD-VTSDKIPNLSGLTSLTLLDISHS 122

Query: 217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGIC 276
                I      L  ++ +DLS N    ++   L  +L +L S ++  + +      GI 
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL-KTLPELKSLNIQFDGVHDY--RGIE 178

Query: 277 KANGLVNLSLHKN 289
               L  L     
Sbjct: 179 DFPKLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.5 bits (150), Expect = 6e-11
 Identities = 27/180 (15%), Positives = 62/180 (34%), Gaps = 12/180 (6%)

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
             L ++        +   + +L  + L +  ++            +  L ++      + 
Sbjct: 28  GLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGI--EYAHNIKDLTINNI--HATN 80

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
             + I  L  LE+L +           +  GL SL++LD+S +     +   + ++L K+
Sbjct: 81  Y-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI-NTLPKV 138

Query: 258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG 317
            S D+S N         +     L +L++  +  +      I +   L +         G
Sbjct: 139 NSIDLSYNGAITD-IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 16/79 (20%), Positives = 33/79 (41%), Gaps = 2/79 (2%)

Query: 404 INLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP 463
           + ++    +     +     L  L +    +T +  P+L+ L  LT LD+S +     I 
Sbjct: 71  LTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 464 QGLQNL-KLALFNVSFNKL 481
             +  L K+   ++S+N  
Sbjct: 130 TKINTLPKVNSIDLSYNGA 148

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 21/123 (17%), Positives = 47/123 (38%), Gaps = 20/123 (16%)

Query: 81  NLQSLNLSG-----EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
           NL+ L + G     +   ++  L+SL+ L+++ +  +  I   ++    + +++LS N  
Sbjct: 89  NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN-- 146

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
                    I       + +L  L+ LN+  + +         +F +L  L        I
Sbjct: 147 -------GAI--TDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT--I 193

Query: 196 SEI 198
              
Sbjct: 194 GGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 34/180 (18%), Positives = 68/180 (37%), Gaps = 9/180 (5%)

Query: 281 LVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS 340
            +N  L ++    +   +  +  +L    + +   + D    +     IK +   +   +
Sbjct: 25  YLNGLLGQS---STANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHAT 79

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
              P  IS  + LE+++I     TS     L  + SL     S ++   S+       P 
Sbjct: 80  NYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137

Query: 401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG 460
           ++ I+LS N     I  LK   +L SL++  + +  +    + + P L  L      + G
Sbjct: 138 VNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 69/311 (22%), Positives = 123/311 (39%), Gaps = 78/311 (25%)

Query: 593 GPFGRVY------ILSLPSGELI--AVKKL-VNFGCQSSKTLKTEVKTLAKI-RHKNIVK 642
           G FG+V       I      E +  AVK L  +   +    L +E++ +  I +HKNI+ 
Sbjct: 92  GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 151

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGD--LICRQDFQLQWSIR-------------LKIAIG 687
           +LG    D  +++I E+   G+L +     R                       +     
Sbjct: 152 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211

Query: 688 VAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
           +A+G+ YL  +  +    HR++ ++N+L+  +   K+ DF L R +         + +Y 
Sbjct: 212 LARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI--------NNIDY- 258

Query: 747 LSCYN------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLD 793
              Y             APE  + +  T Q D +SFGV++ E+ T G       P E  +
Sbjct: 259 ---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 313

Query: 794 VVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           + K ++            +  K ANC    Y         +   C   +P +RP+  ++V
Sbjct: 314 LFKLLKEG--------HRM-DKPANCTNELY--------MMMRDCWHAVPSQRPTFKQLV 356

Query: 850 KALHSLSTRTS 860
           + L  + T T+
Sbjct: 357 EDLDRILTLTT 367

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.9 bits (206), Expect = 1e-17
 Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 29/202 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKL--------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G +G VY      GE  A+KK+        +        T   E+  L +++H NIVK+ 
Sbjct: 13  GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS------TTIREISILKELKHSNIVKLY 66

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
              H+ + + L++E L    L  L+   +  L+        + +  G+AY H   V   L
Sbjct: 67  DVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV---L 122

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE--YGYSK 759
           HR++K +N+L++ + E K+ DF L R     AF       + E     Y AP+   G SK
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR-----AFGIPVRKYTHEIVTLWYRAPDVLMG-SK 176

Query: 760 KATAQMDAYSFGVVLLELITGR 781
           K +  +D +S G +  E++ G 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT 198

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 85.5 bits (212), Expect = 2e-17
 Identities = 54/199 (27%), Positives = 86/199 (43%), Gaps = 22/199 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G +G V +     +    A+K  +  +    S+  L  EV  L  + H NI+K+  FF  
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
             + +L+ E  + G L D I  +    +      I   V  G+ YLHK    +++HR++K
Sbjct: 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHKH---NIVHRDLK 163

Query: 710 SKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGYSKKAT 762
            +N+LL   + D   K+ DF L  +            + Y    Y APE     Y +K  
Sbjct: 164 PENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY----YIAPEVLRKKYDEKC- 218

Query: 763 AQMDAYSFGVVLLELITGR 781
              D +S GV+L  L+ G 
Sbjct: 219 ---DVWSIGVILFILLAGY 234

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 63/333 (18%), Positives = 124/333 (37%), Gaps = 63/333 (18%)

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSS 216
           +L+V+      L  +VP       +  +LDL  N   ISE+  D    L+ L  L L ++
Sbjct: 34  HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNN--DISELRKDDFKGLQHLYALVLVNN 88

Query: 217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS----GSFP 272
               +   +F  L+ L  L +S+N+L  E+P +L SSL++L    +  N++     G F 
Sbjct: 89  KISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVEL---RIHDNRIRKVPKGVFS 144

Query: 273 NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLI 332
                   +  + +  N               LE    +   F G          ++  +
Sbjct: 145 G----LRNMNCIEMGGN--------------PLENSGFEPGAFDG---------LKLNYL 177

Query: 333 RAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQG-LGSVKSLYRFSASQNSFYGSL 391
           R    + +  IP    +   L ++ +D+N+  + I    L     LYR     N     +
Sbjct: 178 RISEAKLT-GIPKD--LPETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQI-RMI 232

Query: 392 PPN-FCDSPVMSIINLSQNSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPS-------L 442
                   P +  ++L  N +S ++P  L   + L  + L  N++T ++  +        
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFG 290

Query: 443 AELPVLTYLDLSDNNLT-GPIP----QGLQNLK 470
            +      + L +N +    +     + + +  
Sbjct: 291 VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRL 323

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 43/235 (18%), Positives = 71/235 (30%), Gaps = 41/235 (17%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLSRNH 144
              + L+L +N  ++           L  L L NN I                L +S+NH
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113

Query: 145 IEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-- 202
           +  +IP       +L  L +  N +      VF     +  +++  N    S        
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170

Query: 203 -------------------GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT 243
                                 E L +L L  +    +  +  +    L  L L  N + 
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR 230

Query: 244 GEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS 298
             +     S L  L    +  NKLS   P G+     L  + LH N     +  +
Sbjct: 231 -MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.0 bits (133), Expect = 5e-08
 Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 11/164 (6%)

Query: 342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPV 400
           A+P  IS       + + NN  +         ++ LY      N     +    F     
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRK 103

Query: 401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLT 459
           +  + +S+N +  +IP       LV L + DN +  ++P    + L  +  +++  N L 
Sbjct: 104 LQKLYISKNHLV-EIPP-NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160

Query: 460 -GPIPQG-LQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGN 501
                 G    LKL    +S  KL+  +P  L   L   +L  N
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPETLNELHLDHN 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 29/202 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKL--------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G +G VY      G ++A+K++        +        T   E+  L ++ H NIV ++
Sbjct: 32  GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS------TAIREISLLKELHHPNIVSLI 85

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
              HS+  + L++EF++   L  ++      LQ S        + +G+A+ H+  +   L
Sbjct: 86  DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI---L 141

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE--YGYSK 759
           HR++K +N+L+++D   KL DF L R     AF     + + E     Y AP+   G SK
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR-----AFGIPVRSYTHEVVTLWYRAPDVLMG-SK 195

Query: 760 KATAQMDAYSFGVVLLELITGR 781
           K +  +D +S G +  E+ITG+
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGK 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 75/320 (23%), Positives = 123/320 (38%), Gaps = 91/320 (28%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FGRV+      +L      ++AVK L            + E   +A+  + NIVK+LG
Sbjct: 58  GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 117

Query: 646 FFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR---------------------L 682
                + + L++E++  G L + +           S                       L
Sbjct: 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177

Query: 683 KIAIGVAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
            IA  VA G+AYL  + +V    HR++ ++N L+  +   K+ DF L R +         
Sbjct: 178 CIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNI--------Y 225

Query: 742 SSEYALSCYN------------APE---YGYSKKATAQMDAYSFGVVLLELIT-GRQAEQ 785
           S++Y    Y              PE   Y    + T + D +++GVVL E+ + G Q   
Sbjct: 226 SADY----YKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPYY 278

Query: 786 AEPAESLDVVKWVRRKINITNGAIQVLD-PKIANC----YQQQMLGALEIALRCTSVMPE 840
               E  +V+ +VR      +G   +L  P+  NC    Y         +   C S +P 
Sbjct: 279 GMAHE--EVIYYVR------DG--NILACPE--NCPLELY--------NLMRLCWSKLPA 318

Query: 841 KRPSMFEVVKALHSLSTRTS 860
            RPS   + + L  +  R  
Sbjct: 319 DRPSFCSIHRILQRMCERAE 338

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 69/307 (22%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       ++   +   +AVK L  +      + L +E+K L+ +  H NIV +L
Sbjct: 34  GAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR---------------LKIAIG 687
           G         +I E+   G L + +   R  F    +                 L  +  
Sbjct: 94  GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153

Query: 688 VAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
           VA+G+A+L  K+ +    HR++ ++NILL      K+ DF L R +         +    
Sbjct: 154 VAKGMAFLASKNCI----HRDLAARNILLTHGRITKICDFGLARDI--------KNDSNY 201

Query: 747 LSCYN--------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKW 797
           +   N        APE  ++   T + D +S+G+ L EL + G       P   + V   
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSK 256

Query: 798 VRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
             +   I  G    +     +     Y        +I   C    P KRP+  ++V+ + 
Sbjct: 257 FYKM--IKEG--FRM-LSPEHAPAEMY--------DIMKTCWDADPLKRPTFKQIVQLIE 303

Query: 854 SLSTRTS 860
              + ++
Sbjct: 304 KQISEST 310

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.6 bits (207), Expect = 4e-17
 Identities = 73/326 (22%), Positives = 126/326 (38%), Gaps = 80/326 (24%)

Query: 593 GPFGRVY------ILSLPSGELI--AVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVK 642
           G FG+V       +       +   AVK L +   +   + L +E++ +  I +HKNI+ 
Sbjct: 80  GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 139

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGD--LICRQDFQLQWSIR-------------LKIAIG 687
           +LG    D  +++I E+   G+L +     R                       +  A  
Sbjct: 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199

Query: 688 VAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
           VA+G+ YL  K  +    HR++ ++N+L+  D   K+ DF L R +           +Y 
Sbjct: 200 VARGMEYLASKKCI----HRDLAARNVLVTEDNVMKIADFGLARDI--------HHIDY- 246

Query: 747 LSCYN------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLD 793
              Y             APE  + +  T Q D +SFGV+L E+ T G       P E  +
Sbjct: 247 ---YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E 301

Query: 794 VVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           + K ++            +  K +NC    Y         +   C   +P +RP+  ++V
Sbjct: 302 LFKLLKEG--------HRM-DKPSNCTNELY--------MMMRDCWHAVPSQRPTFKQLV 344

Query: 850 KALHSLSTRTSLLSIELSSSQEHSIP 875
           + L  +   TS  + E+     H   
Sbjct: 345 EDLDRIVALTS--NQEMGYYHHHHHH 368

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 66/307 (21%), Positives = 115/307 (37%), Gaps = 73/307 (23%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       +    +   +AVK L +      K  L +E+K ++ + +H+NIV +L
Sbjct: 57  GAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLL 116

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR-----------LKIAIGVAQG 691
           G       + +I E+   G L + +    +  +   +             L  +  VAQG
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQG 176

Query: 692 LAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY 750
           +A+L  K+ +    HR+V ++N+LL      K+ DF L R +        M+       Y
Sbjct: 177 MAFLASKNCI----HRDVAARNVLLTNGHVAKIGDFGLARDI--------MNDSN----Y 220

Query: 751 N------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKW 797
                        APE  +    T Q D +S+G++L E+ + G          S    K 
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS-KFYKL 279

Query: 798 VRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH 853
           V+       G    +  + A      Y         I   C ++ P  RP+  ++   L 
Sbjct: 280 VKD------G--YQM-AQPAFAPKNIY--------SIMQACWALEPTHRPTFQQICSFLQ 322

Query: 854 SLSTRTS 860
             +    
Sbjct: 323 EQAQEDR 329

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 47/195 (24%), Positives = 85/195 (43%), Gaps = 14/195 (7%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFFH 648
           G +G V    +  +G ++A+KK            K    E+K L ++RH+N+V +L    
Sbjct: 36  GSYGMVMKCRNKDTGRIVAIKK-FLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             +  +L++EF+   ++ D +      L + +  K    +  G+ + H   +   +HR++
Sbjct: 95  KKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI---IHRDI 150

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMD 766
           K +NIL+      KL DF   R +           E A   Y APE   G   K    +D
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVG-DVKYGKAVD 207

Query: 767 AYSFGVVLLELITGR 781
            ++ G ++ E+  G 
Sbjct: 208 VWAIGCLVTEMFMGE 222

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 81.8 bits (203), Expect = 4e-17
 Identities = 46/192 (23%), Positives = 87/192 (45%), Gaps = 24/192 (12%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G F  V++     +G+L A+K +         +L+ E+  L KI+H+NIV +   + S  
Sbjct: 20  GAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT 79

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVPHLLHRNVK 709
             +L+ + +  G L D I  +     ++ +    +   V   + YLH++ +   +HR++K
Sbjct: 80  HYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENGI---VHRDLK 133

Query: 710 SKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKKAT 762
            +N+L    + + +  +TDF L ++       +   +      Y APE      YSK   
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPG----YVAPEVLAQKPYSKAV- 188

Query: 763 AQMDAYSFGVVL 774
              D +S GV+ 
Sbjct: 189 ---DCWSIGVIT 197

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 69/311 (22%), Positives = 125/311 (40%), Gaps = 78/311 (25%)

Query: 593 GPFGRVY------ILSLPSGELI--AVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVK 642
           G FG+V       I      E +  AVK L +   +   + L +E++ +  I +HKNI+ 
Sbjct: 46  GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR-------------LKIAIG 687
           +LG    D  +++I E+   G+L + +   R                       +     
Sbjct: 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165

Query: 688 VAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYA 746
           +A+G+ YL  +  +    HR++ ++N+L+  +   K+ DF L R +         + +Y 
Sbjct: 166 LARGMEYLASQKCI----HRDLAARNVLVTENNVMKIADFGLARDI--------NNIDY- 212

Query: 747 LSCYN------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLD 793
              Y             APE  + +  T Q D +SFGV++ E+ T G       P E  +
Sbjct: 213 ---YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 267

Query: 794 VVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVV 849
           + K ++            +  K ANC    Y         +   C   +P +RP+  ++V
Sbjct: 268 LFKLLKEG--------HRM-DKPANCTNELY--------MMMRDCWHAVPSQRPTFKQLV 310

Query: 850 KALHSLSTRTS 860
           + L  + T T+
Sbjct: 311 EDLDRILTLTT 321

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.9 bits (203), Expect = 6e-17
 Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 83/314 (26%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G FG+V       +        +AVK L  N      + L +E   L ++ H +++K+ G
Sbjct: 34  GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG 93

Query: 646 FFHSDESIFLIYEFLQMGSLGD--LICRQDFQLQWSIR---------------------L 682
               D  + LI E+ + GSL       R+                              +
Sbjct: 94  ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153

Query: 683 KIAIGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
             A  ++QG+ YL     V    HR++ ++NIL+    + K++DF L R V         
Sbjct: 154 SFAWQISQGMQYLAEMKLV----HRDLAARNILVAEGRKMKISDFGLSRDV--------Y 201

Query: 742 SSEYALSCYN------------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEP 788
             +     Y             A E  +    T Q D +SFGV+L E++T G       P
Sbjct: 202 EEDS----YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257

Query: 789 AESLDVVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPS 844
            E   +   ++       G    +  +  NC    Y         + L+C    P+KRP 
Sbjct: 258 PE--RLFNLLK------TG--HRM-ERPDNCSEEMY--------RLMLQCWKQEPDKRPV 298

Query: 845 MFEVVKALHSLSTR 858
             ++ K L  +  +
Sbjct: 299 FADISKDLEKMMVK 312

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 83.6 bits (207), Expect = 6e-17
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 23/200 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVK---KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V +     +G+  AVK   K         ++L  EV+ L ++ H NI+K+  FF 
Sbjct: 37  GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE 96

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
                +L+ E    G L D I  +    +     +I   V  G+ Y+HK+    ++HR++
Sbjct: 97  DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGITYMHKN---KIVHRDL 152

Query: 709 KSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGYSKKA 761
           K +N+LL     D   ++ DF L      +        + Y    Y APE     Y +K 
Sbjct: 153 KPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY----YIAPEVLHGTYDEKC 208

Query: 762 TAQMDAYSFGVVLLELITGR 781
               D +S GV+L  L++G 
Sbjct: 209 ----DVWSTGVILYILLSGC 224

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.9 bits (205), Expect = 7e-17
 Identities = 48/214 (22%), Positives = 90/214 (42%), Gaps = 37/214 (17%)

Query: 593 GPFGRVY---ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-- 647
           G +G VY          +  A+K++   G   S +   E+  L +++H N++ +   F  
Sbjct: 32  GTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLS 89

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA--------QGLAYLHKDY 699
           H+D  ++L++++ +   L  +I            +++  G+          G+ YLH ++
Sbjct: 90  HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148

Query: 700 VPHLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYALSC------ 749
           V   LHR++K  NIL+  +       K+ D    R      F S +     L        
Sbjct: 149 V---LHRDLKPANILVMGEGPERGRVKIADMGFAR-----LFNSPLKPLADLDPVVVTFW 200

Query: 750 YNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE   G ++  T  +D ++ G +  EL+T  
Sbjct: 201 YRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSE 233

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 82.4 bits (204), Expect = 1e-16
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 39/211 (18%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKV 643
           G  G V +     + + +A++     K      + +     ++TE++ L K+ H  I+K+
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
             FF   E  +++ E ++ G L D +      L+ +        +   + YLH++ +   
Sbjct: 206 KNFF-DAEDYYIVLELMEGGELFDKVVGNKR-LKEATCKLYFYQMLLAVQYLHENGI--- 260

Query: 704 LHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE-- 754
           +HR++K +N+LL +  E    K+TDF   +I+GE +   T+       C    Y APE  
Sbjct: 261 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-------CGTPTYLAPEVL 313

Query: 755 -----YGYSKKATAQMDAYSFGVVLLELITG 780
                 GY++      D +S GV+L   ++G
Sbjct: 314 VSVGTAGYNRAV----DCWSLGVILFICLSG 340

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFH- 648
           G +G V       +   +A+KK+  F  Q+   +TL+ E+K L + RH+NI+ +      
Sbjct: 38  GAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRA 96

Query: 649 ----SDESIFLIYEFLQMGS-LGDLICRQD----------FQLQWSIRLKIAIGVAQGLA 693
                 + ++++ +   M + L  L+  Q           +Q+     L+       GL 
Sbjct: 97  PTIEQMKDVYIVQDL--METDLYKLLKTQHLSNDHICYFLYQI-----LR-------GLK 142

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNA 752
           Y+H   V   LHR++K  N+LL+   + K+ DF L R+       +   +EY A   Y A
Sbjct: 143 YIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 753 PEY-GYSKKATAQMDAYSFGVVLLELITGR 781
           PE    SK  T  +D +S G +L E+++ R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.6 bits (204), Expect = 1e-16
 Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 33/205 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVN-FGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G  G V           +A+KKL   F  Q+   +  + E+  +  + HKNI+ +L  F 
Sbjct: 73  GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT 131

Query: 649 SDES------IFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQ---GLAYLHK 697
             ++      ++L+ E   M +  +L  + + +   +     +++  + Q   G+ +LH 
Sbjct: 132 PQKTLEEFQDVYLVMEL--MDA--NLCQVIQMELDHE-----RMSYLLYQMLCGIKHLHS 182

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYG 756
                ++HR++K  NI++ +D   K+ DF L R  G     S M + Y     Y APE  
Sbjct: 183 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT----SFMMTPYVVTRYYRAPEVI 235

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
                   +D +S G ++ E++  +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK 260

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 36/206 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V I     +G  +AVK     K+ +        +K E++ L   RH +I+K+   
Sbjct: 22  GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIKLYQV 79

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLAYLHKDYV 700
             +    F++ E++  G L D IC+         R++          +   + Y H+  V
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHG-------RVEEMEARRLFQQILSAVDYCHRHMV 132

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYG 756
              +HR++K +N+LLDA    K+ DF L  ++ +  F  T       SC    Y APE  
Sbjct: 133 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-------SCGSPNYAAPEVI 182

Query: 757 YSKK-ATAQMDAYSFGVVLLELITGR 781
             +  A  ++D +S GV+L  L+ G 
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT 208

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 41/210 (19%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG VY      SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+S  
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG 120

Query: 652 S------IFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQ--------GLAYL 695
                  + L+ +++       +  + R         +  + +   +         LAY+
Sbjct: 121 EKKDEVYLNLVLDYVPE----TVYRVARH----YSRAKQTLPVIYVKLYMYQLFRSLAYI 172

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEP-KLTDFALDRIVGEAAFQSTMSSEYALS-CYNAP 753
           H   +    HR++K +N+LLD D    KL DF   + +         +  Y  S  Y AP
Sbjct: 173 HSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRAP 225

Query: 754 E--YGYSKKATAQMDAYSFGVVLLELITGR 781
           E  +G +   T+ +D +S G VL EL+ G+
Sbjct: 226 ELIFG-ATDYTSSIDVWSAGCVLAELLLGQ 254

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.8 bits (200), Expect = 2e-16
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 40/210 (19%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL--------VNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G +G VY  +   + E +A+K++        V        T   EV  L +++H+NI+++
Sbjct: 45  GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG------TAIREVSLLKELQHRNIIEL 98

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVP 701
               H +  + LI+E+ +     DL    D     S+R+       +  G+ + H     
Sbjct: 99  KSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRC- 153

Query: 702 HLLHRNVKSKNILLDADFEP-----KLTDFALDRIVGEAAFQS---TMSSEYALSCYNAP 753
             LHR++K +N+LL           K+ DF L R     AF       + E     Y  P
Sbjct: 154 --LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-----AFGIPIRQFTHEIITLWYRPP 206

Query: 754 E--YGYSKKATAQMDAYSFGVVLLELITGR 781
           E   G S+  +  +D +S   +  E++   
Sbjct: 207 EILLG-SRHYSTSVDIWSIACIWAEMLMKT 235

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 36/208 (17%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL-------VNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G +  VY  L+  +G  +A+K++                T   E+  + +++H+NIV++ 
Sbjct: 16  GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS------TAIREISLMKELKHENIVRLY 69

Query: 645 GFFHSDESIFLIYEFLQ------MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
              H++  + L++EF+       M S       +  +L   ++      + QGLA+ H++
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELN-LVK-YFQWQLLQGLAFCHEN 127

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS---TMSSEYALSCYNAPE- 754
            +   LHR++K +N+L++   + KL DF L R     AF     T SSE     Y AP+ 
Sbjct: 128 KI---LHRDLKPQNLLINKRGQLKLGDFGLAR-----AFGIPVNTFSSEVVTLWYRAPDV 179

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGR 781
             G S+  +  +D +S G +L E+ITG+
Sbjct: 180 LMG-SRTYSTSIDIWSCGCILAEMITGK 206

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 28/213 (13%)

Query: 123 SSLETLNLSNNLIW--------------VLDLSRNHIEGKIPESI-GSLVNLQVLNLGSN 167
            S + L+LS N +               VLDLSR  I+  I +    SL +L  L L  N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 168 LLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVI-PDS 225
            +       F   S L  L   +    ++ + +   G L+ L++L +  +       P+ 
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETN--LASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL----VSFDVSQNKLSGSFPNGICKANGL 281
           F  L +L  LDLS N +   +  +    L ++    +S D+S N ++     G  K   L
Sbjct: 145 FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRL 202

Query: 282 VNLSLHKNFFNGSIPGSINECL-NLERFQVQDN 313
             L+L  N    S+P  I + L +L++  +  N
Sbjct: 203 KELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 55/198 (27%), Positives = 75/198 (37%), Gaps = 29/198 (14%)

Query: 81  NLQSLNLSG----EISSSVCE-LSSLSNLNLADNLFNQPIPLHL-SQCSSLETLNLSNNL 134
            LQ L+LS      I     + LS LS L L  N   Q + L   S  SSL+ L      
Sbjct: 53  ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETN 111

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF--VFGNFSELVVLDLSQNA 192
           +  L+             IG L  L+ LN+  NL+  S      F N + L  LDLS N 
Sbjct: 112 LASLE----------NFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNK 160

Query: 193 YLISEIPSDI-GKLEKLE----QLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVP 247
             I  I       L ++      L L  +  + + P +F  ++ L  L L  N L   VP
Sbjct: 161 --IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LKELALDTNQLK-SVP 216

Query: 248 QSLGSSLLKLVSFDVSQN 265
             +   L  L    +  N
Sbjct: 217 DGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 24/167 (14%)

Query: 352 QLEQVQIDNNRFTS---SIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLS 407
            L  + +  N   S       GL S++ L    A + +   SL          +  +N++
Sbjct: 77  HLSTLILTGNPIQSLALGAFSGLSSLQKLV---AVETNL-ASLENFPIGHLKTLKELNVA 132

Query: 408 QNSISGQIPELKKCRKLVSL---SLADNSLTGEIPP----SLAELPVLTY-LDLSDNNLT 459
            N I       +    L +L    L+ N +   I       L ++P+L   LDLS N + 
Sbjct: 133 HNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

Query: 460 GPIPQGL-QNLKLALFNVSFNKLSGRVPYSLISGLPAS---YLQGNP 502
             I  G  + ++L    +  N+L   VP  +   L +    +L  NP
Sbjct: 191 F-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNP 235

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 26/201 (12%)

Query: 593 GPFGRVYI-LSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G FG V       + +  AVK     +   + + T+  EV+ L K+ H NI+K+      
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRN 707
             S +++ E    G L D I ++     +S     +I   V  G+ Y+HK    +++HR+
Sbjct: 93  SSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKH---NIVHRD 146

Query: 708 VKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGYSKK 760
           +K +NILL   + D + K+ DF L     +         + Y    Y APE     Y +K
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY----YIAPEVLRGTYDEK 202

Query: 761 ATAQMDAYSFGVVLLELITGR 781
                D +S GV+L  L++G 
Sbjct: 203 C----DVWSAGVILYILLSGT 219

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 81.7 bits (202), Expect = 3e-16
 Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 33/210 (15%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKT--------LKTEVKTLAKIRHK 638
           G +G V +          A+K     +                   +  E+  L  + H 
Sbjct: 47  GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106

Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           NI+K+   F   +  +L+ EF + G L + I  +    +      I   +  G+ YLHK 
Sbjct: 107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-NIMKQILSGICYLHKH 165

Query: 699 YVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGE-AAFQSTMSSEYALSCYNAPE 754
              +++HR++K +NILL   ++    K+ DF L     +    +  + + Y    Y APE
Sbjct: 166 ---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY----YIAPE 218

Query: 755 ---YGYSKKATAQMDAYSFGVVLLELITGR 781
                Y++K     D +S GV++  L+ G 
Sbjct: 219 VLKKKYNEKC----DVWSCGVIMYILLCGY 244

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 38/207 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVN-FGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G +G V   +   SGE +A+KKL   F  +    +  + E+  L  ++H+N++ +L  F 
Sbjct: 35  GAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFT 93

Query: 649 SDES------IFLIYEFLQMGSLGDL--ICRQ---DFQLQWSI--RLKIAIGVAQGLAYL 695
              S       +L+  F  M +  DL  I      + ++Q+ +   LK       GL Y+
Sbjct: 94  PASSLRNFYDFYLVMPF--MQT--DLQKIMGLKFSEEKIQYLVYQMLK-------GLKYI 142

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE- 754
           H   V   +HR++K  N+ ++ D E K+ DF L R        + M+       Y APE 
Sbjct: 143 HSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEV 194

Query: 755 YGYSKKATAQMDAYSFGVVLLELITGR 781
                     +D +S G ++ E++TG+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.9 bits (197), Expect = 4e-16
 Identities = 49/246 (19%), Positives = 84/246 (34%), Gaps = 66/246 (26%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G +G V + +   +  + A+K     K+     +  + +KTEV+ + K+ H NI ++   
Sbjct: 37  GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------------------- 687
           +  ++ I L+ E    G L D +            + +                      
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 688 --------------------VAQGLAYLHKDYVPHLLHRNVKSKNILL--DADFEPKLTD 725
                               +   L YLH   +    HR++K +N L   +  FE KL D
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHNQGI---CHRDIKPENFLFSTNKSFEIKLVD 213

Query: 726 FALDRIVGEAAFQSTMSSEYALSC----YNAPE------YGYSKKATAQMDAYSFGVVLL 775
           F L +   +    +              + APE        Y  K     DA+S GV+L 
Sbjct: 214 FGLSKEFYKL--NNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAGVLLH 267

Query: 776 ELITGR 781
            L+ G 
Sbjct: 268 LLLMGA 273

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 79.3 bits (196), Expect = 5e-16
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 19/197 (9%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G F +V +   + +G  +A+K +        S + L  EV+ +  + H NIVK+     +
Sbjct: 26  GNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
           +++++LI E+   G + D +     +++          +   + Y H+  +   +HR++K
Sbjct: 86  EKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRI---VHRDLK 141

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYGYSKK-ATAQ 764
           ++N+LLDAD   K+ DF                      C    Y APE    KK    +
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDA-------FCGAPPYAAPELFQGKKYDGPE 194

Query: 765 MDAYSFGVVLLELITGR 781
           +D +S GV+L  L++G 
Sbjct: 195 VDVWSLGVILYTLVSGS 211

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 48/214 (22%), Positives = 88/214 (41%), Gaps = 44/214 (20%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVK---V 643
           G +G+V   L   +    AVK     KL       +  +K E++ L ++RHKN+++   V
Sbjct: 16  GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRHKNVIQLVDV 74

Query: 644 LGFFHSDESIFLIYEFLQMGS--LGDLICRQDFQLQWSIRLKI--AIGVAQ----GLAYL 695
           L +    + ++++ E+   G   + D +  +        R  +  A G       GL YL
Sbjct: 75  L-YNEEKQKMYMVMEYCVCGMQEMLDSVPEK--------RFPVCQAHGYFCQLIDGLEYL 125

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SC---- 749
           H   +   +H+++K  N+LL      K++        G A      +++     S     
Sbjct: 126 HSQGI---VHKDIKPGNLLLTTGGTLKISAL------GVAEALHPFAADDTCRTSQGSPA 176

Query: 750 YNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           +  PE   G    +  ++D +S GV L  + TG 
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.5 bits (194), Expect = 8e-16
 Identities = 60/315 (19%), Positives = 115/315 (36%), Gaps = 69/315 (21%)

Query: 593 GPFGRVY--ILSLPSGE-LIAVKKL-VNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V    +         A+K++         +    E++ L K+  H NI+ +LG  
Sbjct: 36  GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95

Query: 648 HSDESIFLIYEFLQMGSL---------------GDLICRQDFQLQWSIRLKIAIGVAQGL 692
                ++L  E+   G+L                 +       L     L  A  VA+G+
Sbjct: 96  EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGM 155

Query: 693 AYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN 751
            YL  K ++    HR++ ++NIL+  ++  K+ DF L R             E  +    
Sbjct: 156 DYLSQKQFI----HRDLAARNILVGENYVAKIADFGLSR-----------GQEVYVKKTM 200

Query: 752 --------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKI 802
                   A E       T   D +S+GV+L E+++ G            ++ + + +  
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ-- 256

Query: 803 NITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
               G    L  K  NC    Y        ++  +C    P +RPS  +++ +L+ +   
Sbjct: 257 ----G--YRL-EKPLNCDDEVY--------DLMRQCWREKPYERPSFAQILVSLNRMLEE 301

Query: 859 TSLLSIELSSSQEHS 873
                +  +  ++ +
Sbjct: 302 RKTY-VNTTLYEKFT 315

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 78.9 bits (195), Expect = 8e-16
 Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 36/231 (15%)

Query: 569 FYPLRVTEHDLVIGMDEKSSAGNG-GPFGRVY-ILSLPSGELIAVKKLVN-FGCQSS--K 623
           FY   VT+    +    +     G G +G V   +   +G  +A+KKL   F  +    +
Sbjct: 11  FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70

Query: 624 TLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFLQMGS-LGDLICRQ---D 673
             + E++ L  +RH+N++ +L  F  DE+       +L+  F  MG+ LG L+  +   +
Sbjct: 71  AYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF--MGTDLGKLMKHEKLGE 127

Query: 674 FQLQWSI--RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI 731
            ++Q+ +   LK       GL Y+H      ++HR++K  N+ ++ D E K+ DF L R 
Sbjct: 128 DRIQFLVYQMLK-------GLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177

Query: 732 VGEAAFQSTMSSEYALSCYNAPEY-GYSKKATAQMDAYSFGVVLLELITGR 781
                  S M+       Y APE      + T  +D +S G ++ E+ITG+
Sbjct: 178 A-----DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 77.7 bits (192), Expect = 9e-16
 Identities = 47/203 (23%), Positives = 85/203 (41%), Gaps = 29/203 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           G FG V++     SG    +K +     Q     ++ E++ L  + H NI+K+   F   
Sbjct: 33  GAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY 92

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL------KIAIGVAQGLAYLHKDYVPHLL 704
            +++++ E  + G L + I     + +    L      ++   +   LAY H  +V   +
Sbjct: 93  HNMYIVMETCEGGELLERIVSAQARGK---ALSEGYVAELMKQMMNALAYFHSQHV---V 146

Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGY 757
           H+++K +NIL          K+ DF L  +       +  + +      Y APE      
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL----YMAPEVFKRDV 202

Query: 758 SKKATAQMDAYSFGVVLLELITG 780
           + K     D +S GVV+  L+TG
Sbjct: 203 TFKC----DIWSAGVVMYFLLTG 221

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 24/192 (12%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G +G V I +   +    A KK+  +  +     K E++ +  + H NI+++   F  + 
Sbjct: 20  GSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT 79

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
            I+L+ E    G L + +  +     +      +I   V   +AY HK  V    HR++K
Sbjct: 80  DIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLNV---AHRDLK 133

Query: 710 SKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGYSKKAT 762
            +N L      D   KL DF L           T   + Y    Y +P+     Y  +  
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY----YVSPQVLEGLYGPEC- 188

Query: 763 AQMDAYSFGVVL 774
              D +S GV++
Sbjct: 189 ---DEWSAGVMM 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 54/197 (27%), Positives = 85/197 (43%), Gaps = 32/197 (16%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG V       + +  AVK        N   + + T+  EV+ L K+ H NI+K+   
Sbjct: 33  GSFGEVLKCKDRITQQEYAVKVINKASAKN---KDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLL 704
                S +++ E    G L D I ++     +S     +I   V  G+ Y+HK  +   +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHNI---V 143

Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMS-SEYALSCYNAPE---YGY 757
           HR++K +NILL   + D + K+ DF L     +         + Y    Y APE     Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY----YIAPEVLRGTY 199

Query: 758 SKKATAQMDAYSFGVVL 774
            +K     D +S GV+L
Sbjct: 200 DEKC----DVWSAGVIL 212

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 42/210 (20%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTL---KTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V I+    + ++ A+K +    C     +     E++ +  + H  +V +   F 
Sbjct: 26  GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQ-------WSIRLKIA-IGVAQGLAYLHKDYV 700
            +E +F++ + L  G  GDL     + LQ        +++L I  + +A  L YL     
Sbjct: 86  DEEDMFMVVDLLL-G--GDLR----YHLQQNVHFKEETVKLFICELVMA--LDYLQNQ-- 134

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS--SEYALSCYNAPE---- 754
             ++HR++K  NILLD      +TDF +  ++      +TM+    Y      APE    
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM-----APEMFSS 188

Query: 755 ---YGYSKKATAQMDAYSFGVVLLELITGR 781
               GYS       D +S GV   EL+ GR
Sbjct: 189 RKGAGYSFAV----DWWSLGVTAYELLRGR 214

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 43/214 (20%), Positives = 87/214 (40%), Gaps = 43/214 (20%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT----EVKTLAKIRHKNIVKVLGFF 647
           G FG V       +G  +A+KK++          +      ++ LA + H NIV++  +F
Sbjct: 34  GTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88

Query: 648 HSDES-------IFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQ-------- 690
           ++          + ++ E++       L   CR      +  ++     + +        
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD----TLHRCCRN----YYRRQVAPPPILIKVFLFQLIR 140

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
            +  LH     ++ HR++K  N+L++ AD   KL DF   + +  +       +      
Sbjct: 141 SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRY 196

Query: 750 YNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE  +G ++  T  +D +S G +  E++ G 
Sbjct: 197 YRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGE 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 43/210 (20%)

Query: 593 GPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G +G V +  +  + E +AVK     + V+        +K E+     + H+N+VK  G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN----IKKEICINKMLNHENVVKFYGH 73

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ--------GLAYLHKD 698
                  +L  E+   G L D I            +      AQ        G+ YLH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-------GMPEP--DAQRFFHQLMAGVVYLHGI 124

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SC----YNA 752
            +    HR++K +N+LLD     K++DF      G A      + E  L   C    Y A
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDF------GLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 753 PEYGYSKK-ATAQMDAYSFGVVLLELITGR 781
           PE    ++     +D +S G+VL  ++ G 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.1 bits (193), Expect = 2e-15
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 50/214 (23%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG V+    + S E +A+KK++      ++    E++ +  ++H N+V +  FF+S+ 
Sbjct: 51  GSFGVVFQAKLVESDE-VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYSNG 105

Query: 652 S------IFLIYEFLQMGSLGDLI-----CRQD----------FQLQWSIRLKIAIGVAQ 690
                  + L+ E++   ++          +Q           +QL             +
Sbjct: 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL------------LR 152

Query: 691 GLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
            LAY+H   +    HR++K +N+LLD      KL DF   +I+          S      
Sbjct: 153 SLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---GEPNVSYICSRY 206

Query: 750 YNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE  +G +   T  +D +S G V+ EL+ G+
Sbjct: 207 YRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQ 239

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 44/210 (20%), Positives = 82/210 (39%), Gaps = 47/210 (22%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD 650
           G +  V+  +++ + E + VK L     +  K  + E+K L  +R   NI+ +       
Sbjct: 47  GKYSEVFEAINITNNEKVVVKILKPV--KKKKIKR-EIKILENLRGGPNIITLADIVKDP 103

Query: 651 ES--IFLIYEFLQ-------MGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
            S    L++E +          +L D   R   +++     LK        L Y H   +
Sbjct: 104 VSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-----LK-------ALDYCHSMGI 151

Query: 701 PHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----- 754
              +HR+VK  N+++D +  + +L D+ L             +   A   +  PE     
Sbjct: 152 ---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG---QEYNVRVASRYFKGPELLVDY 205

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGRQ 782
             Y YS      +D +S G +L  +I  ++
Sbjct: 206 QMYDYS------LDMWSLGCMLASMIFRKE 229

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 76.6 bits (189), Expect = 4e-15
 Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 57/214 (26%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKV 643
           G  G V +     + + +A+K     K      + +     ++TE++ L K+ H  I+K+
Sbjct: 21  GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQ---------DFQLQWSIRLKIAIGVAQGLAY 694
             FF   E  +++ E ++ G L D +             +  Q          +   + Y
Sbjct: 81  KNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ----------MLLAVQY 129

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSC-- 749
           LH++ +   +HR++K +N+LL +  E    K+TDF   +I+GE +   T+       C  
Sbjct: 130 LHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-------CGT 179

Query: 750 --YNAPE-------YGYSKKATAQMDAYSFGVVL 774
             Y APE        GY++      D +S GV+L
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 23/164 (14%), Positives = 44/164 (26%), Gaps = 35/164 (21%)

Query: 628 EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG 687
               L++I    + +VL   H+     ++ E+++ GSL ++    D        ++    
Sbjct: 81  RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQS 137

Query: 688 VAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL 747
           +A      H+     +         + +  D +  L   A                    
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174

Query: 748 SCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES 791
                        A  Q D    G  L  L+  R         S
Sbjct: 175 --TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 30/209 (14%)

Query: 593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK-----------IRHKNIV 641
           G +G V       G  +A+K++ N               L K             H NI+
Sbjct: 33  GSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92

Query: 642 KVLGFFHSDES-----IFLIYEFLQMGS-LGDLICRQDFQLQWSIRLK-IAIGVAQGLAY 694
            +   F   E      ++L+ E   M + L  +I  Q   +     ++     +  GL  
Sbjct: 93  GLRDIFVHFEEPAMHKLYLVTEL--MRTDLAQVIHDQRIVIS-PQHIQYFMYHILLGLHV 149

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAP 753
           LH+  V   +HR++   NILL  + +  + DF L R            + Y     Y AP
Sbjct: 150 LHEAGV---VHRDLHPGNILLADNNDITICDFNLAR----EDTADANKTHYVTHRWYRAP 202

Query: 754 EY-GYSKKATAQMDAYSFGVVLLELITGR 781
           E     K  T  +D +S G V+ E+   +
Sbjct: 203 ELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 45/190 (23%), Positives = 74/190 (38%), Gaps = 21/190 (11%)

Query: 67  CVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLE 126
           C  +  AS     +N    NL+  +   +      + L+L++NL        L   + L 
Sbjct: 4   CEVSKVASHL--EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLT 58

Query: 127 TLNLSNNLIWV------------LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP 174
            LNL    +              LDLS N ++  +P    +L  L VL++  N L+    
Sbjct: 59  QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS 233
                  EL  L L  N   +  +P  +     KLE+L L ++    +      GL++L 
Sbjct: 118 GALRGLGELQELYLKGNE--LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175

Query: 234 ILDLSQNNLT 243
            L L +N+L 
Sbjct: 176 TLLLQENSLY 185

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 49/181 (27%), Positives = 72/181 (39%), Gaps = 28/181 (15%)

Query: 81  NLQSLNLSG----EISSSV-CELSSLSNLNLADN-LFNQPIPLHLSQCSSLETLNLSNNL 134
           +   L+LS       S +     + L+ LNL    L    +   L     L TL+LS+N 
Sbjct: 32  DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPV---LGTLDLSHNQ 88

Query: 135 I-------------WVLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNF 180
           +              VLD+S N +   +P      L  LQ L L  N L    P +    
Sbjct: 89  LQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 181 SELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
            +L  L L+ N   ++E+P+ +   LE L+ L LQ +  +  IP  F G   L    L  
Sbjct: 148 PKLEKLSLANNN--LTELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204

Query: 240 N 240
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 52/190 (27%), Positives = 81/190 (42%), Gaps = 28/190 (14%)

Query: 336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTS-SIPQGLGSVKSLYRFSASQNSFYGSLPPN 394
            N        ++    +L Q+ +D    T   +   L  + +L     S N    SLP  
Sbjct: 40  ENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLD---LSHNQL-QSLPLL 95

Query: 395 FCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSL-AELPVLTYL 451
               P ++++++S N ++  +P   L+   +L  L L  N L   +PP L    P L  L
Sbjct: 96  GQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKL 153

Query: 452 DLSDNNLTGPIPQG----LQNLK-LALFNVSFNKLSGRVPYSL--ISGLPASYLQGNPGL 504
            L++NNLT  +P G    L+NL  L L     N L   +P        LP ++L GNP L
Sbjct: 154 SLANNNLTE-LPAGLLNGLENLDTLLLQE---NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

Query: 505 CGPGLSNSCD 514
           C      +C+
Sbjct: 209 C------NCE 212

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 34/139 (24%), Positives = 54/139 (38%), Gaps = 22/139 (15%)

Query: 353 LEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNS 410
             +V  D    T+ +P  L      L+    S+N    +           ++ +NL +  
Sbjct: 12  HLEVNCDKRNLTA-LPPDLPKDTTILH---LSENLL-YTFSLATLMPYTRLTQLNLDRAE 66

Query: 411 ISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG----- 465
           ++ ++        L +L L+ N L   +P     LP LT LD+S N LT  +P G     
Sbjct: 67  LT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGL 123

Query: 466 --LQNLKLALFNVSFNKLS 482
             LQ L L       N+L 
Sbjct: 124 GELQELYL-----KGNELK 137

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 40/224 (17%), Positives = 83/224 (37%), Gaps = 29/224 (12%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
                NL    ++   +  EL+S+  +   ++       +      ++  L L+ N +  
Sbjct: 25  ETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFLNGNKLTD 82

Query: 136 ----------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV 185
                       L L  N ++  +  S+  L  L+ L+L  N +S  +     +  +L  
Sbjct: 83  IKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLES 138

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
           L L  N   I++I + + +L KL+ L L+ +    +      GL  L  L LS+N+++  
Sbjct: 139 LYLGNN--KITDI-TVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHIS-- 191

Query: 246 VPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
             ++L + L  L   ++   +      N          +     
Sbjct: 192 DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 49/227 (21%), Positives = 81/227 (35%), Gaps = 32/227 (14%)

Query: 81  NLQSLNLSG-EIS--SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
           NL  L L   ++   SS+ +L  L +L+L  N  +    L       LE+L L NN I  
Sbjct: 91  NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL--VHLPQLESLYLGNNKITD 148

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
           +              +  L  L  L+L  N +S  +       ++L  L LS+N   IS+
Sbjct: 149 I------------TVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH--ISD 192

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
           +   +  L+ L+ L L S        +    L   + +  +  +L      S      K 
Sbjct: 193 L-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 251

Query: 258 ---VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINE 301
                     N++S  F          V +   K  F+G +   + E
Sbjct: 252 NVKWHLPEFTNEVSFIF-------YQPVTIGKAKARFHGRVTQPLKE 291

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 53/272 (19%), Positives = 95/272 (34%), Gaps = 34/272 (12%)

Query: 106 LADNLFNQPIPLH----LSQCSSLETLNLSNNLIW------------VLDLSRNHIEGKI 149
           L       P P+         +     NL    +              +  + + I+  +
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SV 61

Query: 150 PESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLE 209
            + I  L N+  L L  N L+   P    N   L  L L +N   + ++ S +  L+KL+
Sbjct: 62  -QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK--VKDL-SSLKDLKKLK 115

Query: 210 QLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG 269
            L L+ +G   +  +  V L  L  L L  N +T      L S L KL +  +  N++S 
Sbjct: 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVL-SRLTKLDTLSLEDNQIS- 169

Query: 270 SFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRI 329
                +     L NL L KN  +  +   +    NL+  ++          +   +L   
Sbjct: 170 DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 226

Query: 330 KLIRAESNRFSGAIPDSISMAAQLEQVQIDNN 361
             ++          P+ IS     E+  +  +
Sbjct: 227 NTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 48/255 (18%), Positives = 85/255 (33%), Gaps = 17/255 (6%)

Query: 228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLH 287
                   +L + ++T  V Q+    L  +     + + +      GI     +  L L+
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLN 76

Query: 288 KNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI 347
            N     I   +    NL    + +N    D    L  L ++K +  E N  S    + +
Sbjct: 77  GNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--DINGL 130

Query: 348 SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLS 407
               QLE + + NN+ T      L  +  L   S   N     + P       +  + LS
Sbjct: 131 VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLS 186

Query: 408 QNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQ 467
           +N IS  +  L   + L  L L       +     + L V   +  +D +L  P      
Sbjct: 187 KNHIS-DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS-D 244

Query: 468 NLKLALFNVSFNKLS 482
           +      NV ++   
Sbjct: 245 DGDYEKPNVKWHLPE 259

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 42/197 (21%), Positives = 83/197 (42%), Gaps = 21/197 (10%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG V+  +   +G +   K +         T+K E+  + ++ H  ++ +   F    
Sbjct: 62  GAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            + LI EFL  G L D I  +D+++  +  +       +GL ++H+  +   +H ++K +
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI---VHLDIKPE 178

Query: 712 NILLDADFEP--KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----YGYSKKATA 763
           NI+ +       K+ DF L   +           ++E+A     APE             
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA-----APEIVDREPVGFYT-- 231

Query: 764 QMDAYSFGVVLLELITG 780
             D ++ GV+   L++G
Sbjct: 232 --DMWAIGVLGYVLLSG 246

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 43/210 (20%)

Query: 593 GPFGRVYIL-SLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G +G V +  +  + E +AVK     + V+      + +K E+     + H+N+VK  G 
Sbjct: 18  GAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKMLNHENVVKFYGH 73

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ--------GLAYLHKD 698
                  +L  E+   G L D I            +      AQ        G+ YLH  
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDI-------GMPEP--DAQRFFHQLMAGVVYLHGI 124

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYAL--SC----YNA 752
            +    HR++K +N+LLD     K++DF      G A      + E  L   C    Y A
Sbjct: 125 GI---THRDIKPENLLLDERDNLKISDF------GLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 753 PEYGYSKK-ATAQMDAYSFGVVLLELITGR 781
           PE    ++     +D +S G+VL  ++ G 
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 74/312 (23%)

Query: 593 GPFGRVY------ILSLPSGELIAVKKLVNFGCQSSKT-LKTEVKTLAKI-RHKNIVKVL 644
           G FG+V       I        +AVK L      S +  L +E+K + ++  H+NIV +L
Sbjct: 56  GAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 115

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLI--CRQDFQLQWSIR--------------------L 682
           G       I+LI+E+   G L + +   R+ F                           L
Sbjct: 116 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175

Query: 683 KIAIGVAQGLAYL-HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM 741
             A  VA+G+ +L  K  V    HR++ ++N+L+      K+ DF L R +        M
Sbjct: 176 CFAYQVAKGMEFLEFKSCV----HRDLAARNVLVTHGKVVKICDFGLARDI--------M 223

Query: 742 SSEYALSCYN--------APEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESL 792
           S    +   N        APE  +    T + D +S+G++L E+ + G       P   +
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYPGI 278

Query: 793 DVVKWVRRKINITNGAIQVLDPKIANC----YQQQMLGALEIALRCTSVMPEKRPSMFEV 848
            V     +   I NG    +  +        Y         I   C +    KRPS   +
Sbjct: 279 PVDANFYKL--IQNG--FKM-DQPFYATEEIY--------IIMQSCWAFDSRKRPSFPNL 325

Query: 849 VKALHSLSTRTS 860
              L        
Sbjct: 326 TSFLGCQLADAE 337

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 49/218 (22%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSS-KTLKTEVKTLAKIRHK--NI 640
           G+GG FG VY  + +     +A+K     ++ ++G   +   +  EV  L K+      +
Sbjct: 52  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 641 VKVLGFFHSDESIFLIYEFLQ-MGSLGDLI----------CRQDFQLQWSIRLKIAIGVA 689
           +++L +F   +S  LI E  + +  L D I           R  F  Q          V 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW-Q----------VL 159

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           + + + H   V   LHR++K +NIL+D +  E KL DF      G  A      + Y   
Sbjct: 160 EAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDF------GSGALLK--DTVYTDF 208

Query: 749 C----YNAPEYGYSKK-ATAQMDAYSFGVVLLELITGR 781
                Y+ PE+    +        +S G++L +++ G 
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.1 bits (190), Expect = 8e-15
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 36/206 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +     +G  +AVK     K+ +        ++ E++ L   RH +I+K+   
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQKIRSLD--VVGKIRREIQNLKLFRHPHIIKLYQV 84

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA------QGLAYLHKDYV 700
             +   IF++ E++  G L D IC+         RL              G+ Y H+  V
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNG-------RLDEKESRRLFQQILSGVDYCHRHMV 137

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYG 756
              +HR++K +N+LLDA    K+ DF L  ++ +  F  T       SC    Y APE  
Sbjct: 138 ---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-------SCGSPNYAAPEVI 187

Query: 757 YSKK-ATAQMDAYSFGVVLLELITGR 781
             +  A  ++D +S GV+L  L+ G 
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGT 213

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.8 bits (187), Expect = 9e-15
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 29/200 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           GPF  V   ++  +G+  AVK     K  +    S++ LK E      ++H +IV++L  
Sbjct: 35  GPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET 94

Query: 647 FHSDESIFLIYEFLQMGSLGDLIC-RQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVPHL 703
           + SD  +++++EF+    L   I  R D    +S  +       + + L Y H + +   
Sbjct: 95  YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI--- 151

Query: 704 LHRNVKSKNILLDADFEP---KLTDFALDRIVGE--AAFQSTMSSEYALSCYNAPE---- 754
           +HR+VK   +LL +       KL  F +   +GE        + + +    + APE    
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH----FMAPEVVKR 207

Query: 755 YGYSKKATAQMDAYSFGVVL 774
             Y K      D +  GV+L
Sbjct: 208 EPYGKPV----DVWGCGVIL 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 37/206 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G FG+V +     + + +A+K      L          ++ E+  L  +RH +I+K+   
Sbjct: 20  GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR--VEREISYLKLLRHPHIIKLYDV 77

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVA------QGLAYLHKDYV 700
             +   I ++ E+   G L D I  +        R+    G          + Y H+  +
Sbjct: 78  ITTPTDIVMVIEYAG-GELFDYIVEKK-------RMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEYG 756
              +HR++K +N+LLD +   K+ DF L  I+ +  F  T       SC    Y APE  
Sbjct: 130 ---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-------SCGSPNYAAPEVI 179

Query: 757 YSKK-ATAQMDAYSFGVVLLELITGR 781
             K  A  ++D +S G+VL  ++ GR
Sbjct: 180 NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 50/222 (22%), Positives = 81/222 (36%), Gaps = 55/222 (24%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK-TLKTEVKTLAKIR----HK 638
           G GG FG V+    L     +A+K     +++ +   S   T   EV  L K+     H 
Sbjct: 40  GKGG-FGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDL-------------ICRQDFQLQWSIRLKIA 685
            ++++L +F + E   L+ E        DL               R  F  Q        
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKGPLGEGPSRCFFG-Q-------- 147

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSE 744
             V   + + H   V   +HR++K +NIL+D      KL DF      G  A        
Sbjct: 148 --VVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDF------GSGAL--LHDEP 194

Query: 745 YALSC----YNAPEYGYSKK-ATAQMDAYSFGVVLLELITGR 781
           Y        Y+ PE+    +        +S G++L +++ G 
Sbjct: 195 YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 52/248 (20%)

Query: 551 FHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELI 609
           F+R         + ++++  P R       +G          G +G V       +G  +
Sbjct: 15  FYRQE-------LNKTIWEVPERYQNLS-PVGS---------GAYGSVCAAFDTKTGLRV 57

Query: 610 AVKKLVN-FGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFL 660
           AVKKL   F       +T + E++ L  ++H+N++ +L  F    S      ++L+    
Sbjct: 58  AVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL- 115

Query: 661 QMGS-LGDLICRQ---DFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL 714
            MG+ L +++  Q   D  +Q+ I   L+       GL Y+H   +   +HR++K  N+ 
Sbjct: 116 -MGADLNNIVKCQKLTDDHVQFLIYQILR-------GLKYIHSADI---IHRDLKPSNLA 164

Query: 715 LDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSKKATAQMDAYSFGVV 773
           ++ D E K+ DF L R          M+   A   Y APE           +D +S G +
Sbjct: 165 VNEDCELKILDFGLARHT-----ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219

Query: 774 LLELITGR 781
           + EL+TGR
Sbjct: 220 MAELLTGR 227

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 50/160 (31%), Positives = 69/160 (43%), Gaps = 10/160 (6%)

Query: 137 VLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
           +LDLS N++     E     L NL  L L  N L+      F     L  LDLS N   +
Sbjct: 43  LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN--HL 100

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSL---G 251
             +   +   L+ LE L L ++    V  ++F  +  L  L LSQN ++   P  L   G
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDG 159

Query: 252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLV--NLSLHKN 289
           + L KL+  D+S NKL       + K    V   L LH N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 46/167 (27%), Positives = 68/167 (40%), Gaps = 30/167 (17%)

Query: 99  SSLSNLNLADN----LFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDL 140
           S  + L+L+ N    L  +  P  L+    L +L LS+N +                LDL
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTPTRLTN---LHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95

Query: 141 SRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP 199
           S NH+   + E +   L  L+VL L +N +       F + ++L  L LSQN   IS  P
Sbjct: 96  SSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN--QISRFP 152

Query: 200 SDI----GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS-QNN 241
            ++     KL KL  L L S+    +       L +     L   NN
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 37/190 (19%), Positives = 64/190 (33%), Gaps = 30/190 (15%)

Query: 180 FSELVVLDLSQNAYLISEIPSDI--GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL 237
            S   +LDLS N   +S + ++    +L  L  L L  +  + +  ++FV + +L  LDL
Sbjct: 38  PSYTALLDLSHNN--LSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95

Query: 238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIP 296
           S N+L   + + L S L  L    +  N +              L  L L +N       
Sbjct: 96  SSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN------- 146

Query: 297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL--E 354
                   + R                  LP++ L+   SN+        +         
Sbjct: 147 -------QISR--FPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192

Query: 355 QVQIDNNRFT 364
            + + NN   
Sbjct: 193 GLYLHNNPLE 202

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 42/182 (23%), Positives = 72/182 (39%), Gaps = 28/182 (15%)

Query: 342 AIPDSISMAAQLEQVQIDNNRFTS----SIPQGLGSVKSLYRFSASQNSFYGSLPPN-FC 396
            +P S+   +    + + +N  +       P  L ++ SL     S N     +    F 
Sbjct: 32  NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLL---LSHNHL-NFISSEAFV 85

Query: 397 DSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDL 453
             P +  ++LS N +   + E      + L  L L +N +   +   +  ++  L  L L
Sbjct: 86  PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYL 143

Query: 454 SDNNLTGPIPQG----LQNL-KLALFNVSFNKLSGRVPYSLISGLPAS-----YLQGNPG 503
           S N ++   P         L KL L ++S NKL  ++P + +  LPA      YL  NP 
Sbjct: 144 SQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPL 201

Query: 504 LC 505
            C
Sbjct: 202 EC 203

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 48/210 (22%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKL--------VNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G FG V+      +G+ +A+KK+                 T   E+K L  ++H+N+V +
Sbjct: 28  GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI------TALREIKILQLLKHENVVNL 81

Query: 644 LGFFHSDE--------SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL 695
           +    +          SI+L+++F +   L  L+     +   S   ++   +  GL Y+
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 140

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA--AFQSTMSSEYALSCYNAP 753
           H++ +   LHR++K+ N+L+  D   KL DF L R    A  +  +  ++      Y  P
Sbjct: 141 HRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 197

Query: 754 E--YGYSKKATAQMDAYSFGVVLLELITGR 781
           E   G  +     +D +  G ++ E+ T  
Sbjct: 198 ELLLG-ERDYGPPIDLWGAGCIMAEMWTRS 226

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 43/211 (20%), Positives = 80/211 (37%), Gaps = 44/211 (20%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTL----------KTEVKTLAKIRHKNIV 641
           G F  V +   L +    A+K L        K              E   ++++ H   V
Sbjct: 41  GSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLAYL 695
           K+   F  DE ++    + + G L          ++                +   L YL
Sbjct: 94  KLYFTFQDDEKLYFGLSYAKNGELL-------KYIRKIGSFDETCTRFYTAEIVSALEYL 146

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS-----EYALSCY 750
           H      ++HR++K +NILL+ D   ++TDF   +++   + Q+  +S     +Y     
Sbjct: 147 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 751 NAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
            +PE    K A    D ++ G ++ +L+ G 
Sbjct: 200 -SPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.0 bits (185), Expect = 2e-14
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 35/200 (17%)

Query: 604 PSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFFHSDES-----IFLI 656
           P+GE++A+KK+  F       +TL+ E+K L   +H+NI+ +      D       +++I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92

Query: 657 YEFLQMGS-LGDLICRQ---DFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
            E   M + L  +I  Q   D  +Q+ I   L+        +  LH     +++HR++K 
Sbjct: 93  QEL--MQTDLHRVISTQMLSDDHIQYFIYQTLR-------AVKVLHG---SNVIHRDLKP 140

Query: 711 KNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--------YNAPEY-GYSKKA 761
            N+L++++ + K+ DF L RI+ E+A  ++  +              Y APE    S K 
Sbjct: 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY 200

Query: 762 TAQMDAYSFGVVLLELITGR 781
           +  MD +S G +L EL   R
Sbjct: 201 SRAMDVWSCGCILAELFLRR 220

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 19/197 (9%)

Query: 592 GGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD 650
           GG FG+V+      +G  +A K +   G +  + +K E+  + ++ H N++++   F S 
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKS 710
             I L+ E++  G L D I  + + L     +     + +G+ ++H+ Y+   LH ++K 
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI---LHLDLKP 215

Query: 711 KNILLDADFEP--KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE---YGYSKKATA 763
           +NIL         K+ DF L R             + E+      APE   Y +    T 
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL-----APEVVNYDFVSFPT- 269

Query: 764 QMDAYSFGVVLLELITG 780
             D +S GV+   L++G
Sbjct: 270 --DMWSVGVIAYMLLSG 284

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 40/207 (19%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG   +     + EL+AVK  +  G    + ++ E+     +RH NIV+      +  
Sbjct: 31  GNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPT 89

Query: 652 SIFLIYEFLQMGSLGDLIC----------RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
            + +I E+   G L + IC          R  FQ       ++  GV+    Y H   + 
Sbjct: 90  HLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-------QLLSGVS----YCHSMQI- 137

Query: 702 HLLHRNVKSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPEY 755
              HR++K +N LLD    P  K+ DF   +     +   +       +     Y APE 
Sbjct: 138 --CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-------TVGTPAYIAPEV 188

Query: 756 GYSKK-ATAQMDAYSFGVVLLELITGR 781
              ++      D +S GV L  ++ G 
Sbjct: 189 LLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.9 bits (184), Expect = 4e-14
 Identities = 45/197 (22%), Positives = 87/197 (44%), Gaps = 21/197 (10%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG V+      +G   A K ++       +T++ E++T++ +RH  +V +   F  D 
Sbjct: 168 GAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            + +IYEF+  G L + +  +  ++     ++    V +GL ++H++     +H ++K +
Sbjct: 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPE 284

Query: 712 NILLDADFEP--KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----YGYSKKATA 763
           NI+         KL DF L   +           ++E+A     APE             
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA-----APEVAEGKPVGYYT-- 337

Query: 764 QMDAYSFGVVLLELITG 780
             D +S GV+   L++G
Sbjct: 338 --DMWSVGVLSYILLSG 352

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 55/277 (19%), Positives = 93/277 (33%), Gaps = 37/277 (13%)

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
                + +  +IP  +    N   L      L       F  F +L  +++SQN  L   
Sbjct: 14  FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL-EV 69

Query: 198 IPSDI-GKLEKLEQLFLQ-SSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           I +D+   L KL ++ ++ ++    + P++F  L +L  L +S   +   +P       L
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128

Query: 256 KLVSFDVSQNKLSGSFPNGICK--ANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
           + V  D+  N    +         +   V L L+KN     I  S      L+   + DN
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS 373
                  + L  LP                 D    A+    + I   R  S    GL +
Sbjct: 188 -------NNLEELP----------------NDVFHGASGPVILDISRTRIHSLPSYGLEN 224

Query: 374 VKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
           +K L   S         LP        +   +L+  S
Sbjct: 225 LKKLRARSTYNLK---KLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.6 bits (173), Expect = 5e-13
 Identities = 49/277 (17%), Positives = 98/277 (35%), Gaps = 40/277 (14%)

Query: 186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGE 245
               ++   ++EIPSD+       +L    +    +   +F G   L  +++SQN++   
Sbjct: 14  FLCQESK--VTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69

Query: 246 VPQSLGSSLLKLVSFDVSQ-NKLSGSFPNGICKANG-LVNLSLHKNFFNGSIP-GSINEC 302
           +   + S+L KL    + + N L         +    L  L +        +P       
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127

Query: 303 LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNR 362
           L      +QDN         + ++          N F G       ++ +   + ++ N 
Sbjct: 128 LQKVLLDIQDN-------INIHTIE--------RNSFVG-------LSFESVILWLNKNG 165

Query: 363 FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE--LK 419
               I     +   L   + S N+    LP + F  +    I+++S+  I   +P   L+
Sbjct: 166 IQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLE 223

Query: 420 KCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN 456
             +KL + S  +        P+L +L  L    L+  
Sbjct: 224 NLKKLRARSTYNLKKL----PTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 39/217 (17%), Positives = 73/217 (33%), Gaps = 25/217 (11%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI---------------WVLDLSR- 142
            +   L               S    LE + +S N +                 + + + 
Sbjct: 30  RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89

Query: 143 NHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD 201
           N++   I      +L NLQ L + +  +         +  + V+LD+  N   I  I  +
Sbjct: 90  NNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN-IHTIERN 147

Query: 202 I--GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVS 259
              G   +   L+L  +G   +   +F G Q   +     NNL  E+P  +       V 
Sbjct: 148 SFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVI 206

Query: 260 FDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP 296
            D+S+ ++  S P+   +   L  L     +    +P
Sbjct: 207 LDISRTRIH-SLPSYGLE--NLKKLRARSTYNLKKLP 240

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 38/202 (18%), Positives = 72/202 (35%), Gaps = 25/202 (12%)

Query: 81  NLQSLNLSG-EISSSV-----CELSSLSNLNLAD--NLFNQPIPLHLSQCSSLETLNLSN 132
           +L+ + +S  ++   +       L  L  + +    NL     P       +L+ L +SN
Sbjct: 55  DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYIN-PEAFQNLPNLQYLLISN 113

Query: 133 NLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP-FVFGNFS-ELVVLDLSQ 190
             I  L                  +   +L++  N+   ++    F   S E V+L L++
Sbjct: 114 TGIKHLP----------DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163

Query: 191 NAYLISEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS 249
           N   I EI +      +  E     ++    +  D F G     ILD+S+  +   +P  
Sbjct: 164 NG--IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 220

Query: 250 LGSSLLKLVSFDVSQNKLSGSF 271
              +L KL +      K   + 
Sbjct: 221 GLENLKKLRARSTYNLKKLPTL 242

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 42/259 (16%), Positives = 75/259 (28%), Gaps = 38/259 (14%)

Query: 231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNF 290
           S  +    ++ +T E+P  L  + ++L        KL             L  + + +N 
Sbjct: 10  SNRVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQND 65

Query: 291 FNGSIP-GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISM 349
               I     +    L   +++         + L  +            F          
Sbjct: 66  VLEVIEADVFSNLPKLHEIRIEKA-------NNLLYIN--------PEAFQNL------- 103

Query: 350 AAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPN-FCD-SPVMSIINL 406
              L+ + I N      +P                 N    ++  N F   S    I+ L
Sbjct: 104 -PNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 407 SQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDNNLTGPIP 463
           ++N I  +I        +        +N+L  E+P            LD+S   +     
Sbjct: 162 NKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPS 219

Query: 464 QGLQNLKLALFNVSFNKLS 482
            GL+NLK  L   S   L 
Sbjct: 220 YGLENLK-KLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 30/159 (18%), Positives = 52/159 (32%), Gaps = 17/159 (10%)

Query: 354 EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSIS 412
                  ++ T  IP  L    +              +    F     +  I +SQN + 
Sbjct: 12  RVFLCQESKVTE-IPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67

Query: 413 GQIPE--LKKCRKLVSLSLAD-NSLTGEIPPS-LAELPVLTYLDLSDNNLTGPIPQG--L 466
             I         KL  + +   N+L   I P     LP L YL +S+  +   +P    +
Sbjct: 68  EVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKI 125

Query: 467 QNLKLALFNVSFNKLSGRVPYSLISGLPAS----YLQGN 501
            +L+  L ++  N     +  +   GL       +L  N
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 45/205 (21%), Positives = 81/205 (39%), Gaps = 30/205 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLG 645
           G F  V       +G   A K     +        S+  ++ EV  L ++ H N++ +  
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            + +   + LI E +  G L D + +++   +      I   +  G+ YLH   +    H
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-ILDGVNYLHTKKI---AH 138

Query: 706 RNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----Y 755
            ++K +NI+L     P    KL DF L   + +      +  + E+      APE     
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV-----APEIVNYE 193

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
               +A    D +S GV+   L++G
Sbjct: 194 PLGLEA----DMWSIGVITYILLSG 214

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.8 bits (179), Expect = 8e-14
 Identities = 49/197 (24%), Positives = 81/197 (41%), Gaps = 32/197 (16%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF--- 647
           G  G+V       +G+  A+K L       S   + EV    +     +IV +L  +   
Sbjct: 40  GVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDVYENM 94

Query: 648 -HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLL 704
            H    + +I E ++ G L   I  +  Q  ++ R   +I   +   + +LH   +    
Sbjct: 95  HHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSHNI---A 150

Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE----YGY 757
           HR+VK +N+L    + D   KLTDF   +   + A Q+   + Y    Y APE      Y
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPY----YVAPEVLGPEKY 206

Query: 758 SKKATAQMDAYSFGVVL 774
            K      D +S GV++
Sbjct: 207 DKSC----DMWSLGVIM 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 8e-14
 Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 47/207 (22%)

Query: 604 PSGELIAVKKLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLGFFHSD------------ 650
              + +A+KK+V    QS K  L+ E+K + ++ H NIVKV                   
Sbjct: 34  DCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92

Query: 651 --ESIFLIYEFLQMGS-LGDLICRQD----------FQLQWSIRLKIAIGVAQGLAYLHK 697
              S++++ E+  M + L +++ +            +QL     L+       GL Y+H 
Sbjct: 93  ELNSVYIVQEY--METDLANVLEQGPLLEEHARLFMYQL-----LR-------GLKYIHS 138

Query: 698 DYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPE- 754
             V   LHR++K  N+ ++  D   K+ DF L RI+          SE      Y +P  
Sbjct: 139 ANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL 195

Query: 755 YGYSKKATAQMDAYSFGVVLLELITGR 781
                  T  +D ++ G +  E++TG+
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 71.4 bits (176), Expect = 1e-13
 Identities = 46/213 (21%), Positives = 79/213 (37%), Gaps = 63/213 (29%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G F  V   +   +G   A K     KL     +  + L+ E +   K++H NIV++   
Sbjct: 17  GAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 647 FHSDESIFLIYEFLQMGSLGDLI--------------CRQDFQLQWSIRLKIAIGVAQGL 692
              +   +L+++ +  G L + I               +Q               + + +
Sbjct: 74  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------------ILESI 118

Query: 693 AYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           AY H + +   +HRN+K +N+LL         KL DF L   V ++              
Sbjct: 119 AYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-------A 168

Query: 750 ----YNAPE----YGYSKKATAQMDAYSFGVVL 774
               Y +PE      YSK      D ++ GV+L
Sbjct: 169 GTPGYLSPEVLKKDPYSKPV----DIWACGVIL 197

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 38/208 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHK------NIVK 642
           G FG+V         + +A+K + N   F  Q+      E++ L  +R +      N++ 
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMNVIH 163

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYV 700
           +L  F     I + +E L M +L +LI +  FQ  +S+ L  K A  + Q L  LHK   
Sbjct: 164 MLENFTFRNHICMTFELLSM-NLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHK--- 218

Query: 701 PHLLHRNVKSKNILL--DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPE--- 754
             ++H ++K +NILL        K+ DF      G + ++      Y  S  Y APE   
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDF------GSSCYEHQRVYTYIQSRFYRAPEVIL 272

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGR 781
              Y       +D +S G +L EL+TG 
Sbjct: 273 GARYGMP----IDMWSLGCILAELLTGY 296

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 39/199 (19%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT-----LKTEVKTLAKIRHKNIVKVLGF 646
           G    VY      + +  A+K L        KT     ++TE+  L ++ H NI+K+   
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVL-------KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLL 704
           F +   I L+ E +  G L D I  + +   +S R        + + +AYLH++ +   +
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENGI---V 170

Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----Y 755
           HR++K +N+L      D   K+ DF L +IV       T+  +  Y      APE     
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC-----APEILRGC 225

Query: 756 GYSKKATAQMDAYSFGVVL 774
            Y  +     D +S G++ 
Sbjct: 226 AYGPEV----DMWSVGIIT 240

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 43/265 (16%), Positives = 86/265 (32%), Gaps = 42/265 (15%)

Query: 121 QCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF 180
           +C   E   ++       D+ R      IP       + Q L L    L       F N 
Sbjct: 9   ECHQEEDFRVTCK-----DIQR------IP---SLPPSTQTLKLIETHLRTIPSHAFSNL 54

Query: 181 SELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSS-GFHGVIPDSFVGLQSLSILDLS 238
             +  + +S +   + ++ S     L K+  + ++++     + PD+   L  L  L + 
Sbjct: 55  PNISRIYVSIDVT-LQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICK--ANGLVNLSLHKNFFNGSIP 296
              L      +   S       +++ N    S P    +   N  + L L+ N F  S+ 
Sbjct: 114 NTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQ 172

Query: 297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQV 356
           G       L+   +  N               + +I  ++  F G       + +    +
Sbjct: 173 GYAFNGTKLDAVYLNKN-------------KYLTVIDKDA--FGG-------VYSGPSLL 210

Query: 357 QIDNNRFTSSIPQGLGSVKSLYRFS 381
            +     T+   +GL  +K L   +
Sbjct: 211 DVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 40/191 (20%), Positives = 80/191 (41%), Gaps = 25/191 (13%)

Query: 81  NLQSLNLSG-----EISSSV-CELSSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNN 133
           N+  + +S      ++ S     LS ++++ + +      I    L +   L+ L + N 
Sbjct: 56  NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT 115

Query: 134 LIWVL-DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP-FVFGNF-SELVVLDLSQ 190
            + +  DL+           + S     +L +  N    S+P   F    +E + L L  
Sbjct: 116 GLKMFPDLT----------KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165

Query: 191 NAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIP-DSFVGLQS-LSILDLSQNNLTGEVPQ 248
           N    + +        KL+ ++L  + +  VI  D+F G+ S  S+LD+SQ ++T  +P 
Sbjct: 166 NG--FTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS 222

Query: 249 SLGSSLLKLVS 259
                L +L++
Sbjct: 223 KGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 38/287 (13%), Positives = 79/287 (27%), Gaps = 89/287 (31%)

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           I  +P         + L L  +    +   +F  L ++S + +S +    ++      +L
Sbjct: 26  IPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNL 79

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNL---SLHKNFFNGSIPG--SINECLNLERFQ 309
            K+   ++   +          K   L  L    +         P    +         +
Sbjct: 80  SKVTHIEIRNTRNLTYIDPDALK--ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136

Query: 310 VQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQ 369
           + DN             P +  I   +  F G       +  +   +++ NN FT S+  
Sbjct: 137 ITDN-------------PYMTSIPVNA--FQG-------LCNETLTLKLYNNGFT-SVQG 173

Query: 370 GLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSL 429
                           +F G+                                KL ++ L
Sbjct: 174 Y---------------AFNGT--------------------------------KLDAVYL 186

Query: 430 ADNSLTGEIPP-SLAELP-VLTYLDLSDNNLT---GPIPQGLQNLKL 471
             N     I   +   +    + LD+S  ++T       + L+ L  
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIA 233

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 30/160 (18%), Positives = 58/160 (36%), Gaps = 15/160 (9%)

Query: 352 QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNS 410
           Q E  ++        IP    S ++L      +     ++P + F + P +S I +S + 
Sbjct: 12  QEEDFRVTCKDIQR-IPSLPPSTQTLK---LIETHL-RTIPSHAFSNLPNISRIYVSIDV 66

Query: 411 ISGQIPE--LKKCRKLVSLSLADNSLTGEIPPS-LAELPVLTYLDLSDNNLTG-PIPQGL 466
              Q+         K+  + + +      I P  L ELP+L +L + +  L   P    +
Sbjct: 67  TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126

Query: 467 QNL-KLALFNVSFNKLSGRVPYSLISGLPAS----YLQGN 501
            +     +  ++ N     +P +   GL        L  N
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNN 166

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 41/220 (18%), Positives = 90/220 (40%), Gaps = 48/220 (21%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-----------HKNI 640
           G F  V++   + +   +A+K +       ++  + E+K L ++              +I
Sbjct: 30  GHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88

Query: 641 VKVLGFF----HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAY 694
           +K+L  F     +   + +++E L   +L  LI + + +    +    +I+  +  GL Y
Sbjct: 89  LKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHR-GIPLIYVKQISKQLLLGLDY 146

Query: 695 LHKDYVPHLLHRNVKSKNILLD------ADFEPKLTDFALDRIVGEAAFQSTMSSEYALS 748
           +H+     ++H ++K +N+L++         + K+ D       G A +     +    +
Sbjct: 147 MHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL------GNACWYDEHYTNSIQT 198

Query: 749 C-YNAPE------YGYSKKATAQMDAYSFGVVLLELITGR 781
             Y +PE      +G         D +S   ++ ELITG 
Sbjct: 199 REYRSPEVLLGAPWGCG------ADIWSTACLIFELITGD 232

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 30/205 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLG 645
           G F  V       +G+  A K     +L +     S+  ++ EV  L +IRH NI+ +  
Sbjct: 16  GQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHD 75

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F +   + LI E +  G L D +  ++   +      +   +  G+ YLH   +    H
Sbjct: 76  IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ-ILDGVHYLHSKRI---AH 131

Query: 706 RNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----Y 755
            ++K +NI+L     P    KL DF +   +        +  + E+      APE     
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV-----APEIVNYE 186

Query: 756 GYSKKATAQMDAYSFGVVLLELITG 780
               +A    D +S GV+   L++G
Sbjct: 187 PLGLEA----DMWSIGVITYILLSG 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 44/197 (22%), Positives = 78/197 (39%), Gaps = 22/197 (11%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE 651
           G FG V+  +   S +    K  V         +K E+  L   RH+NI+ +   F S E
Sbjct: 16  GEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESFESME 74

Query: 652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
            + +I+EF+    + + I    F+L     +     V + L +LH   +    H +++ +
Sbjct: 75  ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI---GHFDIRPE 131

Query: 712 NILLDADFEP--KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE----YGYSKKATA 763
           NI+         K+ +F   R +        +  + EY      APE       S     
Sbjct: 132 NIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY-----APEVHQHDVVSTAT-- 184

Query: 764 QMDAYSFGVVLLELITG 780
             D +S G ++  L++G
Sbjct: 185 --DMWSLGTLVYVLLSG 199

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 43/236 (18%), Positives = 83/236 (35%), Gaps = 56/236 (23%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  FG V  +  + SG+  A+KK++       +    E+  +  + H NI+K++ +F+
Sbjct: 16  GTGS-FGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFY 70

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWS--------------------------IRL 682
           +                                                        ++ 
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 683 KIAIG--------------VAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFA 727
            I  G              + + + ++H   +    HR++K +N+L+++ D   KL DF 
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI---CHRDIKPQNLLVNSKDNTLKLCDFG 187

Query: 728 LDRIVGEAAFQSTMSSEYALSCYNAPE--YGYSKKATAQMDAYSFGVVLLELITGR 781
             + +  +       +      Y APE   G + + T  +D +S G V  ELI G+
Sbjct: 188 SAKKLIPSEP---SVAYICSRFYRAPELMLG-ATEYTPSIDLWSIGCVFGELILGK 239

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 55/214 (25%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAKIRHKNIV 641
           G FGRV+++ S  +G   A+K L        K              E   L+ + H  I+
Sbjct: 17  GSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLAYL 695
           ++ G F   + IF+I ++++ G  G+L       L+ S R    +       V   L YL
Sbjct: 70  RMWGTFQDAQQIFMIMDYIE-G--GELF----SLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 696 HKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YN 751
           H      +++R++K +NILLD +   K+TDF   + V +  +  T+       C    Y 
Sbjct: 123 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TL-------CGTPDYI 170

Query: 752 APE----YGYSKKATAQMDAYSFGVVLLELITGR 781
           APE      Y+K      D +SFG+++ E++ G 
Sbjct: 171 APEVVSTKPYNKSI----DWWSFGILIYEMLAGY 200

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 44/209 (21%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK----TLKTEVKTLAKI-RHKNIV 641
           G    V   +  P+ +  AVK        +F  +  +        EV  L K+  H NI+
Sbjct: 28  GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 87

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDY 699
           ++   + ++   FL+++ ++ G L D +  +      S +   KI   + + +  LHK  
Sbjct: 88  QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLN 144

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE- 754
           +   +HR++K +NILLD D   KLTDF     +        +       C    Y APE 
Sbjct: 145 I---VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-------CGTPSYLAPEI 194

Query: 755 ---------YGYSKKATAQMDAYSFGVVL 774
                     GY K+     D +S GV++
Sbjct: 195 IECSMNDNHPGYGKEV----DMWSTGVIM 219

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 63/213 (29%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G F  V   +   +G   A K     KL     +  + L+ E +   K++H NIV++   
Sbjct: 40  GAFSVVRRCVHKTTGLEFAAKIINTKKLSA---RDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 647 FHSDESIFLIYEFLQMGSLGDLI--------------CRQDFQLQWSIRLKIAIGVAQGL 692
              +   +L+++ +  G L + I               +Q               + + +
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ---------------ILESI 141

Query: 693 AYLHKDYVPHLLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSC 749
           AY H + +   +HRN+K +N+LL +  +    KL DF L   V ++              
Sbjct: 142 AYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF-------A 191

Query: 750 ----YNAPE----YGYSKKATAQMDAYSFGVVL 774
               Y +PE      YSK      D ++ GV+L
Sbjct: 192 GTPGYLSPEVLKKDPYSKPV----DIWACGVIL 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 45/209 (21%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAKIRHKNIV 641
           G FGRV ++    SG   A+K L        K              E + L  +    +V
Sbjct: 52  GSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICR-QDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           K+   F  + +++++ E++  G +   + R   F    + R   A  +     YLH    
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA-RFYAA-QIVLTFEYLHSL-- 160

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE-- 754
             L++R++K +N+L+D     ++TDF   + V    +  T+       C      APE  
Sbjct: 161 -DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TL-------CGTPEALAPEII 210

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
              GY+K      D ++ GV++ E+  G 
Sbjct: 211 LSKGYNKAV----DWWALGVLIYEMAAGY 235

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 48/239 (20%), Positives = 88/239 (36%), Gaps = 75/239 (31%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKT---------------------L 625
           G +G V +  +       A+K     KL+       +                      +
Sbjct: 24  GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83

Query: 626 KTEVKTLAKIRHKNIVK---VLGFFHSDESIFLIYEFLQMGSLGDLI---------CRQD 673
             E+  L K+ H N+VK   VL    +++ +++++E +  G + ++           R  
Sbjct: 84  YQEIAILKKLDHPNVVKLVEVLDD-PNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142

Query: 674 FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI-V 732
           FQ            + +G+ YLH   +   +HR++K  N+L+  D   K+ DF +     
Sbjct: 143 FQ-D----------LIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 733 GEAAFQSTMSSEYALSC----YNAPE------YGYSKKATAQMDAYSFGVVLLELITGR 781
           G  A  S        +     + APE        +S KA    D ++ GV L   + G+
Sbjct: 189 GSDALLSN-------TVGTPAFMAPESLSETRKIFSGKAL---DVWAMGVTLYCFVFGQ 237

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 70.0 bits (172), Expect = 6e-13
 Identities = 51/203 (25%), Positives = 95/203 (46%), Gaps = 31/203 (15%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD 650
           G   RV   ++L + +  AVK +          +  EV+ L + + H+N+++++ FF  +
Sbjct: 24  GAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83

Query: 651 ESIFLIYEFLQMGSLGDLICRQDF--QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +  +L++E ++ GS+   I ++    +L+ S+ ++    VA  L +LH   +    HR++
Sbjct: 84  DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD---VASALDFLHNKGI---AHRDL 137

Query: 709 KSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-C----YNAPE------ 754
           K +NIL    +     K+ DF L   +      S +S+   L+ C    Y APE      
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197

Query: 755 ---YGYSKKATAQMDAYSFGVVL 774
                Y K+     D +S GV+L
Sbjct: 198 EEASIYDKRC----DLWSLGVIL 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 42/196 (21%), Positives = 81/196 (41%), Gaps = 28/196 (14%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G F  V   + + +G+  A   +       +  + L+ E +    ++H NIV++      
Sbjct: 22  GAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE 81

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRN 707
           +   +LI++ +  G L + I  +++   +S          + + + + H+  V   +HRN
Sbjct: 82  EGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMGV---VHRN 135

Query: 708 VKSKNILL---DADFEPKLTDFALDRIV--GEAAFQSTMSSEYALSCYNAPE----YGYS 758
           +K +N+LL         KL DF L   V   + A+     +      Y +PE      Y 
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPG----YLSPEVLRKDPYG 191

Query: 759 KKATAQMDAYSFGVVL 774
           K      D ++ GV+L
Sbjct: 192 KPV----DLWACGVIL 203

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 36/188 (19%), Positives = 64/188 (34%), Gaps = 27/188 (14%)

Query: 93  SSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI------------WVLDL 140
                L++    NL        +     + S ++  N  N+ I              L L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQSLAGMQFFTNLKELHL 70

Query: 141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS 200
           S N I   +   +  L  L+ L++  N L           + L  L L  N   + +   
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGI---PSACLSRLFLDNNE--LRDT-D 122

Query: 201 DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSF 260
            +  L+ LE L ++++    +       L  L +LDL  N +T        + L K+   
Sbjct: 123 SLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGGL---TRLKKVNWI 177

Query: 261 DVSQNKLS 268
           D++  K  
Sbjct: 178 DLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 46/229 (20%), Positives = 89/229 (38%), Gaps = 27/229 (11%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNL---NLADNLFNQPIPLHLSQCSSLETLNLSNNLI-- 135
            +Q+ N       S+  +   +NL   +L+ N  +   PL     + LE L+++ N +  
Sbjct: 42  GVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDLSPL--KDLTKLEELSVNRNRLKN 99

Query: 136 ---------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
                      L L  N +     +S+  L NL++L++ +N L   V    G  S+L VL
Sbjct: 100 LNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVL 155

Query: 187 DLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEV 246
           DL  N   I+     + +L+K+  + L        + +       L I +  ++     +
Sbjct: 156 DLHGNE--ITNT-GGLTRLKKVNWIDLTGQ---KCVNEPVKYQPELYITNTVKDPDGRWI 209

Query: 247 PQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSI 295
                S+    V   V   +L         K +  +N+   +  F+G++
Sbjct: 210 SPYYISNGGSYVDGCVL-WELPVYTDEVSYKFSEYINVGETEAIFDGTV 257

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.1 bits (115), Expect = 5e-06
 Identities = 40/235 (17%), Positives = 74/235 (31%), Gaps = 39/235 (16%)

Query: 228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLH 287
           GL +    +L + ++T  V Q     L  + +F+   + +      G+     L  L L 
Sbjct: 17  GLANAVKQNLGKQSVTDLVSQK---ELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHLS 71

Query: 288 KNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI 347
            N  +  +   + +   LE   V  N              R+K +    +          
Sbjct: 72  HNQIS-DLSP-LKDLTKLEELSVNRN--------------RLKNLNGIPS---------- 105

Query: 348 SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLS 407
              A L ++ +DNN         L  +K+L   S   N               + +++L 
Sbjct: 106 ---ACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLH 158

Query: 408 QNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
            N I+     L + +K+  + L       E      EL +   +   D     P 
Sbjct: 159 GNEIT-NTGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 15/78 (19%), Positives = 31/78 (39%), Gaps = 6/78 (7%)

Query: 406 LSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG 465
                I+ Q+         V  +L   S+T ++     EL  +   +  ++N+      G
Sbjct: 4   QRPTPIN-QVFPDPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ--SLAG 58

Query: 466 LQNL-KLALFNVSFNKLS 482
           +Q    L   ++S N++S
Sbjct: 59  MQFFTNLKELHLSHNQIS 76

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 71.3 bits (174), Expect = 6e-13
 Identities = 32/178 (17%), Positives = 64/178 (35%), Gaps = 26/178 (14%)

Query: 74  SLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQ-----PIPLHLSQCSSLETL 128
           ++ +    L  L    E       L ++  +  A     +        +   + + +  L
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDL 188
           +L++  + VL              +  L+ +  L+L  N L  ++P        L VL  
Sbjct: 447 HLAHKDLTVL------------CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493

Query: 189 SQNAYLISEIPSDIGKLEKLEQLFLQS---SGFHGVIPDSFVGLQSLSILDLSQNNLT 243
           S NA  +  +   +  L +L++L L +        + P   V    L +L+L  N+L 
Sbjct: 494 SDNA--LENVD-GVANLPRLQELLLCNNRLQQSAAIQP--LVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 67.5 bits (164), Expect = 1e-11
 Identities = 29/133 (21%), Positives = 59/133 (44%), Gaps = 21/133 (15%)

Query: 81  NLQSLNLSGEISSSVCELSSLSN---LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
           +++ L+L+ +  + +C L  L     L+L+ N     +P  L+    LE L  S+N +  
Sbjct: 442 DVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL-- 498

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV--FGNFSELVVLDLSQNAYLI 195
                 +++G     + +L  LQ L L +N L      +    +   LV+L+L  N+  +
Sbjct: 499 -----ENVDG-----VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNS--L 545

Query: 196 SEIPSDIGKLEKL 208
            +      +L ++
Sbjct: 546 CQEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.5 bits (146), Expect = 1e-09
 Identities = 43/247 (17%), Positives = 75/247 (30%), Gaps = 36/247 (14%)

Query: 252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ 311
           ++  +L   ++S  K +    + +     L  L     +   +I   I     L+    +
Sbjct: 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI---ILLMRALDPLLYE 401

Query: 312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGL 371
                     K     R   +    ++F           A +  + + +   T      L
Sbjct: 402 KETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV--LCHL 459

Query: 372 GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLAD 431
             +  +                        + ++LS N +    P L   R L  L  +D
Sbjct: 460 EQLLLV------------------------THLDLSHNRLRALPPALAALRCLEVLQASD 495

Query: 432 NSLTGEIPPSLAELPVLTYLDLSDNNLTG-PIPQGLQNLK-LALFNVSFNKLSGRVPY-- 487
           N+L   +   +A LP L  L L +N L      Q L +   L L N+  N L        
Sbjct: 496 NALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553

Query: 488 SLISGLP 494
            L   LP
Sbjct: 554 RLAEMLP 560

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 35/227 (15%), Positives = 80/227 (35%), Gaps = 28/227 (12%)

Query: 81  NLQSLNLSGEISSSVC-ELSSLSNLNLADNLFNQP--IPLHLSQCSSLETLNLSNN--LI 135
           + +   L  +     C + ++   L   +    +   +   L  C  L+ L   N   L+
Sbjct: 327 SQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLL 386

Query: 136 WVLDLSRNHIE-GKIPESIGSLVNLQVLN--------LGSNLLSGSVPFVFGNFSELVVL 186
            ++ L R         E++     L+ ++           +        +   ++++ VL
Sbjct: 387 TIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446

Query: 187 DLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEV 246
            L+     ++ +   + +L  +  L L  +     +P +   L+ L +L  S N L    
Sbjct: 447 HLAHKD--LTVLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE--- 499

Query: 247 PQSLG--SSLLKLVSFDVSQNKLSGSFPN--GICKANGLVNLSLHKN 289
             ++   ++L +L    +  N+L         +     LV L+L  N
Sbjct: 500 --NVDGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 69.6 bits (171), Expect = 7e-13
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 36/208 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLG 645
           G F  V       +G   A K     +  +     S+  ++ EV  L +I+H N++ +  
Sbjct: 22  GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 81

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG----VAQGLAYLHKDYVP 701
            + +   + LI E +  G L D +  ++   +     + A      +  G+ YLH   + 
Sbjct: 82  VYENKTDVILILELVAGGELFDFLAEKESLTE-----EEATEFLKQILNGVYYLHSLQI- 135

Query: 702 HLLHRNVKSKNILL----DADFEPKLTDFALDRIVGEA-AFQSTMSSEYALSCYNAPE-- 754
              H ++K +NI+L          K+ DF L   +     F++   +      + APE  
Sbjct: 136 --AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPE----FVAPEIV 189

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITG 780
                  +A    D +S GV+   L++G
Sbjct: 190 NYEPLGLEA----DMWSIGVITYILLSG 213

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 47/203 (23%), Positives = 83/203 (40%), Gaps = 26/203 (12%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G FG V ++    + ++ A+K L    +     S+     E   +A      +V++   F
Sbjct: 80  GAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW-EERDIMAFANSPWVVQLFYAF 138

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHR 706
             D  ++++ E++  G L +L+   D   +W+ R   A  V   L  +H   ++    HR
Sbjct: 139 QDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA-RFYTA-EVVLALDAIHSMGFI----HR 192

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE----YGYS 758
           +VK  N+LLD     KL DF     + +       +     +     Y +PE     G  
Sbjct: 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQGGD 247

Query: 759 KKATAQMDAYSFGVVLLELITGR 781
                + D +S GV L E++ G 
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGD 270

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 20/183 (10%)

Query: 99  SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--------------VLDLSRNH 144
           +    L+L  N  +        + + L  L L++N +                L ++ N 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96

Query: 145 IEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI- 202
           ++  +P  +   LVNL  L L  N L    P VF + ++L  L L  N   +  +P  + 
Sbjct: 97  LQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE--LQSLPKGVF 153

Query: 203 GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV 262
            KL  L++L L ++    V   +F  L  L  L L  N L   VP+    SL KL    +
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQL 212

Query: 263 SQN 265
            +N
Sbjct: 213 QEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 56/265 (21%), Positives = 89/265 (33%), Gaps = 86/265 (32%)

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           S IP+D       ++L LQS+    +   +F  L  L +L L+ N L   +P  +   L 
Sbjct: 33  SNIPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELK 85

Query: 256 KLVSFDVSQNKLSGSFPNGICKANGLVN---LSLHKNFFNGSIPGSINECL-NLERFQVQ 311
            L +  V+ NKL  + P G+   + LVN   L L +N    S+P  + + L  L    + 
Sbjct: 86  NLETLWVTDNKLQ-ALPIGV--FDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141

Query: 312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGL 371
            N        +L SLP           F             L+++++ NN+         
Sbjct: 142 YN--------ELQSLP--------KGVFDKL--------TSLKELRLYNNQLKR------ 171

Query: 372 GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLAD 431
                              +P    D                      K  +L +L L +
Sbjct: 172 -------------------VPEGAFD----------------------KLTELKTLKLDN 190

Query: 432 NSLTGEIPPSLAELPVLTYLDLSDN 456
           N L      +   L  L  L L +N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 69.7 bits (171), Expect = 8e-13
 Identities = 45/209 (21%), Positives = 81/209 (38%), Gaps = 38/209 (18%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSK-TLKTEVKTLAKIRHKNIVKVLG 645
           G F  V       +G   A K     +         +  ++ EV  L ++ H NI+ +  
Sbjct: 23  GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDF----QLQWSIRLKIAIGVAQGLAYLHKDYVP 701
            + +   + LI E +  G L D + +++     +    I+      +  G+ YLH   + 
Sbjct: 83  VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ-----ILDGVNYLHTKKI- 136

Query: 702 HLLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE- 754
              H ++K +NI+L     P    KL DF L   + +      +  + E+      APE 
Sbjct: 137 --AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV-----APEI 189

Query: 755 ---YGYSKKATAQMDAYSFGVVLLELITG 780
                   +A    D +S GV+   L++G
Sbjct: 190 VNYEPLGLEA----DMWSIGVITYILLSG 214

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 36/229 (15%)

Query: 572 LRVTEHDLVIGMDEKSSAGNGGPFGRVY-ILSLPSGELIAVKKLVN---FGCQSSKTLKT 627
             V   +  +   E  S    G FG+V         E +A+K + N   F  Q+    + 
Sbjct: 44  YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QI 99

Query: 628 EVKTLAKIRH------KNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR 681
           EV+ L  +          IV +   F     + L++E L   +L DL+   +F+   S+ 
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFR-GVSLN 157

Query: 682 L--KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP--KLTDFALDRIVGEAAF 737
           L  K A  +   L +L    +  ++H ++K +NILL        K+ DF      G +  
Sbjct: 158 LTRKFAQQMCTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDF------GSSCQ 210

Query: 738 QSTMSSEYALS-CYNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
                 +Y  S  Y +PE      Y       +D +S G +L+E+ TG 
Sbjct: 211 LGQRIYQYIQSRFYRSPEVLLGMPYDLA----IDMWSLGCILVEMHTGE 255

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 6/131 (4%)

Query: 137 VLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            + L +N I+  IP         L+ ++L +N +S   P  F     L  L L  N   I
Sbjct: 36  EIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK--I 92

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           +E+P  +   L  L+ L L ++  + +  D+F  L +L++L L  N L   + +   S L
Sbjct: 93  TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151

Query: 255 LKLVSFDVSQN 265
             + +  ++QN
Sbjct: 152 RAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 33/135 (24%), Positives = 51/135 (37%), Gaps = 6/135 (4%)

Query: 157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQS 215
             +  + L  N +    P  F  + +L  +DLS N   ISE+  D    L  L  L L  
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ--ISELAPDAFQGLRSLNSLVLYG 89

Query: 216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI 275
           +    +    F GL SL +L L+ N +   +       L  L    +  NKL  +   G 
Sbjct: 90  NKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147

Query: 276 CKANG-LVNLSLHKN 289
                 +  + L +N
Sbjct: 148 FSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 32/140 (22%), Positives = 51/140 (36%), Gaps = 15/140 (10%)

Query: 103 NLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI-GSLVNLQV 161
            + L  N      P   S    L  ++LSNN I  L                  L +L  
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL-----------APDAFQGLRSLNS 84

Query: 162 LNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHG 220
           L L  N ++     +F     L +L L+ N   I+ +  D    L  L  L L  +    
Sbjct: 85  LVLYGNKITELPKSLFEGLFSLQLLLLNANK--INCLRVDAFQDLHNLNLLSLYDNKLQT 142

Query: 221 VIPDSFVGLQSLSILDLSQN 240
           +   +F  L+++  + L+QN
Sbjct: 143 IAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 29/144 (20%), Positives = 53/144 (36%), Gaps = 11/144 (7%)

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
           + +P  I       ++ L+ +    + P +F   + L  +DLS N ++ E+       L 
Sbjct: 28  TNLPETI------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80

Query: 256 KLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIP-GSINECLNLERFQVQDN 313
            L S  +  NK++   P  +      L  L L+ N  N  +   +  +  NL    + DN
Sbjct: 81  SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138

Query: 314 GFSGDFPDKLWSLPRIKLIRAESN 337
                       L  I+ +    N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 24/154 (15%)

Query: 365 SSIPQGL-GSVKSLYRFSASQNSFYGSLPPN-FCDSPVMSIINLSQNSISGQIPE--LKK 420
           + IP  L  ++  +      QN+    +PP  F     +  I+LS N IS ++     + 
Sbjct: 24  TEIPTNLPETITEIR---LEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQG 78

Query: 421 CRKLVSLSLADNSLTGEIPPSL-AELPVLTYLDLSDNNLTGPIPQG----LQNLK-LALF 474
            R L SL L  N +T E+P SL   L  L  L L+ N +   +       L NL  L+L+
Sbjct: 79  LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLY 136

Query: 475 NVSFNKLSGRVPYSLISGLPAS---YLQGNPGLC 505
           +   NKL   +     S L A    +L  NP +C
Sbjct: 137 D---NKLQ-TIAKGTFSPLRAIQTMHLAQNPFIC 166

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 51/212 (24%)

Query: 593 GPFGRVYI-LSLPSGELIAVK-----KLVNFGCQSSKT---LKTEVKTLAKIR-HKNIVK 642
           G    V   +   +G   AVK            Q  +     + E   L ++  H +I+ 
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL------KIAIGVAQGLAYLH 696
           ++  + S   +FL+++ ++ G L D +  +         L       I   + + +++LH
Sbjct: 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV-------ALSEKETRSIMRSLLEAVSFLH 217

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNA 752
            + +   +HR++K +NILLD + + +L+DF     +        +       C    Y A
Sbjct: 218 ANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLREL-------CGTPGYLA 267

Query: 753 PE----------YGYSKKATAQMDAYSFGVVL 774
           PE           GY K+     D ++ GV+L
Sbjct: 268 PEILKCSMDETHPGYGKEV----DLWACGVIL 295

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 56/217 (25%), Positives = 92/217 (42%), Gaps = 50/217 (23%)

Query: 593 GPFGRVY----ILSLPSGELIAVKKL-----VNFGCQSSKTLKTEVKTLAKIRHKN-IVK 642
           G +G+V+    I    +G+L A+K L     V     +  T +TE + L  IR    +V 
Sbjct: 65  GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSPFLVT 123

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLAYLH 696
           +   F ++  + LI +++  G  G+L       L    R            +   L +LH
Sbjct: 124 LHYAFQTETKLHLILDYIN-G--GELF----THLSQRERFTEHEVQIYVGEIVLALEHLH 176

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFAL--DRIVGEAAFQSTMSSEYALSC----Y 750
           K  +   ++R++K +NILLD++    LTDF L  + +  E              C    Y
Sbjct: 177 KLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-------CGTIEY 226

Query: 751 NAPE------YGYSKKATAQMDAYSFGVVLLELITGR 781
            AP+       G+ K      D +S GV++ EL+TG 
Sbjct: 227 MAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGA 259

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 64.7 bits (158), Expect = 5e-12
 Identities = 36/159 (22%), Positives = 64/159 (40%), Gaps = 24/159 (15%)

Query: 96  CELSSLSNLNLADNLFN--QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI 153
              +    + L   +    + +   LS   + + L LS N I            KI  S+
Sbjct: 20  VVATEAEKVEL-HGMIPPIEKMDATLSTLKACKHLALSTNNI-----------EKI-SSL 66

Query: 154 GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
             + NL++L+LG NL+   +  +      L  L +S N   I+ + S I KL  L  L++
Sbjct: 67  SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQ--IASL-SGIEKLVNLRVLYM 122

Query: 214 QS---SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQS 249
            +   + +  +  D    L  L  L L+ N L  +  ++
Sbjct: 123 SNNKITNWGEI--DKLAALDKLEDLLLAGNPLYNDYKEN 159

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 30/115 (26%), Positives = 46/115 (40%), Gaps = 17/115 (14%)

Query: 81  NLQSLNLSGEISSSVCELSSLSN---LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
             + L LS      +  LS + N   L+L  NL  +   L  +   +LE L +S N I  
Sbjct: 49  ACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWISYNQI-- 105

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQN 191
                  + G     I  LVNL+VL + +N ++            +L  L L+ N
Sbjct: 106 -----ASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 27/151 (17%), Positives = 50/151 (33%), Gaps = 42/151 (27%)

Query: 123 SSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS---GSVPFVFGN 179
              +++  +      L      IE K+  ++ +L   + L L +N +             
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSG 68

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
              L +L L +N          I K+E L+ +                   +L  L +S 
Sbjct: 69  MENLRILSLGRN---------LIKKIENLDAV-----------------ADTLEELWISY 102

Query: 240 NNLTGEVPQSLG--SSLLKLVSFDVSQNKLS 268
           N +      SL     L+ L    +S NK++
Sbjct: 103 NQIA-----SLSGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 26/124 (20%), Positives = 51/124 (41%), Gaps = 7/124 (5%)

Query: 343 IPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMS 402
           +  ++S     + + +  N     I   L  +++L   S  +N     +      +  + 
Sbjct: 40  MDATLSTLKACKHLALSTNNIEK-I-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLT--GEIPPSLAELPVLTYLDLSDNNLTG 460
            + +S N I+  +  ++K   L  L +++N +T  GEI   LA L  L  L L+ N L  
Sbjct: 97  ELWISYNQIA-SLSGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKLEDLLLAGNPLYN 154

Query: 461 PIPQ 464
              +
Sbjct: 155 DYKE 158

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 15/159 (9%)

Query: 630 KTLAKIRHKNIVKVLGFFHSDE-----SIFLIYEFLQMGSLGDLI--CRQDFQLQWSIRL 682
           + L    H N+V++              + L++E +    L   +    +      +I+ 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK- 123

Query: 683 KIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS 742
            +   + +GL +LH   V   +HR++K +NIL+ +  + KL DF L RI     FQ  ++
Sbjct: 124 DMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYS---FQMALT 177

Query: 743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
           S      Y APE          +D +S G +  E+   +
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 66.8 bits (164), Expect = 5e-12
 Identities = 45/205 (21%), Positives = 79/205 (38%), Gaps = 24/205 (11%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKT------EVKTLAKIR---HKNIVK 642
           G +G VY      SG  +A+K  V                  EV  L ++    H N+V+
Sbjct: 20  GAYGTVYKARDPHSGHFVALKS-VRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVR 78

Query: 643 VLGFFHSDE-----SIFLIYEFLQMGSLGDLI-CRQDFQLQWSIRLKIAIGVAQGLAYLH 696
           ++    +        + L++E +    L   +       L       +     +GL +LH
Sbjct: 79  LMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH 137

Query: 697 KDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG 756
            + +   +HR++K +NIL+ +    KL DF L RI     +Q  ++       Y APE  
Sbjct: 138 ANCI---VHRDLKPENILVTSGGTVKLADFGLARIYS---YQMALTPVVVTLWYRAPEVL 191

Query: 757 YSKKATAQMDAYSFGVVLLELITGR 781
                   +D +S G +  E+   +
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRK 216

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 68.3 bits (167), Expect = 6e-12
 Identities = 46/209 (22%), Positives = 83/209 (39%), Gaps = 41/209 (19%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTL---KTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V    +  +G++ A KKL     +  K       E + L K+  + +V +   + 
Sbjct: 195 GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQ--------GLAYLHKDYV 700
           + +++ L+   +   + GDL     F +    +       A         GL  LH++ +
Sbjct: 255 TKDALCLVLTLM---NGGDLK----FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE-- 754
              ++R++K +NILLD     +++D  L   V E                   Y APE  
Sbjct: 308 ---VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR-------VGTVGYMAPEVV 357

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
               Y+       D ++ G +L E+I G+
Sbjct: 358 KNERYTFSP----DWWALGCLLYEMIAGQ 382

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 39/208 (18%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V ++    +G   A+K L      +        TE + L   RH  +  +   F 
Sbjct: 159 GTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAYLHKDYVPH 702
           + + +  + E+   G  G+L     F L                 +   L YLH +   +
Sbjct: 219 THDRLCFVMEYAN-G--GELF----FHLSRERVFSEDRARFYGAEIVSALDYLHSEK--N 269

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPE--- 754
           +++R++K +N++LD D   K+TDF L +  + + A   T        C    Y APE   
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-------CGTPEYLAPEVLE 322

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGR 781
              Y +      D +  GVV+ E++ GR
Sbjct: 323 DNDYGRAV----DWWGLGVVMYEMMCGR 346

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 67.1 bits (164), Expect = 9e-12
 Identities = 43/209 (20%), Positives = 82/209 (39%), Gaps = 35/209 (16%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTL---KTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V ++    + ++ A+K L  +           + E   L     K I  +   F 
Sbjct: 85  GAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144

Query: 649 SDESIFLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLH 705
            D +++L+ ++   G L  L+ + +     + + R  +A  +   +  +H+  YV    H
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA-EMVIAIDSVHQLHYV----H 198

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE------- 754
           R++K  NIL+D +   +L DF     + E     +       +     Y +PE       
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-----AVGTPDYISPEILQAMEG 253

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
               Y  +     D +S GV + E++ G 
Sbjct: 254 GKGRYGPEC----DWWSLGVCMYEMLYGE 278

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 66.1 bits (162), Expect = 1e-11
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 36/207 (17%)

Query: 593 GPFGRVYI-LSLPSGELIAVK--KLVNFGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFH 648
           G F  V   +S  +G+  A K  K    G      +  E+  L   +    ++ +   + 
Sbjct: 40  GKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIG----VAQGLAYLHKDYVPH 702
           +   I LI E+   G +  L   +  +      +     I     + +G+ YLH++ +  
Sbjct: 100 NTSEIILILEYAAGGEIFSLCLPELAE-----MVSENDVIRLIKQILEGVYYLHQNNI-- 152

Query: 703 LLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTM--SSEYALSCYNAPE--- 754
            +H ++K +NILL + +     K+ DF + R +G A     +  + EY      APE   
Sbjct: 153 -VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL-----APEILN 206

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITG 780
               +       D ++ G++   L+T 
Sbjct: 207 YDPITTAT----DMWNIGIIAYMLLTH 229

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 44/287 (15%), Positives = 83/287 (28%), Gaps = 54/287 (18%)

Query: 81  NLQSLNLSG---------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLS 131
           +++ + LSG          +S ++     L     +D    +           L    L 
Sbjct: 33  SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLK 92

Query: 132 NNLIWVLDLSRNHIEGK----IPESIGSLVNLQVLNLGSN-------------LLSGSVP 174
              +  + LS N         + + +     L+ L L +N             L   +V 
Sbjct: 93  CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 152

Query: 175 FVFGNFSELVVLDLSQN------AYLISEIPSDIGKLEKLEQLFLQSSGFH-----GVIP 223
               N   L  +   +N          ++          L  + +  +G        ++ 
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKT---FQSHRLLHTVKMVQNGIRPEGIEHLLL 209

Query: 224 DSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGSFPNGICKA-- 278
           +     Q L +LDL  N  T     +L  +L     L    ++   LS      +  A  
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269

Query: 279 ----NGLVNLSLHKNFFNGSIPGSINECL-----NLERFQVQDNGFS 316
                GL  L L  N        ++   +     +L   ++  N FS
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 49/365 (13%), Positives = 113/365 (30%), Gaps = 82/365 (22%)

Query: 124 SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS--GSVPF--VFGN 179
           S+E  +L  + I   D         +   +    +++ + L  N +    +        +
Sbjct: 5   SIEGKSLKLDAITTEDEK------SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS 58

Query: 180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ 239
             +L + + S             G+++      L+       +  + +    L  + LS 
Sbjct: 59  KKDLEIAEFSDI---------FTGRVKDEIPEALRL------LLQALLKCPKLHTVRLSD 103

Query: 240 NNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP 296
           N       + L   L K   L    +  N L       I +A       L +   N    
Sbjct: 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-------LQELAVNKKAK 156

Query: 297 GSIN-ECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRF-----SGAIPDSISMA 350
            +     +   R ++++     ++     S   +  ++   N          + + ++  
Sbjct: 157 NAPPLRSIICGRNRLENGS-MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215

Query: 351 AQLEQVQIDNNRFT----SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINL 406
            +L+ + + +N FT    S++   L S  +L                          + L
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNL------------------------RELGL 251

Query: 407 SQNSISGQ-----IPELKKC--RKLVSLSLADNSLTGEIPPSLAE-----LPVLTYLDLS 454
           +   +S +     +    K     L +L L  N +  +   +L       +P L +L+L+
Sbjct: 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 311

Query: 455 DNNLT 459
            N  +
Sbjct: 312 GNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 47.4 bits (113), Expect = 1e-05
 Identities = 46/289 (15%), Positives = 89/289 (30%), Gaps = 73/289 (25%)

Query: 231 SLSILDLSQNNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGSFPNGICKA----NGLVN 283
           S+    L  + +T E  +S+ + LL+   +    +S N +       + +       L  
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64

Query: 284 LSLHKNFFN----------GSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR 333
                 F              +  ++ +C  L   ++ DN F                  
Sbjct: 65  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT--------------- 109

Query: 334 AESNRFSGAIP--DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL 391
                     P  D +S    LE + + NN         +   ++L   + ++ +     
Sbjct: 110 -------AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNKKA----- 155

Query: 392 PPNFCDSPVMSIINLSQNSISGQ----IPE-LKKCRKLVSLSLADNSLTGE-----IPPS 441
                ++P +  I   +N +         +  +  R L ++ +  N +  E     +   
Sbjct: 156 ----KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211

Query: 442 LAELPVLTYLDLSDNNLTGPIPQGLQNLKLAL--------FNVSFNKLS 482
           LA    L  LDL DN  T     G   L +AL          ++   LS
Sbjct: 212 LAYCQELKVLDLQDNTFT---HLGSSALAIALKSWPNLRELGLNDCLLS 257

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 51/208 (24%), Positives = 83/208 (39%), Gaps = 40/208 (19%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG+V ++    +G   A+K L      +        TE + L   RH  +  +   F 
Sbjct: 16  GTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ 75

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAYLHKDYVPH 702
           + + +  + E+   G  G+L     F L                 +   L YLH   V  
Sbjct: 76  THDRLCFVMEYAN-G--GELF----FHLSRERVFTEERARFYGAEIVSALEYLHSRDV-- 126

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPE--- 754
            ++R++K +N++LD D   K+TDF L +  + + A   T        C    Y APE   
Sbjct: 127 -VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------CGTPEYLAPEVLE 178

Query: 755 -YGYSKKATAQMDAYSFGVVLLELITGR 781
              Y +      D +  GVV+ E++ GR
Sbjct: 179 DNDYGRAV----DWWGLGVVMYEMMCGR 202

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 46/199 (23%), Positives = 82/199 (41%), Gaps = 38/199 (19%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK-IRHKNIVKVLGFFHSD 650
           G +      +   +    AVK +     +S +    E++ L +  +H NI+ +   +   
Sbjct: 33  GSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDG 88

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + ++++ E ++ G L D I RQ F   +S R    +   + + + YLH   V   +HR++
Sbjct: 89  KYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQGV---VHRDL 142

Query: 709 KSKNILL---DADFEP-KLTDFALDRIV-GEAAFQSTMSSEYALSC----YNAPE----Y 755
           K  NIL      + E  ++ DF   + +  E     T        C    + APE     
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP-------CYTANFVAPEVLERQ 195

Query: 756 GYSKKATAQMDAYSFGVVL 774
           GY        D +S GV+L
Sbjct: 196 GYDAAC----DIWSLGVLL 210

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 65.5 bits (160), Expect = 3e-11
 Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 53/214 (24%)

Query: 604 PSGELIAVKKLVN-FGCQSS--KTLKTEVKTLAKIR-HKNIVKVLGFFHSD--ESIFLIY 657
            +GE++AVKK+ + F   +   +T + E+  L ++  H+NIV +L    +D    ++L++
Sbjct: 32  RTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90

Query: 658 EFLQMGS-LGDLICRQ---DFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNVKSK 711
           ++  M + L  +I          Q+ +   +K        + YLH      LLHR++K  
Sbjct: 91  DY--METDLHAVIRANILEPVHKQYVVYQLIK-------VIKYLHS---GGLLHRDMKPS 138

Query: 712 NILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-------------------YNA 752
           NILL+A+   K+ DF L R        +                             Y A
Sbjct: 139 NILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRA 198

Query: 753 PE-----YGYSKKATAQMDAYSFGVVLLELITGR 781
           PE       Y+K     +D +S G +L E++ G+
Sbjct: 199 PEILLGSTKYTK----GIDMWSLGCILGEILCGK 228

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 65.8 bits (161), Expect = 3e-11
 Identities = 79/466 (16%), Positives = 142/466 (30%), Gaps = 116/466 (24%)

Query: 79  SINLQSLNLSG-EISSSVCE-----LSSLSNLNLADNLFN----QPIPLHLSQCSSLETL 128
           S+++QSL++   E+S +        L     + L D        + I   L    +L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 129 NLSNNLI-------------------WVLDLSRNHIEGK----IPESIGSLVNLQVLNLG 165
           NL +N +                     L L    + G     +  ++ +L  LQ L+L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 166 SNLLSGSVPFVFG-----NFSELVVLDLSQNAYLISEIPSDIGKL----EKLEQLFLQSS 216
            NLL  +   +           L  L L     L +     +  +       ++L + ++
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYC-SLSAASCEPLASVLRAKPDFKELTVSNN 180

Query: 217 GFHGVIPDSFVGLQSLS-----------ILDLSQNNLTGEVPQSLGSSLLK---LVSFDV 262
                   +  G++ L             L L    +T +  + L   +     L    +
Sbjct: 181 DI------NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234

Query: 263 SQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDK 322
             NKL       +C      +  L                L +    +   G   D    
Sbjct: 235 GSNKLGDVGMAELCPGLLHPSSRLRT--------------LWIWECGITAKGCG-DLCRV 279

Query: 323 LWSLPRIKLIRAESNRFSGAIPDSISMA-----AQLEQVQIDNNRFTSSIPQGLGSVKSL 377
           L +   +K +    N         +         QLE + + +  FT++      SV   
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV--- 336

Query: 378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG----QIPE-LKKC-RKLVSLSLAD 431
                        L  N      +  + +S N +      ++ + L +    L  L LAD
Sbjct: 337 -------------LAQN----RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD 379

Query: 432 NSLTGEIPPSLAEL----PVLTYLDLSDNNLTGPIPQGLQNLKLAL 473
             ++     SLA        L  LDLS+N L      G+  L  ++
Sbjct: 380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVESV 422

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 58.8 bits (143), Expect = 4e-09
 Identities = 73/453 (16%), Positives = 122/453 (26%), Gaps = 135/453 (29%)

Query: 75  LTVASINLQSLNLSG---------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQ---- 121
           L   S  +Q L+L            +SS++  L +L  L+L+DNL        L +    
Sbjct: 80  LQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLD 139

Query: 122 -CSSLETLNLSNNLIW------------------VLDLSRNHIEGKIPESIG-----SLV 157
               LE L L    +                    L +S N I       +      S  
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC 199

Query: 158 NLQVLNLGSNLLS----GSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
            L+ L L S  ++      +  +  + + L  L L  N                     L
Sbjct: 200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK--------------------L 239

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGS 270
              G   + P        L  L + +  +T +    L   L     L    ++ N+L   
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

Query: 271 FPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIK 330
               +C+        L              E L ++         S              
Sbjct: 300 GARLLCETLLEPGCQL--------------ESLWVKSCSFTAACCS-------------- 331

Query: 331 LIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGS 390
                           ++    L ++QI NNR   +       V+ L +      S    
Sbjct: 332 -----------HFSSVLAQNRFLLELQISNNRLEDA------GVRELCQGLGQPGS---- 370

Query: 391 LPPNFCDSPVMSIINLSQNSISGQ-----IPELKKCRKLVSLSLADNSLTGEIPPSLAEL 445
                    V+ ++ L+   +S          L     L  L L++N L       L E 
Sbjct: 371 ---------VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 421

Query: 446 -----PVLTYLDLSDNNLTGPIPQGLQNLKLAL 473
                 +L  L L D   +    +    L+   
Sbjct: 422 VRQPGCLLEQLVLYDIYWS---EEMEDRLQALE 451

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.1 bits (123), Expect = 1e-06
 Identities = 60/377 (15%), Positives = 106/377 (28%), Gaps = 89/377 (23%)

Query: 123 SSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLS----GSVPFVFG 178
             +++L++        +LS         E +  L   QV+ L    L+      +     
Sbjct: 3   LDIQSLDIQCE-----ELSDARWA----ELLPLLQQCQVVRLDDCGLTEARCKDISSALR 53

Query: 179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
               L  L+L  N                     L   G H V+         +  L L 
Sbjct: 54  VNPALAELNLRSN--------------------ELGDVGVHCVLQGLQTPSCKIQKLSLQ 93

Query: 239 QNNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSI 295
              LTG     L S+L     L    +S N L  +    +C+        L K       
Sbjct: 94  NCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK------- 146

Query: 296 PGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG----AIPDSI-SMA 350
                  L LE   +            L + P  K +   +N  +      +   +    
Sbjct: 147 -------LQLEYCSLSAASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSP 198

Query: 351 AQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
            QLE +++++   TS   + L  +                          +  + L  N 
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGI--------------------VASKASLRELALGSNK 238

Query: 411 ISGQ----IPE--LKKCRKLVSLSLADNSLTGE----IPPSLAELPVLTYLDLSDNNLTG 460
           +       +    L    +L +L + +  +T +    +   L     L  L L+ N L  
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG- 297

Query: 461 PIPQGLQNLKLALFNVS 477
              +G + L   L    
Sbjct: 298 --DEGARLLCETLLEPG 312

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 45/301 (14%), Positives = 92/301 (30%), Gaps = 54/301 (17%)

Query: 230 QSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA----NGLVNLS 285
             +  LD+    L+      L   L +     +    L+ +    I  A      L  L+
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 286 LHKNFFNGSIPGSINECL-----NLERFQVQDNGFS----GDFPDKLWSLPRIKLIRAES 336
           L  N         + + L      +++  +Q+   +    G     L +LP ++ +    
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 337 NRFSGAIPDSISMAAQ-----LEQVQIDNNRFTSSIPQGLGSV----KSLYRFSASQNSF 387
           N    A    +          LE++Q++    +++  + L SV          + S N  
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182

Query: 388 YGS--------LPPNFCDSPVMSIINLSQNSISGQ-----IPELKKCRKLVSLSLADNSL 434
             +        L  + C    +  + L    ++          +     L  L+L  N L
Sbjct: 183 NEAGVRVLCQGLKDSPC---QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239

Query: 435 TGEIPPSLAE-----LPVLTYLDLSDNNLTGPIPQGLQNLKLAL--------FNVSFNKL 481
                  L          L  L + +  +T    +G  +L   L         +++ N+L
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGIT---AKGCGDLCRVLRAKESLKELSLAGNEL 296

Query: 482 S 482
            
Sbjct: 297 G 297

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 30/195 (15%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSD 650
           G F      +   S +  AVK +     +     + E+  L     H NIVK+   FH  
Sbjct: 22  GSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78

Query: 651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNV 708
              FL+ E L  G L + I ++     +S      I   +   ++++H   V   +HR++
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVGV---VHRDL 132

Query: 709 KSKNILL---DADFEPKLTDFALDRIVGEA--AFQSTMSSEYALSCYNAPE----YGYSK 759
           K +N+L    + + E K+ DF   R+        ++   + +    Y APE     GY +
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH----YAAPELLNQNGYDE 188

Query: 760 KATAQMDAYSFGVVL 774
                 D +S GV+L
Sbjct: 189 SC----DLWSLGVIL 199

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.3 bits (155), Expect = 7e-11
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 56/217 (25%)

Query: 593 GPFGRVY----ILSLPSGELIAVKKLVNFGCQSSKTL---------KTEVKTLAKIRHKN 639
           G FG+V+    I    + +L A+K L        K           K E   L ++ H  
Sbjct: 35  GSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDILVEVNHPF 87

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLA 693
           IVK+   F ++  ++LI +FL+ G  GDL      +L   +             +A  L 
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLR-G--GDLF----TRLSKEVMFTEEDVKFYLAELALALD 140

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC--- 749
           +LH   +   ++R++K +NILLD +   KLTDF L +  +       +        C   
Sbjct: 141 HLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-------CGTV 190

Query: 750 -YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
            Y APE     G+++ A    D +SFGV++ E++TG 
Sbjct: 191 EYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGT 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 40/214 (18%), Positives = 80/214 (37%), Gaps = 43/214 (20%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTL----------KTEVKTLAKIRHKNIV 641
           G F  V ++ +  +G++ A+K +       +K            + E   L     + I 
Sbjct: 72  GAFSEVAVVKMKQTGQVYAMKIM-------NKWDMLKRGEVSCFREERDVLVNGDRRWIT 124

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHK-D 698
           ++   F  +  ++L+ E+   G L  L+ +       + + R  +A  +   +  +H+  
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA-RFYLA-EIVMAIDSVHRLG 182

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC----YNAPE 754
           YV    HR++K  NILLD     +L DF     +       ++      +     Y +PE
Sbjct: 183 YV----HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV-----AVGTPDYLSPE 233

Query: 755 YGYSKKATAQMDAY-------SFGVVLLELITGR 781
              +        +Y       + GV   E+  G+
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 62.2 bits (152), Expect = 2e-10
 Identities = 50/212 (23%), Positives = 96/212 (45%), Gaps = 44/212 (20%)

Query: 593 GPFGRVY----ILSLPSGELIAVKKLV-NFGCQSSKTL---KTEVKTLAKIRHKNIVKVL 644
           G +G+V+    +    +G++ A+K L      +++K     K E   L +++H  IV ++
Sbjct: 28  GGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI 87

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG------VAQGLAYLHKD 698
             F +   ++LI E+L  G  G+L      QL+                ++  L +LH+ 
Sbjct: 88  YAFQTGGKLYLILEYLS-G--GELF----MQLEREGIFMEDTACFYLAEISMALGHLHQK 140

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAP 753
            +   ++R++K +NI+L+     KLTDF L +  + +     T        C    Y AP
Sbjct: 141 GI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-------CGTIEYMAP 190

Query: 754 E----YGYSKKATAQMDAYSFGVVLLELITGR 781
           E     G+++      D +S G ++ +++TG 
Sbjct: 191 EILMRSGHNRAV----DWWSLGALMYDMLTGA 218

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 39/223 (17%), Positives = 82/223 (36%), Gaps = 51/223 (22%)

Query: 604 PSGELIAVKKLVN-FGCQSS--KTLKTEVKTLAKIRHKNIVKVLGFF-----HSDESIFL 655
            + + +A+KK+   F       + L+ E+  L +++   I+++            + +++
Sbjct: 49  NTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107

Query: 656 IYEFLQMGS-LGDLI-CRQ---DFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           + E     S L  L        +  ++  +   L        G  ++H+  +   +HR++
Sbjct: 108 VLEI--ADSDLKKLFKTPIFLTEEHIKTILYNLLL-------GENFIHESGI---IHRDL 155

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC------------------- 749
           K  N LL+ D   K+ DF L R +      + ++                          
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR 215

Query: 750 -YNAPE--YGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA 789
            Y APE      +  T  +D +S G +  EL+   Q+   +P 
Sbjct: 216 WYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 62.5 bits (152), Expect = 3e-10
 Identities = 47/212 (22%), Positives = 80/212 (37%), Gaps = 44/212 (20%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKIRHKNIVKVLGFFH 648
           G FG V+   +  +G+L A KKL     +  K       E K LAK+  + IV +   F 
Sbjct: 196 GGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIG----------VAQGLAYLHKD 698
           +   + L+   +  G  GD+     + +                     +  GL +LH+ 
Sbjct: 256 TKTDLCLVMTIMN-G--GDIR----YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSC----YNAP 753
            +   ++R++K +N+LLD D   +++D  L   +                      + AP
Sbjct: 309 NI---IYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-------AGTPGFMAP 358

Query: 754 E----YGYSKKATAQMDAYSFGVVLLELITGR 781
           E      Y        D ++ GV L E+I  R
Sbjct: 359 ELLLGEEYDFSV----DYFALGVTLYEMIAAR 386

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 62.6 bits (152), Expect = 4e-10
 Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 56/217 (25%)

Query: 593 GPFGRVYIL-SLPSGELIAVKKLVNFGCQSSKTLK---------TEVKTLAKIRHKN--- 639
           G FG VY      +G++ A+K L        K +K          E   L+ +   +   
Sbjct: 200 GGFGEVYGCRKADTGKMYAMKCL------DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLA 693
           IV +   FH+ + +  I + +  G  GDL     + L              A  +  GL 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMN-G--GDLH----YHLSQHGVFSEADMRFYAAEIILGLE 306

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---- 749
           ++H  +V   ++R++K  NILLD     +++D  L     +    +        S     
Sbjct: 307 HMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--------SVGTHG 355

Query: 750 YNAPE-----YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE       Y   A    D +S G +L +L+ G 
Sbjct: 356 YMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGH 388

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 45/225 (20%), Positives = 86/225 (38%), Gaps = 56/225 (24%)

Query: 593 GPFGRVY--ILSLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHK------NIV 641
           G FG+V   +        +A+K + N   +   +    + E+  L KI+ K        V
Sbjct: 30  GTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKENKFLCV 85

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDY 699
            +  +F+    + + +E L   +  + +   +FQ  + +     +A  +   L +LH+  
Sbjct: 86  LMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRFLHE-- 141

Query: 700 VPHLLHRNVKSKNILL-DADFEP------------------KLTDFALDRIVGEAAFQST 740
              L H ++K +NIL  +++FE                   ++ DF      G A F   
Sbjct: 142 -NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF------GSATFDHE 194

Query: 741 MSSEYALS-CYNAPE----YGYSKKATAQMDAYSFGVVLLELITG 780
             +    +  Y  PE     G+++      D +S G +L E   G
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQP----CDVWSIGCILFEYYRG 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 61.2 bits (148), Expect = 9e-10
 Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 55/216 (25%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAKI-RHKNI 640
           G FG+V +     + EL AVK L        K              E + LA   +   +
Sbjct: 352 GSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGKPPFL 404

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAY 694
            ++   F + + ++ + E++  G  GDL+    + +Q   R K       A  +A GL +
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVN-G--GDLM----YHIQQVGRFKEPHAVFYAAEIAIGLFF 457

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSC---- 749
           L    +   ++R++K  N++LD++   K+ DF +    + +     T        C    
Sbjct: 458 LQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-------CGTPD 507

Query: 750 YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE      Y K      D ++FGV+L E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQ 539

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 46/200 (23%), Positives = 80/200 (40%), Gaps = 37/200 (18%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFH-- 648
           G  G+V  I +  + E  A+K L     Q     + EV+   +  +  +IV+++  +   
Sbjct: 73  GINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENL 127

Query: 649 --SDESIFLIYEFLQMGSLGDLICRQDFQL----QWSIRLKIAIGVAQGLAYLHKDYVPH 702
               + + ++ E L  G L   I  +  Q     + S  +K    + + + YLH   +  
Sbjct: 128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS---IGEAIQYLHSINI-- 182

Query: 703 LLHRNVKSKNILL---DADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSCYNAPE---- 754
             HR+VK +N+L      +   KLTDF          +  +   + Y    Y APE    
Sbjct: 183 -AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGP 237

Query: 755 YGYSKKATAQMDAYSFGVVL 774
             Y K      D +S GV++
Sbjct: 238 EKYDKSC----DMWSLGVIM 253

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 56/225 (24%)

Query: 593 GPFGRVY--ILSLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRHK------NIV 641
           G FG+V   I     G  +AVK + N   +   +    ++E++ L  +           V
Sbjct: 25  GAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTFRCV 80

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDY 699
           ++L +F     I +++E L + S  D I    F   + +    K+A  + + + +LH   
Sbjct: 81  QMLEWFEHHGHICIVFELLGL-STYDFIKENGFL-PFRLDHIRKMAYQICKSVNFLHS-- 136

Query: 700 VPHLLHRNVKSKNILL-DADFEP------------------KLTDFALDRIVGEAAFQST 740
              L H ++K +NIL   +D+                    K+ DF      G A +   
Sbjct: 137 -NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF------GSATYDDE 189

Query: 741 MSSEYALS-CYNAPE----YGYSKKATAQMDAYSFGVVLLELITG 780
             S    +  Y APE     G+S+      D +S G +L+E   G
Sbjct: 190 HHSTLVSTRHYRAPEVILALGWSQP----CDVWSIGCILIEYYLG 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 60.2 bits (146), Expect = 2e-09
 Identities = 46/243 (18%), Positives = 83/243 (34%), Gaps = 61/243 (25%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVN-FGCQSSKTLKT---EVKTLAKIRHKNIVKVLGFF 647
           G +G V          ++A+KK++  F  +     K    E+  L ++ H ++VKVL   
Sbjct: 64  GSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIV 121

Query: 648 H-----SDESIFLIYEFLQM---------GSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
                   + ++++ E               L +L   +               +  G+ 
Sbjct: 122 IPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI-KTLLYN----------LLVGVK 170

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC---- 749
           Y+H   +   LHR++K  N L++ D   K+ DF L R V      ++             
Sbjct: 171 YVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 750 ---------------------YNAPE-YGYSKKATAQMDAYSFGVVLLELITGRQAEQAE 787
                                Y APE     +  T  +D +S G +  EL+   +   A 
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287

Query: 788 PAE 790
            A+
Sbjct: 288 HAD 290

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.5 bits (143), Expect = 4e-09
 Identities = 98/654 (14%), Positives = 172/654 (26%), Gaps = 251/654 (38%)

Query: 287 HKNFFNGSIPGSINECL--NLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP 344
           H +F  G       + L    + F V +     D  D    +P+  L + E +    +  
Sbjct: 6   HMDFETGEHQYQYKDILSVFEDAF-VDNFDCK-DVQD----MPKSILSKEEIDHIIMS-K 58

Query: 345 DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSII 404
           D++S   +L         F + + +    V+   +F          L  N+    +MS I
Sbjct: 59  DAVSGTLRL---------FWTLLSKQEEMVQ---KF------VEEVLRINY--KFLMSPI 98

Query: 405 NLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
              Q   S       + R         + L  +     A+  V                Q
Sbjct: 99  KTEQRQPSMMTRMYIEQR---------DRLYND-NQVFAKYNV-------------SRLQ 135

Query: 465 GLQNLKLALFNVSFNKLSGRVPYSLISGLPASY--LQGNPGLCGPGLSNSCDENQPKHRT 522
               L+ AL  +                 PA    + G  G  G            K   
Sbjct: 136 PYLKLRQALLELR----------------PAKNVLIDGVLG-SG------------K--- 163

Query: 523 SGPTALACVMISLAVAVGIMMVAAGFFVFHRYSKKKSQAGVWRSLFFYPLRVTEHDLVIG 582
              T +A + + L+  V   M    F +F            W +L          + V+ 
Sbjct: 164 ---TWVA-LDVCLSYKVQCKM---DFKIF------------WLNL----KNCNSPETVLE 200

Query: 583 M--------DEKSSAGNGGPFG------------------RVYILSLPSGELI------- 609
           M        D   ++ +                       + Y   L    L+       
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL----LVLLNVQNA 256

Query: 610 AVKKLVNFGCQSSKTLKT-------EVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM 662
                 N  C   K L T       +  + A   H ++         DE   L+ ++L  
Sbjct: 257 KAWNAFNLSC---KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDC 313

Query: 663 GSLGDL---ICR-------------QDFQLQW-------SIRLKIAIGVA---------- 689
               DL   +               +D    W         +L   I  +          
Sbjct: 314 -RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYR 372

Query: 690 ---QGLAYLHKD-YVP--------------------HLLHRNVKSKNILLDADFEPK--- 722
                L+      ++P                    + LH+   S   L++   +     
Sbjct: 373 KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK--YS---LVEKQPKESTIS 427

Query: 723 LTDFALDRIVGEAAFQSTMSSEYAL-----SCYNAPE-YGYSKKATAQMDAYSFGVVLLE 776
           +    L+        +  + +EYAL       YN P+ +         +D Y +  +   
Sbjct: 428 IPSIYLE-------LKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHI--- 477

Query: 777 LITGRQAEQAEPAES--------LDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
              G   +  E  E         LD  +++ +KI   + A       I N  QQ
Sbjct: 478 ---GHHLKNIEHPERMTLFRMVFLDF-RFLEQKIRHDSTAWNASGS-ILNTLQQ 526

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 59.1 bits (142), Expect = 6e-09
 Identities = 94/641 (14%), Positives = 186/641 (29%), Gaps = 149/641 (23%)

Query: 185 VLDLSQNAYLISEI------PSDIGKLEKLEQLF--LQSSGFHGVIPDSFVGLQSLSILD 236
           V D+ ++     EI         +       +LF  L S     V    FV      +L 
Sbjct: 38  VQDMPKSILSKEEIDHIIMSKDAV---SGTLRLFWTLLSKQEEMV--QKFVE----EVLR 88

Query: 237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGS---FPNG-ICKA-------NGLVNLS 285
           ++   L   +        +    +   +++L      F    + +          L+ L 
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148

Query: 286 LHKN-FFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL-WSLPRIKLIRAESNRFSGAI 343
             KN   +G + GS    + L+               K+ W    + L    S       
Sbjct: 149 PAKNVLIDG-VLGSGKTWVALD--VCLSYKVQCKMDFKIFW----LNLKNCNS------- 194

Query: 344 PDSI-----SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP--PNFC 396
           P+++      +  Q++      +  +S+I   + S+++  R       +   L    N  
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ 254

Query: 397 DSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN 456
           ++   +  NL              C+ L++       +T  +  +       T++ L  +
Sbjct: 255 NAKAWNAFNL-------------SCKILLTTR--FKQVTDFLSAA-----TTTHISLDHH 294

Query: 457 NLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNP---GLCGPGLSNSC 513
           ++T    +    L   L +     L            P   L  NP    +    + +  
Sbjct: 295 SMTLTPDEVKSLLLKYL-DCRPQDL------------PREVLTTNPRRLSIIAESIRDGL 341

Query: 514 DENQP-KHRTSGPTALACVM-ISLAVAVGIMMVAA--GFFVFHRYSKKKSQ--AGVWRSL 567
                 KH       L  ++  SL V              VF   +   +   + +W  +
Sbjct: 342 ATWDNWKHVNC--DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDV 399

Query: 568 FFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKT 627
                   +  +V+    K S     P       S+PS  L                LK 
Sbjct: 400 IKS-----DVMVVVNKLHKYSLVEKQPKESTI--SIPSIYL---------------ELKV 437

Query: 628 EVKTLAKIRHKNIV----KVLGFFHSDESIFL----IYEFL-------QMGSLGDLICRQ 672
           +++    + H++IV        F   D          Y  +       +      L    
Sbjct: 438 KLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496

Query: 673 DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK-----LTDFA 727
               ++ +  KI        A+     + + L +    K  + D D + +     + DF 
Sbjct: 497 FLDFRF-LEQKI---RHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF- 551

Query: 728 LDRIVGEAAFQSTMSS--EYALSCYNAPEYGYSKKATAQMD 766
           L +I  E    S  +     AL    A +    ++A  Q+ 
Sbjct: 552 LPKI-EENLICSKYTDLLRIAL---MAEDEAIFEEAHKQVQ 588

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.2 bits (124), Expect = 7e-07
 Identities = 103/665 (15%), Positives = 175/665 (26%), Gaps = 245/665 (36%)

Query: 99  SSLSNLNLADNLFNQPIPLH-----------LSQCSSLETL-NLSNNLIWVLDLSRNHIE 146
            +L  L  A N+      +            L  C S +    +   + W L+L   +  
Sbjct: 142 QALLELRPAKNVL-----IDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW-LNLKNCN-- 193

Query: 147 GKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLE 206
              PE++  L  LQ       LL    P    N++     D S N      I   I  ++
Sbjct: 194 --SPETV--LEMLQ------KLLYQIDP----NWTSR--SDHSSN------IKLRIHSIQ 231

Query: 207 KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNK 266
              +  L+S  +             L +L                         +V   K
Sbjct: 232 AELRRLLKSKPYE----------NCLLVLL------------------------NVQNAK 257

Query: 267 LSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGD-----FPD 321
              +F    CK   L+  +  K   +  +  +    ++L+         + D        
Sbjct: 258 AWNAFNLS-CKI--LL-TTRFKQVTD-FLSAATTTHISLDHHS---MTLTPDEVKSLLLK 309

Query: 322 KLW----SLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
            L      LPR      E    +   P  +S+ A  E ++     +          V   
Sbjct: 310 YLDCRPQDLPR------EVLTTN---PRRLSIIA--ESIRDGLATW-----DNWKHVN-C 352

Query: 378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLS-LADNSLTG 436
            + +    S    L P                       E +K      LS    ++   
Sbjct: 353 DKLTTIIESSLNVLEPA----------------------EYRKM--FDRLSVFPPSAH-- 386

Query: 437 EIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPAS 496
            IP  L  L ++ + D+  ++    +   L    L            + P      +P+ 
Sbjct: 387 -IPTIL--LSLI-WFDVIKSD-VMVVVNKLHKYSLVE----------KQPKESTISIPSI 431

Query: 497 YLQGNPGLCGPGLSNSCDENQPKHRTSGPTALACVMISLAVAVGIMMVAAGFFVFHRYSK 556
           YL+         L    +     HR+                    +V    +   +   
Sbjct: 432 YLE---------LKVKLENEYALHRS--------------------IVDH--YNIPKTFD 460

Query: 557 KKSQAGVWRSLFFYPLRVTEHDLVIG--MDEKSSAGNGGPFGRVYILSLPSGELIAVKKL 614
                  +   +FY      H   IG  +           F  V+ L             
Sbjct: 461 SDDLIPPYLDQYFY-----SH---IGHHLKNIEHPERMTLFRMVF-LDF----------- 500

Query: 615 VNFGCQSSKTLKTEVKTLAKIRHKNI-VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQD 673
             F       L+       KIRH +      G   +       Y+          IC  D
Sbjct: 501 -RF-------LE------QKIRHDSTAWNASGSILNTLQQLKFYK--------PYICDND 538

Query: 674 FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG 733
            + +   RL  AI     L +L K    +L+    K  ++L  A           + I  
Sbjct: 539 PKYE---RLVNAI-----LDFLPK-IEENLICS--KYTDLLRIALMAED------EAIFE 581

Query: 734 EAAFQ 738
           EA  Q
Sbjct: 582 EAHKQ 586

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.0 bits (141), Expect = 6e-09
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 41/209 (19%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V +  +  +G+L AVK L               TE + L+    H  + ++   F
Sbjct: 34  GSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + +F + EF+  G  GDL+    F +Q S R         A  +   L +LH   + 
Sbjct: 94  QTPDRLFFVMEFVN-G--GDLM----FHIQKSRRFDEARARFYAAEIISALMFLHDKGI- 145

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPE-- 754
             ++R++K  N+LLD +   KL DF + +  +      +T        C    Y APE  
Sbjct: 146 --IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF-------CGTPDYIAPEIL 196

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
               Y        D ++ GV+L E++ G 
Sbjct: 197 QEMLYGPAV----DWWAMGVLLYEMLCGH 221

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 24/121 (19%), Positives = 41/121 (33%), Gaps = 20/121 (16%)

Query: 104 LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW-------------VLDLSRNHIEGKIP 150
           + L   L  Q      +       L+L    I               +D S N I  K+ 
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KL- 57

Query: 151 ESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQ 210
           +    L  L+ L + +N +      +     +L  L L+ N   + E+  D+  L  L+ 
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN--SLVEL-GDLDPLASLKS 114

Query: 211 L 211
           L
Sbjct: 115 L 115

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.2 bits (123), Expect = 1e-07
 Identities = 19/107 (17%), Positives = 42/107 (39%), Gaps = 6/107 (5%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
           ++ L+   IE +      + V  + L+L    +   +  +     +   +D S N   I 
Sbjct: 1   MVKLTAELIE-QA-AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDN--EIR 55

Query: 197 EIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT 243
           ++      L +L+ L + ++    +       L  L+ L L+ N+L 
Sbjct: 56  KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 20/119 (16%), Positives = 37/119 (31%), Gaps = 15/119 (12%)

Query: 75  LTVASINLQSLNLSGEISSSVCELSSLSNL---NLADNLFNQPIPLHLSQCSSLETLNLS 131
           L        +++ S      +     L  L    + +N   +           L  L L+
Sbjct: 37  LGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96

Query: 132 NNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSN---LLSGSVPFVFGNFSELVVLD 187
           NN +  L      +     + + SL +L  L +  N          +V     ++ VLD
Sbjct: 97  NNSLVEL----GDL-----DPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 16/57 (28%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT 459
            I+ S N I  ++      R+L +L + +N +          LP LT L L++N+L 
Sbjct: 46  AIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 21/127 (16%), Positives = 39/127 (30%), Gaps = 16/127 (12%)

Query: 185 VLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG 244
           ++ L+    LI +         +  +L L+      VI +    L     +D S N +  
Sbjct: 1   MVKLTAE--LIEQAAQ-YTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR- 55

Query: 245 EVPQSLG--SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINEC 302
                L     L +L +  V+ N++             L  L L  N         + + 
Sbjct: 56  ----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDL 106

Query: 303 LNLERFQ 309
             L   +
Sbjct: 107 DPLASLK 113

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 18/104 (17%), Positives = 36/104 (34%), Gaps = 8/104 (7%)

Query: 404 INLSQNSISGQIPELKK-CRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
           ++L    I   I  L     +  ++  +DN +  ++      L  L  L +++N +    
Sbjct: 24  LDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNNRICRIG 80

Query: 463 PQGLQNL-KLALFNVSFNKLSGRVPYSLISGLP---ASYLQGNP 502
               Q L  L    ++ N L        ++ L       +  NP
Sbjct: 81  EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 124

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 8/160 (5%)

Query: 157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQS 215
            + + L+L S  L+      F   ++L  L+L  N   +  + + +   L +L  L L +
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ--LQTLSAGVFDDLTELGTLGLAN 92

Query: 216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI 275
           +    +    F  L  L  L L  N L   +P  +   L KL    ++ N+L  S P G 
Sbjct: 93  NQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA 150

Query: 276 C-KANGLVNLSLHKNFFNGSIP-GSINECLNLERFQVQDN 313
             K   L  LSL  N    S+P G+ +    L+   +  N
Sbjct: 151 FDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 38/139 (27%), Positives = 61/139 (43%), Gaps = 7/139 (5%)

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLIS 196
           LDL    +      +   L  L  LNL  N L  ++   VF + +EL  L L+ N   ++
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ--LA 96

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            +P  +   L +L++L+L  +    +    F  L  L  L L+ N L   +P      L 
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 256 KLVSFDVSQNKLSGSFPNG 274
            L +  +S N+L  S P+G
Sbjct: 156 NLQTLSLSTNQLQ-SVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 41/158 (25%), Positives = 63/158 (39%), Gaps = 18/158 (11%)

Query: 103 NLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI-GSLVNLQV 161
            L+L                + L  LNL  N +             +   +   L  L  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-----------QTLSAGVFDDLTELGT 87

Query: 162 LNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFH 219
           L L +N L+ S+P  VF + ++L  L L  N   +  +PS +  +L KL++L L ++   
Sbjct: 88  LGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQ--LKSLPSGVFDRLTKLKELRLNTNQLQ 144

Query: 220 GVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL 257
            +   +F  L +L  L LS N L   VP      L KL
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKL 181

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 57.7 bits (140), Expect = 7e-09
 Identities = 67/229 (29%), Positives = 92/229 (40%), Gaps = 60/229 (26%)

Query: 593 GPFGRVY-ILSLPSGELIAVKKLVN---FGCQSSKTLKTEVKTLAKIRH-----KNIVKV 643
           G FGRV     + + +  AVK + N   +   +    K E   L KI++      NIVK 
Sbjct: 46  GTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNIVKY 101

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRL--KIAIGVAQGLAYLHKDYVP 701
            G F   + + LI+E L   SL ++I R ++   + I       I + + L YL K    
Sbjct: 102 HGKFMYYDHMCLIFEPLGP-SLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKM--- 156

Query: 702 HLLHRNVKSKNILL-DADFEP------------------------KLTDFALDRIVGEAA 736
            L H ++K +NILL D  FE                         KL DF      G A 
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF------GCAT 210

Query: 737 FQSTMSSEYALS-CYNAPE----YGYSKKATAQMDAYSFGVVLLELITG 780
           F+S        +  Y APE     G+        D +SFG VL EL TG
Sbjct: 211 FKSDYHGSIINTRQYRAPEVILNLGWDVS----SDMWSFGCVLAELYTG 255

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 29/116 (25%), Positives = 46/116 (39%), Gaps = 16/116 (13%)

Query: 97  ELSSLSNLNLADNLFNQP-IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS 155
             S +  L L ++  N+  +     +   LE L+  N  +         I       +  
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-------TSIAN-----LPK 62

Query: 156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQL 211
           L  L+ L L  N +SG +  +      L  L+LS N   I ++ S I  L+KLE L
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN--KIKDL-STIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 15/113 (13%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
            L+ L+     ++S  ++ +L+ L  L L+DN  +  + +   +C +L  LNLS N I  
Sbjct: 43  ELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSN---LLSGSVPFVFGNFSELVVLD 187
           L            E +  L NL+ L+L +     L+     VF    +L  LD
Sbjct: 103 LS---------TIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 26/136 (19%), Positives = 41/136 (30%), Gaps = 28/136 (20%)

Query: 81  NLQSLNLSG------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL 134
           +++ L L        ++     E   L  L+  +              +S+  L   N L
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----------TSIANLPKLNKL 66

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLSQN-- 191
              L+LS N + G +        NL  LNL  N +   S          L  LDL     
Sbjct: 67  -KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

Query: 192 -------AYLISEIPS 200
                    +   +P 
Sbjct: 126 TNLNDYRENVFKLLPQ 141

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.1 bits (107), Expect = 1e-05
 Identities = 25/78 (32%), Positives = 39/78 (50%), Gaps = 6/78 (7%)

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGP- 461
            ++     ++  I  L K  KL  L L+DN ++G +     + P LT+L+LS N +    
Sbjct: 46  FLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS 104

Query: 462 ---IPQGLQNLK-LALFN 475
                + L+NLK L LFN
Sbjct: 105 TIEPLKKLENLKSLDLFN 122

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 4e-05
 Identities = 21/81 (25%), Positives = 39/81 (48%), Gaps = 3/81 (3%)

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
           +++ S+++         +  +L  LS  +  LT  I  +L +L  L  L+LSDN ++G +
Sbjct: 23  VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80

Query: 463 PQGLQNL-KLALFNVSFNKLS 482
               +    L   N+S NK+ 
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 24/119 (20%), Positives = 42/119 (35%), Gaps = 18/119 (15%)

Query: 179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
             S++  L L  +     ++     + E+LE L   + G   +   +   L  L  L+LS
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLS--------GSFPNGICKANGLVNLSLHKN 289
            N ++G   + L      L   ++S NK+             N       L +L L   
Sbjct: 73  DNRVSG-GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLEN-------LKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 7/114 (6%)

Query: 350 AAQLEQVQIDNNRFTS-SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQ 408
            + ++++ +DN+R     +       + L   S        S+  N      +  + LS 
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELSD 73

Query: 409 NSISGQIPEL-KKCRKLVSLSLADNSLT--GEIPPSLAELPVLTYLDLSDNNLT 459
           N +SG +  L +KC  L  L+L+ N +     I P L +L  L  LDL +  +T
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSLDLFNCEVT 126

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.2 bits (139), Expect = 1e-08
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 41/209 (19%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKI-RHKNIVKVLGFF 647
           G FG+V +     + EL AVK L                E + LA   +   + ++   F
Sbjct: 31  GSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK------IAIGVAQGLAYLHKDYVP 701
            + + ++ + E++  G  GDL+    + +Q   R K       A  +A GL +L    + 
Sbjct: 91  QTMDRLYFVMEYVN-G--GDLM----YHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI- 142

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPE-- 754
             ++R++K  N++LD++   K+ DF + +  + +     T        C    Y APE  
Sbjct: 143 --IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-------CGTPDYIAPEII 193

Query: 755 --YGYSKKATAQMDAYSFGVVLLELITGR 781
               Y K      D ++FGV+L E++ G+
Sbjct: 194 AYQPYGKSV----DWWAFGVLLYEMLAGQ 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 43/210 (20%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT---LKTEVKTLAKI-RHKNIVKVLGFF 647
           G + +V ++ L  +  + A+K +        +    ++TE     +   H  +V +   F
Sbjct: 20  GSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK-------IAIGVAQGLAYLHKDYV 700
            ++  +F + E++  G  GDL+    F +Q   +L         A  ++  L YLH+  +
Sbjct: 80  QTESRLFFVIEYVN-G--GDLM----FHMQRQRKLPEEHARFYSAE-ISLALNYLHERGI 131

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC----YNAPE- 754
              ++R++K  N+LLD++   KLTD+ + +  +      ST        C    Y APE 
Sbjct: 132 ---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-------CGTPNYIAPEI 181

Query: 755 ---YGYSKKATAQMDAYSFGVVLLELITGR 781
                Y        D ++ GV++ E++ GR
Sbjct: 182 LRGEDYGFSV----DWWALGVLMFEMMAGR 207

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 52/216 (24%), Positives = 83/216 (38%), Gaps = 55/216 (25%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTL----------KTEVKTLAK-IRHKNI 640
           G FG+V +          AVK L        K             +E   L K ++H  +
Sbjct: 49  GSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVKHPFL 101

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAY 694
           V +   F + + ++ + +++  G  G+L     + LQ             A  +A  L Y
Sbjct: 102 VGLHFSFQTADKLYFVLDYIN-G--GELF----YHLQRERCFLEPRARFYAAEIASALGY 154

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL-DRIVGEAAFQSTMSSEYALSC---- 749
           LH   +   ++R++K +NILLD+     LTDF L    +   +  ST        C    
Sbjct: 155 LHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-------CGTPE 204

Query: 750 YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE      Y +      D +  G VL E++ G 
Sbjct: 205 YLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGL 236

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 16/116 (13%)

Query: 97  ELSSLSNLNLADNLFNQP-IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS 155
             +++  L L +   N   I    ++  +LE L+L N  +         +       +  
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-------ISVSN-----LPK 69

Query: 156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQL 211
           L  L+ L L  N + G +  +      L  L+LS N   + +I S +  L+KLE L
Sbjct: 70  LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN--KLKDI-STLEPLKKLECL 122

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 1e-06
 Identities = 27/113 (23%), Positives = 48/113 (42%), Gaps = 15/113 (13%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
           NL+ L+L    + S  ++ +L  L  L L++N     + +   +  +L  LNLS N +  
Sbjct: 50  NLEFLSLINVGLISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSN---LLSGSVPFVFGNFSELVVLD 187
           +      +     E +  L  L+ L+L +     L+     VF    +L  LD
Sbjct: 110 IS----TL-----EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 25/78 (32%), Positives = 38/78 (48%), Gaps = 6/78 (7%)

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGP- 461
            ++L    +   +  L K  KL  L L++N + G +     +LP LT+L+LS N L    
Sbjct: 53  FLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS 111

Query: 462 ---IPQGLQNLK-LALFN 475
                + L+ LK L LFN
Sbjct: 112 TLEPLKKLECLKSLDLFN 129

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 26/119 (21%), Positives = 38/119 (31%), Gaps = 18/119 (15%)

Query: 179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLS 238
             + +  L L        +I     +   LE L L + G   V   +   L  L  L+LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 239 QNNLTGEVPQSLGSSLLKLVSFDVSQNKLS--------GSFPNGICKANGLVNLSLHKN 289
           +N + G     L   L  L   ++S NKL                     L +L L   
Sbjct: 80  ENRIFG-GLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLEC-------LKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)

Query: 403 IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPI 462
           +++  +++         +   L  LSL +  L   +   L +LP L  L+LS+N + G +
Sbjct: 30  VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSENRIFGGL 87

Query: 463 PQGLQNL-KLALFNVSFNKLS 482
               + L  L   N+S NKL 
Sbjct: 88  DMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 33/122 (27%), Positives = 49/122 (40%), Gaps = 9/122 (7%)

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
           G I    +    LE + + N    S +   L  +  L +   S+N  +G L       P 
Sbjct: 39  GKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96

Query: 401 MSIINLSQNSIS--GQIPELKKCRKLVSLSLADNSLTGEIPP----SLAELPVLTYLDLS 454
           ++ +NLS N +     +  LKK   L SL L +  +T  +          LP LTYLD  
Sbjct: 97  LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGY 155

Query: 455 DN 456
           D 
Sbjct: 156 DR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 7/113 (6%)

Query: 351 AQLEQVQIDNNRFT-SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQN 409
           A + ++ +DN +     I        +L   S        S+  N    P +  + LS+N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVS-NLPKLPKLKKLELSEN 81

Query: 410 SISGQIPEL-KKCRKLVSLSLADNSLT--GEIPPSLAELPVLTYLDLSDNNLT 459
            I G +  L +K   L  L+L+ N L     + P L +L  L  LDL +  +T
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 48/217 (22%), Positives = 92/217 (42%), Gaps = 57/217 (26%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAKI-RHKNI 640
           G + +V ++ L  +  + A++ +        K           ++TE     +   H  +
Sbjct: 63  GSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQASNHPFL 115

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLK-------IAIGVAQGLA 693
           V +   F ++  +F + E++  G  GDL+    F +Q   +L         A  ++  L 
Sbjct: 116 VGLHSCFQTESRLFFVIEYVN-G--GDLM----FHMQRQRKLPEEHARFYSAE-ISLALN 167

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC--- 749
           YLH+  +   ++R++K  N+LLD++   KLTD+ + +  +      ST        C   
Sbjct: 168 YLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-------CGTP 217

Query: 750 -YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
            Y APE      Y        D ++ GV++ E++ GR
Sbjct: 218 NYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGR 250

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 54.9 bits (133), Expect = 5e-08
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 55/216 (25%)

Query: 593 GPFGRVYILSL-PSGELIAVKKLVNFGCQSSKT----------LKTEVKTLAK-IRHKNI 640
           G FG+V++     + +  A+K L        K              E + L+    H  +
Sbjct: 28  GSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKI------AIGVAQGLAY 694
             +   F + E++F + E+L  G  GDL+    + +Q   +  +      A  +  GL +
Sbjct: 81  THMFCTFQTKENLFFVMEYLN-G--GDLM----YHIQSCHKFDLSRATFYAAEIILGLQF 133

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI-VGEAAFQSTMSSEYALSC---- 749
           LH   +   ++R++K  NILLD D   K+ DF + +  +   A  +T        C    
Sbjct: 134 LHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-------CGTPD 183

Query: 750 YNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
           Y APE      Y+       D +SFGV+L E++ G+
Sbjct: 184 YIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQ 215

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 32/153 (20%), Positives = 55/153 (35%), Gaps = 26/153 (16%)

Query: 635 IRHKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAY 694
           I         GF        +  E        D +  +         +  +  VA+G+ +
Sbjct: 156 ITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL-------ICYSFQVAKGMEF 208

Query: 695 LHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN--- 751
           L        +HR++ ++NILL      K+ DF L R +              +   +   
Sbjct: 209 LAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI--------YKDPDYVRKGDARL 257

Query: 752 -----APEYGYSKKATAQMDAYSFGVVLLELIT 779
                APE  + +  T Q D +SFGV+L E+ +
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 55/286 (19%), Positives = 97/286 (33%), Gaps = 44/286 (15%)

Query: 8   LSFLCLH-----LLVCLTFFAFTSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNW 62
            S LCL        VC  ++   S     D  L     +              +     +
Sbjct: 21  FSCLCLPELLKVSGVCKRWYRLAS-----DESLWQTLDLTGKNLHPDVTGRLLSQGVIAF 75

Query: 63  TGVTCVTTATASLTVASINLQSLNLSGE------ISSSVCELSSLSNLNLADNLFNQPIP 116
                      +   +   +Q ++LS        +   + + S L NL+L     + PI 
Sbjct: 76  RCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIV 135

Query: 117 LHLSQCSSLETLNLSN----------------------NLIWVLDLSRNHIEGKIPESIG 154
             L++ S+L  LNLS                       NL W  D +  H++  +     
Sbjct: 136 NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE 195

Query: 155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQ 214
           ++  L +     NL    +  +      LV LDLS +  L ++   +  +L  L+ L L 
Sbjct: 196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSL- 254

Query: 215 SSGFHGVIPDSFVGL---QSLSILDLSQNNLTGEVPQSLGSSLLKL 257
            S  + +IP++ + L    +L  L +    +     Q L  +L  L
Sbjct: 255 -SRCYDIIPETLLELGEIPTLKTLQVF-GIVPDGTLQLLKEALPHL 298

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 42/196 (21%), Positives = 74/196 (37%), Gaps = 50/196 (25%)

Query: 593 GPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFH-- 648
           G  G+V    +  + E  A+K L     Q     + EV+   +  +  +IV+++  +   
Sbjct: 29  GINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENL 83

Query: 649 --SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIR--LKIAIGVAQGLAYLHKDYVPHLL 704
               + + ++ E L  G L   I  +  Q  ++ R   +I   + + + YLH   +    
Sbjct: 84  YAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINI---A 139

Query: 705 HRNVKSKNILL---DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE---YGYS 758
           HR+VK +N+L      +   KLTDF                         A E     Y 
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AKETTGEKYD 176

Query: 759 KKATAQMDAYSFGVVL 774
           K      D +S GV++
Sbjct: 177 KSC----DMWSLGVIM 188

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 23/133 (17%), Positives = 52/133 (39%), Gaps = 9/133 (6%)

Query: 185 VLDLSQNAYLISEIPSDIG--KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
            L L+ N    + + +     KL +L ++   ++    +   +F G   ++ + L+ N L
Sbjct: 36  ELRLNNNE--FTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93

Query: 243 TGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI-CKANGLVNLSLHKNFFNGSIPGSINE 301
              V   +   L  L +  +  N+++    N      + +  LSL+ N    ++     +
Sbjct: 94  E-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150

Query: 302 CL-NLERFQVQDN 313
            L +L    +  N
Sbjct: 151 TLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 29/134 (21%), Positives = 47/134 (35%), Gaps = 20/134 (14%)

Query: 99  SSLSNLNLADNLFNQ-PIPLHLSQCSSLETLNLSNNLI--------------WVLDLSRN 143
              + L L +N F          +   L  +N SNN I                + L+ N
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 144 HIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI 202
            +E  +   +   L +L+ L L SN ++      F   S + +L L  N   I+ +    
Sbjct: 92  RLEN-VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQ--ITTVAPGA 148

Query: 203 -GKLEKLEQLFLQS 215
              L  L  L L +
Sbjct: 149 FDTLHSLSTLNLLA 162

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 33/144 (22%), Positives = 57/144 (39%), Gaps = 16/144 (11%)

Query: 342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPN-FCDSP 399
            IP+ I       +++++NN FT     G+   +  L + + S N     +    F  + 
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGAS 81

Query: 400 VMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP-SLAELPVLTYLDLSDN 456
            ++ I L+ N +   +     K    L +L L  N +T  +   S   L  +  L L DN
Sbjct: 82  GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 457 NLTGPIPQG----LQNLK-LALFN 475
            +T  +  G    L +L  L L  
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLA 162

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 26/127 (20%), Positives = 42/127 (33%), Gaps = 14/127 (11%)

Query: 94  SVCELSSLSNLN-LADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPES 152
             C     S L    D   +     HL    +L  L + N           H++      
Sbjct: 3   DACCPHGSSGLRCTRDGALD--SLHHLPGAENLTELYIENQ---------QHLQHLELRD 51

Query: 153 IGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLF 212
           +  L  L+ L +  + L    P  F     L  L+LS NA  +  +     +   L++L 
Sbjct: 52  LRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA--LESLSWKTVQGLSLQELV 109

Query: 213 LQSSGFH 219
           L  +  H
Sbjct: 110 LSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.3 bits (122), Expect = 7e-07
 Identities = 24/103 (23%), Positives = 38/103 (36%), Gaps = 4/103 (3%)

Query: 166 SNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPD 224
           +   +            L  L +      +  +   D+  L +L  L +  SG   V PD
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQ-HLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74

Query: 225 SFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKL 267
           +F     LS L+LS N L     +++    L L    +S N L
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTV--QGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.0 bits (103), Expect = 1e-04
 Identities = 18/95 (18%), Positives = 38/95 (40%), Gaps = 4/95 (4%)

Query: 390 SLPPNFCDSPVMSIINLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPP-SLAELP 446
               +   +  ++ + +        +    L+   +L +L++  + L   + P +    P
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 447 VLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKL 481
            L+ L+LS N L     + +Q L L    +S N L
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 29/110 (26%), Positives = 49/110 (44%), Gaps = 14/110 (12%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
            L L  N     +P+ + +  +L +++L +N +S      F N ++L+ L LS N   + 
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR--LR 91

Query: 197 EIPSDI-GKLEKLEQLFLQ----SSGFHGVIPD-SFVGLQSLSILDLSQN 240
            IP      L+ L  L L     S      +P+ +F  L +LS L +  N
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDISV-----VPEGAFNDLSALSHLAIGAN 136

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 41/123 (33%), Positives = 61/123 (49%), Gaps = 7/123 (5%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF-VFGNFSELVVLDLSQNAYLI 195
           +L L  N I    P    SL+NL+ L LGSN L  ++P  VF + ++L VLDL  N   +
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQ--L 100

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           + +PS +  +L  L++LF+  +     +P     L  L+ L L QN L   +P      L
Sbjct: 101 TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRL 158

Query: 255 LKL 257
             L
Sbjct: 159 SSL 161

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 38/139 (27%), Positives = 56/139 (40%), Gaps = 14/139 (10%)

Query: 103 NLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI-GSLVNLQV 161
            L L DN   +  P       +L+ L L +N +  L           P  +  SL  L V
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL-----------PVGVFDSLTQLTV 92

Query: 162 LNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV 221
           L+LG+N L+     VF     L  L +  N   ++E+P  I +L  L  L L  +    +
Sbjct: 93  LDLGTNQLTVLPSAVFDRLVHLKELFMCCNK--LTELPRGIERLTHLTHLALDQNQLKSI 150

Query: 222 IPDSFVGLQSLSILDLSQN 240
              +F  L SL+   L  N
Sbjct: 151 PHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 38/133 (28%), Positives = 55/133 (41%), Gaps = 27/133 (20%)

Query: 157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS 216
            N Q+L L  N ++   P VF +   L  L L  N            +L  L        
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN------------QLGALP------- 80

Query: 217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGIC 276
              GV    F  L  L++LDL  N LT  +P ++   L+ L    +  NKL+   P GI 
Sbjct: 81  --VGV----FDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132

Query: 277 KANGLVNLSLHKN 289
           +   L +L+L +N
Sbjct: 133 RLTHLTHLALDQN 145

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 48/289 (16%), Positives = 94/289 (32%), Gaps = 64/289 (22%)

Query: 61  NWTGVTCVTTATASLTVASINLQSLNLSG-EISSSVCEL---------SSLSNLNLADNL 110
           N            +      ++ SLNLSG  +     +          +++++LNL+ N 
Sbjct: 32  NNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNF 91

Query: 111 FNQPIPLHLSQ-----CSSLETLNLSNNLI-------------------WVLDLSRNHIE 146
            +      L +       ++  L+L  N                       L+L  N + 
Sbjct: 92  LSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151

Query: 147 GKIPESIGSL-----VNLQVLNLGSNLLSG------SVPFVFGNFSELVVLDLSQN---- 191
            K  + +  +      N+  LNL  N L+       +        S +  LDLS N    
Sbjct: 152 IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS-VTSLDLSANLLGL 210

Query: 192 --AYLISEIPSDIGKLEKLEQLFLQSSGFHGV----IPDSFVGLQSLSILDLSQN---NL 242
                ++ I S I     +  L L  +  HG     +      L+ L  + L  +   N+
Sbjct: 211 KSYAELAYIFSSIPN--HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNM 268

Query: 243 TGEVPQSLGSSLLK---LVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
           + E  ++LG++      ++  D +  ++  S    I      ++     
Sbjct: 269 SKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 58/391 (14%), Positives = 116/391 (29%), Gaps = 105/391 (26%)

Query: 119 LSQCSSLETLNLSNNLIW-------------------VLDLSRNHIEGKIPESIGSLV-- 157
            S    + +L+LS N ++                    L+LS N +  K  + +  ++  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 158 ---NLQVLNLGSNLLSGS-----VPFVFGNFSELVVLDLSQNAYLISEIPSDIGK--LEK 207
              N+  LNL  N LS       V  +      + VLDL  N         D       +
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN---------DFSSKSSSE 128

Query: 208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL----LKLVSFDVS 263
            +Q F                  S++ L+L  N+L  +    L   L      + S ++ 
Sbjct: 129 FKQAFSNLP-------------ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLR 175

Query: 264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL 323
            N L+      + K    +  S+                L+L    +    ++ +     
Sbjct: 176 GNNLASKNCAELAKFLASIPASV--------------TSLDLSANLLGLKSYA-ELAYIF 220

Query: 324 WSLP-RIKLIRAESNRFSGAIPDSISMA----AQLEQVQIDNNRFTSSIPQGLGSVKSLY 378
            S+P  +  +    N   G   +++ +       L+ V +D +   +   +   ++ +  
Sbjct: 221 SSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA- 279

Query: 379 RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG----QIPELKK--CRKLVSLSLADN 432
                           F +   + +++ +   I       I  L +    K    SL + 
Sbjct: 280 ----------------FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQ 323

Query: 433 SLTGE----IPPSLAELPV-LTYLDLSDNNL 458
            L              +P  L     +   L
Sbjct: 324 CLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 4/106 (3%)

Query: 137 VLDLSRNHIEGKIPESI-GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
            L L+ N +     + + G L +L  L L  N L+G  P  F   S +  L L +N   I
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK--I 90

Query: 196 SEIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQN 240
            EI + +   L +L+ L L  +    V+P SF  L SL+ L+L+ N
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.4 bits (114), Expect = 6e-06
 Identities = 34/205 (16%), Positives = 72/205 (35%), Gaps = 22/205 (10%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNL--FNQPIPLHLSQCSSLETLNLSNNLIWVL 138
           + + L    +I     E+S +  ++L+  L        L +   ++L         +  L
Sbjct: 140 HFEGLFWG-DIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL 198

Query: 139 DLSRNHIEGKIPESIGS--LVNLQVLNL--------GSNLLSGSVPFVFGN-FSELVVLD 187
           ++    +   + E I    L NL+ L L            ++   P    + F  L  L 
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258

Query: 188 LSQNAYLISEIPSDIGK---LEKLEQLFLQSS--GFHGV--IPDSFVGLQSLSILDLSQN 240
           +       + +     +   L +LE + + +      G   + D    ++ L  +++  N
Sbjct: 259 IVDAE-EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317

Query: 241 NLTGEVPQSLGSSLLKLVSFDVSQN 265
            L+ E+ + L  SL   +    SQ 
Sbjct: 318 YLSDEMKKELQKSLPMKIDVSDSQE 342

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 41.9 bits (97), Expect = 7e-04
 Identities = 20/196 (10%), Positives = 59/196 (30%), Gaps = 37/196 (18%)

Query: 291 FNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA 350
               +   ++    L   +++      +        P +K +   S     ++ + I  +
Sbjct: 160 EQVDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGS 216

Query: 351 A-----QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIIN 405
                 +L       +            + S  RF                  P +  + 
Sbjct: 217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF------------------PNLKWLG 258

Query: 406 LSQNSISGQIPEL----KKCRKLVSLSLADNSLTGE----IPPSLAELPVLTYLDLSDNN 457
           +        + E+        +L ++ ++   LT E    +   + ++  L ++++  N 
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318

Query: 458 LTGPIPQGLQNLKLAL 473
           L+    +  + L+ +L
Sbjct: 319 LS---DEMKKELQKSL 331

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.4 bits (115), Expect = 9e-06
 Identities = 43/257 (16%), Positives = 75/257 (29%), Gaps = 41/257 (15%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDL 140
            ++S+ L G+   +   L                I    S  + LE + L   ++    L
Sbjct: 67  KVRSVELKGKPHFADFNLVPDGWGGYVYPW----IEAMSSSYTWLEEIRLKRMVVTDDCL 122

Query: 141 SRNHIEGKIPESIG-SLVNLQVLNLG--SNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
                     E I  S  N +VL L       +  +  +      L  LDL ++  +   
Sbjct: 123 ----------ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRES-DVDDV 171

Query: 198 IPSDIGKLEK----LEQLFLQSSGFHGVIPDSFV-----GLQSLSILDLSQNNLTGEVPQ 248
               +         L  L +  S     +  S +        +L  L L+   +  E   
Sbjct: 172 SGHWLSHFPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLKLN-RAVPLEKLA 228

Query: 249 SLGSSLLKLVSFDVS--QNKLSGSFPNGICKA----NGLVNLSLHKNFFNGSIPGSINEC 302
           +L     +L          ++     +G+  A      L  LS   +     +P   + C
Sbjct: 229 TLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288

Query: 303 -----LNLERFQVQDNG 314
                LNL    VQ   
Sbjct: 289 SRLTTLNLSYATVQSYD 305

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 40/231 (17%), Positives = 85/231 (36%), Gaps = 25/231 (10%)

Query: 56  NIHYCNWTGVTCVTTATASLTVASINLQSLNLSG---EIS-SSVCELS----SLSNLNLA 107
           ++   +   V+      +       +L SLN+S    E+S S++  L     +L +L L 
Sbjct: 162 DLRESDVDDVSGH--WLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLN 219

Query: 108 DNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSN 167
             +  + +   L +   LE L             R  +   +  ++     L+ L+   +
Sbjct: 220 RAVPLEKLATLLQRAPQLEELGTG----GYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275

Query: 168 LLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS----SGFHGVIP 223
            +   +P V+   S L  L+LS       ++   + +  KL++L++      +G   V+ 
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE-VLA 334

Query: 224 DSFVGLQSLSILDLSQ------NNLTGEVPQSLGSSLLKLVSFDVSQNKLS 268
            +   L+ L +             LT +   S+     KL S      +++
Sbjct: 335 STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.3 bits (107), Expect = 7e-05
 Identities = 30/209 (14%), Positives = 63/209 (30%), Gaps = 36/209 (17%)

Query: 67  CVT-TATASLTVASINLQSLNLSG-----------EISSSVCELSSLSNLNLADNLFNQP 114
            V     A+L   +  L+ L   G            +S ++     L  L+   +     
Sbjct: 221 AVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAY 280

Query: 115 IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP 174
           +P   S CS L TLNLS   +             + + +     LQ L +   +    + 
Sbjct: 281 LPAVYSVCSRLTTLNLSYATV---------QSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331

Query: 175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI 234
            +     +L  L +  +   + E    + + + L  + +              G   L  
Sbjct: 332 VLASTCKDLRELRVFPSEPFVMEPNVALTE-QGLVSVSM--------------GCPKLES 376

Query: 235 LDLSQNNLTGEVPQSLGSSLLKLVSFDVS 263
           +      +T     ++  +   +  F + 
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRFRLC 405

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 44.9 bits (106), Expect = 9e-05
 Identities = 29/205 (14%), Positives = 68/205 (33%), Gaps = 17/205 (8%)

Query: 81  NLQSLNLSG------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL 134
            L +LNLS       ++   +C+   L  L + D + +  + +  S C  L  L +  + 
Sbjct: 290 RLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSE 349

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLS---- 189
            +V++ +    E  +         L+ +      ++  ++  +  N   +    L     
Sbjct: 350 PFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEP 409

Query: 190 QNAYLISEIPSDIG------KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLT 243
           +    ++  P DIG        + L +L L       V        + + +L ++    +
Sbjct: 410 KAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDS 469

Query: 244 GEVPQSLGSSLLKLVSFDVSQNKLS 268
                 + S    L   ++      
Sbjct: 470 DLGMHHVLSGCDSLRKLEIRDCPFG 494

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 46/220 (20%), Positives = 77/220 (35%), Gaps = 30/220 (13%)

Query: 120 SQCS-SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG 178
                     NL    +                +   L ++  +   ++ +  SV     
Sbjct: 15  DDAFAETIKANLKKKSVTDA------------VTQNELNSIDQIIANNSDIK-SVQ-GIQ 60

Query: 179 NFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL 237
               +  L L  N   + +I +    +L  L  L L  +    +    F  L +L  L L
Sbjct: 61  YLPNVRYLALGGNK--LHDISALK--ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVL 116

Query: 238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGIC-KANGLVNLSLHKNFFNGSIP 296
            +N L   +P  +   L  L   +++ N+L  S P G+  K   L  L L  N    S+P
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP 173

Query: 297 -GSINECLNLERFQVQDNGF----SGDFPDKLWSLPRIKL 331
            G  ++   L+  ++  N       G F D+L SL  I L
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVF-DRLTSLQYIWL 212

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 48/205 (23%), Positives = 72/205 (35%), Gaps = 32/205 (15%)

Query: 60  CNWTGVTCVTTATASLTVASI--NLQSLNLSGEISSSVC---ELSSLSNLNLADN-LFNQ 113
                      +       +   ++  +  +     SV     L ++  L L  N L + 
Sbjct: 19  AETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI 78

Query: 114 PIPLHLSQCSSLETLNLSNN---------------LIWVLDLSRNHIEGKIPESI-GSLV 157
                L+    L  L L+ N               L   L L  N ++  +P+ +   L 
Sbjct: 79  SALKELTN---LTYLILTGNQLQSLPNGVFDKLTNLKE-LVLVENQLQ-SLPDGVFDKLT 133

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSS 216
           NL  LNL  N L      VF   + L  LDLS N   +  +P  +  KL +L+ L L  +
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQ--LQSLPEGVFDKLTQLKDLRLYQN 191

Query: 217 GFHGVIPD-SFVGLQSLSILDLSQN 240
               V PD  F  L SL  + L  N
Sbjct: 192 QLKSV-PDGVFDRLTSLQYIWLHDN 215

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.8 bits (111), Expect = 2e-05
 Identities = 46/239 (19%), Positives = 78/239 (32%), Gaps = 86/239 (35%)

Query: 613 KLVNFGCQSSKTLKTEVKTLAKIR--------HKNIVKVLGFF--------HSDESIFLI 656
           K+V      ++T   E++ L  +R         + +V++L  F        H    I ++
Sbjct: 68  KVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTH----ICMV 123

Query: 657 YEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL 715
           +E L    L   I + ++Q L      KI   V QGL YLH      ++H ++K +NILL
Sbjct: 124 FEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILL 180

Query: 716 DAD-------------------------------------------------FEPKLTDF 726
             +                                                  + K+ D 
Sbjct: 181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADL 240

Query: 727 ALDRIVGEAAFQSTMSSEYALSCYNAPE----YGYSKKATAQMDAYSFGVVLLELITGR 781
                V +   +   + +Y      + E     GY+  A    D +S   +  EL TG 
Sbjct: 241 GNACWVHKHFTEDIQTRQYR-----SLEVLIGSGYNTPA----DIWSTACMAFELATGD 290

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.4 bits (109), Expect = 2e-05
 Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 4/84 (4%)

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
           F  D+ +F++ EF   G   DL   +      +    I   +   LA           HR
Sbjct: 131 FFKDDQLFIVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHR 186

Query: 707 NVKSKNILLDADFEPKLTDFALDR 730
           ++   N+LL      KL      +
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGK 210

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 64/456 (14%), Positives = 129/456 (28%), Gaps = 53/456 (11%)

Query: 47  SLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNL 106
                +   N+   NW G    T     ++     L+S++           +S L    L
Sbjct: 81  KGKPRAAMFNLIPENWGGYV--TPWVTEISNNLRQLKSVHFRR------MIVSDLDLDRL 132

Query: 107 ADNLFNQPIPLHLSQCS-----SLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLV---- 157
           A    +    L L +CS      L ++      I  L +  +    K  + +  L     
Sbjct: 133 AKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNT 192

Query: 158 NLQVLNL----GSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
           +L+VLN      + +    +  +  N   LV + +     L  E+         LE+   
Sbjct: 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL--ELVGFFKAAANLEEFCG 250

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQ-NNLTGEVPQSLGSSLLKLVSFDVSQ-NKLSGSF 271
            S      +P+ ++ L     L     + +       L     ++   D+      +   
Sbjct: 251 GSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDH 310

Query: 272 PNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSL----- 326
              I K   L  L       +  +      C  L+R +++         D+   +     
Sbjct: 311 CTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370

Query: 327 -------PRIKLIRAESNRFS----GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK 375
                    ++ +    +  +     +I   +        V +D     + +P   G   
Sbjct: 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRS 430

Query: 376 SLYRFSASQNSFYGSLPPNFCDSPVMSI---------INLSQNSIS--GQIPELKKCRKL 424
            L      +   +        D  +  I         + L     S  G +   + C  L
Sbjct: 431 LLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNL 490

Query: 425 VSLSLADNSLTGEIPPSLAE-LPVLTYLDLSDNNLT 459
             L +     +     +    LP L YL +     +
Sbjct: 491 QKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 54/406 (13%), Positives = 122/406 (30%), Gaps = 70/406 (17%)

Query: 67  CVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLE 126
           C T     L+    NL+SL L G+  +++  L   +          +      +    L+
Sbjct: 60  CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTE----ISNNLRQLK 115

Query: 127 TLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVL 186
           +++     + V DL  + +      +     +L+ L L               F+   +L
Sbjct: 116 SVHFRR--MIVSDLDLDRL------AKARADDLETLKLDK----------CSGFTTDGLL 157

Query: 187 DLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV-------IPDSFVGLQSLSILDLSQ 239
            +  +               K++ L ++ S F          +      L+ L+      
Sbjct: 158 SIVTH-------------CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEF 204

Query: 240 NNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL---SLHKNFFNGSIP 296
             ++ +  +++  +   LVS  V   ++          A  L      SL+++       
Sbjct: 205 AKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263

Query: 297 GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQV 356
            ++     L R  +   G +   P       +I+ +            D  ++  +   +
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLET--EDHCTLIQKCPNL 320

Query: 357 QIDNNRFT------SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS 410
           ++   R          + Q    +K L     +                   +I L+Q  
Sbjct: 321 EVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR---GLIALAQG- 376

Query: 411 ISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAE-LPVLTYLDLSD 455
                     C++L  +++  + +T E   S+   L  L    L  
Sbjct: 377 ----------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVL 412

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 27/105 (25%), Positives = 46/105 (43%), Gaps = 3/105 (2%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
            L+L  N ++         L  L  L+L  N +      VF   ++L +L L +N   + 
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK--LQ 89

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQN 240
            +P+ +  KL +L++L L ++    V    F  L SL  + L  N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 36/122 (29%), Positives = 52/122 (42%), Gaps = 4/122 (3%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
            LDL  N ++         L +L  L LG N L      VF   + L  L+LS N   + 
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ--LQ 89

Query: 197 EIPSDI-GKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
            +P+ +  KL +L++L L ++    +    F  L  L  L L QN L   VP  +   L 
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLT 148

Query: 256 KL 257
            L
Sbjct: 149 SL 150

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 35/140 (25%), Positives = 53/140 (37%), Gaps = 15/140 (10%)

Query: 103 NLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI-GSLVNLQV 161
            L+L  N           + +SL  L L  N +             +P  +   L +L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----------QSLPNGVFNKLTSLTY 80

Query: 162 LNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGFHG 220
           LNL +N L      VF   ++L  L L+ N   +  +P  +  KL +L+ L L  +    
Sbjct: 81  LNLSTNQLQSLPNGVFDKLTQLKELALNTNQ--LQSLPDGVFDKLTQLKDLRLYQNQLKS 138

Query: 221 VIPDSFVGLQSLSILDLSQN 240
           V    F  L SL  + L  N
Sbjct: 139 VPDGVFDRLTSLQYIWLHDN 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 38/168 (22%), Positives = 63/168 (37%), Gaps = 40/168 (23%)

Query: 590 GNGGPFGRVY---------ILSLPSGELIAVK---------KLVNFGCQSSKTLKTEV-K 630
                 G +Y           S P  +  ++K            NF  +++K L+    K
Sbjct: 51  TRDN-QGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 631 TLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMG-SLGDLI--C-RQDFQLQWSIR--LK 683
            L       I   +GF  H D+  FL+   L  G SL   +    +       S R  L+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVL----SERSVLQ 163

Query: 684 IAIGVAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPK--LTDFAL 728
           +A  +   L +LH  +YV    H NV ++NI +D + + +  L  +  
Sbjct: 164 VACRLLDALEFLHENEYV----HGNVTAENIFVDPEDQSQVTLAGYGF 207

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 26/153 (16%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT----LKTEVKTLAKIRH-KNIVKV 643
           G+G  FG +Y+   + +GE +A+K       +  KT    L  E K    ++    I  +
Sbjct: 18  GSGS-FGDIYLGTDIAAGEEVAIK------LECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 644 LGFFHSDESIFLIYEFLQMG-SLGDLI--CRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
                  +   ++ E L  G SL DL   C + F L+ ++ L +A  +   + Y+H    
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-TV-LLLADQMISRIEYIHSK-- 124

Query: 701 PHLLHRNVKSKNILLDADFEPK---LTDFALDR 730
            + +HR+VK  N L+    +     + DF L +
Sbjct: 125 -NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 30/152 (19%), Positives = 62/152 (40%), Gaps = 26/152 (17%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKT----LKTEVKTLAKIRH-KNIVKV 643
           G G  FG ++   +L + + +A+K       +  ++    L+ E +T   +     I  V
Sbjct: 19  GEGS-FGVIFEGTNLLNNQQVAIK------FEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
             F        L+ + L   SL DL  +C + F ++ ++    A  +   +  +H+    
Sbjct: 72  YYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVK-TV-AMAAKQMLARVQSIHEK--- 125

Query: 702 HLLHRNVKSKNILLDADFEPK-----LTDFAL 728
            L++R++K  N L+            + DF +
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 32/168 (19%), Positives = 62/168 (36%), Gaps = 40/168 (23%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G GG FG +Y+  + S E +              +  L TE+K   +      ++     
Sbjct: 44  GQGG-FGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 648 HSDESI-------------------FLIYEFLQMG-SLGDLI--CRQDFQLQWSIR--LK 683
              + +                   F+I +    G  L  +     + F    S +  L+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRF----SRKTVLQ 156

Query: 684 IAIGVAQGLAYLH-KDYVPHLLHRNVKSKNILLDADFEPK--LTDFAL 728
           +++ +   L Y+H  +YV    H ++K+ N+LL+     +  L D+ L
Sbjct: 157 LSLRILDILEYIHEHEYV----HGDIKASNLLLNYKNPDQVYLVDYGL 200

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	876
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.89
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.74
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.69
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.68
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.64
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.62
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.6
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.53
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.48
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.46
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.39
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.38
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.3
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.25
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.13
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.9
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.85
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.85
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.66
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.3
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.27
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.25
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.25
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.19
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.17
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.02
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.76
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.76
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.52
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.23
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.19
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.01
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.93
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.9
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.88
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.83
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.83
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.74
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.62
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.61
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.37
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.2
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.97
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.86
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.81

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=7.8e-67  Score=636.38  Aligned_cols=482  Identities=34%  Similarity=0.545  Sum_probs=332.6

Q ss_pred             CCChhHHHHHHHHHhhccCCCCCCCCCCCCCCCCCccccceEecCCCCCccEEEEeecCCCCCccc---cc---------
Q 002826           25 TSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGE---IS---------   92 (876)
Q Consensus        25 ~~~~~~~~all~~k~~~~~~~~~~~sW~~~~~~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~---~~---------   92 (876)
                      .++++|++||++||+++.||. .+++|+.+  .|||.|+||+|+.     .+|+.++|.+.++.|.   +|         
T Consensus         8 ~~~~~~~~all~~k~~~~~~~-~l~~W~~~--~~~C~w~gv~C~~-----~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L   79 (768)
T 3rgz_A            8 QSLYREIHQLISFKDVLPDKN-LLPDWSSN--KNPCTFDGVTCRD-----DKVTSIDLSSKPLNVGFSAVSSSLLSLTGL   79 (768)
T ss_dssp             CCHHHHHHHHHHHHTTCSCTT-SSTTCCTT--SCGGGSTTEEEET-----TEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred             cCCHHHHHHHHHHHhhCCCcc-cccCCCCC--CCCcCCcceEECC-----CcEEEEECCCCCcCCccCccChhHhccCcc
Confidence            446789999999999999988 89999743  5899999999982     2788888888888776   43         


Q ss_pred             --------------ccccCCCCCCeeecCCCccccccCc--cccCCCCCCcccCCCccc---------------------
Q 002826           93 --------------SSVCELSSLSNLNLADNLFNQPIPL--HLSQCSSLETLNLSNNLI---------------------  135 (876)
Q Consensus        93 --------------~~~~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l---------------------  135 (876)
                                    +.++.+++|++|+|++|.+++.+|.  .|+++++|++|+|++|.+                     
T Consensus        80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls  159 (768)
T 3rgz_A           80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS  159 (768)
T ss_dssp             CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred             cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence                          4666777788888888887777666  666666666666665531                     


Q ss_pred             -------------------------------------------ceeecCCccccccCCCccCCccccceecccccccCCC
Q 002826          136 -------------------------------------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS  172 (876)
Q Consensus       136 -------------------------------------------~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  172 (876)
                                                                 ++|+|++|++++.+|. ++++++|++|+|++|++++.
T Consensus       160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~  238 (768)
T 3rgz_A          160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD  238 (768)
T ss_dssp             SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred             CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence                                                       2355555555555555 77777788888888888777


Q ss_pred             cCccccCCCcceEEEccCCCCc---------------------CCCCCCccccc-CcccEEEecCCCCcccCCccccCCC
Q 002826          173 VPFVFGNFSELVVLDLSQNAYL---------------------ISEIPSDIGKL-EKLEQLFLQSSGFHGVIPDSFVGLQ  230 (876)
Q Consensus       173 ~p~~~~~l~~L~~L~Ls~N~~~---------------------~~~~p~~~~~l-~~L~~L~L~~n~l~~~~~~~~~~l~  230 (876)
                      +|..|+++++|++|+|++|++.                     .+.+|..+..+ ++|++|+|++|++++.+|..|.+++
T Consensus       239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~  318 (768)
T 3rgz_A          239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS  318 (768)
T ss_dssp             HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred             ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence            7777777777777777776532                     11344444433 5555555555555555555444444


Q ss_pred             CCcEEecccCcc-------------------------CCCCCCccccc--------------------------cccccE
Q 002826          231 SLSILDLSQNNL-------------------------TGEVPQSLGSS--------------------------LLKLVS  259 (876)
Q Consensus       231 ~L~~L~Ls~N~l-------------------------~~~ip~~~~~~--------------------------l~~L~~  259 (876)
                      +|++|+|++|++                         ++.+|..+...                          +++|++
T Consensus       319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~  398 (768)
T 3rgz_A          319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE  398 (768)
T ss_dssp             TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred             CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence            444444444444                         33333322110                          122333


Q ss_pred             EEeccccccCcCCcccccCCccceeeeecccccccCCCCC------------------------ccccccceeecccccC
Q 002826          260 FDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSI------------------------NECLNLERFQVQDNGF  315 (876)
Q Consensus       260 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~------------------------~~l~~L~~L~L~~N~l  315 (876)
                      |++++|++++.+|..+.++++|++|+|++|++++.+|..|                        ..+++|++|++++|++
T Consensus       399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l  478 (768)
T 3rgz_A          399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL  478 (768)
T ss_dssp             EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred             EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence            3333333333444445555555555555555555555444                        4455555555555555


Q ss_pred             CCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCC-
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN-  394 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~-  394 (876)
                      ++.+|..+.++++|+.|++++|++++.+|.++..+++|++|+|++|++++.+|..++++++|+.|++++|+++|.+|.. 
T Consensus       479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~  558 (768)
T 3rgz_A          479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM  558 (768)
T ss_dssp             CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred             cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence            5555555555556666666666666666666666666666666666666666666666666666666666666555543 


Q ss_pred             ---------------------------------------------------------------------cCCCCCccEEE
Q 002826          395 ---------------------------------------------------------------------FCDSPVMSIIN  405 (876)
Q Consensus       395 ---------------------------------------------------------------------~~~~~~L~~L~  405 (876)
                                                                                           |..++.|++||
T Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld  638 (768)
T 3rgz_A          559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD  638 (768)
T ss_dssp             GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred             hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence                                                                                 22345677888


Q ss_pred             ccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCcccc
Q 002826          406 LSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSG  483 (876)
Q Consensus       406 Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~  483 (876)
                      |++|+++|.+| +++.+++|+.|+|++|+++|.+|..|+.+++|+.|||++|+++|.+|..+..+ .++.||+|+|+++|
T Consensus       639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g  718 (768)
T 3rgz_A          639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG  718 (768)
T ss_dssp             CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred             CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence            88888888887 79999999999999999999999999999999999999999999999999998 59999999999999


Q ss_pred             ccCCcc-cCCCCCccccCCCCCCCCCCCCCCCCC
Q 002826          484 RVPYSL-ISGLPASYLQGNPGLCGPGLSNSCDEN  516 (876)
Q Consensus       484 ~~p~~~-~~~~~~~~~~~N~~~C~~~~~~~c~~~  516 (876)
                      .+|... +.+++...+.|||++||.|+. .|...
T Consensus       719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~  751 (768)
T 3rgz_A          719 PIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS  751 (768)
T ss_dssp             ECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred             cCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence            999764 888999999999999999987 89654

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=1.2e-56  Score=542.50  Aligned_cols=463  Identities=17%  Similarity=0.229  Sum_probs=330.1

Q ss_pred             ChhHHHHHHHHHhhccCCCCCCCCCCCCC---CCCC--ccc------------cceEecCCCCCccEEEEeecCCCCCcc
Q 002826           27 ASTEKDTLLSFKASIDDSKNSLSTWSNTS---NIHY--CNW------------TGVTCVTTATASLTVASINLQSLNLSG   89 (876)
Q Consensus        27 ~~~~~~all~~k~~~~~~~~~~~sW~~~~---~~~~--C~w------------~gv~c~~~~~~~~~~~~l~l~~~~l~~   89 (876)
                      ..+|++||++||+++.+|     +|+...   +.+|  |.|            .||+|+..    .+|+.++|.+++++|
T Consensus       267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~----~~V~~L~Ls~~~L~G  337 (876)
T 4ecn_A          267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN----GRVTGLSLAGFGAKG  337 (876)
T ss_dssp             HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT----SCEEEEECTTTCCEE
T ss_pred             chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCC----CCEEEEECccCCCCC
Confidence            357999999999999887     786543   2344  999            99999873    289999999999999


Q ss_pred             cccccccCCCCCCeeec-CCCccccc------------------------------------------------------
Q 002826           90 EISSSVCELSSLSNLNL-ADNLFNQP------------------------------------------------------  114 (876)
Q Consensus        90 ~~~~~~~~l~~L~~L~L-~~n~l~~~------------------------------------------------------  114 (876)
                      .+|+++++|++|++|+| ++|.++|.                                                      
T Consensus       338 ~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i  417 (876)
T 4ecn_A          338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI  417 (876)
T ss_dssp             EECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred             cCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence            99999999999999999 88876655                                                      


Q ss_pred             ----------------------cCccccCCCCCCcccCCCcccce-------eecCCccccccCCCccC--Cccccceec
Q 002826          115 ----------------------IPLHLSQCSSLETLNLSNNLIWV-------LDLSRNHIEGKIPESIG--SLVNLQVLN  163 (876)
Q Consensus       115 ----------------------~p~~~~~l~~L~~L~Ls~N~l~~-------LdL~~n~l~~~~p~~~~--~l~~L~~L~  163 (876)
                                            +|..|+++++|++|+|++|.|+.       +.++.|.++|.+|+.++  ++++|++|+
T Consensus       418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~  497 (876)
T 4ecn_A          418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE  497 (876)
T ss_dssp             CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred             ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence                                  55666666666666555544422       11222333335777776  788888888


Q ss_pred             ccccccCCCcCccccCCCcceEEEccCCCCcCC-CCCCcccccC-------cccEEEecCCCCcccCCc--cccCCCCCc
Q 002826          164 LGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS-EIPSDIGKLE-------KLEQLFLQSSGFHGVIPD--SFVGLQSLS  233 (876)
Q Consensus       164 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~-~~p~~~~~l~-------~L~~L~L~~n~l~~~~~~--~~~~l~~L~  233 (876)
                      |++|++.+.+|..|+++++|++|+|++|+++.+ .+|..++.++       +|++|+|++|+++ .+|.  .|.++++|+
T Consensus       498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~  576 (876)
T 4ecn_A          498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLG  576 (876)
T ss_dssp             EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCC
T ss_pred             CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCC
Confidence            888887777787788888888888888763233 5676665555       7888888888877 5666  777788888


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCc-cceeeeecccccccCCCCCccccc--cceeec
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG-LVNLSLHKNFFNGSIPGSINECLN--LERFQV  310 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~--L~~L~L  310 (876)
                      +|+|++|+++ .+| . +..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.|+ .+|..+..+..  |+.|++
T Consensus       577 ~L~Ls~N~l~-~lp-~-~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~L  651 (876)
T 4ecn_A          577 LLDCVHNKVR-HLE-A-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDF  651 (876)
T ss_dssp             EEECTTSCCC-BCC-C-CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEEC
T ss_pred             EEECCCCCcc-cch-h-hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEEC
Confidence            8888888877 777 3 345778888888888877 67777777777 888888888877 56666666644  788888


Q ss_pred             ccccCCCCCCccc---C--CCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCcccc--------ccCc
Q 002826          311 QDNGFSGDFPDKL---W--SLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS--------VKSL  377 (876)
Q Consensus       311 ~~N~l~~~~p~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------l~~L  377 (876)
                      ++|++++.+|...   .  .+++|+.|++++|+++..++..+..+++|+.|+|++|+++ .+|..+..        +++|
T Consensus       652 s~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L  730 (876)
T 4ecn_A          652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL  730 (876)
T ss_dssp             CSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGC
T ss_pred             cCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCc
Confidence            8888877665332   1  3347788888888887544444557777888888888887 55544332        2377


Q ss_pred             cEEeCCCccccCCCCCCcC--CCCCccEEEccCCccccCCcCcccccccceEeccC------CcCCCCCCcCCCCCCCcc
Q 002826          378 YRFSASQNSFYGSLPPNFC--DSPVMSIINLSQNSISGQIPELKKCRKLVSLSLAD------NSLTGEIPPSLAELPVLT  449 (876)
Q Consensus       378 ~~L~ls~N~l~~~~~~~~~--~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~  449 (876)
                      +.|+|++|+++ .+|..+.  .+++|+.|+|++|+|++.+..+..+++|+.|+|++      |++.+.+|..|..+++|+
T Consensus       731 ~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~  809 (876)
T 4ecn_A          731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI  809 (876)
T ss_dssp             CEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCC
T ss_pred             cEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCC
Confidence            88888888877 5666665  77788888888888877555777788888887765      667777787888888888


Q ss_pred             eeeCCCCcccccCCCcccccccceEEccCCccccccCCcc--cCCCCCccccCCCCCC--CCC
Q 002826          450 YLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSL--ISGLPASYLQGNPGLC--GPG  508 (876)
Q Consensus       450 ~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~--~~~~~~~~~~~N~~~C--~~~  508 (876)
                      .|+|++|+| +.+|..+.. .++.||+++|++....+...  ........+.+|++.|  ||+
T Consensus       810 ~L~Ls~N~L-~~Ip~~l~~-~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~  870 (876)
T 4ecn_A          810 QLQIGSNDI-RKVDEKLTP-QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCD  870 (876)
T ss_dssp             EEECCSSCC-CBCCSCCCS-SSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCG
T ss_pred             EEECCCCCC-CccCHhhcC-CCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCC
Confidence            888888888 567776553 67778888887764443332  1123344566666544  554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.6e-56  Score=531.36  Aligned_cols=460  Identities=16%  Similarity=0.261  Sum_probs=316.8

Q ss_pred             hhHHHHHHHHHhhccCCCCC--------CCCCCCCCCCCCccc---cceEecCCCCCccEEEEeecCCCCCccccccccc
Q 002826           28 STEKDTLLSFKASIDDSKNS--------LSTWSNTSNIHYCNW---TGVTCVTTATASLTVASINLQSLNLSGEISSSVC   96 (876)
Q Consensus        28 ~~~~~all~~k~~~~~~~~~--------~~sW~~~~~~~~C~w---~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~   96 (876)
                      ..|+.||.+||+++.++...        ..+|+..  .+||.|   .||+|+..+    +|+.++|.+++++|.+|++++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~--~~~c~w~~~~GV~C~~~~----~V~~L~L~~~~l~g~lp~~l~  102 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN--KELDMWGAQPGVSLNSNG----RVTGLSLEGFGASGRVPDAIG  102 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS--SCGGGTTCCTTEEECTTC----CEEEEECTTSCCEEEECGGGG
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC--CCcccccCCCCeEEcCCC----CEEEEEecCcccCCcCChHHh
Confidence            36899999999998765433        3479754  589999   999998652    899999999999999999999


Q ss_pred             CCCCCCeeecCCCccc------c------ccCccccCCCCCCcccCCCccc-----------------------------
Q 002826           97 ELSSLSNLNLADNLFN------Q------PIPLHLSQCSSLETLNLSNNLI-----------------------------  135 (876)
Q Consensus        97 ~l~~L~~L~L~~n~l~------~------~~p~~~~~l~~L~~L~Ls~N~l-----------------------------  135 (876)
                      +|++|++|+|++|.+.      +      .+|...  +..|+ +++++|.+                             
T Consensus       103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~  179 (636)
T 4eco_A          103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS  179 (636)
T ss_dssp             GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCC
T ss_pred             cCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCcccccccccc
Confidence            9999999999999761      1      111110  11111 11111110                             


Q ss_pred             ----c--eeecCCccccccCCCccCCccccceecccccccCCC-----------------cCcccc--CCCcceEEEccC
Q 002826          136 ----W--VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS-----------------VPFVFG--NFSELVVLDLSQ  190 (876)
Q Consensus       136 ----~--~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~Ls~  190 (876)
                          .  .+....|++++ +|..|+++++|++|+|++|++++.                 +|..++  ++++|++|+|++
T Consensus       180 ~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~  258 (636)
T 4eco_A          180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYN  258 (636)
T ss_dssp             CCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEEC
T ss_pred             ccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecC
Confidence                0  01122566776 677777777777777777777764                 677766  777777777777


Q ss_pred             CCCcCCCCCCcccccCcccEEEecCCC-Ccc-cCCccccCC------CCCcEEecccCccCCCCCC--ccccccccccEE
Q 002826          191 NAYLISEIPSDIGKLEKLEQLFLQSSG-FHG-VIPDSFVGL------QSLSILDLSQNNLTGEVPQ--SLGSSLLKLVSF  260 (876)
Q Consensus       191 N~~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l------~~L~~L~Ls~N~l~~~ip~--~~~~~l~~L~~L  260 (876)
                      |+ +.+.+|..|+++++|++|+|++|+ +++ .+|..+..+      ++|++|+|++|+++ .+|.  .+ ..+++|++|
T Consensus       259 n~-l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l-~~l~~L~~L  335 (636)
T 4eco_A          259 CP-NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSL-QKMKKLGML  335 (636)
T ss_dssp             CT-TCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHH-TTCTTCCEE
T ss_pred             Cc-CCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhh-ccCCCCCEE
Confidence            76 356677777777777777777776 776 666666665      77777777777777 6766  44 347777777


Q ss_pred             EeccccccCcCCcccccCCccceeeeecccccccCCCCCccccc-cceeecccccCCCCCCcccCCCC--cccEEEecCC
Q 002826          261 DVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLN-LERFQVQDNGFSGDFPDKLWSLP--RIKLIRAESN  337 (876)
Q Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~L~~N  337 (876)
                      +|++|+++|.+| .+..+++|++|+|++|+++ .+|..|..+++ |++|++++|+++ .+|..+..++  +|+.|++++|
T Consensus       336 ~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N  412 (636)
T 4eco_A          336 ECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYN  412 (636)
T ss_dssp             ECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSS
T ss_pred             eCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCC
Confidence            777777776677 6777777777777777777 66666777777 777777777777 5666665544  6777777777


Q ss_pred             cccccCccccc-------cCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCC-------CccE
Q 002826          338 RFSGAIPDSIS-------MAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSP-------VMSI  403 (876)
Q Consensus       338 ~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~-------~L~~  403 (876)
                      ++++.+|..+.       .+.+|++|+|++|++++..+..+..+++|+.|++++|+++...+..+....       +|+.
T Consensus       413 ~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~  492 (636)
T 4eco_A          413 EIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS  492 (636)
T ss_dssp             CTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCE
T ss_pred             cCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccE
Confidence            77777777666       666777777777777733333345567777777777777733333333332       6777


Q ss_pred             EEccCCccccCCcCcc--cccccceEeccCCcCCCCCCcCCCCCCCcceeeC------CCCcccccCCCccccc-ccceE
Q 002826          404 INLSQNSISGQIPELK--KCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDL------SDNNLTGPIPQGLQNL-KLALF  474 (876)
Q Consensus       404 L~Ls~N~l~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l-~l~~l  474 (876)
                      |+|++|+++..+..+.  .+++|++|+|++|+|++ +|..+..+++|+.|+|      ++|++.+.+|..+..+ +++.|
T Consensus       493 L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L  571 (636)
T 4eco_A          493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL  571 (636)
T ss_dssp             EECCSSCCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEE
T ss_pred             EECcCCcCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEE
Confidence            7777777775444554  77777777777777775 6777777777777777      4566677777777666 47777


Q ss_pred             EccCCccccccCCcccCCCCCccccCCCCCC
Q 002826          475 NVSFNKLSGRVPYSLISGLPASYLQGNPGLC  505 (876)
Q Consensus       475 ~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C  505 (876)
                      ++++|++ +.+|..+..++..+.+.+||+.|
T Consensus       572 ~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          572 QIGSNDI-RKVNEKITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             ECCSSCC-CBCCSCCCTTCCEEECCSCTTCE
T ss_pred             ECCCCcC-CccCHhHhCcCCEEECcCCCCcc
Confidence            7777777 56776666666777777777666

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.2e-51  Score=490.84  Aligned_cols=443  Identities=21%  Similarity=0.198  Sum_probs=376.8

Q ss_pred             ccceEecCCCC------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc
Q 002826           62 WTGVTCVTTAT------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI  135 (876)
Q Consensus        62 w~gv~c~~~~~------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  135 (876)
                      +.-|.|...+.      ....+..++++++.+++..|..+.++++|++|+|++|.+.+..|..|+++++|++|+|++|.+
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l   93 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL   93 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence            55678865432      123578899999999998899999999999999999999999999999999999999999964


Q ss_pred             --------------ceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc
Q 002826          136 --------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD  201 (876)
Q Consensus       136 --------------~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~  201 (876)
                                    ++|+|++|++++..|..|+++++|++|+|++|++++..+..+.++++|++|+|++|++ ....|..
T Consensus        94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l-~~~~~~~  172 (606)
T 3t6q_A           94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI-HYLSKED  172 (606)
T ss_dssp             SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC-CEECHHH
T ss_pred             cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc-cccChhh
Confidence                          5789999999887788888899999999999988875545555588888888888872 2222334


Q ss_pred             ccccCccc------------------------------------------------------------------------
Q 002826          202 IGKLEKLE------------------------------------------------------------------------  209 (876)
Q Consensus       202 ~~~l~~L~------------------------------------------------------------------------  209 (876)
                      |..+++|+                                                                        
T Consensus       173 ~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~  252 (606)
T 3t6q_A          173 MSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC  252 (606)
T ss_dssp             HHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGG
T ss_pred             hhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhh
Confidence            55555544                                                                        


Q ss_pred             -----EEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCcccee
Q 002826          210 -----QLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL  284 (876)
Q Consensus       210 -----~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  284 (876)
                           .|++++|+++++.+..|.++++|++|++++|+++ .+|..+. .+++|++|++++|++++..|..+..+++|++|
T Consensus       253 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  330 (606)
T 3t6q_A          253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLV-GLSTLKKLVLSANKFENLCQISASNFPSLTHL  330 (606)
T ss_dssp             GSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCC-SCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred             cCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhc-ccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence                 4444455555555556778889999999999998 8888764 58999999999999998888889999999999


Q ss_pred             eeecccccccCCC-CCccccccceeecccccCCCCC--CcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCc
Q 002826          285 SLHKNFFNGSIPG-SINECLNLERFQVQDNGFSGDF--PDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNN  361 (876)
Q Consensus       285 ~L~~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  361 (876)
                      ++++|.+.+.+|. .|..+++|++|++++|.+++..  +..+..+++|+.|++++|++++..|..|..+++|++|++++|
T Consensus       331 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  410 (606)
T 3t6q_A          331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFT  410 (606)
T ss_dssp             ECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTC
T ss_pred             ECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCC
Confidence            9999998865554 5899999999999999998776  788999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCc-cccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccC-C---cCcccccccceEeccCCcCCC
Q 002826          362 RFTSSIPQG-LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ-I---PELKKCRKLVSLSLADNSLTG  436 (876)
Q Consensus       362 ~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~-~---~~~~~l~~L~~L~Ls~N~l~~  436 (876)
                      ++++..|.. +.++++|+.|++++|.+++..|..|..+++|+.|++++|++++. +   ..+..+++|++|+|++|++++
T Consensus       411 ~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~  490 (606)
T 3t6q_A          411 RLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS  490 (606)
T ss_dssp             CEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCE
T ss_pred             cCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCc
Confidence            999876654 89999999999999999999999999999999999999999873 2   258999999999999999999


Q ss_pred             CCCcCCCCCCCcceeeCCCCcccccCCCcccccc-cceEEccCCccccccCCcc--cCCCCCccccCCCCCCCCC
Q 002826          437 EIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK-LALFNVSFNKLSGRVPYSL--ISGLPASYLQGNPGLCGPG  508 (876)
Q Consensus       437 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-l~~l~ls~N~l~~~~p~~~--~~~~~~~~~~~N~~~C~~~  508 (876)
                      ..|..|..+++|++|+|++|++++..|..+..++ + .||+++|++++.+|..+  +.++..+++.+|||.|+|+
T Consensus       491 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             cChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            9999999999999999999999999999999885 7 99999999998777543  6778899999999999875

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-50  Score=495.85  Aligned_cols=443  Identities=21%  Similarity=0.222  Sum_probs=358.7

Q ss_pred             ccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCcccccc-CccccCCCCCCcccCCCccc---
Q 002826           60 CNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPI-PLHLSQCSSLETLNLSNNLI---  135 (876)
Q Consensus        60 C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l---  135 (876)
                      |.|..|.+.+     ..+..++|+++.+++..+..+.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.|   
T Consensus        14 ~~L~~vP~lp-----~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~   88 (844)
T 3j0a_A           14 CNLTQVPQVL-----NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL   88 (844)
T ss_dssp             CCSSCCCSSC-----TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE
T ss_pred             CCCCCCCCCC-----CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc
Confidence            4566666522     25778999999999999999999999999999999766655 88999999999999999875   


Q ss_pred             -----------ceeecCCccccccCCCc--cCCccccceecccccccCCCcC-ccccCCCcceEEEccCCCCcCCCCCCc
Q 002826          136 -----------WVLDLSRNHIEGKIPES--IGSLVNLQVLNLGSNLLSGSVP-FVFGNFSELVVLDLSQNAYLISEIPSD  201 (876)
Q Consensus       136 -----------~~LdL~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~~~~~~~p~~  201 (876)
                                 ++|+|++|++++.+|..  |+++++|++|+|++|++++..+ ..|+++++|++|+|++|. +.+..|..
T Consensus        89 ~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~-i~~~~~~~  167 (844)
T 3j0a_A           89 HPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQ-IFLVCEHE  167 (844)
T ss_dssp             CTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSC-CCCCCSGG
T ss_pred             CHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCc-CCeeCHHH
Confidence                       46889999998866665  8889999999999999887655 578899999999999987 34455667


Q ss_pred             cccc--CcccEEEecCCCCcccCCccccCCCC------CcEEecccCccCCCCCCccccc--------------------
Q 002826          202 IGKL--EKLEQLFLQSSGFHGVIPDSFVGLQS------LSILDLSQNNLTGEVPQSLGSS--------------------  253 (876)
Q Consensus       202 ~~~l--~~L~~L~L~~n~l~~~~~~~~~~l~~------L~~L~Ls~N~l~~~ip~~~~~~--------------------  253 (876)
                      +..+  ++|+.|+|++|.+.+..|..+..+++      |++|+|++|++++.+|..+...                    
T Consensus       168 l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~  247 (844)
T 3j0a_A          168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGF  247 (844)
T ss_dssp             GHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSS
T ss_pred             cccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccc
Confidence            7776  78888888888888877776666655      8888888888776665543321                    


Q ss_pred             -----------------cccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          254 -----------------LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       254 -----------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                                       .++|+.|+|++|.+.+..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+++
T Consensus       248 ~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~  327 (844)
T 3j0a_A          248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG  327 (844)
T ss_dssp             SCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCS
T ss_pred             cccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCC
Confidence                             257888888888888888888888888888888888888888888888888888888888888


Q ss_pred             CCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCC------------------CC---------
Q 002826          317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSI------------------PQ---------  369 (876)
Q Consensus       317 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~------------------p~---------  369 (876)
                      +..|..|.++++|+.|++++|++++..+..|..+++|++|+|++|.+++..                  |.         
T Consensus       328 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~  407 (844)
T 3j0a_A          328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH  407 (844)
T ss_dssp             CCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEE
T ss_pred             ccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceee
Confidence            888888888888888888888888888888888888888888888877421                  11         


Q ss_pred             -------------ccccccCccEEeCCCccccCCCCC-CcCCCCCccEEEccCCccccC-----Cc-CcccccccceEec
Q 002826          370 -------------GLGSVKSLYRFSASQNSFYGSLPP-NFCDSPVMSIINLSQNSISGQ-----IP-ELKKCRKLVSLSL  429 (876)
Q Consensus       370 -------------~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~-----~~-~~~~l~~L~~L~L  429 (876)
                                   .+.++++|+.|++++|++++..+. .+..+++|+.|+|++|.+++.     .+ .|.++++|++|+|
T Consensus       408 ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~L  487 (844)
T 3j0a_A          408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL  487 (844)
T ss_dssp             CCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCC
T ss_pred             cccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEEC
Confidence                         123567777777777777765443 455677888888888888633     22 5788999999999


Q ss_pred             cCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccccceEEccCCccccccCCcccCCCCCccccCCCCCCCCCC
Q 002826          430 ADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGL  509 (876)
Q Consensus       430 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~~~  509 (876)
                      ++|+|++.+|..|.++++|+.|+|++|+|++..|..+. -.++.||+++|++++.+|.. +.++..+++.+|||.|+|++
T Consensus       488 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~~~~-~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPNPDV-FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             CHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCCSCC-CSSCCEEEEEEECCCCSSSC
T ss_pred             CCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCChhH-hCCcCEEEecCCCccccccc
Confidence            99999999999999999999999999999987776665 57899999999999888855 56788899999999999875


Q ss_pred             C
Q 002826          510 S  510 (876)
Q Consensus       510 ~  510 (876)
                      .
T Consensus       566 ~  566 (844)
T 3j0a_A          566 S  566 (844)
T ss_dssp             C
T ss_pred             H
Confidence            3

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.8e-51  Score=498.20  Aligned_cols=404  Identities=34%  Similarity=0.543  Sum_probs=333.6

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc---------------ceeec
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI---------------WVLDL  140 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l---------------~~LdL  140 (876)
                      .+..+++.++.+++.+|..++.+++|++|+|++|.+.+.+|..  .+++|++|+|++|.+               ++|+|
T Consensus       224 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~L  301 (768)
T 3rgz_A          224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDL  301 (768)
T ss_dssp             SCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEEC
T ss_pred             CCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEEC
Confidence            4667788888888888888888888888888888877766654  666677777666643               35666


Q ss_pred             CCccccccCCCccCCccccceecccccccCCCcCcc-ccCCCcceEEEccCCCCcCCCCCCcccc---------------
Q 002826          141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV-FGNFSELVVLDLSQNAYLISEIPSDIGK---------------  204 (876)
Q Consensus       141 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~~~~~~~p~~~~~---------------  204 (876)
                      ++|++++.+|..|+++++|++|+|++|++++.+|.. |.++++|++|+|++|++ .+.+|..+.+               
T Consensus       302 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~~l~~~L~~L~Ls~N~l  380 (768)
T 3rgz_A          302 SGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF-SGELPESLTNLSASLLTLDLSSNNF  380 (768)
T ss_dssp             CSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEE-EECCCTTHHHHTTTCSEEECCSSEE
T ss_pred             cCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCcc-CccccHHHHhhhcCCcEEEccCCCc
Confidence            666666666666666666666666666666555543 66666666666666652 2344444333               


Q ss_pred             ------------cCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCC
Q 002826          205 ------------LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP  272 (876)
Q Consensus       205 ------------l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~  272 (876)
                                  +++|++|++++|++++.+|..|.++++|++|+|++|++++.+|..+. .+++|++|++++|++++.+|
T Consensus       381 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p  459 (768)
T 3rgz_A          381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIP  459 (768)
T ss_dssp             EEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGG-GCTTCCEEECCSSCCCSCCC
T ss_pred             CCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHh-cCCCCCEEECCCCcccCcCC
Confidence                        55677777777778778888899999999999999999988887764 58999999999999999999


Q ss_pred             cccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCC
Q 002826          273 NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQ  352 (876)
Q Consensus       273 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  352 (876)
                      ..+..+++|++|+|++|++++.+|..|..+++|++|++++|++++.+|.++..+++|++|++++|++++.+|..+..+++
T Consensus       460 ~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  539 (768)
T 3rgz_A          460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS  539 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT
T ss_pred             HHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCeeeccCcccCCCCCCcc-------------------------------------------------------------
Q 002826          353 LEQVQIDNNRFTSSIPQGL-------------------------------------------------------------  371 (876)
Q Consensus       353 L~~L~L~~N~l~~~~p~~~-------------------------------------------------------------  371 (876)
                      |++|++++|+++|.+|..+                                                             
T Consensus       540 L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  619 (768)
T 3rgz_A          540 LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV  619 (768)
T ss_dssp             CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred             CCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence            9999999999988777543                                                             


Q ss_pred             ---------ccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcC
Q 002826          372 ---------GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPS  441 (876)
Q Consensus       372 ---------~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~  441 (876)
                               ..+++|+.|++++|+++|.+|..|.+++.|+.|+|++|+++|.+| .++.+++|+.|||++|+++|.+|..
T Consensus       620 ~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~  699 (768)
T 3rgz_A          620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA  699 (768)
T ss_dssp             EEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred             ecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence                     345789999999999999999999999999999999999999888 8999999999999999999999999


Q ss_pred             CCCCCCcceeeCCCCcccccCCCcccccccceEEccCCc-ccc
Q 002826          442 LAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNK-LSG  483 (876)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~-l~~  483 (876)
                      ++.+++|++|||++|+|+|.+|..-.-..+....+.+|+ |.|
T Consensus       700 l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg  742 (768)
T 3rgz_A          700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG  742 (768)
T ss_dssp             GGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred             HhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence            999999999999999999999986433334444455664 443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.6e-49  Score=479.11  Aligned_cols=447  Identities=21%  Similarity=0.188  Sum_probs=290.7

Q ss_pred             ccccceEecCCCC------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCc
Q 002826           60 CNWTGVTCVTTAT------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNN  133 (876)
Q Consensus        60 C~w~gv~c~~~~~------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N  133 (876)
                      |.++-|.|.....      ....++.++++++++++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus         4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n   83 (680)
T 1ziw_A            4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN   83 (680)
T ss_dssp             CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred             eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence            5556666754321      1235778888888888877778888888888888888888888888888888888888888


Q ss_pred             cc--------------ceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC
Q 002826          134 LI--------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP  199 (876)
Q Consensus       134 ~l--------------~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p  199 (876)
                      .|              ++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+  ..++
T Consensus        84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l--~~~~  161 (680)
T 1ziw_A           84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI--QALK  161 (680)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC--CCBC
T ss_pred             ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc--cccC
Confidence            64              5688888888877777888888888888888888877777777777777777777752  2222


Q ss_pred             C-ccc--ccCcccEEEecCCCCcccC---------------------------------------------------Ccc
Q 002826          200 S-DIG--KLEKLEQLFLQSSGFHGVI---------------------------------------------------PDS  225 (876)
Q Consensus       200 ~-~~~--~l~~L~~L~L~~n~l~~~~---------------------------------------------------~~~  225 (876)
                      . .+.  .+++|++|++++|++++..                                                   |.+
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~  241 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT  241 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTT
T ss_pred             HHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhH
Confidence            1 111  1233333333333333222                                                   222


Q ss_pred             ccCCCC--CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcc-----------------------------
Q 002826          226 FVGLQS--LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNG-----------------------------  274 (876)
Q Consensus       226 ~~~l~~--L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~-----------------------------  274 (876)
                      |.+++.  |++|+|++|++++..|. .+..+++|++|+|++|++++..|..                             
T Consensus       242 ~~~l~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i  320 (680)
T 1ziw_A          242 FLGLKWTNLTMLDLSYNNLNVVGND-SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI  320 (680)
T ss_dssp             TGGGGGSCCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred             hhccCcCCCCEEECCCCCcCccCcc-cccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence            322222  44444444444422222 2223444444444444444333322                             


Q ss_pred             ----cccCCccceeeeecccccccCCCCCccccccceeecc----------------------------cccCCCCCCcc
Q 002826          275 ----ICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ----------------------------DNGFSGDFPDK  322 (876)
Q Consensus       275 ----~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~----------------------------~N~l~~~~p~~  322 (876)
                          |..+++|++|++++|.+++..+..|.++++|++|+++                            +|++++..|..
T Consensus       321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~  400 (680)
T 1ziw_A          321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDA  400 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTT
T ss_pred             ChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhh
Confidence                2223333344444444444444444443333333332                            23333333444


Q ss_pred             cCCCCcccEEEecCCcccccCc-cccccCCCCCeeeccCc------------------------ccC--CCCCCcccccc
Q 002826          323 LWSLPRIKLIRAESNRFSGAIP-DSISMAAQLEQVQIDNN------------------------RFT--SSIPQGLGSVK  375 (876)
Q Consensus       323 ~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N------------------------~l~--~~~p~~~~~l~  375 (876)
                      |..+++|+.|++++|++++.+| ..|..+++|++|++++|                        .++  +.+|..+.+++
T Consensus       401 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~  480 (680)
T 1ziw_A          401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR  480 (680)
T ss_dssp             TTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCT
T ss_pred             hhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCC
Confidence            4445555555555555544333 34444444444444444                        443  35677788888


Q ss_pred             CccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc---------CcccccccceEeccCCcCCCCCCcCCCCCC
Q 002826          376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP---------ELKKCRKLVSLSLADNSLTGEIPPSLAELP  446 (876)
Q Consensus       376 ~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~---------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  446 (876)
                      +|+.|++++|++++..+..|.++++|++|+|++|++++..+         .+.++++|++|+|++|+++...+..|.+++
T Consensus       481 ~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~  560 (680)
T 1ziw_A          481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF  560 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc
Confidence            89999999999998888889999999999999999886422         378899999999999999966667899999


Q ss_pred             CcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCc---ccCCCCCccccCCCCCCCCCC
Q 002826          447 VLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYS---LISGLPASYLQGNPGLCGPGL  509 (876)
Q Consensus       447 ~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~---~~~~~~~~~~~~N~~~C~~~~  509 (876)
                      +|+.|||++|+|++..+..+..+ .++.|++++|++++..|..   .+.++..+.+.+|||.|+|+.
T Consensus       561 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          561 ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            99999999999997666667776 6999999999999766643   357788899999999999874

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.9e-51  Score=438.64  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=209.3

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||+||+|++.      +++.||||++........++|.+|++++++++|||||+++|+|.+++..|+|||||
T Consensus        19 ~~lG~G~-fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~   97 (299)
T 4asz_A           19 RELGEGA-FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   97 (299)
T ss_dssp             EEEEC---CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eEEeeCC-CcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence            4455555 9999999763      47889999998765555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          661 QMGSLGDLICRQ------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       661 ~~gsL~~~l~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                      ++|+|.+++++.            ...++|..+.+++.|||.||+|||++   +|+||||||+|||+++++.+||+|||+
T Consensus        98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGl  174 (299)
T 4asz_A           98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGM  174 (299)
T ss_dssp             TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred             CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCccc
Confidence            999999999754            24699999999999999999999999   999999999999999999999999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      |+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......  +....+......   
T Consensus       175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~~~~~---  249 (299)
T 4asz_A          175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECITQGRVL---  249 (299)
T ss_dssp             HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHHTCCC---
T ss_pred             ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCC---
Confidence            998765544444445568999999999999999999999999999999999 89999865432  223332221100   


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                             ..   +...+.++.+++.+||+.||++||||+||.+.|+++.+.
T Consensus       250 -------~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          250 -------QR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -------CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                   01   112234678999999999999999999999999998654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=430.83  Aligned_cols=256  Identities=25%  Similarity=0.387  Sum_probs=199.6

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      .++|.|| ||+||+|++.  ..||||+++....  ...+.|.+|++++++++|||||+++|++.+ +..|+|||||++|+
T Consensus        42 ~~iG~G~-fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           42 TRIGSGS-FGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EECCCCS-SSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eEEeeCC-CcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            4566665 9999999874  3699999864332  234678999999999999999999999865 56899999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++......+++..+.+++.|||.||+|||+.   +|+||||||+|||+++++.+||+|||+|+..............
T Consensus       118 L~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~  194 (307)
T 3omv_A          118 LYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP  194 (307)
T ss_dssp             HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------C
T ss_pred             HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeeccc
Confidence            9999987777899999999999999999999999   9999999999999999999999999999876543333334556


Q ss_pred             cccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          745 YALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       745 ~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      .||+.|||||++.+   ..++.++|||||||++|||+||+.||........ ....+...         ...|.+...+.
T Consensus       195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~~~~~---------~~~p~~~~~~~  264 (307)
T 3omv_A          195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFMVGRG---------YASPDLSKLYK  264 (307)
T ss_dssp             CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHTT---------CCCCCSTTSCT
T ss_pred             ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcC---------CCCCCcccccc
Confidence            79999999998753   4689999999999999999999999976443221 11111111         11122222223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ..+..+.+++.+||+.||++||||.||++.|+.+....
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            34456889999999999999999999999999886543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=9e-51  Score=435.37  Aligned_cols=251  Identities=24%  Similarity=0.417  Sum_probs=206.6

Q ss_pred             CCCCCCCCceEEEEEEe------CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSL------PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .++|.|| ||+||+|.+      .+++.||||++.... ....++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus        32 ~~lG~G~-fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey  110 (308)
T 4gt4_A           32 EELGEDR-FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY  110 (308)
T ss_dssp             EEEEECS-SCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEeccCC-CcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence            4566666 999999976      357899999996543 23467899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEc
Q 002826          660 LQMGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLT  724 (876)
Q Consensus       660 ~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~  724 (876)
                      |++|+|.+++...               ...++|..+.+++.|||.||+|||+.   +|+||||||+|||+++++.+||+
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~  187 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKIS  187 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEEC
Confidence            9999999999643               23589999999999999999999999   99999999999999999999999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhh
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      |||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||......  ++...+.....
T Consensus       188 DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i~~~~~  265 (308)
T 4gt4_A          188 DLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMIRNRQV  265 (308)
T ss_dssp             CSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHHHTTCC
T ss_pred             CcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            9999998765544444556679999999999999999999999999999999999 89999865432  33333322110


Q ss_pred             cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       804 ~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .         |    .+...+..+.+++.+||+.||++||||+||++.|+.+.
T Consensus       266 ~---------~----~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          266 L---------P----CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             C---------C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             C---------C----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            0         1    11122346789999999999999999999999998763

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=438.94  Aligned_cols=253  Identities=23%  Similarity=0.394  Sum_probs=201.3

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .++|.|| ||+||+|++.      +++.||||++........++|.+|++++++++|||||+++|+|.+++..|+|||||
T Consensus        47 ~~LG~G~-fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           47 WELGEGA-FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEECS-SEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEccCC-CcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            4566666 9999999764      57899999997765555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccC--------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          661 QMGSLGDLICRQD--------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       661 ~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      ++|+|.+++++..              .+++|.++.+++.|||.||+|||+.   +|+||||||+|||+++++.+||+||
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DF  202 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDF  202 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEccc
Confidence            9999999997542              3589999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||......  .....+...... 
T Consensus       203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~~~i~~g~~~-  279 (329)
T 4aoj_A          203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT--EAIDCITQGREL-  279 (329)
T ss_dssp             C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH--HHHHHHHHTCCC-
T ss_pred             ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCCCC-
Confidence            99998765444444455679999999999999999999999999999999999 89999764432  223333221111 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                               ..+   ...+.++.+++.+||+.||++||||+||++.|+.+.+.
T Consensus       280 ---------~~p---~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          280 ---------ERP---RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---------CCC---TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------CCc---ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                     111   11234678999999999999999999999999998654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=7.7e-49  Score=466.76  Aligned_cols=437  Identities=18%  Similarity=0.165  Sum_probs=317.5

Q ss_pred             ceEecCCCC------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc--
Q 002826           64 GVTCVTTAT------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--  135 (876)
Q Consensus        64 gv~c~~~~~------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--  135 (876)
                      .|.|.....      ....+..++|+++.+++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.|  
T Consensus        15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~   94 (606)
T 3vq2_A           15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS   94 (606)
T ss_dssp             EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred             ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence            577754322      224678899999999999888999999999999999999999999999999999998777653  


Q ss_pred             ------------ceeecCCccccccCCCccCCccccceecccccccCC-CcCccccCCCcceEEEccCCCCcCCCCCCcc
Q 002826          136 ------------WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLSQNAYLISEIPSDI  202 (876)
Q Consensus       136 ------------~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~  202 (876)
                                  ++|+|++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++ .+..|..|
T Consensus        95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l-~~~~~~~~  173 (606)
T 3vq2_A           95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI-QTITVNDL  173 (606)
T ss_dssp             CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCC-CEECTTTT
T ss_pred             cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcc-eecChhhh
Confidence                        345555555555554555555555555555555553 3355555555555555555541 22223344


Q ss_pred             cccCccc----EEEecCCCCcccCCccccCCCCCcEEecccCccCC----------------------------------
Q 002826          203 GKLEKLE----QLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG----------------------------------  244 (876)
Q Consensus       203 ~~l~~L~----~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------------------  244 (876)
                      +.+++|+    +|++++|+++++.+..|... +|+.|++++|.+++                                  
T Consensus       174 ~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~  252 (606)
T 3vq2_A          174 QFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP  252 (606)
T ss_dssp             HHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCG
T ss_pred             hhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccCh
Confidence            4444433    45555555555444444433 55555555554320                                  


Q ss_pred             ------------------------CCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC----
Q 002826          245 ------------------------EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP----  296 (876)
Q Consensus       245 ------------------------~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~----  296 (876)
                                              .+|.  +..+++|+.|++++|.+. .+| .+..+++|++|++++|.+. .+|    
T Consensus       253 ~~~~~l~~l~l~~l~l~~~~~~~~~~~~--~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l~-~lp~~~l  327 (606)
T 3vq2_A          253 SIMEGLCDVTIDEFRLTYTNDFSDDIVK--FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLK-QFPTLDL  327 (606)
T ss_dssp             GGGTTGGGSEEEEEEECCCTTCCGGGGS--CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCCS-SCCCCCC
T ss_pred             HHhhhhhhccHhheeccccccccccccc--cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccCc-ccccCCC
Confidence                                    0111  112333333333333333 122 3444444444555544442 222    


Q ss_pred             ----------------CCCccccccceeecccccCCCC--CCcccCCCCcccEEEecCCcccccCccccccCCCCCeeec
Q 002826          297 ----------------GSINECLNLERFQVQDNGFSGD--FPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQI  358 (876)
Q Consensus       297 ----------------~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  358 (876)
                                      ..+..+++|++|++++|++++.  .|..+..+++|+.|++++|++++ +|..+..+++|+.|++
T Consensus       328 ~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l  406 (606)
T 3vq2_A          328 PFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDF  406 (606)
T ss_dssp             SSCCEEEEESCSSCEECCCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEEC
T ss_pred             CccceeeccCCcCccchhhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeEC
Confidence                            2455677788888888888765  37788888999999999999886 4588899999999999


Q ss_pred             cCcccCCCCC-CccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccC-Cc-CcccccccceEeccCCcCC
Q 002826          359 DNNRFTSSIP-QGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ-IP-ELKKCRKLVSLSLADNSLT  435 (876)
Q Consensus       359 ~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~-~~-~~~~l~~L~~L~Ls~N~l~  435 (876)
                      ++|++++..| ..+.++++|+.|++++|.+++..|..|..+++|+.|++++|++++. +| .+..+++|++|+|++|+++
T Consensus       407 ~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~  486 (606)
T 3vq2_A          407 QHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE  486 (606)
T ss_dssp             TTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC
T ss_pred             CCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCC
Confidence            9999998887 6899999999999999999999999999999999999999999983 45 7999999999999999999


Q ss_pred             CCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCcc--c-CCCCCccccCCCCCCCCCC
Q 002826          436 GEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSL--I-SGLPASYLQGNPGLCGPGL  509 (876)
Q Consensus       436 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~--~-~~~~~~~~~~N~~~C~~~~  509 (876)
                      +.+|..|..+++|++|+|++|++++.+|..+..+ .++.||+++|+++ .+|..+  + .++..+++.+|||.|+|++
T Consensus       487 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             ccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            9999999999999999999999999889999988 5999999999998 567553  2 3577889999999999875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-48  Score=465.73  Aligned_cols=451  Identities=18%  Similarity=0.232  Sum_probs=371.1

Q ss_pred             CChhHHHHHHHHHhhccCCCCCCCCCCCCCC--CCCccccc-eEecCCCCCccEEEEeecCCCCCcccccccccCCCCCC
Q 002826           26 SASTEKDTLLSFKASIDDSKNSLSTWSNTSN--IHYCNWTG-VTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLS  102 (876)
Q Consensus        26 ~~~~~~~all~~k~~~~~~~~~~~sW~~~~~--~~~C~w~g-v~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~  102 (876)
                      .++.....-.|+++-...-.+  ..|....+  ...|.|.. ..|...+. ...|+.-                .-.+++
T Consensus        24 ~~~~~~~d~~aL~~~~~~~~~--~~w~~~~~~~~~~~~W~~~~~~c~w~~-~~GV~C~----------------~~~~V~   84 (636)
T 4eco_A           24 RTAEYIKDYLALKEIWDALNG--KNWSQQGFGTQPGANWNFNKELDMWGA-QPGVSLN----------------SNGRVT   84 (636)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTG--GGCCCCC------CCCCCSSCGGGTTC-CTTEEEC----------------TTCCEE
T ss_pred             hhhhHHHHHHHHHHHHHHcCC--CCcccCCcCCccCCCCCCCCCcccccC-CCCeEEc----------------CCCCEE
Confidence            345666778888877666543  36864332  22357862 22322210 0122210                004678


Q ss_pred             eeecCCCccccccCccccCCCCCCcccCCCcccc-----------------------eeecCCccccccCCCccCCc-c-
Q 002826          103 NLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW-----------------------VLDLSRNHIEGKIPESIGSL-V-  157 (876)
Q Consensus       103 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----------------------~LdL~~n~l~~~~p~~~~~l-~-  157 (876)
                      .|+|++|++.|.+|.+|++|++|++|+|++|.+.                       .+++++|.+.+.+|..+..+ . 
T Consensus        85 ~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~  164 (636)
T 4eco_A           85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD  164 (636)
T ss_dssp             EEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHH
T ss_pred             EEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHH
Confidence            9999999999999999999999999999999641                       15666777777777766632 2 


Q ss_pred             -----------------ccceeccc--ccccCCCcCccccCCCcceEEEccCCCCcCCC-----------------CCCc
Q 002826          158 -----------------NLQVLNLG--SNLLSGSVPFVFGNFSELVVLDLSQNAYLISE-----------------IPSD  201 (876)
Q Consensus       158 -----------------~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~-----------------~p~~  201 (876)
                                       .++.+.+.  +|++++ +|..|+++++|++|+|++|++ .+.                 +|..
T Consensus       165 l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l-~~~~~~~~~~~~~~~~~~~~ip~~  242 (636)
T 4eco_A          165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPF-VAENICEAWENENSEYAQQYKTED  242 (636)
T ss_dssp             HHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCC-CGGGBSSSCSCTTSHHHHHHTTSC
T ss_pred             HhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcc-ccccccccccccccchhcccCchh
Confidence                             22223332  689998 899999999999999999983 333                 9999


Q ss_pred             cc--ccCcccEEEecCCCCcccCCccccCCCCCcEEecccCc-cCC-CCCCcccc-----ccccccEEEeccccccCcCC
Q 002826          202 IG--KLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN-LTG-EVPQSLGS-----SLLKLVSFDVSQNKLSGSFP  272 (876)
Q Consensus       202 ~~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~ip~~~~~-----~l~~L~~L~L~~N~l~~~~~  272 (876)
                      ++  ++++|++|+|++|++.+.+|..|.++++|++|+|++|+ ++| .+|..++.     .+++|++|+|++|+++ .+|
T Consensus       243 l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip  321 (636)
T 4eco_A          243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP  321 (636)
T ss_dssp             CCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCC
T ss_pred             hhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccC
Confidence            99  99999999999999999999999999999999999999 998 78887754     1399999999999999 788


Q ss_pred             c--ccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCc-ccEEEecCCcccccCcccccc
Q 002826          273 N--GICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPR-IKLIRAESNRFSGAIPDSISM  349 (876)
Q Consensus       273 ~--~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~  349 (876)
                      .  .+.++++|++|++++|+++|.+| .|..+++|++|++++|+++ .+|..+..+++ |+.|++++|+++ .+|..+..
T Consensus       322 ~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~  398 (636)
T 4eco_A          322 VETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDA  398 (636)
T ss_dssp             CHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCT
T ss_pred             chhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhh
Confidence            8  99999999999999999999999 9999999999999999999 88889999999 999999999999 77888877


Q ss_pred             CC--CCCeeeccCcccCCCCCCccc-------cccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcC-cc
Q 002826          350 AA--QLEQVQIDNNRFTSSIPQGLG-------SVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE-LK  419 (876)
Q Consensus       350 l~--~L~~L~L~~N~l~~~~p~~~~-------~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~-~~  419 (876)
                      ..  +|++|++++|++++.+|..+.       .+++|+.|++++|++++..+..+..+++|+.|+|++|+++..++. +.
T Consensus       399 ~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~  478 (636)
T 4eco_A          399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK  478 (636)
T ss_dssp             TCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSE
T ss_pred             cccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhc
Confidence            65  899999999999999999998       888999999999999966556677799999999999999965553 33


Q ss_pred             cc-------cccceEeccCCcCCCCCCcCCC--CCCCcceeeCCCCcccccCCCccccc-ccceEEc------cCCcccc
Q 002826          420 KC-------RKLVSLSLADNSLTGEIPPSLA--ELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNV------SFNKLSG  483 (876)
Q Consensus       420 ~l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~l------s~N~l~~  483 (876)
                      ..       ++|++|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++ +|..+..+ +++.|++      ++|++.+
T Consensus       479 ~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~  556 (636)
T 4eco_A          479 DENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLR  556 (636)
T ss_dssp             ETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCC
T ss_pred             cccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccc
Confidence            33       39999999999999 7788776  99999999999999997 89888887 5999999      5688899


Q ss_pred             ccCCcc--cCCCCCccccCCCC
Q 002826          484 RVPYSL--ISGLPASYLQGNPG  503 (876)
Q Consensus       484 ~~p~~~--~~~~~~~~~~~N~~  503 (876)
                      .+|..+  +.++..+++.+|.-
T Consensus       557 ~~p~~l~~l~~L~~L~Ls~N~l  578 (636)
T 4eco_A          557 EWPEGITLCPSLTQLQIGSNDI  578 (636)
T ss_dssp             CCCTTGGGCSSCCEEECCSSCC
T ss_pred             cChHHHhcCCCCCEEECCCCcC
Confidence            999765  67788889999976

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-48  Score=418.40  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|....++|.|+ ||+||+|... +|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+|||||
T Consensus        75 ~y~~~~~iG~G~-fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           75 YLDNFIKIGEGS-TGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             TEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hcEEeEEeecCc-CeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            344556666666 9999999764 79999999998766666778899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +||+|.+++.+.  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999763  589999999999999999999999   999999999999999999999999999987754321  2


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|++||.......  ....+.....          +.+ ..+
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~----------~~~-~~~  293 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLP----------PRL-KNL  293 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSC----------CCC-SCG
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCC----------CCC-Ccc
Confidence            345579999999999999999999999999999999999999998654322  2222222110          000 011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+.++.+++.+||+.||++|||+.|+++.
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1223467899999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.5e-48  Score=418.20  Aligned_cols=250  Identities=23%  Similarity=0.227  Sum_probs=201.0

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..++|.|| ||+||+|+. .+|+.||||++.....     ..+|+.+++.++|||||++++++.+++..|+|||||+||+
T Consensus        63 ~~~lG~G~-fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~  136 (336)
T 4g3f_A           63 QPRVGRGS-FGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS  136 (336)
T ss_dssp             EEEEEEET-TEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             CcEeccCC-CeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence            34566666 999999976 4799999999975421     2469999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhccccccc---cc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQ---ST  740 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~---~~  740 (876)
                      |.+++.+.+ .+++..+..++.||+.||+|||++   +|+||||||+|||++.++ ++||+|||+|+........   ..
T Consensus       137 L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          137 LGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence            999997764 699999999999999999999999   999999999999999887 6999999999877543221   12


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|||||++.+..++.++||||+||++|||+||++||........  ...+..   ..        +.....+
T Consensus       213 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~---~~--------~~~~~~~  279 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIAS---EP--------PPIREIP  279 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHHHH---SC--------CGGGGSC
T ss_pred             CCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHHc---CC--------CCchhcC
Confidence            2345699999999999999999999999999999999999999987554332  111111   11        1111222


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...+..+.+++.+||++||++|||+.|+++.|......
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            23345678999999999999999999999988876543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.9e-49  Score=425.61  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|| ||+||+|+. .+|+.||||++.....  ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        26 Y~~~~~lG~G~-fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy  104 (350)
T 4b9d_A           26 YVRLQKIGEGS-FGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY  104 (350)
T ss_dssp             EEEEEEC-------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             eEEeEEEecCC-CeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            44445566655 999999965 5799999999976432  2346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          660 LQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       660 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+||+|.+++... +..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....... 
T Consensus       105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  180 (350)
T 4b9d_A          105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-  180 (350)
T ss_dssp             CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH-
T ss_pred             CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc-
Confidence            9999999999755 45679999999999999999999999   999999999999999999999999999987754321 


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       ......||+.|||||++.+..++.++||||+||++|||+||++||.......     ...+.....   ...+.     
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~~~~---~~~~~-----  246 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-----LVLKIISGS---FPPVS-----  246 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHTC---CCCCC-----
T ss_pred             -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-----HHHHHHcCC---CCCCC-----
Confidence             2234569999999999999999999999999999999999999998654322     111111111   00111     


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        ...+.++.++|.+||+.||++|||+.|+++
T Consensus       247 --~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          247 --LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112346789999999999999999999986

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.5e-47  Score=450.14  Aligned_cols=409  Identities=18%  Similarity=0.162  Sum_probs=348.3

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc--------------ceeecC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLS  141 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--------------~~LdL~  141 (876)
                      .+..++++++.+.+..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.|              ++|+|+
T Consensus        58 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~  137 (606)
T 3t6q_A           58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG  137 (606)
T ss_dssp             TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECC
T ss_pred             cceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECC
Confidence            456678888888887788888888888888888888887788888888888888888753              467788


Q ss_pred             CccccccCCCccCCccccceecccccccCCCcCccccCCCcce--EEEccCCCCc-------------------------
Q 002826          142 RNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELV--VLDLSQNAYL-------------------------  194 (876)
Q Consensus       142 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~Ls~N~~~-------------------------  194 (876)
                      +|++++..+..+..+++|++|+|++|++++..|..|+.+++|+  +|++++|++.                         
T Consensus       138 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~  217 (606)
T 3t6q_A          138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV  217 (606)
T ss_dssp             SSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHH
T ss_pred             CCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHH
Confidence            8888765444444577777777777777766666666666666  5555555421                         


Q ss_pred             ------------------------------------------------CCCCC-CcccccCcccEEEecCCCCcccCCcc
Q 002826          195 ------------------------------------------------ISEIP-SDIGKLEKLEQLFLQSSGFHGVIPDS  225 (876)
Q Consensus       195 ------------------------------------------------~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~  225 (876)
                                                                      +..++ ..|.++++|++|++++|+++ .+|..
T Consensus       218 ~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~  296 (606)
T 3t6q_A          218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG  296 (606)
T ss_dssp             HHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSS
T ss_pred             HhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChh
Confidence                                                            22333 33788999999999999999 56888


Q ss_pred             ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCc-ccccCCccceeeeecccccccC--CCCCccc
Q 002826          226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN-GICKANGLVNLSLHKNFFNGSI--PGSINEC  302 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l  302 (876)
                      +.++++|++|++++|++++..|. .+..+++|++|++++|++.+.+|. .+..+++|++|++++|.+++..  +..+..+
T Consensus       297 l~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l  375 (606)
T 3t6q_A          297 LVGLSTLKKLVLSANKFENLCQI-SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL  375 (606)
T ss_dssp             CCSCTTCCEEECTTCCCSBGGGG-CGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTC
T ss_pred             hcccccCCEEECccCCcCcCchh-hhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccC
Confidence            99999999999999999944444 446799999999999999876655 4899999999999999999877  8899999


Q ss_pred             cccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCcc-ccccCCCCCeeeccCcccCCCCCCccccccCccEEe
Q 002826          303 LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD-SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFS  381 (876)
Q Consensus       303 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  381 (876)
                      ++|++|++++|++++..|..|..+++|+.|++++|++++..+. .+..+++|++|++++|++++..|..+..+++|++|+
T Consensus       376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  455 (606)
T 3t6q_A          376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN  455 (606)
T ss_dssp             TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence            9999999999999999999999999999999999999988765 489999999999999999999999999999999999


Q ss_pred             CCCccccCC---CCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCc
Q 002826          382 ASQNSFYGS---LPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       382 ls~N~l~~~---~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      +++|++++.   .+..+..+++|+.|+|++|++++.+| .|..+++|++|+|++|++++..|..|..+++| .|+|++|+
T Consensus       456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~  534 (606)
T 3t6q_A          456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH  534 (606)
T ss_dssp             CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred             CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence            999999873   34679999999999999999999877 79999999999999999999999999999999 99999999


Q ss_pred             ccccCCCccccc-ccceEEccCCccccccCC
Q 002826          458 LTGPIPQGLQNL-KLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       458 l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~  487 (876)
                      +++.+|..+..+ +++.+++++|++.+..+.
T Consensus       535 l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          535 ISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             CCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             ccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            999888888877 689999999999987763

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.2e-47  Score=451.06  Aligned_cols=428  Identities=20%  Similarity=0.219  Sum_probs=301.4

Q ss_pred             CccccceEecCCCC--------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccC
Q 002826           59 YCNWTGVTCVTTAT--------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNL  130 (876)
Q Consensus        59 ~C~w~gv~c~~~~~--------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  130 (876)
                      .|.|.|| |+....        ....+..++++++++++..|..+..+++|++|+|++|++++..|..|+++++|++|+|
T Consensus         3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L   81 (549)
T 2z81_A            3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL   81 (549)
T ss_dssp             EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence            5999998 865421        1235788999999999988999999999999999999999999999999999998877


Q ss_pred             CCcccceeecCCccccccCCCccCCccccceecccccccCCC-cCccccCCCcceEEEccCCCCcCCCCC-CcccccCcc
Q 002826          131 SNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS-VPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKL  208 (876)
Q Consensus       131 s~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L  208 (876)
                      ++|.          +++..|..|+++++|++|+|++|++++. .|..|+++++|++|+|++|++ .+.+| ..|.++++|
T Consensus        82 s~n~----------l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~-~~~~~~~~~~~l~~L  150 (549)
T 2z81_A           82 SDNH----------LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET-FSEIRRIDFAGLTSL  150 (549)
T ss_dssp             TTSC----------CCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS-CCEECTTTTTTCCEE
T ss_pred             CCCc----------cCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCcc-ccccCHhhhhccccc
Confidence            7664          3444444455555555555555555532 344455555555555555542 23333 345555555


Q ss_pred             cEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccC-------------------
Q 002826          209 EQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG-------------------  269 (876)
Q Consensus       209 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-------------------  269 (876)
                      ++|++++|++++..|..+..+++|++|++++|.++ .+|..++..+++|++|++++|++++                   
T Consensus       151 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~  229 (549)
T 2z81_A          151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA  229 (549)
T ss_dssp             EEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEE
T ss_pred             CeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccccee
Confidence            55555555555555555555555555555555544 4444333334455555555555443                   


Q ss_pred             --------cCCc----ccccCCccceeeeecccccccCC---------CC--------------------------Cccc
Q 002826          270 --------SFPN----GICKANGLVNLSLHKNFFNGSIP---------GS--------------------------INEC  302 (876)
Q Consensus       270 --------~~~~----~~~~l~~L~~L~L~~N~i~~~~~---------~~--------------------------~~~l  302 (876)
                              ..+.    .+..+++|+.|++++|.+.+...         ..                          +...
T Consensus       230 l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~  309 (549)
T 2z81_A          230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL  309 (549)
T ss_dssp             EESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHS
T ss_pred             ccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhc
Confidence                    2221    22345566666666666554211         00                          1223


Q ss_pred             cccceeecccccCCCCCCccc-CCCCcccEEEecCCcccccCcc---ccccCCCCCeeeccCcccCCCCC--CccccccC
Q 002826          303 LNLERFQVQDNGFSGDFPDKL-WSLPRIKLIRAESNRFSGAIPD---SISMAAQLEQVQIDNNRFTSSIP--QGLGSVKS  376 (876)
Q Consensus       303 ~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~  376 (876)
                      .+|++|++++|+++ .+|..+ ..+++|+.|++++|++++..|.   .+..+++|++|++++|++++..+  ..+..+++
T Consensus       310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~  388 (549)
T 2z81_A          310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN  388 (549)
T ss_dssp             TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred             ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence            56788888888887 566655 5799999999999999987643   47888999999999999986543  45889999


Q ss_pred             ccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCC
Q 002826          377 LYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN  456 (876)
Q Consensus       377 L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  456 (876)
                      |++|++++|+++ .+|..+..+++|++|++++|++++.+..+  .++|++|+|++|+|++.+    ..+++|++|+|++|
T Consensus       389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N  461 (549)
T 2z81_A          389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRN  461 (549)
T ss_dssp             CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSS
T ss_pred             CCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCC
Confidence            999999999998 67888999999999999999998665443  268999999999999753    58899999999999


Q ss_pred             cccccCCCcccccccceEEccCCccccccCCcc--cCCCCCccccCCCCCCCCC
Q 002826          457 NLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSL--ISGLPASYLQGNPGLCGPG  508 (876)
Q Consensus       457 ~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~--~~~~~~~~~~~N~~~C~~~  508 (876)
                      +|+ .+|.....-.++.||+++|++++.+|..+  +.++..+++.+|||.|+|+
T Consensus       462 ~l~-~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          462 KLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             CCS-SCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             ccC-cCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            999 67774332368999999999998777543  6778889999999999875

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=443.97  Aligned_cols=415  Identities=20%  Similarity=0.219  Sum_probs=302.0

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS  155 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~  155 (876)
                      .+..++++++++++..+..+.++++|++|+|++|++++..|..|+++++|++|+|++|.+          ++..|..|++
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l----------~~~~~~~~~~   98 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI----------QSLALGAFSG   98 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC----------CEECTTTTTT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcC----------CccCHhhhcC
Confidence            577899999999998888999999999999999999998899999999999997777653          3333444555


Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCC---
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL---  232 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L---  232 (876)
                      +++|++|+|++|++++..+..|+++++|++|+|++|.+....+|..|.++++|++|++++|++++..+..|..+++|   
T Consensus        99 l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~  178 (570)
T 2z63_A           99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL  178 (570)
T ss_dssp             CTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTC
T ss_pred             ccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchh
Confidence            55555555555555444333445555555555555542111244445555555555555555544444444444444   


Q ss_pred             -cEEecccCccCCCCCCccc------------------------------------------------------------
Q 002826          233 -SILDLSQNNLTGEVPQSLG------------------------------------------------------------  251 (876)
Q Consensus       233 -~~L~Ls~N~l~~~ip~~~~------------------------------------------------------------  251 (876)
                       +.|++++|.+++ +++..+                                                            
T Consensus       179 ~~~L~l~~n~l~~-~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l  257 (570)
T 2z63_A          179 NLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL  257 (570)
T ss_dssp             CCEEECTTCCCCE-ECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGS
T ss_pred             hhhcccCCCCcee-cCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhcccccc
Confidence             444554444442 222222                                                            


Q ss_pred             ---------------------cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeec
Q 002826          252 ---------------------SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQV  310 (876)
Q Consensus       252 ---------------------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  310 (876)
                                           ..+++|++|++++|+++ .+|..+..+ +|++|++++|.+. .+|.  ..+++|++|++
T Consensus       258 ~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l  332 (570)
T 2z63_A          258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTF  332 (570)
T ss_dssp             EEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEE
T ss_pred             chhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeC
Confidence                                 23455555555555555 345555555 5555666655555 2232  34556666666


Q ss_pred             ccccCCCCCCcccCCCCcccEEEecCCcccccC--ccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCcccc
Q 002826          311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI--PDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFY  388 (876)
Q Consensus       311 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~  388 (876)
                      ++|.+.+..+.  ..+++|+.|++++|++++..  |..+..+++|++|++++|++++..+. +..+++|+.|++++|.+.
T Consensus       333 ~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~  409 (570)
T 2z63_A          333 TSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLK  409 (570)
T ss_dssp             ESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEE
T ss_pred             cCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccc
Confidence            66666555444  67889999999999998765  77888999999999999999965554 999999999999999999


Q ss_pred             CCCC-CCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCC-CCCCcCCCCCCCcceeeCCCCcccccCCCc
Q 002826          389 GSLP-PNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLT-GEIPPSLAELPVLTYLDLSDNNLTGPIPQG  465 (876)
Q Consensus       389 ~~~~-~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  465 (876)
                      +..| ..|..+++|++|++++|.+++.++ .+.++++|++|+|++|+++ +.+|..|..+++|++|+|++|++++..|..
T Consensus       410 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~  489 (570)
T 2z63_A          410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA  489 (570)
T ss_dssp             SCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTT
T ss_pred             cccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhh
Confidence            8876 578999999999999999998777 7899999999999999998 578999999999999999999999988999


Q ss_pred             cccc-ccceEEccCCccccccCCcc--cCCCCCccccCCCCCCCCCC
Q 002826          466 LQNL-KLALFNVSFNKLSGRVPYSL--ISGLPASYLQGNPGLCGPGL  509 (876)
Q Consensus       466 ~~~l-~l~~l~ls~N~l~~~~p~~~--~~~~~~~~~~~N~~~C~~~~  509 (876)
                      +..+ +++.|++++|++++..|..+  +.++..+++.+||+.|+|+.
T Consensus       490 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             hhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            9887 59999999999998766443  56778889999999998864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-47  Score=405.02  Aligned_cols=242  Identities=21%  Similarity=0.294  Sum_probs=190.9

Q ss_pred             CCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEEEEEcC
Q 002826          588 SAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFLIYEFL  660 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  660 (876)
                      ++|.|| ||+||+|.. .+++.||+|++....  ....+.+.+|++++++++|||||+++++|.+    ++.+|+|||||
T Consensus        33 ~iG~G~-fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           33 EIGRGS-FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEECS-SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             EEecCc-CcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            355555 999999966 479999999996542  2234678999999999999999999999875    34689999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +||+|.+++.+.+ .+++..+..++.||+.||+|||++.. +|+||||||+|||++. ++.+||+|||+|+.....    
T Consensus       112 ~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----  185 (290)
T 3fpq_A          112 TSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----  185 (290)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----
Confidence            9999999997654 79999999999999999999999811 3999999999999984 799999999999865432    


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|||||++.+ +++.++|||||||++|||+||+.||........    ..+......      ..+.+...
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~~i~~~~------~~~~~~~~  254 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGV------KPASFDKV  254 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTC------CCGGGGGC
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HHHHHHcCC------CCCCCCcc
Confidence            2234569999999998765 689999999999999999999999975432221    111111110      01111111


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         .+.++.+++.+||+.||++|||++|+++
T Consensus       255 ---~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          255 ---AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1235789999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-48  Score=413.67  Aligned_cols=246  Identities=20%  Similarity=0.275  Sum_probs=202.7

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.-...+|.|+ ||+||+|+. .+|+.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        34 y~i~~~lG~G~-fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           34 FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEEEEeccc-CeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            43444555555 999999965 58999999999653   22455789999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ||+||+|.+++.+.+ .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus       113 y~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          113 YAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            999999999997764 699999999999999999999999   9999999999999999999999999999987644433


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......+||+.|||||++.+..++.++||||+||++|||+||++||.......  ....+.   ......    .+    
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~---~~~~~~----p~----  255 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--IFAKII---KLEYDF----PE----  255 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HTCCCC----CT----
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH---cCCCCC----Cc----
Confidence            34455679999999999998899999999999999999999999998654322  111111   111001    11    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVV  849 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell  849 (876)
                         ..+.++.+++.+|++.||++|||++|+.
T Consensus       256 ---~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          256 ---KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1233578999999999999999999874

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.9e-47  Score=419.39  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=206.5

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|....++|.|+ ||+||+|.. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|+|||||
T Consensus       152 ~y~~~~~iG~G~-fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          152 YLDNFIKIGEGS-TGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             TEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hcEeeeEeccCc-CcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            455556666666 999999976 479999999998776667778999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +||+|.+++...  .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            999999999754  589999999999999999999999   99999999999999999999999999998775432  12


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....+||+.|||||++.+..|+.++||||+||++|||++|++||.......  ....+.....          +.+ ..+
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~----------~~~-~~~  370 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLP----------PRL-KNL  370 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCC----------CCC-SCT
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCC----------CCC-ccc
Confidence            345579999999999999999999999999999999999999997654322  2222222110          000 011


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1223467899999999999999999999873

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-47  Score=410.45  Aligned_cols=263  Identities=25%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC----eEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----SIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  662 (876)
                      ..+|.|| ||+||+|++ +|+.||||++.... .....++.|+..+.+++|||||+++|+|.+++    .+|+|||||++
T Consensus         9 ~~iG~G~-fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            9 ESIGKGR-FGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEECS-SSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEeeCC-CeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            3455555 999999988 69999999986532 11223345666677889999999999998754    58999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC-----CCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY-----VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+|.+++++.  .++|..+.+++.|++.||+|||+++     .++|+||||||+|||++.++++||+|||+|+.......
T Consensus        86 gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  163 (303)
T 3hmm_A           86 GSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             CBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCC
Confidence            9999999764  5899999999999999999999862     45899999999999999999999999999987754332


Q ss_pred             c--cccccccccccccCccccCCC------CCCCccchHHHHHHHHHHHhCCCCCCCCCcch----------hhHHHHHH
Q 002826          738 Q--STMSSEYALSCYNAPEYGYSK------KATAQMDAYSFGVVLLELITGRQAEQAEPAES----------LDVVKWVR  799 (876)
Q Consensus       738 ~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~----------~~~~~~~~  799 (876)
                      .  .......||+.|||||++.+.      .++.++|||||||++|||+||++||.......          ........
T Consensus       164 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  243 (303)
T 3hmm_A          164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK  243 (303)
T ss_dssp             EESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             ceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHH
Confidence            2  122345699999999998654      35779999999999999999988775432211          11111111


Q ss_pred             HHhhcccccccccChhhhhh--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          800 RKINITNGAIQVLDPKIANC--YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       800 ~~~~~~~~~~~~~d~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ..      ....++|.++..  ..+....+.+++.+||+.||++||||.||++.|+++.++.+
T Consensus       244 ~~------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          244 VV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HH------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HH------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcC
Confidence            11      111223333221  12445678899999999999999999999999999876543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.2e-47  Score=399.29  Aligned_cols=243  Identities=23%  Similarity=0.351  Sum_probs=185.7

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |++.+..|.|+||+||+|.. .+|+.||+|++.+..   ......+.+|++++++++|||||++++++.+++..|+||||
T Consensus        15 Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   94 (275)
T 3hyh_A           15 YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY   94 (275)
T ss_dssp             CEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            34444444455999999976 479999999997542   23356789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      + +|+|.+++.+.+ .+++..+..++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+......   
T Consensus        95 ~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---  166 (275)
T 3hyh_A           95 A-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---  166 (275)
T ss_dssp             C-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             C-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC---
Confidence            9 679999997654 799999999999999999999999   99999999999999999999999999998765432   


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......||+.|||||++.+..+ +.++||||+||++|||+||+.||.......  ....+.   ......    .+    
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~~i~---~~~~~~----p~----  233 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFKNIS---NGVYTL----PK----  233 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HTCCCC----CT----
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH---cCCCCC----CC----
Confidence            2334569999999999987765 689999999999999999999997644322  111111   111001    11    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ..+.++.+++.+|++.||++|||++|+++
T Consensus       234 ---~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 ---FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence               12345789999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-47  Score=418.34  Aligned_cols=257  Identities=24%  Similarity=0.337  Sum_probs=205.1

Q ss_pred             cCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccC-ccccceeeEEEeC-CeEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRH-KNIVKVLGFFHSD-ESIFLI  656 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~-~~~~lv  656 (876)
                      ..+.+|.|+||+||+|.+.      .++.||||++..... ...+.+.+|++++++++| ||||+++|+|.++ +..|+|
T Consensus        68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV  147 (353)
T 4ase_A           68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI  147 (353)
T ss_dssp             EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred             EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence            3344444559999999753      246899999975432 234678999999999965 8999999999764 568999


Q ss_pred             EEcCCCCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          657 YEFLQMGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      ||||++|+|.+++++.               ...+++..+..++.|||.||+|||++   +|+||||||+|||+++++.+
T Consensus       148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~v  224 (353)
T 4ase_A          148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVV  224 (353)
T ss_dssp             EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCE
Confidence            9999999999999753               23489999999999999999999999   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      ||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |+.||....... .+...+..
T Consensus       225 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~~~i~~  303 (353)
T 4ase_A          225 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKE  303 (353)
T ss_dssp             EECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHH
T ss_pred             EECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HHHHHHHc
Confidence            9999999998765444444455678999999999999999999999999999999998 999998654332 22222222


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ...          +..+.   ..+.++.+++.+||+.||++||||.||++.|+++.+..
T Consensus       304 g~~----------~~~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          304 GTR----------MRAPD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             TCC----------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCC----------CCCCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            111          11111   12345789999999999999999999999999986543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=6.1e-46  Score=441.79  Aligned_cols=401  Identities=21%  Similarity=0.192  Sum_probs=341.5

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc--------------ceeecC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLS  141 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--------------~~LdL~  141 (876)
                      .+..++++++.+++..|..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+              ++|+|+
T Consensus        57 ~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  136 (606)
T 3vq2_A           57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA  136 (606)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECC
T ss_pred             cCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCC
Confidence            577899999999998899999999999999999999999999999999999999999974              579999


Q ss_pred             Cccccc-cCCCccCCccccceecccccccCCCcCccccCCCcce----EEEccCCCCcCCCCCCc---------------
Q 002826          142 RNHIEG-KIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELV----VLDLSQNAYLISEIPSD---------------  201 (876)
Q Consensus       142 ~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~~~~~~~p~~---------------  201 (876)
                      +|.+++ .+|..|+++++|++|+|++|++++..|..|+.+++|+    +|++++|+  +..+|..               
T Consensus       137 ~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~--l~~~~~~~~~~~~L~~L~L~~n  214 (606)
T 3vq2_A          137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP--IDFIQDQAFQGIKLHELTLRGN  214 (606)
T ss_dssp             SSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC--CCEECTTTTTTCEEEEEEEESC
T ss_pred             CCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCC--cceeCcccccCceeeeeeccCC
Confidence            999986 6799999999999999999999988888777666554    56666665  3334433               


Q ss_pred             ------------------------------------------------------------------ccccCcccEEEecC
Q 002826          202 ------------------------------------------------------------------IGKLEKLEQLFLQS  215 (876)
Q Consensus       202 ------------------------------------------------------------------~~~l~~L~~L~L~~  215 (876)
                                                                                        +..+++|+.|++++
T Consensus       215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~  294 (606)
T 3vq2_A          215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG  294 (606)
T ss_dssp             CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred             ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence                                                                              23344455555555


Q ss_pred             CCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc-
Q 002826          216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS-  294 (876)
Q Consensus       216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-  294 (876)
                      |.+... | .+..+++|++|++++|+++ .+|. +  .+++|++|++++|+..+..  .+..+++|++|++++|.+++. 
T Consensus       295 ~~~~~l-~-~l~~~~~L~~L~l~~n~l~-~lp~-~--~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~  366 (606)
T 3vq2_A          295 VSIKYL-E-DVPKHFKWQSLSIIRCQLK-QFPT-L--DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG  366 (606)
T ss_dssp             CCCCCC-C-CCCTTCCCSEEEEESCCCS-SCCC-C--CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEE
T ss_pred             ccchhh-h-hccccccCCEEEcccccCc-cccc-C--CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCc
Confidence            555432 3 5666677777777777774 7773 3  5778888888888554333  567889999999999999877 


Q ss_pred             -CCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCc-cccccCCCCCeeeccCcccCCCCCCccc
Q 002826          295 -IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP-DSISMAAQLEQVQIDNNRFTSSIPQGLG  372 (876)
Q Consensus       295 -~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~  372 (876)
                       .|..+..+++|++|++++|.+++ +|..+.++++|+.|++++|++++..| ..+..+++|++|++++|++++..|..+.
T Consensus       367 ~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  445 (606)
T 3vq2_A          367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFL  445 (606)
T ss_dssp             ECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             chhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhc
Confidence             37889999999999999999985 66899999999999999999999888 7899999999999999999999999999


Q ss_pred             cccCccEEeCCCccccC-CCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcce
Q 002826          373 SVKSLYRFSASQNSFYG-SLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTY  450 (876)
Q Consensus       373 ~l~~L~~L~ls~N~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  450 (876)
                      ++++|+.|++++|.+++ .+|..|..+++|+.|+|++|++++.++ .+..+++|++|+|++|++++.+|..|..+++|++
T Consensus       446 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  525 (606)
T 3vq2_A          446 GLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLST  525 (606)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCE
T ss_pred             CCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCE
Confidence            99999999999999998 579999999999999999999999877 7999999999999999999999999999999999


Q ss_pred             eeCCCCcccccCCCccccc--ccceEEccCCccccccCCc
Q 002826          451 LDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLSGRVPYS  488 (876)
Q Consensus       451 L~Ls~N~l~~~~p~~~~~l--~l~~l~ls~N~l~~~~p~~  488 (876)
                      |||++|+|+ .+|..+..+  .++.+++++|++.+..|..
T Consensus       526 L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          526 LDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             EECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             EECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            999999999 677778877  3899999999999877743

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=453.58  Aligned_cols=417  Identities=20%  Similarity=0.203  Sum_probs=356.4

Q ss_pred             CCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcc---------------cceeecCCccccc
Q 002826           83 QSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL---------------IWVLDLSRNHIEG  147 (876)
Q Consensus        83 ~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---------------l~~LdL~~n~l~~  147 (876)
                      .+++++. +|.   -.++|++|||++|.+++..|..|+++++|++|+|++|.               |++|+|++|++++
T Consensus        12 s~~~L~~-vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~   87 (844)
T 3j0a_A           12 RFCNLTQ-VPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF   87 (844)
T ss_dssp             SCCCSSC-CCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCE
T ss_pred             cCCCCCC-CCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcc
Confidence            3445553 344   45899999999999999999999999999999999992               5789999999999


Q ss_pred             cCCCccCCccccceecccccccCCCcCcc--ccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCcc
Q 002826          148 KIPESIGSLVNLQVLNLGSNLLSGSVPFV--FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDS  225 (876)
Q Consensus       148 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~  225 (876)
                      ..|..|+++++|++|+|++|++++..|..  |+++++|++|+|++|.+.....+..|+++++|++|+|++|++++..+..
T Consensus        88 ~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~  167 (844)
T 3j0a_A           88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHE  167 (844)
T ss_dssp             ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGG
T ss_pred             cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHH
Confidence            99999999999999999999999866655  9999999999999998432223457999999999999999999999999


Q ss_pred             ccCC--CCCcEEecccCccCCCCCCccccccc------cccEEEeccccccCcCCccccc--------------------
Q 002826          226 FVGL--QSLSILDLSQNNLTGEVPQSLGSSLL------KLVSFDVSQNKLSGSFPNGICK--------------------  277 (876)
Q Consensus       226 ~~~l--~~L~~L~Ls~N~l~~~ip~~~~~~l~------~L~~L~L~~N~l~~~~~~~~~~--------------------  277 (876)
                      |..+  ++|+.|+|++|.+++..|..+.. ++      +|++|++++|++++..+..+..                    
T Consensus       168 l~~l~~~~L~~L~L~~n~l~~~~~~~~~~-~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~  246 (844)
T 3j0a_A          168 LEPLQGKTLSFFSLAANSLYSRVSVDWGK-CMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAG  246 (844)
T ss_dssp             GHHHHHCSSCCCEECCSBSCCCCCCCCCS-SSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCS
T ss_pred             cccccCCccceEECCCCccccccccchhh-cCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccc
Confidence            9988  89999999999999877776533 33      4999999999888766655543                    


Q ss_pred             ------------------CCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcc
Q 002826          278 ------------------ANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRF  339 (876)
Q Consensus       278 ------------------l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  339 (876)
                                        .++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|++++|++
T Consensus       247 ~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l  326 (844)
T 3j0a_A          247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL  326 (844)
T ss_dssp             SSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCC
T ss_pred             ccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCC
Confidence                              26899999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCC------------------C--------
Q 002826          340 SGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP------------------P--------  393 (876)
Q Consensus       340 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~------------------~--------  393 (876)
                      ++..|..|..+++|++|++++|++++..+..|.++++|+.|++++|.+++...                  .        
T Consensus       327 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L  406 (844)
T 3j0a_A          327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLI  406 (844)
T ss_dssp             SCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEE
T ss_pred             CccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCccccccccccccee
Confidence            99999999999999999999999998888889999999999999999875321                  1        


Q ss_pred             --------------CcCCCCCccEEEccCCccccCCc--CcccccccceEeccCCcCC-----CCCCcCCCCCCCcceee
Q 002826          394 --------------NFCDSPVMSIINLSQNSISGQIP--ELKKCRKLVSLSLADNSLT-----GEIPPSLAELPVLTYLD  452 (876)
Q Consensus       394 --------------~~~~~~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~  452 (876)
                                    .+..+++|+.|+|++|++++..+  .+..+++|+.|+|++|.++     +..|..|.++++|+.|+
T Consensus       407 ~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~  486 (844)
T 3j0a_A          407 HLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY  486 (844)
T ss_dssp             ECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCC
T ss_pred             ecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEE
Confidence                          12356778888888888876554  3566788888888888886     45567799999999999


Q ss_pred             CCCCcccccCCCccccc-ccceEEccCCccccccCCcccCCCCCccccCCCCC
Q 002826          453 LSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGL  504 (876)
Q Consensus       453 Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~  504 (876)
                      |++|+|++..|..+..+ .++.|++++|++++..|..+..++..+.+++|.-.
T Consensus       487 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~  539 (844)
T 3j0a_A          487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLL  539 (844)
T ss_dssp             CCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCC
T ss_pred             CCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCC
Confidence            99999999888888887 59999999999998666665677788888887643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.6e-46  Score=450.03  Aligned_cols=395  Identities=17%  Similarity=0.250  Sum_probs=346.9

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccC-CCcccc-----------------------------------------
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNL-SNNLIW-----------------------------------------  136 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L-s~N~l~-----------------------------------------  136 (876)
                      .+++.|+|++|++.|.+|.+|++|++|++|+| ++|.+.                                         
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~  402 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD  402 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence            57899999999999999999999999999999 777531                                         


Q ss_pred             ------------------------eeec--CCccccccCCCccCCccccceecccccccCC-----------------Cc
Q 002826          137 ------------------------VLDL--SRNHIEGKIPESIGSLVNLQVLNLGSNLLSG-----------------SV  173 (876)
Q Consensus       137 ------------------------~LdL--~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----------------~~  173 (876)
                                              .+.+  ..|++++ +|..|+++++|++|+|++|+|++                 .+
T Consensus       403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i  481 (876)
T 4ecn_A          403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE  481 (876)
T ss_dssp             HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred             HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence                                    0111  3488888 89999999999999999999998                 38


Q ss_pred             Ccccc--CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCC-Ccc-cCCccccCCC-------CCcEEecccCcc
Q 002826          174 PFVFG--NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG-FHG-VIPDSFVGLQ-------SLSILDLSQNNL  242 (876)
Q Consensus       174 p~~~~--~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~~~~~~~l~-------~L~~L~Ls~N~l  242 (876)
                      |..++  ++++|++|+|++|+ ..+.+|..|.++++|++|+|++|+ +++ .+|..+..++       +|++|+|++|++
T Consensus       482 P~~l~f~~L~~L~~L~Ls~N~-l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L  560 (876)
T 4ecn_A          482 NEELSWSNLKDLTDVELYNCP-NMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL  560 (876)
T ss_dssp             TSCCCGGGCTTCCEEEEESCT-TCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCC
T ss_pred             ChhhhhccCCCCCEEECcCCC-CCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcC
Confidence            88877  99999999999998 478899999999999999999998 998 7888776665       999999999999


Q ss_pred             CCCCCC--ccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccc-cceeecccccCCCCC
Q 002826          243 TGEVPQ--SLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLN-LERFQVQDNGFSGDF  319 (876)
Q Consensus       243 ~~~ip~--~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~  319 (876)
                      + .+|.  .+ ..+++|+.|+|++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|+++ .+
T Consensus       561 ~-~ip~~~~l-~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~l  634 (876)
T 4ecn_A          561 E-EFPASASL-QKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI  634 (876)
T ss_dssp             C-BCCCHHHH-TTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SC
T ss_pred             C-ccCChhhh-hcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cC
Confidence            9 8998  55 46999999999999999 778 8999999999999999999 88989999999 999999999999 78


Q ss_pred             CcccCCCCc--ccEEEecCCcccccCcccc---c--cCCCCCeeeccCcccCCCCCCcc-ccccCccEEeCCCccccCCC
Q 002826          320 PDKLWSLPR--IKLIRAESNRFSGAIPDSI---S--MAAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSL  391 (876)
Q Consensus       320 p~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~  391 (876)
                      |..+..++.  |+.|++++|++++.+|...   .  .+.+|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++...
T Consensus       635 p~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip  713 (876)
T 4ecn_A          635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIP  713 (876)
T ss_dssp             CSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCC
T ss_pred             chhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccC
Confidence            888887754  9999999999998776533   2  3458999999999999 566554 58999999999999999444


Q ss_pred             CCCcCCC-------CCccEEEccCCccccCCcCcc--cccccceEeccCCcCCCCCCcCCCCCCCcceeeCCC------C
Q 002826          392 PPNFCDS-------PVMSIINLSQNSISGQIPELK--KCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSD------N  456 (876)
Q Consensus       392 ~~~~~~~-------~~L~~L~Ls~N~l~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N  456 (876)
                      +..+...       ++|+.|+|++|+|+..+..+.  .+++|+.|+|++|+|++ +|..+..+++|+.|+|++      |
T Consensus       714 ~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N  792 (876)
T 4ecn_A          714 ENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGN  792 (876)
T ss_dssp             TTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCC
T ss_pred             hHHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccc
Confidence            4444433       289999999999996666776  99999999999999997 798999999999999976      8


Q ss_pred             cccccCCCccccc-ccceEEccCCccccccCCcccCCCCCccccCCCCC
Q 002826          457 NLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGL  504 (876)
Q Consensus       457 ~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~  504 (876)
                      ++.+.+|..+..+ +|+.|++++|++ +.+|..+..++..+.+.+||+.
T Consensus       793 ~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~  840 (876)
T 4ecn_A          793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNI  840 (876)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred             cccccChHHHhcCCCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence            8999999999988 599999999999 8999888888899999999864

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1e-44  Score=437.21  Aligned_cols=410  Identities=19%  Similarity=0.210  Sum_probs=269.8

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc----------------ceee
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI----------------WVLD  139 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l----------------~~Ld  139 (876)
                      .+..+++.++.+++..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|.+                +.|+
T Consensus        98 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~  177 (680)
T 1ziw_A           98 NLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLE  177 (680)
T ss_dssp             TCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEE
T ss_pred             CCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEE
Confidence            345566666666665556677777777777777777776677777777777777776642                4567


Q ss_pred             cCCccccccCCCccCCc---------------------------cccceecccccccCCCcCccccCCCc--ceEEEccC
Q 002826          140 LSRNHIEGKIPESIGSL---------------------------VNLQVLNLGSNLLSGSVPFVFGNFSE--LVVLDLSQ  190 (876)
Q Consensus       140 L~~n~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~--L~~L~Ls~  190 (876)
                      +++|++++..|..|..+                           ++|+.|+|++|++++..|..|.+++.  |++|+|++
T Consensus       178 L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~  257 (680)
T 1ziw_A          178 LSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY  257 (680)
T ss_dssp             CTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTT
T ss_pred             CCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCC
Confidence            77777666655544332                           22333334444444444444444332  44444444


Q ss_pred             CCCcCCCCCCcccccCcccEEEecCCCCcccCCccccC---------------------------------CCCCcEEec
Q 002826          191 NAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVG---------------------------------LQSLSILDL  237 (876)
Q Consensus       191 N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~---------------------------------l~~L~~L~L  237 (876)
                      |++ .+..|..|..+++|++|+|++|++.+..|..|.+                                 +++|++|++
T Consensus       258 n~l-~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l  336 (680)
T 1ziw_A          258 NNL-NVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM  336 (680)
T ss_dssp             SCC-CEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEEC
T ss_pred             CCc-CccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEEC
Confidence            441 1222333444444444444444444444333333                                 333333333


Q ss_pred             ccCccCCCCCCccccccc----------------------------cccEEEeccccccCcCCcccccCCccceeeeecc
Q 002826          238 SQNNLTGEVPQSLGSSLL----------------------------KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN  289 (876)
Q Consensus       238 s~N~l~~~ip~~~~~~l~----------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  289 (876)
                      ++|++++ ++...+..++                            +|+.|++++|++++..|..|..+++|++|+|++|
T Consensus       337 ~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  415 (680)
T 1ziw_A          337 EDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN  415 (680)
T ss_dssp             CSCCBCC-CCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCccCC-CChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCC
Confidence            3333332 1111112222                            3444444445555555555555666666666666


Q ss_pred             cccccCC-CCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCccc--ccCccccccCCCCCeeeccCcccCCC
Q 002826          290 FFNGSIP-GSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS--GAIPDSISMAAQLEQVQIDNNRFTSS  366 (876)
Q Consensus       290 ~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~  366 (876)
                      .+++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.++  +..|..|..+++|++|++++|++++.
T Consensus       416 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i  495 (680)
T 1ziw_A          416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANI  495 (680)
T ss_dssp             CCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCC
T ss_pred             cCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcC
Confidence            6654443 34555666666666666666555666666666666666666665  45778889999999999999999988


Q ss_pred             CCCccccccCccEEeCCCccccCCC--------CCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCC
Q 002826          367 IPQGLGSVKSLYRFSASQNSFYGSL--------PPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGE  437 (876)
Q Consensus       367 ~p~~~~~l~~L~~L~ls~N~l~~~~--------~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~  437 (876)
                      .|..|.++++|++|++++|++++..        +..|.++++|++|+|++|+++..++ .|.++++|++|+|++|+|++.
T Consensus       496 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l  575 (680)
T 1ziw_A          496 NDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL  575 (680)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred             ChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcC
Confidence            8888999999999999999998753        2348899999999999999997776 699999999999999999988


Q ss_pred             CCcCCCCCCCcceeeCCCCcccccCCCccc-cc-ccceEEccCCccccccCC
Q 002826          438 IPPSLAELPVLTYLDLSDNNLTGPIPQGLQ-NL-KLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       438 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l-~l~~l~ls~N~l~~~~p~  487 (876)
                      .+..|..+++|+.|+|++|+|++..|..+. .+ +++.+++++|++.+..+.
T Consensus       576 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            888899999999999999999987777665 44 688999999999987763

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.3e-47  Score=403.09  Aligned_cols=245  Identities=25%  Similarity=0.299  Sum_probs=190.2

Q ss_pred             ccccCCCCCCCCceEEEEEEe----CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL----PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      |.-...+|.|| ||+||+|+.    .+++.||+|++.+...  .....+.+|++++++++|||||++++++.+++..|+|
T Consensus        26 Y~i~~~lG~G~-fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv  104 (304)
T 3ubd_A           26 FELLKVLGQGS-FGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI  104 (304)
T ss_dssp             EEEEEEEECGG-GCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred             cEEEEEEecCC-CeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            44445555555 999999965    2578999999965321  2334688899999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      ||||+||+|.+++.+.+ .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus       105 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          105 LDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             ECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            99999999999998765 799999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .......||+.|||||++.+..++.++||||+||++|||+||+.||.......  ....+.   ......        
T Consensus       181 --~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~---~~~~~~--------  245 (304)
T 3ubd_A          181 --KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMTMIL---KAKLGM--------  245 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HCCCCC--------
T ss_pred             --ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHHHHH---cCCCCC--------
Confidence              12334569999999999999999999999999999999999999998654332  122111   111001        


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSM-----FEVVK  850 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~ell~  850 (876)
                      +   ...+.++.+++.+||+.||++|||+     +|+++
T Consensus       246 p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          246 P---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            1   1123457899999999999999985     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.5e-45  Score=392.22  Aligned_cols=248  Identities=21%  Similarity=0.345  Sum_probs=185.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCC--------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--------  651 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  651 (876)
                      +|.....+|.|| ||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+        
T Consensus         6 dy~~~~~lG~G~-fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            6 DFEPIQCLGRGG-FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HEEEEEEEEECC---EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hCEEeeEEecCC-CeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            455566677766 999999976 4799999999975432 23467889999999999999999999987644        


Q ss_pred             ----eEEEEEEcCCCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          652 ----SIFLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       652 ----~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                          ..|+|||||++|+|.+++.+..  ...++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence                3799999999999999997653  2356777899999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccccc----------cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHH
Q 002826          726 FALDRIVGEAAFQ----------STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVV  795 (876)
Q Consensus       726 fGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~  795 (876)
                      ||+|+........          ...+..+||+.|||||++.+..++.++||||+||++|||++   ||....    +..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence            9999887543211          12234569999999999999999999999999999999996   665321    111


Q ss_pred             HHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          796 KWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       796 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .........      ...+.    .........+++.+||++||++|||+.|+++
T Consensus       235 ~~~~~~~~~------~~p~~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDVRNL------KFPPL----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHTT------CCCHH----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcC------CCCCC----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111      11121    2233345678999999999999999999987

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=423.57  Aligned_cols=401  Identities=20%  Similarity=0.233  Sum_probs=354.4

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc--------------ceeecC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI--------------WVLDLS  141 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--------------~~LdL~  141 (876)
                      .+..+++.++++++..+..+.++++|++|+|++|.+++..|..|+++++|++|+|++|.+              ++|+|+
T Consensus        53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~  132 (570)
T 2z63_A           53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA  132 (570)
T ss_dssp             SCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC
T ss_pred             CceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC
Confidence            567899999999998888999999999999999999999999999999999999999854              578999


Q ss_pred             Cccccc-cCCCccCCccccceecccccccCCCcCccccCCCcc----eEEEccCCCCcCCCCC-CcccccCcccEEEecC
Q 002826          142 RNHIEG-KIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL----VVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQS  215 (876)
Q Consensus       142 ~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~~  215 (876)
                      +|.+++ .+|..|+++++|++|++++|++++..|..|+.+++|    +.|++++|.  +..++ ..+... +|+.|++++
T Consensus       133 ~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~--l~~~~~~~~~~~-~L~~L~l~~  209 (570)
T 2z63_A          133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP--MNFIQPGAFKEI-RLHKLTLRN  209 (570)
T ss_dssp             SSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC--CCEECTTTTTTC-EEEEEEEES
T ss_pred             CCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC--ceecCHHHhccC-cceeEeccc
Confidence            999987 468889999999999999999988888888888888    889999997  34444 334433 677777777


Q ss_pred             C----------------------------------------------------------CCcccCCccccCCCCCcEEec
Q 002826          216 S----------------------------------------------------------GFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       216 n----------------------------------------------------------~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      |                                                          .+.+..|..|..+++|++|++
T Consensus       210 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l  289 (570)
T 2z63_A          210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSL  289 (570)
T ss_dssp             CCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEE
T ss_pred             ccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEe
Confidence            6                                                          344556778888999999999


Q ss_pred             ccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCC
Q 002826          238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG  317 (876)
Q Consensus       238 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (876)
                      ++|.++ .+|..+.. + +|++|++++|++. .+|.  ..+++|+.|++++|.+.+..+.  ..+++|++|++++|++++
T Consensus       290 ~~~~l~-~l~~~~~~-~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~  361 (570)
T 2z63_A          290 VSVTIE-RVKDFSYN-F-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSF  361 (570)
T ss_dssp             ESCEEC-SCCBCCSC-C-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBE
T ss_pred             cCccch-hhhhhhcc-C-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCc
Confidence            999999 78888764 6 9999999999998 5555  4789999999999999877665  789999999999999986


Q ss_pred             CC--CcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCC-CccccccCccEEeCCCccccCCCCCC
Q 002826          318 DF--PDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIP-QGLGSVKSLYRFSASQNSFYGSLPPN  394 (876)
Q Consensus       318 ~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~  394 (876)
                      ..  |..+.++++|++|++++|++++..+. +..+++|++|++++|++++..| ..+.++++|+.|++++|.+.+..|..
T Consensus       362 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  440 (570)
T 2z63_A          362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI  440 (570)
T ss_dssp             EEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTT
T ss_pred             cccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhh
Confidence            65  78899999999999999999977666 9999999999999999998776 57899999999999999999999999


Q ss_pred             cCCCCCccEEEccCCccc-cCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-cc
Q 002826          395 FCDSPVMSIINLSQNSIS-GQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KL  471 (876)
Q Consensus       395 ~~~~~~L~~L~Ls~N~l~-~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l  471 (876)
                      |.++++|+.|++++|+++ +.+| .+..+++|++|+|++|++++..|..|..+++|++|++++|++++..|..+..+ ++
T Consensus       441 ~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  520 (570)
T 2z63_A          441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL  520 (570)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTC
T ss_pred             hhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCC
Confidence            999999999999999998 4455 89999999999999999999999999999999999999999999888888887 59


Q ss_pred             ceEEccCCccccccCCc
Q 002826          472 ALFNVSFNKLSGRVPYS  488 (876)
Q Consensus       472 ~~l~ls~N~l~~~~p~~  488 (876)
                      +.|++++|+++|.+|..
T Consensus       521 ~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          521 QKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             CEEECCSSCBCCCTTTT
T ss_pred             cEEEecCCcccCCCcch
Confidence            99999999999998853

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=5e-45  Score=425.58  Aligned_cols=407  Identities=21%  Similarity=0.253  Sum_probs=297.8

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS  155 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~  155 (876)
                      .+..++++++.+++..|..+..+++|++|+|++|++++..|..|+++++|++|+|++|+|          + .+|..  .
T Consensus        22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l----------~-~lp~~--~   88 (520)
T 2z7x_B           22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL----------V-KISCH--P   88 (520)
T ss_dssp             TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC----------C-EEECC--C
T ss_pred             cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce----------e-ecCcc--c
Confidence            455667777777666666677777777777777777776677777777777665554443          3 33444  6


Q ss_pred             ccccceecccccccCC-CcCccccCCCcceEEEccCCCCcCCCCCCcccccCcc--cEEEecCCCC--cccCCccccCCC
Q 002826          156 LVNLQVLNLGSNLLSG-SVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL--EQLFLQSSGF--HGVIPDSFVGLQ  230 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~~~~~~~l~  230 (876)
                      +++|++|+|++|++++ .+|..|+++++|++|+|++|++  ..  ..+..+++|  ++|++++|++  .+..|..|..+.
T Consensus        89 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l--~~--~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~  164 (520)
T 2z7x_B           89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHL--EK--SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN  164 (520)
T ss_dssp             CCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSC--CG--GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred             cCCccEEeccCCccccccchhhhccCCcceEEEecCccc--ch--hhccccccceeeEEEeecccccccccccccccccc
Confidence            7788888888888876 3677888888888888888873  22  356677777  8888888888  667777766654


Q ss_pred             -CCcEEecccCccCCCCCCccccccccccEEEecccc-------ccCcCCcccccCC-----------------------
Q 002826          231 -SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNK-------LSGSFPNGICKAN-----------------------  279 (876)
Q Consensus       231 -~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~-----------------------  279 (876)
                       +...+++++|++.+.++...+..+++|+.|++++|+       +.+.+| .+..++                       
T Consensus       165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~  243 (520)
T 2z7x_B          165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQL  243 (520)
T ss_dssp             EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHH
T ss_pred             cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHH
Confidence             233456666666666666555667777777777775       443333 344444                       


Q ss_pred             ----ccceeeeecccccccCCCCC-----ccccccceeecccccCCCCCC-cccCCC---CcccEEEecCCcccccCccc
Q 002826          280 ----GLVNLSLHKNFFNGSIPGSI-----NECLNLERFQVQDNGFSGDFP-DKLWSL---PRIKLIRAESNRFSGAIPDS  346 (876)
Q Consensus       280 ----~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~l---~~L~~L~L~~N~l~~~~~~~  346 (876)
                          +|++|++++|++++.+|..+     ..+++|+.+++++|.+  .+| ..+..+   ++|+.|++++|.+.+..  .
T Consensus       244 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~  319 (520)
T 2z7x_B          244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--C  319 (520)
T ss_dssp             HHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--C
T ss_pred             hhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--c
Confidence                55566666666665666655     6666666666666666  233 333333   45666677776665322  1


Q ss_pred             cccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccC--CCCCCcCCCCCccEEEccCCccccCCc--Cccccc
Q 002826          347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYG--SLPPNFCDSPVMSIINLSQNSISGQIP--ELKKCR  422 (876)
Q Consensus       347 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~~~~~~~~~~L~~L~Ls~N~l~~~~~--~~~~l~  422 (876)
                      +..+++|++|++++|++++.+|..++++++|+.|++++|++++  .+|..|..+++|++|++++|++++.+|  .+..++
T Consensus       320 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  399 (520)
T 2z7x_B          320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK  399 (520)
T ss_dssp             CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCT
T ss_pred             hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCc
Confidence            2678899999999999999899999999999999999999987  556789999999999999999998444  488999


Q ss_pred             ccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCcc---cCCCCCccc
Q 002826          423 KLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSL---ISGLPASYL  498 (876)
Q Consensus       423 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~---~~~~~~~~~  498 (876)
                      +|++|+|++|++++..|..+.  ++|+.|||++|+++ .+|..+..+ +++.|++++|+++ .+|...   +.++..+++
T Consensus       400 ~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l  475 (520)
T 2z7x_B          400 SLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWL  475 (520)
T ss_dssp             TCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred             cCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEEC
Confidence            999999999999988887775  79999999999999 788877776 6999999999998 577553   556777899


Q ss_pred             cCCCCCCCCC
Q 002826          499 QGNPGLCGPG  508 (876)
Q Consensus       499 ~~N~~~C~~~  508 (876)
                      .+||+.|+|+
T Consensus       476 ~~N~~~c~c~  485 (520)
T 2z7x_B          476 HTNPWDCSCP  485 (520)
T ss_dssp             CSSCBCCCHH
T ss_pred             cCCCCcccCC
Confidence            9999999875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.2e-43  Score=422.05  Aligned_cols=431  Identities=19%  Similarity=0.187  Sum_probs=330.8

Q ss_pred             ceEecCCCC------CccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccce
Q 002826           64 GVTCVTTAT------ASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV  137 (876)
Q Consensus        64 gv~c~~~~~------~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  137 (876)
                      .|.|...+.      .+..++.++|++|+|++..+.+|.++++|++|+|++|+|+++.|.+|++|++|++|+|++|    
T Consensus        35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N----  110 (635)
T 4g8a_A           35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN----  110 (635)
T ss_dssp             EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC----
T ss_pred             EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC----
Confidence            466764332      1235788999999999888889999999999999999999988899999999998866554    


Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG  217 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~  217 (876)
                            +|++..+..|.++++|++|+|++|+|++..+..|+++++|++|+|++|.+....+|..+..+++|++|+|++|+
T Consensus       111 ------~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~  184 (635)
T 4g8a_A          111 ------PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  184 (635)
T ss_dssp             ------CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             ------cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcc
Confidence                  55566677899999999999999999988888899999999999999985445667888999999999999999


Q ss_pred             CcccCCccccCCCCCc----EEecccCccCCCCCCccccccccccEEEecccc---------------------------
Q 002826          218 FHGVIPDSFVGLQSLS----ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNK---------------------------  266 (876)
Q Consensus       218 l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~---------------------------  266 (876)
                      ++++.+..|..+.+++    .++++.|.++ .++...+. ...+..+++.+|.                           
T Consensus       185 l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~-~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~  262 (635)
T 4g8a_A          185 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR  262 (635)
T ss_dssp             CCEECGGGGHHHHTCTTCCCEEECTTCCCC-EECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCT
T ss_pred             ccccccccccchhhhhhhhhhhhcccCccc-ccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccc
Confidence            9988888887766544    5777888776 44443332 2233344444332                           


Q ss_pred             -------------------------------------------------------ccCcCCcccccCCccceeeeecccc
Q 002826          267 -------------------------------------------------------LSGSFPNGICKANGLVNLSLHKNFF  291 (876)
Q Consensus       267 -------------------------------------------------------l~~~~~~~~~~l~~L~~L~L~~N~i  291 (876)
                                                                             +...  ..+....+|+.|++++|.+
T Consensus       263 ~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~  340 (635)
T 4g8a_A          263 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKF  340 (635)
T ss_dssp             TSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEE
T ss_pred             cccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccc
Confidence                                                                   1111  1122334455566666655


Q ss_pred             cccCCC-------------------CCccccccceeecccccCCC--CCCcccCCCCcccEEEecCCcccccCccccccC
Q 002826          292 NGSIPG-------------------SINECLNLERFQVQDNGFSG--DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA  350 (876)
Q Consensus       292 ~~~~~~-------------------~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  350 (876)
                      .+..+.                   .+..+++|+.|++++|.+..  ..+..+..+.+|+.+++..|.+.. .+..+..+
T Consensus       341 ~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l  419 (635)
T 4g8a_A          341 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGL  419 (635)
T ss_dssp             SSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTC
T ss_pred             cCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-cccccccc
Confidence            433222                   12345566666666666542  334445556666666666666653 34556778


Q ss_pred             CCCCeeeccCcccCCCCC-CccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcccc-CCc-CcccccccceE
Q 002826          351 AQLEQVQIDNNRFTSSIP-QGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG-QIP-ELKKCRKLVSL  427 (876)
Q Consensus       351 ~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~-~~~-~~~~l~~L~~L  427 (876)
                      ++|+.+++++|+.....+ ..+..+++++.++++.|.+.+..+..+..++.|+.|+|++|++.. .+| .|..+++|++|
T Consensus       420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L  499 (635)
T 4g8a_A          420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  499 (635)
T ss_dssp             TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence            889999998887775554 457889999999999999999999999999999999999998654 455 79999999999


Q ss_pred             eccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCcc---cCCCCCccccCCCC
Q 002826          428 SLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSL---ISGLPASYLQGNPG  503 (876)
Q Consensus       428 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~---~~~~~~~~~~~N~~  503 (876)
                      +|++|+|++.+|..|.++++|++|+|++|+|++..|..+..+ +|+.||+++|++++..|..+   ..++..+.+.+|||
T Consensus       500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~  579 (635)
T 4g8a_A          500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF  579 (635)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred             ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence            999999999999999999999999999999999888889888 59999999999998888654   35678889999999


Q ss_pred             CCCCCC
Q 002826          504 LCGPGL  509 (876)
Q Consensus       504 ~C~~~~  509 (876)
                      .|+|.+
T Consensus       580 ~C~C~~  585 (635)
T 4g8a_A          580 ACTCEH  585 (635)
T ss_dssp             CCSGGG
T ss_pred             cccCCc
Confidence            999863

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=2.9e-43  Score=403.51  Aligned_cols=362  Identities=19%  Similarity=0.201  Sum_probs=242.3

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccC-CCccCCccccceecccccccCCCcCccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKI-PESIGSLVNLQVLNLGSNLLSGSVPFVF  177 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~  177 (876)
                      ++|++|+|++|.+++..|..|+++++|++|+|++|          .+.+.+ |..|.++++|++|+|++|++++..|..|
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n----------~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~   99 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQ----------TPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAF   99 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCC----------STTCEECTTTTTTCTTCCEEECTTCTTCEECTTTT
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCC----------cccceECcccccccccCCEEeCCCCccCccChhhc
Confidence            67889999999998888888888888887765554          444333 5678888889999999998888888888


Q ss_pred             cCCCcceEEEccCCCCcCCCCCCc--ccccCcccEEEecCCCCcccCCcc-ccCCCCCcEEecccCccCCCCCCcccccc
Q 002826          178 GNFSELVVLDLSQNAYLISEIPSD--IGKLEKLEQLFLQSSGFHGVIPDS-FVGLQSLSILDLSQNNLTGEVPQSLGSSL  254 (876)
Q Consensus       178 ~~l~~L~~L~Ls~N~~~~~~~p~~--~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  254 (876)
                      +++++|++|+|++|++ .+.+|..  |..+++|++|+|++|++++..|.. |.++++|++|+|++|++++..|..+. .+
T Consensus       100 ~~l~~L~~L~L~~n~l-~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~-~l  177 (455)
T 3v47_A          100 NGLANLEVLTLTQCNL-DGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLL-NF  177 (455)
T ss_dssp             TTCTTCCEEECTTSCC-BTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSG-GG
T ss_pred             cCcccCCEEeCCCCCC-CccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhh-cc
Confidence            8888888888888873 2323333  778888888888888888877766 77888888888888888865555543 24


Q ss_pred             --ccccEEEeccccccCcCCccc--------ccCCccceeeeecccccccCCCCCccc---cccceeecccccCCCCCCc
Q 002826          255 --LKLVSFDVSQNKLSGSFPNGI--------CKANGLVNLSLHKNFFNGSIPGSINEC---LNLERFQVQDNGFSGDFPD  321 (876)
Q Consensus       255 --~~L~~L~L~~N~l~~~~~~~~--------~~l~~L~~L~L~~N~i~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~  321 (876)
                        .+|+.|++++|.+.+..+..+        ..+++|++|++++|.+++..|..+..+   ++|+.|++++|.+.+... 
T Consensus       178 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~-  256 (455)
T 3v47_A          178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF-  256 (455)
T ss_dssp             TTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCT-
T ss_pred             ccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccccc-
Confidence              678888888888876554432        245677777777777776666655544   667777777776543211 


Q ss_pred             ccCCCCcccEEEecCCcccccCccccccC--CCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCC
Q 002826          322 KLWSLPRIKLIRAESNRFSGAIPDSISMA--AQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSP  399 (876)
Q Consensus       322 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~  399 (876)
                                   ..+.+.+..+..+..+  ++|+.|++++|++++..|..+..+++|++|++++|++++..|..|.+++
T Consensus       257 -------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  323 (455)
T 3v47_A          257 -------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLT  323 (455)
T ss_dssp             -------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             -------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcc
Confidence                         1111111222222222  4566666666666665666666666666666666666666666666666


Q ss_pred             CccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEcc
Q 002826          400 VMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVS  477 (876)
Q Consensus       400 ~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls  477 (876)
                      +|++|+|++|++++.++ .|..+++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..+..+ +++.|+++
T Consensus       324 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  403 (455)
T 3v47_A          324 HLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLH  403 (455)
T ss_dssp             TCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEcc
Confidence            66666666666665544 45666666666666666666666666666666666666666665444445554 36666666


Q ss_pred             CCccccccC
Q 002826          478 FNKLSGRVP  486 (876)
Q Consensus       478 ~N~l~~~~p  486 (876)
                      +|++++.+|
T Consensus       404 ~N~l~~~~~  412 (455)
T 3v47_A          404 TNPWDCSCP  412 (455)
T ss_dssp             SSCBCCCTT
T ss_pred             CCCcccCCC
Confidence            666666665

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=1.3e-42  Score=408.88  Aligned_cols=403  Identities=22%  Similarity=0.255  Sum_probs=254.7

Q ss_pred             EeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCc--
Q 002826           79 SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSL--  156 (876)
Q Consensus        79 ~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l--  156 (876)
                      .++++++++++ +|..+.  ++|++|+|++|.+++..|..|+++++|++|+|++|          +|++..|..|.++  
T Consensus        35 ~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N----------~l~~~~~~~~~~l~~  101 (562)
T 3a79_B           35 MVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHN----------RIRSLDFHVFLFNQD  101 (562)
T ss_dssp             EEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSC----------CCCEECTTTTTTCTT
T ss_pred             EEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCC----------CCCcCCHHHhCCCCC
Confidence            34555555553 444333  55556666666655555555555555555533333          2333334444444  


Q ss_pred             -------------------cccceecccccccCCC-cCccccCCCcceEEEccCCCCcCCCCCCcccccCcc--cEEEec
Q 002826          157 -------------------VNLQVLNLGSNLLSGS-VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL--EQLFLQ  214 (876)
Q Consensus       157 -------------------~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L--~~L~L~  214 (876)
                                         ++|++|+|++|++++. .|..|+++++|++|+|++|++  ..  ..+..+++|  ++|+++
T Consensus       102 L~~L~Ls~N~l~~lp~~~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l--~~--~~~~~l~~L~L~~L~L~  177 (562)
T 3a79_B          102 LEYLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF--RQ--LDLLPVAHLHLSCILLD  177 (562)
T ss_dssp             CCEEECTTSCCCEECSCCCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBC--CT--TTTGGGTTSCEEEEEEE
T ss_pred             CCEEECCCCcCCccCccccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcc--cc--CchhhhhhceeeEEEee
Confidence                               4555555555555432 234455555555555555542  11  123333333  555555


Q ss_pred             CCCC--cccCCccccCCC--CCcEEecccCccCCCCCCccccccccccEEEecccc-----ccCcCCcccccC-------
Q 002826          215 SSGF--HGVIPDSFVGLQ--SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNK-----LSGSFPNGICKA-------  278 (876)
Q Consensus       215 ~n~l--~~~~~~~~~~l~--~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~-----l~~~~~~~~~~l-------  278 (876)
                      +|++  ++..|..|..+.  .| .+++++|.+.+.++...+..+++|+.|++++|+     +.+. ...+..+       
T Consensus       178 ~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~  255 (562)
T 3a79_B          178 LVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVT  255 (562)
T ss_dssp             ESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEE
T ss_pred             cccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEE
Confidence            5554  444444444432  12 334444444444444444456777777777774     1110 1112222       


Q ss_pred             --------------------CccceeeeecccccccCCCCC-----ccccccceeecccccCCCCCC-cccCC---CCcc
Q 002826          279 --------------------NGLVNLSLHKNFFNGSIPGSI-----NECLNLERFQVQDNGFSGDFP-DKLWS---LPRI  329 (876)
Q Consensus       279 --------------------~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~~~~---l~~L  329 (876)
                                          ++|++|++++|.+++.+|..+     ..+++|+.+++..|.+  .+| ..+..   ..+|
T Consensus       256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L  333 (562)
T 3a79_B          256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNI  333 (562)
T ss_dssp             EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCC
T ss_pred             ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcc
Confidence                                256666666666666666655     5555555555555555  233 22222   2457


Q ss_pred             cEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCC--CCCcCCCCCccEEEcc
Q 002826          330 KLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL--PPNFCDSPVMSIINLS  407 (876)
Q Consensus       330 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~--~~~~~~~~~L~~L~Ls  407 (876)
                      +.|++++|.+....  ....+++|++|++++|++++.+|..+.++++|+.|++++|++++..  |..|..+++|+.|+++
T Consensus       334 ~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~  411 (562)
T 3a79_B          334 KMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS  411 (562)
T ss_dssp             SEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECT
T ss_pred             eEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECC
Confidence            78888888775322  1267889999999999999889999999999999999999998743  5678999999999999


Q ss_pred             CCccccCCc--CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccc
Q 002826          408 QNSISGQIP--ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGR  484 (876)
Q Consensus       408 ~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~  484 (876)
                      +|++++.+|  .+..+++|++|+|++|++++.+|..+.  ++|++|+|++|+|+ .+|..+..+ +++.|++++|+++ .
T Consensus       412 ~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~  487 (562)
T 3a79_B          412 LNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-S  487 (562)
T ss_dssp             TSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-C
T ss_pred             CCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-C
Confidence            999998444  588899999999999999887777665  78999999999999 677766666 5899999999998 5


Q ss_pred             cCCcc---cCCCCCccccCCCCCCCCC
Q 002826          485 VPYSL---ISGLPASYLQGNPGLCGPG  508 (876)
Q Consensus       485 ~p~~~---~~~~~~~~~~~N~~~C~~~  508 (876)
                      +|...   +.++..+++.+|||.|+|+
T Consensus       488 l~~~~~~~l~~L~~L~l~~N~~~c~c~  514 (562)
T 3a79_B          488 VPDGVFDRLTSLQYIWLHDNPWDCTCP  514 (562)
T ss_dssp             CCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred             CCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence            66542   5567778899999999875

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=414.92  Aligned_cols=386  Identities=20%  Similarity=0.220  Sum_probs=311.3

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccc-cCCCccC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEG-KIPESIG  154 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~-~~p~~~~  154 (876)
                      .+..++++++.+++..|..++.+++|++|+|++|++++ +|..  .+++|++|+|++|          ++++ .+|..|+
T Consensus        46 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N----------~l~~~~~p~~~~  112 (520)
T 2z7x_B           46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFN----------AFDALPICKEFG  112 (520)
T ss_dssp             TCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEECCSS----------CCSSCCCCGGGG
T ss_pred             cccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEeccCC----------ccccccchhhhc
Confidence            57789999999999999999999999999999999996 5655  7889988866555          5555 4677888


Q ss_pred             CccccceecccccccCCCcCccccCCCcc--eEEEccCCCCc-CCCCCCcccc--------------------------c
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSEL--VVLDLSQNAYL-ISEIPSDIGK--------------------------L  205 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~~~-~~~~p~~~~~--------------------------l  205 (876)
                      ++++|++|+|++|++++   ..|..+++|  ++|+|++|++. .+..|..+..                          +
T Consensus       113 ~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l  189 (520)
T 2z7x_B          113 NMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV  189 (520)
T ss_dssp             GCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTC
T ss_pred             cCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcc
Confidence            88888888888888875   456667777  88888888731 2344544444                          5


Q ss_pred             CcccEEEecCCC-------CcccCCccccCCCCCcEEecccCccCCCCCCcccc--ccccccEEEeccccccCcCCccc-
Q 002826          206 EKLEQLFLQSSG-------FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS--SLLKLVSFDVSQNKLSGSFPNGI-  275 (876)
Q Consensus       206 ~~L~~L~L~~n~-------l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~--~l~~L~~L~L~~N~l~~~~~~~~-  275 (876)
                      ++|+.|++++|.       +.+.+| .|..+++|+.|++++|.+++..+..+..  ..++|++|++++|+++|.+|..+ 
T Consensus       190 ~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~  268 (520)
T 2z7x_B          190 ANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDF  268 (520)
T ss_dssp             SEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCC
T ss_pred             cceeeccccccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchh
Confidence            666666666665       555444 5667777777777777766432222211  13589999999999999999998 


Q ss_pred             ----ccCCccceeeeecccccccCC-CCCccc---cccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCcccc
Q 002826          276 ----CKANGLVNLSLHKNFFNGSIP-GSINEC---LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI  347 (876)
Q Consensus       276 ----~~l~~L~~L~L~~N~i~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~  347 (876)
                          .++++|+.+++++|.+  .+| ..+..+   .+|+.|++++|.+....  .+..+++|++|++++|++++..|..+
T Consensus       269 ~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~  344 (520)
T 2z7x_B          269 DYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENC  344 (520)
T ss_dssp             CCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTC
T ss_pred             hcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhh
Confidence                9999999999999999  445 455555   67999999999987433  12688999999999999999999999


Q ss_pred             ccCCCCCeeeccCcccCC--CCCCccccccCccEEeCCCccccCCCCC-CcCCCCCccEEEccCCccccCCc-Ccccccc
Q 002826          348 SMAAQLEQVQIDNNRFTS--SIPQGLGSVKSLYRFSASQNSFYGSLPP-NFCDSPVMSIINLSQNSISGQIP-ELKKCRK  423 (876)
Q Consensus       348 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~  423 (876)
                      ..+++|++|++++|++++  .+|..+..+++|+.|++++|.+++.+|. .|..+++|+.|++++|++++..+ .+.  ++
T Consensus       345 ~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~  422 (520)
T 2z7x_B          345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PR  422 (520)
T ss_dssp             CCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TT
T ss_pred             ccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--cc
Confidence            999999999999999996  5667899999999999999999985554 58899999999999999987666 443  79


Q ss_pred             cceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCc-cccc-ccceEEccCCccccccC
Q 002826          424 LVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG-LQNL-KLALFNVSFNKLSGRVP  486 (876)
Q Consensus       424 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-~l~~l~ls~N~l~~~~p  486 (876)
                      |++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +|.. +..+ +++.|++++|++++..+
T Consensus       423 L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~  485 (520)
T 2z7x_B          423 IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSCP  485 (520)
T ss_dssp             CCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccCC
Confidence            999999999999 778877799999999999999994 6654 7777 58999999999998766

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.3e-42  Score=394.75  Aligned_cols=357  Identities=20%  Similarity=0.251  Sum_probs=266.1

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCc-CccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSV-PFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS  215 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~  215 (876)
                      +|||++|++++..|..|+++++|++|+|++|.+.+.+ +..|.++++|++|+|++|++ .+..|..|.++++|++|+|++
T Consensus        34 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l-~~~~~~~~~~l~~L~~L~L~~  112 (455)
T 3v47_A           34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQ  112 (455)
T ss_dssp             EEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTT-CEECTTTTTTCTTCCEEECTT
T ss_pred             EEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCcc-CccChhhccCcccCCEEeCCC
Confidence            3355566667777888888888888888888887444 56788888888888888872 334466778888888888888


Q ss_pred             CCCcccCCcc--ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccC--Cccceeeeecccc
Q 002826          216 SGFHGVIPDS--FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA--NGLVNLSLHKNFF  291 (876)
Q Consensus       216 n~l~~~~~~~--~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~i  291 (876)
                      |++++..+..  |.++++|++|+|++|++++..|..++..+++|++|++++|++++..+..+..+  .+|+.|++++|.+
T Consensus       113 n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l  192 (455)
T 3v47_A          113 CNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL  192 (455)
T ss_dssp             SCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBC
T ss_pred             CCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcc
Confidence            8887644433  77788888888888888755566655667778888888777777777776665  5677777777777


Q ss_pred             cccCCCCCc--------cccccceeecccccCCCCCCcccCCC---CcccEEEecCCcccccCccccccCCCCCeeeccC
Q 002826          292 NGSIPGSIN--------ECLNLERFQVQDNGFSGDFPDKLWSL---PRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDN  360 (876)
Q Consensus       292 ~~~~~~~~~--------~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  360 (876)
                      .+..+..+.        .+++|++|++++|++++..|..+...   ++|+.|++++|.+.+.              .+..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~--------------~~~~  258 (455)
T 3v47_A          193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS--------------SFGH  258 (455)
T ss_dssp             TTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSC--------------CTTC
T ss_pred             cccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccccc--------------ccch
Confidence            655444322        34455555555555555444444332   4455555555544321              1112


Q ss_pred             cccCCCCCCccccc--cCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCC
Q 002826          361 NRFTSSIPQGLGSV--KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGE  437 (876)
Q Consensus       361 N~l~~~~p~~~~~l--~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~  437 (876)
                      +.+.+..+..+..+  ++|+.|++++|.+++..|..|..+++|+.|+|++|++++.++ .|..+++|++|+|++|++++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  338 (455)
T 3v47_A          259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSI  338 (455)
T ss_dssp             CSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             hhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCc
Confidence            23333333344433  689999999999999999999999999999999999999877 899999999999999999988


Q ss_pred             CCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCc--ccCCCCCccccCCCCCCCCC
Q 002826          438 IPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYS--LISGLPASYLQGNPGLCGPG  508 (876)
Q Consensus       438 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~--~~~~~~~~~~~~N~~~C~~~  508 (876)
                      .|..|..+++|++|+|++|++++..|..+..+ +++.|++++|++++..|..  .+.++..+++.+||+.|+|+
T Consensus       339 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          339 DSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            89999999999999999999999889999888 5999999999999644432  25677888999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-42  Score=386.19  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=196.1

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe------CCeE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS------DESI  653 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~  653 (876)
                      |.....+|.|+ ||+||+|.. .+|+.||||++.....  ...+.+.+|+++|+.++|||||++++++..      .+..
T Consensus        56 Y~~~~~lG~G~-fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~  134 (398)
T 4b99_A           56 YEIIETIGNGA-YGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV  134 (398)
T ss_dssp             EEEEEEEEECS-SCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred             eEEEEEEeccc-CeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence            44444555555 999999965 5899999999965432  223567899999999999999999999764      3679


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      |+|||||+ |+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       135 ~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          135 YVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             EEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             EEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            99999996 58999997654 799999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccc--cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccccc
Q 002826          734 EAA--FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGAI  809 (876)
Q Consensus       734 ~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~  809 (876)
                      ...  .........||+.|||||++.+. .++.++||||+||++|||++|++||.+......  ...+.... .......
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCGGGT
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCChHHh
Confidence            322  12234456799999999997764 579999999999999999999999987543321  12111111 1000000


Q ss_pred             cc------------c----ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          810 QV------------L----DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       810 ~~------------~----d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..            +    ...+..........+.+++.+||..||++|||+.|+++.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00            0    000111111224567899999999999999999999873

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2e-42  Score=379.91  Aligned_cols=258  Identities=19%  Similarity=0.296  Sum_probs=192.8

Q ss_pred             cccCCCCCCCCceEEEEEEe----CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL----PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |++.+..|.|+||+||+|+.    .+++.||+|++...  ....++.+|+++++.+ +|||||++++++.++++.|+|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            44444444455999999964    25789999998654  4566788999999998 69999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~~~~~~~  737 (876)
                      |+++|+|.+++.    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus       101 ~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          101 YLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             CCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             CCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999999984    489999999999999999999999   99999999999999876 7999999999976543211


Q ss_pred             --------------------------ccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcc
Q 002826          738 --------------------------QSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAE  790 (876)
Q Consensus       738 --------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~  790 (876)
                                                .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.....+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                      0112344699999999998765 5899999999999999999999999765544


Q ss_pred             hhhHHHHHHHHhh---------ccccc---ccc--------------cC---hhh----------hhhcHHHHHHHHHHH
Q 002826          791 SLDVVKWVRRKIN---------ITNGA---IQV--------------LD---PKI----------ANCYQQQMLGALEIA  831 (876)
Q Consensus       791 ~~~~~~~~~~~~~---------~~~~~---~~~--------------~d---~~~----------~~~~~~~~~~~~~li  831 (876)
                      ...+.........         .....   ...              .+   |..          ...+...+.++.+++
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence            3322222111000         00000   000              00   000          011112245678999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 002826          832 LRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       832 ~~cl~~dP~~RPs~~ell~  850 (876)
                      .+|++.||++|||++|+++
T Consensus       334 ~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHT
T ss_pred             HHHCcCChhHCcCHHHHhc
Confidence            9999999999999999986

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=2e-42  Score=406.52  Aligned_cols=399  Identities=17%  Similarity=0.186  Sum_probs=302.0

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc---------------ceeec
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI---------------WVLDL  140 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l---------------~~LdL  140 (876)
                      .+..++++++.+++..|..++.+++|++|+|++|.+++..|..|+++++|++|+|++|.+               ++|++
T Consensus        51 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L  130 (549)
T 2z81_A           51 NLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI  130 (549)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEE
T ss_pred             cccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEEC
Confidence            577899999999999999999999999999999999998888899999999998888764               34556


Q ss_pred             CCccccccC-CCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcc-cccCcccEEEecCCCC
Q 002826          141 SRNHIEGKI-PESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDI-GKLEKLEQLFLQSSGF  218 (876)
Q Consensus       141 ~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~-~~l~~L~~L~L~~n~l  218 (876)
                      ++|++.+.+ +..|.++++|++|+|++|++++..|..++++++|++|++++|.  ...+|..+ ..+++|++|++++|++
T Consensus       131 ~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~--~~~~~~~~~~~l~~L~~L~L~~n~l  208 (549)
T 2z81_A          131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE--SAFLLEIFADILSSVRYLELRDTNL  208 (549)
T ss_dssp             EESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB--STTHHHHHHHSTTTBSEEEEESCBC
T ss_pred             CCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc--ccccchhhHhhcccccEEEccCCcc
Confidence            666533333 3456666666666666666665566666666666666666665  34444432 3456666666666666


Q ss_pred             cccC--C-ccccCCCCCcEEecccCccCCCCCCcc---ccccccccEEEeccccccCcC---------------------
Q 002826          219 HGVI--P-DSFVGLQSLSILDLSQNNLTGEVPQSL---GSSLLKLVSFDVSQNKLSGSF---------------------  271 (876)
Q Consensus       219 ~~~~--~-~~~~~l~~L~~L~Ls~N~l~~~ip~~~---~~~l~~L~~L~L~~N~l~~~~---------------------  271 (876)
                      ++..  | .....+++|+.|++++|.+++..+..+   ...+++|+.+++++|.+.+..                     
T Consensus       209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l  288 (549)
T 2z81_A          209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI  288 (549)
T ss_dssp             TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred             ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence            5531  1 122345566666666666553222211   123556677777777665431                     


Q ss_pred             --------------CcccccCCccceeeeecccccccCCCCC-ccccccceeecccccCCCCCC---cccCCCCcccEEE
Q 002826          272 --------------PNGICKANGLVNLSLHKNFFNGSIPGSI-NECLNLERFQVQDNGFSGDFP---DKLWSLPRIKLIR  333 (876)
Q Consensus       272 --------------~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~  333 (876)
                                    +..+....+|+.|++++|.++ .+|..+ ..+++|++|++++|++++..|   ..+..+++|+.|+
T Consensus       289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~  367 (549)
T 2z81_A          289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV  367 (549)
T ss_dssp             ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred             cccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence                          111233467899999999998 455554 689999999999999998764   3478899999999


Q ss_pred             ecCCcccccCc--cccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcc
Q 002826          334 AESNRFSGAIP--DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI  411 (876)
Q Consensus       334 L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l  411 (876)
                      +++|++++..+  ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.+++. |..+  .++|++|+|++|+|
T Consensus       368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l  443 (549)
T 2z81_A          368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNL  443 (549)
T ss_dssp             CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEECCSSCC
T ss_pred             ccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh--cCCceEEECCCCCh
Confidence            99999987654  56899999999999999999 7888999999999999999999854 3333  26899999999999


Q ss_pred             ccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccC
Q 002826          412 SGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVP  486 (876)
Q Consensus       412 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p  486 (876)
                      ++.+   ..+++|++|+|++|+|+ .+|. ...+++|++|||++|+|++.+|..+..+ +++.|++++|++.+.+|
T Consensus       444 ~~~~---~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  514 (549)
T 2z81_A          444 DSFS---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  514 (549)
T ss_dssp             SCCC---CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred             hhhc---ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence            9864   57899999999999999 5665 5689999999999999999888888887 59999999999999888

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=1.9e-42  Score=375.41  Aligned_cols=295  Identities=27%  Similarity=0.472  Sum_probs=177.1

Q ss_pred             CCChhHHHHHHHHHhhccCCCCCCCCCCCCCCCCCcc--ccceEecCCCCCccEEEEeecCCCCCcc--cccccccCCCC
Q 002826           25 TSASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCN--WTGVTCVTTATASLTVASINLQSLNLSG--EISSSVCELSS  100 (876)
Q Consensus        25 ~~~~~~~~all~~k~~~~~~~~~~~sW~~~~~~~~C~--w~gv~c~~~~~~~~~~~~l~l~~~~l~~--~~~~~~~~l~~  100 (876)
                      .|.++|++||++||+++.||. .+++|..+  .+||.  |.||+|+..+. ..+|+.++|.+++++|  .+|+.++++++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~--~~~C~~~w~gv~C~~~~~-~~~l~~L~L~~~~l~~~~~~~~~l~~l~~   77 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDTQ-TYRVNNLDLSGLNLPKPYPIPSSLANLPY   77 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSSS-CCCEEEEEEECCCCSSCEECCGGGGGCTT
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCCC--CCCCcCCCcceEeCCCCC-CceEEEEECCCCCccCCcccChhHhCCCC
Confidence            478899999999999998876 78999754  47998  99999976431 1267777777777777  77777777777


Q ss_pred             CCeeecCC-CccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccC
Q 002826          101 LSNLNLAD-NLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGN  179 (876)
Q Consensus       101 L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  179 (876)
                      |++|+|++ |.+.+.+|..|+++++|++|+|          ++|++++.+|..|.++++|++|+|++|++++.+|..|++
T Consensus        78 L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~L----------s~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  147 (313)
T 1ogq_A           78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYI----------THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             CSEEEEEEETTEESCCCGGGGGCTTCSEEEE----------EEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred             CCeeeCCCCCcccccCChhHhcCCCCCEEEC----------cCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhc
Confidence            77777774 7776666666666666665533          334444556666666666666666666666555555555


Q ss_pred             CCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCC-CCcEEecccCccCCCCCCcccccccccc
Q 002826          180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQ-SLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       180 l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                      +++|++|+|++|+                         +++.+|..+..++ +|++|+|++|++++.+|..+.. +. |+
T Consensus       148 l~~L~~L~L~~N~-------------------------l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~-l~-L~  200 (313)
T 1ogq_A          148 LPNLVGITFDGNR-------------------------ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LN-LA  200 (313)
T ss_dssp             CTTCCEEECCSSC-------------------------CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG-CC-CS
T ss_pred             CCCCCeEECcCCc-------------------------ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhC-Cc-cc
Confidence            5555555555554                         4444444444444 4555555555555444443322 32 55


Q ss_pred             EEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCc
Q 002826          259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR  338 (876)
Q Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  338 (876)
                      +|+|++|++++..|..|..+++|++|+|++|.+++.+|. +..+++|++|++++|++++.+|..+..+++|+.|++++|+
T Consensus       201 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~  279 (313)
T 1ogq_A          201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN  279 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSE
T ss_pred             EEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCc
Confidence            555555555444444455555555555555555443333 4444555555555555555555555555555555555555


Q ss_pred             ccccCccccccCCCCCeeeccCcc
Q 002826          339 FSGAIPDSISMAAQLEQVQIDNNR  362 (876)
Q Consensus       339 l~~~~~~~~~~l~~L~~L~L~~N~  362 (876)
                      +++.+|.. ..+++|+.|++++|+
T Consensus       280 l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          280 LCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             ccccCCCC-ccccccChHHhcCCC
Confidence            55555443 444555555555554

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-42  Score=400.33  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      +.+...|.-...+|.|+ ||+||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+++..|+
T Consensus       153 ~~il~~Y~i~~~lG~G~-fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGA-FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             SCGGGTEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEE
T ss_pred             CcCccccEEEEEEeecc-CeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            33444444445555555 999999966 4799999999977655556788999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC--CCeEEccccchhhcc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD--FEPKLTDFALDRIVG  733 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~--~~~kl~DfGla~~~~  733 (876)
                      |||||+||+|.+++.+....+++..+..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+.
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~  308 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  308 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence            9999999999999977666899999999999999999999999   99999999999999854  899999999998876


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ....   .....||+.|||||++.+..++.++||||+||++|||++|++||........  ...+.   ...   ....+
T Consensus       309 ~~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--~~~i~---~~~---~~~~~  377 (573)
T 3uto_A          309 PKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVK---SCD---WNMDD  377 (573)
T ss_dssp             TTSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH---TTC---CCCCS
T ss_pred             CCCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHH---hCC---CCCCc
Confidence            4432   2334699999999999999999999999999999999999999986543321  11111   111   11111


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +..    ...+..+.++|.+||+.||++|||+.|+++.
T Consensus       378 ~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          378 SAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111    1223457899999999999999999999873

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-41  Score=368.85  Aligned_cols=273  Identities=32%  Similarity=0.535  Sum_probs=223.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +|.....+|.|| ||.||+|...+|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        40 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  118 (321)
T 2qkw_B           40 NFDHKFLIGHGV-FGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME  118 (321)
T ss_dssp             CCSCCCCSCBCS-SSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred             ccCccceeecCC-CeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence            455555555555 9999999988899999999876655556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccC---CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          662 MGSLGDLICRQD---FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       662 ~gsL~~~l~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      +|+|.+++....   ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus       119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  195 (321)
T 2qkw_B          119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT  195 (321)
T ss_dssp             TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred             CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            999999997553   3589999999999999999999999   9999999999999999999999999999875533222


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-hhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .....|...... .......+++...
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  274 (321)
T 2qkw_B          196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQIVDPNLA  274 (321)
T ss_dssp             CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCSSSSSSCT
T ss_pred             ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHHhcChhhc
Confidence            22334458999999999888889999999999999999999999998654332 344444433221 1223444454443


Q ss_pred             -hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          818 -NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       818 -~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                       ....+....+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence             344567788999999999999999999999999999886543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.9e-41  Score=390.77  Aligned_cols=246  Identities=19%  Similarity=0.205  Sum_probs=194.0

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHH---HHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKT---EVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||+||+|+.. +|+.||||++.+..   ......+.+   ++++++.++|||||+++++|.+.+..|+
T Consensus       191 f~i~k~LG~G~-fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lyl  269 (689)
T 3v5w_A          191 FSVHRIIGRGG-FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF  269 (689)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             eEEEEEEeccc-CeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEE
Confidence            44445555555 9999999664 79999999996531   122333334   4666777799999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||++||+|.+++.+.+ .+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       270 VmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          270 ILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            999999999999998765 699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      .    ....+||+.|||||++.. ..|+.++||||+||++|||++|++||........  ....+.......        
T Consensus       346 ~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~~i~~~~~--------  411 (689)
T 3v5w_A          346 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTMAV--------  411 (689)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHHHHHHCCC--------
T ss_pred             C----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhhcCCCC--------
Confidence            2    234569999999999864 5789999999999999999999999976443322  122222111110        


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVK  850 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~  850 (876)
                      .+   +...+.++.++|.+|++.||++|++     +.||++
T Consensus       412 ~~---p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          412 EL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CC---CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            01   1112345789999999999999998     677765

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=9.9e-41  Score=379.99  Aligned_cols=364  Identities=24%  Similarity=0.322  Sum_probs=165.2

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcc---cceeecCCccccccCCCc
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNL---IWVLDLSRNHIEGKIPES  152 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~---l~~LdL~~n~l~~~~p~~  152 (876)
                      ++..+++.++++ |.+|++++++++|++|++++|.+.+.+|..++++++|+.++++.|.   ++.|++++|++++ +|..
T Consensus        12 ~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~   89 (454)
T 1jl5_A           12 FLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL   89 (454)
T ss_dssp             -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC
T ss_pred             cchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC
Confidence            677889999999 8999999999999999999999999999999999987555444432   3445555555543 2221


Q ss_pred             cCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCC
Q 002826          153 IGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL  232 (876)
Q Consensus       153 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  232 (876)
                         .++|++|+|++|++++ +|..   +++|++|++++|+  +..+|...   ++|++|++++|++++ +| .|.++++|
T Consensus        90 ---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~--l~~l~~~~---~~L~~L~L~~n~l~~-lp-~~~~l~~L  155 (454)
T 1jl5_A           90 ---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNN--LKALSDLP---PLLEYLGVSNNQLEK-LP-ELQNSSFL  155 (454)
T ss_dssp             ---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSC--CSCCCSCC---TTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred             ---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCc--cCcccCCC---CCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence               2345555555555553 3322   2445555555554  22333211   345555555555554 33 35555555


Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      ++|++++|+++ .+|..    .++|++|++++|++++ +| .+..+++|++|++++|++++ +|...   ++|++|++++
T Consensus       156 ~~L~l~~N~l~-~lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~  224 (454)
T 1jl5_A          156 KIIDVDNNSLK-KLPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGN  224 (454)
T ss_dssp             CEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCS
T ss_pred             CEEECCCCcCc-ccCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcC
Confidence            55555555554 24432    2345555555555553 23 34555555555555555543 22211   2455555555


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCC--
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGS--  390 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--  390 (876)
                      |+++ .+|. +..+++|+.|++++|++++ +|..   .++|++|++++|++++ +|..   .++|+.|++++|++++.  
T Consensus       225 n~l~-~lp~-~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~~  294 (454)
T 1jl5_A          225 NILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE  294 (454)
T ss_dssp             SCCS-SCCC-CTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC
T ss_pred             CcCC-cccc-cCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcccC
Confidence            5554 3332 4445555555555555543 2221   2444555555555443 2322   13444444444444431  


Q ss_pred             CCCC-------------cCCC-CCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCC
Q 002826          391 LPPN-------------FCDS-PVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDN  456 (876)
Q Consensus       391 ~~~~-------------~~~~-~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  456 (876)
                      .|..             +..+ ++|+.|++++|++++.+..   +++|++|+|++|++++ +|.   .+++|++|++++|
T Consensus       295 ~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N  367 (454)
T 1jl5_A          295 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYN  367 (454)
T ss_dssp             CCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSS
T ss_pred             cCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccccc---CCcCCEEECCCCcccc-ccc---hhhhccEEECCCC
Confidence            1100             1112 3566666666666553222   3556666666666663 333   3556666666666


Q ss_pred             cccc--cCCCccccc--------------ccceEEccCCcccc
Q 002826          457 NLTG--PIPQGLQNL--------------KLALFNVSFNKLSG  483 (876)
Q Consensus       457 ~l~~--~~p~~~~~l--------------~l~~l~ls~N~l~~  483 (876)
                      ++++  .+|.++..+              +++.||+++|+++|
T Consensus       368 ~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~  410 (454)
T 1jl5_A          368 PLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE  410 (454)
T ss_dssp             CCSSCCCCCTTCCEEECCC------------------------
T ss_pred             CCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence            6665  455555443              24555555555554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7e-40  Score=385.48  Aligned_cols=399  Identities=18%  Similarity=0.211  Sum_probs=317.8

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCccc-----------ceeecCCcc
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI-----------WVLDLSRNH  144 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l-----------~~LdL~~n~  144 (876)
                      .+..++++++.+++..+..+..+++|++|+|++|++++..|..|+++++|++|+|++|.|           ++|||++|+
T Consensus        53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~l~~L~~L~Ls~N~  132 (562)
T 3a79_B           53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLRHLDLSFND  132 (562)
T ss_dssp             TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSCCCTTCSEEECCSSC
T ss_pred             CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCccccccCCEEECCCCC
Confidence            577899999999998889999999999999999999999999999999999999999975           579999999


Q ss_pred             ccc-cCCCccCCccccceecccccccCCCcCccccCCCcc--eEEEccCCCCc-CCCCCCcccccC-cccEEEecCCCCc
Q 002826          145 IEG-KIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL--VVLDLSQNAYL-ISEIPSDIGKLE-KLEQLFLQSSGFH  219 (876)
Q Consensus       145 l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~~~-~~~~p~~~~~l~-~L~~L~L~~n~l~  219 (876)
                      +++ .+|..|+++++|++|+|++|++++.   .|.++++|  ++|+|++|++. .+..|..+..+. +.-.++++.|.+.
T Consensus       133 l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~  209 (562)
T 3a79_B          133 FDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF  209 (562)
T ss_dssp             CSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCC
T ss_pred             ccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccch
Confidence            997 4578999999999999999999864   45555555  99999999831 345566666654 1114455666655


Q ss_pred             ccCCc-cccCCCCCcEEecccC----------------------------ccCCC----CCCccccccccccEEEecccc
Q 002826          220 GVIPD-SFVGLQSLSILDLSQN----------------------------NLTGE----VPQSLGSSLLKLVSFDVSQNK  266 (876)
Q Consensus       220 ~~~~~-~~~~l~~L~~L~Ls~N----------------------------~l~~~----ip~~~~~~l~~L~~L~L~~N~  266 (876)
                      +.+++ .+..+++|+.|++++|                            .+++.    ++...  ..++|++|++++|+
T Consensus       210 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~--~~~~L~~L~l~~n~  287 (562)
T 3a79_B          210 SVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF--WPRPVEYLNIYNLT  287 (562)
T ss_dssp             CCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH--TTSSEEEEEEEEEE
T ss_pred             hhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh--hcccccEEEEeccE
Confidence            44332 2344555555555555                            33311    11111  13489999999999


Q ss_pred             ccCcCCccc-----ccCCccceeeeecccccccCC-CCCccc---cccceeecccccCCCCCCcccCCCCcccEEEecCC
Q 002826          267 LSGSFPNGI-----CKANGLVNLSLHKNFFNGSIP-GSINEC---LNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN  337 (876)
Q Consensus       267 l~~~~~~~~-----~~l~~L~~L~L~~N~i~~~~~-~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  337 (876)
                      ++|.+|..+     .+++.|+.++++.|.+  .+| ..+..+   .+|++|++++|.+....  ....+++|++|++++|
T Consensus       288 l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n  363 (562)
T 3a79_B          288 ITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQN  363 (562)
T ss_dssp             ECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSS
T ss_pred             eeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCC
Confidence            999999887     7778888888888877  333 223222   57999999999986432  1267899999999999


Q ss_pred             cccccCccccccCCCCCeeeccCcccCCC--CCCccccccCccEEeCCCccccCCCC-CCcCCCCCccEEEccCCccccC
Q 002826          338 RFSGAIPDSISMAAQLEQVQIDNNRFTSS--IPQGLGSVKSLYRFSASQNSFYGSLP-PNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       338 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                      ++++..|..+..+++|++|++++|++++.  +|..+.++++|+.|++++|++++.+| ..|..+++|+.|+|++|++++.
T Consensus       364 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~  443 (562)
T 3a79_B          364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS  443 (562)
T ss_dssp             CCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGG
T ss_pred             ccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcc
Confidence            99999999999999999999999999963  35678999999999999999998444 5688999999999999999876


Q ss_pred             Cc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCc-cccc-ccceEEccCCccccccCC
Q 002826          415 IP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG-LQNL-KLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       415 ~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l-~l~~l~ls~N~l~~~~p~  487 (876)
                      .+ .+.  ++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|.. +..+ +++.|++++|++.+.+|.
T Consensus       444 ~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  515 (562)
T 3a79_B          444 VFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG  515 (562)
T ss_dssp             GGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred             hhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence            65 333  79999999999999 67777779999999999999999 46655 7777 588999999999987774

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.2e-40  Score=362.09  Aligned_cols=283  Identities=30%  Similarity=0.514  Sum_probs=222.0

Q ss_pred             cccchhhhhh--cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          572 LRVTEHDLVI--GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       572 ~~~~~~~l~~--~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      .+++..++..  +.+...+..|.|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            3455555554  33444444444559999999988899999999865432 23347899999999999999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      +.+..++||||+++|+|.+++...   ...+++..+..++.|++.|++|||+.+.++|+||||||+||+++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            999999999999999999999765   33499999999999999999999998777999999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCC---CcchhhHHHHHHHHh
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAE---PAESLDVVKWVRRKI  802 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~---~~~~~~~~~~~~~~~  802 (876)
                      ||+++....... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||...   ........+|.....
T Consensus       178 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          178 FGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             CccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            999987653322 2233445899999999988888999999999999999999999999631   122233444544332


Q ss_pred             hcccccccccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          803 NITNGAIQVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      .. .......++... ....++...+.+++.+||+.||++|||++|++++|++..
T Consensus       257 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          257 KE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            21 123333344333 445677788999999999999999999999999998743

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.2e-39  Score=369.29  Aligned_cols=350  Identities=16%  Similarity=0.201  Sum_probs=237.4

Q ss_pred             ccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccc
Q 002826           89 GEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNL  168 (876)
Q Consensus        89 ~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~  168 (876)
                      +..+.+++++++|++|+|++|.+++. | .|+.+++|++|+|++|.          +++. |  ++.+++|++|+|++|+
T Consensus        32 ~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~----------l~~~-~--~~~l~~L~~L~Ls~N~   96 (457)
T 3bz5_A           32 ATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNN----------ITTL-D--LSQNTNLTYLACDSNK   96 (457)
T ss_dssp             TTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSC----------CSCC-C--CTTCTTCSEEECCSSC
T ss_pred             cccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCc----------CCeE-c--cccCCCCCEEECcCCC
Confidence            34445666777777777777777764 4 57777777766554443          3332 2  6667777777777777


Q ss_pred             cCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCC
Q 002826          169 LSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ  248 (876)
Q Consensus       169 l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~  248 (876)
                      +++. +  |+++++|++|+|++|+  +..+|  +..+++|++|++++|+++++   .+.++++|++|++++|+..+.++ 
T Consensus        97 l~~~-~--~~~l~~L~~L~L~~N~--l~~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~~-  165 (457)
T 3bz5_A           97 LTNL-D--VTPLTKLTYLNCDTNK--LTKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD-  165 (457)
T ss_dssp             CSCC-C--CTTCTTCCEEECCSSC--CSCCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCCC-
T ss_pred             Ccee-e--cCCCCcCCEEECCCCc--CCeec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCcccccc-
Confidence            7654 2  6677777777777776  34444  66677777777777777764   26667777777777775444552 


Q ss_pred             ccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCc
Q 002826          249 SLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPR  328 (876)
Q Consensus       249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  328 (876)
                        +..+++|++|++++|++++. |  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +..+++
T Consensus       166 --~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~  234 (457)
T 3bz5_A          166 --VTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ  234 (457)
T ss_dssp             --CTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred             --cccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence              23466777777777777753 3  66667777777777777654   36667777777777777775 34  666777


Q ss_pred             ccEEEecCCcccccCccccccCC-------CCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCC--------
Q 002826          329 IKLIRAESNRFSGAIPDSISMAA-------QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP--------  393 (876)
Q Consensus       329 L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~--------  393 (876)
                      |+.|++++|++++..+..+..+.       +|+.|++++|++.+.+|  ++.+++|+.|++++|.+.+.+|.        
T Consensus       235 L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L  312 (457)
T 3bz5_A          235 LTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITEL  312 (457)
T ss_dssp             CSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCC
T ss_pred             CCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEe
Confidence            77777777777766555444443       45667777777666665  45677888888888876665553        


Q ss_pred             CcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccccce
Q 002826          394 NFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLAL  473 (876)
Q Consensus       394 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~  473 (876)
                      .+.++++|+.|++++|+|++.  .+..+++|+.|++++|+|++        ++.|..|++++|.++|. +   ....+..
T Consensus       313 ~l~~~~~L~~L~L~~N~l~~l--~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-~---~~~~l~~  378 (457)
T 3bz5_A          313 DLSQNPKLVYLYLNNTELTEL--DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-G---QTITMPK  378 (457)
T ss_dssp             CCTTCTTCCEEECTTCCCSCC--CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-E---EEEECCC
T ss_pred             chhhcccCCEEECCCCccccc--ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-c---eeeecCc
Confidence            245557788888888888875  37888888888888888885        35677788888888875 1   1124677


Q ss_pred             EEccCCccccccCCcccC
Q 002826          474 FNVSFNKLSGRVPYSLIS  491 (876)
Q Consensus       474 l~ls~N~l~~~~p~~~~~  491 (876)
                      +++++|+++|.+|..++.
T Consensus       379 l~l~~N~l~g~ip~~~~~  396 (457)
T 3bz5_A          379 ETLTNNSLTIAVSPDLLD  396 (457)
T ss_dssp             BCCBTTBEEEECCTTCBC
T ss_pred             cccccCcEEEEcChhHhc
Confidence            899999999999976543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.8e-40  Score=352.85  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=206.7

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ++....|.....+|.|+ ||+||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++...+..++
T Consensus        16 ~~~~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGA-SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             SCGGGTBCCCEEEEEET-TEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CChhhceeeeeeeccCC-CeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            34444555556666666 999999975 5899999999987666677889999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++|+|.+++.+.  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        95 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             EEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999999764  589999999999999999999999   9999999999999999999999999998876543


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ..  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........  ..........     ....  
T Consensus       170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~-----~~~~--  238 (297)
T 3fxz_A          170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATNGTP-----ELQN--  238 (297)
T ss_dssp             TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHHCSC-----CCSC--
T ss_pred             cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCCCC-----CCCC--
Confidence            22  23345689999999999888899999999999999999999999976543321  1111111000     0000  


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                          .......+.+++.+||+.||++|||+.|+++.
T Consensus       239 ----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          239 ----PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                11223457899999999999999999999873

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=359.45  Aligned_cols=255  Identities=28%  Similarity=0.482  Sum_probs=206.0

Q ss_pred             CCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ..+|.|| ||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus        16 ~~lG~G~-~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           16 EVLGKGC-FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEECCS-SEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCC-CEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            4455555 9999999764 7999999998766555667899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc------
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS------  739 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~------  739 (876)
                      .+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........      
T Consensus        95 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  171 (310)
T 3s95_A           95 RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL  171 (310)
T ss_dssp             HHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------------
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccc
Confidence            999988777899999999999999999999999   99999999999999999999999999998765332111      


Q ss_pred             ------ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          740 ------TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       740 ------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                            ......||+.|+|||.+.+..++.++||||||+++|||++|..||....................         
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~---------  242 (310)
T 3s95_A          172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR---------  242 (310)
T ss_dssp             --------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH---------
T ss_pred             cccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc---------
Confidence                  11144689999999999999999999999999999999999999876443322110001100000         


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                          ......+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       243 ----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          243 ----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                00111223578999999999999999999999999998653

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=363.12  Aligned_cols=265  Identities=21%  Similarity=0.291  Sum_probs=206.6

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      .+.+.+.+..|.|+||+||+|...    .+..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            333444444455559999999774    34569999997542 2334678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++++|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            9999999999999987766899999999999999999999999   9999999999999999999999999999877543


Q ss_pred             cc-ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          736 AF-QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       736 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      .. ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+......      .. 
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~~------~~-  275 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYRL------PA-  275 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCC------CC-
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCCC------CC-
Confidence            21 122333446778999999988889999999999999999999 999997644332  22221111000      00 


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccc
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS  863 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~  863 (876)
                            ....+..+.+++.+||+.||++|||+.|+++.|+++.......+
T Consensus       276 ------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~  319 (325)
T 3kul_A          276 ------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLR  319 (325)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC---
T ss_pred             ------CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccccc
Confidence                  11223467899999999999999999999999999987665543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.7e-40  Score=349.76  Aligned_cols=254  Identities=22%  Similarity=0.381  Sum_probs=209.0

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .....+|.|| ||+||+|...+++.||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||++++
T Consensus        13 ~~~~~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           13 TFVQEIGSGQ-FGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             EEEEEEEECS-SCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             eeeheecCCC-ccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            3345556555 999999998889999999997543 45678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus        91 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  166 (269)
T 4hcu_A           91 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTG  166 (269)
T ss_dssp             BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTS
T ss_pred             cHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc-ccccC
Confidence            99999987777899999999999999999999999   999999999999999999999999999987654322 22334


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..+++.|+|||......++.++||||+|+++|||++ |+.||.......  .......   .   .. ...+.      .
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~---~---~~-~~~~~------~  231 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST---G---FR-LYKPR------L  231 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---T---CC-CCCCT------T
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhc---C---cc-CCCCC------c
Confidence            446788999999988889999999999999999999 999997654332  1111111   1   00 01111      1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ....+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            133578999999999999999999999999998764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.9e-40  Score=365.82  Aligned_cols=253  Identities=24%  Similarity=0.400  Sum_probs=204.2

Q ss_pred             cCCCCCCCCceEEEEEEe--------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEE
Q 002826          586 KSSAGNGGPFGRVYILSL--------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  655 (876)
                      ...+|.|+ ||.||+|+.        .++..||||++..... ...+.+.+|+++++++ +||||+++++++.+++..|+
T Consensus        86 ~~~LG~G~-fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  164 (370)
T 2psq_A           86 GKPLGEGC-FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  164 (370)
T ss_dssp             EEEESCCS-SSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred             eeEEeeCC-CeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence            34455555 999999965        2456899999965432 2245788999999999 89999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC
Q 002826          656 IYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE  720 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~  720 (876)
                      ||||+++|+|.+++....               ..+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.
T Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~  241 (370)
T 2psq_A          165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV  241 (370)
T ss_dssp             EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred             EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCC
Confidence            999999999999997643               3488999999999999999999999   9999999999999999999


Q ss_pred             eEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHH
Q 002826          721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVR  799 (876)
Q Consensus       721 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~  799 (876)
                      +||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........  ...+.
T Consensus       242 ~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~--~~~~~  319 (370)
T 2psq_A          242 MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--FKLLK  319 (370)
T ss_dssp             EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHH
T ss_pred             EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH--HHHHh
Confidence            99999999987664433333344457889999999988899999999999999999999 9999987554332  22211


Q ss_pred             HHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       800 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ...      ..    .   ........+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       320 ~~~------~~----~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~  364 (370)
T 2psq_A          320 EGH------RM----D---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  364 (370)
T ss_dssp             TTC------CC----C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC------CC----C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            110      00    0   011223467899999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.9e-39  Score=350.00  Aligned_cols=264  Identities=33%  Similarity=0.515  Sum_probs=212.5

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCC----ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ..+|.|| ||.||+|.. +++.||+|++....    ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        37 ~~lg~G~-~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  114 (307)
T 2nru_A           37 NKMGEGG-FGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN  114 (307)
T ss_dssp             CEEEECS-SEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             CccccCC-CeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCC
Confidence            4455555 999999987 78999999986532    12346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcc--CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          663 GSLGDLICRQ--DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       663 gsL~~~l~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++|.+++...  ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus       115 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  191 (307)
T 2nru_A          115 GSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM  191 (307)
T ss_dssp             CBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred             CcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence            9999998643  34689999999999999999999999   999999999999999999999999999987654332223


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|+|||...+ .++.++||||||+++|||++|++||........ ...+..............+++.+....
T Consensus       192 ~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          192 TSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             CSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             ccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHHHHHhhhhhhhhhhhccccccccc
Confidence            334568999999998765 578999999999999999999999986543321 122222222222223444455555556


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ......+.+++.+||+.||++|||++|+++.|+++..
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            6677889999999999999999999999999998754

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=6.2e-39  Score=368.24  Aligned_cols=342  Identities=25%  Similarity=0.376  Sum_probs=180.2

Q ss_pred             EEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCc
Q 002826           77 VASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSL  156 (876)
Q Consensus        77 ~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l  156 (876)
                      +..+++.++++.. +| .+..+++|++|+|++|.+++..|  ++++++|++|+|++|          ++++..|  ++++
T Consensus        48 l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n----------~l~~~~~--~~~l  111 (466)
T 1o6v_A           48 VTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN----------QIADITP--LANL  111 (466)
T ss_dssp             CCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS----------CCCCCGG--GTTC
T ss_pred             ccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCC----------ccccChh--hcCC
Confidence            3344555555443 22 25556666666666666655433  555555555543333          3333222  5556


Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      ++|++|+|++|++++..+  +.++++|++|+|++|.  +..+| .+..+++|++|+++ |.+.+..  .+.++++|++|+
T Consensus       112 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~--l~~~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~  183 (466)
T 1o6v_A          112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNT--ISDIS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLD  183 (466)
T ss_dssp             TTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEE--ECCCG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCc--cCCCh-hhccCCcccEeecC-CcccCch--hhccCCCCCEEE
Confidence            666666666666654332  5566666666666665  33333 35556666666654 3343322  255566666666


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      +++|+++ .++.  +..+++|++|++++|++++..|  +..+++|++|++++|.+++.  ..+..+++|+.|++++|.++
T Consensus       184 l~~n~l~-~~~~--l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~  256 (466)
T 1o6v_A          184 ISSNKVS-DISV--LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS  256 (466)
T ss_dssp             CCSSCCC-CCGG--GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred             CcCCcCC-CChh--hccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccc
Confidence            6666655 3332  2345566666666666554433  44555566666666655532  23555555555555555555


Q ss_pred             CCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcC
Q 002826          317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFC  396 (876)
Q Consensus       317 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~  396 (876)
                      +..+  +..+++|+.|++++|++++..+  +..+++|+.|++++|++++..|  +..+++|+.|++++|++++..|  +.
T Consensus       257 ~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~  328 (466)
T 1o6v_A          257 NLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VS  328 (466)
T ss_dssp             CCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GG
T ss_pred             cchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hc
Confidence            4433  5555555555555555554433  5555555555555555554332  4555555555555555554443  44


Q ss_pred             CCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          397 DSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       397 ~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      .+++|+.|++++|++++. +.+..+++|+.|++++|++++..|  +..+++|+.|++++|++++
T Consensus       329 ~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          329 SLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             GCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             cCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            555555555555555543 345555555555555555554444  5555555555555555553

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4e-40  Score=349.26  Aligned_cols=254  Identities=23%  Similarity=0.374  Sum_probs=207.3

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ....+|.|| ||.||+|+..++..||+|++.... ...+++.+|++++++++||||+++++++.+++..++||||+++++
T Consensus        12 ~~~~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   89 (268)
T 3sxs_A           12 LLKELGSGQ-FGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGC   89 (268)
T ss_dssp             EEEEEEEET-TEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred             eeeeeccCC-CceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence            334455555 999999999888899999997543 456789999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++...+..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........ .....
T Consensus        90 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~  165 (268)
T 3sxs_A           90 LLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGT  165 (268)
T ss_dssp             HHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSC
T ss_pred             HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCC
Confidence            9999987766799999999999999999999999   9999999999999999999999999999876543322 22334


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .+|+.|+|||...+..++.++||||+|+++|||++ |+.||........  .....   ...    ....+.      ..
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~---~~~----~~~~~~------~~  230 (268)
T 3sxs_A          166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--VLKVS---QGH----RLYRPH------LA  230 (268)
T ss_dssp             CCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHH---TTC----CCCCCT------TS
T ss_pred             CcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--HHHHH---cCC----CCCCCC------cC
Confidence            46778999999888888999999999999999999 9999976443321  11111   110    001111      11


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ...+.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            235789999999999999999999999999997654

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=371.59  Aligned_cols=316  Identities=20%  Similarity=0.200  Sum_probs=192.5

Q ss_pred             ecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCC
Q 002826          139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGF  218 (876)
Q Consensus       139 dL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l  218 (876)
                      +.++++++ .+|..+.  +++++|+|++|+|++..|..|.++++|++|+|++|. +.+..|..|.++++|++|+|++|++
T Consensus        17 ~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~n~l   92 (477)
T 2id5_A           17 LCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VSAVEPGAFNNLFNLRTLGLRSNRL   92 (477)
T ss_dssp             ECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSC-CCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             EeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCc-cCEeChhhhhCCccCCEEECCCCcC
Confidence            33444443 3344332  356666666666665555566666666666666664 1222244455555555555555555


Q ss_pred             cccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCC
Q 002826          219 HGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS  298 (876)
Q Consensus       219 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~  298 (876)
                      +++.+..|.++++|++|+|++|++++ +++..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..
T Consensus        93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  171 (477)
T 2id5_A           93 KLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEA  171 (477)
T ss_dssp             CSCCTTSSTTCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHH
T ss_pred             CccCcccccCCCCCCEEECCCCcccc-CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhH
Confidence            55555566777777777777777763 33333445677777777777777666666666777777777777766655555


Q ss_pred             CccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCcc
Q 002826          299 INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY  378 (876)
Q Consensus       299 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  378 (876)
                      |..+++|+.|++++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|++|++++|++++..+..+.++++|+
T Consensus       172 l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~  251 (477)
T 2id5_A          172 LSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR  251 (477)
T ss_dssp             HTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCC
T ss_pred             hcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccC
Confidence            66666666666666666666666666666666666666666555555555555666666666666643334566666666


Q ss_pred             EEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCc
Q 002826          379 RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       379 ~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      .|++++|.+++..+..|..+++|+.|+|++|++++..+ .|..+++|++|+|++|+|++..+..|..+++|++|+|++|+
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  331 (477)
T 2id5_A          252 FLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP  331 (477)
T ss_dssp             EEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSC
T ss_pred             eeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCC
Confidence            66666666666666666666666666666666665544 55666666666666666665555556666666666666666


Q ss_pred             cc
Q 002826          458 LT  459 (876)
Q Consensus       458 l~  459 (876)
                      ++
T Consensus       332 l~  333 (477)
T 2id5_A          332 LA  333 (477)
T ss_dssp             EE
T ss_pred             cc
Confidence            55

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1e-39  Score=353.35  Aligned_cols=256  Identities=30%  Similarity=0.392  Sum_probs=195.6

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|.|| ||+||+|+. +|+.||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        41 i~~~lG~G~-~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           41 IKEKIGAGS-FGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEECS-SEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             eeeEeecCC-CeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence            344555555 999999987 7899999998754322  235688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          663 GSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       663 gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+|.+++.+.+  ..+++..+..++.|++.|++|||+.   +  |+||||||+||+++.++.+||+|||+++......  
T Consensus       119 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--  193 (309)
T 3p86_A          119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--  193 (309)
T ss_dssp             CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----------
T ss_pred             CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc--
Confidence            99999997653  2389999999999999999999999   8  9999999999999999999999999998654322  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ....+.... ..    ..+      
T Consensus       194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--~~~~~~~~~-~~----~~~------  260 (309)
T 3p86_A          194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--VVAAVGFKC-KR----LEI------  260 (309)
T ss_dssp             --------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--HHHHHHHSC-CC----CCC------
T ss_pred             cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcC-CC----CCC------
Confidence            12234458999999999999889999999999999999999999998654332  122111110 00    000      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                       .......+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus       261 -~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          261 -PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             -CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence             111233578999999999999999999999999998776543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-39  Score=355.50  Aligned_cols=266  Identities=27%  Similarity=0.330  Sum_probs=203.6

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC----eEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----SIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~  660 (876)
                      ....+|.|| ||+||+|+.. ++.||||++.... .......+|+.++++++||||+++++++.+..    ..++||||+
T Consensus        28 ~~~~lg~G~-~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~  104 (322)
T 3soc_A           28 LLEVKARGR-FGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFH  104 (322)
T ss_dssp             EEEEEECST-TCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             hhheecccC-ceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecC
Confidence            334455555 9999999874 8999999996532 33445667999999999999999999998744    479999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc-------CCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD-------YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      ++|+|.+++.+.  .+++..+.+++.|++.|++|||+.       +.++|+||||||+||+++.++.+||+|||+++...
T Consensus       105 ~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~  182 (322)
T 3soc_A          105 EKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE  182 (322)
T ss_dssp             TTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEEC
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccc
Confidence            999999999764  489999999999999999999986       23489999999999999999999999999998776


Q ss_pred             ccccccccccccccccccCccccCCC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-----------hHHHH
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSK-----KATAQMDAYSFGVVLLELITGRQAEQAEPAESL-----------DVVKW  797 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-----------~~~~~  797 (876)
                      ............||+.|+|||.+.+.     .++.++|||||||++|||+||+.||........           ....+
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (322)
T 3soc_A          183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDM  262 (322)
T ss_dssp             TTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHH
T ss_pred             cccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhh
Confidence            54433334445689999999998763     456678999999999999999999986543211           11111


Q ss_pred             HHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          798 VRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       798 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ........  ....+.....  ....+..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       263 ~~~~~~~~--~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          263 QEVVVHKK--KRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHHTTSC--CCCCCCGGGG--SSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhccc--CCCCcccccc--ccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111110  1111111111  1234566899999999999999999999999999987543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.6e-38  Score=356.35  Aligned_cols=376  Identities=20%  Similarity=0.206  Sum_probs=255.5

Q ss_pred             CCCCCCCCCCCCCcc-ccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCC
Q 002826           47 SLSTWSNTSNIHYCN-WTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSL  125 (876)
Q Consensus        47 ~~~sW~~~~~~~~C~-w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L  125 (876)
                      .+++|...  .+||. |.++.|....        +.+............-..++++++|++++|.++...+..|..+++|
T Consensus         2 ~~~~~~~~--~~C~~~~~~~~c~~~~--------~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L   71 (390)
T 3o6n_A            2 NVKPRQPE--YKCIDSNLQYDCVFYD--------VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV   71 (390)
T ss_dssp             -----CCE--ECBCC------EEEES--------CEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCC
T ss_pred             CcCCCCCc--cceehhhhhhccceee--------eeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccC
Confidence            36788654  46664 6666664322        1111111112222223457899999999999998777778999999


Q ss_pred             CcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc-ccc
Q 002826          126 ETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGK  204 (876)
Q Consensus       126 ~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~-~~~  204 (876)
                      ++|+|+          +|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|+  +..+|.. |.+
T Consensus        72 ~~L~L~----------~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~--l~~l~~~~~~~  139 (390)
T 3o6n_A           72 ELLNLN----------DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND--LSSLPRGIFHN  139 (390)
T ss_dssp             SEEECT----------TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC--CCCCCTTTTTT
T ss_pred             cEEECC----------CCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCc--cCcCCHHHhcC
Confidence            988555          455566677899999999999999999999889999999999999999998  6678776 688


Q ss_pred             cCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCcccee
Q 002826          205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL  284 (876)
Q Consensus       205 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  284 (876)
                      +++|++|++++|++++..|..|.++++|++|++++|+++ .++.   ..+++|+.|++++|.+++.     ...++|++|
T Consensus       140 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~---~~l~~L~~L~l~~n~l~~~-----~~~~~L~~L  210 (390)
T 3o6n_A          140 TPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLIPSLFHANVSYNLLSTL-----AIPIAVEEL  210 (390)
T ss_dssp             CTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS-BCCG---GGCTTCSEEECCSSCCSEE-----ECCSSCSEE
T ss_pred             CCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC-cccc---ccccccceeeccccccccc-----CCCCcceEE
Confidence            999999999999999988888999999999999999998 4442   3478888888888887742     334567777


Q ss_pred             eeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          285 SLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       285 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      ++++|.++......   .++|+.|++++|.+++                        .  ..+..+++|++|++++|+++
T Consensus       211 ~l~~n~l~~~~~~~---~~~L~~L~l~~n~l~~------------------------~--~~l~~l~~L~~L~Ls~n~l~  261 (390)
T 3o6n_A          211 DASHNSINVVRGPV---NVELTILKLQHNNLTD------------------------T--AWLLNYPGLVEVDLSYNELE  261 (390)
T ss_dssp             ECCSSCCCEEECCC---CSSCCEEECCSSCCCC------------------------C--GGGGGCTTCSEEECCSSCCC
T ss_pred             ECCCCeeeeccccc---cccccEEECCCCCCcc------------------------c--HHHcCCCCccEEECCCCcCC
Confidence            77777776442211   2345555555555543                        2  33445555555555555555


Q ss_pred             CCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCC
Q 002826          365 SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAE  444 (876)
Q Consensus       365 ~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  444 (876)
                      +..|..+..+++|+.|++++|++++ +|..+..+++|+.|+|++|++++.++.+..+++|++|+|++|+++.. |  +..
T Consensus       262 ~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~  337 (390)
T 3o6n_A          262 KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTL-K--LST  337 (390)
T ss_dssp             EEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCCC-C--CCT
T ss_pred             CcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCCCcccee-C--chh
Confidence            5555555555555555555555553 34445566777777888888876666777788888888888888754 2  667


Q ss_pred             CCCcceeeCCCCcccccCCCcccccccceEEccCCccccccCCcccCCCCCccccCCCCCCCCCC
Q 002826          445 LPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGL  509 (876)
Q Consensus       445 l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~~~  509 (876)
                      +++|+.|++++|++++.                       .....+..+....+.+++..|+++.
T Consensus       338 ~~~L~~L~l~~N~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~c~~~~  379 (390)
T 3o6n_A          338 HHTLKNLTLSHNDWDCN-----------------------SLRALFRNVARPAVDDADQHCKIDY  379 (390)
T ss_dssp             TCCCSEEECCSSCEEHH-----------------------HHHHHTTTCCTTTBCCCCSCCCTTC
T ss_pred             hccCCEEEcCCCCccch-----------------------hHHHHHHHHHhhcccccCceecccc
Confidence            77788888888877642                       1112233445556778888887653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4e-39  Score=352.63  Aligned_cols=271  Identities=18%  Similarity=0.152  Sum_probs=212.7

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|| ||+||+|.. .+|+.||||++....  ....+.+|+++++++ +||||+++++++...+..++||||+
T Consensus        11 y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~   87 (330)
T 2izr_A           11 FRVGKKIGCGN-FGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL   87 (330)
T ss_dssp             EEEEEECCC-C-TTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEeeccC-CceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence            44445555555 999999975 589999999987543  334688999999999 9999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC-----eEEccccchhhcccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE-----PKLTDFALDRIVGEA  735 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~-----~kl~DfGla~~~~~~  735 (876)
                       +++|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++.....
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~  163 (330)
T 2izr_A           88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP  163 (330)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence             8999999987666899999999999999999999999   9999999999999998876     999999999876533


Q ss_pred             cccc-----ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHH-Hhhccccc
Q 002826          736 AFQS-----TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRR-KINITNGA  808 (876)
Q Consensus       736 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~  808 (876)
                      ....     ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .....+.. .....   
T Consensus       164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  240 (330)
T 2izr_A          164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP---  240 (330)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---
Confidence            2111     12345689999999999999999999999999999999999999987543322 11111111 10110   


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccccccCCCCC
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQE  871 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~~~~~~~~~  871 (876)
                          .+....   ..+ .+.+++..||+.||.+||++.++.+.|+++..+.........+|+.
T Consensus       241 ----~~~~~~---~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~  295 (330)
T 2izr_A          241 ----IEVLCE---NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG  295 (330)
T ss_dssp             ----HHHHTT---TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred             ----HHHHhc---cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence                000011   112 6889999999999999999999999999987766554444444443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-39  Score=348.33  Aligned_cols=255  Identities=19%  Similarity=0.312  Sum_probs=207.0

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .....+|.|| ||+||+++..++..||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        27 ~~~~~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (283)
T 3gen_A           27 TFLKELGTGQ-FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG  104 (283)
T ss_dssp             EEEEECC----CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred             HhHhhcCCCC-CceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence            3345555555 999999999889999999997543 45678999999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus       105 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  180 (283)
T 3gen_A          105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVG  180 (283)
T ss_dssp             BHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTS
T ss_pred             cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccC
Confidence            99999987666799999999999999999999999   999999999999999999999999999987654322 22233


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..+|+.|+|||...+..++.++||||+|+++|||+| |+.||........  ...+..   .   ... ..+.      .
T Consensus       181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~~---~---~~~-~~~~------~  245 (283)
T 3gen_A          181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIAQ---G---LRL-YRPH------L  245 (283)
T ss_dssp             TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHHT---T---CCC-CCCT------T
T ss_pred             CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHHhc---c---cCC-CCCC------c
Confidence            446788999999988889999999999999999998 9999976543321  111111   1   000 0111      1


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ....+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            1235789999999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-39  Score=346.41  Aligned_cols=264  Identities=20%  Similarity=0.311  Sum_probs=204.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +.|++.+..|.|+||.||+|+. .+++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            3334444444455999999965 479999999986543333   357889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        91 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             ECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999997654 689999999999999999999999   999999999999999999999999999987654321


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.........     ......      ...+...
T Consensus       167 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~------~~~~~~~  234 (294)
T 4eqm_A          167 -TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA-----IKHIQD------SVPNVTT  234 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH-----HHHHSS------CCCCHHH
T ss_pred             -cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhhc------cCCCcch
Confidence             1223345899999999998888999999999999999999999999865433221     111110      0011111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccCCcc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRP-SMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ell~~L~~i~~~~~~  861 (876)
                      ......+..+.+++.+|++.||++|| +++++.+.|+.+..+...
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~  279 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA  279 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence            22223345688999999999999998 999999999998765543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.8e-40  Score=365.38  Aligned_cols=261  Identities=22%  Similarity=0.356  Sum_probs=196.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|| ||.||+|+..    ++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        47 ~~~~~~lG~G~-fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           47 ISIDKVVGAGE-FGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             CCCCEEEEECS-SSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ceeeeEEeeCC-CeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            33344455554 9999999764    57789999986542 223467889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence            99999999999988777899999999999999999999999   999999999999999999999999999987754321


Q ss_pred             c-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          738 Q-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       738 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      . .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......  ....+.......      .   
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~~~~~~------~---  271 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDEGYRLP------P---  271 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHTTEECC------C---
T ss_pred             cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCC------C---
Confidence            1 11222335678999999988889999999999999999998 999997644322  222221111000      0   


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                          ....+..+.+++.+||+.||++||++.|+++.|+++.......
T Consensus       272 ----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~~  314 (373)
T 2qol_A          272 ----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSL  314 (373)
T ss_dssp             ----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGGG
T ss_pred             ----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcccc
Confidence                1122346789999999999999999999999999987655433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2.8e-38  Score=362.77  Aligned_cols=346  Identities=23%  Similarity=0.361  Sum_probs=301.8

Q ss_pred             cCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCc
Q 002826           96 CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF  175 (876)
Q Consensus        96 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  175 (876)
                      ..+++|+.|++++|.+.. +| .+..+++|++|+|++          |++++..|  +.++++|++|+|++|++++..+ 
T Consensus        43 ~~l~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~----------n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-  107 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSN----------NQLTDITP--LKNLTKLVDILMNNNQIADITP-  107 (466)
T ss_dssp             HHHHTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCS----------SCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-
T ss_pred             hHhccccEEecCCCCCcc-Cc-chhhhcCCCEEECCC----------CccCCchh--hhccccCCEEECCCCccccChh-
Confidence            457899999999999987 45 488899998886555          55554444  9999999999999999997665 


Q ss_pred             cccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccc
Q 002826          176 VFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL  255 (876)
Q Consensus       176 ~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~  255 (876)
                       ++++++|++|+|++|+  +..+|. +.++++|++|++++|++.+.  ..+.++++|++|+++ |.+. .++.  +..++
T Consensus       108 -~~~l~~L~~L~L~~n~--l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~-~~~~--~~~l~  177 (466)
T 1o6v_A          108 -LANLTNLTGLTLFNNQ--ITDIDP-LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVT-DLKP--LANLT  177 (466)
T ss_dssp             -GTTCTTCCEEECCSSC--CCCCGG-GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCC-CCGG--GTTCT
T ss_pred             -hcCCCCCCEEECCCCC--CCCChH-HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-Cccc-Cchh--hccCC
Confidence             9999999999999998  566665 89999999999999999875  358999999999997 6666 3433  45699


Q ss_pred             cccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEec
Q 002826          256 KLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE  335 (876)
Q Consensus       256 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  335 (876)
                      +|++|++++|++++.  ..+..+++|++|++++|.+++..|  +..+++|++|++++|++++.  ..+..+++|+.|+++
T Consensus       178 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~  251 (466)
T 1o6v_A          178 TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLA  251 (466)
T ss_dssp             TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECC
T ss_pred             CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECC
Confidence            999999999999864  358999999999999999998766  88899999999999999864  468899999999999


Q ss_pred             CCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCC
Q 002826          336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQI  415 (876)
Q Consensus       336 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  415 (876)
                      +|++++..+  +..+++|++|++++|++++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++++..
T Consensus       252 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~  325 (466)
T 1o6v_A          252 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS  325 (466)
T ss_dssp             SSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCG
T ss_pred             CCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCch
Confidence            999997766  8899999999999999997554  8899999999999999998665  889999999999999999877


Q ss_pred             cCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCcccc
Q 002826          416 PELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSG  483 (876)
Q Consensus       416 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~  483 (876)
                      + +..+++|++|++++|++++.  ..+..+++|+.|++++|++++..|  +..+ +++.|++++|++++
T Consensus       326 ~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          326 P-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             G-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred             h-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence            6 88999999999999999975  579999999999999999998877  6666 58999999999986

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-39  Score=354.43  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|| ||.||+|.. .+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus        17 y~~~~~lG~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~   95 (328)
T 3fe3_A           17 YRLLKTIGKGN-FAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY   95 (328)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence            33344455555 999999976 5899999999975422  2345678999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......   
T Consensus        96 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  168 (328)
T 3fe3_A           96 ASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---  168 (328)
T ss_dssp             CTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---
Confidence            99999999997654 689999999999999999999999   99999999999999999999999999998765432   


Q ss_pred             ccccccccccccCccccCCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKAT-AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......||+.|+|||.+.+..+. .++||||+||++|||++|+.||........  ...+.   ......     |    
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~---~~~~~~-----p----  234 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL--RERVL---RGKYRI-----P----  234 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---HCCCCC-----C----
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHH---hCCCCC-----C----
Confidence            23445699999999998877654 789999999999999999999986543321  11111   111000     0    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        ...+..+.+++.+||+.||.+|||++|+++.
T Consensus       235 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          235 --FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              0123357899999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.2e-39  Score=347.05  Aligned_cols=270  Identities=14%  Similarity=0.118  Sum_probs=211.4

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.| +||.||+|.. .+|+.||+|++...  .....+.+|+.+++.+ +|+|++++++++.+....++||||+
T Consensus        12 y~~~~~lg~G-~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   88 (298)
T 1csn_A           12 YKVGRRIGEG-SFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   88 (298)
T ss_dssp             EEEEEEEEEC-SSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEEEEEeec-CCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence            3333445544 5999999975 58999999998653  3345688999999999 7999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC-----eEEccccchhhcccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE-----PKLTDFALDRIVGEA  735 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~-----~kl~DfGla~~~~~~  735 (876)
                       +++|.+++...+..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.     +||+|||+++.....
T Consensus        89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence             8899999987776799999999999999999999999   9999999999999987765     999999999877543


Q ss_pred             ccc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhcccccc
Q 002826          736 AFQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAI  809 (876)
Q Consensus       736 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  809 (876)
                      ...     .......||+.|+|||...+..++.++||||||+++|||++|+.||........ .....+......     
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  239 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-----  239 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-----
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC-----
Confidence            221     123445689999999999988899999999999999999999999987543221 111111111100     


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccccccCC
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSS  868 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~~~~~~  868 (876)
                          +.........+..+.+++.+||+.||++|||++++++.|+++.++.........+
T Consensus       240 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~d  294 (298)
T 1csn_A          240 ----TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD  294 (298)
T ss_dssp             ----SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCG
T ss_pred             ----ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccc
Confidence                0011111123456889999999999999999999999999998765544333333

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.9e-40  Score=369.71  Aligned_cols=255  Identities=22%  Similarity=0.367  Sum_probs=205.1

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+|.|+ ||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus       119 ~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  197 (377)
T 3cbl_A          119 GEQIGRGN-FGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG  197 (377)
T ss_dssp             EEEEEEET-TEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eeEeccCC-CCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence            34455555 9999999876 799999999865321 22346788999999999999999999999999999999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +|.+++...+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.............
T Consensus       198 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~  274 (377)
T 3cbl_A          198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL  274 (377)
T ss_dssp             BHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSC
T ss_pred             CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCC
Confidence            99999987766799999999999999999999999   999999999999999999999999999986544322222222


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||.+....++.++|||||||++|||+| |+.||.......  ..+.+.......       .|      ..
T Consensus       275 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~~~~-------~~------~~  339 (377)
T 3cbl_A          275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGGRLP-------CP------EL  339 (377)
T ss_dssp             CEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTCCCC-------CC------TT
T ss_pred             CCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCCC-------CC------CC
Confidence            335778999999888889999999999999999998 999997644322  222222111000       01      11


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      .+..+.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~  376 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH  376 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence            2335789999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-40  Score=358.62  Aligned_cols=264  Identities=24%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             ccccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  655 (876)
                      .+++.+..|.|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....++
T Consensus        11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   90 (295)
T 3ugc_A           11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL   90 (295)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred             HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence            334444444455999999973     4789999999976554555788999999999999999999999865  356899


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++|+|.+++......+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           91 IMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             EEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             EEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            9999999999999988766799999999999999999999999   9999999999999999999999999999877543


Q ss_pred             ccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh----------hHHHHHHHHhhc
Q 002826          736 AFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL----------DVVKWVRRKINI  804 (876)
Q Consensus       736 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~  804 (876)
                      ... .......++..|+|||.+.+..++.++||||||+++|||+||..||.....+..          ............
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            221 222334477789999999888899999999999999999999999875332211          000011110000


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .  ...       ......+..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus       248 ~--~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          248 N--GRL-------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             T--CCC-------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             c--CcC-------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0  000       00112234688999999999999999999999999998754

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=366.79  Aligned_cols=336  Identities=19%  Similarity=0.176  Sum_probs=200.6

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      +++++|+|++|++++..|..|.++++|++|+|+          +|.+++..|..|.++++|++|+|++|++++..+..|.
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~----------~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  101 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELN----------ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFT  101 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECT----------TSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSST
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECC----------CCccCEeChhhhhCCccCCEEECCCCcCCccCccccc
Confidence            477888888888888777788888888776444          4455566677788888888888888888766666777


Q ss_pred             CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccccc
Q 002826          179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       179 ~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                      ++++|++|+|++|++ ....|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|...+..+++|+
T Consensus       102 ~l~~L~~L~Ls~n~i-~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~l~~l~~L~  179 (477)
T 2id5_A          102 GLSNLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLI  179 (477)
T ss_dssp             TCTTCCEEECTTSCC-CEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCS-SCCHHHHTTCTTCC
T ss_pred             CCCCCCEEECCCCcc-ccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCc-ccChhHhcccCCCc
Confidence            777777777777762 3333455666666666666666666666666666666666666666666 44444444455666


Q ss_pred             EEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCc
Q 002826          259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR  338 (876)
Q Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  338 (876)
                      .|+|++|++.+..+..|..+++|+.|++++|.+.+.+|                        .......+|+.|++++|+
T Consensus       180 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~------------------------~~~~~~~~L~~L~l~~n~  235 (477)
T 2id5_A          180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT------------------------PNCLYGLNLTSLSITHCN  235 (477)
T ss_dssp             EEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEEC------------------------TTTTTTCCCSEEEEESSC
T ss_pred             EEeCCCCcCcEeChhhcccCcccceeeCCCCccccccC------------------------cccccCccccEEECcCCc
Confidence            66666665555555555555555555555554444444                        433334455555555555


Q ss_pred             ccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-C
Q 002826          339 FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-E  417 (876)
Q Consensus       339 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~  417 (876)
                      +++..+..+..+++|+.|+|++|++++..+..|.++++|+.|++++|++++..|..|.++++|+.|+|++|+|++.++ .
T Consensus       236 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  315 (477)
T 2id5_A          236 LTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV  315 (477)
T ss_dssp             CCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGG
T ss_pred             ccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhH
Confidence            554444445555555555555555555555555555555555666665555555666666666666666666665555 4


Q ss_pred             cccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccccc
Q 002826          418 LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKL  471 (876)
Q Consensus       418 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l  471 (876)
                      |..+++|++|+|++|.++..-+. ..-...+..+++.+|.....-|..+.+..+
T Consensus       316 ~~~l~~L~~L~l~~N~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~~~~g~~l  368 (477)
T 2id5_A          316 FHSVGNLETLILDSNPLACDCRL-LWVFRRRWRLNFNRQQPTCATPEFVQGKEF  368 (477)
T ss_dssp             BSCGGGCCEEECCSSCEECSGGG-HHHHTTTTSSCCTTCCCBEEESGGGTTCBG
T ss_pred             cCCCcccCEEEccCCCccCccch-HhHHhhhhccccCccCceeCCchHHcCCch
Confidence            56666666666666666532211 000112233445555555445555554433

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.1e-39  Score=353.45  Aligned_cols=253  Identities=20%  Similarity=0.272  Sum_probs=202.6

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc------CHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      ++...|.....+|.|+ ||+||+|... +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         9 ~~~~~y~~~~~LG~G~-fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQ-FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             CGGGTEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             ChhhceEEeeEEeeCc-CEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            3444444445555555 9999999765 7999999999764322      357889999999999999999999999999


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccc
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDF  726 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~Df  726 (876)
                      +..|+||||+++|+|.+++... ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            9999999999999999999764 4799999999999999999999999   999999999999998776    7999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++......   ......||+.|+|||++.+..++.++||||+||++|||++|++||........  ..   ...... 
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~---~i~~~~-  234 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NITAVS-  234 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HH---HHHTTC-
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HH---HHHhcC-
Confidence            9998765432   23345699999999999988899999999999999999999999986543221  11   111111 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ..+++..   +......+.+++.+||..||++|||+.|+++
T Consensus       235 ---~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 ---YDFDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ---CCCCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CCCCchh---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               0111111   1223346789999999999999999999986

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=362.35  Aligned_cols=261  Identities=25%  Similarity=0.359  Sum_probs=208.2

Q ss_pred             cccCCCCCCCCceEEEEEEe--------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeE
Q 002826          584 DEKSSAGNGGPFGRVYILSL--------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESI  653 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  653 (876)
                      +.+.+..|.|+||+||+|+.        .++..||+|++..... .....+.+|+++++++ +||||+++++++.+++..
T Consensus        71 y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~  150 (382)
T 3tt0_A           71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL  150 (382)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             eEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCce
Confidence            33434444445999999975        2346899999975432 2236788999999999 999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC
Q 002826          654 FLIYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD  718 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~  718 (876)
                      ++||||+++|+|.+++....               ..+++..+.+++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus       151 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             EEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTT
T ss_pred             EEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCC
Confidence            99999999999999997653               3589999999999999999999999   99999999999999999


Q ss_pred             CCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHH
Q 002826          719 FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKW  797 (876)
Q Consensus       719 ~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~  797 (876)
                      +.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ....
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~--~~~~  305 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKL  305 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH
Confidence            9999999999987765433333445567889999999988899999999999999999999 999997654332  2222


Q ss_pred             HHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          798 VRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       798 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                      +......      ..       .......+.+++.+||+.||++|||++|+++.|+++.......
T Consensus       306 ~~~~~~~------~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          306 LKEGHRM------DK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             HHTTCCC------CC-------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             HHcCCCC------CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            2211100      00       0112346789999999999999999999999999997655444

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=358.46  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=205.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|+ ||.||+|+..      +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus        49 ~~~~~~lg~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           49 IEYVRDIGEGA-FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             CEEEEEEEECS-SCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             CeeeeeeeecC-CeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            33344555555 9999999763      358999999875432 224678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccC-----------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCc
Q 002826          656 IYEFLQMGSLGDLICRQD-----------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN  712 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~N  712 (876)
                      ||||+++|+|.+++....                       ..+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence            999999999999997642                       5689999999999999999999999   99999999999


Q ss_pred             eeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch
Q 002826          713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAES  791 (876)
Q Consensus       713 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~  791 (876)
                      |+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  284 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  284 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH
Confidence            9999999999999999988764433333445568889999999888889999999999999999999 999997644322


Q ss_pred             hhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                        ....+..   ..   ....       ....+..+.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus       285 --~~~~~~~---~~---~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          285 --VIYYVRD---GN---ILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             --HHHHHHT---TC---CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             --HHHHHhC---CC---cCCC-------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence              1221111   10   0001       11223467899999999999999999999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=352.18  Aligned_cols=250  Identities=20%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|.....+|.|+ ||+||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         6 ~y~~~~~lG~G~-~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            6 KYMIAEDLGRGE-FGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceEeeeEEecCC-CeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            444445555555 9999999765 78999999986432 34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC--CCCeEEccccchhhccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA--DFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ++|+|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.  ++.+||+|||+++....... 
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~-  159 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-  159 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence            99999999987766799999999999999999999999   9999999999999987  78999999999987654322 


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                        .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......  ....+..   ..   . .+++.   
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~---~~---~-~~~~~---  225 (321)
T 1tki_A          160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIENIMN---AE---Y-TFDEE---  225 (321)
T ss_dssp             --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHH---TC---C-CCCHH---
T ss_pred             --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHHHHHc---CC---C-CCChh---
Confidence              233458999999999988888999999999999999999999998654322  1111111   11   0 01111   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+...+..+.+++.+|++.||++|||+.|+++.
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111224467899999999999999999999983

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=6.9e-39  Score=355.62  Aligned_cols=278  Identities=13%  Similarity=0.110  Sum_probs=205.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeCC------CcEEEEEEEecCCccC-----------HHHHHHHHHHHhhccCcccccee
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPS------GELIAVKKLVNFGCQS-----------SKTLKTEVKTLAKIRHKNIVKVL  644 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~  644 (876)
                      +|.....+|.|| ||+||+|....      ++.||||++.......           ...+..|+..++.++||||++++
T Consensus        36 ~y~~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           36 AWKVGLPIGQGG-FGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             EEEEEEECCCC--CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             eEEEEEEEecCC-CeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            444445555555 99999997754      4789999986543211           11233455666777899999999


Q ss_pred             eEEEeC----CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CC
Q 002826          645 GFFHSD----ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--AD  718 (876)
Q Consensus       645 ~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~  718 (876)
                      +++...    ...|+||||+ +++|.+++......+++..+..++.|++.||+|||+.   +|+||||||+|||++  .+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred             eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence            999774    4589999999 9999999988767899999999999999999999999   999999999999998  88


Q ss_pred             CCeEEccccchhhcccccccc-----ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh
Q 002826          719 FEPKLTDFALDRIVGEAAFQS-----TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD  793 (876)
Q Consensus       719 ~~~kl~DfGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~  793 (876)
                      +.+||+|||+++.+.......     ......||+.|+|||.+.+..++.++|||||||++|||+||+.||........ 
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~-  269 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK-  269 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH-
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH-
Confidence            999999999998765432211     11334589999999999998899999999999999999999999985333322 


Q ss_pred             HHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccccccCCC
Q 002826          794 VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSS  869 (876)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~~~~~~~  869 (876)
                      ...........  .....+++.+.  ....+..+.+++..||+.+|++||++.++++.|+++.++.........+|
T Consensus       270 ~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  341 (364)
T 3op5_A          270 YVRDSKIRYRE--NIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL  341 (364)
T ss_dssp             HHHHHHHHHHH--CHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred             HHHHHHHHhhh--hHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence            22222211111  01111111110  01224568899999999999999999999999999877655544333333

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.2e-39  Score=351.77  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=200.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +|.....+|.|+ ||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus         8 ~y~i~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            8 DWDLVQTLGEGA-YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             CEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hceeeeEEecCC-CEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            444455566555 9999999765 899999999865432 2346688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             CCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            9999999998654 3699999999999999999999999   99999999999999999999999999998765433333


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||............+......        .. .   
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------~~-~---  230 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------LN-P---  230 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------ST-T---
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------CC-c---
Confidence            3445679999999999876654 778999999999999999999998765544333333221100        00 0   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       +......+.+++.+||+.||++|||+.|+++.
T Consensus       231 -~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 -WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             11223456789999999999999999999875

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.3e-38  Score=345.22  Aligned_cols=265  Identities=23%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      .+...|.....+|.|+ ||+||+|+..+|+.||+|++......  ....+.+|++++++++||||+++++++.+++..++
T Consensus        18 ~l~~~y~~~~~lG~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   96 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGT-YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL   96 (311)
T ss_dssp             CSSCEEEEEEEEEECS-SCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred             chHhhhHhhhhccCCC-CeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence            3344555555666655 99999999888999999999654322  23678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++ ++.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..+..
T Consensus        97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            9999986 89888887777799999999999999999999999   9999999999999999999999999999876533


Q ss_pred             ccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc-cc----
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG-AI----  809 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----  809 (876)
                      .  .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ .............. ..    
T Consensus       173 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          173 V--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTT
T ss_pred             c--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhc
Confidence            2  12334458999999998875 5689999999999999999999999987544332 22221111110000 00    


Q ss_pred             ---------cccC-hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          810 ---------QVLD-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       810 ---------~~~d-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                               ...+ ............++.+++.+|++.||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                     0000 0011111223346789999999999999999999987

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=361.25  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=203.9

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ....+|.|| ||+||+|.+      .+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus        75 ~~~~LG~G~-fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~  153 (367)
T 3l9p_A           75 LIRGLGHGA-FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILL  153 (367)
T ss_dssp             EEEECCCCS-SSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EeeEeeeCC-CEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEE
Confidence            344455555 999999974      256789999986432 233456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---CeEEccccc
Q 002826          658 EFLQMGSLGDLICRQD------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---EPKLTDFAL  728 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~~kl~DfGl  728 (876)
                      ||+++|+|.+++....      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++   .+||+|||+
T Consensus       154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999997643      4589999999999999999999999   999999999999999554   599999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      ++...............||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ....+......   
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~~i~~~~~~---  305 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGRM---  305 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCCC---
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC---
Confidence            987654433333444557889999999988889999999999999999998 999997654322  22222211100   


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                         ..       .......+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       306 ---~~-------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          306 ---DP-------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             ---CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             ---CC-------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence               00       11123357899999999999999999999999999876443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-38  Score=344.31  Aligned_cols=260  Identities=23%  Similarity=0.300  Sum_probs=198.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhh--ccCccccceeeEEEeC----CeEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK--IRHKNIVKVLGFFHSD----ESIFL  655 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~----~~~~l  655 (876)
                      +|.....+|.|| ||+||+|+. +|+.||||++..   .....+.+|.+++..  ++||||+++++++.+.    ...++
T Consensus         9 ~y~~~~~lg~G~-~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            9 DITLLECVGKGR-YGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GCEEEEEEEECS-SEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cEEEEEeeccCC-CcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            344445555555 999999987 799999999864   344556667777766  7999999999997653    45899


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhh--------ccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH--------KDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      ||||+++|+|.+++..  ..+++..+.+++.|++.|++|||        +.   +|+||||||+||+++.++.+||+|||
T Consensus        84 v~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence            9999999999999954  36899999999999999999999        77   99999999999999999999999999


Q ss_pred             chhhccccccc--cccccccccccccCccccCCC------CCCCccchHHHHHHHHHHHhC----------CCCCCCCCc
Q 002826          728 LDRIVGEAAFQ--STMSSEYALSCYNAPEYGYSK------KATAQMDAYSFGVVLLELITG----------RQAEQAEPA  789 (876)
Q Consensus       728 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlGv~l~elltg----------~~p~~~~~~  789 (876)
                      +++........  .......||+.|+|||.+.+.      .++.++||||||+++|||+||          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            99776543221  112334689999999998766      345789999999999999999          888866444


Q ss_pred             chhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          790 ESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ................  ....+.+.  .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQ--QRPNIPNR--WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SSCCHHHHHHHHTTSC--CCCCCCGG--GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcchhhhhHHHhccC--CCCCCChh--hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            3332222222111110  11111111  12234566789999999999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-38  Score=354.82  Aligned_cols=265  Identities=20%  Similarity=0.279  Sum_probs=211.8

Q ss_pred             cccccccchhhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeE
Q 002826          568 FFYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF  646 (876)
Q Consensus       568 ~~~~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  646 (876)
                      ...+..+..+++...|.....+|.|+ ||+||+|... +|+.||+|++..........+.+|+++++.++||||++++++
T Consensus        38 ~~~~~~~~~~~~~~~y~i~~~LG~G~-~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~  116 (387)
T 1kob_A           38 VPQPVEVKQGSVYDYYDILEELGSGA-FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA  116 (387)
T ss_dssp             CCCCCCCBCSCGGGTEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred             CCCcccccCCccccceEEEEEEecCC-CEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence            34455566666666666666666665 9999999664 799999999976544455678999999999999999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC--CCCeEEc
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA--DFEPKLT  724 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~--~~~~kl~  724 (876)
                      +.+.+..++||||+++|+|.+++...+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+
T Consensus       117 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             EECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEE
Confidence            9999999999999999999999987766899999999999999999999999   9999999999999974  5789999


Q ss_pred             cccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc
Q 002826          725 DFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI  804 (876)
Q Consensus       725 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  804 (876)
                      |||+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+...   
T Consensus       194 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~~~i~~~---  265 (387)
T 1kob_A          194 DFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKRC---  265 (387)
T ss_dssp             CCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHHC---
T ss_pred             ecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--HHHHHHhC---
Confidence            9999987654322   223358999999999998889999999999999999999999998644321  12211111   


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .   . .+++..   .......+.+++.+||+.||++|||+.|+++.
T Consensus       266 ~---~-~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          266 D---W-EFDEDA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             C---C-CCCSST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             C---C-CCCccc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0   0 011111   11223467899999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-38  Score=342.64  Aligned_cols=245  Identities=25%  Similarity=0.343  Sum_probs=201.6

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|| ||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus        50 ~~~lg~G~-~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  128 (321)
T 2c30_A           50 YVKIGEGS-TGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA  128 (321)
T ss_dssp             EEEEEEET-TEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred             cEEeccCC-CeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence            34566665 9999999775 799999999987666667889999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+.  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  .....
T Consensus       129 L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~  201 (321)
T 2c30_A          129 LTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSL  201 (321)
T ss_dssp             HHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCC
T ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccc
Confidence            99998653  589999999999999999999999   999999999999999999999999999887654321  22345


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .||+.|+|||...+..++.++||||||+++|||++|+.||.......  ........   .       .+... ......
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~---~-------~~~~~-~~~~~~  268 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDS---P-------PPKLK-NSHKVS  268 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS---S-------CCCCT-TGGGSC
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcC---C-------CCCcC-ccccCC
Confidence            68999999999998889999999999999999999999997643322  12221111   0       00000 011123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..+.+++.+||+.||++|||+.|+++.
T Consensus       269 ~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          269 PVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            457899999999999999999999985

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-39  Score=359.63  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=202.6

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCC-eEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE-SIFL  655 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~l  655 (876)
                      ....+|.|| ||.||+|++      .+++.||||++..... ...+.+.+|+++++++ +||||+++++++.+.+ ..++
T Consensus        26 ~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i  104 (359)
T 3vhe_A           26 LGKPLGRGA-FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  104 (359)
T ss_dssp             EEEEEEECS-SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             eceeecCCC-CceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence            334455555 999999963      3568999999975432 2235688999999999 7999999999998755 4899


Q ss_pred             EEEcCCCCCHHHHhhccCC-------------------------------------------------------------
Q 002826          656 IYEFLQMGSLGDLICRQDF-------------------------------------------------------------  674 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~-------------------------------------------------------------  674 (876)
                      ||||+++|+|.+++.....                                                             
T Consensus       105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3vhe_A          105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED  184 (359)
T ss_dssp             EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred             EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence            9999999999999976432                                                             


Q ss_pred             ----cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccc
Q 002826          675 ----QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCY  750 (876)
Q Consensus       675 ----~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  750 (876)
                          .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...............||+.|
T Consensus       185 ~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y  261 (359)
T 3vhe_A          185 LYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  261 (359)
T ss_dssp             TTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGG
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCcee
Confidence                189999999999999999999999   9999999999999999999999999999876544333344455688999


Q ss_pred             cCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHH
Q 002826          751 NAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE  829 (876)
Q Consensus       751 ~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~  829 (876)
                      +|||.+.+..++.++||||||+++|||+| |+.||........ ............  .     +      ......+.+
T Consensus       262 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~--~-----~------~~~~~~l~~  327 (359)
T 3vhe_A          262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTRMR--A-----P------DYTTPEMYQ  327 (359)
T ss_dssp             CCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHTCCCC--C-----C------TTCCHHHHH
T ss_pred             EChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcCCCCC--C-----C------CCCCHHHHH
Confidence            99999988889999999999999999998 9999987554332 122221111000  0     0      112235789


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          830 IALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       830 li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ++.+||+.||++|||+.|+++.|+++.+.
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=344.50  Aligned_cols=254  Identities=20%  Similarity=0.274  Sum_probs=202.5

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc------CHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      ++...|.....+|.|+ ||.||+|... +|+.||+|++......      ..+.+.+|++++++++||||+++++++.+.
T Consensus         8 ~~~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   86 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQ-FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   86 (326)
T ss_dssp             CHHHHEEEEEEEECCS-SEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CcccceEeceEEeeCC-CeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            3444444445555555 9999999765 7999999999754322      357899999999999999999999999999


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccc
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDF  726 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~Df  726 (876)
                      +..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            9999999999999999999764 4689999999999999999999999   999999999999998877    8999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++......   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......  ....+..   .. 
T Consensus       163 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~---~~-  233 (326)
T 2y0a_A          163 GLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSA---VN-  233 (326)
T ss_dssp             TTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHH---TC-
T ss_pred             CCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHHHHh---cC-
Confidence            9998765332   2234468999999999988889999999999999999999999997644322  1111111   10 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        . ...+.   .+......+.+++.+||+.||++|||+.|+++.
T Consensus       234 --~-~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 --Y-EFEDE---YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             --C-CCCHH---HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --C-CcCcc---ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence              0 01111   111223467899999999999999999999973

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-39  Score=344.82  Aligned_cols=266  Identities=25%  Similarity=0.343  Sum_probs=195.5

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      .|+..+.+.+.+..|.|+||+||+|+..  ..||+|++.....  ...+.+.+|++++++++||||+++++++ ..+..+
T Consensus        19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           19 WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CBCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred             CccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence            4555544454444455559999999863  4699999865432  2235788999999999999999999965 456789


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+++++|.+++......+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999999987777899999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccccccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      ...........||+.|+|||.+.   ...++.++||||+|+++|||++|+.||....... ..........         
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~---------  242 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMVGRGS---------  242 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHHHHTS---------
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHhcccc---------
Confidence            32223334456899999999876   5667889999999999999999999998654332 2222222211         


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..+.........+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~e  289 (289)
T 3og7_A          243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE  289 (289)
T ss_dssp             CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTCC
T ss_pred             cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhhC
Confidence            11111112223345688999999999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-38  Score=339.28  Aligned_cols=249  Identities=25%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCH-------HHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSS-------KTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +..+..+.|+||+||+|+. .+++.||+|++........       +.+.+|++++++++||||+++++++.+..  ++|
T Consensus        22 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv   99 (287)
T 4f0f_A           22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMV   99 (287)
T ss_dssp             EEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEE
T ss_pred             eehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEE
Confidence            3334444445999999976 4899999999865433221       57889999999999999999999987655  699


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeCCCCC-----eEEccccch
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLDADFE-----PKLTDFALD  729 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~~~~~-----~kl~DfGla  729 (876)
                      |||+++++|.+.+.+....+++..+..++.|++.|++|||+.   +  |+||||||+||+++.++.     +||+|||++
T Consensus       100 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~  176 (287)
T 4f0f_A          100 MEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS  176 (287)
T ss_dssp             EECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred             EEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence            999999999999987777899999999999999999999999   8  999999999999987776     999999998


Q ss_pred             hhccccccccccccccccccccCccccC--CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGY--SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      +.....     .....||+.|+|||.+.  ...++.++||||+|+++|||++|+.||..................     
T Consensus       177 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----  246 (287)
T 4f0f_A          177 QQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG-----  246 (287)
T ss_dssp             BCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC-----
T ss_pred             cccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC-----
Confidence            754432     23345899999999983  455788999999999999999999999876655443333322211     


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ....+.       ...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       247 ~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          247 LRPTIP-------EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCC-------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111       12234678999999999999999999999999875

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-38  Score=347.60  Aligned_cols=246  Identities=22%  Similarity=0.270  Sum_probs=199.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|+.. +|+.||+|++.+.   .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         7 y~~~~~lG~G~-fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E   85 (337)
T 1o6l_A            7 FDYLKLLGKGT-FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEecCC-CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence            44445556555 9999999765 7999999999753   22455678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        86 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  159 (337)
T 1o6l_A           86 YANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             CCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--
Confidence            999999999997654 689999999999999999999999   99999999999999999999999999997643221  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||........  ...+.   ....        .+. 
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~---~~~~--------~~p-  225 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FELIL---MEEI--------RFP-  225 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---HCCC--------CCC-
T ss_pred             CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH--HHHHH---cCCC--------CCC-
Confidence            123345689999999999988999999999999999999999999976543221  11111   1110        000 


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                        ......+.+++.+||+.||++||     +++|+++.
T Consensus       226 --~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              11234578999999999999999     89999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.2e-39  Score=351.80  Aligned_cols=256  Identities=22%  Similarity=0.374  Sum_probs=198.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcE----EEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGEL----IAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      |.....+|.|| ||+||+|... +++.    ||+|.+... .....+.+.+|+.++++++||||++++++|.++. .++|
T Consensus        17 y~~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v   94 (327)
T 3poz_A           17 FKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             EEEEEEEEEET-TEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred             cccceEEeeCC-CeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence            44445556555 9999999753 5554    577776433 2245678999999999999999999999998754 7899


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      +||+++|+|.+++.+....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             EECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            999999999999988777899999999999999999999999   99999999999999999999999999999876544


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .........+|..|+|||.+.+..++.++|||||||++|||+| |+.||........  ...+.......      .   
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~~~~------~---  240 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEKGERLP------Q---  240 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCCC------C---
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--HHHHHcCCCCC------C---
Confidence            3333444457889999999998899999999999999999999 9999987554432  22222111100      0   


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                          .......+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       241 ----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          241 ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                111233678999999999999999999999999988653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=342.61  Aligned_cols=268  Identities=24%  Similarity=0.243  Sum_probs=206.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCC--eEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  658 (876)
                      .|.+.+..|.|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|||
T Consensus        10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (319)
T 4euu_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (319)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence            3444444455559999999765 69999999997533 244577889999999999999999999998755  7899999


Q ss_pred             cCCCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee----CCCCCeEEccccchhhc
Q 002826          659 FLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL----DADFEPKLTDFALDRIV  732 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll----~~~~~~kl~DfGla~~~  732 (876)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++..
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            999999999997653  3389999999999999999999999   99999999999999    77788999999999876


Q ss_pred             cccccccccccccccccccCccccC--------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-h
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGY--------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-N  803 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~  803 (876)
                      .....   .....||+.|+|||.+.        +..++.++|||||||++|||++|+.||.......... +...... .
T Consensus       167 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~  242 (319)
T 4euu_A          167 EDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIITG  242 (319)
T ss_dssp             CTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHHHH
T ss_pred             CCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHhcC
Confidence            54332   23345899999999865        5678999999999999999999999997644332211 1111111 1


Q ss_pred             ccccccccc-------------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          804 ITNGAIQVL-------------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       804 ~~~~~~~~~-------------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      .+......+             -+............+.+++.+||+.||++|||++|+++...+-.-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            110000000             011113345666788999999999999999999999999887543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.7e-39  Score=339.59  Aligned_cols=252  Identities=22%  Similarity=0.374  Sum_probs=206.8

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|+ ||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus        13 ~~~lg~G~-~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           13 VQEIGSGQ-FGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEET-TEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeEecCCC-ceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            34455555 999999998889999999997643 4567899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++....... .......
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~  166 (267)
T 3t9t_A           91 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTK  166 (267)
T ss_dssp             HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTT
T ss_pred             HHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc-ccccccc
Confidence            999987766799999999999999999999999   999999999999999999999999999987653221 1223345


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||...+..++.++||||+|+++|||++ |+.||.......  ....+..   .   .... .+.      ...
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~---~---~~~~-~~~------~~~  231 (267)
T 3t9t_A          167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDIST---G---FRLY-KPR------LAS  231 (267)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---T---CCCC-CCT------TSC
T ss_pred             ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhc---C---CcCC-CCc------cCc
Confidence            6788999999888889999999999999999999 899997644322  1111111   1   0001 111      123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            4578999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.7e-39  Score=349.39  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=205.5

Q ss_pred             ccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .+.+..+.|+||.||+|..      .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  105 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV  105 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence            3334444445999999965      3468999999865432 23467889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccC-----------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCcee
Q 002826          658 EFLQMGSLGDLICRQD-----------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNIL  714 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIl  714 (876)
                      ||+++++|.+++....                       ..+++..+.+++.|++.|++|||+.   +|+||||||+||+
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIl  182 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNIL  182 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEE
Confidence            9999999999997643                       2489999999999999999999999   9999999999999


Q ss_pred             eCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhh
Q 002826          715 LDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLD  793 (876)
Q Consensus       715 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~  793 (876)
                      ++.++.+||+|||+++...............+++.|+|||...+..++.++||||+|+++|||++ |+.||........ 
T Consensus       183 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  261 (314)
T 2ivs_A          183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL-  261 (314)
T ss_dssp             EETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            99999999999999987754433333444557888999999888889999999999999999999 9999987554332 


Q ss_pred             HHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          794 VVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                       ...+....      ....       .......+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       262 -~~~~~~~~------~~~~-------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          262 -FNLLKTGH------RMER-------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             -HHHHHTTC------CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -HHHhhcCC------cCCC-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence             22221110      0000       112234678999999999999999999999999998654

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.4e-37  Score=367.81  Aligned_cols=337  Identities=22%  Similarity=0.234  Sum_probs=244.0

Q ss_pred             cCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCc
Q 002826           96 CELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPF  175 (876)
Q Consensus        96 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  175 (876)
                      ..+++++.|++++|.+....+..|+++++|++|+|+          +|.+++..|..|+.+++|++|+|++|.+++..|.
T Consensus        48 l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~----------~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  117 (597)
T 3oja_B           48 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLN----------DLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH  117 (597)
T ss_dssp             GGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECT----------TSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             ccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECC----------CCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH
Confidence            357899999999999999888889999999988554          5566777788999999999999999999999999


Q ss_pred             cccCCCcceEEEccCCCCcCCCCCCc-ccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccc
Q 002826          176 VFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL  254 (876)
Q Consensus       176 ~~~~l~~L~~L~Ls~N~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  254 (876)
                      .|+++++|++|+|++|.  +..+|.. |.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .++.   ..+
T Consensus       118 ~~~~l~~L~~L~L~~n~--l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~---~~l  191 (597)
T 3oja_B          118 VFQNVPLLTVLVLERND--LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL---SLI  191 (597)
T ss_dssp             TTTTCTTCCEEECCSSC--CCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCS-BCCG---GGC
T ss_pred             HHcCCCCCCEEEeeCCC--CCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCC-CcCh---hhh
Confidence            99999999999999998  5677766 689999999999999999998989999999999999999998 4442   347


Q ss_pred             ccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEe
Q 002826          255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRA  334 (876)
Q Consensus       255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  334 (876)
                      ++|+.|++++|.+++     +...++|+.|++++|.++...+..+   ++|+.|+|++|.++                  
T Consensus       192 ~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~------------------  245 (597)
T 3oja_B          192 PSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLT------------------  245 (597)
T ss_dssp             TTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCC------------------
T ss_pred             hhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccccC---CCCCEEECCCCCCC------------------
Confidence            788888888888874     2344567777777777764333221   34555555555544                  


Q ss_pred             cCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccC
Q 002826          335 ESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       335 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                            +  +..+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++.
T Consensus       246 ------~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i  316 (597)
T 3oja_B          246 ------D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHV  316 (597)
T ss_dssp             ------C--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCC
T ss_pred             ------C--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCcc
Confidence                  3  2345555555555666555555555555555555555555555554 244455566777777777777765


Q ss_pred             CcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccccceEEccCCccccccCCcccCCCC
Q 002826          415 IPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLP  494 (876)
Q Consensus       415 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~~~~~~  494 (876)
                      ++.+..+++|+.|+|++|+|++..   +..+++|+.|+|++|++++                       ..+...+..+.
T Consensus       317 ~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~-----------------------~~~~~~~~~~~  370 (597)
T 3oja_B          317 ERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDC-----------------------NSLRALFRNVA  370 (597)
T ss_dssp             GGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEH-----------------------HHHHHHTTTCC
T ss_pred             CcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCC-----------------------hhHHHHHHHHh
Confidence            556777778888888888877542   5566677777777776664                       22222344455


Q ss_pred             CccccCCCCCCCCCC
Q 002826          495 ASYLQGNPGLCGPGL  509 (876)
Q Consensus       495 ~~~~~~N~~~C~~~~  509 (876)
                      ...+.+++..|+.+.
T Consensus       371 ~~~~~~~~~~C~~~~  385 (597)
T 3oja_B          371 RPAVDDADQHCKIDY  385 (597)
T ss_dssp             TTTBCCCCCCCCTTC
T ss_pred             hhccccccccCCcch
Confidence            566788888898743

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-39  Score=353.47  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=204.1

Q ss_pred             ccccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      |.....+|.|| ||.||+|..      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus        47 y~~~~~lG~G~-~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  125 (344)
T 1rjb_A           47 LEFGKVLGSGA-FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  125 (344)
T ss_dssp             EEEEEEEEECS-SEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ceeeeeecCCC-CceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence            33344455555 999999975      356789999997532 23456789999999999 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccCC----------------------cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCc
Q 002826          655 LIYEFLQMGSLGDLICRQDF----------------------QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN  712 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~N  712 (876)
                      +||||+++|+|.+++.....                      .+++..+..++.|++.||+|||+.   +|+||||||+|
T Consensus       126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~N  202 (344)
T 1rjb_A          126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  202 (344)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhh
Confidence            99999999999999976532                      378999999999999999999999   99999999999


Q ss_pred             eeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch
Q 002826          713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAES  791 (876)
Q Consensus       713 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~  791 (876)
                      |+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.......
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            9999999999999999987764433333444557889999999888889999999999999999998 999998755433


Q ss_pred             hhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      . ..........      ....       ......+.+++.+||+.||.+|||+.|+++.|+.+......
T Consensus       283 ~-~~~~~~~~~~------~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          283 N-FYKLIQNGFK------MDQP-------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             H-HHHHHHTTCC------CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             H-HHHHHhcCCC------CCCC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence            2 2222221110      0000       11234678999999999999999999999999998776543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.9e-39  Score=365.04  Aligned_cols=251  Identities=25%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|.|+ ||+||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+++|+|.
T Consensus       194 ~~lG~G~-fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~  270 (454)
T 1qcf_A          194 KKLGAGQ-FGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL  270 (454)
T ss_dssp             EEEECCS-SEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred             EEcccCC-ceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence            4455555 999999999889999999997543 56788999999999999999999999986 56789999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++... +..+++..+.+++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       271 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~  346 (454)
T 1qcf_A          271 DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAK  346 (454)
T ss_dssp             HHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSS
T ss_pred             HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCc
Confidence            999754 34688999999999999999999999   999999999999999999999999999987654321 1223334


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||.+....++.++|||||||++|||+| |+.||......  .....+.......       .|      ...+
T Consensus       347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~~~-------~~------~~~~  411 (454)
T 1qcf_A          347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRMP-------RP------ENCP  411 (454)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHHTCCCC-------CC------TTSC
T ss_pred             ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC-------CC------CCCC
Confidence            6788999999988889999999999999999999 99999764432  2222222211110       01      1123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ..+.+++.+||+.||++|||++++++.|+++....
T Consensus       412 ~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          412 EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            46789999999999999999999999999987654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-39  Score=350.18  Aligned_cols=270  Identities=25%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEE
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFF  647 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~  647 (876)
                      +....+...+++..+..|.|+||.||+|++     .+++.||+|++.... ......+.+|++++++++||||+++++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            344445555455555555555999999983     478999999997543 23457889999999999999999999999


Q ss_pred             EeC--CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          648 HSD--ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       648 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      .+.  ...++||||+++++|.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D  169 (302)
T 4e5w_A           93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD  169 (302)
T ss_dssp             EC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             ecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence            876  678999999999999999977767899999999999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCc----------chhhH
Q 002826          726 FALDRIVGEAAFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA----------ESLDV  794 (876)
Q Consensus       726 fGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~----------~~~~~  794 (876)
                      ||+++........ .......||..|+|||.+.+..++.++||||+|+++|||++|+.|+.....          .....
T Consensus       170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  249 (302)
T 4e5w_A          170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV  249 (302)
T ss_dssp             CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred             ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence            9999877643321 223445578889999998888889999999999999999999998643211          01111


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ...........   ..       ......+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       250 ~~~~~~~~~~~---~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          250 TRLVNTLKEGK---RL-------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHHHTTC---CC-------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhccC---CC-------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11111110000   00       011122346889999999999999999999999999874

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.1e-39  Score=350.09  Aligned_cols=257  Identities=19%  Similarity=0.293  Sum_probs=188.8

Q ss_pred             ccCCCCCCCCceEEEEEEeCC-Cc---EEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeE-----
Q 002826          585 EKSSAGNGGPFGRVYILSLPS-GE---LIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-----  653 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~-~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-----  653 (876)
                      ++.+..|.|+||+||+|.... ++   .||||++....  ....+.+.+|++++++++||||+++++++...+..     
T Consensus        26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (323)
T 3qup_A           26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI  105 (323)
T ss_dssp             EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred             EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence            333444444599999997653 32   89999986542  23346788999999999999999999999876654     


Q ss_pred             -EEEEEcCCCCCHHHHhhcc-----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          654 -FLIYEFLQMGSLGDLICRQ-----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       654 -~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                       ++||||+++|+|.+++...     ...+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg  182 (323)
T 3qup_A          106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFG  182 (323)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeecc
Confidence             9999999999999998643     22589999999999999999999999   99999999999999999999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........  ........  . 
T Consensus       183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~~--~-  257 (323)
T 3qup_A          183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--YNYLIGGN--R-  257 (323)
T ss_dssp             C-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTC--C-
T ss_pred             ccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--HHHHhcCC--C-
Confidence            9987765443333444557888999999988889999999999999999999 9999986544332  12111110  0 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                         ...       ....+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       258 ---~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          258 ---LKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             ---CCC-------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---CCC-------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence               000       1122346789999999999999999999999999987543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2e-37  Score=352.84  Aligned_cols=357  Identities=21%  Similarity=0.301  Sum_probs=255.4

Q ss_pred             EEeecCCCCCcccccccccCCCCC-------------CeeecCCCccccccCccccCCCCCCcccCCCccc---------
Q 002826           78 ASINLQSLNLSGEISSSVCELSSL-------------SNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI---------  135 (876)
Q Consensus        78 ~~l~l~~~~l~~~~~~~~~~l~~L-------------~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l---------  135 (876)
                      ..+++.++++.|.+|++++++++|             ++|++++|.+++ +|..   .++|++|+|++|.+         
T Consensus        37 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~lp~~~~~  112 (454)
T 1jl5_A           37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTELPELPQS  112 (454)
T ss_dssp             HHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSCCCCCTT
T ss_pred             hhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC---cCCCCEEEccCCcCCccccccCC
Confidence            345566666777777777777654             777777777766 3331   35777777777753         


Q ss_pred             -ceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEec
Q 002826          136 -WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQ  214 (876)
Q Consensus       136 -~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~  214 (876)
                       +.|++++|++++ +|..   .++|++|+|++|++++ +| .|+++++|++|++++|+  +..+|..+   .+|++|+++
T Consensus       113 L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~--l~~lp~~~---~~L~~L~L~  181 (454)
T 1jl5_A          113 LKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNS--LKKLPDLP---PSLEFIAAG  181 (454)
T ss_dssp             CCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC--CSCCCCCC---TTCCEEECC
T ss_pred             CcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCc--CcccCCCc---ccccEEECc
Confidence             567888888875 2321   1689999999999996 66 59999999999999998  55677654   589999999


Q ss_pred             CCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc
Q 002826          215 SSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS  294 (876)
Q Consensus       215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  294 (876)
                      +|++++ +| .|.++++|++|++++|+++ .+|..    .++|++|++++|+++ .+| .+..+++|++|++++|++++ 
T Consensus       182 ~n~l~~-l~-~~~~l~~L~~L~l~~N~l~-~l~~~----~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-  251 (454)
T 1jl5_A          182 NNQLEE-LP-ELQNLPFLTAIYADNNSLK-KLPDL----PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-  251 (454)
T ss_dssp             SSCCSS-CC-CCTTCTTCCEEECCSSCCS-SCCCC----CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-
T ss_pred             CCcCCc-Cc-cccCCCCCCEEECCCCcCC-cCCCC----cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-
Confidence            999998 45 5999999999999999999 56654    358999999999999 566 48999999999999999996 


Q ss_pred             CCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccc
Q 002826          295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV  374 (876)
Q Consensus       295 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  374 (876)
                      +|..   +++|++|++++|++++ +|..   +++|+.|++++|++++.. .   ..++|++|++++|++++ ++    .+
T Consensus       252 l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~-~---~~~~L~~L~l~~N~l~~-i~----~~  315 (454)
T 1jl5_A          252 LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRS-LC----DL  315 (454)
T ss_dssp             CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSE-EC----CC
T ss_pred             cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCccc-C---cCCcCCEEECcCCcCCc-cc----CC
Confidence            4443   4799999999999996 4543   478999999999999742 1   12689999999999985 33    23


Q ss_pred             -cCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCC--CCCcCCCCC------
Q 002826          375 -KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTG--EIPPSLAEL------  445 (876)
Q Consensus       375 -~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l------  445 (876)
                       ++|+.|++++|++++ +|..   +++|+.|++++|++++.+.   .+++|++|+|++|++++  .+|.++..+      
T Consensus       316 ~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~  388 (454)
T 1jl5_A          316 PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEVPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHL  388 (454)
T ss_dssp             CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC--
T ss_pred             cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccc
Confidence             589999999999997 5544   5889999999999996544   57999999999999998  788999888      


Q ss_pred             -------CCcceeeCCCCcccc--cCCCcccccccceEEccCCccccccCC
Q 002826          446 -------PVLTYLDLSDNNLTG--PIPQGLQNLKLALFNVSFNKLSGRVPY  487 (876)
Q Consensus       446 -------~~L~~L~Ls~N~l~~--~~p~~~~~l~l~~l~ls~N~l~~~~p~  487 (876)
                             ++|+.||+++|++++  .+|.++..     |.+.+|.+.+.+|.
T Consensus       389 ~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~-----L~~~~~~~~~~~~~  434 (454)
T 1jl5_A          389 AEVPELPQNLKQLHVETNPLREFPDIPESVED-----LRMNSERVVDPYEF  434 (454)
T ss_dssp             ---------------------------------------------------
T ss_pred             cccccccCcCCEEECCCCcCCccccchhhHhh-----eeCcCcccCCcccc
Confidence                   899999999999997  77766544     55677777766653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.4e-38  Score=336.80  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=198.5

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .....+|.|+ ||+||+|... +|+.||+|++.......  ...+.+|++++++++||||+++++++.+++..++||||+
T Consensus         5 ~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            5 EKLEKIGEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEECS-SSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eeeeEecCCC-CeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            3344555555 9999999764 79999999997544322  367889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++ ++.+.+......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        84 ~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  157 (292)
T 3o0g_A           84 DQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC  157 (292)
T ss_dssp             SE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--SC
T ss_pred             CC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--cc
Confidence            86 67776666566899999999999999999999999   99999999999999999999999999998765332  22


Q ss_pred             cccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc-------
Q 002826          741 MSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL-------  812 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------  812 (876)
                      .....||+.|+|||.+.+.. ++.++||||+||++|||++|..||..............+.............       
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T 3o0g_A          158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence            34456899999999987665 7999999999999999999888865544333322222222111110000000       


Q ss_pred             -------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 -------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 -------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                             ..............+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                   00001111223456789999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.6e-38  Score=338.04  Aligned_cols=258  Identities=22%  Similarity=0.356  Sum_probs=196.8

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|.|+ ||+||+|+..+|+.||+|++.....  .....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~~lg~G~-~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   84 (288)
T 1ob3_A            6 GLEKIGEGT-YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ   84 (288)
T ss_dssp             EEEEEEEET-TEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred             hhhhcccCC-CEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC
Confidence            344555555 9999999888899999999965432  2346788999999999999999999999999999999999986


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                       +|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  158 (288)
T 1ob3_A           85 -DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYT  158 (288)
T ss_dssp             -EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             -CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccc
Confidence             99999987666799999999999999999999999   99999999999999999999999999998765322  1223


Q ss_pred             cccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc------ccccChh
Q 002826          743 SEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA------IQVLDPK  815 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~d~~  815 (876)
                      ...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ......+.........      ....++.
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccccccc
Confidence            4458999999998865 458999999999999999999999998654322 1222222111100000      0000111


Q ss_pred             --------hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          816 --------IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       816 --------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                              ...........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    01111223456789999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.7e-39  Score=350.52  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=199.3

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcE----EEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGEL----IAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ....+|.|| ||+||+|... +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..++|||
T Consensus        17 ~~~~lG~G~-~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e   94 (325)
T 3kex_A           17 KLKVLGSGV-FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQ   94 (325)
T ss_dssp             EEEEEECCS-SCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEE
T ss_pred             eeeeeeecC-CceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEE
Confidence            334455555 9999999754 5554    7778775432 233456778999999999999999999986 567899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  171 (325)
T 3kex_A           95 YLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ  171 (325)
T ss_dssp             CCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTC
T ss_pred             eCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccccc
Confidence            9999999999987666899999999999999999999999   9999999999999999999999999999987654433


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......++..|+|||.+.+..++.++||||||+++|||+| |+.||.......  ....+.......       .+.  
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~~-------~~~--  240 (325)
T 3kex_A          172 LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGERLA-------QPQ--  240 (325)
T ss_dssp             CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCBCC-------CCT--
T ss_pred             ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCCCC-------CCC--
Confidence            33445567889999999988889999999999999999999 999998654332  222222111000       010  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                          .....+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       241 ----~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          241 ----ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             ----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ----cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0122467899999999999999999999999998654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=348.77  Aligned_cols=269  Identities=14%  Similarity=0.133  Sum_probs=201.6

Q ss_pred             cccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCcc-----------CHHHHHHHHHHHhhccCccccceeeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGCQ-----------SSKTLKTEVKTLAKIRHKNIVKVLGF  646 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~  646 (876)
                      +.+.+.+..+.|+||.||+|...    ++..||+|++......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            33444444455559999999775    6789999998754321           12345678888999999999999999


Q ss_pred             EEe----CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC--C
Q 002826          647 FHS----DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF--E  720 (876)
Q Consensus       647 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~--~  720 (876)
                      +.+    .+..|+||||+ +++|.+++...+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence            988    67899999999 999999997665 799999999999999999999999   999999999999998777  9


Q ss_pred             eEEccccchhhccccccc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHH
Q 002826          721 PKLTDFALDRIVGEAAFQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVV  795 (876)
Q Consensus       721 ~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~  795 (876)
                      +||+|||+++.+......     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999999876533211     112344689999999999888899999999999999999999999965333322222


Q ss_pred             HHHHHHhhcccccccccChhhhhhcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          796 KWVRRKINITNGAIQVLDPKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       796 ~~~~~~~~~~~~~~~~~d~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                      ........       .+.+.......  ..+..+.+++.+||+.||++|||++|+++.|+.+.-.....
T Consensus       272 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  333 (345)
T 2v62_A          272 TAKTNLLD-------ELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPL  333 (345)
T ss_dssp             HHHHHHHH-------TTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCC
T ss_pred             HHHHhhcc-------cccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCC
Confidence            22111111       11111111111  23446889999999999999999999999999977644443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.2e-38  Score=346.00  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=206.1

Q ss_pred             cCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ...+|.|| ||.||+|+.      .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+++..++||
T Consensus        28 ~~~lg~G~-~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~  106 (313)
T 1t46_A           28 GKTLGAGA-FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT  106 (313)
T ss_dssp             EEEEEECS-SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHhhCccC-CcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence            34455554 999999974      3578999999975432 2346788999999999 9999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCC-----------------cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC
Q 002826          658 EFLQMGSLGDLICRQDF-----------------QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE  720 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~  720 (876)
                      ||+++|+|.+++.....                 .+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  183 (313)
T 1t46_A          107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI  183 (313)
T ss_dssp             ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTE
T ss_pred             ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCC
Confidence            99999999999976532                 489999999999999999999999   9999999999999999999


Q ss_pred             eEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHH
Q 002826          721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVR  799 (876)
Q Consensus       721 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~  799 (876)
                      +||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||+| |+.||........ ......
T Consensus       184 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~  262 (313)
T 1t46_A          184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FYKMIK  262 (313)
T ss_dssp             EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-HHHHHH
T ss_pred             EEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-HHHHhc
Confidence            99999999987765443333344557888999999888889999999999999999999 9999987554332 222222


Q ss_pred             HHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       800 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ....      ....       ...+..+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       263 ~~~~------~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          263 EGFR------MLSP-------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HTCC------CCCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCC------CCCc-------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            1111      0001       11234678999999999999999999999999988654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.2e-38  Score=349.55  Aligned_cols=244  Identities=22%  Similarity=0.287  Sum_probs=196.5

Q ss_pred             CCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          588 SAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      .+|.|+ ||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus        96 ~lG~G~-~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           96 ILGGGR-FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             ECC------CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             EEecCc-CEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            355555 999999966 479999999998765556678999999999999999999999999999999999999999999


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee--CCCCCeEEccccchhhccccccccccccc
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL--DADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll--~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      +++......+++..+..++.|++.||+|||+.   +|+||||||+||++  +.++.+||+|||+++.......   ....
T Consensus       175 ~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~  248 (373)
T 2x4f_A          175 DRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVN  248 (373)
T ss_dssp             HHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCC
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccc
Confidence            99977666799999999999999999999999   99999999999999  5678999999999987654322   2334


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .||+.|+|||++....++.++|||||||++|||++|+.||........ .......    .   ....++..    ....
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~i~~~----~---~~~~~~~~----~~~~  316 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET-LNNILAC----R---WDLEDEEF----QDIS  316 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHT----C---CCSCSGGG----TTSC
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc----c---CCCChhhh----ccCC
Confidence            589999999999888899999999999999999999999986543221 1111111    0   01111111    1223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       317 ~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          317 EEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            46789999999999999999999998

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=341.39  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=192.7

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|| ||+||+|+. .++.||+|++...  ...+.+.+|++++++++||||+++++++.+  ..++||||+++++|
T Consensus        13 ~~~lg~G~-~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L   86 (307)
T 2eva_A           13 EEVVGRGA-FGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSL   86 (307)
T ss_dssp             EEEEECCS-SSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBH
T ss_pred             eeEeecCC-CceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCH
Confidence            34455555 999999987 5889999998642  345678999999999999999999998873  47899999999999


Q ss_pred             HHHhhccCC--cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC-eEEccccchhhccccccccccc
Q 002826          666 GDLICRQDF--QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE-PKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       666 ~~~l~~~~~--~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~-~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      .+++.....  .+++..+.+++.|+++|++|||+.+..+|+||||||+||+++.++. +||+|||+++.....     ..
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~  161 (307)
T 2eva_A           87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MT  161 (307)
T ss_dssp             HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred             HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cc
Confidence            999976542  4789999999999999999999932229999999999999998876 799999999765432     12


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ...||+.|+|||...+..++.++||||||+++|||++|+.||................  ...        +..   ...
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~--------~~~---~~~  228 (307)
T 2eva_A          162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GTR--------PPL---IKN  228 (307)
T ss_dssp             ---CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TCC--------CCC---BTT
T ss_pred             cCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CCC--------CCc---ccc
Confidence            3348999999999998899999999999999999999999997644333221111111  100        000   111


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .+..+.+++.+||+.||++|||+.|+++.|+.+.+...
T Consensus       229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            23357899999999999999999999999999876543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.8e-38  Score=346.66  Aligned_cols=244  Identities=22%  Similarity=0.348  Sum_probs=195.7

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.+.+..|.|+||.||+|.. .+|+.||+|++...   .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            34444444455999999976 58999999998642   123346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      + +|+|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|||+++.......  
T Consensus        91 ~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~--  163 (336)
T 3h4j_B           91 A-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF--  163 (336)
T ss_dssp             C-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred             C-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence            9 679999887654 699999999999999999999999   999999999999999999999999999987654332  


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       .....||+.|+|||.+.+..+ ++++||||+||++|||++|+.||........                ...+......
T Consensus       164 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~~~~~  226 (336)
T 3h4j_B          164 -LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNSCVYV  226 (336)
T ss_dssp             -TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCSSCCC
T ss_pred             -cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHcCCCC
Confidence             234468999999999887765 7899999999999999999999986543321                0000000000


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+...+..+.+++.+||+.||.+|||++|+++.
T Consensus       227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            111123457899999999999999999999874

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=4.1e-37  Score=367.73  Aligned_cols=393  Identities=21%  Similarity=0.216  Sum_probs=292.3

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS  155 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~  155 (876)
                      .+..++|+++++++..+.+|.+|++|++|+|++|+|++..+..|+++++|++|+|++|+          +++..+..|++
T Consensus        77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~----------l~~l~~~~~~~  146 (635)
T 4g8a_A           77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN----------LASLENFPIGH  146 (635)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC----------CCCSTTCCCTT
T ss_pred             CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc----------CCCCChhhhhc
Confidence            56779999999998888899999999999999999999888999999999999777664          34444445555


Q ss_pred             ccccceecccccccCCC-cCccccCCCcceEEEccCCCCcCCCCCCcccccCccc----EEEecCCCCcccCCcc-----
Q 002826          156 LVNLQVLNLGSNLLSGS-VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLE----QLFLQSSGFHGVIPDS-----  225 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~----~L~L~~n~l~~~~~~~-----  225 (876)
                      +++|++|+|++|++++. .|..++++++|++|+|++|++ .+..|..|..+.+++    .++++.|.+..+.+..     
T Consensus       147 L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l-~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~  225 (635)
T 4g8a_A          147 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR  225 (635)
T ss_dssp             CTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC-CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCE
T ss_pred             CcccCeeccccCccccCCCchhhccchhhhhhcccCccc-cccccccccchhhhhhhhhhhhcccCcccccCcccccchh
Confidence            55566666666555432 345555555566666655551 111222333322221    2333333333222211     


Q ss_pred             --------------------------------------------------------------------------------
Q 002826          226 --------------------------------------------------------------------------------  225 (876)
Q Consensus       226 --------------------------------------------------------------------------------  225 (876)
                                                                                                      
T Consensus       226 ~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~  305 (635)
T 4g8a_A          226 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCL  305 (635)
T ss_dssp             EEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGG
T ss_pred             hhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhh
Confidence                                                                                            


Q ss_pred             ------------------ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeee
Q 002826          226 ------------------FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLH  287 (876)
Q Consensus       226 ------------------~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  287 (876)
                                        +....+|+.|++++|++. .++..   .+..|+.++++.|.+..  +.....+++|+.|+++
T Consensus       306 ~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~-~~~~~---~l~~L~~l~l~~n~~~~--~~~~~~l~~L~~L~ls  379 (635)
T 4g8a_A          306 TNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG-QFPTL---KLKSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLS  379 (635)
T ss_dssp             TTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEES-SCCCC---BCTTCCEEEEESCCSCC--BCCCCBCTTCCEEECC
T ss_pred             cccccccccccccccccccccchhhhhhhccccccc-CcCcc---cchhhhhcccccccCCC--Ccccccccccccchhh
Confidence                              111223333444444433 22211   13344444444444432  2233467899999999


Q ss_pred             cccccc--cCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCc-cccccCCCCCeeeccCcccC
Q 002826          288 KNFFNG--SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP-DSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       288 ~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  364 (876)
                      +|.+..  ..+..+..+.+|+.+++..|.+.. .+..+..+++|+.+++..|......+ ..|..+.+++.+++++|+++
T Consensus       380 ~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~  458 (635)
T 4g8a_A          380 RNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR  458 (635)
T ss_dssp             SSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCE
T ss_pred             ccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccc
Confidence            999864  445567788899999999999884 56678899999999999988876655 56789999999999999999


Q ss_pred             CCCCCccccccCccEEeCCCccc-cCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCC
Q 002826          365 SSIPQGLGSVKSLYRFSASQNSF-YGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSL  442 (876)
Q Consensus       365 ~~~p~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~  442 (876)
                      +..|..+..+++|+.|++++|.+ .+..|..|..+++|++|||++|+|++.+| .|.++++|++|+|++|+|++..|..|
T Consensus       459 ~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~  538 (635)
T 4g8a_A          459 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY  538 (635)
T ss_dssp             ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGG
T ss_pred             cccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHH
Confidence            99999999999999999999985 45678999999999999999999999887 79999999999999999999999999


Q ss_pred             CCCCCcceeeCCCCcccccCCCccccc--ccceEEccCCccccccC
Q 002826          443 AELPVLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKLSGRVP  486 (876)
Q Consensus       443 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~l~~l~ls~N~l~~~~p  486 (876)
                      .++++|++|||++|+|++..|..+..+  .++.|++++|++++...
T Consensus       539 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~  584 (635)
T 4g8a_A          539 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE  584 (635)
T ss_dssp             TTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred             hCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence            999999999999999999999999887  59999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6.5e-39  Score=342.48  Aligned_cols=255  Identities=21%  Similarity=0.334  Sum_probs=191.4

Q ss_pred             cccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      +++.+..|.|+||.||+|...    .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e   95 (281)
T 1mp8_A           17 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME   95 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             eEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEe
Confidence            334444444559999999764    245799999865322 23457889999999999999999999984 567899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A           96 LCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             CCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            9999999999987766799999999999999999999999   9999999999999999999999999999877543221


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......+++.|+|||......++.++||||+|+++|||++ |+.||.......  ....+....      ...+.    
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~------~~~~~----  239 (281)
T 1mp8_A          173 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------RLPMP----  239 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------CCCCC----
T ss_pred             -ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCC------CCCCC----
Confidence             1223346788999999888889999999999999999997 999998654432  222221110      00111    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                         ...+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       240 ---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          240 ---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               11234678999999999999999999999999998653

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=353.40  Aligned_cols=256  Identities=19%  Similarity=0.221  Sum_probs=202.6

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI  653 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  653 (876)
                      ..+...|.....+|.|| ||+||+|.. .+|+.||+|++.....  .....+.+|+++++.++||||+++++++.+++..
T Consensus         7 ~~~~~~Y~i~~~LG~G~-fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   85 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGA-FSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH   85 (444)
T ss_dssp             CHHHHHEEEEEEEEEC---CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred             ccccCCeEEEEEeccCC-CeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence            34444555556666666 999999965 5899999999975432  2345688999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchh
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDR  730 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~  730 (876)
                      |+||||+++|+|.+.+...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++   .++.+||+|||+++
T Consensus        86 ~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           86 YLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999999987654 699999999999999999999999   999999999999998   46889999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .......  ......||+.|+|||++.+..++.++||||+||++|+|++|++||.......  ....+...      ...
T Consensus       162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~~------~~~  231 (444)
T 3soa_A          162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQIKAG------AYD  231 (444)
T ss_dssp             CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHT------CCC
T ss_pred             EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHHHHhC------CCC
Confidence            7654321  2234569999999999998889999999999999999999999997644322  12222111      111


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...+..    ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          232 FPSPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CCTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCcccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111111    1223457899999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.6e-39  Score=353.66  Aligned_cols=264  Identities=25%  Similarity=0.322  Sum_probs=203.8

Q ss_pred             ccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEE--eCCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH--SDESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~  657 (876)
                      ....+|.|+ ||.||+|++     .+++.||+|++........+.+.+|++++++++||||+++++++.  +.+..++||
T Consensus        27 ~~~~lg~G~-~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~  105 (327)
T 3lxl_A           27 YISQLGKGN-FGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM  105 (327)
T ss_dssp             EEEEEEEET-TEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEE
T ss_pred             hhhhccCCC-CeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEE
Confidence            334455554 999999973     478999999997665455567899999999999999999999987  456799999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  182 (327)
T 3lxl_A          106 EYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD  182 (327)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred             eecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence            99999999999987666799999999999999999999999   999999999999999999999999999987754322


Q ss_pred             -ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh----------HHHHHHHHhhccc
Q 002826          738 -QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD----------VVKWVRRKINITN  806 (876)
Q Consensus       738 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~~~~~  806 (876)
                       ........||..|+|||.+.+..++.++||||+|+++|||++|+.||.....+...          ...........  
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  260 (327)
T 3lxl_A          183 YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG--  260 (327)
T ss_dssp             EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT--
T ss_pred             cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc--
Confidence             12233445788899999988888899999999999999999999998653322110          00111100000  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                       ...       .........+.+++.+||+.||++|||++|+++.|+.+.......
T Consensus       261 -~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  308 (327)
T 3lxl_A          261 -QRL-------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC  308 (327)
T ss_dssp             -CCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred             -cCC-------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence             000       011122346889999999999999999999999999987654433

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.7e-38  Score=347.60  Aligned_cols=249  Identities=21%  Similarity=0.340  Sum_probs=197.0

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC-----CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      |.....+|.| +||+||+|.. .+|+.||||++...     .....+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        26 y~~~~~lG~G-~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           26 YELCEVIGKG-PFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             EEEEEEEEEC-SSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eEEeeEEeeC-CCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3334445555 4999999966 47999999998542     122467899999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC---eEEccccchh
Q 002826          657 YEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE---PKLTDFALDR  730 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~---~kl~DfGla~  730 (876)
                      |||+++++|.+.+.+.   +..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||+++
T Consensus       105 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999998887543   34589999999999999999999999   9999999999999986554   9999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .......  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   .....+..   ..   . 
T Consensus       182 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~i~~---~~---~-  249 (351)
T 3c0i_A          182 QLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLFEGIIK---GK---Y-  249 (351)
T ss_dssp             ECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHHHHHHH---TC---C-
T ss_pred             EecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHHHHHHc---CC---C-
Confidence            7754321  22345699999999999988899999999999999999999999976321   11111111   10   0 


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..++..   +......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 KMNPRQ---WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            011111   1122346789999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-37  Score=343.63  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=200.3

Q ss_pred             hhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      ...|.....+|.|+ ||.||+|... +|+.||+|++......  ..+.+.+|+++++.++||||+++++++.+++..|+|
T Consensus        28 ~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGA-FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCC-CeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            33455555566555 9999999664 7999999999754322  235688999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEccccchhhcc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFALDRIVG  733 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~DfGla~~~~  733 (876)
                      |||+++|+|.+++.... .+++..+..++.||+.|++|||+.   +|+||||||+||+++.+   +.+||+|||+++...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999987653 689999999999999999999999   99999999999999865   459999999998765


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ...   ......||+.|+|||++.+..++.++||||+||++|||++|++||.......  ....+...      ......
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~------~~~~~~  251 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAG------AYDYPS  251 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT------CCCCCT
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhC------CCCCCc
Confidence            432   2234568999999999998889999999999999999999999997644321  22221111      111111


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +..    ......+.+++.+||+.||++|||+.|+++.
T Consensus       252 ~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          252 PEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             TGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111    1223467899999999999999999998864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.8e-38  Score=343.81  Aligned_cols=248  Identities=24%  Similarity=0.362  Sum_probs=184.0

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |.....+|.|| ||+||+|+.. +++.||||++...  ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        55 y~~~~~lG~G~-~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  131 (349)
T 2w4o_A           55 FEVESELGRGA-TSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT  131 (349)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEeeEEeeCC-CEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence            33344455555 9999999775 6889999999754  345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeEEccccchhhccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~DfGla~~~~~~~~~  738 (876)
                      +++|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++......  
T Consensus       132 ~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--  205 (349)
T 2w4o_A          132 GGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--  205 (349)
T ss_dssp             SCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--
Confidence            999999997654 689999999999999999999999   9999999999999975   8899999999998765432  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............    ....   .....+.   
T Consensus       206 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i----~~~~---~~~~~~~---  274 (349)
T 2w4o_A          206 -LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI----LNCE---YYFISPW---  274 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH----HTTC---CCCCTTT---
T ss_pred             -ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH----HhCC---CccCCch---
Confidence             1233458999999999998889999999999999999999999997654433211111    1111   1111111   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       +......+.+++.+||+.||++|||+.|+++.
T Consensus       275 -~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 -WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             -TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -hhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11223467899999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.9e-38  Score=359.10  Aligned_cols=246  Identities=24%  Similarity=0.442  Sum_probs=199.7

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC-eEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE-SIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~gs  664 (876)
                      ...+|.|+ ||.||+|.. .|+.||||++...  ...+.+.+|++++++++||||+++++++.+.+ ..|+||||+++|+
T Consensus       198 ~~~lG~G~-fg~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          198 LQTIGKGE-FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEECS-SEEEEEEEE-TTEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EeeecCcC-CeeEEEEEe-cCCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            34555555 999999988 4889999999754  35678999999999999999999999987765 7999999999999


Q ss_pred             HHHHhhccCC-cCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++.+.+. .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......     ..
T Consensus       274 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~  345 (450)
T 1k9a_A          274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DT  345 (450)
T ss_dssp             HHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----------
T ss_pred             HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cC
Confidence            9999987643 479999999999999999999999   99999999999999999999999999998543221     12


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ  822 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  822 (876)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |+.||.......  ....+......          .   .+..
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~~----------~---~p~~  410 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKM----------D---APDG  410 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTTCCC----------C---CCTT
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC----------C---CCCc
Confidence            246788999999988899999999999999999998 999998654432  22222211100          0   0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       823 ~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       411 ~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          411 CPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            234678999999999999999999999999998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.5e-38  Score=350.12  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=192.5

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.....+|.|| ||.||+|+.+ +++.||+|++.+...   .....+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus        53 ~y~~~~~LG~G~-fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           53 DFDLLRVIGRGS-YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HcEEEEEEeeCC-CeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            344445566555 9999999765 688999999976422   2335678899999887 899999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       132 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999997654 699999999999999999999999   99999999999999999999999999997633221


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh---hHHHHHHHHh-hccccccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKI-NITNGAIQVL  812 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~  812 (876)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||........   .......... ....      
T Consensus       208 --~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------  279 (396)
T 4dc2_A          208 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------  279 (396)
T ss_dssp             --CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred             --CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence              123445699999999999999999999999999999999999999975332111   0111111111 1110      


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                        .+   +......+.+++.+||+.||++||++
T Consensus       280 --~~---p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 --RI---PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             --CC---CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             --CC---CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence              00   11123457899999999999999996

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-38  Score=346.25  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=204.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||.||+|...      +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++
T Consensus        27 y~~~~~lg~G~-~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  105 (322)
T 1p4o_A           27 ITMSRELGQGS-FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  105 (322)
T ss_dssp             EEEEEEEEECS-SSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             eeeeeEeccCC-ceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence            33334455554 9999999653      478899999865422 233568899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccC---------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          656 IYEFLQMGSLGDLICRQD---------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      ||||+++|+|.+++....         ..+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Df  182 (322)
T 1p4o_A          106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  182 (322)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcC
Confidence            999999999999987532         3578999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.......  ....+..   ..
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~---~~  257 (322)
T 1p4o_A          183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVME---GG  257 (322)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHT---TC
T ss_pred             ccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHHHHc---CC
Confidence            99987765443333444557889999999888889999999999999999999 899987644322  1111111   10


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                        . ...       ....+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       258 --~-~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          258 --L-LDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             --C-CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             --c-CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence              0 000       1122345789999999999999999999999999986643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=3.2e-37  Score=351.34  Aligned_cols=339  Identities=17%  Similarity=0.168  Sum_probs=278.5

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS  155 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~  155 (876)
                      ++..+++.++++++. | .++.+++|++|+|++|.+++. |  ++.+++|++|+|++|.          +++. |  +++
T Consensus        43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~----------l~~~-~--~~~  104 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNK----------LTNL-D--VTP  104 (457)
T ss_dssp             TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSC----------CSCC-C--CTT
T ss_pred             CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCC----------Ccee-e--cCC
Confidence            467799999999975 4 799999999999999999985 4  8899999988666554          4443 3  788


Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      +++|++|+|++|++++. |  ++++++|++|++++|+  +..+|  ++.+++|++|++++|+..+.+  .+..+++|++|
T Consensus       105 l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~--l~~l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L  175 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNT--LTEID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTL  175 (457)
T ss_dssp             CTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSC--CSCCC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEE
T ss_pred             CCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCc--cceec--cccCCcCCEEECCCCCccccc--ccccCCcCCEE
Confidence            89999999999999864 4  8889999999999998  44454  788899999999999655544  47888999999


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      ++++|+++ .+|   +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|+.|++++|++
T Consensus       176 ~ls~n~l~-~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          176 DCSFNKIT-ELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             ECCSSCCC-CCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred             ECCCCccc-eec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence            99999998 466   34688999999999999865   37888999999999999997 45  88889999999999999


Q ss_pred             CCCCCcccCCCC-------cccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCC--------ccccccCccEE
Q 002826          316 SGDFPDKLWSLP-------RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQ--------GLGSVKSLYRF  380 (876)
Q Consensus       316 ~~~~p~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~--------~~~~l~~L~~L  380 (876)
                      ++..+..+.+++       +|+.|++++|++.+.+|  +..+++|+.|++++|+..+.+|.        .+.+.++|+.|
T Consensus       246 ~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L  323 (457)
T 3bz5_A          246 TELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYL  323 (457)
T ss_dssp             SCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEE
T ss_pred             CCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEE
Confidence            987766666555       56677777777776666  56788999999999987766654        25566899999


Q ss_pred             eCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          381 SASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       381 ~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      ++++|++++. +  +..+++|+.|++++|+|++       ++.|..|++++|+++|.     ..+..|+.+++++|+++|
T Consensus       324 ~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~-------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g  388 (457)
T 3bz5_A          324 YLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD-------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTI  388 (457)
T ss_dssp             ECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB-------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEE
T ss_pred             ECCCCccccc-c--cccCCcCcEEECCCCCCCC-------ccccccccccCCcEEec-----ceeeecCccccccCcEEE
Confidence            9999999985 3  8999999999999999986       35677889999999976     466778899999999999


Q ss_pred             cCCCcccc
Q 002826          461 PIPQGLQN  468 (876)
Q Consensus       461 ~~p~~~~~  468 (876)
                      .+|..+..
T Consensus       389 ~ip~~~~~  396 (457)
T 3bz5_A          389 AVSPDLLD  396 (457)
T ss_dssp             ECCTTCBC
T ss_pred             EcChhHhc
Confidence            99987554

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-38  Score=364.72  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ....+|.|+ ||.||+|.+. +++.||||++.... ...+++.+|++++++++||||++++++|.+.+..++||||+++|
T Consensus       224 ~~~~lG~G~-fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g  301 (495)
T 1opk_A          224 MKHKLGGGQ-YGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG  301 (495)
T ss_dssp             EEEESGGGT-TSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eeeEecCCC-CeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence            334566555 9999999876 48999999986543 45788999999999999999999999999999999999999999


Q ss_pred             CHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          664 SLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       664 sL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      +|.+++.+. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       302 ~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~  377 (495)
T 1opk_A          302 NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHA  377 (495)
T ss_dssp             BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCT
T ss_pred             CHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce-eecC
Confidence            999999764 45689999999999999999999999   999999999999999999999999999987654322 2223


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...++..|+|||.+....++.++|||||||++|||+| |+.||.......  ..+.+......          .   ...
T Consensus       378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~----------~---~~~  442 (495)
T 1opk_A          378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRM----------E---RPE  442 (495)
T ss_dssp             TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCC----------C---CCT
T ss_pred             CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC----------C---CCC
Confidence            3446788999999988889999999999999999999 999998654432  22222211110          0   011


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ..+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~  481 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  481 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSC
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccc
Confidence            223467899999999999999999999999999875543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-38  Score=342.32  Aligned_cols=250  Identities=22%  Similarity=0.308  Sum_probs=196.9

Q ss_pred             cCCCCCCCCceEEEEEEeC-CC-------cEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          586 KSSAGNGGPFGRVYILSLP-SG-------ELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ...+|.| +||+||+|... ++       ..||+|++........+.+.+|++++++++||||+++++++.+++..++||
T Consensus        13 ~~~lg~G-~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           13 NESLGQG-TFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEE-TTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeccC-CCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence            3445554 49999999654 33       579999997766566788999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC--------eEEccccch
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE--------PKLTDFALD  729 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~--------~kl~DfGla  729 (876)
                      ||+++++|.+++.+....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.        +||+|||++
T Consensus        92 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~  168 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS  168 (289)
T ss_dssp             ECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSC
T ss_pred             ECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCccc
Confidence            99999999999988766699999999999999999999999   9999999999999998877        999999998


Q ss_pred             hhccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      +......      ...||+.|+|||.+.+ ..++.++||||||+++|||++|..|+........ ..........    .
T Consensus       169 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~~~~----~  237 (289)
T 4fvq_A          169 ITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYEDRHQ----L  237 (289)
T ss_dssp             TTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCC----C
T ss_pred             ccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhccCC----C
Confidence            7654322      2237888999999876 6789999999999999999996555443222211 1111111001    0


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      ...           ....+.+++.+||+.||++|||++|+++.|+++......
T Consensus       238 ~~~-----------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          238 PAP-----------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             CCC-----------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             CCC-----------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence            011           122467899999999999999999999999999875443

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.2e-38  Score=336.38  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=187.2

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc----cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC----QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ...+|.|| ||.||+|.. .|+.||+|++.....    ...+.+.+|+++++.++||||+++++++.+++..++||||++
T Consensus        12 ~~~lg~G~-~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (271)
T 3dtc_A           12 EEIIGIGG-FGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR   89 (271)
T ss_dssp             EEEEEEET-TEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCT
T ss_pred             eeeeccCC-CeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCC
Confidence            34455555 999999987 489999999865322    234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC--------CCCeEEccccchhhcc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA--------DFEPKLTDFALDRIVG  733 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~--------~~~~kl~DfGla~~~~  733 (876)
                      +++|.+++..  ..+++..+..++.|++.|++|||+.+..+|+||||||+||+++.        ++.+||+|||+++...
T Consensus        90 ~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~  167 (271)
T 3dtc_A           90 GGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH  167 (271)
T ss_dssp             TEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----
T ss_pred             CCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccc
Confidence            9999999864  46899999999999999999999993223999999999999986        6789999999998765


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ....    ....||+.|+|||...+..++.++||||+|+++|||++|+.||.........  .   ......  ..... 
T Consensus       168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~---~~~~~~--~~~~~-  235 (271)
T 3dtc_A          168 RTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--Y---GVAMNK--LALPI-  235 (271)
T ss_dssp             ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--H---HHHTSC--CCCCC-
T ss_pred             cccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--H---hhhcCC--CCCCC-
Confidence            4321    2345899999999998888999999999999999999999999864432211  1   111000  00000 


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                            ....+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       236 ------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 ------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                  111234678999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=345.08  Aligned_cols=247  Identities=20%  Similarity=0.305  Sum_probs=196.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|. |+||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus        17 y~i~~~LG~-G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e   95 (384)
T 4fr4_A           17 FEILRAIGK-GSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD   95 (384)
T ss_dssp             EEEEEEEEC-CTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEee-CCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            333444555 459999999764 68999999996532   2445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+. ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......  
T Consensus        96 ~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--  169 (384)
T 4fr4_A           96 LLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--  169 (384)
T ss_dssp             CCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred             cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--
Confidence            99999999999765 3699999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          739 STMSSEYALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                       ......||+.|+|||++..   ..++.++||||+||++|||++|+.||.........  ...........         
T Consensus       170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~---------  237 (384)
T 4fr4_A          170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK--EIVHTFETTVV---------  237 (384)
T ss_dssp             -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH--HHHHHHHHCCC---------
T ss_pred             -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH--HHHHHHhhccc---------
Confidence             2344569999999999863   45889999999999999999999999864433221  11111111110         


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPS-MFEVVK  850 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~ell~  850 (876)
                        ..+......+.+++.+||+.||++||+ ++++.+
T Consensus       238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              001112346789999999999999998 677664

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-38  Score=344.80  Aligned_cols=256  Identities=22%  Similarity=0.372  Sum_probs=196.6

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcE----EEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGEL----IAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      |.....+|.|| ||+||+|... +++.    ||+|.+... .......+.+|+.++++++||||+++++++..+. .++|
T Consensus        17 y~~~~~lG~G~-~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v   94 (327)
T 3lzb_A           17 FKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             EEEEEEEEECS-SEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred             ceEEEEeeeCC-CeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence            34445555555 9999999753 5554    467766433 2345678999999999999999999999998754 7899


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      +||+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~  171 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred             EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence            999999999999988777899999999999999999999999   99999999999999999999999999998876443


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........  ...+.......      ..  
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~~~~~~~~~~~------~~--  241 (327)
T 3lzb_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--SSILEKGERLP------QP--  241 (327)
T ss_dssp             --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHHHHTTCCCC------CC--
T ss_pred             ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--HHHHHcCCCCC------CC--
Confidence            3333344457888999999988899999999999999999999 9999987554432  22222111000      00  


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                           ......+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       242 -----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          242 -----PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                 11223578999999999999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.2e-38  Score=336.10  Aligned_cols=263  Identities=18%  Similarity=0.204  Sum_probs=204.1

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEE-EeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-HSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||+||+|.. .+++.||+|++....  ....+.+|+++++.++|++++..++++ .+.+..++||||+
T Consensus        11 y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 4hgt_A           11 YRLGRKIGSGS-FGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             CEEEEEEEECS-SSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeeeecCCC-CeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence            33344455554 999999975 589999999875532  334588899999999988877777766 5677889999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccchhhcccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGla~~~~~~~~  737 (876)
                       +++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||+++.......
T Consensus        88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence             8899999987666899999999999999999999999   99999999999999   7889999999999987654322


Q ss_pred             c-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-h-HHHHHHHHhhccccccc
Q 002826          738 Q-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-D-VVKWVRRKINITNGAIQ  810 (876)
Q Consensus       738 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~-~~~~~~~~~~~~~~~~~  810 (876)
                      .     .......||+.|+|||...+..++.++|||||||++|||++|+.||........ . ............     
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  238 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----  238 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-----
Confidence            1     122345689999999999998999999999999999999999999986443221 1 111111111110     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                           ........+..+.+++.+||+.||++|||++|+++.|+++.++....
T Consensus       239 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          239 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             -----HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             -----hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence                 00111122346889999999999999999999999999988765543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-37  Score=335.24  Aligned_cols=264  Identities=18%  Similarity=0.202  Sum_probs=206.1

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEE-EeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-HSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~  659 (876)
                      +|.....+|.|+ ||.||+|+. .+|+.||+|++....  ..+.+.+|+.+++.++|++++..++++ .+.+..++||||
T Consensus        10 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A           10 RYRLGRKIGSGS-FGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TEEEEEEEEEET-TEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEEccCC-CeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            344444555555 999999975 689999999986543  345688999999999998877777665 557788999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchhhccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~~~~~~~  736 (876)
                      + +++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++   .++.+||+|||+++......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9 8899999986666899999999999999999999999   999999999999994   78999999999998765432


Q ss_pred             cc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-hhHH-HHHHHHhhcccccc
Q 002826          737 FQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-LDVV-KWVRRKINITNGAI  809 (876)
Q Consensus       737 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-~~~~-~~~~~~~~~~~~~~  809 (876)
                      ..     .......||+.|+|||...+..++.++||||||+++|||++|+.||....... .... ..........    
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----  238 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----  238 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc----
Confidence            21     11234568999999999999899999999999999999999999998644322 1111 1111111111    


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                            ........+..+.+++.+||+.||++|||+.|+++.|+++..+....
T Consensus       239 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          239 ------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             ------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence                  00111122346889999999999999999999999999997766554

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-38  Score=346.90  Aligned_cols=257  Identities=24%  Similarity=0.397  Sum_probs=203.7

Q ss_pred             ccCCCCCCCCceEEEEEEe--------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          585 EKSSAGNGGPFGRVYILSL--------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      ....+|.|| ||.||+|+.        .+++.||+|++..... .....+.+|+++++++ +||||+++++++.+++..+
T Consensus        39 ~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  117 (334)
T 2pvf_A           39 LGKPLGEGA-FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  117 (334)
T ss_dssp             EEEEEEECS-SCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred             EeeEEeecC-ceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence            334455554 999999975        3578899999865432 2345688999999999 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          655 LIYEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +||||+++|+|.+++....               ..+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus       118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  194 (334)
T 2pvf_A          118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENN  194 (334)
T ss_dssp             EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCC
Confidence            9999999999999997653               2489999999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~  798 (876)
                      .+||+|||+++...............+|+.|+|||...+..++.++||||||+++|||++ |+.||.......  ....+
T Consensus       195 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~  272 (334)
T 2pvf_A          195 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--LFKLL  272 (334)
T ss_dssp             CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH
T ss_pred             CEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--HHHHH
Confidence            999999999987764433333344457888999999888888999999999999999999 999997654332  22222


Q ss_pred             HHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ......      ..       .......+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       273 ~~~~~~------~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          273 KEGHRM------DK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHTCCC------CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             hcCCCC------CC-------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            211100      00       11123457899999999999999999999999999875433

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.6e-37  Score=340.01  Aligned_cols=249  Identities=22%  Similarity=0.348  Sum_probs=193.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCC--------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--------  651 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------  651 (876)
                      +|.....+|.|| ||.||+|+.. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.+        
T Consensus         7 ~y~~~~~lG~G~-~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            7 DFEPIQCMGRGG-FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HEEEEEEEECC--CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             cCceeeEecCCC-CeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            454555666665 9999999775 899999999975432 34567899999999999999999999986643        


Q ss_pred             -------------------------------------------------eEEEEEEcCCCCCHHHHhhccC--CcCCHHH
Q 002826          652 -------------------------------------------------SIFLIYEFLQMGSLGDLICRQD--FQLQWSI  680 (876)
Q Consensus       652 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~--~~l~~~~  680 (876)
                                                                       ..++||||+++++|.+++.+..  ...++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             3899999999999999997653  3456778


Q ss_pred             HHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc----------ccccccccccccc
Q 002826          681 RLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF----------QSTMSSEYALSCY  750 (876)
Q Consensus       681 ~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~----------~~~~~~~~gt~~y  750 (876)
                      +.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......          ........||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            999999999999999999   999999999999999999999999999987764321          1123345689999


Q ss_pred             cCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHH
Q 002826          751 NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEI  830 (876)
Q Consensus       751 ~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~l  830 (876)
                      +|||.+.+..++.++||||+|+++|||++|..|+..    .   ..........          ............+.++
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~---~~~~~~~~~~----------~~~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----R---VRIITDVRNL----------KFPLLFTQKYPQEHMM  305 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----H---HHHHHHHHTT----------CCCHHHHHHCHHHHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----H---HHHHHHhhcc----------CCCcccccCChhHHHH
Confidence            999999888899999999999999999998765311    1   1111111111          1111222334466899


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 002826          831 ALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       831 i~~cl~~dP~~RPs~~ell~~  851 (876)
                      +.+||+.||++|||+.|+++.
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-38  Score=344.32  Aligned_cols=257  Identities=23%  Similarity=0.367  Sum_probs=197.5

Q ss_pred             CCCCCCCCceEEEEEEeCC-----CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLPS-----GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||+||+|....     +..||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        50 ~~lG~G~-~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           50 KVIGAGE-FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEECS-SSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             cEEecCC-CeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4455555 99999996542     34699999975432 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  739 (876)
                      ++++|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ..
T Consensus       129 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  205 (333)
T 1mqb_A          129 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY  205 (333)
T ss_dssp             TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred             CCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccccc
Confidence            99999999987767899999999999999999999999   999999999999999999999999999987754321 11


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......+|..|+|||.+....++.++||||||+++|||++ |+.||.......  ....+.....      ....     
T Consensus       206 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~~------~~~~-----  272 (333)
T 1mqb_A          206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGFR------LPTP-----  272 (333)
T ss_dssp             -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTCC------CCCC-----
T ss_pred             ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCCc------CCCc-----
Confidence            2223346788999999988889999999999999999999 999997644322  2222111100      0000     


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                        ......+.+++.+||+.||++||++.|+++.|+++.......
T Consensus       273 --~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~  314 (333)
T 1mqb_A          273 --MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL  314 (333)
T ss_dssp             --TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGG
T ss_pred             --ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhh
Confidence              112345789999999999999999999999999987654443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-38  Score=337.87  Aligned_cols=252  Identities=19%  Similarity=0.293  Sum_probs=203.3

Q ss_pred             CCCCCCCceEEEEEEeC---CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          588 SAGNGGPFGRVYILSLP---SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .+|.|+ ||.||+|...   +++.||+|++..... ...+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus        17 ~lg~G~-~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           17 ELGCGN-FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEECCT-TEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             cccccC-ceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            455555 9999999653   688899999976432 2346788999999999999999999999 556799999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-ccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~  742 (876)
                      +|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus        95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  171 (287)
T 1u59_A           95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  171 (287)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence            99999987767799999999999999999999999   999999999999999999999999999987753322 12233


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...+|+.|+|||...+..++.++||||+|+++|||++ |+.||.......  ....+...      ......       .
T Consensus       172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~------~~~~~~-------~  236 (287)
T 1u59_A          172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQG------KRMECP-------P  236 (287)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTT------CCCCCC-------T
T ss_pred             cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcC------CcCCCC-------C
Confidence            3456889999999888888999999999999999998 999997654322  22222111      001111       1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ..+..+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       237 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          237 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            22346889999999999999999999999999986543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-38  Score=356.15  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=200.4

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|| ||+||+|+.. +++.||+|++.+..   ......+.+|+.+++.++||||++++++|.+++..|+||
T Consensus        75 ~y~~~~~LG~G~-fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~  153 (437)
T 4aw2_A           75 DFEILKVIGRGA-FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM  153 (437)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             heEEEEEEEeCC-CEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence            444455566655 9999999775 58899999996521   123345889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999999999987666899999999999999999999999   999999999999999999999999999977654322


Q ss_pred             ccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          738 QSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                       .......||+.|+|||++.     ...++.++||||+||++|||++|++||........ ............  .    
T Consensus       231 -~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~--~----  302 (437)
T 4aw2_A          231 -VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKERFQ--F----  302 (437)
T ss_dssp             -EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCC--C----
T ss_pred             -cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhcccccc--C----
Confidence             2233456999999999876     55689999999999999999999999987543322 111111110110  0    


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                       |.   ........+.+++.+|+..+|++  ||+++|+++.
T Consensus       303 -p~---~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          303 -PT---QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -CS---SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -Cc---ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             00   00112345789999999988888  9999999874

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=347.19  Aligned_cols=273  Identities=16%  Similarity=0.127  Sum_probs=208.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeCC---------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccc----------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPS---------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVK----------  642 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~----------  642 (876)
                      +|.....+|.| +||.||+|....         ++.||+|++...     ..+.+|++++++++||||++          
T Consensus        43 ~y~~~~~lg~G-~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           43 QWKLKSFQTRD-NQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             EEEEEEEEEEE-TTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             eEEEEEEecCC-CCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            34444455555 599999997753         889999998653     46889999999999999998          


Q ss_pred             -----eeeEEEe-CCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee
Q 002826          643 -----VLGFFHS-DESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL  715 (876)
Q Consensus       643 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll  715 (876)
                           +++++.. ++..++||||+ +++|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence                 6777776 67899999999 99999999865 45799999999999999999999999   99999999999999


Q ss_pred             CCCC--CeEEccccchhhccccccc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 002826          716 DADF--EPKLTDFALDRIVGEAAFQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEP  788 (876)
Q Consensus       716 ~~~~--~~kl~DfGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~  788 (876)
                      +.++  .+||+|||+++........     .......||+.|+|||...+..++.++||||||+++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  9999999999876543211     11233468999999999998899999999999999999999999998754


Q ss_pred             cchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccccccCC
Q 002826          789 AESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSS  868 (876)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~~~~~~  868 (876)
                      .................   ....++..  .+......+.+++.+||+.||++|||++|+++.|+++.++.........+
T Consensus       273 ~~~~~~~~~~~~~~~~~---~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d  347 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKP---GPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG  347 (352)
T ss_dssp             TCHHHHHHHHHHHHHSC---CCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred             cCHHHHHHHHHhccCCh---hhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence            33333333322221111   11111100  00112346889999999999999999999999999998776655433333


Q ss_pred             C
Q 002826          869 S  869 (876)
Q Consensus       869 ~  869 (876)
                      |
T Consensus       348 w  348 (352)
T 2jii_A          348 L  348 (352)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.8e-38  Score=360.54  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=199.7

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|.|+ ||.||+|...++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.
T Consensus       190 ~~lG~G~-fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~  266 (452)
T 1fmk_A          190 VKLGQGC-FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL  266 (452)
T ss_dssp             EEEEECS-SCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred             eeecCCC-CeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence            4455555 999999999888899999987543 456789999999999999999999999876 6789999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++... +..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       267 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~  342 (452)
T 1fmk_A          267 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAK  342 (452)
T ss_dssp             HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCc
Confidence            999754 34689999999999999999999999   999999999999999999999999999987654321 1222334


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||.+....++.++||||||+++|||++ |+.||.......  ....+.....      ....       ...+
T Consensus       343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------~~~~-------~~~~  407 (452)
T 1fmk_A          343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR------MPCP-------PECP  407 (452)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC------CCCC-------TTSC
T ss_pred             ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC------CCCC-------CCCC
Confidence            6788999999888889999999999999999999 999997644322  2222211110      0011       1223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      ..+.+++.+||+.||++|||++++++.|+++......
T Consensus       408 ~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          408 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            4678999999999999999999999999998765443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=348.95  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=193.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|+ ||.||+|+.. +|+.||+|++.+.   .......+.+|..+++.+ +||||+++++++.+.+..|+||
T Consensus        25 y~~~~~lG~G~-fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~  103 (353)
T 3txo_A           25 FEFIRVLGKGS-FGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM  103 (353)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeeCC-CEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence            33444555555 9999999764 7999999999753   223456788899999988 7999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       104 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~-  178 (353)
T 3txo_A          104 EFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG-  178 (353)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC-
Confidence            9999999999997654 699999999999999999999999   99999999999999999999999999997543221 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||........  ...+.   ......     |   
T Consensus       179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~---~~~~~~-----p---  244 (353)
T 3txo_A          179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL--FEAIL---NDEVVY-----P---  244 (353)
T ss_dssp             --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHH---HCCCCC-----C---
T ss_pred             -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH--HHHHH---cCCCCC-----C---
Confidence             123345699999999999888899999999999999999999999987543321  11111   111000     1   


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSM------FEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~------~ell~  850 (876)
                         ......+.+++.+|++.||++||++      .|+++
T Consensus       245 ---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          245 ---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence               1122357899999999999999998      77765

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-37  Score=337.11  Aligned_cols=260  Identities=23%  Similarity=0.365  Sum_probs=191.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||+||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            7 FKQLEKLGNGT-YATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             eeEeeEECCCC-CEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            34445555555 9999999764 799999999975432 34467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-----CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          661 QMGSLGDLICRQ-----DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       661 ~~gsL~~~l~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ++ +|.+++...     ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 DN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             CC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             CC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            85 999988654     24589999999999999999999999   9999999999999999999999999999876532


Q ss_pred             ccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccccccc--
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGAIQV--  811 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--  811 (876)
                      .  .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........  ...+.... .........  
T Consensus       162 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          162 V--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--LKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             C--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCTTTCGGGG
T ss_pred             c--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhHhhhhh
Confidence            2  12334468999999999876 4689999999999999999999999986544321  22221111 000000000  


Q ss_pred             ----cChh--------h----h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          812 ----LDPK--------I----A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       812 ----~d~~--------~----~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                          ..+.        +    . .........+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                0000        0    0 0011223468899999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.1e-38  Score=347.09  Aligned_cols=264  Identities=26%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC--CeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  653 (876)
                      .|++..+..|.|+||+||++.+     .+++.||||++..... .....+.+|++++++++||||+++++++.+.  ...
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            4434444444455999998854     3688999999975432 2346788999999999999999999999884  678


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      ++||||+++++|.+++.+.  .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999999765  489999999999999999999999   99999999999999999999999999998776


Q ss_pred             ccccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhh----------HHHHHHHHh
Q 002826          734 EAAFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLD----------VVKWVRRKI  802 (876)
Q Consensus       734 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~----------~~~~~~~~~  802 (876)
                      ..... .......+|..|+|||.+.+..++.++||||+|+++|||++|+.||.........          .........
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43221 2233445788899999998888899999999999999999999998764322111          111111100


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ..   ...       ......+..+.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus       266 ~~---~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          266 RG---ERL-------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TT---CCC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cc---cCC-------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            00   000       0111223468899999999999999999999999999876543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.2e-37  Score=329.91  Aligned_cols=252  Identities=22%  Similarity=0.304  Sum_probs=202.5

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      ++...|.....+|.|| ||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            6 DINQYYTLENTIGRGS-WGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             CHHHHEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhEEeeeEEeecC-CEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            4444555555566655 9999999765 6789999999876667778899999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccchhhcc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVG  733 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGla~~~~  733 (876)
                      |||+++++|.+++.... .+++..+.+++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||++....
T Consensus        85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           85 MELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999999887654 689999999999999999999999   99999999999999   788999999999998765


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ...   ......||+.|+|||...+. ++.++||||+|+++|||++|+.||.......  .......   ..   ... .
T Consensus       161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~---~~---~~~-~  227 (277)
T 3f3z_A          161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLKIRE---GT---FTF-P  227 (277)
T ss_dssp             TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CC---CCC-C
T ss_pred             Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHh---CC---CCC-C
Confidence            432   22344589999999987654 8999999999999999999999997644322  1111111   10   000 0


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +   ..+......+.+++.+|++.||++|||+.|+++
T Consensus       228 ~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 E---KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             H---HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             c---hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0   111122346789999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-38  Score=338.87  Aligned_cols=243  Identities=23%  Similarity=0.329  Sum_probs=198.0

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus         8 y~~~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e   86 (318)
T 1fot_A            8 FQILRTLGTGS-FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   86 (318)
T ss_dssp             EEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             cEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence            34445555555 9999999765 79999999996531   2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        87 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---  159 (318)
T 1fot_A           87 YIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---  159 (318)
T ss_dssp             CCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence            999999999997654 689999999999999999999999   9999999999999999999999999999865432   


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                        .....||+.|+|||++.+..++.++||||+||++|||++|+.||........     ...........    .+    
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~i~~~~~~~----p~----  224 (318)
T 1fot_A          160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELRF----PP----  224 (318)
T ss_dssp             --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHCCCCC----CT----
T ss_pred             --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCCCCC----CC----
Confidence              2234589999999999988899999999999999999999999976443221     11111111000    01    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                         .....+.+++.+|+..||++||     +++|+++.
T Consensus       225 ---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          225 ---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence               1223578999999999999999     88998853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.1e-38  Score=337.51  Aligned_cols=258  Identities=23%  Similarity=0.368  Sum_probs=208.6

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +|.....+|.|| ||+||+|... +++.||+|++... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus        14 ~~~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           14 DITMKHKLGGGQ-YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GEEEEEESGGGT-TCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ceeEEeecCCCC-ceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            333445555555 9999999775 5899999998653 244577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          661 QMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++++|.+++.+. ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... .
T Consensus        92 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~  167 (288)
T 3kfa_A           92 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  167 (288)
T ss_dssp             TTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-E
T ss_pred             CCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-c
Confidence            999999999764 45699999999999999999999999   999999999999999999999999999987764332 2


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.......  ..+........      ..      
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~~------~~------  233 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYRM------ER------  233 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCCC------CC------
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCCC------CC------
Confidence            2333446788999999988889999999999999999999 999998654433  22222211100      00      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                       ....+..+.+++.+|++.||++|||+.|+++.|+.+..+..
T Consensus       234 -~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          234 -PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             11123467899999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.4e-37  Score=333.82  Aligned_cols=264  Identities=19%  Similarity=0.252  Sum_probs=197.2

Q ss_pred             hhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-----ccCHHHHHHHHHHHhhcc---CccccceeeEEEe
Q 002826          579 LVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-----CQSSKTLKTEVKTLAKIR---HKNIVKVLGFFHS  649 (876)
Q Consensus       579 l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  649 (876)
                      +..+.|++.+..|.|+||+||+|+. .+|+.||+|++....     ......+.+|++++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3344444444445555999999976 579999999986432     122457778888888875   9999999999987


Q ss_pred             CC-----eEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEE
Q 002826          650 DE-----SIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKL  723 (876)
Q Consensus       650 ~~-----~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl  723 (876)
                      ..     ..++||||+++ +|.+++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            55     58999999975 9999997663 3499999999999999999999999   9999999999999999999999


Q ss_pred             ccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 002826          724 TDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       724 ~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      +|||+++......   ......||+.|+|||.+.+..++.++||||+||++|||++|++||........ ..........
T Consensus       162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~  237 (308)
T 3g33_A          162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGL  237 (308)
T ss_dssp             CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCC
T ss_pred             eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence            9999998765332   22344589999999999888899999999999999999999999987544322 2222211110


Q ss_pred             cccc-cc-----------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          804 ITNG-AI-----------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       804 ~~~~-~~-----------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .... ..           ....+.......+....+.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000 00           00001111122233456889999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=352.39  Aligned_cols=271  Identities=24%  Similarity=0.247  Sum_probs=208.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCC--eEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e  658 (876)
                      .|.+....|.|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+  ..++|||
T Consensus        10 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e   89 (396)
T 4eut_A           10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME   89 (396)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred             ceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence            3444444455559999999765 69999999997533 234577889999999999999999999998755  7899999


Q ss_pred             cCCCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee----CCCCCeEEccccchhhc
Q 002826          659 FLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL----DADFEPKLTDFALDRIV  732 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll----~~~~~~kl~DfGla~~~  732 (876)
                      |+++|+|.+++.+..  ..+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+|||+++..
T Consensus        90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999997653  2389999999999999999999999   99999999999999    77788999999999876


Q ss_pred             cccccccccccccccccccCccccCC--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-h
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS--------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-N  803 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~  803 (876)
                      ....   ......||+.|+|||.+.+        ..++.++|||||||++|||++|+.||.......... +...... .
T Consensus       167 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~~~  242 (396)
T 4eut_A          167 EDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIITG  242 (396)
T ss_dssp             CCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHHHS
T ss_pred             cCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHhcC
Confidence            5433   2234568999999998754        456789999999999999999999997644322211 1111111 1


Q ss_pred             ccccccccc-------------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          804 ITNGAIQVL-------------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       804 ~~~~~~~~~-------------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .+......+             -+............+.+++.+||+.||++|||+.|+++.++++..+..
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~~  312 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMV  312 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCEE
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhceE
Confidence            110000000             011113335667788999999999999999999999999999877653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-37  Score=330.15  Aligned_cols=252  Identities=21%  Similarity=0.311  Sum_probs=202.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +|.....+|.|+ ||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         8 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            8 DWDLVQTLGEGA-YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HEEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEeecCC-CcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            444445566555 9999999765 799999999965432 3346788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+..........
T Consensus        87 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           87 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999998654 4689999999999999999999999   99999999999999999999999999998765433223


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......|++.|+|||...+..+ +.++||||+|+++|||++|+.||............+......        . +.   
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~-~~---  230 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------L-NP---  230 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------S-TT---
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------c-Cc---
Confidence            3345568999999999877654 778999999999999999999998765544333333221100        0 00   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       .......+.+++.+||+.||++|||+.|+++.
T Consensus       231 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          231 -WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             11123457899999999999999999999873

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-37  Score=335.92  Aligned_cols=269  Identities=21%  Similarity=0.259  Sum_probs=199.8

Q ss_pred             hcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc--cCccccceeeEEEeC----CeEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI--RHKNIVKVLGFFHSD----ESIF  654 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~----~~~~  654 (876)
                      ..|.....+|.|| ||.||+|+.. ++.||||++...   ......+|.+++...  +||||+++++++.+.    ...+
T Consensus        37 ~~y~~~~~lg~G~-~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           37 KQIQMVKQIGKGR-YGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHCEEEEEEEEET-TEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             cceEEEeEeecCC-CeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            3454455555555 9999999874 999999998643   334455566666555  899999999999887    7899


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC-----CCCccccccccCceeeCCCCCeEEccccch
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY-----VPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      +||||+++|+|.+++...  .+++..+.+++.|++.|++|||+.+     .++|+||||||+||+++.++.+||+|||++
T Consensus       112 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            999999999999999664  5899999999999999999999862     338999999999999999999999999999


Q ss_pred             hhccccccc--cccccccccccccCccccCCCCCCCc------cchHHHHHHHHHHHhC----------CCCCCCCCcch
Q 002826          730 RIVGEAAFQ--STMSSEYALSCYNAPEYGYSKKATAQ------MDAYSFGVVLLELITG----------RQAEQAEPAES  791 (876)
Q Consensus       730 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlGv~l~elltg----------~~p~~~~~~~~  791 (876)
                      +........  .......||+.|+|||.+.+.....+      +|||||||++|||+||          +.||.......
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            776533221  11234468999999999887766665      9999999999999999          66665433322


Q ss_pred             hhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .............  .....+....  ........+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       270 ~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          270 PSYEDMREIVCIK--KLRPSFPNRW--SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             CCHHHHHHHHTTS--CCCCCCCGGG--GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             CchhhhHHHHhhh--ccCccccccc--hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            2222221111100  0111111111  122456678999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-37  Score=339.87  Aligned_cols=251  Identities=22%  Similarity=0.278  Sum_probs=188.5

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|.....+|.|| ||+||+++.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        21 ~y~~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   98 (361)
T 3uc3_A           21 RYDFVKDIGSGN-FGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA   98 (361)
T ss_dssp             TEEEEEEESSST-TSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cEEEEEEeccCC-CEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence            344445555555 9999999765 89999999997643 34567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC--eEEccccchhhccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE--PKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~  738 (876)
                      ++|+|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.  +||+|||+++......  
T Consensus        99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--  172 (361)
T 3uc3_A           99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  172 (361)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred             CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence            9999999997654 699999999999999999999999   9999999999999987665  9999999987543222  


Q ss_pred             cccccccccccccCccccCCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQ-MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......||+.|+|||.+.+..+..+ +||||+||++|||++|+.||........ .....+.........     |...
T Consensus       173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~~~~~~-----~~~~  245 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILSVKYSI-----PDDI  245 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHTTCCCC-----CTTS
T ss_pred             -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhcCCCCC-----CCcC
Confidence             2233458999999999877766555 8999999999999999999986443221 222222222111000     0000


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                          .....+.+++.+||+.||++|||+.|+++.
T Consensus       246 ----~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          246 ----RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                112357899999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.1e-38  Score=339.56  Aligned_cols=260  Identities=19%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             cccccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC----
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----  651 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  651 (876)
                      +.+.+.+..+.|+||.||+|...    +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            33444444555559999999653    355899999865432  22356889999999999999999999998754    


Q ss_pred             -eEEEEEEcCCCCCHHHHhhc-----cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          652 -SIFLIYEFLQMGSLGDLICR-----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       652 -~~~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                       ..++||||+++++|.+++..     ....+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence             35999999999999999843     235699999999999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhc
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINI  804 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  804 (876)
                      ||+++...............+++.|+|||...+..++.++||||||+++|||++ |+.||........  ........  
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~--  266 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--YDYLLHGH--  266 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--HHHHHTTC--
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHHcCC--
Confidence            999987754433333344457888999999988889999999999999999999 8999976544332  22111110  


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      .    ...       .......+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus       267 ~----~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          267 R----LKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             C----CCC-------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             C----CCC-------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            0    000       1122346789999999999999999999999999987543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-38  Score=341.90  Aligned_cols=264  Identities=20%  Similarity=0.286  Sum_probs=194.3

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCC----
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----  651 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  651 (876)
                      ...|.....+|.|| ||.||+|+. .+++.||+|++.......   ...+.+|++++++++||||+++++++....    
T Consensus        11 ~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGG-MSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCC-CEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            33444445555555 999999975 589999999997643333   246889999999999999999999987654    


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++++|.+++...+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            3599999999999999997654 689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          732 VGEAAFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       732 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      ....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........     ........     
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~-----  235 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVRED-----  235 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCC-----
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCC-----
Confidence            6543221 222344589999999999888999999999999999999999999976543322     11111110     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHhhcccCCc
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSM-FEVVKALHSLSTRTS  860 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-~ell~~L~~i~~~~~  860 (876)
                      ...+.  ......+..+.+++.+||+.||++||++ +++...+..+.....
T Consensus       236 ~~~~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          236 PIPPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             CCCHH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             CCCcc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            00011  1111234467899999999999999954 455566666544333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.9e-37  Score=336.38  Aligned_cols=254  Identities=19%  Similarity=0.264  Sum_probs=202.7

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc------CHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      .+...|.....+|.|+ ||.||+|... +|+.||+|++......      ..+.+.+|+++++.++||||+++++++.+.
T Consensus         9 ~~~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQ-FAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             CHHHHEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhccEEEeeEeeecC-CEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3433444445555555 9999999765 7999999999754322      357799999999999999999999999999


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccc
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDF  726 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~Df  726 (876)
                      +..++||||+++++|.+++... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+||+||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999999764 4689999999999999999999999   999999999999999887    7999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++......   ......||+.|+|||...+..++.++||||+|+++|||++|+.||.......  ...   ...... 
T Consensus       164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~---~i~~~~-  234 (321)
T 2a2a_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA---NITSVS-  234 (321)
T ss_dssp             TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH---HHHTTC-
T ss_pred             ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHH---HHHhcc-
Confidence            9998765432   2234458999999999988889999999999999999999999997644322  111   111111 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         ...++...   ......+.+++.+||+.||++|||+.|+++.
T Consensus       235 ---~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 ---YDFDEEFF---SHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             ---CCCCHHHH---TTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ---cccChhhh---cccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence               01112111   1223467899999999999999999999873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-38  Score=344.70  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|+ ||.||+|+.+ +|+.||+|++....   ......+..|..+++.+ +||||+++++++.+.+..|+||
T Consensus        19 y~~~~~lG~G~-fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~   97 (345)
T 1xjd_A           19 FILHKMLGKGS-FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   97 (345)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEeeCC-CeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence            33344455555 9999999775 78999999997532   24456788899999987 8999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        98 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-  172 (345)
T 1xjd_A           98 EYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  172 (345)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC-
Confidence            9999999999997654 689999999999999999999999   99999999999999999999999999997643221 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+..   ..        +.+.
T Consensus       173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~---~~--------~~~p  238 (345)
T 1xjd_A          173 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRM---DN--------PFYP  238 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CC--------CCCC
T ss_pred             -CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHh---CC--------CCCC
Confidence             12334568999999999998889999999999999999999999998654322  1111111   11        0011


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMF-EVV  849 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~-ell  849 (876)
                         ......+.+++.+||+.||++||++. |++
T Consensus       239 ---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 ---RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               11234578999999999999999997 654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.2e-37  Score=342.53  Aligned_cols=244  Identities=20%  Similarity=0.243  Sum_probs=198.9

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        42 ~y~~~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           42 QFDRIKTLGTGS-FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HCEEEEEeecCc-CcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            344445555555 9999999765 79999999996532   234567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-  195 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-  195 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB-
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCc-
Confidence            9999999999997654 689999999999999999999999   99999999999999999999999999998764322 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                          ....||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .   ..........    +.    
T Consensus       196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~---~~~i~~~~~~----~p----  258 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--I---YEKIVSGKVR----FP----  258 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCCC----CC----
T ss_pred             ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--H---HHHHHcCCCC----CC----
Confidence                23458999999999998889999999999999999999999998654322  1   1111111100    00    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                         ......+.+++.+||+.||++||+     ++|+++.
T Consensus       259 ---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          259 ---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence               112345789999999999999998     8888763

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-37  Score=341.95  Aligned_cols=245  Identities=20%  Similarity=0.281  Sum_probs=192.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.....+|.|+ ||.||+|+.+ +++.||+|++.......   .+.+.+|+.+++++ +||||+++++++.+.+..|+||
T Consensus        11 y~~~~~lG~G~-fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~   89 (345)
T 3a8x_A           11 FDLLRVIGRGS-YAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI   89 (345)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEEEEEEecC-CeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence            44445555555 9999999765 68999999997643222   34577899999988 8999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-  164 (345)
T 3a8x_A           90 EYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-  164 (345)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-
Confidence            9999999999997654 689999999999999999999999   99999999999999999999999999997643221 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh---hHHHHHHHHh-hcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---DVVKWVRRKI-NITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~d  813 (876)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||........   .......... ....    .+ 
T Consensus       165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~----~~-  238 (345)
T 3a8x_A          165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----RI-  238 (345)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----CC-
T ss_pred             -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----CC-
Confidence             123345699999999999988899999999999999999999999975322110   0011111111 1110    01 


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSM  845 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  845 (876)
                            +......+.+++.+||+.||++||++
T Consensus       239 ------p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          239 ------PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                  11123457899999999999999996

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=341.46  Aligned_cols=249  Identities=16%  Similarity=0.203  Sum_probs=188.6

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccC--ccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRH--KNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |++.+..|.|+||.||+|...+++.||+|++......  ..+.+.+|++++++++|  |||+++++++.+++..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            3344444445599999998889999999999754322  23678899999999986  999999999999999999999 


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +.+++|.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.........
T Consensus        90 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~  164 (343)
T 3dbq_A           90 CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV  164 (343)
T ss_dssp             CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence            56779999997754 789999999999999999999999   999999999999997 5789999999998776443333


Q ss_pred             ccccccccccccCccccCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          740 TMSSEYALSCYNAPEYGYS-----------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.................  ..   
T Consensus       165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~~---  239 (343)
T 3dbq_A          165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN--HE---  239 (343)
T ss_dssp             -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT--SC---
T ss_pred             cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC--cc---
Confidence            3345569999999998753           6788999999999999999999999976433222111111100  00   


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           .....   .....+.+++.+||+.||++|||+.|+++.
T Consensus       240 -----~~~~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          240 -----IEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -----CCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----cCCcc---cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence                 00001   112357899999999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-37  Score=347.04  Aligned_cols=270  Identities=21%  Similarity=0.276  Sum_probs=199.7

Q ss_pred             ccccCCCCCCC-CceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGG-PFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g-~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ +||+||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus        27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  106 (389)
T 3gni_B           27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS  106 (389)
T ss_dssp             EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence            33344455550 59999999765 799999999975432  223567889999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+++|+|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.+........
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          107 FMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             CCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             ccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            99999999999765 35699999999999999999999999   999999999999999999999999998865432111


Q ss_pred             -----ccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-----
Q 002826          738 -----QSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-----  805 (876)
Q Consensus       738 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  805 (876)
                           ........||+.|+|||.+.+  ..++.++||||+||++|||++|+.||......... ...........     
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTST  262 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC-------------
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhcCCCCccccccc
Confidence                 111223468899999999887  57899999999999999999999999875443321 11100000000     


Q ss_pred             ----------------ccccccc----------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhcc
Q 002826          806 ----------------NGAIQVL----------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLS  856 (876)
Q Consensus       806 ----------------~~~~~~~----------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~  856 (876)
                                      ......+          +.............+.+++.+||+.||++|||+.|+++.  ++++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence                            0000000          000001122234568899999999999999999999865  55544

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.4e-37  Score=339.04  Aligned_cols=263  Identities=24%  Similarity=0.303  Sum_probs=205.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhh--ccCccccceeeEEEeCC----eEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAK--IRHKNIVKVLGFFHSDE----SIFL  655 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l  655 (876)
                      .|.....+|.|+ ||.||+|+. +|+.||||++..   .....+.+|++++..  ++||||+++++++...+    ..++
T Consensus        43 ~y~~~~~lg~G~-~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  117 (342)
T 1b6c_B           43 TIVLQESIGKGR-FGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL  117 (342)
T ss_dssp             HCEEEEEEEEET-TEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEE
T ss_pred             cEEEEeeecCCC-CcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEE
Confidence            444444555555 999999987 699999999864   345677889998887  68999999999998875    7999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhh--------ccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH--------KDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      ||||+++|+|.+++.+.  .+++..+.+++.|++.|++|||        +.   +|+||||||+||+++.++++||+|||
T Consensus       118 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          118 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             EEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECC
Confidence            99999999999999764  5899999999999999999999        77   99999999999999999999999999


Q ss_pred             chhhcccccccc--ccccccccccccCccccCCCC------CCCccchHHHHHHHHHHHhC----------CCCCCCCCc
Q 002826          728 LDRIVGEAAFQS--TMSSEYALSCYNAPEYGYSKK------ATAQMDAYSFGVVLLELITG----------RQAEQAEPA  789 (876)
Q Consensus       728 la~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGv~l~elltg----------~~p~~~~~~  789 (876)
                      +++.........  ......||+.|+|||.+.+..      ++.++||||||+++|||+||          +.||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            998765432211  234456899999999987652      23689999999999999999          778876544


Q ss_pred             chhhHHHHHHHHhhcccccccccChhhhh--hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          790 ESLDVVKWVRRKINITNGAIQVLDPKIAN--CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      .......+.......      ...+.+..  ...+....+.+++.+||+.||++|||+.|+++.|+++.++..
T Consensus       273 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          273 SDPSVEEMRKVVCEQ------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             SSCCHHHHHHHHTTS------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             CcccHHHHHHHHHHH------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence            333333333222111      11122221  122455678999999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-38  Score=349.17  Aligned_cols=257  Identities=25%  Similarity=0.359  Sum_probs=192.3

Q ss_pred             CCCCCCCCceEEEEEEeC--CC--cEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP--SG--ELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  660 (876)
                      ..+|.| +||+||+|...  ++  ..||+|.+..... ...+++.+|+.++++++||||+++++++.+ ++..++||||+
T Consensus        95 ~~LG~G-~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           95 EVIGRG-HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEECC-SSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             cEeeeC-CCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            345555 49999999753  22  4689998865322 334678999999999999999999998754 56789999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc--
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ--  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--  738 (876)
                      ++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  
T Consensus       174 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~  250 (373)
T 3c1x_A          174 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  250 (373)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------------
T ss_pred             CCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccc
Confidence            99999999987777789999999999999999999999   9999999999999999999999999999876533211  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......+|+.|+|||.+.+..++.++||||||+++|||+| |.+||........  .......   .    ....|.  
T Consensus       251 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~---~----~~~~p~--  319 (373)
T 3c1x_A          251 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQG---R----RLLQPE--  319 (373)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTT---C----CCCCCT--
T ss_pred             cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcC---C----CCCCCC--
Confidence            12233457788999999988889999999999999999999 6777765443322  2221111   0    001111  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                          ..+..+.+++.+||+.||++|||++|+++.|+++.......
T Consensus       320 ----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          320 ----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             ----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence                12235789999999999999999999999999987655433

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.4e-37  Score=332.47  Aligned_cols=254  Identities=19%  Similarity=0.236  Sum_probs=192.6

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      .+..|.|+||+||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++.+++..|+||||+++++
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            34445555999999975 47999999999876656678899999999985 79999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC---eEEccccchhhcccccc----
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEAAF----  737 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~---~kl~DfGla~~~~~~~~----  737 (876)
                      |.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|||+++.......    
T Consensus        98 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  173 (316)
T 2ac3_A           98 ILSHIHKRR-HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI  173 (316)
T ss_dssp             HHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------
T ss_pred             HHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccc
Confidence            999997654 689999999999999999999999   9999999999999998765   99999999876542211    


Q ss_pred             -ccccccccccccccCccccCC-----CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh---------h-HHHHHHHH
Q 002826          738 -QSTMSSEYALSCYNAPEYGYS-----KKATAQMDAYSFGVVLLELITGRQAEQAEPAESL---------D-VVKWVRRK  801 (876)
Q Consensus       738 -~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~---------~-~~~~~~~~  801 (876)
                       ........||+.|+|||.+..     ..++.++||||+||++|||++|+.||........         . ........
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  253 (316)
T 2ac3_A          174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI  253 (316)
T ss_dssp             --------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHH
T ss_pred             cccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHH
Confidence             111223458999999998764     4578899999999999999999999986543210         0 00111111


Q ss_pred             hhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       802 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...   .....++.    +......+.+++.+||+.||++|||+.|+++.
T Consensus       254 ~~~---~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          254 QEG---KYEFPDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHC---CCCCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcc---CcccCchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111   00100010    11223467899999999999999999999884

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.8e-38  Score=333.00  Aligned_cols=248  Identities=21%  Similarity=0.266  Sum_probs=196.4

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC--CeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD--ESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~  660 (876)
                      ....+|.|+ ||+||+|+. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.  +..++||||+
T Consensus        14 ~~~~lg~G~-~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~   91 (271)
T 3kmu_A           14 FLTKLNENH-SGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM   91 (271)
T ss_dssp             EEEEEEEET-TEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred             HHHHhcCCC-cceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence            334455555 999999988 589999999976432  2345788999999999999999999999886  7889999999


Q ss_pred             CCCCHHHHhhccCC-cCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          661 QMGSLGDLICRQDF-QLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       661 ~~gsL~~~l~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ++|+|.+++.+... .+++..+..++.|++.|++|||+.   +  |+||||||+||+++.++.++++|||++.....   
T Consensus        92 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---  165 (271)
T 3kmu_A           92 PYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---  165 (271)
T ss_dssp             TTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc---
Confidence            99999999987643 589999999999999999999998   7  99999999999999999999999887654322   


Q ss_pred             ccccccccccccccCccccCCCCCCC---ccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATA---QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                          ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||........     ........  ..    +
T Consensus       166 ----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~--~~----~  230 (271)
T 3kmu_A          166 ----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEG--LR----P  230 (271)
T ss_dssp             ----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----HHHHHHSC--CC----C
T ss_pred             ----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----HHHHHhcC--CC----C
Confidence                2235789999999987654444   79999999999999999999976543321     11111000  11    1


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...   ...+..+.+++.+||+.||++|||++|+++.|+++.++
T Consensus       231 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~~  271 (271)
T 3kmu_A          231 TIP---PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK  271 (271)
T ss_dssp             CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC-
T ss_pred             CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            111   11234578999999999999999999999999998653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.8e-38  Score=342.91  Aligned_cols=260  Identities=23%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             cccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +.+.+..|.|+||.||+|..      .+++.||+|++.... .....++.+|+.++++++||||+++++++.+.+..|+|
T Consensus        32 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (327)
T 2yfx_A           32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFIL  111 (327)
T ss_dssp             CEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEE
Confidence            34444444455999999973      367899999986432 23345788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccC------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeEEcccc
Q 002826          657 YEFLQMGSLGDLICRQD------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFA  727 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~DfG  727 (876)
                      |||+++++|.+++....      ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.   +..+||+|||
T Consensus       112 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg  188 (327)
T 2yfx_A          112 MELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG  188 (327)
T ss_dssp             EECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred             EecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccc
Confidence            99999999999997653      4589999999999999999999999   9999999999999984   4569999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      +++...............+++.|+|||.+.+..++.++||||||+++|||+| |+.||.......  ....+.....   
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~---  263 (327)
T 2yfx_A          189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLEFVTSGGR---  263 (327)
T ss_dssp             HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHTTCC---
T ss_pred             cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HHHHHhcCCC---
Confidence            9987654433333344557889999999888889999999999999999998 999997644322  2222211100   


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                         ....       ......+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus       264 ---~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          264 ---MDPP-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             ---CCCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             ---CCCC-------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence               0001       11234578999999999999999999999999998765443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.8e-37  Score=338.24  Aligned_cols=247  Identities=21%  Similarity=0.289  Sum_probs=178.2

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .+|.|| ||+||+|... +++.||||++..   .....+.+|+.+++.++ ||||+++++++.+++..|+||||+++|+|
T Consensus        18 ~lG~G~-~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           18 PLGEGS-FSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CSEEET-TEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             ccccCC-CeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            455555 9999999764 799999999965   34567889999999997 99999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---CeEEccccchhhccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---EPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      .+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++   .+||+|||+++.......  ...
T Consensus        94 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~  167 (325)
T 3kn6_A           94 FERIKKK-KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLK  167 (325)
T ss_dssp             HHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--ccc
Confidence            9999765 4799999999999999999999999   999999999999997665   899999999986653321  223


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch--hhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES--LDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ...||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......  ....+.........   .....    ..+
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~---~~~~~----~~~  240 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD---FSFEG----EAW  240 (325)
T ss_dssp             ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC---CCCCS----HHH
T ss_pred             ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC---CCCCc----ccc
Confidence            4457999999999998899999999999999999999999998644321  11222222211111   11111    112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......+.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            2234568899999999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=330.40  Aligned_cols=247  Identities=19%  Similarity=0.322  Sum_probs=179.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||.||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        12 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           12 DFKVGNLLGKGS-FAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceeeeeecCCC-ceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            444445555555 999999976 589999999996432   233467899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999987767899999999999999999999999   999999999999999999999999999987653221


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                        ......||+.|+|||...+..++.++||||+|+++|||++|+.||........     .......        +....
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~--------~~~~~  232 (278)
T 3cok_A          168 --KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVLA--------DYEMP  232 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCSS--------CCCCC
T ss_pred             --cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhhc--------ccCCc
Confidence              12234588999999999888899999999999999999999999986543321     0100000        00011


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ......+.+++.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          233 ---SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               112345789999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.3e-38  Score=340.87  Aligned_cols=258  Identities=24%  Similarity=0.335  Sum_probs=203.6

Q ss_pred             cccCCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCC-eEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE-SIF  654 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~~~  654 (876)
                      +.+.+..|.|+||+||+|..      .+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++...+ ..+
T Consensus        29 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~  108 (316)
T 2xir_A           29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  108 (316)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceE
Confidence            33444444445999999963      3578999999975432 2235788999999999 7999999999988754 589


Q ss_pred             EEEEcCCCCCHHHHhhccCCc---------------CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          655 LIYEFLQMGSLGDLICRQDFQ---------------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~---------------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +||||+++++|.+++......               +++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCC
Confidence            999999999999999765432               88999999999999999999999   999999999999999999


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWV  798 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~  798 (876)
                      .+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||+| |+.||........ .....
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~-~~~~~  264 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRL  264 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-HHHHH
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH-HHHHh
Confidence            999999999987654433333344557889999999988889999999999999999998 9999976544332 12221


Q ss_pred             HHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          799 RRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       799 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ......      ...       ......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       265 ~~~~~~------~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          265 KEGTRM------RAP-------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HHTCCC------CCC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccCccC------CCC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111100      000       11223578999999999999999999999999998754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=335.63  Aligned_cols=246  Identities=19%  Similarity=0.306  Sum_probs=189.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--------------------------cCHHHHHHHHHHHhhc
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--------------------------QSSKTLKTEVKTLAKI  635 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~~l  635 (876)
                      |.....+|.| +||.||+|.. .+++.||+|++.....                          ...+.+.+|+++++++
T Consensus        15 y~~~~~lG~G-~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l   93 (298)
T 2zv2_A           15 YTLKDEIGKG-SYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL   93 (298)
T ss_dssp             EEEEEEEEC---CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred             eEEEeEEeec-CCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence            3334445555 4999999965 4789999999865321                          1135688999999999


Q ss_pred             cCccccceeeEEEe--CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCce
Q 002826          636 RHKNIVKVLGFFHS--DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNI  713 (876)
Q Consensus       636 ~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NI  713 (876)
                      +||||+++++++.+  .+..++||||+++++|.+++..  ..+++..+..++.|++.||+|||+.   +|+||||||+||
T Consensus        94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNL  168 (298)
T ss_dssp             CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGE
T ss_pred             CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHE
Confidence            99999999999987  5689999999999999887643  4689999999999999999999999   999999999999


Q ss_pred             eeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCcc
Q 002826          714 LLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK---ATAQMDAYSFGVVLLELITGRQAEQAEPAE  790 (876)
Q Consensus       714 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGv~l~elltg~~p~~~~~~~  790 (876)
                      +++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~  246 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM  246 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence            999999999999999987654321  223456899999999987654   377899999999999999999999764332


Q ss_pred             hhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          791 SLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .  ....+..   ..   ...  +..    ......+.+++.+||+.||++|||+.|+++
T Consensus       247 ~--~~~~~~~---~~---~~~--~~~----~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          247 C--LHSKIKS---QA---LEF--PDQ----PDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H--HHHHHHH---CC---CCC--CSS----SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H--HHHHHhc---cc---CCC--CCc----cccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1  1111111   10   000  000    112235789999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-37  Score=331.13  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      +++...|.....+|.|| ||+||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus        18 g~i~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGA-FGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SCHHHHEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             CChhhheeecceeccCC-CeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence            45555666666666666 999999966 479999999997643 235678999999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccc
Q 002826          655 LIYEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFAL  728 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGl  728 (876)
                      +||||+++++|.+++...   +..+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||+
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            999999999999988543   46799999999999999999999999   99999999999999   4568899999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ++......   ......||+.|+|||.+. ..++.++||||+|+++|||++|+.||........  ..........   .
T Consensus       174 a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~---~  244 (285)
T 3is5_A          174 AELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEPN---Y  244 (285)
T ss_dssp             CCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCCC---C
T ss_pred             ceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCcc---c
Confidence            98765432   123445899999999875 4678999999999999999999999986543322  1111110000   0


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          ...    .......+.+++.+||+.||++|||+.|+++
T Consensus       245 ----~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          245 ----AVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----ccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000    0012345779999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=339.26  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=201.1

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFLIYE  658 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e  658 (876)
                      .....+|. |+||.||+|.. .+|+.||+|++........+.+.+|+++++.++||||+++++++..    ....++|||
T Consensus        32 ~~~~~lg~-G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e  110 (317)
T 2buj_A           32 LFIQKLGE-GGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP  110 (317)
T ss_dssp             EEEEEEEC---CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred             EEEEEecC-CCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence            33344555 45999999976 5899999999876555556788999999999999999999999873    347899999


Q ss_pred             cCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          659 FLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |+++|+|.+++.+   .+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.++.....
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             CCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             eCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            9999999999876   356799999999999999999999999   9999999999999999999999999988765321


Q ss_pred             ccc-------cccccccccccccCccccCCCC---CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          736 AFQ-------STMSSEYALSCYNAPEYGYSKK---ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       736 ~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      ...       .......||+.|+|||.+....   ++.++||||||+++|||++|+.||.................... 
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-  266 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI-  266 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--C-
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCC-
Confidence            100       0112334789999999987543   68899999999999999999999864221111111111110000 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                              +.    .......+.+++.+||+.||.+|||+.|+++.|+.+.+..+.
T Consensus       267 --------~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          267 --------PQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             --------CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             --------Cc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                    00    011234688999999999999999999999999999765544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-37  Score=367.72  Aligned_cols=251  Identities=20%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             CCCCCCCceEEEEEEeC---CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          588 SAGNGGPFGRVYILSLP---SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      .+|.|+ ||.||+|.+.   ++..||||++..... ...+++.+|++++++++|||||++++++.+ +..++||||+++|
T Consensus       343 ~LG~G~-fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGN-FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECS-SSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred             EEecCC-CcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence            355555 9999999653   567899999976432 356789999999999999999999999976 5699999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-ccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~  742 (876)
                      +|.+++......+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .....
T Consensus       421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            99999987777899999999999999999999999   999999999999999999999999999987753321 12222


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...+++.|+|||++....++.++|||||||++|||++ |+.||.......  ....+.....      ...       ..
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~------~~~-------p~  562 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR------MEC-------PP  562 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCC------CCC-------CT
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC------CCC-------CC
Confidence            3345678999999988899999999999999999998 999998654332  2222221110      001       11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..+..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            2234688999999999999999999999999987543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.1e-37  Score=335.95  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             CCCCCCCCceEEEEEEeCC----CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEE-eCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLPS----GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFH-SDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||+||+|...+    +..||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++||||+
T Consensus        31 ~~lg~G~-~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           31 EVIGRGH-FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEET-TEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             ceeeecC-CceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            4455555 99999997542    23689999865332 23467889999999999999999999865 456789999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc--c
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF--Q  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--~  738 (876)
                      ++|+|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  .
T Consensus       110 ~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~  186 (298)
T 3f66_A          110 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV  186 (298)
T ss_dssp             TTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhcc
Confidence            99999999987777799999999999999999999999   999999999999999999999999999987654322  1


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                      .......+|+.|+|||...+..++.++||||+|+++|||++ |.+||.......  ........   .   . ...+.  
T Consensus       187 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~---~---~-~~~~~--  255 (298)
T 3f66_A          187 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQG---R---R-LLQPE--  255 (298)
T ss_dssp             -----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTT---C---C-CCCCT--
T ss_pred             ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcC---C---C-CCCCc--
Confidence            22334457788999999988889999999999999999999 566665433322  11111111   0   0 00111  


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                          ..+..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       256 ----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          256 ----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                112357899999999999999999999999999876543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=334.98  Aligned_cols=243  Identities=21%  Similarity=0.228  Sum_probs=189.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|| ||+||+|... +|+.||||++......  .......|+..+.++ +||||++++++|.+++..++||
T Consensus        58 ~y~~~~~LG~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           58 SFQRLSRLGHGS-YGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HEEEEEEEEEET-TEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             heeeeheeccCC-CeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            455555666666 9999999775 7999999998654322  223445566666655 8999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+ +++|.+++...+..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 5699999887777899999999999999999999999   99999999999999999999999999988765432 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    .   +.. ...      ....+...
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~---~~~-~~~------~~~~~~~~  274 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----G---WQQ-LRQ------GYLPPEFT  274 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----H---HHH-HTT------TCCCHHHH
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----H---HHH-Hhc------cCCCcccc
Confidence              2233458999999998775 68999999999999999999977654311    1   110 000      11112221


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ......+.+++.+||+.||++|||+.|+++
T Consensus       275 ---~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 ---AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               123456889999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-37  Score=347.50  Aligned_cols=256  Identities=19%  Similarity=0.276  Sum_probs=193.7

Q ss_pred             cchhhhhhcccccCC-CCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe-
Q 002826          574 VTEHDLVIGMDEKSS-AGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS-  649 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~-~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  649 (876)
                      +...++..+|+...+ +|.|+ ||+||+|... +|+.||||++..     ...+.+|++++.++ +||||+++++++.. 
T Consensus        54 ~~~~~~~~~y~~~~~~LG~G~-~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           54 IKKNAIIDDYKVTSQVLGLGI-NGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CBCSCGGGTEEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             cCCCcccccceeccceeeecc-CeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            344455556666544 55555 9999999664 799999999853     34677899887554 89999999999876 


Q ss_pred             ---CCeEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeE
Q 002826          650 ---DESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPK  722 (876)
Q Consensus       650 ---~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~k  722 (876)
                         .+..|+||||+++|+|.+++.+.+ ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.   ++.+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~k  204 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  204 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEE
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEE
Confidence               567899999999999999997653 4699999999999999999999999   9999999999999997   78999


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh--hHHHHHHH
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL--DVVKWVRR  800 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~--~~~~~~~~  800 (876)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+..
T Consensus       205 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          205 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             ECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             EEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            99999998654322   23345689999999999988999999999999999999999999986543321  11111111


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .      ......+..    ......+.+++.+||+.||++|||+.|+++.
T Consensus       282 ~------~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 G------QYEFPNPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             T------CCCCCTTTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C------cccCCCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1      011111111    1223467899999999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-37  Score=339.82  Aligned_cols=245  Identities=22%  Similarity=0.288  Sum_probs=187.5

Q ss_pred             ccccCCCCCCCCceEEEEEEe----CCCcEEEEEEEecCC----ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL----PSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      |.....+|.|| ||.||+|+.    .+|+.||+|++....    ......+.+|+++++.++||||+++++++.+++..|
T Consensus        19 y~~~~~lG~G~-~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           19 FELLRVLGKGG-YGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             EEEEEEEEEET-TEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             eEEEEEEEeCC-CEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            33444555555 999999976    479999999997542    123456788999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+++++|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           98 LILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             EEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             EEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            9999999999999997654 689999999999999999999999   999999999999999999999999999876543


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ...  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........  ...+.   .....    +.+
T Consensus       174 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~---~~~~~----~p~  242 (327)
T 3a62_A          174 DGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--IDKIL---KCKLN----LPP  242 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH---HTCCC----CCT
T ss_pred             CCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--HHHHH---hCCCC----CCC
Confidence            221  22344689999999999888899999999999999999999999986543221  11111   11100    111


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                             .....+.+++.+||+.||++||     ++.|+++
T Consensus       243 -------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          243 -------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                   1223578999999999999999     7778876

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-37  Score=333.65  Aligned_cols=260  Identities=21%  Similarity=0.293  Sum_probs=194.8

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc---CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ---SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||.||+|.. .+|+.||+|++......   ....+.+|+.++++++||||+++++++.+++..++||
T Consensus        33 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           33 NFRIEKKIGRGQ-FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GEEEEEEEECC---CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceEEEEeecCCC-CceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            343444455554 999999975 58999999999753322   3456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          658 EFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       658 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      ||+++++|.+++..   ....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999864   345689999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ...  ......|++.|+|||...+..++.++||||||+++|||++|+.||.............+..   ..  . .... 
T Consensus       189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~--~-~~~~-  259 (310)
T 2wqm_A          189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ---CD--Y-PPLP-  259 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT---TC--S-CCCC-
T ss_pred             CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc---cc--C-CCCc-
Confidence            321  1223458899999999988889999999999999999999999997654433222222211   10  0 0000 


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                        .   ......+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       260 --~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          260 --S---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             --T---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --c---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence              0   112335789999999999999999999999999987543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-37  Score=354.68  Aligned_cols=247  Identities=24%  Similarity=0.410  Sum_probs=199.5

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      .+.|.+.+..|.|+||.||+|... +|+.||||++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            344445555555559999999765 89999999996532   23456789999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++|+|.+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            9999999999999765 4699999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .   .....||+.|+|||.+.+..+ +.++||||+||++|||++|+.||........     ........   ..  .| 
T Consensus       171 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-----~~~i~~~~---~~--~p-  236 (476)
T 2y94_A          171 F---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-----FKKICDGI---FY--TP-  236 (476)
T ss_dssp             C---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-----HHHHHTTC---CC--CC-
T ss_pred             c---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-----HHHHhcCC---cC--CC-
Confidence            2   234468999999999887654 7899999999999999999999986543221     11111111   00  01 


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                           ......+.+++.+||+.||++|||+.|+++
T Consensus       237 -----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 -----QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                 111235789999999999999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.1e-37  Score=332.56  Aligned_cols=254  Identities=24%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      |.....+|.|+ ||.||+|...+++.||+|++.... ...+.+.+|++++++++||||+++++++. ++..++||||+++
T Consensus        15 y~~~~~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   91 (279)
T 1qpc_A           15 LKLVERLGAGQ-FGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN   91 (279)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred             hhheeeecCCC-CeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence            33445555555 999999998888899999986543 45678999999999999999999999986 4568999999999


Q ss_pred             CCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          663 GSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       663 gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      ++|.+++... +..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  167 (279)
T 1qpc_A           92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAR  167 (279)
T ss_dssp             CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECC
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc-ccc
Confidence            9999999754 23689999999999999999999999   999999999999999999999999999987654322 122


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....++..|+|||...+..++.++||||||+++|||++ |+.||.......  ....+...      ......       
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~------~~~~~~-------  232 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERG------YRMVRP-------  232 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT------CCCCCC-------
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhcc------cCCCCc-------
Confidence            33446778999999888888999999999999999999 999997644322  12211111      000011       


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ......+.+++.+|++.||++|||+.++++.|+++...
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            11234678999999999999999999999999998654

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.9e-37  Score=331.04  Aligned_cols=262  Identities=21%  Similarity=0.267  Sum_probs=195.7

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      .+|.....+|.|+ ||.||+|... +++.||+|++.......   .+.+.+|+.++++++||||+++++++.+++..++|
T Consensus        34 ~~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           34 GPYRLRRLVGRGG-MGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             CCEEEEEEEEECS-SSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEcCCC-CeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            3444445555555 9999999764 78999999986543322   36788999999999999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999997654 689999999999999999999999   99999999999999999999999999998765432


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      . .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......      ..........       +..
T Consensus       189 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-------~~~  254 (309)
T 2h34_A          189 L-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAHINQAI-------PRP  254 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHHHHSCC-------CCG
T ss_pred             c-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHHhccCC-------CCc
Confidence            1 1223445899999999998888999999999999999999999999764322      1111111110       000


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcccCCcc
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRP-SMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ell~~L~~i~~~~~~  861 (876)
                      .......+..+.+++.+||+.||++|| |++++++.|+.+......
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~  300 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ  300 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence            111122234578999999999999999 999999999998665543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=341.75  Aligned_cols=248  Identities=12%  Similarity=0.127  Sum_probs=199.7

Q ss_pred             ccCCCCCCCCceEEEEE------EeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc---CccccceeeEEEeCCeEEE
Q 002826          585 EKSSAGNGGPFGRVYIL------SLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR---HKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  655 (876)
                      ....+|.|| ||+||+|      ...+++.||+|++..   ....++..|++++++++   |+||+++++++..++..|+
T Consensus        69 ~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l  144 (365)
T 3e7e_A           69 VHHLLGEGA-FAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL  144 (365)
T ss_dssp             EEEEEEECS-SEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred             EEEEeeccC-CEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence            334455555 9999999      345799999999864   35667888888888886   9999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhc----cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-----------CCC
Q 002826          656 IYEFLQMGSLGDLICR----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-----------DFE  720 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-----------~~~  720 (876)
                      ||||+++|+|.+++..    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.           ++.
T Consensus       145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence            9999999999999975    345799999999999999999999999   9999999999999998           899


Q ss_pred             eEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 002826          721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       721 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~  800 (876)
                      +||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||........        
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--------  293 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC--------  293 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--------
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--------
Confidence            999999999766533333344556799999999999998899999999999999999999999864322111        


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhcccCC
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKR-PSMFEVVKALHSLSTRT  859 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Ps~~ell~~L~~i~~~~  859 (876)
                        .    .    ...+...+  ....+.+++..|++.+|.+| |+++++.+.|+++.++.
T Consensus       294 --~----~----~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          294 --K----P----EGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             --E----E----CSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             --e----e----chhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence              0    0    01111111  12356789999999999999 78999999999986654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.5e-37  Score=342.86  Aligned_cols=249  Identities=17%  Similarity=0.236  Sum_probs=190.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhcc--CccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIR--HKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||.||+|...+++.||||++.....  ...+.+.+|++++++++  ||||+++++++..++..|+|||
T Consensus        58 y~~~~~LG~G~-fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E  136 (390)
T 2zmd_A           58 YSILKQIGSGG-SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  136 (390)
T ss_dssp             EEEEEEEECCS-SEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEccCC-CeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe
Confidence            33344455555 9999999888899999999975432  23467889999999996  5999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                       +.+++|.+++.+.. .+++..+..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||+++........
T Consensus       137 -~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          137 -CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             -CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             -cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence             56789999997754 789999999999999999999999   999999999999995 589999999999877544322


Q ss_pred             cccccccccccccCccccCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          739 STMSSEYALSCYNAPEYGYS-----------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      .......||+.|+|||++.+           ..++.++|||||||++|||++|+.||..........    .......  
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~~~~~~~--  284 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL----HAIIDPN--  284 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHCTT--
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH----HHHhCcc--
Confidence            23345569999999998754           368899999999999999999999997643322111    1111100  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..    ......   ....+.+++.+||+.||++|||+.|+++.
T Consensus       285 ~~----~~~~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          285 HE----IEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             SC----CCCCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cc----CCCCcc---chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            00    000111   12357899999999999999999999864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-37  Score=333.22  Aligned_cols=256  Identities=20%  Similarity=0.313  Sum_probs=200.3

Q ss_pred             CCCCCCCCceEEEEEEeC-C---CcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeE-EEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLP-S---GELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-FLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv~e~~  660 (876)
                      ..+|.|| ||+||+|... +   +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||+
T Consensus        27 ~~lg~G~-~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           27 RVIGKGH-FGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEET-TEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             ceeccCC-CceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            4455555 9999999653 2   33799999865332 2346788999999999999999999999876554 9999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc--c
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF--Q  738 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~--~  738 (876)
                      .+++|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  .
T Consensus       106 ~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (298)
T 3pls_A          106 CHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSV  182 (298)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCS
T ss_pred             cCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccccc
Confidence            99999999988777899999999999999999999999   999999999999999999999999999987654321  1


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......+++.|+|||...+..++.++||||+|+++|||++|..|+...... ..............      .      
T Consensus       183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~------~------  249 (298)
T 3pls_A          183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRRLP------Q------  249 (298)
T ss_dssp             CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCCCC------C------
T ss_pred             ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCCCC------C------
Confidence            2233445788999999999989999999999999999999965554432222 22222222111100      0      


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                       .......+.+++.+||+.||++|||++|+++.|+++.++..
T Consensus       250 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          250 -PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence             01122357899999999999999999999999999876543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.9e-37  Score=337.64  Aligned_cols=259  Identities=22%  Similarity=0.271  Sum_probs=197.9

Q ss_pred             hhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC-----CccCHHHHHHHHHHHhhccCccccceeeEEEe
Q 002826          576 EHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF-----GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS  649 (876)
Q Consensus       576 ~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  649 (876)
                      ..++...|.....+|.|+ ||+||+|.. .+++.||+|++...     .....+.+.+|++++++++||||+++++++.+
T Consensus        21 ~~~~~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGS-YGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             HHHHHHHEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhheeecceeeecC-CeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            345556666666677666 999999966 47899999998643     22345678999999999999999999999999


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhcc---------------------------------------CCcCCHHHHHHHHHHHHH
Q 002826          650 DESIFLIYEFLQMGSLGDLICRQ---------------------------------------DFQLQWSIRLKIAIGVAQ  690 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~i~~  690 (876)
                      .+..++||||+++|+|.+++...                                       ...+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            99999999999999999998521                                       122467788899999999


Q ss_pred             HHHHhhccCCCCccccccccCceeeCCCC--CeEEccccchhhccccc--cccccccccccccccCccccCC--CCCCCc
Q 002826          691 GLAYLHKDYVPHLLHRNVKSKNILLDADF--EPKLTDFALDRIVGEAA--FQSTMSSEYALSCYNAPEYGYS--KKATAQ  764 (876)
Q Consensus       691 ~l~~LH~~~~~~i~H~Dlkp~NIll~~~~--~~kl~DfGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~  764 (876)
                      |++|||+.   +|+||||||+||+++.++  .+||+|||+++......  .........||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            99999999   999999999999998766  89999999998764321  1112344568999999998864  678899


Q ss_pred             cchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCC
Q 002826          765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPS  844 (876)
Q Consensus       765 ~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  844 (876)
                      +||||||+++|||++|+.||........  ...+..   .   ......+...    .....+.+++.+||+.||++|||
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~---~---~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT--ISQVLN---K---KLCFENPNYN----VLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---C---CCCTTSGGGG----GSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHh---c---ccccCCcccc----cCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999999976543321  111111   1   1111111111    12346789999999999999999


Q ss_pred             HHHHHH
Q 002826          845 MFEVVK  850 (876)
Q Consensus       845 ~~ell~  850 (876)
                      +.|+++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3e-38  Score=346.12  Aligned_cols=260  Identities=24%  Similarity=0.359  Sum_probs=205.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CC-----cEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SG-----ELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  654 (876)
                      |.....+|.|| ||.||+|... ++     ..||+|++..... ...+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus        48 ~~~~~~lG~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  126 (333)
T 2i1m_A           48 LQFGKTLGAGA-FGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVL  126 (333)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ceeeeEeccCC-CcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceE
Confidence            33334455555 9999999764 23     4899999975432 2346788999999999 8999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhcc-------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          655 LIYEFLQMGSLGDLICRQ-------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      +||||+++|+|.+++.+.             ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus       127 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEE
T ss_pred             EEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeE
Confidence            999999999999998653             23579999999999999999999999   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      ||+|||+++...............+|+.|+|||...+..++.++||||||+++|||+| |..||........ .......
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~  282 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FYKLVKD  282 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HHHHHHH
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HHHHHhc
Confidence            9999999987654433333344557888999999888889999999999999999999 9999976543322 2222222


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ....       ..+.      ..+..+.+++.+||+.||++|||+.|+++.|+++..+..
T Consensus       283 ~~~~-------~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          283 GYQM-------AQPA------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             TCCC-------CCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCC-------CCCC------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            1110       0011      112457899999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.5e-37  Score=344.91  Aligned_cols=251  Identities=21%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|| ||+||+|+.. +++.||+|++.+.   .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        70 ~y~~~~~LG~G~-fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~  148 (410)
T 3v8s_A           70 DYEVVKVIGRGA-FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  148 (410)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEcCC-CEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            344445555555 9999999765 6899999999652   1233456889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||++||+|.+++.+.  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       149 E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          149 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             CCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            999999999999754  589999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccccccccccccccCccccCCCC----CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKK----ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                       .......||+.|+|||++....    ++.++|||||||++|||++|+.||........ ............       -
T Consensus       224 -~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~~~-------~  294 (410)
T 3v8s_A          224 -VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMNHKNSLT-------F  294 (410)
T ss_dssp             -EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCC-------C
T ss_pred             -ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH-HHHHHhcccccc-------C
Confidence             1233456999999999987654    78899999999999999999999986543322 111111111111       0


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEK--RPSMFEVVKA  851 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~ell~~  851 (876)
                      |..    ......+.+++.+|+..+|.+  ||+++|+++.
T Consensus       295 p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          295 PDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            100    012345789999999999988  9999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.7e-37  Score=341.38  Aligned_cols=247  Identities=20%  Similarity=0.263  Sum_probs=197.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|+.. +|+.||+|++...   .....+.+..|..+++.+ +||+|+++++++.+.+..|+|
T Consensus        21 ~y~~~~~lG~G~-fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           21 DFNFLMVLGKGS-FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TEEEEEEEEEET-TEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HcEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            344445555555 9999999775 5889999999753   224456788999999988 799999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||++||+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       100 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999997654 689999999999999999999999   99999999999999999999999999997643221


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......  .   .+.........    .   
T Consensus       176 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~---~~~i~~~~~~~----p---  241 (353)
T 2i0e_A          176 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--L---FQSIMEHNVAY----P---  241 (353)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H---HHHHHHCCCCC----C---
T ss_pred             --cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--H---HHHHHhCCCCC----C---
Confidence              12334569999999999998889999999999999999999999998654322  1   11111111000    0   


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                          ......+.+++.+||+.||++||+     ++|+++.
T Consensus       242 ----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          242 ----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                112346789999999999999995     5677653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=347.21  Aligned_cols=263  Identities=24%  Similarity=0.332  Sum_probs=203.6

Q ss_pred             cccCCCCCCCCceEEEEEEe-----CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC--eEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL-----PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE--SIFLI  656 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv  656 (876)
                      +++.+..+.|+||.||+|+.     .+|+.||+|++........+.+.+|++++++++||||+++++++...+  ..++|
T Consensus        43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  122 (326)
T 2w1i_A           43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI  122 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred             ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence            33344444455999999973     478999999997655455678999999999999999999999987644  78999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++++|.+++......+++..+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            999999999999988766799999999999999999999999   99999999999999999999999999998775432


Q ss_pred             cc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh----------hHHHHHHHHhhcc
Q 002826          737 FQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL----------DVVKWVRRKINIT  805 (876)
Q Consensus       737 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~  805 (876)
                      .. .......++..|+|||...+..++.++||||||+++|||+||+.||.....+..          .............
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN  279 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred             cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence            21 122334467789999998888889999999999999999999998864321110          0000000100000


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                        ..    +.   .....+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       280 --~~----~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          280 --GR----LP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             --CC----CC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --CC----CC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence              00    00   0112234688999999999999999999999999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.3e-37  Score=351.02  Aligned_cols=258  Identities=20%  Similarity=0.264  Sum_probs=190.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||+||+|.. .+|+.||||++...  .....+++.+|+.+++.++||||+++++++...      ..
T Consensus        63 ~y~~~~~lG~G~-~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  141 (464)
T 3ttj_A           63 RYQNLKPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD  141 (464)
T ss_dssp             TEEEEEEEEECS-SCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCC-CeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence            444445555555 999999965 47999999999754  223346788999999999999999999999654      46


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       142 ~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          142 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             EEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            8999999987 56666643   489999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc---
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI---  809 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  809 (876)
                      ....   ......||+.|+|||++.+..++.++||||+||++|||++|++||.+....+. ....++..........   
T Consensus       215 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          215 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             --CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTTS
T ss_pred             CCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHHc
Confidence            5432   23445689999999999999999999999999999999999999987543221 1111111000000000   


Q ss_pred             --------------------cccChh----hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          810 --------------------QVLDPK----IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       810 --------------------~~~d~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                          ..+...    ...........+.+++.+||+.||++|||+.|+++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                000000    001112235678999999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-37  Score=333.28  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=197.1

Q ss_pred             cCCCCCCCCceEEEEEEeCC----CcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          586 KSSAGNGGPFGRVYILSLPS----GELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ...+|.|+ ||+||+|....    +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+ +..++||||+
T Consensus        17 ~~~lg~G~-~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   94 (281)
T 3cc6_A           17 NRILGEGF-FGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY   94 (281)
T ss_dssp             EEEEEECS-SSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEEEecC-CeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence            34455555 99999996532    3469999987542 2335678899999999999999999999865 4568999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.+....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........ .
T Consensus        95 ~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~  170 (281)
T 3cc6_A           95 PYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-K  170 (281)
T ss_dssp             TTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--------
T ss_pred             CCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc-c
Confidence            99999999987777799999999999999999999999   9999999999999999999999999999876543221 2


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .....+++.|+|||...+..++.++||||||+++|||++ |+.||.......  ............      . +     
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~~~------~-~-----  236 (281)
T 3cc6_A          171 ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDRLP------K-P-----  236 (281)
T ss_dssp             --CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCCCC------C-C-----
T ss_pred             cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCCCC------C-C-----
Confidence            233446788999999888889999999999999999998 999997644433  222222211100      0 0     


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                       ......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       237 -~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          237 -DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence             1122357899999999999999999999999998754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.1e-37  Score=362.87  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=204.8

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|.|+ ||.||+|.+.++..||||++.... ...+.+.+|++++++++||||+++++++.+ +..|+||||+++|+|.
T Consensus       273 ~~lG~G~-fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~  349 (535)
T 2h8h_A          273 VKLGQGC-FGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL  349 (535)
T ss_dssp             EEEEECS-SEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred             eecccCC-CeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence            4455555 999999999888899999997543 456789999999999999999999999876 6789999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++... +..+++..+.+++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... .......
T Consensus       350 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~  425 (535)
T 2h8h_A          350 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAK  425 (535)
T ss_dssp             HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTT
T ss_pred             HHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCc
Confidence            999754 34689999999999999999999999   999999999999999999999999999987654321 1222334


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ++..|+|||.+....++.++|||||||++|||++ |+.||.......  ....+.....      ....       ....
T Consensus       426 ~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~------~~~~-------~~~~  490 (535)
T 2h8h_A          426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR------MPCP-------PECP  490 (535)
T ss_dssp             SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC------CCCC-------TTCC
T ss_pred             CcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC------CCCC-------CCCC
Confidence            6788999999888889999999999999999999 999997643322  2222221110      0011       1223


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      ..+.+++.+||+.||++|||+.++++.|+++......
T Consensus       491 ~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          491 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            4678999999999999999999999999998765443

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.3e-37  Score=331.28  Aligned_cols=260  Identities=22%  Similarity=0.364  Sum_probs=194.0

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|| ||+||+|... +|+.||+|++......  ..+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (311)
T 4agu_A            5 YEKIGKIGEGS-YGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY   83 (311)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEeeEEeecC-CeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence            34445566555 9999999765 6999999998654322  135678899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  
T Consensus        84 ~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  157 (311)
T 4agu_A           84 CDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--  157 (311)
T ss_dssp             CSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--
Confidence            9999999887654 4689999999999999999999999   999999999999999999999999999987653321  


Q ss_pred             ccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-c------------
Q 002826          740 TMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-T------------  805 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~------------  805 (876)
                      ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........  ...+...... .            
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ--LYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhcccccccccccccccc
Confidence            2234458999999998865 5689999999999999999999999987544322  1111111100 0            


Q ss_pred             cccccccCh----hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDP----KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .......++    ............+.+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000000000    0011112234568899999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.9e-37  Score=338.70  Aligned_cols=267  Identities=26%  Similarity=0.276  Sum_probs=201.8

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-----Cccccceee
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-----HKNIVKVLG  645 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~  645 (876)
                      ..+..+++..+.|.+.+..|.|+||+||+|+. .+++.||||++... ......+..|+++++.++     ||||+++++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~  103 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG  103 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence            34455555555555555445555999999976 57899999998642 234456788999999996     999999999


Q ss_pred             EEEeCCeEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-------
Q 002826          646 FFHSDESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-------  717 (876)
Q Consensus       646 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-------  717 (876)
                      ++...+..++||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.       
T Consensus       104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~  179 (360)
T 3llt_A          104 KFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSL  179 (360)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEE
T ss_pred             eeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccc
Confidence            999999999999999 889999997653 4589999999999999999999999   9999999999999975       


Q ss_pred             ------------------CCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh
Q 002826          718 ------------------DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT  779 (876)
Q Consensus       718 ------------------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt  779 (876)
                                        ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          180 ITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             EEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred             cchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence                              789999999999765432     223458999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHHhh-cccc---------cccccC--------hhh--------------hhhcHHHHHHH
Q 002826          780 GRQAEQAEPAESLDVVKWVRRKIN-ITNG---------AIQVLD--------PKI--------------ANCYQQQMLGA  827 (876)
Q Consensus       780 g~~p~~~~~~~~~~~~~~~~~~~~-~~~~---------~~~~~d--------~~~--------------~~~~~~~~~~~  827 (876)
                      |+.||.......  ....+..... ....         ....++        |..              ......+...+
T Consensus       255 g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          255 GSLLFRTHEHME--HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SSCSCCCSSHHH--HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCCCCcHHH--HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999998654322  1222211110 0000         000000        000              00000112567


Q ss_pred             HHHHHHccCCCCCCCCCHHHHHH
Q 002826          828 LEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       828 ~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .+++.+||+.||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            89999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3e-37  Score=339.41  Aligned_cols=247  Identities=28%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .|.....+|.|+ ||+||+|+. .+|+.||||++.......   ...+.+|++++++++||||+++++++.+++..++||
T Consensus        55 ~y~~~~~lG~G~-~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           55 LFSDLREIGHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             heeeeeEEccCC-CEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            344555666666 999999975 589999999997543222   246789999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||++ |++.+++......+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9998 589888876666899999999999999999999999   9999999999999999999999999999765432  


Q ss_pred             ccccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          738 QSTMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                          ....||+.|+|||.+.   ...++.++|||||||++|||++|+.||........     ........   .....+
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-----~~~~~~~~---~~~~~~  275 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE---SPALQS  275 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC---CCCCCC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhcC---CCCCCC
Confidence                2345899999999873   56789999999999999999999999976433221     11111111   000100


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                         .   .....+.+++.+||+.||++|||+.|+++.-.
T Consensus       276 ---~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          276 ---G---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             ---T---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             ---C---CCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence               0   11235789999999999999999999987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-37  Score=338.17  Aligned_cols=245  Identities=21%  Similarity=0.292  Sum_probs=198.5

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--------CHHHHHHHHHHHhhccCccccceeeEE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--------SSKTLKTEVKTLAKIRHKNIVKVLGFF  647 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~  647 (876)
                      +++...|.....+|.|+ ||+||+|.. .+++.||||++......        ....+.+|++++++++||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~-~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGA-FGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSS-SCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecC-CEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34444566666666666 999999965 57999999999764321        234677899999999999999999999


Q ss_pred             EeCCeEEEEEEcCCCC-CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          648 HSDESIFLIYEFLQMG-SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       648 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      .+.+..++||||+.+| +|.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999999999776 9999997654 699999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........           . 
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-----------~-  239 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-----------A-  239 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-----------T-
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-----------h-
Confidence            99987654332   223458999999999887765 7899999999999999999999965221100           0 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           ...+     .......+.+++.+||+.||++|||+.|+++.
T Consensus       240 -----~~~~-----~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 -----AIHP-----PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----CCCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----ccCC-----CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000     00122357899999999999999999999985

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-37  Score=344.53  Aligned_cols=253  Identities=18%  Similarity=0.224  Sum_probs=198.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||+||+|+.+ +|+.||+|++.+..   ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus        62 ~f~~~~~lG~G~-fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm  140 (412)
T 2vd5_A           62 DFEILKVIGRGA-FSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM  140 (412)
T ss_dssp             GEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred             hEEEEEEEeeCC-CeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            444445555555 9999999774 79999999996532   122345788999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.+.+..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            99999999999987666899999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccccccccccccccCccccC-------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          738 QSTMSSEYALSCYNAPEYGY-------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                       .......||+.|+|||++.       ...++.++|||||||++|||++|+.||........ ............     
T Consensus       218 -~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~-----  290 (412)
T 2vd5_A          218 -VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYKEHLS-----  290 (412)
T ss_dssp             -EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHHHCC-----
T ss_pred             -cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCcC-----
Confidence             1223346999999999876       35689999999999999999999999987543321 111111110000     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKR---PSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~ell~~  851 (876)
                        -|..   ....+..+.+++.+|+. +|++|   |+++|+++.
T Consensus       291 --~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          291 --LPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --CC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --CCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              0110   11123467899999999 99998   689998764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.9e-37  Score=332.92  Aligned_cols=250  Identities=21%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             CCCCCCCceEEEEEEe---CCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          588 SAGNGGPFGRVYILSL---PSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~---~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+|.|| ||+||+|..   .+++.||||++.......  .+++.+|+++++.++||||+++++++ +.+..++||||+++
T Consensus        24 ~lg~G~-~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~  101 (291)
T 1xbb_A           24 ELGSGN-FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAEL  101 (291)
T ss_dssp             EEEECS-SEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             cccccc-CeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence            455555 999999943   357899999997543222  46788999999999999999999999 66788999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc-ccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ-STM  741 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~  741 (876)
                      ++|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........ ...
T Consensus       102 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (291)
T 1xbb_A          102 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  177 (291)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCccccc
Confidence            99999997653 689999999999999999999999   9999999999999999999999999999876543221 222


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....+++.|+|||...+..++.++||||||+++|||++ |+.||.......  ....+...      .....       .
T Consensus       178 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~------~~~~~-------~  242 (291)
T 1xbb_A          178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKG------ERMGC-------P  242 (291)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTT------CCCCC-------C
T ss_pred             ccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcC------CCCCC-------C
Confidence            33346788999999888888999999999999999999 999998654322  22222111      00001       1


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       243 ~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          243 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            12234688999999999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-37  Score=329.19  Aligned_cols=242  Identities=24%  Similarity=0.392  Sum_probs=193.8

Q ss_pred             ccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          585 EKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ....+|.|| ||+||+|... +++.||+|++....   ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        13 ~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (279)
T 3fdn_A           13 IGRPLGKGK-FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA   91 (279)
T ss_dssp             EEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EeeEEecCC-CeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecC
Confidence            344555555 9999999654 68899999986432   234567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.......    
T Consensus        92 ~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----  163 (279)
T 3fdn_A           92 PLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----  163 (279)
T ss_dssp             TTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc----
Confidence            9999999997654 689999999999999999999999   99999999999999999999999999986554322    


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||........  ......   .....        .   
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~~~~--------~---  227 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--YKRISR---VEFTF--------P---  227 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---TCCCC--------C---
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--HHHHHh---CCCCC--------C---
Confidence            2334589999999999988899999999999999999999999986543321  111111   11000        0   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......+.+++.+||+.||++|||++|+++.
T Consensus       228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1122357799999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-36  Score=327.63  Aligned_cols=252  Identities=21%  Similarity=0.322  Sum_probs=198.6

Q ss_pred             hhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          579 LVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       579 l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +...|.....+|.|+ ||.||+|+.. +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            7 IRKTFIFMEVLGSGA-FSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHHHEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhccceeeeeccCCC-CceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            333454455555555 9999999764 79999999998655445567899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccchhhccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  734 (876)
                      ||+++++|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||+++....
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999999987654 689999999999999999999999   99999999999999   7789999999999876543


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ..    .....||+.|+|||...+..++.++||||+|+++|||++|+.||.......  ....+..   ..   .....+
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~---~~---~~~~~~  229 (304)
T 2jam_A          162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFEKIKE---GY---YEFESP  229 (304)
T ss_dssp             BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHH---CC---CCCCTT
T ss_pred             Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHc---CC---CCCCcc
Confidence            21    223358899999999998889999999999999999999999997644322  1221111   11   111111


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .    ....+..+.+++.+|++.||++|||+.|+++.
T Consensus       230 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          230 F----WDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1    11223467899999999999999999999873

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-37  Score=332.23  Aligned_cols=249  Identities=24%  Similarity=0.412  Sum_probs=193.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC-CeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-ESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~  661 (876)
                      |.....+|.|| ||+||+|+. +|+.||+|++...  ...+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus        23 y~~~~~lg~G~-~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           23 LKLLQTIGKGE-FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             EEEEEEEEECS-SCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             ceEEeEEecCC-CceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            33445555555 999999987 5899999998653  3567789999999999999999999997654 57899999999


Q ss_pred             CCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          662 MGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       662 ~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      +++|.+++.+.+ ..+++..+.+++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++......    
T Consensus        99 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----  171 (278)
T 1byg_A           99 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  171 (278)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence            999999997653 2388999999999999999999999   99999999999999999999999999987654322    


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                       ....+++.|+|||...+..++.++||||+|+++|||++ |+.||........  ...+..   .   .....       
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--~~~~~~---~---~~~~~-------  235 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEK---G---YKMDA-------  235 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--HHHHTT---T---CCCCC-------
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHhc---C---CCCCC-------
Confidence             12246788999999988889999999999999999998 9999987554332  111111   0   00001       


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ....+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            112234678999999999999999999999999998653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.8e-36  Score=324.08  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=198.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      +|.....+|.|+ ||.||+|... +|+.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus         7 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   85 (284)
T 3kk8_A            7 NYDVKEELGKGA-FSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD   85 (284)
T ss_dssp             TEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhhhhhhhcCcC-CeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            444445555555 9999999664 799999999965432  223567899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC---eEEccccchhhcccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE---PKLTDFALDRIVGEA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~---~kl~DfGla~~~~~~  735 (876)
                      |+++++|.+.+.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.+......
T Consensus        86 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           86 LVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             cCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            999999999887653 689999999999999999999999   9999999999999986655   999999999776543


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ..   .....||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.......  ........      ......+.
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~------~~~~~~~~  230 (284)
T 3kk8_A          162 EA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAG------AYDYPSPE  230 (284)
T ss_dssp             CB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT------CCCCCTTT
T ss_pred             cc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHHHhc------cccCCchh
Confidence            22   234458999999999998889999999999999999999999997644322  11111111      11111111


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .    ......+.+++.+|++.||++|||+.|+++.
T Consensus       231 ~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          231 W----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             T----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             h----cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1    1123457899999999999999999999884

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.9e-37  Score=336.35  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=198.0

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEE--EEEEEecCC-ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELI--AVKKLVNFG-CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ...+|. |+||.||+|+.. +|+.+  |+|++.... ....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        30 ~~~lg~-G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  108 (327)
T 1fvr_A           30 QDVIGE-GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA  108 (327)
T ss_dssp             EEEEEC-GGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             eeeeec-CCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence            344554 459999999664 56654  999886532 23456789999999999 8999999999999999999999999


Q ss_pred             CCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          661 QMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       661 ~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                      ++++|.+++.+..               ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~D  185 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD  185 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcc
Confidence            9999999997643               4689999999999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhc
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINI  804 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  804 (876)
                      ||+++......   ......+++.|+|||...+..++.++||||+|+++|||++ |+.||.......     ........
T Consensus       186 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~~~~~~~  257 (327)
T 1fvr_A          186 FGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-----LYEKLPQG  257 (327)
T ss_dssp             TTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHGGGT
T ss_pred             cCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-----HHHHhhcC
Confidence            99987543221   1223346788999999888888999999999999999998 999997654322     11111111


Q ss_pred             ccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       805 ~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                         .....       .......+.+++.+||+.||++|||+.|+++.|+++.++...
T Consensus       258 ---~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  304 (327)
T 1fvr_A          258 ---YRLEK-------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  304 (327)
T ss_dssp             ---CCCCC-------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             ---CCCCC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence               00000       111234678999999999999999999999999998765443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.6e-37  Score=354.08  Aligned_cols=245  Identities=22%  Similarity=0.255  Sum_probs=188.9

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||.||+|.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus       150 y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e  228 (446)
T 4ejn_A          150 FEYLKLLGKGT-FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME  228 (446)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred             cEEeEEEeeCc-CEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence            44445555555 999999965 47999999999753   22334567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       229 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  303 (446)
T 4ejn_A          229 YANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-  303 (446)
T ss_dssp             CCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             eCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-
Confidence            999999999997654 78999999999999999999998 7   99999999999999999999999999998643322 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+..   .....    .    
T Consensus       304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~---~~~~~----p----  369 (446)
T 4ejn_A          304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--FELILM---EEIRF----P----  369 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---CCCCC----C----
T ss_pred             -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--HHHHHh---CCCCC----C----
Confidence             123445699999999999888999999999999999999999999976543321  111111   11000    0    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                         ......+.+++.+||+.||++||     +++|+++
T Consensus       370 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          370 ---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               11224578999999999999999     9999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=337.62  Aligned_cols=258  Identities=22%  Similarity=0.322  Sum_probs=192.1

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .....+|.|+ ||+||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            5 IKLDKLGEGT-YATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEECS-SEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             EEEEEEcCCC-CEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            3344555555 9999999765 7999999998653321 12245579999999999999999999999999999999998


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      + +|.+++...+..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~  157 (324)
T 3mtl_A           84 K-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY  157 (324)
T ss_dssp             E-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             c-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc--ccc
Confidence            5 99999988777899999999999999999999999   99999999999999999999999999997654322  123


Q ss_pred             ccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--cccccccC-----
Q 002826          742 SSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--NGAIQVLD-----  813 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d-----  813 (876)
                      ....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......  ....+.+.....  ........     
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhhhcchhhc
Confidence            34458999999998876 568999999999999999999999998754432  222222221110  00000000     


Q ss_pred             ---------hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 ---------PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                               .............+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                     0001111223456789999999999999999999987

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-37  Score=342.59  Aligned_cols=248  Identities=23%  Similarity=0.257  Sum_probs=188.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHH-HhhccCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKT-LAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|+.+ +++.||+|++.+...   .....+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        39 ~y~~~~~lG~G~-fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           39 DFHFLKVIGKGS-FGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GEEEEEEEECCT-TCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             heEEEEEEeeCC-CeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            344445555555 9999999765 689999999976432   223456667776 5778999999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||++||+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       118 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~  193 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  193 (373)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence            99999999999997654 688999999999999999999999   99999999999999999999999999998643222


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||........     .+........    +.+  
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-----~~~i~~~~~~----~~~--  260 (373)
T 2r5t_A          194 --STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM-----YDNILNKPLQ----LKP--  260 (373)
T ss_dssp             --CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH-----HHHHHHSCCC----CCS--
T ss_pred             --CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHhcccC----CCC--
Confidence              123445699999999999998999999999999999999999999976443221     1111111100    111  


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                           .....+.+++.+||+.||++||++.+.++.+
T Consensus       261 -----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          261 -----NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             -----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             -----CCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                 1223578999999999999999986444433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.4e-37  Score=365.85  Aligned_cols=248  Identities=21%  Similarity=0.321  Sum_probs=196.1

Q ss_pred             CCCCCCCceEEEEEEe---CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          588 SAGNGGPFGRVYILSL---PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      .+|.|| ||+||+|.+   ..++.||||++.....  ...+++.+|++++++++|||||++++++.+ +..++||||+++
T Consensus       376 ~LG~G~-fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          376 ELGSGN-FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEECS-SEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EeccCC-CEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            456655 999999954   3568999999975432  235789999999999999999999999964 568999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTM  741 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~  741 (876)
                      |+|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus       454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999764 4689999999999999999999999   999999999999999999999999999988754322 2223


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....+|+.|+|||++....++.++|||||||++|||++ |+.||.......  ....+......      .       ..
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~~------~-------~p  594 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGERM------G-------CP  594 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCCC------C-------CC
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC------C-------CC
Confidence            33446788999999988899999999999999999998 999997654432  22222211100      0       01


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ...+..+.+++.+||+.||++|||+.++++.|+++.
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            122346889999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-37  Score=343.43  Aligned_cols=261  Identities=25%  Similarity=0.365  Sum_probs=187.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhcc-CccccceeeEEEeCC--eEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDE--SIFL  655 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~~~l  655 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||||++....  ......+.+|+.+++.+. ||||+++++++...+  ..|+
T Consensus        10 ~y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A           10 KYELVKKLGKGA-YGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TEEEEEC--------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             ceEEEEEeeeCC-CeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            444445555555 999999965 579999999986432  223456778999999997 999999999997644  7899


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++ +|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        89 v~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           89 VFDYMET-DLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             EEECCSE-EHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EecccCc-CHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            9999985 899998763  689999999999999999999999   9999999999999999999999999999865321


Q ss_pred             c-------------------cccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHH
Q 002826          736 A-------------------FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVV  795 (876)
Q Consensus       736 ~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~  795 (876)
                      .                   .........||+.|+|||++.+ ..++.++||||+||++|||++|++||.+......  .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~  240 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ--L  240 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H
Confidence            1                   0112334569999999999876 6789999999999999999999999987543221  1


Q ss_pred             HHHHHHhhcccc--c----------------------ccccC---hhhhhh------cHHHHHHHHHHHHHccCCCCCCC
Q 002826          796 KWVRRKINITNG--A----------------------IQVLD---PKIANC------YQQQMLGALEIALRCTSVMPEKR  842 (876)
Q Consensus       796 ~~~~~~~~~~~~--~----------------------~~~~d---~~~~~~------~~~~~~~~~~li~~cl~~dP~~R  842 (876)
                      ..+......+..  .                      .....   +.+...      .......+.+++.+||+.||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            111111110000  0                      00000   000000      00123468899999999999999


Q ss_pred             CCHHHHHHH
Q 002826          843 PSMFEVVKA  851 (876)
Q Consensus       843 Ps~~ell~~  851 (876)
                      ||+.|+++.
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-36  Score=346.99  Aligned_cols=261  Identities=19%  Similarity=0.213  Sum_probs=203.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC-ccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      .|.....+|.| +||.||+|.. .+++.||||++....  ...++.+|+++++.++| +++..+..++.+.+..++||||
T Consensus         8 ~y~i~~~LG~G-~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            8 KFRLGRKIGSG-SFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TEECCCCCEEC-SSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEEEEEeeC-CCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            34444445554 5999999975 579999999886543  33457889999999987 5566666667778899999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccchhhccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGla~~~~~~~  736 (876)
                      + +++|.+++......+++..+..++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            9 8899999987667899999999999999999999999   99999999999999   578999999999998776432


Q ss_pred             cc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHH-HHHhhcccccc
Q 002826          737 FQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWV-RRKINITNGAI  809 (876)
Q Consensus       737 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~  809 (876)
                      ..     .......||..|+|||.+.+..++.++|||||||++|||++|+.||........ .....+ .....      
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------  234 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA------  234 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH------
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc------
Confidence            21     112355689999999999999999999999999999999999999987544321 111111 11110      


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                          ............++.+++.+||+.+|++||++.+|++.|+++..+.
T Consensus       235 ----~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          235 ----TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             ----SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ----ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence                0111111222456889999999999999999999999999986543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.2e-37  Score=344.85  Aligned_cols=254  Identities=22%  Similarity=0.341  Sum_probs=189.5

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--------cCHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--------QSSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      .+...|.....+|.|| ||+||+|.. .+++.||+|++.....        .....+.+|++++++++||||+++++++.
T Consensus       132 ~~~~~y~~~~~LG~G~-~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGA-CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHTTEEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhccEEEEeEEeeCC-CeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            3444555555566665 999999965 4789999999965321        12235789999999999999999999985


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEcc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTD  725 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~D  725 (876)
                       .+..|+||||+++|+|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.+   +.+||+|
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D  285 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  285 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence             456899999999999999887654 689999999999999999999999   99999999999999754   4599999


Q ss_pred             ccchhhccccccccccccccccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      ||+++......   ......||+.|+|||++.+   ..++.++||||+||++|||++|+.||........ ........ 
T Consensus       286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~i~~~-  360 (419)
T 3i6u_A          286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSG-  360 (419)
T ss_dssp             SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HHHHHHTT-
T ss_pred             cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HHHHHhcC-
Confidence            99998775432   2234568999999999753   5678899999999999999999999976443322 11211110 


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                           .... .+   ..+......+.+++.+||+.||++|||+.|+++.
T Consensus       361 -----~~~~-~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          361 -----KYNF-IP---EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             -----CCCC-CH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----CCCC-Cc---hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                 0010 11   1112234568899999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-36  Score=324.69  Aligned_cols=255  Identities=20%  Similarity=0.299  Sum_probs=199.8

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc------cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC------QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      .|.....+|.|+ ||.||+|... +|+.||+|++.....      ...+.+.+|++++++++||||+++++++.+.+..+
T Consensus         6 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            6 HYEMGEELGSGQ-FAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhHHhhcccC-ceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            344445555555 9999999775 799999999975432      23578999999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccccchh
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDFALDR  730 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~DfGla~  730 (876)
                      +||||+++++|.+++.+.. .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++    .+||+|||.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997643 689999999999999999999999   999999999999998876    89999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .......   .....|++.|+|||......++.++||||||+++|||++|+.||........  ..   ......    .
T Consensus       161 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~---~~~~~~----~  228 (283)
T 3bhy_A          161 KIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LT---NISAVN----Y  228 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH---HHHTTC----C
T ss_pred             eccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HH---HhHhcc----c
Confidence            7654321   2334589999999999888899999999999999999999999976543221  11   111110    0


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhcc
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK--ALHSLS  856 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~--~L~~i~  856 (876)
                      ..++..   .......+.+++.+||+.||++|||+.|+++  .++.+.
T Consensus       229 ~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          229 DFDEEY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CCCHHH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             CCcchh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            011111   1122346789999999999999999999997  355543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.9e-36  Score=346.59  Aligned_cols=256  Identities=23%  Similarity=0.328  Sum_probs=203.2

Q ss_pred             chhhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC--CccCHHHHHHHHHHHhhccCccccceeeEEEeCC
Q 002826          575 TEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF--GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE  651 (876)
Q Consensus       575 ~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  651 (876)
                      ..+++...|.....+|.|+ ||+||+|... +++.||||++...  .......+.+|++++++++||||+++++++.+.+
T Consensus        16 ~~g~~~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGS-FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCS-SSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCChhcceEEeEEEeecC-CEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            3455666666666666665 9999999764 7999999999643  2245678899999999999999999999999999


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccc
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFAL  728 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGl  728 (876)
                      ..|+||||+++|+|.+.+.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++   .++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            9999999999999999887654 689999999999999999999999   999999999999995   456899999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ++......   ......||+.|+|||++.+ .++.++||||+||++|+|++|++||.......  ....+...      .
T Consensus       171 a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~------~  238 (486)
T 3mwu_A          171 STCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVETG------K  238 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT------C
T ss_pred             CeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhC------C
Confidence            98765432   2334468999999999875 58999999999999999999999998654322  22222111      0


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+..    ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          239 YAFDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCSCSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            01111111    1223457899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.8e-36  Score=331.16  Aligned_cols=265  Identities=22%  Similarity=0.342  Sum_probs=200.1

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe-------
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-------  649 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  649 (876)
                      ...|.....+|.|| ||+||+|+. .+|+.||+|++.....  .....+.+|+++++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGT-FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCS-TTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCC-CcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            33455555666665 999999976 5899999999865432  234578899999999999999999999987       


Q ss_pred             -CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccc
Q 002826          650 -DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFAL  728 (876)
Q Consensus       650 -~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGl  728 (876)
                       .+..++||||+++ ++.+.+......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence             4568999999986 88888877666799999999999999999999999   999999999999999999999999999


Q ss_pred             hhhccccc--cccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hc
Q 002826          729 DRIVGEAA--FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NI  804 (876)
Q Consensus       729 a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~  804 (876)
                      ++.+....  .........||+.|+|||.+.+ ..++.++||||+||++|||++|++||.......  ....+.... ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~  248 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSI  248 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence            98765221  1223345568999999998875 457999999999999999999999998754332  122222211 11


Q ss_pred             ccccccccC---------------hhhhhhcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          805 TNGAIQVLD---------------PKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       805 ~~~~~~~~d---------------~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ........+               +.......  .....+.+++.+|++.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            111111000               00000000  013457899999999999999999999984

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-36  Score=350.35  Aligned_cols=250  Identities=22%  Similarity=0.269  Sum_probs=200.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||.||+|+.. +|+.||+|++...   .......+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus       186 f~~~~~LG~G~-fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  264 (576)
T 2acx_A          186 FRQYRVLGKGG-FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT  264 (576)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            33445555555 9999999764 7999999999653   22445678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |++||+|.+++...+ ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       265 y~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             cCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            999999999987653 3599999999999999999999999   999999999999999999999999999987654322


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....+.........         
T Consensus       342 ---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~~~~~---------  408 (576)
T 2acx_A          342 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEVPEEY---------  408 (576)
T ss_dssp             ---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHCCCCC---------
T ss_pred             ---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcccccC---------
Confidence               2334699999999999988899999999999999999999999987543221 111111111111101         


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                        .......+.+++.+||+.||++||     ++.|+++.
T Consensus       409 --p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          409 --SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              111234678999999999999999     78888764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-37  Score=338.47  Aligned_cols=269  Identities=20%  Similarity=0.243  Sum_probs=193.8

Q ss_pred             ccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHH--HhhccCccccceeeEEEe-----CCeEEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKT--LAKIRHKNIVKVLGFFHS-----DESIFLIY  657 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~-----~~~~~lv~  657 (876)
                      ....+|.|| ||.||+|+. +++.||||++...   ....+..|.++  ++.++||||+++++++..     ....++||
T Consensus        17 ~~~~lg~G~-~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~   91 (336)
T 3g2f_A           17 LLELIGRGR-YGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM   91 (336)
T ss_dssp             EEEEEEECS-SEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             eeeecccCC-CeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence            344455555 999999977 7899999999653   23344444444  556899999999986643     23678999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC------CCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY------VPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ||+++|+|.+++....  .++..+.+++.|++.||+|||+.+      .++|+||||||+||+++.++.+||+|||+++.
T Consensus        92 e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~  169 (336)
T 3g2f_A           92 EYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR  169 (336)
T ss_dssp             CCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence            9999999999997654  589999999999999999999873      23899999999999999999999999999987


Q ss_pred             cccccc------ccccccccccccccCccccCC-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh------
Q 002826          732 VGEAAF------QSTMSSEYALSCYNAPEYGYS-------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESL------  792 (876)
Q Consensus       732 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~------  792 (876)
                      +.....      ........||+.|+|||.+.+       ..++.++|||||||++|||++|+.||........      
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  249 (336)
T 3g2f_A          170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ  249 (336)
T ss_dssp             CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred             cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence            653221      122234468999999999876       3456789999999999999999777654322111      


Q ss_pred             -------hHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcccc
Q 002826          793 -------DVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLS  863 (876)
Q Consensus       793 -------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~~  863 (876)
                             ....+ ...... ......+.+. .......+..+.+++.+||+.||++|||++|+++.|+++...+..-.
T Consensus       250 ~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          250 TEVGNHPTFEDM-QVLVSR-EKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             HHHCSSCCHHHH-HHHHTT-SCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             cccCCCchHHHH-Hhhhcc-cccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence                   00000 000000 0011111111 11122355678999999999999999999999999999987766553

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.1e-37  Score=335.44  Aligned_cols=251  Identities=19%  Similarity=0.275  Sum_probs=195.3

Q ss_pred             hhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      ..+|.....+|.|+ ||.||+|..+ +|+.||+|++.....    ...+|++++.++ +||||+++++++.+++..|+||
T Consensus        21 ~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGS-YSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCC-CEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            33455555566655 9999999764 799999999976432    235688888888 7999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC----CCeEEccccchhhcc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD----FEPKLTDFALDRIVG  733 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~----~~~kl~DfGla~~~~  733 (876)
                      ||+++|+|.+++.+.+ .+++..+..++.||+.|++|||+.   +|+||||||+||++.++    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997654 689999999999999999999999   99999999999998543    359999999998765


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhccccccccc
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  812 (876)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....+.. .....+..   ..   ....
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~---~~---~~~~  243 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS---GK---FSLS  243 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH---CC---CCCC
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc---CC---cccC
Confidence            4321  22344689999999998877788999999999999999999999986433221 22222111   11   1110


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .    ..+......+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          244 G----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             S----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             c----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1    1112233467899999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-37  Score=335.93  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=198.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc-----CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ-----SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      .|.....+|.|| ||.||+|... +|+.||+|++......     ....+.+|+++++.++||||+++++++.+.+..++
T Consensus        11 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           11 RYEKLDFLGEGQ-FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             --CEEEEEEEET-TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             ccEEEeEEeecC-CEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            444445555555 9999999775 6999999998643221     13467899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++ +|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999987 89999987777799999999999999999999999   9999999999999999999999999999876533


Q ss_pred             ccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc--
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL--  812 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  812 (876)
                      .  .......||+.|+|||.+.+. .++.++||||+||++|||++|.+||....... ....................  
T Consensus       166 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          166 N--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             C--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTS
T ss_pred             c--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhhhhcc
Confidence            2  123345689999999998654 57899999999999999999999987654322 12222221111000000000  


Q ss_pred             -----------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          813 -----------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       813 -----------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                                 ..............+.+++.+||+.||++|||+.|+++.-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                       0001111223345789999999999999999999999853

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.9e-37  Score=329.24  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=198.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  657 (876)
                      |.....+|.|| ||.||+|... +|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+  .+..++||
T Consensus         8 y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   86 (279)
T 2w5a_A            8 YEVLYTIGTGS-YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM   86 (279)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred             eeeehhccCCC-CcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence            33445555555 9999999765 799999999975432  234568899999999999999999998854  57899999


Q ss_pred             EcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCC-----ccccccccCceeeCCCCCeEEccccch
Q 002826          658 EFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPH-----LLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       658 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      ||+++++|.+++...   ...+++..+.+++.|++.|++|||+.   +     |+||||||+||+++.++.+||+|||.+
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999754   34599999999999999999999999   7     999999999999999999999999999


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      +.......  ......|++.|+|||...+..++.++||||||+++|||++|+.||.......  ....+...      ..
T Consensus       164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~~~------~~  233 (279)
T 2w5a_A          164 RILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREG------KF  233 (279)
T ss_dssp             HHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT------CC
T ss_pred             eeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHhhc------cc
Confidence            87654321  1123358899999999988889999999999999999999999998654321  22221111      11


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ..+..       .....+.+++.+||+.||++|||+.|+++.+..-.+
T Consensus       234 ~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          234 RRIPY-------RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ccCCc-------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            11111       123467899999999999999999999997765544

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-36  Score=335.51  Aligned_cols=267  Identities=24%  Similarity=0.282  Sum_probs=198.8

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ++..+.++..+..|.|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            343333344444444459999999765 799999999976422 234678899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++++|.+++.+.+ .+++..+..++.|++.|++|||+.+  +|+||||||+||+++.++.+||+|||+++.....
T Consensus       109 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             EECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999999997654 6899999999999999999999831  7999999999999999999999999999766432


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----------
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----------  805 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  805 (876)
                      .    .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....................          
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            2    22345899999999999889999999999999999999999999875543321110000000000          


Q ss_pred             -------------cccccccChhh----h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 -------------NGAIQVLDPKI----A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 -------------~~~~~~~d~~~----~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                   ......++...    . .........+.+++.+||+.||++|||++|+++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                         00000000000    0 0000123468899999999999999999999873

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.5e-37  Score=329.29  Aligned_cols=250  Identities=21%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|.....+|.|| ||.||+|... +++.||+|++..........+.+|+++++.++||||+++++++.+++..++||||+
T Consensus        20 ~y~i~~~lg~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   98 (302)
T 2j7t_A           20 VWEIVGELGDGA-FGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC   98 (302)
T ss_dssp             TEEEEEEEECST-TCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred             ceeecceeccCC-CeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence            343444555555 9999999775 69999999997766666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++.+....+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++.......  ..
T Consensus        99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  173 (302)
T 2j7t_A           99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QK  173 (302)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cc
Confidence            99999999887666799999999999999999999999   99999999999999999999999999986543221  11


Q ss_pred             cccccccccccCcccc-----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          741 MSSEYALSCYNAPEYG-----YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .....||+.|+|||..     ....++.++||||||+++|||++|+.||........     ........  ......+ 
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~--~~~~~~~-  245 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSD--PPTLLTP-  245 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC--CCCCSSG-
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhccC--CcccCCc-
Confidence            2234588999999987     466788999999999999999999999976443221     11111110  0000111 


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                           ......+.+++.+||+.||++|||+.|+++
T Consensus       246 -----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          246 -----SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 112345789999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.6e-37  Score=325.07  Aligned_cols=245  Identities=24%  Similarity=0.401  Sum_probs=189.7

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +.+....+.|+||.||+|... +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            344444444559999999775 79999999996532   23456788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........  
T Consensus        93 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  166 (276)
T 2h6d_A           93 VSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF--  166 (276)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             cCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc--
Confidence            99999999997654 689999999999999999999999   999999999999999999999999999987654321  


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       .....|++.|+|||...+..+ +.++||||+|+++|||++|+.||.......  ....+..   ..   .. + |    
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~---~~---~~-~-~----  231 (276)
T 2h6d_A          167 -LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRG---GV---FY-I-P----  231 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CC---CC-C-C----
T ss_pred             -eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhc---Cc---cc-C-c----
Confidence             223458899999999887654 689999999999999999999997643322  1111111   10   00 0 0    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        ......+.+++.+|++.||++|||+.|+++.
T Consensus       232 --~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          232 --EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              1112357899999999999999999999984

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=326.41  Aligned_cols=244  Identities=23%  Similarity=0.322  Sum_probs=192.0

Q ss_pred             CCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          588 SAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      .+|.|+ ||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        29 ~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           29 VLGKGT-YGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             EEEECS-SSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEeecC-cEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            455555 999999975 578999999998766566678999999999999999999999999999999999999999999


Q ss_pred             HHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhcccccccccccc
Q 002826          667 DLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       667 ~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      +++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++. ++.+||+|||.++.......  ....
T Consensus       108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~  182 (295)
T 2clq_A          108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET  182 (295)
T ss_dssp             HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CC
T ss_pred             HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccc
Confidence            9997652  3567899999999999999999999   9999999999999987 89999999999987653221  1233


Q ss_pred             ccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          744 EYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ..|++.|+|||.....  .++.++||||||+++|||++|+.||.............  ......        +.+.   .
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~--------~~~~---~  249 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV--GMFKVH--------PEIP---E  249 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH--HHHCCC--------CCCC---T
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh--cccccc--------cccc---c
Confidence            4589999999987654  37889999999999999999999997533322211111  111111        1111   1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            12345789999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-36  Score=330.51  Aligned_cols=262  Identities=18%  Similarity=0.232  Sum_probs=201.9

Q ss_pred             cccchhhhhhcccccC-CCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhcc-CccccceeeE
Q 002826          572 LRVTEHDLVIGMDEKS-SAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIR-HKNIVKVLGF  646 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~-~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~  646 (876)
                      ..+...+...++|.+. +..|.|+||+||+|... +|+.||+|++....  ......+.+|+.+++.++ ||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4444555555555553 44444449999999665 79999999986532  234678899999999994 6999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeE
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPK  722 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~k  722 (876)
                      +.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.   ++.+|
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence            99999999999999999999998654 45799999999999999999999999   9999999999999987   78999


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      |+|||+++.......   .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||........  ......  
T Consensus       175 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~--  247 (327)
T 3lm5_A          175 IVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YLNISQ--  247 (327)
T ss_dssp             ECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH--
T ss_pred             EeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHHHh--
Confidence            999999987654321   2334589999999999988999999999999999999999999976543321  111111  


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ..   .....+.    .......+.+++.+||+.||++|||+.|+++.
T Consensus       248 -~~---~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 -VN---VDYSEET----FSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -TC---CCCCTTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -cc---cccCchh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             10   0000111    11223457899999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-36  Score=325.19  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=199.2

Q ss_pred             hcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe----------
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----------  649 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----------  649 (876)
                      .+|.....+|.|+ ||.||+|... +++.||+|++....    ..+.+|++++++++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGG-FGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSS-SCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCC-ceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            3555555565555 9999999775 89999999997532    467789999999999999999999864          


Q ss_pred             ------CCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeE
Q 002826          650 ------DESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK  722 (876)
Q Consensus       650 ------~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~k  722 (876)
                            ....++||||+++++|.+++.+. ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence                  44589999999999999999754 45799999999999999999999999   999999999999999999999


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      |+|||+++......   ......|++.|+|||...+..++.++||||||+++|||++|..|+..    ..   .......
T Consensus       163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~----~~---~~~~~~~  232 (284)
T 2a19_B          163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE----TS---KFFTDLR  232 (284)
T ss_dssp             ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH----HH---HHHHHHH
T ss_pred             ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh----HH---HHHHHhh
Confidence            99999998765432   12334589999999999888899999999999999999999987632    11   1111111


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      ..      .+.+       .....+.+++.+||+.||++|||+.|+++.|+.+......
T Consensus       233 ~~------~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          233 DG------IISD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             TT------CCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             cc------cccc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            10      0111       1123467899999999999999999999999998765544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.1e-37  Score=326.40  Aligned_cols=243  Identities=22%  Similarity=0.351  Sum_probs=196.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|... +++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        16 y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   94 (284)
T 2vgo_A           16 FDIGRPLGKGK-FGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE   94 (284)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceeeheecCCC-CeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence            33334455554 9999999765 68899999986431   2345678999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++++|.+++.+.+ .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.......  
T Consensus        95 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  168 (284)
T 2vgo_A           95 FAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--  168 (284)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC--
T ss_pred             eCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc--
Confidence            999999999997654 689999999999999999999999   99999999999999999999999999987654322  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                        .....|++.|+|||...+..++.++||||+|+++|||++|+.||........     ........        ..+. 
T Consensus       169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~~--------~~~~-  232 (284)
T 2vgo_A          169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----HRRIVNVD--------LKFP-  232 (284)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHTTC--------CCCC-
T ss_pred             --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----HHHHhccc--------cCCC-
Confidence              2234589999999999988899999999999999999999999976443221     11111111        0010 


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        ......+.+++.+|++.||++|||+.|+++
T Consensus       233 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 --PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              112335789999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=327.11  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .|.....+|.|+ ||.||+|... +|+.||+|++...  .....+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        30 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  106 (314)
T 3com_A           30 VFDVLEKLGEGS-YGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC  106 (314)
T ss_dssp             CEEEEEECC-----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhheeeccCC-CeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence            344445555555 9999999765 6999999999754  34577899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++......+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||+++.......  .
T Consensus       107 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~  181 (314)
T 3com_A          107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--K  181 (314)
T ss_dssp             TTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--C
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--c
Confidence            99999999976666899999999999999999999999   999999999999999999999999999977654321  2


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....|++.|+|||...+..++.++||||||+++|||++|+.||........  ......   ..  ......+      
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~--~~~~~~~------  248 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPT---NP--PPTFRKP------  248 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH---SC--CCCCSSG------
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhc---CC--CcccCCc------
Confidence            2344589999999999888899999999999999999999999976443221  111111   10  0000001      


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            112346789999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-36  Score=323.81  Aligned_cols=245  Identities=20%  Similarity=0.270  Sum_probs=191.6

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFLI  656 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  656 (876)
                      +......|.|+||+||+|.. .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            34444344445999999966 478899999987542  2234678899999999999999999999876    3568999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeC-CCCCeEEccccchhhcc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLD-ADFEPKLTDFALDRIVG  733 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~  733 (876)
                      |||+++++|.+++.+.. .+++..+..++.|++.|++|||+.   +  |+||||||+||+++ .++.+||+|||+++...
T Consensus       108 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~  183 (290)
T 1t4h_A          108 TELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence            99999999999997653 689999999999999999999999   7  99999999999998 78999999999997654


Q ss_pred             ccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ...    .....||+.|+|||.+. +.++.++||||+|+++|+|++|+.||........    .........      ..
T Consensus       184 ~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~  248 (290)
T 1t4h_A          184 ASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGV------KP  248 (290)
T ss_dssp             TTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTC------CC
T ss_pred             ccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHHHhccC------Cc
Confidence            332    22345899999999876 4589999999999999999999999976443222    111111110      00


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +....   .....+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 ASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCC---CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11111   11235789999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.5e-36  Score=345.92  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  654 (876)
                      .+...|.....+|.|| ||+||+|+.. +++.||+|++....  ......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        34 ~~~~~y~~~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGA-YGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CHHHHEEEEEEEECC----EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             chhcCeEEeeEEecCC-CEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3444555556666665 9999999765 78999999997543  234577899999999999999999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeEEccccchhh
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFALDRI  731 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~DfGla~~  731 (876)
                      +||||+++|+|.+.+.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       113 lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999999887653 689999999999999999999999   9999999999999976   45599999999987


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      .....   ......||+.|+|||++. ..++.++||||+||++|+|++|++||.......  ....+...      ....
T Consensus       189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~------~~~~  256 (494)
T 3lij_A          189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRKVEKG------KYTF  256 (494)
T ss_dssp             CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT------CCCC
T ss_pred             CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhC------CCCC
Confidence            65432   233456999999999876 468999999999999999999999998654322  22222211      1111


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..+..    ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            11211    1223457899999999999999999999864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-36  Score=346.63  Aligned_cols=264  Identities=20%  Similarity=0.298  Sum_probs=182.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  653 (876)
                      .|.....+|.| +||+||+|.. .+|+.||||++.....  ...+++.+|+++++.++||||+++++++...     +..
T Consensus        54 ~y~~~~~lG~G-~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           54 RYEIRHLIGTG-SYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TEEECCC--------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CeEEeeEeeec-CCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            34444445554 5999999965 4799999999965322  2346788999999999999999999999543     579


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      |+||||++ ++|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       133 ~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEeccc-cchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            99999985 5999998654 4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccc-------------------------cccccccccccccCcccc-CCCCCCCccchHHHHHHHHHHHh--------
Q 002826          734 EAAFQ-------------------------STMSSEYALSCYNAPEYG-YSKKATAQMDAYSFGVVLLELIT--------  779 (876)
Q Consensus       734 ~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGv~l~ellt--------  779 (876)
                      .....                         .......||+.|+|||++ ....++.++||||+||++|||++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            22110                         123445689999999975 45679999999999999999999        


Q ss_pred             ---CCCCCCCCCcc------------------hhhHHHHHHHHhhccc-----------------ccccccChhhhhhcH
Q 002826          780 ---GRQAEQAEPAE------------------SLDVVKWVRRKINITN-----------------GAIQVLDPKIANCYQ  821 (876)
Q Consensus       780 ---g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~-----------------~~~~~~d~~~~~~~~  821 (876)
                         |+++|.+....                  ..+....+........                 .........+.....
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               66666543210                  0011111111000000                 000000001111222


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+.+++.+||..||++|||+.|+++.
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            335578899999999999999999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-36  Score=327.63  Aligned_cols=247  Identities=22%  Similarity=0.325  Sum_probs=200.8

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|| ||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus        24 y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  102 (303)
T 3a7i_A           24 FTKLEKIGKGS-FGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL  102 (303)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HHHhhhhcccC-CeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence            44455566665 999999965 4799999999975432 34578899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      ++++|.+++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++........  .
T Consensus       103 ~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  175 (303)
T 3a7i_A          103 GGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  175 (303)
T ss_dssp             TTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--C
T ss_pred             CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc--c
Confidence            99999999865  3689999999999999999999999   999999999999999999999999999977654321  2


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....|++.|+|||...+..++.++||||||+++|||++|+.||.......  ........      ....+..      
T Consensus       176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~------~~~~~~~------  241 (303)
T 3a7i_A          176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKN------NPPTLEG------  241 (303)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHS------CCCCCCS------
T ss_pred             cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcC------CCCCCcc------
Confidence            234458999999999998889999999999999999999999997643322  11111111      0011111      


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                       .....+.+++.+||+.||++|||+.|+++..
T Consensus       242 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          242 -NYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             -SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             -ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence             1223578999999999999999999998853

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.6e-36  Score=331.74  Aligned_cols=260  Identities=18%  Similarity=0.255  Sum_probs=188.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      .|.....+|.|+ ||+||+|.. .+++.||+|++......  ....+.+|++++++++||||+++++++.+++..++|||
T Consensus        35 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (329)
T 3gbz_A           35 RYRRITKLGEGT-YGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFE  113 (329)
T ss_dssp             GEEEEEEEEECS-SSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hEEEEEEEEecC-CeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEe
Confidence            444445555555 999999965 58999999998654322  23567789999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-----CCCCeEEccccchhhcc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-----ADFEPKLTDFALDRIVG  733 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-----~~~~~kl~DfGla~~~~  733 (876)
                      |+++ +|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++     .++.+||+|||+++...
T Consensus       114 ~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          114 YAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             CCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             cCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9985 9999997654 689999999999999999999999   999999999999994     45569999999998775


Q ss_pred             ccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc---
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI---  809 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  809 (876)
                      ....  ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ................   
T Consensus       189 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~  265 (329)
T 3gbz_A          189 IPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDTTWPGV  265 (329)
T ss_dssp             -------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSTTG
T ss_pred             Cccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchhhhhhh
Confidence            3321  23344579999999998764 489999999999999999999999987543321 2222221110000000   


Q ss_pred             -----------cccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          810 -----------QVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       810 -----------~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                                 ......+. .........+.+++.+||+.||++|||+.|+++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                       00000000 001112356789999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-36  Score=331.25  Aligned_cols=261  Identities=22%  Similarity=0.385  Sum_probs=193.8

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|| ||.||+|... +|+.||+|++.......  .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        27 y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  105 (331)
T 4aaa_A           27 YENLGLVGEGS-YGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF  105 (331)
T ss_dssp             EEEEEEGGGGT-TSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             heeeeEEeecC-CEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence            34445555555 9999999765 69999999986543222  35577899999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++++|.++.... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......  
T Consensus       106 ~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  179 (331)
T 4aaa_A          106 VDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--  179 (331)
T ss_dssp             CSEEHHHHHHHST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             CCcchHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence            9998888876544 3699999999999999999999999   999999999999999999999999999987654321  


Q ss_pred             ccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc--------------
Q 002826          740 TMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI--------------  804 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------------  804 (876)
                      ......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||........ ...........              
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcccc
Confidence            22344589999999998765 689999999999999999999999987554322 11111110000              


Q ss_pred             ccc-cccccC-hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          805 TNG-AIQVLD-PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       805 ~~~-~~~~~d-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ... ...... .............+.+++.+||+.||++|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000 000000 00111122335678999999999999999999999873

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-36  Score=335.44  Aligned_cols=253  Identities=23%  Similarity=0.299  Sum_probs=197.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe----CCCcEEEEEEEecCC----ccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCe
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL----PSGELIAVKKLVNFG----CQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  652 (876)
                      +|.....+|.|| ||+||+|+.    .+|+.||||++....    ......+.+|+++++.+ +||||+++++++.+.+.
T Consensus        55 ~y~~~~~lG~G~-~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           55 NFELLKVLGTGA-YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GEEEEEEEEETT-TEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             ceEEEEEeccCC-CEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            344445555555 999999976    478999999986432    23445677899999999 69999999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~  209 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  209 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             EEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence            999999999999999997654 689999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      ..... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||........ .....+......     
T Consensus       210 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~-----  282 (355)
T 1vzo_A          210 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-----  282 (355)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC-----
T ss_pred             ccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhccC-----
Confidence            43222 12234468999999999875  3478899999999999999999999976443221 122222221111     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKAL  852 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~L  852 (876)
                         +..   .......+.+++.+||+.||++||     |++|+++..
T Consensus       283 ---~~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 ---PPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---CCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---CCC---CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               001   111234578999999999999999     999998764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-36  Score=333.65  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=193.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||||++.....  ...+.+.+|+++++.++||||+++++++...      ..
T Consensus        26 ~y~~~~~lG~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           26 VYRDLQPVGSGA-YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             eEEEeEEeeecC-CeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            444445555555 999999976 5799999999865322  2245678999999999999999999999765      34


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+ +++|.+++..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          105 FYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            69999999 7799999876  3689999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc---
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA---  808 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  808 (876)
                      ...     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ...............   
T Consensus       179 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          179 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHT
T ss_pred             ccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence            432     234468999999998776 6789999999999999999999999986543221 111111100000000   


Q ss_pred             -------------ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002826          809 -------------IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSL  855 (876)
Q Consensus       809 -------------~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i  855 (876)
                                   .......+..........+.+++.+|+..||++|||+.|+++.  ++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                         0000111112222334568899999999999999999999983  4444

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.5e-36  Score=333.56  Aligned_cols=249  Identities=20%  Similarity=0.325  Sum_probs=197.3

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCcc--------CHHHHHHHHHHHhhc-cCccccceeeEEEeCC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQ--------SSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDE  651 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  651 (876)
                      .|.....+|.|+ ||.||+|... +|+.||||++......        ..+.+.+|+.+++++ +||||+++++++...+
T Consensus        95 ~y~~~~~lg~G~-~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           95 KYDPKDVIGRGV-SSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hcccceEEecCC-CEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            444445566555 9999999775 7999999999754321        134677899999999 7999999999999999


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            999999999999999999765 3689999999999999999999999   999999999999999999999999999987


Q ss_pred             ccccccccccccccccccccCccccC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGY------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      .....   ......||+.|+|||++.      ...++.++|||||||++|||++|+.||.......  ....+...    
T Consensus       250 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~i~~~----  320 (365)
T 2y7j_A          250 LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLRMIMEG----  320 (365)
T ss_dssp             CCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT----
T ss_pred             cCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhC----
Confidence            65432   223456899999999864      3357889999999999999999999997643221  11111111    


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        ......+..    ......+.+++.+||+.||++|||+.|+++
T Consensus       321 --~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          321 --QYQFSSPEW----DDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --CCCCCHHHH----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCCCCccc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              001111111    122345789999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.9e-36  Score=328.86  Aligned_cols=255  Identities=18%  Similarity=0.229  Sum_probs=196.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEe--CCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHS--DESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  657 (876)
                      +|.....+|.|+ ||+||+|.. .+++.||+|++..   ...+.+.+|++++++++ ||||+++++++.+  ....++||
T Consensus        37 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           37 DYQLVRKLGRGK-YSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             ceEEEEEecccC-CeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            344445555555 999999965 5899999999864   45678999999999997 9999999999988  66799999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAA  736 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  736 (876)
                      ||+++++|.+++.    .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++ .+||+|||+++......
T Consensus       113 e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             ECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             eccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            9999999999884    488999999999999999999999   999999999999999776 89999999998765433


Q ss_pred             cccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-----ccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-----NGAIQ  810 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  810 (876)
                      .   .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.....................     .....
T Consensus       186 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  262 (330)
T 3nsz_A          186 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  262 (330)
T ss_dssp             C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             c---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence            2   234458899999999876 66899999999999999999999999765544332222221110000     00000


Q ss_pred             ccChhhh-----------------hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIA-----------------NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~-----------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..++...                 .........+.+++.+||+.||++|||++|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0111100                 001113456889999999999999999999987

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-37  Score=331.32  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=193.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC--CCc--EEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP--SGE--LIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|+ ||+||+|++.  +++  .||+|++....   ....+.+.+|++++++++||||+++++++.+++ .++
T Consensus        20 y~~~~~lg~G~-~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           20 LRLLEKLGDGS-FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             EEEEEECC-----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             eeeeeeecCCC-ceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            33444555555 9999999753  333  68999986542   223467889999999999999999999998755 889


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++++|.+++......+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9999999999999987666799999999999999999999999   9999999999999999999999999999877543


Q ss_pred             ccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          736 AFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       736 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ... .......+|..|+|||...+..++.++||||||+++|||++ |+.||.......  ......   ...  ...   
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~---~~~--~~~---  244 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKID---KEG--ERL---  244 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHH---TSC--CCC---
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHH---ccC--CCC---
Confidence            221 12233457788999999888888999999999999999999 999997654322  111111   110  000   


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                      +.    ....+..+.+++.+||+.||++|||+.|+++.|+++.+....
T Consensus       245 ~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  288 (291)
T 1u46_A          245 PR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR  288 (291)
T ss_dssp             CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred             CC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence            00    112234688999999999999999999999999998765443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-36  Score=327.40  Aligned_cols=247  Identities=21%  Similarity=0.316  Sum_probs=198.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .|.....+|.|| ||.||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        16 ~y~~~~~lg~G~-~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           16 RYVRGRFLGKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEEEEEeecC-CEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            333444455555 9999999765 688999999875432   23457889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        95 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             ECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            9999999999887654 689999999999999999999999   999999999999999999999999999987653221


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                        ......||+.|+|||...+..++.++||||+|+++|||++|+.||........     ........   .. +.    
T Consensus       171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~---~~-~~----  235 (294)
T 2rku_A          171 --RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-----YLRIKKNE---YS-IP----  235 (294)
T ss_dssp             --CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHTTC---CC-CC----
T ss_pred             --ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHhhcc---CC-Cc----
Confidence              12334589999999999888899999999999999999999999976543221     11111111   00 00    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         ......+.+++.+||+.||++|||+.|+++.
T Consensus       236 ---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          236 ---KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1112357889999999999999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.6e-36  Score=342.35  Aligned_cols=198  Identities=23%  Similarity=0.367  Sum_probs=160.0

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~  653 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||||++.....  ...+.+.+|+++++.++||||+++++++...     +..
T Consensus        27 ~y~~~~~lG~G~-~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~  105 (432)
T 3n9x_A           27 NYIIKHLIGRGS-YGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL  105 (432)
T ss_dssp             TEEEEEEEEEET-TEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CEEEEEEEeecC-CEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence            444445555555 999999965 4789999999965322  2346788999999999999999999999776     579


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      |+||||+++ +|.+++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       106 ~lv~e~~~~-~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          106 YIVLEIADS-DLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             EEEEECCSE-EHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             EEEEecCCc-CHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence            999999875 999999764 4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             ccccc--------------------cccccccccccccCcccc-CCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002826          734 EAAFQ--------------------STMSSEYALSCYNAPEYG-YSKKATAQMDAYSFGVVLLELITGRQAEQ  785 (876)
Q Consensus       734 ~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlGv~l~elltg~~p~~  785 (876)
                      .....                    .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            33211                    123456789999999985 55679999999999999999998555443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.9e-36  Score=333.40  Aligned_cols=261  Identities=21%  Similarity=0.256  Sum_probs=191.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccC-----------HHHHHHHHHHHhhccCccccceeeEEEe-
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQS-----------SKTLKTEVKTLAKIRHKNIVKVLGFFHS-  649 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~-  649 (876)
                      .|.....+|.|| ||.||+|...+|+.||||++.......           .+.+.+|++++++++||||+++++++.. 
T Consensus        23 ~y~~~~~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  101 (362)
T 3pg1_A           23 PYTVQRFISSGS-YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF  101 (362)
T ss_dssp             SCEEEEEEEEET-TEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred             ceEEeEEeccCC-CEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence            444444555555 999999988889999999986532221           2678899999999999999999999854 


Q ss_pred             ----CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcc
Q 002826          650 ----DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTD  725 (876)
Q Consensus       650 ----~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~D  725 (876)
                          ....|+||||++ |+|.+++......+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|
T Consensus       102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          102 EEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence                336899999998 589998887777899999999999999999999999   999999999999999999999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-  803 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-  803 (876)
                      ||+++......   ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ .......... 
T Consensus       178 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~  253 (362)
T 3pg1_A          178 FNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ-LNKIVEVVGTP  253 (362)
T ss_dssp             TTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred             cCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCC
Confidence            99997654332   2233458899999998876 6789999999999999999999999987543221 1111110000 


Q ss_pred             ----------------cccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          804 ----------------ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       804 ----------------~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                      .......................+.+++.+||+.||++|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence                            000000111111112222334568899999999999999999999874

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=6.8e-36  Score=334.92  Aligned_cols=312  Identities=19%  Similarity=0.207  Sum_probs=226.8

Q ss_pred             CccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC-CcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      .++++++|++++|.++...+..|.++++|++|+|++|+  +..++ ..|..+++|++|+|++|++++..|..|.++++|+
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  120 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ--IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT  120 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSC--CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCc--ccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC
Confidence            35677777777777775555567777777777777776  34443 4677777788888888888877778888888888


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      +|+|++|+++ .+|..++..+++|++|++++|++++..+..+..+++|++|++++|++++.   .+..+++|+.|++++|
T Consensus       121 ~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n  196 (390)
T 3o6n_A          121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYN  196 (390)
T ss_dssp             EEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSS
T ss_pred             EEECCCCccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccc
Confidence            8888888888 77777766788888888888888877777788888888888888888754   3566777888888888


Q ss_pred             cCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCC
Q 002826          314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPP  393 (876)
Q Consensus       314 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~  393 (876)
                      .+++     +...++|+.|++++|+++.....   ..++|+.|++++|++++.  ..+..+++|++|++++|.+++..|.
T Consensus       197 ~l~~-----~~~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~  266 (390)
T 3o6n_A          197 LLST-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYH  266 (390)
T ss_dssp             CCSE-----EECCSSCSEEECCSSCCCEEECC---CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESG
T ss_pred             cccc-----cCCCCcceEEECCCCeeeecccc---ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChh
Confidence            7763     23345778888888888755332   246788888888888753  4677777788888888877777777


Q ss_pred             CcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccccce
Q 002826          394 NFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLAL  473 (876)
Q Consensus       394 ~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~l~~  473 (876)
                      .|..+++|+.|+|++|++++.+..+..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++.            
T Consensus       267 ~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~------------  333 (390)
T 3o6n_A          267 PFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL------------  333 (390)
T ss_dssp             GGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC------------
T ss_pred             HccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee------------
Confidence            777777777777777777766556666777777777777777 4555666777777777777777632            


Q ss_pred             EEccCCccccccCCcccCCCCCccccCCCCCCCC
Q 002826          474 FNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP  507 (876)
Q Consensus       474 l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~  507 (876)
                                  |...+.++..+++.+||+.|++
T Consensus       334 ------------~~~~~~~L~~L~l~~N~~~~~~  355 (390)
T 3o6n_A          334 ------------KLSTHHTLKNLTLSHNDWDCNS  355 (390)
T ss_dssp             ------------CCCTTCCCSEEECCSSCEEHHH
T ss_pred             ------------CchhhccCCEEEcCCCCccchh
Confidence                        2222344566677778877754

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-36  Score=344.09  Aligned_cols=250  Identities=21%  Similarity=0.266  Sum_probs=198.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||.||+|+.. +|+.||+|++....   ......+.+|++++++++||||+++++++.+.+..|+|||
T Consensus       187 f~~~~~LG~G~-fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE  265 (543)
T 3c4z_A          187 FLDFRVLGRGG-FGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMT  265 (543)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeCC-CeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEE
Confidence            33344455555 9999999775 79999999996532   2345678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          659 FLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       659 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |++||+|.+++...   ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       266 ~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~  342 (543)
T 3c4z_A          266 IMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG  342 (543)
T ss_dssp             CCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             eccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence            99999999998754   34699999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ..+..+.........       
T Consensus       343 ~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~~~~-------  412 (543)
T 3c4z_A          343 QT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQAVTY-------  412 (543)
T ss_dssp             CC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCCCCC-------
T ss_pred             Cc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcccCC-------
Confidence            21  12334699999999999998999999999999999999999999987543211 112222211111000       


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSM-----FEVVK  850 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~ell~  850 (876)
                          +...+..+.+++.+||+.||++||++     .|+++
T Consensus       413 ----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          413 ----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                11123467899999999999999975     66654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-36  Score=332.56  Aligned_cols=253  Identities=22%  Similarity=0.266  Sum_probs=181.7

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEE--------eCCeEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFH--------SDESIF  654 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~~~~  654 (876)
                      ++.+..+.|+||.||+|.. .+++.||+|++........+.+.+|+.+++++. ||||+++++++.        .....+
T Consensus        31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~  110 (337)
T 3ll6_A           31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL  110 (337)
T ss_dssp             EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred             EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence            3444444445999999976 479999999987655455677889999999996 999999999994        334589


Q ss_pred             EEEEcCCCCCHHHHhhc--cCCcCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeCCCCCeEEccccchh
Q 002826          655 LIYEFLQMGSLGDLICR--QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +||||++ |+|.+++..  ....+++..+..++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  186 (337)
T 3ll6_A          111 LLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT  186 (337)
T ss_dssp             EEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred             EEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence            9999996 599998865  345699999999999999999999998   7  9999999999999999999999999998


Q ss_pred             hcccccccc----------ccccccccccccCcccc---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHH
Q 002826          731 IVGEAAFQS----------TMSSEYALSCYNAPEYG---YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKW  797 (876)
Q Consensus       731 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~  797 (876)
                      .........          ......||+.|+|||.+   ....++.++||||||+++|||++|+.||.......     .
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~  261 (337)
T 3ll6_A          187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-----I  261 (337)
T ss_dssp             CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred             eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-----h
Confidence            765322111          11134588999999987   56678899999999999999999999997533221     1


Q ss_pred             HHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          798 VRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       798 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                      ........  ...           .....+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       262 ~~~~~~~~--~~~-----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          262 VNGKYSIP--PHD-----------TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             ----CCCC--TTC-----------CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hcCcccCC--ccc-----------ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            11111110  000           01123678999999999999999999999999987543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.5e-36  Score=348.50  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=199.1

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-------------cCHHHHHHHHHHHhhccCccccce
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-------------QSSKTLKTEVKTLAKIRHKNIVKV  643 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~  643 (876)
                      .+...|.....+|.|+ ||+||+|... +++.||+|++.....             ...+.+.+|+.++++++||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~-~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGA-YGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             CGGGTEEEEEEEEC---CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcccceEEEeEecccC-CeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3444555556666655 9999999764 689999999965321             234678899999999999999999


Q ss_pred             eeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC---C
Q 002826          644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF---E  720 (876)
Q Consensus       644 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~---~  720 (876)
                      ++++.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++   .
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999999987654 699999999999999999999999   999999999999998765   6


Q ss_pred             eEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 002826          721 PKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       721 ~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~  800 (876)
                      +||+|||+++......   ......||+.|+|||++. +.++.++||||+||++|+|++|++||.......  ....+..
T Consensus       188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~  261 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVEK  261 (504)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc
Confidence            9999999998765432   233456899999999876 468999999999999999999999998754332  2222221


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .   .   . .++..   .+...+..+.+++.+|++.||++|||+.|+++.
T Consensus       262 ~---~---~-~~~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          262 G---K---Y-YFDFN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             C---C---C-CCCHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             C---C---C-CCCcc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1   0   0 00111   111223468899999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.7e-36  Score=345.29  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      .|.....+|.|+ ||+||+|... +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        27 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           27 RYKGQRVLGKGS-FGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ceEEeeEEecCC-CEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            344444455554 9999999765 89999999996543   245678999999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---CCCCCeEEccccchhhccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---DADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---~~~~~~kl~DfGla~~~~~  734 (876)
                      ||+.+|+|.+++.... .+++..+..++.|++.|++|||+.   +|+||||||+||++   +.++.+||+|||+++....
T Consensus       106 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          106 EVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             CCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            9999999999987654 689999999999999999999999   99999999999999   4678999999999987764


Q ss_pred             cccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      ...   .....||+.|+|||++.+ .++.++||||+||++|+|++|++||.......  ....+...      ......+
T Consensus       182 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~------~~~~~~~  249 (484)
T 3nyv_A          182 SKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKKVEKG------KYTFELP  249 (484)
T ss_dssp             CCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC------CCCCCSG
T ss_pred             ccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHcC------CCCCCCc
Confidence            332   233458999999998765 68999999999999999999999998654322  22222221      0111111


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..    ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       250 ~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          250 QW----KKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            11    1223467899999999999999999999874

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=328.30  Aligned_cols=259  Identities=24%  Similarity=0.302  Sum_probs=193.9

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +++....+.|+||.||+|....  .||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            3444444555599999998743  49999986532  2234567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc---cc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA---FQ  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~---~~  738 (876)
                      +++|.+++.+.+..+++..+..++.|++.|++|||+.   +|+||||||+||+++ ++.+||+|||+++......   ..
T Consensus       113 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          113 GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            9999999987776799999999999999999999999   999999999999998 6799999999987654211   11


Q ss_pred             cccccccccccccCccccCC---------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          739 STMSSEYALSCYNAPEYGYS---------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      .......|++.|+|||....         ..++.++||||||+++|||++|+.||.....+..  ...+.   ..   ..
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~---~~---~~  260 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--IWQMG---TG---MK  260 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--HHHHH---TT---CC
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHhc---cC---CC
Confidence            22334458899999998764         3578899999999999999999999986543321  11111   11   00


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                      ....+.      .....+.+++.+||+.||++|||+.|+++.|+++.++....
T Consensus       261 ~~~~~~------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~  307 (319)
T 2y4i_B          261 PNLSQI------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL  307 (319)
T ss_dssp             CCCCCS------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred             CCCCcC------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence            000000      11234789999999999999999999999999998876554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.1e-37  Score=343.97  Aligned_cols=237  Identities=19%  Similarity=0.163  Sum_probs=180.7

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHH---HHHhhccCcccccee-------eEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEV---KTLAKIRHKNIVKVL-------GFFH  648 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~~  648 (876)
                      |.....+|.|+ ||+||+|.. .+|+.||||++...   .....+.+.+|+   +.++.++|||||+++       +++.
T Consensus        75 y~~~~~lG~G~-~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~  153 (377)
T 3byv_A           75 LVRGTVLGQED-PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  153 (377)
T ss_dssp             EEEEEEEEEET-TEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEE
T ss_pred             EEEcceeecCC-CEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhh
Confidence            33344555555 999999976 57999999999743   223346788999   455555899999998       6665


Q ss_pred             eCC-----------------eEEEEEEcCCCCCHHHHhhccC------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccc
Q 002826          649 SDE-----------------SIFLIYEFLQMGSLGDLICRQD------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH  705 (876)
Q Consensus       649 ~~~-----------------~~~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H  705 (876)
                      +.+                 ..|+||||+ +|+|.+++.+.+      ..+++..+.+++.|++.||+|||+.   +|+|
T Consensus       154 ~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH  229 (377)
T 3byv_A          154 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH  229 (377)
T ss_dssp             CTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             ccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            543                 289999999 579999997642      2234688889999999999999999   9999


Q ss_pred             cccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCC-----------CCCCccchHHHHHHH
Q 002826          706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-----------KATAQMDAYSFGVVL  774 (876)
Q Consensus       706 ~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlGv~l  774 (876)
                      |||||+|||++.++.+||+|||+++..+..     .....| +.|+|||++.+.           .++.++|||||||++
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence            999999999999999999999999864331     223446 889999998876           789999999999999


Q ss_pred             HHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          775 LELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       775 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      |||++|+.||........               ..... +    .....+..+.+++.+||+.||++|||+.|+++
T Consensus       304 ~elltg~~Pf~~~~~~~~---------------~~~~~-~----~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          304 YWIWCADLPITKDAALGG---------------SEWIF-R----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHSSCCC------CC---------------SGGGG-S----SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHCCCCCcccccccc---------------hhhhh-h----hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999975432211               00000 0    00112346789999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.1e-36  Score=335.77  Aligned_cols=264  Identities=17%  Similarity=0.255  Sum_probs=199.7

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCH-----------------HHHHHHHHHHhhccCccc
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSS-----------------KTLKTEVKTLAKIRHKNI  640 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~ni  640 (876)
                      +...+.+.+....+.|+||.||+|.. +|+.||+|++........                 +.+.+|++++++++||||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            33333344444444555999999988 999999999965322111                 789999999999999999


Q ss_pred             cceeeEEEeCCeEEEEEEcCCCCCHHHH------hhcc-CCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCc
Q 002826          641 VKVLGFFHSDESIFLIYEFLQMGSLGDL------ICRQ-DFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKN  712 (876)
Q Consensus       641 v~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~N  712 (876)
                      +++++++.+.+..++||||+++++|.++      +.+. ...+++..+..++.|++.|++|||+ .   +|+||||||+|
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            9999999999999999999999999998      6543 4679999999999999999999999 8   99999999999


Q ss_pred             eeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCC-CCCC-ccchHHHHHHHHHHHhCCCCCCCCCcc
Q 002826          713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-KATA-QMDAYSFGVVLLELITGRQAEQAEPAE  790 (876)
Q Consensus       713 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlGv~l~elltg~~p~~~~~~~  790 (876)
                      |+++.++.+||+|||.++.....    ......|+..|+|||...+. .++. ++||||+|+++|||++|+.||......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred             EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence            99999999999999999876443    23344589999999998876 5555 899999999999999999999875542


Q ss_pred             hhhHHHHHHHHh-hcccccccccCh----hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          791 SLDVVKWVRRKI-NITNGAIQVLDP----KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       791 ~~~~~~~~~~~~-~~~~~~~~~~d~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .. ....+.... ...........+    ............+.+++.+||+.||++|||+.|+++
T Consensus       259 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            21 122111110 000000000000    000011223456889999999999999999999987

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-36  Score=324.98  Aligned_cols=242  Identities=20%  Similarity=0.256  Sum_probs=191.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||+||+|... +++.||+|++.....  .....+.+|+..+..+ +||||+++++++.+++..++||
T Consensus        12 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           12 EFHELEKIGSGE-FGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhhhhhcCCC-ceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            444555566665 9999999765 899999999976432  2345778899999999 9999999999999999999999


Q ss_pred             EcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-----------------
Q 002826          658 EFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-----------------  717 (876)
Q Consensus       658 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-----------------  717 (876)
                      ||+++++|.+++.+.   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.                 
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            999999999999764   25689999999999999999999999   9999999999999984                 


Q ss_pred             --CCCeEEccccchhhccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhH
Q 002826          718 --DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDV  794 (876)
Q Consensus       718 --~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~  794 (876)
                        ...+||+|||.++......      ...||+.|+|||.+.+. .++.++||||||+++|||++|.+|+....    . 
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----~-  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----Q-  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----H-
T ss_pred             CCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----H-
Confidence              4479999999988765432      23489999999998765 56689999999999999999998764321    1 


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......   .   ....+.       ......+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~---~---~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 WHEIRQ---G---RLPRIP-------QVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHHHT---T---CCCCCS-------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHHHc---C---CCCCCC-------cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            111111   0   111111       1123457899999999999999999999863

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.1e-36  Score=334.04  Aligned_cols=258  Identities=21%  Similarity=0.264  Sum_probs=187.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC------e
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------S  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+++.||||++.....  .....+.+|+.+++.++||||+++++++...+      .
T Consensus        26 ~y~~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~  104 (371)
T 2xrw_A           26 RYQNLKPIGSGA-QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD  104 (371)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred             heeEeeeeEecC-CEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence            444455565555 999999965 4799999999975322  22356789999999999999999999997654      7


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+++ +|.+.+..   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       105 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          105 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            8999999986 78888753   588999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH------------
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR------------  800 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~------------  800 (876)
                      ....   ......||+.|+|||.+.+..++.++||||+||++|||++|+.||........ .......            
T Consensus       178 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          178 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHTTS
T ss_pred             cccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHHh
Confidence            5332   22334589999999999988899999999999999999999999987543221 1111000            


Q ss_pred             ------Hhhcccc-----cc----cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 ------KINITNG-----AI----QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ------~~~~~~~-----~~----~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                            .......     ..    ...-|............+.+++.+||+.||++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                  0000000     00    000000001122335678999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.4e-36  Score=333.07  Aligned_cols=246  Identities=21%  Similarity=0.318  Sum_probs=197.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||.||++... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus        43 y~~~~~lg~G~-~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           43 YVRGRFLGKGG-FAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEeeCC-CeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            33334455555 9999999765 688999999875422   234678899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++++|.+++.... .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus       122 ~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-  196 (335)
T 2owb_A          122 LCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-  196 (335)
T ss_dssp             CCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             cCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence            999999999987653 689999999999999999999999   999999999999999999999999999987653221 


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                       ......||..|+|||.+.+..++.++||||||+++|||++|+.||........  ......   .....    .+    
T Consensus       197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~---~~~~~----~~----  262 (335)
T 2owb_A          197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--YLRIKK---NEYSI----PK----  262 (335)
T ss_dssp             -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---TCCCC----CT----
T ss_pred             -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHHhc---CCCCC----Cc----
Confidence             12334589999999999888899999999999999999999999976543221  111111   11000    01    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         .....+.+++.+||+.||++|||+.|+++.
T Consensus       263 ---~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          263 ---HINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               112357789999999999999999999973

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.5e-36  Score=335.67  Aligned_cols=259  Identities=19%  Similarity=0.325  Sum_probs=180.3

Q ss_pred             CCCCCCCCceEEEEEEeC---CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP---SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  661 (876)
                      .+.+|.|+||+||+|+..   +++.||+|++...  .....+.+|++++++++||||+++++++..  +...|+||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            434444559999999865   5889999998643  344678899999999999999999999965  678999999997


Q ss_pred             CCCHHHHhhcc--------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee----CCCCCeEEccccch
Q 002826          662 MGSLGDLICRQ--------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL----DADFEPKLTDFALD  729 (876)
Q Consensus       662 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll----~~~~~~kl~DfGla  729 (876)
                      + +|.+++...        ...+++..+..++.||+.||+|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            5 888877532        22489999999999999999999999   99999999999999    67799999999999


Q ss_pred             hhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-------hhHHHHHHH
Q 002826          730 RIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAES-------LDVVKWVRR  800 (876)
Q Consensus       730 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-------~~~~~~~~~  800 (876)
                      +....... ........||+.|+|||++.+ ..++.++||||+||++|||++|++||.....+.       .+....+..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            87753321 122344568999999999876 458999999999999999999999997654321       111111111


Q ss_pred             Hhhcc-cccccccC--------------hhhhhh---------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          801 KINIT-NGAIQVLD--------------PKIANC---------YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       801 ~~~~~-~~~~~~~d--------------~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..... ......+.              ......         .......+.+++.+||+.||++|||+.|+++.
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11100 00000000              000000         00013467899999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.2e-36  Score=327.42  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=193.0

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--------cCHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--------QSSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      .+...|.....+|.|+ ||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGA-CGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCC-CEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence            3444555555566655 9999999664 689999999864321        12245789999999999999999999987


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC---eEEcc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE---PKLTD  725 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~---~kl~D  725 (876)
                      .++ .|+||||+++++|.+++... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+|
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            654 89999999999999998754 4789999999999999999999999   9999999999999987654   99999


Q ss_pred             ccchhhccccccccccccccccccccCcccc---CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYG---YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      ||+++.......   .....||+.|+|||.+   ....++.++||||||+++|||++|+.||........ ....+... 
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~-  235 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSG-  235 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHT-
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhC-
Confidence            999987654321   2234589999999986   356688999999999999999999999976443322 22222111 


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                           ... ..+..   +......+.+++.+||+.||++|||+.|+++
T Consensus       236 -----~~~-~~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 -----KYN-FIPEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -----CCC-CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----ccc-cCchh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                 000 11111   1223456789999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.1e-36  Score=338.61  Aligned_cols=197  Identities=24%  Similarity=0.330  Sum_probs=166.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc------cCccccceeeEEEeCCeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI------RHKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~~  654 (876)
                      .|.....+|.|+ ||+||+|.. .+++.||||++... ......+.+|+.+++.+      +|+||+++++++...+..+
T Consensus        98 ry~~~~~LG~G~-fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  175 (429)
T 3kvw_A           98 RYEVLKVIGKGS-FGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC  175 (429)
T ss_dssp             TEEEEEEEEESS-SEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred             cEEEEEEcccCc-cEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence            444445555555 999999965 46899999998643 23345677899988888      4679999999999999999


Q ss_pred             EEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC--eEEccccchhh
Q 002826          655 LIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE--PKLTDFALDRI  731 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~--~kl~DfGla~~  731 (876)
                      +||||++ ++|.+++.... ..+++..+.+++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||+++.
T Consensus       176 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          176 MTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999997 59999987653 4589999999999999999999999   9999999999999999887  99999999976


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA  789 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~  789 (876)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus       252 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          252 EHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            5432     2234589999999999888899999999999999999999999987544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-36  Score=329.15  Aligned_cols=256  Identities=25%  Similarity=0.324  Sum_probs=180.1

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ....+|. |+||.||+|.. .+++.||+|++.... ....+++.+|++++++++||||+++++++...+..++||||+++
T Consensus        19 ~~~~lg~-G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   97 (303)
T 2vwi_A           19 LQEVIGS-GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG   97 (303)
T ss_dssp             EEEECC----CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred             hhheecc-ccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccC
Confidence            3344555 45999999975 478999999886433 23346788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhc-------cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          663 GSLGDLICR-------QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       663 gsL~~~l~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ++|.+++..       ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999999864       244689999999999999999999999   9999999999999999999999999999876532


Q ss_pred             cc---ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc-c
Q 002826          736 AF---QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI-Q  810 (876)
Q Consensus       736 ~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~  810 (876)
                      ..   ........||+.|+|||...+ ..++.++||||||+++|||++|+.||.......... ..   ......... .
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~---~~~~~~~~~~~  250 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-LT---LQNDPPSLETG  250 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-HH---HTSSCCCTTC-
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-HH---hccCCCccccc
Confidence            21   111233458999999998765 468899999999999999999999998755433211 11   111100000 0


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ..++.   ........+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          251 VQDKE---MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             ----C---CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccch---hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            00111   111223467899999999999999999999873

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=324.36  Aligned_cols=248  Identities=17%  Similarity=0.258  Sum_probs=191.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC----ccCHHHHHHHHHHHhhccCccccceeeEEE--eCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG----CQSSKTLKTEVKTLAKIRHKNIVKVLGFFH--SDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l  655 (876)
                      |.....+|.| +||.||+|... +++.||+|++....    ......+.+|++++++++||||+++++++.  +.+..++
T Consensus         7 y~i~~~lg~G-~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (305)
T 2wtk_C            7 YLMGDLLGEG-SYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM   85 (305)
T ss_dssp             BCCCCEEEEC-SSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred             eeEeeEEecC-CCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence            3344445554 49999999764 78999999996532    233567899999999999999999999984  4568999


Q ss_pred             EEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          656 IYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      ||||++++ +.+++... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            99999886 77776543 45799999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccccccccccccccccCccccCCCC--CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSKK--ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      ...........||+.|+|||...+..  .+.++||||+|+++|||++|+.||.......  ....+.   ...   .. +
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~---~~~---~~-~  232 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LFENIG---KGS---YA-I  232 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH---HCC---CC-C
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HHHHHh---cCC---CC-C
Confidence            33223334456899999999887543  3779999999999999999999998644321  111111   111   00 0


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .       ......+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          233 P-------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             C-------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             C-------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0       1123357899999999999999999999974

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.2e-35  Score=323.09  Aligned_cols=306  Identities=20%  Similarity=0.301  Sum_probs=162.8

Q ss_pred             ccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcC
Q 002826           95 VCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP  174 (876)
Q Consensus        95 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  174 (876)
                      +.++++|++|++++|.+... | .+..+++|++|+|++|.          +++. |. +..+++|++|+|++|++++.  
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~----------i~~~-~~-~~~l~~L~~L~L~~n~i~~~--  103 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQ----------ITDI-SP-LSNLVKLTNLYIGTNKITDI--  103 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSC----------CCCC-GG-GTTCTTCCEEECCSSCCCCC--
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCc----------cccc-hh-hhcCCcCCEEEccCCcccCc--
Confidence            34566777777777766553 2 26666666655444433          3322 22 66666666666666666532  


Q ss_pred             ccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccc
Q 002826          175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL  254 (876)
Q Consensus       175 ~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  254 (876)
                      ..|.++++|++|+|++|+  +..+|. +..+++|++|++++|...... ..+..+++|++|++++|.++ .++.  +..+
T Consensus       104 ~~~~~l~~L~~L~l~~n~--i~~~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~-~~~~--~~~l  176 (347)
T 4fmz_A          104 SALQNLTNLRELYLNEDN--ISDISP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK-DVTP--IANL  176 (347)
T ss_dssp             GGGTTCTTCSEEECTTSC--CCCCGG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCC-CCGG--GGGC
T ss_pred             hHHcCCCcCCEEECcCCc--ccCchh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcC-Cchh--hccC
Confidence            246666666666666665  334433 555555555555555433322 22555555555555555555 2322  2335


Q ss_pred             ccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEe
Q 002826          255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRA  334 (876)
Q Consensus       255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  334 (876)
                      ++|++|++++|++++..+  +..+++|+.|++++|.+++..+                          +..+++|+.|++
T Consensus       177 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--------------------------~~~~~~L~~L~l  228 (347)
T 4fmz_A          177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--------------------------VANMTRLNSLKI  228 (347)
T ss_dssp             TTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--------------------------GGGCTTCCEEEC
T ss_pred             CCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--------------------------hhcCCcCCEEEc
Confidence            555555555555543222  4444444444444444443222                          344444444444


Q ss_pred             cCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccC
Q 002826          335 ESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       335 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                      ++|++++..+  +..+++|++|++++|++++.  ..+..+++|+.|++++|.+++.  +.+..+++|+.|++++|++++.
T Consensus       229 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~  302 (347)
T 4fmz_A          229 GNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNE  302 (347)
T ss_dssp             CSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGG
T ss_pred             cCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCc
Confidence            4444443322  44445555555555555432  2345555555555555555543  2355566666666666666655


Q ss_pred             Cc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc
Q 002826          415 IP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       415 ~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      .+ .+..+++|++|+|++|++++..|  +..+++|++||+++|.|+
T Consensus       303 ~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          303 DMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             GHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            54 46666777777777777765544  666777777777777664

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5e-36  Score=321.56  Aligned_cols=248  Identities=20%  Similarity=0.297  Sum_probs=180.3

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |.....+|.|| ||+||+|.. .+|+.||+|++.......  .+.+.++...++.++||||+++++++.+++..++||||
T Consensus         9 y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~   87 (290)
T 3fme_A            9 LEPIMELGRGA-YGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL   87 (290)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred             hhhHHhcCCCC-CeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence            33445555555 999999976 589999999996542211  22344555568888999999999999999999999999


Q ss_pred             CCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          660 LQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       660 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      +++ +|.+++..   .+..+++..+..++.|++.|++|||+.  .+|+||||||+||+++.++.+||+|||+++......
T Consensus        88 ~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  164 (290)
T 3fme_A           88 MDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV  164 (290)
T ss_dssp             CSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----------
T ss_pred             hcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc
Confidence            985 88887754   356799999999999999999999985  289999999999999999999999999998765432


Q ss_pred             cccccccccccccccCcccc----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYG----YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .   .....||+.|+|||.+    ....++.++||||+|+++|||++|+.||.................   .   ....
T Consensus       165 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~---~~~~  235 (290)
T 3fme_A          165 A---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP---S---PQLP  235 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC---C---CCCC
T ss_pred             c---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC---C---CCcc
Confidence            2   2233589999999995    556788999999999999999999999986444333222221111   0   0000


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .       ......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~-------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          236 A-------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             T-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             c-------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            0       112345789999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4e-36  Score=332.88  Aligned_cols=256  Identities=23%  Similarity=0.343  Sum_probs=179.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC------Ce
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  652 (876)
                      .|.....+|.|+ ||.||+|.. .+|+.||||++.....  .....+.+|+++++.++||||+++++++...      ..
T Consensus        30 ~y~~~~~lG~G~-~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           30 RYQNLSPVGSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TEEEEEECC-----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEeeEEeecC-CeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            444445555555 999999964 5799999999865322  2345778999999999999999999998654      56


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+|+||+ +++|.+++..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            89999998 6799998865  4699999999999999999999999   9999999999999999999999999999875


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc-ccc--
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT-NGA--  808 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~--  808 (876)
                      ...     .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......  ....+....... ...  
T Consensus       183 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~~  255 (367)
T 2fst_X          183 ADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK  255 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHT
T ss_pred             ccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence            432     233458999999999876 678999999999999999999999998654322  111111111000 000  


Q ss_pred             --------------ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 --------------IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 --------------~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                    .......+..........+.+++.+||+.||++|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                          0000001111112224568899999999999999999999874

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.4e-37  Score=339.35  Aligned_cols=251  Identities=13%  Similarity=0.069  Sum_probs=177.2

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---cCHHHHHHHHHHHhhc--cCcccccee-------eEEEe
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---QSSKTLKTEVKTLAKI--RHKNIVKVL-------GFFHS  649 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~~~  649 (876)
                      |.....+|.|| ||+||+|... +|+.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++..
T Consensus        64 y~~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~  142 (371)
T 3q60_A           64 LKLVEPLRVGD-RSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV  142 (371)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred             eeeeeeccCCC-CEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence            44445566655 9999999764 899999999987543   2235677886555555  599988755       45443


Q ss_pred             C-----------------CeEEEEEEcCCCCCHHHHhhccCCcCCHHHH------HHHHHHHHHHHHHhhccCCCCcccc
Q 002826          650 D-----------------ESIFLIYEFLQMGSLGDLICRQDFQLQWSIR------LKIAIGVAQGLAYLHKDYVPHLLHR  706 (876)
Q Consensus       650 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i~H~  706 (876)
                      .                 ...|+||||++ |+|.+++...+..+++..+      ..++.|++.||+|||+.   +|+||
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr  218 (371)
T 3q60_A          143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG  218 (371)
T ss_dssp             TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence            3                 33899999999 7999999875445566666      78889999999999999   99999


Q ss_pred             ccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCC
Q 002826          707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAE  784 (876)
Q Consensus       707 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~  784 (876)
                      ||||+|||++.++.+||+|||+++..+...     ....+|+.|+|||.+.+  ..++.++|||||||++|||++|+.||
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998765322     13346689999999887  67899999999999999999999999


Q ss_pred             CCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          785 QAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..........  +..... ..........+.    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          294 GLVTPGIKGS--WKRPSL-RVPGTDSLAFGS----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TBCCTTCTTC--CCBCCT-TSCCCCSCCCTT----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCcCcccccc--hhhhhh-hhccccccchhh----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            8754322100  000000 000000000111    1122446789999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.2e-36  Score=332.77  Aligned_cols=255  Identities=20%  Similarity=0.266  Sum_probs=189.0

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC-----------
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----------  650 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----------  650 (876)
                      |.....+|.| +||+||+|.. .+|+.||+|++....    ....+|+++++.++||||+++++++...           
T Consensus         9 y~~~~~lG~G-~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            9 YSLGKTLGTG-SFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             EEEEEEEECC--CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             EEEEEEEEec-cCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            3334445554 5999999965 589999999986542    2234799999999999999999998543           


Q ss_pred             ---------------------------CeEEEEEEcCCCCCHHHHhhc---cCCcCCHHHHHHHHHHHHHHHHHhhccCC
Q 002826          651 ---------------------------ESIFLIYEFLQMGSLGDLICR---QDFQLQWSIRLKIAIGVAQGLAYLHKDYV  700 (876)
Q Consensus       651 ---------------------------~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  700 (876)
                                                 ...++||||+++ +|.+.+..   .+..+++..+..++.|++.||+|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                       348899999985 88777753   356799999999999999999999999  


Q ss_pred             CCccccccccCceeeC-CCCCeEEccccchhhccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHH
Q 002826          701 PHLLHRNVKSKNILLD-ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELI  778 (876)
Q Consensus       701 ~~i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~ell  778 (876)
                       +|+||||||+||+++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++||||+||++|||+
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  236 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI  236 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHH
Confidence             999999999999997 68899999999998765432   22334578999999988764 4899999999999999999


Q ss_pred             hCCCCCCCCCcchhhHHHHHHHHhhcc--------cccc-----cccChhhh-hhcHHHHHHHHHHHHHccCCCCCCCCC
Q 002826          779 TGRQAEQAEPAESLDVVKWVRRKINIT--------NGAI-----QVLDPKIA-NCYQQQMLGALEIALRCTSVMPEKRPS  844 (876)
Q Consensus       779 tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~-----~~~d~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs  844 (876)
                      +|++||......+ .....+.......        ....     ......+. ......+..+.+++.+||+.||++|||
T Consensus       237 ~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          237 LGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             hCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            9999998754332 2222221110000        0000     00000111 111123456889999999999999999


Q ss_pred             HHHHHH
Q 002826          845 MFEVVK  850 (876)
Q Consensus       845 ~~ell~  850 (876)
                      +.|+++
T Consensus       316 ~~e~l~  321 (383)
T 3eb0_A          316 PYEAMA  321 (383)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.5e-35  Score=317.51  Aligned_cols=253  Identities=23%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc---------cCHHHHHHHHHHHhhcc-CccccceeeE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC---------QSSKTLKTEVKTLAKIR-HKNIVKVLGF  646 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~  646 (876)
                      .+..+|.....+|.|+ ||.||+|... +|+.||+|++.....         ...+.+.+|++++++++ ||||++++++
T Consensus        14 ~~~~~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           14 GFYENYEPKEILGRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             -CTTTEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             chhhccceeeeecCCC-ceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            3334555555566655 9999999765 789999999975431         11346778999999995 9999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      +.+++..++||||+++++|.+++... ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence            99999999999999999999999765 3689999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHH
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGY------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~  800 (876)
                      |+++......   ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.......  .......
T Consensus       169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~  243 (298)
T 1phk_A          169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--MLRMIMS  243 (298)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HHHHHhc
Confidence            9998765432   223345899999999864      4567889999999999999999999997643322  1111111


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .      ......+..    ...+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~------~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          244 G------NYQFGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             T------CCCCCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             C------CcccCcccc----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1      011111111    122346789999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-35  Score=329.15  Aligned_cols=262  Identities=21%  Similarity=0.309  Sum_probs=196.3

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  654 (876)
                      .|.....+|.|| ||.||+|.. .+++.||+|++..... .....+.+|++++++++||||+++++++...     ...|
T Consensus        28 ~y~~~~~lG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  106 (364)
T 3qyz_A           28 RYTNLSYIGEGA-YGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY  106 (364)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             cEEEEEEeecCC-CeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence            444445555555 999999965 4789999999975332 2236788999999999999999999999764     4689


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+++ +|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       107 iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          107 IVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             EEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            99999985 999998654  589999999999999999999999   999999999999999999999999999987654


Q ss_pred             cccc-cccccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc-ccccc
Q 002826          735 AAFQ-STMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN-GAIQV  811 (876)
Q Consensus       735 ~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  811 (876)
                      .... .......||+.|+|||.+. ...++.++||||+||++|||++|++||........ ............. .....
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHHHHh
Confidence            3221 2234456899999999765 44589999999999999999999999987554332 1111110000000 00000


Q ss_pred             c---------------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          812 L---------------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       812 ~---------------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .               ..............+.+++.+|++.||++|||+.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0               000111112234568899999999999999999999873

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.8e-35  Score=349.95  Aligned_cols=306  Identities=18%  Similarity=0.179  Sum_probs=196.0

Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG  217 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~  217 (876)
                      |++++|.+....+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|                         .
T Consensus        56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-------------------------~  110 (597)
T 3oja_B           56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN-------------------------A  110 (597)
T ss_dssp             EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSS-------------------------C
T ss_pred             EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCC-------------------------c
Confidence            344444554444444555555666666666555555555555555555555555                         4


Q ss_pred             CcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCC
Q 002826          218 FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPG  297 (876)
Q Consensus       218 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~  297 (876)
                      +++..|..|.++++|++|+|++|.|+ .+|..++..+++|++|+|++|++++..|..|..+++|++|+|++|.+++.   
T Consensus       111 l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---  186 (597)
T 3oja_B          111 IRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---  186 (597)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---
T ss_pred             CCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---
Confidence            55555555556666666666666665 55555545566666666666666655555566666666666666666543   


Q ss_pred             CCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCc
Q 002826          298 SINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSL  377 (876)
Q Consensus       298 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  377 (876)
                      .+..+++|+.|++++|.+++     +...++|+.|++++|.++...+..   .++|+.|+|++|.+++  +..+..+++|
T Consensus       187 ~~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L  256 (597)
T 3oja_B          187 DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGL  256 (597)
T ss_dssp             CGGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTC
T ss_pred             ChhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCC
Confidence            24445566666666666653     233456777777777776544332   2578888888888875  3667778888


Q ss_pred             cEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCc
Q 002826          378 YRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       378 ~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      +.|++++|.+++..|..|..+++|+.|+|++|.+++.+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.
T Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~  335 (597)
T 3oja_B          257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNS  335 (597)
T ss_dssp             SEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSC
T ss_pred             CEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCC
Confidence            8888888888877777788888888888888888776556666777777777777777 566667777777777777777


Q ss_pred             ccccCCCcccccccceEEccCCccccccCCcccCCCCCccccCCCCCCCC
Q 002826          458 LTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGP  507 (876)
Q Consensus       458 l~~~~p~~~~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~  507 (876)
                      |++.                        |...+.++..+.+.+|||.|++
T Consensus       336 l~~~------------------------~~~~~~~L~~L~l~~N~~~~~~  361 (597)
T 3oja_B          336 IVTL------------------------KLSTHHTLKNLTLSHNDWDCNS  361 (597)
T ss_dssp             CCCC------------------------CCCTTCCCSEEECCSSCEEHHH
T ss_pred             CCCc------------------------ChhhcCCCCEEEeeCCCCCChh
Confidence            7643                        2222345566788888888865

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.7e-35  Score=321.60  Aligned_cols=268  Identities=19%  Similarity=0.287  Sum_probs=199.5

Q ss_pred             ccccCCCCCCCCceEEEEEEe--CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhc---cCccccceeeEEE-----eC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL--PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKI---RHKNIVKVLGFFH-----SD  650 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~  650 (876)
                      |.....+|.|+ ||.||+|..  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.     ..
T Consensus        13 y~~~~~lg~G~-~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           13 YECVAEIGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             eeeeeeecccc-cEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            44445555555 999999976  4688999999864322  2234677888888777   7999999999987     45


Q ss_pred             CeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      ...++||||++ |+|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCccc
Confidence            67999999998 5999999765 34589999999999999999999999   9999999999999999999999999999


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-ccccc
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-ITNGA  808 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  808 (876)
                      +......   ......||..|+|||...+..++.++||||||+++|||++|+.||........ .......... .....
T Consensus       168 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGS
T ss_pred             ccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHcCCCCcccC
Confidence            8765322   23345589999999999888899999999999999999999999986543221 1111111100 00000


Q ss_pred             c-----------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhcccCC
Q 002826          809 I-----------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLSTRT  859 (876)
Q Consensus       809 ~-----------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~~~  859 (876)
                      .           .................+.+++.+||+.||++|||+.|+++.  ++++....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~  307 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK  307 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence            0           000011112222334567899999999999999999999953  55554433

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-35  Score=320.06  Aligned_cols=251  Identities=23%  Similarity=0.364  Sum_probs=188.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe-----------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-----------  649 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----------  649 (876)
                      +|.....+|.|+ ||.||+|+. .+|+.||+|++... ....+.+.+|++++++++||||+++++++.+           
T Consensus         7 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            7 DFEEIAVLGQGA-FGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cchhhheeccCC-cEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            454555566665 999999976 48999999998643 2334678899999999999999999998865           


Q ss_pred             --CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          650 --DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       650 --~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                        .+..++||||+++++|.+++......+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  161 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFG  161 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCc
Confidence              3568999999999999999987777789999999999999999999999   99999999999999999999999999


Q ss_pred             chhhcccccc------------ccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhH
Q 002826          728 LDRIVGEAAF------------QSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDV  794 (876)
Q Consensus       728 la~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~  794 (876)
                      +++.......            ........||+.|+|||.+.+. .++.++||||+|+++|||++   ||.... +.   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-~~---  234 (303)
T 1zy4_A          162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-ER---  234 (303)
T ss_dssp             CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-HH---
T ss_pred             chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-hH---
Confidence            9987642210            1122344588999999998754 68999999999999999998   443211 11   


Q ss_pred             HHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          795 VKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...........    ..+.+.   ........+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          235 VNILKKLRSVS----IEFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHHHSTT----CCCCTT---CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHhccccc----cccCcc---ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            11111111111    011111   112233457899999999999999999999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.9e-36  Score=355.77  Aligned_cols=246  Identities=20%  Similarity=0.260  Sum_probs=198.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      +|.....+|.|+ ||.||+|+.. +++.||||++.+.   .....+.+..|..++..+ +||+|+++++++.+.+..|+|
T Consensus       342 ~f~~~~~LG~G~-fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          342 DFNFLMVLGKGS-FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TEEEEEESSBTT-TBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             ceEEEEEEccCC-CEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            344445566655 9999999764 7899999999753   224456778899999988 799999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       421 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  496 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  496 (674)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT
T ss_pred             EeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC
Confidence            99999999999998754 699999999999999999999999   99999999999999999999999999998643222


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     ..+.........        
T Consensus       497 --~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~~~~--------  561 (674)
T 3pfq_A          497 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIMEHNVAY--------  561 (674)
T ss_dssp             --CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHSSCCCC--------
T ss_pred             --cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-----HHHHHHhCCCCC--------
Confidence              12334569999999999999999999999999999999999999998754332     111111111001        


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSM-----FEVVK  850 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~ell~  850 (876)
                         +.....++.+++.+||+.||++||++     +||++
T Consensus       562 ---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          562 ---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               11223467899999999999999997     66664

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-35  Score=321.71  Aligned_cols=250  Identities=16%  Similarity=0.211  Sum_probs=188.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhcc--CccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIR--HKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|. |+||.||+|...+++.||+|++.....  ...+.+.+|++++++++  ||||+++++++.+++..++|||
T Consensus        30 y~~~~~lg~-G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           30 YSILKQIGS-GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEC-CSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             EEEEEEecC-CCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            333444555 459999999888899999999965432  23467889999999997  5999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                       +.+++|.+++.+.. .+++..+..++.|++.||+|||+.   +|+||||||+||++++ +.+||+|||+++........
T Consensus       109 -~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          109 -CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             -CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             -cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence             56789999997654 789999999999999999999999   9999999999999964 89999999999877543322


Q ss_pred             cccccccccccccCccccCC-----------CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          739 STMSSEYALSCYNAPEYGYS-----------KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      .......|++.|+|||....           ..++.++||||||+++|||++|+.||.............    ....  
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~--  256 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI----IDPN--  256 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH----HCTT--
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH----Hhcc--
Confidence            22334568999999998765           467889999999999999999999997644322211111    1100  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL  852 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L  852 (876)
                      ..    .....   .....+.+++.+||+.||++|||+.|+++.-
T Consensus       257 ~~----~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          257 HE----IEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             SC----CCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cc----cCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            00    00001   1123578999999999999999999999753

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.3e-35  Score=323.82  Aligned_cols=264  Identities=21%  Similarity=0.305  Sum_probs=200.1

Q ss_pred             hhhhhhcccccCCCCCCCCceEEEEEEe--CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCcc------ccceeeEE
Q 002826          576 EHDLVIGMDEKSSAGNGGPFGRVYILSL--PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN------IVKVLGFF  647 (876)
Q Consensus       576 ~~~l~~~~~~~~~~g~~g~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~  647 (876)
                      .++...+.|++.+..|.|+||+||+|..  .+++.||+|++.... ...+.+.+|+++++.++|++      ++++++++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            3444444444444445555999999965  378999999986432 33467889999999998765      99999999


Q ss_pred             EeCCeEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---------
Q 002826          648 HSDESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---------  717 (876)
Q Consensus       648 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---------  717 (876)
                      .+.+..++||||+ +++|.+++.+.+ ..+++..+.+++.|++.||+|||+.   +|+||||||+||+++.         
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999 789999997663 4689999999999999999999999   9999999999999987         


Q ss_pred             ----------CCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Q 002826          718 ----------DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAE  787 (876)
Q Consensus       718 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~  787 (876)
                                ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                      678999999999765432     22345899999999999888999999999999999999999999865


Q ss_pred             CcchhhHHHHHHHHh-hccccccc------c---------------------cCh--hhhhhcHHHHHHHHHHHHHccCC
Q 002826          788 PAESLDVVKWVRRKI-NITNGAIQ------V---------------------LDP--KIANCYQQQMLGALEIALRCTSV  837 (876)
Q Consensus       788 ~~~~~~~~~~~~~~~-~~~~~~~~------~---------------------~d~--~~~~~~~~~~~~~~~li~~cl~~  837 (876)
                      ....  ....+.... ..+.....      .                     ..+  ........+...+.+++.+||+.
T Consensus       238 ~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          238 DSKE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             CHHH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             ChHH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence            4332  112111111 00000000      0                     000  00011223456789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 002826          838 MPEKRPSMFEVVKA  851 (876)
Q Consensus       838 dP~~RPs~~ell~~  851 (876)
                      ||++|||+.|+++.
T Consensus       316 dP~~Rpt~~ell~h  329 (339)
T 1z57_A          316 DPAKRITLREALKH  329 (339)
T ss_dssp             STTTSCCHHHHTTS
T ss_pred             CcccccCHHHHhcC
Confidence            99999999999864

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.7e-36  Score=358.15  Aligned_cols=255  Identities=22%  Similarity=0.346  Sum_probs=198.9

Q ss_pred             cccCCCCCCCCceEEEEEEeC----CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          584 DEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ++..+..|.|+||.||+|...    .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ++..++|||
T Consensus       392 y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E  470 (656)
T 2j0j_A          392 IELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME  470 (656)
T ss_dssp             EEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             EEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEE
Confidence            334444444559999999764    356799999865322 22367889999999999999999999985 456899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       471 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~  547 (656)
T 2j0j_A          471 LCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  547 (656)
T ss_dssp             CCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred             cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence            9999999999987766799999999999999999999999   9999999999999999999999999999877543321


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......+|+.|+|||.+....++.++||||||+++|||++ |..||.......  ....+......      ...    
T Consensus       548 -~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~~------~~~----  614 (656)
T 2j0j_A          548 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGERL------PMP----  614 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCCC------CCC----
T ss_pred             -eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCCC------CCC----
Confidence             2233446788999999988889999999999999999997 999998654332  22222211100      011    


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                         ...+..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       615 ---~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          615 ---PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence               11234678999999999999999999999999998643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-35  Score=326.46  Aligned_cols=265  Identities=20%  Similarity=0.291  Sum_probs=187.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCe-------E
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES-------I  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------~  653 (876)
                      +|.....+|. |+||+||+|... +|+.||||++.... .......+|++.++.++||||+++++++...+.       .
T Consensus        24 ~y~~~~~lg~-G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           24 RFQVERMAGQ-GTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TEEEC-----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ceEEEEEEec-CCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            3444444554 559999999764 79999999986543 334566778888999999999999999976443       8


Q ss_pred             EEEEEcCCCCCHHHHhh---ccCCcCCHHHHHHHHHHHHHHHHHhh--ccCCCCccccccccCceeeCC-CCCeEEcccc
Q 002826          654 FLIYEFLQMGSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLH--KDYVPHLLHRNVKSKNILLDA-DFEPKLTDFA  727 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfG  727 (876)
                      ++||||+++ ++.+.+.   .....+++..+..++.|++.|+.|||  +.   +|+||||||+||+++. ++.+||+|||
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence            899999987 5554443   23457899999999999999999999  77   9999999999999996 8999999999


Q ss_pred             chhhccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      +++.......   .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .....+.......
T Consensus       178 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~  253 (360)
T 3e3p_A          178 SAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVLGCPSR  253 (360)
T ss_dssp             TCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCH
T ss_pred             CceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHcCCCCH
Confidence            9987654332   2334589999999988654 489999999999999999999999987543321 2222221100000


Q ss_pred             ccccccCh-----------------hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhcc
Q 002826          807 GAIQVLDP-----------------KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLS  856 (876)
Q Consensus       807 ~~~~~~d~-----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~  856 (876)
                      .....+++                 .+..........+.+++.+||+.||++|||+.|+++.  ++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence            00000000                 0001111235678999999999999999999999974  44443

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=324.32  Aligned_cols=247  Identities=24%  Similarity=0.350  Sum_probs=189.0

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe------CCeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS------DESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~  654 (876)
                      |.....+|.|+ ||.||+|.. .+|+.||+|++.... .....+.+|+.+++++ +||||+++++++..      .+..+
T Consensus        26 y~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~  103 (326)
T 2x7f_A           26 FELVELVGNGT-YGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW  103 (326)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred             EEEEEEeccCC-CEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence            33444455555 999999976 479999999987543 4567889999999999 79999999999987      46899


Q ss_pred             EEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcc
Q 002826          655 LIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVG  733 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~  733 (876)
                      +||||+++++|.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            999999999999999764 35689999999999999999999999   99999999999999999999999999988765


Q ss_pred             ccccccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccc
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGA  808 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  808 (876)
                      ....  ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||........  ......   ..  .
T Consensus       181 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~---~~--~  251 (326)
T 2x7f_A          181 RTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA--LFLIPR---NP--A  251 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHH---SC--C
T ss_pred             cCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH--HHHhhc---Cc--c
Confidence            3221  123345899999999876     56688999999999999999999999976443221  111111   10  0


Q ss_pred             ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          809 IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       809 ~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .....+       .....+.+++.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          252 PRLKSK-------KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CCCSCS-------CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccCCcc-------ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            000011       11236789999999999999999999987

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=1.1e-34  Score=319.81  Aligned_cols=302  Identities=23%  Similarity=0.327  Sum_probs=225.6

Q ss_pred             EEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCC
Q 002826           76 TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGS  155 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~  155 (876)
                      .+..+++.++++... + .+..+++|++|+|++|.+++..+  +..+++|++|+|++|.+          ++ + +.|..
T Consensus        45 ~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i----------~~-~-~~~~~  108 (347)
T 4fmz_A           45 SITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI----------TD-I-SALQN  108 (347)
T ss_dssp             TCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC----------CC-C-GGGTT
T ss_pred             cccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcc----------cC-c-hHHcC
Confidence            456788888888653 3 48899999999999999998655  99999999887776655          33 2 35899


Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      +++|++|+|++|++++..+  +.++++|++|++++|.. .. .+..+..+++|++|++++|.+.+..+  +..+++|++|
T Consensus       109 l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~-~~-~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L  182 (347)
T 4fmz_A          109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHN-LS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL  182 (347)
T ss_dssp             CTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTT-CC-CCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred             CCcCCEEECcCCcccCchh--hccCCceeEEECCCCCC-cc-cccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEE
Confidence            9999999999999996544  89999999999999972 33 34459999999999999999987654  8899999999


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      ++++|+++ .++.  +..+++|+.|++++|++++..+  +..+++|++|++++|.+++..+  +..+++|++|++++|.+
T Consensus       183 ~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l  255 (347)
T 4fmz_A          183 SLNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI  255 (347)
T ss_dssp             ECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EccCCccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCcc
Confidence            99999999 5655  4569999999999999996655  8899999999999999986554  77778888888888877


Q ss_pred             CCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCc
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNF  395 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~  395 (876)
                      ++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|.                        .|
T Consensus       256 ~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~------------------------~l  307 (347)
T 4fmz_A          256 SDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDME------------------------VI  307 (347)
T ss_dssp             CCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHH------------------------HH
T ss_pred             CCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChh------------------------Hh
Confidence            753  3466666666666666666543  2345555555555555555544444                        44


Q ss_pred             CCCCCccEEEccCCccccCCcCcccccccceEeccCCcCC
Q 002826          396 CDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLT  435 (876)
Q Consensus       396 ~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~  435 (876)
                      ..+++|+.|++++|++++.++ +..+++|++|++++|+|+
T Consensus       308 ~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          308 GGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             HTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC---
T ss_pred             hccccCCEEEccCCccccccC-hhhhhccceeehhhhccc
Confidence            445555555555555555444 555666666666666654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-35  Score=327.34  Aligned_cols=256  Identities=21%  Similarity=0.319  Sum_probs=191.4

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeE-----
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI-----  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-----  653 (876)
                      .|.....+|.|| ||+||+|.. .+|+.||+|++......  ....+.+|+.+++.++||||+++++++...+..     
T Consensus        43 ~y~~~~~lG~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           43 TYVSPTHVGSGA-YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             cEEEEeEEecCC-CeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            444455566655 999999965 47999999999754322  246788999999999999999999999876654     


Q ss_pred             -EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          654 -FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       654 -~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                       ++||||++ ++|.+++.   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       122 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             EEEEEcccc-ccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence             99999998 48888774   3589999999999999999999999   9999999999999999999999999999866


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc-
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ-  810 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  810 (876)
                      ...     .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ ................. 
T Consensus       195 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          195 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred             ccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCcHHHHHH
Confidence            432     233458999999998876 6789999999999999999999999987543221 11111110000000000 


Q ss_pred             ---------------ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          811 ---------------VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       811 ---------------~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                     .....+..........+.+++.+|++.||++|||+.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                           00011111222335678899999999999999999999875

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-35  Score=333.58  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=198.8

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc--------Ccccccee
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR--------HKNIVKVL  644 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~  644 (876)
                      +..+++..+.|++.+..|.|+||+||+|.. .+++.||||++... ....+.+.+|+++++.++        |+||++++
T Consensus        29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~  107 (397)
T 1wak_A           29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLL  107 (397)
T ss_dssp             SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred             EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence            344555555455555555555999999965 57899999998643 234567889999999996        78899999


Q ss_pred             eEEE----eCCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC
Q 002826          645 GFFH----SDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF  719 (876)
Q Consensus       645 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~  719 (876)
                      +++.    .....++||||+.+ ++.+.+.+. ...+++..+..++.|++.||+|||+++  +|+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~  184 (397)
T 1wak_A          108 DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEEEEETTEEEEEEEECCCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCH
T ss_pred             cceeecCCCCceEEEEEeccCc-cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccc
Confidence            9987    45679999999954 666655443 457999999999999999999999852  799999999999999775


Q ss_pred             -------------------------------------------------CeEEccccchhhccccccccccccccccccc
Q 002826          720 -------------------------------------------------EPKLTDFALDRIVGEAAFQSTMSSEYALSCY  750 (876)
Q Consensus       720 -------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y  750 (876)
                                                                       .+||+|||+++.....     .....||+.|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y  259 (397)
T 1wak_A          185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQY  259 (397)
T ss_dssp             HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGG
T ss_pred             hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcc
Confidence                                                             8999999999876532     2334589999


Q ss_pred             cCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh----hHHHHHHHHh-hcccc-------ccccc------
Q 002826          751 NAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL----DVVKWVRRKI-NITNG-------AIQVL------  812 (876)
Q Consensus       751 ~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~-~~~~~-------~~~~~------  812 (876)
                      +|||++.+..++.++|||||||++|||++|+.||........    .......... .....       ....+      
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            999999888899999999999999999999999986543321    1111111111 00000       00000      


Q ss_pred             ----C--h--------hhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 ----D--P--------KIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 ----d--~--------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                          +  +        ............+.+++.+||+.||++|||+.|+++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                0  0        000223556678999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=323.20  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=189.7

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEE------------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH------------  648 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------------  648 (876)
                      .|.....+|.|| ||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.            
T Consensus        12 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           12 RYMDLKPLGCGG-NGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TEEEEEECC------CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             ceeEEEEeccCC-CeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            444445555555 9999999775 59999999997655455677889999999999999999999873            


Q ss_pred             --eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEcc
Q 002826          649 --SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTD  725 (876)
Q Consensus       649 --~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~D  725 (876)
                        +.+..++||||++ |+|.+++..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++ +++.+||+|
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence              3467899999998 599999865  3689999999999999999999999   999999999999997 567999999


Q ss_pred             ccchhhcccccc-ccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh
Q 002826          726 FALDRIVGEAAF-QSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN  803 (876)
Q Consensus       726 fGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  803 (876)
                      ||+++....... ........+|..|+|||.... ..++.++||||||+++|||++|+.||........ ..........
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~  243 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ-MQLILESIPV  243 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHSCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCC
Confidence            999987653211 122334457889999998754 6789999999999999999999999987543221 1111110000


Q ss_pred             cc----ccccccc-----------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          804 IT----NGAIQVL-----------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       804 ~~----~~~~~~~-----------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..    ......+           ..............+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            00    0000000           00011111223457889999999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-35  Score=331.78  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCe------EEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~lv  656 (876)
                      |.....+|.|| ||+||+|+...+..||+|++....    ....+|+++++.++||||+++++++...+.      .++|
T Consensus        42 Y~~~~~lG~G~-~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           42 YTNCKVIGNGS-FGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             EEEeEEEeeCC-CeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            44444455555 999999998777779999886532    223479999999999999999999966433      8899


Q ss_pred             EEcCCCCCHHHHhh--ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEccccchhhcc
Q 002826          657 YEFLQMGSLGDLIC--RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDFALDRIVG  733 (876)
Q Consensus       657 ~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~  733 (876)
                      |||++++.+.....  .....+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+|||+++...
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            99998854333322  2255799999999999999999999999   999999999999999 78999999999998764


Q ss_pred             ccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh---------
Q 002826          734 EAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN---------  803 (876)
Q Consensus       734 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~---------  803 (876)
                      ....   .....||+.|+|||.+.+. .++.++||||+||++|||++|++||....... ......+....         
T Consensus       194 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          194 AGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             TTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH
T ss_pred             CCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHhh
Confidence            3321   2334589999999988664 58999999999999999999999998755332 22222221100         


Q ss_pred             ---cccccccccC-hhhh-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002826          804 ---ITNGAIQVLD-PKIA-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSL  855 (876)
Q Consensus       804 ---~~~~~~~~~d-~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i  855 (876)
                         .......... ..+. .........+.+++.+||+.||++|||+.|+++.  ++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence               0000000000 0011 1111234578899999999999999999999974  4444

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-35  Score=334.29  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=188.7

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC------CeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l  655 (876)
                      |.....+|.|+ ||+||+|... +|+.||||++....    ....+|+++++.++||||+++++++...      ...++
T Consensus        56 y~~~~~lG~G~-fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           56 YTDTKVIGNGS-FGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             EEeeeEEeeCC-CEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            44445555555 9999999775 69999999986532    2334799999999999999999998542      23679


Q ss_pred             EEEcCCCCCHHHHhh---ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-CCeEEccccchhh
Q 002826          656 IYEFLQMGSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-FEPKLTDFALDRI  731 (876)
Q Consensus       656 v~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-~~~kl~DfGla~~  731 (876)
                      ||||+++ ++.+.+.   +....+++..+..++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++.
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            9999987 6766654   2356799999999999999999999999   99999999999999965 6689999999987


Q ss_pred             ccccccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhh-------
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN-------  803 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  803 (876)
                      ......   .....||+.|+|||++.+. .++.++||||+||++|||++|++||......+ .+.+.++....       
T Consensus       207 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          207 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHH
T ss_pred             cccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            643321   2334589999999998764 68999999999999999999999998754322 22222221100       


Q ss_pred             -cccccccccChhh-----h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          804 -ITNGAIQVLDPKI-----A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       804 -~~~~~~~~~d~~~-----~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ........-.+.+     . .........+.+++.+||+.||++|||+.|+++.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence             0000000000100     0 0111224568899999999999999999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.7e-35  Score=311.93  Aligned_cols=253  Identities=23%  Similarity=0.324  Sum_probs=199.5

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeE
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESI  653 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  653 (876)
                      +++...|.....+|.|| ||.||+|... +++.||+|++....  ......+.+|++++++++||||+++++++.+.+..
T Consensus        18 ~~~~~~y~i~~~lg~G~-~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGS-FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCC-CEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            34444555556666655 9999999765 79999999996542  24567889999999999999999999999999999


Q ss_pred             EEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC---CCeEEccccchh
Q 002826          654 FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD---FEPKLTDFALDR  730 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~---~~~kl~DfGla~  730 (876)
                      ++||||+++++|.+++.... .+++..+..++.|++.|++|||+.   +++||||||+||+++.+   +.+||+|||+++
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999999886654 689999999999999999999999   99999999999999754   479999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      .......   .....|++.|+|||...+ .++.++||||+|+++|+|++|+.||.......  ....+..   ..   ..
T Consensus       173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~---~~---~~  240 (287)
T 2wei_A          173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKRVET---GK---YA  240 (287)
T ss_dssp             TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CC---CC
T ss_pred             eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc---CC---CC
Confidence            7654321   223347889999998765 48899999999999999999999997654322  1221111   10   00


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ...+..    ...+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            001111    112345789999999999999999999997

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.2e-35  Score=324.54  Aligned_cols=205  Identities=23%  Similarity=0.289  Sum_probs=166.2

Q ss_pred             hhhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-Cc-----cccceeeEEEe
Q 002826          577 HDLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HK-----NIVKVLGFFHS  649 (876)
Q Consensus       577 ~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~  649 (876)
                      ++...+.+++.+..|.|+||+||+|... +++.||||++... .....++..|+.+++.++ |+     +++++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3333334444444444559999999654 7899999999643 233456778999998885 44     49999999999


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CCCCeEEccc
Q 002826          650 DESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--ADFEPKLTDF  726 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~Df  726 (876)
                      .+..++||||+++ +|.+++.... ..+++..+..++.|++.|++|||++ ..+|+||||||+|||++  .++.+||+||
T Consensus       128 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          128 RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999999975 9999997653 4689999999999999999999952 12899999999999995  4788999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPA  789 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~  789 (876)
                      |+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus       206 G~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          206 GSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             TTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999876532     2334589999999999998999999999999999999999999987543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.6e-35  Score=319.22  Aligned_cols=259  Identities=32%  Similarity=0.468  Sum_probs=182.5

Q ss_pred             CCCcEEecccCccCC--CCCCccccccccccEEEecc-ccccCcCCcccccCCccceeeeecccccccCCCCCccccccc
Q 002826          230 QSLSILDLSQNNLTG--EVPQSLGSSLLKLVSFDVSQ-NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLE  306 (876)
Q Consensus       230 ~~L~~L~Ls~N~l~~--~ip~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  306 (876)
                      .+++.|+|++|++++  .+|..+. .+++|++|+|++ |++.+.+|..|.++++|++|+|++|.+++.+|..|..+++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~-~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhHh-CCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            467777777777776  6666554 477777777774 777777777777777777777777777777777777777777


Q ss_pred             eeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCC-CCCeeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          307 RFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAA-QLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       307 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                      +|++++|.+++.+|..+..+++|++|++++|++++.+|..+..+. +|++|++++|++++.+|..+..++ |+.|++++|
T Consensus       129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N  207 (313)
T 1ogq_A          129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRN  207 (313)
T ss_dssp             EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSS
T ss_pred             EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCC
Confidence            777777777777777777777777777777777777777777666 777777777777766777776665 777777777


Q ss_pred             cccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCc
Q 002826          386 SFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG  465 (876)
Q Consensus       386 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  465 (876)
                      .+++..|..|..+++|+.|+|++|++++.++.+..+++|++|+|++|++++.+|..|..+++|++|+|++|+++|.+|..
T Consensus       208 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~  287 (313)
T 1ogq_A          208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG  287 (313)
T ss_dssp             EEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred             cccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence            77666666666666666666666666665555666666666666666666666666666666666666666666555543


Q ss_pred             ccccccceEEccCCccccccCCcccCCCCCccccCCCCCCCCCCCCCC
Q 002826          466 LQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSC  513 (876)
Q Consensus       466 ~~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~~~~~~c  513 (876)
                       ..                     +.++..+++.+||++||.|++ .|
T Consensus       288 -~~---------------------l~~L~~l~l~~N~~lc~~p~~-~C  312 (313)
T 1ogq_A          288 -GN---------------------LQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             -TT---------------------GGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             -cc---------------------ccccChHHhcCCCCccCCCCC-CC
Confidence             11                     345677889999999998876 46

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.7e-35  Score=325.50  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=194.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  654 (876)
                      +|.....+|.|| ||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++...     ...+
T Consensus        12 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   90 (353)
T 2b9h_A           12 DFQLKSLLGEGA-YGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY   90 (353)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred             ceEEeeEEcCCC-CeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence            444445555555 9999999765 799999999964322 2245678999999999999999999998764     6799


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +||||+++ +|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        91 lv~e~~~~-~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           91 IIQELMQT-DLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             EEECCCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EEEeccCc-cHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            99999974 999998763  689999999999999999999999   999999999999999999999999999987653


Q ss_pred             cccc--------cccccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          735 AAFQ--------STMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       735 ~~~~--------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      ....        .......||+.|+|||.+. ...++.++||||+||++|||++|++||........  ...+.......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~  242 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFGIIGTP  242 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCC
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCC
Confidence            2211        1122346899999999765 46789999999999999999999999987543321  11111111000


Q ss_pred             c---ccccc---------------cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 N---GAIQV---------------LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~---~~~~~---------------~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .   .....               ...............+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0   00000               0011111122334567899999999999999999999873

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.1e-35  Score=333.57  Aligned_cols=251  Identities=19%  Similarity=0.293  Sum_probs=184.6

Q ss_pred             cccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcC
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      +++...+..|.|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.+++..|+||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            444444544555599998877778999999998652   345678999999987 8999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCc------CCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC-------------CCe
Q 002826          661 QMGSLGDLICRQDFQ------LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD-------------FEP  721 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~------l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~-------------~~~  721 (876)
                      + |+|.+++......      .++..+.+++.||+.||+|||+.   +|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 5999999765321      12334578999999999999999   99999999999999654             489


Q ss_pred             EEccccchhhccccccc--cccccccccccccCccccCC-------CCCCCccchHHHHHHHHHHHh-CCCCCCCCCcch
Q 002826          722 KLTDFALDRIVGEAAFQ--STMSSEYALSCYNAPEYGYS-------KKATAQMDAYSFGVVLLELIT-GRQAEQAEPAES  791 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~  791 (876)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++|||||||++|||+| |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999877543211  12234569999999998865       568999999999999999999 999997543322


Q ss_pred             hhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .   ..........    . . +  ..........+.+++.+||+.||++|||+.|+++
T Consensus       248 ~---~i~~~~~~~~----~-~-~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S---NIIRGIFSLD----E-M-K--CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---HHHHTCCCCC----C-C-T--TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHhcCCCCcc----c-c-c--ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   1111111110    0 0 0  0112234567889999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2e-35  Score=323.85  Aligned_cols=253  Identities=20%  Similarity=0.273  Sum_probs=169.6

Q ss_pred             hhhhcccccCC-CCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe----CC
Q 002826          578 DLVIGMDEKSS-AGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DE  651 (876)
Q Consensus       578 ~l~~~~~~~~~-~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~  651 (876)
                      ++..+|....+ +|.|| ||+||+|... +|+.||+|++...    .....+....++.++||||+++++++..    ..
T Consensus        25 ~~~~~y~i~~~~lG~G~-~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGV-NGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             CGGGTEEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccceeEecceeeeeCC-CeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            34445554455 55555 9999999765 7999999998642    2222333334566789999999999976    44


Q ss_pred             eEEEEEEcCCCCCHHHHhhccC-CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeEEcccc
Q 002826          652 SIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPKLTDFA  727 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~kl~DfG  727 (876)
                      ..++||||+++|+|.+++.+.. ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.   ++.+||+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            5899999999999999998663 4699999999999999999999999   9999999999999976   4569999999


Q ss_pred             chhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc
Q 002826          728 LDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG  807 (876)
Q Consensus       728 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  807 (876)
                      +++......    .....||+.|+|||.+....++.++||||+|+++|||++|+.||..........  .........  
T Consensus       177 ~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~--  248 (336)
T 3fhr_A          177 FAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLG--  248 (336)
T ss_dssp             TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred             cceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhcc--
Confidence            997654322    233457999999999988888999999999999999999999997654332110  000000000  


Q ss_pred             cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          808 AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       808 ~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ......+.    +......+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPE----WSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTT----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchh----hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00001111    1122346789999999999999999999998

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=332.80  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=184.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |.....+|.|| ||+||.....+|+.||||++....   ...+.+|+++++.+ +|||||++++++.+.+..|+||||++
T Consensus        26 y~~~~~LG~G~-~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           26 FCPKDVLGHGA-EGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEECG-GGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EecCCeeecCc-CEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            33444555555 999776666689999999986532   23467899999999 79999999999999999999999997


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-----CCCeEEccccchhhccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-----DFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-----~~~~kl~DfGla~~~~~~~  736 (876)
                      + +|.+++........+..+..++.|++.||+|||+.   +|+||||||+||+++.     ...+||+|||+++......
T Consensus       102 g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~  177 (432)
T 3p23_A          102 A-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR  177 (432)
T ss_dssp             E-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred             C-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence            5 99999987765666667789999999999999999   9999999999999953     3468899999998765332


Q ss_pred             c-ccccccccccccccCccccC---CCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          737 F-QSTMSSEYALSCYNAPEYGY---SKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       737 ~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      . ........||+.|+|||++.   ...++.++||||+||++|||++ |+.||.........   .   .....  ....
T Consensus       178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~---~---~~~~~--~~~~  249 (432)
T 3p23_A          178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---I---LLGAC--SLDC  249 (432)
T ss_dssp             --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH---H---HTTCC--CCTT
T ss_pred             cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH---H---HhccC--Cccc
Confidence            1 12234456999999999987   4567889999999999999999 99998654332211   1   11100  1111


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      ..+     .......+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          250 LHP-----EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             SCT-----TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCc-----cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            111     1123445789999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=9.7e-35  Score=321.08  Aligned_cols=265  Identities=19%  Similarity=0.237  Sum_probs=197.2

Q ss_pred             cchhhhhhcccccCCCCCCCCceEEEEEEeC-CC-cEEEEEEEecCCccCHHHHHHHHHHHhhccCcc------ccceee
Q 002826          574 VTEHDLVIGMDEKSSAGNGGPFGRVYILSLP-SG-ELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN------IVKVLG  645 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~  645 (876)
                      ...++...+.|++.+..|.|+||+||+|... ++ +.||+|++... ......+.+|++++++++|++      ++.+++
T Consensus        11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~   89 (355)
T 2eu9_A           11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSD   89 (355)
T ss_dssp             CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred             cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence            3344544444444444455559999999764 44 78999998643 234567888999999998776      899999


Q ss_pred             EEEeCCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceee---------
Q 002826          646 FFHSDESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILL---------  715 (876)
Q Consensus       646 ~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll---------  715 (876)
                      ++...+..++||||+ ++++.+++... ...+++..+..++.|++.||+|||+.   +|+||||||+||++         
T Consensus        90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~  165 (355)
T 2eu9_A           90 WFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLY  165 (355)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEE
T ss_pred             eeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccc
Confidence            999999999999999 55777766554 35799999999999999999999999   99999999999999         


Q ss_pred             ----------CCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCC
Q 002826          716 ----------DADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQ  785 (876)
Q Consensus       716 ----------~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~  785 (876)
                                +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.
T Consensus       166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (355)
T 2eu9_A          166 NEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQ  240 (355)
T ss_dssp             CCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence                      56789999999999765432     233458999999999998899999999999999999999999998


Q ss_pred             CCCcchhhHHHHHHHHh-hcccccc-------------cccCh----------------hhhhhcHHHHHHHHHHHHHcc
Q 002826          786 AEPAESLDVVKWVRRKI-NITNGAI-------------QVLDP----------------KIANCYQQQMLGALEIALRCT  835 (876)
Q Consensus       786 ~~~~~~~~~~~~~~~~~-~~~~~~~-------------~~~d~----------------~~~~~~~~~~~~~~~li~~cl  835 (876)
                      .......  ...+.... ..+....             ...+.                ........+...+.+++.+||
T Consensus       241 ~~~~~~~--~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  318 (355)
T 2eu9_A          241 THENREH--LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML  318 (355)
T ss_dssp             CSSHHHH--HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred             CCCHHHH--HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence            6543321  11111111 1000000             00000                000011233557889999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 002826          836 SVMPEKRPSMFEVVK  850 (876)
Q Consensus       836 ~~dP~~RPs~~ell~  850 (876)
                      +.||++|||+.|+++
T Consensus       319 ~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          319 EFDPAQRITLAEALL  333 (355)
T ss_dssp             CSSTTTSCCHHHHTT
T ss_pred             cCChhhCcCHHHHhc
Confidence            999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.1e-35  Score=322.01  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=190.8

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCe------
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDES------  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------  652 (876)
                      .|.....+|.|| ||.||+|.. .+|+.||||++......  ....+.+|+.+++.++||||+++++++...+.      
T Consensus        25 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           25 TYVSPTHVGSGA-YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             eEEEeeeEecCC-CeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            444445566655 999999976 47999999999654322  23567899999999999999999999987643      


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+++ +|.+++..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          104 FYLVMPFMQT-DLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CEEEEECCSE-EGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             EEEEeccccC-CHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            5999999984 88887743   589999999999999999999999   9999999999999999999999999999865


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-cccc--
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-TNGA--  808 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~--  808 (876)
                      ...     .....||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........  ...+...... ....  
T Consensus       177 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          177 DAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH--HHHHHHHHCBCCHHHHT
T ss_pred             CCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHH
Confidence            432     223458899999998876 6789999999999999999999999987543221  1111111000 0000  


Q ss_pred             --------------ccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          809 --------------IQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       809 --------------~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                    .....+.+..........+.+++.+|++.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                          0000111111222335578899999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=315.66  Aligned_cols=249  Identities=23%  Similarity=0.319  Sum_probs=177.1

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC--HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS--SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      +|.....+|.|+ ||.||+|... +|+.||||++.......  .+.+.++..+++.++||||+++++++.+++..++|||
T Consensus        26 ~y~~~~~lg~G~-~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           26 DLENLGEMGSGT-CGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GEEEEEEC-------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccccceeeecC-CeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            344445566555 9999999775 79999999997643221  2234445557788899999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+ ++.+..+.......+++..+..++.|++.|++|||+ .   +|+||||||+||+++.++.+||+|||+++.......
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            99 556666665556679999999999999999999998 6   899999999999999999999999999977654321


Q ss_pred             ccccccccccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          738 QSTMSSEYALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                         .....||+.|+|||.+.     ...++.++||||||+++|||++|+.||...............   ...    ..+
T Consensus       181 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~----~~~  250 (318)
T 2dyl_A          181 ---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEP----PLL  250 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---SCC----CCC
T ss_pred             ---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---cCC----CCC
Confidence               22345889999999974     456888999999999999999999999864433221111111   110    000


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       +.    .......+.+++.+||+.||.+|||+.|+++
T Consensus       251 -~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          251 -PG----HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -Cc----cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             00    0012235789999999999999999999987

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.7e-33  Score=308.01  Aligned_cols=286  Identities=19%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCC-CCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEI-PSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      +|+.+++++|.++ .+|..+.  ++|++|+|++|.  +..+ |..|.++++|++|+|++|+++++.|..|.++++|++|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNND--ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSC--CCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCc--CCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            5667777777766 4454442  467777777776  3334 34577777777777777777777777888888888888


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccc--ccCCCCCccccccceeeccccc
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN--GSIPGSINECLNLERFQVQDNG  314 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~  314 (876)
                      |++|+++ .+|..++   ++|++|++++|++++..+..|..+++|++|++++|.++  +..+..|..+ +|++|++++|+
T Consensus       109 L~~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~  183 (332)
T 2ft3_A          109 ISKNHLV-EIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK  183 (332)
T ss_dssp             CCSSCCC-SCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred             CCCCcCC-ccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence            8888887 7777654   67888888888888766667778888888888888875  3667777777 78888888888


Q ss_pred             CCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCC
Q 002826          315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN  394 (876)
Q Consensus       315 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~  394 (876)
                      +++ +|..+.  ++|+.|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|+++ .+|..
T Consensus       184 l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~  259 (332)
T 2ft3_A          184 LTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG  259 (332)
T ss_dssp             CSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred             CCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence            775 444433  56777777777777666667777777777777777777666666777777777777777766 55556


Q ss_pred             cCCCCCccEEEccCCccccCCc-Cccc------ccccceEeccCCcCC--CCCCcCCCCCCCcceeeCCCCc
Q 002826          395 FCDSPVMSIINLSQNSISGQIP-ELKK------CRKLVSLSLADNSLT--GEIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       395 ~~~~~~L~~L~Ls~N~l~~~~~-~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      +..+++|+.|++++|+|++..+ .|..      ...|+.|++++|.+.  +..|..|..+++|+.|++++|+
T Consensus       260 l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          260 LPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred             hhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence            6666667777777777665544 3332      355677777777766  5666677777777777777663

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=2.7e-33  Score=306.26  Aligned_cols=287  Identities=21%  Similarity=0.296  Sum_probs=179.6

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      +|++++++++.++ .+|..+.  ++|++|+|++|+  +..+|. .|.++++|++|+|++|+++++.|..|.++++|++|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNK--ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSC--CCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCc--CCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            4555555555554 3333332  355555555555  333332 455666666666666666666677777777777777


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccc--cCCCCCccccccceeeccccc
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNG--SIPGSINECLNLERFQVQDNG  314 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~  314 (876)
                      |++|+++ .+|..++   ++|++|++++|++++..+..|.++++|++|++++|.++.  ..+..|..+++|++|++++|+
T Consensus       107 Ls~n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             CCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             CCCCcCC-ccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            7777777 6666553   567777777777776666667777777777777777753  566667777777777777777


Q ss_pred             CCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCC
Q 002826          315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN  394 (876)
Q Consensus       315 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~  394 (876)
                      ++. +|..+.  ++|+.|++++|++++..|..+..+++|++|++++|++++..+..+..+++|++|++++|+++ .+|..
T Consensus       183 l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~  258 (330)
T 1xku_A          183 ITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG  258 (330)
T ss_dssp             CCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred             ccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence            763 343332  56777777777777666666666677777777777776655556666666666666666666 45555


Q ss_pred             cCCCCCccEEEccCCccccCCc-Cccc------ccccceEeccCCcCCC--CCCcCCCCCCCcceeeCCCCc
Q 002826          395 FCDSPVMSIINLSQNSISGQIP-ELKK------CRKLVSLSLADNSLTG--EIPPSLAELPVLTYLDLSDNN  457 (876)
Q Consensus       395 ~~~~~~L~~L~Ls~N~l~~~~~-~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~  457 (876)
                      +..+++|++|++++|+|++..+ .|..      ...|+.|++++|.+..  ..|..|..+.+|+.++|++|+
T Consensus       259 l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          259 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             hccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            6666666666666666665544 3322      3566667777776653  455666667777777776664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-35  Score=319.08  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=190.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc------CHHHHHHHHHHHhhcc--CccccceeeEEEeCCe
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIR--HKNIVKVLGFFHSDES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~  652 (876)
                      .|.....+|.| +||.||+|.. .+++.||||++......      ....+.+|+.++++++  ||||+++++++.+++.
T Consensus        44 ~y~~~~~lg~G-~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           44 QYQVGPLLGSG-GFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TEEEEEECSSS-SSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             ceEEEEEEeeC-CCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            34344445554 5999999965 57999999999754322      2345678999999996  5999999999999999


Q ss_pred             EEEEEEcCCC-CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEccccchh
Q 002826          653 IFLIYEFLQM-GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDFALDR  730 (876)
Q Consensus       653 ~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~DfGla~  730 (876)
                      .++|||++.+ ++|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++ +++.+||+|||+++
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            9999999986 89999997654 689999999999999999999999   999999999999999 78999999999998


Q ss_pred             hccccccccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ......    .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....       .....    .    
T Consensus       199 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~~~~~----~----  259 (320)
T 3a99_A          199 LLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG----Q----  259 (320)
T ss_dssp             ECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC----C----
T ss_pred             cccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------hhhcc----c----
Confidence            765432    223458999999998876554 678999999999999999999986421       01110    0    


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ....+       .....+.+++.+||+.||++|||+.|+++.
T Consensus       260 ~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          260 VFFRQ-------RVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCCSS-------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111       112357899999999999999999999873

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=100.00  E-value=1.4e-34  Score=315.42  Aligned_cols=289  Identities=18%  Similarity=0.237  Sum_probs=187.9

Q ss_pred             CCChhHHHHHHHHHhhc-cCCCCCCCCCC--CCCCCCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCC
Q 002826           25 TSASTEKDTLLSFKASI-DDSKNSLSTWS--NTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSL  101 (876)
Q Consensus        25 ~~~~~~~~all~~k~~~-~~~~~~~~sW~--~~~~~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L  101 (876)
                      +...+|++||++||+++ .|+.+.+++|.  .....++|.|.|++|.....                 .+.  -...+++
T Consensus        23 ~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~-----------------~l~--~~~~~~l   83 (328)
T 4fcg_A           23 TALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATAD-----------------LLE--DATQPGR   83 (328)
T ss_dssp             CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHH-----------------HHH--HHTSTTC
T ss_pred             ccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHH-----------------HHh--cccccce
Confidence            34568999999999999 57777788994  11235899999999953210                 000  0124567


Q ss_pred             CeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCC
Q 002826          102 SNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFS  181 (876)
Q Consensus       102 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  181 (876)
                      +.|+|++|.++ .+|..++.+++|++|+|+          +|+++ .+|..|+.+++|++|+|++|+++ .+|..|++++
T Consensus        84 ~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~----------~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~  150 (328)
T 4fcg_A           84 VALELRSVPLP-QFPDQAFRLSHLQHMTID----------AAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLN  150 (328)
T ss_dssp             CEEEEESSCCS-SCCSCGGGGTTCSEEEEE----------SSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCT
T ss_pred             eEEEccCCCch-hcChhhhhCCCCCEEECC----------CCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCc
Confidence            77777777776 466667777777766444          34444 56677777777777777777777 5676777777


Q ss_pred             cceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEE
Q 002826          182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFD  261 (876)
Q Consensus       182 ~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~  261 (876)
                      +|++|+|++|+ ..+.+|..+...               ..+..|.++++|++|+|++|+|+ .+|..+ ..+++|++|+
T Consensus       151 ~L~~L~L~~n~-~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l-~~l~~L~~L~  212 (328)
T 4fcg_A          151 RLRELSIRACP-ELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASI-ANLQNLKSLK  212 (328)
T ss_dssp             TCCEEEEEEET-TCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGG-GGCTTCCEEE
T ss_pred             CCCEEECCCCC-CccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhh-cCCCCCCEEE
Confidence            77777777765 355666654430               11223445666666666666666 565554 3366666666


Q ss_pred             eccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccc
Q 002826          262 VSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG  341 (876)
Q Consensus       262 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  341 (876)
                      |++|++++ +|..+..+++|++|+|++|.+.+.+|..|..+++|++|++++|++.+.+|..+.++++|+.|++++|++.+
T Consensus       213 L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~  291 (328)
T 4fcg_A          213 IRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLS  291 (328)
T ss_dssp             EESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred             ccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence            66666663 44456666666666666666666666666666666666666666666666666666777777777766666


Q ss_pred             cCccccccCCCCCeeeccCcccC
Q 002826          342 AIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       342 ~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      .+|+.+..+++|+.+++..|.+.
T Consensus       292 ~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          292 RLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCCGGGGGSCTTCEEECCGGGSC
T ss_pred             hccHHHhhccCceEEeCCHHHHH
Confidence            77777777777777776666554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.2e-33  Score=307.27  Aligned_cols=287  Identities=22%  Similarity=0.321  Sum_probs=169.4

Q ss_pred             CCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccC
Q 002826          100 SLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGN  179 (876)
Q Consensus       100 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  179 (876)
                      +++.+++++|.++. +|..+.  ++|++|          +|++|++++..|..|.++++|++|+|++|++++..|..|++
T Consensus        34 ~l~~l~~~~~~l~~-ip~~~~--~~l~~L----------~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  100 (332)
T 2ft3_A           34 HLRVVQCSDLGLKA-VPKEIS--PDTTLL----------DLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSP  100 (332)
T ss_dssp             ETTEEECCSSCCSS-CCSCCC--TTCCEE----------ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTT
T ss_pred             cCCEEECCCCCccc-cCCCCC--CCCeEE----------ECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhC
Confidence            56777777777764 454442  445544          45555566666777888888888888888888777778888


Q ss_pred             CCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCC--CCCCccccccccc
Q 002826          180 FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTG--EVPQSLGSSLLKL  257 (876)
Q Consensus       180 l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~ip~~~~~~l~~L  257 (876)
                      +++|++|+|++|+  +..+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++.  ..|.. +..+ +|
T Consensus       101 l~~L~~L~L~~n~--l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~~l-~L  174 (332)
T 2ft3_A          101 LRKLQKLYISKNH--LVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGA-FDGL-KL  174 (332)
T ss_dssp             CTTCCEEECCSSC--CCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTS-SCSC-CC
T ss_pred             cCCCCEEECCCCc--CCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCccc-ccCC-cc
Confidence            8888888888887  456666554  567777777777766666666667777777777776651  22222 2223 55


Q ss_pred             cEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCC
Q 002826          258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN  337 (876)
Q Consensus       258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  337 (876)
                      ++|++++|++++ +|..+.  ++|++|++++|.+++..+                        ..|..+++|+.|++++|
T Consensus       175 ~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~------------------------~~l~~l~~L~~L~L~~N  227 (332)
T 2ft3_A          175 NYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIEL------------------------EDLLRYSKLYRLGLGHN  227 (332)
T ss_dssp             SCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCT------------------------TSSTTCTTCSCCBCCSS
T ss_pred             CEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCH------------------------HHhcCCCCCCEEECCCC
Confidence            555555555553 232221  344444444444444444                        44444444444444444


Q ss_pred             cccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCC------CCCccEEEccCCcc
Q 002826          338 RFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCD------SPVMSIINLSQNSI  411 (876)
Q Consensus       338 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~------~~~L~~L~Ls~N~l  411 (876)
                      ++++..+..+..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|+.      ...|+.|++++|.+
T Consensus       228 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~  306 (332)
T 2ft3_A          228 QIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPV  306 (332)
T ss_dssp             CCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSS
T ss_pred             cCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcc
Confidence            444444444555555555555555555 44555555555555555555555555555543      25577777777777


Q ss_pred             c--cCCc-CcccccccceEeccCCc
Q 002826          412 S--GQIP-ELKKCRKLVSLSLADNS  433 (876)
Q Consensus       412 ~--~~~~-~~~~l~~L~~L~Ls~N~  433 (876)
                      .  +..+ .|..+++|+.|+|++|+
T Consensus       307 ~~~~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          307 PYWEVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             CGGGSCGGGGTTBCCSTTEEC----
T ss_pred             cccccCcccccccchhhhhhccccc
Confidence            6  3444 57778888888888774

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=8e-35  Score=318.05  Aligned_cols=251  Identities=22%  Similarity=0.290  Sum_probs=171.3

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHH-HHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVK-TLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      .....+|.|+ ||.||+|... +|+.||||++..... ....++..|+. +++.++||||+++++++.+++..++||||+
T Consensus        25 ~~~~~lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~  103 (327)
T 3aln_A           25 KDLGEIGRGA-YGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM  103 (327)
T ss_dssp             EC-CEEEECS-SEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hehheeccCC-CEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence            3344555555 9999999764 799999999976432 22344555665 677789999999999999999999999999


Q ss_pred             CCCCHHHHhhc----cCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          661 QMGSLGDLICR----QDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       661 ~~gsL~~~l~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      ++ +|.+++..    ....+++..+.+++.|++.|+.|||+.  .+|+||||||+||+++.++.+||+|||+++......
T Consensus       104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  180 (327)
T 3aln_A          104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI  180 (327)
T ss_dssp             SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred             CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence            86 88877753    245789999999999999999999995  289999999999999999999999999998765432


Q ss_pred             cccccccccccccccCcccc----CCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          737 FQSTMSSEYALSCYNAPEYG----YSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .   .....||+.|+|||.+    .+..++.++||||||+++|||++|+.||........    ..   .....+....+
T Consensus       181 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~---~~~~~~~~~~~  250 (327)
T 3aln_A          181 A---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD----QL---TQVVKGDPPQL  250 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCCC
T ss_pred             c---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH----HH---HHHhcCCCCCC
Confidence            1   2233589999999998    456689999999999999999999999976432111    00   01100000011


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ...   ........+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          251 SNS---EEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCC---SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCc---ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            110   011123468899999999999999999999873

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-35  Score=317.91  Aligned_cols=241  Identities=22%  Similarity=0.325  Sum_probs=185.5

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc------CHHHHHHHHHHHhhc----cCccccceeeEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKI----RHKNIVKVLGFFH  648 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~~~~~  648 (876)
                      ..+|.....+|.|| ||.||+|.. .+++.||+|++......      ....+.+|+.+++++    +||||+++++++.
T Consensus        30 ~~~y~~~~~lg~G~-~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           30 EAEYRLGPLLGKGG-FGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ---CEEEEEEEEET-TEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhceEEeeEEEcCC-CEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            33454455555555 999999966 47899999998654321      223456799999999    8999999999999


Q ss_pred             eCCeEEEEEEc-CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC-CCCCeEEccc
Q 002826          649 SDESIFLIYEF-LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD-ADFEPKLTDF  726 (876)
Q Consensus       649 ~~~~~~lv~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~-~~~~~kl~Df  726 (876)
                      +.+..++|||| +.+++|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++ .++.+||+||
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEc
Confidence            99999999999 78999999997654 689999999999999999999999   999999999999999 8899999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++......    .....|+..|+|||...+..+ +.++||||+|+++|||++|+.||....       ........  
T Consensus       185 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~--  251 (312)
T 2iwi_A          185 GSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EILEAELH--  251 (312)
T ss_dssp             SSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHTCCC--
T ss_pred             chhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HHhhhccC--
Confidence            9998765432    233458999999998776555 458999999999999999999986421       11110000  


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                            +.       ......+.+++.+||+.||++|||+.|+++.
T Consensus       252 ------~~-------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          252 ------FP-------AHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ------CC-------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------Cc-------ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00       1123357899999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-34  Score=321.09  Aligned_cols=259  Identities=17%  Similarity=0.237  Sum_probs=192.0

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-----------CccccceeeEEEeC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-----------HKNIVKVLGFFHSD  650 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~  650 (876)
                      |.....+|.| +||+||+|.. .+++.||||++... ....+.+.+|++++++++           ||||+++++++...
T Consensus        21 y~~~~~lg~G-~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~   98 (373)
T 1q8y_A           21 YILVRKLGWG-HFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   98 (373)
T ss_dssp             EEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             EEEEEeeeec-CCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence            3334445555 5999999975 58999999998642 234567889999999886           89999999999865


Q ss_pred             C----eEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC------CCC
Q 002826          651 E----SIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD------ADF  719 (876)
Q Consensus       651 ~----~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~------~~~  719 (876)
                      +    ..++||||+ +++|.+++.+. ...+++..+..++.||+.||+|||+++  +|+||||||+||+++      ..+
T Consensus        99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred             CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence            4    789999999 88999999764 345999999999999999999999942  899999999999994      445


Q ss_pred             CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-----hhH
Q 002826          720 EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-----LDV  794 (876)
Q Consensus       720 ~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-----~~~  794 (876)
                      .+||+|||+++.....     .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......     ...
T Consensus       176 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  250 (373)
T 1q8y_A          176 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  250 (373)
T ss_dssp             EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence            8999999999876532     233458999999999988889999999999999999999999998654221     111


Q ss_pred             HHHHHHHhhcccc----------------cccccC-----------hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002826          795 VKWVRRKINITNG----------------AIQVLD-----------PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFE  847 (876)
Q Consensus       795 ~~~~~~~~~~~~~----------------~~~~~d-----------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  847 (876)
                      ..........+..                ....+.           .............+.+++.+||+.||++|||+.|
T Consensus       251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  330 (373)
T 1q8y_A          251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  330 (373)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence            1111111000000                000000           0001223456778899999999999999999999


Q ss_pred             HHHH
Q 002826          848 VVKA  851 (876)
Q Consensus       848 ll~~  851 (876)
                      +++.
T Consensus       331 ll~h  334 (373)
T 1q8y_A          331 LVNH  334 (373)
T ss_dssp             HHTC
T ss_pred             HhhC
Confidence            9883

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1e-33  Score=302.52  Aligned_cols=244  Identities=13%  Similarity=0.055  Sum_probs=186.0

Q ss_pred             cccchhh-hhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeE
Q 002826          572 LRVTEHD-LVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGF  646 (876)
Q Consensus       572 ~~~~~~~-l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~  646 (876)
                      ..+..++ +..+.|++.+..+.|+||.||+|... +|+.||+|++.......   .+.+.+|+..+++++||||++++++
T Consensus        20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            4555666 55555555555555559999999765 59999999997654333   2678899999999999999999999


Q ss_pred             EEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       647 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      +.+++..|+||||++|++|.+++.+.   .....+.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+++
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~  173 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP  173 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec
Confidence            99999999999999999999999542   35567889999999999999999   9999999999999999999999855


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |                      |++       .++.++|||||||++|||+||+.||............     ...  
T Consensus       174 ~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-----~~~--  217 (286)
T 3uqc_A          174 A----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-----ERD--  217 (286)
T ss_dssp             C----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-----CBC--
T ss_pred             c----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-----HHH--
Confidence            3                      333       2678999999999999999999999875543210000     000  


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                       ..... +.........+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       218 -~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          218 -TAGQP-IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             -TTSCB-CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             -hccCC-CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence             00000 00111112234468899999999999999 99999999999876544

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.9e-35  Score=338.36  Aligned_cols=267  Identities=21%  Similarity=0.256  Sum_probs=198.1

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC-ccCHHHHHHHHHHHhhccCccccceeeEEEe------CCeE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG-CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS------DESI  653 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~  653 (876)
                      .|.....+|.| +||+||+|.. .+|+.||||++.... ....+.+.+|++++++++||||+++++++..      .+..
T Consensus        15 rY~i~~~LG~G-~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           15 PWEMKERLGTG-GFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             --CCCCCCCBC-SSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CeEEEEEEeeC-CCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            34444455555 4999999966 479999999986532 2234678899999999999999999999765      6678


Q ss_pred             EEEEEcCCCCCHHHHhhccC--CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC---eEEccccc
Q 002826          654 FLIYEFLQMGSLGDLICRQD--FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE---PKLTDFAL  728 (876)
Q Consensus       654 ~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~---~kl~DfGl  728 (876)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997643  3688999999999999999999999   9999999999999997665   99999999


Q ss_pred             hhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHH-------
Q 002826          729 DRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRK-------  801 (876)
Q Consensus       729 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-------  801 (876)
                      ++.......   .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......    .|....       
T Consensus       171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~~  243 (676)
T 3qa8_A          171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNEH  243 (676)
T ss_dssp             CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC------
T ss_pred             ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccchh
Confidence            987654332   234468999999999998899999999999999999999999997532211    110000       


Q ss_pred             h---hcccccc--cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHhhcccCC
Q 002826          802 I---NITNGAI--QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFE-----VVKALHSLSTRT  859 (876)
Q Consensus       802 ~---~~~~~~~--~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e-----ll~~L~~i~~~~  859 (876)
                      .   ....+..  ....+............+.+++.+|++.||++|||+.|     ..+.++++....
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            0   0000000  00001111223345567899999999999999999988     556677666544

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.9e-32  Score=299.53  Aligned_cols=291  Identities=21%  Similarity=0.288  Sum_probs=196.0

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      .+++.++++++.++. +|..+.  ++|++|          +|++|++++..+..|+++++|++|+|++|++++..|..|+
T Consensus        31 c~l~~l~~~~~~l~~-lp~~~~--~~l~~L----------~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (330)
T 1xku_A           31 CHLRVVQCSDLGLEK-VPKDLP--PDTALL----------DLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA   97 (330)
T ss_dssp             EETTEEECTTSCCCS-CCCSCC--TTCCEE----------ECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred             CCCeEEEecCCCccc-cCccCC--CCCeEE----------ECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence            468888888888875 454443  345544          5556666666667788888888888888888877788888


Q ss_pred             CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccccc
Q 002826          179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       179 ~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                      ++++|++|+|++|+  +..+|..+.  ++|++|++++|++++..+..|.++++|++|++++|.++.              
T Consensus        98 ~l~~L~~L~Ls~n~--l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--------------  159 (330)
T 1xku_A           98 PLVKLERLYLSKNQ--LKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKS--------------  159 (330)
T ss_dssp             TCTTCCEEECCSSC--CSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCG--------------
T ss_pred             CCCCCCEEECCCCc--CCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCc--------------
Confidence            88888888888887  556666554  567777777777776666666667777777777776652              


Q ss_pred             EEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCc
Q 002826          259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR  338 (876)
Q Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  338 (876)
                               .+..+..+..+++|++|++++|.++. +|..+.  ++|++|++++|++++..|..|..+++|+.|++++|+
T Consensus       160 ---------~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~  227 (330)
T 1xku_A          160 ---------SGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS  227 (330)
T ss_dssp             ---------GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSC
T ss_pred             ---------cCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCc
Confidence                     01233334444444444444444442 222222  466666666666666666666667777777777777


Q ss_pred             ccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCC------CCccEEEccCCccc
Q 002826          339 FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDS------PVMSIINLSQNSIS  412 (876)
Q Consensus       339 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~------~~L~~L~Ls~N~l~  412 (876)
                      +++..+..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..|+..      ..++.|++++|.+.
T Consensus       228 l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~  306 (330)
T 1xku_A          228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ  306 (330)
T ss_dssp             CCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred             CceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCccc
Confidence            77666667777777777777777777 667777777777777777777777777666543      67888888888886


Q ss_pred             c--CCc-CcccccccceEeccCCc
Q 002826          413 G--QIP-ELKKCRKLVSLSLADNS  433 (876)
Q Consensus       413 ~--~~~-~~~~l~~L~~L~Ls~N~  433 (876)
                      .  ..| .|..+.+++.++|++|+
T Consensus       307 ~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          307 YWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             GGGSCGGGGTTCCCGGGEEC----
T ss_pred             ccccCccccccccceeEEEecccC
Confidence            3  333 68888899999998885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.9e-33  Score=301.57  Aligned_cols=239  Identities=19%  Similarity=0.266  Sum_probs=181.1

Q ss_pred             cccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHH-hhccCccccceeeEEEe
Q 002826          572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTL-AKIRHKNIVKVLGFFHS  649 (876)
Q Consensus       572 ~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~  649 (876)
                      ..+..+++..+|+...+..|.|+||.||+|.. .+++.||+|++..     ...+.+|++++ +..+||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A            8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             CCCBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             ccCcccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            34555667777777745444444999999966 5799999999853     35677899988 55589999999999987


Q ss_pred             ----CCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCe
Q 002826          650 ----DESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEP  721 (876)
Q Consensus       650 ----~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~  721 (876)
                          .+..++||||+++|+|.+++.+. ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.   ++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~  159 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAIL  159 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCE
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcE
Confidence                67799999999999999999775 34699999999999999999999999   9999999999999997   7899


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRK  801 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~  801 (876)
                      ||+|||++.....                        ..++.++||||+||++|||++|+.||........     ....
T Consensus       160 kl~Dfg~a~~~~~------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~  210 (299)
T 3m2w_A          160 KLTDFGFAKETTG------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGM  210 (299)
T ss_dssp             EECCCTTCEECTT------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCS
T ss_pred             EEecccccccccc------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHHH
Confidence            9999998754321                        2356789999999999999999999976433211     0000


Q ss_pred             h-hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          802 I-NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       802 ~-~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      . ...........    ..+......+.+++.+||+.||++|||+.|+++.
T Consensus       211 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          211 KTRIRMGQYEFPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CCSSCTTCCSSCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhccccCCc----hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0 00000000000    1111234568899999999999999999999973

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.4e-33  Score=338.26  Aligned_cols=246  Identities=22%  Similarity=0.287  Sum_probs=189.9

Q ss_pred             chhhhhhcccccCCCCCCCCceEEEEEEeC--CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCC
Q 002826          575 TEHDLVIGMDEKSSAGNGGPFGRVYILSLP--SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE  651 (876)
Q Consensus       575 ~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  651 (876)
                      ..+++..+.|++....+.|+||+||+|...  +|+.||||++..... .....+.+|++++++++||||+++++++.+.+
T Consensus        73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  152 (681)
T 2pzi_A           73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD  152 (681)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred             CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence            344555444444444444449999999764  689999999865322 23456889999999999999999999998866


Q ss_pred             e-----EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          652 S-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       652 ~-----~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      .     .|+||||++|++|.+++..   .+++..+..++.||+.||.|||+.   +|+||||||+||+++.+ .+||+||
T Consensus       153 ~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          153 RHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             TTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCC
T ss_pred             CCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEec
Confidence            5     7999999999999987754   689999999999999999999999   99999999999999986 9999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++.....      ....||+.|+|||++.+.. +.++|||||||++|||++|.+||........              
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------------  284 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------------  284 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------------
T ss_pred             ccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------------
Confidence            999876432      3345899999999876654 8899999999999999999988764221110              


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcc
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRP-SMFEVVKALHSLS  856 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ell~~L~~i~  856 (876)
                        . ...+     .......+.+++.+||++||++|| +++++.+.+.++.
T Consensus       285 --~-~~~~-----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          285 --P-EDDP-----VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             --C-TTCH-----HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --c-cccc-----ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence              0 0000     112234678999999999999999 5777777776653

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.98  E-value=3.4e-33  Score=314.66  Aligned_cols=233  Identities=18%  Similarity=0.130  Sum_probs=172.8

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc---cCHHHHHHHHHHHhhccC-cccccee-----------------
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRH-KNIVKVL-----------------  644 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~-----------------  644 (876)
                      ..+|.|| ||+||+|.. .+|+.||||++.....   ...+.+++|+.+++.++| +|.....                 
T Consensus        84 ~~LG~G~-fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           84 TVLGQED-PYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEET-TEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             cccccCC-CEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            4455555 999999974 5799999999874322   235788999999999976 3221111                 


Q ss_pred             ----eEEEe-----CCeEEEEEEcCCCCCHHHHhh------ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccc
Q 002826          645 ----GFFHS-----DESIFLIYEFLQMGSLGDLIC------RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK  709 (876)
Q Consensus       645 ----~~~~~-----~~~~~lv~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlk  709 (876)
                          .++..     ....+++|+++ +++|.+++.      ..+..+++..+..++.|++.||+|||+.   +|+|||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK  238 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR  238 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence                11111     12467777765 569999884      2245688899999999999999999999   99999999


Q ss_pred             cCceeeCCCCCeEEccccchhhccccccccccccccccccccCcccc----------CCCCCCCccchHHHHHHHHHHHh
Q 002826          710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYG----------YSKKATAQMDAYSFGVVLLELIT  779 (876)
Q Consensus       710 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlGv~l~ellt  779 (876)
                      |+|||++.++.+||+|||+++..+..     .....| +.|+|||++          ....++.++|||||||++|||++
T Consensus       239 p~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          239 PVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             GGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            99999999999999999998865543     233456 889999988          55568889999999999999999


Q ss_pred             CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          780 GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       780 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      |+.||........               ....+.     .....+..+.+++.+||+.||++|||+.|+++
T Consensus       313 g~~Pf~~~~~~~~---------------~~~~~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          313 ADLPNTDDAALGG---------------SEWIFR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             SSCCCCTTGGGSC---------------SGGGGS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcchhhh---------------HHHHHh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999976443221               000000     00011246889999999999999999777654

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=6e-33  Score=304.36  Aligned_cols=239  Identities=14%  Similarity=0.110  Sum_probs=176.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--------cCHHHHHHHHHHHhhcc------------------
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--------QSSKTLKTEVKTLAKIR------------------  636 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~------------------  636 (876)
                      |.....+|.|+ ||+||+|+. +|+.||||++.....        ...+.+.+|+.++++++                  
T Consensus        22 y~~~~~lG~G~-~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~   99 (336)
T 2vuw_A           22 LQRCEKIGEGV-FGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS   99 (336)
T ss_dssp             HHTCEEEEEET-TEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred             chheeeecccC-ceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence            33444555554 999999987 789999999976432        23378899999999997                  


Q ss_pred             --------CccccceeeEEEe-------------CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHh
Q 002826          637 --------HKNIVKVLGFFHS-------------DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYL  695 (876)
Q Consensus       637 --------h~niv~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~L  695 (876)
                              ||||+++++++.+             .+..|+||||+++|++.+.+.+  ..+++..+..++.||+.||+||
T Consensus       100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A          100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHH
Confidence                    4555555555543             6789999999999977666644  4689999999999999999999


Q ss_pred             h-ccCCCCccccccccCceeeCCCC--------------------CeEEccccchhhccccccccccccccccccccCcc
Q 002826          696 H-KDYVPHLLHRNVKSKNILLDADF--------------------EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE  754 (876)
Q Consensus       696 H-~~~~~~i~H~Dlkp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE  754 (876)
                      | +.   +|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|+|||
T Consensus       178 H~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE  247 (336)
T 2vuw_A          178 EASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDED  247 (336)
T ss_dssp             HHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSG
T ss_pred             HHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecccChh
Confidence            9 88   999999999999999876                    8999999999876532       235899999999


Q ss_pred             ccCCCCCCCccchHHHHHH-HHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHH
Q 002826          755 YGYSKKATAQMDAYSFGVV-LLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALR  833 (876)
Q Consensus       755 ~~~~~~~~~~~Dv~SlGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~  833 (876)
                      ++.+.. +.++||||+|++ .+++++|..||....... ...+........    .   ...........+.++.+++.+
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~----~---~~~~~~~~~~~s~~~~dli~~  318 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH-YLTDKMLKQMTF----K---TKCNTPAMKQIKRKIQEFHRT  318 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH-HHHHHHHHTCCC----S---SCCCSHHHHHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh-HHHHhhhhhhcc----C---cccchhhhhhcCHHHHHHHHH
Confidence            988665 889999998777 788899998874211000 011111100000    0   011112334566789999999


Q ss_pred             ccCCCCCCCCCHHHHH
Q 002826          834 CTSVMPEKRPSMFEVV  849 (876)
Q Consensus       834 cl~~dP~~RPs~~ell  849 (876)
                      ||+.|     |++|++
T Consensus       319 ~L~~d-----sa~e~l  329 (336)
T 2vuw_A          319 MLNFS-----SATDLL  329 (336)
T ss_dssp             GGGSS-----SHHHHH
T ss_pred             HhccC-----CHHHHH
Confidence            99976     999988

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.9e-35  Score=339.10  Aligned_cols=349  Identities=19%  Similarity=0.223  Sum_probs=218.6

Q ss_pred             EEEEeecCCCCCccccccc-ccCCCCCCeeecCCCcccc----ccCccccCCCCCCcccCCCcccceeecCCccccccCC
Q 002826           76 TVASINLQSLNLSGEISSS-VCELSSLSNLNLADNLFNQ----PIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIP  150 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~-~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p  150 (876)
                      ++..+++++++++...... +..+++|++|+|++|.++.    .++..+..+++|++|+|++|.|          ++..+
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l----------~~~~~   73 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL----------GDVGV   73 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC----------HHHHH
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcC----------ChHHH
Confidence            6778888888887654433 7788889999999998875    3567788888888876665544          33222


Q ss_pred             Ccc-CCcc----ccceecccccccCC----CcCccccCCCcceEEEccCCCCcCCCCCCcc-----cccCcccEEEecCC
Q 002826          151 ESI-GSLV----NLQVLNLGSNLLSG----SVPFVFGNFSELVVLDLSQNAYLISEIPSDI-----GKLEKLEQLFLQSS  216 (876)
Q Consensus       151 ~~~-~~l~----~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~-----~~l~~L~~L~L~~n  216 (876)
                      ..+ ..++    +|++|+|++|+++.    .++..|.++++|++|+|++|++ ....+..+     ...++|++|+|++|
T Consensus        74 ~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i-~~~~~~~l~~~l~~~~~~L~~L~L~~n  152 (461)
T 1z7x_W           74 HCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL-GDAGLQLLCEGLLDPQCRLEKLQLEYC  152 (461)
T ss_dssp             HHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBC-HHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcC-chHHHHHHHHHHhcCCCcceEEECCCC
Confidence            222 2233    68899999998874    4578888888899999988873 21112222     22457888888888


Q ss_pred             CCcccC----CccccCCCCCcEEecccCccCCCCCCcccc----ccccccEEEeccccccCc----CCcccccCCcccee
Q 002826          217 GFHGVI----PDSFVGLQSLSILDLSQNNLTGEVPQSLGS----SLLKLVSFDVSQNKLSGS----FPNGICKANGLVNL  284 (876)
Q Consensus       217 ~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L  284 (876)
                      ++++..    +..+..+++|++|+|++|.++...+..+..    ..++|++|+|++|++++.    ++..+..+++|++|
T Consensus       153 ~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L  232 (461)
T 1z7x_W          153 SLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLREL  232 (461)
T ss_dssp             CCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEE
T ss_pred             CCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEE
Confidence            887643    555666788888888888877433333322    244788888888888753    46666777888888


Q ss_pred             eeecccccccC-----CCCCccccccceeecccccCCCC----CCcccCCCCcccEEEecCCcccccCccccccC-----
Q 002826          285 SLHKNFFNGSI-----PGSINECLNLERFQVQDNGFSGD----FPDKLWSLPRIKLIRAESNRFSGAIPDSISMA-----  350 (876)
Q Consensus       285 ~L~~N~i~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-----  350 (876)
                      +|++|.+++..     +..+..+++|++|++++|++++.    ++..+..+++|+.|++++|++++..+..+...     
T Consensus       233 ~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~  312 (461)
T 1z7x_W          233 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG  312 (461)
T ss_dssp             ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTT
T ss_pred             eccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCC
Confidence            88888776432     22233466777777777777643    45556666777777777777765544444322     


Q ss_pred             CCCCeeeccCcccCCC----CCCccccccCccEEeCCCccccCCCCCCcCC-----CCCccEEEccCCcccc----CCc-
Q 002826          351 AQLEQVQIDNNRFTSS----IPQGLGSVKSLYRFSASQNSFYGSLPPNFCD-----SPVMSIINLSQNSISG----QIP-  416 (876)
Q Consensus       351 ~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----~~~L~~L~Ls~N~l~~----~~~-  416 (876)
                      ++|++|++++|.+++.    ++..+..+++|++|++++|.+++..+..++.     .+.|+.|+|++|++++    .++ 
T Consensus       313 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~  392 (461)
T 1z7x_W          313 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  392 (461)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             ccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHH
Confidence            4666666666666644    3344444555666655555555433332221     3445555555555542    222 


Q ss_pred             CcccccccceEeccCCcCC
Q 002826          417 ELKKCRKLVSLSLADNSLT  435 (876)
Q Consensus       417 ~~~~l~~L~~L~Ls~N~l~  435 (876)
                      .+..+++|++|+|++|+++
T Consensus       393 ~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          393 TLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             HHHHCCCCCEEECCSSSCC
T ss_pred             HHHhCCCccEEECCCCCCC
Confidence            3444455555555555544

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=7.6e-36  Score=342.45  Aligned_cols=355  Identities=16%  Similarity=0.150  Sum_probs=238.9

Q ss_pred             CCCCeeecCCCccccccCcc-ccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccc
Q 002826           99 SSLSNLNLADNLFNQPIPLH-LSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF  177 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  177 (876)
                      ++|++|||++|+++...... +..+++|++|+|++|.+....     . ..++..+..+++|++|+|++|++++..+..+
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~-----~-~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l   76 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEAR-----C-KDISSALRVNPALAELNLRSNELGDVGVHCV   76 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHH-----H-HHHHHHHHTCTTCCEEECTTCCCHHHHHHHH
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHH-----H-HHHHHHHHhCCCcCEEeCCCCcCChHHHHHH
Confidence            56788999998887654433 778888887766655432100     0 1345667778888899998888875444333


Q ss_pred             -cCCC----cceEEEccCCCCcC---CCCCCcccccCcccEEEecCCCCcccCCcccc-----CCCCCcEEecccCccCC
Q 002826          178 -GNFS----ELVVLDLSQNAYLI---SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV-----GLQSLSILDLSQNNLTG  244 (876)
Q Consensus       178 -~~l~----~L~~L~Ls~N~~~~---~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~  244 (876)
                       ..++    +|++|+|++|++..   ..+|..+..+++|++|+|++|++++..+..+.     ..++|++|+|++|++++
T Consensus        77 ~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~  156 (461)
T 1z7x_W           77 LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA  156 (461)
T ss_dssp             HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred             HHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCH
Confidence             3455    68888888887321   13466777888888888888888754443332     25578888888888874


Q ss_pred             CC----CCccccccccccEEEeccccccCcCCccccc-----CCccceeeeeccccccc----CCCCCccccccceeecc
Q 002826          245 EV----PQSLGSSLLKLVSFDVSQNKLSGSFPNGICK-----ANGLVNLSLHKNFFNGS----IPGSINECLNLERFQVQ  311 (876)
Q Consensus       245 ~i----p~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~  311 (876)
                      ..    +.. +..+++|++|+|++|++++..+..+..     .++|++|+|++|.+++.    ++..+..+++|++|+++
T Consensus       157 ~~~~~l~~~-l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls  235 (461)
T 1z7x_W          157 ASCEPLASV-LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG  235 (461)
T ss_dssp             GGHHHHHHH-HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECC
T ss_pred             HHHHHHHHH-HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEecc
Confidence            32    222 234678888888888877554444432     55788888888887753    35566677888888888


Q ss_pred             cccCCCCC-----CcccCCCCcccEEEecCCccccc----CccccccCCCCCeeeccCcccCCCCCCccccc-----cCc
Q 002826          312 DNGFSGDF-----PDKLWSLPRIKLIRAESNRFSGA----IPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV-----KSL  377 (876)
Q Consensus       312 ~N~l~~~~-----p~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L  377 (876)
                      +|.+++..     +..+..+++|+.|++++|++++.    ++..+..+++|++|++++|++++..+..+...     ++|
T Consensus       236 ~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L  315 (461)
T 1z7x_W          236 SNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL  315 (461)
T ss_dssp             SSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCC
T ss_pred             CCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccc
Confidence            88776532     22333577888888888887764    46666677788888888887765444333332     577


Q ss_pred             cEEeCCCccccCC----CCCCcCCCCCccEEEccCCccccCCc-Cccc-----ccccceEeccCCcCCC----CCCcCCC
Q 002826          378 YRFSASQNSFYGS----LPPNFCDSPVMSIINLSQNSISGQIP-ELKK-----CRKLVSLSLADNSLTG----EIPPSLA  443 (876)
Q Consensus       378 ~~L~ls~N~l~~~----~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~  443 (876)
                      +.|++++|.+++.    ++..+..+++|+.|+|++|.+++..+ .+..     .++|++|+|++|++++    .+|..+.
T Consensus       316 ~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~  395 (461)
T 1z7x_W          316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLL  395 (461)
T ss_dssp             CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHH
T ss_pred             eeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHH
Confidence            8888888877654    34555566778888888887765432 2322     5677888888887775    5677777


Q ss_pred             CCCCcceeeCCCCcccc
Q 002826          444 ELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       444 ~l~~L~~L~Ls~N~l~~  460 (876)
                      .+++|++||+++|++++
T Consensus       396 ~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          396 ANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HCCCCCEEECCSSSCCH
T ss_pred             hCCCccEEECCCCCCCH
Confidence            77778888888887764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=2.4e-31  Score=293.69  Aligned_cols=175  Identities=23%  Similarity=0.252  Sum_probs=96.5

Q ss_pred             ecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc-ccccCcccEEEecCCC
Q 002826          139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-IGKLEKLEQLFLQSSG  217 (876)
Q Consensus       139 dL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~-~~~l~~L~~L~L~~n~  217 (876)
                      ||++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|+  +..+|.. |.++++|++|+|++|+
T Consensus        58 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~L~~n~  135 (353)
T 2z80_A           58 DLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY--LSNLSSSWFKPLSSLTFLNLLGNP  135 (353)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC--CSSCCHHHHTTCTTCSEEECTTCC
T ss_pred             ECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc--CCcCCHhHhCCCccCCEEECCCCC
Confidence            444445555555677888888888888888887777778888888888888876  4455544 5555556666665555


Q ss_pred             CcccCC-ccccCCCCCcEEecccCc-cCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccC
Q 002826          218 FHGVIP-DSFVGLQSLSILDLSQNN-LTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSI  295 (876)
Q Consensus       218 l~~~~~-~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  295 (876)
                      ++++.+ ..|.++++|++|++++|+ ++ .++...+..+++|++|++++|++++..|..+..+++|++|++++|.++...
T Consensus       136 l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~  214 (353)
T 2z80_A          136 YKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLL  214 (353)
T ss_dssp             CSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHH
T ss_pred             CcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccch
Confidence            554433 345555555555555553 33 333333334455555555555554444444444444444444444443222


Q ss_pred             CCCCccccccceeecccccCC
Q 002826          296 PGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       296 ~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      +..+..+++|++|++++|.++
T Consensus       215 ~~~~~~~~~L~~L~L~~n~l~  235 (353)
T 2z80_A          215 EIFVDVTSSVECLELRDTDLD  235 (353)
T ss_dssp             HHHHHHTTTEEEEEEESCBCT
T ss_pred             hhhhhhcccccEEECCCCccc
Confidence            222223334444444444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=2.4e-31  Score=287.56  Aligned_cols=286  Identities=19%  Similarity=0.226  Sum_probs=189.5

Q ss_pred             CCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccce
Q 002826           58 HYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV  137 (876)
Q Consensus        58 ~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  137 (876)
                      ..|.|.+|.|...+..                .+|..+.  ++|++|+|++|+++...+..|+++++|++|+|++|.|+.
T Consensus         5 C~C~~~~l~c~~~~l~----------------~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~   66 (306)
T 2z66_A            5 CSCSGTEIRCNSKGLT----------------SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF   66 (306)
T ss_dssp             CEEETTEEECCSSCCS----------------SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCE
T ss_pred             CeeCCCEEEcCCCCcc----------------cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCc
Confidence            4599999999765321                2333332  588999999999987666678888888888777666532


Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC--CcccccCcccEEEecC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP--SDIGKLEKLEQLFLQS  215 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p--~~~~~l~~L~~L~L~~  215 (876)
                      +        +..|..+..+++|++|+|++|.++ .+|..|.++++|++|+|++|+  +..++  ..+..+++|++|++++
T Consensus        67 ~--------~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~~l~~L~~L~l~~  135 (306)
T 2z66_A           67 K--------GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN--LKQMSEFSVFLSLRNLIYLDISH  135 (306)
T ss_dssp             E--------EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSE--EESSTTTTTTTTCTTCCEEECTT
T ss_pred             c--------cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCc--ccccccchhhhhccCCCEEECCC
Confidence            2        233556667888888888888887 566678888888888888887  44444  3577777777777777


Q ss_pred             CCCcccCCccccCCCCCcEEecccCccCC-CCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc
Q 002826          216 SGFHGVIPDSFVGLQSLSILDLSQNNLTG-EVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS  294 (876)
Q Consensus       216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  294 (876)
                      |++.+..+..|.++++|++|+|++|++++ .+|..+ ..+++|++|+|++|++++..|..+..+++|++|+|++|++++.
T Consensus       136 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  214 (306)
T 2z66_A          136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF-TELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL  214 (306)
T ss_dssp             SCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCC-TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             CcCCccchhhcccCcCCCEEECCCCccccccchhHH-hhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence            77777777777777777777777777764 244433 4467777777777777766666666677777777777777666


Q ss_pred             CCCCCccccccceeecccccCCCCCCcccCCCC-cccEEEecCCcccccCc--cccccCCCCCeeeccCcccCCCCCCcc
Q 002826          295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLP-RIKLIRAESNRFSGAIP--DSISMAAQLEQVQIDNNRFTSSIPQGL  371 (876)
Q Consensus       295 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~  371 (876)
                      .+..|..+++|++|++++|++++..|..+..++ +|+.|++++|.+++..+  .....+...+.+.+..+.+....|..+
T Consensus       215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~  294 (306)
T 2z66_A          215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK  294 (306)
T ss_dssp             CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGG
T ss_pred             ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhh
Confidence            555666666666666666666666666666663 66666666666654321  111122233334444455554444444


Q ss_pred             cc
Q 002826          372 GS  373 (876)
Q Consensus       372 ~~  373 (876)
                      .+
T Consensus       295 ~g  296 (306)
T 2z66_A          295 QG  296 (306)
T ss_dssp             TT
T ss_pred             CC
Confidence            33

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-30  Score=288.29  Aligned_cols=282  Identities=20%  Similarity=0.196  Sum_probs=220.0

Q ss_pred             CccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      ..+...+.++++|.++ .+|..+.  ++|++|+|++|+  +..+|. .|.++++|++|+|++|++++..|..|.++++|+
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  103 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNR--ITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLE  103 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSC--CCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCc--CcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCC
Confidence            4455567889999998 5665554  489999999998  555655 688899999999999999988888899999999


Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCC-cccccCCccceeeeecc-cccccCCCCCccccccceeecc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKN-FFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      +|+|++|+|+ .+|...+..+++|++|+|++|++++..+ ..+..+++|++|++++| .+++..+..|.++++|++|+++
T Consensus       104 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  182 (353)
T 2z80_A          104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID  182 (353)
T ss_dssp             EEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred             EEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence            9999999998 6777656678899999999999985544 47888899999999988 5777777888888888888888


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCC
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL  391 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  391 (876)
                      +|++++..|..+..+++|+.|++++|+++...+..+..+++|++|++++|++++..+..+..                  
T Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------------  244 (353)
T 2z80_A          183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------------  244 (353)
T ss_dssp             ETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC----------------------
T ss_pred             CCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc------------------
Confidence            88888888888888888888888888887655555566788888888888887654443321                  


Q ss_pred             CCCcCCCCCccEEEccCCcccc-----CCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCC
Q 002826          392 PPNFCDSPVMSIINLSQNSISG-----QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       392 ~~~~~~~~~L~~L~Ls~N~l~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                         ......++.++|++|.+++     .++.+..+++|++|+|++|+++...+..|..+++|++|+|++|++++..|
T Consensus       245 ---~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          245 ---GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             -----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             ---ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence               1123446666777777665     23368889999999999999995544557999999999999999987554

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.1e-30  Score=282.34  Aligned_cols=164  Identities=18%  Similarity=0.239  Sum_probs=86.2

Q ss_pred             CCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCC-CCCCccccccCccEEeCCCccccCCCCCCcCCCCCccE
Q 002826          325 SLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS-SIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSI  403 (876)
Q Consensus       325 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~  403 (876)
                      .+++|++|++++|++++..+..+..+++|++|++++|++++ ..|..+..+++|+.|++++|++++..|..|..+++|+.
T Consensus       124 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  203 (306)
T 2z66_A          124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  203 (306)
T ss_dssp             TCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             hccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCE
Confidence            33333333333333333333334444444444444444443 24444445555555555555555555555555556666


Q ss_pred             EEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCC-CcceeeCCCCcccccCCC--ccccc-ccceEEccC
Q 002826          404 INLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELP-VLTYLDLSDNNLTGPIPQ--GLQNL-KLALFNVSF  478 (876)
Q Consensus       404 L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~--~~~~l-~l~~l~ls~  478 (876)
                      |+|++|++++.++ .+..+++|++|+|++|++++..|..+..++ +|++|+|++|++++..+.  ....+ ....+.+..
T Consensus       204 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~  283 (306)
T 2z66_A          204 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV  283 (306)
T ss_dssp             EECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCG
T ss_pred             EECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccc
Confidence            6666666665554 566667777777777777767777777764 777777777777653221  11111 122344455


Q ss_pred             CccccccCCc
Q 002826          479 NKLSGRVPYS  488 (876)
Q Consensus       479 N~l~~~~p~~  488 (876)
                      |.+.+..|..
T Consensus       284 ~~~~C~~p~~  293 (306)
T 2z66_A          284 ERMECATPSD  293 (306)
T ss_dssp             GGCBEEESGG
T ss_pred             cccccCCchh
Confidence            6666655543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.7e-29  Score=286.80  Aligned_cols=244  Identities=15%  Similarity=0.158  Sum_probs=148.8

Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      ...++.+++.++ .+|..+.   ++|++|+|++|+|++..+..|.++++|++|+|++|.|+++.+..|.++++|++|+|+
T Consensus        56 ~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~  131 (452)
T 3zyi_A           56 FSKVVCTRRGLS-EVPQGIP---SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF  131 (452)
T ss_dssp             SCEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CcEEEECCCCcC-ccCCCCC---CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence            345666666666 5665543   456666666666666666666666666666666666666666666666666666666


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccC-cccCCCCCCccccccCccEEeCCCccccCC
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDN-NRFTSSIPQGLGSVKSLYRFSASQNSFYGS  390 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~  390 (876)
                      +|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++ |.++...+..|.++++|+.|++++|++++.
T Consensus       132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            6666655555666666666666666666666566666666666666666 334333333466666666666666666543


Q ss_pred             CCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc
Q 002826          391 LPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL  469 (876)
Q Consensus       391 ~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  469 (876)
                       | .+..+++|+.|+|++|++++..+ .|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+
T Consensus       212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  289 (452)
T 3zyi_A          212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL  289 (452)
T ss_dssp             -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred             -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence             2 35566666666666666666555 56666666666666666666666666666666666666666665444444444


Q ss_pred             -ccceEEccCCcc
Q 002826          470 -KLALFNVSFNKL  481 (876)
Q Consensus       470 -~l~~l~ls~N~l  481 (876)
                       +++.|++++|++
T Consensus       290 ~~L~~L~L~~Np~  302 (452)
T 3zyi_A          290 RYLVELHLHHNPW  302 (452)
T ss_dssp             TTCCEEECCSSCE
T ss_pred             cCCCEEEccCCCc
Confidence             244444444443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=1.2e-29  Score=271.23  Aligned_cols=254  Identities=19%  Similarity=0.206  Sum_probs=128.2

Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      ++++++++.  +..+|..+  .++|++|+|++|+++++.+..|.++++|++|+|++|++++..|.. +..+++|++|+|+
T Consensus        14 ~~~~c~~~~--l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~   88 (285)
T 1ozn_A           14 VTTSCPQQG--LQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA-FTGLALLEQLDLS   88 (285)
T ss_dssp             CEEECCSSC--CSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTT-TTTCTTCCEEECC
T ss_pred             eEEEcCcCC--cccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhh-cCCccCCCEEeCC
Confidence            344444443  33444332  234555555555555555555555555555555555555222222 2335555555555


Q ss_pred             ccc-ccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCccccc
Q 002826          264 QNK-LSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGA  342 (876)
Q Consensus       264 ~N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  342 (876)
                      +|+ ++...|..|..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..|..+++|+.|++++|++++.
T Consensus        89 ~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  168 (285)
T 1ozn_A           89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSV  168 (285)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccccc
Confidence            554 4444445555555555555555555555555555555555555555555544444555555555555555555555


Q ss_pred             CccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCccccc
Q 002826          343 IPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCR  422 (876)
Q Consensus       343 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~  422 (876)
                      .+..|..+++|++|++++|++++..|..+.++++|+.|++++|++++..+..|..+++|+.|++++|.+....+......
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~  248 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWA  248 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHH
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHH
Confidence            55455555555555555555555555555555555555555555554444445555555555555555543332111122


Q ss_pred             ccceEeccCCcCCCCCCcCC
Q 002826          423 KLVSLSLADNSLTGEIPPSL  442 (876)
Q Consensus       423 ~L~~L~Ls~N~l~~~~p~~~  442 (876)
                      .++.+..+.|.+....|..+
T Consensus       249 ~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          249 WLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             HHHHCCSEECCCBEEESGGG
T ss_pred             HHHhcccccCccccCCchHh
Confidence            33333444444444444433

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.4e-29  Score=268.80  Aligned_cols=252  Identities=19%  Similarity=0.189  Sum_probs=204.6

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      ++++.+++.++ .+|..+   .++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++|++++
T Consensus        14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            57788888887 777654   35788888888888877777788888888888888888888888888888888888888


Q ss_pred             cc-CCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCC
Q 002826          313 NG-FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL  391 (876)
Q Consensus       313 N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  391 (876)
                      |. ++...|..|..+++|++|++++|++++..|..+..+++|++|++++|++++..+..+..+++|+.|++++|++++..
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  169 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP  169 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence            87 77777888888888888888888888888888888888999999999888777777888889999999999988877


Q ss_pred             CCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcccccc
Q 002826          392 PPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLK  470 (876)
Q Consensus       392 ~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  470 (876)
                      +..|..+++|+.|+|++|++++..+ .+..+++|++|+|++|++++..+..|..+++|++|+|++|++....+..-..-.
T Consensus       170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~  249 (285)
T 1ozn_A          170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW  249 (285)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHH
T ss_pred             HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHH
Confidence            7788889999999999999988766 788899999999999999987778899999999999999998854332100002


Q ss_pred             cceEEccCCccccccCCc
Q 002826          471 LALFNVSFNKLSGRVPYS  488 (876)
Q Consensus       471 l~~l~ls~N~l~~~~p~~  488 (876)
                      ++.+..+.|.+.+..|..
T Consensus       250 l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          250 LQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             HHHCCSEECCCBEEESGG
T ss_pred             HHhcccccCccccCCchH
Confidence            344556777777777754

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=6.7e-31  Score=301.93  Aligned_cols=233  Identities=17%  Similarity=0.161  Sum_probs=147.5

Q ss_pred             cccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeee
Q 002826          207 KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSL  286 (876)
Q Consensus       207 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  286 (876)
                      +|++|+|++|++++..|..|.++++|++|+|++|.|++..|   +..+++|++|+|++|+|++..+     .++|++|++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L  106 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA  106 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence            56666666666666666666666666666666666664333   3345666666666666553221     244555555


Q ss_pred             ecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCC
Q 002826          287 HKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSS  366 (876)
Q Consensus       287 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  366 (876)
                      ++|.|++..+..                           +++|+.|++++|++++..|..+..+++|++|+|++|++++.
T Consensus       107 ~~N~l~~~~~~~---------------------------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  159 (487)
T 3oja_A          107 ANNNISRVSCSR---------------------------GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTV  159 (487)
T ss_dssp             CSSCCCCEEECC---------------------------CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred             cCCcCCCCCccc---------------------------cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCc
Confidence            555554433322                           34455555555555555555555555566666666666555


Q ss_pred             CCCccc-cccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCC
Q 002826          367 IPQGLG-SVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAEL  445 (876)
Q Consensus       367 ~p~~~~-~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  445 (876)
                      +|..+. .+++|+.|+|++|.+++..+  +..+++|+.|+|++|.|++.++.+..+++|+.|+|++|+|++ +|..+..+
T Consensus       160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l  236 (487)
T 3oja_A          160 NFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFS  236 (487)
T ss_dssp             EGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCC
T ss_pred             ChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccC
Confidence            555554 45666666666666665532  234778888888888888887788888999999999999984 67778889


Q ss_pred             CCcceeeCCCCccc-ccCCCccccc-ccceEEcc
Q 002826          446 PVLTYLDLSDNNLT-GPIPQGLQNL-KLALFNVS  477 (876)
Q Consensus       446 ~~L~~L~Ls~N~l~-~~~p~~~~~l-~l~~l~ls  477 (876)
                      ++|+.|++++|.+. +.+|..+..+ .+..++++
T Consensus       237 ~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             TTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            99999999999987 5566665554 24444443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=1.9e-30  Score=281.06  Aligned_cols=260  Identities=19%  Similarity=0.200  Sum_probs=147.3

Q ss_pred             ccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCC
Q 002826          152 SIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQS  231 (876)
Q Consensus       152 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  231 (876)
                      .++..++|++|++++|.+  .+|..+...  |+.|+|++|++....+|..+..                 ..-.+.++++
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~-----------------~~~~~~~l~~   96 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILF-----------------GALRVLGISG   96 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHH-----------------HHHHHHTTSC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHH-----------------HHHHhcCcCC
Confidence            345566677777777777  455444432  6666666665222222322220                 0000114566


Q ss_pred             CcEEecccCccCCCCCCccc-cccccccEEEeccccccCcCCcccccC-----CccceeeeecccccccCCCCCcccccc
Q 002826          232 LSILDLSQNNLTGEVPQSLG-SSLLKLVSFDVSQNKLSGSFPNGICKA-----NGLVNLSLHKNFFNGSIPGSINECLNL  305 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~i~~~~~~~~~~l~~L  305 (876)
                      |++|+|++|++++.+|..++ ..+++|++|+|++|++++. |..+..+     ++|++|+|++|+|++..|..|..+++|
T Consensus        97 L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  175 (312)
T 1wwl_A           97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL  175 (312)
T ss_dssp             CCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSC
T ss_pred             ccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCC
Confidence            66666666666666665543 4566666666666666655 5555555     667777777777766666667777777


Q ss_pred             ceeecccccCCCC--CCccc--CCCCcccEEEecCCcccc---cCccccccCCCCCeeeccCcccCCCCCCccccccCcc
Q 002826          306 ERFQVQDNGFSGD--FPDKL--WSLPRIKLIRAESNRFSG---AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY  378 (876)
Q Consensus       306 ~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~L~~N~l~~---~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~  378 (876)
                      ++|++++|++.+.  .|..+  ..+++|+.|++++|++++   .....+..+++|++|+|++|++++.+|.         
T Consensus       176 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------  246 (312)
T 1wwl_A          176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA---------  246 (312)
T ss_dssp             CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC---------
T ss_pred             CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch---------
Confidence            7777777766543  22222  556666666666666652   1223334555566666666666544431         


Q ss_pred             EEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcc
Q 002826          379 RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL  458 (876)
Q Consensus       379 ~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  458 (876)
                                    ..+..+++|++|+|++|+|+..+..+.  ++|++|+|++|+|++. |. +..+++|++|+|++|++
T Consensus       247 --------------~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l  308 (312)
T 1wwl_A          247 --------------PSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPF  308 (312)
T ss_dssp             --------------SCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTT
T ss_pred             --------------hhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCC
Confidence                          223334455555555555553333333  6677777777777655 44 67777777777777777


Q ss_pred             cc
Q 002826          459 TG  460 (876)
Q Consensus       459 ~~  460 (876)
                      ++
T Consensus       309 ~~  310 (312)
T 1wwl_A          309 LD  310 (312)
T ss_dssp             TC
T ss_pred             CC
Confidence            64

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2e-28  Score=278.69  Aligned_cols=248  Identities=20%  Similarity=0.218  Sum_probs=162.2

Q ss_pred             cceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEE
Q 002826          182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFD  261 (876)
Q Consensus       182 ~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~  261 (876)
                      +...++.+++.  +..+|..+.  ++++.|+|++|+++++.+..|.++++|++|+|++|+|+ .++...+.++++|++|+
T Consensus        44 ~~~~v~c~~~~--l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~  118 (440)
T 3zyj_A           44 QFSKVICVRKN--LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE  118 (440)
T ss_dssp             TSCEEECCSCC--CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEE
T ss_pred             CCCEEEeCCCC--cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEE
Confidence            35567777765  566776654  46666777777776666666666666777777666666 44444444566666666


Q ss_pred             eccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccc
Q 002826          262 VSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG  341 (876)
Q Consensus       262 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  341 (876)
                      |++|+|++..+..|..+++|++|+|++|.|+.+.+..|..+++|++|++++|                       |.+..
T Consensus       119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~-----------------------~~l~~  175 (440)
T 3zyj_A          119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL-----------------------KRLSY  175 (440)
T ss_dssp             CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC-----------------------TTCCE
T ss_pred             CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC-----------------------CCcce
Confidence            6666666544445555555555555555555444445555555555555442                       23333


Q ss_pred             cCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-Cccc
Q 002826          342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKK  420 (876)
Q Consensus       342 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~  420 (876)
                      ..+..|..+++|++|+|++|+++ .+| .+..+++|+.|++++|++++..|..|.++++|+.|+|++|+|++..+ .|..
T Consensus       176 i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  253 (440)
T 3zyj_A          176 ISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN  253 (440)
T ss_dssp             ECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTT
T ss_pred             eCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcC
Confidence            33345555566666666666665 333 35666777777777777777777777777777777888888777666 6778


Q ss_pred             ccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc
Q 002826          421 CRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       421 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      +++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          254 LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            888888888888888777778888888888888888876

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=6.4e-31  Score=285.49  Aligned_cols=279  Identities=16%  Similarity=0.154  Sum_probs=173.1

Q ss_pred             CCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccc
Q 002826          125 LETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGK  204 (876)
Q Consensus       125 L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~  204 (876)
                      +.++.+.+|.+..++++.+.+....+..+..+++|++|+|++|++++..|..|.++++|++|+|++|+  +..+++ +..
T Consensus         2 i~~l~~~g~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~--l~~~~~-~~~   78 (317)
T 3o53_A            2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV--LYETLD-LES   78 (317)
T ss_dssp             CCEEEEETTEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSC--CEEEEE-ETT
T ss_pred             cccccCCcCceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCc--CCcchh-hhh
Confidence            34566666777777888888876666667778888999999998888777888888888888888887  222322 666


Q ss_pred             cCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCcccee
Q 002826          205 LEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL  284 (876)
Q Consensus       205 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  284 (876)
                      +++|++|+|++|++++..     ..++|++|++++|+|+ .++..   .+++|++|++++|++++..+..+..+++|++|
T Consensus        79 l~~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~-~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  149 (317)
T 3o53_A           79 LSTLRTLDLNNNYVQELL-----VGPSIETLHAANNNIS-RVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYL  149 (317)
T ss_dssp             CTTCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCS-EEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEE
T ss_pred             cCCCCEEECcCCcccccc-----CCCCcCEEECCCCccC-CcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEE
Confidence            666666666666666432     2256666666666666 33322   13455555555555555444455555555555


Q ss_pred             eeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          285 SLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       285 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      +|++|.+++..+..+.                       ..+++|++|++++|++++..+  ...+++|++|+|++|+++
T Consensus       150 ~Ls~N~l~~~~~~~~~-----------------------~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~  204 (317)
T 3o53_A          150 DLKLNEIDTVNFAELA-----------------------ASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLA  204 (317)
T ss_dssp             ECTTSCCCEEEGGGGG-----------------------GGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCcccHHHHh-----------------------hccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCC
Confidence            5555555444333332                       234555555555555554321  123556666666666666


Q ss_pred             CCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccc-cCCc-CcccccccceEecc-CCcCCCCCCcC
Q 002826          365 SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSIS-GQIP-ELKKCRKLVSLSLA-DNSLTGEIPPS  441 (876)
Q Consensus       365 ~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~~-~~~~l~~L~~L~Ls-~N~l~~~~p~~  441 (876)
                      + +|..+..+++|+.|++++|++++ +|..+..+++|+.|++++|.++ +.++ .+..+++|+.|+++ .+.+++..|..
T Consensus       205 ~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~  282 (317)
T 3o53_A          205 F-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE  282 (317)
T ss_dssp             E-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred             c-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence            3 33346666666666666666663 4556677777777777777777 4444 57778888888888 44466655544


Q ss_pred             C
Q 002826          442 L  442 (876)
Q Consensus       442 ~  442 (876)
                      .
T Consensus       283 ~  283 (317)
T 3o53_A          283 C  283 (317)
T ss_dssp             C
T ss_pred             c
Confidence            3

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=1.1e-28  Score=268.81  Aligned_cols=224  Identities=18%  Similarity=0.242  Sum_probs=119.6

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEec
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      ++++|+|++|+++ .+|..+.++++|++|+|++|.  +..+|..++++++|++|+|++|+++ .+|..|.++++|++|+|
T Consensus        82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~--l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG--LMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSC--CCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCC--ccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            3444444444444 333334444444444444444  2244444444444555555555555 34555555566666666


Q ss_pred             ccCccCCCCCCccc--------cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceee
Q 002826          238 SQNNLTGEVPQSLG--------SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQ  309 (876)
Q Consensus       238 s~N~l~~~ip~~~~--------~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  309 (876)
                      ++|++.+.+|..+.        .++++|++|+|++|+++ .+|..+..+++|++|+|++|.+++ +|..|..+++|++|+
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~  235 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD  235 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence            66555555555442        23666666666666666 555566666666666666666663 333455555566666


Q ss_pred             cccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccc
Q 002826          310 VQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF  387 (876)
Q Consensus       310 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  387 (876)
                      +++|.+.+.+|..+.++++|+.|++++|++.+.+|..+..+++|++|+|++|++.+.+|..++++++|+.+++..|.+
T Consensus       236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            665555555555555555555555555555555555555555555555555555555555555555555554444433

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.7e-28  Score=285.82  Aligned_cols=265  Identities=26%  Similarity=0.315  Sum_probs=178.5

Q ss_pred             ceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecC
Q 002826          136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS  215 (876)
Q Consensus       136 ~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~  215 (876)
                      +.|++++|+++ .+|..+.  ++|++|+|++|+|+ .+|.   .+++|++|+|++|+  ++.+|.   .+++|++|+|++
T Consensus        43 ~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~--l~~lp~---~l~~L~~L~Ls~  110 (622)
T 3g06_A           43 AVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQ--LTSLPV---LPPGLLELSIFS  110 (622)
T ss_dssp             CEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCC--CSCCCC---CCTTCCEEEECS
T ss_pred             cEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCc--CCcCCC---CCCCCCEEECcC
Confidence            34566666666 6677665  78999999999998 4554   56888999999987  556776   567788888888


Q ss_pred             CCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccC
Q 002826          216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSI  295 (876)
Q Consensus       216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  295 (876)
                      |+++++.+    .+++|+.|++++|+|+ .+|..    +++|++|+|++|++++. |.   .+++|+.|++++|.|++ +
T Consensus       111 N~l~~l~~----~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l  176 (622)
T 3g06_A          111 NPLTHLPA----LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-L  176 (622)
T ss_dssp             CCCCCCCC----CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-C
T ss_pred             CcCCCCCC----CCCCcCEEECCCCCCC-cCCCC----CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-C
Confidence            88876433    4677778888888877 56653    36777777777777642 32   23455566666666553 2


Q ss_pred             CCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCcccccc
Q 002826          296 PGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK  375 (876)
Q Consensus       296 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  375 (876)
                      |   ..+++|+.|++++|+|                        ++. |.   .+++|+.|++++|+++ .+|..   ++
T Consensus       177 ~---~~~~~L~~L~Ls~N~l------------------------~~l-~~---~~~~L~~L~L~~N~l~-~l~~~---~~  221 (622)
T 3g06_A          177 P---MLPSGLQELSVSDNQL------------------------ASL-PT---LPSELYKLWAYNNRLT-SLPAL---PS  221 (622)
T ss_dssp             C---CCCTTCCEEECCSSCC------------------------SCC-CC---CCTTCCEEECCSSCCS-SCCCC---CT
T ss_pred             c---ccCCCCcEEECCCCCC------------------------CCC-CC---ccchhhEEECcCCccc-ccCCC---CC
Confidence            2   2234444444444444                        432 21   1245566666666665 33332   35


Q ss_pred             CccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCC
Q 002826          376 SLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSD  455 (876)
Q Consensus       376 ~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  455 (876)
                      +|+.|++++|+|++ +|   ..+++|+.|+|++|+|+..++   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++
T Consensus       222 ~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~  293 (622)
T 3g06_A          222 GLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  293 (622)
T ss_dssp             TCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred             CCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence            66677777777765 33   344677888888888875544   5678889999999988 6788888999999999999


Q ss_pred             CcccccCCCccccc
Q 002826          456 NNLTGPIPQGLQNL  469 (876)
Q Consensus       456 N~l~~~~p~~~~~l  469 (876)
                      |++++..|..+..+
T Consensus       294 N~l~~~~~~~l~~L  307 (622)
T 3g06_A          294 NPLSERTLQALREI  307 (622)
T ss_dssp             CCCCHHHHHHHHHH
T ss_pred             CCCCCcCHHHHHhc
Confidence            99988887776654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.96  E-value=2.7e-32  Score=323.28  Aligned_cols=325  Identities=14%  Similarity=0.074  Sum_probs=159.4

Q ss_pred             CccccceecccccccCCC----cCccccCCCcceEEEccCCCCc---CCCCCCcccccCcccEEEecCCCCcccCCcccc
Q 002826          155 SLVNLQVLNLGSNLLSGS----VPFVFGNFSELVVLDLSQNAYL---ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV  227 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~~~---~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~  227 (876)
                      ++++|++|+|++|.+++.    ++..+.++++|++|+|++|.+.   ...++..+.++++|++|+|++|.+.+ +|..+.
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~  240 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK  240 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence            456666666666665544    2333445566666666666521   01222234455666666666666654 345555


Q ss_pred             CCCCCcEEecccCccC---CCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCC-CCCcccc
Q 002826          228 GLQSLSILDLSQNNLT---GEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIP-GSINECL  303 (876)
Q Consensus       228 ~l~~L~~L~Ls~N~l~---~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~  303 (876)
                      ++++|+.|+++.+...   +..+..+ ..+++|+.|+++++... .+|..+..+++|++|+|++|.+++... ..+..++
T Consensus       241 ~~~~L~~L~l~~~~~~~~~~~~~~~l-~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~  318 (592)
T 3ogk_B          241 AAANLEEFCGGSLNEDIGMPEKYMNL-VFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP  318 (592)
T ss_dssp             HCTTCCEEEECBCCCCTTCTTSSSCC-CCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCT
T ss_pred             hhhHHHhhcccccccccchHHHHHHh-hccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCc
Confidence            6666666666543221   1112222 23455666666554322 445555555666666666665543322 2234555


Q ss_pred             ccceeecccccCC-CCCCcccCCCCcccEEEec-----------CCcccccCc-cccccCCCCCeeeccCcccCCCCCCc
Q 002826          304 NLERFQVQDNGFS-GDFPDKLWSLPRIKLIRAE-----------SNRFSGAIP-DSISMAAQLEQVQIDNNRFTSSIPQG  370 (876)
Q Consensus       304 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~  370 (876)
                      +|++|+++ |.+. +.++..+..+++|+.|+++           .|.+++... ..+..+++|++|+++.|++++..+..
T Consensus       319 ~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~  397 (592)
T 3ogk_B          319 NLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLES  397 (592)
T ss_dssp             TCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHH
T ss_pred             CCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHH
Confidence            66666665 2222 2222233445556666666           244443322 22334556666666656665544444


Q ss_pred             ccc-ccCccEEeCC----CccccCC-----CCCCcCCCCCccEEEccCCc--cccCCc-Cc-ccccccceEeccCCcCCC
Q 002826          371 LGS-VKSLYRFSAS----QNSFYGS-----LPPNFCDSPVMSIINLSQNS--ISGQIP-EL-KKCRKLVSLSLADNSLTG  436 (876)
Q Consensus       371 ~~~-l~~L~~L~ls----~N~l~~~-----~~~~~~~~~~L~~L~Ls~N~--l~~~~~-~~-~~l~~L~~L~Ls~N~l~~  436 (876)
                      +.. +++|+.|+++    .|.+++.     ++..+.++++|+.|+|++|.  +++... .+ ..+++|++|+|++|++++
T Consensus       398 l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~  477 (592)
T 3ogk_B          398 IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESD  477 (592)
T ss_dssp             HHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSH
T ss_pred             HHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCH
Confidence            443 5556666664    4455442     11224445566666665322  333222 22 225556666666666554


Q ss_pred             -CCCcCCCCCCCcceeeCCCCccccc-CCCccccc-ccceEEccCCcccc
Q 002826          437 -EIPPSLAELPVLTYLDLSDNNLTGP-IPQGLQNL-KLALFNVSFNKLSG  483 (876)
Q Consensus       437 -~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l-~l~~l~ls~N~l~~  483 (876)
                       .++..+.++++|++|+|++|.+++. ++.....+ +++.|++++|+++.
T Consensus       478 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          478 EGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence             2233345556666666666665432 22222223 35556666666553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.5e-28  Score=277.78  Aligned_cols=247  Identities=19%  Similarity=0.215  Sum_probs=206.6

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCC-CCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEI-PSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~-p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      ..+.++.+++.++ .+|..+.  ++++.|+|++|+  +..+ +..|.++++|++|+|++|+++++.+..|.++++|++|+
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~--i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~  118 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQ--IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLE  118 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCC--CCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEE
T ss_pred             CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCc--CCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEE
Confidence            4567889999998 6666554  689999999998  4444 46799999999999999999999999999999999999


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeec-ccccccCCCCCccccccceeecccccC
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK-NFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      |++|+|+ .+|...+..+++|++|+|++|+|+...+..|..+++|++|+|++ |.+..+.+..|.++++|++|++++|++
T Consensus       119 L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l  197 (440)
T 3zyj_A          119 LFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL  197 (440)
T ss_dssp             CCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred             CCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence            9999999 77777777899999999999999988888999999999999999 566666667899999999999999999


Q ss_pred             CCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCc
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNF  395 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~  395 (876)
                      +. +| .+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..|
T Consensus       198 ~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  275 (440)
T 3zyj_A          198 RE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLF  275 (440)
T ss_dssp             SS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             cc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHh
Confidence            84 44 47778888888888888888778888888888888888888877777777777777777777777776666667


Q ss_pred             CCCCCccEEEccCCccc
Q 002826          396 CDSPVMSIINLSQNSIS  412 (876)
Q Consensus       396 ~~~~~L~~L~Ls~N~l~  412 (876)
                      ..+++|+.|+|++|.+.
T Consensus       276 ~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          276 TPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             SSCTTCCEEECCSSCEE
T ss_pred             ccccCCCEEEcCCCCcc
Confidence            77777777777777664

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.4e-28  Score=279.02  Aligned_cols=89  Identities=22%  Similarity=0.209  Sum_probs=52.2

Q ss_pred             cccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcc
Q 002826          371 LGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLT  449 (876)
Q Consensus       371 ~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  449 (876)
                      +..+++|+.|++++|.+++..|..|.++++|+.|+|++|++++..+ .|..+++|+.|+|++|+|++..+..|..+++|+
T Consensus       214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  293 (452)
T 3zyi_A          214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV  293 (452)
T ss_dssp             CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred             ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence            3344444444555555544445555555555555555555555444 456666666666666666666666666677777


Q ss_pred             eeeCCCCccc
Q 002826          450 YLDLSDNNLT  459 (876)
Q Consensus       450 ~L~Ls~N~l~  459 (876)
                      .|+|++|.+.
T Consensus       294 ~L~L~~Np~~  303 (452)
T 3zyi_A          294 ELHLHHNPWN  303 (452)
T ss_dssp             EEECCSSCEE
T ss_pred             EEEccCCCcC
Confidence            7777777665

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.96  E-value=3.3e-30  Score=279.16  Aligned_cols=201  Identities=18%  Similarity=0.218  Sum_probs=138.2

Q ss_pred             cCCccceeeeecccccccCCCCC--ccccccceeecccccCCCCCCcccCCC-----CcccEEEecCCcccccCcccccc
Q 002826          277 KANGLVNLSLHKNFFNGSIPGSI--NECLNLERFQVQDNGFSGDFPDKLWSL-----PRIKLIRAESNRFSGAIPDSISM  349 (876)
Q Consensus       277 ~l~~L~~L~L~~N~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~  349 (876)
                      ++++|++|+|++|++++.+|..+  ..+++|++|++++|++++. |..+..+     ++|++|++++|++++..|..|..
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            34555555555555555555443  5555555555555555544 4444444     56666666666666555566666


Q ss_pred             CCCCCeeeccCcccCCC--CCCcc--ccccCccEEeCCCccccC---CCCCCcCCCCCccEEEccCCccccCCc--Cccc
Q 002826          350 AAQLEQVQIDNNRFTSS--IPQGL--GSVKSLYRFSASQNSFYG---SLPPNFCDSPVMSIINLSQNSISGQIP--ELKK  420 (876)
Q Consensus       350 l~~L~~L~L~~N~l~~~--~p~~~--~~l~~L~~L~ls~N~l~~---~~~~~~~~~~~L~~L~Ls~N~l~~~~~--~~~~  420 (876)
                      +++|++|+|++|++++.  .|..+  ..+++|++|++++|++++   .....+..+++|+.|+|++|++++.++  .+..
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  251 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW  251 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCC
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhh
Confidence            66666666666665543  12222  566777777777777762   222345577889999999999998774  6778


Q ss_pred             ccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCcccc
Q 002826          421 CRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSG  483 (876)
Q Consensus       421 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~  483 (876)
                      +++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+ +++.|++++|++++
T Consensus       252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            899999999999999 7777776  8999999999999976 66 6666 58999999999985

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=5.7e-28  Score=283.03  Aligned_cols=297  Identities=20%  Similarity=0.306  Sum_probs=208.4

Q ss_pred             CCCCCCCCCCCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCc
Q 002826           48 LSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLET  127 (876)
Q Consensus        48 ~~sW~~~~~~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  127 (876)
                      .++|...  .+||.|+|..|....                     ...+...+++.|++++|.++ .+|..+.  ++|++
T Consensus        12 w~~W~~~--~~~~~~~~r~~~~~~---------------------~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~   65 (622)
T 3g06_A           12 WSAWRRA--APAEESRGRAAVVQK---------------------MRACLNNGNAVLNVGESGLT-TLPDCLP--AHITT   65 (622)
T ss_dssp             HHHHHHT--CCGGGHHHHHHHHHH---------------------HHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSE
T ss_pred             HHHHHhc--CCcchhccccccCcc---------------------cccccCCCCcEEEecCCCcC-ccChhhC--CCCcE
Confidence            4567543  479999886653221                     01122356999999999998 4677665  67877


Q ss_pred             ccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCc
Q 002826          128 LNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEK  207 (876)
Q Consensus       128 L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~  207 (876)
                      |+|++|          +|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|++|+|++|+  +..+|.   .+++
T Consensus        66 L~L~~N----------~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~--l~~l~~---~l~~  122 (622)
T 3g06_A           66 LVIPDN----------NLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNP--LTHLPA---LPSG  122 (622)
T ss_dssp             EEECSC----------CCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCC--CCCCCC---CCTT
T ss_pred             EEecCC----------CCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCc--CCCCCC---CCCC
Confidence            765555          444 3454   47899999999999984 554   78999999999998  667777   6789


Q ss_pred             ccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeee
Q 002826          208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLH  287 (876)
Q Consensus       208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  287 (876)
                      |+.|++++|+++++ |..   +++|++|+|++|+|+ .+|..    +++|+.|++++|+|++ +|   ..+++|+.|+|+
T Consensus       123 L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~-~l~~~----~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls  189 (622)
T 3g06_A          123 LCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLA-SLPAL----PSELCKLWAYNNQLTS-LP---MLPSGLQELSVS  189 (622)
T ss_dssp             CCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC-CC---CCCTTCCEEECC
T ss_pred             cCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCC-CcCCc----cCCCCEEECCCCCCCC-Cc---ccCCCCcEEECC
Confidence            99999999999975 443   589999999999999 66653    5789999999999995 55   457899999999


Q ss_pred             cccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCC
Q 002826          288 KNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSI  367 (876)
Q Consensus       288 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  367 (876)
                      +|.|++ +|..   +++|+.|++++|.++. +|..   +++|+.|++++|+|++                         +
T Consensus       190 ~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-------------------------l  236 (622)
T 3g06_A          190 DNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-------------------------L  236 (622)
T ss_dssp             SSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-------------------------C
T ss_pred             CCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-------------------------C
Confidence            999996 3432   3678888888888773 3321   2455555555555553                         2


Q ss_pred             CCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCC
Q 002826          368 PQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELP  446 (876)
Q Consensus       368 p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  446 (876)
                      |   ..+++|+.|++++|+|++ +|.   .+++|+.|+|++|+|+..++.+.++++|+.|+|++|++++.+|..+..++
T Consensus       237 p---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          237 P---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             C---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             C---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            2   223445555555555543 222   34566667777777765544677777777777777777776666555443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=5.1e-30  Score=278.33  Aligned_cols=265  Identities=16%  Similarity=0.157  Sum_probs=164.0

Q ss_pred             cceEEEccCCCCcCCCCCC-cccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEE
Q 002826          182 ELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSF  260 (876)
Q Consensus       182 ~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L  260 (876)
                      +++.++++++.  +...+. .+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|   +..+++|++|
T Consensus        11 ~l~i~~ls~~~--l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L   85 (317)
T 3o53_A           11 RYKIEKVTDSS--LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTL   85 (317)
T ss_dssp             EEEEESCCTTT--HHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEE
T ss_pred             ceeEeeccccc--hhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEE
Confidence            34555666665  222222 23445566677777776666666666666666677776666663322   3446666666


Q ss_pred             EeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCccc
Q 002826          261 DVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS  340 (876)
Q Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  340 (876)
                      +|++|++++..     ..++|++|++++|+|++..+..                           +++|+.|++++|+++
T Consensus        86 ~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---------------------------~~~L~~L~l~~N~l~  133 (317)
T 3o53_A           86 DLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---------------------------GQGKKNIYLANNKIT  133 (317)
T ss_dssp             ECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---------------------------CSSCEEEECCSSCCC
T ss_pred             ECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---------------------------cCCCCEEECCCCCCC
Confidence            66666665322     2255555555555555444332                           234444555555554


Q ss_pred             ccCccccccCCCCCeeeccCcccCCCCCCcc-ccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcc
Q 002826          341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELK  419 (876)
Q Consensus       341 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~  419 (876)
                      +..+..+..+++|++|++++|++++..+..+ ..+++|++|++++|.+++..+  ...+++|+.|+|++|++++.++.+.
T Consensus       134 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~  211 (317)
T 3o53_A          134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQ  211 (317)
T ss_dssp             SGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGG
T ss_pred             CccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchhhhc
Confidence            4444445555555555555555554444443 245555566666665554422  2236778888888888888777888


Q ss_pred             cccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc-ccCCCccccc-ccceEEcc-CCccccccC
Q 002826          420 KCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT-GPIPQGLQNL-KLALFNVS-FNKLSGRVP  486 (876)
Q Consensus       420 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l-~l~~l~ls-~N~l~~~~p  486 (876)
                      .+++|++|+|++|+|+ .+|..+..+++|+.|++++|+++ +.+|..+..+ +++.++++ .+.+.|..|
T Consensus       212 ~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~  280 (317)
T 3o53_A          212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE  280 (317)
T ss_dssp             GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred             ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence            8899999999999998 56778888999999999999998 6677777766 47777887 445665444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.95  E-value=1.4e-28  Score=282.62  Aligned_cols=251  Identities=17%  Similarity=0.147  Sum_probs=142.7

Q ss_pred             CCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcc
Q 002826          141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHG  220 (876)
Q Consensus       141 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~  220 (876)
                      +..++...+.......++|++|+|++|.+++..|..|+++++|++|+|++|.  +..+++ +..+++|++|+|++|++++
T Consensus        18 ~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~~-l~~l~~L~~L~Ls~N~l~~   94 (487)
T 3oja_A           18 TDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV--LYETLD-LESLSTLRTLDLNNNYVQE   94 (487)
T ss_dssp             CTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSC--CEEEEE-CTTCTTCCEEECCSSEEEE
T ss_pred             chhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCC--CCCCcc-cccCCCCCEEEecCCcCCC
Confidence            3333333333333445578888888888877777777777777777777776  222222 5556666666666666654


Q ss_pred             cCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCc
Q 002826          221 VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSIN  300 (876)
Q Consensus       221 ~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~  300 (876)
                      +.+     .++|++|+|++|+|++ ++..   .+++|++|+|++|++++..|..+..+++|++|+|++|.|++.+|..|.
T Consensus        95 l~~-----~~~L~~L~L~~N~l~~-~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~  165 (487)
T 3oja_A           95 LLV-----GPSIETLHAANNNISR-VSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA  165 (487)
T ss_dssp             EEE-----CTTCCEEECCSSCCCC-EEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred             CCC-----CCCcCEEECcCCcCCC-CCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHh
Confidence            322     2556666666666663 2222   134555555555555555555555555555555555555544444443


Q ss_pred             cccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEE
Q 002826          301 ECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRF  380 (876)
Q Consensus       301 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  380 (876)
                                             ..+++|+.|+|++|.+++..+  +..+++|+.|+|++|++++. |..+..+++|+.|
T Consensus       166 -----------------------~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L  219 (487)
T 3oja_A          166 -----------------------ASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWI  219 (487)
T ss_dssp             -----------------------GGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEE
T ss_pred             -----------------------hhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEE
Confidence                                   134444444555554444322  22355555666666666543 3335566666666


Q ss_pred             eCCCccccCCCCCCcCCCCCccEEEccCCccc-cCCc-CcccccccceEecc
Q 002826          381 SASQNSFYGSLPPNFCDSPVMSIINLSQNSIS-GQIP-ELKKCRKLVSLSLA  430 (876)
Q Consensus       381 ~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~~-~~~~l~~L~~L~Ls  430 (876)
                      ++++|.+++ +|..+..+++|+.|++++|.+. +.+| .+..++.|+.|+++
T Consensus       220 ~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          220 SLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             EecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            666666664 4555666677777777777776 3333 56777888888876

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.94  E-value=4.1e-30  Score=304.57  Aligned_cols=361  Identities=18%  Similarity=0.137  Sum_probs=224.8

Q ss_pred             CCCCCCeeecCCCccccccCccccCC--CCCCcccCCCcc----------------cceeecCCcccccc----CCCccC
Q 002826           97 ELSSLSNLNLADNLFNQPIPLHLSQC--SSLETLNLSNNL----------------IWVLDLSRNHIEGK----IPESIG  154 (876)
Q Consensus        97 ~l~~L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~----------------l~~LdL~~n~l~~~----~p~~~~  154 (876)
                      .+++|++|+|++|.+++..+..+..+  ++|++|+|++|.                |++|+|++|.+++.    ++..+.
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~  189 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ  189 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence            56777777777777776666666553  347777777653                45677777777655    233445


Q ss_pred             CccccceecccccccCC----CcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCc---ccCCcccc
Q 002826          155 SLVNLQVLNLGSNLLSG----SVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFH---GVIPDSFV  227 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~---~~~~~~~~  227 (876)
                      .+++|++|+|++|.+++    .++..+.++++|++|+|++|.  ...+|..+.++++|++|+++.+...   +..+..+.
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~--~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~  267 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFE--ILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLV  267 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCB--GGGGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCcc--HHHHHHHHhhhhHHHhhcccccccccchHHHHHHhh
Confidence            66777777777777762    334445567777777777776  4456666777777777777653322   23345566


Q ss_pred             CCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCC-cccccCCccceeeeecccccccCCCCCccccccc
Q 002826          228 GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKNFFNGSIPGSINECLNLE  306 (876)
Q Consensus       228 ~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  306 (876)
                      .+++|+.|+++++... .+|..+ ..+++|++|+|++|.+++... ..+..+++|++|+++++...+.++..+..+++|+
T Consensus       268 ~~~~L~~L~l~~~~~~-~l~~~~-~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~  345 (592)
T 3ogk_B          268 FPRKLCRLGLSYMGPN-EMPILF-PFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLK  345 (592)
T ss_dssp             CCTTCCEEEETTCCTT-TGGGGG-GGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCC
T ss_pred             ccccccccCccccchh-HHHHHH-hhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCC
Confidence            6777777777775443 555443 447777777777777654333 2346677777777773322223333345667777


Q ss_pred             eeecc-----------cccCCCCCCc-ccCCCCcccEEEecCCcccccCcccccc-CCCCCeeecc----CcccCCC---
Q 002826          307 RFQVQ-----------DNGFSGDFPD-KLWSLPRIKLIRAESNRFSGAIPDSISM-AAQLEQVQID----NNRFTSS---  366 (876)
Q Consensus       307 ~L~L~-----------~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~---  366 (876)
                      +|+++           .|.+++.... .+..+++|++|+++.|++++..+..+.. +++|+.|+++    .|.+++.   
T Consensus       346 ~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~  425 (592)
T 3ogk_B          346 RLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD  425 (592)
T ss_dssp             EEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH
T ss_pred             EEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH
Confidence            77777           3555533222 2344677777777777777666666654 6777777775    5666643   


Q ss_pred             --CCCccccccCccEEeCCCcc--ccCCCCCCcC-CCCCccEEEccCCccccC-Cc-CcccccccceEeccCCcCCCC-C
Q 002826          367 --IPQGLGSVKSLYRFSASQNS--FYGSLPPNFC-DSPVMSIINLSQNSISGQ-IP-ELKKCRKLVSLSLADNSLTGE-I  438 (876)
Q Consensus       367 --~p~~~~~l~~L~~L~ls~N~--l~~~~~~~~~-~~~~L~~L~Ls~N~l~~~-~~-~~~~l~~L~~L~Ls~N~l~~~-~  438 (876)
                        ++..+.++++|++|++++|.  +++..+..+. .+++|+.|+|++|++++. ++ .+..+++|++|+|++|++++. +
T Consensus       426 ~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  505 (592)
T 3ogk_B          426 NGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAI  505 (592)
T ss_dssp             HHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHH
T ss_pred             HHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHH
Confidence              22335567777777776432  4443333333 356777777777777652 22 346677777777777776543 2


Q ss_pred             CcCCCCCCCcceeeCCCCccccc
Q 002826          439 PPSLAELPVLTYLDLSDNNLTGP  461 (876)
Q Consensus       439 p~~~~~l~~L~~L~Ls~N~l~~~  461 (876)
                      +..+..+++|++|+|++|++++.
T Consensus       506 ~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          506 AAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHhcCccCeeECcCCcCCHH
Confidence            33345677777777777777654

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=3.2e-28  Score=283.48  Aligned_cols=183  Identities=19%  Similarity=0.057  Sum_probs=130.2

Q ss_pred             CCCCceEEEEE-EeCCCcEEEEEEEecCCc----------cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEE
Q 002826          591 NGGPFGRVYIL-SLPSGELIAVKKLVNFGC----------QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       591 ~~g~~g~Vy~~-~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ..|..|.+..+ +...|+.||+|++.....          ...+++.+|+++|+++ .|+||+++++++++++..|||||
T Consensus       243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVME  322 (569)
T 4azs_A          243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVME  322 (569)
T ss_dssp             C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEE
T ss_pred             ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEe
Confidence            33435555554 334699999999975432          1235688999999999 79999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |++|++|.+++.+.+ .+++.   +|+.||+.||+|+|++   ||+||||||+|||+++++++||+|||+|+....... 
T Consensus       323 yv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~-  394 (569)
T 4azs_A          323 KLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS-  394 (569)
T ss_dssp             CCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C-
T ss_pred             cCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc-
Confidence            999999999997764 56654   5789999999999999   999999999999999999999999999987654321 


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                       ......||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       395 -~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 -WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             -cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence             2334569999999999865 466789999999998887666443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=1.2e-26  Score=245.68  Aligned_cols=218  Identities=22%  Similarity=0.323  Sum_probs=134.9

Q ss_pred             CCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccc
Q 002826           57 IHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW  136 (876)
Q Consensus        57 ~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  136 (876)
                      .++|.|.|+.|.....    ...+++.+++++. +|..+.  ++|++|+|++|++++                       
T Consensus         2 ~~~C~~~~~~C~c~~~----~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~-----------------------   51 (270)
T 2o6q_A            2 EALCKKDGGVCSCNNN----KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSS-----------------------   51 (270)
T ss_dssp             CCCBGGGTCSBEEETT----TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSC-----------------------
T ss_pred             CccCCCCCCCCEeCCC----CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCe-----------------------
Confidence            3799999999965421    1234444444442 333222  344444444444444                       


Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQS  215 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~  215 (876)
                                 ..+..|.++++|++|+|++|+++...+..|.++++|++|+|++|+  +..+|. .|.++++|++|+|++
T Consensus        52 -----------~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~l~~  118 (270)
T 2o6q_A           52 -----------LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK--LQALPIGVFDQLVNLAELRLDR  118 (270)
T ss_dssp             -----------CCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC--CCCCCTTTTTTCSSCCEEECCS
T ss_pred             -----------eCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc--CCcCCHhHcccccCCCEEECCC
Confidence                       444455555555555555555554444455555555555555555  333433 345566666666666


Q ss_pred             CCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccC
Q 002826          216 SGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSI  295 (876)
Q Consensus       216 n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~  295 (876)
                      |++++..+..|.++++|++|+|++|+|+ .+|...+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..
T Consensus       119 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  197 (270)
T 2o6q_A          119 NQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP  197 (270)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CccCeeCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence            6666666666777777777777777777 555555556777777777777777666666777777777777777777766


Q ss_pred             CCCCccccccceeecccccCCCC
Q 002826          296 PGSINECLNLERFQVQDNGFSGD  318 (876)
Q Consensus       296 ~~~~~~l~~L~~L~L~~N~l~~~  318 (876)
                      +..|..+++|+.|++++|.+...
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          198 EGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCS
T ss_pred             HHHhccccCCCEEEecCCCeeCC
Confidence            66777777888888888877644

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.4e-26  Score=246.17  Aligned_cols=226  Identities=17%  Similarity=0.147  Sum_probs=154.1

Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccc
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      ..+.++.+++ .+|..+.   ++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++|
T Consensus        11 ~~~c~~~~l~-~ip~~l~---~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC---TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             eEEecCCCcc-ccCCCCC---CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            4455555565 5665542   35666666666666655556666666666666666666666666666666777777766


Q ss_pred             cCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCC-CCCccccccCccEEeCCCccccCCCC
Q 002826          314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSS-IPQGLGSVKSLYRFSASQNSFYGSLP  392 (876)
Q Consensus       314 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ls~N~l~~~~~  392 (876)
                      ++++..+..|.++++|++|++++|++++..+..+..+++|++|++++|++++. +|..+.++++|+.|++++|++++..+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A           87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            66666666666666667777766666666665666666777777777776653 46666667777777777777766666


Q ss_pred             CCcCCCCCcc----EEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCC
Q 002826          393 PNFCDSPVMS----IINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       393 ~~~~~~~~L~----~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                      ..|..+..|+    .|++++|++++.++......+|++|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus       167 ~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          167 TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             GGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             HHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence            6665555555    6788888887776654455578888888888887777777888888888888888876443

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.93  E-value=1.5e-25  Score=238.15  Aligned_cols=221  Identities=15%  Similarity=0.170  Sum_probs=134.3

Q ss_pred             EEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccc
Q 002826          186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN  265 (876)
Q Consensus       186 L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N  265 (876)
                      .+.++..  ...+|..+.  ++|++|++++|++++..+..|.++++|++|+|++|+++ .++...+..+++|++|+|++|
T Consensus        12 ~~c~~~~--l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           12 YQCMELN--FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             EECTTSC--CSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTC
T ss_pred             EEecCCC--ccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCC
Confidence            4444443  455565543  35677777777777666667777777777777777776 455444455667777777777


Q ss_pred             cccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCC-CCcccCCCCcccEEEecCCcccccCc
Q 002826          266 KLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGD-FPDKLWSLPRIKLIRAESNRFSGAIP  344 (876)
Q Consensus       266 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~  344 (876)
                      ++++..+..|.++++|++|++++|.+++..+..|..+++|++|++++|++++. +|..+.++++|+.|++++|++++..+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~  166 (276)
T 2z62_A           87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC  166 (276)
T ss_dssp             CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred             ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence            77666666666666677777777766666555666666666666666666653 36666666666666666666666555


Q ss_pred             cccccCCCCC----eeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-Ccc
Q 002826          345 DSISMAAQLE----QVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELK  419 (876)
Q Consensus       345 ~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~  419 (876)
                      ..+..+.+|+    .|++++|+++                        +..+..+.. .+|+.|+|++|++++.++ .|.
T Consensus       167 ~~~~~l~~L~~l~l~L~ls~n~l~------------------------~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~  221 (276)
T 2z62_A          167 TDLRVLHQMPLLNLSLDLSLNPMN------------------------FIQPGAFKE-IRLKELALDTNQLKSVPDGIFD  221 (276)
T ss_dssp             GGGHHHHTCTTCCEEEECCSSCCC------------------------EECTTSSCS-CCEEEEECCSSCCSCCCTTTTT
T ss_pred             HHhhhhhhccccceeeecCCCccc------------------------ccCccccCC-CcccEEECCCCceeecCHhHhc
Confidence            5555555554    4455555554                        333333322 245555555555555544 345


Q ss_pred             cccccceEeccCCcCCC
Q 002826          420 KCRKLVSLSLADNSLTG  436 (876)
Q Consensus       420 ~l~~L~~L~Ls~N~l~~  436 (876)
                      .+++|++|+|++|++++
T Consensus       222 ~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          222 RLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             TCCSCCEEECCSSCBCC
T ss_pred             ccccccEEEccCCcccc
Confidence            56666666666666653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1.2e-24  Score=230.21  Aligned_cols=177  Identities=22%  Similarity=0.273  Sum_probs=88.1

Q ss_pred             ceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEe
Q 002826          183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV  262 (876)
Q Consensus       183 L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L  262 (876)
                      .+++++++|+  +..+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|+|+ .+|..++..+++|++|+|
T Consensus        18 ~~~l~~~~~~--l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l   92 (270)
T 2o6q_A           18 KNSVDCSSKK--LTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWV   92 (270)
T ss_dssp             TTEEECTTSC--CSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEEC
T ss_pred             CCEEEccCCC--CCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEEC
Confidence            3444444444  334444332  34555555555555555555666666666666666665 555555455555555555


Q ss_pred             ccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCccccc
Q 002826          263 SQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGA  342 (876)
Q Consensus       263 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  342 (876)
                      ++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++.
T Consensus        93 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A           93 TDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            55555544444445555555555555555544444445555555555555554444333344444444444444444433


Q ss_pred             CccccccCCCCCeeeccCcccC
Q 002826          343 IPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       343 ~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      .+..|..+++|++|+|++|+++
T Consensus       173 ~~~~~~~l~~L~~L~L~~N~l~  194 (270)
T 2o6q_A          173 PEGAFDKLTELKTLKLDNNQLK  194 (270)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCS
T ss_pred             ChhHhccCCCcCEEECCCCcCC
Confidence            3333434444444444444443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=2.4e-25  Score=235.91  Aligned_cols=207  Identities=18%  Similarity=0.231  Sum_probs=101.3

Q ss_pred             CccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcE
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI  234 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  234 (876)
                      .+++|+.|++++|.++. + ..++.+++|++|+|++|+  +..+ ..+..+++|++|+|++|++++..+..|.++++|++
T Consensus        39 ~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~--l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  113 (272)
T 3rfs_A           39 ELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNK--LHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE  113 (272)
T ss_dssp             HHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSC--CCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             cccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCC--CCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCE
Confidence            34444555555554442 1 124444455555555544  2222 23444445555555555555444444555555555


Q ss_pred             EecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccccc
Q 002826          235 LDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG  314 (876)
Q Consensus       235 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  314 (876)
                      |+|++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|++|++++|++++..+..|..+++|++|++++|+
T Consensus       114 L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~  192 (272)
T 3rfs_A          114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ  192 (272)
T ss_dssp             EECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence            555555555 3333333345555555555555554444444555555555555555554444445555555555555555


Q ss_pred             CCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccc
Q 002826          315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV  374 (876)
Q Consensus       315 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  374 (876)
                      +++..+..+..+++|+.|++++|.+.+.       +++|+.|+++.|+++|.+|.+++.+
T Consensus       193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            5554444455555555555555554432       2235555555555555555555443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.92  E-value=1.9e-25  Score=236.72  Aligned_cols=228  Identities=16%  Similarity=0.193  Sum_probs=161.5

Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      +.++..+++.++.+.+.  ..+..+++|+.|++++|.  +..++ .+..+++|++|++++|++++.  ..+..+++|++|
T Consensus        18 ~~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~--i~~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L   90 (272)
T 3rfs_A           18 FAETIKANLKKKSVTDA--VTQNELNSIDQIIANNSD--IKSVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYL   90 (272)
T ss_dssp             HHHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSC--CCCCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEE
T ss_pred             HHHHHHHHhcCcccccc--cccccccceeeeeeCCCC--ccccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEE
Confidence            45677888888887654  335678889999999887  44443 477788888888888888764  467788888888


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      +|++|+++ .++...+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|++
T Consensus        91 ~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  169 (272)
T 3rfs_A           91 ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL  169 (272)
T ss_dssp             ECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCc
Confidence            88888887 55555555677888888888888776666677777777777777777766666677777777777777777


Q ss_pred             CCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCc
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNF  395 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~  395 (876)
                      ++..+..+..+++|+.|++++|++++..+..+..+++|++|++++|.+.+.       +++|+.++++.|.++|.+|..+
T Consensus       170 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~  242 (272)
T 3rfs_A          170 QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA  242 (272)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTT
T ss_pred             CccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcc
Confidence            766666666677777777777777766666666666666666666666533       3345555566666666665555


Q ss_pred             CCC
Q 002826          396 CDS  398 (876)
Q Consensus       396 ~~~  398 (876)
                      +.+
T Consensus       243 ~~~  245 (272)
T 3rfs_A          243 GSV  245 (272)
T ss_dssp             SCB
T ss_pred             ccc
Confidence            544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=2.1e-24  Score=230.60  Aligned_cols=203  Identities=20%  Similarity=0.200  Sum_probs=137.6

Q ss_pred             ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcccccc
Q 002826          226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL  305 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  305 (876)
                      +.++++++++++++|+++ .+|..++   ++++.|+|++|++++..+..|..+++|++|+|++|.|++..+.  ..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            566778888888888888 7777664   5778888888888777777777777788888777777754432  455566


Q ss_pred             ceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          306 ERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       306 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                      ++|++++|+++ .+|..+..++                        +|++|++++|++++..|..|.++++|+.|++++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~------------------------~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLP------------------------ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCT------------------------TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCC------------------------CCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            66666666655 3344444444                        4455555555555444445555555555555555


Q ss_pred             cccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          386 SFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       386 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      ++++..+..|..+++|+.|+|++|+|++.++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus       135 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            5555555556666667777777777776655 4667788888888888888 667777777888888888888864

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.8e-24  Score=231.13  Aligned_cols=202  Identities=17%  Similarity=0.225  Sum_probs=132.5

Q ss_pred             ccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccc
Q 002826          177 FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK  256 (876)
Q Consensus       177 ~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  256 (876)
                      ++++++|+++++++|.  +..+|..+.  ++++.|+|++|++++..+..|.++++|++|+|++|+|+ .++..  ..+++
T Consensus         6 ~~~l~~l~~l~~~~~~--l~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~--~~l~~   78 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRN--LTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPV   78 (290)
T ss_dssp             EECSTTCCEEECTTSC--CSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCTT
T ss_pred             ccccCCccEEECCCCC--CCcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC--CCCCc
Confidence            4566667777777665  456666554  56777777777777777777888888888888888887 45443  35777


Q ss_pred             ccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecC
Q 002826          257 LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAES  336 (876)
Q Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  336 (876)
                      |++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus        79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (290)
T 1p9a_G           79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN  157 (290)
T ss_dssp             CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence            777777777776 5566666677777777777777766666666666777777777666666555566666666666666


Q ss_pred             CcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccc
Q 002826          337 NRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF  387 (876)
Q Consensus       337 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  387 (876)
                      |++++..+..|..+++|+.|+|++|+++ .+|..+...++|+.+++++|.+
T Consensus       158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence            6666555555555666666666666665 4444444444444444444444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2e-24  Score=224.13  Aligned_cols=198  Identities=15%  Similarity=0.162  Sum_probs=156.4

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccc-cccCCCcCccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGS-NLLSGSVPFVF  177 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~  177 (876)
                      ++|++|+|++|++++..+..|+++++|++|+|++|.         .+++..+..|.++++|++|+|++ |++++..+..|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~---------~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f  101 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV---------TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL  101 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCS---------SCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCC---------CcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence            389999999999999888899999999988655543         15555667889999999999998 99998778889


Q ss_pred             cCCCcceEEEccCCCCcCCCCCCcccccCccc---EEEecCC-CCcccCCccccCCCCCc-EEecccCccCCCCCCcccc
Q 002826          178 GNFSELVVLDLSQNAYLISEIPSDIGKLEKLE---QLFLQSS-GFHGVIPDSFVGLQSLS-ILDLSQNNLTGEVPQSLGS  252 (876)
Q Consensus       178 ~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~---~L~L~~n-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~ip~~~~~  252 (876)
                      .++++|++|+|++|+  +..+|. |..+++|+   +|++++| +++++.+..|.++++|+ +|++++|+++ .+|...+.
T Consensus       102 ~~l~~L~~L~l~~n~--l~~lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~  177 (239)
T 2xwt_C          102 KELPLLKFLGIFNTG--LKMFPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFN  177 (239)
T ss_dssp             ECCTTCCEEEEEEEC--CCSCCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTT
T ss_pred             CCCCCCCEEeCCCCC--Cccccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcC
Confidence            999999999999998  556776 77788887   9999999 88888888888899999 9999999888 78877776


Q ss_pred             ccccccEEEecccc-ccCcCCcccccC-CccceeeeecccccccCCCCCccccccceeecccc
Q 002826          253 SLLKLVSFDVSQNK-LSGSFPNGICKA-NGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       253 ~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      . ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|++++..+.   .+++|+.|+++++
T Consensus       178 ~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          178 G-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             T-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             C-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            4 788888888884 776666667777 7777777777777644333   3445555555544

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=1.3e-25  Score=248.49  Aligned_cols=250  Identities=15%  Similarity=0.163  Sum_probs=123.2

Q ss_pred             ecCCCCcccCCccccCCCCCcEEecccCccCCCCCC----ccccccc-cccEEEeccccccCcCCcccccC-----Cccc
Q 002826          213 LQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ----SLGSSLL-KLVSFDVSQNKLSGSFPNGICKA-----NGLV  282 (876)
Q Consensus       213 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L~  282 (876)
                      ++.|++++.+|..+...++|++|+|++|+|+ ..+.    ..+..++ +|++|+|++|+|++..+..+..+     ++|+
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~   83 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT   83 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCC
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCcc
Confidence            3344444444443333333444444444444 2221    1112233 44444444444444434434333     4444


Q ss_pred             eeeeecccccccCCCCCccc-----cccceeecccccCCCCCCcccC----C-CCcccEEEecCCcccccCcc----ccc
Q 002826          283 NLSLHKNFFNGSIPGSINEC-----LNLERFQVQDNGFSGDFPDKLW----S-LPRIKLIRAESNRFSGAIPD----SIS  348 (876)
Q Consensus       283 ~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~~~----~~~  348 (876)
                      +|+|++|.+++..+..+...     ++|++|++++|++++..+..+.    . .++|++|++++|++++....    .+.
T Consensus        84 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~  163 (362)
T 3goz_A           84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILA  163 (362)
T ss_dssp             EEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred             EEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHh
Confidence            44444444444333322222     4455555555555444333322    2 13555555555555533222    223


Q ss_pred             cCC-CCCeeeccCcccCCCCCCcccc----c-cCccEEeCCCccccCC----CCCCcCC-CCCccEEEccCCccccCCc-
Q 002826          349 MAA-QLEQVQIDNNRFTSSIPQGLGS----V-KSLYRFSASQNSFYGS----LPPNFCD-SPVMSIINLSQNSISGQIP-  416 (876)
Q Consensus       349 ~l~-~L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~ls~N~l~~~----~~~~~~~-~~~L~~L~Ls~N~l~~~~~-  416 (876)
                      ... +|++|+|++|++++..+..+..    . ++|+.|++++|.+++.    ++..+.. .++|+.|+|++|.+++... 
T Consensus       164 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~  243 (362)
T 3goz_A          164 AIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE  243 (362)
T ss_dssp             TSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred             cCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence            333 5666666666665444433332    2 3566666666666542    2223333 2467777777777765433 


Q ss_pred             ----CcccccccceEeccCCcCCCCCC-------cCCCCCCCcceeeCCCCcccccCC
Q 002826          417 ----ELKKCRKLVSLSLADNSLTGEIP-------PSLAELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       417 ----~~~~l~~L~~L~Ls~N~l~~~~p-------~~~~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                          .+..+++|++|+|++|++.+..+       ..+..+++|+.||+++|++.+..|
T Consensus       244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence                24566777777777777554333       356777788888888888775533

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.9e-24  Score=231.26  Aligned_cols=209  Identities=19%  Similarity=0.172  Sum_probs=99.6

Q ss_pred             CcccEEEecCCCCcccCCccc--cCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccce
Q 002826          206 EKLEQLFLQSSGFHGVIPDSF--VGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVN  283 (876)
Q Consensus       206 ~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  283 (876)
                      ++|++|++++|++++..|..+  ..+++|++|+|++|++++..+..-                     ...+..+++|++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~---------------------~~~~~~~~~L~~  149 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLA---------------------ELQQWLKPGLKV  149 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHH---------------------HHHTTBCSCCCE
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhH---------------------HHHhhhccCCCE
Confidence            345555555555555444444  445555555555555543222100                     012223444444


Q ss_pred             eeeecccccccCCCCCccccccceeecccccCCCC--C--CcccCCCCcccEEEecCCcccccCc--c-ccccCCCCCee
Q 002826          284 LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGD--F--PDKLWSLPRIKLIRAESNRFSGAIP--D-SISMAAQLEQV  356 (876)
Q Consensus       284 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~~--~-~~~~l~~L~~L  356 (876)
                      |+|++|++++..+..|..+++|++|+|++|++.+.  +  +..+..+++|++|++++|+++...+  . .+..+++|++|
T Consensus       150 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L  229 (310)
T 4glp_A          150 LSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSL  229 (310)
T ss_dssp             EEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSE
T ss_pred             EEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEE
Confidence            44444444444444444444444455544444321  1  1122344455555555555432111  1 23444555555


Q ss_pred             eccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCC
Q 002826          357 QIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTG  436 (876)
Q Consensus       357 ~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~  436 (876)
                      +|++|++++..|..+..+.                     .+++|++|+|++|+|+..+..+.  ++|++|+|++|+|++
T Consensus       230 ~Ls~N~l~~~~p~~~~~~~---------------------~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          230 DLSHNSLRATVNPSAPRCM---------------------WSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNR  286 (310)
T ss_dssp             ECTTSCCCCCCCSCCSSCC---------------------CCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCS
T ss_pred             ECCCCCCCccchhhHHhcc---------------------CcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCC
Confidence            5555555544444443331                     11355555555555553333332  566666677776664


Q ss_pred             CCCcCCCCCCCcceeeCCCCcccc
Q 002826          437 EIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       437 ~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      . |. +..+++|+.|+|++|+|+.
T Consensus       287 ~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          287 A-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             C-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             C-ch-hhhCCCccEEECcCCCCCC
Confidence            3 22 5666777777777777653

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=1.4e-23  Score=217.82  Aligned_cols=84  Identities=15%  Similarity=0.170  Sum_probs=32.5

Q ss_pred             ccEEEecCCCCcccCCccccCCCCCcEEecccCc-cCCCCCCccccccccccEEEecc-ccccCcCCcccccCCccceee
Q 002826          208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNN-LTGEVPQSLGSSLLKLVSFDVSQ-NKLSGSFPNGICKANGLVNLS  285 (876)
Q Consensus       208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~ip~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~  285 (876)
                      |++|++++|+++++.+..|.++++|++|++++|+ ++ .++...+.++++|++|++++ |++++..+..|..+++|++|+
T Consensus        33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            3333333333433333344444444444444443 33 33332233333444444443 333333333333333333333


Q ss_pred             eeccccc
Q 002826          286 LHKNFFN  292 (876)
Q Consensus       286 L~~N~i~  292 (876)
                      +++|+++
T Consensus       112 l~~n~l~  118 (239)
T 2xwt_C          112 IFNTGLK  118 (239)
T ss_dssp             EEEECCC
T ss_pred             CCCCCCc
Confidence            3333333

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=3.7e-24  Score=231.38  Aligned_cols=203  Identities=17%  Similarity=0.177  Sum_probs=120.3

Q ss_pred             ccccEEEeccccccCcCCccc--ccCCccceeeeecccccccCC----CCCccccccceeecccccCCCCCCcccCCCCc
Q 002826          255 LKLVSFDVSQNKLSGSFPNGI--CKANGLVNLSLHKNFFNGSIP----GSINECLNLERFQVQDNGFSGDFPDKLWSLPR  328 (876)
Q Consensus       255 ~~L~~L~L~~N~l~~~~~~~~--~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  328 (876)
                      ++|++|+|++|++++..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|++++|++++..+..|..+++
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~  170 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA  170 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence            345555555555555555554  555555555555555554332    12234555555555555555555555555555


Q ss_pred             ccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCC--C-CcCCCCCccEEE
Q 002826          329 IKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP--P-NFCDSPVMSIIN  405 (876)
Q Consensus       329 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~--~-~~~~~~~L~~L~  405 (876)
                      |++|++++|++.+...                    -..+..+..+++|++|++++|+++...+  . .+..+++|++||
T Consensus       171 L~~L~Ls~N~l~~~~~--------------------~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~  230 (310)
T 4glp_A          171 LTSLDLSDNPGLGERG--------------------LMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLD  230 (310)
T ss_dssp             CCEEECCSCTTCHHHH--------------------HHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEE
T ss_pred             CCEEECCCCCCccchh--------------------hhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEE
Confidence            5555555555433100                    0001122344455555555555532111  1 234556677777


Q ss_pred             ccCCccccCCc-Ccccc---cccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCc
Q 002826          406 LSQNSISGQIP-ELKKC---RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNK  480 (876)
Q Consensus       406 Ls~N~l~~~~~-~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~  480 (876)
                      |++|+|++..| .+..+   ++|++|+|++|+|+ .+|..+.  ++|++|||++|+|++. |. +..+ +++.|++++|+
T Consensus       231 Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~  305 (310)
T 4glp_A          231 LSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNP  305 (310)
T ss_dssp             CTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTT
T ss_pred             CCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCC
Confidence            77777777643 45554   79999999999999 6677664  8999999999999973 43 3444 58899999999


Q ss_pred             cc
Q 002826          481 LS  482 (876)
Q Consensus       481 l~  482 (876)
                      ++
T Consensus       306 l~  307 (310)
T 4glp_A          306 FL  307 (310)
T ss_dssp             TS
T ss_pred             CC
Confidence            97

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.90  E-value=7.4e-27  Score=276.66  Aligned_cols=129  Identities=16%  Similarity=0.183  Sum_probs=63.7

Q ss_pred             cCCCCCCeeecCCCccccccCcccc-CCCCCCcccCCCcccceeecCCcccccc-CCCccCCccccceecccccccCCCc
Q 002826           96 CELSSLSNLNLADNLFNQPIPLHLS-QCSSLETLNLSNNLIWVLDLSRNHIEGK-IPESIGSLVNLQVLNLGSNLLSGSV  173 (876)
Q Consensus        96 ~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~LdL~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~  173 (876)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++|.         .++.. ++..+.++++|++|+|++|.+++..
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~---------~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~  172 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE---------GFSTDGLAAIAATCRNLKELDLRESDVDDVS  172 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE---------EEEHHHHHHHHHHCTTCCEEECTTCEEECCC
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC---------CCCHHHHHHHHHhCCCCCEEeCcCCccCCcc
Confidence            3567777777777777766666665 57777777666552         11111 2222234455555555555554433


Q ss_pred             Ccccc----CCCcceEEEccCCCCcCCCCC-----CcccccCcccEEEecCC-CCcccCCccccCCCCCcEEec
Q 002826          174 PFVFG----NFSELVVLDLSQNAYLISEIP-----SDIGKLEKLEQLFLQSS-GFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       174 p~~~~----~l~~L~~L~Ls~N~~~~~~~p-----~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      +..+.    .+++|++|+|++|.   ..++     ..+.++++|++|+|++| .+.+ ++..+..+++|+.|++
T Consensus       173 ~~~l~~~~~~~~~L~~L~l~~~~---~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l  242 (594)
T 2p1m_B          173 GHWLSHFPDTYTSLVSLNISCLA---SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGT  242 (594)
T ss_dssp             GGGGGGSCTTCCCCCEEECTTCC---SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEEC
T ss_pred             hHHHHHHhhcCCcCcEEEecccC---CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEccc
Confidence            32222    33455555555553   1111     11123355555555555 2222 3444445555555553

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=4.1e-23  Score=215.90  Aligned_cols=158  Identities=16%  Similarity=0.193  Sum_probs=112.4

Q ss_pred             ccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCC
Q 002826          304 NLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSAS  383 (876)
Q Consensus       304 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls  383 (876)
                      +++.|+|++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+++
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            45555555555555555555555555555555555555555556666666666666666665555666666777777777


Q ss_pred             CccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccccc
Q 002826          384 QNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGP  461 (876)
Q Consensus       384 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  461 (876)
                      +|++++..+..|..+++|+.|+|++|+|++.++ .|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            777776666667777788888888888887776 688888888899999998888888888999999999999998865

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=3.6e-25  Score=244.85  Aligned_cols=79  Identities=20%  Similarity=0.169  Sum_probs=40.4

Q ss_pred             eecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCC----CccCCcc-ccceecccccccCCCcCcccc
Q 002826          104 LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIP----ESIGSLV-NLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus       104 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      ++|++|.+++.+|..+...++|++|+|++          |.+++..+    ..|.+++ +|++|+|++|++++..+..|.
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~----------n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~   72 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSL----------NNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELV   72 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTT----------SCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccC----------CCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHH
Confidence            45556666665555555555555543333          33333333    4444555 555666666655555454444


Q ss_pred             CC-----CcceEEEccCCC
Q 002826          179 NF-----SELVVLDLSQNA  192 (876)
Q Consensus       179 ~l-----~~L~~L~Ls~N~  192 (876)
                      .+     ++|++|+|++|+
T Consensus        73 ~~l~~~~~~L~~L~Ls~n~   91 (362)
T 3goz_A           73 QILAAIPANVTSLNLSGNF   91 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSC
T ss_pred             HHHhccCCCccEEECcCCc
Confidence            43     555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=5.7e-23  Score=214.84  Aligned_cols=181  Identities=14%  Similarity=0.156  Sum_probs=128.9

Q ss_pred             CCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceee
Q 002826          230 QSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQ  309 (876)
Q Consensus       230 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~  309 (876)
                      .+.+++++++|.++ .+|..+.   ++++.|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+
T Consensus        14 ~~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~   89 (251)
T 3m19_A           14 EGKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLG   89 (251)
T ss_dssp             GGGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEE
Confidence            34667888888887 7777653   4777788888888777777777777777777777777777777777777777777


Q ss_pred             cccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccC
Q 002826          310 VQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYG  389 (876)
Q Consensus       310 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~  389 (876)
                      |++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus        90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  169 (251)
T 3m19_A           90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS  169 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence            77777776666677777777777777777776666666667777777777777775555566666666666666666666


Q ss_pred             CCCCCcCCCCCccEEEccCCccccC
Q 002826          390 SLPPNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       390 ~~~~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                      ..+..|..+++|+.|+|++|.+++.
T Consensus       170 ~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          170 VPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             cCHHHHhCCCCCCEEEeeCCceeCC
Confidence            6666666666666666666666554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=1.1e-25  Score=246.57  Aligned_cols=268  Identities=18%  Similarity=0.228  Sum_probs=160.5

Q ss_pred             CCccccceEecCCCCCccEEEEeecCCCCCcccccccccCC--CCCCeeecCCCccccccCccccCCCCCCcccCCCccc
Q 002826           58 HYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCEL--SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI  135 (876)
Q Consensus        58 ~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l  135 (876)
                      -|..|+++.|++.     .+..+++.++.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++   
T Consensus        35 vc~~W~~~~~~~~-----~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~---  102 (336)
T 2ast_B           35 VCKRWYRLASDES-----LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSN---  102 (336)
T ss_dssp             SCHHHHHHHTCST-----TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTT---
T ss_pred             HHHHHHHHhcCch-----hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccC---
Confidence            4778999988644     2445777777766   3455666  7888888888888876555 44677777665444   


Q ss_pred             ceeecCCcccccc-CCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCC-CCCCcccccCcccEEEe
Q 002826          136 WVLDLSRNHIEGK-IPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS-EIPSDIGKLEKLEQLFL  213 (876)
Q Consensus       136 ~~LdL~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~-~~p~~~~~l~~L~~L~L  213 (876)
                             |.+++. +|..+..+++|++|+|++|++++..+..++++++|++|+|++|..+.. .+|..+.++++|++|++
T Consensus       103 -------~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l  175 (336)
T 2ast_B          103 -------SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL  175 (336)
T ss_dssp             -------CEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC
T ss_pred             -------CCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcC
Confidence                   444444 566677788888888888887777777777778888888887731111 24444566666666666


Q ss_pred             cCC-CCccc-CCccccCCC-CCcEEecccCc--cC-CCCCCccccccccccEEEecccc-ccCcCCcccccCCccceeee
Q 002826          214 QSS-GFHGV-IPDSFVGLQ-SLSILDLSQNN--LT-GEVPQSLGSSLLKLVSFDVSQNK-LSGSFPNGICKANGLVNLSL  286 (876)
Q Consensus       214 ~~n-~l~~~-~~~~~~~l~-~L~~L~Ls~N~--l~-~~ip~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L  286 (876)
                      ++| ++++. ++..+..++ +|++|+|++|.  ++ +.+|..+ ..+++|++|++++|. +++..+..            
T Consensus       176 ~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~-~~~~~L~~L~l~~~~~l~~~~~~~------------  242 (336)
T 2ast_B          176 SWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV-RRCPNLVHLDLSDSVMLKNDCFQE------------  242 (336)
T ss_dssp             CCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHH-HHCTTCSEEECTTCTTCCGGGGGG------------
T ss_pred             CCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHH-hhCCCCCEEeCCCCCcCCHHHHHH------------
Confidence            666 66543 345555566 66666666663  33 1223222 234555555555555 44344444            


Q ss_pred             ecccccccCCCCCccccccceeeccccc-CCCCCCcccCCCCcccEEEecCCcccccCccccccC-CCCCeeeccCcccC
Q 002826          287 HKNFFNGSIPGSINECLNLERFQVQDNG-FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA-AQLEQVQIDNNRFT  364 (876)
Q Consensus       287 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~  364 (876)
                                  +..+++|++|++++|. +.......+..+++|+.|++++| ++   .+.+..+ .+++.|++++|+++
T Consensus       243 ------------l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~  306 (336)
T 2ast_B          243 ------------FFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFT  306 (336)
T ss_dssp             ------------GGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSC
T ss_pred             ------------HhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCc
Confidence                        4444555555555553 21111124555666666666666 22   2233333 23666777888888


Q ss_pred             CCCCCcccc
Q 002826          365 SSIPQGLGS  373 (876)
Q Consensus       365 ~~~p~~~~~  373 (876)
                      +..|..+++
T Consensus       307 ~~~~~~~~~  315 (336)
T 2ast_B          307 TIARPTIGN  315 (336)
T ss_dssp             CTTCSSCSS
T ss_pred             cccCCcccc
Confidence            777776654

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=2.9e-23  Score=223.94  Aligned_cols=207  Identities=18%  Similarity=0.302  Sum_probs=119.4

Q ss_pred             EecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccc
Q 002826          212 FLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFF  291 (876)
Q Consensus       212 ~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  291 (876)
                      .+..+.+....  .+..+++|++|++++|+++ .+|. + ..+++|++|+|++|++++..+  +..+++|++|+|++|++
T Consensus        25 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~~-~-~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l   97 (308)
T 1h6u_A           25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-V-QYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL   97 (308)
T ss_dssp             HTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTT-G-GGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred             HhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cchh-h-hccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcC
Confidence            34444444322  2344556666666666665 4442 2 335555555555555553332  55555555555555555


Q ss_pred             cccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCcc
Q 002826          292 NGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGL  371 (876)
Q Consensus       292 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  371 (876)
                      ++.                          ..+..+++|+.|++++|++++..  .+..+++|++|++++|++++..+  +
T Consensus        98 ~~~--------------------------~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l  147 (308)
T 1h6u_A           98 KNV--------------------------SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--L  147 (308)
T ss_dssp             SCC--------------------------GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--G
T ss_pred             CCc--------------------------hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--c
Confidence            432                          13444555555555555555432  15555556666666666554332  5


Q ss_pred             ccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCccee
Q 002826          372 GSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYL  451 (876)
Q Consensus       372 ~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  451 (876)
                      ..+++|+.|++++|.+++..+  +..+++|+.|++++|++++.++ +..+++|++|+|++|++++..|  +..+++|+.|
T Consensus       148 ~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  222 (308)
T 1h6u_A          148 AGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV  222 (308)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEE
T ss_pred             cCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEE
Confidence            556666666666666654333  6666777777777777765544 6777778888888888775543  7777888888


Q ss_pred             eCCCCcccc
Q 002826          452 DLSDNNLTG  460 (876)
Q Consensus       452 ~Ls~N~l~~  460 (876)
                      +|++|++++
T Consensus       223 ~l~~N~i~~  231 (308)
T 1h6u_A          223 TLTNQTITN  231 (308)
T ss_dssp             EEEEEEEEC
T ss_pred             EccCCeeec
Confidence            888888774

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.89  E-value=1.2e-25  Score=251.25  Aligned_cols=247  Identities=18%  Similarity=0.190  Sum_probs=114.2

Q ss_pred             CCCccCCccccceecccccccCCCcC----ccccCCCcceEEEccCCCC--cCCCCCCcc-------cccCcccEEEecC
Q 002826          149 IPESIGSLVNLQVLNLGSNLLSGSVP----FVFGNFSELVVLDLSQNAY--LISEIPSDI-------GKLEKLEQLFLQS  215 (876)
Q Consensus       149 ~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~~--~~~~~p~~~-------~~l~~L~~L~L~~  215 (876)
                      ++..+..+++|++|+|++|++++..+    ..|..+++|++|+|++|.+  +.+.+|..+       ..+++|++|+|++
T Consensus        24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~  103 (386)
T 2ca6_A           24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  103 (386)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence            44455555666666666666654422    2345566666666666531  111223222       3445555555555


Q ss_pred             CCCcc----cCCccccCCCCCcEEecccCccCCCCCCccccc---c---------ccccEEEecccccc-CcCC---ccc
Q 002826          216 SGFHG----VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSS---L---------LKLVSFDVSQNKLS-GSFP---NGI  275 (876)
Q Consensus       216 n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~---l---------~~L~~L~L~~N~l~-~~~~---~~~  275 (876)
                      |++++    .+|..+..+++|++|+|++|.|++..+..+...   +         ++|++|+|++|+++ +..+   ..+
T Consensus       104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l  183 (386)
T 2ca6_A          104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  183 (386)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence            55554    244445555555555555555542222111111   1         45555555555544 1222   233


Q ss_pred             ccCCccceeeeeccccc--c---cCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccC
Q 002826          276 CKANGLVNLSLHKNFFN--G---SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA  350 (876)
Q Consensus       276 ~~l~~L~~L~L~~N~i~--~---~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  350 (876)
                      ..+++|++|+|++|+|+  +   ..+..+..+++|+.|+|++|.++...                    .+.+|..+..+
T Consensus       184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g--------------------~~~l~~~l~~~  243 (386)
T 2ca6_A          184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG--------------------SSALAIALKSW  243 (386)
T ss_dssp             HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--------------------HHHHHHHGGGC
T ss_pred             HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--------------------HHHHHHHHccC
Confidence            34445555555555444  1   22223444444444444444443000                    03334444444


Q ss_pred             CCCCeeeccCcccCCC----CCCcc--ccccCccEEeCCCccccC----CCCCCc-CCCCCccEEEccCCccccCC
Q 002826          351 AQLEQVQIDNNRFTSS----IPQGL--GSVKSLYRFSASQNSFYG----SLPPNF-CDSPVMSIINLSQNSISGQI  415 (876)
Q Consensus       351 ~~L~~L~L~~N~l~~~----~p~~~--~~l~~L~~L~ls~N~l~~----~~~~~~-~~~~~L~~L~Ls~N~l~~~~  415 (876)
                      ++|+.|+|++|++++.    +|..+  +.+++|+.|++++|.+++    .+|..+ .++++|+.|+|++|.+++..
T Consensus       244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~  319 (386)
T 2ca6_A          244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED  319 (386)
T ss_dssp             TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred             CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence            4455555555544433    23333  224555555555555554    244444 34566666677777766554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.89  E-value=3.3e-27  Score=279.63  Aligned_cols=369  Identities=14%  Similarity=0.165  Sum_probs=268.0

Q ss_pred             EEEEeecCCCCCccccccccc-CCCCCCeeecCCC-ccccc-cCccccCCCCCCcccCCCcccceeecCCccccccCC--
Q 002826           76 TVASINLQSLNLSGEISSSVC-ELSSLSNLNLADN-LFNQP-IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIP--  150 (876)
Q Consensus        76 ~~~~l~l~~~~l~~~~~~~~~-~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p--  150 (876)
                      .+..++|.++.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+          ++..+  
T Consensus       106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i----------~~~~~~~  175 (594)
T 2p1m_B          106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDV----------DDVSGHW  175 (594)
T ss_dssp             TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEE----------ECCCGGG
T ss_pred             CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCcc----------CCcchHH
Confidence            466788999999888777776 6999999999999 55543 455566899999987776654          33322  


Q ss_pred             --CccCCccccceecccccc--cCC-CcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC-------CC
Q 002826          151 --ESIGSLVNLQVLNLGSNL--LSG-SVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS-------GF  218 (876)
Q Consensus       151 --~~~~~l~~L~~L~L~~N~--l~~-~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n-------~l  218 (876)
                        .....+++|++|+|++|.  ++. ..+..+.++++|++|+|++|. ..+.+|..+..+++|++|+++.+       .+
T Consensus       176 l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~-~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~  254 (594)
T 2p1m_B          176 LSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV-PLEKLATLLQRAPQLEELGTGGYTAEVRPDVY  254 (594)
T ss_dssp             GGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTS-CHHHHHHHHHHCTTCSEEECSBCCCCCCHHHH
T ss_pred             HHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCC-cHHHHHHHHhcCCcceEcccccccCccchhhH
Confidence              333467899999999997  221 122223457999999999995 24457777889999999996554       34


Q ss_pred             cccCCccccCCCCCcEE-ecccCccCCCCCCccccccccccEEEeccccccCcCCc-ccccCCccceeeeeccccccc-C
Q 002826          219 HGVIPDSFVGLQSLSIL-DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN-GICKANGLVNLSLHKNFFNGS-I  295 (876)
Q Consensus       219 ~~~~~~~~~~l~~L~~L-~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~i~~~-~  295 (876)
                      .+. +..+.++++|+.| .+.+.... .+|..+ ..+++|++|+|++|.+++.... .+..+++|++|++++| ++.. .
T Consensus       255 ~~l-~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~-~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l  330 (594)
T 2p1m_B          255 SGL-SVALSGCKELRCLSGFWDAVPA-YLPAVY-SVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGL  330 (594)
T ss_dssp             HHH-HHHHHTCTTCCEEECCBTCCGG-GGGGGH-HHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHH
T ss_pred             HHH-HHHHhcCCCcccccCCcccchh-hHHHHH-HhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHH
Confidence            443 3478899999999 55544332 444433 3588999999999997754322 3567899999999998 4422 2


Q ss_pred             CCCCccccccceeecc---------cccCCCCCCcccC-CCCcccEEEecCCcccccCccccc-cCCCCCeeecc--C--
Q 002826          296 PGSINECLNLERFQVQ---------DNGFSGDFPDKLW-SLPRIKLIRAESNRFSGAIPDSIS-MAAQLEQVQID--N--  360 (876)
Q Consensus       296 ~~~~~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~--~--  360 (876)
                      +.....+++|++|++.         .|.+++.....+. ++++|+.|.++.|.+++.....+. .+++|+.|+++  +  
T Consensus       331 ~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~  410 (594)
T 2p1m_B          331 EVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPK  410 (594)
T ss_dssp             HHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTT
T ss_pred             HHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCC
Confidence            2223458899999983         3556544333343 489999999999999887766665 58999999999  4  


Q ss_pred             --cccCCCCC-----CccccccCccEEeCCCccccCCCCCCcCC-CCCccEEEccCCccccCCc-Cc-ccccccceEecc
Q 002826          361 --NRFTSSIP-----QGLGSVKSLYRFSASQNSFYGSLPPNFCD-SPVMSIINLSQNSISGQIP-EL-KKCRKLVSLSLA  430 (876)
Q Consensus       361 --N~l~~~~p-----~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-~~~L~~L~Ls~N~l~~~~~-~~-~~l~~L~~L~Ls  430 (876)
                        |.+++...     ..+..+++|+.|++++ .+++..+..+.. +++|+.|+|++|.+++... .+ ..+++|++|+|+
T Consensus       411 ~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~  489 (594)
T 2p1m_B          411 APDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIR  489 (594)
T ss_dssp             CCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEE
T ss_pred             CcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECc
Confidence              66663221     2256788999999987 666555555554 7899999999999976433 44 678999999999


Q ss_pred             CCcCCCCCCc-CCCCCCCcceeeCCCCcccc
Q 002826          431 DNSLTGEIPP-SLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       431 ~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      +|++++.... ....+++|++|++++|+++.
T Consensus       490 ~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~  520 (594)
T 2p1m_B          490 DCPFGDKALLANASKLETMRSLWMSSCSVSF  520 (594)
T ss_dssp             SCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred             CCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence            9999654443 44568999999999999854

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=1.7e-22  Score=222.29  Aligned_cols=200  Identities=16%  Similarity=0.142  Sum_probs=115.8

Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccE-EEe
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVS-FDV  262 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~-L~L  262 (876)
                      ++++.++|+  ++++|..+.  +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+|...|.++++|.+ +.+
T Consensus        12 ~~v~C~~~~--Lt~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESK--VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTT--CCSCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCC--CCccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            345666665  556666552  467777777777776666777777788888888887765677766666776654 555


Q ss_pred             ccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc-ccCCCCCCcccCCCC-cccEEEecCCccc
Q 002826          263 SQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD-NGFSGDFPDKLWSLP-RIKLIRAESNRFS  340 (876)
Q Consensus       263 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~L~~N~l~  340 (876)
                      +.|+|+...|..|..+++|++|++++|+|+...+..+....++..|++.+ |++....+..|..+. .++.|++++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            66777766666777777777777777777666665666666666666644 445544444444443 3455555555555


Q ss_pred             ccCccccccCCCCCeeeccC-cccCCCCCCccccccCccEEeCCCcccc
Q 002826          341 GAIPDSISMAAQLEQVQIDN-NRFTSSIPQGLGSVKSLYRFSASQNSFY  388 (876)
Q Consensus       341 ~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~ls~N~l~  388 (876)
                      .+.+..|. ..+|+.|++++ |.++...+..|.++++|+.|++++|+|+
T Consensus       168 ~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~  215 (350)
T 4ay9_X          168 EIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH  215 (350)
T ss_dssp             EECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred             CCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence            43333332 23444444432 3333222233444444444444444444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.89  E-value=5e-24  Score=246.74  Aligned_cols=181  Identities=16%  Similarity=0.154  Sum_probs=145.7

Q ss_pred             CCCCCCceEEEEEEeCCCcEEEEEEEecCCccC--------HHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          589 AGNGGPFGRVYILSLPSGELIAVKKLVNFGCQS--------SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+.|+||+||+++. .++.+|+|+........        .+++.+|++++++++||||+++..++...+..|+||||+
T Consensus       343 ~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~  421 (540)
T 3en9_A          343 LIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYI  421 (540)
T ss_dssp             -----CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECC
T ss_pred             EEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECC
Confidence            444455999999954 68899999875432221        235789999999999999997777777777889999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc-
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS-  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~-  739 (876)
                      ++++|.+++.+         +..++.|+++|++|||++   +|+||||||+|||++.  ++||+|||+++......... 
T Consensus       422 ~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          422 NGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             CSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             CCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            99999999865         568999999999999999   9999999999999998  99999999998876432211 


Q ss_pred             ----ccccccccccccCccccCC--CCCCCccchHHHHHHHHHHHhCCCCC
Q 002826          740 ----TMSSEYALSCYNAPEYGYS--KKATAQMDAYSFGVVLLELITGRQAE  784 (876)
Q Consensus       740 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlGv~l~elltg~~p~  784 (876)
                          ......||+.|||||++..  ..|+...|+|+..+-..+-+.++.+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                1234568999999999875  45777889999999999988887765

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=5.5e-23  Score=221.70  Aligned_cols=189  Identities=20%  Similarity=0.329  Sum_probs=93.6

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEec
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      ++..+.+..+.+++.++  +..+++|++|++++|.  +..+| .+..+++|++|+|++|++++..+  +.++++|++|+|
T Consensus        20 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~--i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L   92 (308)
T 1h6u_A           20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTG--VTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELEL   92 (308)
T ss_dssp             HHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEEC
T ss_pred             HHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCC--ccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEc
Confidence            34444555555543322  3345556666666665  33444 35555556666666665554433  556666666666


Q ss_pred             ccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCC
Q 002826          238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG  317 (876)
Q Consensus       238 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (876)
                      ++|+++ .++ . +..+++|++|+|++|++++. + .+..+++|++|++++|.+++..+  +..+++|+.|++++|++++
T Consensus        93 ~~n~l~-~~~-~-~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~  165 (308)
T 1h6u_A           93 SGNPLK-NVS-A-IAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD  165 (308)
T ss_dssp             CSCCCS-CCG-G-GTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             cCCcCC-Cch-h-hcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence            666665 333 1 23355566666666655532 2 15555555555555555554332  4444555555555555543


Q ss_pred             CCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       318 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      ..+  +..+++|+.|++++|++++..+  +..+++|++|++++|+++
T Consensus       166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCC
T ss_pred             Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccC
Confidence            222  4444444444444444443322  334444444444444444

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=2.3e-25  Score=248.84  Aligned_cols=227  Identities=20%  Similarity=0.276  Sum_probs=120.5

Q ss_pred             ccCCCCCcEEecccCcc---CCCCCCcc------ccccccccEEEeccccccC----cCCcccccCCccceeeeeccccc
Q 002826          226 FVGLQSLSILDLSQNNL---TGEVPQSL------GSSLLKLVSFDVSQNKLSG----SFPNGICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l---~~~ip~~~------~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~  292 (876)
                      |..+++|++|+|++|.+   ++.+|..+      +..+++|++|+|++|++++    .+|..+..+++|++|+|++|.|+
T Consensus        56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~  135 (386)
T 2ca6_A           56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG  135 (386)
T ss_dssp             TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence            44555566666655432   22333322      1234555555555555554    24444555555555555555554


Q ss_pred             ccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCccc-ccCc---cccccCCCCCeeeccCcccCC---
Q 002826          293 GSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS-GAIP---DSISMAAQLEQVQIDNNRFTS---  365 (876)
Q Consensus       293 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~~---  365 (876)
                      ...+..+...  |..  +..|.+++.       .++|++|++++|+++ +.++   ..+..+++|++|+|++|+++.   
T Consensus       136 ~~~~~~l~~~--l~~--l~~~~~~~~-------~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~  204 (386)
T 2ca6_A          136 PQAGAKIARA--LQE--LAVNKKAKN-------APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI  204 (386)
T ss_dssp             HHHHHHHHHH--HHH--HHHHHHHHT-------CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHH
T ss_pred             HHHHHHHHHH--HHH--Hhhhhhccc-------CCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHH
Confidence            3322222211  000  000000000       034444444444443 1222   234445555555555555541   


Q ss_pred             --CCCCccccccCccEEeCCCcccc----CCCCCCcCCCCCccEEEccCCccccC----Cc-Cc--ccccccceEeccCC
Q 002826          366 --SIPQGLGSVKSLYRFSASQNSFY----GSLPPNFCDSPVMSIINLSQNSISGQ----IP-EL--KKCRKLVSLSLADN  432 (876)
Q Consensus       366 --~~p~~~~~l~~L~~L~ls~N~l~----~~~~~~~~~~~~L~~L~Ls~N~l~~~----~~-~~--~~l~~L~~L~Ls~N  432 (876)
                        ..|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.+++.    ++ .+  +.+++|++|+|++|
T Consensus       205 ~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n  284 (386)
T 2ca6_A          205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN  284 (386)
T ss_dssp             HHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSS
T ss_pred             HHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCC
Confidence              23335555666666666666664    44555666677777777777777654    22 34  34788888888888


Q ss_pred             cCCC----CCCcCC-CCCCCcceeeCCCCcccccCC
Q 002826          433 SLTG----EIPPSL-AELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       433 ~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                      ++++    .+|..+ .++++|++|+|++|++++..|
T Consensus       285 ~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          285 EIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             cCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            8886    366666 668888899999998886554

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=5.4e-22  Score=218.19  Aligned_cols=238  Identities=15%  Similarity=0.118  Sum_probs=141.7

Q ss_pred             cEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCC-cccccCCccce-eee
Q 002826          209 EQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLVN-LSL  286 (876)
Q Consensus       209 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L  286 (876)
                      ++++.++++++.+ |..+  .+++++|+|++|+|+ .+|...|.++++|++|+|++|++.+.+| ..|.+++++.+ +.+
T Consensus        12 ~~v~C~~~~Lt~i-P~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVTEI-PSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCCSC-CTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCCcc-CcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            4566667777643 4433  246777777777777 6666666667777777777777654443 45666666554 555


Q ss_pred             ecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecC-CcccccCccccccCC-CCCeeeccCcccC
Q 002826          287 HKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAES-NRFSGAIPDSISMAA-QLEQVQIDNNRFT  364 (876)
Q Consensus       287 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  364 (876)
                      +.|+|+.+.|+.|..+++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .++.|+|++|+|+
T Consensus        88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            66777766677777777777777777777766666666666666666644 556655555555543 4666677777766


Q ss_pred             CCCCCccccccCccEEeCCC-ccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCC-cCCCCCCcC
Q 002826          365 SSIPQGLGSVKSLYRFSASQ-NSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADN-SLTGEIPPS  441 (876)
Q Consensus       365 ~~~p~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N-~l~~~~p~~  441 (876)
                      . +|.......+|+.+++++ |.++.+.+..|.++++|++|||++|+|+..++ .|.+   |+.|.+.++ +++ .+| .
T Consensus       168 ~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~---L~~L~~l~~~~l~-~lP-~  241 (350)
T 4ay9_X          168 E-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN---LKKLRARSTYNLK-KLP-T  241 (350)
T ss_dssp             E-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT---CCEEECTTCTTCC-CCC-C
T ss_pred             C-CChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc---chHhhhccCCCcC-cCC-C
Confidence            3 333333445566666653 44554444556666666666666666665544 2333   333332222 233 444 2


Q ss_pred             CCCCCCcceeeCCCC
Q 002826          442 LAELPVLTYLDLSDN  456 (876)
Q Consensus       442 ~~~l~~L~~L~Ls~N  456 (876)
                      +..+++|+.++++++
T Consensus       242 l~~l~~L~~l~l~~~  256 (350)
T 4ay9_X          242 LEKLVALMEASLTYP  256 (350)
T ss_dssp             TTTCCSCCEEECSCH
T ss_pred             chhCcChhhCcCCCC
Confidence            556666666666554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=1.7e-24  Score=236.93  Aligned_cols=235  Identities=14%  Similarity=0.155  Sum_probs=143.3

Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      ++++.|++++|.+++..+. +..+++|++|+|++|.+....+|..+..+++|++|+|++|++++..+..+..+++|++|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            4555555555555544443 334555555555555421111444455556666666666666655666666677777777


Q ss_pred             cccC-ccCCC-CCCccccccccccEEEeccc-cccCc-CCcccccCC-ccceeeeecc--ccc-ccCCCCCcccccccee
Q 002826          237 LSQN-NLTGE-VPQSLGSSLLKLVSFDVSQN-KLSGS-FPNGICKAN-GLVNLSLHKN--FFN-GSIPGSINECLNLERF  308 (876)
Q Consensus       237 Ls~N-~l~~~-ip~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~N--~i~-~~~~~~~~~l~~L~~L  308 (876)
                      |++| .+++. ++.. +..+++|++|++++| ++++. ++..+..++ +|++|+|++|  .++ +.++..+..+++|++|
T Consensus       149 L~~~~~l~~~~l~~~-~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L  227 (336)
T 2ast_B          149 LSGCSGFSEFALQTL-LSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL  227 (336)
T ss_dssp             CTTCBSCCHHHHHHH-HHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred             CCCCCCCCHHHHHHH-HhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence            7777 55532 3322 334667777777777 66643 455566777 7777777777  344 3445566677788888


Q ss_pred             eccccc-CCCCCCcccCCCCcccEEEecCCc-ccccCccccccCCCCCeeeccCcccCCCCCCcccccc-CccEEeCCCc
Q 002826          309 QVQDNG-FSGDFPDKLWSLPRIKLIRAESNR-FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVK-SLYRFSASQN  385 (876)
Q Consensus       309 ~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~ls~N  385 (876)
                      ++++|. +++..+..+..+++|+.|++++|. ++......+..+++|+.|++++| ++   ...+..+. .+..|++++|
T Consensus       228 ~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n  303 (336)
T 2ast_B          228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCS  303 (336)
T ss_dssp             ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCC
T ss_pred             eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecc
Confidence            888887 666777778888888888888884 33222235677778888888877 33   22333332 3555566777


Q ss_pred             cccCCCCCCcCC
Q 002826          386 SFYGSLPPNFCD  397 (876)
Q Consensus       386 ~l~~~~~~~~~~  397 (876)
                      ++++..|..+..
T Consensus       304 ~l~~~~~~~~~~  315 (336)
T 2ast_B          304 HFTTIARPTIGN  315 (336)
T ss_dssp             CSCCTTCSSCSS
T ss_pred             cCccccCCcccc
Confidence            777666665543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.86  E-value=2.7e-22  Score=232.03  Aligned_cols=215  Identities=21%  Similarity=0.315  Sum_probs=110.9

Q ss_pred             CCCCCCCCCCCCc-----cccce-EecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccC
Q 002826           48 LSTWSNTSNIHYC-----NWTGV-TCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQ  121 (876)
Q Consensus        48 ~~sW~~~~~~~~C-----~w~gv-~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~  121 (876)
                      +.+|...  .++|     .|.|+ .|...     .+..+++.++++++ +|..+.  ++|++|+|++|.|+. +|   ..
T Consensus        33 l~~W~~~--~~~~~~~~~~~~~l~~C~~~-----~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip---~~   98 (571)
T 3cvr_A           33 WDKWEKQ--ALPGENRNEAVSLLKECLIN-----QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP---EL   98 (571)
T ss_dssp             HHHHHTT--CCTTCCHHHHHHHHHHHHHT-----TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC---CC
T ss_pred             HHHHhcc--CCccccccchhhhccccccC-----CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc---cc
Confidence            4457432  3567     79999 78643     34556666666665 555442  566666666666653 44   33


Q ss_pred             CCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCc
Q 002826          122 CSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD  201 (876)
Q Consensus       122 l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~  201 (876)
                      +++|++|+|          ++|+|++ +|. |.+  +|++|+|++|+|++ +|.   .+++|++|+|++|+  ++.+|. 
T Consensus        99 l~~L~~L~L----------s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~--l~~lp~-  157 (571)
T 3cvr_A           99 PASLEYLDA----------CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQ--LTMLPE-  157 (571)
T ss_dssp             CTTCCEEEC----------CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSC--CSCCCC-
T ss_pred             cCCCCEEEc----------cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCc--cCcCCC-
Confidence            445554433          3333443 444 443  56666666666654 333   45556666666665  333444 


Q ss_pred             ccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCcc
Q 002826          202 IGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGL  281 (876)
Q Consensus       202 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  281 (876)
                        .+++|++|+|++|+|++ +|. |.  ++|++|+|++|+|+ .+|. +..   +|                 +...+.|
T Consensus       158 --~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~---~L-----------------~~~~~~L  209 (571)
T 3cvr_A          158 --LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV---RN-----------------HHSEETE  209 (571)
T ss_dssp             --CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------------------------CC
T ss_pred             --cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH---hh-----------------hcccccc
Confidence              34455555555555554 333 33  55555555555555 4444 221   33                 0000111


Q ss_pred             ceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCC
Q 002826          282 VNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSL  326 (876)
Q Consensus       282 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  326 (876)
                      +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus       210 ~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          210 IFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             EEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             eEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            55555555555 344444455666666666666665555555443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=3.4e-21  Score=195.19  Aligned_cols=180  Identities=18%  Similarity=0.229  Sum_probs=115.1

Q ss_pred             EEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEecc
Q 002826          185 VLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQ  264 (876)
Q Consensus       185 ~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~  264 (876)
                      .++++++.  +..+|..+  .++|++|++++|+++++.+..|.++++|++|+|++|+++ .+|...+..+++|++|+|++
T Consensus        11 ~v~c~~~~--l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           11 TVECYSQG--RTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             EEECCSSC--CSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred             EEEecCCC--ccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECCC
Confidence            44455554  34444433  235666666666666655556666667777777777666 55555555566677777776


Q ss_pred             ccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCc
Q 002826          265 NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP  344 (876)
Q Consensus       265 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  344 (876)
                      |++++..+..|..+++|++|+|++|+|++..+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+.+.  
T Consensus        86 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--  163 (208)
T 2o6s_A           86 NQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--  163 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred             CcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence            666655555566666777777777777666666666777777777777777766665666677777777777765532  


Q ss_pred             cccccCCCCCeeeccCcccCCCCCCccccccC
Q 002826          345 DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKS  376 (876)
Q Consensus       345 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  376 (876)
                           +++|++|+++.|+++|.+|..++.++.
T Consensus       164 -----~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          164 -----CPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             -----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             -----CCCHHHHHHHHHhCCceeeccCccccC
Confidence                 345777777777777777776665543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=3e-21  Score=195.58  Aligned_cols=181  Identities=17%  Similarity=0.155  Sum_probs=101.5

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      +.++++++.++ .+|..+   .++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++
T Consensus        10 ~~v~c~~~~l~-~~p~~~---~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~   85 (208)
T 2o6s_A           10 TTVECYSQGRT-SVPTGI---PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLST   85 (208)
T ss_dssp             TEEECCSSCCS-SCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCcc-CCCCCC---CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCC
Confidence            45666666666 566544   23566666666666654444455555555555555555544444445555555555555


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCC
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP  392 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~  392 (876)
                      |++++.                        .+..|..+++|++|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus        86 n~l~~~------------------------~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  141 (208)
T 2o6s_A           86 NQLQSL------------------------PNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPD  141 (208)
T ss_dssp             SCCCCC------------------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             CcCCcc------------------------CHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCH
Confidence            544443                        33444444455555555555554444445555555555555555555555


Q ss_pred             CCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCC
Q 002826          393 PNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPV  447 (876)
Q Consensus       393 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  447 (876)
                      ..|..+++|+.|++++|.+.+      .+++|++|+++.|+++|.+|..++.++.
T Consensus       142 ~~~~~l~~L~~L~l~~N~~~~------~~~~l~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          142 GVFDRLTSLQYIWLHDNPWDC------TCPGIRYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             TTTTTCTTCCEEECCSCCBCC------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             HHhccCCCccEEEecCCCeec------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence            555556666666666665543      3456677777777777777777766554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=3.8e-21  Score=222.48  Aligned_cols=168  Identities=25%  Similarity=0.375  Sum_probs=97.4

Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      ++|++|+|++|+|+ .+|   ..+++|++|+|++|+  ++.+|. +.+  +|++|+|++|+|++ +|.   .+++|++|+
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~--l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  146 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNR--LSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN  146 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSC--CSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCC--CCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence            45555555555555 333   234555555555554  333554 433  55555565555655 333   456666666


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcccccc-------ceee
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL-------ERFQ  309 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L-------~~L~  309 (876)
                      |++|+|+ .+|.    .+++|++|+|++|+|++ +|. |.  ++|++|+|++|+|+ .+|. |..  +|       +.|+
T Consensus       147 Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~  213 (571)
T 3cvr_A          147 ADNNQLT-MLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFR  213 (571)
T ss_dssp             CCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEE
T ss_pred             CCCCccC-cCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEe
Confidence            6666666 3554    24566666666666664 444 44  66666666666666 3343 443  55       7777


Q ss_pred             cccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCC
Q 002826          310 VQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAA  351 (876)
Q Consensus       310 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  351 (876)
                      |++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+.
T Consensus       214 Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred             cCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence            7777777 4566666677777777777777777776665543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.83  E-value=5.4e-22  Score=238.13  Aligned_cols=238  Identities=18%  Similarity=0.156  Sum_probs=118.6

Q ss_pred             ChhHHHHHHHHHhhccCC-CCCCCCCCCCCCCCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeee
Q 002826           27 ASTEKDTLLSFKASIDDS-KNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLN  105 (876)
Q Consensus        27 ~~~~~~all~~k~~~~~~-~~~~~sW~~~~~~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~  105 (876)
                      ...++++|+++..+...+ ...-.+|... +...+.|.+++++..     ++..++|..                     
T Consensus       130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~-----~~~~l~L~~---------------------  182 (727)
T 4b8c_D          130 VDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSGTATNSAVSTP-----LTPKIELFA---------------------  182 (727)
T ss_dssp             --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred             cccchhhhhhhhhhcccccCcccCCCcCC-CCccccCCCceecCC-----ccceEEeeC---------------------
Confidence            467889999999887533 2234467533 245677888877654     344444444                     


Q ss_pred             cCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceE
Q 002826          106 LADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVV  185 (876)
Q Consensus       106 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  185 (876)
                         |.+... |     ...|+.++|++|.|..++++.|.+. ..|+.|..+++|++|+|++|+++ .+|..+.++++|++
T Consensus       183 ---n~~~~~-~-----~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~  251 (727)
T 4b8c_D          183 ---NGKDEA-N-----QALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTR  251 (727)
T ss_dssp             -------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSC
T ss_pred             ---CCCCcc-h-----hhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCE
Confidence               444331 1     1234555666666666777777776 66778888888888888888887 56666668888888


Q ss_pred             EEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccc
Q 002826          186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN  265 (876)
Q Consensus       186 L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N  265 (876)
                      |+|++|.  +..+|..|.++++|++|+|++|+|+ .+|..|.+|++|++|+|++|.|+ .+|..+ ..+++|++|+|++|
T Consensus       252 L~Ls~N~--l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~-~~l~~L~~L~L~~N  326 (727)
T 4b8c_D          252 LYLNGNS--LTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEF-GNLCNLQFLGVEGN  326 (727)
T ss_dssp             CBCTTSC--CSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSST-TSCTTCCCEECTTS
T ss_pred             EEeeCCc--CcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhh-hcCCCccEEeCCCC
Confidence            8888887  4477877888888888888888888 55777888888888888888887 777774 45888888888888


Q ss_pred             cccCcCCcccccCCc-cceeeeecccccccCCCCCccccccceeecccc
Q 002826          266 KLSGSFPNGICKANG-LVNLSLHKNFFNGSIPGSINECLNLERFQVQDN  313 (876)
Q Consensus       266 ~l~~~~~~~~~~l~~-L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  313 (876)
                      +|++.+|..+..+.. +..|+|++|.+++.+|..      |+.|+++.|
T Consensus       327 ~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n  369 (727)
T 4b8c_D          327 PLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD  369 (727)
T ss_dssp             CCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             ccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence            888777777655432 234677777777766653      344555555

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=3.3e-20  Score=190.76  Aligned_cols=160  Identities=26%  Similarity=0.318  Sum_probs=130.9

Q ss_pred             CCCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccc
Q 002826           57 IHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW  136 (876)
Q Consensus        57 ~~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  136 (876)
                      .+.|.|++|.|.....                +.+|..+.  ++|++|+|++|.+++..|..|..+++|++|+|++    
T Consensus        16 ~~~Cs~~~v~c~~~~l----------------~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~----   73 (229)
T 3e6j_A           16 QCSCSGTTVDCRSKRH----------------ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGS----   73 (229)
T ss_dssp             TCEEETTEEECTTSCC----------------SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS----
T ss_pred             CCEEeCCEeEccCCCc----------------CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCC----
Confidence            3789999999975531                23444433  8899999999999999899999999999885554    


Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                            |+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+  +..+|..+..+++|++|+|++|
T Consensus        74 ------N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~--l~~lp~~~~~l~~L~~L~L~~N  145 (229)
T 3e6j_A           74 ------NQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNK--LTELPRGIERLTHLTHLALDQN  145 (229)
T ss_dssp             ------SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC--CCSCCTTGGGCTTCSEEECCSS
T ss_pred             ------CCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCc--ccccCcccccCCCCCEEECCCC
Confidence                  45555556778899999999999999998888888999999999999998  5688888888888888888888


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCC
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEV  246 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~i  246 (876)
                      +|+++.+..|..+++|++|+|++|.++...
T Consensus       146 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          146 QLKSIPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             cCCccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            888877777888888888888888887443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=1.4e-20  Score=200.92  Aligned_cols=189  Identities=20%  Similarity=0.288  Sum_probs=95.1

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEec
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      ++..+.+..+.+++..+  +..+++|++|++++|.  +..+| .+..+++|++|+|++|++++..+  +.++++|++|+|
T Consensus        25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~--i~~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l   97 (291)
T 1h6t_A           25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD--IKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL   97 (291)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred             HHHHHHhcCCCcccccc--hhhcCcccEEEccCCC--cccCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence            33444444444443222  2344555555555554  33333 24455555555555555554433  555555555555


Q ss_pred             ccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCC
Q 002826          238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG  317 (876)
Q Consensus       238 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (876)
                      ++|+++ .+|.  +..+++|++|+|++|++++.  ..+..+++|++|++++|++++.  ..+..+++|+.|++++|++++
T Consensus        98 ~~n~l~-~~~~--l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A           98 DENKVK-DLSS--LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             CSSCCC-CGGG--GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCCcCC-CChh--hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcccc
Confidence            555555 3332  23355555555555555532  3455555555555555555543  345555555555555555554


Q ss_pred             CCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       318 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      ..+  +..+++|+.|++++|++++. + .+..+++|+.|++++|+++
T Consensus       171 ~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          171 IVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             chh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            433  55555555555555555542 2 2555555555555555555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=3.1e-20  Score=217.35  Aligned_cols=172  Identities=19%  Similarity=0.268  Sum_probs=90.8

Q ss_pred             cCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCC
Q 002826          153 IGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL  232 (876)
Q Consensus       153 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  232 (876)
                      +..|++|+.|+|++|.++.. | .|..+++|+.|+|++|+  +..+|. +..+++|+.|+|++|+++++  ..+..+++|
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~--l~~~~~-l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L  111 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNK--LTDIKP-LTNLKNLGWLFLDENKIKDL--SSLKDLKKL  111 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSC--CCCCGG-GGGCTTCCEEECCSSCCCCC--TTSTTCTTC
T ss_pred             hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCC--CCCChh-hccCCCCCEEECcCCCCCCC--hhhccCCCC
Confidence            34566666666666666532 2 35666666666666665  334443 55566666666666666542  245555666


Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      ++|+|++|+|+ .++.  +..+++|+.|+|++|+|++.  ..+..+++|+.|+|++|.|++..|  +..+++|+.|+|++
T Consensus       112 ~~L~Ls~N~l~-~l~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~  184 (605)
T 1m9s_A          112 KSLSLEHNGIS-DING--LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK  184 (605)
T ss_dssp             CEEECTTSCCC-CCGG--GGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             CEEEecCCCCC-CCcc--ccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcC
Confidence            66666666655 3322  23355555555555555543  344555555555555555554443  44455555555555


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCccc
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFS  340 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~  340 (876)
                      |+|++.  ..+..+++|+.|+|++|+++
T Consensus       185 N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          185 NHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             SCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             CCCCCC--hHHccCCCCCEEEccCCcCc
Confidence            555432  23444444444444444444

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.81  E-value=1e-20  Score=200.59  Aligned_cols=127  Identities=13%  Similarity=0.091  Sum_probs=102.9

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc------------------CHHHHHHHHHHHhhccCccccceeeEEEe
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ------------------SSKTLKTEVKTLAKIRHKNIVKVLGFFHS  649 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  649 (876)
                      ...|.|+||.||+|...+|+.||+|++......                  ....+.+|++++++++  | +++.+++..
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~  172 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW  172 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence            444445599999998888999999998643211                  2346889999999999  5 777776644


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                       +..|+||||++|++|.+ +..       .....++.|++.|++|||+.   +|+||||||+||+++ ++.+||+|||++
T Consensus       173 -~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a  239 (282)
T 1zar_A          173 -EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQS  239 (282)
T ss_dssp             -ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTC
T ss_pred             -cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCC
Confidence             45699999999999988 422       22457999999999999999   999999999999999 999999999998


Q ss_pred             h
Q 002826          730 R  730 (876)
Q Consensus       730 ~  730 (876)
                      +
T Consensus       240 ~  240 (282)
T 1zar_A          240 V  240 (282)
T ss_dssp             E
T ss_pred             e
Confidence            6

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=8.8e-20  Score=213.46  Aligned_cols=200  Identities=24%  Similarity=0.325  Sum_probs=142.5

Q ss_pred             CCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccc
Q 002826           98 LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF  177 (876)
Q Consensus        98 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~  177 (876)
                      +..+..++|+.+.+....+  +..|++|+.|+|++|.|          +. +| .|..+++|+.|+|++|+|++..|  +
T Consensus        20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i----------~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l   83 (605)
T 1m9s_A           20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI----------KS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--L   83 (605)
T ss_dssp             HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCC----------CC-CT-TGGGCTTCCEEECTTSCCCCCGG--G
T ss_pred             HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCC----------CC-Ch-HHccCCCCCEEEeeCCCCCCChh--h
Confidence            3445566777777766544  56677777776655544          32 22 47778888888888888876555  7


Q ss_pred             cCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccc
Q 002826          178 GNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL  257 (876)
Q Consensus       178 ~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L  257 (876)
                      ..+++|+.|+|++|+  +..+| .+..+++|+.|+|++|+++++  ..+..+++|+.|+|++|+|+ .+ . .+..+++|
T Consensus        84 ~~l~~L~~L~Ls~N~--l~~l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~-~l-~-~l~~l~~L  155 (605)
T 1m9s_A           84 TNLKNLGWLFLDENK--IKDLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-DI-T-VLSRLTKL  155 (605)
T ss_dssp             GGCTTCCEEECCSSC--CCCCT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCC-CC-G-GGGSCTTC
T ss_pred             ccCCCCCEEECcCCC--CCCCh-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccC-Cc-h-hhcccCCC
Confidence            788888888888887  44444 677888888888888888764  45778888888888888887 34 2 23457888


Q ss_pred             cEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCC
Q 002826          258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWS  325 (876)
Q Consensus       258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  325 (876)
                      +.|+|++|+|++..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++++.....+..
T Consensus       156 ~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~  219 (605)
T 1m9s_A          156 DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSN  219 (605)
T ss_dssp             SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred             CEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence            888888888886655  77888888888888888764  35777888888888888887554443333

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=2.7e-20  Score=198.77  Aligned_cols=170  Identities=23%  Similarity=0.299  Sum_probs=80.2

Q ss_pred             cccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEE
Q 002826          254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR  333 (876)
Q Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  333 (876)
                      +++|++|++++|.++.. + .+..+++|++|+|++|++++..+  +..+++|++|++++|++++ +| .+..+++|+.|+
T Consensus        45 l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~  118 (291)
T 1h6t_A           45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (291)
T ss_dssp             HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             cCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEE
Confidence            44444444444444422 1 23444444444444444443322  4444444444444444442 11 244444444444


Q ss_pred             ecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcccc
Q 002826          334 AESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG  413 (876)
Q Consensus       334 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~  413 (876)
                      +++|++++.  ..+..+++|+.|++++|+++                        +.  ..+..+++|+.|+|++|++++
T Consensus       119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~------------------------~~--~~l~~l~~L~~L~L~~N~l~~  170 (291)
T 1h6t_A          119 LEHNGISDI--NGLVHLPQLESLYLGNNKIT------------------------DI--TVLSRLTKLDTLSLEDNQISD  170 (291)
T ss_dssp             CTTSCCCCC--GGGGGCTTCCEEECCSSCCC------------------------CC--GGGGGCTTCSEEECCSSCCCC
T ss_pred             CCCCcCCCC--hhhcCCCCCCEEEccCCcCC------------------------cc--hhhccCCCCCEEEccCCcccc
Confidence            444444432  23444444444444444444                        32  234444445555555555554


Q ss_pred             CCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          414 QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       414 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      .++ +..+++|++|+|++|++++. | .+..+++|+.|++++|+++.
T Consensus       171 ~~~-l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          171 IVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             chh-hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            443 55555666666666666532 2 25666666666666666653

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=2.9e-19  Score=182.43  Aligned_cols=154  Identities=16%  Similarity=0.183  Sum_probs=85.9

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCC-cccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      +.+++++|.++ .+|..++   ..+++|+|++|+|++..+ ..|..+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        14 ~~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   89 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT   89 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence            46777777776 5666543   245666666666665533 335556666666666666655555555555555555555


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCC
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL  391 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  391 (876)
                      +|++++..+..|.++++|++|                        +|++|+|++..|..|.++++|+.|+|++|++++..
T Consensus        90 ~N~l~~~~~~~~~~l~~L~~L------------------------~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  145 (220)
T 2v70_A           90 SNRLENVQHKMFKGLESLKTL------------------------MLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA  145 (220)
T ss_dssp             SSCCCCCCGGGGTTCSSCCEE------------------------ECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred             CCccCccCHhHhcCCcCCCEE------------------------ECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence            555554444444444444444                        44444444444444555555555555555555555


Q ss_pred             CCCcCCCCCccEEEccCCccccC
Q 002826          392 PPNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       392 ~~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                      |..|..+++|+.|+|++|.+...
T Consensus       146 ~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          146 PGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             TTTTTTCTTCCEEECCSCCEECS
T ss_pred             HHHhcCCCCCCEEEecCcCCcCC
Confidence            55555555666666666666543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=2.9e-19  Score=182.41  Aligned_cols=150  Identities=16%  Similarity=0.228  Sum_probs=85.0

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      +.+++++|+++ .+|..+.   ++|+.|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|.++++|++|+|++
T Consensus        14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~   89 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG   89 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred             CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence            46777777777 6776553   4667777777777665555666666666666666666666666666666666666666


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCcc
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS  386 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  386 (876)
                      |+|+...+..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|.
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  163 (220)
T 2v9t_B           90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP  163 (220)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCC
Confidence            66654444445555555555555555554444444444444444444444443333334444444443333333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=7.1e-20  Score=202.11  Aligned_cols=178  Identities=21%  Similarity=0.187  Sum_probs=100.5

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccc-cCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGIC-KANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      +++++++|+++ .+|..++   ..++.|+|++|+|++..+..|. .+++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence            46677777776 6666543   3466667777766665555555 66666666666666666666666666666666666


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCC
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSL  391 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~  391 (876)
                      +|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..                  
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~------------------  158 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKD------------------  158 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-------------------
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcC------------------
Confidence            66666555555555666666666666655555555555555555555555555322222210                  


Q ss_pred             CCCcCCCCCccEEEccCCccccCCc-Ccccccc--cceEeccCCcCC
Q 002826          392 PPNFCDSPVMSIINLSQNSISGQIP-ELKKCRK--LVSLSLADNSLT  435 (876)
Q Consensus       392 ~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~--L~~L~Ls~N~l~  435 (876)
                         +..+++|+.|||++|+|++.++ .+..++.  |+.|+|++|.+.
T Consensus       159 ---~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          159 ---GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             ------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             ---cccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence               0234445555555555554443 3444444  355666666654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.80  E-value=1.3e-19  Score=200.04  Aligned_cols=175  Identities=18%  Similarity=0.171  Sum_probs=96.2

Q ss_pred             EEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCcccc-CCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          185 VLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV-GLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       185 ~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      .+++++|+  +..+|..+.  ..++.|+|++|+|+++.+..|. ++++|++|+|++|+|+ .++...+..+++|++|+|+
T Consensus        22 ~l~c~~~~--l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls   96 (361)
T 2xot_A           22 ILSCSKQQ--LPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS   96 (361)
T ss_dssp             EEECCSSC--CSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECC
T ss_pred             EEEeCCCC--cCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECC
Confidence            44555544  344444332  2355555555555555555555 5666666666666665 4444434455666666666


Q ss_pred             cccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCccc---CCCCcccEEEecCCccc
Q 002826          264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKL---WSLPRIKLIRAESNRFS  340 (876)
Q Consensus       264 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~  340 (876)
                      +|+|++..+..|..+++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+..|   ..+++|+.|+|++|+|+
T Consensus        97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A           97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            666655555555666666666666666665556666666666666666666664444434   34555666666666655


Q ss_pred             ccCccccccCCC--CCeeeccCcccC
Q 002826          341 GAIPDSISMAAQ--LEQVQIDNNRFT  364 (876)
Q Consensus       341 ~~~~~~~~~l~~--L~~L~L~~N~l~  364 (876)
                      +..+..+..++.  ++.|+|++|.+.
T Consensus       177 ~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          177 KLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             ccCHHHhhhccHhhcceEEecCCCcc
Confidence            544445554444  245555555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.80  E-value=4.6e-19  Score=180.91  Aligned_cols=151  Identities=21%  Similarity=0.265  Sum_probs=103.5

Q ss_pred             eeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCcc
Q 002826          307 RFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS  386 (876)
Q Consensus       307 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  386 (876)
                      .+++++|.++ .+|..+.  ++|+.|++++|+|++..+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~   91 (220)
T 2v9t_B           15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK   91 (220)
T ss_dssp             EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence            4455555554 3333332  456666666666666666666666666666666666666666666666777777777777


Q ss_pred             ccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          387 FYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       387 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      |++..+..|.++++|+.|+|++|+|++..+ .|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus        92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B           92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            766666666777777777777777777665 67777888888888888887777778888888888888888764

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=4.9e-20  Score=193.59  Aligned_cols=171  Identities=18%  Similarity=0.239  Sum_probs=127.3

Q ss_pred             CccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcE
Q 002826          155 SLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSI  234 (876)
Q Consensus       155 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  234 (876)
                      .+.+++.+++++|.+++..  .+..+++|++|++++|.  +..+| .+..+++|++|+|++|++++..+  +.++++|++
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~--i~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSN--IQSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEE   89 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCE
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCC--cccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCE
Confidence            5667778888888887443  57778888888888886  55666 67778888888888888887654  788888888


Q ss_pred             EecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccccc
Q 002826          235 LDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG  314 (876)
Q Consensus       235 L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~  314 (876)
                      |+|++|+++ .+|....   ++|++|+|++|+|++.  ..+..+++|++|+|++|+|++. + .+..+++|+.|++++|+
T Consensus        90 L~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A           90 LSVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             EECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred             EECCCCccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence            888888888 5655332   7888888888888753  3577788888888888888764 2 57777777888888877


Q ss_pred             CCCCCCcccCCCCcccEEEecCCccccc
Q 002826          315 FSGDFPDKLWSLPRIKLIRAESNRFSGA  342 (876)
Q Consensus       315 l~~~~p~~~~~l~~L~~L~L~~N~l~~~  342 (876)
                      +++.  ..+..+++|+.|++++|++++.
T Consensus       162 i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          162 ITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             Ccch--HHhccCCCCCEEeCCCCcccCC
Confidence            7765  5677777777777777777655

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.79  E-value=6.7e-19  Score=179.68  Aligned_cols=114  Identities=17%  Similarity=0.165  Sum_probs=49.8

Q ss_pred             ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcccccc
Q 002826          226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL  305 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  305 (876)
                      |.++++|++|+|++|+|+ .++...+..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+++.|..|..+++|
T Consensus        53 ~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  131 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSV  131 (220)
T ss_dssp             GGGCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTC
T ss_pred             hccCCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccC
Confidence            344444444444444444 2332222334444444444444444334444444444444444444444444444444444


Q ss_pred             ceeecccccCCCCCCcccCCCCcccEEEecCCccc
Q 002826          306 ERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS  340 (876)
Q Consensus       306 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  340 (876)
                      ++|+|++|+|++..|..|..+++|+.|++++|.+.
T Consensus       132 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A          132 RLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             SEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             CEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            44444444444444444444444444444444443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=1.3e-21  Score=227.68  Aligned_cols=106  Identities=21%  Similarity=0.327  Sum_probs=58.1

Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      |+.|+|++|+|+ .+|.  +..+++|+.|+|++|+|+ .+|..++.+++|+.|+|++|+|++ +| .|..+++|+.|+|+
T Consensus       443 L~~L~Ls~n~l~-~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          443 VRVLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             CSEEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             ceEEEecCCCCC-CCcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            555666666665 3454  234555666666666655 445555555555555555555554 33 45555555555555


Q ss_pred             cccCCCCC-CcccCCCCcccEEEecCCcccccC
Q 002826          312 DNGFSGDF-PDKLWSLPRIKLIRAESNRFSGAI  343 (876)
Q Consensus       312 ~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~  343 (876)
                      +|+|++.. |..+..+++|+.|+|++|++++.+
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~  549 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE  549 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence            55555444 555555555555555555555443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=1.5e-18  Score=178.29  Aligned_cols=156  Identities=13%  Similarity=0.113  Sum_probs=118.1

Q ss_pred             cceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCC
Q 002826          305 LERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQ  384 (876)
Q Consensus       305 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~  384 (876)
                      .+.++.++++++ .+|..+.  ++|++|++++|++++..|..|..+++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            344555555555 3343332  6667777777777776677777777777777777777755556677777888888888


Q ss_pred             ccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCC
Q 002826          385 NSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       385 N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                      |+|++..+..|..+++|+.|+|++|+|+..+..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            8887777777888888888888888888666688889999999999999998777889999999999999999886443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=1.7e-21  Score=226.60  Aligned_cols=203  Identities=15%  Similarity=0.118  Sum_probs=123.8

Q ss_pred             cCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccc
Q 002826          227 VGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLE  306 (876)
Q Consensus       227 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  306 (876)
                      ..+++|+.|+|++|+|+ .+|..+.. +++|+.|++++|......|.           .+..+.+.+.+|..+..+++|+
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~-l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~  412 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELES-CKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLK  412 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHH-HHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHH-HHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhcc
Confidence            34556666666666665 66665543 66666666655431100000           0011122334444555555555


Q ss_pred             eee-cccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          307 RFQ-VQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       307 ~L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                      .|+ ++.|.+           ..|+.+.+++|.++...+.      .|+.|+|++|+|++ +|. ++++++|+.|+|++|
T Consensus       413 ~L~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N  473 (567)
T 1dce_A          413 AVDPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHN  473 (567)
T ss_dssp             HHCGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSS
T ss_pred             cCcchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCcc
Confidence            555 444433           2344455555555543322      36677777777764 454 777777777777777


Q ss_pred             cccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCC-CcCCCCCCCcceeeCCCCcccccCC
Q 002826          386 SFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEI-PPSLAELPVLTYLDLSDNNLTGPIP  463 (876)
Q Consensus       386 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p  463 (876)
                      .|+ .+|..|+.+++|+.|+|++|+|++. |.++.+++|++|+|++|+|++.+ |..|+.+++|+.|+|++|+|++.+|
T Consensus       474 ~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          474 RLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             CCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             ccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            776 5666777777777777777777764 47777778888888888887766 7778888888888888888876554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.78  E-value=8.5e-20  Score=198.85  Aligned_cols=218  Identities=13%  Similarity=0.089  Sum_probs=131.7

Q ss_pred             CCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccc----ccccCCCCCccccc
Q 002826          229 LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNF----FNGSIPGSINECLN  304 (876)
Q Consensus       229 l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~----i~~~~~~~~~~l~~  304 (876)
                      +++|+.|+|.+ +++ .|++..|.++++|+.|++++|.+..+.+.+|....++..+.+..+.    .......+|.++.+
T Consensus       100 ~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~  177 (329)
T 3sb4_A          100 KQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP  177 (329)
T ss_dssp             CTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred             cCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence            55555555555 555 5555555555555555555555554555555555555544444321    22233445555555


Q ss_pred             cc-eeecccccCCCCCCccc----CCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccE
Q 002826          305 LE-RFQVQDNGFSGDFPDKL----WSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYR  379 (876)
Q Consensus       305 L~-~L~L~~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  379 (876)
                      |+ .+.+....   .++..+    ....+++.+.+.++-...........+++|+.|+|++|+++...+..|.++++|+.
T Consensus       178 L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~  254 (329)
T 3sb4_A          178 LETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLK  254 (329)
T ss_dssp             CEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCE
T ss_pred             cceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCE
Confidence            55 33333211   111111    12345556666554322111111223677888888888887666667888888888


Q ss_pred             EeCCCccccCCCCCCcCCCCCcc-EEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeC
Q 002826          380 FSASQNSFYGSLPPNFCDSPVMS-IINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDL  453 (876)
Q Consensus       380 L~ls~N~l~~~~~~~~~~~~~L~-~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  453 (876)
                      +++.+| ++.+.+..|.++.+|+ .+++.+ +++.+.+ .|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus       255 l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          255 IKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence            888877 7767777888888888 888877 6665555 7888888888888888888777778888888887763

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=1.6e-19  Score=189.67  Aligned_cols=171  Identities=21%  Similarity=0.330  Sum_probs=112.6

Q ss_pred             CCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcc
Q 002826           97 ELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV  176 (876)
Q Consensus        97 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  176 (876)
                      .+.++..+++++|.+++..  .+..+++|++|++++|.|          + .+| .+..+++|++|+|++|+|++..+  
T Consensus        17 ~l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i----------~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--   80 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNI----------Q-SLA-GMQFFTNLKELHLSHNQISDLSP--   80 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCC----------C-CCT-TGGGCTTCCEEECCSSCCCCCGG--
T ss_pred             HHHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCc----------c-cch-HHhhCCCCCEEECCCCccCCChh--
Confidence            3555667777777776643  567777777665555443          3 233 56777778888888887775544  


Q ss_pred             ccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccc
Q 002826          177 FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK  256 (876)
Q Consensus       177 ~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  256 (876)
                      |.++++|++|+|++|+  +..+|....  ++|++|+|++|++++.  ..+..+++|++|+|++|+|+ .++ . +..+++
T Consensus        81 l~~l~~L~~L~L~~N~--l~~l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~-~~~-~-l~~l~~  151 (263)
T 1xeu_A           81 LKDLTKLEELSVNRNR--LKNLNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLK-SIV-M-LGFLSK  151 (263)
T ss_dssp             GTTCSSCCEEECCSSC--CSCCTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCC-BCG-G-GGGCTT
T ss_pred             hccCCCCCEEECCCCc--cCCcCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCC-CCh-H-HccCCC
Confidence            7777777788887776  455554322  6777777777777754  34677777777777777776 444 2 344677


Q ss_pred             ccEEEeccccccCcCCcccccCCccceeeeeccccccc
Q 002826          257 LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS  294 (876)
Q Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  294 (876)
                      |++|+|++|++++.  ..+..+++|+.|++++|.++..
T Consensus       152 L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          152 LEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            77777777777654  5566666777777777766644

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=1.2e-19  Score=197.55  Aligned_cols=292  Identities=15%  Similarity=0.111  Sum_probs=149.5

Q ss_pred             cccccccc--CCCCCCeeecCCCccccccCccccC-CCCCCcccCCCcccceeecCCccccccCCCccCCccccceeccc
Q 002826           89 GEISSSVC--ELSSLSNLNLADNLFNQPIPLHLSQ-CSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLG  165 (876)
Q Consensus        89 ~~~~~~~~--~l~~L~~L~L~~n~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~  165 (876)
                      |.++..+.  .+.+++.|.++++ +....-..+.. +++|++|||++|+|....        ..+.   .++.++.+.+.
T Consensus        13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~--------~~~~---~~~~~~~~~~~   80 (329)
T 3sb4_A           13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYS--------GKAG---TYPNGKFYIYM   80 (329)
T ss_dssp             TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEE--------ESSS---SSGGGCCEEEC
T ss_pred             CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEec--------Cccc---ccccccccccc
Confidence            44444444  3677888888764 22222223333 677777766666654111        1111   11223444444


Q ss_pred             ccccCCCcCccccC--------CCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          166 SNLLSGSVPFVFGN--------FSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       166 ~N~l~~~~p~~~~~--------l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      .|.   +.+.+|.+        +++|+.|+|.+ .  +..++. .|.++++|+.|++.+|.+..+.+.+|.++.++..+.
T Consensus        81 ~~~---I~~~aF~~~~~~~~~g~~~L~~l~L~~-~--i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~  154 (329)
T 3sb4_A           81 ANF---VPAYAFSNVVNGVTKGKQTLEKVILSE-K--IKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIP  154 (329)
T ss_dssp             TTE---ECTTTTEEEETTEEEECTTCCC-CBCT-T--CCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEEC
T ss_pred             ccc---cCHHHhcccccccccccCCCcEEECCc-c--ccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEec
Confidence            442   23345555        66677777666 3  444543 366667777777777766666667777766666666


Q ss_pred             cccCc----cCCCCCCcccccccccc-EEEeccccccCcCCccc----ccCCccceeeeecccccccCCCCC-ccccccc
Q 002826          237 LSQNN----LTGEVPQSLGSSLLKLV-SFDVSQNKLSGSFPNGI----CKANGLVNLSLHKNFFNGSIPGSI-NECLNLE  306 (876)
Q Consensus       237 Ls~N~----l~~~ip~~~~~~l~~L~-~L~L~~N~l~~~~~~~~----~~l~~L~~L~L~~N~i~~~~~~~~-~~l~~L~  306 (876)
                      +..+.    .. .+....|.++..|+ .+++....   .++..+    ....++..+.+.++-.. .....+ ..+++|+
T Consensus       155 ~~~~~~~~~~~-~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~  229 (329)
T 3sb4_A          155 LGSSDAYRFKN-RWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLV  229 (329)
T ss_dssp             TTCTHHHHTST-TTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCC
T ss_pred             Ccchhhhhccc-cccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCe
Confidence            65532    22 23333444455555 33333221   111111    12334444444443211 000011 1245555


Q ss_pred             eeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCC-eeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          307 RFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLE-QVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       307 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                      .++|++|+++.+.+.+|.++++|+.+++.+| ++.+.+.+|.++.+|+ .+++.+ .++...+..|.++++|+.+++++|
T Consensus       230 ~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n  307 (329)
T 3sb4_A          230 SLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD  307 (329)
T ss_dssp             EEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred             EEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence            5555555555555555555556666666555 5555555566666666 666655 455444556666666666666666


Q ss_pred             cccCCCCCCcCCCCCccEEE
Q 002826          386 SFYGSLPPNFCDSPVMSIIN  405 (876)
Q Consensus       386 ~l~~~~~~~~~~~~~L~~L~  405 (876)
                      +++.+.+..|.++++|+.++
T Consensus       308 ~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          308 KITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             CCCEECTTTTCTTCCCCEEE
T ss_pred             ccCccchhhhcCCcchhhhc
Confidence            66666666666666666654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=1.6e-19  Score=216.77  Aligned_cols=196  Identities=18%  Similarity=0.170  Sum_probs=103.1

Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      +.++.|+|.+|.+... +.     ..|+.++|+.|.               +..+++..|++. ..++.|..+++|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~-----~~l~~l~Ls~~~---------------i~~~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQ-----ALLQHKKLSQYS---------------IDEDDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCcc-hh-----hHhhcCccCccc---------------ccCcccccccee-cChhhhccCCCCcEEE
Confidence            3455666666666532 21     224445555553               223344445554 4566777777777777


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      |++|+|. .+|..++ .+++|++|+|++|+|+ .+|..|.++++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+
T Consensus       231 Ls~n~l~-~l~~~~~-~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIF-KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT  306 (727)
T ss_dssp             CTTSCCS-CCCGGGG-GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC
T ss_pred             CCCCCCC-CCChhhc-CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC
Confidence            7777777 7777666 4777777777777777 66777777777888888888777 56777778888888888888776


Q ss_pred             CCCCcccCCCCcccEEEecCCcccccCccccccCCC-CCeeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          317 GDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQ-LEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       317 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                       .+|..|..+++|+.|+|++|+|++.+|..+..+.. +..++|++|.+++.+|..+      ..|++++|
T Consensus       307 -~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l------~~l~l~~n  369 (727)
T 4b8c_D          307 -TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER------RFIEINTD  369 (727)
T ss_dssp             -CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred             -ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc------ceeEeecc
Confidence             56666888888888888888888777777655422 2346788888887777543      34455555

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=4.1e-18  Score=169.94  Aligned_cols=179  Identities=18%  Similarity=0.256  Sum_probs=117.3

Q ss_pred             cEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCC-ccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccC
Q 002826          330 KLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQ-GLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQ  408 (876)
Q Consensus       330 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~  408 (876)
                      +.+++++|+++ .+|..+.  .+|++|++++|++++..+. .|..+++|++|++++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            44555555554 2333332  2677777777777755554 367777788888888888777778888888888888888


Q ss_pred             CccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCc-ccccccceEEccCCccccccC
Q 002826          409 NSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQG-LQNLKLALFNVSFNKLSGRVP  486 (876)
Q Consensus       409 N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~l~~l~ls~N~l~~~~p  486 (876)
                      |+|++.++ .|.++++|++|+|++|+|++.+|..|..+++|++|+|++|++++..+-. +.. .+....+..+......|
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~-~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH-HHHHHCCSGGGCBBCSS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHH-HHHHcCCCCCCCCCCCC
Confidence            88888777 5888888999999999999888889999999999999999998755421 111 11112333444444444


Q ss_pred             CcccCCCCCccccCCCCCCCCCCCCCC
Q 002826          487 YSLISGLPASYLQGNPGLCGPGLSNSC  513 (876)
Q Consensus       487 ~~~~~~~~~~~~~~N~~~C~~~~~~~c  513 (876)
                      .. +.+.....+..+...|..+.+..|
T Consensus       167 ~~-l~~~~l~~l~~~~~~C~~~~~~~c  192 (192)
T 1w8a_A          167 SK-VRDVQIKDLPHSEFKCSSENSEGC  192 (192)
T ss_dssp             TT-TTTSBGGGSCTTTCCCCCC---CC
T ss_pred             hH-HcCCChhhCcHhhcCcCCCCCCCC
Confidence            33 233444456666666765544333

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.74  E-value=3.9e-18  Score=170.92  Aligned_cols=153  Identities=19%  Similarity=0.246  Sum_probs=84.0

Q ss_pred             ccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCe
Q 002826          276 CKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQ  355 (876)
Q Consensus       276 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  355 (876)
                      ..+++|+.|++++|.|+ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|+                 
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~-----------------   99 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKD-----------------   99 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTT-----------------
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCc-----------------
Confidence            45566666666666665 233 45555555555555554431  1234444444444444444                 


Q ss_pred             eeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCc-cccCCcCcccccccceEeccCCcC
Q 002826          356 VQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS-ISGQIPELKKCRKLVSLSLADNSL  434 (876)
Q Consensus       356 L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~-l~~~~~~~~~l~~L~~L~Ls~N~l  434 (876)
                             +++..|..+..+++|+.|++++|++++..|..+..+++|++|++++|. ++ .++.+..+++|++|++++|++
T Consensus       100 -------l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i  171 (197)
T 4ezg_A          100 -------VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGV  171 (197)
T ss_dssp             -------CBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCC
T ss_pred             -------cCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCC
Confidence                   444444444445555555555555554444555555555666666665 33 334566677777777777777


Q ss_pred             CCCCCcCCCCCCCcceeeCCCCccc
Q 002826          435 TGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       435 ~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      ++. + .+..+++|+.|++++|++.
T Consensus       172 ~~~-~-~l~~l~~L~~L~l~~N~i~  194 (197)
T 4ezg_A          172 HDY-R-GIEDFPKLNQLYAFSQTIG  194 (197)
T ss_dssp             CCC-T-TGGGCSSCCEEEECBC---
T ss_pred             cCh-H-HhccCCCCCEEEeeCcccC
Confidence            643 3 5667777777777777765

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=1.1e-17  Score=167.70  Aligned_cols=152  Identities=16%  Similarity=0.233  Sum_probs=121.0

Q ss_pred             cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccE
Q 002826          252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKL  331 (876)
Q Consensus       252 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  331 (876)
                      ..+++|++|++++|+++ .+| .+..+++|++|++++|.++.  +..+..+++|++|++++|++++..+..+..+++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45899999999999999 555 69999999999999997763  347899999999999999999888999999999999


Q ss_pred             EEecCCcccccCccccccCCCCCeeeccCcc-cCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCc
Q 002826          332 IRAESNRFSGAIPDSISMAAQLEQVQIDNNR-FTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNS  410 (876)
Q Consensus       332 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~  410 (876)
                      |++++|++++..+..+..+++|++|++++|+ ++ .+| .+..+++|+.|++++|++++..  .+..+++|+.|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            9999999998888889999999999999998 55 444 5666777777766666665422  34444444555544444


Q ss_pred             c
Q 002826          411 I  411 (876)
Q Consensus       411 l  411 (876)
                      +
T Consensus       193 i  193 (197)
T 4ezg_A          193 I  193 (197)
T ss_dssp             -
T ss_pred             c
Confidence            4

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.72  E-value=1.7e-16  Score=176.46  Aligned_cols=240  Identities=13%  Similarity=0.146  Sum_probs=112.6

Q ss_pred             cccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeee
Q 002826          207 KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSL  286 (876)
Q Consensus       207 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  286 (876)
                      +|+.+.+.+| ++.+...+|.+. +|+.+.+.. .++ .++...|.++++|+.++|++|+++.+...+|. ..+|+.+.|
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~l  210 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLL  210 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEEC
T ss_pred             CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEe
Confidence            4455554433 444444445442 355555543 444 44444444555555555555555543334443 345555555


Q ss_pred             ecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC--
Q 002826          287 HKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT--  364 (876)
Q Consensus       287 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--  364 (876)
                      ..| ++.+...+|.++++|+.+.+.+| ++.+...+|.+ .+|+.+.+ .|.++.+...+|.++.+|+.+++.+|.+.  
T Consensus       211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~  286 (401)
T 4fdw_A          211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDD  286 (401)
T ss_dssp             CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCC
T ss_pred             CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCC
Confidence            432 44445555555555555555543 33344444444 45555555 33344455555555555555555555443  


Q ss_pred             ---CCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcC
Q 002826          365 ---SSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPS  441 (876)
Q Consensus       365 ---~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  441 (876)
                         ...+..|.++++|+.+.+. |.++.+....                       |.++++|+.++|..| ++.+.+.+
T Consensus       287 ~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~a-----------------------F~~c~~L~~l~lp~~-l~~I~~~a  341 (401)
T 4fdw_A          287 PEAMIHPYCLEGCPKLARFEIP-ESIRILGQGL-----------------------LGGNRKVTQLTIPAN-VTQINFSA  341 (401)
T ss_dssp             TTCEECTTTTTTCTTCCEECCC-TTCCEECTTT-----------------------TTTCCSCCEEEECTT-CCEECTTS
T ss_pred             cccEECHHHhhCCccCCeEEeC-CceEEEhhhh-----------------------hcCCCCccEEEECcc-ccEEcHHh
Confidence               1223334444444444444 2233333344                       444555555555332 44344445


Q ss_pred             CCCCCCcceeeCCCCcccccCCCccccc--ccceEEccCCcc
Q 002826          442 LAELPVLTYLDLSDNNLTGPIPQGLQNL--KLALFNVSFNKL  481 (876)
Q Consensus       442 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~l~~l~ls~N~l  481 (876)
                      |.++ +|+.|++++|.+....+..|..+  .+..+++..|.+
T Consensus       342 F~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          342 FNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             SSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             CCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            5555 55555555555443333334433  234444444433

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=3.5e-17  Score=163.17  Aligned_cols=112  Identities=16%  Similarity=0.278  Sum_probs=52.8

Q ss_pred             ccceeecccccCCCCCCc-ccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeC
Q 002826          304 NLERFQVQDNGFSGDFPD-KLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSA  382 (876)
Q Consensus       304 ~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l  382 (876)
                      +|++|++++|+|++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|++
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            333444444444333332 2334444444444444444444444444444444444444444444444444555555555


Q ss_pred             CCccccCCCCCCcCCCCCccEEEccCCccccCC
Q 002826          383 SQNSFYGSLPPNFCDSPVMSIINLSQNSISGQI  415 (876)
Q Consensus       383 s~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  415 (876)
                      ++|++++..|..|..+++|++|+|++|.+++..
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            555555555555555555555555555555443

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.69  E-value=4.1e-16  Score=173.43  Aligned_cols=270  Identities=12%  Similarity=0.131  Sum_probs=132.8

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      ..++.+.+.+ .++.+...+|.++ +|+.+.|.+|           ++.+-..+|.+ .+|+.+.|.+ .++.+.+.+|.
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-----------i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~  177 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-----------LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFY  177 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-----------CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTT
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-----------ccEECHHhcCC-CCceEEEeCC-CccEehHHHhh
Confidence            4444554432 3444445555553 4555544332           23333344444 2466666654 45545555666


Q ss_pred             CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccccc
Q 002826          179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       179 ~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                      ++++|+.++|++|+  +..+|.......+|+.+.|.+ .+..+...+|.++++|+.+++..| ++ .++...|.+ .+|+
T Consensus       178 ~c~~L~~l~l~~n~--l~~I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~  251 (401)
T 4fdw_A          178 YCYNLKKADLSKTK--ITKLPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGIT  251 (401)
T ss_dssp             TCTTCCEEECTTSC--CSEECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCS
T ss_pred             CcccCCeeecCCCc--ceEechhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCcc
Confidence            66666666666554  444544422245555555552 255555555555555555555543 44 455555543 4555


Q ss_pred             EEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCc
Q 002826          259 SFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNR  338 (876)
Q Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  338 (876)
                      .+++ .|.++.+...+|.++++|+.+++.+|.+..                   +.+..+.+.+|.++++|+.+++. |.
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~l~-~~  310 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFEIP-ES  310 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEECCC-TT
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEEeC-Cc
Confidence            5555 333444444555555555555555544430                   00002333444444555555554 23


Q ss_pred             ccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCC-CccEEEccCCccc
Q 002826          339 FSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSP-VMSIINLSQNSIS  412 (876)
Q Consensus       339 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~-~L~~L~Ls~N~l~  412 (876)
                      ++.+...+|.++.+|+.+.|.+| ++...+..|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       311 i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          311 IRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             CCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             eEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            44444445555555555555333 443444455555 555555555555545555555553 5566666665543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.68  E-value=1.2e-17  Score=174.92  Aligned_cols=135  Identities=16%  Similarity=0.119  Sum_probs=101.6

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcE--EEEEEEecCCccC------------------------HHHHHHHHHHHhhccC
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGEL--IAVKKLVNFGCQS------------------------SKTLKTEVKTLAKIRH  637 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~h  637 (876)
                      ++....|.|+||.||+|.. .+|+.  ||||++.......                        ...+.+|+..+++++|
T Consensus        50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  129 (258)
T 1zth_A           50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE  129 (258)
T ss_dssp             EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence            3344445555999999977 68999  9999875431110                        1257889999999998


Q ss_pred             ccc--cceeeEEEeCCeEEEEEEcCCC-C----CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhh-ccCCCCccccccc
Q 002826          638 KNI--VKVLGFFHSDESIFLIYEFLQM-G----SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLH-KDYVPHLLHRNVK  709 (876)
Q Consensus       638 ~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i~H~Dlk  709 (876)
                      +++  +.++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|+.||| +.   +|+|||||
T Consensus       130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlk  198 (258)
T 1zth_A          130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLS  198 (258)
T ss_dssp             TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCS
T ss_pred             CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCC
Confidence            864  333332    356899999942 3    67766432    234567889999999999999 88   99999999


Q ss_pred             cCceeeCCCCCeEEccccchhhc
Q 002826          710 SKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       710 p~NIll~~~~~~kl~DfGla~~~  732 (876)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999998654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=1.1e-16  Score=155.91  Aligned_cols=136  Identities=25%  Similarity=0.273  Sum_probs=85.9

Q ss_pred             CCCCCeeecCCCccc-cccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcc
Q 002826           98 LSSLSNLNLADNLFN-QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV  176 (876)
Q Consensus        98 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  176 (876)
                      .++|++|+|++|.++ +.+|..+..+++|++|+|++|          .+++.  ..|..+++|++|+|++|++++.+|..
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n----------~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~   90 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----------GLISV--SNLPKLPKLKKLELSENRIFGGLDML   90 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESS----------CCCCC--SSCCCCSSCCEEEEESCCCCSCCCHH
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCC----------CCCCh--hhhccCCCCCEEECcCCcCchHHHHH
Confidence            466777777777776 556666677777766644444          33333  55666777777777777777656666


Q ss_pred             ccCCCcceEEEccCCCCcCCCCC--CcccccCcccEEEecCCCCcccCC---ccccCCCCCcEEecccCccCCCCCC
Q 002826          177 FGNFSELVVLDLSQNAYLISEIP--SDIGKLEKLEQLFLQSSGFHGVIP---DSFVGLQSLSILDLSQNNLTGEVPQ  248 (876)
Q Consensus       177 ~~~l~~L~~L~Ls~N~~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~ip~  248 (876)
                      +.++++|++|+|++|+  +..+|  ..+..+++|++|++++|.+++..+   ..|..+++|++|++++|.++ ++|.
T Consensus        91 ~~~l~~L~~L~Ls~N~--l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A           91 AEKLPNLTHLNLSGNK--LKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             HHHCTTCCEEECBSSS--CCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             HhhCCCCCEEeccCCc--cCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            6667777777777776  44444  456666666666666666665544   35666666666666666665 4444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.66  E-value=1.3e-16  Score=155.41  Aligned_cols=131  Identities=25%  Similarity=0.269  Sum_probs=75.8

Q ss_pred             CcccEEEecCCccc-ccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEE
Q 002826          327 PRIKLIRAESNRFS-GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIIN  405 (876)
Q Consensus       327 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~  405 (876)
                      ++|+.|++++|+++ +.+|..+..+++|++|++++|++++.  ..+..+++|++|++++|.+++.+|..+..+++|++|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            34445555555544 34444445555555555555555533  4455555555555555555554555555556666666


Q ss_pred             ccCCccccCC--cCcccccccceEeccCCcCCCCCC---cCCCCCCCcceeeCCCCccc
Q 002826          406 LSQNSISGQI--PELKKCRKLVSLSLADNSLTGEIP---PSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       406 Ls~N~l~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      |++|++++.+  +.+..+++|++|+|++|++++..+   ..|..+++|++|++++|.+.
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6666666543  356666777777777777765444   46677777777777777665

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.64  E-value=8.5e-16  Score=153.04  Aligned_cols=127  Identities=15%  Similarity=0.202  Sum_probs=88.2

Q ss_pred             cEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          233 SILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       233 ~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      +++++++|+++ .+|..++   ++|++|+|++|+|+ .+|..|..+++|++|+|++|.|+++.+..|.++++|++|+|++
T Consensus        13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            56777777777 6776553   46777777777776 5566777777777777777777766666777777777777777


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      |+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            7777666666666777777777777666655556666666666666666665

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=1.6e-15  Score=149.05  Aligned_cols=131  Identities=17%  Similarity=0.204  Sum_probs=75.5

Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      .+.+++++|+++ .+|..++   ++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+++
T Consensus         9 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            9 GTEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             TTEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            345666666665 5554432   455666666666665555555556666666666666665555555666666666666


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCC
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSS  366 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  366 (876)
                      +|+|++..+..|..+++|++|++++|++++..+..+..+++|++|++++|.+++.
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            6666655555555566666666666666555554555555666666666655543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.62  E-value=1.8e-15  Score=150.60  Aligned_cols=123  Identities=28%  Similarity=0.463  Sum_probs=53.1

Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC-CcccccCcccEEEecCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~~n  216 (876)
                      +++++|+++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|+  +..++ ..|.++++|++|+|++|
T Consensus        15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~--i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNR--ISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSC--CCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCc--CCEeCHhHccCCCCCCEEECCCC
Confidence            344444444 3343332  34555555555554 344445555555555555554  22222 22444444444444444


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccc
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKL  267 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l  267 (876)
                      +|+++.|..|.++++|++|+|++|+|+ .+|...+..+++|++|+|++|.+
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~  138 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL  138 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCE
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCe
Confidence            444444444444444444444444444 33333333334444444444433

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=2.4e-15  Score=147.66  Aligned_cols=128  Identities=22%  Similarity=0.305  Sum_probs=62.9

Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      +.+++++|+  +..+|..+.  ++|++|++++|+++++.+..|.++++|++|+|++|+|+ .+|...+..+++|++|+|+
T Consensus        10 ~~l~~~~~~--l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A           10 TEIRCNSKG--LTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             TEEECCSSC--CSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             CEEEecCCC--CccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECC
Confidence            344444444  334443322  34555555555555544445555555555555555555 4444433445555555555


Q ss_pred             cccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       264 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      +|+|++..+..+..+++|++|+|++|.|++..+..|..+++|++|++++|.++
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            55555444444444555555555555554444444444444444444444444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=4.6e-16  Score=148.16  Aligned_cols=127  Identities=25%  Similarity=0.267  Sum_probs=79.8

Q ss_pred             CCCCCeeecCCCccc-cccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcc
Q 002826           98 LSSLSNLNLADNLFN-QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFV  176 (876)
Q Consensus        98 l~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  176 (876)
                      .++|+.|++++|.++ +.+|..++.+++|++|+|++|.          +++.  ..++.+++|++|+|++|++++.+|..
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~----------l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~   83 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----------LTSI--ANLPKLNKLKKLELSDNRVSGGLEVL   83 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSC----------CCCC--TTCCCCTTCCEEECCSSCCCSCTHHH
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCC----------CCCc--hhhhcCCCCCEEECCCCcccchHHHH
Confidence            356777777777777 5667777777777766554443          3333  55666777777777777777656666


Q ss_pred             ccCCCcceEEEccCCCCcCCCCC--CcccccCcccEEEecCCCCcccCC---ccccCCCCCcEEecc
Q 002826          177 FGNFSELVVLDLSQNAYLISEIP--SDIGKLEKLEQLFLQSSGFHGVIP---DSFVGLQSLSILDLS  238 (876)
Q Consensus       177 ~~~l~~L~~L~Ls~N~~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~~---~~~~~l~~L~~L~Ls  238 (876)
                      +.++++|++|++++|+  +..+|  ..+..+++|++|++++|++++..+   ..+..+++|++|+++
T Consensus        84 ~~~l~~L~~L~ls~N~--i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           84 AEKCPNLTHLNLSGNK--IKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             HHHCTTCCEEECTTSC--CCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             hhhCCCCCEEECCCCc--CCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            6667777777777776  33332  455556666666666666655444   345555666665554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.61  E-value=3.6e-16  Score=148.87  Aligned_cols=124  Identities=28%  Similarity=0.286  Sum_probs=57.2

Q ss_pred             ccEEEecCCccc-ccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEcc
Q 002826          329 IKLIRAESNRFS-GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLS  407 (876)
Q Consensus       329 L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls  407 (876)
                      |+.|++++|.++ +.+|..+..+++|++|++++|++++.  ..+.++++|+.|++++|.+++.+|..+..+++|++|+++
T Consensus        19 l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls   96 (149)
T 2je0_A           19 VKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS   96 (149)
T ss_dssp             CSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECT
T ss_pred             CeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECC
Confidence            334444444433 33333334444444444444444432  334444444444444444444344444444445555555


Q ss_pred             CCccccCC--cCcccccccceEeccCCcCCCCCC---cCCCCCCCcceeeCC
Q 002826          408 QNSISGQI--PELKKCRKLVSLSLADNSLTGEIP---PSLAELPVLTYLDLS  454 (876)
Q Consensus       408 ~N~l~~~~--~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls  454 (876)
                      +|++++.+  ..+..+++|++|++++|++++..+   ..+..+++|+.||++
T Consensus        97 ~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           97 GNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             TSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             CCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            55554432  345555555555555555554443   345555555555554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.60  E-value=2e-14  Score=160.45  Aligned_cols=309  Identities=13%  Similarity=0.115  Sum_probs=142.8

Q ss_pred             cccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCc
Q 002826           94 SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSV  173 (876)
Q Consensus        94 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  173 (876)
                      +|.++++|+.+.|.. .++.+...+|.++++|+.++|.++           ++..-...|.++++|+.+.+..+ ++.+.
T Consensus        66 AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-----------l~~I~~~aF~~c~~L~~i~~p~~-l~~i~  132 (394)
T 4fs7_A           66 AFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-----------VKMIGRCTFSGCYALKSILLPLM-LKSIG  132 (394)
T ss_dssp             TTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-----------CCEECTTTTTTCTTCCCCCCCTT-CCEEC
T ss_pred             HhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-----------ceEccchhhcccccchhhcccCc-eeeec
Confidence            455566666666653 355555556666666666655432           22223345555666666555443 33344


Q ss_pred             CccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccc
Q 002826          174 PFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSS  253 (876)
Q Consensus       174 p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~  253 (876)
                      ..+|.+...+.........   ..-...|.++++|+.+.+.++ +..+....|.++.+|+.+++..| ++ .++...|.+
T Consensus       133 ~~aF~~~~~~~~~~~~~~~---~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~  206 (394)
T 4fs7_A          133 VEAFKGCDFKEITIPEGVT---VIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAE  206 (394)
T ss_dssp             TTTTTTCCCSEEECCTTCC---EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CC-EECTTTTTT
T ss_pred             ceeeecccccccccCcccc---ccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ce-EeCchhhcc
Confidence            4555555433333322221   111123555555555555433 22344455555555555555544 33 444444555


Q ss_pred             cccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEE
Q 002826          254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR  333 (876)
Q Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  333 (876)
                      +..|+.+.+..+...  +.+.+....+|+.+.+..+ ++.+...+|.++.+|+.+.+..+..+ .....|.....++.+.
T Consensus       207 ~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~  282 (394)
T 4fs7_A          207 CILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVI  282 (394)
T ss_dssp             CTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEE
T ss_pred             ccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceec
Confidence            555555554444322  1222223344444444332 22233444555555555555444322 3334444444444444


Q ss_pred             ecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcccc
Q 002826          334 AESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG  413 (876)
Q Consensus       334 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~  413 (876)
                      ...+.+   ....|..+.+|+.+.+.++                         ++.+....|.++.+|+.++|..+ ++.
T Consensus       283 ~~~~~i---~~~~F~~~~~L~~i~l~~~-------------------------i~~I~~~aF~~c~~L~~i~lp~~-v~~  333 (394)
T 4fs7_A          283 YGSVIV---PEKTFYGCSSLTEVKLLDS-------------------------VKFIGEEAFESCTSLVSIDLPYL-VEE  333 (394)
T ss_dssp             ECSSEE---CTTTTTTCTTCCEEEECTT-------------------------CCEECTTTTTTCTTCCEECCCTT-CCE
T ss_pred             cCceee---ccccccccccccccccccc-------------------------cceechhhhcCCCCCCEEEeCCc-ccE
Confidence            444322   2233444444444444332                         33344444555555555555432 333


Q ss_pred             CCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCC
Q 002826          414 QIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSD  455 (876)
Q Consensus       414 ~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  455 (876)
                      +.. +|.++++|+.+++..| ++.+...+|.++++|+.+++..
T Consensus       334 I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~  375 (394)
T 4fs7_A          334 IGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK  375 (394)
T ss_dssp             ECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred             EhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence            222 4555555555555544 4444445555555555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.56  E-value=3.7e-14  Score=158.20  Aligned_cols=316  Identities=13%  Similarity=0.105  Sum_probs=200.4

Q ss_pred             cccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccC
Q 002826          111 FNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQ  190 (876)
Q Consensus       111 l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  190 (876)
                      ++.+...+|.++++|+++.|.+           +++.+-..+|.++++|+.++|.++ ++.+...+|.++++|+.+.+..
T Consensus        59 VtsIg~~AF~~c~~L~~i~lp~-----------~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~  126 (394)
T 4fs7_A           59 VVSIGYAAFQGCRKVTEIKIPS-----------TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPL  126 (394)
T ss_dssp             EEEECTTTTTTCTTEEEEECCT-----------TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred             EeEhHHHHhhCCCCceEEEeCC-----------CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccC
Confidence            4445556666666666665542           233333455666666666666543 4444455566666665554444


Q ss_pred             CCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCc
Q 002826          191 NAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGS  270 (876)
Q Consensus       191 N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~  270 (876)
                      +                          +..+...+|.++..++.....  .+. .+....|.++.+|+.+.+.++. ..+
T Consensus       127 ~--------------------------l~~i~~~aF~~~~~~~~~~~~--~~~-~i~~~aF~~c~~L~~i~l~~~~-~~I  176 (394)
T 4fs7_A          127 M--------------------------LKSIGVEAFKGCDFKEITIPE--GVT-VIGDEAFATCESLEYVSLPDSM-ETL  176 (394)
T ss_dssp             T--------------------------CCEECTTTTTTCCCSEEECCT--TCC-EECTTTTTTCTTCCEEECCTTC-CEE
T ss_pred             c--------------------------eeeecceeeecccccccccCc--ccc-ccchhhhcccCCCcEEecCCcc-cee
Confidence            3                          222333444444332222221  122 3334445555666666665443 224


Q ss_pred             CCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccC
Q 002826          271 FPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMA  350 (876)
Q Consensus       271 ~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  350 (876)
                      ...+|.++.+|+.+++..| ++.+...+|.++..|+.+.+.++...  +.+.+....+|+.+.+..+ ++.+....|..+
T Consensus       177 ~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~  252 (394)
T 4fs7_A          177 HNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGC  252 (394)
T ss_dssp             CTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTC
T ss_pred             ccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceeccccccccc
Confidence            4555666666666666655 44455667777777777776665432  2333444567777777543 344566677888


Q ss_pred             CCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEec
Q 002826          351 AQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSL  429 (876)
Q Consensus       351 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~L  429 (876)
                      ..|+.+.+..+..+ .....|.....++.+....+.+   ....|..+.+|+.+.+..+ ++.+.. +|.++.+|+.++|
T Consensus       253 ~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~l  327 (394)
T 4fs7_A          253 TDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDL  327 (394)
T ss_dssp             SSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECC
T ss_pred             ccceeEEcCCCcce-eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEe
Confidence            88888888777554 5566778888888887766543   3457888999999999865 554444 7999999999999


Q ss_pred             cCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCC
Q 002826          430 ADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFN  479 (876)
Q Consensus       430 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N  479 (876)
                      ..+ ++.+...+|.++.+|+.+++..| ++..-...|.+. +|+.+++..|
T Consensus       328 p~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          328 PYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             CCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence            755 77677899999999999999887 776667788886 6888888754

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=1.1e-16  Score=160.37  Aligned_cols=131  Identities=21%  Similarity=0.204  Sum_probs=51.8

Q ss_pred             cccceecccccccCCCcCc------cccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCC
Q 002826          157 VNLQVLNLGSNLLSGSVPF------VFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQ  230 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  230 (876)
                      ..++.++++.|.+++..|.      .|.++++|++|+|++|+  +..+| .+.++++|++|++++|+++. +|..+..++
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~--l~~l~-~~~~l~~L~~L~l~~n~l~~-l~~~~~~~~   93 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN--IEKIS-SLSGMENLRILSLGRNLIKK-IENLDAVAD   93 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEE--ESCCC-CHHHHTTCCEEEEEEEEECS-CSSHHHHHH
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCC--Ccccc-ccccCCCCCEEECCCCCccc-ccchhhcCC
Confidence            3444444444444444333      33333444444444433  22233 33333333333333333331 233333334


Q ss_pred             CCcEEecccCccCCCCCCccccccccccEEEeccccccCcCC-cccccCCccceeeeeccccccc
Q 002826          231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKNFFNGS  294 (876)
Q Consensus       231 ~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~  294 (876)
                      +|++|+|++|+|+ .+| . +..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.
T Consensus        94 ~L~~L~L~~N~l~-~l~-~-~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~  155 (198)
T 1ds9_A           94 TLEELWISYNQIA-SLS-G-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             HCSEEEEEEEECC-CHH-H-HHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred             cCCEEECcCCcCC-cCC-c-cccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence            4444444444444 233 1 1224444444444444442211 2334444444444444444433

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.54  E-value=7.5e-15  Score=143.99  Aligned_cols=82  Identities=17%  Similarity=0.304  Sum_probs=37.4

Q ss_pred             cccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCc--ccccCCcccee
Q 002826          207 KLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN--GICKANGLVNL  284 (876)
Q Consensus       207 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L  284 (876)
                      +|++|+|++|++++.  ..|.++++|++|+|++|+|+ .+|+.++..+++|++|+|++|+|+ .+|.  .+..+++|+.|
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L  118 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  118 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence            444444444444433  34444555555555555554 344443334455555555555543 2222  34444444444


Q ss_pred             eeeccccc
Q 002826          285 SLHKNFFN  292 (876)
Q Consensus       285 ~L~~N~i~  292 (876)
                      ++++|.++
T Consensus       119 ~l~~N~i~  126 (176)
T 1a9n_A          119 CILRNPVT  126 (176)
T ss_dssp             ECCSSGGG
T ss_pred             EecCCCCC
Confidence            44444444

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.53  E-value=8.1e-15  Score=143.76  Aligned_cols=134  Identities=17%  Similarity=0.197  Sum_probs=79.1

Q ss_pred             ccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcccccc
Q 002826          226 FVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNL  305 (876)
Q Consensus       226 ~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  305 (876)
                      +.++.+|++|++++|+++ .+|. +....++|++|+|++|+|++.  ..+..+++|++|+|++|.|++..+..|..+++|
T Consensus        15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L   90 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   90 (176)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence            455666666666666666 4443 333233666666666666644  456666666666666666665544445666666


Q ss_pred             ceeecccccCCCCCCc--ccCCCCcccEEEecCCcccccCcc---ccccCCCCCeeeccCcccC
Q 002826          306 ERFQVQDNGFSGDFPD--KLWSLPRIKLIRAESNRFSGAIPD---SISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       306 ~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~  364 (876)
                      ++|++++|+|+ .+|.  .+..+++|+.|++++|+++...+.   .+..+++|+.|++++|.+.
T Consensus        91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            66666666665 3333  556666666666666666533221   3556666666666666554

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.53  E-value=3.2e-16  Score=157.10  Aligned_cols=152  Identities=19%  Similarity=0.232  Sum_probs=100.3

Q ss_pred             cCcccEEEecCCCCcccCCc------cccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccC
Q 002826          205 LEKLEQLFLQSSGFHGVIPD------SFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKA  278 (876)
Q Consensus       205 l~~L~~L~L~~n~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  278 (876)
                      ...++.++++.+.+.+..|.      .|..+++|++|+|++|+|+ .+| . +..+++|++|+|++|+++ .+|..+..+
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~-~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-S-LSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-C-HHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-c-cccCCCCCEEECCCCCcc-cccchhhcC
Confidence            34444455555555555444      6777777777777777777 466 3 345777777777777777 456666666


Q ss_pred             CccceeeeecccccccCCCCCccccccceeecccccCCCCCC-cccCCCCcccEEEecCCcccccCccc----------c
Q 002826          279 NGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFP-DKLWSLPRIKLIRAESNRFSGAIPDS----------I  347 (876)
Q Consensus       279 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~  347 (876)
                      ++|++|+|++|++++. | .+..+++|++|++++|++++..+ ..+..+++|++|++++|++++.+|..          +
T Consensus        93 ~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~  170 (198)
T 1ds9_A           93 DTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVV  170 (198)
T ss_dssp             HHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHH
T ss_pred             CcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHH
Confidence            7777777777777753 3 46677777777777777774333 46777778888888888877665542          5


Q ss_pred             ccCCCCCeeeccCcccC
Q 002826          348 SMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       348 ~~l~~L~~L~L~~N~l~  364 (876)
                      ..+++|+.||  +|.++
T Consensus       171 ~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          171 KRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHCSSCSEEC--CGGGT
T ss_pred             HhCCCcEEEC--CcccC
Confidence            6666777665  55554

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=5.4e-15  Score=160.33  Aligned_cols=138  Identities=12%  Similarity=0.067  Sum_probs=92.8

Q ss_pred             cccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCc--------------cCHHHH--------HHHHHHHhhccCcccc
Q 002826          584 DEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGC--------------QSSKTL--------KTEVKTLAKIRHKNIV  641 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~--------~~E~~~l~~l~h~niv  641 (876)
                      |++...+|.|++|.||+|..++|+.||||+++....              ......        .+|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            444444444559999999989999999998753211              011122        2344455555333322


Q ss_pred             ceeeEEEeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCC-
Q 002826          642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFE-  720 (876)
Q Consensus       642 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~-  720 (876)
                      .. ..+.. ...++||||++|++|.++...       ....+++.|++.++.|||+.   ||+||||||.|||+++++. 
T Consensus       177 vp-~p~~~-~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          177 VP-EPIAQ-SRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             CC-CEEEE-ETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECS
T ss_pred             CC-eeeec-cCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCc
Confidence            11 11111 123699999999888765422       13456889999999999999   9999999999999987763 


Q ss_pred             ---------eEEccccchhhcc
Q 002826          721 ---------PKLTDFALDRIVG  733 (876)
Q Consensus       721 ---------~kl~DfGla~~~~  733 (876)
                               +.|+||+-+....
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEETT
T ss_pred             ccccccccceEEEEeCCcccCC
Confidence                     8999999776543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.48  E-value=1.5e-13  Score=133.72  Aligned_cols=107  Identities=21%  Similarity=0.210  Sum_probs=89.0

Q ss_pred             CCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccC
Q 002826          353 LEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLAD  431 (876)
Q Consensus       353 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~  431 (876)
                      .+.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++ .|..+++|++|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            467788888887 4665553  678888888888888888888888889999999999988777 578899999999999


Q ss_pred             CcCCCCCCcCCCCCCCcceeeCCCCcccccC
Q 002826          432 NSLTGEIPPSLAELPVLTYLDLSDNNLTGPI  462 (876)
Q Consensus       432 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  462 (876)
                      |+|++..+..|..+++|++|+|++|+++...
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            9999877888999999999999999988543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.46  E-value=2e-13  Score=132.84  Aligned_cols=106  Identities=17%  Similarity=0.185  Sum_probs=72.0

Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ  311 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~  311 (876)
                      .+.+++++|+++ .+|..++   ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|+
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            467777777777 6776553   567777777777776666667777777777777777776666666666667777777


Q ss_pred             cccCCCCCCcccCCCCcccEEEecCCcccc
Q 002826          312 DNGFSGDFPDKLWSLPRIKLIRAESNRFSG  341 (876)
Q Consensus       312 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  341 (876)
                      +|+|++..+..|..+++|+.|+|++|.++.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            766666555566666666666666666653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=3.5e-13  Score=131.53  Aligned_cols=104  Identities=22%  Similarity=0.247  Sum_probs=87.1

Q ss_pred             CeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCC
Q 002826          354 EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADN  432 (876)
Q Consensus       354 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N  432 (876)
                      +.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++ .|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            56777888776 5666554  678888888888888888888888888999999999988777 4788999999999999


Q ss_pred             cCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          433 SLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       433 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      +|++..+..|..+++|++|+|++|++..
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCccc
Confidence            9997777779999999999999999984

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=3.9e-13  Score=131.22  Aligned_cols=104  Identities=20%  Similarity=0.346  Sum_probs=62.5

Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      +.+++++|+  ++.+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|...+..+++|++|+|+
T Consensus        15 ~~l~~~~n~--l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~   89 (174)
T 2r9u_A           15 TLVNCQNIR--LASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLN   89 (174)
T ss_dssp             SEEECCSSC--CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred             cEEEeCCCC--CCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECC
Confidence            455666665  455555443  56666666666666666666666666777777777666 4555555556666666666


Q ss_pred             cccccCcCCcccccCCccceeeeeccccc
Q 002826          264 QNKLSGSFPNGICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       264 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~  292 (876)
                      +|+|++..+..|..+++|++|+|++|.+.
T Consensus        90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             CCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            66666444444555555555555555554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.39  E-value=6.9e-12  Score=139.75  Aligned_cols=115  Identities=11%  Similarity=0.173  Sum_probs=65.8

Q ss_pred             cccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-Cc
Q 002826          340 SGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-EL  418 (876)
Q Consensus       340 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~  418 (876)
                      +.+...+|..+.+|+.+.+.++..+ .....|.++++|+.+.+. +.++.+....|.++.+|+.++|..+ ++.+.. +|
T Consensus       254 ~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF  330 (394)
T 4gt6_A          254 ARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF  330 (394)
T ss_dssp             EEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred             eEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence            3344455555556666655544332 344455556666666654 3444455556666666666666543 433333 56


Q ss_pred             ccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcc
Q 002826          419 KKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL  458 (876)
Q Consensus       419 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  458 (876)
                      .++.+|+.+.|..+ ++.+...+|.++++|+.+++.+|..
T Consensus       331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred             hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence            66777777777543 5545556677777777777766654

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.38  E-value=2.9e-11  Score=134.76  Aligned_cols=330  Identities=12%  Similarity=0.158  Sum_probs=165.4

Q ss_pred             cccCCC-CCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCC
Q 002826           94 SVCELS-SLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS  172 (876)
Q Consensus        94 ~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  172 (876)
                      +|.+.. .|+.+.+.++ ++.+...+|.++++|+.+.++.|.-       +.++.+-..+|.+..+|+.+.+..+ ++.+
T Consensus        58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p-------~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKP-------SCVKKIGRQAFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCC-------CCCCEECTTTTTTCTTCCBCGGGTT-CSEE
T ss_pred             hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCC-------CeeeEechhhchhcccceeeccCCc-ccee
Confidence            344443 4777777543 6666667777777777776554421       1233333456666667776666544 4445


Q ss_pred             cCccccCCCcceEEEccCCCCcCCCCC-CcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccc
Q 002826          173 VPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLG  251 (876)
Q Consensus       173 ~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~  251 (876)
                      ...+|.+..+|+.+.+..+   ...++ ..|....+|+.+.+..+ +..+...+|.+ .+|+.+.+..+- + .+....|
T Consensus       129 ~~~aF~~c~~L~~i~lp~~---~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~-~-~i~~~af  201 (394)
T 4gt6_A          129 DSEAFHHCEELDTVTIPEG---VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKV-T-RIGTNAF  201 (394)
T ss_dssp             CTTTTTTCTTCCEEECCTT---CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTC-C-EECTTTT
T ss_pred             hhhhhhhhcccccccccce---eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcc-c-ccccchh
Confidence            5566677777777777654   22333 23556666666666543 44444445543 456666665432 2 2334444


Q ss_pred             cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccE
Q 002826          252 SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKL  331 (876)
Q Consensus       252 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  331 (876)
                      .++.++.......+.... ....+..........+          ..+.....+..+.+. +.++.....+|.++++|+.
T Consensus       202 ~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~  269 (394)
T 4gt6_A          202 SECFALSTITSDSESYPA-IDNVLYEKSANGDYAL----------IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLAS  269 (394)
T ss_dssp             TTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEE----------EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCE
T ss_pred             hhccccceeccccccccc-ccceeecccccccccc----------cccccccccceEEcC-CcceEcccceeeecccccE
Confidence            455555555554444331 1111110000000000          000011122222221 1222233445555555555


Q ss_pred             EEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcc
Q 002826          332 IRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI  411 (876)
Q Consensus       332 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l  411 (876)
                      +.+..+.. .+...+|.++.+|+.+.+. +.++......|.++.+|+.+.+..+ ++.+....|.++.+|+.+.+..+ +
T Consensus       270 i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v  345 (394)
T 4gt6_A          270 VKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-V  345 (394)
T ss_dssp             EECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-C
T ss_pred             Eecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-c
Confidence            55544433 2445555666666666664 3344344455666666666666543 55455666777777777777544 5


Q ss_pred             ccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcc
Q 002826          412 SGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNL  458 (876)
Q Consensus       412 ~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  458 (876)
                      +.+.. +|.++++|+.+++.+|...   -..|....+|+.+.+..|.+
T Consensus       346 ~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          346 TKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred             CEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence            44434 6777888888888777643   14566677777777766654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=1.9e-12  Score=141.70  Aligned_cols=107  Identities=20%  Similarity=0.198  Sum_probs=85.0

Q ss_pred             ccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCC-CccccccCccccCCCCCCcccCCCccccee
Q 002826           60 CNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLAD-NLFNQPIPLHLSQCSSLETLNLSNNLIWVL  138 (876)
Q Consensus        60 C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~L  138 (876)
                      |.|.+|.|...              ++|++ +|. +..+++|++|+|++ |.|++..|..|++|++|++|+         
T Consensus         8 C~~~~v~~~~~--------------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~---------   62 (347)
T 2ifg_A            8 HGSSGLRCTRD--------------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT---------   62 (347)
T ss_dssp             SSSSCEECCSS--------------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEE---------
T ss_pred             ccCCEEEcCCC--------------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEE---------
Confidence            88988888543              13443 677 88899999999996 999988888899998888774         


Q ss_pred             ecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCC
Q 002826          139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY  193 (876)
Q Consensus       139 dL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~  193 (876)
                       |++|+|++..|..|.+|++|++|+|++|+|++..+..|..++ |++|+|++|.+
T Consensus        63 -l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~  115 (347)
T 2ifg_A           63 -IVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL  115 (347)
T ss_dssp             -CCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCC
T ss_pred             -CCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCc
Confidence             445566777788888899999999999999877777777766 88888888873

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.30  E-value=2.1e-14  Score=158.05  Aligned_cols=135  Identities=12%  Similarity=0.150  Sum_probs=59.4

Q ss_pred             CCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccc-----cCCccceeeeeccccccc----CCCCCc
Q 002826          230 QSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGIC-----KANGLVNLSLHKNFFNGS----IPGSIN  300 (876)
Q Consensus       230 ~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~i~~~----~~~~~~  300 (876)
                      ++|++|+|++|.|+......+...+++|++|+|++|+|+......++     ..++|++|+|++|.|+..    ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            35555555555554222222333344555555555555433222221     234455555555555421    111223


Q ss_pred             cccccceeecccccCCCCC----CcccCCCCcccEEEecCCcccccC----ccccccCCCCCeeeccCcccC
Q 002826          301 ECLNLERFQVQDNGFSGDF----PDKLWSLPRIKLIRAESNRFSGAI----PDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       301 ~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      .+++|++|+|++|.|++..    +..+...++|+.|+|++|.|++..    ...+...++|++|+|++|.|+
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            3444455555555444211    233344445555555555554322    222333445555555555554

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.25  E-value=3.5e-14  Score=156.28  Aligned_cols=87  Identities=18%  Similarity=0.109  Sum_probs=35.5

Q ss_pred             cccceecccccccCCCcCccccC-----CCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccc-----
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGN-----FSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF-----  226 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~-----  226 (876)
                      ++|++|+|++|.|+......+..     .++|++|+|++|.+....+..-...+++|++|+|++|+++......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            34555555555554332222221     14555555555542110011111223444555555554443222222     


Q ss_pred             cCCCCCcEEecccCccC
Q 002826          227 VGLQSLSILDLSQNNLT  243 (876)
Q Consensus       227 ~~l~~L~~L~Ls~N~l~  243 (876)
                      ...++|++|+|++|.|+
T Consensus       152 ~~~~~L~~L~Ls~n~l~  168 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLT  168 (372)
T ss_dssp             STTCCCCEEECCSSCCH
T ss_pred             hcCCccceeeCCCCCCC
Confidence            12344555555555554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.23  E-value=1.7e-11  Score=134.20  Aligned_cols=129  Identities=11%  Similarity=0.061  Sum_probs=63.0

Q ss_pred             ecccc-cCCCCCCcccCCCCcccEEEecC-CcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCcc
Q 002826          309 QVQDN-GFSGDFPDKLWSLPRIKLIRAES-NRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS  386 (876)
Q Consensus       309 ~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  386 (876)
                      +++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus        14 ~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~   91 (347)
T 2ifg_A           14 RCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (347)
T ss_dssp             ECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence            44444 4442 333 44455555555553 55555555555555555555555555555555555555555555555555


Q ss_pred             ccCCCCCCcCCCCCccEEEccCCccccCCc--CcccccccceEeccCCcCCCCCCc
Q 002826          387 FYGSLPPNFCDSPVMSIINLSQNSISGQIP--ELKKCRKLVSLSLADNSLTGEIPP  440 (876)
Q Consensus       387 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~  440 (876)
                      |++..+..|..++ |+.|+|++|.+...-.  .|..+.+.....+..++++-..|.
T Consensus        92 l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           92 LESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             cceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            5544444444444 6666666666654322  233333333333444444444443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=4.4e-11  Score=125.24  Aligned_cols=138  Identities=15%  Similarity=0.023  Sum_probs=106.4

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      .....+||+.+.||++.. .++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            344455565899999976 47899999986532233456889999999994 6788899999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC---------------------------------------------
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY---------------------------------------------  699 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------------  699 (876)
                      +.+.+..      ......++.+++++++.||+..                                             
T Consensus        97 l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  170 (263)
T 3tm0_A           97 CSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL  170 (263)
T ss_dssp             HHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred             hhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence            9876321      1223467889999999999810                                             


Q ss_pred             -----------CCCccccccccCceeeCCCCCeEEccccchh
Q 002826          700 -----------VPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       700 -----------~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                                 .+.++|+|++|.||+++++..+.|+||+.+.
T Consensus       171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                       1368999999999999876556799998653

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.17  E-value=9.4e-10  Score=121.78  Aligned_cols=313  Identities=11%  Similarity=0.098  Sum_probs=136.1

Q ss_pred             ccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcC
Q 002826           95 VCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVP  174 (876)
Q Consensus        95 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p  174 (876)
                      +..-.+|+.+.+.. .++.+...+|.++++|+.++|.++           ++.+-..+|.+. +|+.+.+..+ ++.+..
T Consensus        42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-----------v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~  107 (379)
T 4h09_A           42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-----------VTSIGDGAFADT-KLQSYTGMER-VKKFGD  107 (379)
T ss_dssp             GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-----------CCEECTTTTTTC-CCCEEEECTT-CCEECT
T ss_pred             cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-----------ceEechhhhcCC-CCceEECCce-eeEecc
Confidence            33445566666643 355555566666666666655432           222233444443 4555554433 333444


Q ss_pred             ccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccc
Q 002826          175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL  254 (876)
Q Consensus       175 ~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l  254 (876)
                      .+|.+ .+|+.+++..+   ...+......-.+|+.+.+..+ ++.+....|.++.+++.+.+..+... .+......  
T Consensus       108 ~aF~~-~~L~~i~lp~~---~~~i~~~~F~~~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~-~~~~~~~~--  179 (379)
T 4h09_A          108 YVFQG-TDLDDFEFPGA---TTEIGNYIFYNSSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKN-YVAENYVL--  179 (379)
T ss_dssp             TTTTT-CCCSEEECCTT---CCEECTTTTTTCCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSS-EEEETTEE--
T ss_pred             ceecc-CCcccccCCCc---cccccccccccceeeeeeccce-eeccccchhcccccccccccccccce-eeccccee--
Confidence            44544 35666666554   2222222112223444443322 33333444555555555544443322 11000000  


Q ss_pred             ccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEe
Q 002826          255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRA  334 (876)
Q Consensus       255 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  334 (876)
                               .|... .....+.....+..+.+..+. .......|..+.+|+.+.+..+ +.......|.+...|+.+.+
T Consensus       180 ---------~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~l  247 (379)
T 4h09_A          180 ---------YNKNK-TILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAI  247 (379)
T ss_dssp             ---------EETTS-SEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEE
T ss_pred             ---------ccccc-ceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEc
Confidence                     00000 111122222333333332221 1233344444555555544333 22233344444444544444


Q ss_pred             cCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccC
Q 002826          335 ESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ  414 (876)
Q Consensus       335 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~  414 (876)
                      ..+ ++.+...+|..+.+|+.+.+..+                         +.......|.++.+|+.+++.++.++.+
T Consensus       248 p~~-v~~I~~~aF~~~~~l~~i~l~~~-------------------------i~~i~~~aF~~c~~L~~i~l~~~~i~~I  301 (379)
T 4h09_A          248 PKN-VTSIGSFLLQNCTALKTLNFYAK-------------------------VKTVPYLLCSGCSNLTKVVMDNSAIETL  301 (379)
T ss_dssp             CTT-CCEECTTTTTTCTTCCEEEECCC-------------------------CSEECTTTTTTCTTCCEEEECCTTCCEE
T ss_pred             CCC-ccEeCccccceeehhcccccccc-------------------------ceecccccccccccccccccccccccee
Confidence            433 33333444444444444444322                         3333344455555555555555555544


Q ss_pred             Cc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc
Q 002826          415 IP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL  469 (876)
Q Consensus       415 ~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  469 (876)
                      .. .|.++.+|+.++|..+ ++.+...+|.++++|+.+.+..+ ++..-...|.+.
T Consensus       302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            33 5566666666666543 44444556666666666666544 443333444443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=1.2e-10  Score=121.53  Aligned_cols=133  Identities=16%  Similarity=0.068  Sum_probs=101.1

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCcc--ccceeeEEEeCCeEEEEEEcCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ...+++||..+.||++...+|+.+++|+....   ....+.+|+++++.+++.+  +.+++++...++..++||||++|.
T Consensus        24 ~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~  100 (264)
T 1nd4_A           24 WAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ  100 (264)
T ss_dssp             EEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             eEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCc
Confidence            34455677679999998878889999997543   2356788999999996544  556888888888899999999998


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC--------------------------------------------
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY--------------------------------------------  699 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------------  699 (876)
                      ++.  ...    .+   ...++.++++.++.||+..                                            
T Consensus       101 ~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          101 DLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             ETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence            884  211    11   2356778888888888742                                            


Q ss_pred             -----------CCCccccccccCceeeCCCCCeEEccccchh
Q 002826          700 -----------VPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       700 -----------~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                                 .+.++|+|++|.||+++++..+.|+|||.+.
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                       1139999999999999877667799998754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.13  E-value=2.2e-09  Score=118.75  Aligned_cols=152  Identities=11%  Similarity=0.082  Sum_probs=106.7

Q ss_pred             cCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCcc
Q 002826          323 LWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMS  402 (876)
Q Consensus       323 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~  402 (876)
                      +.....+..+.+..+. .......+....+|+.+.+..+ ++......|.+...|+.+.+..+ ++.+....|.+...|+
T Consensus       190 ~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~  266 (379)
T 4h09_A          190 YPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK  266 (379)
T ss_dssp             CCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred             ccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence            3333444444443332 2244555666677777777654 33345556777777888877665 5556677888899999


Q ss_pred             EEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCC
Q 002826          403 IINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFN  479 (876)
Q Consensus       403 ~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N  479 (876)
                      .+.+..+ +..... .|.++++|+.+.+.+|.++.+.+.+|.++.+|+.++|..+ ++..-...|.+. +|+.+.+..+
T Consensus       267 ~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          267 TLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             ccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            9999765 544444 7999999999999999999788899999999999999865 765556678775 5776666543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.90  E-value=2.4e-10  Score=124.52  Aligned_cols=162  Identities=12%  Similarity=0.135  Sum_probs=73.2

Q ss_pred             ccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCcccc--CCCCCcEEeccc--CccCCCC----
Q 002826          175 FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV--GLQSLSILDLSQ--NNLTGEV----  246 (876)
Q Consensus       175 ~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~--~l~~L~~L~Ls~--N~l~~~i----  246 (876)
                      ..+..+++|+.|+|++|.  ...++. + .+++|++|.|..|.++......+.  .+++|++|+|+.  |...+..    
T Consensus       166 ~ll~~~P~L~~L~L~g~~--~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTN--NLSIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHHTCTTCCEEEEECCB--TCBCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHHhcCCCCcEEEEeCCC--Cceecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            344455666666666552  112232 2 255666666666665432222232  466666666642  2211110    


Q ss_pred             -CCccc-cccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCC----C
Q 002826          247 -PQSLG-SSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDF----P  320 (876)
Q Consensus       247 -p~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~----p  320 (876)
                       ...+. ..+++|++|+|++|.+.+..+..+..                     ...+++|++|+|+.|.+++..    +
T Consensus       242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~---------------------a~~~~~L~~LdLs~n~L~d~G~~~L~  300 (362)
T 2ra8_A          242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLE---------------------SDILPQLETMDISAGVLTDEGARLLL  300 (362)
T ss_dssp             TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHH---------------------CSSGGGCSEEECCSSCCBHHHHHHHH
T ss_pred             HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHh---------------------CccCCCCCEEECCCCCCChHHHHHHH
Confidence             00010 12345555555555444222111110                     012445555555555555422    2


Q ss_pred             cccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcc
Q 002826          321 DKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNR  362 (876)
Q Consensus       321 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  362 (876)
                      ..+..+++|+.|++++|.|+...-..+...- ...+++++|+
T Consensus       301 ~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~~~  341 (362)
T 2ra8_A          301 DHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSDSQ  341 (362)
T ss_dssp             TTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCSBC
T ss_pred             hhcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecCCc
Confidence            2223456666666666666544333333210 3557777776

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=1.2e-10  Score=127.00  Aligned_cols=191  Identities=17%  Similarity=0.158  Sum_probs=88.4

Q ss_pred             cccccCCCCCCeeecCCCccc---------cccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCcccccee
Q 002826           92 SSSVCELSSLSNLNLADNLFN---------QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVL  162 (876)
Q Consensus        92 ~~~~~~l~~L~~L~L~~n~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L  162 (876)
                      .+++..+++|+.|.+.++...         +.++..+..+++|++|+|++|.         .+  .++. + .+++|++|
T Consensus       132 ~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~---------~l--~l~~-~-~~~~L~~L  198 (362)
T 2ra8_A          132 VENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTN---------NL--SIGK-K-PRPNLKSL  198 (362)
T ss_dssp             HTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCB---------TC--BCCS-C-BCTTCSEE
T ss_pred             HHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCC---------Cc--eecc-c-cCCCCcEE
Confidence            445566778888887665331         1233344555666666554431         01  1121 2 25666666


Q ss_pred             cccccccCCCcCcccc--CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccc--cCCCCCcEEecc
Q 002826          163 NLGSNLLSGSVPFVFG--NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF--VGLQSLSILDLS  238 (876)
Q Consensus       163 ~L~~N~l~~~~p~~~~--~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~--~~l~~L~~L~Ls  238 (876)
                      +|..|.++......+.  .+++|++|+|+.+....+.-+ .                +.++ ...+  ..+++|++|+|+
T Consensus       199 ~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~-~----------------~~~l-~~~l~~~~~p~Lr~L~L~  260 (362)
T 2ra8_A          199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG-D----------------MNVF-RPLFSKDRFPNLKWLGIV  260 (362)
T ss_dssp             EEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS-C----------------GGGT-GGGSCTTTCTTCCEEEEE
T ss_pred             EEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch-h----------------HHHH-HHHHhcCCCCCcCEEeCC
Confidence            6666665533323332  456666666643110000000 0                0000 0011  134556666666


Q ss_pred             cCccCCCCCCccc--cccccccEEEeccccccCc----CCcccccCCccceeeeecccccccCCCCCccccccceeeccc
Q 002826          239 QNNLTGEVPQSLG--SSLLKLVSFDVSQNKLSGS----FPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQD  312 (876)
Q Consensus       239 ~N~l~~~ip~~~~--~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  312 (876)
                      +|.+++..+..++  ..+++|++|+|+.|.|.+.    ++..+..+++|+.|+|++|.|+...-..+...- ...+++++
T Consensus       261 ~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al-g~~~~~~~  339 (362)
T 2ra8_A          261 DAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL-PMKIDVSD  339 (362)
T ss_dssp             SCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC-CSEEECCS
T ss_pred             CCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc-CCEEEecC
Confidence            6655432222221  1255666666666666543    222334456666777766666533222222200 24466666


Q ss_pred             cc
Q 002826          313 NG  314 (876)
Q Consensus       313 N~  314 (876)
                      ++
T Consensus       340 ~~  341 (362)
T 2ra8_A          340 SQ  341 (362)
T ss_dssp             BC
T ss_pred             Cc
Confidence            65

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.85  E-value=5.7e-09  Score=114.48  Aligned_cols=140  Identities=16%  Similarity=0.227  Sum_probs=103.6

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEe--cCCc-cCHHHHHHHHHHHhhcc--CccccceeeEEEeC---CeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLV--NFGC-QSSKTLKTEVKTLAKIR--HKNIVKVLGFFHSD---ESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e  658 (876)
                      ..++ +|.++.||+++.. +..+++|+..  .... .....+.+|+.+++.+.  +..++++++++.+.   +..|+|||
T Consensus        44 ~~l~-~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           44 EQFK-GGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EECC-C-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEcC-CcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            3444 4558999999875 4678888765  3211 22456888999999996  45688899988776   45899999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC---------------------------------------
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY---------------------------------------  699 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  699 (876)
                      |++|.++.+..   ...++...+..++.++++.|+.||+..                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99998775421   224678888899999999999999731                                       


Q ss_pred             ----------------CCCccccccccCceeeCCCCC--eEEccccchhh
Q 002826          700 ----------------VPHLLHRNVKSKNILLDADFE--PKLTDFALDRI  731 (876)
Q Consensus       700 ----------------~~~i~H~Dlkp~NIll~~~~~--~kl~DfGla~~  731 (876)
                                      .+.++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            247999999999999997653  58999998764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.85  E-value=4.8e-11  Score=123.27  Aligned_cols=58  Identities=21%  Similarity=0.271  Sum_probs=28.4

Q ss_pred             ccccCcccEEEecCCCCcccCCccccCCC--CCcEEecccCccCCCCCC------ccccccccccEEE
Q 002826          202 IGKLEKLEQLFLQSSGFHGVIPDSFVGLQ--SLSILDLSQNNLTGEVPQ------SLGSSLLKLVSFD  261 (876)
Q Consensus       202 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~ip~------~~~~~l~~L~~L~  261 (876)
                      +..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+++.+|.      .+...+++|+.||
T Consensus       192 ~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          192 VQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             HHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             HhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            33444444444444444433  1222222  666666666666654542      1233466666554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.66  E-value=5e-09  Score=112.05  Aligned_cols=183  Identities=20%  Similarity=0.146  Sum_probs=116.4

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-Ccc--ccceeeEEEeCC---eEEEEEEcCCCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKN--IVKVLGFFHSDE---SIFLIYEFLQMGS  664 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~~gs  664 (876)
                      ++|....||++.    +.+++|+....  .....+.+|+++++.+. +..  +.+++......+   ..|+|||+++|.+
T Consensus        29 ~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~  102 (304)
T 3sg8_A           29 GEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVP  102 (304)
T ss_dssp             EECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEE
T ss_pred             CCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeE
Confidence            445588898753    56888986432  23467889999999884 332  445555443332   3588999999988


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc----------------------------------------------
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD----------------------------------------------  698 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------------------------------------------  698 (876)
                      +.+...   ..++..++..++.++++.++.||+.                                              
T Consensus       103 l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          103 LTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             CCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             CCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            865332   2467777888888999988888861                                              


Q ss_pred             ---------CCCCccccccccCceeeCC--CCCeEEccccchhhccccccccccccc---cc---------cccccC-cc
Q 002826          699 ---------YVPHLLHRNVKSKNILLDA--DFEPKLTDFALDRIVGEAAFQSTMSSE---YA---------LSCYNA-PE  754 (876)
Q Consensus       699 ---------~~~~i~H~Dlkp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~---~g---------t~~y~a-PE  754 (876)
                               ..+.++|+|++|.||++++  +..+.++||+.+..-............   .+         ..++.. |+
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~  259 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT  259 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence                     1136899999999999987  456789999987653221100000000   00         001111 22


Q ss_pred             ccCCCCCCCccchHHHHHHHHHHHhCCCCC
Q 002826          755 YGYSKKATAQMDAYSFGVVLLELITGRQAE  784 (876)
Q Consensus       755 ~~~~~~~~~~~Dv~SlGv~l~elltg~~p~  784 (876)
                      ....  .....+.|++|.++|.+.+|+.+|
T Consensus       260 ~~~r--~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          260 VLEK--YRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence            1110  011258999999999999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=8.7e-07  Score=92.74  Aligned_cols=131  Identities=13%  Similarity=0.063  Sum_probs=96.9

Q ss_pred             CCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCCCHHHHh
Q 002826          592 GGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSLGDLI  669 (876)
Q Consensus       592 ~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l  669 (876)
                      |.+.+.||+.... ++..+++|+-..   .....+.+|...++.+. +--|.++++++.+.+..++|||+++|.++.+..
T Consensus        35 G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~  111 (272)
T 4gkh_A           35 GQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVL  111 (272)
T ss_dssp             SSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHH
T ss_pred             CCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccc
Confidence            3334578987654 567889998653   23456888999999884 334778899999999999999999998887765


Q ss_pred             hccCCcCCHHHHHHHHHHHHHHHHHhhcc---------------------------------------------------
Q 002826          670 CRQDFQLQWSIRLKIAIGVAQGLAYLHKD---------------------------------------------------  698 (876)
Q Consensus       670 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------------  698 (876)
                      ...     ......+..+++..++.||+.                                                   
T Consensus       112 ~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  186 (272)
T 4gkh_A          112 EEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL  186 (272)
T ss_dssp             HHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred             cCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence            332     123345667777777777743                                                   


Q ss_pred             ----CCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          699 ----YVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       699 ----~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                          ..+.++|+|+.+.||++++++.+-|+||+.+.
T Consensus       187 ~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          187 LPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                01247899999999999987777799998654

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.27  E-value=6.2e-08  Score=100.00  Aligned_cols=39  Identities=28%  Similarity=0.349  Sum_probs=15.8

Q ss_pred             cccccEEEeccccccC--cCCcccccCCccceeeeeccccc
Q 002826          254 LLKLVSFDVSQNKLSG--SFPNGICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       254 l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~i~  292 (876)
                      +++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|+
T Consensus       169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~  209 (267)
T 3rw6_A          169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK  209 (267)
T ss_dssp             CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred             CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence            3444444444444443  12233333444444444444333

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.25  E-value=4.8e-08  Score=95.93  Aligned_cols=122  Identities=16%  Similarity=0.162  Sum_probs=65.4

Q ss_pred             CcccccccccCCCCCCeeecCCC-ccccc----cCccccCCCCCCcccCCCcccceeecCCccccc----cCCCccCCcc
Q 002826           87 LSGEISSSVCELSSLSNLNLADN-LFNQP----IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEG----KIPESIGSLV  157 (876)
Q Consensus        87 l~~~~~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~----~~p~~~~~l~  157 (876)
                      +...+...+...++|++|+|++| .+...    +...+...++|++|+|++|.|          ..    .+...+...+
T Consensus        24 ~~~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i----------~~~g~~~l~~~L~~n~   93 (185)
T 1io0_A           24 VEETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRS----------NDPVAFALAEMLKVNN   93 (185)
T ss_dssp             HHHHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCC----------CHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCC----------ChHHHHHHHHHHHhCC
Confidence            34445666777888888888888 77643    333444455555554444433          21    1122333345


Q ss_pred             ccceecccccccCCC----cCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEe--cCCCCccc----CCcccc
Q 002826          158 NLQVLNLGSNLLSGS----VPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL--QSSGFHGV----IPDSFV  227 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L--~~n~l~~~----~~~~~~  227 (876)
                      +|++|+|++|.|+..    +...+...+                         +|++|+|  ++|.|+..    +...+.
T Consensus        94 ~L~~L~L~~N~i~~~g~~~l~~~L~~n~-------------------------~L~~L~L~~~~N~i~~~g~~~l~~~L~  148 (185)
T 1io0_A           94 TLKSLNVESNFISGSGILALVEALQSNT-------------------------SLIELRIDNQSQPLGNNVEMEIANMLE  148 (185)
T ss_dssp             SCCEEECCSSCCCHHHHHHHHHGGGGCS-------------------------SCCEEECCCCSSCCCHHHHHHHHHHHH
T ss_pred             CcCEEECcCCcCCHHHHHHHHHHHHhCC-------------------------CceEEEecCCCCCCCHHHHHHHHHHHH
Confidence            566666666666532    223333344                         4455555  44555432    223344


Q ss_pred             CCCCCcEEecccCccC
Q 002826          228 GLQSLSILDLSQNNLT  243 (876)
Q Consensus       228 ~l~~L~~L~Ls~N~l~  243 (876)
                      ..++|++|+|++|.|.
T Consensus       149 ~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          149 KNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HCSSCCEEECCCSSHH
T ss_pred             hCCCcCEEeccCCCCC
Confidence            5567777777777765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.19  E-value=6.1e-06  Score=87.94  Aligned_cols=132  Identities=20%  Similarity=0.180  Sum_probs=91.3

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCc---cccceeeEEE-eCCeEEEEEEcCCCCCHH
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHK---NIVKVLGFFH-SDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~gsL~  666 (876)
                      ++|....||+.    |+.+++|+-..  ......+.+|+++++.+.+.   .+.+++.++. ..+..++||||++|.++.
T Consensus        28 ~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~  101 (306)
T 3tdw_A           28 GEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILG  101 (306)
T ss_dssp             EECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECH
T ss_pred             CCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECc
Confidence            45657889987    56788888422  12346788999999999642   3667777764 355688999999998886


Q ss_pred             HHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc------------------------------------------------
Q 002826          667 DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD------------------------------------------------  698 (876)
Q Consensus       667 ~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------------  698 (876)
                      +..-   ..++......++.++++.++.||+.                                                
T Consensus       102 ~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  178 (306)
T 3tdw_A          102 EDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS  178 (306)
T ss_dssp             HHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred             hhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence            6321   1234555555666666666666542                                                


Q ss_pred             ---------CCCCccccccccCceeeCC---CCCe-EEccccchhh
Q 002826          699 ---------YVPHLLHRNVKSKNILLDA---DFEP-KLTDFALDRI  731 (876)
Q Consensus       699 ---------~~~~i~H~Dlkp~NIll~~---~~~~-kl~DfGla~~  731 (876)
                               ..+.++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                     1235699999999999987   4564 8999987653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.17  E-value=1.3e-07  Score=92.83  Aligned_cols=69  Identities=14%  Similarity=0.174  Sum_probs=35.4

Q ss_pred             CccccCCCCCcEEecccC-ccCCC----CCCccccccccccEEEeccccccCcC----CcccccCCccceeeeeccccc
Q 002826          223 PDSFVGLQSLSILDLSQN-NLTGE----VPQSLGSSLLKLVSFDVSQNKLSGSF----PNGICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       223 ~~~~~~l~~L~~L~Ls~N-~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~i~  292 (876)
                      ...+...++|++|+|++| .|+..    +...+ ...++|++|+|++|+|....    ...+...++|++|+|++|.|+
T Consensus        29 ~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L-~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~  106 (185)
T 1io0_A           29 KRIQNNDPDLEEVNLNNIMNIPVPTLKACAEAL-KTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS  106 (185)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHH-TTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHH-HhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence            344566777888888887 77621    11111 12455666666666665321    222233344555555555444

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=2.7e-06  Score=92.88  Aligned_cols=76  Identities=8%  Similarity=0.063  Sum_probs=53.8

Q ss_pred             CCCCceEEEEEEeC-------CCcEEEEEEEecCC---ccCHHHHHHHHHHHhhcc-C--ccccceeeEEEeC---CeEE
Q 002826          591 NGGPFGRVYILSLP-------SGELIAVKKLVNFG---CQSSKTLKTEVKTLAKIR-H--KNIVKVLGFFHSD---ESIF  654 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~---~~~~  654 (876)
                      ++|....+|+++..       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.++++++.+.   +..+
T Consensus        30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~  109 (357)
T 3ats_A           30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF  109 (357)
T ss_dssp             TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred             CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence            56668999998664       26788898764322   112356788999999885 3  3577888887654   4578


Q ss_pred             EEEEcCCCCCHH
Q 002826          655 LIYEFLQMGSLG  666 (876)
Q Consensus       655 lv~e~~~~gsL~  666 (876)
                      +||||++|.++.
T Consensus       110 ~v~e~l~G~~l~  121 (357)
T 3ats_A          110 FLMDYVEGVVPP  121 (357)
T ss_dssp             EEEECCCCBCCC
T ss_pred             EEEEecCCCChh
Confidence            999999987654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.93  E-value=3.8e-05  Score=83.06  Aligned_cols=134  Identities=14%  Similarity=0.221  Sum_probs=79.7

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC--ccccceee------EEEeCCeEEEEEEcCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH--KNIVKVLG------FFHSDESIFLIYEFLQM  662 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~------~~~~~~~~~lv~e~~~~  662 (876)
                      +||..+.||++...+| .+++|+...    ....+..|.++++.+..  -.+.+++.      +....+..++||||++|
T Consensus        41 ~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           41 QGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             C----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             cccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            4556899999987555 588998864    23455567777776642  12344443      22346778999999998


Q ss_pred             CCHH--------------HHhhcc--CC--c---------CCHHHH-------------------------------HHH
Q 002826          663 GSLG--------------DLICRQ--DF--Q---------LQWSIR-------------------------------LKI  684 (876)
Q Consensus       663 gsL~--------------~~l~~~--~~--~---------l~~~~~-------------------------------~~i  684 (876)
                      .++.              ..++..  ..  +         ..|...                               ..+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            6542              011111  00  0         122211                               011


Q ss_pred             HHHHHHHHHHhhc----------cCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          685 AIGVAQGLAYLHK----------DYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       685 ~~~i~~~l~~LH~----------~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                      ...+..++++|++          ...+.++|+|+++.||+++.++.+.|+||+.+
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            1123345666653          12348999999999999988889999999865

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.76  E-value=9.5e-05  Score=81.84  Aligned_cols=73  Identities=15%  Similarity=0.160  Sum_probs=46.6

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-------cCHHHHHHHHHHHhhccC--c-cccceeeEEEeCCeEEEE
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-------QSSKTLKTEVKTLAKIRH--K-NIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~lv  656 (876)
                      .+| +|..+.||+++.. +++.|+||.......       ....++..|+++++.+..  | .+.+++.+  +.+..++|
T Consensus        37 ~lg-~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           37 EIG-DGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             ECC-SSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             ECC-CCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            344 4559999999654 578999998653211       123567789999988842  3 34455543  34456899


Q ss_pred             EEcCCCC
Q 002826          657 YEFLQMG  663 (876)
Q Consensus       657 ~e~~~~g  663 (876)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.76  E-value=0.00014  Score=77.02  Aligned_cols=132  Identities=20%  Similarity=0.210  Sum_probs=89.0

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc---CccccceeeEEEeCCeEEEEEEcCCCCCHH-
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR---HKNIVKVLGFFHSDESIFLIYEFLQMGSLG-  666 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~gsL~-  666 (876)
                      +||....+|+.+. +++.+++|+....   ....+..|++.++.+.   ...++++++++...+..++||||++|..+. 
T Consensus        45 ~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~  120 (312)
T 3jr1_A           45 YSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQ  120 (312)
T ss_dssp             CCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCT
T ss_pred             CCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCc
Confidence            4556999999886 5778889987642   3567889999999984   357888999988888999999999987642 


Q ss_pred             -------H---HhhccCC---------------------cCCHHHHH---HHHH----------------HHHHH-HHHh
Q 002826          667 -------D---LICRQDF---------------------QLQWSIRL---KIAI----------------GVAQG-LAYL  695 (876)
Q Consensus       667 -------~---~l~~~~~---------------------~l~~~~~~---~i~~----------------~i~~~-l~~L  695 (876)
                             +   .++....                     .-+|....   ++..                .+... ...|
T Consensus       121 ~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L  200 (312)
T 3jr1_A          121 SSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTL  200 (312)
T ss_dssp             THHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHh
Confidence                   1   1222111                     12354321   1111                11111 2234


Q ss_pred             hc-cCCCCccccccccCceeeCCCCCeEEcccc
Q 002826          696 HK-DYVPHLLHRNVKSKNILLDADFEPKLTDFA  727 (876)
Q Consensus       696 H~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfG  727 (876)
                      .. ...+.++|+|+.+.|++++.++ +.|.|++
T Consensus       201 ~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          201 SKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             TTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             ccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            22 2246899999999999999887 8899974

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.53  E-value=2e-05  Score=75.34  Aligned_cols=84  Identities=12%  Similarity=0.089  Sum_probs=43.5

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCccccc----CcccEEEecCCC-CcccCCccccCCCCC
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKL----EKLEQLFLQSSG-FHGVIPDSFVGLQSL  232 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~~~~~~~l~~L  232 (876)
                      +|+.|||+++.++..--..+.++++|++|+|+++..+...--..+..+    ++|++|+|++|. ++...-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            566666666666654444556666666666666642111111112222    245566665553 554333345556666


Q ss_pred             cEEecccCc
Q 002826          233 SILDLSQNN  241 (876)
Q Consensus       233 ~~L~Ls~N~  241 (876)
                      ++|+|+++.
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            666666653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.52  E-value=0.00059  Score=71.68  Aligned_cols=75  Identities=17%  Similarity=0.177  Sum_probs=53.4

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC---ccccceeeEEEeCCeEEEEEEcCCC
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH---KNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      +..+|+|. .+.||+++..||+.|.+|+...........+..|+..|+.+.-   --+.+++++.    ..++||||+++
T Consensus        20 v~~~g~G~-~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           20 VAERGHSH-RWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEET-TEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             EEecCCCC-CeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            34455544 9999999999999999998765444445678899999998842   2345555542    23689999987


Q ss_pred             CCH
Q 002826          663 GSL  665 (876)
Q Consensus       663 gsL  665 (876)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            643

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.43  E-value=3.8e-05  Score=73.32  Aligned_cols=33  Identities=18%  Similarity=0.192  Sum_probs=15.2

Q ss_pred             ccEEEecCCCCcccCCccccCCCCCcEEecccC
Q 002826          208 LEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQN  240 (876)
Q Consensus       208 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  240 (876)
                      |++|+++++.++...-..+.++++|++|+|+++
T Consensus        63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            344444444443333333445555555555555

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.23  E-value=0.0011  Score=73.79  Aligned_cols=78  Identities=8%  Similarity=0.016  Sum_probs=46.3

Q ss_pred             CCccccccccCceeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCC---CCCCccchHHHHHHHHHH
Q 002826          701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK---KATAQMDAYSFGVVLLEL  777 (876)
Q Consensus       701 ~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlGv~l~el  777 (876)
                      +.++|+|++|.||+++.++ ++++||+.+..-............ -...|++|+.....   ......++......+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN-LILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH-HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH-HHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            4899999999999998776 999999987653321100000000 11235666654311   111234556777777877


Q ss_pred             HhC
Q 002826          778 ITG  780 (876)
Q Consensus       778 ltg  780 (876)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            664

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.19  E-value=0.0014  Score=70.26  Aligned_cols=140  Identities=14%  Similarity=0.105  Sum_probs=74.9

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC--ccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..+.+|++.-.+|+....+|+.+++|......   ...+..|+.+++.+..  -.+.+++.+..+.+  ++|||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            44555554445778776557778787654321   1345567787777743  23556666643333  68999998777


Q ss_pred             HHHHhhccC-------------------------CcCCHHHHHH--------------------HHHHHHHHHHHhh---
Q 002826          665 LGDLICRQD-------------------------FQLQWSIRLK--------------------IAIGVAQGLAYLH---  696 (876)
Q Consensus       665 L~~~l~~~~-------------------------~~l~~~~~~~--------------------i~~~i~~~l~~LH---  696 (876)
                      +.+++....                         ..++......                    ....+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         0111111000                    0001111222221   


Q ss_pred             ccCCCCccccccccCceeeCCC----CCeEEccccchhh
Q 002826          697 KDYVPHLLHRNVKSKNILLDAD----FEPKLTDFALDRI  731 (876)
Q Consensus       697 ~~~~~~i~H~Dlkp~NIll~~~----~~~kl~DfGla~~  731 (876)
                      ......++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123489999999999999874    6789999987654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.01  E-value=0.0016  Score=70.82  Aligned_cols=136  Identities=15%  Similarity=0.150  Sum_probs=80.2

Q ss_pred             CCCCCceEEEEEEeC--------CCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcC
Q 002826          590 GNGGPFGRVYILSLP--------SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       590 g~~g~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..||....+|++..+        +++.|.+|+... .......+.+|..+++.+. +.-..++++++.+    .+||||+
T Consensus        58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i  132 (379)
T 3feg_A           58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI  132 (379)
T ss_dssp             C-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred             cCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence            345668899998775        357899998522 2234566778999999885 3333566666543    2899999


Q ss_pred             CCCCHHHH-----------------hhcc----CCcCC--HHHHHHHHHHHHH-------------------HHHHhh--
Q 002826          661 QMGSLGDL-----------------ICRQ----DFQLQ--WSIRLKIAIGVAQ-------------------GLAYLH--  696 (876)
Q Consensus       661 ~~gsL~~~-----------------l~~~----~~~l~--~~~~~~i~~~i~~-------------------~l~~LH--  696 (876)
                      +|.++..-                 ++..    +....  +..+.++..++..                   .+.+|.  
T Consensus       133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~  212 (379)
T 3feg_A          133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL  212 (379)
T ss_dssp             SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred             cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence            98654310                 1111    11122  3444444433321                   122222  


Q ss_pred             --cc-CCCCccccccccCceeeCCC----CCeEEccccchh
Q 002826          697 --KD-YVPHLLHRNVKSKNILLDAD----FEPKLTDFALDR  730 (876)
Q Consensus       697 --~~-~~~~i~H~Dlkp~NIll~~~----~~~kl~DfGla~  730 (876)
                        .. ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              11 22479999999999999876    789999998764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0014  Score=73.06  Aligned_cols=69  Identities=16%  Similarity=0.304  Sum_probs=46.6

Q ss_pred             CCCCceEEEEEEeCC--------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc-cceeeEEEeCCeEEEEEEcCC
Q 002826          591 NGGPFGRVYILSLPS--------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI-VKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +||....+|++..++        ++.|.+|+....  .....+..|..+++.+...++ .++++.+.+    .+|+||++
T Consensus        82 ~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~  155 (429)
T 1nw1_A           82 KGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP  155 (429)
T ss_dssp             CCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred             CCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeC
Confidence            355589999998753        578999987432  122566689999998854334 566665532    28999998


Q ss_pred             CCCH
Q 002826          662 MGSL  665 (876)
Q Consensus       662 ~gsL  665 (876)
                      |.++
T Consensus       156 G~~l  159 (429)
T 1nw1_A          156 SRPL  159 (429)
T ss_dssp             EEEC
T ss_pred             Cccc
Confidence            7443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.93  E-value=0.01  Score=63.29  Aligned_cols=135  Identities=14%  Similarity=0.152  Sum_probs=80.0

Q ss_pred             CCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCc--cccceeeE-----EEeCCeEEEEEEcCCCCCH
Q 002826          593 GPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHK--NIVKVLGF-----FHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       593 g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~~gsL  665 (876)
                      |....||++...+|+.+++|+..... .....+..|..+++.+...  .+++++..     ....+..++||++++|.++
T Consensus        36 g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~  114 (328)
T 1zyl_A           36 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  114 (328)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence            44789999887778889999986332 3456778899998888522  24444443     2235677899999988543


Q ss_pred             H-----H------H---hhcc--------CCcCCHHHH----HHH---------------HHHHHHHHHHhhcc----CC
Q 002826          666 G-----D------L---ICRQ--------DFQLQWSIR----LKI---------------AIGVAQGLAYLHKD----YV  700 (876)
Q Consensus       666 ~-----~------~---l~~~--------~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~----~~  700 (876)
                      .     .      .   ++..        ....++...    ..+               ...+...++.+.+.    ..
T Consensus       115 ~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  194 (328)
T 1zyl_A          115 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  194 (328)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCC
Confidence            1     0      0   1110        011222111    000               00111122222211    23


Q ss_pred             CCccccccccCceeeCCCCCeEEccccchh
Q 002826          701 PHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       701 ~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ..++|+|+++.||+++ + .+.++||+.+.
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            4789999999999999 4 89999998664

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.90  E-value=0.0011  Score=60.10  Aligned_cols=55  Identities=22%  Similarity=0.299  Sum_probs=43.3

Q ss_pred             EEEccCCccc--cCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCccc
Q 002826          403 IINLSQNSIS--GQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT  459 (876)
Q Consensus       403 ~L~Ls~N~l~--~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  459 (876)
                      .++.+++.++  .++..+.  ++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5777888776  4443332  46889999999999777888899999999999999875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.88  E-value=0.0024  Score=68.06  Aligned_cols=137  Identities=12%  Similarity=0.117  Sum_probs=77.8

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCcc--ccceeeE------EEeCCeEEEEEEcCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN--IVKVLGF------FHSDESIFLIYEFLQM  662 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e~~~~  662 (876)
                      ++|....+|+++..+| .+++|+....  .....+..|+.+++.+....  +.+++..      ....+..++||+|++|
T Consensus        31 ~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G  107 (322)
T 2ppq_A           31 AEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG  107 (322)
T ss_dssp             CC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred             CCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCC
Confidence            3455789999987655 6779987642  22345677888888884322  3333321      1234678999999998


Q ss_pred             CCHHH--------------Hhhcc----CCc-------CCHHHHHH------------HHHHHHHHHHHhhcc----CCC
Q 002826          663 GSLGD--------------LICRQ----DFQ-------LQWSIRLK------------IAIGVAQGLAYLHKD----YVP  701 (876)
Q Consensus       663 gsL~~--------------~l~~~----~~~-------l~~~~~~~------------i~~~i~~~l~~LH~~----~~~  701 (876)
                      ..+..              .++..    ...       ..|.....            +...+.+.++++++.    ...
T Consensus       108 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~  187 (322)
T 2ppq_A          108 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA  187 (322)
T ss_dssp             BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCc
Confidence            65311              01111    000       11222110            001234445555432    124


Q ss_pred             CccccccccCceeeCCCCCeEEccccchh
Q 002826          702 HLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       702 ~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +++|+|+.+.||+++++..+.++||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            79999999999999877656899998653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.83  E-value=0.0025  Score=67.35  Aligned_cols=67  Identities=9%  Similarity=0.055  Sum_probs=40.7

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc-cceeeEEEeCCeEEEEEEcC-CCCCH
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI-VKVLGFFHSDESIFLIYEFL-QMGSL  665 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~gsL  665 (876)
                      +||....+|++     +.+++|+..... .......+|+.+++.+...++ .+++++.  .+.-++|+||+ +|.++
T Consensus        27 ~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           27 LGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             ESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             CCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            45658999998     568888875421 111223568888888853333 3555443  33456899999 66444

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.83  E-value=0.0068  Score=65.11  Aligned_cols=67  Identities=10%  Similarity=0.075  Sum_probs=44.6

Q ss_pred             CCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC---ccccceeeE------EEeCCeEEEEEEcCCC
Q 002826          592 GGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH---KNIVKVLGF------FHSDESIFLIYEFLQM  662 (876)
Q Consensus       592 ~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~------~~~~~~~~lv~e~~~~  662 (876)
                      +|....||++...+| .+++|+.....      ...|+.+++.+..   |.+++.+..      ....+..++||+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333689999987777 89999876543      1456666766632   224555432      2345778999999998


Q ss_pred             CCH
Q 002826          663 GSL  665 (876)
Q Consensus       663 gsL  665 (876)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            755

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.74  E-value=0.00024  Score=69.20  Aligned_cols=65  Identities=15%  Similarity=0.198  Sum_probs=30.1

Q ss_pred             cCCCCCcEEecccC-ccCCC----CCCccccccccccEEEeccccccCcCCc----ccccCCccceeeeeccccc
Q 002826          227 VGLQSLSILDLSQN-NLTGE----VPQSLGSSLLKLVSFDVSQNKLSGSFPN----GICKANGLVNLSLHKNFFN  292 (876)
Q Consensus       227 ~~l~~L~~L~Ls~N-~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~i~  292 (876)
                      .+-+.|+.|+|++| +|...    +-..+. .-+.|+.|+|++|+|......    .+..-+.|+.|+|++|.|.
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~-~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig  111 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAAC-NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT  111 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHT-TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHh-hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence            34456777777764 55411    111111 234556666666655532222    2223344555555555444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.62  E-value=0.00013  Score=70.99  Aligned_cols=92  Identities=18%  Similarity=0.191  Sum_probs=46.6

Q ss_pred             cccccccCCCCCCeeecCCC-ccccc----cCccccCCCCCCcccCCCcccceeecCCcccccc----CCCccCCccccc
Q 002826           90 EISSSVCELSSLSNLNLADN-LFNQP----IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGK----IPESIGSLVNLQ  160 (876)
Q Consensus        90 ~~~~~~~~l~~L~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~----~p~~~~~l~~L~  160 (876)
                      .+...+.+-+.|++|+|++| .|...    +-..+..-+.|++|+|++|          +|...    +.+.+..-+.|+
T Consensus        32 ~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n----------~igd~ga~alA~aL~~N~tL~  101 (197)
T 1pgv_A           32 CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANT----------AISDSEARGLIELIETSPSLR  101 (197)
T ss_dssp             HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTS----------CCBHHHHTTHHHHHHHCSSCC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCC----------CCChHHHHHHHHHHhcCCccC
Confidence            44555566778888888875 66532    2334444445555444433          33322    122233345667


Q ss_pred             eecccccccCCCc----CccccCCCcceEEEccCC
Q 002826          161 VLNLGSNLLSGSV----PFVFGNFSELVVLDLSQN  191 (876)
Q Consensus       161 ~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N  191 (876)
                      +|+|++|.|+..-    ..++..-+.|++|+|++|
T Consensus       102 ~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          102 VLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             EEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             eEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            7777777665321    222333344555555543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.61  E-value=0.0027  Score=57.65  Aligned_cols=55  Identities=18%  Similarity=0.268  Sum_probs=25.1

Q ss_pred             EEecccCccC-CCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccc
Q 002826          234 ILDLSQNNLT-GEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFF  291 (876)
Q Consensus       234 ~L~Ls~N~l~-~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i  291 (876)
                      +++.++++++ ..+|..+.   ++|++|+|++|+|+.+.+..|..+++|++|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555555553 23444332   2344555555555544444444444444444444443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.48  E-value=0.0091  Score=66.72  Aligned_cols=70  Identities=23%  Similarity=0.141  Sum_probs=44.9

Q ss_pred             CCCCceEEEEEEeCC-CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc-cceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          591 NGGPFGRVYILSLPS-GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI-VKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      +||-...+|++...+ ++.+++|+..... .......+|..+++.+...++ .++++++.  +  ..||||++|.++
T Consensus       117 sgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          117 NGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             CC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             CCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            456689999998765 5788898874322 111123689999998864444 56677662  2  259999987544

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.37  E-value=0.025  Score=55.19  Aligned_cols=103  Identities=15%  Similarity=0.075  Sum_probs=68.3

Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      -||.+++...+.++++.+++.++.|.+.+|.-.-.+.  .-..+=+-|..|++..+|.|...+ +.+.            
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence            3899999988999999999999999999987762210  001223346889999999887774 1110            


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCC
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQA  783 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p  783 (876)
                        .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              0122356888753 3456788999999999998874443

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.20  E-value=0.0074  Score=65.68  Aligned_cols=69  Identities=13%  Similarity=0.124  Sum_probs=42.3

Q ss_pred             CCCceEEEEEEeCC---------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCcc-ccceeeEEEeCCeEEEEEEcCC
Q 002826          592 GGPFGRVYILSLPS---------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN-IVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       592 ~g~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ||....+|++...+         ++.+++|+..... ........|.++++.+...+ +.++++..  .+  ++||||++
T Consensus        43 ~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e~i~  117 (369)
T 3c5i_A           43 SGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEEWLY  117 (369)
T ss_dssp             ---CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCC
T ss_pred             CcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEEEec
Confidence            55578999987654         2688888764321 11112467888888885434 44666543  22  68999999


Q ss_pred             CCCH
Q 002826          662 MGSL  665 (876)
Q Consensus       662 ~gsL  665 (876)
                      |.++
T Consensus       118 G~~l  121 (369)
T 3c5i_A          118 GDPL  121 (369)
T ss_dssp             SEEC
T ss_pred             CCcC
Confidence            8543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.76  E-value=0.012  Score=64.87  Aligned_cols=70  Identities=17%  Similarity=0.184  Sum_probs=45.6

Q ss_pred             CCCCceEEEEEEeCC--------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCcc-ccceeeEEEeCCeEEEEEEcCC
Q 002826          591 NGGPFGRVYILSLPS--------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKN-IVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .||....+|++...+        ++.|.+|+.... ........+|..+++.+...+ ..++++.+  .+  +.||||++
T Consensus        79 sGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~efI~  153 (424)
T 3mes_A           79 FSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEFID  153 (424)
T ss_dssp             CCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCC
T ss_pred             CCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEEeC
Confidence            466688999987753        678999886432 222223467888888885323 44555533  22  68999999


Q ss_pred             CCCH
Q 002826          662 MGSL  665 (876)
Q Consensus       662 ~gsL  665 (876)
                      |.++
T Consensus       154 G~~l  157 (424)
T 3mes_A          154 GEPL  157 (424)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.86  E-value=0.2  Score=54.87  Aligned_cols=30  Identities=27%  Similarity=0.379  Sum_probs=24.8

Q ss_pred             CccccccccCceee------CCCCCeEEccccchhh
Q 002826          702 HLLHRNVKSKNILL------DADFEPKLTDFALDRI  731 (876)
Q Consensus       702 ~i~H~Dlkp~NIll------~~~~~~kl~DfGla~~  731 (876)
                      .++|+|+.+.||++      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999987653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.81  E-value=4.2  Score=39.69  Aligned_cols=82  Identities=15%  Similarity=0.141  Sum_probs=62.0

Q ss_pred             cCccccceeeEEEeCCeEEEEEEcCCCC-CHHHHhhccCCcCCHHHHHHHHHHHHHHHH-HhhccCCCCccccccccCce
Q 002826          636 RHKNIVKVLGFFHSDESIFLIYEFLQMG-SLGDLICRQDFQLQWSIRLKIAIGVAQGLA-YLHKDYVPHLLHRNVKSKNI  713 (876)
Q Consensus       636 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~i~H~Dlkp~NI  713 (876)
                      .||+.  -..+-.+++.+.+.++.-+++ +.. .+    ..++...+++++..|+.... +++..     .|--+.|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i----~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI----RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH----HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH----HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceE
Confidence            57777  444556677888888865443 333 33    24778899999999988777 67665     7888999999


Q ss_pred             eeCCCCCeEEccccch
Q 002826          714 LLDADFEPKLTDFALD  729 (876)
Q Consensus       714 ll~~~~~~kl~DfGla  729 (876)
                      +++.++.+++.-.|+-
T Consensus       116 ~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECTTCCEEESCCEET
T ss_pred             EEeCCCcEEEEEcCCc
Confidence            9999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	876
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-52
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-51
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-48
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-48
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-46
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-45
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-44
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-44
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-44
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-44
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-43
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-43
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-42
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-42
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-39
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-38
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-34
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-33
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-32
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-32
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-32
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	7e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-29
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-28
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-25
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-25
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-24
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-11
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-19
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-04
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-14
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	7e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.001
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 1e-53
 Identities = 60/270 (22%), Positives = 110/270 (40%), Gaps = 18/270 (6%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G+G  FG VY         + +  +     Q  +  K EV  L K RH NI+  +G+  +
Sbjct: 17  GSGS-FGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-ST 74

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              + ++ ++ +  SL   +   + + +    + IA   AQG+ YLH      ++HR++K
Sbjct: 75  APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLK 131

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY---GYSKKATAQMD 766
           S NI L  D   K+ DF L  +    +             + APE          + Q D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
            Y+FG+VL EL+TG+      P  +++    +   +         L P ++         
Sbjct: 192 VYAFGIVLYELMTGQL-----PYSNINNRDQIIFMVG-----RGYLSPDLSKVRSNCPKA 241

Query: 827 ALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
              +   C     ++RP   +++ ++  L+
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-52
 Identities = 58/267 (21%), Positives = 130/267 (48%), Gaps = 20/267 (7%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G+G  FG V++    + + +A+K +   G  S +    E + + K+ H  +V++ G    
Sbjct: 14  GSGQ-FGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              I L++EF++ G L D +  Q         L + + V +G+AYL +     ++HR++ 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLA 128

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           ++N L+  +   K++DF + R V +  + S+  +++ +  + +PE     + +++ D +S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVWS 187

Query: 770 FGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           FGV++ E+ +  +      + S +VV+ +           ++  P++A+ +        +
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNS-EVVEDIST-------GFRLYKPRLASTH------VYQ 233

Query: 830 IALRCTSVMPEKRPSMFEVVKALHSLS 856
           I   C    PE RP+   +++ L  ++
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-51
 Identities = 61/271 (22%), Positives = 122/271 (45%), Gaps = 22/271 (8%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G G  FG V++        +AVK L   G  S      E   + +++H+ +V++     +
Sbjct: 22  GAGQ-FGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78

Query: 650 DESIFLIYEFLQMGSLGDLICRQD-FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            E I++I E+++ GSL D +      +L  +  L +A  +A+G+A++ +    + +HR++
Sbjct: 79  QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           ++ NIL+      K+ DF L R++ +  + +   +++ +  + APE       T + D +
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 194

Query: 769 SFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           SFG++L E++T  +     P   +   + ++   N+  G   V                 
Sbjct: 195 SFGILLTEIVTHGRI----PYPGMTNPEVIQ---NLERGYRMVRPDNCPE-------ELY 240

Query: 829 EIALRCTSVMPEKRPSMFEVVKALHSLSTRT 859
           ++   C    PE RP+   +   L    T T
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 3e-48
 Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 28/270 (10%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF-H 648
           G G  FG V  L    G  +AVK + N    +++    E   + ++RH N+V++LG    
Sbjct: 16  GKGE-FGDVM-LGDYRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
               ++++ E++  GSL D +  +    L     LK ++ V + + YL      + +HR+
Sbjct: 72  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRD 128

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N+L+  D   K++DF L +        ST  +      + APE    KK + + D 
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183

Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA 827
           +SFG++L E+ +  +     P   + +   V R   +  G                    
Sbjct: 184 WSFGILLWEIYSFGRV----PYPRIPLKDVVPR---VEKGYKMDAPDGCPP-------AV 229

Query: 828 LEIALRCTSVMPEKRPSMFEVVKALHSLST 857
            E+   C  +    RPS  ++ + L  + T
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-48
 Identities = 56/263 (21%), Positives = 114/263 (43%), Gaps = 20/263 (7%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G G  FG V          +A+K +   G  S      E K +  + H+ +V++ G    
Sbjct: 13  GTGQ-FGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVK 709
              IF+I E++  G L + +     + Q    L++   V + + YL        LHR++ 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLA 127

Query: 710 SKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYS 769
           ++N L++     K++DF L R V +  + S++ S++ +  ++ PE     K +++ D ++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIWA 186

Query: 770 FGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALE 829
           FGV++ E+ +  +     P E     +       I  G +++  P +A+           
Sbjct: 187 FGVLMWEIYSLGKM----PYERFTNSETAEH---IAQG-LRLYRPHLAS------EKVYT 232

Query: 830 IALRCTSVMPEKRPSMFEVVKAL 852
           I   C     ++RP+   ++  +
Sbjct: 233 IMYSCWHEKADERPTFKILLSNI 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-48
 Identities = 60/271 (22%), Positives = 123/271 (45%), Gaps = 22/271 (8%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G G  FG V++ +      +A+K L   G  S +    E + + K+RH+ +V++      
Sbjct: 26  GQGC-FGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 83

Query: 650 DESIFLIYEFLQMGSLGDLICRQDFQL-QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           +  I+++ E++  GSL D +  +  +  +    + +A  +A G+AY+ +    + +HR++
Sbjct: 84  EP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 139

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           ++ NIL+  +   K+ DF L R++ +  + +   +++ +  + APE     + T + D +
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI-KWTAPEAALYGRFTIKSDVW 198

Query: 769 SFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           SFG++L EL T              V + V  ++    G      P+             
Sbjct: 199 SFGILLTELTTKG-----RVPYPGMVNREVLDQVE--RGYRMPCPPECPE-------SLH 244

Query: 829 EIALRCTSVMPEKRPSMFEVVKALHSLSTRT 859
           ++  +C    PE+RP+   +   L    T T
Sbjct: 245 DLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-47
 Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 28/295 (9%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS 649
           G G  FG V+      GE +AVK   +   + S   + E+     +RH+NI+  +   + 
Sbjct: 12  GKGR-FGEVW-RGKWRGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68

Query: 650 DES----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV----- 700
           D      ++L+ ++ + GSL D + R    +     +K+A+  A GLA+LH + V     
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC--YNAPEY--- 755
           P + HR++KSKNIL+  +    + D  L      A     ++  + +    Y APE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 756 ---GYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV- 811
                  ++  + D Y+ G+V  E+              L     V    ++      V 
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 812 ---LDPKIANCYQ--QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
              L P I N +Q  + +    +I   C       R +   + K L  LS +  +
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (420), Expect = 2e-46
 Identities = 65/296 (21%), Positives = 117/296 (39%), Gaps = 48/296 (16%)

Query: 590 GNGGPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVK 642
           G G  FGRV+      +L      ++AVK L            + E   +A+  + NIVK
Sbjct: 22  GEGA-FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ-----------------------LQWS 679
           +LG     + + L++E++  G L + +                             L  +
Sbjct: 81  LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140

Query: 680 IRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS 739
            +L IA  VA G+AYL +      +HR++ ++N L+  +   K+ DF L R +  A +  
Sbjct: 141 EQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197

Query: 740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
              ++     +  PE  +  + T + D +++GVVL E+ +       +P   +   + + 
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL----QPYYGMAHEEVIY 253

Query: 800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                      V D  I  C +   L    +   C S +P  RPS   + + L  +
Sbjct: 254 ----------YVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 3e-46
 Identities = 59/276 (21%), Positives = 123/276 (44%), Gaps = 26/276 (9%)

Query: 590 GNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  +G VY          +AVK L        +    E   + +I+H N+V++LG   
Sbjct: 26  GGGQ-YGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            +   ++I EF+  G+L D +   + Q +   + L +A  ++  + YL K    + +HR+
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRD 140

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           + ++N L+  +   K+ DF L R++    + +   +++ +  + APE     K + + D 
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDV 199

Query: 768 YSFGVVLLELITGRQA--EQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           ++FGV+L E+ T   +     + ++  ++++   R              +   C ++   
Sbjct: 200 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------MERPEGCPEK--- 244

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL 861
              E+   C    P  RPS  E+ +A  ++   +S+
Sbjct: 245 -VYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 3e-46
 Identities = 61/291 (20%), Positives = 115/291 (39%), Gaps = 38/291 (13%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G   G V+ +   PSG ++A K + +         +  E++ L +     IV   G F
Sbjct: 15  GAGN-GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           +SD  I +  E +  GSL  ++ +   ++   I  K++I V +GL YL + +   ++HR+
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRD 130

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           VK  NIL+++  E KL DF +   + +    S  +S      Y +PE       + Q D 
Sbjct: 131 VKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDI 186

Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG- 826
           +S G+ L+E+  GR       A+ L+++   + + +      +   P             
Sbjct: 187 WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRP 246

Query: 827 ---------------------------ALEIALRCTSVMPEKRPSMFEVVK 850
                                        +   +C    P +R  + +++ 
Sbjct: 247 PMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 8e-46
 Identities = 59/271 (21%), Positives = 111/271 (40%), Gaps = 28/271 (10%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G G  +GR   I     G+++  K+L   +      + L +EV  L +++H NIV+    
Sbjct: 13  GTGS-YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71

Query: 647 FH--SDESIFLIYEFLQMGSLGDLIC---RQDFQLQWSIRLKIAIGVAQGLAYLHK--DY 699
               ++ +++++ E+ + G L  +I    ++   L     L++   +   L   H+  D 
Sbjct: 72  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131

Query: 700 VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK 759
              +LHR++K  N+ LD     KL DF L RI+      S   +      Y +PE     
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRM 189

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC 819
               + D +S G +L EL          P  +    +   +   I  G  + +  + ++ 
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMP-----PFTAFSQKELAGK---IREGKFRRIPYRYSD- 240

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                    EI  R  ++    RPS+ E+++
Sbjct: 241 ------ELNEIITRMLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 9e-46
 Identities = 54/267 (20%), Positives = 105/267 (39%), Gaps = 25/267 (9%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G+G  FG+VY   +  +  L A K +     +  +    E+  LA   H NIVK+L  F+
Sbjct: 21  GDGA-FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            + +++++ EF   G++  ++   +  L  S    +       L YLH      ++HR++
Sbjct: 80  YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDL 136

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY-----GYSKKATA 763
           K+ NIL   D + KL DF +              S      + APE         +    
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDY 194

Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
           + D +S G+ L+E+          P   L+ ++ + +   I       L  + +      
Sbjct: 195 KADVWSLGITLIEMAEIEP-----PHHELNPMRVLLK---IAKSEPPTL-AQPSRWSSN- 244

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVK 850
                +   +C     + R +  ++++
Sbjct: 245 ---FKDFLKKCLEKNVDARWTTSQLLQ 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-45
 Identities = 59/273 (21%), Positives = 123/273 (45%), Gaps = 25/273 (9%)

Query: 590 GNGGPFGRVYILSLPSGE-----LIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKV 643
           G G  FG VY   L +        +A+K L   +  +       E   + +  H NI+++
Sbjct: 16  GAGE-FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 74

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
            G     + + +I E+++ G+L   +  +D +      + +  G+A G+ YL      + 
Sbjct: 75  EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNY 131

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKAT 762
           +HR++ ++NIL++++   K++DF L R++ +    +  +S   +   + APE    +K T
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 191

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
           +  D +SFG+V+ E++T  +    E +   +V+K +     +         P   +C   
Sbjct: 192 SASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGFRL---------PTPMDCPSA 241

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                 ++ ++C      +RP   ++V  L  L
Sbjct: 242 ----IYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-44
 Identities = 53/271 (19%), Positives = 104/271 (38%), Gaps = 26/271 (9%)

Query: 590 GNGGPFGRVY---ILSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVL 644
           G+G  FG V           + +AVK L N     +    L  E   + ++ +  IV+++
Sbjct: 16  GSGN-FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G     ES  L+ E  ++G L   + +    ++    +++   V+ G+ YL +    + +
Sbjct: 75  GICE-AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEE---SNFV 129

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC-YNAPEYGYSKKATA 763
           HR++ ++N+LL      K++DF L + +          +       + APE     K ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189

Query: 764 QMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ 823
           + D +SFGV++ E  +  Q     P   +   +       +  G                
Sbjct: 190 KSDVWSFGVLMWEAFSYGQK----PYRGMKGSEVTAM---LEKGERMGCPAGCPR----- 237

Query: 824 MLGALEIALRCTSVMPEKRPSMFEVVKALHS 854
                ++   C +   E RP    V   L +
Sbjct: 238 --EMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 53/264 (20%), Positives = 100/264 (37%), Gaps = 21/264 (7%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G  +G V + ++  + E +AVK + +       + +K E+     + H+N+VK  G  
Sbjct: 14  GEGA-YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
                 +L  E+   G L D I   D  +      +    +  G+ YLH      + HR+
Sbjct: 73  REGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRD 128

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKK-ATAQMD 766
           +K +N+LLD     K++DF L  +      +  ++       Y APE    ++     +D
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
            +S G+VL  ++ G            +   W  +K  +                      
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------NPWKKIDSA---- 235

Query: 827 ALEIALRCTSVMPEKRPSMFEVVK 850
            L +  +     P  R ++ ++ K
Sbjct: 236 PLALLHKILVENPSARITIPDIKK 259

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 2e-44
 Identities = 53/271 (19%), Positives = 109/271 (40%), Gaps = 24/271 (8%)

Query: 590 GNGGPFGRVY---ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLG 645
           G G  FG V             +A+K L     ++  + +  E + + ++ +  IV+++G
Sbjct: 18  GCGN-FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
                E++ L+ E    G L   +  +  ++  S   ++   V+ G+ YL +    + +H
Sbjct: 77  VCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKKATAQ 764
           R++ ++N+LL      K++DF L + +G      T  S       + APE    +K +++
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
            D +S+GV + E ++  Q     P + +   + +     I  G      P+         
Sbjct: 193 SDVWSYGVTMWEALSYGQK----PYKKMKGPEVMAF---IEQGKRMECPPECPP------ 239

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                +   C     E RP    V + + + 
Sbjct: 240 -ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 58/274 (21%), Positives = 116/274 (42%), Gaps = 26/274 (9%)

Query: 590 GNGGPFGRVY----ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVKVL 644
           G G  FG V      L       +A+K L   +  +  +   +E   + +  H N++ + 
Sbjct: 35  GAGE-FGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G       + +I EF++ GSL   + + D Q      + +  G+A G+ YL      + +
Sbjct: 94  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYV 150

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS---CYNAPEYGYSKKA 761
           HR++ ++NIL++++   K++DF L R + +     T +S         + APE    +K 
Sbjct: 151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
           T+  D +S+G+V+ E+++  +    +     DV+  + +   +         P   +C  
Sbjct: 211 TSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVINAIEQDYRL---------PPPMDCPS 260

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                  ++ L C       RP   ++V  L  +
Sbjct: 261 A----LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (410), Expect = 2e-44
 Identities = 49/264 (18%), Positives = 108/264 (40%), Gaps = 22/264 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G+G  FG V+  +   +G +   K +         T+K E+  + ++ H  ++ +   F 
Sbjct: 38  GSGA-FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
               + LI EFL  G L D I  +D+++  +  +       +GL ++H+     ++H ++
Sbjct: 97  DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDI 153

Query: 709 KSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           K +NI+ +       K+ DF L   +        +    A + + APE    +      D
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIVDREPVGFYTD 210

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
            ++ GV+   L++G       P    D ++ ++   N+     +  +   ++   +    
Sbjct: 211 MWAIGVLGYVLLSGLS-----PFAGEDDLETLQ---NVKRCDWEFDEDAFSSVSPE---- 258

Query: 827 ALEIALRCTSVMPEKRPSMFEVVK 850
           A +         P KR ++ + ++
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALE 282

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (408), Expect = 3e-44
 Identities = 52/264 (19%), Positives = 111/264 (42%), Gaps = 22/264 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  FG V+      +G   A K ++       +T++ E++T++ +RH  +V +   F 
Sbjct: 35  GTGA-FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            D  + +IYEF+  G L + +  +  ++     ++    V +GL ++H+    + +H ++
Sbjct: 94  DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDL 150

Query: 709 KSKNILLDADF--EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           K +NI+       E KL DF L   +     + ++      + + APE    K      D
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTD 207

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
            +S GV+   L++G       P    +  + +R   N+ +    + D   +   +     
Sbjct: 208 MWSVGVLSYILLSGLS-----PFGGENDDETLR---NVKSCDWNMDDSAFSGISED---- 255

Query: 827 ALEIALRCTSVMPEKRPSMFEVVK 850
             +   +     P  R ++ + ++
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 4e-44
 Identities = 66/292 (22%), Positives = 117/292 (40%), Gaps = 28/292 (9%)

Query: 572 LRVTEHDLVIGMDEKSSAGNGGPFGRVYILSLP----SGELIAVKKLVNFGCQSS-KTLK 626
           + +    L++  +E    G G  FG VY  +L          AVK L             
Sbjct: 20  VVIGPSSLIVHFNEV--IGRGH-FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 76

Query: 627 TEVKTLAKIRHKNIVKVLGF-FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIA 685
           TE   +    H N++ +LG    S+ S  ++  +++ G L + I  +         +   
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 136

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
           + VA+G+ +L        +HR++ ++N +LD  F  K+ DF L R + +  F S  +   
Sbjct: 137 LQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 746 ALS--CYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKIN 803
           A     + A E   ++K T + D +SFGV+L EL+T        P   ++          
Sbjct: 194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA----PPYPDVNTFDITVY--- 246

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
           +  G   +      +          E+ L+C     E RPS  E+V  + ++
Sbjct: 247 LLQGRRLLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 9e-44
 Identities = 68/289 (23%), Positives = 123/289 (42%), Gaps = 34/289 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLG 645
           G+G  FG VY    + + E++A+KK+   G QS+   + +  EV+ L K+RH N ++  G
Sbjct: 24  GHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            +  + + +L+ E+    +   L   +   LQ      +  G  QGLAYLH     +++H
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHS---HNMIH 138

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY---GYSKKAT 762
           R+VK+ NILL      KL DF      G A+  +  +S      + APE        +  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDF------GSASIMAPANSFVGTPYWMAPEVILAMDEGQYD 192

Query: 763 AQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
            ++D +S G+  +EL   +      P  +++ +  +    +I       L     +  + 
Sbjct: 193 GKVDVWSLGITCIELAERKP-----PLFNMNAMSALY---HIAQNESPALQSG--HWSEY 242

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLLSIELSSSQE 871
                      C   +P+ RP+   ++K  H    R    ++ +   Q 
Sbjct: 243 ----FRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMDLIQR 285

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-43
 Identities = 60/288 (20%), Positives = 112/288 (38%), Gaps = 42/288 (14%)

Query: 590 GNGGPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIV 641
           G G  FG+V       ++   +   +AVK L      +  + L +E+K L+ +  H NIV
Sbjct: 32  GAGA-FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQ-----------------DFQLQWSIRLKI 684
            +LG         +I E+   G L + + R+                 +  L     L  
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           +  VA+G+A+L      + +HR++ ++NILL      K+ DF L R +   +      + 
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
                + APE  ++   T + D +S+G+ L EL +   +            K ++    +
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
                        +   +      +I   C    P KRP+  ++V+ +
Sbjct: 268 ---------LSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 2e-43
 Identities = 58/265 (21%), Positives = 114/265 (43%), Gaps = 29/265 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLG 645
           G G  FG VY+     S  ++A+K L     + +     L+ EV+  + +RH NI+++ G
Sbjct: 15  GKGK-FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 73

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
           +FH    ++LI E+  +G++   + +   +            +A  L+Y H      ++H
Sbjct: 74  YFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHS---KRVIH 129

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K +N+LL +  E K+ DF        +   +   +      Y  PE    +    ++
Sbjct: 130 RDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD----YLPPEMIEGRMHDEKV 185

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +S GV+  E + G+      P E+    +  +R        I  ++    +   +   
Sbjct: 186 DLWSLGVLCYEFLVGKP-----PFEANTYQETYKR--------ISRVEFTFPDFVTEG-- 230

Query: 826 GALEIALRCTSVMPEKRPSMFEVVK 850
            A ++  R     P +RP + EV++
Sbjct: 231 -ARDLISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-43
 Identities = 61/262 (23%), Positives = 117/262 (44%), Gaps = 22/262 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G   G VY  + + +G+ +A++++        + +  E+  + + ++ NIV  L  + 
Sbjct: 29  GQGA-SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
             + ++++ E+L  GSL D++              +     Q L +LH +    ++HR++
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLHSN---QVIHRDI 142

Query: 709 KSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAY 768
           KS NILL  D   KLTDF     +     QS  S+      + APE    K    ++D +
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 769 SFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGAL 828
           S G++ +E+I G       P  + + ++ +      TNG  ++ +P+             
Sbjct: 201 SLGIMAIEMIEGEP-----PYLNENPLRALYLI--ATNGTPELQNPE--KLSAI----FR 247

Query: 829 EIALRCTSVMPEKRPSMFEVVK 850
           +   RC  +  EKR S  E+++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQ 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 8e-43
 Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 26/271 (9%)

Query: 590 GNGGPFGRVY--ILSLPSGE--LIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVK 642
           G+G  FG V       PSG+   +AVK L        + +     EV  +  + H+N+++
Sbjct: 17  GDGS-FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           + G       + ++ E   +GSL D + +           + A+ VA+G+ YL       
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYN-APEYGYSKKA 761
            +HR++ ++N+LL      K+ DF L R + +      M     +     APE   ++  
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
           +   D + FGV L E+ T  Q    EP   L+  + + +   I     ++  P+  +C Q
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQ----EPWIGLNGSQILHK---IDKEGERLPRPE--DCPQ 242

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
                   + ++C +  PE RP+   +   L
Sbjct: 243 D----IYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 2e-42
 Identities = 59/271 (21%), Positives = 113/271 (41%), Gaps = 25/271 (9%)

Query: 590 GNGGPFGRVYILSLPS----GELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVL 644
           G G  FG V+     S       +A+K   N    S  +    E  T+ +  H +IVK++
Sbjct: 16  GEGQ-FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
           G    +  +++I E   +G L   +  + + L  +  +  A  ++  LAYL        +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES---KRFV 130

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           HR++ ++N+L+ ++   KL DF L R + ++ +    S       + APE    ++ T+ 
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSA 189

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
            D + FGV + E++        +P + +     + R   I NG    + P          
Sbjct: 190 SDVWMFGVCMWEILMHGV----KPFQGVKNNDVIGR---IENGERLPMPPNCPP------ 236

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                +  +C +  P +RP   E+   L ++
Sbjct: 237 -TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-42
 Identities = 61/293 (20%), Positives = 110/293 (37%), Gaps = 47/293 (16%)

Query: 590 GNGGPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIV 641
           G+G  FG+V       I        +AVK L      S  + L +E+K + ++  H+NIV
Sbjct: 46  GSGA-FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 104

Query: 642 KVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQ----------------------LQWS 679
            +LG       I+LI+E+   G L + +  +  +                      L + 
Sbjct: 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164

Query: 680 IRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS 739
             L  A  VA+G+ +L        +HR++ ++N+L+      K+ DF L R +   +   
Sbjct: 165 DLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221

Query: 740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVR 799
              +      + APE  +    T + D +S+G++L E+ +        P   + V     
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV----NPYPGIPVDANFY 277

Query: 800 RKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
           + I                   +++     I   C +    KRPS   +   L
Sbjct: 278 KLIQ------NGFKMDQPFYATEEI---YIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-42
 Identities = 60/273 (21%), Positives = 118/273 (43%), Gaps = 27/273 (9%)

Query: 590 GNGGPFGRVYI-LSLPSGEL----IAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKV 643
           G+G  FG VY  L +P GE     +A+K+L      +++K +  E   +A + + ++ ++
Sbjct: 18  GSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           LG      ++ LI + +  G L D +      +     L   + +A+G+ YL       L
Sbjct: 77  LGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRL 132

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATA 763
           +HR++ ++N+L+      K+TDF L +++G    +           + A E    +  T 
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192

Query: 764 QMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQ 822
           Q D +S+GV + EL+T G +     PA   ++   + +   +         P+   C   
Sbjct: 193 QSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGERL---------PQPPICTID 241

Query: 823 QMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
                  I ++C  +  + RP   E++     +
Sbjct: 242 ----VYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 8e-42
 Identities = 56/279 (20%), Positives = 107/279 (38%), Gaps = 34/279 (12%)

Query: 590 GNGGPFGRVY------ILSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKIRHKNIVK 642
           G G  FG VY      ++       +A+K +      +       E   + +    ++V+
Sbjct: 29  GQGS-FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 87

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQD---------FQLQWSIRLKIAIGVAQGLA 693
           +LG     +   +I E +  G L   +                  S  +++A  +A G+A
Sbjct: 88  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147

Query: 694 YLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP 753
           YL+       +HR++ ++N ++  DF  K+ DF + R + E  +            + +P
Sbjct: 148 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 754 EYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD 813
           E       T   D +SFGVVL E+ T  +     P + L   + +R           V++
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----PYQGLSNEQVLR----------FVME 250

Query: 814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKAL 852
             + +          E+   C    P+ RPS  E++ ++
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 6e-41
 Identities = 59/269 (21%), Positives = 110/269 (40%), Gaps = 29/269 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS--KTLKTEVKTLAKIRHKNIVKVLGF 646
           G G  F  VY  L   +   +A  +L +     S  +  K E + L  ++H NIV+    
Sbjct: 18  GRGS-FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76

Query: 647 FHS----DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           + S     + I L+ E +  G+L   + R    ++  +       + +GL +LH    P 
Sbjct: 77  WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR-TPP 134

Query: 703 LLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
           ++HR++K  NI +       K+ D  L  +   +  ++ + +      + APE  Y +K 
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FMAPEM-YEEKY 189

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
              +D Y+FG+ +LE+ T        P         + R+  +T+G       K+A    
Sbjct: 190 DESVDVYAFGMCMLEMATSEY-----PYSECQNAAQIYRR--VTSGVKPASFDKVAI--- 239

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                  EI   C     ++R S+ +++ 
Sbjct: 240 ---PEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 3e-40
 Identities = 62/305 (20%), Positives = 121/305 (39%), Gaps = 42/305 (13%)

Query: 590 GNGGPFGRVYILSLPSGEL---IAVKKLVNFGCQSS-KTLKTEVKTLAKI-RHKNIVKVL 644
           G G  FG+V    +    L    A+K++  +  +   +    E++ L K+  H NI+ +L
Sbjct: 19  GEGN-FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 77

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQ---------------LQWSIRLKIAIGVA 689
           G       ++L  E+   G+L D + +                   L     L  A  VA
Sbjct: 78  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137

Query: 690 QGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSC 749
           +G+ YL +      +HR++ ++NIL+  ++  K+ DF L R       ++          
Sbjct: 138 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 191

Query: 750 YNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI 809
           + A E       T   D +S+GV+L E+++        P   +   +   +   +  G  
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCAELYEK---LPQG-- 242

Query: 810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHS-LSTRTSLLSIELSS 868
                K  NC  +      ++  +C    P +RPS  +++ +L+  L  R + ++  L  
Sbjct: 243 -YRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 297

Query: 869 SQEHS 873
              ++
Sbjct: 298 KFTYA 302

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-39
 Identities = 50/271 (18%), Positives = 99/271 (36%), Gaps = 25/271 (9%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS---KTLKTEVKTLAKIRHKNIVKVLG 645
           G G  F  V +   L +    A+K L             +  E   ++++ H   VK+  
Sbjct: 17  GEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F  DE ++    + + G L   I +       +        +   L YLH      ++H
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHG---KGIIH 131

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K +NILL+ D   ++TDF   +++   + Q+  +S    + Y +PE    K A    
Sbjct: 132 RDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS 191

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D ++ G ++ +L+ G    +A     +           I        +      +  +  
Sbjct: 192 DLWALGCIIYQLVAGLPPFRAGNEYLI--------FQKIIKL-----EYDFPEKFFPK-- 236

Query: 826 GALEIALRCTSVMPEKRPSMFEVVKALHSLS 856
            A ++  +   +   KR    E+       +
Sbjct: 237 -ARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (367), Expect = 3e-39
 Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 19/263 (7%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G  F  V +     + +L+A+K +     +    +++ E+  L KI+H NIV +   +
Sbjct: 18  GTGA-FSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
            S   ++LI + +  G L D I  + F        ++   V   + YLH   + H   + 
Sbjct: 77  ESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 135

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
                  LD D +  ++DF L ++       S +S+      Y APE    K  +  +D 
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDC 192

Query: 768 YSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGA 827
           +S GV+   L+ G       P    +  K   +   I     +   P   +        A
Sbjct: 193 WSIGVIAYILLCGYP-----PFYDENDAKLFEQ---ILKAEYEFDSPYWDDISDS----A 240

Query: 828 LEIALRCTSVMPEKRPSMFEVVK 850
            +         PEKR +  + ++
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-39
 Identities = 52/264 (19%), Positives = 97/264 (36%), Gaps = 23/264 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  FG V+  +   S +    K  V         +K E+  L   RH+NI+ +   F 
Sbjct: 14  GRGE-FGIVHRCVETSSKKTYMAKF-VKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           S E + +I+EF+    + + I    F+L     +     V + L +LH     ++ H ++
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDI 128

Query: 709 KSKNILLDADFEP--KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           + +NI+         K+ +F   R +            +    Y APE       +   D
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLK---PGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 767 AYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
            +S G ++  L++G     AE  + +          NI N      +        +    
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQQI--------IENIMNAEYTFDEEAFKEISIE---- 233

Query: 827 ALEIALRCTSVMPEKRPSMFEVVK 850
           A++   R      + R +  E ++
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQ 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 43/296 (14%)

Query: 590 GNGGPFGRVYI--------LSLPSGELIAVKKL-VNFGCQSSKTLKTEVKTLAKI-RHKN 639
           G G  FG+V +                +AVK L  +   +    L +E++ +  I +HKN
Sbjct: 22  GEGA-FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLI---------------CRQDFQLQWSIRLKI 684
           I+ +LG    D  +++I E+   G+L + +                  + QL     +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 140

Query: 685 AIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE 744
           A  VA+G+ YL        +HR++ ++N+L+  D   K+ DF L R +    +    ++ 
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI 804
                + APE  + +  T Q D +SFGV+L E+ T   +    P   + V +  +    +
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEELFKL---L 250

Query: 805 TNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS 860
             G          N           +   C   +P +RP+  ++V+ L  +   TS
Sbjct: 251 KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 299

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 9e-38
 Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 41/290 (14%)

Query: 590 GNGGPFGRVY------ILSLPSGELIAVKKLVNFGCQSS-KTLKTEVKTLAKIRHKNIVK 642
           G G  FG+V       I    +   +AVK L      S  + L +E+K L  I H   V 
Sbjct: 22  GRGA-FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80

Query: 643 VLG--FFHSDESIFLIYEFLQMGSLGDLICRQDFQ---------------LQWSIRLKIA 685
            L          + +I EF + G+L   +  +  +               L     +  +
Sbjct: 81  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140

Query: 686 IGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY 745
             VA+G+ +L        +HR++ ++NILL      K+ DF L R + +           
Sbjct: 141 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 197

Query: 746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT 805
               + APE  + +  T Q D +SFGV+L E+ +   +    P   + + +   R++   
Sbjct: 198 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----PYPGVKIDEEFCRRLK-- 251

Query: 806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL 855
               +    +  +    +M    +  L C    P +RP+  E+V+ L +L
Sbjct: 252 ----EGTRMRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (351), Expect = 2e-37
 Identities = 64/279 (22%), Positives = 110/279 (39%), Gaps = 39/279 (13%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS---------KTLKTEVKTLAKIR-HK 638
           G G     V   +  P+ +  AVK +   G  S          +    EV  L K+  H 
Sbjct: 12  GRGV-SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70

Query: 639 NIVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
           NI+++   + ++   FL+++ ++ G L D +  +   L      KI   + + +  LHK 
Sbjct: 71  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHK- 128

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST-------MSSEYALSCYN 751
              +++HR++K +NILLD D   KLTDF     +               ++ E      N
Sbjct: 129 --LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN 186

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV 811
               GY K+     D +S GV++  L+ G       P      +  +R    I +G  Q 
Sbjct: 187 DNHPGYGKEV----DMWSTGVIMYTLLAGSP-----PFWHRKQMLMLRM---IMSGNYQF 234

Query: 812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
             P+  +          ++  R   V P+KR +  E + 
Sbjct: 235 GSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  135 bits (340), Expect = 6e-36
 Identities = 54/273 (19%), Positives = 104/273 (38%), Gaps = 27/273 (9%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G GG    V++   L     +AVK L   +          + E +  A + H  IV V  
Sbjct: 16  GFGG-MSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 74

Query: 646 FFHSDES----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
              ++       +++ E++   +L D++  +   +     +++     Q L + H+    
Sbjct: 75  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ---N 130

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-CYNAPEYGYSKK 760
            ++HR+VK  NI++ A    K+ DF + R + ++    T ++    +  Y +PE      
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 761 ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY 820
             A+ D YS G VL E++TG       P      V    + +             ++   
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEP-----PFTGDSPVSVAYQHVREDPIPPSARHEGLSA-- 243

Query: 821 QQQMLGALEIALRCTSVMPEKRP-SMFEVVKAL 852
                    + L+  +  PE R  +  E+   L
Sbjct: 244 -----DLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 53/272 (19%), Positives = 105/272 (38%), Gaps = 31/272 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS------KTLKTEVKTLAKIRHKNIVK 642
           G+G  F  V       +G   A K +     +SS      + ++ EV  L +I+H N++ 
Sbjct: 19  GSGQ-FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           +   + +   + LI E +  G L D +  ++  L      +    +  G+ YLH      
Sbjct: 78  LHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHS---LQ 133

Query: 703 LLHRNVKSKNILLDADFEP----KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYS 758
           + H ++K +NI+L     P    K+ DF L   +      +   + +    + APE    
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNY 190

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
           +    + D +S GV+   L++G      +  +            N++    +  D   +N
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------LANVSAVNYEFEDEYFSN 242

Query: 819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                   A +   R     P+KR ++ + ++
Sbjct: 243 TSAL----AKDFIRRLLVKDPKKRMTIQDSLQ 270

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-34
 Identities = 53/271 (19%), Positives = 109/271 (40%), Gaps = 30/271 (11%)

Query: 590 GNGGPFGRVY-ILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFF 647
           G G   G+V  I +  + E  A+K L     Q     + EV+   +  +  +IV+++  +
Sbjct: 21  GLGI-NGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 648 HS----DESIFLIYEFLQMGSLGDLICRQDFQ-LQWSIRLKIAIGVAQGLAYLHKDYVPH 702
            +     + + ++ E L  G L   I  +  Q        +I   + + + YLH     +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---IN 131

Query: 703 LLHRNVKSKNILLDADFEP---KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSK 759
           + HR+VK +N+L  +       KLTDF   +        +++++      Y APE    +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPE 188

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC 819
           K     D +S GV++  L+ G     +     L +   ++ +I    G  +  +P+ +  
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSN--HGLAISPGMKTRIR--MGQYEFPNPEWSEV 244

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
            ++       +        P +R ++ E + 
Sbjct: 245 SEE----VKMLIRNLLKTEPTQRMTITEFMN 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (333), Expect = 4e-34
 Identities = 43/266 (16%), Positives = 91/266 (34%), Gaps = 30/266 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSS------KTLKTEVKTLAKIRHKNIVK 642
           G GG FG VY      +G++ A+K L     +           +  +  ++      IV 
Sbjct: 13  GRGG-FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 71

Query: 643 VLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH 702
           +   FH+ + +  I + +  G L   + +     +  +R   A  +  GL ++H      
Sbjct: 72  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR-FYAAEIILGLEHMHN---RF 127

Query: 703 LLHRNVKSKNILLDADFEPKLTDFALDRIVGEA-AFQSTMSSEYALSCYNAPEYGYSKKA 761
           +++R++K  NILLD     +++D  L     +     S  +  Y           Y   A
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSA 187

Query: 762 TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ 821
               D +S G +L +L+ G    +    +    +  +   +            ++ + + 
Sbjct: 188 ----DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVELPDSFS 233

Query: 822 QQMLGALEIALRCTSVMPEKRPSMFE 847
            +      +          +R     
Sbjct: 234 PE---LRSLLEGLLQRDVNRRLGCLG 256

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  130 bits (327), Expect = 8e-34
 Identities = 59/262 (22%), Positives = 110/262 (41%), Gaps = 30/262 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL---VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLG 645
           G G  FGRV++  S  +G   A+K L   +    +  +    E   L+ + H  I+++ G
Sbjct: 13  GTGS-FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F   + IF+I ++++ G L  L+ +         +   A  V   L YLH      +++
Sbjct: 72  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHS---KDIIY 127

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K +NILLD +   K+TDF   + V +  +    + +Y      APE   +K     +
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI-----APEVVSTKPYNKSI 182

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +SFG+++ E++ G       P    + +K       I N  ++   P           
Sbjct: 183 DWWSFGILIYEMLAGYT-----PFYDSNTMKTYE---KILNAELR-FPPFFNE------- 226

Query: 826 GALEIALRCTSVMPEKRPSMFE 847
              ++  R  +    +R    +
Sbjct: 227 DVKDLLSRLITRDLSQRLGNLQ 248

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 37/280 (13%), Positives = 92/280 (32%), Gaps = 25/280 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  FG ++   +L + + +A+K         +  L+ E +T   +     +  + +F 
Sbjct: 14  GEGS-FGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
            +    ++   L   SL DL+     +         A  +   +  +H+     L++R++
Sbjct: 71  QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDI 127

Query: 709 KSKNILLDADFEP-----KLTDFALDRIVGEAAFQSTMSSEYALS-----CYNAPEYGYS 758
           K  N L+            + DF + +   +   +  +      +      Y +      
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG 187

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
           ++ + + D  + G V +  + G    Q   A +    K+ R      +  ++ L      
Sbjct: 188 REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEKKQSTPLRELCAGFPE 246

Query: 819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
            + +             ++  +  P    +      +  R
Sbjct: 247 EFYK-------YMHYARNLAFDATPDYDYLQGLFSKVLER 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 50/278 (17%), Positives = 96/278 (34%), Gaps = 23/278 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G+G  FG +Y+   + +GE +A+K            L  E K    ++    +  + +  
Sbjct: 16  GSGS-FGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 72

Query: 649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNV 708
           ++    ++   L   SL DL      +      L +A  +   + Y+H     + +HR+V
Sbjct: 73  AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDV 129

Query: 709 KSKNIL---LDADFEPKLTDFALDRIVGEAAFQSTMSSEYALS-----CYNAPEYGYSKK 760
           K  N L           + DF L +   +A     +      +      Y +       +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189

Query: 761 ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY 820
            + + D  S G VL+    G    Q   A +    K+ R      +  I+VL     + +
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR 858
                        C S+  + +P    + +   +L  R
Sbjct: 249 A-------TYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-33
 Identities = 57/267 (21%), Positives = 111/267 (41%), Gaps = 28/267 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAK-IRHKNIVKVL 644
           G G  FG+V++     + +  A+K L          ++    E + L+    H  +  + 
Sbjct: 11  GKGS-FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 69

Query: 645 GFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLL 704
             F + E++F + E+L  G L   I +   +   S     A  +  GL +LH      ++
Sbjct: 70  CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIILGLQFLHS---KGIV 125

Query: 705 HRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           +R++K  NILLD D   K+ DF + +        +  ++      Y APE    +K    
Sbjct: 126 YRDLKLDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHS 183

Query: 765 MDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           +D +SFGV+L E++ G+     +  E  ++   +R             +P      +++ 
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMD-----------NPFYPRWLEKE- 229

Query: 825 LGALEIALRCTSVMPEKRPSMFEVVKA 851
             A ++ ++     PEKR  +   ++ 
Sbjct: 230 --AKDLLVKLFVREPEKRLGVRGDIRQ 254

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 62/278 (22%), Positives = 107/278 (38%), Gaps = 23/278 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G G  +G VY   +  +GE++A+KK+           T   E+  L ++ H NIVK+L  
Sbjct: 11  GEGT-YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
            H++  ++L++EFL       +       +   +       + QGLA+ H   V   LHR
Sbjct: 70  IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LHR 126

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSKKATAQM 765
           ++K +N+L++ +   KL DF L R  G      T + E     Y APE     K  +  +
Sbjct: 127 DLKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAV 184

Query: 766 DAYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM 824
           D +S G +  E++T R     +   + L  +       +          P     + +  
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWA 244

Query: 825 LG------------ALEIALRCTSVMPEKRPSMFEVVK 850
                            +  +     P KR S    + 
Sbjct: 245 RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  125 bits (314), Expect = 2e-32
 Identities = 58/276 (21%), Positives = 106/276 (38%), Gaps = 21/276 (7%)

Query: 590 GNGGPFGRVYILSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G  +G VY      GE  A+KK+           T   E+  L +++H NIVK+    
Sbjct: 11  GEGT-YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69

Query: 648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRN 707
           H+ + + L++E L       L   +   L+        + +  G+AY H      +LHR+
Sbjct: 70  HTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHD---RRVLHRD 125

Query: 708 VKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDA 767
           +K +N+L++ + E K+ DF L R  G    +        L          SKK +  +D 
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184

Query: 768 YSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLG 826
           +S G +  E++ G         A+ L  +  +    N  N       PK    +      
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244

Query: 827 ------------ALEIALRCTSVMPEKRPSMFEVVK 850
                        +++  +   + P +R +  + ++
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-32
 Identities = 60/284 (21%), Positives = 108/284 (38%), Gaps = 29/284 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQS-SKTLKTEVKTLAKIRHKNIVKVLGFF 647
           G G  +G V       +   +A+KK+  F  Q+  +    E+K L + RH+NI+ +    
Sbjct: 17  GEGA-YGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 75

Query: 648 HSDESIFLIYEFLQMGSLG----DLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
            +     +   +L    +G     L+  Q   L           + +GL Y+H     ++
Sbjct: 76  RAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS---ANV 130

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEY-GYSKKA 761
           LHR++K  N+LL+   + K+ DF L R+       +   +EY A   Y APE    SK  
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 762 TAQMDAYSFGVVLLELITGR---------------QAEQAEPAESLDVVKWVRRKINITN 806
           T  +D +S G +L E+++ R                     P++         +  N   
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                        +      AL++  +  +  P KR  + + + 
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-32
 Identities = 59/284 (20%), Positives = 107/284 (37%), Gaps = 34/284 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSK-----TLKTEVKTLAKIRHKNIVKV 643
           G G  F  VY      + +++A+KK+       +K     T   E+K L ++ H NI+ +
Sbjct: 7   GEGQ-FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 644 LGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHL 703
           L  F    +I L+++F++      +I      L  S      +   QGL YLH+ ++   
Sbjct: 66  LDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI--- 121

Query: 704 LHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSKKAT 762
           LHR++K  N+LLD +   KL DF L +  G        + +     Y APE    ++   
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 763 AQMDAYSFGVVLLELITGRQAEQAE----------------PAESLDVVKWVRRKINITN 806
             +D ++ G +L EL+        +                  E    +  +   +   +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                L    +          L++        P  R +  + +K
Sbjct: 240 FPGIPLHHIFSAAGDD----LLDLIQGLFLFNPCARITATQALK 279

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 6e-31
 Identities = 52/284 (18%), Positives = 104/284 (36%), Gaps = 30/284 (10%)

Query: 590 GNGGPFGRVY--ILSLPSGELIAVKKLVNFGCQSSKTLKT-----EVKTLAKIRHKNIVK 642
           G G  +G+V+        G  +A+K++     +    L T      ++ L    H N+V+
Sbjct: 16  GEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74

Query: 643 VLGFFHSDES-----IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK 697
           +        +     + L++E +       L    +  +       +   + +GL +LH 
Sbjct: 75  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134

Query: 698 DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGY 757
                ++HR++K +NIL+ +  + KL DF L RI       +++        Y APE   
Sbjct: 135 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTL---WYRAPEVLL 188

Query: 758 SKKATAQMDAYSFGVVLLELITGRQAEQAE-PAESLDVVKWVRRKINITNGAIQVLDPKI 816
                  +D +S G +  E+   +   +     + L  +  V       +    V  P+ 
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248

Query: 817 ANCYQQQML----------GALEIALRCTSVMPEKRPSMFEVVK 850
           A   +                 ++ L+C +  P KR S +  + 
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 7e-31
 Identities = 51/272 (18%), Positives = 104/272 (38%), Gaps = 41/272 (15%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL------VNFGCQSSKTLKTEVKTLAKIR--HKNI 640
           G+GG FG VY  + +     +A+K +            +   +  EV  L K+      +
Sbjct: 13  GSGG-FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           +++L +F   +S  LI E  +          +   LQ  +       V + + + H    
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN--- 128

Query: 701 PHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEY-GYS 758
             +LHR++K +NIL+D +  E KL DF    ++ +  +     +      Y+ PE+  Y 
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV----YSPPEWIRYH 184

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
           +        +S G++L +++ G    + +                I  G +     ++++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRGQVF-FRQRVSS 229

Query: 819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                      +   C ++ P  RP+  E+  
Sbjct: 230 -------ECQHLIRWCLALRPSDRPTFEEIQN 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 6e-30
 Identities = 64/287 (22%), Positives = 120/287 (41%), Gaps = 39/287 (13%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G+G  +G V   +   +G  +A+KKL         +K    E++ L  +RH+N++ +L  
Sbjct: 27  GSGA-YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85

Query: 647 FHSDES------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           F  DE+       +L+  F  MG+    + + + +L       +   + +GL Y+H    
Sbjct: 86  FTPDETLDDFTDFYLVMPF--MGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHA--- 139

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSK 759
             ++HR++K  N+ ++ D E K+ DF L R        S M+       Y APE      
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-----SEMTGYVVTRWYRAPEVILNWM 194

Query: 760 KATAQMDAYSFGVVLLELITGR----------------QAEQAEPAESLDVVKWVRRKIN 803
           + T  +D +S G ++ E+ITG+                +     PAE +  ++    K N
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK-N 253

Query: 804 ITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
              G  ++     A+        A+ +  +   +  E+R +  E + 
Sbjct: 254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 49/278 (17%), Positives = 104/278 (37%), Gaps = 23/278 (8%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G G  +G V+   +  + E++A+K++   +       +   E+  L +++HKNIV++   
Sbjct: 11  GEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 647 FHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHR 706
            HSD+ + L++EF                    I       + +GL + H     ++LHR
Sbjct: 70  LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVLHR 125

Query: 707 NVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMD 766
           ++K +N+L++ + E KL +F L R  G      +      L          +K  +  +D
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVT-LWYRPPDVLFGAKLYSTSID 184

Query: 767 AYSFGVVLLELITGR--------------QAEQAEPAESLDVVKWVRRKINITNGAIQVL 812
            +S G +  EL                  +  +     + +    + +  +     +   
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
              + N   +      ++        P +R S  E ++
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 1e-29
 Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           GNG  FG VY      SGEL+A+KK++    Q  +    E++ + K+ H NIV++  FF+
Sbjct: 29  GNGS-FGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 649 SDES------IFLIYEFLQMGSLGDL--ICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           S         + L+ +++            R    L           + + LAY+H    
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 140

Query: 701 PHLLHRNVKSKNILLDAD-FEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAP-EYGYS 758
             + HR++K +N+LLD D    KL DF   + +          S      Y AP     +
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGA 197

Query: 759 KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN 818
              T+ +D +S G VL EL+ G+     +      +V+ ++     T   I+ ++P    
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREMNPNYTE 256

Query: 819 CYQQQMLG--------------ALEIALRCTSVMPEKRPSMFEVVK 850
               Q+                A+ +  R     P  R +  E   
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-28
 Identities = 58/295 (19%), Positives = 105/295 (35%), Gaps = 43/295 (14%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLV--NFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G G  FG V+      +G+ +A+KK++  N       T   E+K L  ++H+N+V ++  
Sbjct: 19  GQGT-FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77

Query: 647 FHSDES--------IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD 698
             +  S        I+L+++F +    G L      +   S   ++   +  GL Y+H+ 
Sbjct: 78  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHR- 135

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM-------SSEYALSCYN 751
               +LHR++K+ N+L+  D   KL DF L R    A             +  Y      
Sbjct: 136 --NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193

Query: 752 APEYGYSKKATAQMDAYSFGVVLLELITGR----------------QAEQAEPAESLDVV 795
             E  Y        D +  G ++ E+ T                  Q   +   E    V
Sbjct: 194 LGERDYGPPI----DLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNV 249

Query: 796 KWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
                   +     Q    K       +   AL++  +   + P +R    + + 
Sbjct: 250 DNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 4e-26
 Identities = 56/260 (21%), Positives = 98/260 (37%), Gaps = 27/260 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLK---TEVKTLAKIRHKNIVKVLG 645
           G G  FG+V +     +G   A+K L      +   +    TE + L   RH  +  +  
Sbjct: 14  GKGT-FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F + + +  + E+   G L   + R+    +   R      +   L YLH      +++
Sbjct: 73  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR-FYGAEIVSALEYLHS---RDVVY 128

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K +N++LD D   K+TDF L +        +TM +      Y APE          +
Sbjct: 129 RDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDNDYGRAV 186

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D +  GVV+ E++ GR     +  E L     +  +I         L P+          
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEEIRFPRT----LSPE---------- 231

Query: 826 GALEIALRCTSVMPEKRPSM 845
            A  +        P++R   
Sbjct: 232 -AKSLLAGLLKKDPKQRLGG 250

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 2e-25
 Identities = 54/266 (20%), Positives = 105/266 (39%), Gaps = 27/266 (10%)

Query: 590 GNGGPFGRVY----ILSLPSGELIAVKKL----VNFGCQSSKTLKTEVKTLAKIRHK-NI 640
           G G  +G+V+    I    +G+L A+K L    +    ++++  +TE + L  IR    +
Sbjct: 33  GTGA-YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91

Query: 641 VKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYV 700
           V +   F ++  + LI +++  G L   +  Q  +            +   L +LHK   
Sbjct: 92  VTLHYAFQTETKLHLILDYINGGELFTHL-SQRERFTEHEVQIYVGEIVLALEHLHK--- 147

Query: 701 PHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPE-YGYSK 759
             +++R++K +NILLD++    LTDF L +       +        +         G   
Sbjct: 148 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDS 207

Query: 760 KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC 819
                +D +S GV++ EL+TG      +  ++         +  I+   ++   P     
Sbjct: 208 GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--------QAEISRRILKSEPPYPQEM 259

Query: 820 YQQQMLGALEIALRCTSVMPEKRPSM 845
                  A ++  R     P+KR   
Sbjct: 260 SAL----AKDLIQRLLMKDPKKRLGC 281

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 47/258 (18%), Positives = 96/258 (37%), Gaps = 30/258 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKT---EVKTLAKIRHKNIVKVLG 645
           G G  FGRV +     SG   A+K L        K ++    E + L  +    +VK+  
Sbjct: 50  GTGS-FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108

Query: 646 FFHSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
            F  + +++++ E++  G +   + R   +         A  +     YLH      L++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHS---LDLIY 164

Query: 706 RNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQM 765
           R++K +N+L+D     ++TDF   +       +    +        APE   SK     +
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYNKAV 219

Query: 766 DAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML 825
           D ++ GV++ E+  G     A+  + + + + +                +  + +     
Sbjct: 220 DWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG-----------KVRFPSHFSSD-- 264

Query: 826 GALEIALRCTSVMPEKRP 843
              ++      V   KR 
Sbjct: 265 -LKDLLRNLLQVDLTKRF 281

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 5e-25
 Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 33/284 (11%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKL--VNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGF 646
           G+G  +G V       +G  +AVKKL         +K    E++ L  ++H+N++ +L  
Sbjct: 27  GSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85

Query: 647 FHSDESI-----FLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVP 701
           F    S+       +   L    L +++  Q  +L       +   + +GL Y+H     
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHS---A 140

Query: 702 HLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKA 761
            ++HR++K  N+ ++ D E K+ DF L R   +       +  Y                
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY----RAPEIMLNWMHY 196

Query: 762 TAQMDAYSFGVVLLELITGR-------QAEQAE--------PAESLDVVKWVRRKINITN 806
              +D +S G ++ EL+TGR         +Q +        P   L          N   
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256

Query: 807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK 850
              Q+     AN +      A+++  +   +  +KR +  + + 
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  102 bits (254), Expect = 3e-24
 Identities = 78/299 (26%), Positives = 119/299 (39%), Gaps = 27/299 (9%)

Query: 218 FHGVIPDSFVGLQSLSILDLSQNNLTG--EVPQSLGSSLLKLVSFDVSQN-KLSGSFPNG 274
           + GV+ D+      ++ LDLS  NL     +P SL + L  L    +     L G  P  
Sbjct: 38  WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPA 96

Query: 275 ICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRA 334
           I K   L  L +     +G+IP  +++   L       N  SG  P  + SLP +  I  
Sbjct: 97  IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156

Query: 335 ESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN 394
           + NR SGAIPDS    ++L      +    +       +  +L     S+N   G     
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216

Query: 395 FCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLS 454
           F        I+L++NS++  + ++   + L  L L +N + G +P  L +L  L  L++S
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS 276

Query: 455 DNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSC 513
            NNL G IPQG                        +     S    N  LCG  L  +C
Sbjct: 277 FNNLCGEIPQGGN----------------------LQRFDVSAYANNKCLCGSPLP-AC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 98.3 bits (243), Expect = 6e-23
 Identities = 74/311 (23%), Positives = 118/311 (37%), Gaps = 67/311 (21%)

Query: 29  TEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLS 88
            +K  LL  K  + +   +LS+W  T++     W GV C  T T +  V +++L  LNL 
Sbjct: 6   QDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLC-DTDTQTYRVNNLDLSGLNLP 63

Query: 89  G--EISSSVCELSSLSNLNLADNL-FNQPIPLHLSQCSSLETLNLSNNLIWV-------- 137
               I SS+  L  L+ L +        PIP  +++ + L  L +++  +          
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 138 ------LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
                 LD S N + G +P SI SL NL  +    N +SG++P  +G+FS+L        
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 192 AYLISEIPSDIGKLEKLEQLF--------------------------------------- 212
             L  +IP     L                                              
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243

Query: 213 -------LQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQN 265
                  L+++  +G +P     L+ L  L++S NNL GE+PQ  G +L +      + N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANN 301

Query: 266 KLSGSFPNGIC 276
           K     P   C
Sbjct: 302 KCLCGSPLPAC 312

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (252), Expect = 6e-24
 Identities = 46/288 (15%), Positives = 95/288 (32%), Gaps = 40/288 (13%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFF 647
           G G  +  V+  +++ + E + VK L        K +K E+K L  +R   NI+ +    
Sbjct: 44  GRGK-YSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIV 99

Query: 648 HSDES--IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLH 705
               S    L++E +       L       L           + + L Y H      ++H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHS---MGIMH 152

Query: 706 RNVKSKNILLDADF-EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQ 764
           R+VK  N+++D +  + +L D+ L         Q       +            +     
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYS 210

Query: 765 MDAYSFGVVLLELITGR--------QAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI 816
           +D +S G +L  +I  +          +Q      +   + +   I+  N  +      I
Sbjct: 211 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 270

Query: 817 ANCYQQQMLG--------------ALEIALRCTSVMPEKRPSMFEVVK 850
              + ++                 AL+   +      + R +  E ++
Sbjct: 271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 96.2 bits (238), Expect = 8e-22
 Identities = 60/385 (15%), Positives = 126/385 (32%), Gaps = 41/385 (10%)

Query: 98  LSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLV 157
           L+      L        +    +    + TL      I         I+G     +  L 
Sbjct: 21  LAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI-------KSIDG-----VEYLN 66

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG 217
           NL  +N  +N L+   P    N ++LV + ++ N        +++  L  L     Q + 
Sbjct: 67  NLTQINFSNNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITD 124

Query: 218 FHGVIPDSFVGLQ-----SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFP 272
              +   + +        ++S +       + +               +++  +      
Sbjct: 125 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS 184

Query: 273 NGICKANGLVN------LSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSL 326
           N +   + L        L    N  +   P  I    NL+   +  N         L SL
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASL 240

Query: 327 PRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS 386
             +  +   +N+ S   P  +S   +L ++++  N+ ++  P    +  +    + +Q  
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298

Query: 387 FYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELP 446
                     +   ++ + L  N+IS   P +    KL  L  A+N ++     SLA L 
Sbjct: 299 DI----SPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLT 351

Query: 447 VLTYLDLSDNNLTGPIP-QGLQNLK 470
            + +L    N ++   P   L  + 
Sbjct: 352 NINWLSAGHNQISDLTPLANLTRIT 376

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.5 bits (192), Expect = 5e-16
 Identities = 63/383 (16%), Positives = 123/383 (32%), Gaps = 51/383 (13%)

Query: 81  NLQSLNLSG-EISS--SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV 137
            + +L      I S   V  L++L+ +N ++N      P  L   + L  + ++NN I  
Sbjct: 45  QVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
           +          +         +  ++   NL + +   +  N    +       +     
Sbjct: 103 IT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLS 160

Query: 198 IPSDIGKLEKLEQLFLQSSGF----HGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSS 253
             + +  L+ L  L                     L +L  L  + N ++   P  + ++
Sbjct: 161 FGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTN 220

Query: 254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDN 313
           L +L    ++ N+L       +     L +L L  N  +   P  ++    L   ++  N
Sbjct: 221 LDEL---SLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 273

Query: 314 GFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS 373
             S   P  L  L  +  +    N+     P S      L  + +  N  +   P  + S
Sbjct: 274 QISNISP--LAGLTALTNLELNENQLEDISPISNLK--NLTYLTLYFNNISDISP--VSS 327

Query: 374 VKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNS 433
           +  L R                        +  + N +S  +  L     +  LS   N 
Sbjct: 328 LTKLQR------------------------LFFANNKVSD-VSSLANLTNINWLSAGHNQ 362

Query: 434 LTGEIPPSLAELPVLTYLDLSDN 456
           ++   P  LA L  +T L L+D 
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 66.2 bits (160), Expect = 5e-12
 Identities = 29/125 (23%), Positives = 46/125 (36%), Gaps = 17/125 (13%)

Query: 81  NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPI-PLHLSQCSSLETLNLSNNLIW--- 136
            L  L L     S++  L+ L+ L   +   NQ      +S   +L  L L  N I    
Sbjct: 264 KLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 323

Query: 137 ---------VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLD 187
                     L  + N +      S+ +L N+  L+ G N +S   P    N + +  L 
Sbjct: 324 PVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 379

Query: 188 LSQNA 192
           L+  A
Sbjct: 380 LNDQA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 64.6 bits (156), Expect = 2e-11
 Identities = 67/395 (16%), Positives = 128/395 (32%), Gaps = 69/395 (17%)

Query: 164 LGSNLLSGSVP----FVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFH 219
           LGS  ++   P    F     +E +   L +    +++  S    L+++  L     G  
Sbjct: 1   LGSATITQDTPINQIFTDTALAEKMKTVLGKTN--VTDTVS-QTDLDQVTTLQADRLGIK 57

Query: 220 GVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVS------------FDVSQNKL 267
            +  D    L +L+ ++ S N LT   P    + L+ ++                +   L
Sbjct: 58  SI--DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL 115

Query: 268 SGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLP 327
           +                +L++   + +    I+    L   Q    G        L +L 
Sbjct: 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT 175

Query: 328 RIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF 387
            ++ +   SN+ S     +      LE +   NN+ +   P G+ +  +L   S + N  
Sbjct: 176 TLERLDISSNKVSDISVLAKLT--NLESLIATNNQISDITPLGILT--NLDELSLNGNQL 231

Query: 388 YGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIP-------- 439
                        ++ ++L+ N IS   P L    KL  L L  N ++   P        
Sbjct: 232 KD--IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISPLAGLTALT 288

Query: 440 ------------PSLAELPVLTYLDLSDNNLTGPIP-QGLQNLK---------------- 470
                         ++ L  LTYL L  NN++   P   L  L+                
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLA 348

Query: 471 ----LALFNVSFNKLSGRVPYSLISGLPASYLQGN 501
               +   +   N++S   P + ++ +    L   
Sbjct: 349 NLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.0 bits (235), Expect = 1e-21
 Identities = 46/225 (20%), Positives = 86/225 (38%), Gaps = 24/225 (10%)

Query: 569 FYPLRVTEHDLVIGMDE---KSSAGNGGPFGRVYI-LSLPSGELIAVKKL--VNFGCQSS 622
           FY + V +    + +         G+G   G V           +A+KKL         +
Sbjct: 3   FYSVEVGDSTFTV-LKRYQNLKPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 623 KTLKTEVKTLAKIRHKNIVKVLGFFHSDES------IFLIYEFLQMGSLGDLICRQDFQL 676
           K    E+  +  + HKNI+ +L  F   ++      ++L+ E +       +    D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--- 117

Query: 677 QWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA 736
                  +   +  G+ +LH      ++HR++K  NI++ +D   K+ DF L R  G   
Sbjct: 118 -HERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-- 171

Query: 737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR 781
               M+       Y APE          +D +S G ++ E++  +
Sbjct: 172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.2 bits (217), Expect = 1e-19
 Identities = 46/271 (16%), Positives = 98/271 (36%), Gaps = 13/271 (4%)

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           + ++P D+        L LQ++    +    F  L++L  L L  N ++   P +    L
Sbjct: 22  LEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP-L 78

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG 314
           +KL    +S+N+L             L            S+   +N+ + +E        
Sbjct: 79  VKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LK 137

Query: 315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV 374
            SG        + ++  IR      +  IP  +     L ++ +D N+ T      L  +
Sbjct: 138 SSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGL 194

Query: 375 KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSL 434
            +L +   S NS       +  ++P +  ++L+ N +      L   + +  + L +N++
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254

Query: 435 TG------EIPPSLAELPVLTYLDLSDNNLT 459
           +         P    +    + + L  N + 
Sbjct: 255 SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.3 bits (194), Expect = 1e-16
 Identities = 56/266 (21%), Positives = 95/266 (35%), Gaps = 38/266 (14%)

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDL 188
           +L  +   +LDL  N I         +L NL  L L +N +S   P  F    +L  L L
Sbjct: 28  DLPPDTA-LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86

Query: 189 SQNAYLISEIPSDIG------------------------KLEKLEQLFLQSSGFHGVIPD 224
           S+N   + E+P  +                             + +L        G+   
Sbjct: 87  SKN--QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 144

Query: 225 SFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNL 284
           +F G++ LS + ++  N+T  +PQ L  SL +L    +  NK++      +   N L  L
Sbjct: 145 AFQGMKKLSYIRIADTNIT-TIPQGLPPSLTEL---HLDGNKITKVDAASLKGLNNLAKL 200

Query: 285 SLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG--- 341
            L  N  +    GS+    +L    + +N      P  L     I+++   +N  S    
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259

Query: 342 ---AIPDSISMAAQLEQVQIDNNRFT 364
                P   +  A    V + +N   
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.9 bits (180), Expect = 8e-15
 Identities = 56/279 (20%), Positives = 97/279 (34%), Gaps = 31/279 (11%)

Query: 60  CNWTGVTCVTTATASL------TVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQ 113
           C+   V C       +        A ++LQ+  ++         L +L  L L +N  ++
Sbjct: 10  CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69

Query: 114 PIPLHLSQCSSLETLNLSNNLI-----------WVLDLSRNHIEGKIPESIGSLVNLQVL 162
             P   +    LE L LS N +             L +  N I          L  + V+
Sbjct: 70  ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129

Query: 163 NLGS--NLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHG 220
            LG+     SG     F    +L  + ++     I+ IP  +     L +L L  +    
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTN--ITTIPQGL--PPSLTELHLDGNKITK 185

Query: 221 VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG 280
           V   S  GL +L+ L LS N+++        ++   L    ++ NKL    P G+     
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAV-DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243

Query: 281 LVNLSLHKNFFNG------SIPGSINECLNLERFQVQDN 313
           +  + LH N  +         PG   +  +     +  N
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 62.7 bits (151), Expect = 4e-11
 Identities = 31/176 (17%), Positives = 65/176 (36%), Gaps = 5/176 (2%)

Query: 294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL 353
            +P  +    +     +Q+N  +        +L  +  +   +N+ S   P + +   +L
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 354 EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG 413
           E++ +  N+      +   +++ L            S+        V+ +      S   
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 414 QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL 469
           +    +  +KL  + +AD ++T  IP  L   P LT L L  N +T      L+ L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGL 194

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.1 bits (126), Expect = 5e-08
 Identities = 24/163 (14%), Positives = 53/163 (32%), Gaps = 2/163 (1%)

Query: 327 PRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS 386
           P   L+  ++N+ +            L  + + NN+ +   P     +  L R   S+N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 387 FYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELP 446
                         + +       +   +        +V L       +G    +   + 
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150

Query: 447 VLTYLDLSDNNLTGPIPQGLQNLKLALFNVSFNKLSGRVPYSL 489
            L+Y+ ++D N+T        +L     ++  NK++     SL
Sbjct: 151 KLSYIRIADTNITTIPQGLPPSLT--ELHLDGNKITKVDAASL 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 42.7 bits (99), Expect = 1e-04
 Identities = 34/207 (16%), Positives = 60/207 (28%), Gaps = 24/207 (11%)

Query: 40  SIDDSKNSLSTWSNTSNIHYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELS 99
            +  S  +         +             A   +   S    +      I   +    
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PP 171

Query: 100 SLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNL 159
           SL+ L+L  N   +     L   ++L  L LS N I  +D         + E   +   L
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231

Query: 160 QVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSD-------IGKLEKLEQLF 212
                        VP    +   + V+ L  N   IS I S+         K      + 
Sbjct: 232 VK-----------VPGGLADHKYIQVVYLHNNN--ISAIGSNDFCPPGYNTKKASYSGVS 278

Query: 213 LQSS--GFHGVIPDSFVGLQSLSILDL 237
           L S+   +  + P +F  +   + + L
Sbjct: 279 LFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.9 bits (219), Expect = 2e-19
 Identities = 34/209 (16%), Positives = 78/209 (37%), Gaps = 21/209 (10%)

Query: 590 GNGGPFGRVYI-LSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH 648
           G G  F  V++   + +   +A+K +       ++  + E+K L ++   +  K      
Sbjct: 22  GWGH-FSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 649 ---------------SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLA 693
                          +   + +++E L    L  +   +   +      +I+  +  GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 694 YLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNA 752
           Y+H+     ++H ++K +N+L++  D    L    +  +     +    ++      Y +
Sbjct: 140 YMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 753 PEYGYSKKATAQMDAYSFGVVLLELITGR 781
           PE           D +S   ++ ELITG 
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (212), Expect = 4e-19
 Identities = 46/266 (17%), Positives = 79/266 (29%), Gaps = 5/266 (1%)

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           +  +P  I      +++FL  +    V   SF   ++L+IL L  N L      +     
Sbjct: 23  LQAVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG 314
           L          +L    P        L  L L +       PG       L+   +QDN 
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV 374
                 D    L  +  +    NR S     +      L+++ +  NR     P     +
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 375 KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSL 434
             L       N+              +  + L+ N              L     + + +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 435 TGEIPPSLAELPVLTYLDLSDNNLTG 460
              +P  LA   +     L+ N+L G
Sbjct: 261 PCSLPQRLAGRDL---KRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.5 bits (181), Expect = 5e-15
 Identities = 60/279 (21%), Positives = 97/279 (34%), Gaps = 29/279 (10%)

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
              + L  N I      S  +  NL +L L SN+L+      F   + L  LDLS NA L
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
            S  P+    L +L  L L   G   + P  F GL +L  L L  N L      +     
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF---- 149

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG 314
                                     L +L LH N  +     +     +L+R  +  N 
Sbjct: 150 ---------------------RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR 188

Query: 315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV 374
            +   P     L R+  +   +N  S    ++++    L+ +++++N +           
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLW 247

Query: 375 KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG 413
             L +F  S +    SLP          +  L+ N + G
Sbjct: 248 AWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 53/277 (19%), Positives = 93/277 (33%), Gaps = 10/277 (3%)

Query: 230 QSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
           +        Q  L   VP  + ++  ++    +  N++S            L  L LH N
Sbjct: 11  EPKVTTSCPQQGLQ-AVPVGIPAASQRI---FLHGNRISHVPAASFRACRNLTILWLHSN 66

Query: 290 FFNGSIPGSINECLNLERFQVQDNGFSGD-FPDKLWSLPRIKLIRAESNRFSGAIPDSIS 348
                   +      LE+  + DN       P     L R+  +  +        P    
Sbjct: 67  VLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR 126

Query: 349 MAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQ 408
             A L+ + + +N   +        + +L       N         F     +  + L Q
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186

Query: 409 NSISGQIPE-LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQ 467
           N ++   P   +   +L++L L  N+L+     +LA L  L YL L+DN           
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246

Query: 468 NLKLALFNVSFNKLSGRVPYSL----ISGLPASYLQG 500
              L  F  S +++   +P  L    +  L A+ LQG
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.0 bits (128), Expect = 2e-08
 Identities = 39/194 (20%), Positives = 60/194 (30%), Gaps = 21/194 (10%)

Query: 81  NLQSLNLSGE-----ISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLI 135
            L +L+L               L++L  L L DN              +L          
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL---------- 155

Query: 136 WVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLI 195
             L L  N I      +   L +L  L L  N ++   P  F +   L+ L L  N    
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLL 255
                 +  L  L+ L L  + +      +      L     S + +   +PQ L    L
Sbjct: 216 LPTE-ALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDL 273

Query: 256 KLVSFDVSQNKLSG 269
           K     ++ N L G
Sbjct: 274 K----RLAANDLQG 283

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 68.7 bits (167), Expect = 7e-14
 Identities = 29/199 (14%), Positives = 60/199 (30%), Gaps = 28/199 (14%)

Query: 590 GNGGPFGRVYILSLPSGELIAVK----------KLVNFGCQSSKTLKTEVKTLAKIRHKN 639
           G G     V+           VK          K+                  A+   + 
Sbjct: 9   GEGK-ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 640 IVKVLGFFHSDESIFLIYEFLQMGSLGDLICRQDFQLQW-SIRLKIAIGVAQGLAYLHKD 698
           + K+ G       +  +Y +     L +LI  ++          ++   + + +A  +  
Sbjct: 68  LQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121

Query: 699 YVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY-ALSCYNAPEYGY 757
               ++H ++   N+L+  +    + DF     VGE         E       N   Y +
Sbjct: 122 --RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE-----EGWREILERDVRNIITY-F 172

Query: 758 SKKATAQMDAYSFGVVLLE 776
           S+    + D  S    +L+
Sbjct: 173 SRTYRTEKDINSAIDRILQ 191

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.5 bits (142), Expect = 7e-10
 Identities = 49/326 (15%), Positives = 91/326 (27%), Gaps = 26/326 (7%)

Query: 158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSG 217
               L L +  LS S+P +  +   L  L  S N+  ++E+P     L+ L         
Sbjct: 39  QAHELELNNLGLS-SLPELPPH---LESLVASCNS--LTELPELPQSLKSLLVDNNNLKA 92

Query: 218 FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICK 277
              + P          +L+    +           +   L   DV  N L          
Sbjct: 93  LSDLPP----------LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142

Query: 278 ANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN 337
                  +  +          +           +           +     ++ +    N
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202

Query: 338 RFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCD 397
                   + +   +       +    +     L  +  L +     +            
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262

Query: 398 SPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNN 457
            P +  +N S N I            L  L++++N L  E+P      P L  L  S N+
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPS---LEELNVSNNKLI-ELPALP---PRLERLIASFNH 315

Query: 458 LTGPIPQGLQNLKLALFNVSFNKLSG 483
           L   +P+  QNLK    +V +N L  
Sbjct: 316 LAE-VPELPQNLK--QLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 6e-07
 Identities = 25/100 (25%), Positives = 36/100 (36%), Gaps = 20/100 (20%)

Query: 109 NLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNL 168
           N  +  I        SLE LN+SNN +            ++P        L+ L    N 
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-----------IELPALPP---RLERLIASFNH 315

Query: 169 LSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKL 208
           L+  VP +  N   L  L +  N   + E P     +E L
Sbjct: 316 LA-EVPELPQN---LKQLHVEYNP--LREFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 7e-06
 Identities = 14/84 (16%), Positives = 34/84 (40%), Gaps = 16/84 (19%)

Query: 81  NLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLD 139
           +L+ LN+S  ++         L  L  + N   + +P       +L+ L++  N +    
Sbjct: 285 SLEELNVSNNKLIELPALPPRLERLIASFNHLAE-VP---ELPQNLKQLHVEYNPL---- 336

Query: 140 LSRNHIEGKIPESIGSLVNLQVLN 163
                   + P+   S+ +L++ +
Sbjct: 337 -------REFPDIPESVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.0 bits (107), Expect = 1e-05
 Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 11/88 (12%)

Query: 167 NLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSF 226
           N  S  +  +      L  L++S N   + E+P+   +LE+L       +     +P+  
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNK--LIELPALPPRLERL---IASFNHL-AEVPEL- 322

Query: 227 VGLQSLSILDLSQNNLTG--EVPQSLGS 252
              Q+L  L +  N L    ++P+S+  
Sbjct: 323 --PQNLKQLHVEYNPLREFPDIPESVED 348

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 56/331 (16%), Positives = 97/331 (29%), Gaps = 46/331 (13%)

Query: 183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNL 242
              L+L+     +S +P     LE L                             S N+L
Sbjct: 40  AHELELNNLG--LSSLPELPPHLESL---------------------------VASCNSL 70

Query: 243 TGEVPQSLGS------SLLKLVSFDVSQNKLSGSFPNGICKA--NGLVNLSLHKNFFNGS 294
           T E+P+   S          L +       L     +         L N S  K     +
Sbjct: 71  T-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDN 129

Query: 295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLE 354
                   L      +       +   +L +LP +  I A++N         +S+ + + 
Sbjct: 130 NSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVA 189

Query: 355 QVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQ 414
              I            L ++ +      +      SL         ++ +     S++  
Sbjct: 190 GNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFL 249

Query: 415 IPELKKCRKLVSLS---LADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKL 471
                    L  L       N+ + EI       P L  L++S+N L   +P     L+ 
Sbjct: 250 DVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE- 307

Query: 472 ALFNVSFNKLSGRVPYSLISGLPASYLQGNP 502
                SFN L+  VP  L   L   +++ NP
Sbjct: 308 -RLIASFNHLA-EVP-ELPQNLKQLHVEYNP 335

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 21/71 (29%), Positives = 31/71 (43%), Gaps = 9/71 (12%)

Query: 415 IPELKKC--RKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNLKLA 472
           +  L+ C  R+   L L +  L+  +P      P L  L  S N+LT  +P+  Q+LK  
Sbjct: 29  VSRLRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLK-- 81

Query: 473 LFNVSFNKLSG 483
              V  N L  
Sbjct: 82  SLLVDNNNLKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 18/94 (19%), Positives = 26/94 (27%), Gaps = 10/94 (10%)

Query: 212 FLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSF 271
               +     I        SL  L++S N L       L +   +L     S N L+   
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHLA-EV 319

Query: 272 PNGICKANGLVNLSLHKNFFNGSIPGSINECLNL 305
           P        L  L +  N      P       +L
Sbjct: 320 PELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.3 bits (130), Expect = 2e-09
 Identities = 27/126 (21%), Positives = 50/126 (39%), Gaps = 9/126 (7%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS 196
           VL L+   +   +   +  L+ +  L+L  N L    P      + L  L++ Q +    
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55

Query: 197 EIPSDIGKLEKLEQLFLQSSGFHGV-IPDSFVGLQSLSILDLSQNNLTGE--VPQSLGSS 253
           E    +  L +L++L L ++           V    L +L+L  N+L  E  + + L   
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 254 LLKLVS 259
           L  + S
Sbjct: 116 LPSVSS 121

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.6 bits (102), Expect = 1e-05
 Identities = 27/110 (24%), Positives = 37/110 (33%), Gaps = 6/110 (5%)

Query: 160 QVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFH 219
           +VL+L    L+  V         +  LDLS N   +  +P  +  L  LE L        
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHN--RLRALPPALAALRCLEVLQASD--NA 54

Query: 220 GVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG 269
               D    L  L  L L  N L          S  +LV  ++  N L  
Sbjct: 55  LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.2 bits (96), Expect = 6e-05
 Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 17/105 (16%)

Query: 83  QSLNLSGEISSSVCELSSLSN---LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIW--- 136
           + L+L+ +  + +C L  L     L+L+ N      P  L+    LE L  S+N +    
Sbjct: 1   RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 137 ---------VLDLSRNHIEG-KIPESIGSLVNLQVLNLGSNLLSG 171
                     L L  N ++     + + S   L +LNL  N L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 18/104 (17%), Positives = 34/104 (32%), Gaps = 5/104 (4%)

Query: 358 IDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPE 417
           + +   T      L  +  +     S N      PP       + ++  + ++    +  
Sbjct: 5   LAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQ-ASDNALENVDG 60

Query: 418 LKKCRKLVSLSLADNSLTG-EIPPSLAELPVLTYLDLSDNNLTG 460
           +    +L  L L +N L        L   P L  L+L  N+L  
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 9e-09
 Identities = 40/260 (15%), Positives = 82/260 (31%), Gaps = 19/260 (7%)

Query: 223 PDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG-SFPNGICKANGL 281
           PD    L S  ++         + P +   S  ++   D+S + +   +    + + + L
Sbjct: 14  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 73

Query: 282 VNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG 341
            NLSL     +  I  ++ +  NL R  +       +F  +       +L     +    
Sbjct: 74  QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 133

Query: 342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVM 401
                + +A       I                  L  +  +      S     C + V 
Sbjct: 134 FTEKHVQVAVAHVSETITQLN--------------LSGYRKNLQKSDLSTLVRRCPNLVH 179

Query: 402 SIINLSQNSISGQIPELKKCRKLVSLSLAD-NSLTGEIPPSLAELPVLTYLDLSDNNLTG 460
             ++ S    +    E  +   L  LSL+    +  E    L E+P L  L +      G
Sbjct: 180 LDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239

Query: 461 PIP---QGLQNLKLALFNVS 477
            +    + L +L++   + +
Sbjct: 240 TLQLLKEALPHLQINCSHFT 259

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.1 bits (131), Expect = 1e-08
 Identities = 50/278 (17%), Positives = 97/278 (34%), Gaps = 22/278 (7%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
           +++L   NL  +++  +     ++      +  +QP+  H S    ++ ++LSN++I   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVI--- 58

Query: 139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEI 198
                     +   +     LQ L+L    LS  +       S LV L+LS  +      
Sbjct: 59  ------EVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA 112

Query: 199 -PSDIGKLEKLEQL-----FLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGS 252
             + +    +L++L     F  +     V         +   L   + NL      +L  
Sbjct: 113 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 172

Query: 253 SLLKLVSFDVSQN-KLSGSFPNGICKANGLVNLSLHK-NFFNGSIPGSINECLNLERFQV 310
               LV  D+S +  L         + N L +LSL +           + E   L+  QV
Sbjct: 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 232

Query: 311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSIS 348
                 G       +LP +++     + F+     +I 
Sbjct: 233 FGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIG 267

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 44/275 (16%), Positives = 90/275 (32%), Gaps = 42/275 (15%)

Query: 138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISE 197
           LDL+  ++   +   + S   +       + +   +   F  F  +  +DLS +   +S 
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 198 IPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQN-NLTGEVPQSLGSSLLK 256
           +   + +  KL+ L L+       I ++     +L  L+LS     +    Q+L SS  +
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 257 LVSFDVS----------------------QNKLSGSFPNGICKANGLVNLSLHKNFFN-- 292
           L   ++S                      Q  LSG   N        +            
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 293 -------GSIPGSINECLNLERFQVQD-NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP 344
                          +   L+   +        +   +L  +P +K +     +  G +P
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTL-----QVFGIVP 237

Query: 345 DSI--SMAAQLEQVQIDNNRFTSSIPQGLGSVKSL 377
           D     +   L  +QI+ + FT+     +G+ K+ 
Sbjct: 238 DGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQ 272

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (92), Expect = 7e-04
 Identities = 41/236 (17%), Positives = 73/236 (30%), Gaps = 13/236 (5%)

Query: 78  ASINLQSLNLSG------EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLS 131
           +   +Q ++LS        +   + + S L NL+L     + PI   L++ S+L  LNLS
Sbjct: 44  SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103

Query: 132 NNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
                                +  L      +     +  +V  V    ++L +    +N
Sbjct: 104 GC--SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN 161

Query: 192 AYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ-NNLTGEVPQSL 250
                           +      S          F  L  L  L LS+  ++  E    L
Sbjct: 162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL 221

Query: 251 GSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLE 306
           G  +  L +  V      G+          L +L ++ + F      +I    N E
Sbjct: 222 G-EIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSHFTTIARPTIGNKKNQE 273

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.9 bits (120), Expect = 2e-07
 Identities = 32/210 (15%), Positives = 60/210 (28%), Gaps = 17/210 (8%)

Query: 120 SQCSSLETLNLSNN-----------LIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNL 168
           S+ +S   +N                  +L LS N +      ++     L  LN     
Sbjct: 7   SKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN----- 61

Query: 169 LSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVG 228
           L  +          L VL     ++   +    +G+      +   S      +P   + 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 229 LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHK 288
                     + N    +P  L +   KL    ++ N L+      +     L  L L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 289 NFFNGSIPGSINECLNLERFQVQDNGFSGD 318
           N    +IP        L    +  N +  +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 28/199 (14%), Positives = 60/199 (30%), Gaps = 15/199 (7%)

Query: 79  SINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVL 138
            +N    NL+  +   +      + L+L++NL        L   + L  LNL    +  L
Sbjct: 14  EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70

Query: 139 DLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAY----- 193
            +          +   + +    L   +      +   F   + L +  L          
Sbjct: 71  QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130

Query: 194 ----LISEIPSDIGKLEKLEQLFLQSS-GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ 248
                +  +P  +       +    ++     +      GL++L  L L +N+L   +P+
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 249 SLGSSLLKLVSFDVSQNKL 267
                   L    +  N  
Sbjct: 190 GFF-GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 29/208 (13%), Positives = 56/208 (26%), Gaps = 7/208 (3%)

Query: 275 ICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRA 334
           + K    + ++  K     ++P  + +  +     + +N         L    R+  +  
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 335 ESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPN 394
             +R              L  + + +N+  S    G            S N         
Sbjct: 63  --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLGA 119

Query: 395 FCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLAD-NSLTGEIPPSLAELPVLTYLDL 453
                 +  + L  N +    P L      +       N+LT      L  L  L  L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 454 SDNNLTGPIPQGLQNLKLALFNVSFNKL 481
            +N+L         +  L    +  N  
Sbjct: 180 QENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (120), Expect = 3e-07
 Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 7/85 (8%)

Query: 404 INLSQNSISGQIPE--LKKCRKLVSLSLADNSLTGE----IPPSLAELPVLTYLDLSDNN 457
           +++    +S       L   ++   + L D  LT      I  +L   P L  L+L  N 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 458 LTGPIPQGLQNLKLALFNVSFNKLS 482
           L       +    L   +    KLS
Sbjct: 67  LGDVGVHCVLQG-LQTPSCKIQKLS 90

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (118), Expect = 6e-07
 Identities = 17/80 (21%), Positives = 28/80 (35%), Gaps = 10/80 (12%)

Query: 401 MSIINLSQNSISGQIPE-----LKKCRKLVSLSLADNSLTGEIPPSLAE-----LPVLTY 450
           + ++ L+   +S          L     L  L L++N L       L E       +L  
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 451 LDLSDNNLTGPIPQGLQNLK 470
           L L D   +  +   LQ L+
Sbjct: 431 LVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (116), Expect = 1e-06
 Identities = 16/103 (15%), Positives = 31/103 (30%), Gaps = 20/103 (19%)

Query: 79  SINLQSLNLSGE------ISSSVCELSSLSNLNLADNLFN----QPIPLHLSQCSSLETL 128
           S+++QSL++  E       +  +  L     + L D        + I   L    +L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 129 NLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSG 171
           NL +          N +       +   +      +    L  
Sbjct: 61  NLRS----------NELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.0 bits (112), Expect = 4e-06
 Identities = 16/98 (16%), Positives = 37/98 (37%), Gaps = 8/98 (8%)

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK---LVSFDVSQNKLSGS 270
           + +G   +          L +L L+  +++     SL ++LL    L   D+S N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 271 FPNGICKA-----NGLVNLSLHKNFFNGSIPGSINECL 303
               + ++       L  L L+  +++  +   +    
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (106), Expect = 2e-05
 Identities = 18/105 (17%), Positives = 34/105 (32%), Gaps = 12/105 (11%)

Query: 108 DNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSN 167
           D    +         S L  L L++  +       +     +  ++ +  +L+ L+L +N
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDV------SDSSCSSLAATLLANHSLRELDLSNN 407

Query: 168 LLSGSVPFVFG-----NFSELVVLDLSQNAYLISEIPSDIGKLEK 207
            L  +               L  L L    Y   E+   +  LEK
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDI-YWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 12/77 (15%), Positives = 26/77 (33%), Gaps = 4/77 (5%)

Query: 182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGV----IPDSFVGLQSLSILDL 237
           ++  LD+       +     +  L++ + + L   G        I  +     +L+ L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 238 SQNNLTGEVPQSLGSSL 254
             N L       +   L
Sbjct: 63  RSNELGDVGVHCVLQGL 79

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 15/94 (15%), Positives = 32/94 (34%), Gaps = 11/94 (11%)

Query: 127 TLNLSNNLIWVLDLSRNHI-EGKIPESIGSLVNLQVLNLGSNLLSG----SVPFVFGNFS 181
           +L++ +     LD+    + + +  E +  L   QV+ L    L+      +        
Sbjct: 1   SLDIQS-----LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP 55

Query: 182 ELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQS 215
            L  L+L  N  L       + +  +     +Q 
Sbjct: 56  ALAELNLRSN-ELGDVGVHCVLQGLQTPSCKIQK 88

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 8e-05
 Identities = 19/97 (19%), Positives = 29/97 (29%), Gaps = 15/97 (15%)

Query: 418 LKKCRKLVSLSLADNSLTGE----IPPSLAELPVLTYLDLSDNNLTGPIPQGL------Q 467
            +    L  L LAD  ++      +  +L     L  LDLS+N L       L       
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 468 NLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGL 504
              L    +     S  +   L      +  +  P L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL-----QALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/77 (19%), Positives = 23/77 (29%), Gaps = 8/77 (10%)

Query: 207 KLEQLFLQSSGFHGV----IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL----LKLV 258
            L  L+L            +  + +   SL  LDLS N L       L  S+      L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 259 SFDVSQNKLSGSFPNGI 275
              +     S    + +
Sbjct: 430 QLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 4e-04
 Identities = 12/98 (12%), Positives = 25/98 (25%), Gaps = 4/98 (4%)

Query: 231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG----SFPNGICKANGLVNLSL 286
            +  LD+    L+      L   L +     +    L+        + +     L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 287 HKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLW 324
             N         + + L     ++Q             
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 4e-04
 Identities = 19/85 (22%), Positives = 26/85 (30%), Gaps = 19/85 (22%)

Query: 99  SSLSNLNLADNLFN----QPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIG 154
           S L  L LAD   +      +   L    SL  L+LSN          N +       + 
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN----------NCLGDAGILQLV 418

Query: 155 SLV-----NLQVLNLGSNLLSGSVP 174
             V      L+ L L     S  + 
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.004
 Identities = 9/65 (13%), Positives = 20/65 (30%), Gaps = 10/65 (15%)

Query: 403 IINLSQNSISGQIPE-----LKKCRKLVSLSLADNSLTGEIPPSLAEL-----PVLTYLD 452
           ++ L    ++    +     L+    L  L+L  N L       + +        +  L 
Sbjct: 31  VVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLS 90

Query: 453 LSDNN 457
           L +  
Sbjct: 91  LQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.004
 Identities = 23/109 (21%), Positives = 32/109 (29%), Gaps = 24/109 (22%)

Query: 158 NLQVLNLGSNLLSG----SVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
            L+VL L    +S     S+         L  LDLS N         D G L+ +E +  
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL------GDAGILQLVESVRQ 423

Query: 214 QSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV 262
                             L  L L     + E+   L +      S  V
Sbjct: 424 PGC--------------LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.3 bits (113), Expect = 2e-06
 Identities = 32/333 (9%), Positives = 97/333 (29%), Gaps = 35/333 (10%)

Query: 183 LVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHG----VIPDSFVGLQSLSILDLS 238
           L +  ++        + + + + + ++++ L  +         + ++    + L I + S
Sbjct: 10  LKLDAITTED--EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 239 QN---NLTGEVPQ------SLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKN 289
                 +  E+P+             KL +  +S N    +    +           H  
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 290 FFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPD---- 345
             N  +       +     ++  N  + + P     +     +   S +           
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 346 --SISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSI 403
             ++ M     + +   +     +           + +   +    +L       P +  
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 404 INLSQNSISGQIPE-------LKKCRKLVSLSLADNSLTGEIPPSLAE-----LPVLTYL 451
           + L+   +S +            +   L +L L  N +  +   +L       +P L +L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307

Query: 452 DLSDNNLT--GPIPQGLQNLKLALFNVSFNKLS 482
           +L+ N  +    +   ++ +         ++L 
Sbjct: 308 ELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 2e-04
 Identities = 11/96 (11%), Positives = 34/96 (35%), Gaps = 8/96 (8%)

Query: 73  ASLTVASINLQSLNLSGE----ISSSVCELSSLSNLNLADNLFN----QPIPLHLSQCSS 124
           A  ++   +L+   ++ E    + + + E  S+  + L+ N       + +  +++    
Sbjct: 1   ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60

Query: 125 LETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQ 160
           LE    S+     +          + +++     L 
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.0 bits (107), Expect = 5e-06
 Identities = 33/194 (17%), Positives = 59/194 (30%), Gaps = 12/194 (6%)

Query: 60  CNWTGVTCVTTATASL-TVASINLQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPL 117
           C  T V C       +     ++   L L+  E+     +       +L      +    
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 118 HLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF 177
            +   +         + I  L L  N I+    +    L  L+ LNL  N +S  +P  F
Sbjct: 68  GIEPNA-----FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122

Query: 178 GNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL 237
            + + L  L+    +   +         E L +  L         P     ++ + I DL
Sbjct: 123 EHLNSLTSLN--LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDL 177

Query: 238 SQNNLTGEVPQSLG 251
             +        S G
Sbjct: 178 PHSEFKCSSENSEG 191

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 7e-06
 Identities = 38/251 (15%), Positives = 74/251 (29%), Gaps = 43/251 (17%)

Query: 221 VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG 280
           + PD    L +   +   ++N+T  V Q+    L  + +       ++            
Sbjct: 12  IFPDP--ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGVT------------ 54

Query: 281 LVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS 340
                        +I G +    NL   +++DN  +   P K  +      +     +  
Sbjct: 55  -------------TIEG-VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNV 100

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
            AI    S+           +    +    L  +        + +   G     +     
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160

Query: 401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG 460
             +           +  L    KL +L   DN ++   P  LA LP L  + L +N ++ 
Sbjct: 161 AQVS---------DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD 209

Query: 461 PIP-QGLQNLK 470
             P     NL 
Sbjct: 210 VSPLANTSNLF 220

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 34/261 (13%), Positives = 67/261 (25%), Gaps = 43/261 (16%)

Query: 195 ISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSL 254
           I+ I  D   L    ++    S     +  +   L  ++ L      +T          L
Sbjct: 9   INVIFPD-PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI---EGVQYL 62

Query: 255 LKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNG 314
             L+  ++  N+++   P         + LS +      +I G  +            + 
Sbjct: 63  NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122

Query: 315 FSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV 374
                   L  L                                      + I       
Sbjct: 123 TPLAGLSNLQVL----------------------------------YLDLNQITNISPLA 148

Query: 375 KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSL 434
                   S  +   S      +   ++ +    N IS  I  L     L+ + L +N +
Sbjct: 149 GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207

Query: 435 TGEIPPSLAELPVLTYLDLSD 455
           +   P  LA    L  + L++
Sbjct: 208 SDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 7e-04
 Identities = 19/72 (26%), Positives = 30/72 (41%), Gaps = 14/72 (19%)

Query: 118 HLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVF 177
            L+  S L TL   +N I  +              + SL NL  ++L +N +S   P   
Sbjct: 168 PLANLSKLTTLKADDNKISDI------------SPLASLPNLIEVHLKNNQISDVSP--L 213

Query: 178 GNFSELVVLDLS 189
            N S L ++ L+
Sbjct: 214 ANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 0.001
 Identities = 13/78 (16%), Positives = 33/78 (42%), Gaps = 5/78 (6%)

Query: 405 NLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQ 464
           +++Q +    I         + ++   +++T  +  + A+L  +T L      +T    +
Sbjct: 2   SITQPTAINVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT--IE 57

Query: 465 GLQNLK-LALFNVSFNKL 481
           G+Q L  L    +  N++
Sbjct: 58  GVQYLNNLIGLELKDNQI 75

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (104), Expect = 9e-06
 Identities = 25/113 (22%), Positives = 44/113 (38%), Gaps = 6/113 (5%)

Query: 137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNA-YLI 195
            LDL            + +     VLN  S++ + ++  +  N  EL+ L+LS N  Y +
Sbjct: 26  ALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRL 80

Query: 196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQ 248
            ++ S + K   L+ L L  +          +    L  L L  N+L+     
Sbjct: 81  DDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 10/111 (9%)

Query: 82  LQSLNLSG-EISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDL 140
            Q+L+L G      +   +    LN   ++    + +       L +LNLSNN +     
Sbjct: 24  QQALDLKGLRSDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLNLSNNRL----- 77

Query: 141 SRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQN 191
              +    +   +    NL++LNL  N L            +L  L L  N
Sbjct: 78  ---YRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 7e-05
 Identities = 29/234 (12%), Positives = 61/234 (26%), Gaps = 11/234 (4%)

Query: 231 SLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNF 290
           S  +    ++ +T E+P  L  + ++L        KL             L  + + +N 
Sbjct: 9   SNRVFLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQND 64

Query: 291 FNGSIPGSINECLNLERFQVQ---DNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSI 347
               I   +   L           +N    +            L+ + +          I
Sbjct: 65  VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI 124

Query: 348 SMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLS 407
               ++     DN    +        +           +    +     +   +  +NLS
Sbjct: 125 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLS 184

Query: 408 QNSISGQIPE--LKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLT 459
            N+   ++P          V L ++   +       L  L  L        NL 
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.002
 Identities = 13/56 (23%), Positives = 20/56 (35%), Gaps = 4/56 (7%)

Query: 218 FHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPN 273
              +  D F G     ILD+S+  +   +P     +L KL +      K     P 
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 6/66 (9%), Positives = 20/66 (30%), Gaps = 4/66 (6%)

Query: 135 IWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYL 194
             +     N++E    +         +L++    +     +   N  +L           
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---- 234

Query: 195 ISEIPS 200
           + ++P+
Sbjct: 235 LKKLPT 240

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 2e-04
 Identities = 14/67 (20%), Positives = 22/67 (32%), Gaps = 3/67 (4%)

Query: 404 INLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG-PI 462
           + L+   I  Q  +     +   L L    +   I    A L     +D SDN +     
Sbjct: 1   VKLTAELIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG 58

Query: 463 PQGLQNL 469
              L+ L
Sbjct: 59  FPLLRRL 65

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 21/151 (13%), Positives = 46/151 (30%), Gaps = 16/151 (10%)

Query: 92  SSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPE 151
           ++          L+L        I    +     + ++ S+N I  LD            
Sbjct: 11  AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLD------------ 57

Query: 152 SIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQL 211
               L  L+ L + +N +      +     +L  L L+ N+ +       +  L+ L  L
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 212 FLQSSGFHGVI---PDSFVGLQSLSILDLSQ 239
            +  +               +  + +LD  +
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQVRVLDFQK 148

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 0.001
 Identities = 22/140 (15%), Positives = 46/140 (32%), Gaps = 2/140 (1%)

Query: 336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGL-GSVKSLYRFSASQNSFYGSLPPN 394
           +   +      +  A  L ++ I+N +    +       +  L   +  ++      P  
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 395 FCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPS-LAELPVLTYLDL 453
           F  +P +S +NLS N++     +  +   L  L L+ N L        L          +
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGV 135

Query: 454 SDNNLTGPIPQGLQNLKLAL 473
            +  L       L ++  A 
Sbjct: 136 PEQKLQCHGQGPLAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 27/158 (17%), Positives = 46/158 (29%), Gaps = 13/158 (8%)

Query: 94  SVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESI 153
             C     S L    +        HL    +L  L + N           H++      +
Sbjct: 3   DACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQ---------QHLQHLELRDL 52

Query: 154 GSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFL 213
             L  L+ L +  + L    P  F     L  L+LS NA     +     +   L++L L
Sbjct: 53  RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL--ESLSWKTVQGLSLQELVL 110

Query: 214 QSSGFH-GVIPDSFVGLQSLSILDLSQNNLTGEVPQSL 250
             +  H           +   +  + +  L       L
Sbjct: 111 SGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 29/231 (12%), Positives = 63/231 (27%), Gaps = 42/231 (18%)

Query: 221 VIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANG 280
           +  D+   L       L + N+T  V Q+    L ++ +    +  +             
Sbjct: 11  IFTDT--ALAEKMKTVLGKTNVTDTVSQT---DLDQVTTLQADRLGIK------------ 53

Query: 281 LVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFS 340
                        SI G +    NL +    +N  +   P K  +     L+        
Sbjct: 54  -------------SIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADI 99

Query: 341 GAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV 400
             + +  ++           +         L  ++      +  ++  G       +   
Sbjct: 100 TPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSS 159

Query: 401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYL 451
             + +L           L     L  L ++ N ++      LA+L  L  L
Sbjct: 160 NQVTDL---------KPLANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 19/69 (27%), Positives = 32/69 (46%), Gaps = 9/69 (13%)

Query: 410 SISGQIPELKKCRKLVSLSLADNSLTGEIPP------SLAELPVLTYLDLSDNNLTGPIP 463
           +I   I   ++ + +V+       L G IPP      +L+ L    +L LS NN+   I 
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS 64

Query: 464 --QGLQNLK 470
              G++NL+
Sbjct: 65  SLSGMENLR 73

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	876
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.75
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.72
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.72
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.7
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.53
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.51
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.44
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.32
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.32
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.43
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.36
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.35
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.15
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.33
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.25
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.19
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.28
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.2
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.91
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.36

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=410.18  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ..+|.| +||+||+|+.+  ..||||++....  ....+.+.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus        14 ~~lG~G-~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          14 QRIGSG-SFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS   89 (276)
T ss_dssp             SEEEEC-SSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred             EEEeeC-CCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence            345555 49999999864  469999986542  2334678999999999999999999998754 56899999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++...+..+++..+.+++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+|+..............
T Consensus        90 L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  166 (276)
T d1uwha_          90 LYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL  166 (276)
T ss_dssp             HHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------C
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCccccccc
Confidence            9999987777899999999999999999999999   9999999999999999999999999999877644333344556


Q ss_pred             cccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          745 YALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       745 ~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      .||+.|||||++.+   ..++.++|||||||++|||+||+.||........ ....+.+..         ..|.......
T Consensus       167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~---------~~p~~~~~~~  236 (276)
T d1uwha_         167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGY---------LSPDLSKVRS  236 (276)
T ss_dssp             CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTS---------CCCCGGGSCT
T ss_pred             ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCC---------CCCcchhccc
Confidence            79999999998764   3578999999999999999999999986543322 122222111         1122222223


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ..+..+.+++.+||+.||++||||+|+++.|+.+.+.
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            3345688999999999999999999999999988653

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-48  Score=403.31  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=197.3

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|+ ||+||+|++.+++.||||++... ....+++.+|++++++++|||||+++|+|.+++..++||||+++|+|
T Consensus        10 ~~~iG~G~-fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L   87 (263)
T d1sm2a_          10 VQEIGSGQ-FGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   87 (263)
T ss_dssp             EEEEECCS-SCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred             EEEEeeCC-CeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence            34556555 99999999989999999998653 35667899999999999999999999999999999999999999999


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      .+++......+++..+.+++.|||.||+|||+.   +|+||||||+||++++++.+||+|||+++........ ......
T Consensus        88 ~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~  163 (263)
T d1sm2a_          88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTK  163 (263)
T ss_dssp             HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------
T ss_pred             HHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce-eeccee
Confidence            999988777899999999999999999999999   9999999999999999999999999999877543322 223446


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG-RQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      ||+.|+|||++.+..++.++|||||||++|||+|+ ++||.....  ......+.....       ...|.      ..+
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~~-------~~~p~------~~~  228 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR-------LYKPR------LAS  228 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHHTCC-------CCCCT------TSC
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHhcCC-------CCCcc------ccC
Confidence            89999999999999999999999999999999995 555543222  222333222111       11111      112


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ..+.+++.+||+.||++||||+|+++.|+++.+
T Consensus       229 ~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            357899999999999999999999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-48  Score=403.34  Aligned_cols=251  Identities=21%  Similarity=0.301  Sum_probs=200.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +|.....+|.|| ||+||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus         6 dy~~~~~lG~G~-fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           6 DWDLVQTLGEGA-YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             EEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ceEEEEEEecCc-CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            344445566655 999999976 4799999999965432 3345788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +++|+|.+++.+. ..+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+.........
T Consensus        85 ~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            9999999999654 4799999999999999999999999   99999999999999999999999999998876444334


Q ss_pred             ccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      ......||+.|||||++.+..+ +.++||||+||++|||+||++||............+....  ..       .+.   
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~--~~-------~~~---  228 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK--TY-------LNP---  228 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC--TT-------STT---
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC--CC-------CCc---
Confidence            4556679999999999877665 6789999999999999999999987554333222221110  00       000   


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                       +...+.++.+++.+||+.||++|||++|+++
T Consensus       229 -~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 -WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1112345778999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=401.09  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=204.7

Q ss_pred             hcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          581 IGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       581 ~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..|.....+|.|| ||+||+|.. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        20 ~~Y~~~~~iG~G~-fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGA-SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSS-SCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCc-CcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            3455556666665 999999975 57999999999876666778899999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      ++||+|.+++.+.  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc--
Confidence            9999999988654  589999999999999999999999   999999999999999999999999999987754322  


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|+|||++.+..++.++||||+||++|||+||+.||.......  ...........     ..   .   .
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~~~-----~~---~---~  238 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALYLIATNGTP-----EL---Q---N  238 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHHCSC-----CC---S---S
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--HHHHHHhCCCC-----CC---C---C
Confidence            2344569999999999999899999999999999999999999997644322  11111111100     00   0   0


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +...+..+.+++.+||++||++|||+.|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122346789999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=394.36  Aligned_cols=252  Identities=19%  Similarity=0.337  Sum_probs=209.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      |.-...+|.|+ ||+||+|++++++.||||++.... ...+++.+|++++++++||||++++|+|.+++..++||||+++
T Consensus         6 ~~~~~~iG~G~-fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           6 LTFLKELGTGQ-FGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCEET-TEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             CEEeEEEecCC-CeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            33345555555 999999999889999999997643 5667899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMS  742 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~  742 (876)
                      |++.+++......+++..+.+++.|+++||+|||+.   +|+||||||+||+++.++.+||+|||+++....... ....
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~  159 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSV  159 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeec
Confidence            999999887777899999999999999999999999   999999999999999999999999999987654332 2334


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...||+.|+|||.+....++.++|||||||++|||+| |+.||......+  ....+...      . ....|.      
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~------~-~~~~p~------  224 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG------L-RLYRPH------  224 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT------C-CCCCCT------
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC------C-CCCCcc------
Confidence            4568999999999998899999999999999999998 899998655332  22222211      1 111111      


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ..+..+.+++.+||++||++|||++|+++.|.+|
T Consensus       225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1224678999999999999999999999999764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-47  Score=403.37  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=207.5

Q ss_pred             cCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|| ||+||+|.+. +|+.||||++... ....+++.+|++++++++|||||+++|+|.+++..++||||+++|+
T Consensus        22 ~~~iG~G~-fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~   99 (287)
T d1opja_          22 KHKLGGGQ-YGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   99 (287)
T ss_dssp             EEETTTTT-TSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEEeeCC-CeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence            34566655 9999999775 6899999998654 3567789999999999999999999999999999999999999999


Q ss_pred             HHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccc
Q 002826          665 LGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSS  743 (876)
Q Consensus       665 L~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  743 (876)
                      |.+++.+. ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+....... .....
T Consensus       100 l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~  175 (287)
T d1opja_         100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAG  175 (287)
T ss_dssp             HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETT
T ss_pred             hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc-eeecc
Confidence            99998754 56799999999999999999999999   999999999999999999999999999998764432 22334


Q ss_pred             ccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          744 EYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       744 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|..||...... ....+.+.....          +...   ...
T Consensus       176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~~~~i~~~~~----------~~~~---~~~  241 (287)
T d1opja_         176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLEKDYR----------MERP---EGC  241 (287)
T ss_dssp             EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCC----------CCCC---TTC
T ss_pred             ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHHHHHHhcCCC----------CCCC---ccc
Confidence            45888999999999889999999999999999999977766543322 222222222111          1111   112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      +..+.+++.+||+.||++||||.|+++.|+.+.++..
T Consensus       242 ~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~  278 (287)
T d1opja_         242 PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  278 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCC
Confidence            3467899999999999999999999999999876544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-47  Score=406.68  Aligned_cols=254  Identities=22%  Similarity=0.372  Sum_probs=193.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CC---cEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SG---ELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      .+.+|.|+||+||+|..+ ++   ..||||++..... ...+.|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            334444559999999764 33   2589998865322 334678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc--
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS--  739 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~--  739 (876)
                      +|+|.+++......+++.++.+++.||++||+|||+.   +|+||||||+|||++.++.+||+|||+++.........  
T Consensus       111 ~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~  187 (299)
T d1jpaa_         111 NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY  187 (299)
T ss_dssp             TEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------
T ss_pred             CCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCccee
Confidence            9999999988777899999999999999999999999   99999999999999999999999999998876432221  


Q ss_pred             -ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          740 -TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       740 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       ......||+.|||||.+.++.++.++|||||||++|||+| |++||......  +....+.......      .     
T Consensus       188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~~------~-----  254 (299)
T d1jpaa_         188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRLP------P-----  254 (299)
T ss_dssp             --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCCC------C-----
T ss_pred             eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCCCC------C-----
Confidence             1223457899999999998999999999999999999998 89999765432  2233322211110      0     


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                        +.+.+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       255 --~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         255 --PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence              112234678999999999999999999999999998653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-47  Score=394.21  Aligned_cols=243  Identities=23%  Similarity=0.398  Sum_probs=200.3

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|| ||+||+|+.+ +|+.||+|++.+.   .......+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 y~i~~~iG~G~-fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           8 FEIGRPLGKGK-FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEecCC-CcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            33445566665 9999999764 7999999998642   23456788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+++|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+......  
T Consensus        87 y~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~--  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--  160 (263)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred             ecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence            999999999997654 699999999999999999999999   99999999999999999999999999998765432  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                        .....||+.|||||++.+..++.++||||+||++|||++|+.||........  .   .......        +.++.
T Consensus       161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~---~~i~~~~--------~~~p~  225 (263)
T d2j4za1         161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--Y---KRISRVE--------FTFPD  225 (263)
T ss_dssp             --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H---HHHHTTC--------CCCCT
T ss_pred             --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--H---HHHHcCC--------CCCCc
Confidence              2344699999999999999999999999999999999999999976543221  1   1111111        00111


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ..+.++.+++.+||++||++|||++|+++
T Consensus       226 ---~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         226 ---FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               12345789999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=399.07  Aligned_cols=250  Identities=23%  Similarity=0.395  Sum_probs=201.1

Q ss_pred             cCCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          586 KSSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      ...+|.|| ||+||+|.+++++.||||++... ....+.+.+|++++++++|||||+++|++.+ +..++||||+++|+|
T Consensus        18 ~~~iG~G~-fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L   94 (272)
T d1qpca_          18 VERLGAGQ-FGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSL   94 (272)
T ss_dssp             EEEEEEET-TEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBH
T ss_pred             eEEEecCC-CcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcH
Confidence            34566665 99999999988999999999654 3567789999999999999999999998854 567899999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++... +..+++..+.+++.||++||+|||+.   +|+||||||+|||+++++.+||+|||+|+....... ......
T Consensus        95 ~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~  170 (272)
T d1qpca_          95 VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGA  170 (272)
T ss_dssp             HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTC
T ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc-cccccc
Confidence            9987654 34589999999999999999999999   999999999999999999999999999988764332 223445


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQM  824 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  824 (876)
                      .||+.|||||++..+.++.++|||||||++|||+||..|+...... ......+...      .... .|   .   ..+
T Consensus       171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~------~~~~-~p---~---~~~  236 (272)
T d1qpca_         171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERG------YRMV-RP---D---NCP  236 (272)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTT------CCCC-CC---T---TCC
T ss_pred             CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhc------CCCC-Cc---c---cCh
Confidence            6899999999998888999999999999999999965555432222 1222222211      1111 11   1   123


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          825 LGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       825 ~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ..+.+++.+||+.||++||||+||++.|+++-
T Consensus       237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            35789999999999999999999999999864

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=400.80  Aligned_cols=247  Identities=20%  Similarity=0.283  Sum_probs=201.1

Q ss_pred             cCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCC
Q 002826          586 KSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGS  664 (876)
Q Consensus       586 ~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs  664 (876)
                      ...+|.|| ||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+++|+
T Consensus        17 ~~~iG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~   95 (288)
T d2jfla1          17 IGELGDGA-FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   95 (288)
T ss_dssp             EEEEEEET-TEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             eEEEeeCC-CcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence            44555555 999999976 4799999999987665666789999999999999999999999999999999999999999


Q ss_pred             HHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          665 LGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       665 L~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      |.+++.+.+..+++..+..++.||+.||+|||++   +|+||||||+|||++.++++||+|||+|+......  ......
T Consensus        96 L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~~~~~  170 (288)
T d2jfla1          96 VDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSF  170 (288)
T ss_dssp             HHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HHHTCC
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc--cccccc
Confidence            9999877666899999999999999999999999   99999999999999999999999999997654321  123345


Q ss_pred             cccccccCccccC-----CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          745 YALSCYNAPEYGY-----SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       745 ~gt~~y~aPE~~~-----~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      .||+.|||||++.     ...++.++||||+||++|||+||+.||........  ...+..   ..  .....      .
T Consensus       171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~~---~~--~~~~~------~  237 (288)
T d2jfla1         171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAK---SE--PPTLA------Q  237 (288)
T ss_dssp             CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHH---SC--CCCCS------S
T ss_pred             ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHc---CC--CCCCC------c
Confidence            6999999999873     45678999999999999999999999987554332  111111   10  00000      1


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +...+.++.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11223467899999999999999999999763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-47  Score=396.82  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=188.5

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe--CCeEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--DESIFLI  656 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv  656 (876)
                      +|.....+|.|| ||+||+|+. .+|+.||+|++.....  ...+.+.+|++++++++|||||++++++.+  ++..|+|
T Consensus         5 dy~~~~~iG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           5 DYEVLYTIGTGS-YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hCEEeEEEecCC-CeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            344455666666 999999966 5799999999965432  223568899999999999999999999865  4568999


Q ss_pred             EEcCCCCCHHHHhhcc---CCcCCHHHHHHHHHHHHHHHHHhhccCC--CCccccccccCceeeCCCCCeEEccccchhh
Q 002826          657 YEFLQMGSLGDLICRQ---DFQLQWSIRLKIAIGVAQGLAYLHKDYV--PHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      |||+++|+|.+++.+.   ...+++..+..++.|++.||+|||+++.  .+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643   4579999999999999999999999721  1399999999999999999999999999998


Q ss_pred             ccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      ......  ......||+.|||||++.+..++.++|||||||++|||+||++||......+  ....+...   .   ...
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--~~~~i~~~---~---~~~  233 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREG---K---FRR  233 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHT---C---CCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--HHHHHHcC---C---CCC
Confidence            764332  2234568999999999999899999999999999999999999997654332  22222111   1   111


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      +.       ...+.++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         234 IP-------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC-------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11       112345789999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=397.43  Aligned_cols=249  Identities=20%  Similarity=0.307  Sum_probs=202.2

Q ss_pred             CCCCCCCceEEEEEEeC---CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCC
Q 002826          588 SAGNGGPFGRVYILSLP---SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  663 (876)
                      ++|.|| ||+||+|.+.   ++..||||++..... ...+++.+|++++++++|||||+++|++.+ +..|+||||+++|
T Consensus        16 ~iG~G~-fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g   93 (285)
T d1u59a_          16 ELGCGN-FGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG   93 (285)
T ss_dssp             EEECCT-TEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred             EEeccc-CeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence            356665 9999999653   455899999975432 334678999999999999999999999865 5689999999999


Q ss_pred             CHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-ccccc
Q 002826          664 SLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTMS  742 (876)
Q Consensus       664 sL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~  742 (876)
                      +|.+++......+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....... .....
T Consensus        94 ~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (285)
T d1u59a_          94 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  170 (285)
T ss_dssp             EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred             cHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccccc
Confidence            99999877767899999999999999999999999   999999999999999999999999999988764332 22233


Q ss_pred             cccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcH
Q 002826          743 SEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQ  821 (876)
Q Consensus       743 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  821 (876)
                      ...||+.|+|||++....++.++|||||||++|||+| |+.||......  +....+...      ....+.       .
T Consensus       171 ~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~------~~~~~p-------~  235 (285)
T d1u59a_         171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG------KRMECP-------P  235 (285)
T ss_dssp             SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTT------CCCCCC-------T
T ss_pred             ccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------CCCCCC-------C
Confidence            4568899999999988899999999999999999998 89999865432  222222221      111111       1


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcc
Q 002826          822 QQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLS  856 (876)
Q Consensus       822 ~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~  856 (876)
                      ..+.++.+++.+||+.||++||||.+|++.|+.+.
T Consensus       236 ~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            12346789999999999999999999999998764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=400.64  Aligned_cols=261  Identities=25%  Similarity=0.320  Sum_probs=199.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      +|.....+|.|+ ||+||+|+. .+|+.||+|++..... ....++.+|+.++++++|||||+++++|.++++.|+||||
T Consensus         7 ~y~~~~~iG~G~-fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy   85 (322)
T d1s9ja_           7 DFEKISELGAGN-GGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   85 (322)
T ss_dssp             GEEEEEEEECCS-SCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCEEEEEEecCC-CeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            344455566555 999999976 5799999999976432 3346789999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      ++||+|.+++.+.+ .+++..+..++.|++.|++|||+ .   +|+||||||+|||+++++++||+|||+|+......  
T Consensus        86 ~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--  159 (322)
T d1s9ja_          86 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--  159 (322)
T ss_dssp             CTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT--
T ss_pred             CCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc--
Confidence            99999999997664 69999999999999999999997 5   89999999999999999999999999998765432  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc-----------c
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN-----------G  807 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~  807 (876)
                        .....||+.|||||++.+..++.++||||+||++|||++|+.||......................           .
T Consensus       160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (322)
T d1s9ja_         160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  237 (322)
T ss_dssp             --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred             --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence              233469999999999999999999999999999999999999998755432211110000000000           0


Q ss_pred             cccccChh----hhhh-------------cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 AIQVLDPK----IANC-------------YQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ~~~~~d~~----~~~~-------------~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .....+..    ..+.             ....+.++.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            00000000    0000             00113467899999999999999999999873

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-46  Score=392.96  Aligned_cols=254  Identities=23%  Similarity=0.363  Sum_probs=195.6

Q ss_pred             CCCCCCCCceEEEEEEeCCC-----cEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSLPSG-----ELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|| ||+||+|.++..     ..||||++..... ....++.+|++++++++|||||+++|++.+.+..++||||+
T Consensus        13 ~~iG~G~-fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~   91 (283)
T d1mqba_          13 KVIGAGE-FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM   91 (283)
T ss_dssp             EEEEECS-SSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eEEeeCC-CeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence            3345554 999999976532     4799999865432 22457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QS  739 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~  739 (876)
                      .++++.+++......+++..+.+++.||+.|++|||+.   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus        92 ~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~  168 (283)
T d1mqba_          92 ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY  168 (283)
T ss_dssp             TTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------------
T ss_pred             ccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccce
Confidence            99999999887777899999999999999999999999   999999999999999999999999999988754322 22


Q ss_pred             ccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhh
Q 002826          740 TMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANC  819 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  819 (876)
                      ......||+.|||||++.++.++.++|||||||++|||++|..|+...... ......+.....          +...  
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~----------~~~~--  235 (283)
T d1mqba_         169 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFR----------LPTP--  235 (283)
T ss_dssp             -----CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC----------CCCC--
T ss_pred             EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccCC----------CCCc--
Confidence            233446899999999999999999999999999999999976665443322 222222221111          1111  


Q ss_pred             cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          820 YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       820 ~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                       ...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus       236 -~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         236 -MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence             11234578999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-46  Score=392.57  Aligned_cols=247  Identities=21%  Similarity=0.314  Sum_probs=195.8

Q ss_pred             CCCCCCCceEEEEEEeC---CCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCC
Q 002826          588 SAGNGGPFGRVYILSLP---SGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQM  662 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  662 (876)
                      ++|.|| ||+||+|.+.   .++.||||++......  ..+++.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus        14 ~iG~G~-fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          14 ELGSGN-FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEECS-SEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CcccCC-CeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            466666 9999999753   3568999999653322  24678999999999999999999999964 567899999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc-cccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF-QSTM  741 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~  741 (876)
                      |+|.+++.+.. .+++..+.+++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||+++....... ....
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999997654 699999999999999999999999   999999999999999999999999999987654322 2233


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....||+.|||||.+.+..++.++|||||||++|||+| |+.||......  .....+....      .    +..+   
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~------~----~~~p---  232 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE------R----MGCP---  232 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC------C----CCCC---
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC------C----CCCC---
Confidence            44568999999999988889999999999999999998 89999865432  2222222211      0    0111   


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      ...+..+.+++.+||+.||++|||++||++.|+.+
T Consensus       233 ~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            11234678999999999999999999999998875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-45  Score=399.49  Aligned_cols=263  Identities=20%  Similarity=0.331  Sum_probs=211.9

Q ss_pred             cccccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEE
Q 002826          570 YPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFH  648 (876)
Q Consensus       570 ~~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  648 (876)
                      .|..+..+.+..+|.-...+|.|| ||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.
T Consensus        15 ~p~~l~~~~il~~Y~i~~~lG~G~-fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   93 (350)
T d1koaa2          15 QPVEIKHDHVLDHYDIHEELGTGA-FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE   93 (350)
T ss_dssp             CCCCCBCSCGGGTEEEEEEEEEET-TEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             CCCcCCCCCCccCeEEEEEEecCc-CeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            345555556665665556666666 999999976 579999999997765555678899999999999999999999999


Q ss_pred             eCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CCCCeEEccc
Q 002826          649 SDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--ADFEPKLTDF  726 (876)
Q Consensus       649 ~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~Df  726 (876)
                      +++..|+||||++||+|.+++.+....+++..+..++.||+.||+|||+.   +|+||||||+|||++  .++.+||+||
T Consensus        94 ~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2          94 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeec
Confidence            99999999999999999999977666799999999999999999999999   999999999999996  4588999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++.......   .....||+.|||||++.+..++.++||||+||++|||++|+.||......+  ....+..   .. 
T Consensus       171 G~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~~i~~---~~-  241 (350)
T d1koaa2         171 GLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRNVKS---CD-  241 (350)
T ss_dssp             TTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---TC-
T ss_pred             chheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC-
Confidence            99987764432   233458999999999999899999999999999999999999998654322  1221111   11 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                        ... ++..   ....+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 --~~~-~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         242 --WNM-DDSA---FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --CCS-CCGG---GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --CCC-Cccc---ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              000 1111   11123457899999999999999999999884

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=385.69  Aligned_cols=240  Identities=21%  Similarity=0.301  Sum_probs=190.4

Q ss_pred             CCCCCCCceEEEEEEeC-CCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEe----CCeEEEEEEcC
Q 002826          588 SAGNGGPFGRVYILSLP-SGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS----DESIFLIYEFL  660 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  660 (876)
                      ++|.|| ||+||+|... +++.||+|++....  ....+.+.+|++++++++|||||++++++.+    +...|+||||+
T Consensus        16 ~iG~G~-fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          16 EIGRGS-FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEECS-SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             EEecCc-CcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            355555 9999999764 78999999986542  2234578899999999999999999999875    34689999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCC--ccccccccCceeeC-CCCCeEEccccchhhcccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPH--LLHRNVKSKNILLD-ADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--i~H~Dlkp~NIll~-~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ++|+|.+++.+.. .+++..+..++.||++||+|||++   +  |+||||||+|||++ +++.+||+|||+|+...... 
T Consensus        95 ~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~-  169 (270)
T d1t4ha_          95 TSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-  169 (270)
T ss_dssp             CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS-
T ss_pred             CCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc-
Confidence            9999999997654 789999999999999999999998   6  99999999999997 57899999999998654322 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                         .....||+.|||||++.+ +++.++||||+||++|||++|+.||........    ..+......      ..+.+.
T Consensus       170 ---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~----~~~~i~~~~------~~~~~~  235 (270)
T d1t4ha_         170 ---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGV------KPASFD  235 (270)
T ss_dssp             ---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTC------CCGGGG
T ss_pred             ---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH----HHHHHHcCC------CCcccC
Confidence               234569999999998765 589999999999999999999999975432221    111111110      011111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .   ....++.+++.+||++||++|||+.|+++
T Consensus       236 ~---~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 K---VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             G---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c---cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1   12235789999999999999999999976

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.2e-45  Score=399.41  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=212.6

Q ss_pred             ccccccchhhhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEE
Q 002826          569 FYPLRVTEHDLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFF  647 (876)
Q Consensus       569 ~~~~~~~~~~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  647 (876)
                      ..|..++.+.+...|.....+|.|| ||+||+|.. .+|+.||||++..........+.+|++++++++|||||++++++
T Consensus        17 p~p~~~~~~~~~d~Y~i~~~lG~G~-fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   95 (352)
T d1koba_          17 PQPVEVKQGSVYDYYDILEELGSGA-FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF   95 (352)
T ss_dssp             CCCCCCBCSCGGGTEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             CCCccCCCCCcccceEEEEEEecCC-CeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3445555566655555555566655 999999975 58999999999766545566788999999999999999999999


Q ss_pred             EeCCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC--CCCCeEEcc
Q 002826          648 HSDESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD--ADFEPKLTD  725 (876)
Q Consensus       648 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~--~~~~~kl~D  725 (876)
                      .+++..|+|||||+||+|.+++.+.+..+++..+..++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|
T Consensus        96 ~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~D  172 (352)
T d1koba_          96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIID  172 (352)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECC
T ss_pred             EECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEee
Confidence            999999999999999999998877777899999999999999999999999   999999999999998  578999999


Q ss_pred             ccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          726 FALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       726 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      ||+|+.+.....   .....||+.|+|||++.+..++.++||||+||++|||+||+.||.......  ....+..   ..
T Consensus       173 FGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~i~~---~~  244 (352)
T d1koba_         173 FGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQNVKR---CD  244 (352)
T ss_dssp             CTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHHHHH---CC
T ss_pred             cccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC
Confidence            999988765432   233458999999999999999999999999999999999999997654332  2222211   11


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         .. +.+   ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       245 ---~~-~~~---~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         245 ---WE-FDE---DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ---CC-CCS---STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ---CC-CCc---ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               00 001   1111223457899999999999999999999874

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=395.89  Aligned_cols=247  Identities=20%  Similarity=0.288  Sum_probs=197.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.-...+|.|| ||+||+|+. .+|+.||||++...   .....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus        10 y~i~~~lG~G~-fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_          10 FKFGKILGEGS-FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             EEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CEEEEEEeeCC-CeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            33334555555 999999976 57999999999642   22445778999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |++||+|.+++...+ .+++..+..++.|++.|++|||+.   +|+||||||+|||+++++.+||+|||+|+.+......
T Consensus        89 y~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          89 YAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             ccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            999999999987654 799999999999999999999999   9999999999999999999999999999887644333


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......||+.|||||++.+..++.++||||+||++|||++|+.||........     .........   . +.+    
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~~~~---~-~p~----  231 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEY---D-FPE----  231 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHTTCC---C-CCT----
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-----HHHHHcCCC---C-CCc----
Confidence            334455799999999999999999999999999999999999999986543221     111111110   0 111    


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         ..+..+.++|.+||+.||++|||++|+++
T Consensus       232 ---~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         232 ---KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               12345789999999999999999999754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-45  Score=393.41  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=186.1

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |+...|.-...+|. |+||+||+|+.. +|+.||||++..... .....+.+|++++++++|||||++++++.+++..|+
T Consensus         6 di~d~Y~~~~~lG~-G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           6 DIRDIYDFRDVLGT-GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             CGGGTEEEEEESBS-GGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCccceEEEEEEee-ccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            34333444444555 559999999764 799999999975432 334567899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchhhc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIV  732 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~~~  732 (876)
                      ||||++||+|.+++.+. ..+++..+..++.|++.||+|||+.   +|+||||||+||++.   +++.+||+|||+++..
T Consensus        85 vmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             EECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             EEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999999765 4799999999999999999999999   999999999999994   5789999999999876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                      .....   .....||+.|||||++.+..++.++||||+||++|||++|+.||.......  ....+.   ...   ....
T Consensus       161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~---~~~---~~~~  229 (307)
T d1a06a_         161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQIL---KAE---YEFD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH---TTC---CCCC
T ss_pred             cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHh---ccC---CCCC
Confidence            54332   234569999999999999999999999999999999999999998654332  111111   111   0000


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      .+.    ....+..+.+++.+||+.||++|||++|+++.
T Consensus       230 ~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 SPY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             Ccc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            111    11223457899999999999999999999884

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=400.32  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=199.2

Q ss_pred             CCCCCCCCceEEEEEEeCC-C-----cEEEEEEEecC-CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLPS-G-----ELIAVKKLVNF-GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ..+|.|| ||+||+|+... +     ..||+|++... .......+.+|+.+++++ +|||||+++|++.+.+..|+|||
T Consensus        43 ~~lG~G~-fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (325)
T d1rjba_          43 KVLGSGA-FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  121 (325)
T ss_dssp             EEEEECS-SEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eEEeeCC-CeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence            4455555 99999997642 2     36999998643 234456788999999998 89999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC----------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC
Q 002826          659 FLQMGSLGDLICRQD----------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD  716 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~  716 (876)
                      |+++|+|.+++....                      ..+++..+..++.||+.||+|||+.   +|+||||||+||+++
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~  198 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT  198 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccc
Confidence            999999999997542                      2488999999999999999999999   999999999999999


Q ss_pred             CCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHH
Q 002826          717 ADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVV  795 (876)
Q Consensus       717 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~  795 (876)
                      .++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |++||...+.... +.
T Consensus       199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-~~  277 (325)
T d1rjba_         199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-FY  277 (325)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HH
T ss_pred             cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH-HH
Confidence            999999999999987765444334445568999999999998999999999999999999998 8999986554332 22


Q ss_pred             HHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 002826          796 KWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALH  853 (876)
Q Consensus       796 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~  853 (876)
                      ..++....          +..+   ...+..+.+++.+||+.||++||||+||+++|.
T Consensus       278 ~~~~~~~~----------~~~p---~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         278 KLIQNGFK----------MDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHTTCC----------CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhcCCC----------CCCC---CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            22222111          1111   112346789999999999999999999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-45  Score=392.33  Aligned_cols=256  Identities=26%  Similarity=0.426  Sum_probs=204.5

Q ss_pred             ccccCCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||+||+|+++      +++.||||++...... ..+++.+|++++++++||||++++++|.+.+..++
T Consensus        15 ~~~~~~lG~G~-fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~   93 (301)
T d1lufa_          15 IEYVRDIGEGA-FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL   93 (301)
T ss_dssp             CEEEEEEEECS-SCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             cEEeEEEeeCC-CeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence            44455666666 9999999763      4678999998654322 24678999999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccC-----------------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCc
Q 002826          656 IYEFLQMGSLGDLICRQD-----------------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKN  712 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~N  712 (876)
                      ||||+++|+|.+++....                       ..+++..+.+++.|++.||+|||+.   +|+||||||+|
T Consensus        94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~N  170 (301)
T d1lufa_          94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  170 (301)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccc
Confidence            999999999999986432                       2488999999999999999999999   99999999999


Q ss_pred             eeeCCCCCeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCcch
Q 002826          713 ILLDADFEPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR-QAEQAEPAES  791 (876)
Q Consensus       713 Ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~-~p~~~~~~~~  791 (876)
                      ||++.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||++|. +||......+
T Consensus       171 ILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e  250 (301)
T d1lufa_         171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE  250 (301)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             eEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH
Confidence            999999999999999998776544444444566889999999999999999999999999999999985 5666543322


Q ss_pred             hhHHHHHHHHhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          792 LDVVKWVRRKINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                        ....++..      .....       +...+.++.+++.+||+.+|++||||.||+++|+++.+
T Consensus       251 --~~~~v~~~------~~~~~-------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         251 --VIYYVRDG------NILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             --HHHHHHTT------CCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             --HHHHHHcC------CCCCC-------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              22222211      11111       11223467899999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-45  Score=385.48  Aligned_cols=251  Identities=24%  Similarity=0.397  Sum_probs=197.8

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCCCCCHH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQMGSLG  666 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~  666 (876)
                      ..+|.|| ||+||+|..++++.||||++... ....+.|.+|+.++++++|||||+++|+|.+ +..++||||+++|+|.
T Consensus        23 ~~iG~G~-fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~   99 (285)
T d1fmka3          23 VKLGQGC-FGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL   99 (285)
T ss_dssp             EEEEECS-SCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred             eEEeeCC-CeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchh
Confidence            4566665 99999999988889999998654 4567889999999999999999999999854 5678999999999999


Q ss_pred             HHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccccccc
Q 002826          667 DLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSEY  745 (876)
Q Consensus       667 ~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~  745 (876)
                      +++... ...++|..+.+++.||+.|++|||+.   +|+||||||+|||++.++++||+|||+++....... .......
T Consensus       100 ~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~  175 (285)
T d1fmka3         100 DFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAK  175 (285)
T ss_dssp             HHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------------
T ss_pred             hhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc-eeecccc
Confidence            988754 45699999999999999999999999   999999999999999999999999999987754332 2334456


Q ss_pred             ccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHHHH
Q 002826          746 ALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQML  825 (876)
Q Consensus       746 gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  825 (876)
                      ||+.|+|||++..+.++.++|||||||++|||+||..|+...... ......+.+...      ....+       ..+.
T Consensus       176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~------~~~~~-------~~~~  241 (285)
T d1fmka3         176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYR------MPCPP-------ECPE  241 (285)
T ss_dssp             CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC------CCCCT-------TSCH
T ss_pred             ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCC------CCCCc-------ccCH
Confidence            899999999999999999999999999999999976665543322 223333322111      11111       1234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          826 GALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       826 ~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      .+.+++.+||+.||++||||++|++.|+++...
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            678999999999999999999999999987644

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-45  Score=391.48  Aligned_cols=246  Identities=26%  Similarity=0.339  Sum_probs=197.3

Q ss_pred             hhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      ...|.....+|.|| ||+||+|+. .+|+.||||++.......   .+.+.+|++++++++|||||++++++.+++..|+
T Consensus        14 ~~~y~~l~~lG~G~-fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   92 (309)
T d1u5ra_          14 EKLFSDLREIGHGS-FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (309)
T ss_dssp             HHHEEEEEEEEECS-SSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHhcEeeEEEecCC-CeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEE
Confidence            33466667777776 999999965 579999999997644322   2468899999999999999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      |||||++|++..++... ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 v~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          93 VMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             EEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999987666543 4799999999999999999999999   9999999999999999999999999999865432


Q ss_pred             ccccccccccccccccCccccCC---CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccccc
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYS---KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVL  812 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (876)
                            ....||+.|||||++.+   ..++.++|||||||++|||++|+.||........     ........   ...+
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~---~~~~  234 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE---SPAL  234 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSC---CCCC
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCC---CCCC
Confidence                  23459999999998753   4588999999999999999999999976433221     11111111   0111


Q ss_pred             ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                      .+      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 QS------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            11      112346789999999999999999999976

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=384.32  Aligned_cols=253  Identities=19%  Similarity=0.277  Sum_probs=201.7

Q ss_pred             hhhhcccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc------cCHHHHHHHHHHHhhccCccccceeeEEEeC
Q 002826          578 DLVIGMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC------QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD  650 (876)
Q Consensus       578 ~l~~~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  650 (876)
                      ++...|.....+|.|+ ||+||+|+. .+|+.||||++.+...      ...+.+.+|++++++++|||||++++++.++
T Consensus         7 ~i~d~Y~~~~~lG~G~-fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQ-FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK   85 (293)
T ss_dssp             CGGGTEEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CcccCEEEeEEEecCC-CeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3433344445555555 999999976 5799999999965322      2357899999999999999999999999999


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC----CeEEccc
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF----EPKLTDF  726 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~----~~kl~Df  726 (876)
                      +..|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++    .+|++||
T Consensus        86 ~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          86 TDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999999997654 799999999999999999999999   999999999999998766    5999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN  806 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  806 (876)
                      |+++.......   .....||+.|+|||++.+..++.++||||+||++|||++|+.||........  ..   ...... 
T Consensus       162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~---~i~~~~-  232 (293)
T d1jksa_         162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LA---NVSAVN-  232 (293)
T ss_dssp             TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHTTC-
T ss_pred             hhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HH---HHHhcC-
Confidence            99987754332   2344689999999999988999999999999999999999999986543321  11   111111 


Q ss_pred             ccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          807 GAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       807 ~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .. ..+..   ....+..+.+++.+||+.||++|||++|+++
T Consensus       233 --~~-~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 --YE-FEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --CC-CCHHH---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CC-CCchh---cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00 11111   1122346789999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-45  Score=380.28  Aligned_cols=244  Identities=25%  Similarity=0.426  Sum_probs=192.3

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL  665 (876)
                      ..+|.|+ ||.||+|+. .|+.||||+++..  ...+.+.+|++++++++||||++++|+|.+ ++.+|+||||+++|+|
T Consensus        13 ~~lG~G~-fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L   88 (262)
T d1byga_          13 QTIGKGE-FGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL   88 (262)
T ss_dssp             EEEEECS-SCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred             EEEecCC-CeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence            4455555 999999998 5889999998653  456789999999999999999999999865 4668999999999999


Q ss_pred             HHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccccccc
Q 002826          666 GDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTMSSE  744 (876)
Q Consensus       666 ~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~  744 (876)
                      .+++.+. ...+++..+.+++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++......     ...
T Consensus        89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~  160 (262)
T d1byga_          89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTG  160 (262)
T ss_dssp             HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCC-----ccc
Confidence            9999765 34589999999999999999999999   99999999999999999999999999998764332     223


Q ss_pred             cccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhcHHH
Q 002826          745 YALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCYQQQ  823 (876)
Q Consensus       745 ~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  823 (876)
                      .+|..|+|||.+.++.+++++||||||+++|||+| |++||.......  ....+...      ....+.+       ..
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~------~~~~~~~-------~~  225 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG------YKMDAPD-------GC  225 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTT------CCCCCCT-------TC
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC------CCCCCCc-------cC
Confidence            47888999999988899999999999999999998 788887654432  33333221      1111111       11


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          824 MLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       824 ~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      +..+.+++.+||+.||++||||.|++++|+.++.
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            2357899999999999999999999999998854

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=389.25  Aligned_cols=255  Identities=22%  Similarity=0.392  Sum_probs=200.9

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCc----EEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGE----LIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  656 (876)
                      |.....+|.|| ||+||+|.+. +|+    +||+|++... .....+++.+|++++++++|||||+++|+|.++ ..+++
T Consensus        11 y~~~~~lG~G~-fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v   88 (317)
T d1xkka_          11 FKKIKVLGSGA-FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI   88 (317)
T ss_dssp             EEEEEEEEECS-SEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred             CEEeeEEecCC-CeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence            44555666666 9999999764 454    5888888643 334567899999999999999999999999764 56788


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      +||+.+|+|.+++......+++..+.+++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+|+......
T Consensus        89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            899999999999988877899999999999999999999999   99999999999999999999999999999876544


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                      .........||+.|+|||.+.++.++.++|||||||++|||+| |++||...+...  +...+.......      . | 
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~~~------~-p-  235 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGERLP------Q-P-  235 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCCCC------C-C-
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCCCC------C-C-
Confidence            4444444568999999999998899999999999999999999 788887655433  233333221110      0 1 


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                           ...+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       236 -----~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         236 -----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                 1123457899999999999999999999999988754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=382.13  Aligned_cols=251  Identities=22%  Similarity=0.370  Sum_probs=191.3

Q ss_pred             CCCCCCCCceEEEEEEeCC----CcEEEEEEEecCCcc-CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLPS----GELIAVKKLVNFGCQ-SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|. |+||+||+|....    +..||||++...... ..+.+.+|++++++++|||||+++|++. ++..|+||||++
T Consensus        13 ~~iG~-G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~   90 (273)
T d1mp8a_          13 RCIGE-GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT   90 (273)
T ss_dssp             EEEEE-CSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             EEEee-CCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence            34555 4599999997642    356889988643322 3467889999999999999999999996 467899999999


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQSTM  741 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  741 (876)
                      +|++.+++......+++..+..++.||++||+|||+.   +|+||||||+||+++.++.+||+|||+|+........ ..
T Consensus        91 ~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~  166 (273)
T d1mp8a_          91 LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KA  166 (273)
T ss_dssp             TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------------
T ss_pred             CCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcce-ec
Confidence            9999999887777899999999999999999999999   9999999999999999999999999999876543222 23


Q ss_pred             ccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          742 SSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       742 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      ....||+.|+|||.+....++.++|||||||++|||+| |++||.......  ....+....      ...+.+      
T Consensus       167 ~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~------~~~~~~------  232 (273)
T d1mp8a_         167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGE------RLPMPP------  232 (273)
T ss_dssp             ----CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTC------CCCCCT------
T ss_pred             cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCC------CCCCCC------
Confidence            34458899999999998899999999999999999998 899998755433  222222211      111111      


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                       ..+..+.+++.+||+.||++|||++||++.|+.+.++
T Consensus       233 -~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         233 -NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             1234678999999999999999999999999988643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-44  Score=381.18  Aligned_cols=256  Identities=24%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             CCCCCCceEEEEEEeCCC----cEEEEEEEecC-CccCHHHHHHHHHHHhhccCccccceeeEEEe-CCeEEEEEEcCCC
Q 002826          589 AGNGGPFGRVYILSLPSG----ELIAVKKLVNF-GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS-DESIFLIYEFLQM  662 (876)
Q Consensus       589 ~g~~g~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~  662 (876)
                      +|.|| ||+||+|.+.++    ..||||++... .....+++.+|++++++++|||||+++|++.+ ++..++||||+++
T Consensus        35 iG~G~-fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~  113 (311)
T d1r0pa_          35 IGRGH-FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKH  113 (311)
T ss_dssp             EEEET-TEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTT
T ss_pred             EeecC-CeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeec
Confidence            55555 999999977432    36899998643 22334679999999999999999999999876 5689999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc--cc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ--ST  740 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~--~~  740 (876)
                      |+|.+++.......++..+.+++.|++.||.|+|+.   +|+||||||+|||+++++.+||+|||+++........  ..
T Consensus       114 g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         114 GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             CchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            999999988877889999999999999999999999   9999999999999999999999999999877543221  22


Q ss_pred             cccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhhhc
Q 002826          741 MSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIANCY  820 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  820 (876)
                      .....||+.|+|||......++.++||||||+++|||+||+.||....... +...++.....       ...|.     
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~-------~~~p~-----  257 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR-------LLQPE-----  257 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC-------CCCCT-----
T ss_pred             cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC-------CCCcc-----
Confidence            334568999999999998999999999999999999999888876543222 22222221111       11111     


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCccc
Q 002826          821 QQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSLL  862 (876)
Q Consensus       821 ~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~~  862 (876)
                       ..+..+.+++.+||+.||++||||+||++.|+++.......
T Consensus       258 -~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         258 -YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence             11235789999999999999999999999999998765554

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-44  Score=384.15  Aligned_cols=246  Identities=22%  Similarity=0.269  Sum_probs=201.2

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      |.....+|.|+ ||.||+|+. .+|+.||||++.+.   .....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus         7 y~~~~~lG~G~-fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           7 FDYLKLLGKGT-FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             EEEEEEEEECS-SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEecCc-CeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            44445555555 999999976 58999999999753   23456778899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |++||+|.+++.+.+ .+++..+..++.|++.|++|||++   +|+||||||+|||++.+|.+||+|||+|+......  
T Consensus        86 y~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--  159 (337)
T d1o6la_          86 YANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--  159 (337)
T ss_dssp             CCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--
T ss_pred             ccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC--
Confidence            999999999987764 689999999999999999999999   99999999999999999999999999998764322  


Q ss_pred             cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhhh
Q 002826          739 STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIAN  818 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  818 (876)
                      .......||+.|+|||++.+..++.++||||+||++|||++|++||........  ..   ......        +.++ 
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~---~i~~~~--------~~~p-  225 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--FE---LILMEE--------IRFP-  225 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HHHHCC--------CCCC-
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH--HH---HHhcCC--------CCCC-
Confidence            223445699999999999999999999999999999999999999987554321  11   111111        0011 


Q ss_pred             hcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002826          819 CYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVKA  851 (876)
Q Consensus       819 ~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~~  851 (876)
                        ...+.++.++|.+||++||++||+     ++|+++.
T Consensus       226 --~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence              112345789999999999999995     8888763

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-43  Score=373.38  Aligned_cols=256  Identities=20%  Similarity=0.272  Sum_probs=195.2

Q ss_pred             ccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---HHHHHHHHHHHhhccCccccceeeEEEeCC----eEEEE
Q 002826          585 EKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---SKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----SIFLI  656 (876)
Q Consensus       585 ~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  656 (876)
                      ++.+..|.|+||+||+|.. .+|+.||||++......+   ...+.+|+++++.++|||||++++++...+    ..|+|
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lv   89 (277)
T d1o6ya_          10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV   89 (277)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEE
Confidence            3444444455999999965 589999999997644333   346889999999999999999999998754    38999


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      |||++|++|.+++...+ .+++.++..++.||+.|++|||+.   +|+||||||+||+++.++..+++|||.+.......
T Consensus        90 mE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          90 MEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            99999999999887654 699999999999999999999999   99999999999999999999999999987654322


Q ss_pred             -cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChh
Q 002826          737 -FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPK  815 (876)
Q Consensus       737 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  815 (876)
                       .........||+.|||||++.+..+++++||||+||++|||+||++||........     ...........     +.
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~~~~~-----~~  235 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVREDPIP-----PS  235 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCCCCC-----GG
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhcCCCC-----Cc
Confidence             22233445699999999999988999999999999999999999999986543221     11111111000     00


Q ss_pred             hhhhcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhcc
Q 002826          816 IANCYQQQMLGALEIALRCTSVMPEKRP-SMFEVVKALHSLS  856 (876)
Q Consensus       816 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~ell~~L~~i~  856 (876)
                        ......+..+.+++.+|+++||++|| |++|+.+.|.++.
T Consensus       236 --~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         236 --ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             --GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence              11112234678999999999999999 8999999988764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=379.47  Aligned_cols=254  Identities=21%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC--CC--cEEEEEEEecCCc---cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP--SG--ELIAVKKLVNFGC---QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.-...+|.|| ||+||+|+..  ++  ..||||++.....   ...+++.+|++++++++|||||+++|+|.+ +..++
T Consensus        10 ~~~~~~iG~G~-fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_          10 LRLLEKLGDGS-FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             EEEEEECC-----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             eEEEEEEecCC-CeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            34445667666 9999999753  33  3789999865322   224578999999999999999999999965 46789


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||+++|++.+.+..+...+++..+.+++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            9999999999998887767899999999999999999999999   9999999999999999999999999999987644


Q ss_pred             ccc-cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHHHhhcccccccccC
Q 002826          736 AFQ-STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRRKINITNGAIQVLD  813 (876)
Q Consensus       736 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  813 (876)
                      ... .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.......  ....+.+.   .  ..    
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~---~--~~----  233 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE---G--ER----  233 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTS---C--CC----
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhC---C--CC----
Confidence            322 22334457889999999998899999999999999999998 899997654332  22222211   1  00    


Q ss_pred             hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhc
Q 002826          814 PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSL  855 (876)
Q Consensus       814 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i  855 (876)
                      +..   ....+..+.+++.+||+.||++||||.||.+.|++.
T Consensus       234 ~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         234 LPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            000   111223578999999999999999999999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-44  Score=383.01  Aligned_cols=251  Identities=20%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             hhcccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          580 VIGMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       580 ~~~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ...|.-...+|.|+ ||+||+|... +|+.||||++.... .+...+.+|+++++.++|||||++++++.+++..|+|||
T Consensus         4 ~~rY~i~~~lG~G~-fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGE-FGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCC-CeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            33444445555555 9999999764 79999999997643 334568899999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCC--CCeEEccccchhhccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDAD--FEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~--~~~kl~DfGla~~~~~~~  736 (876)
                      ||+||+|.+++.+.+..+++..+..++.||+.|++|||+.   +|+||||||+|||++.+  ..+||+|||+++......
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999987776899999999999999999999999   99999999999999854  589999999998765433


Q ss_pred             cccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhh
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKI  816 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  816 (876)
                      .   .....+|+.|+|||...+..++.++||||+||++|||++|+.||........  ...+..   ..   . .++...
T Consensus       159 ~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~~i~~---~~---~-~~~~~~  226 (321)
T d1tkia_         159 N---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMN---AE---Y-TFDEEA  226 (321)
T ss_dssp             E---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHH---TC---C-CCCHHH
T ss_pred             c---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HHHHHh---CC---C-CCChhh
Confidence            2   2334588999999999999999999999999999999999999987543321  111111   11   0 011111


Q ss_pred             hhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          817 ANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       817 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                         +...+.++.+++.+|++.||++|||+.|+++
T Consensus       227 ---~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 ---FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               1112345789999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-44  Score=382.08  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=192.0

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeC-CeEEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSD-ESIFLIY  657 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~lv~  657 (876)
                      ..+|.|| ||.||+|...      +++.||||++..... ...+.+.+|+..+.++ +|+||+.+++++.++ +..++||
T Consensus        19 ~~iG~G~-fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          19 KPLGRGA-FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEECS-SCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eEEeecC-CeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            4455555 9999999752      357899999865332 2345677888888887 689999999998764 4689999


Q ss_pred             EcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeE
Q 002826          658 EFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPK  722 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~k  722 (876)
                      ||+++|+|.+++....               ..+++..+..++.||+.||+|||+.   +|+||||||+|||+++++.+|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEE
Confidence            9999999999996532               3488999999999999999999999   999999999999999999999


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCcchhhHHHHHHHH
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITG-RQAEQAEPAESLDVVKWVRRK  801 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~  801 (876)
                      |+|||+|+...............||+.|||||.+.+..++.++|||||||++|||+|| .+||....... .....+...
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~~~~~~~~~  253 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEG  253 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHHHHHHT
T ss_pred             EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcC
Confidence            9999999877654433444556799999999999999999999999999999999997 45676544332 222222221


Q ss_pred             hhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccC
Q 002826          802 INITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTR  858 (876)
Q Consensus       802 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~  858 (876)
                      ...          ...   ...+.++.+++.+||+.||++||||.|++++|+++.+.
T Consensus       254 ~~~----------~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         254 TRM----------RAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CCC----------CCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC----------CCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            111          111   11233578999999999999999999999999998653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=377.46  Aligned_cols=264  Identities=26%  Similarity=0.321  Sum_probs=196.9

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeCC----eEEEEEEcCCC
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----SIFLIYEFLQM  662 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~~~~  662 (876)
                      ..+|.|| ||+||+|+. +|+.||||++.... ......+.|+..+..++|||||+++|+|.+++    .+|+||||+++
T Consensus         9 ~~iG~G~-fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           9 ESIGKGR-FGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEECCS-SSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEeeCC-CeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            3456655 999999987 78999999986432 11222344555666789999999999998754    68999999999


Q ss_pred             CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC-----CCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          663 GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY-----VPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       663 gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      |+|.+++++.  .++|..+.+++.|+|.|++|+|+..     ..+|+||||||+|||++.++.+||+|||+++.......
T Consensus        86 g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~  163 (303)
T d1vjya_          86 GSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  163 (303)
T ss_dssp             CBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             CCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCc
Confidence            9999999764  5899999999999999999999731     24999999999999999999999999999988754322


Q ss_pred             c--cccccccccccccCccccCCCC------CCCccchHHHHHHHHHHHhCCCCCCCCCcchh---------hHHHHHHH
Q 002826          738 Q--STMSSEYALSCYNAPEYGYSKK------ATAQMDAYSFGVVLLELITGRQAEQAEPAESL---------DVVKWVRR  800 (876)
Q Consensus       738 ~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~---------~~~~~~~~  800 (876)
                      .  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||........         ...+..+.
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (303)
T d1vjya_         164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK  243 (303)
T ss_dssp             EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred             ceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH
Confidence            1  2234567999999999876542      56789999999999999999988754332211         11111111


Q ss_pred             HhhcccccccccChhhhhh--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          801 KINITNGAIQVLDPKIANC--YQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                      ..     ....++|.+...  ..+....+.+++.+||+.||++||||.||++.|+++.++.+
T Consensus       244 ~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         244 VV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            11     111222332211  22345668899999999999999999999999999876544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=381.00  Aligned_cols=253  Identities=25%  Similarity=0.388  Sum_probs=205.1

Q ss_pred             CCCCCCCCceEEEEEEe------CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEE
Q 002826          587 SSAGNGGPFGRVYILSL------PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      ..+|.|| ||.||+|++      .+++.||||++..... ....++.+|+.+++++ +|||||+++|+|.+++..++|||
T Consensus        29 ~~iG~G~-fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          29 KTLGAGA-FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEECS-SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eEEeecC-CeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            3455555 999999975      3567899999975432 3345788999999999 69999999999999999999999


Q ss_pred             cCCCCCHHHHhhccC-----------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          659 FLQMGSLGDLICRQD-----------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      |+++|+|.+++.+..                 ..+++..+.+++.||+.|++|||++   +++||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence            999999999987542                 2588999999999999999999999   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      |++|||.++...............||+.|+|||.+.++.++.++|||||||++|||+| |.+||...+.. ..+.+.+..
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~~~~~i~~  263 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKE  263 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHH
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhc
Confidence            9999999998775554455566679999999999998999999999999999999999 55555544332 223333333


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      .....       .+      ...+..+.+++.+||++||++||||.||+++|+++..
T Consensus       264 ~~~~~-------~~------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         264 GFRML-------SP------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCCC-------CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCC-------Cc------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            21111       11      1123467899999999999999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.3e-43  Score=373.86  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=200.0

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|.....+|.|+ ||+||+|+. .+|+.||||++...   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         5 dy~i~~~lG~G~-fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           5 DFQILRTLGTGS-FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HeEEEEEEecCc-CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            344455666665 999999976 57999999999642   2245678899999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||++||++.+++.... .+++..+..++.||+.|++|||++   +|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-  158 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-  158 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence            9999999999887654 688999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                          ....||+.|||||++.+..++.++||||+||++|||+||+.||........     ..+.......    +.+   
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~i~~~~~~----~p~---  222 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-----YEKILNAELR----FPP---  222 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHCCCC----CCT---
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-----HHHHHcCCCC----CCC---
Confidence                345699999999999998999999999999999999999999986543221     1111111100    111   


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVKA  851 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~~  851 (876)
                          ..+.++.+++.+|+++||++||     |++|+++.
T Consensus       223 ----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         223 ----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                1123578999999999999996     89999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-43  Score=379.83  Aligned_cols=258  Identities=20%  Similarity=0.289  Sum_probs=200.4

Q ss_pred             cchhhhhhcccccCC-CCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhc-cCccccceeeEEEe-
Q 002826          574 VTEHDLVIGMDEKSS-AGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHS-  649 (876)
Q Consensus       574 ~~~~~l~~~~~~~~~-~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  649 (876)
                      +....+..+|+...+ +|.|+ ||+||+|+. .+|+.||||++..     ...+.+|++++.++ +|||||+++++|.+ 
T Consensus         4 ~~~~~i~~~y~i~~~~lG~G~-fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~   77 (335)
T d2ozaa1           4 IKKNAIIDDYKVTSQVLGLGI-NGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL   77 (335)
T ss_dssp             CBCSCGGGTEEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCCCCcccCEEEeeEEeeecc-CeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence            444555556655556 55555 999999965 5899999999853     35678899987665 89999999999876 


Q ss_pred             ---CCeEEEEEEcCCCCCHHHHhhcc-CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC---CCCeE
Q 002826          650 ---DESIFLIYEFLQMGSLGDLICRQ-DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA---DFEPK  722 (876)
Q Consensus       650 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~---~~~~k  722 (876)
                         +...|+|||||+||+|.+++.+. ...+++..+..++.||+.|++|||+.   +|+||||||+|||++.   ++.+|
T Consensus        78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~K  154 (335)
T d2ozaa1          78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILK  154 (335)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEE
T ss_pred             ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccc
Confidence               45689999999999999999765 35799999999999999999999999   9999999999999985   46799


Q ss_pred             EccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh
Q 002826          723 LTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI  802 (876)
Q Consensus       723 l~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~  802 (876)
                      |+|||+|+......   ......||+.|||||++.+..++.++||||+||++|||+||++||........  ....... 
T Consensus       155 l~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~~-  228 (335)
T d2ozaa1         155 LTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKTR-  228 (335)
T ss_dssp             ECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C-
T ss_pred             ccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHHH-
Confidence            99999998765433   23445699999999999988999999999999999999999999976543221  1111111 


Q ss_pred             hcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          803 NITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       803 ~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                       ..........+    .+...+.++.+++.+|++.||++|||+.|+++.
T Consensus       229 -i~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         229 -IRMGQYEFPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -CCSCSSSCCTT----HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HhcCCCCCCCc----ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             11001111111    122334568899999999999999999999873

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=378.58  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             CCCCCCCCceEEEEEEeC--------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEE
Q 002826          587 SSAGNGGPFGRVYILSLP--------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLI  656 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  656 (876)
                      ..+|.|| ||.||+|+..        ++..||||++..... ....++.+|+..+.++ +|||||+++++|.+++..++|
T Consensus        19 ~~iG~G~-fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          19 KPLGEGA-FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EECC------CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eEEeecC-CcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            4455555 9999999652        234799999876432 2346788899999888 899999999999999999999


Q ss_pred             EEcCCCCCHHHHhhccC---------------CcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCe
Q 002826          657 YEFLQMGSLGDLICRQD---------------FQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEP  721 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~  721 (876)
                      |||+++|+|.+++....               ..+++.++.+++.|++.||+|||+.   +|+||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCe
Confidence            99999999999996542               3589999999999999999999999   99999999999999999999


Q ss_pred             EEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHh-CCCCCCCCCcchhhHHHHHHH
Q 002826          722 KLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELIT-GRQAEQAEPAESLDVVKWVRR  800 (876)
Q Consensus       722 kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~  800 (876)
                      ||+|||+++...............||+.|+|||.+.++.+++++|||||||++|||++ |++||.......  ....+..
T Consensus       175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--~~~~i~~  252 (299)
T d1fgka_         175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLLKE  252 (299)
T ss_dssp             EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHT
T ss_pred             EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--HHHHHHc
Confidence            9999999998875544444555668999999999998999999999999999999998 788887644332  2222221


Q ss_pred             HhhcccccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          801 KINITNGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       801 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                      ...      ....+       ..+..+.+++.+||+.||++||||.||++.|+++..
T Consensus       253 ~~~------~~~p~-------~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         253 GHR------MDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             TCC------CCCCS-------SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC------CCCCc-------cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            111      11111       123357899999999999999999999999998754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=379.55  Aligned_cols=254  Identities=22%  Similarity=0.324  Sum_probs=204.3

Q ss_pred             CCCCCCCCceEEEEEEeC------CCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          587 SSAGNGGPFGRVYILSLP------SGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ..+|.|| ||+||+|.+.      +++.||||++..... .....+.+|++++++++|||||+++|+|..++..++||||
T Consensus        26 ~~lG~G~-fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~  104 (308)
T d1p4oa_          26 RELGQGS-FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  104 (308)
T ss_dssp             EEEEECS-SSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEeeCC-CeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence            4566665 9999999653      367899999865322 2234688999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhcc---------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          660 LQMGSLGDLICRQ---------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       660 ~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +++|+|.+++...         ...+++..+.+++.|+|+||.|||+.   +|+||||||+|||++.++++||+|||+++
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccce
Confidence            9999999998643         13478999999999999999999999   99999999999999999999999999999


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCC-CCCCCCCcchhhHHHHHHHHhhcccccc
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGR-QAEQAEPAESLDVVKWVRRKINITNGAI  809 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (876)
                      ...............||+.|+|||.+.+..++.++||||||+++|||+||. +||.......  ....+..   ..  . 
T Consensus       182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~~~i~~---~~--~-  253 (308)
T d1p4oa_         182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVME---GG--L-  253 (308)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHT---TC--C-
T ss_pred             eccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh---CC--C-
Confidence            876554444455567899999999999999999999999999999999985 6665433222  1222111   11  0 


Q ss_pred             cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCC
Q 002826          810 QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRT  859 (876)
Q Consensus       810 ~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~  859 (876)
                          +.   .+...+..+.+++.+||+.+|++||||+||+++|++..+..
T Consensus       254 ----~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         254 ----LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             ----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             ----CC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence                00   01112346889999999999999999999999999886654

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=369.91  Aligned_cols=268  Identities=22%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYE  658 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  658 (876)
                      +|.....+|.|+ ||+||+|.. .+|+.||||++.....  ....++.+|++++++++|||||++++++.+++..|+|||
T Consensus         3 ~Y~~~~~lG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGT-YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCc-CeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            455556667666 999999965 5899999999964322  335788999999999999999999999999999999999


Q ss_pred             cCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccc
Q 002826          659 FLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       659 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  738 (876)
                      |+.++.+..........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||.|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            9987544444444466799999999999999999999999   99999999999999999999999999998875433  


Q ss_pred             cccccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccc--------
Q 002826          739 STMSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAI--------  809 (876)
Q Consensus       739 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------  809 (876)
                      .......||+.|+|||...... ++.++||||+||++|||++|+.||........ ................        
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhccccccccc
Confidence            2334456999999999866554 58899999999999999999999986543221 1111111111000000        


Q ss_pred             ------cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhcc
Q 002826          810 ------QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLS  856 (876)
Q Consensus       810 ------~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~  856 (876)
                            .................+.+++.+|+..||++|||++|+++.  ++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~  290 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT  290 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence                  000111111122234568899999999999999999999985  55553

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.6e-42  Score=361.60  Aligned_cols=249  Identities=24%  Similarity=0.305  Sum_probs=197.5

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccC---------HHHHHHHHHHHhhcc-CccccceeeEEEeCC
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQS---------SKTLKTEVKTLAKIR-HKNIVKVLGFFHSDE  651 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  651 (876)
                      |.....+|.| +||+||+|+. .+|+.||||++.......         .+.+.+|+.++++++ |||||++++++.+++
T Consensus         5 y~~~~~iG~G-~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~   83 (277)
T d1phka_           5 YEPKEILGRG-VSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT   83 (277)
T ss_dssp             EEEEEEEEEC-SSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CEEceEEecC-cCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence            3333445554 5999999976 589999999997643211         235778999999997 999999999999999


Q ss_pred             eEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhh
Q 002826          652 SIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRI  731 (876)
Q Consensus       652 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~  731 (876)
                      ..|+||||+++|+|.+++...+ .+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          84 FFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence            9999999999999999997655 799999999999999999999999   999999999999999999999999999988


Q ss_pred             ccccccccccccccccccccCccccC------CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGY------SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      ......   .....||+.|+|||.+.      ...++.++||||+||++|||++|+.||........  ...+..   ..
T Consensus       160 ~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~--~~~i~~---~~  231 (277)
T d1phka_         160 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--LRMIMS---GN  231 (277)
T ss_dssp             CCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH---TC
T ss_pred             ccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH--HHHHHh---CC
Confidence            765332   23456899999999864      34578899999999999999999999987543321  111111   11


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                         .....+...    ..+.++.+++.+||++||++|||+.|+++.
T Consensus       232 ---~~~~~~~~~----~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         232 ---YQFGSPEWD----DYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ---CCCCTTTGG----GSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ---CCCCCcccc----cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               111111111    223467899999999999999999998763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8e-43  Score=379.21  Aligned_cols=243  Identities=20%  Similarity=0.227  Sum_probs=199.6

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecC---CccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNF---GCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      +|..+..+|.|+ ||+||+|+. .+|+.||||++...   .....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus        42 ~y~i~~~lG~G~-fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          42 QFDRIKTLGTGS-FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GEEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEEEEeecCc-CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            454555666555 999999976 47999999998642   2244567889999999999999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+.+|+|.+++.+.+ .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999997665 699999999999999999999999   9999999999999999999999999999876532  


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                         .....||+.|||||++.+..++.++||||+||++|||+||+.||.......  ....+.   ......         
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~i~---~~~~~~---------  257 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IYEKIV---SGKVRF---------  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH---HCCCCC---------
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--HHHHHh---cCCCCC---------
Confidence               223469999999999999999999999999999999999999997643222  111111   111000         


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                        +...+.++.+++.+||+.||++|+     |++|+++
T Consensus       258 --p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              011234578999999999999994     8999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=376.04  Aligned_cols=252  Identities=21%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             CCCCCCCCceEEEEEEeC-CCc--EEEEEEEecC-CccCHHHHHHHHHHHhhc-cCccccceeeEEEeCCeEEEEEEcCC
Q 002826          587 SSAGNGGPFGRVYILSLP-SGE--LIAVKKLVNF-GCQSSKTLKTEVKTLAKI-RHKNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      ..+|.|+ ||+||+|.+. +|.  .||||++... .....+++.+|+++++++ +|||||+++|+|.+++..++||||++
T Consensus        16 ~~iG~G~-fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          16 DVIGEGN-FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEECGG-GCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEeeCC-CcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            3455555 9999999775 444  4788887543 223456799999999999 79999999999999999999999999


Q ss_pred             CCCHHHHhhcc---------------CCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccc
Q 002826          662 MGSLGDLICRQ---------------DFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDF  726 (876)
Q Consensus       662 ~gsL~~~l~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~Df  726 (876)
                      +|+|.+++.+.               ...+++..+.+++.|||.|+.|+|+.   +|+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence            99999998653               35799999999999999999999999   9999999999999999999999999


Q ss_pred             cchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCC-CCCCCCcchhhHHHHHHHHhhcc
Q 002826          727 ALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQ-AEQAEPAESLDVVKWVRRKINIT  805 (876)
Q Consensus       727 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~  805 (876)
                      |+++.......   .....||..|+|||.+....++.++|||||||++|||++|.. ||......  .....+..   . 
T Consensus       172 G~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~~---~-  242 (309)
T d1fvra_         172 GLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ---G-  242 (309)
T ss_dssp             TCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGG---T-
T ss_pred             ccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHHHh---c-
Confidence            99976543321   223458899999999998899999999999999999999764 56543322  22222111   1 


Q ss_pred             cccccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCc
Q 002826          806 NGAIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTS  860 (876)
Q Consensus       806 ~~~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~  860 (876)
                        .    .+...   ...+..+.+++.+||+.||++||||+||++.|+++.++..
T Consensus       243 --~----~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         243 --Y----RLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             --C----CCCCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             --C----CCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence              0    11111   1123467899999999999999999999999999876543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-42  Score=377.28  Aligned_cols=246  Identities=19%  Similarity=0.214  Sum_probs=193.4

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCC---ccCHHHHHH---HHHHHhhccCccccceeeEEEeCCeEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFG---CQSSKTLKT---EVKTLAKIRHKNIVKVLGFFHSDESIFL  655 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~l  655 (876)
                      |.....+|.|| ||.||+|+.. +|+.||||++.+..   ......+.+   |+++++.++|||||++++++.+++..|+
T Consensus         6 y~i~~~lG~G~-fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           6 FSVHRIIGRGG-FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             EEEEEEEEECS-SCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             CeeeeEEecCC-CeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            33344555555 9999999764 79999999986421   123333444   4667777789999999999999999999


Q ss_pred             EEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccc
Q 002826          656 IYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEA  735 (876)
Q Consensus       656 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~  735 (876)
                      ||||++||+|.+++.+.. .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        85 vmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            999999999999997654 689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             ccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccCh
Q 002826          736 AFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDP  814 (876)
Q Consensus       736 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  814 (876)
                      .    .....||+.|+|||++.. ..++.++||||+||++|||+||+.||.........  ...+......        +
T Consensus       161 ~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~--------~  226 (364)
T d1omwa3         161 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA--------V  226 (364)
T ss_dssp             C----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCC--------C
T ss_pred             c----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCC--------C
Confidence            2    234469999999999864 56899999999999999999999999875543321  1212111111        0


Q ss_pred             hhhhhcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 002826          815 KIANCYQQQMLGALEIALRCTSVMPEKRPS-----MFEVVK  850 (876)
Q Consensus       815 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~ell~  850 (876)
                      ...   ...+.++.++|.+||+.||++|||     ++|+++
T Consensus       227 ~~~---~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCC---SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC---CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            111   112335789999999999999999     688875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-42  Score=369.19  Aligned_cols=255  Identities=22%  Similarity=0.288  Sum_probs=192.5

Q ss_pred             CCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc-----CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          587 SSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ-----SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      ..+|.|+ ||+||+|.. .+|+.||||++......     ..+.+.+|++++++++|||||++++++.++++.|+||||+
T Consensus         4 ~~lG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           4 DFLGEGQ-FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEET-TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             eEeccCc-CeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            3455555 999999976 47999999998643221     1346889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .++++..+.. ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~  156 (299)
T d1ua2a_          83 ETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--A  156 (299)
T ss_dssp             SEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--C
T ss_pred             cchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc--c
Confidence            9877666554 445789999999999999999999999   999999999999999999999999999987654322  2


Q ss_pred             cccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc--cc----------
Q 002826          741 MSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT--NG----------  807 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~----------  807 (876)
                      .....||+.|+|||.+... .++.++||||+||++|||+||++||......+  ....+.+.....  ..          
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~~~~  234 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSLPDY  234 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhccchh
Confidence            2344689999999987654 57999999999999999999999997654322  122221111000  00          


Q ss_pred             --cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          808 --AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       808 --~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        ........+.........++.+++.+|++.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              0000000111112223457889999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-43  Score=374.10  Aligned_cols=245  Identities=23%  Similarity=0.329  Sum_probs=196.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecC---CccCHHHHHHHHHHHh-hccCccccceeeEEEeCCeEEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNF---GCQSSKTLKTEVKTLA-KIRHKNIVKVLGFFHSDESIFLIY  657 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~  657 (876)
                      |.-...+|.|+ ||+||+|... +|+.||||++.+.   .....+.+..|..++. .++|||||++++++.+++..|+||
T Consensus         4 y~i~~~iG~G~-fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           4 FILHKMLGKGS-FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             eEEeeEEecCC-CcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            33344555555 9999999664 7999999999642   2244556667777665 679999999999999999999999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAF  737 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~  737 (876)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+++...... 
T Consensus        83 Ey~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-  157 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-  157 (320)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-
T ss_pred             eecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-
Confidence            9999999999997654 689999999999999999999999   99999999999999999999999999998665332 


Q ss_pred             ccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccccChhhh
Q 002826          738 QSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQVLDPKIA  817 (876)
Q Consensus       738 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  817 (876)
                       .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.....  ....+..   ..        +.++
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~---~~--------~~~p  223 (320)
T d1xjda_         158 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRM---DN--------PFYP  223 (320)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH---CC--------CCCC
T ss_pred             -ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHc---CC--------CCCC
Confidence             22344569999999999999999999999999999999999999998654332  1111111   11        1111


Q ss_pred             hhcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002826          818 NCYQQQMLGALEIALRCTSVMPEKRPSMF-EVVK  850 (876)
Q Consensus       818 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~-ell~  850 (876)
                      .   ..+.++.+++.+||+.||++|||+. |+++
T Consensus       224 ~---~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 R---WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             T---TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             c---cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            1   1234578999999999999999996 6754

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3e-41  Score=363.93  Aligned_cols=294  Identities=27%  Similarity=0.476  Sum_probs=177.8

Q ss_pred             CChhHHHHHHHHHhhccCCCCCCCCCCCCCCCCCcc--ccceEecCCCCCccEEEEeecCCCCCcc--cccccccCCCCC
Q 002826           26 SASTEKDTLLSFKASIDDSKNSLSTWSNTSNIHYCN--WTGVTCVTTATASLTVASINLQSLNLSG--EISSSVCELSSL  101 (876)
Q Consensus        26 ~~~~~~~all~~k~~~~~~~~~~~sW~~~~~~~~C~--w~gv~c~~~~~~~~~~~~l~l~~~~l~~--~~~~~~~~l~~L  101 (876)
                      |.++|++||++||+++.||. .+++|..+  .|||.  |.||+|+..+ .+.+|+.++|.+++++|  .+|+++++|++|
T Consensus         3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~--~d~C~~~w~gv~C~~~~-~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L   78 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT--TDCCNRTWLGVLCDTDT-QTYRVNNLDLSGLNLPKPYPIPSSLANLPYL   78 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCG-GGTTCCTT--SCTTTTCSTTEEECCSS-SCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred             CCHHHHHHHHHHHHHCCCCC-cCCCCCCC--CCCCCCcCCCeEEeCCC-CcEEEEEEECCCCCCCCCCCCChHHhcCccc
Confidence            78999999999999999875 68999754  48995  9999998653 34578888888888887  467777777777


Q ss_pred             CeeecCC-CccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCC
Q 002826          102 SNLNLAD-NLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNF  180 (876)
Q Consensus       102 ~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  180 (876)
                      ++|+|++ |+++|.+|.+|++|++|++|+|          ++|++.+..|..+..+.+|+++++++|++.+.+|..    
T Consensus        79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~L----------s~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~----  144 (313)
T d1ogqa_          79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYI----------THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS----  144 (313)
T ss_dssp             SEEEEEEETTEESCCCGGGGGCTTCSEEEE----------EEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGG----
T ss_pred             cccccccccccccccccccccccccchhhh----------ccccccccccccccchhhhcccccccccccccCchh----
Confidence            7777765 5666655555555555554432          233333444444444555555555555544444444    


Q ss_pred             CcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCC-cEEecccCccCCCCCCccccccccccE
Q 002826          181 SELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL-SILDLSQNNLTGEVPQSLGSSLLKLVS  259 (876)
Q Consensus       181 ~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~ip~~~~~~l~~L~~  259 (876)
                                           +.++++|+.+++++|.+.+.+|+.+..+.++ +.+++++|++++..|..+. .+ ++..
T Consensus       145 ---------------------l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~-~l-~~~~  201 (313)
T d1ogqa_         145 ---------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA-NL-NLAF  201 (313)
T ss_dssp             ---------------------GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGG-GC-CCSE
T ss_pred             ---------------------hccCcccceeecccccccccccccccccccccccccccccccccccccccc-cc-cccc
Confidence                                 4444444444444444555555555555554 5566666666654444432 12 3334


Q ss_pred             EEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcc
Q 002826          260 FDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRF  339 (876)
Q Consensus       260 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  339 (876)
                      +++++|...+.+|..+..+++++.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..|.++++|++|+|++|+|
T Consensus       202 l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l  280 (313)
T d1ogqa_         202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL  280 (313)
T ss_dssp             EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred             ccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcc
Confidence            5555555555555555555555566665555554433 345555555555555555555555555566666666666666


Q ss_pred             cccCccccccCCCCCeeeccCcc
Q 002826          340 SGAIPDSISMAAQLEQVQIDNNR  362 (876)
Q Consensus       340 ~~~~~~~~~~l~~L~~L~L~~N~  362 (876)
                      +|.+|. +..+++|+.+++++|+
T Consensus       281 ~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         281 CGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEECCC-STTGGGSCGGGTCSSS
T ss_pred             cccCCC-cccCCCCCHHHhCCCc
Confidence            555553 3445555555555554

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.4e-41  Score=358.02  Aligned_cols=260  Identities=22%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             ccccCCCCCCCCceEEEEEEeCCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEcC
Q 002826          583 MDEKSSAGNGGPFGRVYILSLPSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEFL  660 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  660 (876)
                      |.....+|.|+ ||+||+|+.++|+.||||++....  ......+.+|+.++++++|||||++++++.+++..+++|||+
T Consensus         4 Y~~~~~iG~G~-fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~   82 (286)
T d1ob3a_           4 YHGLEKIGEGT-YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (286)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             ceeccEEecCC-CcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence            34455566555 999999998999999999996542  233578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccccccc
Q 002826          661 QMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQST  740 (876)
Q Consensus       661 ~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  740 (876)
                      .++.+..+.. ....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+........  .
T Consensus        83 ~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~  156 (286)
T d1ob3a_          83 DQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--K  156 (286)
T ss_dssp             SEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             hhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc--c
Confidence            8866665554 445799999999999999999999999   999999999999999999999999999988764332  2


Q ss_pred             cccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcc----cccccc----
Q 002826          741 MSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINIT----NGAIQV----  811 (876)
Q Consensus       741 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~----  811 (876)
                      .....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .....+......    ......    
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhcc
Confidence            233458889999998765 4578999999999999999999999986543221 111111111000    000000    


Q ss_pred             -----cChh-hhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          812 -----LDPK-IANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       812 -----~d~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                           ..+. ...........+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 0000 00111122346789999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=364.34  Aligned_cols=265  Identities=19%  Similarity=0.276  Sum_probs=197.2

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CC-CcEEEEEEEecCC--ccCHHHHHHHHHHHhhc---cCccccceeeEEEe-----C
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PS-GELIAVKKLVNFG--CQSSKTLKTEVKTLAKI---RHKNIVKVLGFFHS-----D  650 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~  650 (876)
                      |.....+|.|+ ||+||+|+. ++ ++.||||++....  ......+.+|+++++.+   +||||++++++|..     .
T Consensus         9 Y~i~~~LG~G~-fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           9 YECVAEIGEGA-YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             EEEEEEEEEET-TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             EEEEEEEeccc-CeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            43445555555 999999976 44 6779999986432  22344567788887776   79999999999864     3


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      ...+++|||++++++..........+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhh
Confidence            468999999999877766666667799999999999999999999999   99999999999999999999999999987


Q ss_pred             hccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhc-ccc--
Q 002826          731 IVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINI-TNG--  807 (876)
Q Consensus       731 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~--  807 (876)
                      ......   ......||+.|+|||++.+..++.++||||+||++|||++|++||......+. ........... ...  
T Consensus       165 ~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCGGGSC
T ss_pred             hhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCchhccc
Confidence            654332   23455699999999999999999999999999999999999999986543321 11111111100 000  


Q ss_pred             ---------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhc
Q 002826          808 ---------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSL  855 (876)
Q Consensus       808 ---------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i  855 (876)
                               ...................+.+++.+||++||++|||++|+++.  ++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                     00000011111222234567899999999999999999999874  5544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=360.49  Aligned_cols=238  Identities=21%  Similarity=0.318  Sum_probs=189.1

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc------CHHHHHHHHHHHhhcc--CccccceeeEEEeCCeEE
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ------SSKTLKTEVKTLAKIR--HKNIVKVLGFFHSDESIF  654 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~  654 (876)
                      |++.+..|.|+||+||+|+. .+|+.||||++......      ...++.+|++++++++  |||||++++++.+++..|
T Consensus         6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~   85 (273)
T d1xwsa_           6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV   85 (273)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred             EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence            34444445555999999976 57999999999653221      2234678999999996  899999999999999999


Q ss_pred             EEEEcCCC-CCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-CCCeEEccccchhhc
Q 002826          655 LIYEFLQM-GSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-DFEPKLTDFALDRIV  732 (876)
Q Consensus       655 lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-~~~~kl~DfGla~~~  732 (876)
                      +||||+.+ +++.+++.+.. .+++..+..++.|++.|++|||+.   +|+||||||+|||++. ++.+||+|||+|+..
T Consensus        86 lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          86 LILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             EEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence            99999976 57888876654 799999999999999999999999   9999999999999985 479999999999865


Q ss_pred             cccccccccccccccccccCccccCCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKA-TAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQV  811 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (876)
                      ....    .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....       +..+.    .    ..
T Consensus       162 ~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~i~~~----~----~~  222 (273)
T d1xwsa_         162 KDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------EIIRG----Q----VF  222 (273)
T ss_dssp             CSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HHHHC----C----CC
T ss_pred             cccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------HHhhc----c----cC
Confidence            4332    334569999999999876554 677999999999999999999996421       11111    0    01


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      +.+.       .+.++.+++.+||+.||++|||++|+++.
T Consensus       223 ~~~~-------~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         223 FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CSSC-------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCC-------CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1111       12357899999999999999999999873

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.6e-40  Score=353.29  Aligned_cols=263  Identities=14%  Similarity=0.115  Sum_probs=205.3

Q ss_pred             cccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccC-ccccceeeEEEeCCeEEEEEEcCC
Q 002826          584 DEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~  661 (876)
                      |++.+.+|.|+||+||+|+.. +|+.||||++...  .....+.+|++.++.++| +|++.+++++.++...++||||+ 
T Consensus         7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            344444445559999999764 7999999988653  334567889999999965 89999999999999999999998 


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCC-----CCCeEEccccchhhccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDA-----DFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~-----~~~~kl~DfGla~~~~~~~  736 (876)
                      +++|.+++...+..+++.++..++.|++.|++|||+.   +|+||||||+||+++.     ++.+||+|||+|+......
T Consensus        84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            6799999987777899999999999999999999999   9999999999999974     5789999999998765322


Q ss_pred             cc-----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchh-hHHHHHHHHhhccccccc
Q 002826          737 FQ-----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESL-DVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       737 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  810 (876)
                      ..     .......||+.|||||.+.+..++.++||||+||++|||+||+.||........ .....+.......     
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~-----  235 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-----  235 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-----
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC-----
Confidence            11     123345699999999999999999999999999999999999999986544332 1111111111000     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhcccCCcc
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLSTRTSL  861 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~~~~~  861 (876)
                          ...+.....+.++.+++..|+..+|++||+++.+.+.|+++.++...
T Consensus       236 ----~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         236 ----PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             ----CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             ----ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence                00111112234678999999999999999999999999998655443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-40  Score=353.69  Aligned_cols=258  Identities=18%  Similarity=0.167  Sum_probs=195.1

Q ss_pred             cccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccce-eeEEEeCCeEEEEEEcCC
Q 002826          584 DEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKV-LGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       584 ~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e~~~  661 (876)
                      |++.+.+|.|+||+||+|+. .+|+.||||++....  ...++..|+++++.++|+|++.. .+++.+++..++||||+.
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            34444444555999999965 579999999986543  33457889999999987765555 555677888999999995


Q ss_pred             CCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeC---CCCCeEEccccchhhccccccc
Q 002826          662 MGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLD---ADFEPKLTDFALDRIVGEAAFQ  738 (876)
Q Consensus       662 ~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~---~~~~~kl~DfGla~~~~~~~~~  738 (876)
                       +++.+.+......+++..+..++.|++.||+|||++   +|+||||||+|||++   .+..+|++|||+|+........
T Consensus        87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          87 -PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             -CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             -CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence             577777766667899999999999999999999999   999999999999986   4567999999999887543221


Q ss_pred             -----cccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhH--HHHHHHHhhcccccccc
Q 002826          739 -----STMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDV--VKWVRRKINITNGAIQV  811 (876)
Q Consensus       739 -----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  811 (876)
                           .......||+.|||||.+.+..++.++|||||||++|||+||+.||..........  ..+........      
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~------  236 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------  236 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC------
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC------
Confidence                 12334569999999999999899999999999999999999999998755433211  11111111110      


Q ss_pred             cChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhccc
Q 002826          812 LDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKALHSLST  857 (876)
Q Consensus       812 ~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~L~~i~~  857 (876)
                          ........+.++.+++.+||+.+|++||+++++.+.|+.+..
T Consensus       237 ----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         237 ----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                111111223468899999999999999999999999988644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=354.07  Aligned_cols=261  Identities=21%  Similarity=0.277  Sum_probs=192.0

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc-cCHHHHHHHHHHHhhccCccccceeeEEEeCC----eEEEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC-QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE----SIFLI  656 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  656 (876)
                      |..+..+|.|+ ||+||+|.. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++....    ..+++
T Consensus        10 Y~~~~~LG~G~-fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l   88 (345)
T d1pmea_          10 YTNLSYIGEGA-YGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL   88 (345)
T ss_dssp             EEEEEECC----CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             eEEEEEEeecc-CeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence            44445555555 999999965 6899999999965432 23457889999999999999999999997643    23445


Q ss_pred             EEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccccc
Q 002826          657 YEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAA  736 (876)
Q Consensus       657 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~  736 (876)
                      ++|+.+|+|.+++...  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        89 ~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          89 VTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            5567789999999754  589999999999999999999999   99999999999999999999999999998765432


Q ss_pred             c-ccccccccccccccCccccC-CCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccc--c-----
Q 002826          737 F-QSTMSSEYALSCYNAPEYGY-SKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITN--G-----  807 (876)
Q Consensus       737 ~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-----  807 (876)
                      . ........||+.|+|||.+. ...++.++||||+||++|||++|+.||.........  ...........  .     
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL--NHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHTCC
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH--HHHhhhccCCChhhhhhhh
Confidence            2 22234556899999999875 456789999999999999999999999875543221  11110000000  0     


Q ss_pred             ----------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          808 ----------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       808 ----------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                                ....-.............++.+++.+|++.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00000000111111223467899999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=354.03  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=193.1

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeCC------e
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSDE------S  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~  652 (876)
                      .|..+..+|.|+ ||+||+|.. .+|+.||||++.....  ...+.+.+|+++|++++|||||+++++|...+      +
T Consensus        19 ~Y~~i~~lG~G~-fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~   97 (346)
T d1cm8a_          19 VYRDLQPVGSGA-YGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD   97 (346)
T ss_dssp             SEEEEEEC-------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             cEEEEEEEecCC-CeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence            454555566655 999999965 5799999999965322  22356789999999999999999999997654      5


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+ +.++.++....  .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+|+..
T Consensus        98 ~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          98 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceecc
Confidence            79999999 55888877543  699999999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhcccc----
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNG----  807 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----  807 (876)
                      ...     .+...||+.|+|||.+.+ ..++.++||||+||++|||++|++||........ ..............    
T Consensus       172 ~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         172 DSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHT
T ss_pred             CCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHHHhh
Confidence            532     234568999999998765 4578999999999999999999999987543221 11111110000000    


Q ss_pred             ------------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhcc
Q 002826          808 ------------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLS  856 (876)
Q Consensus       808 ------------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~  856 (876)
                                  ....-...+..........+.+++.+|+..||++|||++|+++.  ++++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                        00000011111112233467899999999999999999999985  66654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-39  Score=345.65  Aligned_cols=263  Identities=21%  Similarity=0.320  Sum_probs=191.7

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCC--ccCHHHHHHHHHHHhhccCccccceeeEEEe--------C
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFG--CQSSKTLKTEVKTLAKIRHKNIVKVLGFFHS--------D  650 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~  650 (876)
                      .|..+..+|.|+ ||+||+|+. .+|+.||||++....  .....++.+|++++++++|||++++++++..        .
T Consensus        11 rY~i~~~LG~G~-fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          11 KYEKLAKIGQGT-FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GEEEEEEEEECS-SSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CEEEEEEEecCc-CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            444445566655 999999976 589999999985432  2345678899999999999999999999855        3


Q ss_pred             CeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          651 ESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       651 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +..|+||||++++.+... ......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++
T Consensus        90 ~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             -CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence            468999999988655544 44455789999999999999999999999   99999999999999999999999999998


Q ss_pred             hcccccc--ccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hccc
Q 002826          731 IVGEAAF--QSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITN  806 (876)
Q Consensus       731 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~  806 (876)
                      .......  ........||+.|+|||.+... .++.++||||+||++|||++|+.||.......  ......... ....
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  243 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLCGSITP  243 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence            7653321  1223334689999999987754 68999999999999999999999997644322  122222211 1110


Q ss_pred             cccccc---------------Chhhhhhc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          807 GAIQVL---------------DPKIANCY--QQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       807 ~~~~~~---------------d~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                      ......               .+......  ......+.+++.+||++||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000               00000000  1113456789999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-39  Score=354.24  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccccceeeEEEeC------CeEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD------ESIF  654 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  654 (876)
                      .|.....+|.|| ||+||+|+.. +|+.||||++.....    ...+|++++++++||||++++++|...      .+.|
T Consensus        21 ~Y~~~k~LG~G~-fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGS-FGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEET-TEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCc-CeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            455555566655 9999999764 799999999975432    234799999999999999999998643      3579


Q ss_pred             EEEEcCCCCCHHHHhh--ccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhh
Q 002826          655 LIYEFLQMGSLGDLIC--RQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRI  731 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~  731 (876)
                      +||||++++.+..+..  +....+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+||+|||+++.
T Consensus        96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            9999998764443332  2355799999999999999999999999   999999999999999765 899999999987


Q ss_pred             ccccccccccccccccccccCccccCC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHH---------
Q 002826          732 VGEAAFQSTMSSEYALSCYNAPEYGYS-KKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRK---------  801 (876)
Q Consensus       732 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~---------  801 (876)
                      ......   .....||+.|+|||.+.+ ..++.++||||+||++|||++|++||......+. .....+..         
T Consensus       173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHH
T ss_pred             ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhh
Confidence            654332   233468999999998764 5689999999999999999999999986543221 11111110         


Q ss_pred             --h-hcccccccccC--hhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhccc
Q 002826          802 --I-NITNGAIQVLD--PKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA--LHSLST  857 (876)
Q Consensus       802 --~-~~~~~~~~~~d--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~--L~~i~~  857 (876)
                        . ...........  +...........++.+++.+|+..||++|||++|+++.  ++++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence              0 00000000000  00001111224467899999999999999999999973  555543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-39  Score=341.82  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=198.6

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCcc--CHHHHHHHHHHHhhccCccccceeeEEEeCCeEEEEEEc
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQ--SSKTLKTEVKTLAKIRHKNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      |..+..+|.|| ||+||+|+. .+|+.||||++......  ...++.+|+.+++.++||||+++++++.+.+..++|+|+
T Consensus         4 y~~i~~LG~G~-fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~   82 (292)
T d1unla_           4 YEKLEKIGEGT-YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_dssp             EEEEEEEEECS-SSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEeeeEEecCc-CeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence            44455666666 999999975 58999999999654322  246788999999999999999999999999999999999


Q ss_pred             CCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhcccccccc
Q 002826          660 LQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGEAAFQS  739 (876)
Q Consensus       660 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  739 (876)
                      +.++++..++... ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||.++.......  
T Consensus        83 ~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--  156 (292)
T d1unla_          83 CDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--  156 (292)
T ss_dssp             CSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred             ccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence            9999888877554 4789999999999999999999999   999999999999999999999999999987764332  


Q ss_pred             ccccccccccccCccccCCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hccccccccc-----
Q 002826          740 TMSSEYALSCYNAPEYGYSKK-ATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNGAIQVL-----  812 (876)
Q Consensus       740 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----  812 (876)
                      ......++..|+|||.+.... ++.++||||+||++|||++|+.||......... ...+.... ..........     
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHHHHhhcCCCChhhhhhhhhccc
Confidence            223334678899999877654 689999999999999999999997654333322 22221111 1100000000     


Q ss_pred             ---------ChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          813 ---------DPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       813 ---------d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                               ..............+.+++.+|++.||++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     00111122223456789999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-39  Score=346.89  Aligned_cols=251  Identities=23%  Similarity=0.304  Sum_probs=196.9

Q ss_pred             cccccCCCCCCCCceEEEEEEe----CCCcEEEEEEEecC----CccCHHHHHHHHHHHhhccC-ccccceeeEEEeCCe
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL----PSGELIAVKKLVNF----GCQSSKTLKTEVKTLAKIRH-KNIVKVLGFFHSDES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  652 (876)
                      +|.....+|.|| ||+||+|..    .+|+.||||++...    .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        25 ~y~~~~~IG~G~-fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          25 NFELLKVLGTGA-YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GEEEEEEEEETT-TEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             ceEEEEEEecCC-CeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            355556666666 999999964    25899999998542    22345678899999999977 899999999999999


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .++||||+.+|+|.+++...+ .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            999999999999999997765 577899999999999999999999   9999999999999999999999999999876


Q ss_pred             cccccccccccccccccccCccccCCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHhhccccccc
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSK--KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKINITNGAIQ  810 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (876)
                      ...... ......|++.|+|||.+...  .++.++||||+||++|||++|+.||........ .....+......     
T Consensus       180 ~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i~~~~~~~~-----  252 (322)
T d1vzoa_         180 VADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKSE-----  252 (322)
T ss_dssp             CGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHCC-----
T ss_pred             cccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcccCC-----
Confidence            543322 23345689999999988654  468899999999999999999999987654432 111112111111     


Q ss_pred             ccChhhhhhcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002826          811 VLDPKIANCYQQQMLGALEIALRCTSVMPEKRP-----SMFEVVK  850 (876)
Q Consensus       811 ~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~ell~  850 (876)
                         +.+   +...+..+.+++.+||++||++||     |++|+++
T Consensus       253 ---~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ---PPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ---CCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ---CCC---cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence               011   112344678999999999999999     4788876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-38  Score=343.16  Aligned_cols=255  Identities=18%  Similarity=0.228  Sum_probs=192.8

Q ss_pred             cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEe--CCeEEEEE
Q 002826          582 GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHS--DESIFLIY  657 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  657 (876)
                      +|.....+|.|+ ||+||+|+. .+|+.||||++..   ...+++.+|+++++.++ ||||+++++++..  ....++||
T Consensus        36 ~y~i~~~LG~G~-fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          36 DYQLVRKLGRGK-YSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GEEEEEEEEECS-SEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             CeEEEEEEecCc-CeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            444445555555 999999976 5799999999864   34678899999999995 9999999999975  45699999


Q ss_pred             EcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCC-CeEEccccchhhccccc
Q 002826          658 EFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADF-EPKLTDFALDRIVGEAA  736 (876)
Q Consensus       658 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~-~~kl~DfGla~~~~~~~  736 (876)
                      ||+++++|.++.    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++ .+|++|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999997764    3689999999999999999999999   999999999999998654 69999999998765433


Q ss_pred             cccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHH-----------hhc
Q 002826          737 FQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRK-----------INI  804 (876)
Q Consensus       737 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~  804 (876)
                      .   .....+|+.|+|||...+. .++.++||||+||++|||++|+.||.................           ...
T Consensus       185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 E---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             c---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            2   3345689999999997765 479999999999999999999999987654432211111100           000


Q ss_pred             --ccccccccC----hhh----h-hhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002826          805 --TNGAIQVLD----PKI----A-NCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK  850 (876)
Q Consensus       805 --~~~~~~~~d----~~~----~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~  850 (876)
                        .........    ...    . ........++.+++.+|++.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000000000    000    0 011122346789999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-38  Score=345.12  Aligned_cols=258  Identities=20%  Similarity=0.247  Sum_probs=186.6

Q ss_pred             cccccCCCCCCCCceEEEEEEeC-CCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEe------CCe
Q 002826          582 GMDEKSSAGNGGPFGRVYILSLP-SGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHS------DES  652 (876)
Q Consensus       582 ~~~~~~~~g~~g~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  652 (876)
                      .|.....+|.|+ ||+||+|... +|+.||||++.....  ....++.+|+.++++++|||||+++++|..      ..+
T Consensus        18 ~Y~i~~~LG~G~-fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGA-QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC---CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCc-CeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            455556666666 9999999764 799999999975432  223568899999999999999999999964      368


Q ss_pred             EEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhc
Q 002826          653 IFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIV  732 (876)
Q Consensus       653 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~  732 (876)
                      .|+||||+.++.+ +.+.   ..+++..+..++.||+.|++|||+.   ||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~l~-~~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchHHH-Hhhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence            9999999977544 4443   3589999999999999999999999   9999999999999999999999999998876


Q ss_pred             cccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh----------
Q 002826          733 GEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI----------  802 (876)
Q Consensus       733 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~----------  802 (876)
                      ....   ......+|+.|+|||.+.+..+++++||||+||++|||++|+.||........ .....+...          
T Consensus       170 ~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         170 GTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHHTTS
T ss_pred             cccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHH-HHHHHHhccCCCHHHHHHh
Confidence            5432   23344589999999999999999999999999999999999999986543221 111111000          


Q ss_pred             --------hccccc-----c----cccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002826          803 --------NITNGA-----I----QVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVKA  851 (876)
Q Consensus       803 --------~~~~~~-----~----~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~~  851 (876)
                              ......     .    ....+.........+..+.+++.+|++.||++||||+|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    000000     0    000111112233456678999999999999999999999865

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-38  Score=344.29  Aligned_cols=260  Identities=23%  Similarity=0.310  Sum_probs=191.3

Q ss_pred             ccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCc--cCHHHHHHHHHHHhhccCccccceeeEEEeC-----CeEE
Q 002826          583 MDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGC--QSSKTLKTEVKTLAKIRHKNIVKVLGFFHSD-----ESIF  654 (876)
Q Consensus       583 ~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  654 (876)
                      |.....+|.|| ||+||+|+. .+|+.||||++.....  ...+++.+|++++++++|||+|++++++...     ...+
T Consensus        20 Y~i~~~LG~G~-fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~   98 (348)
T d2gfsa1          20 YQNLSPVGSGA-YGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV   98 (348)
T ss_dssp             EEEEEECGGGT-TSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred             eEEEEEEecCC-CeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence            44445566655 999999965 5899999999975432  2235678999999999999999999998642     3456


Q ss_pred             EEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccchhhccc
Q 002826          655 LIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALDRIVGE  734 (876)
Q Consensus       655 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~~~~~  734 (876)
                      +|++|+.+|+|.+++..+  .+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.+.....
T Consensus        99 ~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1          99 YLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             EEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             EEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc
Confidence            667788899999999653  699999999999999999999999   999999999999999999999999999876543


Q ss_pred             cccccccccccccccccCccccCCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCcchhhHHHHHHHHh-hcccc-----
Q 002826          735 AAFQSTMSSEYALSCYNAPEYGYSK-KATAQMDAYSFGVVLLELITGRQAEQAEPAESLDVVKWVRRKI-NITNG-----  807 (876)
Q Consensus       735 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~-----  807 (876)
                      .     .....|++.|+|||...+. .++.++||||+||++|||++|++||.+......  ...+.... .....     
T Consensus       174 ~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         174 E-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             G-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHHHHTTC
T ss_pred             c-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChHHhhhc
Confidence            2     2334588999999986654 568899999999999999999999986543321  11111111 00000     


Q ss_pred             -----------cccccChhhhhhcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhc
Q 002826          808 -----------AIQVLDPKIANCYQQQMLGALEIALRCTSVMPEKRPSMFEVVK--ALHSL  855 (876)
Q Consensus       808 -----------~~~~~d~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ell~--~L~~i  855 (876)
                                 ........+..........+.+++.+|++.||++|||++|+++  .+.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                       0000011111112223456789999999999999999999998  34444

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-34  Score=311.43  Aligned_cols=273  Identities=16%  Similarity=0.191  Sum_probs=189.8

Q ss_pred             hhhhh-cccccCCCCCCCCceEEEEEEe-CCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-----------Cccccce
Q 002826          577 HDLVI-GMDEKSSAGNGGPFGRVYILSL-PSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-----------HKNIVKV  643 (876)
Q Consensus       577 ~~l~~-~~~~~~~~g~~g~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~  643 (876)
                      +|... +.|++.+..|.|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++           |+||+++
T Consensus         7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_           7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            45433 4355445445555999999976 589999999996532 23456788999988885           5789999


Q ss_pred             eeEEEe--CCeEEEEEEcCCCCCHHH-H-hhccCCcCCHHHHHHHHHHHHHHHHHhhc-cCCCCccccccccCceeeCCC
Q 002826          644 LGFFHS--DESIFLIYEFLQMGSLGD-L-ICRQDFQLQWSIRLKIAIGVAQGLAYLHK-DYVPHLLHRNVKSKNILLDAD  718 (876)
Q Consensus       644 ~~~~~~--~~~~~lv~e~~~~gsL~~-~-l~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~i~H~Dlkp~NIll~~~  718 (876)
                      ++++..  ....+++++++..+.... . .......+++..+..++.|++.|++|||+ .   +|+||||||+|||++.+
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~  162 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV  162 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence            998865  345666777665543322 2 22335678999999999999999999998 6   89999999999999865


Q ss_pred             C------CeEEccccchhhccccccccccccccccccccCccccCCCCCCCccchHHHHHHHHHHHhCCCCCCCCCcch-
Q 002826          719 F------EPKLTDFALDRIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVLLELITGRQAEQAEPAES-  791 (876)
Q Consensus       719 ~------~~kl~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l~elltg~~p~~~~~~~~-  791 (876)
                      +      .++++|||.++.....     .....||+.|+|||......++.++||||+||+++||++|+.||....... 
T Consensus       163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~  237 (362)
T d1q8ya_         163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  237 (362)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence            4      3999999998755432     234458999999999988889999999999999999999999997543221 


Q ss_pred             ----hhHHHHHHHHhhccc----------------cccccc-----Ch------hhhhhcHHHHHHHHHHHHHccCCCCC
Q 002826          792 ----LDVVKWVRRKINITN----------------GAIQVL-----DP------KIANCYQQQMLGALEIALRCTSVMPE  840 (876)
Q Consensus       792 ----~~~~~~~~~~~~~~~----------------~~~~~~-----d~------~~~~~~~~~~~~~~~li~~cl~~dP~  840 (876)
                          ......+........                .....+     .+      ............+.+++.+|++.||+
T Consensus       238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  317 (362)
T d1q8ya_         238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  317 (362)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence                111111111000000                000000     00      01122356677899999999999999


Q ss_pred             CCCCHHHHHHH--HhhcccC
Q 002826          841 KRPSMFEVVKA--LHSLSTR  858 (876)
Q Consensus       841 ~RPs~~ell~~--L~~i~~~  858 (876)
                      +|||++|+++.  +++....
T Consensus       318 ~Rpta~e~L~Hp~f~~~~~~  337 (362)
T d1q8ya_         318 KRADAGGLVNHPWLKDTLGM  337 (362)
T ss_dssp             TCBCHHHHHTCGGGTTCTTC
T ss_pred             HCcCHHHHhcCcccCCCCCc
Confidence            99999999985  6655433

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=3.3e-32  Score=292.72  Aligned_cols=258  Identities=32%  Similarity=0.472  Sum_probs=180.6

Q ss_pred             CCcEEecccCccCC--CCCCccccccccccEEEecc-ccccCcCCcccccCCccceeeeecccccccCCCCCccccccce
Q 002826          231 SLSILDLSQNNLTG--EVPQSLGSSLLKLVSFDVSQ-NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLER  307 (876)
Q Consensus       231 ~L~~L~Ls~N~l~~--~ip~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  307 (876)
                      +++.|+|++|+++|  .+|+.++ ++++|++|+|++ |+++|.+|..|.++++|++|+|++|+|.+..+..+..+.+|+.
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~-~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLA-NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGG-GCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHHh-cCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            45566666666665  3455554 366666666664 5666666666666666666666666666666666666666777


Q ss_pred             eecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCC-CeeeccCcccCCCCCCccccccCccEEeCCCcc
Q 002826          308 FQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQL-EQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS  386 (876)
Q Consensus       308 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  386 (876)
                      +++++|.+.+.+|..+.++++|+.+++++|++++.+|+.+..+.++ +.+++++|++++..|..+..+..+ .+++++|.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence            7777777666677777777777777777777777777766666654 667777777777777766665544 57777777


Q ss_pred             ccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCcc
Q 002826          387 FYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGL  466 (876)
Q Consensus       387 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~  466 (876)
                      +.+.+|..+..++.++.+++++|.+++.++.+..+++|+.|+|++|+|+|.+|..|+++++|++|||++|+|+|.+|.. 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~-  287 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-  287 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCc-
Confidence            7777777777777777777777777777777777777888888888887777777777777777777777777766642 


Q ss_pred             cccccceEEccCCccccccCCcccCCCCCccccCCCCCCCCCCCCCC
Q 002826          467 QNLKLALFNVSFNKLSGRVPYSLISGLPASYLQGNPGLCGPGLSNSC  513 (876)
Q Consensus       467 ~~l~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N~~~C~~~~~~~c  513 (876)
                      ..                     +.++..+++.||+.+||.|++ +|
T Consensus       288 ~~---------------------L~~L~~l~l~~N~~l~g~plp-~c  312 (313)
T d1ogqa_         288 GN---------------------LQRFDVSAYANNKCLCGSPLP-AC  312 (313)
T ss_dssp             TT---------------------GGGSCGGGTCSSSEEESTTSS-CC
T ss_pred             cc---------------------CCCCCHHHhCCCccccCCCCC-CC
Confidence            11                     334566788888889998876 66

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=5e-29  Score=275.64  Aligned_cols=355  Identities=21%  Similarity=0.278  Sum_probs=216.3

Q ss_pred             ecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccc
Q 002826           81 NLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQ  160 (876)
Q Consensus        81 ~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~  160 (876)
                      .+...++++.++  ..++.+|++|++++|.|+..  +.+..|++|++|+|++|+          |++. | .|+++++|+
T Consensus        28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~----------l~~l-~-~l~~L~~L~   91 (384)
T d2omza2          28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ----------LTDI-T-PLKNLTKLV   91 (384)
T ss_dssp             HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSC----------CCCC-G-GGTTCTTCC
T ss_pred             HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCc----------CCCC-c-cccCCcccc
Confidence            344455555544  34677888888888888763  357778888877655554          4433 2 288888888


Q ss_pred             eecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccC
Q 002826          161 VLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQN  240 (876)
Q Consensus       161 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  240 (876)
                      +|+|++|++++..|  ++++++|+.|++++|.  ...++ .......+..+....|.+....+.................
T Consensus        92 ~L~L~~n~i~~i~~--l~~l~~L~~L~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  166 (384)
T d2omza2          92 DILMNNNQIADITP--LANLTNLTGLTLFNNQ--ITDID-PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT  166 (384)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCCEEECCSSC--CCCCG-GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC
T ss_pred             cccccccccccccc--cccccccccccccccc--ccccc-cccccccccccccccccccccccccccccccccccccccc
Confidence            88888888885543  7888888888888886  33333 2345566777777777765443333322222222222222


Q ss_pred             ccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCC
Q 002826          241 NLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFP  320 (876)
Q Consensus       241 ~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  320 (876)
                      .+.     . +.............|...  ....+..+++++.+++++|.+++..|  +..+++|++|++++|++++.  
T Consensus       167 ~~~-----~-~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--  234 (384)
T d2omza2         167 DLK-----P-LANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--  234 (384)
T ss_dssp             CCG-----G-GTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--
T ss_pred             hhh-----h-hccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--
Confidence            111     0 112333344444444432  34445566666666666666665443  34556666777777766632  


Q ss_pred             cccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCC
Q 002826          321 DKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPV  400 (876)
Q Consensus       321 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~  400 (876)
                      ..+..+++|+.|++++|++++..+  +..+++|+.|++++|++++..  .+..++.++.+++++|.+++.  ..+..++.
T Consensus       235 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~  308 (384)
T d2omza2         235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKN  308 (384)
T ss_dssp             GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTT
T ss_pred             chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcc
Confidence            245666677777777777665433  556667777777777766433  255666667777777776642  34566667


Q ss_pred             ccEEEccCCccccCCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCC
Q 002826          401 MSIINLSQNSISGQIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFN  479 (876)
Q Consensus       401 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N  479 (876)
                      ++.|++++|++++.. .+..+++|++|+|++|+|++ ++ .|.++++|++|++++|+|++..|  +.++ +++.|++++|
T Consensus       309 l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         309 LTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             cCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            777777777776543 36667777777777777763 33 46677777777777777775443  5555 4667777766

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.2e-27  Score=264.29  Aligned_cols=356  Identities=20%  Similarity=0.327  Sum_probs=270.1

Q ss_pred             eecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcc
Q 002826          104 LNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSEL  183 (876)
Q Consensus       104 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L  183 (876)
                      ..+..+.+++.++  ...+.+|++|++++|.|          +. + +.+..+++|++|+|++|+|++..|  |+++++|
T Consensus        27 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I----------~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L   90 (384)
T d2omza2          27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGI----------KS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKL   90 (384)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECCSSCC----------CC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTC
T ss_pred             HHhCCCCCCCccC--HHHhCCCCEEECCCCCC----------CC-c-cccccCCCCCEEeCcCCcCCCCcc--ccCCccc
Confidence            4566666666544  34566777776555544          32 2 357788999999999999986543  8899999


Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      ++|++++|+  +..++ .++++++|+.|++++|.+++..+  ......+..+....|.+. .+.................
T Consensus        91 ~~L~L~~n~--i~~i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~  164 (384)
T d2omza2          91 VDILMNNNQ--IADIT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQ  164 (384)
T ss_dssp             CEEECCSSC--CCCCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC-CCGGGTTCTTCSEEEEEES
T ss_pred             ccccccccc--ccccc-ccccccccccccccccccccccc--cccccccccccccccccc-ccccccccccccccccccc
Confidence            999999998  44554 37888899999999888886533  445667888888888887 3333322222233332222


Q ss_pred             cccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccC
Q 002826          264 QNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAI  343 (876)
Q Consensus       264 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~  343 (876)
                      ...     ...+...+.........|...  ....+..+++++.+++++|.+++..|  +...++|+.|++++|++++. 
T Consensus       165 ~~~-----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-  234 (384)
T d2omza2         165 VTD-----LKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-  234 (384)
T ss_dssp             CCC-----CGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-
T ss_pred             cch-----hhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc-
Confidence            222     233455556666666666554  45567889999999999999997765  45678999999999999853 


Q ss_pred             ccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccc
Q 002826          344 PDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRK  423 (876)
Q Consensus       344 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~  423 (876)
                       ..+..+++|+.|++++|++++..+  +..+++|+.|++++|++++..+  +..++.++.++++.|++++ ++.+..+++
T Consensus       235 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~-~~~~~~~~~  308 (384)
T d2omza2         235 -GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKN  308 (384)
T ss_dssp             -GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC-CGGGGGCTT
T ss_pred             -chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccccccccccc-ccccchhcc
Confidence             468889999999999999996543  7889999999999999986543  7788999999999999986 446888999


Q ss_pred             cceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc-ccceEEccCCccccccCCcccCCCCCccccCC
Q 002826          424 LVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL-KLALFNVSFNKLSGRVPYSLISGLPASYLQGN  501 (876)
Q Consensus       424 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~l~~l~ls~N~l~~~~p~~~~~~~~~~~~~~N  501 (876)
                      ++.|++++|++++..|  +..+++|++|++++|+|++ +| .+..+ +|+.|++++|++++..|..-+.++..+++.+|
T Consensus       309 l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N  383 (384)
T d2omza2         309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred             cCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence            9999999999997643  8899999999999999985 44 57777 59999999999998777555667777788776

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=9.2e-27  Score=248.79  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=209.7

Q ss_pred             CCccccceEecCCCCCccEEEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccce
Q 002826           58 HYCNWTGVTCVTTATASLTVASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWV  137 (876)
Q Consensus        58 ~~C~w~gv~c~~~~~~~~~~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  137 (876)
                      +-|.|++|.|...+               |+ .+|+.+.  +++++|+|++|+|+...+..|.++++|++|+++      
T Consensus         8 c~c~~~~~~C~~~~---------------L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~------   63 (305)
T d1xkua_           8 CQCHLRVVQCSDLG---------------LE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILI------   63 (305)
T ss_dssp             CEEETTEEECTTSC---------------CC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC------
T ss_pred             CEecCCEEEecCCC---------------CC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccc------
Confidence            44899999997642               22 4555553  689999999999998777889999999987554      


Q ss_pred             eecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCC
Q 002826          138 LDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSS  216 (876)
Q Consensus       138 LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n  216 (876)
                          +|.++...|..|.++++|++|++++|+++. +|..+  ...|+.|++++|.  +..++. .+.....+..+....|
T Consensus        64 ----~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~--l~~l~~~~~~~~~~~~~l~~~~n  134 (305)
T d1xkua_          64 ----NNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENE--ITKVRKSVFNGLNQMIVVELGTN  134 (305)
T ss_dssp             ----SSCCCCBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSC--CCBBCHHHHTTCTTCCEEECCSS
T ss_pred             ----cccccccchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccc--hhhhhhhhhhccccccccccccc
Confidence                555666778889999999999999999984 44433  3578899999997  455554 3667788888888888


Q ss_pred             CCc--ccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccccc
Q 002826          217 GFH--GVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS  294 (876)
Q Consensus       217 ~l~--~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~  294 (876)
                      ...  ...+..|.++++|+.+++++|+++ .+|..+   .++|+.|++++|.+++..+..|.+++.++.|++++|.+++.
T Consensus       135 ~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~---~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~  210 (305)
T d1xkua_         135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  210 (305)
T ss_dssp             CCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC---CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             cccccCCCccccccccccCccccccCCcc-ccCccc---CCccCEEECCCCcCCCCChhHhhcccccccccccccccccc
Confidence            653  445677888999999999999998 777765   56889999999999988888899999999999999999988


Q ss_pred             CCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccc------cCCCCCeeeccCccc
Q 002826          295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSIS------MAAQLEQVQIDNNRF  363 (876)
Q Consensus       295 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~------~l~~L~~L~L~~N~l  363 (876)
                      .+..|.++++|++|+|++|+|+ .+|..|..+++|++|+|++|+|+.+....|.      .+.+|+.|+|++|.+
T Consensus       211 ~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~  284 (305)
T d1xkua_         211 DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV  284 (305)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSS
T ss_pred             ccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcC
Confidence            8888999999999999999988 4577888888888888888888865444442      334455555555544

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=2.2e-26  Score=245.85  Aligned_cols=239  Identities=21%  Similarity=0.318  Sum_probs=120.3

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      .+|-++++++ .+|..+.  +++++|+|++|+|+...+.+|.++++|++|++++|+                        
T Consensus        14 ~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~------------------------   66 (305)
T d1xkua_          14 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK------------------------   66 (305)
T ss_dssp             EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC------------------------
T ss_pred             EEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccc------------------------
Confidence            4455666665 4455553  466667777776665444556666666666666665                        


Q ss_pred             CCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeeccccc--cc
Q 002826          217 GFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFN--GS  294 (876)
Q Consensus       217 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~  294 (876)
                       +..+.|..|.++++|++|++++|+|+ .+|...   ...+..|++++|.+.+..+..+.....+..++...|...  ..
T Consensus        67 -~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~  141 (305)
T d1xkua_          67 -ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI  141 (305)
T ss_dssp             -CCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB
T ss_pred             -ccccchhhhhCCCccCEecccCCccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC
Confidence             44444555555666666666666665 455443   235555566666665544444555555555555555332  22


Q ss_pred             CCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccc
Q 002826          295 IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSV  374 (876)
Q Consensus       295 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  374 (876)
                      .+..|..+++|+.+++++|.++. +|..+  +++|+.|++++|.+++..+..|..++.++.|++++|.+++..+..+.++
T Consensus       142 ~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l  218 (305)
T d1xkua_         142 ENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT  218 (305)
T ss_dssp             CTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred             CccccccccccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccc
Confidence            33445555555555555555542 22222  3444555555555544444444444444444444444444444444444


Q ss_pred             cCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcc
Q 002826          375 KSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSI  411 (876)
Q Consensus       375 ~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l  411 (876)
                      ++|++|+|++|+|+. +|..|..+++|++|+|++|+|
T Consensus       219 ~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i  254 (305)
T d1xkua_         219 PHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNI  254 (305)
T ss_dssp             TTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCC
T ss_pred             ccceeeecccccccc-cccccccccCCCEEECCCCcc
Confidence            444444444444431 233333333333333333333

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.1e-27  Score=247.95  Aligned_cols=252  Identities=17%  Similarity=0.209  Sum_probs=142.3

Q ss_pred             EEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEe-cc
Q 002826          186 LDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDV-SQ  264 (876)
Q Consensus       186 L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L-~~  264 (876)
                      ++.++++  ...+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|+|. .++...+..+..+..++. ..
T Consensus        16 v~c~~~~--L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          16 TSCPQQG--LQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EECCSSC--CSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSC
T ss_pred             EEcCCCC--CCccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-ccccccccccccccccccccc
Confidence            3444444  445555443  34566666666666665666666666777777766666 455555555566666554 34


Q ss_pred             ccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCc
Q 002826          265 NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIP  344 (876)
Q Consensus       265 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~  344 (876)
                      |.++...+..|.++++|++|++++|.+....+..+..+.+|+.+++++|+|+++.+..|..+++|+.|++++|++++..+
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            45555555556666666666666666655555556666666666666666665555555566666666666666665555


Q ss_pred             cccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCccccccc
Q 002826          345 DSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKL  424 (876)
Q Consensus       345 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L  424 (876)
                      .+|.++++|+.+++++|++++..|..|.++++|+.|++++|++.+..+..|..+++|++|+|++|.+...-+...-...+
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l  250 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL  250 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHH
Confidence            56666666666666666666555555555555555555555555555555555555555555555554332211111233


Q ss_pred             ceEeccCCcCCCCCCcCC
Q 002826          425 VSLSLADNSLTGEIPPSL  442 (876)
Q Consensus       425 ~~L~Ls~N~l~~~~p~~~  442 (876)
                      +.+....++++...|..+
T Consensus       251 ~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         251 QKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             HHCCSEECCCBEEESGGG
T ss_pred             HhCcCCCCceEeCCchHH
Confidence            344444444444444433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.9e-26  Score=243.52  Aligned_cols=249  Identities=18%  Similarity=0.202  Sum_probs=193.4

Q ss_pred             EEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecc-c
Q 002826          234 ILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQ-D  312 (876)
Q Consensus       234 ~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~-~  312 (876)
                      .++.++++++ .+|..++   +++++|+|++|+|+...+.+|.++++|++|++++|++..+.+..+..+..++.+... .
T Consensus        15 ~v~c~~~~L~-~iP~~ip---~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP---AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC---TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCC-ccCCCCC---CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            4566777777 7777654   356778888888876666777888888888888888887777778888888877654 5


Q ss_pred             ccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCC
Q 002826          313 NGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLP  392 (876)
Q Consensus       313 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~  392 (876)
                      |.++...+..|.++++|++|++++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            66776777788888888888888888887777778888888888888888887777778888888888888888888888


Q ss_pred             CCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccccCCCccccc--
Q 002826          393 PNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTGPIPQGLQNL--  469 (876)
Q Consensus       393 ~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--  469 (876)
                      ..|.++++|+.+++++|++++..| .|.++++|++|++++|++++..|..|..+++|++|+|++|++.+.-+.  ..+  
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~--~~l~~  248 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA--RPLWA  248 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG--HHHHH
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc--hHHHH
Confidence            888888888888888888888766 788888899999999999888888888899999999999988754321  111  


Q ss_pred             ccceEEccCCccccccCCc
Q 002826          470 KLALFNVSFNKLSGRVPYS  488 (876)
Q Consensus       470 ~l~~l~ls~N~l~~~~p~~  488 (876)
                      .++.+....+++.+..|..
T Consensus       249 ~l~~~~~~~~~~~C~~p~~  267 (284)
T d1ozna_         249 WLQKFRGSSSEVPCSLPQR  267 (284)
T ss_dssp             HHHHCCSEECCCBEEESGG
T ss_pred             HHHhCcCCCCceEeCCchH
Confidence            1344555666666666644

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.2e-23  Score=219.31  Aligned_cols=201  Identities=17%  Similarity=0.226  Sum_probs=134.5

Q ss_pred             cCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccc
Q 002826          178 GNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKL  257 (876)
Q Consensus       178 ~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L  257 (876)
                      .+...+.+.|.+++.  ++.+|+.+.  ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+|..  ..+++|
T Consensus         7 ~~~~~~~~v~C~~~~--L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~~--~~l~~L   79 (266)
T d1p9ag_           7 SKVASHLEVNCDKRN--LTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD--GTLPVL   79 (266)
T ss_dssp             ECSTTCCEEECTTSC--CSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC--SCCTTC
T ss_pred             cccCCCeEEEccCCC--CCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccccc--cccccc
Confidence            345566666777776  556776664  46778888888888777778888888888888888887 66543  347788


Q ss_pred             cEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCC
Q 002826          258 VSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESN  337 (876)
Q Consensus       258 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  337 (876)
                      ++|+|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.+++++|
T Consensus        80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N  158 (266)
T d1p9ag_          80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (266)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence            88888888877 34556677777777777777777666666666667777777766666655556666666666666666


Q ss_pred             cccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccc
Q 002826          338 RFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSF  387 (876)
Q Consensus       338 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l  387 (876)
                      ++++..++.|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus       159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred             cccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence            666555555666666666666666665 4555554555555555444444

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.8e-23  Score=218.00  Aligned_cols=202  Identities=19%  Similarity=0.175  Sum_probs=135.9

Q ss_pred             cCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccc
Q 002826          227 VGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLE  306 (876)
Q Consensus       227 ~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  306 (876)
                      ....++...+.++++|+ .+|+.++   +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+.  .++.+++|+
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~   80 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLG   80 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCC
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccc
Confidence            34556667788888888 6777653   46777888888887666667777777777777777776432  234555566


Q ss_pred             eeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCcc
Q 002826          307 RFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNS  386 (876)
Q Consensus       307 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~  386 (876)
                      +|+|++|++++ .+..+.+                        +++|++|++++|++.+..+..+..+.+++.|++++|.
T Consensus        81 ~L~Ls~N~l~~-~~~~~~~------------------------l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~  135 (266)
T d1p9ag_          81 TLDLSHNQLQS-LPLLGQT------------------------LPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNE  135 (266)
T ss_dssp             EEECCSSCCSS-CCCCTTT------------------------CTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSC
T ss_pred             ccccccccccc-ccccccc------------------------ccccccccccccccceeeccccccccccccccccccc
Confidence            66666665552 2334444                        4445555555555554444555555666666666666


Q ss_pred             ccCCCCCCcCCCCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          387 FYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       387 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      ++...+..+..++.|+.+++++|+|++.++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus       136 l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C  209 (266)
T d1p9ag_         136 LKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (266)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             cceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence            666666666667777777777777777666 5777888888888888888 677777788888999999988763

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=6.7e-20  Score=198.76  Aligned_cols=138  Identities=22%  Similarity=0.262  Sum_probs=64.4

Q ss_pred             CCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCCcCcccc
Q 002826           99 SSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFG  178 (876)
Q Consensus        99 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~  178 (876)
                      .++++|||++|.++. +|+.   +++|++|+|++          |+|+ .+|+.+   .+|+.|++++|+++ .++..  
T Consensus        38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~----------N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l--   96 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPEL---PPHLESLVASC----------NSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL--   96 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCSC---CTTCSEEECCS----------SCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC--
T ss_pred             cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCC----------CCCc-ccccch---hhhhhhhhhhcccc-hhhhh--
Confidence            356677777776654 4432   34455443333          3333 344433   35566666666665 22221  


Q ss_pred             CCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccccc
Q 002826          179 NFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLV  258 (876)
Q Consensus       179 ~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~  258 (876)
                       .+.|++|++++|.  +..+|. ++.+++|+.|++++|.+.....    ....+..+.+..+... .. ..+ ..++.++
T Consensus        97 -p~~L~~L~L~~n~--l~~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~-~~-~~l-~~l~~l~  165 (353)
T d1jl5a_          97 -PPLLEYLGVSNNQ--LEKLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE-EL-PEL-QNLPFLT  165 (353)
T ss_dssp             -CTTCCEEECCSSC--CSSCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS-SC-CCC-TTCTTCC
T ss_pred             -ccccccccccccc--cccccc-hhhhccceeecccccccccccc----ccccccchhhcccccc-cc-ccc-cccccce
Confidence             1245666666665  344443 3455555555555555543211    1233444444444433 11 111 2244555


Q ss_pred             EEEecccccc
Q 002826          259 SFDVSQNKLS  268 (876)
Q Consensus       259 ~L~L~~N~l~  268 (876)
                      .+++++|.+.
T Consensus       166 ~L~l~~n~~~  175 (353)
T d1jl5a_         166 AIYADNNSLK  175 (353)
T ss_dssp             EEECCSSCCS
T ss_pred             eccccccccc
Confidence            5555555544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=4.5e-19  Score=192.11  Aligned_cols=198  Identities=23%  Similarity=0.308  Sum_probs=108.7

Q ss_pred             EEEeecCCCCCcccccccccCCCCCCeeecCCCccccccCccccCCCCCCcccCCCcccceeecCCccccccCCCccCCc
Q 002826           77 VASINLQSLNLSGEISSSVCELSSLSNLNLADNLFNQPIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSL  156 (876)
Q Consensus        77 ~~~l~l~~~~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l  156 (876)
                      +..++|++++|+ .+|+.   +++|++|+|++|+|+. +|+.+   .+|++|++++|.++.           +++ +  .
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~~---~~L~~L~l~~n~l~~-----------l~~-l--p   97 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLKA-----------LSD-L--P   97 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCSC-----------CCS-C--C
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccch---hhhhhhhhhhcccch-----------hhh-h--c
Confidence            345677777775 35543   4567777777777764 45443   456666555554421           111 1  1


Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      +.|++|+|++|.++ .+|. ++.+++|++|++++|.  ....|..   ...+..+.+..+...  .+..+..++.++.|+
T Consensus        98 ~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~--~~~~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~  168 (353)
T d1jl5a_          98 PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNS--LKKLPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIY  168 (353)
T ss_dssp             TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSC--CSCCCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEE
T ss_pred             cccccccccccccc-cccc-hhhhccceeecccccc--ccccccc---cccccchhhcccccc--ccccccccccceecc
Confidence            35777777777776 3443 5677777777777776  3334332   344556666555543  234566677777777


Q ss_pred             cccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCC
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFS  316 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  316 (876)
                      +++|.+. .++...    ...+.+...++.+. .++ .+..++.|+.+++++|.... .+.   ...++..+.+.+|.+.
T Consensus       169 l~~n~~~-~~~~~~----~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~  237 (353)
T d1jl5a_         169 ADNNSLK-KLPDLP----LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLT  237 (353)
T ss_dssp             CCSSCCS-SCCCCC----TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCS
T ss_pred             ccccccc-cccccc----cccccccccccccc-ccc-cccccccccccccccccccc-ccc---cccccccccccccccc
Confidence            7777776 443321    23345555555544 222 23455666666666665442 221   2234444455555444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=5.3e-20  Score=188.64  Aligned_cols=218  Identities=17%  Similarity=0.118  Sum_probs=128.4

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC-CcccccCcccEEEec-
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP-SDIGKLEKLEQLFLQ-  214 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p-~~~~~l~~L~~L~L~-  214 (876)
                      +++.++++++ .+|+.+.  +++++|+|++|+|+...+.+|.++++|++|+|++|.+ ...+| ..|.++++++++.+. 
T Consensus        12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~-~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV-LEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTT-CCEECSSSEESCTTCCEEEEEC
T ss_pred             EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccc-cceeeccccccccccccccccc
Confidence            3455555555 4555443  4677777777777755556777777777777777762 22333 346677777777665 


Q ss_pred             CCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCC-ccceeeeecccccc
Q 002826          215 SSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKAN-GLVNLSLHKNFFNG  293 (876)
Q Consensus       215 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~  293 (876)
                      .|++....+..|.++++|++|++++|+++...+......+..+..+..+++++....+..|..++ .++.|++++|+++.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~  167 (242)
T d1xwdc1          88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE  167 (242)
T ss_dssp             CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred             cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccc
Confidence            35677777777888888888888888877332333334455666666666666655555555543 56666666666665


Q ss_pred             cCCCCCccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeec
Q 002826          294 SIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQI  358 (876)
Q Consensus       294 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  358 (876)
                      +.+..|....-++.+.+++|+++...+..|.++++|++|++++|+|+...+..|..+++|+.+++
T Consensus       168 i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         168 IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            44444433222233344555555444444555555555555555555444444555544444444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=1e-19  Score=186.40  Aligned_cols=219  Identities=16%  Similarity=0.119  Sum_probs=119.0

Q ss_pred             eEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEec
Q 002826          184 VVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVS  263 (876)
Q Consensus       184 ~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~  263 (876)
                      +.++.+++.  +..+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+...+|...|.++++++++++.
T Consensus        11 ~~i~c~~~~--l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESK--VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCS--CSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCC--CCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            345555554  445665543  3566666666667666666677777777777777777655666556666677776654


Q ss_pred             c-ccccCcCCcccccCCccceeeeecccccccCCCC-CccccccceeecccccCCCCCCcccCCCCcccEEEecCCcccc
Q 002826          264 Q-NKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGS-INECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAESNRFSG  341 (876)
Q Consensus       264 ~-N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  341 (876)
                      . |++....+..|.++++|++|++++|.+....+.. +..+..+..+...++.+....+..|.+++              
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~--------------  152 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------  152 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB--------------
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc--------------
Confidence            3 5565555666666666666666666665332211 22333333334444444433333333332              


Q ss_pred             cCccccccCCCCCeeeccCcccCCCCCCccccccCcc-EEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCc-Ccc
Q 002826          342 AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLY-RFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIP-ELK  419 (876)
Q Consensus       342 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~-~~~  419 (876)
                               ..++.|++++|+++...+..+ ..+++. .+++++|+++...+..|.++++|++|+|++|+|+..++ .|.
T Consensus       153 ---------~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~  222 (242)
T d1xwdc1         153 ---------FESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE  222 (242)
T ss_dssp             ---------SSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCT
T ss_pred             ---------ccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHc
Confidence                     144445555555543222222 223332 23345555555445556666666666666666665544 466


Q ss_pred             cccccceEecc
Q 002826          420 KCRKLVSLSLA  430 (876)
Q Consensus       420 ~l~~L~~L~Ls  430 (876)
                      ++++|+.|++.
T Consensus       223 ~l~~L~~l~~~  233 (242)
T d1xwdc1         223 NLKKLRARSTY  233 (242)
T ss_dssp             TCCEEESSSEE
T ss_pred             CCcccccCcCC
Confidence            66666665554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.81  E-value=6.5e-21  Score=187.66  Aligned_cols=165  Identities=15%  Similarity=0.144  Sum_probs=114.5

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCcc------------------CHHHHHHHHHHHhhccCccccceeeEEEe
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQ------------------SSKTLKTEVKTLAKIRHKNIVKVLGFFHS  649 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~  649 (876)
                      .+|.|| ||+||+|..++|+.||||++......                  .......|+..+.++.|++++..+++.. 
T Consensus         7 ~IG~G~-~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~~-   84 (191)
T d1zara2           7 LMGEGK-ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEG-   84 (191)
T ss_dssp             EEEECS-SEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEET-
T ss_pred             EeeeCc-ceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEecC-
Confidence            345555 99999998889999999987532110                  0123456888999999999998876532 


Q ss_pred             CCeEEEEEEcCCCCCHHHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccCCCCccccccccCceeeCCCCCeEEccccch
Q 002826          650 DESIFLIYEFLQMGSLGDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDYVPHLLHRNVKSKNILLDADFEPKLTDFALD  729 (876)
Q Consensus       650 ~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla  729 (876)
                         .+++|||+++..+.+        ++...+.+++.|++.+++|||+.   +|+||||||+|||++++ .++++|||.|
T Consensus        85 ---~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a  149 (191)
T d1zara2          85 ---NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQS  149 (191)
T ss_dssp             ---TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred             ---CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCc
Confidence               379999999865433        33445678899999999999999   99999999999999865 4899999998


Q ss_pred             hhccccccccccccccccccccCccccCCCCCCCccchHHHHHHH
Q 002826          730 RIVGEAAFQSTMSSEYALSCYNAPEYGYSKKATAQMDAYSFGVVL  774 (876)
Q Consensus       730 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlGv~l  774 (876)
                      +.................    -.|. ..+.++.++|+||..--+
T Consensus       150 ~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         150 VEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ccCCCCCcHHHHHHHHHH----HHHH-HcCCCCCcccHHHHHHHH
Confidence            766432211100000000    0011 134567889999976544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1.1e-19  Score=184.38  Aligned_cols=191  Identities=19%  Similarity=0.304  Sum_probs=101.7

Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      +.++..++++.+++++.+  .++.+.+|+.|++++|.  +..++ .+..+++|++|++++|++++..|  +.++++|+++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~--i~~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTG--VTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCC--CCcch-hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            444455566666665433  34555666666666665  44442 46666666666666666665432  6666666667


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      ++++|.++ .++. + ..+++|+.+++++|...+.  ..+...+.+..+.++.+.+....  .+..+++|+.|++++|.+
T Consensus        91 ~~~~n~~~-~i~~-l-~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~  163 (227)
T d1h6ua2          91 ELSGNPLK-NVSA-I-AGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQV  163 (227)
T ss_dssp             ECCSCCCS-CCGG-G-TTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCC
T ss_pred             cccccccc-cccc-c-ccccccccccccccccccc--chhccccchhhhhchhhhhchhh--hhcccccccccccccccc
Confidence            76666666 4442 2 2466666666666665432  22444555555555555554222  244455555555555555


Q ss_pred             CCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccC
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFT  364 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  364 (876)
                      ++..  .+.++++|+.|++++|++++..  .++.+++|++|+|++|+++
T Consensus       164 ~~~~--~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         164 SDLT--PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCC
T ss_pred             ccch--hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCC
Confidence            4322  2444555555555555554321  1444444555555555444

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=7.8e-20  Score=185.34  Aligned_cols=186  Identities=17%  Similarity=0.268  Sum_probs=99.3

Q ss_pred             cccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCCCCCcccCCCCcccEEE
Q 002826          254 LLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIR  333 (876)
Q Consensus       254 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  333 (876)
                      +.+|++|++++|+|+..  ..+..+++|++|++++|+|++..|  +..+++|+++++++|.++. + ..+..+++|+.++
T Consensus        40 l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~  113 (227)
T d1h6ua2          40 LDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLD  113 (227)
T ss_dssp             HHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEE
T ss_pred             cCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-ccccccccccccc
Confidence            33444444444444321  123444444444444444443222  4444444455555444442 1 1344555555555


Q ss_pred             ecCCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCcccc
Q 002826          334 AESNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISG  413 (876)
Q Consensus       334 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~  413 (876)
                      +++++..+.  ..+.....+..+.++++.+....  .+.+.++|+.|++++|.+.+..  .+.++++|+.|+|++|++++
T Consensus       114 l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~  187 (227)
T d1h6ua2         114 LTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD  187 (227)
T ss_dssp             CTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred             ccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCC
Confidence            555554432  22344555666666666555322  2455566666666666665332  25666677777777777765


Q ss_pred             CCcCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCC
Q 002826          414 QIPELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLS  454 (876)
Q Consensus       414 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  454 (876)
                      . +.+.++++|++|+|++|+|++..|  +.++++|+.|+++
T Consensus       188 l-~~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         188 I-SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             C-GGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             C-hhhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            3 446777777777777777774432  6777777777775

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=4.3e-19  Score=174.57  Aligned_cols=130  Identities=20%  Similarity=0.315  Sum_probs=89.1

Q ss_pred             CcEEecccCccCCCCCCccccccccccEEEeccccccC-cCCcccccCCccceeeeecccccccCCCCCccccccceeec
Q 002826          232 LSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSG-SFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQV  310 (876)
Q Consensus       232 L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  310 (876)
                      .++++.++|+++ .+|..++   +++++|+|++|+|++ ..+..|.++++|+.|+|++|.+.+..++.|..+++|++|+|
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence            346677777777 6666653   466677777777764 33555666777777777777777666777777777777777


Q ss_pred             ccccCCCCCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeeccCcccCC
Q 002826          311 QDNGFSGDFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQIDNNRFTS  365 (876)
Q Consensus       311 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  365 (876)
                      ++|+|+...|..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|.+..
T Consensus        86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence            7777776666667777777777777777776667777777777777777776663

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.75  E-value=1e-18  Score=171.86  Aligned_cols=174  Identities=16%  Similarity=0.203  Sum_probs=92.5

Q ss_pred             ccEEEeccccccCcCCcccccCCccceeeeeccccccc-CCCCCccccccceeecccccCCCCCCcccCCCCcccEEEec
Q 002826          257 LVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGS-IPGSINECLNLERFQVQDNGFSGDFPDKLWSLPRIKLIRAE  335 (876)
Q Consensus       257 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~  335 (876)
                      .++++.++|+++ .+|..+.  +++++|+|++|+|++. .+..|.++++|+.|+|++|++.                   
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-------------------   67 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-------------------   67 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-------------------
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-------------------
Confidence            345666666666 3444332  3455555555555432 2333444444444444444444                   


Q ss_pred             CCcccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCC
Q 002826          336 SNRFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQI  415 (876)
Q Consensus       336 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~  415 (876)
                           ...+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....
T Consensus        68 -----~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          68 -----GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             -----CBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             -----cccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence                 444444444444555555555555444444555555555555555555555555666666666666666665544


Q ss_pred             cCcccccccceEeccCCcCCCCCCcCCCCCCCcceeeCCCCcccc
Q 002826          416 PELKKCRKLVSLSLADNSLTGEIPPSLAELPVLTYLDLSDNNLTG  460 (876)
Q Consensus       416 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  460 (876)
                      ....-...++.+.+..|.++...|..+   ..++.+||+.|.|+.
T Consensus       143 ~~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C  184 (192)
T d1w8aa_         143 HLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC  184 (192)
T ss_dssp             GGHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred             chHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence            322222345666677777776666543   345567777777763

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=3.1e-18  Score=169.36  Aligned_cols=169  Identities=17%  Similarity=0.268  Sum_probs=94.4

Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      ++++..+.++.+.+++.++  ...+.+|++|++++|.  +..++ .+..+++|++|++++|++++..|  +.++++|++|
T Consensus        17 l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~--i~~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L   89 (199)
T d2omxa2          17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG--IKSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDI   89 (199)
T ss_dssp             HHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             HHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCC--CCCcc-ccccCCCcCcCccccccccCccc--ccCCcccccc
Confidence            4455556667776665443  2355667777777776  34442 35666666677776666665432  6667777777


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      ++++|.+. .++.  +.++++|+.|++++|.+...  ..+..+++|+.|++++|++...  ..+..+++|++|++.+|++
T Consensus        90 ~l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l  162 (199)
T d2omxa2          90 LMNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQV  162 (199)
T ss_dssp             ECCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCC
T ss_pred             cccccccc-cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccc
Confidence            77777666 4443  23466666666666666532  2345555566666665555421  1344555555555555555


Q ss_pred             CCCCCcccCCCCcccEEEecCCccc
Q 002826          316 SGDFPDKLWSLPRIKLIRAESNRFS  340 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~~N~l~  340 (876)
                      ++..  .+.++++|+.|++++|+++
T Consensus       163 ~~l~--~l~~l~~L~~L~ls~N~i~  185 (199)
T d2omxa2         163 TDLK--PLANLTTLERLDISSNKVS  185 (199)
T ss_dssp             CCCG--GGTTCTTCCEEECCSSCCC
T ss_pred             cCCc--cccCCCCCCEEECCCCCCC
Confidence            4321  2444444444444444444

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=2.2e-18  Score=170.50  Aligned_cols=98  Identities=22%  Similarity=0.316  Sum_probs=52.2

Q ss_pred             cccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCccccCCCCCCcCCCCCccEEEccCCccccCCcCcccccccce
Q 002826          347 ISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQNSFYGSLPPNFCDSPVMSIINLSQNSISGQIPELKKCRKLVS  426 (876)
Q Consensus       347 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~l~~L~~  426 (876)
                      +..+++|+.|++++|.+...  ..+..+++|+.|++++|++...  +.+..+++|+.|++++|++++. +.+.++++|++
T Consensus       102 l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~  176 (199)
T d2omxa2         102 LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL-KPLANLTTLER  176 (199)
T ss_dssp             GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCE
T ss_pred             cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccCC-ccccCCCCCCE
Confidence            33444444444444444321  1244445555555555554321  2345555666666666666543 34666777777


Q ss_pred             EeccCCcCCCCCCcCCCCCCCccee
Q 002826          427 LSLADNSLTGEIPPSLAELPVLTYL  451 (876)
Q Consensus       427 L~Ls~N~l~~~~p~~~~~l~~L~~L  451 (876)
                      |++++|++++ ++ .++.+++|+.|
T Consensus       177 L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         177 LDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             EECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             EECCCCCCCC-Cc-cccCCCCCCcC
Confidence            7777777764 33 46667776664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=6.4e-18  Score=168.60  Aligned_cols=184  Identities=19%  Similarity=0.265  Sum_probs=91.9

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEec
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDL  237 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  237 (876)
                      ++...++..+.+++.++.  ..+.+|++|++++|.  +..++ .+..+++|++|+|++|+++++.  .+..+++|++|++
T Consensus        25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~--i~~l~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l   97 (210)
T d1h6ta2          25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSD--IKSVQ-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL   97 (210)
T ss_dssp             HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSC--CCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             HHHHHHhCcCccCCccCH--HHhcCccEEECcCCC--CCCch-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence            333445555555544332  234556666666665  33332 2555556666666666665432  2455666666666


Q ss_pred             ccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccCCC
Q 002826          238 SQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGFSG  317 (876)
Q Consensus       238 s~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  317 (876)
                      ++|+|+ .+|.  +..+++|+.|++++|.+..  ...+..+++++.+++++|.+++  +..+..+++|+.+++++|++++
T Consensus        98 ~~n~i~-~l~~--l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2          98 DENKVK-DLSS--LKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CSSCCC-CGGG--GTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC
T ss_pred             cccccc-cccc--ccccccccccccccccccc--cccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            666665 4442  2335566666666665542  2234555555555555555542  2234444555555555555543


Q ss_pred             CCCcccCCCCcccEEEecCCcccccCccccccCCCCCeeecc
Q 002826          318 DFPDKLWSLPRIKLIRAESNRFSGAIPDSISMAAQLEQVQID  359 (876)
Q Consensus       318 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  359 (876)
                      ..  .+.++++|+.|++++|+|++. + .+..+++|++|+|+
T Consensus       171 i~--~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         171 IV--PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             cc--cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            22  144455555555555555432 2 24444455555443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.72  E-value=1.1e-17  Score=166.86  Aligned_cols=164  Identities=20%  Similarity=0.289  Sum_probs=88.2

Q ss_pred             ccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEE
Q 002826          156 LVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSIL  235 (876)
Q Consensus       156 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  235 (876)
                      +.+|++|++++|.++...  .+..+++|++|+|++|+  +..++ .+..+++|++|++++|+++++ | .+.++++|+.|
T Consensus        45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~--i~~l~-~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L  117 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNK--LTDIK-PLANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSL  117 (210)
T ss_dssp             HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSC--CCCCG-GGTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEE
T ss_pred             hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCcc--ccCcc-ccccCcccccccccccccccc-c-ccccccccccc
Confidence            344555555555554321  14445555555555554  23333 244455555555555555542 2 35555666666


Q ss_pred             ecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCccccccceeecccccC
Q 002826          236 DLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINECLNLERFQVQDNGF  315 (876)
Q Consensus       236 ~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  315 (876)
                      ++++|.+. .++.  +..+++++.+++++|.+++  +..+..+++|+++++++|+++++.+  +.++++|++|++++|+|
T Consensus       118 ~l~~~~~~-~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         118 SLEHNGIS-DING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             ECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             cccccccc-cccc--ccccccccccccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCC
Confidence            66666555 3332  2335566666666666553  2334556666666666666654322  56666677777777766


Q ss_pred             CCCCCcccCCCCcccEEEec
Q 002826          316 SGDFPDKLWSLPRIKLIRAE  335 (876)
Q Consensus       316 ~~~~p~~~~~l~~L~~L~L~  335 (876)
                      ++ +| .+.++++|++|+|+
T Consensus       191 ~~-l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         191 SD-LR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CB-CG-GGTTCTTCSEEEEE
T ss_pred             CC-Ch-hhcCCCCCCEEEcc
Confidence            63 33 46677777777765

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=9.9e-21  Score=213.11  Aligned_cols=355  Identities=18%  Similarity=0.223  Sum_probs=193.1

Q ss_pred             cEEEEeecCCCCCccc-ccccccCCCCCCeeecCCCcccc----ccCccccCCCCCCcccCCCcccceeecCCccccccC
Q 002826           75 LTVASINLQSLNLSGE-ISSSVCELSSLSNLNLADNLFNQ----PIPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKI  149 (876)
Q Consensus        75 ~~~~~l~l~~~~l~~~-~~~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~  149 (876)
                      ..+..++++++++++. +.+-+..++++++|+|++|.++.    .++..+..+++|++|+|++|.|+.-     .+. .+
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~-----~~~-~l   75 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV-----GVH-CV   75 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHH-----HHH-HH
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChH-----HHH-HH
Confidence            4688899999999874 34556678999999999999874    3566778899999887777765210     000 11


Q ss_pred             CCccC-CccccceecccccccCCC----cCccccCCCcceEEEccCCCCcCCCC---CCcc-cccCcccEEEecCCCCcc
Q 002826          150 PESIG-SLVNLQVLNLGSNLLSGS----VPFVFGNFSELVVLDLSQNAYLISEI---PSDI-GKLEKLEQLFLQSSGFHG  220 (876)
Q Consensus       150 p~~~~-~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~~~~~~~---p~~~-~~l~~L~~L~L~~n~l~~  220 (876)
                      ...+. ...+|++|+|++|++++.    ++..+..+++|++|+|++|++....+   ...+ ...............+..
T Consensus        76 ~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~  155 (460)
T d1z7xw1          76 LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA  155 (460)
T ss_dssp             HHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBG
T ss_pred             HHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccch
Confidence            22232 235799999999998754    45667888999999999997311000   0111 111223344444443321


Q ss_pred             c----CCccccCCCCCcEEecccCccCCC----CCCccccccccccEEEeccccccCcC----CcccccCCccceeeeec
Q 002826          221 V----IPDSFVGLQSLSILDLSQNNLTGE----VPQSLGSSLLKLVSFDVSQNKLSGSF----PNGICKANGLVNLSLHK  288 (876)
Q Consensus       221 ~----~~~~~~~l~~L~~L~Ls~N~l~~~----ip~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~  288 (876)
                      .    ....+.....++.++++++.+...    ....+.........+++..+.+....    ...+...+.++.+++++
T Consensus       156 ~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~  235 (460)
T d1z7xw1         156 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS  235 (460)
T ss_dssp             GGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCS
T ss_pred             hhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhh
Confidence            1    011233456677788877765411    00111111234556777776654221    12234566777777777


Q ss_pred             ccccc-----cCCCCCccccccceeecccccCCCCC----CcccCCCCcccEEEecCCcccccCcccc-----ccCCCCC
Q 002826          289 NFFNG-----SIPGSINECLNLERFQVQDNGFSGDF----PDKLWSLPRIKLIRAESNRFSGAIPDSI-----SMAAQLE  354 (876)
Q Consensus       289 N~i~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~  354 (876)
                      |.+..     ..+..+.....++.+++++|.+....    ...+...+.++.+++++|.++......+     .....|+
T Consensus       236 n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~  315 (460)
T d1z7xw1         236 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLE  315 (460)
T ss_dssp             SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCC
T ss_pred             ccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccc
Confidence            76542     12223344556777777777665322    2234456667777777777654322222     1234566


Q ss_pred             eeeccCcccCCCCCCcc----ccccCccEEeCCCccccCC----CCCCcC-CCCCccEEEccCCccccC----Cc-Cccc
Q 002826          355 QVQIDNNRFTSSIPQGL----GSVKSLYRFSASQNSFYGS----LPPNFC-DSPVMSIINLSQNSISGQ----IP-ELKK  420 (876)
Q Consensus       355 ~L~L~~N~l~~~~p~~~----~~l~~L~~L~ls~N~l~~~----~~~~~~-~~~~L~~L~Ls~N~l~~~----~~-~~~~  420 (876)
                      .+++++|.++......+    ...++|++|+|++|++++.    ++..+. ..+.|++|+|++|.|+..    +. .+..
T Consensus       316 ~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~  395 (460)
T d1z7xw1         316 SLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA  395 (460)
T ss_dssp             EEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHH
T ss_pred             cccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhc
Confidence            66666666654322222    2234555555555555432    111111 234455555555555421    11 2334


Q ss_pred             ccccceEeccCCcCC
Q 002826          421 CRKLVSLSLADNSLT  435 (876)
Q Consensus       421 l~~L~~L~Ls~N~l~  435 (876)
                      +++|++|+|++|+|+
T Consensus       396 ~~~L~~L~Ls~N~i~  410 (460)
T d1z7xw1         396 NHSLRELDLSNNCLG  410 (460)
T ss_dssp             CCCCCEEECCSSSCC
T ss_pred             CCCCCEEECCCCcCC
Confidence            455555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=7e-21  Score=214.36  Aligned_cols=378  Identities=16%  Similarity=0.108  Sum_probs=208.4

Q ss_pred             CCCeeecCCCcccccc-CccccCCCCCCcccCCCcccceeecCCccccccCCCccCCccccceecccccccCCC----cC
Q 002826          100 SLSNLNLADNLFNQPI-PLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGS----VP  174 (876)
Q Consensus       100 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p  174 (876)
                      +|+.||++.|++++.. ..-+..+++|++|+|++|.|+.-     .+ ..++..+...++|++|+|++|+|+..    +.
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~-----~~-~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~   76 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEA-----RC-KDISSALRVNPALAELNLRSNELGDVGVHCVL   76 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHH-----HH-HHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHH-----HH-HHHHHHHhcCCCCCEEECcCCcCChHHHHHHH
Confidence            5677888888887642 34456667777665555543210     00 12334456677788888888777521    12


Q ss_pred             cccc-CCCcceEEEccCCCCcCC---CCCCcccccCcccEEEecCCCCcccCCcccc-----CCCCCcEEecccCccCCC
Q 002826          175 FVFG-NFSELVVLDLSQNAYLIS---EIPSDIGKLEKLEQLFLQSSGFHGVIPDSFV-----GLQSLSILDLSQNNLTGE  245 (876)
Q Consensus       175 ~~~~-~l~~L~~L~Ls~N~~~~~---~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~  245 (876)
                      ..+. ...+|++|+|++|++...   .++..+..+++|++|+|++|.++......+.     .......+......+...
T Consensus        77 ~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~  156 (460)
T d1z7xw1          77 QGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA  156 (460)
T ss_dssp             HTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGG
T ss_pred             HHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchh
Confidence            2222 234677777777762111   1233455667777777777776543211111     112233333333332210


Q ss_pred             CCCc---cccccccccEEEeccccccCcCCc----cc-ccCCccceeeeecccccccC----CCCCccccccceeecccc
Q 002826          246 VPQS---LGSSLLKLVSFDVSQNKLSGSFPN----GI-CKANGLVNLSLHKNFFNGSI----PGSINECLNLERFQVQDN  313 (876)
Q Consensus       246 ip~~---~~~~l~~L~~L~L~~N~l~~~~~~----~~-~~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L~~N  313 (876)
                      --..   .......++.++++++.+....-.    .+ ........+++..+.+....    ...+.....++.+++.+|
T Consensus       157 ~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n  236 (460)
T d1z7xw1         157 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN  236 (460)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSS
T ss_pred             hhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhc
Confidence            0000   011235677777777765421111    11 11234556666666554211    112345567788888888


Q ss_pred             cCCC-----CCCcccCCCCcccEEEecCCcccccC----ccccccCCCCCeeeccCcccCCCCCCcc-----ccccCccE
Q 002826          314 GFSG-----DFPDKLWSLPRIKLIRAESNRFSGAI----PDSISMAAQLEQVQIDNNRFTSSIPQGL-----GSVKSLYR  379 (876)
Q Consensus       314 ~l~~-----~~p~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~  379 (876)
                      .+..     ..+........++.+++++|.+....    ...+...+.++.+++++|.+++.....+     .....|+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~  316 (460)
T d1z7xw1         237 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLES  316 (460)
T ss_dssp             BCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCE
T ss_pred             cccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccc
Confidence            7642     22334445667888888888776432    2334566778888888888763222211     12346788


Q ss_pred             EeCCCccccCCCCCC----cCCCCCccEEEccCCccccCC-----cCcc-cccccceEeccCCcCCCC----CCcCCCCC
Q 002826          380 FSASQNSFYGSLPPN----FCDSPVMSIINLSQNSISGQI-----PELK-KCRKLVSLSLADNSLTGE----IPPSLAEL  445 (876)
Q Consensus       380 L~ls~N~l~~~~~~~----~~~~~~L~~L~Ls~N~l~~~~-----~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l  445 (876)
                      +++++|.++......    +...++|+.|+|++|+|+...     ..+. ..+.|++|+|++|+|+..    ++..+..+
T Consensus       317 l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~  396 (460)
T d1z7xw1         317 LWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLAN  396 (460)
T ss_dssp             EECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHC
T ss_pred             ccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcC
Confidence            888888776543332    334567888888888876421     1222 356688888888888642    33445567


Q ss_pred             CCcceeeCCCCcccccCCCcc----c-c-cccceEEccCCcccc
Q 002826          446 PVLTYLDLSDNNLTGPIPQGL----Q-N-LKLALFNVSFNKLSG  483 (876)
Q Consensus       446 ~~L~~L~Ls~N~l~~~~p~~~----~-~-l~l~~l~ls~N~l~~  483 (876)
                      ++|++|||++|+|+......+    . + .+++.|++++|.+..
T Consensus       397 ~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         397 HSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             CCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             CCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            888888888888874322222    1 1 146778888877764

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.8e-15  Score=141.95  Aligned_cols=87  Identities=18%  Similarity=0.223  Sum_probs=39.1

Q ss_pred             cCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCC
Q 002826          153 IGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSL  232 (876)
Q Consensus       153 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  232 (876)
                      |.+..+|++|+|++|+|+. ++..+..+++|+.|||++|+  +..++ .|..+++|++|++++|+++.+.+..+..+++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~--i~~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNE--IRKLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSC--CCEEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCC--CCccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3444455555555555552 34444455555555555554  23332 23444444444444444443333333334444


Q ss_pred             cEEecccCccC
Q 002826          233 SILDLSQNNLT  243 (876)
Q Consensus       233 ~~L~Ls~N~l~  243 (876)
                      ++|++++|+|+
T Consensus        90 ~~L~L~~N~i~  100 (162)
T d1a9na_          90 TELILTNNSLV  100 (162)
T ss_dssp             CEEECCSCCCC
T ss_pred             ccceecccccc
Confidence            44444444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=3.3e-15  Score=141.49  Aligned_cols=128  Identities=17%  Similarity=0.197  Sum_probs=87.3

Q ss_pred             ccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCcccccccc
Q 002826          177 FGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLK  256 (876)
Q Consensus       177 ~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~  256 (876)
                      |.+..+|++|||++|+  +..+|..+..+++|+.|+|++|+|+.+  +.|..+++|++|++++|+|+ .+|+.++..+++
T Consensus        14 ~~n~~~lr~L~L~~n~--I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~   88 (162)
T d1a9na_          14 YTNAVRDRELDLRGYK--IPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPD   88 (162)
T ss_dssp             EECTTSCEEEECTTSC--CCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTT
T ss_pred             ccCcCcCcEEECCCCC--CCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCccccccccc
Confidence            5566677777777776  566666566677777777777777754  34677777777777777777 666666666777


Q ss_pred             ccEEEeccccccCcCC-cccccCCccceeeeecccccccCC---CCCccccccceee
Q 002826          257 LVSFDVSQNKLSGSFP-NGICKANGLVNLSLHKNFFNGSIP---GSINECLNLERFQ  309 (876)
Q Consensus       257 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~  309 (876)
                      |++|++++|+|+.... ..+..+++|++|++++|.++....   ..+..+++|+.||
T Consensus        89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            7777777777764322 356677777777777777763321   2466677777765

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.54  E-value=6.8e-15  Score=132.39  Aligned_cols=101  Identities=25%  Similarity=0.401  Sum_probs=55.4

Q ss_pred             eeecCCccccccCCCccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCC
Q 002826          137 VLDLSRNHIEGKIPESIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSS  216 (876)
Q Consensus       137 ~LdL~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n  216 (876)
                      +|||++|+|+ .++ .+.++++|++|+|++|+|+ .+|..|+.+++|++|++++|+  +..+| .+..+++|++|++++|
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~--i~~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA--LENVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC--CCCCG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccc--ccccC-ccccccccCeEECCCC
Confidence            3455555554 222 3556666666666666665 344556666666666666665  33443 3555555555555555


Q ss_pred             CCcccC-CccccCCCCCcEEecccCccC
Q 002826          217 GFHGVI-PDSFVGLQSLSILDLSQNNLT  243 (876)
Q Consensus       217 ~l~~~~-~~~~~~l~~L~~L~Ls~N~l~  243 (876)
                      +++... ...+..+++|++|++++|.++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            555432 234555566666666666655

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.5e-16  Score=164.69  Aligned_cols=61  Identities=13%  Similarity=0.190  Sum_probs=32.5

Q ss_pred             cccccceeecccc-cCCCCCCcccCCCCcccEEEecC-CcccccCccccccCCCCCeeeccCc
Q 002826          301 ECLNLERFQVQDN-GFSGDFPDKLWSLPRIKLIRAES-NRFSGAIPDSISMAAQLEQVQIDNN  361 (876)
Q Consensus       301 ~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N  361 (876)
                      .+++|++|++++| .+++.....+..+++|++|++++ +.+++.....++.+++|+.|+++++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            3455555555553 34444445555555566666655 3455444444555556666666554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.51  E-value=2.7e-14  Score=128.32  Aligned_cols=102  Identities=25%  Similarity=0.308  Sum_probs=74.4

Q ss_pred             ceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEeccc
Q 002826          160 QVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQ  239 (876)
Q Consensus       160 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  239 (876)
                      |+|+|++|+|+ .++ .++++++|++||+++|+  +..+|..+..+++|+.|++++|+|++. | .+..+++|++|++++
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~--l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~   74 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNR--LRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCN   74 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSC--CCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCc--cCcchhhhhhhhccccccccccccccc-C-ccccccccCeEECCC
Confidence            57888888887 444 37888888888888887  567777777888888888888888754 2 477778888888888


Q ss_pred             CccCCCCCC-ccccccccccEEEecccccc
Q 002826          240 NNLTGEVPQ-SLGSSLLKLVSFDVSQNKLS  268 (876)
Q Consensus       240 N~l~~~ip~-~~~~~l~~L~~L~L~~N~l~  268 (876)
                      |+|+ .+|. ..+..+++|++|++++|+++
T Consensus        75 N~i~-~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          75 NRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             SCCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             CccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence            8877 4443 23345677777777777775

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=1.5e-15  Score=158.67  Aligned_cols=195  Identities=18%  Similarity=0.214  Sum_probs=89.1

Q ss_pred             ccCCccccceecccccccCCCcCccccCCCcceEEEccCCCCcCC-CCCCcccccCcccEEEecCC-CCccc-CCccccC
Q 002826          152 SIGSLVNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLIS-EIPSDIGKLEKLEQLFLQSS-GFHGV-IPDSFVG  228 (876)
Q Consensus       152 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~-~~p~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~  228 (876)
                      .+.++++|++|+|++|.+++..+..++.+++|++|+|+++..+.. .+..-+.++++|++|+++++ +++.. ....+..
T Consensus        66 l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~  145 (284)
T d2astb2          66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH  145 (284)
T ss_dssp             HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH
T ss_pred             HHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcc
Confidence            345556666666666666555555566666666666666431110 01111233445555555443 22211 0111111


Q ss_pred             -CCCCcEEecccCccCCCCCCccccccccccEEEeccccccCc-CCcccccCCccceeeeecc-cccccCCCCCcccccc
Q 002826          229 -LQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGS-FPNGICKANGLVNLSLHKN-FFNGSIPGSINECLNL  305 (876)
Q Consensus       229 -l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L  305 (876)
                       .++|+.|++++..                       +.++.. +...+.++++|++|++++| .+++.....+..+++|
T Consensus       146 ~~~~L~~L~l~~~~-----------------------~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L  202 (284)
T d2astb2         146 VSETITQLNLSGYR-----------------------KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  202 (284)
T ss_dssp             SCTTCCEEECCSCG-----------------------GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             cccccchhhhcccc-----------------------cccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence             2344444444321                       112211 1111233455555555543 3444444455555566


Q ss_pred             ceeeccc-ccCCCCCCcccCCCCcccEEEecCCcccc-cCccccccCCCCCeeeccCcccCCCCCCcccc
Q 002826          306 ERFQVQD-NGFSGDFPDKLWSLPRIKLIRAESNRFSG-AIPDSISMAAQLEQVQIDNNRFTSSIPQGLGS  373 (876)
Q Consensus       306 ~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  373 (876)
                      ++|++++ +.+++.....+..+++|+.|+++++ ++. ..+.....   +..|.+..+.+++..+..+++
T Consensus       203 ~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~---lp~L~i~~~~ls~~~~~~~~~  268 (284)
T d2astb2         203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEA---LPHLQINCSHFTTIARPTIGN  268 (284)
T ss_dssp             CEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHH---STTSEESCCCSCCTTCSSCSS
T ss_pred             CEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHh---CccccccCccCCCCCCCccCc
Confidence            6666665 3455444455566666666666665 221 11111122   333445666776665555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=1.8e-15  Score=163.16  Aligned_cols=16  Identities=25%  Similarity=0.389  Sum_probs=9.5

Q ss_pred             CCCccEEEccCCcccc
Q 002826          398 SPVMSIINLSQNSISG  413 (876)
Q Consensus       398 ~~~L~~L~Ls~N~l~~  413 (876)
                      .+.|+.|+|++|++..
T Consensus       301 ~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         301 MPDLLFLELNGNRFSE  316 (344)
T ss_dssp             CTTCCEEECTTSBSCT
T ss_pred             CCCCCEEECCCCcCCC
Confidence            3456666666666654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.44  E-value=1.5e-15  Score=163.61  Aligned_cols=96  Identities=15%  Similarity=0.218  Sum_probs=53.1

Q ss_pred             cccccccCCCCCCeeecCCCccccc----cCccccCCCCCCcccCCCcccceeecCCcccccc-------CCCccCCccc
Q 002826           90 EISSSVCELSSLSNLNLADNLFNQP----IPLHLSQCSSLETLNLSNNLIWVLDLSRNHIEGK-------IPESIGSLVN  158 (876)
Q Consensus        90 ~~~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~LdL~~n~l~~~-------~p~~~~~l~~  158 (876)
                      .+..++.+.+.|+.|+|++|.+...    +...+...++|+.|+++++.+       +.....       +...+...++
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~-------~~~~~~~~~~~~~l~~~l~~~~~   94 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT-------GRVKDEIPEALRLLLQALLKCPK   94 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT-------TSCGGGSHHHHHHHHHHHTTCTT
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcc-------cccccccchHHHHHHHHHhhCCC
Confidence            3455677788888888888887543    334456667777776665432       111111       1122344556


Q ss_pred             cceecccccccCCC----cCccccCCCcceEEEccCCC
Q 002826          159 LQVLNLGSNLLSGS----VPFVFGNFSELVVLDLSQNA  192 (876)
Q Consensus       159 L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~  192 (876)
                      |+.|+|++|.++..    +...+...++|++|++++|.
T Consensus        95 L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~  132 (344)
T d2ca6a1          95 LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG  132 (344)
T ss_dssp             CCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC
T ss_pred             cccccccccccccccccchhhhhcccccchheeccccc
Confidence            66666666666543    12223344555555555554

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=5.8e-15  Score=144.84  Aligned_cols=91  Identities=21%  Similarity=0.319  Sum_probs=47.1

Q ss_pred             CCCCCcccccCcccEEEecCCCCcccCCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCccc
Q 002826          196 SEIPSDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGI  275 (876)
Q Consensus       196 ~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~  275 (876)
                      ..+|..+..+++|++|+|++|+|+.+ + .+.++++|++|+|++|+|+ .+|.. +..+++|++|++++|+|+..  ..+
T Consensus        38 ~~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~-~~~~~~L~~L~l~~N~i~~l--~~~  111 (198)
T d1m9la_          38 EKMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENL-DAVADTLEELWISYNQIASL--SGI  111 (198)
T ss_dssp             CCCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSH-HHHHHHCCEEECSEEECCCH--HHH
T ss_pred             hhhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccc-cccccccccccccccccccc--ccc
Confidence            33444455555555555555555543 2 3555666666666666665 45432 22244566666666655532  224


Q ss_pred             ccCCccceeeeeccccc
Q 002826          276 CKANGLVNLSLHKNFFN  292 (876)
Q Consensus       276 ~~l~~L~~L~L~~N~i~  292 (876)
                      ..+++|+.|+|++|+|+
T Consensus       112 ~~l~~L~~L~L~~N~i~  128 (198)
T d1m9la_         112 EKLVNLRVLYMSNNKIT  128 (198)
T ss_dssp             HHHHHSSEEEESEEECC
T ss_pred             cccccccccccccchhc
Confidence            44555555555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.32  E-value=4.1e-14  Score=138.70  Aligned_cols=118  Identities=20%  Similarity=0.240  Sum_probs=90.7

Q ss_pred             CCccccCCCCCcEEecccCccCCCCCCccccccccccEEEeccccccCcCCcccccCCccceeeeecccccccCCCCCcc
Q 002826          222 IPDSFVGLQSLSILDLSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLSGSFPNGICKANGLVNLSLHKNFFNGSIPGSINE  301 (876)
Q Consensus       222 ~~~~~~~l~~L~~L~Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~  301 (876)
                      .+.++..+++|++|+|++|+|+ .++. + ..+++|++|+|++|+|+ .+|..+..+++|++|++++|+|+.+  ..+..
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~~-l-~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~  113 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KISS-L-SGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEK  113 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCCC-H-HHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHH
T ss_pred             hhhHHhcccccceeECcccCCC-Cccc-c-cCCccccChhhcccccc-ccccccccccccccccccccccccc--ccccc
Confidence            3567888999999999999998 6753 3 56889999999999988 4566666677899999999988854  23777


Q ss_pred             ccccceeecccccCCCCCC-cccCCCCcccEEEecCCcccccCcc
Q 002826          302 CLNLERFQVQDNGFSGDFP-DKLWSLPRIKLIRAESNRFSGAIPD  345 (876)
Q Consensus       302 l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~  345 (876)
                      +++|+.|++++|+|+.... ..+.++++|+.|++++|++....+.
T Consensus       114 l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_         114 LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             cccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence            8888888888888874432 4677888888888888887755443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.32  E-value=1.3e-12  Score=122.34  Aligned_cols=107  Identities=23%  Similarity=0.193  Sum_probs=65.4

Q ss_pred             ccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCCC-cccccCcccEEEecCCCCcccCCccccCCCCCcEEe
Q 002826          158 NLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIPS-DIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLSILD  236 (876)
Q Consensus       158 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  236 (876)
                      ..+.++.++++++ ..|..+..+++|++|++++|+ .+..++. .|.++++|+.|+|++|+|+.+.+++|.++++|++|+
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~-~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~   86 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQ-HLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN   86 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCS-SCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCc-cccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence            3455666666665 455566666677777776554 2444443 366666666666666666666666666666666666


Q ss_pred             cccCccCCCCCCccccccccccEEEecccccc
Q 002826          237 LSQNNLTGEVPQSLGSSLLKLVSFDVSQNKLS  268 (876)
Q Consensus       237 Ls~N~l~~~ip~~~~~~l~~L~~L~L~~N~l~  268 (876)
                      |++|+|+ .+|..++. ..+|++|+|++|.+.
T Consensus        87 Ls~N~l~-~l~~~~~~-~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          87 LSFNALE-SLSWKTVQ-GLSLQELVLSGNPLH  116 (156)
T ss_dssp             CCSSCCS-CCCSTTTC-SCCCCEEECCSSCCC
T ss_pred             ccCCCCc-ccChhhhc-cccccccccCCCccc
Confidence            6666666 56665554 235666666666553

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=6e-12  Score=117.74  Aligned_cols=138  Identities=14%  Similarity=0.101  Sum_probs=63.1

Q ss_pred             eeecccccCCCCCCcccCCCCcccEEEecCC-cccccCccccccCCCCCeeeccCcccCCCCCCccccccCccEEeCCCc
Q 002826          307 RFQVQDNGFSGDFPDKLWSLPRIKLIRAESN-RFSGAIPDSISMAAQLEQVQIDNNRFTSSIPQGLGSVKSLYRFSASQN  385 (876)
Q Consensus       307 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N  385 (876)
                      .++.+++++. ..|..+..+++|+.|++++| .|+.+.+++|.++++|+.|+|++|+|+...|..|..+++|++|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            3444444443 23334444444444444433 244444444555555555555555555444444555555555555555


Q ss_pred             cccCCCCCCcCCCCCccEEEccCCccccC--CcCcccccccceEeccCCcCCCCCCcCCCCCC
Q 002826          386 SFYGSLPPNFCDSPVMSIINLSQNSISGQ--IPELKKCRKLVSLSLADNSLTGEIPPSLAELP  446 (876)
Q Consensus       386 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  446 (876)
                      +|+...+..|... .|+.|+|++|.+.-.  ..++..+.......+..++++...|..+.+++
T Consensus        91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~p  152 (156)
T d2ifga3          91 ALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP  152 (156)
T ss_dssp             CCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCCC
T ss_pred             CCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcCC
Confidence            5543333333322 455666666655311  11222222223333344556655555555554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.43  E-value=3e-07  Score=93.27  Aligned_cols=137  Identities=15%  Similarity=0.045  Sum_probs=98.6

Q ss_pred             CCCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhcc-CccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          587 SSAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIR-HKNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       587 ~~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .+..+|++.+.||++.. +++.+.+|+...........+.+|+..+..+. +--+.+++.++.+++..++||++++|.++
T Consensus        19 ~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~   97 (263)
T d1j7la_          19 VKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC   97 (263)
T ss_dssp             EECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred             EEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccc
Confidence            33455666789999875 66677889886654445566788999988874 43467788888888999999999999888


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhccC----------------------------------------------
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKDY----------------------------------------------  699 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  699 (876)
                      .+.....      ....+++.++++.++.||+..                                              
T Consensus        98 ~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (263)
T d1j7la_          98 SEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELY  171 (263)
T ss_dssp             HHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHH
T ss_pred             ccccccc------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHH
Confidence            6654221      123345566667777777430                                              


Q ss_pred             ----------CCCccccccccCceeeCCCCCeEEccccchh
Q 002826          700 ----------VPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       700 ----------~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                                .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       172 ~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         172 DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                      1247899999999999987666799998654

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=1.4e-08  Score=95.00  Aligned_cols=84  Identities=25%  Similarity=0.207  Sum_probs=37.7

Q ss_pred             cccceecccccccCCCcCccccCCCcceEEEccCCCCcCCCCC---CcccccCcccEEEecCCCCcccCCccccCCCCCc
Q 002826          157 VNLQVLNLGSNLLSGSVPFVFGNFSELVVLDLSQNAYLISEIP---SDIGKLEKLEQLFLQSSGFHGVIPDSFVGLQSLS  233 (876)
Q Consensus       157 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~~~~~~~p---~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  233 (876)
                      ..+..|++.+|..+ .++..+.++++|++|+|++|+  ++.++   ..+..+++|+.|+|++|+|+...+-.+....+|+
T Consensus        42 ~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~--i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~  118 (162)
T d1koha1          42 NIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNR--LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE  118 (162)
T ss_dssp             TCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSC--CCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred             cchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcc--ccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence            33344444444332 333344445555555555554  22221   2233444444444444445443332333334456


Q ss_pred             EEecccCccC
Q 002826          234 ILDLSQNNLT  243 (876)
Q Consensus       234 ~L~Ls~N~l~  243 (876)
                      .|++++|.++
T Consensus       119 ~L~L~~Npl~  128 (162)
T d1koha1         119 ELWLDGNSLS  128 (162)
T ss_dssp             SCCCTTSTTS
T ss_pred             eeecCCCCcC
Confidence            6666666655

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=8.9e-09  Score=96.40  Aligned_cols=55  Identities=33%  Similarity=0.387  Sum_probs=28.6

Q ss_pred             CCCccEEEccCCccccCCc-CcccccccceEeccCCcCCCCCCc-------CCCCCCCcceee
Q 002826          398 SPVMSIINLSQNSISGQIP-ELKKCRKLVSLSLADNSLTGEIPP-------SLAELPVLTYLD  452 (876)
Q Consensus       398 ~~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~~L~  452 (876)
                      +++|+.|||++|.|+...+ .+....+|+.|+|++|.++.....       .+..+|+|+.||
T Consensus        90 l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          90 APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             STTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             CCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            4444444555555544333 223334566666666666644332       245567777665

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.15  E-value=1.8e-06  Score=86.79  Aligned_cols=131  Identities=16%  Similarity=0.059  Sum_probs=89.0

Q ss_pred             CCCCCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccC--ccccceeeEEEeCCeEEEEEEcCCCCCH
Q 002826          588 SAGNGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRH--KNIVKVLGFFHSDESIFLIYEFLQMGSL  665 (876)
Q Consensus       588 ~~g~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL  665 (876)
                      .+.+|.+-+.||+....++..+.+|.....   ....+..|+..++.+..  -.+.++++++.+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344455467899998888888999986543   23457788888888743  3466778888888889999999998665


Q ss_pred             HHHhhccCCcCCHHHHHHHHHHHHHHHHHhhcc-----------------------------------------------
Q 002826          666 GDLICRQDFQLQWSIRLKIAIGVAQGLAYLHKD-----------------------------------------------  698 (876)
Q Consensus       666 ~~~l~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----------------------------------------------  698 (876)
                      .+.      ....   .+.+.++++.++-||+.                                               
T Consensus        94 ~~~------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSS------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTS------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            321      1111   11223444444444421                                               


Q ss_pred             --------CCCCccccccccCceeeCCCCCeEEccccchh
Q 002826          699 --------YVPHLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       699 --------~~~~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                              ..+.++|+|+.|.||+++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                    11258999999999999987667899998653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.33  E-value=0.00054  Score=72.78  Aligned_cols=72  Identities=15%  Similarity=0.167  Sum_probs=45.7

Q ss_pred             CCCCceEEEEEEeC-CCcEEEEEEEecCC-------ccCHHHHHHHHHHHhhcc-C--ccccceeeEEEeCCeEEEEEEc
Q 002826          591 NGGPFGRVYILSLP-SGELIAVKKLVNFG-------CQSSKTLKTEVKTLAKIR-H--KNIVKVLGFFHSDESIFLIYEF  659 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv~e~  659 (876)
                      ++|....||+++.. +++.|+||.-....       .....+...|.+.++.+. +  ..+++++.+  +.+..++|||+
T Consensus        35 g~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~  112 (392)
T d2pula1          35 GDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMED  112 (392)
T ss_dssp             CSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECC
T ss_pred             CCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEec
Confidence            45668999999765 46789999764311       112345667888888773 2  345555544  44556789999


Q ss_pred             CCCCC
Q 002826          660 LQMGS  664 (876)
Q Consensus       660 ~~~gs  664 (876)
                      +++..
T Consensus       113 L~~~~  117 (392)
T d2pula1         113 LSHLK  117 (392)
T ss_dssp             CTTSE
T ss_pred             cCCcc
Confidence            98754

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.26  E-value=1.6e-05  Score=73.98  Aligned_cols=37  Identities=11%  Similarity=0.310  Sum_probs=16.7

Q ss_pred             CCccEEEccCCccccCC-----cCcccccccceEeccCCcCC
Q 002826          399 PVMSIINLSQNSISGQI-----PELKKCRKLVSLSLADNSLT  435 (876)
Q Consensus       399 ~~L~~L~Ls~N~l~~~~-----~~~~~l~~L~~L~Ls~N~l~  435 (876)
                      +.|+.|+|++|.|+..-     ..+...+.|++|+|++|++.
T Consensus        72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred             ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCC
Confidence            34444555555444211     12344455555555555443

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.25  E-value=0.001  Score=68.54  Aligned_cols=68  Identities=10%  Similarity=0.081  Sum_probs=48.6

Q ss_pred             ceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc--ccee-----eEEEeCCeEEEEEEcCCCC
Q 002826          595 FGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI--VKVL-----GFFHSDESIFLIYEFLQMG  663 (876)
Q Consensus       595 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~-----~~~~~~~~~~lv~e~~~~g  663 (876)
                      --.||+++.++|+.|++|+.... ....+++..|...+..|....+  +..+     ..+..++..+.++++++|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            35899999999999999997643 3456788899999988853322  1111     1234467789999999874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.19  E-value=2.1e-05  Score=73.15  Aligned_cols=37  Identities=16%  Similarity=0.121  Sum_probs=17.4

Q ss_pred             ccccceeccccc-ccCCC----cCccccCCCcceEEEccCCC
Q 002826          156 LVNLQVLNLGSN-LLSGS----VPFVFGNFSELVVLDLSQNA  192 (876)
Q Consensus       156 l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~  192 (876)
                      .++|++|+|+++ .++..    +-.++...++|++|+|++|.
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~   55 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTA   55 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSC
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccc
Confidence            355666666653 34311    12233444455555555554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.28  E-value=0.00013  Score=67.33  Aligned_cols=20  Identities=5%  Similarity=-0.042  Sum_probs=12.4

Q ss_pred             CccccCCCCCcEEecccCcc
Q 002826          223 PDSFVGLQSLSILDLSQNNL  242 (876)
Q Consensus       223 ~~~~~~l~~L~~L~Ls~N~l  242 (876)
                      .+.+...++|+.|+++.+..
T Consensus       125 a~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_         125 ANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHhCCCcCEEeCcCCCC
Confidence            34455667777777766643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.20  E-value=0.0064  Score=64.24  Aligned_cols=69  Identities=16%  Similarity=0.308  Sum_probs=46.0

Q ss_pred             CCCCceEEEEEEeCC--------CcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc-cceeeEEEeCCeEEEEEEcCC
Q 002826          591 NGGPFGRVYILSLPS--------GELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI-VKVLGFFHSDESIFLIYEFLQ  661 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  661 (876)
                      +||-.-.+|++..++        ++.|.+++.-.  ........+|..+++.+.-.++ .++++++.+    ..|+||++
T Consensus        51 ~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~  124 (395)
T d1nw1a_          51 KGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP  124 (395)
T ss_dssp             CCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred             CCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEec
Confidence            456689999997654        34566666542  2344566789999998853344 467777643    57999998


Q ss_pred             CCCH
Q 002826          662 MGSL  665 (876)
Q Consensus       662 ~gsL  665 (876)
                      |.++
T Consensus       125 g~~l  128 (395)
T d1nw1a_         125 SRPL  128 (395)
T ss_dssp             EEEC
T ss_pred             cccC
Confidence            7544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.91  E-value=0.00034  Score=64.47  Aligned_cols=42  Identities=10%  Similarity=0.094  Sum_probs=20.8

Q ss_pred             cCCCCCcEEeccc-CccCCCCCCccc---cccccccEEEecccccc
Q 002826          227 VGLQSLSILDLSQ-NNLTGEVPQSLG---SSLLKLVSFDVSQNKLS  268 (876)
Q Consensus       227 ~~l~~L~~L~Ls~-N~l~~~ip~~~~---~~l~~L~~L~L~~N~l~  268 (876)
                      .+.++|++|+|++ +.|+...-..++   ...++|++|+|++|.++
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN   59 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence            4456777777776 345411111111   13455666666666554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.36  E-value=0.019  Score=58.23  Aligned_cols=137  Identities=13%  Similarity=0.045  Sum_probs=72.7

Q ss_pred             CCCCceEEEEEEeCCCcEEEEEEEecCCccCHHHHHHHHHHHhhccCccc--ccee----e--EEEeCCeEEEEEEcCCC
Q 002826          591 NGGPFGRVYILSLPSGELIAVKKLVNFGCQSSKTLKTEVKTLAKIRHKNI--VKVL----G--FFHSDESIFLIYEFLQM  662 (876)
Q Consensus       591 ~~g~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~----~--~~~~~~~~~lv~e~~~~  662 (876)
                      .+|.--+.|+++..+|+ +++|++...  ...+++..|++++..+...++  ....    |  +....+..+.++.+..+
T Consensus        27 ~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g  103 (316)
T d2ppqa1          27 AEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG  103 (316)
T ss_dssp             CC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred             CCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeeccc
Confidence            35646788998876654 789987543  234566778888888853222  1111    1  12234567778887776


Q ss_pred             CCHHH-----------H---hhcc----C----CcCC------------------HHHHHHHHHHHHHHHHHhhcc-CCC
Q 002826          663 GSLGD-----------L---ICRQ----D----FQLQ------------------WSIRLKIAIGVAQGLAYLHKD-YVP  701 (876)
Q Consensus       663 gsL~~-----------~---l~~~----~----~~l~------------------~~~~~~i~~~i~~~l~~LH~~-~~~  701 (876)
                      .....           .   ++..    .    ....                  .......+......+...+.. ...
T Consensus       104 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~  183 (316)
T d2ppqa1         104 MWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPA  183 (316)
T ss_dssp             BCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCE
T ss_pred             ccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccccc
Confidence            43211           0   0000    0    0000                  000111122222222222221 234


Q ss_pred             CccccccccCceeeCCCCCeEEccccchh
Q 002826          702 HLLHRNVKSKNILLDADFEPKLTDFALDR  730 (876)
Q Consensus       702 ~i~H~Dlkp~NIll~~~~~~kl~DfGla~  730 (876)
                      +++|+|+.++||+++.+...-|.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccCCcchhhhhcccccceeEecccccc
Confidence            89999999999999988777899998654